Comparison (group1/group2),ProteinDescriptions,Genes,UniProtIds,Log2 Ratio,Standard Deviation,Pvalue,Qvalue, -log10(qvalue),GO Biological Process,GO Molecular Function,GO Cellular Component,# of Ratios,# Unique Total Peptides,# Unique Total EG.Id,EG.Id
SEN / CTL,Delta-1-pyrroline-5-carboxylate synthase,ALDH18A1,P54886,2.91,1.06,4.17E-02,1.71E-02,1.77E+00,"glutamate metabolic process,proline biosynthetic process,ornithine biosynthetic process,cellular amino acid biosynthetic process,phosphorylation,citrulline biosynthetic process,oxidation-reduction process,L-proline biosynthetic process","glutamate 5-kinase activity,glutamate-5-semialdehyde dehydrogenase activity,ATP binding,delta1-pyrroline-5-carboxylate synthetase activity,identical protein binding,poly(A) RNA binding","cytoplasm,mitochondrion,mitochondrial inner membrane",3,48,83,MIDLIIPR.2|M[Oxi]IDLIIPR.2|LGSAVVTR.2|QALHSGQNQLK.3|QALHSGQNQLK.2|NLNGTLHELLR.3|NLNGTLHELLR.2|DNDSLAAR.2|GKDHVVSDFSEHGSLK.4|GKDHVVSDFSEHGSLK.3|GKDHVVSDFSEHGSLK.2|ILHLLTQEALSIHGVK.4|ILHLLTQEALSIHGVK.3|ILHLLTQEALSIHGVK.2|LAAPLLKR.2|VGMGGMEAK.2|VGM[Oxi]GGMEAK.2|VGMGGM[Oxi]EAK.2|VSGHVITDIVEGK.3|VSGHVITDIVEGK.2|DLEEAEGR.2|YLHENLPIPQR.3|YLHENLPIPQR.2|LNSLAIGLR.2|LRHEILLSQSVR.3|LRHEILLSQSVR.2|FASYLTFSPSEVK.3|FASYLTFSPSEVK.2|VSGHVITDIVEGKK.3|VSGHVITDIVEGKK.2|EAVQLVNTR.2|DHVVSDFSEHGSLK.3|DHVVSDFSEHGSLK.2|GDEC[CAM]GLALGR.2|EEVEDLC[CAM]R.2|SWSNIPFITVPLSR.3|SWSNIPFITVPLSR.2|AEIIHHLADLLTDQRDEILLANKK.5|AEIIHHLADLLTDQRDEILLANKK.4|EMAIPVLEAR.2|LASIVEQVSVLQNQGR.3|LASIVEQVSVLQNQGR.2|AEIIHHLADLLTDQR.3|AEIIHHLADLLTDQR.2|DSKC[CAM]EYPAAC[CAM]NALETLLIHR.4|GPVGLEGLLTTK.2|HEILLSQSVR.2|MLATLEPEQR.2|M[Oxi]LATLEPEQR.2|GIPVMGHSEGIC[CAM]HMYVDSEASVDKVTR.5|LGSAVVTRGDEC[CAM]GLALGR.3|QIAASSQDSVGR.2|VGTFFSEVKPAGPTVEQQGEMAR.4|VGTFFSEVKPAGPTVEQQGEM[Oxi]AR.3|VGTFFSEVKPAGPTVEQQGEMAR.3|FGLGAEVGISTSR.2|KVGTFFSEVKPAGPTVEQQGEM[Oxi]AR.4|KVGTFFSEVKPAGPTVEQQGEMAR.4|KVGTFFSEVKPAGPTVEQQGEMAR.3|GIPVMGHSEGIC[CAM]HMYVDSEASVDK.4|GIPVMGHSEGIC[CAM]HMYVDSEASVDK.3|AEIIHHLADLLTDQRDEILLANK.4|AEIIHHLADLLTDQRDEILLANK.3|C[CAM]EYPAAC[CAM]NALETLLIHR.3|C[CAM]EYPAAC[CAM]NALETLLIHR.2|LIDIFYPGDQQSVTFGTK.3|LIDIFYPGDQQSVTFGTK.2|TPLFDQIIDMLRVEQVK.3|EAVQLVNTREEVEDLC[CAM]R.3|EAVQLVNTREEVEDLC[CAM]R.2|AALWALQGGTSVVIANGTHPK.3|AALWALQGGTSVVIANGTHPK.2|EMMLVTSGAVAFGK.2|EM[Oxi]MLVTSGAVAFGK.2|EMM[Oxi]LVTSGAVAFGK.2|PAGPTVEQQGEMAR.2|TEYGDLELC[CAM]IEVVDNVQDAIDHIHK.4|TPLFDQIIDMLR.2|TPLFDQIIDM[Oxi]LR.2|MNIVPIVNTNDAVVPPAEPNSDLQGVNVISVK.4|M[Oxi]NIVPIVNTNDAVVPPAEPNSDLQGVNVISVK.3|MNIVPIVNTNDAVVPPAEPNSDLQGVNVISVK.3|TDLLIVLSDVEGLFDSPPGSDDAK.3
SEN / CTL,Cyclin-dependent kinase inhibitor 2A;Cyclin-dependent kinase 4 inhibitor B,CDKN2A;CDKN2B,P42771;P42772,2.74,0.54,1.34E-02,6.76E-03,2.17E+00,"G1/S transition of mitotic cell cycle,negative regulation of cell-matrix adhesion,cell cycle arrest,Ras protein signal transduction,negative regulation of cell proliferation,negative regulation of cell growth,negative regulation of NF-kappaB transcription factor activity,positive regulation of smooth muscle cell apoptotic process,senescence-associated heterochromatin focus assembly,negative regulation of phosphorylation,negative regulation of cyclin-dependent protein serine/threonine kinase activity,negative regulation of transcription, DNA-templated,cellular senescence,replicative senescence,positive regulation of macrophage apoptotic process,positive regulation of cellular senescence;regulation of cyclin-dependent protein serine/threonine kinase activity,G2/M transition of mitotic cell cycle,cell cycle arrest,mitotic cell cycle checkpoint,negative regulation of cell proliferation,megakaryocyte differentiation,positive regulation of transforming growth factor beta receptor signaling pathway,cellular response to extracellular stimulus,cellular response to nutrient,negative regulation of phosphorylation,positive regulation of transcription from RNA polymerase II promoter,spleen development,negative regulation of epithelial cell proliferation,negative regulation of protein serine/threonine kinase activity,negative regulation of G1/S transition of mitotic cell cycle","cyclin-dependent protein serine/threonine kinase inhibitor activity,protein binding,protein kinase binding,poly(A) RNA binding,NF-kappaB binding;cyclin-dependent protein serine/threonine kinase inhibitor activity,protein binding,protein kinase binding","nucleus,cytoplasm,cytosol,senescence-associated heterochromatin focus;nucleus,nucleoplasm,cytoplasm,cytosol",3,1,2,EGFLDTLVVLHR.3|EGFLDTLVVLHR.2
SEN / CTL,Endoplasmic reticulum-Golgi intermediate compartment protein 1,ERGIC1,Q969X5,2.67,0.95,1.63E-03,1.16E-03,2.94E+00,ER to Golgi vesicle-mediated transport,protein binding,"Golgi membrane,endoplasmic reticulum membrane,endoplasmic reticulum-Golgi intermediate compartment,membrane,integral component of membrane,endoplasmic reticulum-Golgi intermediate compartment membrane",6,14,19,IIPAIWFR.2|LTSNPLASHDYILK.3|LTSNPLASHDYILK.2|IVPTVYEDKSGKQR.4|HEVGHIDNSMK.3|VPGNFHVSTHSATAQPQNPDM[Oxi]THVIHK.6|VPGNFHVSTHSATAQPQNPDMTHVIHK.6|VPGNFHVSTHSATAQPQNPDM[Oxi]THVIHK.5|VPGNFHVSTHSATAQPQNPDMTHVIHK.5|VPGNFHVSTHSATAQPQNPDMTHVIHK.4|QRYSYQYTVANK.3|YDLSPITVK.2|IVPTVYEDK.2|FEGQFSINK.2|IPLNNGAGC[CAM]R.2|FEGQFSINKVPGNFHVSTHSATAQPQNPDMTHVIHK.7|EYVAYSHTGR.2|YSYQYTVANK.2|LSFGDTLQVQNIHGAFNALGGADR.3
SEN / CTL,Voltage-dependent anion-selective channel protein 3,VDAC3,Q9Y277,2.20,0.99,5.67E-02,2.24E-02,1.65E+00,"anion transport,adenine transport,transmembrane transport,regulation of cilium assembly,regulation of anion transmembrane transport","nucleotide binding,voltage-gated anion channel activity,porin activity","nucleus,mitochondrion,mitochondrial outer membrane,pore complex,extracellular exosome",3,18,27,LTLSALIDGK.2|ASGNLETK.2|LSQNNFALGYK.3|LSQNNFALGYK.2|GYGFGMVK.2|LTLSALIDGKNFSAGGHK.4|VGLGFELEA.2|LTLDTIFVPNTGK.3|LTLDTIFVPNTGK.2|LTLDTIFVPNTGKK.3|LTLDTIFVPNTGKK.2|YKVC[CAM]NYGLTFTQK.3|YKVC[CAM]NYGLTFTQK.2|IETSINLAWTAGSNNTR.3|IETSINLAWTAGSNNTR.2|AADFQLHTHVNDGTEFGGSIYQK.4|AADFQLHTHVNDGTEFGGSIYQK.3|WNTDNTLGTEISWENK.3|WNTDNTLGTEISWENK.2|SC[CAM]SGVEFSTSGHAYTDTGK.3|SC[CAM]SGVEFSTSGHAYTDTGK.2|VC[CAM]NYGLTFTQK.2|VNNASLIGLGYTQTLRPGVK.3|VNNASLIGLGYTQTLRPGVK.2|SKLSQNNFALGYK.2|VNEKIETSINLAWTAGSNNTR.3|VNNASLIGLGYTQTLR.2
SEN / CTL,Protein flightless-1 homolog,FLII,Q13045,2.08,0.40,4.87E-07,8.71E-07,6.06E+00,"transcription, DNA-templated,regulation of transcription, DNA-templated,multicellular organism development,actin cytoskeleton organization,actin filament severing","actin binding,protein binding","nucleoplasm,cytoplasm,microtubule organizing center,brush border,focal adhesion",9,58,77,ADLTALFLPR.2|FVFLLDR.2|GLDIYVWR.2|AC[CAM]SAIHAVNLR.3|AC[CAM]SAIHAVNLR.2|C[CAM]FHAWSAFC[CAM]K.3|C[CAM]FHAWSAFC[CAM]K.2|NQLTSLPSAIC[CAM]K.3|NQLTSLPSAIC[CAM]K.2|GYFAVTEK.2|NAEAVLQSPGLSGK.3|NAEAVLQSPGLSGK.2|LEHLSVSHNNLTTLHGELSSLPSLR.6|LEHLSVSHNNLTTLHGELSSLPSLR.5|LEHLSVSHNNLTTLHGELSSLPSLR.4|LEHLSVSHNNLTTLHGELSSLPSLR.3|NIKLEPVPLKGTSLDPR.4|GMSDVAQEK.2|TNGSALC[CAM]TR.2|HVPEDFWPPQPK.3|HVPEDFWPPQPK.2|KQEESADARAPSGK.3|NYLGAEC[CAM]R.2|GGYFPENVK.2|AVQGAQQPSLYQIR.3|AVQGAQQPSLYQIR.2|LGQELC[CAM]GMLHRPR.3|GAQATLSSTTK.2|GNEQHAFTR.2|GVDLSGNDFK.2|KFESLFPGK.2|LLQSLLDTR.2|QLPAMTALQTLHLR.3|KHVPEDFWPPQPK.3|KLYLNSNKLDFDGLPSGIGK.4|KLYLNSNKLDFDGLPSGIGK.3|LAGASPATVAAAAAAGSGPK.3|LAGASPATVAAAAAAGSGPK.2|MTQQQENPK.2|KAVQGAQQPSLYQIR.3|LVHLQTLVLNGNPLLHAQLR.4|LVHLQTLVLNGNPLLHAQLR.3|LVHLQTLVLNGNPLLHAQLR.2|TGLC[CAM]YLPEELAALQK.3|TGLC[CAM]YLPEELAALQK.2|FKNWDDVLTVDYTR.3|KGNEQHAFTR.2|VGLGLGYLELPQINYK.3|VGLGLGYLELPQINYK.2|SLEGTEAQVFK.2|LDFDGLPSGIGK.2|LAEDILNTMFDTSYSK.3|LAEDILNTMFDTSYSK.2|EGEEATAEAEEK.2|NHLVTLPEAIHFLTEIEVLDVR.4|NHLVTLPEAIHFLTEIEVLDVR.3|AC[CAM]QVYIQHMR.2|LYLNSNKLDFDGLPSGIGK.3|NHLVTLPEAIHFLTEIEVLDVRENPNLVMPPKPADR.6|VPFESEDNQGIVYAWVGR.3|VPFESEDNQGIVYAWVGR.2|FYEADC[CAM]YIVLK.2|VPEC[CAM]LYTLPSLR.2|LAGASPATVAAAAAAGSGPKDPMAR.3|LDDLSVLDLSHNQLTEC[CAM]PR.3|NWDDVLTVDYTR.2|NSGVPDDIFKLDDLSVLDLSHNQLTEC[CAM]PRELENAK.5|NSGVPDDIFKLDDLSVLDLSHNQLTEC[CAM]PRELENAK.4|YWVPVEYEEEEK.2|GKAEITLLVQGQELPEFWEALGGEPSEIKK.4|NSGVPDDIFKLDDLSVLDLSHNQLTEC[CAM]PR.4|LPEEEFGHFYTQDC[CAM]YVFLC[CAM]R.3|ASDPDEAKLAEDILNTMFDTSYSK.3|LTNLEEFMAANNNLELVPESLC[CAM]R.3|AAEWYNIDFSLQNQLR.2|TQSNLPTSLEGLSNLADVDLSC[CAM]NDLTR.3|TQSNLPTSLEGLSNLADVDLSC[CAM]NDLTRVPEC[CAM]LYTLPSLR.4
SEN / CTL,Mitochondrial import receptor subunit TOM70,TOMM70A,O94826,2.08,1.10,7.74E-02,2.89E-02,1.54E+00,"protein targeting to mitochondrion,macroautophagy,protein transmembrane transport","protein binding,protein transmembrane transporter activity","mitochondrion,mitochondrial outer membrane,mitochondrial outer membrane translocase complex,membrane,integral component of membrane,extracellular exosome",3,29,43,ILLDQVEEAVADFDEC[CAM]IR.3|ILLDQVEEAVADFDEC[CAM]IR.2|AIEIDNK.2|GFEEVIK.2|SDEDKDKEGEALEVK.4|SDEDKDKEGEALEVK.3|SDEDKDKEGEALEVK.2|LRPESALAQAQK.3|LRPESALAQAQK.2|YGLKPPTL.2|NVDLSTFYQNR.3|NVDLSTFYQNR.2|GLLQLQWK.2|AAAFEQLQK.2|NREPLMPSPQFIK.3|NREPLM[Oxi]PSPQFIK.3|NREPLMPSPQFIK.2|YMAEALLLR.2|ASPAPGSGHPEGPGAHLDMNSLDR.4|ASPAPGSGHPEGPGAHLDMNSLDR.3|C[CAM]IDLEPDNATTYVHK.3|C[CAM]IDLEPDNATTYVHK.2|GLLQLQWKQDLDRGLELISK.4|WKEVAQDC[CAM]TK.2|ATFYLLIGNANAAKPDLDKVISLK.4|SEMEMAHLYSLC[CAM]DAAHAQTEVAK.4|SYFSSFTDDIISQPMLK.3|SYFSSFTDDIISQPMLK.2|QYMEEENYDK.2|ATFYLLIGNANAAKPDLDK.3|ATFYLLIGNANAAKPDLDK.2|PVEAAVVAAAVPSSGSGVGGGGTAGPGTGGLPR.4|QDLDRGLELISK.2|C[CAM]AEGYALYAQALTDQQQFGK.3|C[CAM]AEGYALYAQALTDQQQFGK.2|SYFSSFTDDIISQPMLKGEK.3|YEQAIQC[CAM]YTEAISLC[CAM]PTEK.3|YEQAIQC[CAM]YTEAISLC[CAM]PTEK.2|AGKYEQAIQC[CAM]YTEAISLC[CAM]PTEK.3|QAYTGNNSSQIQAAM[Oxi]K.2|QAYTGNNSSQIQAAMK.2|LDNKKEC[CAM]LEDVTAVC[CAM]ILEGFQNQQSMLLADK.4|RGSMYMQQQQPLLSTQDFNMAADIDPQNADVYHHR.4
SEN / CTL,Voltage-dependent anion-selective channel protein 1,VDAC1,P21796,2.01,1.02,9.46E-18,7.98E-17,1.61E+01,"behavioral fear response,anion transport,mitochondrial calcium ion transport,apoptotic process,neuron-neuron synaptic transmission,learning,viral process,macroautophagy,epithelial cell differentiation,anion transmembrane transport,regulation of mitophagy,regulation of anion transmembrane transport,negative regulation of reactive oxygen species metabolic process","protein binding,voltage-gated anion channel activity,porin activity,protein kinase binding,protein complex binding,ion channel binding","nucleus,mitochondrion,mitochondrial outer membrane,mitochondrial inner membrane,plasma membrane,synaptic vesicle,membrane,mitochondrial nucleoid,myelin sheath,membrane raft,pore complex,extracellular exosome",48,31,53,LTLSALLDGK.2|YQIDPDAC[CAM]FSAK.2|YQIDPDAC[CAM]FSAK.3|VNNSSLIGLGYTQTLKPGIK.3|VNNSSLIGLGYTQTLKPGIK.2|VNNSSLIGLGYTQTLKPGIK.4|GYGFGLIK.2|KLETAVNLAWTAGNSNTR.3|KLETAVNLAWTAGNSNTR.2|YRWTEYGLTFTEK.3|YRWTEYGLTFTEK.2|LTFDSSFSPNTGKK.3|LTFDSSFSPNTGKK.2|GYGFGLIKLDLK.3|GYGFGLIKLDLK.2|LTLSALLDGKNVNAGGHK.4|LTLSALLDGKNVNAGGHK.3|EHINLGC[CAM]DMDFDIAGPSIR.3|EHINLGC[CAM]DM[Oxi]DFDIAGPSIR.3|EHINLGC[CAM]DMDFDIAGPSIR.2|WTEYGLTFTEK.2|VTQSNFAVGYK.2|TKSENGLEFTSSGSANTETTK.3|TKSENGLEFTSSGSANTETTK.2|VTGSLETK.2|GLKLTFDSSFSPNTGKK.4|GLKLTFDSSFSPNTGKK.3|LTFDSSFSPNTGK.3|LTFDSSFSPNTGK.2|LGLGLEFQA.2|DVFTKGYGFGLIK.3|SRVTQSNFAVGYK.3|SRVTQSNFAVGYK.2|VNKKLETAVNLAWTAGNSNTR.4|VNKKLETAVNLAWTAGNSNTR.3|VNNSSLIGLGYTQTLK.3|VNNSSLIGLGYTQTLK.2|REHINLGC[CAM]DMDFDIAGPSIR.4|REHINLGC[CAM]DMDFDIAGPSIR.3|REHINLGC[CAM]DMDFDIAGPSIR.2|LETAVNLAWTAGNSNTR.3|LETAVNLAWTAGNSNTR.2|SENGLEFTSSGSANTETTK.3|SENGLEFTSSGSANTETTK.2|WNTDNTLGTEITVEDQLAR.3|WNTDNTLGTEITVEDQLAR.2|TKSENGLEFTSSGSANTETTKVTGSLETK.4|GALVLGYEGWLAGYQM[Oxi]NFETAK.3|GALVLGYEGWLAGYQMNFETAK.3|SRVTQSNFAVGYKTDEFQLHTNVNDGTEFGGSIYQK.5|NVNAGGHKLGLGLEFQA.2|TDEFQLHTNVNDGTEFGGSIYQK.3|VTQSNFAVGYKTDEFQLHTNVNDGTEFGGSIYQK.4
SEN / CTL,Growth/differentiation factor 15,GDF15,Q99988,1.96,0.87,1.67E-06,2.64E-06,5.58E+00,"signal transduction,transforming growth factor beta receptor signaling pathway,cell-cell signaling,positive regulation of pathway-restricted SMAD protein phosphorylation,regulation of apoptotic process,regulation of MAPK cascade,cell development,SMAD protein signal transduction,positive regulation of myoblast fusion","cytokine activity,transforming growth factor beta receptor binding,protein binding,growth factor activity","extracellular region,extracellular space,nucleus,cytoplasm,extracellular exosome",12,7,7,ASLEDLGWADWVLSPR.2|LKPDTVPAPC[CAM]C[CAM]VPASYNPMVLIQK.3|AALPEGLPEASR.2|LSPPPSQSDQLLAESSSARPQLELHLRPQAAR.5|ASFPGPSELHSEDSR.3|RYEDLLTR.2|TDTGVSLQTYDDLLAK.2
SEN / CTL,Glutathione peroxidase 1,GPX1,P07203,1.89,1.18,6.59E-03,3.83E-03,2.42E+00,"response to reactive oxygen species,temperature homeostasis,endothelial cell development,negative regulation of inflammatory response to antigenic stimulus,purine nucleotide catabolic process,triglyceride metabolic process,glutathione metabolic process,sensory perception of sound,intrinsic apoptotic signaling pathway in response to oxidative stress,response to xenobiotic stimulus,response to symbiotic bacterium,UV protection,response to selenium ion,response to gamma radiation,protein oxidation,lipoxygenase pathway,response to hydroperoxide,regulation of mammary gland epithelial cell proliferation,cellular response to oxidative stress,regulation of gene expression, epigenetic,vasodilation,response to hydrogen peroxide,hydrogen peroxide catabolic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,skeletal muscle tissue regeneration,regulation of neuron apoptotic process,blood vessel endothelial cell migration,fat cell differentiation,cell redox homeostasis,skeletal muscle fiber development,myoblast proliferation,interaction with symbiont,positive regulation of protein kinase B signaling,heart contraction,angiogenesis involved in wound healing,regulation of proteasomal protein catabolic process,negative regulation of release of cytochrome c from mitochondria,cellular oxidant detoxification,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,positive regulation of fibril organization","glutathione peroxidase activity,SH3 domain binding","cytoplasm,mitochondrion,mitochondrial matrix,cytosol,extracellular exosome,Lewy body",6,17,27,FLVGPDGVPLRR.3|YVRPGGGFEPNFMLFEK.3|YVRPGGGFEPNFM[Oxi]LFEK.3|YVRPGGGFEPNFMLFEK.2|PLAGGEPVSLGSLR.3|PLAGGEPVSLGSLR.2|GLVVLGFPC[CAM]NQFGHQENAK.4|GLVVLGFPC[CAM]NQFGHQENAK.3|GLVVLGFPC[CAM]NQFGHQENAK.2|NEEILNSLK.2|LITWSPVC[CAM]R.2|NDVAWNFEK.2|C[CAM]EVNGAGAHPLFAFLR.3|C[CAM]EVNGAGAHPLFAFLR.2|FLVGPDGVPLR.2|NDVAWNFEKFLVGPDGVPLRR.4|EALPAPSDDATALMTDPK.3|EALPAPSDDATALMTDPK.2|DYTQMNELQR.2|DYTQM[Oxi]NELQR.2|LAAAAAAAQSVYAFSARPLAGGEPVSLGSLR.4|LAAAAAAAQSVYAFSARPLAGGEPVSLGSLR.3|FQTIDIEPDIEALLSQGPSC[CAM]A.3|FQTIDIEPDIEALLSQGPSC[CAM]A.2|GLVVLGFPC[CAM]NQFGHQENAKNEEILNSLK.4|LAAAAAAAQSVYAFSAR.2|RFQTIDIEPDIEALLSQGPSC[CAM]A.3
SEN / CTL,"Isocitrate dehydrogenase [NADP], mitochondrial",IDH2,P48735,1.86,1.17,7.05E-09,1.88E-08,7.73E+00,"carbohydrate metabolic process,glyoxylate cycle,tricarboxylic acid cycle,isocitrate metabolic process,2-oxoglutarate metabolic process","magnesium ion binding,isocitrate dehydrogenase (NADP+) activity,NAD binding","mitochondrion,mitochondrial inner membrane,mitochondrial matrix,peroxisome,cytosol,extracellular exosome",27,38,63,IIWQFIK.2|VC[CAM]VETVESGAMTK.2|VC[CAM]VETVESGAM[Oxi]TK.2|NILGGTVFR.2|GRPTSTNPIASIFAWTR.3|GRPTSTNPIASIFAWTR.2|LVPGWTKPITIGR.3|LVPGWTKPITIGR.2|LILPHVDIQLK.3|LILPHVDIQLK.2|LIDDMVAQVLK.2|LIDDMVAQVLK.3|LIDDM[Oxi]VAQVLK.2|DLAGC[CAM]IHGLSNVK.3|DLAGC[CAM]IHGLSNVK.2|LNEHFLNTTDFLDTIK.3|LNEHFLNTTDFLDTIK.2|AGTFKM[Oxi]VFTPK.3|GKLDGNQDLIR.3|GKLDGNQDLIR.2|FAQMLEK.2|NILGGTVFREPIIC[CAM]K.4|NILGGTVFREPIIC[CAM]K.3|NILGGTVFREPIIC[CAM]K.2|ATDFVADR.2|GLEHRGKLDGNQDLIR.4|GLEHRGKLDGNQDLIR.3|TIEAEAAHGTVTR.3|TIEAEAAHGTVTR.2|HAHGDQYKATDFVADR.4|HAHGDQYKATDFVADR.3|ATDFVADRAGTFK.3|HAHGDQYKATDFVADRAGTFK.5|HAHGDQYKATDFVADRAGTFK.4|FKDIFQEIFDK.3|FKDIFQEIFDK.2|HAHGDQYK.2|IKVAKPVVEMDGDEMTR.4|EKLILPHVDIQLK.3|WPLYMSTK.2|LDGNQDLIR.2|NILGGTVFREPIIC[CAM]KNIPR.4|SSGGFVWAC[CAM]K.2|YFDLGLPNR.2|VAKPVVEMDGDEMTR.3|VAKPVVEM[Oxi]DGDEMTR.3|VAKPVVEMDGDEM[Oxi]TR.3|VAKPVVEM[Oxi]DGDEM[Oxi]TR.3|VAKPVVEMDGDEMTR.2|C[CAM]ATITPDEAR.2|HYREHQKGRPTSTNPIASIFAWTR.5|DIFQEIFDK.2|C[CAM]ATITPDEARVEEFK.3|DQTDDQVTIDSALATQK.3|DQTDDQVTIDSALATQK.2|LNEHFLNTTDFLDTIKSNLDR.4|LNEHFLNTTDFLDTIKSNLDR.3|DLAGC[CAM]IHGLSNVKLNEHFLNTTDFLDTIKSNLDR.6|DLAGC[CAM]IHGLSNVKLNEHFLNTTDFLDTIKSNLDR.5|PVVEMDGDEMTR.2|PVVEM[Oxi]DGDEMTR.2|YFDLGLPNRDQTDDQVTIDSALATQK.4|YFDLGLPNRDQTDDQVTIDSALATQK.3
SEN / CTL,Atlastin-3,ATL3,Q6DD88,1.83,0.87,6.27E-02,2.43E-02,1.62E+00,"endoplasmic reticulum organization,Golgi organization,protein homooligomerization,ER to Golgi vesicle-mediated transport","GTPase activity,protein binding,GTP binding,identical protein binding","endoplasmic reticulum,endoplasmic reticulum membrane,membrane,integral component of membrane,endoplasmic reticulum tubular network",3,31,45,GLLEYFK.2|DQHSFELDEK.3|DQHSFELDEK.2|IYQGEDLPHPK.3|IYQGEDLPHPK.2|ALASILLQDHIR.3|ALASILLQDHIR.2|EHQHEEIQNVR.3|EHQHEEIQNVR.2|DLDVVVVSVAGAFRK.3|ELYENFC[CAM]K.2|LAMDEIFQK.2|EQLQALIPYVLNPSK.3|EQLQALIPYVLNPSK.2|SFILDFMLR.2|DAVVGRPSMDK.2|PGPVQVVLVQK.2|SMLQATAEANNLAAAASAK.3|SMLQATAEANNLAAAASAK.2|NHIHSC[CAM]FSDVTC[CAM]FLLPHPGLQVATSPDFDGKLK.6|NHIHSC[CAM]FSDVTC[CAM]FLLPHPGLQVATSPDFDGKLK.5|LQVKEHQHEEIQNVR.3|PFQTLMFLVR.2|PFQTLM[Oxi]FLVR.2|PYLSPDILEEK.2|YQQELEEEIK.2|LKDIAGEFKEQLQALIPYVLNPSK.4|LKDIAGEFKEQLQALIPYVLNPSK.3|GGSDPETTGIQIWSEVFTVEKPGGKK.4|GGSDPETTGIQIWSEVFTVEKPGGKK.3|NHIHSC[CAM]FSDVTC[CAM]FLLPHPGLQVATSPDFDGK.5|NHIHSC[CAM]FSDVTC[CAM]FLLPHPGLQVATSPDFDGK.4|NHIHSC[CAM]FSDVTC[CAM]FLLPHPGLQVATSPDFDGK.3|GADDAMESSKPGPVQVVLVQK.3|GADDAMESSKPGPVQVVLVQK.2|ALASILLQDHIRDLDVVVVSVAGAFRK.4|LAMDEIFQKPFQTLMFLVR.3|LAM[Oxi]DEIFQKPFQTLMFLVR.3|ESGHSNWLGDPEEPLTGFSWR.3|YQQELEEEIKELYENFC[CAM]K.3|DIAGEFKEQLQALIPYVLNPSK.3|DWSFPYEYSYGLQGGMAFLDKR.3|GGSDPETTGIQIWSEVFTVEKPGGK.3|DIYYNNMEEVC[CAM]GGEKPYLSPDILEEK.3|ELGGAIDFGAAYVLEQASSHIGNSTQATVR.3
SEN / CTL,Spondin-1,SPON1,Q9HCB6,1.72,0.71,3.72E-12,1.73E-11,1.08E+01,"cell adhesion,protein O-linked fucosylation",metal ion binding,"proteinaceous extracellular matrix,extracellular space,endoplasmic reticulum lumen,extracellular matrix",27,12,13,AQWPAWQPLNVR.2|AAPSAEFSVDR.2|VTLSAAPPSYFR.2|GFTLIALR.2|IRPLTSLDHPQSPFYDPEGGSITQVAR.4|IRPLTSLDHPQSPFYDPEGGSITQVAR.3|VVQDLIPWDAGTDSGVTYESPNKPTIPQEK.3|EGYTEFSLR.2|SLAELGDC[CAM]NEDLEQVEK.2|RANHWSAIIGGSHSK.4|QVAELGSPVK.2|RIIYFQDEGSLTK.3|NYVLWEYGGYASEGVK.2
SEN / CTL,Osteoclast-stimulating factor 1,OSTF1,Q92882,1.70,1.26,1.24E-01,4.22E-02,1.38E+00,"ossification,signal transduction","protein binding,SH3 domain binding","intracellular,cytoplasm,extracellular exosome",3,13,23,GYADIVQLLLAK.2|GYADIVQLLLAK.3|AGSTALYWAC[CAM]HGGHK.4|AGSTALYWAC[CAM]HGGHK.3|AGSTALYWAC[CAM]HGGHK.2|LGDTALHAAAWK.3|LGDTALHAAAWK.2|GNLSWLR.2|ALYTFEPR.2|LAFDMATNAAC[CAM]ASLLK.3|LAFDMATNAAC[CAM]ASLLK.2|KLAFDMATNAAC[CAM]ASLLK.3|KLAFDMATNAAC[CAM]ASLLK.2|LAFDMATNAAC[CAM]ASLLKK.3|TGLIPSNYVAEQAESIDNPLHEAAK.4|TGLIPSNYVAEQAESIDNPLHEAAK.3|TGLIPSNYVAEQAESIDNPLHEAAKR.4|GRTGLIPSNYVAEQAESIDNPLHEAAK.4|GRTGLIPSNYVAEQAESIDNPLHEAAK.3|DIVEMLFTQPNIELNQQNK.3|DIVEMLFTQPNIELNQQNK.2|AGSTALYWAC[CAM]HGGHKDIVEMLFTQPNIELNQQNK.5|AGSTALYWAC[CAM]HGGHKDIVEMLFTQPNIELNQQNK.4
SEN / CTL,Actin-related protein 2/3 complex subunit 5-like protein,ARPC5L,Q9BPX5,1.62,0.46,2.33E-02,1.08E-02,1.97E+00,"biological_process,Arp2/3 complex-mediated actin nucleation","molecular_function,actin binding","cytoplasm,Arp2/3 protein complex,focal adhesion,extracellular exosome",3,10,13,ALAVGGLGSIIR.2|RVDIDEFDENK.3|RVDIDEFDENK.2|GFEKPTENSSAVLLQWHEK.4|GFEKPTENSSAVLLQWHEK.3|GFEKPTENSSAVLLQWHEK.2|PTENSSAVLLQWHEK.3|VDIDEFDENK.2|SSEIEQAVQSLDR.2|SSEIEQAVQSLDRNGVDLLMK.3|FVDEQEEAAAAAAEPGPDPSEVDGLLR.3|VDIDEFDENKFVDEQEEAAAAAAEPGPDPSEVDGLLR.4|RVDIDEFDENKFVDEQEEAAAAAAEPGPDPSEVDGLLR.4
SEN / CTL,V-type proton ATPase 116 kDa subunit a isoform 1,ATP6V0A1,Q93050,1.58,0.66,6.90E-02,2.62E-02,1.58E+00,"vacuolar acidification,insulin receptor signaling pathway,ATP synthesis coupled proton transport,ATP hydrolysis coupled proton transport,regulation of macroautophagy,transferrin transport,ion transmembrane transport,vacuolar proton-transporting V-type ATPase complex assembly,phagosome acidification,toxin transport","protein binding,proton-transporting ATPase activity, rotational mechanism,ATPase binding","vacuolar proton-transporting V-type ATPase, V0 domain,cell,nucleoplasm,cytoplasm,Golgi apparatus,plasma membrane,endosome membrane,integral component of membrane,vacuolar proton-transporting V-type ATPase complex,phagocytic vesicle membrane,melanosome,intracellular membrane-bounded organelle,extracellular exosome",3,20,24,LGFVAGVINR.2|RGTEHSGSTVPSILNR.4|FLPFSFEHIR.3|LGFVAGVINRER.3|GTEHSGSTVPSILNR.3|GTEHSGSTVPSILNR.2|NFLELTELKFILR.3|EINTNQEALK.2|SVFIIFFQGDQLKNR.3|IDDLQMVLNQTEDHR.3|VQFRDLNPDVNVFQR.3|AIYHTLNLC[CAM]NIDVTQK.3|AIYHTLNLC[CAM]NIDVTQK.2|RNFLELTELK.2|DLNPDVNVFQR.2|ANIPIMDTGENPEVPFPR.3|ANIPIMDTGENPEVPFPR.2|KANIPIMDTGENPEVPFPR.3|MQTNQTPPTYNK.2|M[Oxi]QTNQTPPTYNK.2|QAEIENPLEDPVTGDYVHK.3|ASLYPC[CAM]PETPQER.2|SVFIIFFQGDQLK.2|C[CAM]LIAEVWC[CAM]PVTDLDSIQFALR.3
SEN / CTL,Rho-related GTP-binding protein RhoC,RHOC,P08134,1.57,0.34,1.13E-04,1.12E-04,3.95E+00,"cytokinesis,small GTPase mediated signal transduction,positive regulation of I-kappaB kinase/NF-kappaB signaling,apical junction assembly,wound healing, spreading of cells,regulation of small GTPase mediated signal transduction,positive regulation of lipase activity,skeletal muscle satellite cell migration","signal transducer activity,protein binding,GTP binding","cytosol,plasma membrane,cleavage furrow,extracellular exosome",6,5,7,ISAFGYLEC[CAM]SAK.2|ISAFGYLEC[CAM]SAK.3|EGVREVFEMATR.3|EGVREVFEMATR.2|QEPVRSEEGRDMANR.4|DLRQDEHTR.2|DQFPEVYVPTVFENYIADIEVDGK.3
SEN / CTL,Clusterin,CLU,P10909,1.57,0.90,2.98E-15,1.79E-14,1.37E+01,"cell morphogenesis,microglial cell activation,release of cytochrome c from mitochondria,platelet degranulation,lipid metabolic process,complement activation,complement activation, classical pathway,response to virus,protein import,central nervous system myelin maintenance,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,negative regulation of protein homooligomerization,positive regulation of tumor necrosis factor production,reverse cholesterol transport,innate immune response,positive regulation of nitric oxide biosynthetic process,protein stabilization,positive regulation of NF-kappaB transcription factor activity,chaperone-mediated protein complex assembly,response to misfolded protein,chaperone-mediated protein folding,microglial cell proliferation,regulation of beta-amyloid clearance,regulation of neuron death,positive regulation of neuron death,positive regulation of beta-amyloid formation,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,negative regulation of beta-amyloid formation,regulation of neuronal signal transduction,positive regulation of tau-protein kinase activity,positive regulation of neurofibrillary tangle assembly,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process","protein binding,ubiquitin protein ligase binding,chaperone binding,misfolded protein binding,ATPase activity","extracellular region,extracellular space,nucleus,cytoplasm,mitochondrion,endoplasmic reticulum,Golgi apparatus,cytosol,cell surface,extracellular matrix,platelet alpha granule lumen,mitochondrial membrane,spherical high-density lipoprotein particle,chromaffin granule,protein complex,perinuclear region of cytoplasm,extracellular exosome,blood microparticle,neurofibrillary tangle,apical dendrite",48,25,42,LFDSDPITVTVPVEVSR.2|LFDSDPITVTVPVEVSR.3|ASSIIDELFQDR.2|ELDESLQVAER.2|ELDESLQVAER.3|VTTVASHTSDSDVPSGVTEVVVK.3|VTTVASHTSDSDVPSGVTEVVVK.2|VTTVASHTSDSDVPSGVTEVVVK.4|EILSVDC[CAM]STNNPSQAK.2|EILSVDC[CAM]STNNPSQAK.3|ASSIIDELFQDRFFTREPQDTYHYLPFSLPHR.5|EPQDTYHYLPFSLPHR.4|C[CAM]REILSVDC[CAM]STNNPSQAK.3|RELDESLQVAER.3|FFTREPQDTYHYLPFSLPHR.5|FFTREPQDTYHYLPFSLPHR.4|FFTREPQDTYHYLPFSLPHR.3|FMETVAEK.2|FM[Oxi]ETVAEK.2|KTLLSNLEEAK.3|KTLLSNLEEAK.2|TLLSNLEEAKK.3|TLLSNLEEAKK.2|KYNELLK.2|KTLLSNLEEAKK.3|KTLLSNLEEAKK.2|QQTHMLDVMQDHFSR.4|QQTHM[Oxi]LDVMQDHFSR.4|QQTHMLDVM[Oxi]QDHFSR.4|QQTHM[Oxi]LDVMQDHFSR.3|QQTHMLDVM[Oxi]QDHFSR.3|QQTHMLDVMQDHFSR.3|LFDSDPITVTVPVEVSRK.4|LFDSDPITVTVPVEVSRK.3|EIQNAVNGVK.2|IDSLLENDR.2|RPHFFFPK.2|TLLSNLEEAK.2|ASSIIDELFQDRFFTR.3|IDSLLENDRQQTHMLDVMQDHFSR.4|YVNKEIQNAVNGVK.2|LANLTQGEDQYYLR.2
SEN / CTL,Voltage-dependent anion-selective channel protein 2,VDAC2,P45880,1.55,1.15,5.40E-04,4.45E-04,3.35E+00,"anion transport,negative regulation of protein polymerization,transmembrane transport,regulation of anion transmembrane transport,negative regulation of intrinsic apoptotic signaling pathway","nucleotide binding,voltage-gated anion channel activity,porin activity","nucleus,mitochondrion,mitochondrial outer membrane,mitochondrial inner membrane,synaptic vesicle,mitochondrial nucleoid,myelin sheath,pore complex,extracellular exosome",18,21,28,YQLDPTASISAK.2|LTLSALVDGK.2|VNNSSLIGVGYTQTLRPGVK.3|VNNSSLIGVGYTQTLRPGVK.2|DIFNKGFGFGLVK.3|GFGFGLVK.2|LTFDTTFSPNTGKK.3|LTFDTTFSPNTGKK.2|VTGTLETK.2|LTLSALVDGKSINAGGHK.4|VGLALELEA.2|NNFAVGYR.2|VNNSSLIGVGYTQTLR.3|VNNSSLIGVGYTQTLR.2|YKWC[CAM]EYGLTFTEK.3|YKWC[CAM]EYGLTFTEK.2|FGIAAKYQLDPTASISAK.3|SC[CAM]SGVEFSTSGSSNTDTGK.3|SC[CAM]SGVEFSTSGSSNTDTGK.2|LTFDTTFSPNTGK.2|PMC[CAM]IPPSYADLGK.2|PM[Oxi]C[CAM]IPPSYADLGK.2|WC[CAM]EYGLTFTEK.2|VC[CAM]EDLDTSVNLAWTSGTNC[CAM]TR.3|VC[CAM]EDLDTSVNLAWTSGTNC[CAM]TR.2|TGDFQLHTNVNDGTEFGGSIYQK.3|WNTDNTLGTEIAIEDQIC[CAM]QGLK.3|SC[CAM]SGVEFSTSGSSNTDTGKVTGTLETK.3
SEN / CTL,"Leucine--tRNA ligase, cytoplasmic",LARS,Q9P2J5,1.51,0.33,1.09E-02,5.72E-03,2.24E+00,"tRNA aminoacylation for protein translation,leucyl-tRNA aminoacylation,regulation of translational fidelity","aminoacyl-tRNA editing activity,leucine-tRNA ligase activity,protein binding,ATP binding","nucleus,cytoplasm,cytosol",3,78,124,WQFLTLR.2|KHFEANNGKLPDNK.4|LHLGHTFSLSK.3|LHLGHTFSLSK.2|TEDIIIK.2|NYMMPAK.2|VIYVLPMLTIK.3|VIYVLPMLTIK.2|VIYVLPM[Oxi]LTIK.2|VDIGDTIIYLVH.3|VDIGDTIIYLVH.2|YRELAVEGMHR.3|DNGVVPVVK.2|IREDC[CAM]C[CAM]PGKPLNVFR.4|IREDC[CAM]C[CAM]PGKPLNVFR.3|YQWGIMK.2|VLEPYPSK.2|NLETFC[CAM]EETRR.3|HFEANNGKLPDNK.3|VIASELGSMPELKK.3|VIASELGSMPELKK.2|FDDPLLGPR.2|ELAVEGMHR.2|RNFEATLGWLQEHAC[CAM]SR.4|RNFEATLGWLQEHAC[CAM]SR.3|VMPFVAMIK.2|VM[Oxi]PFVAMIK.2|VMPFVAM[Oxi]IK.2|EDC[CAM]C[CAM]PGKPLNVFR.3|IHLTENGIR.2|SGPASTFNDR.2|TDKQPLQKPSHC[CAM]TIYVAK.4|NMSYQGFTK.2|NM[Oxi]SYQGFTK.2|FASEAEDKIREDC[CAM]C[CAM]PGKPLNVFR.5|FASEAEDKIREDC[CAM]C[CAM]PGKPLNVFR.4|FASEAEDKIREDC[CAM]C[CAM]PGKPLNVFR.3|YFVTFPYPYMNGR.3|YFVTFPYPYMNGR.2|YFVTFPYPYM[Oxi]NGR.2|VIYVLPMLTIKEDK.3|VIYVLPMLTIKEDK.2|C[CAM]EFAVGYQR.2|MIDAGDALIYMEPEK.3|MIDAGDALIYMEPEK.2|M[Oxi]IDAGDALIYMEPEK.2|MIDAGDALIYM[Oxi]EPEK.2|IEPGVSVSLVNPQPSNGHFSTK.4|IEPGVSVSLVNPQPSNGHFSTK.3|IEPGVSVSLVNPQPSNGHFSTK.2|NYPPWQHTTLSVLR.3|NYPPWQHTTLSVLR.2|TGFFEFQAAK.2|PSHC[CAM]TIYVAK.2|QGDNC[CAM]DSIIR.2|ANGHLLLNSEK.2|SLGLSDEEIVK.2|TPISEHAVFNVDLMSK.3|TPISEHAVFNVDLM[Oxi]SK.3|TPISEHAVFNVDLMSK.2|FSEAEHWLDYFPPLAIQDLK.4|FSEAEHWLDYFPPLAIQDLK.3|DGQPC[CAM]MDHDR.2|EMVANWDSLR.2|GKYFVTFPYPYMNGR.3|LYTWVEWVK.2|EKLDQLKQEFEFWYPVDLR.4|EKLDQLKQEFEFWYPVDLR.3|EVWDYVFFK.2|KIHLTENGIRVDIGDTIIYLVH.4|VFASELNAGIIK.2|VFEVNASNLEK.2|AVLMENIVYLTNSLELEHIEVK.4|AVLM[Oxi]ENIVYLTNSLELEHIEVK.3|AVLMENIVYLTNSLELEHIEVK.3|C[CAM]C[CAM]LFPFGLHC[CAM]TGMPIK.3|C[CAM]C[CAM]LFPFGLHC[CAM]TGM[Oxi]PIK.3|C[CAM]C[CAM]LFPFGLHC[CAM]TGMPIK.2|FSEAEHWLDYFPPLAIQDLKR.4|FSEAEHWLDYFPPLAIQDLKR.3|NFEATLGWLQEHAC[CAM]SR.3|NFEATLGWLQEHAC[CAM]SR.2|SFITTDVNPYYDSFVR.3|SFITTDVNPYYDSFVR.2|GTGVVTSVPSDSPDDIAALR.3|GTGVVTSVPSDSPDDIAALR.2|NLETFC[CAM]EETR.2|LALADAGDTVEDANFVEAMADAGILR.4|LALADAGDTVEDANFVEAMADAGILR.3|LALADAGDTVEDANFVEAM[Oxi]ADAGILR.3|VSGKDLVPNHLSYYLYNHVAMWPEQSDKWPTAVR.6|VSGKDLVPNHLSYYLYNHVAMWPEQSDKWPTAVR.5|ILDLQLEFDEK.2|VIASELGSM[Oxi]PELK.2|VIASELGSMPELK.2|ELMGEEILGASLSAPLTSYK.3|ELM[Oxi]GEEILGASLSAPLTSYK.3|ELM[Oxi]GEEILGASLSAPLTSYK.2|ELMGEEILGASLSAPLTSYK.2|DGQPC[CAM]MDHDRQTGEGVGPQEYTLLK.4|VFASELNAGIIKTDQNYEK.3|DLVPNHLSYYLYNHVAM[Oxi]WPEQSDKWPTAVR.5|DLVPNHLSYYLYNHVAMWPEQSDKWPTAVR.5|DLVPNHLSYYLYNHVAMWPEQSDKWPTAVR.4|GFYEGIMLVDGFK.2|GFYEGIM[Oxi]LVDGFK.2|LDQLKQEFEFWYPVDLR.3|SLGLSDEEIVKFSEAEHWLDYFPPLAIQDLKR.5|STGNFLTLTQAIDK.2|SGPASTFNDRVFASELNAGIIK.3|STGNFLTLTQAIDKFSADGM[Oxi]R.3|STGNFLTLTQAIDKFSADGMR.3|STGNFLTLTQAIDKFSADGMR.2|EDKGTGVVTSVPSDSPDDIAALR.3|EDKGTGVVTSVPSDSPDDIAALR.2|NIFLVAATLRPETMFGQTNC[CAM]WVRPDMK.4|QEFEFWYPVDLR.2|QTGEGVGPQEYTLLK.2|SLGLSDEEIVKFSEAEHWLDYFPPLAIQDLK.4|EIELYGC[CAM]PPDFPDEEEEEEETSVKTEDIIIK.4|EIELYGC[CAM]PPDFPDEEEEEEETSVK.3|DLVPNHLSYYLYNHVAMWPEQSDK.3|YGIRDDMVLPFEPVPVIEIPGFGNLSAVTIC[CAM]DELK.4|YIGFETVNGDIFIC[CAM]TQK.2
SEN / CTL,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",ACADM,P11310,1.47,0.43,2.99E-02,1.32E-02,1.88E+00,"fatty acid beta-oxidation,carnitine metabolic process, CoA-linked,fatty acid beta-oxidation using acyl-CoA dehydrogenase,carnitine biosynthetic process,medium-chain fatty acid metabolic process,medium-chain fatty acid catabolic process,lipid homeostasis,oxidation-reduction process","fatty-acyl-CoA binding,acyl-CoA dehydrogenase activity,electron carrier activity,identical protein binding,flavin adenine dinucleotide binding,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,medium-chain-acyl-CoA dehydrogenase activity","nucleus,mitochondrion,mitochondrial matrix,axon,extracellular exosome,peroxisome",3,33,52,ANWYFLLAR.2|GIVFEDVKVPK.3|GIVFEDVKVPK.2|ELNMGQR.2|KGDEYIINGQK.3|KGDEYIINGQK.2|VAM[Oxi]GAFDK.2|GIVFEDVK.2|MWITNGGK.2|ALDEATKYALER.3|ALDEATKYALER.2|DAKIYQIYEGTSQIQR.4|DAKIYQIYEGTSQIQR.3|DAKIYQIYEGTSQIQR.2|TRPVVAAGAVGLAQR.3|TRPVVAAGAVGLAQR.2|AAWEVDSGR.2|AFTGFIVEADTPGIQIGRK.4|AFTGFIVEADTPGIQIGRK.3|AFTGFIVEADTPGIQIGRK.2|NTYYASIAK.2|IYQIYEGTSQIQR.3|IYQIYEGTSQIQR.2|AAWEVDSGRR.2|SDPDPKAPANK.2|TGEYPVPLIR.2|VAM[Oxi]GAFDKTRPVVAAGAVGLAQR.4|VAM[Oxi]GAFDKTRPVVAAGAVGLAQR.3|FAREEIIPVAAEYDK.3|FAREEIIPVAAEYDK.2|PVVAAGAVGLAQR.2|ENVLIGDGAGFK.2|GIVFEDVKVPKENVLIGDGAGFK.4|GIVFEDVKVPKENVLIGDGAGFK.3|AFTGFIVEADTPGIQIGR.3|AFTGFIVEADTPGIQIGR.2|KFAREEIIPVAAEYDK.3|AFAGDIANQLATDAVQILGGNGFNTEYPVEK.5|AFAGDIANQLATDAVQILGGNGFNTEYPVEK.4|AFAGDIANQLATDAVQILGGNGFNTEYPVEK.3|QREPGLGFSFEFTEQQK.3|QREPGLGFSFEFTEQQK.2|EEIIPVAAEYDK.2|LLVEHQAISFMLAEMAM[Oxi]K.3|LLVEHQAISFMLAEMAMK.3|QREPGLGFSFEFTEQQKEFQATAR.4|QREPGLGFSFEFTEQQKEFQATAR.3|FAREEIIPVAAEYDKTGEYPVPLIR.4|EEIIPVAAEYDKTGEYPVPLIR.3|EPGLGFSFEFTEQQK.2|MTEEPLMC[CAM]AYC[CAM]VTEPGAGSDVAGIK.3|M[Oxi]TEEPLMC[CAM]AYC[CAM]VTEPGAGSDVAGIK.3
SEN / CTL,Small nuclear ribonucleoprotein-associated proteins B and B';Small nuclear ribonucleoprotein-associated protein N,SNRPB;SNRPN,P14678;P63162,1.46,0.88,8.73E-02,3.21E-02,1.49E+00,"spliceosomal snRNP assembly,mRNA splicing, via spliceosome,termination of RNA polymerase II transcription,protein methylation,histone mRNA metabolic process,RNA splicing,nuclear import;mRNA splicing, via spliceosome,RNA splicing,response to hormone","protein binding,U2 snRNA binding,poly(A) RNA binding,telomerase RNA binding,histone pre-mRNA DCP binding;RNA binding,protein binding","nucleoplasm,spliceosomal complex,U5 snRNP,U7 snRNP,U1 snRNP,U2 snRNP,U4 snRNP,U12-type spliceosomal complex,cytosol,small nuclear ribonucleoprotein complex,methylosome,SMN-Sm protein complex,U4/U6 x U5 tri-snRNP complex,extracellular exosome,U2-type prespliceosome,catalytic step 2 spliceosome,histone pre-mRNA 3'end processing complex,telomerase holoenzyme complex;spliceosomal complex,U5 snRNP,U1 snRNP,U2 snRNP,U4 snRNP,cytoplasm,small nuclear ribonucleoprotein complex,U4/U6 x U5 tri-snRNP complex,U2-type prespliceosome,catalytic step 2 spliceosome",3,1,1,VLGLVLLR.2
SEN / CTL,Tumor necrosis factor alpha-induced protein 8,TNFAIP8,O95379,1.45,0.20,8.39E-03,4.65E-03,2.33E+00,"apoptotic process,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process","protein binding,cysteine-type endopeptidase inhibitor activity involved in apoptotic process",cytoplasm,3,6,10,SIATTLIDDTSSEVLDELYR.3|SIATTLIDDTSSEVLDELYR.2|EVATDVFNSK.2|EMLHQIIQR.2|VNNVFDHFSDC[CAM]EFLAALYNPFGNFKPHLQK.6|VNNVFDHFSDC[CAM]EFLAALYNPFGNFKPHLQK.5|VNNVFDHFSDC[CAM]EFLAALYNPFGNFKPHLQK.4|VNNVFDHFSDC[CAM]EFLAALYNPFGNFKPHLQK.3|NNQFNQDELALMEK.2|VNNVFDHFSDC[CAM]EFLAALYNPFGNFK.3
SEN / CTL,Hemoglobin subunit alpha,HBA1,P69905,1.44,1.22,5.19E-04,4.31E-04,3.37E+00,"receptor-mediated endocytosis,positive regulation of cell death,oxygen transport,bicarbonate transport,response to hydrogen peroxide,hydrogen peroxide catabolic process,protein heterooligomerization,cellular oxidant detoxification","oxygen transporter activity,iron ion binding,protein binding,oxygen binding,heme binding,peroxidase activity,haptoglobin binding","extracellular region,cytosol,hemoglobin complex,membrane,cytosolic small ribosomal subunit,haptoglobin-hemoglobin complex,extracellular exosome,endocytic vesicle lumen,blood microparticle",12,23,78,VGAHAGEYGAEALER.3|VGAHAGEYGAEALER.2|MFLSFPTTK.2|M[Oxi]FLSFPTTK.2|TYFPHFDLSHGSAQVK.4|TYFPHFDLSHGSAQVK.3|TYFPHFDLSHGSAQVK.2|FLASVSTVLTSK.3|FLASVSTVLTSK.2|VLSPADKTNVKAAWGK.4|VLSPADKTNVKAAWGK.3|TYFPHFDLSHGSAQVKGHGK.5|TYFPHFDLSHGSAQVKGHGK.4|TYFPHFDLSHGSAQVKGHGK.3|TYFPHFDLSHGSAQVKGHGKK.5|TYFPHFDLSHGSAQVKGHGKK.4|TYFPHFDLSHGSAQVKGHGKK.3|VADALTNAVAHVDDM[Oxi]PNALSALSDLHAHK.6|VADALTNAVAHVDDMPNALSALSDLHAHK.6|VADALTNAVAHVDDMPNALSALSDLHAHK.5|VADALTNAVAHVDDM[Oxi]PNALSALSDLHAHK.5|VADALTNAVAHVDDM[Oxi]PNALSALSDLHAHK.4|VADALTNAVAHVDDMPNALSALSDLHAHK.4|VADALTNAVAHVDDM[Oxi]PNALSALSDLHAHK.3|VADALTNAVAHVDDMPNALSALSDLHAHK.3|LLSHC[CAM]LLVTLAAHLPAEFTPAVHASLDK.6|LLSHC[CAM]LLVTLAAHLPAEFTPAVHASLDK.5|LLSHC[CAM]LLVTLAAHLPAEFTPAVHASLDK.4|LLSHC[CAM]LLVTLAAHLPAEFTPAVHASLDK.3|AAWGKVGAHAGEYGAEALER.4|AAWGKVGAHAGEYGAEALER.3|VGAHAGEYGAEALERMFLSFPTTK.5|VGAHAGEYGAEALERM[Oxi]FLSFPTTK.5|VGAHAGEYGAEALERMFLSFPTTK.4|VGAHAGEYGAEALERM[Oxi]FLSFPTTK.4|VGAHAGEYGAEALERMFLSFPTTK.3|VGAHAGEYGAEALERM[Oxi]FLSFPTTK.3|AAWGKVGAHAGEYGAEALERM[Oxi]FLSFPTTK.6|AAWGKVGAHAGEYGAEALERM[Oxi]FLSFPTTK.5|AAWGKVGAHAGEYGAEALERMFLSFPTTK.5|AAWGKVGAHAGEYGAEALERM[Oxi]FLSFPTTK.4|AAWGKVGAHAGEYGAEALERMFLSFPTTK.4|AAWGKVGAHAGEYGAEALERMFLSFPTTK.3|FLASVSTVLTSKYR.3|KVADALTNAVAHVDDM[Oxi]PNALSALSDLHAHK.6|KVADALTNAVAHVDDMPNALSALSDLHAHK.6|KVADALTNAVAHVDDM[Oxi]PNALSALSDLHAHK.5|KVADALTNAVAHVDDMPNALSALSDLHAHK.5|KVADALTNAVAHVDDM[Oxi]PNALSALSDLHAHK.4|KVADALTNAVAHVDDMPNALSALSDLHAHK.4|KVADALTNAVAHVDDM[Oxi]PNALSALSDLHAHK.3|KVADALTNAVAHVDDMPNALSALSDLHAHK.3|LRVDPVNFK.2|VADALTNAVAHVDDMPNALSALSDLHAHKLR.6|VADALTNAVAHVDDM[Oxi]PNALSALSDLHAHKLR.6|VADALTNAVAHVDDMPNALSALSDLHAHKLR.5|VADALTNAVAHVDDM[Oxi]PNALSALSDLHAHKLR.5|VADALTNAVAHVDDMPNALSALSDLHAHKLR.4|VADALTNAVAHVDDM[Oxi]PNALSALSDLHAHKLR.4|VADALTNAVAHVDDM[Oxi]PNALSALSDLHAHKLR.3|KVADALTNAVAHVDDMPNALSALSDLHAHKLR.6|KVADALTNAVAHVDDM[Oxi]PNALSALSDLHAHKLR.6|KVADALTNAVAHVDDM[Oxi]PNALSALSDLHAHKLR.5|KVADALTNAVAHVDDMPNALSALSDLHAHKLR.5|MFLSFPTTKTYFPHFDLSHGSAQVK.5|MFLSFPTTKTYFPHFDLSHGSAQVK.4|M[Oxi]FLSFPTTKTYFPHFDLSHGSAQVK.4|VADALTNAVAHVDDM[Oxi]PNALSALSDLHAHKLRVDPVNFK.7|VADALTNAVAHVDDMPNALSALSDLHAHKLRVDPVNFK.6|VADALTNAVAHVDDM[Oxi]PNALSALSDLHAHKLRVDPVNFK.5|VLSPADKTNVK.2|LLSHC[CAM]LLVTLAAHLPAEFTPAVHASLDKFLASVSTVLTSKYR.7|LLSHC[CAM]LLVTLAAHLPAEFTPAVHASLDKFLASVSTVLTSKYR.6|LLSHC[CAM]LLVTLAAHLPAEFTPAVHASLDKFLASVSTVLTSKYR.5|LLSHC[CAM]LLVTLAAHLPAEFTPAVHASLDKFLASVSTVLTSKYR.4|LLSHC[CAM]LLVTLAAHLPAEFTPAVHASLDKFLASVSTVLTSK.6|LLSHC[CAM]LLVTLAAHLPAEFTPAVHASLDKFLASVSTVLTSK.5|VGAHAGEYGAEALERMFLSFPTTKTYFPHFDLSHGSAQVK.6
SEN / CTL,Creatine kinase M-type,CKM,P06732,1.43,0.29,1.35E-02,6.80E-03,2.17E+00,"creatine metabolic process,phosphorylation,phosphocreatine biosynthetic process","creatine kinase activity,protein binding,ATP binding",cytosol,3,5,6,GGDDLDPNYVLSSR.2|LGSSEVEQVQLVVDGVK.3|GQSIDDMIPAQK.2|SMTEKEQQQLIDDHFLFDKPVSPLLLASGMAR.5|SMTEKEQQQLIDDHFLFDKPVSPLLLASGMAR.4|LSVEALNSLTGEFK.2
SEN / CTL,High mobility group protein HMG-I/HMG-Y,HMGA1,P17096,1.40,1.14,9.53E-03,5.12E-03,2.29E+00,"DNA unwinding involved in DNA replication,nucleosome disassembly,regulation of transcription, DNA-templated,transcription from RNA polymerase II promoter,protein complex assembly,negative regulation of cell proliferation,response to virus,negative regulation of chromatin silencing,senescence-associated heterochromatin focus assembly,negative regulation of transcription, DNA-templated,positive regulation of transcription, DNA-templated,positive regulation of transcription from RNA polymerase II promoter,nuclear transport,establishment of integrated proviral latency,oncogene-induced cell senescence,positive regulation of cellular senescence","transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,DNA binding,AT DNA binding,chromatin binding,transcription factor activity, sequence-specific DNA binding,protein binding,transcription factor binding,enzyme binding,ligand-dependent nuclear receptor transcription coactivator activity,retinoic acid receptor binding,peroxisome proliferator activated receptor binding,retinoid X receptor binding","nucleus,nucleoplasm,transcription factor complex,cytosol,focal adhesion,senescence-associated heterochromatin focus,RNA polymerase II transcription factor complex",12,9,13,KLEKEEEEGISQESSEEEQ.3|KQPPVSPGTALVGSQKEPSEVPTPK.4|KQPPVSPGTALVGSQKEPSEVPTPK.3|KQPPVSPGTALVGSQKEPSEVPTPK.5|SSQPLASKQEK.3|SSQPLASKQEK.2|SSQPLASK.2|EPSEVPTPK.2|KQPPVSPGTALVGSQK.3|KQPPVSPGTALVGSQK.2|SSQPLASKQEKDGTEK.3|QPPVSPGTALVGSQK.2|QPPVSPGTALVGSQKEPSEVPTPK.3
SEN / CTL,Protein-glutamine gamma-glutamyltransferase 2,TGM2,P21980,1.38,0.93,1.00E-20,1.23E-19,1.89E+01,"blood vessel remodeling,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,negative regulation of endoplasmic reticulum calcium ion concentration,positive regulation of apoptotic process,positive regulation of I-kappaB kinase/NF-kappaB signaling,apoptotic cell clearance,positive regulation of cell adhesion,positive regulation of smooth muscle cell proliferation,positive regulation of inflammatory response,protein homooligomerization,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,positive regulation of mitochondrial calcium ion concentration,branching involved in salivary gland morphogenesis,salivary gland cavitation","protein-glutamine gamma-glutamyltransferase activity,protein binding,GTP binding,protein domain specific binding,metal ion binding","mitochondrion,endoplasmic reticulum,cytosol,focal adhesion,extracellular matrix,intrinsic component of plasma membrane,extracellular exosome",90,46,73,SVPLC[CAM]ILYEK.2|RGQPFWLTLHFEGR.3|RGQPFWLTLHFEGR.4|ALLVEPVINSYLLAER.3|ALLVEPVINSYLLAER.2|YLLNLNLEPFSEK.2|YLLNLNLEPFSEK.3|LVVNFESDKLK.3|LVVNFESDKLK.2|WDNNYGDGVSPMSWIGSVDILR.3|GQPFWLTLHFEGR.3|GQPFWLTLHFEGR.2|SEGTYC[CAM]C[CAM]GPVPVR.2|VVSGMVNC[CAM]NDDQGVLLGR.3|VVSGMVNC[CAM]NDDQGVLLGR.2|VVSGM[Oxi]VNC[CAM]NDDQGVLLGR.3|VVSGM[Oxi]VNC[CAM]NDDQGVLLGR.2|VVTNYNSAHDQNSNLLIEYFR.3|VVTNYNSAHDQNSNLLIEYFR.4|YRDC[CAM]LTESNLIK.3|YRDC[CAM]LTESNLIK.2|VKYGQC[CAM]WVFAAVAC[CAM]TVLR.3|VKYGQC[CAM]WVFAAVAC[CAM]TVLR.2|DLYLENPEIK.2|WDNNYGDGVSPMSWIGSVDILRR.3|TVSYNGILGPEC[CAM]GTK.2|TVSYNGILGPEC[CAM]GTK.3|ALLVEPVINSYLLAERDLYLENPEIK.4|ALLVEPVINSYLLAERDLYLENPEIK.3|NYEASVDSLTFSVVTGPAPSQEAGTK.3|YGQC[CAM]WVFAAVAC[CAM]TVLR.3|YGQC[CAM]WVFAAVAC[CAM]TVLR.2|TVEIPDPVEAGEEVKVR.3|TVEIPDPVEAGEEVKVR.2|MDLLPLHMGLHK.3|MDLLPLHM[Oxi]GLHK.3|MDLLPLHMGLHK.2|AIKEGDLSTKYDAPFVFAEVNADVVDWIQQDDGSVHK.5|SSPVYVGR.2|LAEKEETGMAMR.3|LAEKEETGM[Oxi]AMR.3|LAEKEETGM[Oxi]AM[Oxi]R.3|LAEKEETGMAMR.2|C[CAM]DLELETNGRDHHTADLC[CAM]R.4|C[CAM]DLELETNGRDHHTADLC[CAM]R.5|C[CAM]DLELETNGRDHHTADLC[CAM]R.3|SVGRDEREDITHTYK.4|DLYLENPEIKIR.3|EDITHTYK.2|RSSPVYVGR.2|EDITHTYKYPEGSSEEREAFTR.5|EDITHTYKYPEGSSEEREAFTR.4|LVVNFESDK.2|YPEGSSEER.2|TVEIPDPVEAGEEVK.3|TVEIPDPVEAGEEVK.2|VRMDLLPLHMGLHK.3|YPEGSSEEREAFTR.3|DHHTADLC[CAM]R.2|NEFGEIQGDK.2|DC[CAM]LTESNLIK.2|C[CAM]DLELETNGR.2|ALLVEPVINSYLLAERDLYLENPEIKIR.5|ALLVEPVINSYLLAERDLYLENPEIKIR.4|YDAPFVFAEVNADVVDWIQQDDGSVHK.4|YDAPFVFAEVNADVVDWIQQDDGSVHK.3|VRALLVEPVINSYLLAERDLYLENPEIK.4|LVAEVSLQNPLPVALEGC[CAM]TFTVEGAGLTEEQK.4|LVAEVSLQNPLPVALEGC[CAM]TFTVEGAGLTEEQK.3|IRVGQSMNMGSDFDVFAHITNNTAEEYVC[CAM]R.4|EGDLSTKYDAPFVFAEVNADVVDWIQQDDGSVHK.4|QEYVLTQQGFIYQGSAK.2|VGQSMNMGSDFDVFAHITNNTAEEYVC[CAM]R.3
SEN / CTL,Tubulin beta-1 chain,TUBB1,Q9H4B7,1.37,0.46,3.60E-02,1.52E-02,1.82E+00,spindle assembly,"GTPase activity,structural constituent of cytoskeleton,GTP binding","cytoplasm,microtubule,extracellular exosome",3,21,38,NSSC[CAM]FVEWIPNNVK.2|NSSC[CAM]FVEWIPNNVK.3|IMNSFSVMPSPK.3|IMNSFSVMPSPK.2|GASALQLER.2|GHYTEGAELIENVLEVVR.4|GHYTEGAELIENVLEVVR.3|GHYTEGAELIENVLEVVR.2|NTMAAC[CAM]DLR.2|ALSVAELTQQMFDAR.3|ALSVAELTQQMFDAR.2|YLTVAC[CAM]IFR.2|VSEHFSAMFK.2|EIVHIQIGQC[CAM]GNQIGAK.3|EIVHIQIGQC[CAM]GNQIGAK.2|ISVYYNEAYGR.2|FWEM[Oxi]IGEEHGIDLAGSDR.3|FWEMIGEEHGIDLAGSDR.3|FWEMIGEEHGIDLAGSDR.2|HESESC[CAM]DC[CAM]LQGFQIVHSLGGGTGSGMGTLLMNK.5|HESESC[CAM]DC[CAM]LQGFQIVHSLGGGTGSGM[Oxi]GTLLMNK.4|HESESC[CAM]DC[CAM]LQGFQIVHSLGGGTGSGMGTLLMNK.4|HESESC[CAM]DC[CAM]LQGFQIVHSLGGGTGSGMGTLLMNK.3|EVDQQLLSVQTR.2|GLSMAATFIGNNTAIQEIFNR.3|GLSM[Oxi]AATFIGNNTAIQEIFNR.3|GLSM[Oxi]AATFIGNNTAIQEIFNR.2|GLSMAATFIGNNTAIQEIFNR.2|LHFFMPGFAPLTAQGSQQYR.3|LHFFMPGFAPLTAQGSQQYR.2|LGALFQPDSFVHGNSGAGNNWAK.3|AVLVDLEPGTM[Oxi]DSIR.2|AVLVDLEPGTMDSIR.2|AVLEEDEEVTEEAEMEPEDKGH.3|LTTPTYGDLNHLVSLTMSGITTSLR.3|AFVHWYTSEGM[Oxi]DINEFGEAENNIHDLVSEYQQFQDAK.4|AFVHWYTSEGMDINEFGEAENNIHDLVSEYQQFQDAK.4|AVLEEDEEVTEEAEMEPEDK.2
SEN / CTL,Tubulin beta-2A chain,TUBB2A,Q13885,1.32,0.77,2.85E-15,1.75E-14,1.38E+01,"cytoskeleton organization,microtubule-based process","GTPase activity,structural constituent of cytoskeleton,GTP binding","nucleus,cytoplasm,microtubule,extracellular exosome,extracellular vesicle",54,12,25,YLTVAAIFR.2|ESESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.4|ESESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.3|MREIVHIQAGQC[CAM]GNQIGAK.4|MREIVHIQAGQC[CAM]GNQIGAK.3|M[Oxi]REIVHIQAGQC[CAM]GNQIGAK.4|M[Oxi]REIVHIQAGQC[CAM]GNQIGAK.3|MREIVHIQAGQC[CAM]GNQIGAK.2|AILVDLEPGTMDSVR.2|AILVDLEPGTMDSVR.3|AILVDLEPGTM[Oxi]DSVR.2|AILVDLEPGTM[Oxi]DSVR.3|FWEVISDEHGIDPTGSYHGDSDLQLER.4|FWEVISDEHGIDPTGSYHGDSDLQLER.3|INVYYNEAAGNKYVPR.3|INVYYNEAAGNKYVPR.2|EIVHIQAGQC[CAM]GNQIGAK.3|EIVHIQAGQC[CAM]GNQIGAK.2|EIVHIQAGQC[CAM]GNQIGAK.4|KESESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.4|IREEYPDRIMNTFSVMPSPK.4|ALTVPELTQQMFDSK.2|ALTVPELTQQMFDSK.3|REIVHIQAGQC[CAM]GNQIGAK.4|INVYYNEAAGNK.2
SEN / CTL,Elongation factor 1-alpha 1,EEF1A1,P68104,1.31,0.72,2.02E-38,7.81E-37,3.61E+01,"transcription, DNA-templated,regulation of transcription, DNA-templated,translational elongation,cellular response to epidermal growth factor stimulus,regulation of chaperone-mediated autophagy","tRNA binding,translation elongation factor activity,GTPase activity,protein binding,GTP binding,protein kinase binding,poly(A) RNA binding","extracellular space,nucleus,nucleolus,cytoplasm,cytosol,eukaryotic translation elongation factor 1 complex,membrane,cortical actin cytoskeleton,ruffle membrane,extracellular exosome,cytoplasmic side of lysosomal membrane",132,52,144,EHALLAYTLGVK.3|EHALLAYTLGVK.2|IGGIGTVPVGR.2|YYVTIIDAPGHRDFIK.3|YYVTIIDAPGHRDFIK.4|YYVTIIDAPGHRDFIK.2|YYVTIIDAPGHR.3|YYVTIIDAPGHR.2|VETGVLKPGMVVTFAPVNVTTEVK.3|VETGVLKPGM[Oxi]VVTFAPVNVTTEVK.3|VETGVLKPGMVVTFAPVNVTTEVK.4|VETGVLKPGMVVTFAPVNVTTEVK.5|VETGVLKPGM[Oxi]VVTFAPVNVTTEVK.4|SGDAAIVDMVPGKPMC[CAM]VESFSDYPPLGR.3|SGDAAIVDMVPGKPM[Oxi]C[CAM]VESFSDYPPLGR.3|SGDAAIVDMVPGKPM[Oxi]C[CAM]VESFSDYPPLGR.4|SGDAAIVDMVPGKPMC[CAM]VESFSDYPPLGR.4|SGDAAIVDM[Oxi]VPGKPMC[CAM]VESFSDYPPLGR.4|SGDAAIVDM[Oxi]VPGKPM[Oxi]C[CAM]VESFSDYPPLGR.4|SGDAAIVDM[Oxi]VPGKPMC[CAM]VESFSDYPPLGR.3|SGDAAIVDMVPGKPMC[CAM]VESFSDYPPLGR.5|SGDAAIVDM[Oxi]VPGKPM[Oxi]C[CAM]VESFSDYPPLGR.3|QTVAVGVIK.2|THINIVVIGHVDSGK.3|THINIVVIGHVDSGK.2|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLRLPLQDVYK.5|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLRLPLQDVYK.6|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLRLPLQDVYK.7|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLRLPLQDVYK.4|TIEKFEKEAAEMGK.3|TIEKFEKEAAEMGK.4|TIEKFEKEAAEMGK.2|TIEKFEKEAAEM[Oxi]GK.3|TIEKFEKEAAEM[Oxi]GK.2|YEEIVKEVSTYIK.3|YEEIVKEVSTYIK.2|YEEIVKEVSTYIKK.4|YEEIVKEVSTYIKK.3|YEEIVKEVSTYIKK.2|DGNASGTTLLEALDC[CAM]ILPPTRPTDKPLRLPLQDVYK.5|DGNASGTTLLEALDC[CAM]ILPPTRPTDKPLRLPLQDVYK.6|DGNASGTTLLEALDC[CAM]ILPPTRPTDKPLRLPLQDVYK.4|IGYNPDTVAFVPISGWNGDNMLEPSANMPWFK.4|IGYNPDTVAFVPISGWNGDNM[Oxi]LEPSANMPWFK.4|IGYNPDTVAFVPISGWNGDNM[Oxi]LEPSANMPWFK.3|IGYNPDTVAFVPISGWNGDNMLEPSANMPWFK.5|IGYNPDTVAFVPISGWNGDNMLEPSANM[Oxi]PWFK.4|IGYNPDTVAFVPISGWNGDNM[Oxi]LEPSANM[Oxi]PWFK.4|IGYNPDTVAFVPISGWNGDNMLEPSANM[Oxi]PWFK.3|IGYNPDTVAFVPISGWNGDNMLEPSANMPWFK.3|RGNVAGDSKNDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.7|RGNVAGDSKNDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.7|RGNVAGDSKNDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.6|RGNVAGDSKNDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.6|RGNVAGDSKNDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.5|RGNVAGDSKNDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.5|IGGIGTVPVGRVETGVLKPGMVVTFAPVNVTTEVK.4|IGGIGTVPVGRVETGVLKPGMVVTFAPVNVTTEVK.5|IGGIGTVPVGRVETGVLKPGM[Oxi]VVTFAPVNVTTEVK.4|QLIVGVNK.2|DGNASGTTLLEALDC[CAM]ILPPTRPTDKPLR.4|DGNASGTTLLEALDC[CAM]ILPPTRPTDKPLR.5|DGNASGTTLLEALDC[CAM]ILPPTRPTDKPLR.3|NMITGTSQADC[CAM]AVLIVAAGVGEFEAGISK.3|NM[Oxi]ITGTSQADC[CAM]AVLIVAAGVGEFEAGISK.4|NMITGTSQADC[CAM]AVLIVAAGVGEFEAGISK.4|NM[Oxi]ITGTSQADC[CAM]AVLIVAAGVGEFEAGISK.3|KIGYNPDTVAFVPISGWNGDNM[Oxi]LEPSANMPWFK.4|KIGYNPDTVAFVPISGWNGDNMLEPSANMPWFK.4|KIGYNPDTVAFVPISGWNGDNM[Oxi]LEPSANMPWFK.6|KIGYNPDTVAFVPISGWNGDNMLEPSANMPWFK.6|KIGYNPDTVAFVPISGWNGDNM[Oxi]LEPSANMPWFK.5|KIGYNPDTVAFVPISGWNGDNMLEPSANM[Oxi]PWFK.5|KIGYNPDTVAFVPISGWNGDNMLEPSANMPWFK.5|KIGYNPDTVAFVPISGWNGDNM[Oxi]LEPSANM[Oxi]PWFK.4|KIGYNPDTVAFVPISGWNGDNMLEPSANM[Oxi]PWFK.4|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLR.5|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLR.6|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLR.4|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLR.3|DMRQTVAVGVIK.3|DM[Oxi]RQTVAVGVIK.3|DMRQTVAVGVIK.2|SGDAAIVDMVPGK.3|SGDAAIVDM[Oxi]VPGK.3|SGDAAIVDMVPGK.2|SGDAAIVDM[Oxi]VPGK.2|FAVRDMRQTVAVGVIK.4|PLRLPLQDVYK.3|PLRLPLQDVYK.2|TIEKFEK.2|YAWVLDK.2|EKTHINIVVIGHVDSGK.4|NGQTREHALLAYTLGVK.4|NGQTREHALLAYTLGVK.3|NGQTREHALLAYTLGVK.2|RYEEIVK.2|EVSTYIKK.2|LPLQDVYK.2|DGNASGTTLLEALDC[CAM]ILPPTRPTDK.5|DGNASGTTLLEALDC[CAM]ILPPTRPTDK.4|DGNASGTTLLEALDC[CAM]ILPPTRPTDK.3|THINIVVIGHVDSGKSTTTGHLIYK.5|THINIVVIGHVDSGKSTTTGHLIYK.4|KDGNASGTTLLEALDC[CAM]ILPPTRPTDK.5|KDGNASGTTLLEALDC[CAM]ILPPTRPTDK.4|KDGNASGTTLLEALDC[CAM]ILPPTRPTDK.3|STTTGHLIYK.2|FEKEAAEMGK.2|GITIDISLWK.2|PMC[CAM]VESFSDYPPLGR.3|PMC[CAM]VESFSDYPPLGR.2|PM[Oxi]C[CAM]VESFSDYPPLGR.2|RYEEIVKEVSTYIK.3|RYEEIVKEVSTYIK.2|PGM[Oxi]VVTFAPVNVTTEVK.3|PGMVVTFAPVNVTTEVK.2|PGM[Oxi]VVTFAPVNVTTEVK.2|SVEMHHEALSEALPGDNVGFNVK.4|SVEM[Oxi]HHEALSEALPGDNVGFNVK.4|SVEMHHEALSEALPGDNVGFNVK.3|NDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.7|NDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.6|NDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.6|NDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.5|NDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.5|NDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.4|NDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.4|MDSTEPPYSQK.2|M[Oxi]DSTEPPYSQK.2|FETSKYYVTIIDAPGHR.3|LPLQDVYKIGGIGTVPVGR.3|QLIVGVNKMDSTEPPYSQK.3|MDSTEPPYSQKR.2|GNVAGDSKNDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.7|GNVAGDSKNDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.7|GNVAGDSKNDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.6|GNVAGDSKNDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.6|GNVAGDSKNDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.5|GNVAGDSKNDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.5|DGNASGTTLLEALDC[CAM]ILPPTR.3|DGNASGTTLLEALDC[CAM]ILPPTR.2|KDGNASGTTLLEALDC[CAM]ILPPTR.3|NMITGTSQADC[CAM]AVLIVAAGVGEFEAGISKNGQTR.4
SEN / CTL,Probable Xaa-Pro aminopeptidase 3,XPNPEP3,Q9NQH7,1.31,1.60,1.06E-01,3.73E-02,1.43E+00,"glomerular filtration,protein processing","aminopeptidase activity,metallopeptidase activity,manganese ion binding","mitochondrion,extracellular exosome",3,10,14,AILFVPR.2|GVQQLIQR.2|YC[CAM]PHHVGHYLGMDVHDTPDMPR.5|APVEEAFLYAK.2|FTAPQAELYEAVLEIQR.3|FTAPQAELYEAVLEIQR.2|YLGQPSPFTHPHLLRPGEVTPGLSQVEYALR.5|YLGQPSPFTHPHLLRPGEVTPGLSQVEYALR.4|YLGQPSPFTHPHLLRPGEVTPGLSQVEYALR.3|IEDDVVVTQDSPLILSADC[CAM]PK.3|IEDDVVVTQDSPLILSADC[CAM]PK.2|GADILAYPPVVAGGNR.2|LTSQAFIETMFTSK.2|SGTDGAIALTGVDEAYTLEEFQHLLPK.3
SEN / CTL,Tubulin alpha-1A chain,TUBA1A,Q71U36,1.30,0.60,2.73E-49,1.84E-47,4.67E+01,"G2/M transition of mitotic cell cycle,cytoskeleton organization,microtubule-based process,cytoskeleton-dependent intracellular transport,cell division","GTPase activity,structural molecule activity,structural constituent of cytoskeleton,GTP binding,protein domain specific binding","nucleus,cytosol,microtubule,cytoplasmic microtubule,cytoplasmic ribonucleoprotein granule,myelin sheath,recycling endosome,extracellular exosome",135,45,112,AVFVDLEPTVIDEVR.2|AVFVDLEPTVIDEVR.3|LIGQIVSSITASLR.2|LIGQIVSSITASLR.3|QLFHPEQLITGKEDAANNYAR.4|QLFHPEQLITGKEDAANNYAR.3|EIIDLVLDR.2|DVNAAIATIK.2|TIQFVDWC[CAM]PTGFK.2|TIQFVDWC[CAM]PTGFK.3|GHYTIGKEIIDLVLDR.3|GHYTIGKEIIDLVLDR.4|GHYTIGKEIIDLVLDR.2|IHFPLATYAPVISAEK.3|IHFPLATYAPVISAEK.2|IHFPLATYAPVISAEK.4|GHYTIGKEIIDLVLDRIR.4|VGINYQPPTVVPGGDLAK.2|VGINYQPPTVVPGGDLAK.3|VGINYQPPTVVPGGDLAK.4|FDGALNVDLTEFQTNLVPYPR.3|FDGALNVDLTEFQTNLVPYPR.4|TIGGGDDSFNTFFSETGAGKHVPR.4|TIGGGDDSFNTFFSETGAGKHVPR.3|AVC[CAM]MLSNTTAIAEAWAR.3|AVC[CAM]MLSNTTAIAEAWAR.2|AVC[CAM]M[Oxi]LSNTTAIAEAWAR.3|AVC[CAM]M[Oxi]LSNTTAIAEAWAR.2|YMAC[CAM]C[CAM]LLYRGDVVPK.3|YM[Oxi]AC[CAM]C[CAM]LLYRGDVVPK.3|RTIQFVDWC[CAM]PTGFK.3|RTIQFVDWC[CAM]PTGFK.2|NLDIERPTYTNLNR.3|NLDIERPTYTNLNR.2|NLDIERPTYTNLNR.4|KLADQC[CAM]TGLQGFLVFHSFGGGTGSGFTSLLMER.4|KLADQC[CAM]TGLQGFLVFHSFGGGTGSGFTSLLM[Oxi]ER.4|KLADQC[CAM]TGLQGFLVFHSFGGGTGSGFTSLLMER.3|GDVVPKDVNAAIATIK.3|GDVVPKDVNAAIATIK.2|RNLDIERPTYTNLNR.4|RNLDIERPTYTNLNR.3|RNLDIERPTYTNLNR.2|YMAC[CAM]C[CAM]LLYR.2|YMAC[CAM]C[CAM]LLYR.3|YM[Oxi]AC[CAM]C[CAM]LLYR.2|TIGGGDDSFNTFFSETGAGK.2|TIGGGDDSFNTFFSETGAGK.3|LDHKFDLMYAK.3|LDHKFDLMYAK.2|LDHKFDLM[Oxi]YAK.3|LDHKFDLM[Oxi]YAK.2|AYHEQLSVAEITNAC[CAM]FEPANQMVK.3|AYHEQLSVAEITNAC[CAM]FEPANQMVK.4|AYHEQLSVAEITNAC[CAM]FEPANQMVK.5|AYHEQLSVAEITNAC[CAM]FEPANQM[Oxi]VK.5|AYHEQLSVAEITNAC[CAM]FEPANQM[Oxi]VK.4|AYHEQLSVAEITNAC[CAM]FEPANQM[Oxi]VK.3|AVFVDLEPTVIDEVRTGTYR.3|AVFVDLEPTVIDEVRTGTYR.4|QLFHPEQLITGK.3|QLFHPEQLITGK.2|LADQC[CAM]TGLQGFLVFHSFGGGTGSGFTSLLMER.4|LADQC[CAM]TGLQGFLVFHSFGGGTGSGFTSLLMER.5|LADQC[CAM]TGLQGFLVFHSFGGGTGSGFTSLLM[Oxi]ER.4|LADQC[CAM]TGLQGFLVFHSFGGGTGSGFTSLLM[Oxi]ER.3|LADQC[CAM]TGLQGFLVFHSFGGGTGSGFTSLLMER.3|MREC[CAM]ISIHVGQAGVQIGNAC[CAM]WELYC[CAM]LEHGIQPDGQMPSDK.5|MREC[CAM]ISIHVGQAGVQIGNAC[CAM]WELYC[CAM]LEHGIQPDGQMPSDK.6|M[Oxi]REC[CAM]ISIHVGQAGVQIGNAC[CAM]WELYC[CAM]LEHGIQPDGQMPSDK.6|M[Oxi]REC[CAM]ISIHVGQAGVQIGNAC[CAM]WELYC[CAM]LEHGIQPDGQM[Oxi]PSDK.5|M[Oxi]REC[CAM]ISIHVGQAGVQIGNAC[CAM]WELYC[CAM]LEHGIQPDGQMPSDK.5|MREC[CAM]ISIHVGQAGVQIGNAC[CAM]WELYC[CAM]LEHGIQPDGQM[Oxi]PSDK.5|M[Oxi]REC[CAM]ISIHVGQAGVQIGNAC[CAM]WELYC[CAM]LEHGIQPDGQMPSDK.4|MREC[CAM]ISIHVGQAGVQIGNAC[CAM]WELYC[CAM]LEHGIQPDGQM[Oxi]PSDK.4|MREC[CAM]ISIHVGQAGVQIGNAC[CAM]WELYC[CAM]LEHGIQPDGQMPSDK.4|FDLMYAK.2|FDLM[Oxi]YAK.2|EDMAALEK.2|EDM[Oxi]AALEK.2|LSVDYGKK.2|EDAANNYAR.2|LDHKFDLMYAKR.3|LDHKFDLMYAKR.2|TGTYRQLFHPEQLITGKEDAANNYAR.5|TGTYRQLFHPEQLITGKEDAANNYAR.4|TGTYRQLFHPEQLITGKEDAANNYAR.3|RAFVHWYVGEGMEEGEFSEAR.4|RAFVHWYVGEGM[Oxi]EEGEFSEAR.4|RAFVHWYVGEGMEEGEFSEAR.3|RAFVHWYVGEGM[Oxi]EEGEFSEAR.3|RAFVHWYVGEGMEEGEFSEAREDMAALEK.5|RAFVHWYVGEGM[Oxi]EEGEFSEAREDMAALEK.5|RAFVHWYVGEGMEEGEFSEAREDMAALEK.4|VGINYQPPTVVPGGDLAKVQR.3|AFVHWYVGEGMEEGEFSEAR.3|AFVHWYVGEGM[Oxi]EEGEFSEAR.3|AFVHWYVGEGMEEGEFSEAR.2|DYEEVGVDSVEGEGEEEGEEY.3|DYEEVGVDSVEGEGEEEGEEY.2|LSVDYGK.1|AFVHWYVGEGMEEGEFSEAREDMAALEK.4|AFVHWYVGEGM[Oxi]EEGEFSEAREDMAALEK.4|AFVHWYVGEGMEEGEFSEAREDMAALEK.3|EC[CAM]ISIHVGQAGVQIGNAC[CAM]WELYC[CAM]LEHGIQPDGQMPSDK.5|EC[CAM]ISIHVGQAGVQIGNAC[CAM]WELYC[CAM]LEHGIQPDGQMPSDK.4|SKLEFSIYPAPQVSTAVVEPYNSILTTHTTLEHSDC[CAM]AFMVDNEAIYDIC[CAM]RR.6|SKLEFSIYPAPQVSTAVVEPYNSILTTHTTLEHSDC[CAM]AFMVDNEAIYDIC[CAM]RR.5|EDM[Oxi]AALEKDYEEVGVDSVEGEGEEEGEEY.3|EDMAALEKDYEEVGVDSVEGEGEEEGEEY.3|LEFSIYPAPQVSTAVVEPYNSILTTHTTLEHSDC[CAM]AFMVDNEAIYDIC[CAM]RR.5|SKLEFSIYPAPQVSTAVVEPYNSILTTHTTLEHSDC[CAM]AFMVDNEAIYDIC[CAM]R.5
SEN / CTL,Tubulin beta-4B chain,TUBB4B,P68371,1.28,0.70,4.16E-55,5.61E-53,5.23E+01,"G2/M transition of mitotic cell cycle,movement of cell or subcellular component,cytoskeleton organization,microtubule-based process,natural killer cell mediated cytotoxicity","double-stranded RNA binding,GTPase activity,structural constituent of cytoskeleton,GTP binding,MHC class I protein binding,unfolded protein binding","nucleus,cytosol,cytoskeleton,microtubule,extracellular matrix,myelin sheath,extracellular exosome,extracellular vesicle",201,42,123,YLTVAAVFR.2|NSSYFVEWIPNNVK.2|NSSYFVEWIPNNVK.3|SGPFGQIFRPDNFVFGQSGAGNNWAK.3|SGPFGQIFRPDNFVFGQSGAGNNWAK.4|INVYYNEATGGKYVPR.3|GHYTEGAELVDSVLDVVRK.4|GHYTEGAELVDSVLDVVRK.3|GHYTEGAELVDSVLDVVRK.2|GHYTEGAELVDSVLDVVRKEAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.6|ISEQFTAMFR.2|ISEQFTAM[Oxi]FR.2|ISEQFTAMFR.3|KLAVNMVPFPR.3|KLAVNMVPFPR.2|KLAVNM[Oxi]VPFPR.3|AVLVDLEPGTMDSVR.2|AVLVDLEPGTMDSVR.3|AVLVDLEPGTM[Oxi]DSVR.2|AVLVDLEPGTM[Oxi]DSVR.3|LHFFMPGFAPLTSR.3|LHFFMPGFAPLTSR.2|LHFFM[Oxi]PGFAPLTSR.3|LHFFMPGFAPLTSR.4|LHFFM[Oxi]PGFAPLTSR.2|MREIVHLQAGQC[CAM]GNQIGAK.4|MREIVHLQAGQC[CAM]GNQIGAK.3|M[Oxi]REIVHLQAGQC[CAM]GNQIGAK.4|M[Oxi]REIVHLQAGQC[CAM]GNQIGAK.3|MREIVHLQAGQC[CAM]GNQIGAK.2|GHYTEGAELVDSVLDVVR.3|GHYTEGAELVDSVLDVVR.4|GHYTEGAELVDSVLDVVR.2|LTTPTYGDLNHLVSATMSGVTTC[CAM]LR.3|LTTPTYGDLNHLVSATMSGVTTC[CAM]LR.4|LTTPTYGDLNHLVSATM[Oxi]SGVTTC[CAM]LR.4|LTTPTYGDLNHLVSATM[Oxi]SGVTTC[CAM]LR.3|ALTVPELTQQMFDAK.2|ALTVPELTQQMFDAK.3|ALTVPELTQQM[Oxi]FDAK.3|ALTVPELTQQM[Oxi]FDAK.2|MSATFIGNSTAIQELFKR.3|M[Oxi]SATFIGNSTAIQELFKR.3|MSATFIGNSTAIQELFKR.2|M[Oxi]SATFIGNSTAIQELFKR.2|INVYYNEATGGK.2|INVYYNEATGGK.3|EIVHLQAGQC[CAM]GNQIGAK.3|EIVHLQAGQC[CAM]GNQIGAK.2|EIVHLQAGQC[CAM]GNQIGAK.4|KEAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.4|KEAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGM[Oxi]GTLLISK.4|KEAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.3|IREEYPDRIMNTFSVVPSPK.4|IREEYPDRIMNTFSVVPSPK.3|IREEYPDRIM[Oxi]NTFSVVPSPK.4|IREEYPDRIM[Oxi]NTFSVVPSPK.3|IMNTFSVVPSPK.2|IMNTFSVVPSPK.3|IM[Oxi]NTFSVVPSPK.2|IM[Oxi]NTFSVVPSPK.3|LAVNMVPFPR.2|LAVNM[Oxi]VPFPR.2|LAVNMVPFPR.1|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.4|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.3|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.5|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGM[Oxi]GTLLISK.4|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGM[Oxi]GTLLISK.3|FWEVISDEHGIDPTGTYHGDSDLQLER.4|FWEVISDEHGIDPTGTYHGDSDLQLER.5|FWEVISDEHGIDPTGTYHGDSDLQLER.3|TLKLTTPTYGDLNHLVSATMSGVTTC[CAM]LR.4|TLKLTTPTYGDLNHLVSATMSGVTTC[CAM]LR.3|TLKLTTPTYGDLNHLVSATM[Oxi]SGVTTC[CAM]LR.4|RISEQFTAMFR.3|RISEQFTAMFR.2|RISEQFTAM[Oxi]FR.3|RISEQFTAM[Oxi]FR.2|MSATFIGNSTAIQELFK.3|MSATFIGNSTAIQELFK.2|M[Oxi]SATFIGNSTAIQELFK.2|M[Oxi]SATFIGNSTAIQELFK.3|EVDEQMLNVQNK.2|EVDEQMLNVQNK.3|EVDEQM[Oxi]LNVQNK.3|EVDEQM[Oxi]LNVQNK.2|NMMAAC[CAM]DPR.2|NM[Oxi]MAAC[CAM]DPR.2|NMM[Oxi]AAC[CAM]DPR.2|NM[Oxi]M[Oxi]AAC[CAM]DPR.2|LTTPTYGDLNHLVSATMSGVTTC[CAM]LRFPGQLNADLR.4|LTTPTYGDLNHLVSATMSGVTTC[CAM]LRFPGQLNADLR.5|MSMKEVDEQMLNVQNK.3|MSMKEVDEQMLNVQNK.2|MSM[Oxi]KEVDEQMLNVQNK.3|MSMKEVDEQM[Oxi]LNVQNK.3|M[Oxi]SMKEVDEQMLNVQNK.3|M[Oxi]SM[Oxi]KEVDEQMLNVQNK.3|M[Oxi]SMKEVDEQM[Oxi]LNVQNK.3|MSM[Oxi]KEVDEQM[Oxi]LNVQNK.3|M[Oxi]SM[Oxi]KEVDEQM[Oxi]LNVQNK.3|MSMKEVDEQM[Oxi]LNVQNK.2|LTTPTYGDLNHLVSATMSGVTTC[CAM]LRFPGQLNADLRK.5|LTTPTYGDLNHLVSATMSGVTTC[CAM]LRFPGQLNADLRK.6|LTTPTYGDLNHLVSATM[Oxi]SGVTTC[CAM]LRFPGQLNADLRK.5|LTTPTYGDLNHLVSATM[Oxi]SGVTTC[CAM]LRFPGQLNADLRK.4|LTTPTYGDLNHLVSATMSGVTTC[CAM]LRFPGQLNADLRK.4|FPGQLNADLR.2|HGRYLTVAAVFRGR.4|FPGQLNADLRK.3|FPGQLNADLRK.2|TAVC[CAM]DIPPRGLK.3|HGRYLTVAAVFR.3|REIVHLQAGQC[CAM]GNQIGAK.4|REIVHLQAGQC[CAM]GNQIGAK.3|TAVC[CAM]DIPPR.2|IREEYPDR.2|PDNFVFGQSGAGNNWAK.3|PDNFVFGQSGAGNNWAK.2|KLAVNMVPFPRLHFFMPGFAPLTSR.4|VSDTVVEPYNATLSVHQLVENTDETYC[CAM]IDNEALYDIC[CAM]FR.5|VSDTVVEPYNATLSVHQLVENTDETYC[CAM]IDNEALYDIC[CAM]FR.4
SEN / CTL,UDP-glucose 4-epimerase,GALE,Q14376,1.27,0.48,4.44E-02,1.82E-02,1.74E+00,galactose catabolic process,"UDP-N-acetylglucosamine 4-epimerase activity,UDP-glucose 4-epimerase activity,protein homodimerization activity","cytosol,extracellular exosome",3,22,28,VLVTGGAGYIGSHTVLELLEAGYLPVVIDNFHNAFR.4|VLVTGGAGYIGSHTVLELLEAGYLPVVIDNFHNAFR.5|GGGSLPESLR.2|TWNAVLLR.2|YSFMAVIHFAGLK.3|YSFMAVIHFAGLK.2|QNPSGFGTQA.2|MC[CAM]EDLWR.2|VNLTGTIQLLEIMK.3|VNLTGTIQLLEIMK.2|AVGESVQKPLDYYR.3|AVGESVQKPLDYYR.2|FFIEEMIR.2|DYIHVVDLAK.2|DLC[CAM]QADKTWNAVLLR.3|SKFFIEEMIR.2|SVEFEEMDILDQGALQR.3|SVEFEEMDILDQGALQR.2|WQKQNPSGFGTQA.2|IYNLGTGTGYSVLQMVQAMEK.3|IYNLGTGTGYSVLQMVQAMEK.2|EALNVFGNDYDTEDGTGVRDYIHVVDLAK.4|NLVFSSSATVYGNPQYLPLDEAHPTGGC[CAM]TNPYGK.4|YFNPTGAHASGC[CAM]IGEDPQGIPNNLMPYVSQVAIGR.4|EGDVAAC[CAM]YANPSLAQEELGWTAALGLDR.3|YFNPTGAHASGC[CAM]IGEDPQGIPNNLMPYVSQVAIGRR.4|EALNVFGNDYDTEDGTGVR.2|REGDVAAC[CAM]YANPSLAQEELGWTAALGLDR.3
SEN / CTL,Calnexin,CANX,P27824,1.27,0.92,2.53E-04,2.28E-04,3.64E+00,"antigen processing and presentation of peptide antigen via MHC class I,protein folding,aging,protein secretion,antigen processing and presentation of exogenous peptide antigen via MHC class II,protein folding in endoplasmic reticulum,synaptic vesicle endocytosis,chaperone-mediated protein folding,clathrin-dependent endocytosis","glycoprotein binding,calcium ion binding,protein binding,carbohydrate binding,apolipoprotein binding,ionotropic glutamate receptor binding,poly(A) RNA binding,unfolded protein binding","endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum membrane,smooth endoplasmic reticulum,rough endoplasmic reticulum,ribosome,membrane,axon,extracellular matrix,dendrite cytoplasm,melanosome,neuronal cell body,dendritic spine,myelin sheath,protein complex,ER-mitochondrion membrane contact site,extracellular exosome,integral component of lumenal side of endoplasmic reticulum membrane",18,59,93,GTLSGWILSK.2|KIPNPDFFEDLEPFR.3|KIPNPDFFEDLEPFR.2|VTYKAPVPTGEVYFADSFDR.3|C[CAM]ESAPGC[CAM]GVWQRPVIDNPNYKGK.4|IVDDWANDGWGLKK.3|IVDDWANDGWGLKK.2|VTYKAPVPTGEVYFADSFDRGTLSGWILSK.4|VTYKAPVPTGEVYFADSFDRGTLSGWILSK.3|LNKPFLFDTK.3|LNKPFLFDTK.2|RPDADLK.2|TGIYEEK.2|RPDADLKTYFTDKK.4|RPDADLKTYFTDKK.3|KPEDWDERPK.3|KPEDWDERPK.2|LPGDKGLVLMSR.3|LPGDKGLVLMSR.2|PFLFDTK.2|WEVEEMKESK.3|RIVDDWANDGWGLKK.4|RIVDDWANDGWGLKK.3|YDGKWEVEEMKESK.4|YDGKWEVEEMKESK.3|AKKDDTDDEIAK.3|AKKDDTDDEIAK.2|EIEDPEDRKPEDWDERPK.5|EIEDPEDRKPEDWDERPK.4|EIEDPEDRKPEDWDERPK.3|TYFTDKK.2|DKGDEEEEGEEK.3|DKGDEEEEGEEK.2|KTDAPQPDVKEEEEEK.4|QTSGMEYK.2|YDGKWEVEEMK.3|YDGKWEVEEMK.2|DKGDEEEEGEEKLEEK.4|DKGDEEEEGEEKLEEK.3|DKGDEEEEGEEKLEEK.2|WEVEEMK.2|TDAPQPDVK.2|TPELNLDQFHDK.3|TPELNLDQFHDK.2|DDTDDEIAKYDGK.3|IVDDWANDGWGLK.3|IVDDWANDGWGLK.2|QKSDAEEDGGTVSQEEEDRKPK.5|QKSDAEEDGGTVSQEEEDRKPK.4|DDTDDEIAK.2|PVIDNPNYK.2|KDDTDDEIAKYDGK.3|AEEDEILNR.2|GDEEEEGEEKLEEK.3|KTDAPQPDVK.2|RIVDDWANDGWGLK.3|SDAEEDGGTVSQEEEDRKPK.4|SDAEEDGGTVSQEEEDRKPK.3|WKPPM[Oxi]IDNPSYQGIWKPR.4|WKPPMIDNPSYQGIWKPR.4|WKPPMIDNPSYQGIWKPR.3|TDAPQPDVKEEEEEKEEEK.4|TDAPQPDVKEEEEEKEEEK.3|IPNPDFFEDLEPFR.3|IPNPDFFEDLEPFR.2|KDDTDDEIAK.2|TDAPQPDVKEEEEEK.3|APVPTGEVYFADSFDR.3|APVPTGEVYFADSFDR.2|TGIYEEKHAK.2|C[CAM]ESAPGC[CAM]GVWQRPVIDNPNYK.4|C[CAM]ESAPGC[CAM]GVWQRPVIDNPNYK.3|TPYTIMFGPDK.2|TPYTIM[Oxi]FGPDK.2|WKPPMIDNPSYQGIWK.3|TPELNLDQFHDKTPYTIMFGPDK.4|TPELNLDQFHDKTPYTIM[Oxi]FGPDK.4|TPELNLDQFHDKTPYTIMFGPDK.3|TPYTIMFGPDKC[CAM]GEDYK.3|TPELNLDQFHDKTPYTIMFGPDKC[CAM]GEDYK.5|TPELNLDQFHDKTPYTIMFGPDKC[CAM]GEDYK.4|APVPTGEVYFADSFDRGTLSGWILSK.4|APVPTGEVYFADSFDRGTLSGWILSK.3|C[CAM]ESAPGC[CAM]GVWQR.2|IPDPEAVKPDDWDEDAPAK.3|IPDPEAVKPDDWDEDAPAK.2|LNKPFLFDTKPLIVQYEVNFQNGIEC[CAM]GGAYVK.5|LNKPFLFDTKPLIVQYEVNFQNGIEC[CAM]GGAYVK.4|PLIVQYEVNFQNGIEC[CAM]GGAYVK.3|SDAEEDGGTVSQEEEDR.2|THLYTLILNPDNSFEILVDQSVVNSGNLLNDMTPPVNPSR.4|THLYTLILNPDNSFEILVDQSVVNSGNLLNDM[Oxi]TPPVNPSR.4|KTHLYTLILNPDNSFEILVDQSVVNSGNLLNDMTPPVNPSR.4
SEN / CTL,Pyruvate kinase PKM,PKM,P14618,1.27,0.99,2.89E-39,1.30E-37,3.69E+01,"programmed cell death,canonical glycolysis,cell-cell adhesion","magnesium ion binding,pyruvate kinase activity,protein binding,ATP binding,kinase activity,MHC class II protein complex binding,potassium ion binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,mitochondrion,cytosol,plasma membrane,cell-cell adherens junction,cilium,extracellular matrix,vesicle,myelin sheath,extracellular exosome,extracellular vesicle",246,71,161,GDLGIEIPAEK.2|IYVDDGLISLQVK.2|IYVDDGLISLQVK.3|KGVNLPGAAVDLPAVSEKDIQDLK.4|KGVNLPGAAVDLPAVSEKDIQDLK.3|APIIAVTR.2|GSGTAEVELK.2|TATESFASDPILYRPVAVALDTKGPEIR.4|TATESFASDPILYRPVAVALDTKGPEIR.3|TATESFASDPILYRPVAVALDTKGPEIR.5|LAPITSDPTEATAVGAVEASFK.3|LAPITSDPTEATAVGAVEASFK.2|LAPITSDPTEATAVGAVEASFK.4|GADFLVTEVENGGSLGSK.2|GADFLVTEVENGGSLGSK.3|TGLIKGSGTAEVELKK.3|TGLIKGSGTAEVELKK.4|LNFSHGTHEYHAETIKNVR.4|LNFSHGTHEYHAETIKNVR.5|LDIDSPPITAR.2|LDIDSPPITAR.3|GIFPVLC[CAM]KDPVQEAWAEDVDLR.3|GIFPVLC[CAM]KDPVQEAWAEDVDLR.4|SVETLKEMIK.2|C[CAM]C[CAM]SGAIIVLTK.2|C[CAM]C[CAM]SGAIIVLTK.3|GDLGIEIPAEKVFLAQK.3|GDLGIEIPAEKVFLAQK.2|TGLIKGSGTAEVELK.3|EAEAAIYHLQLFEELRR.4|EAEAAIYHLQLFEELRR.3|EAEAAIYHLQLFEELRR.2|C[CAM]DENILWLDYK.2|C[CAM]DENILWLDYK.3|QKGADFLVTEVENGGSLGSK.3|QKGADFLVTEVENGGSLGSK.2|FGVEQDVDMVFASFIR.3|FGVEQDVDMVFASFIR.2|FGVEQDVDM[Oxi]VFASFIR.3|FGVEQDVDM[Oxi]VFASFIR.2|AEGSDVANAVLDGADC[CAM]IMLSGETAKGDYPLEAVR.4|AEGSDVANAVLDGADC[CAM]IMLSGETAKGDYPLEAVR.3|AEGSDVANAVLDGADC[CAM]IMLSGETAKGDYPLEAVR.5|AEGSDVANAVLDGADC[CAM]IM[Oxi]LSGETAKGDYPLEAVR.4|AEGSDVANAVLDGADC[CAM]IM[Oxi]LSGETAKGDYPLEAVR.3|NTGIIC[CAM]TIGPASR.2|NTGIIC[CAM]TIGPASR.3|VNFAMNVGK.2|VNFAM[Oxi]NVGK.2|RFDEILEASDGIMVAR.3|RFDEILEASDGIMVAR.2|RFDEILEASDGIMVAR.4|RFDEILEASDGIM[Oxi]VAR.3|RFDEILEASDGIM[Oxi]VAR.4|RFDEILEASDGIM[Oxi]VAR.2|TATESFASDPILYRPVAVALDTK.3|TATESFASDPILYRPVAVALDTK.4|EAEAAIYHLQLFEELR.3|EAEAAIYHLQLFEELR.2|ITLDNAYMEK.2|ITLDNAYM[Oxi]EK.2|GFFKKGDVVIVLTGWRPGSGFTNTMR.5|GFFKKGDVVIVLTGWRPGSGFTNTMR.4|KGDVVIVLTGWRPGSGFTNTMR.4|KGDVVIVLTGWRPGSGFTNTMR.3|KGDVVIVLTGWRPGSGFTNTM[Oxi]R.4|KGDVVIVLTGWRPGSGFTNTM[Oxi]R.3|KGDVVIVLTGWRPGSGFTNTMR.2|AGKPVIC[CAM]ATQMLESMIKKPRPTR.5|AGKPVIC[CAM]ATQMLESMIKKPRPTR.6|AGKPVIC[CAM]ATQM[Oxi]LESM[Oxi]IKKPRPTR.6|KPRPTRAEGSDVANAVLDGADC[CAM]IMLSGETAKGDYPLEAVR.5|KPRPTRAEGSDVANAVLDGADC[CAM]IMLSGETAKGDYPLEAVR.6|KPRPTRAEGSDVANAVLDGADC[CAM]IMLSGETAKGDYPLEAVR.4|KPRPTRAEGSDVANAVLDGADC[CAM]IM[Oxi]LSGETAKGDYPLEAVR.5|C[CAM]DENILWLDYKNIC[CAM]K.3|APIIAVTRNPQTAR.3|ITLDNAYMEKC[CAM]DENILWLDYK.3|ITLDNAYM[Oxi]EKC[CAM]DENILWLDYK.3|RLAPITSDPTEATAVGAVEASFK.3|RLAPITSDPTEATAVGAVEASFK.4|RLAPITSDPTEATAVGAVEASFK.2|AGKPVIC[CAM]ATQMLESMIK.3|AGKPVIC[CAM]ATQMLESMIK.2|AGKPVIC[CAM]ATQMLESMIK.4|AGKPVIC[CAM]ATQM[Oxi]LESMIK.3|AGKPVIC[CAM]ATQMLESM[Oxi]IK.3|AGKPVIC[CAM]ATQM[Oxi]LESM[Oxi]IK.3|AGKPVIC[CAM]ATQM[Oxi]LESMIK.2|AGKPVIC[CAM]ATQMLESM[Oxi]IK.2|GVNLPGAAVDLPAVSEKDIQDLK.3|GVNLPGAAVDLPAVSEKDIQDLK.4|GVNLPGAAVDLPAVSEKDIQDLK.2|FGVEQDVDMVFASFIRK.3|FGVEQDVDM[Oxi]VFASFIRK.3|FGVEQDVDM[Oxi]VFASFIRK.2|FGVEQDVDMVFASFIRK.2|KGVNLPGAAVDLPAVSEK.3|KGVNLPGAAVDLPAVSEK.4|KGVNLPGAAVDLPAVSEK.2|LNFSHGTHEYHAETIK.4|LNFSHGTHEYHAETIK.3|LNFSHGTHEYHAETIK.2|IISKIENHEGVR.3|IISKIENHEGVR.2|FDEILEASDGIMVAR.2|FDEILEASDGIMVAR.3|FDEILEASDGIM[Oxi]VAR.2|GADFLVTEVENGGSLGSKK.3|GADFLVTEVENGGSLGSKK.4|GADFLVTEVENGGSLGSKK.2|GDVVIVLTGWRPGSGFTNTMR.3|GDVVIVLTGWRPGSGFTNTMR.4|GDVVIVLTGWRPGSGFTNTM[Oxi]R.4|GDVVIVLTGWRPGSGFTNTM[Oxi]R.3|GDVVIVLTGWRPGSGFTNTMR.2|AEGSDVANAVLDGADC[CAM]IMLSGETAK.3|AEGSDVANAVLDGADC[CAM]IMLSGETAK.4|AEGSDVANAVLDGADC[CAM]IM[Oxi]LSGETAK.4|AEGSDVANAVLDGADC[CAM]IM[Oxi]LSGETAK.3|QKGADFLVTEVENGGSLGSKK.3|QKGADFLVTEVENGGSLGSKK.4|MQHLIAR.2|M[Oxi]QHLIAR.2|ASDVHEVR.2|PVAVALDTK.2|GIFPVLC[CAM]K.2|GIFPVLC[CAM]K.1|YRPRAPIIAVTR.3|IENHEGVR.2|PVAVALDTKGPEIR.3|GDYPLEAVR.2|ASDVHEVRK.2|KASDVHEVR.2|TATESFASDPILYR.3|TATESFASDPILYR.2|PGSGFTNTMR.2|PVIC[CAM]ATQMLESMIK.3|PVIC[CAM]ATQMLESMIK.2|DPVQEAWAEDVDLR.3|DPVQEAWAEDVDLR.2|GVNLPGAAVDLPAVSEK.3|GVNLPGAAVDLPAVSEK.2|PHSEAGTAFIQTQQLHAAMADTFLEHMC[CAM]R.6|PHSEAGTAFIQTQQLHAAMADTFLEHMC[CAM]R.5|PHSEAGTAFIQTQQLHAAM[Oxi]ADTFLEHMC[CAM]R.5|PHSEAGTAFIQTQQLHAAMADTFLEHMC[CAM]R.4|PHSEAGTAFIQTQQLHAAMADTFLEHMC[CAM]R.3|GSGTAEVELKK.2|KASDVHEVRK.2|GDVVIVLTGWR.2|KPRPTRAEGSDVANAVLDGADC[CAM]IMLSGETAK.5|KPRPTRAEGSDVANAVLDGADC[CAM]IM[Oxi]LSGETAK.4|KPRPTRAEGSDVANAVLDGADC[CAM]IMLSGETAK.4|KPRPTRAEGSDVANAVLDGADC[CAM]IMLSGETAK.3|KGDVVIVLTGWR.2|IYVDDGLISLQVKQK.2|GIFPVLC[CAM]KDPVQEAWAEDVDLRVNFAMNVGK.4|GIFPVLC[CAM]KDPVQEAWAEDVDLRVNFAM[Oxi]NVGK.4|PTRAEGSDVANAVLDGADC[CAM]IMLSGETAK.3|PTRAEGSDVANAVLDGADC[CAM]IMLSGETAKGDYPLEAVR.4
SEN / CTL,Probable ubiquitin carboxyl-terminal hydrolase FAF-X,USP9X,Q93008,1.26,1.28,2.72E-02,1.22E-02,1.91E+00,"negative regulation of transcription from RNA polymerase II promoter,neuron migration,ubiquitin-dependent protein catabolic process,chromosome segregation,mitotic nuclear division,transforming growth factor beta receptor signaling pathway,female gamete generation,protein deubiquitination,BMP signaling pathway,cellular protein metabolic process,axon extension,cell division","cysteine-type endopeptidase activity,thiol-dependent ubiquitin-specific protease activity,protein binding,cysteine-type peptidase activity,co-SMAD binding","cytoplasm,cytosol,membrane,growth cone",6,82,105,VVIQSNDDIASR.2|SGGLPLVLSMLTR.2|SGGLPLVLSM[Oxi]LTR.2|FLFTTGFHTK.3|HSGDYFTLLR.3|HSGDYFTLLR.2|TNDKWVIPALK.3|YSHVQEVQER.3|YSHVQEVQER.2|LLLTAIGYGHVR.3|LLLTAIGYGHVR.2|VISSVSYYTHR.3|DSLHQPQYVEK.3|DSLHQPQYVEK.2|NVHDLLAK.2|AIC[CAM]LDHAK.2|DHEDYDPQTVR.3|DHEDYDPQTVR.2|AWQTFIIDLLLHC[CAM]HSK.4|VPGQEETVK.2|NDALSMIIK.2|FGTLNGFQILHDR.3|FGTLNGFQILHDR.2|ALGHPAMLSK.2|MNALNEVNK.2|VLGGSFADQK.2|DGLFDTIQR.2|GDLLEGANAYHC[CAM]EK.3|GDLLEGANAYHC[CAM]EK.2|GWLVDLLNK.2|RTGETGIEETILEGHLGVTK.4|RTGETGIEETILEGHLGVTK.3|LWGEPVNLR.2|KIIEDC[CAM]SNSEETVK.3|KIIEDC[CAM]SNSEETVK.2|LLQISSFNGK.2|LPPVLAIQLK.2|HGNPEEEEWLTAER.3|HGNPEEEEWLTAER.2|NHQNLLDSLEQYVK.3|NHQNLLDSLEQYVK.2|AIDLLKEIYTNLGPR.3|GIPDDRDGLFDTIQR.3|ILDYSC[CAM]SQDRDTQK.3|ILDYSC[CAM]SQDRDTQK.2|ELLAFQTSEK.2|YMPDIC[CAM]VIR.2|FDDGDVTEC[CAM]K.2|LYSVVSQLIR.2|RFDYDWEREC[CAM]AIK.3|ALTLQDLDNIWAAQAGK.3|ALTLQDLDNIWAAQAGK.2|ILTDEAVSGWK.2|LAQQISDEASR.2|LMPPDSTTIEK.2|PFGQC[CAM]YEFLTLHTVK.3|EYINEC[CAM]DSDYHEER.3|FNDYFEFPR.2|ALTLQDLDNIWAAQAGKHEAIVK.4|IELFVGGELIDPADDRK.3|LVGVLVHSGQASGGHYYSYIIQR.4|LVGVLVHSGQASGGHYYSYIIQR.3|YISELAITTRPHQIIMPSAIER.4|YISELAITTRPHQIIMPSAIER.3|MAEWIQQNNILSIVLR.3|MAEWIQQNNILSIVLR.2|TGETGIEETILEGHLGVTK.3|HDLINQLQHNHALVTLVAENLATYMESMR.5|HDLINQLQHNHALVTLVAENLATYMESM[Oxi]R.4|HDLINQLQHNHALVTLVAENLATYMESMR.4|DDVFGYPQQFEDKPALSK.3|DGQLWLC[CAM]APQAK.2|EIC[CAM]SLFGEAPQNLSQTQR.3|EIC[CAM]SLFGEAPQNLSQTQR.2|NNFLPNADMETR.2|IC[CAM]QGC[CAM]PHRYEC[CAM]EESFTTLNVDIR.4|LSVPATFMLVSLDEGPGPPIK.3|LSVPATFMLVSLDEGPGPPIK.2|QVDDLEVWSHTNDTIGSVR.3|ASYDTLC[CAM]VLDGDK.2|MDTIDQDDELIR.2|C[CAM]LAENAVYLC[CAM]DR.2|ASYDTLC[CAM]VLDGDKDSVNC[CAM]AR.3|LAWDFSPEQLDHLFDC[CAM]FK.3|ELDMEPYTVAGVAK.2|IIEDC[CAM]SNSEETVK.2|ELIDDFIFPASNVYLQYMR.3|FHIYNGTRPC[CAM]ESVSSSVQLPEDELFAR.4|FHIYNGTRPC[CAM]ESVSSSVQLPEDELFAR.3|LMGDEPDLDPDINK.2|LQVNQVVIHEDFIQSC[CAM]FDR.3|GELEVLLEAAIDLSK.2|MQYSMEYFQFMK.2|QVAQEQFFLMC[CAM]TR.2|NAGATC[CAM]YMNSVIQQLYMIPSIR.3|NAGATC[CAM]YMNSVIQQLYM[Oxi]IPSIR.3|FSEYLLEC[CAM]PSAEVR.2|C[CAM]MVALFSNC[CAM]PVAYQILQGNGDLK.3|GSASDWYDALC[CAM]ILLR.2|FNDYFEFPRELDMEPYTVAGVAK.3|RPYTGNPQYTYNNWSPPVQSNETSNGYFLER.4|YEC[CAM]EESFTTLNVDIR.2|AQENYEGSEEVSPPQTK.2|LEGDNVNPESQLIQQSEQSESETAGSTK.3|HLLNYAYNSNINVPNAEVLLNNEIDWLK.3
SEN / CTL,40S ribosomal protein S11,RPS11,P62280,1.24,0.40,2.75E-02,1.23E-02,1.91E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,osteoblast differentiation,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","structural constituent of ribosome,rRNA binding,poly(A) RNA binding","nucleoplasm,nucleolus,cytoplasm,cytosol,ribosome,focal adhesion,membrane,cytosolic small ribosomal subunit,extracellular matrix,extracellular exosome",3,16,23,NMSVHLSPC[CAM]FR.3|NM[Oxi]SVHLSPC[CAM]FR.3|NMSVHLSPC[CAM]FR.2|ILSGVVTK.2|EAIEGTYIDKK.3|EAIEGTYIDKK.2|KC[CAM]PFTGNVSIR.3|KC[CAM]PFTGNVSIR.2|VLLGETGKEKLPR.3|VLLGETGKEKLPR.2|AYQKQPTIFQNK.3|AYQKQPTIFQNK.2|DYLHYIR.2|QPTIFQNK.2|RVLLGETGK.2|VLLGETGKEK.2|EAIEGTYIDK.2|C[CAM]PFTGNVSIR.2|YYKNIGLGFK.2|DVQIGDIVTVGEC[CAM]RPLSK.3|DVQIGDIVTVGEC[CAM]RPLSK.2|NMSVHLSPC[CAM]FRDVQIGDIVTVGEC[CAM]RPLSK.5|DVQIGDIVTVGEC[CAM]R.2
SEN / CTL,Tubulin beta-6 chain,TUBB6,Q9BUF5,1.24,1.11,1.46E-11,5.89E-11,1.02E+01,"cytoskeleton organization,microtubule-based process","molecular_function,GTPase activity,structural constituent of cytoskeleton,GTP binding","nucleus,cytoplasm,microtubule,extracellular exosome",72,25,55,YLTVATVFR.2|M[Oxi]ASTFIGNSTAIQELFKR.3|MASTFIGNSTAIQELFKR.3|MASTFIGNSTAIQELFKR.2|AALVDLEPGTMDSVR.2|AALVDLEPGTMDSVR.3|AALVDLEPGTM[Oxi]DSVR.2|ISEQFSAMFR.2|GHYTEGAELVDAVLDVVR.3|GHYTEGAELVDAVLDVVR.2|M[Oxi]REIVHIQAGQC[CAM]GNQIGTK.4|MREIVHIQAGQC[CAM]GNQIGTK.4|MREIVHIQAGQC[CAM]GNQIGTK.3|MASTFIGNSTAIQELFK.3|MASTFIGNSTAIQELFK.2|M[Oxi]ASTFIGNSTAIQELFK.2|M[Oxi]ASTFIGNSTAIQELFK.3|EC[CAM]EHC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.4|EC[CAM]EHC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGM[Oxi]GTLLISK.4|EC[CAM]EHC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.3|LTTPTYGDLNHLVSATMSGVTTSLRFPGQLNADLRK.5|LTTPTYGDLNHLVSATMSGVTTSLRFPGQLNADLRK.6|IMNTFSVMPSPK.2|IMNTFSVMPSPK.3|IM[Oxi]NTFSVMPSPK.2|IMNTFSVM[Oxi]PSPK.2|IM[Oxi]NTFSVM[Oxi]PSPK.2|ALTVPELTQQMFDAR.3|ALTVPELTQQMFDAR.2|ALTVPELTQQM[Oxi]FDAR.2|LTTPTYGDLNHLVSATMSGVTTSLR.3|LTTPTYGDLNHLVSATMSGVTTSLR.4|LTTPTYGDLNHLVSATM[Oxi]SGVTTSLR.3|EVDEQMLAIQSK.2|EVDEQM[Oxi]LAIQSK.2|GHYTEGAELVDAVLDVVRK.3|GHYTEGAELVDAVLDVVRK.4|GHYTEGAELVDAVLDVVRK.2|IREEFPDRIMNTFSVMPSPK.4|INVYYNESSSQK.2|INVYYNESSSQK.3|RISEQFSAMFR.3|RISEQFSAMFR.2|SGPFGQLFR.2|VAVC[CAM]DIPPR.2|YLTVATVFRGPMSMK.3|EIVHIQAGQC[CAM]GNQIGTK.3|EIVHIQAGQC[CAM]GNQIGTK.2|GPMSMKEVDEQMLAIQSK.3|SGPFGQLFRPDNFIFGQTGAGNNWAK.4|SGPFGQLFRPDNFIFGQTGAGNNWAK.3|FWEVISDEHGIDPAGGYVGDSALQLER.4|FWEVISDEHGIDPAGGYVGDSALQLER.3|KEC[CAM]EHC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.4|KEC[CAM]EHC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.3
SEN / CTL,Insulin-like growth factor-binding protein 2,IGFBP2,P18065,1.24,0.67,4.32E-06,6.10E-06,5.21E+00,"regulation of cell growth,signal transduction,female pregnancy,aging,response to nutrient,response to mechanical stimulus,response to lithium ion,response to estradiol,response to retinoic acid,cellular response to hormone stimulus,positive regulation of activated T cell proliferation,response to drug,regulation of insulin-like growth factor receptor signaling pathway,response to estrogen,cellular protein metabolic process,response to glucocorticoid,negative regulation of canonical Wnt signaling pathway","receptor binding,insulin-like growth factor I binding,insulin-like growth factor II binding","extracellular region,extracellular space,apical plasma membrane,cytoplasmic vesicle,extracellular exosome",18,11,14,TPC[CAM]QQELDQVLER.2|LEGEAC[CAM]GVYTPR.2|LAAC[CAM]GPPPVAPPAAVAAVAGGAR.3|LAAC[CAM]GPPPVAPPAAVAAVAGGAR.2|LIQGAPTIRGDPEC[CAM]HLFYNEQQEAR.4|MPC[CAM]AELVREPGC[CAM]GC[CAM]C[CAM]SVC[CAM]AR.3|GPLEHLYSLHIPNC[CAM]DK.4|GPLEHLYSLHIPNC[CAM]DK.3|LPDERGPLEHLYSLHIPNC[CAM]DK.5|LPDERGPLEHLYSLHIPNC[CAM]DK.4|C[CAM]PPC[CAM]TPER.2|GDPEC[CAM]HLFYNEQQEAR.3|GEC[CAM]WC[CAM]VNPNTGK.2|C[CAM]YPHPGSELPLQALVMGEGTC[CAM]EK.3
SEN / CTL,NADH-cytochrome b5 reductase 3,CYB5R3,P00387,1.23,0.95,2.06E-04,1.93E-04,3.71E+00,"cholesterol biosynthetic process,blood circulation,L-ascorbic acid metabolic process,oxidation-reduction process","cytochrome-b5 reductase activity, acting on NAD(P)H,AMP binding,ADP binding,flavin adenine dinucleotide binding,NAD binding","cytoplasm,mitochondrion,mitochondrial outer membrane,mitochondrial inner membrane,endoplasmic reticulum,endoplasmic reticulum membrane,lipid particle,hemoglobin complex,membrane,extracellular exosome",15,25,51,FALPSPQHILGLPVGQHIYLSAR.4|FALPSPQHILGLPVGQHIYLSAR.5|FALPSPQHILGLPVGQHIYLSAR.3|GFVDLVIK.2|SVGMIAGGTGITPMLQVIR.3|SVGMIAGGTGITPMLQVIR.2|SVGM[Oxi]IAGGTGITPMLQVIR.3|SVGMIAGGTGITPM[Oxi]LQVIR.3|SVGM[Oxi]IAGGTGITPM[Oxi]LQVIR.3|SVGM[Oxi]IAGGTGITPM[Oxi]LQVIR.2|SVGM[Oxi]IAGGTGITPMLQVIR.2|SVGMIAGGTGITPM[Oxi]LQVIR.2|IDGNLVVRPYTPISSDDDKGFVDLVIK.4|IDGNLVVRPYTPISSDDDKGFVDLVIK.3|LIDREIISHDTRR.4|LIDREIISHDTRR.3|FKLWYTLDR.3|STPAITLESPDIKYPLR.4|STPAITLESPDIKYPLR.3|STPAITLESPDIKYPLR.2|LWYTLDR.2|EIISHDTR.2|LIDREIISHDTR.3|DILLRPELEELR.3|DILLRPELEELR.2|AIMKDPDDHTVC[CAM]HLLFANQTEK.5|AIMKDPDDHTVC[CAM]HLLFANQTEK.4|AIMKDPDDHTVC[CAM]HLLFANQTEK.3|DPDDHTVC[CAM]HLLFANQTEK.4|DPDDHTVC[CAM]HLLFANQTEK.3|DPDDHTVC[CAM]HLLFANQTEK.2|GPSGLLVYQGK.2|FRFALPSPQHILGLPVGQHIYLSAR.5|DILLRPELEELRNK.3|PYTPISSDDDK.2|AIMKDPDDHTVC[CAM]HLLFANQTEKDILLRPELEELR.6|MSQYLESMQIGDTIEFR.3|M[Oxi]SQYLESMQIGDTIEFR.2|MSQYLESMQIGDTIEFR.2|STPAITLESPDIK.2|APEAWDYGQGFVNEEMIR.3|APEAWDYGQGFVNEEM[Oxi]IR.3|APEAWDYGQGFVNEEM[Oxi]IR.2|APEAWDYGQGFVNEEMIR.2|IDGNLVVRPYTPISSDDDK.3|IDGNLVVRPYTPISSDDDK.2|PYTPISSDDDKGFVDLVIK.3|DHLPPPEEEPLVLMC[CAM]GPPPMIQYAC[CAM]LPNLDHVGHPTER.6|DHLPPPEEEPLVLMC[CAM]GPPPMIQYAC[CAM]LPNLDHVGHPTER.5|DHLPPPEEEPLVLMC[CAM]GPPPMIQYAC[CAM]LPNLDHVGHPTER.4|LWYTLDRAPEAWDYGQGFVNEEMIR.3
SEN / CTL,Aspartyl/asparaginyl beta-hydroxylase,ASPH,Q12797,1.23,0.73,5.37E-04,4.45E-04,3.35E+00,"muscle contraction,peptidyl-amino acid modification,ion transmembrane transport,positive regulation of proteolysis,oxidation-reduction process,activation of cysteine-type endopeptidase activity,regulation of cardiac conduction","peptide-aspartate beta-dioxygenase activity,structural molecule activity,calcium ion binding,protein binding,structural constituent of muscle,electron carrier activity","endoplasmic reticulum,endoplasmic reticulum membrane,plasma membrane,integral component of membrane,cortical endoplasmic reticulum,sarcoplasmic reticulum membrane",9,34,40,GLFLPEDENLREK.3|GAIETYQEVASLPDVPADLLK.3|GAIETYQEVASLPDVPADLLK.2|AELDAAEK.2|RGHFASVWQR.3|TC[CAM]TLLEK.2|GSLLTLQR.2|LIRDEGLAVMDK.3|LIRDEGLAVMDK.2|FYFHLGDAMQR.3|FYFHLGDAMQR.2|FPETTGC[CAM]R.2|MHLGLVIPK.2|SLYNVNGLK.2|IAESIPYLK.2|IEEAVNAFK.2|ETGYTELVK.2|GHFASVWQR.2|GKIEEAVNAFKELVR.3|YSIMHPGTHVWPHTGPTNC[CAM]R.4|AQC[CAM]EDDLAEK.2|TIKAELDAAEK.2|NDLGVGYLLIGDNDNAK.3|NDLGVGYLLIGDNDNAK.2|GKIEEAVNAFK.2|TC[CAM]TLLEKFPETTGC[CAM]R.3|KVYEEVLSVTPNDGFAK.3|LGIYDADGDGDFDVDDAK.3|LGIYDADGDGDFDVDDAK.2|GLFLPEDENLR.2|EGIESGDPGTDDGRFYFHLGDAMQR.4|EGIESGDPGTDDGR.2|LIFIVDVWHPELTPQQR.3|SSGNSSSSGSGSGSTSAGSSSPGAR.3|SSGNSSSSGSGSGSTSAGSSSPGAR.2|GDWSQFTLWQQGR.2|VLIFDDSFEHEVWQDASSFR.3|VYEEVLSVTPNDGFAK.2|STSEPAVPPEEAEPHTEPEEQVPVEAEPQNIEDEAK.4|ERSTSEPAVPPEEAEPHTEPEEQVPVEAEPQNIEDEAK.4
SEN / CTL,Putative tubulin-like protein alpha-4B,TUBA4B,Q9H853,1.22,0.44,3.60E-02,1.52E-02,1.82E+00,"cytoskeleton organization,microtubule-based process,biological_process","molecular_function,GTPase activity,structural constituent of cytoskeleton,GTP binding","cellular_component,cytoplasm,microtubule",3,1,2,QIFHPEQLITGK.3|QIFHPEQLITGK.2
SEN / CTL,"Glycogen [starch] synthase, muscle",GYS1,P13807,1.21,0.42,3.92E-02,1.62E-02,1.79E+00,"glycogen biosynthetic process,heart development","glycogen (starch) synthase activity,protein binding,glucose binding,protein kinase binding,glycogen synthase activity, transferring glucose-1-phosphate","cytosol,membrane,inclusion body",3,25,31,LSDLLDWK.2|FSAMHEFQNLHAQSK.4|FSAMHEFQNLHAQSK.3|LSDLLDWKYLGR.3|TQVELLEAPTPALK.3|TQVELLEAPTPALK.2|RKPDIVTPNGLNVK.3|GHFYGHLDFNLDK.3|AAAHC[CAM]AHVFTTVSQITAIEAQHLLK.5|AAAHC[CAM]AHVFTTVSQITAIEAQHLLK.4|AAAHC[CAM]AHVFTTVSQITAIEAQHLLK.3|IGLFNSSADR.2|TQVELLEAPTPALKR.3|TQVELLEAPTPALKR.2|LPVATIFTTHATLLGR.3|GADVFLEALAR.2|QLWDTANTVK.2|TNNFNVETLK.2|VGGIYTVLQTK.2|RLPVATIFTTHATLLGR.3|VIFHPEFLSSTSPLLPVDYEEFVR.4|VIFHPEFLSSTSPLLPVDYEEFVR.3|NGPLEEDGERYDEDEEAAK.3|AFPEHFTYEPNEADAAQGYR.3|YLC[CAM]AGAVDFYNNLENFNVDK.3|LYESLLVGSLPDMNK.2|SLDDSC[CAM]SQLTSFLYSFC[CAM]QQSR.3|VTGDEWGDNYFLVGPYTEQGVR.3|AKVTGDEWGDNYFLVGPYTEQGVR.3|VNGSEQTVVAFFIMPAR.2|YLC[CAM]AGAVDFYNNLENFNVDKEAGER.3
SEN / CTL,Calcium-binding mitochondrial carrier protein SCaMC-1,SLC25A24,Q6NUK1,1.20,0.61,1.59E-03,1.14E-03,2.94E+00,"mitochondrial transport,regulation of cell death,ATP transport,cellular response to oxidative stress,transmembrane transport,cellular response to calcium ion","ATP transmembrane transporter activity,calcium ion binding","mitochondrion,mitochondrial inner membrane,integral component of membrane",6,28,40,QLLAGGIAGAVSR.2|QLLAGGIAGAVSR.3|TSTAPLDR.2|QTLGVTQK.2|DGKLDFEEFMK.3|LLTEEGQK.2|MNIFGGFR.2|M[Oxi]NIFGGFR.2|IFTTGDVNK.2|TGQYSGIYDC[CAM]AKK.3|HEGLGAFYK.2|IMMQVHGSK.2|TSTAPLDRLK.2|FWAYEQYK.2|SYWLDNFAK.2|IFTTGDVNKDGKLDFEEFMK.4|VLPAVGISYVVYENMK.3|VLPAVGISYVVYENM[Oxi]K.3|VLPAVGISYVVYENMK.2|VLPAVGISYVVYENM[Oxi]K.2|YETLFQALDR.2|FWAYEQYKK.2|HSTGIDIGDSLTIPDEFTEDEKK.4|HSTGIDIGDSLTIPDEFTEDEKK.3|SDKMNIFGGFR.2|DYFLFNPVTDIEEIIR.3|DYFLFNPVTDIEEIIR.2|TGQYSGIYDC[CAM]AK.2|NLGIPLGQDAEEK.2|MQAQAMLEGSPQLNMVGLFR.3|MQAQAMLEGSPQLNM[Oxi]VGLFR.3|MQAQAMLEGSPQLNMVGLFR.2|FISGSMAGATAQTFIYPMEVMK.3|FISGSMAGATAQTFIYPMEVMK.2|HSTGIDIGDSLTIPDEFTEDEK.3|DSVNPGVMVLLGC[CAM]GALSSTC[CAM]GQLASYPLALVR.4|DSVNPGVM[Oxi]VLLGC[CAM]GALSSTC[CAM]GQLASYPLALVR.3|DSVNPGVMVLLGC[CAM]GALSSTC[CAM]GQLASYPLALVR.3|NGDGVVDIGELQEGLR.2|GITPNFMKVLPAVGISYVVYENMK.3
SEN / CTL,Cytoplasmic dynein 1 heavy chain 1,DYNC1H1,Q14204,1.20,0.95,8.71E-16,6.03E-15,1.42E+01,"G2/M transition of mitotic cell cycle,ER to Golgi vesicle-mediated transport,microtubule-based movement,mitotic spindle organization,antigen processing and presentation of exogenous peptide antigen via MHC class II,cytoplasmic mRNA processing body assembly,stress granule assembly,establishment of spindle localization","microtubule motor activity,ATP binding,ATPase activity,poly(A) RNA binding,dynein light intermediate chain binding","centrosome,cytosol,cytoplasmic dynein complex,microtubule,membrane,filopodium,extracellular matrix,extracellular exosome",81,337,531,FGNPLLVQDVESYDPVLNPVLNR.3|GNEIVLSAGSTPR.2|IFVFEPPPGVK.2|VTFVNFTVTR.2|LLLIQAFRPDR.3|SLLQALNEVK.2|GIFEALRPLETLPVEGLIR.3|GIFEALRPLETLPVEGLIR.4|GIFEALRPLETLPVEGLIR.2|LLAESVTEVEIFGK.2|LLAESVTEVEIFGK.3|ILDDDTIITTLENLKR.3|ILDDDTIITTLENLKR.2|IQGLTVEQAEAVVR.2|IQGLTVEQAEAVVR.3|TTDLLTDWEK.2|NTISLLVAGLKK.3|FLSDPQVHTVLVER.3|FLSDPQVHTVLVER.2|LGEDLNKWQALLVQIR.3|LGEDLNKWQALLVQIR.2|GKEDEGEEAASPMLQIQR.3|GKEDEGEEAASPMLQIQR.2|VTDFGDKVEDPTFLNQLQSGVNR.3|VTDFGDKVEDPTFLNQLQSGVNR.4|MRAELGEYIR.3|VLRPQVTAVAQQNQGEVPEPQDMK.3|VLRPQVTAVAQQNQGEVPEPQDMK.4|VLRPQVTAVAQQNQGEVPEPQDM[Oxi]K.4|VLRPQVTAVAQQNQGEVPEPQDM[Oxi]K.3|ALPDMEVVGLNFSSATTPELLLK.3|ALPDMEVVGLNFSSATTPELLLK.4|ALPDM[Oxi]EVVGLNFSSATTPELLLK.3|SFEWLSQMR.2|SFEWLSQM[Oxi]R.2|TMTLFSALR.2|TM[Oxi]TLFSALR.2|DYIPVDQEELR.2|DYIPVDQEELR.3|TYAEPLTAAMVEFYTMSQER.3|TYAEPLTAAMVEFYTMSQER.2|ENFIPTIVNFSAEEISDAIR.3|ENFIPTIVNFSAEEISDAIR.2|IQFVGAC[CAM]NPPTDPGRKPLSHR.4|IQFVGAC[CAM]NPPTDPGRKPLSHR.5|C[CAM]LGSLFSMLHQAC[CAM]R.3|C[CAM]LGSLFSM[Oxi]LHQAC[CAM]R.3|C[CAM]LGSLFSMLHQAC[CAM]R.2|ALEHAFQLEHIMDLTR.4|ALEHAFQLEHIM[Oxi]DLTR.4|ALEHAFQLEHIM[Oxi]DLTR.3|ALEHAFQLEHIMDLTR.3|ALEHAFQLEHIMDLTR.2|AERPDVDEKR.3|IKETVDQVEELRR.4|IKETVDQVEELRR.3|KLEHLITELVHQR.4|KLEHLITELVHQR.3|NLESALR.2|TSFLDDAFRK.3|TSFLDDAFRK.2|VPVNLLR.2|KYEFGESDLR.3|KYEFGESDLR.2|QM[Oxi]VEHGGFYR.3|QMVEHGGFYR.3|QMVEHGGFYR.2|RSELEEQQMHLNVGLRK.5|RSELEEQQMHLNVGLRK.4|RSELEEQQMHLNVGLRK.3|SALEQMR.2|SQELEVK.2|ALGHQLGR.2|GVAVLC[CAM]TE.2|GVAVLC[CAM]TE.1|QALVAIFTHLR.3|QALVAIFTHLR.2|SLETC[CAM]MYDHK.3|SLETC[CAM]MYDHK.2|TAEVLANK.2|VPLAIVNK.2|NVVHELR.2|SFDSEFK.2|TFDHYC[CAM]EYR.3|TFDHYC[CAM]EYR.2|VDGHKDIQMPDGIRR.4|VKDDIESLHDK.3|VKDDIESLHDK.2|ADLAAVEAK.2|DLEASIAR.2|KFLSDPQVHTVLVER.4|KFLSDPQVHTVLVER.3|NANEMFR.2|QHLVEVR.2|RKLEHLITELVHQR.4|SLLQALNEVKGR.3|SNSLAFIK.2|AISKDHLYGTLDPNTR.4|AISKDHLYGTLDPNTR.3|AISKDHLYGTLDPNTR.2|RTPVIDADKPVSSQLR.4|RTPVIDADKPVSSQLR.3|SNLPDNLK.2|TVENIKDPLFR.3|TVENIKDPLFR.2|GVTDHTQR.2|GVWSELSK.2|LDMEIER.2|MVVLSLPR.2|VEPAVIEAQNAVK.3|VEPAVIEAQNAVK.2|ETVDQVEELRR.3|GMLHQDHITFAMLLAR.4|GM[Oxi]LHQDHITFAMLLAR.4|GM[Oxi]LHQDHITFAMLLAR.3|GMLHQDHITFAMLLAR.3|LMHVAYEEFEK.3|LM[Oxi]HVAYEEFEK.3|LM[Oxi]HVAYEEFEK.2|LMHVAYEEFEK.2|RVEDVLGK.2|RVEPLRNELQK.3|DHLYGTLDPNTR.3|DHLYGTLDPNTR.2|LSC[CAM]LPAFK.2|VLLTTQGVDMISK.3|VLLTTQGVDMISK.2|VLLTTQGVDM[Oxi]ISK.2|AELGEYIR.2|ALGEYLER.2|QLQNISLAAASGGAK.3|QLQNISLAAASGGAK.2|EVDGLDVSK.2|IFTIESTR.2|TLHTTASNWLHLIPQTLSHLK.5|TLHTTASNWLHLIPQTLSHLK.4|TLHTTASNWLHLIPQTLSHLK.3|TSDQTWVK.2|ALERLEGVEGVAHIIDPK.4|ALERLEGVEGVAHIIDPK.3|AWTQVLLGQAEDK.3|AWTQVLLGQAEDK.2|IKETVDQVEELR.3|KYTGEDFDEDLRTVLR.4|RSELEEQQMHLNVGLR.4|RSELEEQQMHLNVGLR.3|SIPLDEGEDEAQR.3|SIPLDEGEDEAQR.2|SVLVSAGNVK.2|TFSEILNR.2|VMSQEIQEQLHK.3|VMSQEIQEQLHK.2|EWTDGLFTHVLR.3|EWTDGLFTHVLR.2|GTFDNAETK.2|KYTGEDFDEDLR.3|KYTGEDFDEDLR.2|LEGVEGVAHIIDPK.3|LEGVEGVAHIIDPK.2|LEHLITELVHQR.3|LEHLITELVHQR.2|LQGEFQLR.2|LSC[CAM]LPAFKDLIAK.3|RTVENIKDPLFR.3|SMANPPAAVK.2|SM[Oxi]ANPPAAVK.2|TDSTSDGRPAWMR.3|TSFLDDAFRKNLESALR.4|YATLATVSR.2|GWDDLFNK.2|GWDDLFNK.1|IFRQPQGHLLLIGVSGAGK.4|IWAHEALR.2|LLNTFLER.2|LRDQLGTAK.2|SSLQSQC[CAM]LNEVLK.3|SSLQSQC[CAM]LNEVLK.2|TFSSIPVSR.2|FQSISTEFLALMK.3|FQSISTEFLALM[Oxi]K.2|FQSISTEFLALMK.2|KLMHVAYEEFEK.3|KLMHVAYEEFEK.2|LGEDLNKWQALLVQIRK.4|LGEDLNKWQALLVQIRK.3|LLTLPNGER.2|SLAMTKPDR.2|ASLAC[CAM]GPMVK.2|ASLAC[CAM]GPM[Oxi]VK.2|FHATVSFDTDTGLK.3|FHATVSFDTDTGLK.2|HYLDFINHYANLFHEK.4|HYLDFINHYANLFHEK.3|HYLDFINHYANLFHEK.2|LRQNLDALLNQLK.3|LRQNLDALLNQLK.2|NLHVVFTM[Oxi]NPSSEGLKDR.4|NLHVVFTMNPSSEGLKDR.4|NLHVVFTMNPSSEGLKDR.3|NLHVVFTM[Oxi]NPSSEGLKDR.3|NLHVVFTMNPSSEGLKDR.2|RTPNGVVLAPVQLGK.3|SNLPDNLKK.2|TLHTTASNWLHLIPQTLSHLKR.5|VDNEFDQR.2|AATSPALFNR.2|DIQMPDGIR.2|EGLMLDSHEELYK.3|EGLMLDSHEELYK.2|LRQYASYEFVQR.3|LRQYASYEFVQR.2|LVQTPLTDR.2|RVEDVLGKGWENHVEGQK.4|RWTDENIDTVALK.3|VAAPDVVVPTLDTVR.3|VAAPDVVVPTLDTVR.2|WFTSQVIR.2|AERPDVDEK.2|ASVVTLPVYLNFTR.3|ASVVTLPVYLNFTR.2|DSAIQQQVANLQMK.3|DSAIQQQVANLQMK.2|GAIREYQTQLIQR.3|KGKEDEGEEAASPMLQIQR.4|QPQGHLLLIGVSGAGK.3|QPQGHLLLIGVSGAGK.2|TAEVLANKIVPFFK.3|VKDDIESLHDKFK.3|VKDDIESLHDKFK.2|EWTDGLFTHVLRK.3|HEALLYTWLAEHK.3|HEALLYTWLAEHK.2|INMLVIELK.2|KVMSQEIQEQLHK.3|LKQDGDSFR.2|LKVNFLPEIITLSK.3|QNISPDKIPWSALK.3|SIPLDEGEDEAQRR.3|TSFLDDAFR.2|AHQANQLYPFAISLIESVR.4|AHQANQLYPFAISLIESVR.3|AHQANQLYPFAISLIESVR.2|AISKDHLYGTLDPNTREWTDGLFTHVLR.6|AISKDHLYGTLDPNTREWTDGLFTHVLR.5|AISKDHLYGTLDPNTREWTDGLFTHVLR.4|ANEVEQMIR.2|ANEVEQM[Oxi]IR.2|LNTQEIFDDWARK.3|NVHLAPGWLMQLEK.3|NVHLAPGWLM[Oxi]QLEK.3|NVHLAPGWLMQLEK.2|NVHLAPGWLM[Oxi]QLEK.2|QALETVNDYNPLMK.3|QALETVNDYNPLMK.2|RESPEVLLTLDILK.3|RESPEVLLTLDILK.2|SSLQSQC[CAM]LNEVLKAERPDVDEKR.5|TPVIDADKPVSSQLR.3|TPVIDADKPVSSQLR.2|AEVDMDTDAPQVSHKPGGEPK.4|AEVDMDTDAPQVSHKPGGEPK.3|AVDDLNLHSYSNLPIWVNK.4|AVDDLNLHSYSNLPIWVNK.3|AVDDLNLHSYSNLPIWVNK.2|HLLPVETQR.2|LKGTVGEPTYDAEFQHFLR.4|QLIAQVMLYSQGFR.3|QLIAQVMLYSQGFR.2|QLIAQVM[Oxi]LYSQGFR.2|YQVGVHYELTEEEKFYR.4|YQVGVHYELTEEEKFYR.3|AMSRPILYSNWLSK.3|AMSRPILYSNWLSK.2|DLFQVAFNR.2|EHINSVSAMK.2|EHINSVSAM[Oxi]K.2|GTFDNAETKK.2|HEALLYTWLAEHKPLVLC[CAM]GPPGSGK.5|HEALLYTWLAEHKPLVLC[CAM]GPPGSGK.4|HEALLYTWLAEHKPLVLC[CAM]GPPGSGK.3|IKQLQNISLAAASGGAK.3|LQGATC[CAM]NNNK.2|NIHVC[CAM]LGGLFVPEAYITATR.4|NIHVC[CAM]LGGLFVPEAYITATR.3|NIHVC[CAM]LGGLFVPEAYITATR.2|SPLVMDVLNIQGVQR.3|SPLVM[Oxi]DVLNIQGVQR.3|SPLVM[Oxi]DVLNIQGVQR.2|SPLVMDVLNIQGVQR.2|STLKEDVGDEGEEEK.3|TPVSITEHPK.2|YEFGESDLR.2|DFPLNDLLSATELDK.3|DFPLNDLLSATELDK.2|IMFEVQDLK.2|IM[Oxi]FEVQDLK.2|LGGSPFGPAGTGKTESVK.3|NTISLLVAGLK.2|RFHATVSFDTDTGLK.3|RFHATVSFDTDTGLK.2|SAC[CAM]DTVDTWLDDTAK.3|SAC[CAM]DTVDTWLDDTAK.2|WAIAQLNYADMLKR.3|WQALLVQIR.2|EAIVNSC[CAM]VFVHQTLHQANAR.4|EAIVNSC[CAM]VFVHQTLHQANAR.3|EAIVNSC[CAM]VFVHQTLHQANAR.2|ILDDDTIITTLENLK.3|ILDDDTIITTLENLK.2|KASVVTLPVYLNFTR.3|KASVVTLPVYLNFTR.2|LGGSPFGPAGTGK.2|ATSIDPNTYITWIDK.3|ATSIDPNTYITWIDK.2|TKPVTGNLRPEEALQALTIYEGKFGR.5|YQVGVHYELTEEEK.3|YQVGVHYELTEEEK.2|FTQDTQPHYIYSPR.3|FTQDTQPHYIYSPR.2|LVPLLLEDGGEAPAALEAALEEK.4|LVPLLLEDGGEAPAALEAALEEK.3|LVPLLLEDGGEAPAALEAALEEK.2|TPVSITEHPKINEWLTLVEK.4|EYQTQLIQR.2|GWENHVEGQK.2|NLHVVFTMNPSSEGLK.3|NLHVVFTM[Oxi]NPSSEGLK.3|NLHVVFTM[Oxi]NPSSEGLK.2|NLHVVFTMNPSSEGLK.2|PLVLC[CAM]GPPGSGK.2|QNLFTTWSHHLQQANIQFR.4|QNLFTTWSHHLQQANIQFR.3|SELEEQQMHLNVGLR.3|VDDLLIIEEK.2|VPQIEVETHK.2|VWEQIDQMK.2|LSLSNAISTALPLTQLR.3|LSLSNAISTALPLTQLR.2|QTDVLQQLSIQMANAK.3|QTDVLQQLSIQMANAK.2|TEYLSNADER.2|TLMAQSIYGGR.2|TLM[Oxi]AQSIYGGR.2|EALELTDTGLLSGSEER.3|EALELTDTGLLSGSEER.2|LFLTMEINPK.2|LYQEMFAWK.2|VEDPTFLNQLQSGVNR.3|VEDPTFLNQLQSGVNR.2|VQYPQSQAC[CAM]K.2|AWTQVLLGQAEDKAEVDMDTDAPQVSHKPGGEPK.6|AWTQVLLGQAEDKAEVDMDTDAPQVSHKPGGEPK.5|EFGPVVIDYGK.2|EGTEAWEAAMK.2|EQPWVSVQPR.2|ETVDQVEELR.2|PILYSNWLSK.2|EDVGDEGEEEK.2|INEWLTLVEK.2|KLVPLLLEDGGEAPAALEAALEEK.4|KLVPLLLEDGGEAPAALEAALEEK.3|NYMSNPSYNYEIVNR.3|NYM[Oxi]SNPSYNYEIVNR.2|NYMSNPSYNYEIVNR.2|RKDSAIQQQVANLQMK.3|RKDSAIQQQVANLQMK.2|VFEEDALSWEDKLNR.3|YKEEYAVLISEAQAIK.3|YKEEYAVLISEAQAIK.2|DYIPVDQEELRDYVK.3|DYIPVDQEELRDYVK.2|DVLLVAQGEMALEEFLK.3|KIAELEMGLLHLQQNIEIPEISLPIHPMITNVAK.6|KIAELEMGLLHLQQNIEIPEISLPIHPM[Oxi]ITNVAK.5|KIAELEMGLLHLQQNIEIPEISLPIHPMITNVAK.5|KIAELEMGLLHLQQNIEIPEISLPIHPMITNVAK.4|QMSVKEDLDKVEPAVIEAQNAVK.4|QNLDALLNQLK.2|SSLQSQC[CAM]LNEVLKAERPDVDEK.4|TKPVTGNLRPEEALQALTIYEGK.4|TKPVTGNLRPEEALQALTIYEGK.3|GRILDDDTIITTLENLK.3|QYASYEFVQR.2|VSPDMAIFITMNPGYAGR.3|VSPDMAIFITMNPGYAGR.2|ANEVEQMIRDLEASIAR.3|DAATIMQPYFTSNGLVTK.3|DAATIM[Oxi]QPYFTSNGLVTK.2|DAATIMQPYFTSNGLVTK.2|DFPLNDLLSATELDKIR.3|FYFVGDEDLLEIIGNSK.3|FYFVGDEDLLEIIGNSK.2|ITNQVIYLNPPIEEC[CAM]R.3|ITNQVIYLNPPIEEC[CAM]R.2|VLQLYQITQINHGLM[Oxi]MVGPSGSGK.4|VLQLYQITQINHGLM[Oxi]MVGPSGSGK.3|VLQLYQITQINHGLMM[Oxi]VGPSGSGK.3|VLQLYQITQINHGLMMVGPSGSGK.3|VLQLYQITQINHGLM[Oxi]M[Oxi]VGPSGSGK.3|DRAATSPALFNR.2|EDLDKVEPAVIEAQNAVK.3|EDLDKVEPAVIEAQNAVK.2|GTVGEPTYDAEFQHFLR.3|GTVGEPTYDAEFQHFLR.2|MLSAVSQQVQC[CAM]IQEALR.3|M[Oxi]LSAVSQQVQC[CAM]IQEALR.2|MLSAVSQQVQC[CAM]IQEALR.2|LAETVFNFQEK.2|MDLEKPNYIVPDYMPVVYDKLPQPPSHR.5|AKEALELTDTGLLSGSEER.3|AKEALELTDTGLLSGSEER.2|EVWNTYELDLVNYQNK.3|EVWNTYELDLVNYQNK.2|HVPVVYVDYPGPASLTQIYGTFNR.4|HVPVVYVDYPGPASLTQIYGTFNR.3|KEFGPVVIDYGK.2|MQMLEDEDDLAYAETEK.3|MQMLEDEDDLAYAETEK.2|SWSHYTVPAGMTVIQWVSDFSER.4|SWSHYTVPAGMTVIQWVSDFSER.3|SWSHYTVPAGM[Oxi]TVIQWVSDFSER.3|TSAPITC[CAM]ELLNK.2|VAEVLFDAADANAIEEVNLAYENVK.4|VAEVLFDAADANAIEEVNLAYENVK.3|VDNEFDQRLLNTFLER.3|FGQM[Oxi]LGSNMTEFHSQISK.3|FGQMLGSNM[Oxi]TEFHSQISK.3|FGQMLGSNMTEFHSQISK.3|FGQMLGSNMTEFHSQISK.2|IAFIMDESNVLDSGFLER.3|IAFIM[Oxi]DESNVLDSGFLER.3|IAFIMDESNVLDSGFLER.2|LALESIC[CAM]LLLGESTTDWK.3|LALESIC[CAM]LLLGESTTDWK.2|LC[CAM]DEQLSSQSHYDFGLR.3|LC[CAM]DEQLSSQSHYDFGLR.2|SRQELEQHSVDTASTSDAVTFITYVQSLKR.5|SRQELEQHSVDTASTSDAVTFITYVQSLKR.4|YKEEYAVLISEAQAIKADLAAVEAK.4|YKEEYAVLISEAQAIKADLAAVEAK.3|YTGEDFDEDLR.2|DLPPVSGSIIWAK.2|VNFLPEIITLSK.2|VQVALEELQDLK.2|TPNGVVLAPVQLGK.2|WTDENIDTVALK.2|AM[Oxi]SRPILYSNWLSKDYIPVDQEELRDYVK.5|DHLYGTLDPNTREWTDGLFTHVLR.4|DPASGTALQEISFWLNLER.3|EVDGLDVSKEGTEAWEAAMK.3|MQMLEDEDDLAYAETEKK.3|VAAPDVVVPTLDTVRHEALLYTWLAEHKPLVLC[CAM]GPPGSGK.6|VAAPDVVVPTLDTVRHEALLYTWLAEHKPLVLC[CAM]GPPGSGK.5|C[CAM]YLTMTQALEAR.2|ESPEVLLTLDILK.2|LLQDVRQDLADVVQVC[CAM]EGK.3|QDLADVVQVC[CAM]EGK.2|RFNRYPLIIDPSGQATEFIM[Oxi]NEYK.4|RFNRYPLIIDPSGQATEFIMNEYK.4|RFNRYPLIIDPSGQATEFIMNEYK.3|TLMAQSIYGGRVDNEFDQR.3|VFEEDALSWEDK.2|VLTLSEDSPYETLHSFISNAVAPFFK.4|VLTLSEDSPYETLHSFISNAVAPFFK.3|IAELEMGLLHLQQNIEIPEISLPIHPMITNVAK.5|IAELEMGLLHLQQNIEIPEISLPIHPMITNVAK.4|AMSRPILYSNWLSKDYIPVDQEELR.4|DHLYGTLDPNTREWTDGLFTHVLRK.4|FNRYPLIIDPSGQATEFIMNEYKDR.4|LNTQEIFDDWAR.2|TTDLLTDWEKTKPVTGNLRPEEALQALTIYEGK.5|WQASSLPADDLC[CAM]TENAIMLK.3|WQASSLPADDLC[CAM]TENAIM[Oxi]LK.3|WQASSLPADDLC[CAM]TENAIMLK.2|C[CAM]VLNWFGDWSTEALYQVGK.3|C[CAM]VLNWFGDWSTEALYQVGK.2|DPTVEFPPDLC[CAM]SR.2|MLSAVSQQVQC[CAM]IQEALREHSNPNYDK.4|PVTGNLRPEEALQALTIYEGK.3|VQVALEELQDLKGVWSELSK.3|VTDFGDKVEDPTFLNQLQSGVNRWIR.4|AVDDLNLHSYSNLPIWVNKLDMEIER.4|WAIAQLNYADM[Oxi]LK.2|WAIAQLNYADMLK.2|YPLIIDPSGQATEFIMNEYK.3|YPLIIDPSGQATEFIMNEYK.2|EEYAVLISEAQAIK.2|FNYGFEYLGVQDK.2|FYFVGDEDLLEIIGNSKNVAK.3|QELEQHSVDTASTSDAVTFITYVQSLKR.4|SIIM[Oxi]RENFIPTIVNFSAEEISDAIREK.4|EEFVQWVELLPDTQTPSWLGLPNNAER.4|EEFVQWVELLPDTQTPSWLGLPNNAER.3|MFAGVSSIILNEDNSVVLGISSR.3|QDLADVVQVC[CAM]EGKK.2|VWEQIDQMKEQPWVSVQPR.3|EHSNPNYDKTSAPITC[CAM]ELLNK.3|IQFVGAC[CAM]NPPTDPGR.2|LALESIC[CAM]LLLGESTTDWKQIR.3|MDLEKPNYIVPDYMPVVYDK.3|SRQELEQHSVDTASTSDAVTFITYVQSLK.4|SRQELEQHSVDTASTSDAVTFITYVQSLK.3|TTDLLTDWEKTKPVTGNLRPEEALQALTIYEGKFGR.5|FVAWMNGLSVYQIK.2|FVAWM[Oxi]NGLSVYQIK.2|REEFVQWVELLPDTQTPSWLGLPNNAER.4|REEFVQWVELLPDTQTPSWLGLPNNAER.3|ENFIPTIVNFSAEEISDAIREK.3|LDRDPASGTALQEISFWLNLER.3|NVAQYNANHPDFPM[Oxi]QIEQLER.3|NVAQYNANHPDFPMQIEQLER.3|ITTVPLPTAPNIPIIDYEVSISGEWSPWQAK.4|ITTVPLPTAPNIPIIDYEVSISGEWSPWQAK.3|WVYLEGIFTGSADIK.2|FNYGFEYLGVQDKLVQTPLTDR.3|YPLIIDPSGQATEFIMNEYKDR.3|MKLNTQEIFDDWAR.2|QALETVNDYNPLMKDFPLNDLLSATELDKIR.4|DLSSQLLK.1|FNRYPLIIDPSGQATEFIMNEYK.3|PNYIVPDYMPVVYDK.2|IFVGLC[CAM]QVGAWGC[CAM]FDEFNRLEER.3|C[CAM]VLNWFGDWSTEALYQVGKEFTSK.3|MNTLLANGEVPGLFEGDEYATLMTQC[CAM]K.3|QELEQHSVDTASTSDAVTFITYVQSLK.3|QWIVFDGDVDPEWVENLNSVLDDNK.3|RQWIVFDGDVDPEWVENLNSVLDDNK.3|DIQMPDGIRREEFVQWVELLPDTQTPSWLGLPNNAER.4|EALELTDTGLLSGSEERVQVALEELQDLK.3|GEAVDEGEIAENLPEQEILIQSVC[CAM]ETMVPK.3|VQADEQFGIWLDSSSPEQTVPYLWSEETPATPIGQAIHR.4
SEN / CTL,Transmembrane protein 109,TMEM109,Q9BVC6,1.20,0.65,8.09E-02,3.01E-02,1.52E+00,"ion transport,regulation of ion transmembrane transport,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,negative regulation of cell death,cellular response to gamma radiation","molecular_function,voltage-gated ion channel activity","nuclear outer membrane,integral component of membrane,sarcoplasmic reticulum membrane,extracellular exosome",3,5,6,EAPVDVLTQIGR.2|ASGAQLEAK.2|REAPVDVLTQIGR.3|REAPVDVLTQIGR.2|ASGAQLEAKVR.2|RDFAPPGQQK.2
SEN / CTL,Ras GTPase-activating-like protein IQGAP1,IQGAP1,P46940,1.20,0.69,1.67E-32,5.02E-31,3.03E+01,"regulation of cytokine production,signal transduction,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,negative regulation of GTPase activity,negative regulation of dephosphorylation,cellular response to platelet-derived growth factor stimulus,positive regulation of MAP kinase activity,positive regulation of GTPase activity,positive regulation of protein kinase activity,platelet-derived growth factor receptor signaling pathway,positive regulation of focal adhesion assembly,cellular response to calcium ion,cellular response to epidermal growth factor stimulus,glomerular visceral epithelial cell development,cell-cell adhesion,positive regulation of dendrite development,positive regulation of peptidyl-tyrosine autophosphorylation,positive regulation of cellular protein localization,positive regulation of vascular associated smooth muscle cell migration,neuron projection extension,response to angiotensin","GTPase inhibitor activity,GTPase activator activity,calcium ion binding,protein binding,calmodulin binding,phosphatidylinositol-3,4,5-trisphosphate binding,protein kinase binding,protein phosphatase binding,protein domain specific binding,protein complex binding,protein serine/threonine kinase activator activity,S100 protein binding,Rac GTPase binding,mitogen-activated protein kinase binding,cadherin binding involved in cell-cell adhesion","ruffle,nucleus,cytoplasm,cytosol,microtubule,actin filament,plasma membrane,cell-cell adherens junction,focal adhesion,lateral plasma membrane,axon,growth cone,midbody,extrinsic component of cytoplasmic side of plasma membrane,slit diaphragm,cytoplasmic ribonucleoprotein granule,neuron projection,protein complex,membrane raft,extracellular exosome,actin cytoskeleton,microtubule cytoskeleton",120,128,200,NKYQELINDIAR.3|NKYQELINDIAR.2|IIGNLLYYR.2|LIVDVIR.2|QNVAYEYLC[CAM]HLEEAKR.4|TLQALQIPAAKLEGVLAEVAQHYQDTLIR.4|EQLWLANEGLITR.2|EQLWLANEGLITR.3|MREEVITLIR.3|MREEVITLIR.2|IFYPETTDIYDRK.3|IFYPETTDIYDRK.2|ILAIGLINEALDEGDAQK.3|ILAIGLINEALDEGDAQK.2|ATFYGEQVDYYK.2|ATFYGEQVDYYK.3|VDQIQEIVTGNPTVIK.2|VDQIQEIVTGNPTVIK.3|SNQQLENDLNLMDIK.2|SNQQLENDLNLMDIK.3|SNQQLENDLNLM[Oxi]DIK.2|HTDNVIQWLNAMDEIGLPK.3|HTDNVIQWLNAM[Oxi]DEIGLPK.3|HTDNVIQWLNAMDEIGLPK.2|LEGVLAEVAQHYQDTLIR.3|LEGVLAEVAQHYQDTLIR.4|LEGVLAEVAQHYQDTLIR.2|C[CAM]IYC[CAM]IHALSLYLFK.3|C[CAM]IYC[CAM]IHALSLYLFK.2|ILAIGLINEALDEGDAQKTLQALQIPAAK.4|ILAIGLINEALDEGDAQKTLQALQIPAAK.3|YGIQMPAFSK.2|YGIQM[Oxi]PAFSK.2|NKEQLSDMMMINK.3|NKEQLSDMMMINK.2|TLINAEDPPMVVVR.3|TLINAEDPPMVVVR.2|TLINAEDPPM[Oxi]VVVR.2|AVTDKFLSAIVSSVDKIPYGMR.4|AVTDKFLSAIVSSVDKIPYGM[Oxi]R.4|AVTDKFLSAIVSSVDKIPYGM[Oxi]R.3|AVTDKFLSAIVSSVDKIPYGMR.3|MFLGDNAHLSIINEYLSQSYQK.3|MFLGDNAHLSIINEYLSQSYQK.4|M[Oxi]FLGDNAHLSIINEYLSQSYQK.3|QIPAITC[CAM]IQSQWR.2|QIPAITC[CAM]IQSQWR.3|SKVDQIQEIVTGNPTVIK.3|SKVDQIQEIVTGNPTVIK.4|SKVDQIQEIVTGNPTVIK.2|FALGIFAINEAVESGDVGK.3|FALGIFAINEAVESGDVGK.2|SPDVGLYGVIPEC[CAM]GETYHSDLAEAK.3|LQYFRDHINDIIK.3|LAAVALINAAIQK.2|LAAVALINAAIQK.3|YQELINDIAR.2|ALESGDVNTVWK.2|IFYPETTDIYDR.2|NKITLQDVVSHSK.3|LQQTYAALNSK.2|FQPGETLTEILETPATSEQEAEHQR.3|FQPGETLTEILETPATSEQEAEHQR.4|NVIFEISPTEEVGDFEVK.3|NVIFEISPTEEVGDFEVK.2|EKLEAYQHLFYLLQTNPTYLAK.4|EKLEAYQHLFYLLQTNPTYLAK.3|ATGLHFR.2|KLTELGTVDPK.3|KLTELGTVDPK.2|RIPADTFAALK.3|RIPADTFAALK.2|TILLNTK.2|ITLQDVVSHSK.3|ITLQDVVSHSK.2|ELATLQR.2|RQSGQTDPLQK.3|RQSGQTDPLQK.2|MVVSFNR.2|LGNFFSPK.2|YLDELMK.2|LAVGDNNSK.2|TALQEEIK.2|TDPVDIYK.2|DHINDIIK.2|RLAAVALINAAIQK.3|RLAAVALINAAIQK.2|DSLHEKFPDAGEDELLK.4|DSLHEKFPDAGEDELLK.3|GLQQQNSDWYLK.3|GLQQQNSDWYLK.2|RLIVDVIR.2|MLQHAASNK.2|SLNIKTDPVDIYK.3|SLNIKTDPVDIYK.2|SVKEDSNLTLQEK.3|SVKEDSNLTLQEK.2|VNVNLLIFLLNKK.3|ALQSPALGLR.2|TC[CAM]LDNLASK.2|IPADTFAALK.2|KLAVGDNNSK.2|AKVNVNLLIFLLNK.3|LTELGTVDPK.2|RQNVAYEYLC[CAM]HLEEAKR.4|SVKEDSNLTLQEKK.3|LTAEEMDER.2|LTAEEM[Oxi]DER.2|QSGQTDPLQK.2|TEVSLTLTNK.2|AVTDKFLSAIVSSVDK.3|LIFQMPQNK.2|LIFQM[Oxi]PQNK.2|FFQTAC[CAM]DVPELQDK.3|FFQTAC[CAM]DVPELQDK.2|TLINAEDPPMVVVRK.3|VLKDSLHEKFPDAGEDELLK.4|EEIQSSISGVTAAYNR.3|EEIQSSISGVTAAYNR.2|TLQALQIPAAK.2|FLSAIVSSVDK.2|GVLLEIEDLQVNQFK.3|GVLLEIEDLQVNQFK.2|EDSNLTLQEK.2|LAAVALINAAIQKGVAEK.3|QSPEHNLTHPELSVAVEMLSSVALINR.5|QSPEHNLTHPELSVAVEMLSSVALINR.4|QSPEHNLTHPELSVAVEM[Oxi]LSSVALINR.4|QSPEHNLTHPELSVAVEMLSSVALINR.3|LEAYQHLFYLLQTNPTYLAK.4|LEAYQHLFYLLQTNPTYLAK.3|FVHLLDQSDQDFQEELDLMK.4|FVHLLDQSDQDFQEELDLMK.3|FVHLLDQSDQDFQEELDLM[Oxi]K.3|FPDAGEDELLK.2|QNVAYEYLC[CAM]HLEEAK.3|QNVAYEYLC[CAM]HLEEAK.2|FLSAIVSSVDKIPYGMR.3|FLSAIVSSVDKIPYGM[Oxi]R.3|KFVHLLDQSDQDFQEELDLMK.4|KFVHLLDQSDQDFQEELDLMK.3|LPYDVTPEQALAHEEVK.3|LPYDVTPEQALAHEEVK.2|PHYGSVLDNER.2|EQLSDMMMINK.2|EQLSDMMM[Oxi]INK.2|RQNVAYEYLC[CAM]HLEEAK.3|DVYEELLTQAEIQGNINK.3|DVYEELLTQAEIQGNINK.2|EELQSGVDAANSAAQQYQR.3|EELQSGVDAANSAAQQYQR.2|FM[Oxi]DSVIFTLYNYASNQR.3|FMDSVIFTLYNYASNQR.3|FMDSVIFTLYNYASNQR.2|LKAQAHAENNEFITWNDIQAC[CAM]VDHVNLVVQEEHER.6|LKAQAHAENNEFITWNDIQAC[CAM]VDHVNLVVQEEHER.5|VDFTEEEINNMKTELEK.3|VNVNLLIFLLNK.2|LGLAPQIQDLYGK.2|SPDVGLYGVIPEC[CAM]GETYHSDLAEAKK.4|QLSSSVTGLTNIEEENC[CAM]QR.3|QLSSSVTGLTNIEEENC[CAM]QR.2|TALQEEIKSKVDQIQEIVTGNPTVIK.4|TVLELMNPEAQLPQVYPFAADLYQK.4|TVLELM[Oxi]NPEAQLPQVYPFAADLYQK.3|TVLELMNPEAQLPQVYPFAADLYQK.3|VDFTEEEINNMK.2|VDFTEEEINNM[Oxi]K.2|DSLHEKFPDAGEDELLKIIGNLLYYR.4|AQAHAENNEFITWNDIQAC[CAM]VDHVNLVVQEEHER.5|AQAHAENNEFITWNDIQAC[CAM]VDHVNLVVQEEHER.4|ERDVYEELLTQAEIQGNINK.3|ERDVYEELLTQAEIQGNINK.2|FDVPGDENAEM[Oxi]DAR.2|FDVPGDENAEMDAR.2|QSGQTDPLQKEELQSGVDAANSAAQQYQR.4|QSGQTDPLQKEELQSGVDAANSAAQQYQR.3|YMNPAIVAPDAFDIIDLSAGGQLTTDQRR.4|YMNPAIVAPDAFDIIDLSAGGQLTTDQRR.3|FNVDEYSDLVTLTK.2|RQSGQTDPLQKEELQSGVDAANSAAQQYQR.4|RWMEAC[CAM]LGEDLPPTTELEEGLRNGVYLAK.4|SWVNQMESQTGEASK.2|TLSALRSPDVGLYGVIPEC[CAM]GETYHSDLAEAK.4|FALGIFAINEAVESGDVGKTLSALR.3|VNTFSALANIDLALEQGDALALFR.3|LGLAPQIQDLYGKVDFTEEEINNMKTELEK.4|RWMEAC[CAM]LGEDLPPTTELEEGLR.3|TEVSLTLTNKFDVPGDENAEMDAR.3|SWVNQMESQTGEASKLPYDVTPEQALAHEEVK.4|GGYYYYHNLETQEGGWDEPPNFVQNSMQLSR.4|AQEIQDESAVLWLDEIQGGIWQSNK.3|IPADTFAALKNPNAMLVNLEEPLASTYQDILYQAK.4|LGLAPQIQDLYGKVDFTEEEINNMK.3|NPNAMLVNLEEPLASTYQDILYQAK.3|EKAQEIQDESAVLWLDEIQGGIWQSNKDTQEAQK.4|YM[Oxi]NPAIVAPDAFDIIDLSAGGQLTTDQR.3|YMNPAIVAPDAFDIIDLSAGGQLTTDQR.3|RIPADTFAALKNPNAMLVNLEEPLASTYQDILYQAK.4|IPADTFAALKNPNAMLVNLEEPLASTYQDILYQAKQDK.4
SEN / CTL,Tissue alpha-L-fucosidase,FUCA1,P04066,1.19,0.66,6.94E-12,3.02E-11,1.05E+01,"fucose metabolic process,glycosaminoglycan catabolic process,glycoside catabolic process",alpha-L-fucosidase activity,"cytoplasm,lysosomal lumen,extracellular exosome",39,21,32,DGLIVPIFQER.2|WLSINGEAIYASKPWR.3|DLVGELGTALR.2|DVGPHRDLVGELGTALR.3|DVGPHRDLVGELGTALR.4|RYTPDWPSLDSRPLPAWFDEAK.4|FFHPEEWADLFQAAGAK.3|FFHPEEWADLFQAAGAK.2|ITMLGIQGDLK.2|ITM[Oxi]LGIQGDLK.2|FMRDNYPPGFSYADFGPQFTAR.3|YTPDWPSLDSRPLPAWFDEAK.3|YVVLTTK.2|GSAVYAIFLHWPENGVLNLESPITTSTTK.3|GSAVYAIFLHWPENGVLNLESPITTSTTK.4|HHEGFTNWPSPVSWNWNSK.3|HHEGFTNWPSPVSWNWNSK.4|HHEGFTNWPSPVSWNWNSK.2|DLVGELGTALRK.3|DLVGELGTALRK.2|TQHFVSAK.2|FKPQSLPDHKWEMC[CAM]TSIDK.5|FKPQSLPDHKWEMC[CAM]TSIDK.4|FKPQSLPDHKWEMC[CAM]TSIDK.3|DVGPHRDLVGELGTALRK.4|DVGPHRDLVGELGTALRK.3|PLPAWFDEAK.2|WEMC[CAM]TSIDK.2|DNYPPGFSYADFGPQFTAR.3|DNYPPGFSYADFGPQFTAR.2|WLSINGEAIYASK.2|GLFISLPQLPPSAVPAEFAWTIK.3
SEN / CTL,Lipopolysaccharide-responsive and beige-like anchor protein,LRBA,P50851,1.17,1.09,4.97E-03,2.98E-03,2.53E+00,biological_process,molecular_function,"lysosome,endoplasmic reticulum,Golgi apparatus,plasma membrane,membrane,integral component of membrane",12,75,87,VANEAEFILSR.2|LQATMETDDNIR.2|EAVEAQIR.2|EIFVDFAPFLSR.2|ILAYTEGLHGK.3|DLSKPIGALNPK.3|FKAESDLFLAEHHK.4|FKAESDLFLAEHHK.3|AVVFRDIEDSK.3|HVLEISR.2|ASPNVEAPQPHR.3|ASPNVEAPQPHR.2|NPLGSTHPEATLK.3|NPLGSTHPEATLK.2|AFLSDMIK.2|IINILTDK.2|IQNPQILK.2|YRDILEPQNER.3|AFLLMFIK.2|AFLLM[Oxi]FIK.2|NAGLAFIELVNEGR.3|NAGLAFIELVNEGR.2|NC[CAM]LEC[CAM]QQHSQLK.3|NC[CAM]LEC[CAM]QQHSQLK.2|C[CAM]SGIGDNPGSETAAPR.3|C[CAM]SGIGDNPGSETAAPR.2|IPEFNWSQMHQR.3|IPEFNWSQMHQR.2|LDMFGNDDK.2|YRDHVTATQLIQK.3|DNPSIFVHSPHALMLQDVK.4|LLQDMDINR.2|VAVMFNFPDPATVKK.3|SAAAIALPPIAK.2|AQQDVIMVLK.2|TLLGSHGQELLIEGTSLVC[CAM]MK.4|TLLGSHGQELLIEGTSLVC[CAM]MK.3|DGQYLLTGGDR.2|HAEFESLC[CAM]AQYSADKREDEK.4|LDVSNVATDTERLELK.3|GFLVIGYSLEK.2|LDYWEDDLR.2|TSEEFVHINR.2|IEPFTTYFLNLQGGKFDHADR.4|LINDC[CAM]HGSVSEASSEQK.3|LINDC[CAM]HGSVSEASSEQK.2|MDPVNNINVDK.2|HAEFESLC[CAM]AQYSADKR.3|QHEQPGQGIAPDAVNGQR.3|QHEQPGQGIAPDAVNGQR.2|SFGQTPSQLLIEPHPPR.3|SPVDIVTGGISPVRDLDR.3|YILVC[CAM]GFWDK.2|EETPTEGGALSLKPGLPIR.3|HGAWGNSAVSRPLEFWR.3|LDVSNVATDTER.2|VGVGTSFGLPQTR.2|EISNFEYLMFLNTIAGR.3|EISNFEYLMFLNTIAGR.2|LSSAIAFTYNPR.2|YGPDAFFNFPGK.2|LIFQEGKPVTEK.2|SPVDIVTGGISPVR.2|YESWEDDQVPK.2|ATDAQLC[CAM]LESSPK.2|C[CAM]FLGSSETADANR.2|NSPQC[CAM]PESMEVR.2|QLFAYPGC[CAM]DAGIR.2|DINVSVGSQQPDTK.2|YLSNLQNGMPLLK.2|YYYWAVNPQDR.2|GSAMQVSPLMFTDK.2|WHNLPAHQGAVQDQPYQLPVEIDPLIASNTGMHR.5|VAVMFNFPDPATVK.2|WHNLPAHQGAVQDQPYQLPVEIDPLIASNTGMHRR.5|LPSVPTVDSVSQDPVSNMSITER.3|DLENLAGPVSLSTPAQLVAPSVVVK.3|IEPFTTYFLNLQGGK.2|AEQENQELPDEGTLEETLTNETR.3|SESYIGGNC[CAM]YILSGSR.2|SSSSVVELVMLLC[CAM]SQEWQNSIQK.3|YLLQNTALEIFMANR.2|SIVEEEEDDDYVELK.2|SLVNIPADGVTVDPALLPPAC[CAM]LGALGDLSVEQPVQFR.4|FPSNSPVTHVAANTQPGLATPAVITVTANR.3|VEGSPTEEANLPTELQDNSLSPAASEAGEK.3|DSGIGEETATGLGSHVEVTPHTAPPGVSAGPDAISEVLSTLSLEVNK.4
SEN / CTL,Interleukin-8,CXCL8,P10145,1.16,0.53,6.12E-02,2.38E-02,1.62E+00,"angiogenesis,response to molecule of bacterial origin,movement of cell or subcellular component,chemotaxis,inflammatory response,immune response,cell cycle arrest,signal transduction,G-protein coupled receptor signaling pathway,negative regulation of cell proliferation,calcium-mediated signaling,regulation of cell adhesion,neutrophil chemotaxis,receptor internalization,response to endoplasmic reticulum stress,intracellular signal transduction,PERK-mediated unfolded protein response,neutrophil activation,cellular response to fibroblast growth factor stimulus,regulation of single stranded viral RNA replication via double stranded DNA intermediate,negative regulation of G-protein coupled receptor protein signaling pathway,positive regulation of angiogenesis,embryonic digestive tract development,induction of positive chemotaxis,chemokine-mediated signaling pathway,cellular response to lipopolysaccharide,cellular response to interleukin-1,cellular response to tumor necrosis factor,positive regulation of neutrophil chemotaxis,regulation of entry of bacterium into host cell","interleukin-8 receptor binding,protein binding,chemokine activity","extracellular region,extracellular space,intracellular",3,1,2,VIESGPHC[CAM]ANTEIIVK.3|VIESGPHC[CAM]ANTEIIVK.2
SEN / CTL,Laminin subunit alpha-3,LAMA3,Q16787,1.15,0.97,1.18E-02,6.14E-03,2.21E+00,"cell adhesion,epidermis development,extracellular matrix disassembly,regulation of cell adhesion,extracellular matrix organization,regulation of cell migration,hemidesmosome assembly,endodermal cell differentiation,regulation of embryonic development","receptor binding,structural molecule activity","extracellular region,basement membrane,laminin-5 complex,extracellular exosome",9,14,14,LLIDDQLLR.2|VPTQPHAPIPTFGQTIQTTVDR.3|SPQTYMDGLLHYVSVISDNSGLR.3|THQGENNGLANSIR.3|ALTDADNSVNK.2|AQTLNNNVNR.2|C[CAM]QEGYYGNAVHGSC[CAM]R.3|HLC[CAM]VYLEAGK.2|C[CAM]APGYFGNPQK.2|THQGENNGLANSIRDSLNEYEAK.4|AASASESALQTVIK.2|DVSLGGC[CAM]SLNKPPFLMLLK.3|AC[CAM]PC[CAM]PHTNSFATGC[CAM]VVNGGDVR.3|C[CAM]AIGYYNFPFC[CAM]LR.2
SEN / CTL,Lysosome membrane protein 2,SCARB2,Q14108,1.14,0.29,2.72E-08,6.21E-08,7.21E+00,"protein targeting to lysosome,viral entry into host cell","virus receptor activity,protein binding,enzyme binding","lysosomal membrane,focal adhesion,membrane,integral component of membrane,lysosomal lumen,extracellular exosome",12,15,24,KLDDFVETGDIR.3|KLDDFVETGDIR.2|FVSAIEGMHPNQEDHETFVDINPLTGIILK.4|FVSAIEGM[Oxi]HPNQEDHETFVDINPLTGIILK.4|FVSAIEGMHPNQEDHETFVDINPLTGIILK.5|FVSAIEGMHPNQEDHETFVDINPLTGIILK.3|AVDQSIEK.2|EIIEAMLK.2|AYVFERDQSVGDPK.3|AYVFERDQSVGDPK.2|GETPRVEEVGPYTYR.3|LFVTHTVDELLWGYK.3|LFVTHTVDELLWGYK.2|VEEVGPYTYR.2|TSLDWWITDK.2|LDDFVETGDIR.2|GQGSMDEGTADER.2|NGAPIIM[Oxi]SFPHFYQADER.3|NGAPIIMSFPHFYQADER.3|NGAPIIMSFPHFYQADER.2|SVYITFSDYESVQGLPAFR.3|SVYITFSDYESVQGLPAFR.2|TLNIPVLTVIEWSQVHFLR.3|DEVLYVFPSDFC[CAM]R.2
SEN / CTL,Tubulin beta chain,TUBB,P07437,1.14,0.56,1.33E-12,6.70E-12,1.12E+01,"G2/M transition of mitotic cell cycle,movement of cell or subcellular component,microtubule-based process,cellular process,cytoskeleton-dependent intracellular transport,natural killer cell mediated cytotoxicity,spindle assembly,cell division","GTPase activity,structural molecule activity,structural constituent of cytoskeleton,protein binding,GTP binding,protein domain specific binding,ubiquitin protein ligase binding,protein complex binding,GTPase activating protein binding,MHC class I protein binding","extracellular region,nucleus,nuclear envelope lumen,cytoskeleton,microtubule,extracellular matrix,cytoplasmic ribonucleoprotein granule,protein complex,cell body,extracellular exosome",30,8,21,ALTVPELTQQVFDAK.2|ALTVPELTQQVFDAK.3|ISVYYNEATGGKYVPR.3|ISVYYNEATGGK.2|ISVYYNEATGGK.3|FWEVISDEHGIDPTGTYHGDSDLQLDR.4|FWEVISDEHGIDPTGTYHGDSDLQLDR.3|FWEVISDEHGIDPTGTYHGDSDLQLDR.5|MAVTFIGNSTAIQELFKR.3|MAVTFIGNSTAIQELFKR.4|M[Oxi]AVTFIGNSTAIQELFKR.3|M[Oxi]AVTFIGNSTAIQELFKR.2|MAVTFIGNSTAIQELFKR.2|MAVTFIGNSTAIQELFK.3|M[Oxi]AVTFIGNSTAIQELFK.3|MAVTFIGNSTAIQELFK.2|M[Oxi]AVTFIGNSTAIQELFK.2|FWEVISDEHGIDPTGTYHGDSDLQLDRISVYYNEATGGKYVPR.7|FWEVISDEHGIDPTGTYHGDSDLQLDRISVYYNEATGGKYVPR.5|FWEVISDEHGIDPTGTYHGDSDLQLDRISVYYNEATGGK.5|FWEVISDEHGIDPTGTYHGDSDLQLDRISVYYNEATGGK.4
SEN / CTL,Tubulin alpha-8 chain,TUBA8,Q9NY65,1.14,0.25,1.39E-02,6.94E-03,2.16E+00,"cytoskeleton organization,microtubule-based process","GTPase activity,structural constituent of cytoskeleton,GTP binding","cytoplasm,microtubule",3,7,9,KLTDAC[CAM]SGLQGFLIFHSFGGGTGSGFTSLLMER.4|GHYTVGKESIDLVLDR.4|GHYTVGKESIDLVLDR.3|DVNVAIAAIK.2|IHFPLVTYAPIISAEK.3|IHFPLVTYAPIISAEK.2|AVMIDLEPTVVDEVR.2|AYHEQLSVAEITSSC[CAM]FEPNSQMVK.3|INDDDSFTTFFSETGNGK.2
SEN / CTL,Creatine kinase B-type,CKB,P12277,1.13,0.65,1.76E-19,1.90E-18,1.77E+01,"creatine metabolic process,phosphorylation,substantia nigra development,cellular chloride ion homeostasis","creatine kinase activity,protein binding,ATP binding,ubiquitin protein ligase binding","extracellular space,cytoplasm,mitochondrion,cytosol,myelin sheath,extracellular exosome",63,33,80,VLTPELYAELR.2|VLTPELYAELR.3|HGGYKPSDEHKTDLNPDNLQGGDDLDPNYVLSSR.5|HGGYKPSDEHKTDLNPDNLQGGDDLDPNYVLSSR.4|HGGYKPSDEHKTDLNPDNLQGGDDLDPNYVLSSR.6|FC[CAM]TGLTQIETLFK.2|FC[CAM]TGLTQIETLFK.3|TFLVWVNEEDHLR.3|TFLVWVNEEDHLR.2|LAVEALSSLDGDLAGR.2|LAVEALSSLDGDLAGR.3|LLIEMEQR.2|LLIEM[Oxi]EQR.2|LEQGQAIDDLMPAQK.2|LEQGQAIDDLMPAQK.3|LEQGQAIDDLM[Oxi]PAQK.3|LEQGQAIDDLM[Oxi]PAQK.2|LGFSEVELVQMVVDGVK.3|LGFSEVELVQMVVDGVK.2|LGFSEVELVQM[Oxi]VVDGVK.3|LGFSEVELVQM[Oxi]VVDGVK.2|SKDYEFMWNPHLGYILTC[CAM]PSNLGTGLR.4|SKDYEFM[Oxi]WNPHLGYILTC[CAM]PSNLGTGLR.4|SKDYEFMWNPHLGYILTC[CAM]PSNLGTGLR.5|SKDYEFM[Oxi]WNPHLGYILTC[CAM]PSNLGTGLR.3|SKDYEFMWNPHLGYILTC[CAM]PSNLGTGLR.3|LRFPAEDEFPDLSAHNNHMAK.5|LRFPAEDEFPDLSAHNNHMAK.4|LRFPAEDEFPDLSAHNNHM[Oxi]AK.5|LRFPAEDEFPDLSAHNNHM[Oxi]AK.4|LRFPAEDEFPDLSAHNNHM[Oxi]AK.3|LRFPAEDEFPDLSAHNNHMAK.3|SMTEAEQQQLIDDHFLFDKPVSPLLLASGMAR.4|SM[Oxi]TEAEQQQLIDDHFLFDKPVSPLLLASGMAR.5|SMTEAEQQQLIDDHFLFDKPVSPLLLASGM[Oxi]AR.5|SMTEAEQQQLIDDHFLFDKPVSPLLLASGMAR.5|SM[Oxi]TEAEQQQLIDDHFLFDKPVSPLLLASGM[Oxi]AR.4|SM[Oxi]TEAEQQQLIDDHFLFDKPVSPLLLASGMAR.4|SMTEAEQQQLIDDHFLFDKPVSPLLLASGM[Oxi]AR.4|SMTEAEQQQLIDDHFLFDKPVSPLLLASGMAR.3|RGTGGVDTAAVGGVFDVSNADRLGFSEVELVQMVVDGVK.4|RGTGGVDTAAVGGVFDVSNADRLGFSEVELVQMVVDGVK.5|RGTGGVDTAAVGGVFDVSNADRLGFSEVELVQM[Oxi]VVDGVK.4|AGVHIKLPNLGKHEK.4|GFC[CAM]LPPHC[CAM]SR.3|GFC[CAM]LPPHC[CAM]SR.2|HGGYKPSDEHK.3|FPAEDEFPDLSAHNNHMAK.5|FPAEDEFPDLSAHNNHMAK.4|FPAEDEFPDLSAHNNHM[Oxi]AK.4|FPAEDEFPDLSAHNNHMAK.3|FPAEDEFPDLSAHNNHM[Oxi]AK.3|FPAEDEFPDLSAHNNHMAK.2|FSEVLKR.2|PVSPLLLASGMAR.3|PVSPLLLASGMAR.2|PVSPLLLASGM[Oxi]AR.2|GIWHNDNK.2|VLTPELYAELRAK.3|LPNLGKHEK.2|RGTGGVDTAAVGGVFDVSNADR.4|RGTGGVDTAAVGGVFDVSNADR.3|RGTGGVDTAAVGGVFDVSNADR.2|PFSNSHNALK.2|DLFDPIIEDR.2|TDLNPDNLQGGDDLDPNYVLSSR.4|TDLNPDNLQGGDDLDPNYVLSSR.3|GTGGVDTAAVGGVFDVSNADR.3|GTGGVDTAAVGGVFDVSNADR.2|AIEKLAVEALSSLDGDLAGRYYALK.4|DYEFM[Oxi]WNPHLGYILTC[CAM]PSNLGTGLR.4|DYEFMWNPHLGYILTC[CAM]PSNLGTGLR.4|DYEFM[Oxi]WNPHLGYILTC[CAM]PSNLGTGLR.3|DYEFMWNPHLGYILTC[CAM]PSNLGTGLR.3|LAVEALSSLDGDLAGRYYALK.3|SMTEAEQQQLIDDHFLFDK.3|SM[Oxi]TEAEQQQLIDDHFLFDK.3|PSDEHKTDLNPDNLQGGDDLDPNYVLSSR.4|LLIEMEQRLEQGQAIDDLMPAQK.3|STPSGFTLDDVIQTGVDNPGHPYIMTVGC[CAM]VAGDEESYEVFK.4
SEN / CTL,Calpain-2 catalytic subunit,CAPN2,P17655,1.12,0.73,1.83E-21,2.47E-20,1.96E+01,"response to hypoxia,blastocyst development,proteolysis,myoblast fusion,protein autoprocessing,extracellular matrix disassembly,regulation of cytoskeleton organization,proteolysis involved in cellular protein catabolic process,cellular response to amino acid stimulus","calcium-dependent cysteine-type endopeptidase activity,calcium ion binding,cytoskeletal protein binding,cysteine-type peptidase activity,protein heterodimerization activity","chromatin,nucleus,cytoplasm,lysosome,endoplasmic reticulum,Golgi apparatus,cytosol,plasma membrane,focal adhesion,dendrite,cortical actin cytoskeleton,pseudopodium,membrane raft,extracellular exosome,perinuclear endoplasmic reticulum",69,45,77,FADDQLIIDFDNFVR.2|FADDQLIIDFDNFVR.3|LFAQLAGEDAEISAFELQTILR.3|KADYQAVDDEIEANLEEFDISEDDIDDGFRR.4|IRNPWGEVEWTGR.3|IRNPWGEVEWTGR.2|EFYILWTK.2|LGLKEFYILWTK.3|LGLKEFYILWTK.2|RPTEIC[CAM]ADPQFIIGGATR.3|RPTEIC[CAM]ADPQFIIGGATR.4|RPTEIC[CAM]ADPQFIIGGATR.2|IMVDMLDSDGSGK.2|IM[Oxi]VDMLDSDGSGK.2|IMVDM[Oxi]LDSDGSGK.2|GHAYSVTGAEEVESNGSLQK.3|GHAYSVTGAEEVESNGSLQK.2|RHEDGEFWMSFSDFLR.4|RHEDGEFWMSFSDFLR.3|WNDNC[CAM]PSWNTIDPEERER.3|NPWGEVEWTGR.2|ALEEAGFKMPC[CAM]QLHQVIVAR.4|ALEEAGFKMPC[CAM]QLHQVIVAR.3|SDGFSIETC[CAM]K.2|ERSDTFINLR.3|ERSDTFINLR.2|MPC[CAM]QLHQVIVAR.3|M[Oxi]PC[CAM]QLHQVIVAR.3|MPC[CAM]QLHQVIVAR.2|FKLPPGEYILVPSTFEPNKDGDFC[CAM]IR.4|FKLPPGEYILVPSTFEPNKDGDFC[CAM]IR.3|LEIC[CAM]NLTPDTLTSDTYKK.3|LEIC[CAM]NLTPDTLTSDTYKK.2|SDTFINLR.2|GSLLGC[CAM]SIDITSAADSEAITFQK.3|GSLLGC[CAM]SIDITSAADSEAITFQK.2|ALEEAGFK.2|DGDFC[CAM]IR.2|NFFLTNR.2|DREAAEGLGSHDR.3|KALEEAGFK.2|SDTFINLREVLNR.3|FKLPPGEYILVPSTFEPNK.4|FKLPPGEYILVPSTFEPNK.3|FKLPPGEYILVPSTFEPNK.2|QDIKSDGFSIETC[CAM]K.3|SGTMNSYEMR.2|SGTM[Oxi]NSYEMR.2|SGTMNSYEM[Oxi]R.2|RQDIKSDGFSIETC[CAM]K.3|LPPGEYILVPSTFEPNK.3|LPPGEYILVPSTFEPNK.2|MGEDMHTIGFGIYEVPEELSGQTNIHLSK.5|M[Oxi]GEDMHTIGFGIYEVPEELSGQTNIHLSK.4|MGEDMHTIGFGIYEVPEELSGQTNIHLSK.4|MGEDMHTIGFGIYEVPEELSGQTNIHLSK.3|NYPNTFWMNPQYLIK.3|NYPNTFWM[Oxi]NPQYLIK.3|NYPNTFWMNPQYLIK.2|NYPNTFWM[Oxi]NPQYLIK.2|YLNQDYEALR.2|LFAQLAGEDAEISAFELQTILRR.4|LFAQLAGEDAEISAFELQTILRR.3|LEIC[CAM]NLTPDTLTSDTYK.3|LEIC[CAM]NLTPDTLTSDTYK.2|KM[Oxi]GEDMHTIGFGIYEVPEELSGQTNIHLSK.5|KMGEDM[Oxi]HTIGFGIYEVPEELSGQTNIHLSK.5|KMGEDMHTIGFGIYEVPEELSGQTNIHLSK.5|LEEEDEDEEDGESGC[CAM]TFLVGLIQK.4|LEEEDEDEEDGESGC[CAM]TFLVGLIQK.3|DGELLFVHSAEGSEFWSALLEK.3|RLFAQLAGEDAEISAFELQTILR.3|NEC[CAM]LEAGTLFQDPSFPAIPSALGFK.3|LPPGEYILVPSTFEPNKDGDFC[CAM]IR.3|YLNQDYEALRNEC[CAM]LEAGTLFQDPSFPAIPSALGFK.4|WNDNC[CAM]PSWNTIDPEER.2|INGC[CAM]YEALSGGATTEGFEDFTGGIAEWYELK.3
SEN / CTL,Tubulin alpha chain-like 3,TUBAL3,A6NHL2,1.12,0.27,1.71E-02,8.28E-03,2.08E+00,"cytoskeleton organization,microtubule-based process","GTPase activity,structural constituent of cytoskeleton,GTP binding","cytoplasm,microtubule",3,4,7,KLAEQC[CAM]GGLQGFLIFRSFGGGTGSGFTSLLMER.4|SLFHPEQLLSGK.3|SLFHPEQLLSGK.2|SFGGGTGSGFTSLLMER.3|SFGGGTGSGFTSLLM[Oxi]ER.2|SFGGGTGSGFTSLLMER.2|FEGPLNVDLIEFQTNLVPYPR.3
SEN / CTL,Tubulin beta-2B chain,TUBB2B,Q9BVA1,1.12,0.24,1.62E-02,7.94E-03,2.10E+00,"neuron migration,cytoskeleton organization,microtubule-based process","GTPase activity,structural constituent of cytoskeleton,GTP binding","nucleus,cytoplasm,microtubule",3,2,2,INVYYNEATGNKYVPR.3|INVYYNEATGNK.2
SEN / CTL,PRA1 family protein 3,ARL6IP5,O75915,1.11,0.30,2.46E-02,1.12E-02,1.95E+00,"negative regulation of L-glutamate transport,intrinsic apoptotic signaling pathway in response to oxidative stress,negative regulation of mitochondrial membrane potential,L-glutamate transport,positive regulation of stress-activated MAPK cascade,positive regulation of apoptotic process,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process",molecular_function,"endoplasmic reticulum,endoplasmic reticulum membrane,cytoskeleton,plasma membrane,membrane,integral component of membrane,extracellular exosome",3,4,6,TPMGIVLDALEQQEEGINR.3|TPMGIVLDALEQQEEGINR.2|RTPMGIVLDALEQQEEGINR.4|RTPMGIVLDALEQQEEGINR.3|AWDDFFPGSDR.2|TPMGIVLDALEQQEEGINRLTDYISK.4
SEN / CTL,"Peroxiredoxin-5, mitochondrial",PRDX5,P30044,1.09,0.61,6.09E-18,5.30E-17,1.63E+01,"response to reactive oxygen species,apoptotic process,inflammatory response,response to oxidative stress,negative regulation of transcription from RNA polymerase III promoter,cellular response to reactive oxygen species,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,cell redox homeostasis,oxidation-reduction process,cellular oxidant detoxification","RNA polymerase III regulatory region DNA binding,peroxidase activity,receptor binding,thioredoxin peroxidase activity,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,protein dimerization activity","extracellular space,nucleus,cytoplasm,mitochondrion,mitochondrial matrix,peroxisome,cytosol,cytoplasmic vesicle,intracellular membrane-bounded organelle,perinuclear region of cytoplasm,extracellular exosome",48,19,35,THLPGFVEQAEALK.3|THLPGFVEQAEALK.2|THLPGFVEQAEALKAK.4|THLPGFVEQAEALKAK.3|GVLFGVPGAFTPGC[CAM]SK.2|GVLFGVPGAFTPGC[CAM]SK.3|KGVLFGVPGAFTPGC[CAM]SK.3|KGVLFGVPGAFTPGC[CAM]SK.2|FSMVVQDGIVK.2|FSM[Oxi]VVQDGIVK.2|LLADPTGAFGKETDLLLDDSLVSIFGNR.3|LLADPTGAFGKETDLLLDDSLVSIFGNR.4|VNLAELFK.2|LLADPTGAFGKETDLLLDDSLVSIFGNRR.4|LLADPTGAFGKETDLLLDDSLVSIFGNRR.5|LLADPTGAFGKETDLLLDDSLVSIFGNRR.3|ALNVEPDGTGLTC[CAM]SLAPNIISQL.3|ALNVEPDGTGLTC[CAM]SLAPNIISQL.2|ETDLLLDDSLVSIFGNRR.3|RFSMVVQDGIVK.3|RFSM[Oxi]VVQDGIVK.3|RFSMVVQDGIVK.2|RFSM[Oxi]VVQDGIVK.2|VRLLADPTGAFGK.3|LLADPTGAFGK.2|LLADPTGAFGK.1|VGDAIPAVEVFEGEPGNK.3|VGDAIPAVEVFEGEPGNK.2|ETDLLLDDSLVSIFGNR.3|ETDLLLDDSLVSIFGNR.2|VGDAIPAVEVFEGEPGNKVNLAELFK.4|VGDAIPAVEVFEGEPGNKVNLAELFK.3|VGDAIPAVEVFEGEPGNKVNLAELFKGK.4|GVQVVAC[CAM]LSVNDAFVTGEWGR.3|VRLLADPTGAFGKETDLLLDDSLVSIFGNR.4
SEN / CTL,Eukaryotic translation elongation factor 1 epsilon-1,EEF1E1,O43324,1.09,0.32,2.39E-02,1.10E-02,1.96E+00,"translational elongation,tRNA aminoacylation for protein translation,glutathione metabolic process,negative regulation of cell proliferation,positive regulation of apoptotic process,positive regulation of DNA damage response, signal transduction by p53 class mediator,positive regulation of cellular senescence","translation elongation factor activity,glutathione transferase activity","nucleus,cytoplasm,cytosol,extracellular exosome",3,12,17,AIVQQWLEYR.2|WFC[CAM]HIQHYPGIR.4|WFC[CAM]HIQHYPGIR.2|NDIHTLLK.2|VTQVDGHSSKNDIHTLLK.4|VTQVDGHSSKNDIHTLLK.3|VTQVDGHSSKNDIHTLLK.2|VTQVDGHSSK.2|DLNSYLEDK.2|QANKEYLLGSTAEEK.3|QANKEYLLGSTAEEK.2|QHLSSVVFIK.2|FIVDLTVQEK.2|EYLLGSTAEEK.2|QIPVLQTNNGPSLTGLTTIAAHLVK.4|QIPVLQTNNGPSLTGLTTIAAHLVK.3|VYLTGYNFTLADILLYYGLHR.3
SEN / CTL,ADP/ATP translocase 3,SLC25A6,P12236,1.08,1.68,1.48E-01,4.82E-02,1.32E+00,"protein targeting to mitochondrion,apoptotic process,adenine transport,ADP transport,ATP transport,active induction of host immune response by virus,regulation of insulin secretion,transmembrane transport","ATP:ADP antiporter activity,protein binding,adenine transmembrane transporter activity","nucleus,mitochondrion,mitochondrial inner membrane,mitochondrial inner membrane presequence translocase complex,integral component of membrane,extracellular matrix",9,8,15,DFLAGGIAAAISK.2|DFLAGGIAAAISK.3|KGADIMYTGTVDC[CAM]WR.3|KGADIM[Oxi]YTGTVDC[CAM]WR.3|KGADIMYTGTVDC[CAM]WR.2|GMGGAFVLVLYDELKK.3|GM[Oxi]GGAFVLVLYDELKK.3|GMGGAFVLVLYDELKK.2|IFRDEGGK.2|QIFLGGVDKHTQFWR.4|QIFLGGVDKHTQFWR.3|GIVDC[CAM]IVR.2|GM[Oxi]GGAFVLVLYDELKKVI.3|GMGGAFVLVLYDELK.2|GM[Oxi]GGAFVLVLYDELK.2
SEN / CTL,"ATP-dependent 6-phosphofructokinase, platelet type",PFKP,Q01813,1.08,0.74,2.60E-11,1.02E-10,9.99E+00,"fructose 6-phosphate metabolic process,canonical glycolysis,cell-cell adhesion","6-phosphofructokinase activity,ATP binding,protein complex binding,metal ion binding,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,cytosol,cell-cell adherens junction,membrane,extracellular matrix,extracellular exosome",39,52,85,EWSGLLEELAR.2|LAIKLPDDQIPK.3|LAIKLPDDQIPK.2|NVIFQPVAELK.2|IKELVVTQLGYDTR.3|IKELVVTQLGYDTR.2|MLAIYDGFDGFAK.2|M[Oxi]LAIYDGFDGFAK.2|KEWSGLLEELAR.3|KEWSGLLEELAR.2|YLEEIATQMR.2|YLEEIATQM[Oxi]R.2|FTTDDSIC[CAM]VLGISKR.3|FTTDDSIC[CAM]VLGISKR.2|IIEVVDAIMTTAQSHQR.3|IIEVVDAIM[Oxi]TTAQSHQR.3|IIEVVDAIMTTAQSHQR.2|TNC[CAM]NVAVINVGAPAAGMNAAVR.3|TNC[CAM]NVAVINVGAPAAGM[Oxi]NAAVR.3|TNC[CAM]NVAVINVGAPAAGM[Oxi]NAAVR.2|TNC[CAM]NVAVINVGAPAAGMNAAVR.2|GITNLC[CAM]VIGGDGSLTGANLFR.3|GITNLC[CAM]VIGGDGSLTGANLFR.2|GITNLC[CAM]VIGGDGSLTGANLFRK.3|GITNLC[CAM]VIGGDGSLTGANLFRK.2|NGQIDKEAVQK.3|NGQIDKEAVQK.2|VGIADGHR.2|SFAGNLNTYKR.3|SFAGNLNTYKR.2|RFQDAVR.2|ELVVTQLGYDTR.3|ELVVTQLGYDTR.2|KFTTDDSIC[CAM]VLGISKR.4|LPDDQIPK.2|NVIFQPVAELKK.3|DLQSNVEHLTEK.3|DLQSNVEHLTEK.2|RNVIFQPVAELK.3|RNVIFQPVAELK.2|AAC[CAM]NLLQR.2|AMEWITAK.2|RLAIKLPDDQIPK.3|RNVIFQPVAELKK.3|VTILGHVQR.2|FLEHLSGAGK.2|KQTDFEHR.2|SFAGNLNTYK.2|KFTTDDSIC[CAM]VLGISK.3|KFTTDDSIC[CAM]VLGISK.2|LNIIIVAEGAIDTQNKPITSEK.4|LNIIIVAEGAIDTQNKPITSEK.3|NVLGHM[Oxi]QQGGAPSPFDRNFGTK.4|NVLGHMQQGGAPSPFDRNFGTK.4|NVLGHMQQGGAPSPFDRNFGTK.3|LPLMEC[CAM]VQMTQDVQK.3|LPLMEC[CAM]VQMTQDVQK.2|NVLGHMQQGGAPSPFDR.3|NVLGHM[Oxi]QQGGAPSPFDR.3|NVLGHM[Oxi]QQGGAPSPFDR.2|NVLGHMQQGGAPSPFDR.2|M[Oxi]GVEAVIALLEATPDTPAC[CAM]VVSLNGNHAVR.5|MGVEAVIALLEATPDTPAC[CAM]VVSLNGNHAVR.4|M[Oxi]GVEAVIALLEATPDTPAC[CAM]VVSLNGNHAVR.4|M[Oxi]GVEAVIALLEATPDTPAC[CAM]VVSLNGNHAVR.3|MGVEAVIALLEATPDTPAC[CAM]VVSLNGNHAVR.3|RLNIIIVAEGAIDTQNKPITSEK.4|RLNIIIVAEGAIDTQNKPITSEK.3|QTDFEHRIPK.2|GQIKEIGWTDVGGWTGQGGSILGTKR.4|GQIKEIGWTDVGGWTGQGGSILGTKR.3|EIGWTDVGGWTGQGGSILGTK.3|EIGWTDVGGWTGQGGSILGTK.2|EIGWTDVGGWTGQGGSILGTKR.3|FTTDDSIC[CAM]VLGISK.2|YKASYDVSDSGQLEHVQPWSV.3|GQIKEIGWTDVGGWTGQGGSILGTK.3|NESC[CAM]SENYTTDFIYQLYSEEGK.3|NESC[CAM]SENYTTDFIYQLYSEEGKGVFDC[CAM]RK.4|ASYDVSDSGQLEHVQPWSV.2|GLVLRNESC[CAM]SENYTTDFIYQLYSEEGK.3|EKHEEFC[CAM]VPMVMVPATVSNNVPGSDFSIGADTALNTITDTC[CAM]DR.4|HEEFC[CAM]VPMVMVPATVSNNVPGSDFSIGADTALNTITDTC[CAM]DR.4|NESC[CAM]SENYTTDFIYQLYSEEGKGVFDC[CAM]R.3|YAYLNVVGMVGSIDNDFC[CAM]GTDMTIGTDSALHR.3
SEN / CTL,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit,DDOST,P39656,1.07,0.97,1.42E-03,1.03E-03,2.99E+00,"protein glycosylation,protein N-linked glycosylation,protein N-linked glycosylation via asparagine,response to cytokine,T cell activation","oligosaccharyl transferase activity,dolichyl-diphosphooligosaccharide-protein glycotransferase activity","endoplasmic reticulum,endoplasmic reticulum membrane,oligosaccharyltransferase complex,membrane,integral component of membrane,intracellular membrane-bounded organelle,protein complex",9,20,32,NTLLIAGLQAR.2|TLVLLDNLNVR.2|WVFKEEGVLR.3|WVFKEEGVLR.2|LPDVYGVFQFK.3|LPDVYGVFQFK.2|VGPVSHHR.2|ETHSLFFR.2|SSLNPILFR.2|DRGFELTFK.2|YSQTGNYELAVALSR.3|YSQTGNYELAVALSR.2|LGYTHLYSSTQVSVRPLQHTQYER.5|LGYTHLYSSTQVSVRPLQHTQYER.4|LGYTHLYSSTQVSVRPLQHTQYER.3|TLVLLDNLNVRETHSLFFR.4|TADDPSLSLIK.2|WVPFDGDDIQLEFVR.3|WVPFDGDDIQLEFVR.2|TAVIDHHNYDISDLGQHTLIVADTENLLK.5|TAVIDHHNYDISDLGQHTLIVADTENLLK.4|TAVIDHHNYDISDLGQHTLIVADTENLLK.3|GVGMVADPDNPLVLDILTGSSTSYSFFPDKPITQYPHAVGK.6|GVGMVADPDNPLVLDILTGSSTSYSFFPDKPITQYPHAVGK.5|GVGM[Oxi]VADPDNPLVLDILTGSSTSYSFFPDKPITQYPHAVGK.4|GVGMVADPDNPLVLDILTGSSTSYSFFPDKPITQYPHAVGK.4|TAVIDHHNYDISDLGQHTLIVADTENLLKAPTIVGK.5|VIFSGSLDFFSDSFFNSAVQK.3|VIFSGSLDFFSDSFFNSAVQK.2|ELGSEC[CAM]GIEFDEEK.2|GVGMVADPDNPLVLDILTGSSTSYSFFPDK.3|VGETAPPNAYTVTDLVEYSIVIQQLSNGK.3
SEN / CTL,Valine--tRNA ligase,VARS,P26640,1.06,0.46,4.69E-06,6.49E-06,5.19E+00,"tRNA aminoacylation for protein translation,valyl-tRNA aminoacylation,regulation of translational fidelity","aminoacyl-tRNA editing activity,valine-tRNA ligase activity,protein binding,ATP binding","mitochondrion,cytosol",12,72,116,LSAAVTEAFVR.2|SSAQDPQAVLGALGR.2|SSAQDPQAVLGALGR.3|HGLEAISIMDSR.3|HGLEAISIM[Oxi]DSR.3|HGLEAISIMDSR.2|HGLEAISIM[Oxi]DSR.2|VQGSDSDEEVVVATTR.2|VQGSDSDEEVVVATTR.3|KAVLVALK.2|KVDEAIALFQK.3|KVDEAIALFQK.2|ADYNLTR.2|TWHAWMDNIR.3|TWHAWMDNIR.2|VPLEVQEADEAK.3|VPLEVQEADEAK.2|YVLDPPAR.2|DINLDVNR.2|ILPEAHQR.2|WFVTC[CAM]VR.2|AC[CAM]FTMDPK.2|TLLSVPGYK.2|SKDVVEPLLRPQWYVR.4|SKDVVEPLLRPQWYVR.3|KDVSGPMPDSYSPR.3|KDVSGPMPDSYSPR.2|PLSHQPGPEAPALPK.3|GALINVPPPFLGLPR.3|GALINVPPPFLGLPR.2|LGSSLDWDR.2|IETM[Oxi]LGDVAVAVHPK.3|IETMLGDVAVAVHPK.3|IETMLGDVAVAVHPK.2|IETM[Oxi]LGDVAVAVHPK.2|C[CAM]SIHLQLQGLVDPARELGK.4|C[CAM]SIHLQLQGLVDPARELGK.3|EKVEFGVLVSFAYK.3|EKVEFGVLVSFAYK.2|GIEDNPMVVPLC[CAM]NR.3|GIEDNPM[Oxi]VVPLC[CAM]NR.2|GIEDNPMVVPLC[CAM]NR.2|YGEAGEGPGWGGAHPR.3|YGEAGEGPGWGGAHPR.2|LQQTEAELR.2|ADFPAGIPEC[CAM]GTDALR.3|ADFPAGIPEC[CAM]GTDALR.2|DPEAEAALELALSITR.3|DPGVITYDLPTPPGEK.3|DPGVITYDLPTPPGEK.2|KAVLVALKER.2|LHEEGIIYR.2|RAASGYPVKVPLEVQEADEAK.4|RAASGYPVKVPLEVQEADEAK.3|VDEAIALFQK.2|AVLGEVVLYSGARPLSHQPGPEAPALPK.5|AVLGEVVLYSGARPLSHQPGPEAPALPK.4|AVLGEVVLYSGARPLSHQPGPEAPALPK.3|C[CAM]SIHLQLQGLVDPAR.3|C[CAM]SIHLQLQGLVDPAR.2|LVNWSC[CAM]TLNSAISDIEVDKK.4|LVNWSC[CAM]TLNSAISDIEVDKK.3|LVNWSC[CAM]TLNSAISDIEVDKK.2|EAFLQEVWK.2|ITPAHDQNDYEVGQR.3|ITPAHDQNDYEVGQR.2|MRGETTLWNPGC[CAM]DHAGIATQVVVEKK.5|IC[CAM]LQPPPTSR.2|DVVEPLLRPQWYVR.3|KLGSSLDWDR.2|ALSPLEEWLR.2|GFVPSPTSQPGGHESLVDRWIR.4|SLRADYNLTR.2|DPGVITYDLPTPPGEKK.3|RDPGVITYDLPTPPGEK.3|RDPGVITYDLPTPPGEK.2|IQQQQPPPGEK.2|YVEAAWYPWWEQQGFFKPEYGRPNVSAANPR.6|YVEAAWYPWWEQQGFFKPEYGRPNVSAANPR.5|YVEAAWYPWWEQQGFFKPEYGRPNVSAANPR.4|FGLC[CAM]AYMSQGR.2|FGLC[CAM]AYM[Oxi]SQGR.2|LLSPFMPFVTEELFQR.3|LLSPFM[Oxi]PFVTEELFQR.3|LLSPFM[Oxi]PFVTEELFQR.2|LLSPFMPFVTEELFQR.2|GFVPSPTSQPGGHESLVDR.3|GFVPSPTSQPGGHESLVDR.2|AVLGEVVLYSGAR.2|RDPGVITYDLPTPPGEKK.3|VEFGVLVSFAYK.2|MRGETTLWNPGC[CAM]DHAGIATQVVVEK.4|AASGYPVKVPLEVQEADEAK.3|DVSGPMPDSYSPR.2|DVSGPM[Oxi]PDSYSPR.2|C[CAM]GEMAQAASAAVTR.2|C[CAM]GEM[Oxi]AQAASAAVTR.2|LVNWSC[CAM]TLNSAISDIEVDKKELTGR.4|QTLYTC[CAM]LDVGLR.2|SLPIVFDEFVDM[Oxi]DFGTGAVK.3|SLPIVFDEFVDMDFGTGAVK.3|SLPIVFDEFVDMDFGTGAVK.2|IPAYFVTVSDPAVPPGEDPDGR.3|IPAYFVTVSDPAVPPGEDPDGR.2|AASGYPVKVPLEVQEADEAKLQQTEAELR.4|VPLEVQEADEAKLQQTEAELR.3|AAVLVQQWVSYADTELIPAAC[CAM]GATLPALGLR.4|AAVLVQQWVSYADTELIPAAC[CAM]GATLPALGLR.3|GETTLWNPGC[CAM]DHAGIATQVVVEK.3|GVFMMC[CAM]IPPPNVTGSLHLGHALTNAIQDSLTR.4|GVFM[Oxi]MC[CAM]IPPPNVTGSLHLGHALTNAIQDSLTR.4|MPQAPPSLC[CAM]VTPYPEPSEC[CAM]SWK.3|RMPQAPPSLC[CAM]VTPYPEPSEC[CAM]SWKDPEAEAALELALSITR.5|RMPQAPPSLC[CAM]VTPYPEPSEC[CAM]SWKDPEAEAALELALSITR.4|YVEAAWYPWWEQQGFFKPEYGR.3|SLGNVIDPLDVIYGISLQGLHNQLLNSNLDPSEVEK.4
SEN / CTL,"ATP synthase subunit O, mitochondrial",ATP5O,P48047,1.05,0.51,2.94E-05,3.31E-05,4.48E+00,"ATP biosynthetic process,proton transport,mitochondrial ATP synthesis coupled proton transport","transporter activity,protein binding,drug binding,transmembrane transporter activity,proton-transporting ATP synthase activity, rotational mechanism,ATPase activity","nucleus,mitochondrion,mitochondrial inner membrane,mitochondrial proton-transporting ATP synthase complex,plasma membrane,extracellular matrix,extracellular exosome",9,18,35,LVRPPVQVYGIEGR.3|LVRPPVQVYGIEGR.2|FSPLTTNLINLLAENGR.3|FSPLTTNLINLLAENGR.2|TDPSILGGMIVR.2|TDPSILGGMIVR.3|TDPSILGGM[Oxi]IVR.2|QNKLEQVEKELLR.4|QNKLEQVEKELLR.3|SLNDITAK.2|VAASVLNPYVKR.3|LSNTQGVVSAFSTMMSVHR.4|LSNTQGVVSAFSTMMSVHR.3|LSNTQGVVSAFSTM[Oxi]M[Oxi]SVHR.3|LSNTQGVVSAFSTM[Oxi]MSVHR.3|LSNTQGVVSAFSTMM[Oxi]SVHR.3|LSNTQGVVSAFSTMMSVHR.2|SFLSQGQVLKLEAK.3|SFLSQGQVLKLEAK.2|VAQILKEPK.2|ERFSPLTTNLINLLAENGR.4|ERFSPLTTNLINLLAENGR.3|ERFSPLTTNLINLLAENGR.2|SFLSQGQVLK.2|QNKLEQVEK.2|SLNDITAKER.2|YATALYSAASK.2|VAASVLNPYVK.2|LVRPPVQVYGIEGRYATALYSAASK.4|GEVPC[CAM]TVTSASPLEEATLSELK.3|GEVPC[CAM]TVTSASPLEEATLSELK.2|LSNTQGVVSAFSTM[Oxi]MSVHRGEVPC[CAM]TVTSASPLEEATLSELK.5|LSNTQGVVSAFSTMMSVHRGEVPC[CAM]TVTSASPLEEATLSELK.5|LSNTQGVVSAFSTM[Oxi]MSVHRGEVPC[CAM]TVTSASPLEEATLSELK.4|LSNTQGVVSAFSTMMSVHRGEVPC[CAM]TVTSASPLEEATLSELK.4
SEN / CTL,3-hydroxyacyl-CoA dehydrogenase type-2,HSD17B10,Q99714,1.04,0.88,1.11E-01,3.87E-02,1.41E+00,"lipid metabolic process,branched-chain amino acid catabolic process,oxidation-reduction process,mitochondrial tRNA methylation,mitochondrial tRNA processing","3-hydroxyacyl-CoA dehydrogenase activity,protein binding,cholate 7-alpha-dehydrogenase activity,testosterone dehydrogenase [NAD(P)] activity,poly(A) RNA binding,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity","cytoplasm,mitochondrion,mitochondrial matrix,plasma membrane",6,26,51,GGIVGMTLPIAR.2|GGIVGM[Oxi]TLPIAR.2|DLAPIGIR.2|GQTHTLEDFQR.3|GQTHTLEDFQR.2|KGQTHTLEDFQR.3|KGQTHTLEDFQR.2|VDVAVNC[CAM]AGIAVASK.3|VDVAVNC[CAM]AGIAVASK.2|GKFGRVDVAVNC[CAM]AGIAVASK.4|DVQTALALAK.2|VMTIAPGLFGTPLLTSLPEK.4|VMTIAPGLFGTPLLTSLPEK.3|VM[Oxi]TIAPGLFGTPLLTSLPEK.3|VM[Oxi]TIAPGLFGTPLLTSLPEK.2|VMTIAPGLFGTPLLTSLPEK.2|VLDVNLMGTFNVIR.3|VLDVNLM[Oxi]GTFNVIR.2|VLDVNLMGTFNVIR.2|VC[CAM]NFLASQVPFPSR.3|VC[CAM]NFLASQVPFPSR.2|LVGQGASAVLLDLPNSGGEAQAK.4|LVGQGASAVLLDLPNSGGEAQAK.3|LVGQGASAVLLDLPNSGGEAQAK.2|LGNNC[CAM]VFAPADVTSEK.3|LGNNC[CAM]VFAPADVTSEK.2|LVAGEM[Oxi]GQNEPDQGGQR.3|LVAGEMGQNEPDQGGQR.3|LVAGEMGQNEPDQGGQR.2|LVAGEM[Oxi]GQNEPDQGGQR.2|GLVAVITGGASGLGLATAER.3|GLVAVITGGASGLGLATAER.2|FGRVDVAVNC[CAM]AGIAVASK.3|FGRVDVAVNC[CAM]AGIAVASK.2|GVIINTASVAAFEGQVGQAAYSASK.4|GVIINTASVAAFEGQVGQAAYSASK.3|KLGNNC[CAM]VFAPADVTSEK.3|KLGNNC[CAM]VFAPADVTSEK.2|LGNNC[CAM]VFAPADVTSEKDVQTALALAK.4|LGNNC[CAM]VFAPADVTSEKDVQTALALAK.3|SVKGLVAVITGGASGLGLATAER.3|KLGNNC[CAM]VFAPADVTSEKDVQTALALAK.4|KLGNNC[CAM]VFAPADVTSEKDVQTALALAK.3|LGDPAEYAHLVQAIIENPFLNGEVIR.4|LGDPAEYAHLVQAIIENPFLNGEVIR.3|LVGQGASAVLLDLPNSGGEAQAKK.3|GLVAVITGGASGLGLATAERLVGQGASAVLLDLPNSGGEAQAK.5|GLVAVITGGASGLGLATAERLVGQGASAVLLDLPNSGGEAQAK.4|LGDPAEYAHLVQAIIENPFLNGEVIRLDGAIR.4|VM[Oxi]TIAPGLFGTPLLTSLPEKVC[CAM]NFLASQVPFPSR.4|SVKGLVAVITGGASGLGLATAERLVGQGASAVLLDLPNSGGEAQAK.4
SEN / CTL,Hemoglobin subunit delta;Hemoglobin subunit epsilon;Hemoglobin subunit beta;Hemoglobin subunit gamma-1;Hemoglobin subunit gamma-2,HBD;HBE1;HBB;HBG1;HBG2,P02042;P02100;P68871;P69891;P69892,1.04,1.22,2.78E-02,1.24E-02,1.91E+00,"blood coagulation,oxygen transport;blood coagulation,oxygen transport,protein heterooligomerization;receptor-mediated endocytosis,blood coagulation,regulation of blood pressure,positive regulation of cell death,oxygen transport,bicarbonate transport,nitric oxide transport,response to hydrogen peroxide,hydrogen peroxide catabolic process,positive regulation of nitric oxide biosynthetic process,regulation of blood vessel size,protein heterooligomerization,renal absorption,platelet aggregation,cellular oxidant detoxification;blood coagulation,oxygen transport;blood coagulation,oxygen transport","oxygen transporter activity,iron ion binding,protein binding,oxygen binding,heme binding;oxygen transporter activity,iron ion binding,oxygen binding,heme binding,hemoglobin alpha binding;oxygen transporter activity,iron ion binding,protein binding,oxygen binding,heme binding,hemoglobin binding,peroxidase activity,haptoglobin binding;oxygen transporter activity,iron ion binding,oxygen binding,heme binding;oxygen transporter activity,iron ion binding,oxygen binding,heme binding","cytosol,hemoglobin complex,blood microparticle;cytosol,hemoglobin complex,blood microparticle;extracellular region,cytosol,hemoglobin complex,haptoglobin-hemoglobin complex,extracellular exosome,endocytic vesicle lumen,blood microparticle;cytosol,hemoglobin complex;cytosol,hemoglobin complex,blood microparticle",6,1,2,LLVVYPWTQR.2|LLVVYPWTQR.3
SEN / CTL,Cysteine and glycine-rich protein 2,CSRP2,Q16527,1.03,0.88,3.75E-03,2.38E-03,2.62E+00,"multicellular organism development,cell differentiation","molecular_function,zinc ion binding","nucleus,focal adhesion",9,10,14,GFGYGQGAGALVHAQ.2|GYGYGQGAGTLNMDRGER.3|C[CAM]C[CAM]FLC[CAM]MVC[CAM]R.2|C[CAM]C[CAM]FLC[CAM]M[Oxi]VC[CAM]R.2|LGIKPESVQPHRPTTNPNTSK.5|LGIKPESVQPHRPTTNPNTSK.4|TVYHAEEVQC[CAM]DGR.3|TVYHAEEVQC[CAM]DGR.2|C[CAM]GDSVYAAEK.2|SLESTTLTEK.2|SLESTTLTEKEGEIYC[CAM]KGC[CAM]YAK.4|NLDSTTVAIHDEEIYC[CAM]K.3|NLDSTTVAIHDEEIYC[CAM]K.2|GYGYGQGAGTLNMDR.2
SEN / CTL,Alpha-crystallin B chain,CRYAB,P02511,1.03,0.66,2.13E-02,9.92E-03,2.00E+00,"response to hypoxia,lens development in camera-type eye,protein folding,muscle contraction,tubulin complex assembly,muscle organ development,aging,negative regulation of gene expression,regulation of cell death,negative regulation of cell growth,microtubule polymerization or depolymerization,response to estradiol,negative regulation of intracellular transport,response to hydrogen peroxide,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,protein homooligomerization,stress-activated MAPK cascade,apoptotic process involved in morphogenesis,cellular response to gamma radiation,regulation of cellular response to heat,negative regulation of reactive oxygen species metabolic process","structural constituent of eye lens,protein binding,microtubule binding,identical protein binding,protein homodimerization activity,metal ion binding,unfolded protein binding","nucleus,nucleoplasm,cytoplasm,mitochondrion,Golgi apparatus,cytosol,cell surface,postsynaptic density,microtubule cytoskeleton,Z disc,axon,M band,actin filament bundle,dendritic spine,perikaryon,myelin sheath,extracellular exosome,synaptic membrane,cardiac myofibril",6,25,40,FSVNLDVK.2|LFDQFFGEHLLESDLFPTSTSLSPFYLRPPSFLR.4|LFDQFFGEHLLESDLFPTSTSLSPFYLRPPSFLR.6|LFDQFFGEHLLESDLFPTSTSLSPFYLRPPSFLR.5|HFSPEELKVK.3|PFFPFHSPSR.3|HEERQDEHGFISR.4|HEERQDEHGFISR.3|VLGDVIEVHGKHEER.4|VLGDVIEVHGKHEER.3|PAVTAAPKK.2|KQVSGPER.2|RPFFPFHSPSR.3|RPFFPFHSPSR.2|VLGDVIEVHGKHEERQDEHGFISR.6|VLGDVIEVHGKHEERQDEHGFISR.5|VLGDVIEVHGKHEERQDEHGFISR.4|TIPITREEKPAVTAAPKK.4|HFSPEELK.2|APSWFDTGLSEM[Oxi]RLEKDR.4|DRFSVNLDVKHFSPEELK.4|QDEHGFISR.2|EEKPAVTAAPK.2|VLGDVIEVHGK.2|YRIPADVDPLTITSSLSSDGVLTVNGPR.5|YRIPADVDPLTITSSLSSDGVLTVNGPR.4|YRIPADVDPLTITSSLSSDGVLTVNGPR.3|DRFSVNLDVK.2|TIPITREEKPAVTAAPK.3|KYRIPADVDPLTITSSLSSDGVLTVNGPR.5|KYRIPADVDPLTITSSLSSDGVLTVNGPR.4|KYRIPADVDPLTITSSLSSDGVLTVNGPR.3|APSWFDTGLSEMRLEK.3|APSWFDTGLSEM[Oxi]RLEK.2|IPADVDPLTITSSLSSDGVLTVNGPR.4|IPADVDPLTITSSLSSDGVLTVNGPR.3|APSWFDTGLSEM[Oxi]R.2|APSWFDTGLSEMR.2|YRIPADVDPLTITSSLSSDGVLTVNGPRK.4|YRIPADVDPLTITSSLSSDGVLTVNGPRK.3
SEN / CTL,Ketimine reductase mu-crystallin,CRYM,Q14894,1.03,1.00,6.19E-03,3.61E-03,2.44E+00,"negative regulation of transcription from RNA polymerase II promoter,lysine catabolic process,sensory perception of sound,thyroid hormone metabolic process,oxidation-reduction process,thyroid hormone transport","transcription corepressor activity,protein homodimerization activity,thiomorpholine-carboxylate dehydrogenase activity,NADP binding,thyroid hormone binding","nucleus,cytoplasm,mitochondrion,peroxisomal matrix,extracellular exosome",9,13,18,VPAFLSAAEVEEHLR.3|FADTVQGEVR.2|SLGMAVEDTVAAK.2|SLGM[Oxi]AVEDTVAAK.2|PGAHINAVGASRPDWR.4|TAAVSAIATK.2|RTAAVSAIATK.2|HRGYLGVMPAYSAAEDALTTK.4|HRGYLGVMPAYSAAEDALTTK.3|LIYDSWSSGK.2|GYLGVMPAYSAAEDALTTK.3|GYLGVMPAYSAAEDALTTK.2|ESGDVLLSGAEIFAELGEVIK.3|ESGDVLLSGAEIFAELGEVIK.2|EAVLYVDSQEAALK.2|GITSVVPSHQATVLLFEPSNGTLLAVMDGNVITAK.4|GITSVVPSHQATVLLFEPSNGTLLAVMDGNVITAK.3|SSSLLIPPLETALANFSSGPEGGVMQPVR.3
SEN / CTL,Carboxymethylenebutenolidase homolog,CMBL,Q96DG6,1.02,0.20,1.15E-04,1.14E-04,3.94E+00,xenobiotic metabolic process,hydrolase activity,"cytosol,extracellular exosome",6,19,23,NLIEWLNK.2|AVIVIQDIFGWQLPNTR.3|AVIVIQDIFGWQLPNTR.2|AYVTKSPVDAGK.3|LEYGGLGR.2|DVSLLTQK.2|TFSGQTHGFVHR.3|TFSGQTHGFVHR.2|EDC[CAM]SPADKPYIDEARR.4|REDC[CAM]SPADKPYIDEAR.4|AGVSVYGIVK.2|EVQVEHIK.2|KREDC[CAM]SPADKPYIDEAR.4|REDC[CAM]SPADKPYIDEARR.4|IGIVGFC[CAM]WGGTAVHHLMMK.4|DSEDIYNLK.2|EDC[CAM]SPADKPYIDEAR.3|EDC[CAM]SPADKPYIDEAR.2|NPTLFIFAENDVVIPLK.3|NPTLFIFAENDVVIPLK.2|NLIEWLNKYM.2|AGVSVYGIVKDSEDIYNLK.3|SPVDAGKAVIVIQDIFGWQLPNTR.3
SEN / CTL,Chloride intracellular channel protein 1,CLIC1,O00299,1.00,0.89,5.00E-09,1.39E-08,7.86E+00,"chloride transport,signal transduction,regulation of ion transmembrane transport,positive regulation of osteoblast differentiation,regulation of cell cycle,regulation of mitochondrial membrane potential,platelet aggregation,chloride transmembrane transport,glutathione metabolic process","voltage-gated ion channel activity,chloride channel activity,protein binding,cadherin binding involved in cell-cell adhesion,glutathione transferase activity","extracellular space,nucleus,nuclear envelope,cytoplasm,mitochondrion,plasma membrane,brush border,cell-cell adherens junction,membrane,nuclear membrane,vesicle,chloride channel complex,perinuclear region of cytoplasm,extracellular exosome,blood microparticle",63,24,42,LAALNPESNTAGLDIFAK.2|LAALNPESNTAGLDIFAK.3|GFTIPEAFR.2|LFMVLWLK.2|LFM[Oxi]VLWLK.2|LC[CAM]PGGQLPFLLYGTEVHTDTNKIEEFLEAVLC[CAM]PPRYPK.5|LC[CAM]PGGQLPFLLYGTEVHTDTNKIEEFLEAVLC[CAM]PPRYPK.4|FLDGNELTLADC[CAM]NLLPK.2|FLDGNELTLADC[CAM]NLLPK.3|YRGFTIPEAFR.3|YRGFTIPEAFR.2|GVTFNVTTVDTK.2|GVTFNVTTVDTK.3|KFLDGNELTLADC[CAM]NLLPK.3|KFLDGNELTLADC[CAM]NLLPK.2|GVTFNVTTVDTKR.3|GVTFNVTTVDTKR.2|IGNC[CAM]PFSQR.2|VLDNYLTSPLPEEVDETSAEDEGVSQR.3|VLDNYLTSPLPEEVDETSAEDEGVSQR.4|EEFASTC[CAM]PDDEEIELAYEQVAK.3|EEFASTC[CAM]PDDEEIELAYEQVAK.4|VLDNYLTSPLPEEVDETSAEDEGVSQRK.3|VLDNYLTSPLPEEVDETSAEDEGVSQRK.4|NSNPALNDNLEK.2|LHIVQVVC[CAM]KK.3|LHIVQVVC[CAM]KK.2|YLSNAYAR.2|IEEFLEAVLC[CAM]PPRYPK.4|IEEFLEAVLC[CAM]PPRYPK.3|IEEFLEAVLC[CAM]PPRYPK.2|IEEFLEAVLC[CAM]PPR.3|IEEFLEAVLC[CAM]PPR.2|LHIVQVVC[CAM]K.2|LC[CAM]PGGQLPFLLYGTEVHTDTNK.4|LC[CAM]PGGQLPFLLYGTEVHTDTNK.3|ALKVLDNYLTSPLPEEVDETSAEDEGVSQR.4|ALKVLDNYLTSPLPEEVDETSAEDEGVSQR.3|IGNC[CAM]PFSQRLFMVLWLKGVTFNVTTVDTK.4|NSNPALNDNLEKGLLK.2|YLSNAYAREEFASTC[CAM]PDDEEIELAYEQVAK.4|YLSNAYAREEFASTC[CAM]PDDEEIELAYEQVAK.3
SEN / CTL,ELAV-like protein 1,ELAVL1,Q15717,1.00,0.08,2.31E-03,1.57E-03,2.81E+00,"mRNA splicing, via spliceosome,multicellular organism development,regulation of mRNA stability,positive regulation of translation,mRNA stabilization,negative regulation of gene silencing by miRNA,3'-UTR-mediated mRNA stabilization,regulation of stem cell population maintenance","nucleotide binding,RNA binding,double-stranded RNA binding,mRNA binding,mRNA 3'-UTR binding,protein binding,AU-rich element binding,protein kinase binding,mRNA 3'-UTR AU-rich region binding,protein homodimerization activity,poly(A) RNA binding","nucleus,nucleoplasm,cytoplasm,cytosol,membrane,ribonucleoprotein complex",3,21,35,VLVDQTTGLSR.2|DANLYISGLPR.3|DANLYISGLPR.2|FGGPVHHQAQR.3|FGGPVHHQAQR.2|ILQVSFK.2|LGDKILQVSFK.3|VSYARPSSEVIK.3|VSYARPSSEVIK.2|SLFSSIGEVESAK.3|SLFSSIGEVESAK.2|RFGGPVHHQAQR.3|AINTLNGLR.2|DVEDMFSR.2|DVEDM[Oxi]FSR.2|FAANPNQNK.2|NVALLSQLYHSPAR.3|NVALLSQLYHSPAR.2|RSEAEEAITSFNGHKPPGSSEPITVK.5|RSEAEEAITSFNGHKPPGSSEPITVK.4|VAGHSLGYGFVNYVTAK.3|VAGHSLGYGFVNYVTAK.2|VSYARPSSEVIKDANLYISGLPR.4|VSYARPSSEVIKDANLYISGLPR.3|PSSEVIKDANLYISGLPR.3|PSSEVIKDANLYISGLPR.2|SEAEEAITSFNGHKPPGSSEPITVK.4|SEAEEAITSFNGHKPPGSSEPITVK.3|DKVAGHSLGYGFVNYVTAK.3|TNLIVNYLPQNMTQDELR.3|TNLIVNYLPQNM[Oxi]TQDELR.3|TNLIVNYLPQNM[Oxi]TQDELR.2|TNLIVNYLPQNMTQDELR.2|TMTQKDVEDMFSR.2|GFGFVTMTNYEEAAMAIASLNGYR.3
SEN / CTL,Transforming protein RhoA,RHOA,P61586,0.97,0.76,1.96E-06,3.02E-06,5.52E+00,"transforming growth factor beta receptor signaling pathway,Rho protein signal transduction,viral process,cell migration,substantia nigra development,actin cytoskeleton organization,platelet activation,regulation of cell migration,actin cytoskeleton reorganization,positive regulation of cytokinesis,regulation of actin cytoskeleton organization,regulation of osteoblast proliferation,Roundabout signaling pathway,cleavage furrow formation,apolipoprotein A-I-mediated signaling pathway,positive regulation of NF-kappaB import into nucleus,positive regulation of I-kappaB kinase/NF-kappaB signaling,stress fiber assembly,apical junction assembly,endothelial cell migration,ossification involved in bone maturation,wound healing, spreading of cells,positive regulation of neuron differentiation,vascular endothelial growth factor receptor signaling pathway,ephrin receptor signaling pathway,phosphatidylinositol-mediated signaling,negative regulation of axonogenesis,positive regulation of axonogenesis,negative chemotaxis,regulation of small GTPase mediated signal transduction,positive regulation of stress fiber assembly,Wnt signaling pathway, planar cell polarity pathway,positive regulation of lipase activity,trabecula morphogenesis,positive regulation of protein serine/threonine kinase activity,negative regulation of cell migration involved in sprouting angiogenesis,mitotic spindle assembly,endothelial tube lumen extension,skeletal muscle satellite cell migration,mitotic cleavage furrow formation,regulation of cell motility","GTPase activity,protein binding,GTP binding,myosin binding","endosome,endoplasmic reticulum membrane,cytosol,cytoskeleton,plasma membrane,focal adhesion,cell cortex,lamellipodium,cell junction,midbody,extrinsic component of cytoplasmic side of plasma membrane,vesicle,apical junction complex,extracellular exosome,cell periphery,cleavage furrow",27,17,30,HFC[CAM]PNVPIILVGNKK.4|HFC[CAM]PNVPIILVGNKK.3|TC[CAM]LLIVFSK.2|IGAFGYMEC[CAM]SAK.2|IGAFGYM[Oxi]EC[CAM]SAK.2|DGVREVFEMATR.3|DGVREVFEM[Oxi]ATR.3|HFC[CAM]PNVPIILVGNK.3|HFC[CAM]PNVPIILVGNK.2|EVFEMATR.2|DLRNDEHTRR.3|LVIVGDGAC[CAM]GK.2|KLVIVGDGAC[CAM]GK.3|KLVIVGDGAC[CAM]GK.2|MKQEPVKPEEGRDMANR.5|MKQEPVKPEEGRDMANR.4|MKQEPVKPEEGRDMANR.3|KKLVIVGDGAC[CAM]GK.3|KKLVIVGDGAC[CAM]GK.2|MKQEPVKPEEGR.3|M[Oxi]KQEPVKPEEGR.3|MKQEPVKPEEGR.2|QEPVKPEEGR.2|QVELALWDTAGQEDYDR.3|QVELALWDTAGQEDYDR.2|DQFPEVYVPTVFENYVADIEVDGK.4|DQFPEVYVPTVFENYVADIEVDGK.3|LRPLSYPDTDVILMC[CAM]FSIDSPDSLENIPEK.4|LRPLSYPDTDVILMC[CAM]FSIDSPDSLENIPEK.3|LRPLSYPDTDVILMC[CAM]FSIDSPDSLENIPEKWTPEVK.4
SEN / CTL,Epidermal growth factor receptor kinase substrate 8-like protein 2,EPS8L2,Q9H6S3,0.97,0.62,4.95E-04,4.14E-04,3.38E+00,"Rho protein signal transduction,regulation of Rho protein signal transduction,positive regulation of GTPase activity,cell-cell adhesion,positive regulation of ruffle assembly","actin binding,cadherin binding involved in cell-cell adhesion,Rho guanyl-nucleotide exchange factor activity,Rac guanyl-nucleotide exchange factor activity","cytoplasm,plasma membrane,cell-cell adherens junction,vesicle,ruffle membrane,protein complex,extracellular exosome",9,30,35,VGPQVPLSEPGFR.2|LAINLLAK.2|ETQILNC[CAM]ALDDIEWFVAR.3|ETQILNC[CAM]ALDDIEWFVAR.2|SEAITSVDDAIRK.3|NANELSVLK.2|HSPTSEPTPPGDALPPVSSPHTHR.5|HSPTSEPTPPGDALPPVSSPHTHR.4|ILYDFTAR.2|APAEGVLTLR.2|SQTVLNQLR.2|NRVGPQVPLSEPGFR.3|VYSQLTMQK.2|KAPAEGVLTLR.2|ARPPSEGEFIDC[CAM]FQK.3|ARPPSEGEFIDC[CAM]FQK.2|AAEAFKQLNQR.2|DEVLEVLEDGR.2|DEVLEVLEDGRQWWK.3|SEAITSVDDAIR.2|IVENLGILTGPQLFSLNKEELKK.4|IVENLGILTGPQLFSLNK.3|IVENLGILTGPQLFSLNK.2|QSILPPPQGPAPIPFQHR.3|EMSLWESLGESWMRPR.3|NANELSVLKDEVLEVLEDGR.3|QQSGSELEELMNK.2|LLDIESQEELEDFPLPTVQR.3|SGQAGYVPC[CAM]NILGEARPEDAGAPFEQAGQK.4|SGQAGYVPC[CAM]NILGEARPEDAGAPFEQAGQK.3|AVLAQKIEKETQILNC[CAM]ALDDIEWFVAR.4|IVENLGILTGPQLFSLNKEELK.3|FHSGWEPPVDVLQEAPWEVEGLASAPIEEVSPVSR.4|IWTQEMLLQVNDQSLR.2|SQPVSQPLTYESGPDEVR.2
SEN / CTL,Protein S100-A10,S100A10,P60903,0.96,0.46,2.70E-10,9.23E-10,9.03E+00,"membrane raft assembly,membrane budding,positive regulation of GTPase activity,positive regulation of binding,protein heterotetramerization,positive regulation of stress fiber assembly,positive regulation of focal adhesion assembly,establishment of protein localization to plasma membrane,positive regulation of substrate adhesion-dependent cell spreading","calcium ion binding,protein binding,protein homodimerization activity,ion channel binding,lipid binding","extrinsic component of plasma membrane,extracellular exosome,membrane raft",24,12,32,FAGDKGYLTKEDLR.4|FAGDKGYLTKEDLR.3|VLMEKEFPGFLENQKDPLAVDK.4|VLMEKEFPGFLENQKDPLAVDK.3|EFPGFLENQKDPLAVDKIMK.4|EFPGFLENQKDPLAVDK.3|EFPGFLENQKDPLAVDK.2|PSQMEHAMETMMFTFHK.4|PSQMEHAMETMMFTFHK.3|PSQM[Oxi]EHAM[Oxi]ETMMFTFHK.4|PSQM[Oxi]EHAMETM[Oxi]MFTFHK.4|PSQM[Oxi]EHAMETMM[Oxi]FTFHK.4|PSQM[Oxi]EHAMETMMFTFHK.4|PSQMEHAM[Oxi]ETM[Oxi]MFTFHK.4|PSQMEHAM[Oxi]ETMM[Oxi]FTFHK.4|PSQMEHAM[Oxi]ETMMFTFHK.4|PSQMEHAMETM[Oxi]M[Oxi]FTFHK.4|PSQMEHAMETM[Oxi]MFTFHK.4|PSQMEHAMETMM[Oxi]FTFHK.4|PSQM[Oxi]EHAMETMMFTFHK.3|PSQMEHAM[Oxi]ETMM[Oxi]FTFHK.3|PSQMEHAM[Oxi]ETMMFTFHK.3|PSQMEHAMETM[Oxi]MFTFHK.3|PSQMEHAMETMM[Oxi]FTFHK.3|IMKDLDQC[CAM]RDGK.3|IMKDLDQC[CAM]RDGK.2|DLDQC[CAM]RDGK.2|FAGDKGYLTK.2|GYLTKEDLR.2|MPSQMEHAMETMMFTFHK.4|IMKDLDQC[CAM]R.2|EFPGFLENQK.2
SEN / CTL,Tubulin beta-8 chain,TUBB8,Q3ZCM7,0.96,1.04,1.92E-05,2.27E-05,4.64E+00,"oocyte maturation,spindle assembly involved in female meiosis,biological_process","molecular_function,GTPase activity,structural constituent of cytoskeleton,GTP binding","cytoplasm,microtubule,extracellular exosome,meiotic spindle",21,4,13,LPTPTYGDLNHLVSATMSGVTTC[CAM]LR.3|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLLSK.4|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLLSK.3|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGM[Oxi]GTLLLSK.4|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLLSK.5|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGM[Oxi]GTLLLSK.5|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGM[Oxi]GTLLLSK.3|KEAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLLSK.4|KEAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGM[Oxi]GTLLLSK.4|KEAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLLSK.6|KEAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLLSK.5|KEAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLLSK.3|ALTVAELTQQM[Oxi]FDAK.3
SEN / CTL,V-type proton ATPase subunit E 1,ATP6V1E1,P36543,0.96,0.39,4.59E-02,1.86E-02,1.73E+00,"insulin receptor signaling pathway,ATP hydrolysis coupled proton transport,proton transport,regulation of macroautophagy,transferrin transport,ion transmembrane transport,phagosome acidification","protein binding,hydrogen-exporting ATPase activity, phosphorylative mechanism,proton-transporting ATPase activity, rotational mechanism,ATPase binding","mitochondrion,lysosomal membrane,endosome,cytosol,microvillus,apical plasma membrane,proton-transporting two-sector ATPase complex,proton-transporting two-sector ATPase complex, catalytic domain,extracellular exosome",3,16,22,ARDDLITDLLNEAK.3|ARDDLITDLLNEAK.2|VSNTLESR.2|IMEYYEK.2|KQDFPLVK.2|GALFGANANR.2|LDLIAQQMMPEVR.3|LDLIAQQMMPEVR.2|LDLIAQQMM[Oxi]PEVR.2|HMMAFIEQEANEK.3|HMMAFIEQEANEK.2|AEEEFNIEK.2|GALFGANANRK.2|AEEIDAKAEEEFNIEK.3|ARDDLITDLLNEAKQR.3|IQMSNLMNQAR.2|IQM[Oxi]SNLM[Oxi]NQAR.2|IQMSNLM[Oxi]NQAR.2|DDLITDLLNEAK.2|KIQMSNLMNQAR.2|VVKDTTRYQVLLDGLVLQGLYQLLEPR.4|NDVDVQIDQESYLPEDIAGGVEIYNGDRK.3
SEN / CTL,"Myosin light chain kinase 3;Myosin light chain kinase family member 4;Myosin light chain kinase 2, skeletal/cardiac muscle",MYLK3;MYLK4;MYLK2,Q32MK0;Q86YV6;Q9H1R3,0.95,0.72,1.05E-01,3.71E-02,1.43E+00,"regulation of vascular permeability involved in acute inflammatory response,protein phosphorylation,sarcomere organization,sarcomerogenesis,cardiac myofibril assembly,positive regulation of sarcomere organization,cellular response to interleukin-1;protein phosphorylation;striated muscle contraction,neuromuscular synaptic transmission,positive regulation of gene expression,skeletal muscle satellite cell differentiation,peptidyl-threonine phosphorylation,regulation of muscle filament sliding,skeletal muscle cell differentiation,protein autophosphorylation,cardiac muscle tissue morphogenesis,cardiac muscle contraction","calmodulin-dependent protein kinase activity,myosin light chain kinase activity,ATP binding;protein serine/threonine kinase activity,ATP binding;calmodulin-dependent protein kinase activity,myosin light chain kinase activity,protein binding,calmodulin binding,ATP binding","cytoplasm,cytosol,actin cytoskeleton;extracellular exosome;nucleus,cytoplasm,sarcomere",3,1,1,IIDFGLAR.2
SEN / CTL,Tissue factor pathway inhibitor 2,TFPI2,P48307,0.95,2.10,8.05E-02,3.00E-02,1.52E+00,"blood coagulation,negative regulation of endopeptidase activity,cellular response to fluid shear stress","serine-type endopeptidase inhibitor activity,extracellular matrix structural constituent","proteinaceous extracellular matrix,nucleus,extracellular matrix",6,4,4,LQVSVDDQC[CAM]EGSTEK.2|TC[CAM]DAFTYTGC[CAM]GGNDNNFVSR.2|DEGLC[CAM]SANVTR.2|YFFNLSSMTC[CAM]EK.2
SEN / CTL,Annexin A1,ANXA1,P04083,0.95,0.47,9.20E-22,1.31E-20,1.99E+01,"DNA strand renaturation,neutrophil homeostasis,adaptive immune response,monocyte chemotaxis,regulation of leukocyte migration,phagocytosis,inflammatory response,signal transduction,cell surface receptor signaling pathway,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,regulation of cell shape,response to X-ray,myoblast migration involved in skeletal muscle regeneration,peptide cross-linking,insulin secretion,keratinocyte differentiation,prostate gland development,endocrine pancreas development,positive regulation of vesicle fusion,positive regulation of prostaglandin biosynthetic process,actin cytoskeleton reorganization,response to estradiol,DNA duplex unwinding,regulation of interleukin-1 production,positive regulation of interleukin-2 production,positive regulation of neutrophil apoptotic process,DNA rewinding,gliogenesis,positive regulation of T cell proliferation,response to drug,negative regulation of apoptotic process,response to peptide hormone,estrous cycle,innate immune response,positive regulation of T-helper 1 cell differentiation,negative regulation of T-helper 2 cell differentiation,negative regulation of exocytosis,alpha-beta T cell differentiation,regulation of hormone secretion,arachidonic acid secretion,regulation of inflammatory response,cellular response to hydrogen peroxide,hepatocyte differentiation,prolactin secretion,response to interleukin-1,cellular response to glucocorticoid stimulus,granulocyte chemotaxis,positive regulation of wound healing,neutrophil clearance,positive regulation of G1/S transition of mitotic cell cycle,negative regulation of phospholipase A2 activity,negative regulation of interleukin-8 secretion","single-stranded DNA binding,single-stranded RNA binding,helicase activity,receptor binding,structural molecule activity,calcium ion binding,protein binding,phospholipid binding,calcium-dependent phospholipid binding,phospholipase A2 inhibitor activity,protein binding, bridging,double-stranded DNA-dependent ATPase activity,annealing helicase activity,protein homodimerization activity,calcium-dependent protein binding,cadherin binding involved in cell-cell adhesion","cornified envelope,phagocytic cup,extracellular region,extracellular space,nucleus,nucleoplasm,cytoplasm,endosome,plasma membrane,cell-cell adherens junction,focal adhesion,cell surface,basolateral plasma membrane,apical plasma membrane,lateral plasma membrane,extrinsic component of membrane,cytoplasmic vesicle membrane,extrinsic component of external side of plasma membrane,extrinsic component of endosome membrane,motile cilium,early endosome membrane,mitochondrial membrane,vesicle,sarcolemma,mast cell granule,protein complex,extracellular exosome",75,38,69,GLGTDEDTLIEILASR.3|GLGTDEDTLIEILASR.2|GVDEATIIDILTKR.3|DLAKDITSDTSGDFR.3|DLAKDITSDTSGDFR.2|TPAQFDADELR.2|ILVALC[CAM]GGN.2|ILVALC[CAM]GGN.1|ALTGHLEEVVLALLK.3|ALTGHLEEVVLALLK.2|ALTGHLEEVVLALLK.4|GDRSEDFGVNEDLADSDAR.3|GDRSEDFGVNEDLADSDAR.2|RKGTDVNVFNTILTTR.4|RKGTDVNVFNTILTTR.3|RKGTDVNVFNTILTTR.2|GVDEATIIDILTK.2|GVDEATIIDILTK.3|VLDLELKGDIEK.3|VLDLELKGDIEK.2|DITSDTSGDFR.2|DITSDTSGDFR.3|GTDVNVFNTILTTR.2|GTDVNVFNTILTTR.3|TPAQFDADELRAAMK.3|TPAQFDADELRAAM[Oxi]K.3|KGTDVNVFNTILTTR.3|KGTDVNVFNTILTTR.2|QAWFIENEEQEYVQTVK.3|QAWFIENEEQEYVQTVK.2|GGPGSAVSPYPTFNPSSDVAALHK.3|GGPGSAVSPYPTFNPSSDVAALHK.4|GGPGSAVSPYPTFNPSSDVAALHK.2|MYGISLC[CAM]QAILDETKGDYEK.3|M[Oxi]YGISLC[CAM]QAILDETKGDYEK.3|MYGISLC[CAM]QAILDETKGDYEK.2|SSKGGPGSAVSPYPTFNPSSDVAALHK.4|SSKGGPGSAVSPYPTFNPSSDVAALHK.3|SEDFGVNEDLADSDAR.2|SEDFGVNEDLADSDAR.3|C[CAM]LTAIVK.2|PAFFAEK.2|NALLSLAK.2|VLDLELK.2|KALTGHLEEVVLALLK.4|KALTGHLEEVVLALLK.3|KALTGHLEEVVLALLK.2|ALYEAGER.2|C[CAM]ATSKPAFFAEK.3|C[CAM]ATSKPAFFAEK.2|PLDETLKK.2|AAYLQETGKPLDETLKK.4|AAYLQETGKPLDETLKK.3|AAYLQETGKPLDETLKK.2|AAYLQETGK.2|YSKHDMNK.2|ALYEAGERR.2|SEIDMNDIK.2|SEIDM[Oxi]NDIK.2|SEIDMNDIKAFYQK.3|MYGISLC[CAM]QAILDETK.3|M[Oxi]YGISLC[CAM]QAILDETK.2|MYGISLC[CAM]QAILDETK.2|AAYLQETGKPLDETLK.3|AAYLQETGKPLDETLK.2|DLAKDITSDTSGDFRNALLSLAK.4|DITSDTSGDFRNALLSLAK.3|DITSDTSGDFRNALLSLAK.2|ALTGHLEEVVLALLKTPAQFDADELR.4
SEN / CTL,Nucleolar protein 3,NOL3,O60936,0.94,0.40,6.36E-02,2.46E-02,1.61E+00,"response to hypoxia,blood vessel remodeling,response to ischemia,mRNA splice site selection,RNA splicing,cardiac muscle cell apoptotic process,negative regulation of cardiac muscle cell apoptotic process,negative regulation of tumor necrosis factor-mediated signaling pathway,negative regulation of muscle atrophy,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,response to injury involved in regulation of muscle adaptation,regulation of NF-kappaB import into nucleus,negative regulation of apoptotic process,protein oligomerization,negative regulation of necrotic cell death,negative regulation of release of cytochrome c from mitochondria,intrinsic apoptotic signaling pathway,negative regulation of mitochondrial membrane permeability involved in apoptotic process,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,negative regulation of extrinsic apoptotic signaling pathway","RNA binding,death receptor binding,calcium ion binding,protein binding,death effector domain binding,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,caspase binding","nucleolus,mitochondrion,cytosol,membrane,sarcoplasmic reticulum",3,5,6,LVETLQADSGLLLDALLAR.3|LVETLQADSGLLLDALLAR.2|GEAAC[CAM]QELLR.2|GVLTGPEYEALDALPDAERR.3|RLVETLQADSGLLLDALLAR.3|GVLTGPEYEALDALPDAER.2
SEN / CTL,"Stress-70 protein, mitochondrial",HSPA9,P38646,0.94,1.21,1.20E-05,1.51E-05,4.82E+00,"protein folding,protein export from nucleus,erythrocyte differentiation,negative regulation of apoptotic process,negative regulation of erythrocyte differentiation","protein binding,ATP binding,ubiquitin protein ligase binding,poly(A) RNA binding,unfolded protein binding","nucleolus,cytoplasm,mitochondrion,focal adhesion,extracellular matrix,mitochondrial nucleoid,myelin sheath,extracellular exosome",36,68,123,TTPSVVAFTADGER.2|TTPSVVAFTADGER.3|AQFEGIVTDLIR.2|AQFEGIVTDLIR.3|DAGQISGLNVLR.2|DAGQISGLNVLR.3|NAVITVPAYFNDSQR.2|NAVITVPAYFNDSQR.3|AQFEGIVTDLIRR.3|AQFEGIVTDLIRR.2|NAEKYAEEDRR.3|STNGDTFLGGEDFDQALLR.2|STNGDTFLGGEDFDQALLR.3|LYSPSQIGAFVLMK.2|LYSPSQIGAFVLMK.3|LYSPSQIGAFVLM[Oxi]K.3|LYSPSQIGAFVLM[Oxi]K.2|ETGVDLTKDNMALQR.3|ETGVDLTKDNM[Oxi]ALQR.3|ETGVDLTKDNMALQR.2|ETGVDLTKDNM[Oxi]ALQR.2|M[Oxi]KETAENYLGHTAK.4|MKETAENYLGHTAK.3|M[Oxi]KETAENYLGHTAK.3|M[Oxi]KETAENYLGHTAK.2|MKETAENYLGHTAK.2|QAASSLQQASLK.3|QAASSLQQASLK.2|TIAPC[CAM]QK.2|VQQTVQDLFGRAPSK.4|VQQTVQDLFGRAPSK.3|VQQTVQDLFGRAPSK.2|DNMALQR.2|DNM[Oxi]ALQR.2|ETGVDLTK.2|VQQTVQDLFGR.3|VQQTVQDLFGR.2|ASNGDAWVEAHGK.3|ASNGDAWVEAHGK.2|ETAENYLGHTAK.3|ETAENYLGHTAK.2|YDDPEVQKDIK.3|YDDPEVQKDIK.2|LFEM[Oxi]AYK.2|LINRNTTIPTKK.3|RQAVTNPNNTFYATKR.4|YAEEDRR.2|DDIENMVK.2|DDIENM[Oxi]VK.2|SDIGEVILVGGMTR.3|SDIGEVILVGGMTR.2|SDIGEVILVGGM[Oxi]TR.2|VLENAEGAR.2|AMQDAEVSK.2|AM[Oxi]QDAEVSK.2|RTIAPC[CAM]QK.2|EQQIVIQSSGGLSK.3|EQQIVIQSSGGLSK.2|EGSGSSGTGEQKEDQKEEK.4|RYDDPEVQKDIK.3|RYDDPEVQKDIK.2|YDDPEVQK.2|RETGVDLTK.2|DSETGENIR.2|LFEMAYKK.2|QAVTNPNNTFYATK.3|QAVTNPNNTFYATK.2|LLGQFTLIGIPPAPR.3|LLGQFTLIGIPPAPR.2|ERVEAVNMAEGIIHDTETK.4|ERVEAVNM[Oxi]AEGIIHDTETK.4|ERVEAVNMAEGIIHDTETK.3|ERVEAVNM[Oxi]AEGIIHDTETK.3|ERVEAVNMAEGIIHDTETK.2|VINEPTAAALAYGLDK.3|VINEPTAAALAYGLDK.2|EGSGSSGTGEQK.2|MASEREGSGSSGTGEQK.3|QAASSLQQASLKLFEMAYKK.4|KDSETGENIR.2|QAVTNPNNTFYATKR.3|QAVTNPNNTFYATKR.2|RQAVTNPNNTFYATK.3|RQAVTNPNNTFYATK.2|RYDDPEVQK.2|DQLPADEC[CAM]NK.2|AMQDAEVSKSDIGEVILVGGMTR.4|AMQDAEVSKSDIGEVILVGGMTR.3|AM[Oxi]QDAEVSKSDIGEVILVGGMTR.3|EQQIVIQSSGGLSKDDIENMVK.4|EQQIVIQSSGGLSKDDIENM[Oxi]VK.3|EQQIVIQSSGGLSKDDIENMVK.3|SQVFSTAADGQTQVEIK.3|SQVFSTAADGQTQVEIK.2|RETGVDLTKDNMALQR.3|M[Oxi]EEFKDQLPADEC[CAM]NK.3|MEEFKDQLPADEC[CAM]NK.3|MEEFKDQLPADEC[CAM]NK.2|VEAVNMAEGIIHDTETK.3|VEAVNM[Oxi]AEGIIHDTETK.3|VEAVNM[Oxi]AEGIIHDTETK.2|VEAVNMAEGIIHDTETK.2|KSQVFSTAADGQTQVEIK.3|KSQVFSTAADGQTQVEIK.2|GAVVGIDLGTTNSC[CAM]VAVMEGK.3|GAVVGIDLGTTNSC[CAM]VAVM[Oxi]EGK.2|GAVVGIDLGTTNSC[CAM]VAVMEGK.2|ERVEAVNMAEGIIHDTETKMEEFK.4|GTGREQQIVIQSSGGLSKDDIENMVK.4|GTGREQQIVIQSSGGLSKDDIENMVK.3|VINEPTAAALAYGLDKSEDK.3|DSETGENIRQAASSLQQASLK.3|VEAVNMAEGIIHDTETKMEEFKDQLPADEC[CAM]NK.5|VIAVYDLGGGTFDISILEIQK.3|VIAVYDLGGGTFDISILEIQK.2|GVPQIEVTFDIDANGIVHVSAK.3|GVPQIEVTFDIDANGIVHVSAK.2|EMAGDNKLLGQFTLIGIPPAPR.3|QATKDAGQISGLNVLR.2|C[CAM]ELSSSVQTDINLPYLTMDSSGPK.3|SEDKVIAVYDLGGGTFDISILEIQK.3|AKC[CAM]ELSSSVQTDINLPYLTMDSSGPK.3|VINEPTAAALAYGLDKSEDKVIAVYDLGGGTFDISILEIQK.4
SEN / CTL,Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,P04406,0.94,0.83,1.67E-26,3.10E-25,2.45E+01,"microtubule cytoskeleton organization,gluconeogenesis,regulation of macroautophagy,negative regulation of translation,peptidyl-cysteine S-trans-nitrosylation,protein stabilization,neuron apoptotic process,canonical glycolysis,cellular response to interferon-gamma","glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,protein binding,microtubule binding,peptidyl-cysteine S-nitrosylase activity,NADP binding,NAD binding","nucleus,cytoplasm,lipid particle,cytosol,plasma membrane,microtubule cytoskeleton,membrane,intracellular ribonucleoprotein complex,extracellular matrix,nuclear membrane,vesicle,intracellular membrane-bounded organelle,perinuclear region of cytoplasm,extracellular exosome,GAIT complex",174,51,166,LISWYDNEFGYSNR.2|LISWYDNEFGYSNR.3|GALQNIIPASTGAAK.2|GALQNIIPASTGAAK.3|VPTANVSVVDLTC[CAM]R.2|VPTANVSVVDLTC[CAM]R.3|VIPELNGKLTGMAFRVPTANVSVVDLTC[CAM]R.4|IISNASC[CAM]TTNC[CAM]LAPLAK.2|IISNASC[CAM]TTNC[CAM]LAPLAK.3|IISNASC[CAM]TTNC[CAM]LAPLAK.4|AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGK.4|AAFNSGKVDIVAINDPFIDLNYMVYM[Oxi]FQYDSTHGK.4|AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGK.5|AAFNSGKVDIVAINDPFIDLNYM[Oxi]VYMFQYDSTHGK.4|DGRGALQNIIPASTGAAK.3|DGRGALQNIIPASTGAAK.2|DGRGALQNIIPASTGAAK.4|RVIISAPSADAPMFVM[Oxi]GVNHEKYDNSLK.5|RVIISAPSADAPM[Oxi]FVMGVNHEKYDNSLK.4|RVIISAPSADAPMFVM[Oxi]GVNHEKYDNSLK.4|RVIISAPSADAPM[Oxi]FVMGVNHEKYDNSLK.5|RVIISAPSADAPMFVMGVNHEKYDNSLK.5|RVIISAPSADAPMFVMGVNHEKYDNSLK.4|RVIISAPSADAPM[Oxi]FVM[Oxi]GVNHEKYDNSLK.5|RVIISAPSADAPM[Oxi]FVM[Oxi]GVNHEKYDNSLK.4|RVIISAPSADAPMFVMGVNHEKYDNSLK.6|RVIISAPSADAPM[Oxi]FVMGVNHEKYDNSLK.6|RVIISAPSADAPMFVM[Oxi]GVNHEKYDNSLK.6|RVIISAPSADAPM[Oxi]FVMGVNHEKYDNSLK.3|RVIISAPSADAPMFVM[Oxi]GVNHEKYDNSLK.3|RVIISAPSADAPMFVMGVNHEKYDNSLK.3|AENGKLVINGNPITIFQERDPSK.4|AENGKLVINGNPITIFQERDPSK.3|LTGMAFRVPTANVSVVDLTC[CAM]R.3|LTGM[Oxi]AFRVPTANVSVVDLTC[CAM]R.3|LTGMAFRVPTANVSVVDLTC[CAM]R.4|LTGMAFRVPTANVSVVDLTC[CAM]R.2|IKWGDAGAEYVVESTGVFTTMEK.3|IKWGDAGAEYVVESTGVFTTMEK.4|IKWGDAGAEYVVESTGVFTTM[Oxi]EK.3|VIHDNFGIVEGLMTTVHAITATQK.4|VIHDNFGIVEGLMTTVHAITATQK.3|VIHDNFGIVEGLM[Oxi]TTVHAITATQK.5|VIHDNFGIVEGLMTTVHAITATQK.5|VIHDNFGIVEGLM[Oxi]TTVHAITATQK.4|VIHDNFGIVEGLM[Oxi]TTVHAITATQK.3|QASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK.6|QASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK.5|VPTANVSVVDLTC[CAM]RLEKPAKYDDIK.5|VPTANVSVVDLTC[CAM]RLEKPAKYDDIK.4|VVDLMAHMASKE.3|VVDLMAHMASKE.2|VVDLMAHM[Oxi]ASKE.3|VVDLM[Oxi]AHMASKE.3|VVDLM[Oxi]AHM[Oxi]ASKE.3|VVDLM[Oxi]AHMASKE.2|VVDLMAHM[Oxi]ASKE.2|VVDLM[Oxi]AHM[Oxi]ASKE.2|VPTANVSVVDLTC[CAM]RLEKPAK.4|VPTANVSVVDLTC[CAM]RLEKPAK.3|GILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK.5|GILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK.4|GILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK.7|GILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK.6|VIISAPSADAPMFVMGVNHEKYDNSLK.4|VIISAPSADAPMFVMGVNHEKYDNSLK.5|VIISAPSADAPM[Oxi]FVM[Oxi]GVNHEKYDNSLK.4|VIISAPSADAPM[Oxi]FVMGVNHEKYDNSLK.4|VIISAPSADAPMFVM[Oxi]GVNHEKYDNSLK.4|VIISAPSADAPMFVMGVNHEKYDNSLK.3|VIPELNGKLTGMAFR.3|VIPELNGKLTGM[Oxi]AFR.3|WGDAGAEYVVESTGVFTTMEK.3|WGDAGAEYVVESTGVFTTM[Oxi]EK.3|WGDAGAEYVVESTGVFTTM[Oxi]EK.2|WGDAGAEYVVESTGVFTTMEK.2|VDIVAINDPFIDLNYMVYMFQYDSTHGK.4|VDIVAINDPFIDLNYMVYMFQYDSTHGK.3|VDIVAINDPFIDLNYMVYM[Oxi]FQYDSTHGK.3|VDIVAINDPFIDLNYM[Oxi]VYMFQYDSTHGK.4|VDIVAINDPFIDLNYMVYM[Oxi]FQYDSTHGK.4|VDIVAINDPFIDLNYM[Oxi]VYM[Oxi]FQYDSTHGK.3|VDIVAINDPFIDLNYMVYM[Oxi]FQYDSTHGKFHGTVK.5|VDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVK.5|VDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVK.6|VDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVK.4|AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVK.6|AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVK.5|AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVK.7|AAFNSGKVDIVAINDPFIDLNYMVYM[Oxi]FQYDSTHGKFHGTVK.6|LVINGNPITIFQERDPSK.3|LVINGNPITIFQERDPSK.4|LVINGNPITIFQERDPSK.2|RVIISAPSADAPMFVMGVNHEK.4|RVIISAPSADAPMFVMGVNHEK.3|RVIISAPSADAPMFVMGVNHEK.5|RVIISAPSADAPM[Oxi]FVM[Oxi]GVNHEK.5|RVIISAPSADAPM[Oxi]FVMGVNHEK.5|RVIISAPSADAPMFVM[Oxi]GVNHEK.5|RVIISAPSADAPM[Oxi]FVM[Oxi]GVNHEK.4|RVIISAPSADAPM[Oxi]FVMGVNHEK.4|RVIISAPSADAPMFVM[Oxi]GVNHEK.4|RVIISAPSADAPM[Oxi]FVM[Oxi]GVNHEK.3|RVIISAPSADAPM[Oxi]FVMGVNHEK.3|RVIISAPSADAPMFVM[Oxi]GVNHEK.3|RVIISAPSADAPM[Oxi]FVMGVNHEK.2|RVIISAPSADAPMFVMGVNHEK.2|LVINGNPITIFQERDPSKIK.4|LVINGNPITIFQERDPSKIK.3|VVDLMAHMASK.3|VVDLM[Oxi]AHMASK.3|VVDLMAHM[Oxi]ASK.3|VVDLM[Oxi]AHM[Oxi]ASK.3|VVDLMAHMASK.2|VVDLM[Oxi]AHMASK.2|VVDLMAHM[Oxi]ASK.2|VVDLM[Oxi]AHM[Oxi]ASK.2|LTGMAFRVPTANVSVVDLTC[CAM]RLEKPAK.5|LTGM[Oxi]AFRVPTANVSVVDLTC[CAM]RLEKPAK.5|VIISAPSADAPMFVMGVNHEK.3|VIISAPSADAPM[Oxi]FVMGVNHEK.4|VIISAPSADAPMFVM[Oxi]GVNHEK.4|VIISAPSADAPMFVMGVNHEK.4|VIISAPSADAPM[Oxi]FVM[Oxi]GVNHEK.4|VIISAPSADAPM[Oxi]FVMGVNHEK.3|VIISAPSADAPMFVM[Oxi]GVNHEK.3|VIISAPSADAPM[Oxi]FVM[Oxi]GVNHEK.3|VIISAPSADAPMFVMGVNHEK.2|VIISAPSADAPM[Oxi]FVMGVNHEK.2|VIISAPSADAPMFVM[Oxi]GVNHEK.2|GKVKVGVNGFGR.3|LTGM[Oxi]AFR.2|TVDGPSGKLWR.3|TVDGPSGKLWR.2|VGVNGFGR.2|AVGKVIPELNGK.3|AVGKVIPELNGK.2|QASEGPLK.2|LEKPAKYDDIK.3|LEKPAKYDDIK.2|AGAHLQGGAK.2|PAKYDDIK.2|LEKPAKYDDIKK.3|LEKPAKYDDIKK.2|AGAHLQGGAKR.2|LVINGNPITIFQER.3|LVINGNPITIFQER.2|PAKYDDIKK.2|LWRDGRGALQNIIPASTGAAK.4|LWRDGRGALQNIIPASTGAAK.3|GALQNIIPASTGAAKAVGK.3|VIHDNFGIVEGLMTTVHAITATQKTVDGPSGKLWR.6|VIHDNFGIVEGLMTTVHAITATQKTVDGPSGKLWR.5|VPTANVSVVDLTC[CAM]RLEK.3|VPTANVSVVDLTC[CAM]RLEK.2|VIHDNFGIVEGLMTTVHAITATQKTVDGPSGK.5|VIHDNFGIVEGLM[Oxi]TTVHAITATQKTVDGPSGK.5|VIHDNFGIVEGLMTTVHAITATQKTVDGPSGK.4|LTGM[Oxi]AFRVPTANVSVVDLTC[CAM]RLEK.4|LTGMAFRVPTANVSVVDLTC[CAM]RLEK.4|LTGM[Oxi]AFRVPTANVSVVDLTC[CAM]RLEK.3|LTGMAFRVPTANVSVVDLTC[CAM]RLEK.3|AENGKLVINGNPITIFQER.3|AENGKLVINGNPITIFQER.2|LISWYDNEFGYSNRVVDLMAHMASKE.4|YDNSLKIISNASC[CAM]TTNC[CAM]LAPLAK.3
SEN / CTL,Mitogen-activated protein kinase 13;Mitogen-activated protein kinase 8;Mitogen-activated protein kinase 9;Mitogen-activated protein kinase 12;Mitogen-activated protein kinase 10;Mitogen-activated protein kinase 11;Mitogen-activated protein kinase 14,MAPK13;MAPK8;MAPK9;MAPK12;MAPK10;MAPK11;MAPK14,O15264;P45983;P45984;P53778;P53779;Q15759;Q16539,0.94,0.72,1.05E-01,3.71E-02,1.43E+00,"MAPK cascade,transcription, DNA-templated,regulation of transcription, DNA-templated,response to stress,response to osmotic stress,cell cycle,peptidyl-serine phosphorylation,positive regulation of interleukin-6 production,intracellular signal transduction,vascular endothelial growth factor receptor signaling pathway,positive regulation of inflammatory response;protein phosphorylation,response to stress,JNK cascade,JUN phosphorylation,response to UV,positive regulation of gene expression,regulation of macroautophagy,peptidyl-serine phosphorylation,peptidyl-threonine phosphorylation,regulation of histone deacetylation,positive regulation of cyclase activity,negative regulation of protein binding,regulation of protein localization,Fc-epsilon receptor signaling pathway,regulation of circadian rhythm,positive regulation of apoptotic process,negative regulation of apoptotic process,rhythmic process,regulation of sequence-specific DNA binding transcription factor activity,positive regulation of protein metabolic process,cellular response to lipopolysaccharide,cellular response to mechanical stimulus,positive regulation of deacetylase activity,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;protein phosphorylation,response to stress,JNK cascade,JUN phosphorylation,positive regulation of gene expression,positive regulation of macrophage derived foam cell differentiation,Fc-epsilon receptor signaling pathway,regulation of circadian rhythm,response to cadmium ion,rhythmic process,regulation of sequence-specific DNA binding transcription factor activity,positive regulation of podosome assembly,positive regulation of apoptotic signaling pathway;MAPK cascade,transcription, DNA-templated,regulation of transcription, DNA-templated,DNA damage induced protein phosphorylation,cell cycle arrest,signal transduction,muscle organ development,positive regulation of peptidase activity,peptidyl-serine phosphorylation,myoblast differentiation,vascular endothelial growth factor receptor signaling pathway,positive regulation of muscle cell differentiation;activation of MAPK activity,protein phosphorylation,signal transduction,JNK cascade,JUN phosphorylation,response to light stimulus,Fc-epsilon receptor signaling pathway,regulation of circadian rhythm,rhythmic process,regulation of sequence-specific DNA binding transcription factor activity;MAPK cascade,activation of MAPK activity,transcription, DNA-templated,response to stress,signal transduction,Ras protein signal transduction,positive regulation of gene expression,intracellular signal transduction,vascular endothelial growth factor receptor signaling pathway,regulation of sequence-specific DNA binding transcription factor activity,positive regulation of muscle cell differentiation,negative regulation of cardiac muscle cell proliferation,cellular response to virus,regulation of signal transduction by p53 class mediator,positive regulation of interleukin-12 secretion,positive regulation of erythrocyte differentiation;DNA damage checkpoint,activation of MAPK activity,cell morphogenesis,cartilage condensation,angiogenesis,placenta development,chondrocyte differentiation,glucose metabolic process,transcription, DNA-templated,regulation of transcription from RNA polymerase II promoter,apoptotic process,movement of cell or subcellular component,chemotaxis,signal transduction,cell surface receptor signaling pathway,transmembrane receptor protein serine/threonine kinase signaling pathway,Ras protein signal transduction,skeletal muscle tissue development,positive regulation of gene expression,positive regulation of myotube differentiation,myoblast differentiation involved in skeletal muscle regeneration,peptidyl-serine phosphorylation,fatty acid oxidation,regulation of ossification,osteoclast differentiation,positive regulation of cyclase activity,lipopolysaccharide-mediated signaling pathway,response to muramyl dipeptide,intracellular signal transduction,cellular response to vascular endothelial growth factor stimulus,response to muscle stretch,p38MAPK cascade,positive regulation of protein import into nucleus,signal transduction in response to DNA damage,positive regulation of erythrocyte differentiation,positive regulation of myoblast differentiation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of glucose import,vascular endothelial growth factor receptor signaling pathway,regulation of sequence-specific DNA binding transcription factor activity,striated muscle cell differentiation,positive regulation of muscle cell differentiation,positive regulation of cardiac muscle cell proliferation,3'-UTR-mediated mRNA stabilization,cellular response to lipopolysaccharide,cellular response to ionizing radiation,negative regulation of canonical Wnt signaling pathway,positive regulation of brown fat cell differentiation,stress-induced premature senescence,cellular response to virus,regulation of cytokine production involved in inflammatory response,positive regulation of myoblast fusion,regulation of signal transduction by p53 class mediator,positive regulation of reactive oxygen species metabolic process,positive regulation of interleukin-12 secretion,positive regulation of blood vessel endothelial cell migration","protein serine/threonine kinase activity,MAP kinase activity,ATP binding;protein serine/threonine kinase activity,JUN kinase activity,protein binding,ATP binding,kinase activity,enzyme binding,histone deacetylase regulator activity,histone deacetylase binding;JUN kinase activity,protein binding,ATP binding,transcription factor binding;magnesium ion binding,protein serine/threonine kinase activity,MAP kinase activity,protein binding,ATP binding;JUN kinase activity,MAP kinase kinase activity,ATP binding;protein serine/threonine kinase activity,MAP kinase activity,ATP binding;protein serine/threonine kinase activity,MAP kinase activity,MAP kinase kinase activity,protein binding,ATP binding,enzyme binding,protein phosphatase binding,NFAT protein binding","cytosol;nucleus,nucleoplasm,mitochondrion,cytosol;nucleoplasm,mitochondrion,cytosol;nucleoplasm,cytoplasm,mitochondrion,cytosol;nucleoplasm,cytoplasm,mitochondrion,cytosol,plasma membrane;nucleoplasm,cytosol;spindle pole,nucleus,nucleoplasm,cytoplasm,mitochondrion,cytosol,extracellular exosome",3,1,1,ILDFGLAR.2
SEN / CTL,Niban-like protein 1,FAM129B,Q96TA1,0.93,0.50,2.15E-15,1.36E-14,1.39E+01,"negative regulation of apoptotic process,cell-cell adhesion",cadherin binding involved in cell-cell adhesion,"nucleus,nucleoplasm,nucleolus,cytoplasm,cytosol,plasma membrane,adherens junction,cell-cell adherens junction,actin cytoskeleton,extracellular exosome",45,38,58,FDVSSTSVFK.2|FQELIFEDFAR.2|HC[CAM]NNGIPEDSKVEGPAFTDAIR.4|HC[CAM]NNGIPEDSKVEGPAFTDAIR.3|ILTSVDQYLELIGNSLPGTTAK.3|ILTSVDQYLELIGNSLPGTTAK.2|C[CAM]PTQFPLILWHPYAR.3|C[CAM]PTQFPLILWHPYAR.2|EALLQISIPFLLK.2|HEIEGTGLPQAQLLWR.3|HEIEGTGLPQAQLLWR.2|AAPEASSPPASPLQHLLPGK.3|AAPEASSPPASPLQHLLPGK.4|NHVQPYIPSILEALMVPTSQGFTEVR.3|NHVQPYIPSILEALMVPTSQGFTEVR.4|NHVQPYIPSILEALM[Oxi]VPTSQGFTEVR.3|NHVQPYIPSILEALM[Oxi]VPTSQGFTEVR.4|VQQVQPAMQAVIR.2|VQQVQPAM[Oxi]QAVIR.2|NRFSLVPHNYGLVLYENK.4|NRFSLVPHNYGLVLYENK.3|IVFSGNLFQHQEDSKK.4|IVFSGNLFQHQEDSKK.3|FEEVLSK.2|KVPLDER.2|WQAVLQDC[CAM]IR.3|WQAVLQDC[CAM]IR.2|KYDYDSSSVRK.3|KYDYDSSSVRK.2|AVINSAGYK.2|GPTKEELC[CAM]K.2|ARFEEVLSK.2|EALLQISIPFLLKK.3|YDYDSSSVR.2|TDMDQIITSK.2|TDM[Oxi]DQIITSK.2|IVFSGNLFQHQEDSK.3|IVFSGNLFQHQEDSK.2|VEGPAFTDAIR.2|KYDYDSSSVR.2|HYYFC[CAM]MMTEAEQDK.3|QRQWIQISDAVYHMVYEQAK.4|QRQWIQISDAVYHMVYEQAK.3|FSLVPHNYGLVLYENK.3|FSLVPHNYGLVLYENK.2|HC[CAM]NNGIPEDSK.2|EQMDNAVYTFETLLHQELGKGPTKEELC[CAM]K.5|EQMDNAVYTFETLLHQELGKGPTKEELC[CAM]K.4|EQMDNAVYTFETLLHQELGKGPTK.4|FILVENTYEEVVLQTVMK.3|QWIQISDAVYHMVYEQAK.3|QWIQISDAVYHMVYEQAK.2|EQMDNAVYTFETLLHQELGK.3|EQMDNAVYTFETLLHQELGK.2|EVTDMNLNVINEGGIDKLGEYMEK.3|EVTDMNLNVINEGGIDK.2|GLLAQGLRPESPPPAGPLLNGAPAGESPQPK.3|QVVSVVQDEEVGLPFEASPESPPPASPDGVTEIR.3
SEN / CTL,"Trifunctional enzyme subunit alpha, mitochondrial",HADHA,P40939,0.92,0.80,3.87E-10,1.28E-09,8.89E+00,"fatty acid beta-oxidation,response to insulin,cardiolipin acyl-chain remodeling,response to drug","fatty-acyl-CoA binding,3-hydroxyacyl-CoA dehydrogenase activity,acetyl-CoA C-acetyltransferase activity,enoyl-CoA hydratase activity,long-chain-enoyl-CoA hydratase activity,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,protein complex binding,NAD binding","mitochondrion,mitochondrial inner membrane,mitochondrial fatty acid beta-oxidation multienzyme complex,extracellular matrix,mitochondrial nucleoid",33,68,128,LTAYAMTIPFVR.2|LTAYAMTIPFVR.3|LTAYAM[Oxi]TIPFVR.2|VIIVVKDGPGFYTTR.3|VIIVVKDGPGFYTTR.2|DTSASAVAVGLK.2|MQLLEIITTEK.2|M[Oxi]QLLEIITTEK.2|TVLGTPEVLLGALPGAGGTQR.3|TVLGTPEVLLGALPGAGGTQR.4|TVLGTPEVLLGALPGAGGTQR.2|ELHSEFSEVMNEIWASDQIR.3|ELHSEFSEVMNEIWASDQIR.4|C[CAM]LAPMMSEVIR.2|GLYPAPLKIIDVVK.3|FGGGNPELLTQMVSK.2|FGGGNPELLTQMVSK.3|FGGGNPELLTQM[Oxi]VSK.2|MVGVPAALDMMLTGR.3|M[Oxi]VGVPAALDMMLTGR.3|M[Oxi]VGVPAALDMMLTGR.2|MVGVPAALDM[Oxi]MLTGR.2|MVGVPAALDMM[Oxi]LTGR.2|MVGVPAALDMMLTGR.2|SAVLISSK.2|NKFGAPQKDVK.3|GLYPAPLK.2|HVAEDLGK.2|TSKDTSASAVAVGLKQGK.4|TSKDTSASAVAVGLKQGK.3|GFYIYQEGVKR.3|FGELVMTK.2|FGELVM[Oxi]TK.2|KYEAAYGK.2|VIGMHYFSPVDK.3|VIGM[Oxi]HYFSPVDK.3|VIGM[Oxi]HYFSPVDK.2|VIGMHYFSPVDK.2|INSPNSKVNTLSK.3|INSPNSKVNTLSK.2|SEVSSDEDIQFR.3|SEVSSDEDIQFR.2|THINYGVK.2|TILKDATLTALDR.3|TILKDATLTALDR.2|DTSASAVAVGLKQGK.3|TSKDTSASAVAVGLK.3|TSKDTSASAVAVGLK.2|DATLTALDR.2|HVAEDLGKVFGER.3|HVAEDLGKVFGER.2|ADMVIEAVFEDLSLKHR.4|FGAPQKDVK.2|ALM[Oxi]GLYHGQVLC[CAM]K.3|ALMGLYHGQVLC[CAM]K.3|ALMGLYHGQVLC[CAM]K.2|ALM[Oxi]GLYHGQVLC[CAM]K.2|ILQEGVDPK.2|DGPGFYTTR.2|DLNSDMDSILASLK.3|DLNSDMDSILASLK.2|DLNSDM[Oxi]DSILASLK.2|FVDLYGAQKIVDR.3|FVDLYGAQK.2|QFTPC[CAM]QLLADHANSPNKK.4|QFTPC[CAM]QLLADHANSPNKK.3|QFTPC[CAM]QLLADHANSPNKK.2|KTVLGTPEVLLGALPGAGGTQR.4|KTVLGTPEVLLGALPGAGGTQR.3|TIEYLEEVAITFAK.3|TIEYLEEVAITFAK.2|TLQEVTQLSQEAQR.3|TLQEVTQLSQEAQR.2|ADMVIEAVFEDLSLK.3|ADM[Oxi]VIEAVFEDLSLK.3|ADM[Oxi]VIEAVFEDLSLK.2|ADMVIEAVFEDLSLK.2|TILKDATLTALDRGQQQVFK.4|TILKDATLTALDRGQQQVFK.3|MGLVDQLVEPLGPGLKPPEER.4|M[Oxi]GLVDQLVEPLGPGLKPPEER.3|MGLVDQLVEPLGPGLKPPEER.3|MGLVDQLVEPLGPGLKPPEER.2|NFTGSSALLTR.2|TVLGTPEVLLGALPGAGGTQRLPK.4|TVLGTPEVLLGALPGAGGTQRLPK.3|DATLTALDRGQQQVFK.3|DATLTALDRGQQQVFK.2|GFYIYQEGVK.2|KM[Oxi]GLVDQLVEPLGPGLKPPEER.4|KMGLVDQLVEPLGPGLKPPEER.4|KMGLVDQLVEPLGPGLKPPEER.3|KM[Oxi]GLVDQLVEPLGPGLKPPEER.3|PGC[CAM]FIAGADINMLAAC[CAM]K.3|PGC[CAM]FIAGADINMLAAC[CAM]K.2|LPPKSEVSSDEDIQFR.3|TGIEQGSDAGYLC[CAM]ESQK.3|TGIEQGSDAGYLC[CAM]ESQK.2|TLQEVTQLSQEAQRIVEKLEK.4|GLVEKLTAYAMTIPFVR.3|QFTPC[CAM]QLLADHANSPNK.3|SAVLISSKPGC[CAM]FIAGADINMLAAC[CAM]K.4|SAVLISSKPGC[CAM]FIAGADINMLAAC[CAM]K.3|SAVLISSKPGC[CAM]FIAGADINM[Oxi]LAAC[CAM]K.3|VLKEVEAVIPDHC[CAM]IFASNTSALPISEIAAVSKRPEK.6|VLKEVEAVIPDHC[CAM]IFASNTSALPISEIAAVSKRPEK.5|HLAILGAGLMGAGIAQVSVDK.3|HLAILGAGLM[Oxi]GAGIAQVSVDK.3|HLAILGAGLM[Oxi]GAGIAQVSVDK.2|HLAILGAGLMGAGIAQVSVDK.2|VIGMHYFSPVDKMQLLEIITTEK.4|DSIFSNLTGQLDYQGFEK.3|DSIFSNLTGQLDYQGFEK.2|STKPIVAAINGSC[CAM]LGGGLEVAISC[CAM]QYR.4|STKPIVAAINGSC[CAM]LGGGLEVAISC[CAM]QYR.3|KLDSLTTSFGFPVGAATLVDEVGVDVAK.4|KLDSLTTSFGFPVGAATLVDEVGVDVAK.3|DKGLVEKLTAYAMTIPFVR.3|EVEAVIPDHC[CAM]IFASNTSALPISEIAAVSKRPEK.5|EVEAVIPDHC[CAM]IFASNTSALPISEIAAVSKRPEK.4|KLDSLTTSFGFPVGAATLVDEVGVDVAKHVAEDLGK.5|KLDSLTTSFGFPVGAATLVDEVGVDVAKHVAEDLGK.4|EVEAVIPDHC[CAM]IFASNTSALPISEIAAVSK.4|EVEAVIPDHC[CAM]IFASNTSALPISEIAAVSK.3|DLNSDMDSILASLKLPPKSEVSSDEDIQFR.4|VLKEVEAVIPDHC[CAM]IFASNTSALPISEIAAVSK.4|TGIEQGSDAGYLC[CAM]ESQKFGELVM[Oxi]TK.3|ALTSFERDSIFSNLTGQLDYQGFEK.3
SEN / CTL,Adenine phosphoribosyltransferase,APRT,P07741,0.90,1.18,1.30E-03,9.48E-04,3.02E+00,"adenine salvage,lactation,grooming behavior,cellular response to insulin stimulus,purine-containing compound salvage,AMP salvage","adenine binding,adenine phosphoribosyltransferase activity,AMP binding","nucleoplasm,cytoplasm,cytosol,extracellular exosome",15,17,29,GFLFGPSLAQELGLGC[CAM]VLIR.3|GFLFGPSLAQELGLGC[CAM]VLIR.2|DISPVLKDPASFR.3|DISPVLKDPASFR.2|DALEPGQR.2|VVVVDDLLATGGTMNAAC[CAM]ELLGR.3|VVVVDDLLATGGTMNAAC[CAM]ELLGR.4|VVVVDDLLATGGTM[Oxi]NAAC[CAM]ELLGR.3|VVVVDDLLATGGTM[Oxi]NAAC[CAM]ELLGR.2|VVVVDDLLATGGTMNAAC[CAM]ELLGR.2|SFPDFPTPGVVFR.2|SFPDFPTPGVVFR.3|AELEIQK.2|ATHGGRIDYIAGLDSR.4|ATHGGRIDYIAGLDSR.2|LAPVPFFSLLQYE.3|LAPVPFFSLLQYE.2|AELEIQKDALEPGQR.3|AELEIQKDALEPGQR.2|IDYIAGLDSR.2|IRSFPDFPTPGVVFR.3|LPGPTLWASYSLEYGK.3|LPGPTLWASYSLEYGK.2|GKLPGPTLWASYSLEYGK.3|LQAEVLEC[CAM]VSLVELTSLK.3|LQAEVLEC[CAM]VSLVELTSLK.2|SFPDFPTPGVVFRDISPVLKDPASFR.4|GFLFGPSLAQELGLGC[CAM]VLIRK.3|EKLAPVPFFSLLQYE.2
SEN / CTL,Tubulin beta-3 chain,TUBB3,Q13509,0.90,0.95,1.60E-08,4.04E-08,7.39E+00,"cytoskeleton organization,microtubule-based process,mitotic nuclear division,axon guidance","GTPase activity,structural constituent of cytoskeleton,GTP binding,peptide binding","nucleus,cytoplasm,microtubule,axon,dendrite,neuronal cell body,extracellular exosome,cell periphery",42,12,23,ISVYYNEASSHKYVPR.4|LHFFMPGFAPLTAR.3|LHFFMPGFAPLTAR.2|LHFFM[Oxi]PGFAPLTAR.3|MSSTFIGNSTAIQELFKR.3|LATPTYGDLNHLVSATMSGVTTSLRFPGQLNADLRK.5|SGAFGHLFRPDNFIFGQSGAGNNWAK.4|SGAFGHLFRPDNFIFGQSGAGNNWAK.3|MSMKEVDEQMLAIQSK.3|LATPTYGDLNHLVSATMSGVTTSLR.3|LATPTYGDLNHLVSATMSGVTTSLR.4|LATPTYGDLNHLVSATM[Oxi]SGVTTSLR.4|LATPTYGDLNHLVSATM[Oxi]SGVTTSLR.3|EC[CAM]ENC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.4|EC[CAM]ENC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.3|MSSTFIGNSTAIQELFK.2|MSSTFIGNSTAIQELFK.3|M[Oxi]SSTFIGNSTAIQELFK.2|FWEVISDEHGIDPSGNYVGDSDLQLER.3|FWEVISDEHGIDPSGNYVGDSDLQLER.4|ISVYYNEASSHK.3|ISVYYNEASSHK.2|KEC[CAM]ENC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLISK.4
SEN / CTL,Eukaryotic initiation factor 4A-II,EIF4A2,Q14240,0.89,0.61,6.93E-02,2.63E-02,1.58E+00,"nuclear-transcribed mRNA poly(A) tail shortening,translational initiation,regulation of translational initiation,RNA secondary structure unwinding,viral process,negative regulation of RNA-directed RNA polymerase activity","translation initiation factor activity,ATP-dependent RNA helicase activity,helicase activity,protein binding,ATP binding,ATPase activity,poly(A) RNA binding","cytosol,eukaryotic translation initiation factor 4F complex,perinuclear region of cytoplasm",3,18,29,KGVAINFVTEEDKR.4|KGVAINFVTEEDKR.3|KGVAINFVTEEDKR.2|KGVAINFVTEEDK.3|GVAINFVTEEDKR.3|GVAINFVTEEDKR.2|GFKDQIYEIFQK.3|GFKDQIYEIFQK.2|EELTLEGIK.2|LQAEAPHIVVGTPGR.3|LQAEAPHIVVGTPGR.2|DFTVSALHGDMDQK.3|DFTVSALHGDMDQK.2|ILVKKEELTLEGIK.3|KEELTLEGIK.2|DQIYEIFQK.2|ETQALVLAPTR.2|VILALGDYMGATC[CAM]HAC[CAM]IGGTNVR.4|VILALGDYM[Oxi]GATC[CAM]HAC[CAM]IGGTNVR.4|VILALGDYMGATC[CAM]HAC[CAM]IGGTNVR.3|VILALGDYM[Oxi]GATC[CAM]HAC[CAM]IGGTNVR.3|LNTSIQVVLLSATMPTDVLEVTKK.4|LNTSIQVVLLSATM[Oxi]PTDVLEVTKK.3|LNTSIQVVLLSATMPTDVLEVTKK.3|GVAINFVTEEDK.2|VILALGDYMGATC[CAM]HAC[CAM]IGGTNVRNEMQK.4|DIETFYNTTVEEMPMNVADLI.3|LNTSIQVVLLSATMPTDVLEVTK.3|EHGGPEGMDPDGVIESNWNEIVDNFDDMNLK.3
SEN / CTL,Annexin A2,ANXA2,P07355,0.89,1.02,3.01E-28,6.26E-27,2.62E+01,"angiogenesis,membrane raft assembly,positive regulation of protein phosphorylation,negative regulation of receptor internalization,membrane budding,body fluid secretion,collagen fibril organization,positive regulation of vesicle fusion,negative regulation of low-density lipoprotein particle receptor catabolic process,osteoclast development,fibrinolysis,negative regulation of catalytic activity,positive regulation of fibroblast proliferation,positive regulation of binding,protein heterotetramerization,protein targeting to plasma membrane,response to thyroid hormone,cell-cell adhesion,negative regulation of receptor binding,positive regulation of receptor activity","protease binding,calcium ion binding,protein binding,calcium-dependent phospholipid binding,phosphatidylinositol-4,5-bisphosphate binding,cytoskeletal protein binding,Rab GTPase binding,phospholipase A2 inhibitor activity,S100 protein binding,poly(A) RNA binding,calcium-dependent protein binding,cadherin binding involved in cell-cell adhesion,receptor activator activity","ruffle,basement membrane,extracellular space,nucleus,lysosomal membrane,endosome,early endosome,lipid particle,cytosol,plasma membrane,cell-cell junction,cell-cell adherens junction,cell cortex,cell surface,membrane,basolateral plasma membrane,extrinsic component of plasma membrane,midbody,late endosome membrane,vesicle,myelin sheath adaxonal region,sarcolemma,melanosome,Schmidt-Lanterman incisure,macropinosome,perinuclear region of cytoplasm,extracellular exosome,PCSK9-AnxA2 complex,extracellular matrix,membrane raft",222,49,99,GLGTDEDSLIEIIC[CAM]SR.2|GLGTDEDSLIEIIC[CAM]SR.3|GVDEVTIVNILTNR.2|GVDEVTIVNILTNR.3|LSLEGDHSTPPSAYGSVK.3|LSLEGDHSTPPSAYGSVK.2|SLYYYIQQDTKGDYQK.3|SLYYYIQQDTKGDYQK.2|QDIAFAYQR.2|RAEDGSVIDYELIDQDARDLYDAGVK.4|RAEDGSVIDYELIDQDARDLYDAGVK.3|ALLYLC[CAM]GGDD.2|GDLENAFLNLVQC[CAM]IQNKPLYFADR.3|GDLENAFLNLVQC[CAM]IQNKPLYFADR.4|AEDGSVIDYELIDQDAR.2|AEDGSVIDYELIDQDAR.3|AEDGSVIDYELIDQDARDLYDAGVKR.4|DALNIETAIK.2|SALSGHLETVILGLLKTPAQYDASELK.4|DLYDAGVK.2|TDLEKDIISDTSGDFRK.3|TDLEKDIISDTSGDFRK.4|TDLEKDIISDTSGDFRK.2|SNAQRQDIAFAYQR.3|SNAQRQDIAFAYQR.2|SEVDMLK.2|TKGVDEVTIVNILTNR.3|TKGVDEVTIVNILTNR.2|TKGVDEVTIVNILTNR.4|AYTNFDAERDALNIETAIK.3|AYTNFDAERDALNIETAIK.2|AYTNFDAERDALNIETAIK.4|GTDVPKWISIMTER.3|GTDVPKWISIMTER.2|SLYYYIQQDTK.2|SLYYYIQQDTK.3|TNQELQEINR.2|TNQELQEINR.3|TNQELQEINRVYK.3|TNQELQEINRVYK.2|AYTNFDAERDALNIETAIKTK.4|SALSGHLETVILGLLK.3|SALSGHLETVILGLLK.2|SALSGHLETVILGLLK.4|RAEDGSVIDYELIDQDAR.3|RAEDGSVIDYELIDQDAR.4|RAEDGSVIDYELIDQDAR.2|TDLEKDIISDTSGDFR.3|TDLEKDIISDTSGDFR.2|TDLEKDIISDTSGDFR.4|GRRAEDGSVIDYELIDQDAR.4|GRRAEDGSVIDYELIDQDAR.3|GRRAEDGSVIDYELIDQDAR.2|SYSPYDMLESIRK.3|SYSPYDMLESIRK.2|SYSPYDM[Oxi]LESIRK.3|SYSPYDM[Oxi]LESIRK.2|SYSPYDMLESIR.2|SYSPYDMLESIR.3|SYSPYDM[Oxi]LESIR.2|SYSPYDM[Oxi]LESIR.3|TPAQYDASELK.2|TPAQYDASELK.3|WISIMTER.2|WISIM[Oxi]TER.2|EVKGDLENAFLNLVQC[CAM]IQNKPLYFADR.4|EVKGDLENAFLNLVQC[CAM]IQNKPLYFADR.5|EVKGDLENAFLNLVQC[CAM]IQNKPLYFADR.3|KGTDVPKWISIMTER.3|KGTDVPKWISIM[Oxi]TER.4|KGTDVPKWISIM[Oxi]TER.3|TPAQYDASELKASMK.3|TPAQYDASELKASMK.2|TPAQYDASELKASM[Oxi]K.3|TPAQYDASELKASM[Oxi]K.2|KEVKGDLENAFLNLVQC[CAM]IQNKPLYFADR.5|KEVKGDLENAFLNLVQC[CAM]IQNKPLYFADR.4|YKSYSPYDMLESIRK.4|YKSYSPYDMLESIRK.3|AEDGSVIDYELIDQDARDLYDAGVK.3|AEDGSVIDYELIDQDARDLYDAGVK.4|AYTNFDAER.2|DLYDAGVKR.2|SALSGHLETVILGLLKTPAQYDASELKASMK.4|SALSGHLETVILGLLKTPAQYDASELKASMK.5|SALSGHLETVILGLLKTPAQYDASELKASM[Oxi]K.5|KELASALK.2|KLMVALAK.2|PLYFADR.2|DIISDTSGDFRK.3|DIISDTSGDFRK.2|EMYKTDLEK.2|EVKGDLENAFLNLVQC[CAM]IQNK.4|EVKGDLENAFLNLVQC[CAM]IQNK.3|ELASALKSALSGHLETVILGLLK.4|ELASALKSALSGHLETVILGLLK.3|DIISDTSGDFR.2|GDLENAFLNLVQC[CAM]IQNK.3|GDLENAFLNLVQC[CAM]IQNK.2
SEN / CTL,Ragulator complex protein LAMTOR1,LAMTOR1,Q6IAA8,0.88,0.36,1.02E-03,7.73E-04,3.11E+00,"regulation of receptor recycling,endosome organization,lysosome organization,cell cycle arrest,regulation of cholesterol esterification,regulation of cholesterol efflux,cell growth,macroautophagy,positive regulation of TOR signaling,lysosome localization,endosome localization,cellular protein localization,cholesterol homeostasis,positive regulation of MAPK cascade,positive regulation of GTPase activity,regulation of cholesterol import,cellular response to amino acid stimulus","protein binding,guanyl-nucleotide exchange factor activity,protein complex scaffold","lysosome,lysosomal membrane,Golgi apparatus,plasma membrane,late endosome membrane,intracellular membrane-bounded organelle,membrane raft,extracellular exosome,Ragulator complex",6,9,17,TDEQALLSSILAK.2|IAAYAYSALSQIR.2|ALNGAEPNYHSLPSAR.4|ALNGAEPNYHSLPSAR.3|ALNGAEPNYHSLPSAR.2|KLLLDPSSPPTK.3|KLLLDPSSPPTK.2|LAVLSSSLTHWK.3|LAVLSSSLTHWK.2|KLPPLPSLTSQPHQVLASEPIPFSDLQQVSR.6|KLPPLPSLTSQPHQVLASEPIPFSDLQQVSR.5|KLPPLPSLTSQPHQVLASEPIPFSDLQQVSR.4|KLPPLPSLTSQPHQVLASEPIPFSDLQQVSR.3|LLLDPSSPPTK.2|LPPLPSLTSQPHQVLASEPIPFSDLQQVSR.4|LPPLPSLTSQPHQVLASEPIPFSDLQQVSR.3|TASNIIDVSAADSQGMEQHEYMDR.3
SEN / CTL,PDZ and LIM domain protein 1,PDLIM1,O00151,0.88,0.29,2.87E-19,2.87E-18,1.75E+01,"response to hypoxia,regulation of transcription, DNA-templated,response to oxidative stress,cell-cell adhesion","transcription coactivator activity,zinc ion binding,cadherin binding involved in cell-cell adhesion","transcription factor complex,cytoplasm,cytoskeleton,cell-cell adherens junction,focal adhesion",39,27,50,IKGC[CAM]TDNLTLTVAR.3|IKGC[CAM]TDNLTLTVAR.2|C[CAM]GTGIVGVFVK.2|LVGGKDFEQPLAISR.3|LVGGKDFEQPLAISR.2|GHFFVEDQIYC[CAM]EK.3|GHFFVEDQIYC[CAM]EK.2|VTPPEGYEVVTVFPK.2|VTPPEGYEVVTVFPK.3|GC[CAM]TDNLTLTVAR.2|GC[CAM]TDNLTLTVAR.3|MNLASEPQEVLHIGSAHNR.4|M[Oxi]NLASEPQEVLHIGSAHNR.4|MNLASEPQEVLHIGSAHNR.3|MNLASEPQEVLHIGSAHNR.2|ERVTPPEGYEVVTVFPK.3|AALANLC[CAM]IGDVITAIDGENTSNMTHLEAQNR.4|AALANLC[CAM]IGDVITAIDGENTSNM[Oxi]THLEAQNR.4|AALANLC[CAM]IGDVITAIDGENTSNMTHLEAQNR.3|AALANLC[CAM]IGDVITAIDGENTSNM[Oxi]THLEAQNR.3|VWSPLVTEEGKR.3|VWSPLVTEEGKR.2|QELNEPPK.2|VAASIGNAQK.2|HRHPEC[CAM]YVC[CAM]TDC[CAM]GTNLK.4|HRHPEC[CAM]YVC[CAM]TDC[CAM]GTNLK.3|PLDHAQPPSSLVIDK.3|DFEQPLAISR.2|QSTSFLVLQEILESEEKGDPNKPSGFR.5|QSTSFLVLQEILESEEKGDPNKPSGFR.4|QSTSFLVLQEILESEEKGDPNKPSGFR.3|HPEC[CAM]YVC[CAM]TDC[CAM]GTNLK.3|HPEC[CAM]YVC[CAM]TDC[CAM]GTNLK.2|VWSPLVTEEGK.2|SEHKVWSPLVTEEGKR.3|QKGHFFVEDQIYC[CAM]EK.3|QSTSFLVLQEILESEEK.3|QSTSFLVLQEILESEEK.2|TAASGVEANSRPLDHAQPPSSLVIDK.4|TAASGVEANSRPLDHAQPPSSLVIDK.3|TAASGVEANSRPLDHAQPPSSLVIDKESEVYK.5|TAASGVEANSRPLDHAQPPSSLVIDKESEVYK.4|TAASGVEANSRPLDHAQPPSSLVIDKESEVYK.3|VITNQYNNPAGLYSSENISNFNNALESK.4|VITNQYNNPAGLYSSENISNFNNALESK.3|SAMPFTASPASSTTAR.2|SAM[Oxi]PFTASPASSTTAR.2|QELNEPPKQSTSFLVLQEILESEEKGDPNKPSGFR.5|QELNEPPKQSTSFLVLQEILESEEKGDPNKPSGFR.4|QELNEPPKQSTSFLVLQEILESEEK.3
SEN / CTL,"Actin, cytoplasmic 1;Actin, cytoplasmic 2",ACTB;ACTG1,P60709;P63261,0.88,1.26,9.10E-19,8.47E-18,1.71E+01,"retina homeostasis,movement of cell or subcellular component,cytoskeleton organization,substantia nigra development,cell junction assembly,Fc-gamma receptor signaling pathway involved in phagocytosis,ATP-dependent chromatin remodeling,positive regulation of gene expression, epigenetic,vascular endothelial growth factor receptor signaling pathway,ephrin receptor signaling pathway,platelet aggregation;retina homeostasis,movement of cell or subcellular component,cell junction assembly,Fc-gamma receptor signaling pathway involved in phagocytosis,sarcomere organization,vascular endothelial growth factor receptor signaling pathway,ephrin receptor signaling pathway,platelet aggregation","structural constituent of cytoskeleton,protein binding,ATP binding,kinesin binding,Tat protein binding,identical protein binding,nitric-oxide synthase binding,RNA polymerase II core promoter proximal region sequence-specific DNA binding,RNA polymerase II distal enhancer sequence-specific DNA binding,nucleosomal DNA binding;structural constituent of cytoskeleton,protein binding,ATP binding,ubiquitin protein ligase binding","nuclear chromatin,extracellular space,nucleoplasm,cytoplasm,cytosol,cytoskeleton,plasma membrane,focal adhesion,membrane,intracellular ribonucleoprotein complex,cortical cytoskeleton,NuA4 histone acetyltransferase complex,cytoplasmic ribonucleoprotein granule,myelin sheath,protein complex,extracellular exosome,MLL5-L complex,blood microparticle,dense body;extracellular space,nucleus,cytosol,cytoskeleton,plasma membrane,focal adhesion,membrane,myofibril,extracellular matrix,filamentous actin,myelin sheath,extracellular exosome,blood microparticle,dense body",282,34,122,SYELPDGQVITIGNER.2|SYELPDGQVITIGNER.3|VAPEEHPVLLTEAPLNPK.3|VAPEEHPVLLTEAPLNPK.2|VAPEEHPVLLTEAPLNPK.4|GYSFTTTAEREIVR.3|GYSFTTTAEREIVR.2|AVFPSIVGRPR.3|AVFPSIVGRPR.2|DLTDYLMK.2|DLTDYLMK.1|DLTDYLM[Oxi]K.2|GYSFTTTAER.2|YPIEHGIVTNWDDMEKIWHHTFYNELR.5|YSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHR.4|YSVWIGGSILASLSTFQQM[Oxi]WISKQEYDESGPSIVHR.4|AGFAGDDAPR.2|MTQIMFETFNTPAMYVAIQAVLSLYASGR.3|IWHHTFYNELR.3|IWHHTFYNELR.2|GYSFTTTAEREIVRDIK.3|HQGVMVGMGQKDSYVGDEAQSKR.5|HQGVM[Oxi]VGMGQKDSYVGDEAQSKR.4|HQGVMVGMGQKDSYVGDEAQSKR.4|HQGVM[Oxi]VGM[Oxi]GQKDSYVGDEAQSKR.5|HQGVM[Oxi]VGMGQKDSYVGDEAQSKR.5|HQGVM[Oxi]VGM[Oxi]GQKDSYVGDEAQSKR.4|HQGVMVGM[Oxi]GQKDSYVGDEAQSKR.5|HQGVM[Oxi]VGM[Oxi]GQKDSYVGDEAQSKR.3|TTGIVM[Oxi]DSGDGVTHTVPIYEGYALPHAILR.4|TTGIVMDSGDGVTHTVPIYEGYALPHAILR.4|TTGIVM[Oxi]DSGDGVTHTVPIYEGYALPHAILR.3|TTGIVMDSGDGVTHTVPIYEGYALPHAILR.5|TTGIVMDSGDGVTHTVPIYEGYALPHAILR.3|TTGIVM[Oxi]DSGDGVTHTVPIYEGYALPHAILR.5|TTGIVMDSGDGVTHTVPIYEGYALPHAILR.6|TTGIVM[Oxi]DSGDGVTHTVPIYEGYALPHAILR.6|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIMK.4|FRC[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIMK.3|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIM[Oxi]K.3|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIMK.3|FRC[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIM[Oxi]K.4|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIM[Oxi]K.5|FRC[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIMK.5|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIMK.5|FRC[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIMK.4|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIM[Oxi]K.4|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIM[Oxi]K.6|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIMK.6|FRC[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIM[Oxi]K.5|LDLAGRDLTDYLMK.3|LDLAGRDLTDYLMK.2|LDLAGRDLTDYLM[Oxi]K.3|LDLAGRDLTDYLM[Oxi]K.2|C[CAM]DVDIRKDLYANTVLSGGTTMYPGIADR.4|C[CAM]DVDIRKDLYANTVLSGGTTMYPGIADR.3|C[CAM]DVDIRKDLYANTVLSGGTTM[Oxi]YPGIADR.3|C[CAM]DVDIRKDLYANTVLSGGTTM[Oxi]YPGIADR.4|LC[CAM]YVALDFEQEMATAASSSSLEK.3|LC[CAM]YVALDFEQEMATAASSSSLEK.4|LC[CAM]YVALDFEQEM[Oxi]ATAASSSSLEK.3|EKLC[CAM]YVALDFEQEMATAASSSSLEK.3|EKLC[CAM]YVALDFEQEMATAASSSSLEK.4|EKLC[CAM]YVALDFEQEM[Oxi]ATAASSSSLEK.3|C[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIMK.3|C[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIMK.4|C[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIMK.3|C[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIMK.4|C[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIM[Oxi]K.4|C[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIM[Oxi]K.3|C[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIMK.5|C[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIM[Oxi]K.4|C[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIM[Oxi]K.3|KDLYANTVLSGGTTMYPGIADR.3|KDLYANTVLSGGTTM[Oxi]YPGIADR.3|KDLYANTVLSGGTTMYPGIADR.4|KDLYANTVLSGGTTMYPGIADR.2|KDLYANTVLSGGTTM[Oxi]YPGIADR.2|HQGVMVGMGQKDSYVGDEAQSK.4|HQGVMVGM[Oxi]GQKDSYVGDEAQSK.4|HQGVM[Oxi]VGMGQKDSYVGDEAQSK.4|HQGVM[Oxi]VGM[Oxi]GQKDSYVGDEAQSK.4|HQGVMVGMGQKDSYVGDEAQSK.3|HQGVMVGM[Oxi]GQKDSYVGDEAQSK.3|HQGVM[Oxi]VGMGQKDSYVGDEAQSK.3|HQGVM[Oxi]VGM[Oxi]GQKDSYVGDEAQSK.3|DLYANTVLSGGTTMYPGIADR.3|DLYANTVLSGGTTMYPGIADR.2|DLYANTVLSGGTTM[Oxi]YPGIADR.3|DLYANTVLSGGTTMYPGIADR.4|DLYANTVLSGGTTM[Oxi]YPGIADR.4|DLYANTVLSGGTTM[Oxi]YPGIADR.2|EITALAPSTMK.2|EITALAPSTM[Oxi]K.2|QEYDESGPSIVHR.3|QEYDESGPSIVHR.2|YSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHRK.5|YSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHRK.6|YSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHRK.4|IKIIAPPER.2|MQKEITALAPSTMK.3|MQKEITALAPSTMK.2|M[Oxi]QKEITALAPSTMK.3|MQKEITALAPSTM[Oxi]K.3|M[Oxi]QKEITALAPSTM[Oxi]K.3|M[Oxi]QKEITALAPSTM[Oxi]K.2|M[Oxi]QKEITALAPSTMK.2|MQKEITALAPSTM[Oxi]K.2|RGILTLK.2|YPIEHGIVTNWDDMEK.3|YPIEHGIVTNWDDMEK.2|YPIEHGIVTNWDDM[Oxi]EK.3|AVFPSIVGR.2|QEYDESGPSIVHRK.3|QEYDESGPSIVHRK.4|QEYDESGPSIVHRK.2|KYSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHR.5|KYSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHR.6|KYSVWIGGSILASLSTFQQM[Oxi]WISKQEYDESGPSIVHR.5|KYSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHR.4|DSYVGDEAQSK.2|DSYVGDEAQSK.3
SEN / CTL,"Superoxide dismutase [Mn], mitochondrial",SOD2,P04179,0.86,1.13,1.42E-05,1.74E-05,4.76E+00,"response to reactive oxygen species,response to superoxide,age-dependent response to reactive oxygen species,release of cytochrome c from mitochondria,vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure,regulation of transcription from RNA polymerase II promoter,superoxide metabolic process,regulation of blood pressure,negative regulation of cell proliferation,removal of superoxide radicals,oxygen homeostasis,negative regulation of neuron apoptotic process,protein homotetramerization,oxidation-reduction process,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway","superoxide dismutase activity,manganese ion binding","mitochondrion,mitochondrial matrix,extracellular exosome",54,23,42,AIWNVINWENVTER.2|AIWNVINWENVTER.3|GDVTAQIALQPALK.2|GDVTAQIALQPALK.3|HHAAYVNNLNVTEEKYQEALAKGDVTAQIALQPALK.5|GHLQIAAC[CAM]PNQDPLQGTTGLIPLLGIDVWEHAYYLQYK.4|GHLQIAAC[CAM]PNQDPLQGTTGLIPLLGIDVWEHAYYLQYK.5|GHLQIAAC[CAM]PNQDPLQGTTGLIPLLGIDVWEHAYYLQYK.6|HHAAYVNNLNVTEEKYQEALAK.4|HHAAYVNNLNVTEEKYQEALAK.5|HHAAYVNNLNVTEEKYQEALAK.3|LTAASVGVQGSGWGWLGFNKER.3|LTAASVGVQGSGWGWLGFNK.3|LTAASVGVQGSGWGWLGFNK.2|YQEALAK.2|FNGGGHINHSIFWTNLSPNGGGEPKGELLEAIKR.6|FNGGGHINHSIFWTNLSPNGGGEPKGELLEAIKR.5|FNGGGHINHSIFWTNLSPNGGGEPKGELLEAIKR.4|HHAAYVNNLNVTEEK.3|HHAAYVNNLNVTEEK.4|HHAAYVNNLNVTEEK.2|DFGSFDK.2|GELLEAIK.2|RDFGSFDK.2|NVRPDYLK.2|GELLEAIKR.2|HSLPDLPYDYGALEPHINAQIMQLHHSK.6|HSLPDLPYDYGALEPHINAQIM[Oxi]QLHHSK.6|HSLPDLPYDYGALEPHINAQIMQLHHSK.5|HSLPDLPYDYGALEPHINAQIMQLHHSK.4|HSLPDLPYDYGALEPHINAQIMQLHHSK.3|AIWNVINWENVTERYM[Oxi]AC[CAM]KK.4|FNGGGHINHSIFWTNLSPNGGGEPK.4|FNGGGHINHSIFWTNLSPNGGGEPK.3|DFGSFDKFKEK.2|FNGGGHINHSIFWTNLSPNGGGEPKGELLEAIK.5|FNGGGHINHSIFWTNLSPNGGGEPKGELLEAIK.4|YQEALAKGDVTAQIALQPALK.3|EKLTAASVGVQGSGWGWLGFNK.3|ERGHLQIAAC[CAM]PNQDPLQGTTGLIPLLGIDVWEHAYYLQYK.6|ERGHLQIAAC[CAM]PNQDPLQGTTGLIPLLGIDVWEHAYYLQYK.5|ERGHLQIAAC[CAM]PNQDPLQGTTGLIPLLGIDVWEHAYYLQYK.4
SEN / CTL,N-acetylgalactosamine-6-sulfatase,GALNS,P34059,0.85,1.61,6.73E-02,2.57E-02,1.59E+00,keratan sulfate catabolic process,"N-acetylgalactosamine-4-sulfatase activity,sulfuric ester hydrolase activity,N-acetylgalactosamine-6-sulfatase activity,metal ion binding","lysosomal lumen,extracellular exosome",9,12,17,YYEEFPINLK.2|AHFWTWTNSWENFR.3|AHFWTWTNSWENFR.2|AIDGLNLLPTLLQGR.2|NGFYTTNAHAR.3|NGFYTTNAHAR.2|GDTLMAATLGQHK.3|GDTLMAATLGQHK.2|GDTLM[Oxi]AATLGQHK.2|LPLIFHLGR.2|C[CAM]LTPPESIPK.2|HGFDEWFGSPNC[CAM]HFGPYDNK.4|HGFDEWFGSPNC[CAM]HFGPYDNK.3|DPGERFPLSFASAEYQEALSR.3|NAYTPQEIVGGIPDSEQLLPELLK.3|FPLSFASAEYQEALSR.2|ITSVVQQHQEALVPAQPQLNVC[CAM]NWAVMNWAPPGC[CAM]EK.4
SEN / CTL,40S ribosomal protein S20,RPS20,P60866,0.85,0.66,1.32E-01,4.44E-02,1.35E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","structural constituent of ribosome,poly(A) RNA binding","nucleoplasm,cytoplasm,cytosol,membrane,cytosolic small ribosomal subunit,extracellular matrix,extracellular exosome",3,5,10,LIDLHSPSEIVK.3|LIDLHSPSEIVK.2|DTGKTPVEPEVAIHR.4|DTGKTPVEPEVAIHR.3|DTGKTPVEPEVAIHR.2|TPVEPEVAIHR.3|TPVEPEVAIHR.2|VC[CAM]ADLIR.2|RLIDLHSPSEIVK.3|RLIDLHSPSEIVK.2
SEN / CTL,Vasodilator-stimulated phosphoprotein,VASP,P50552,0.84,0.29,2.15E-05,2.52E-05,4.60E+00,"neural tube closure,axon guidance,actin polymerization or depolymerization,positive regulation of actin filament polymerization,cell junction assembly,protein homotetramerization,cell-cell adhesion","actin binding,protein binding,profilin binding,SH3 domain binding,cadherin binding involved in cell-cell adhesion","cytoplasm,cytosol,plasma membrane,cell-cell adherens junction,bicellular tight junction,focal adhesion,actin cytoskeleton,lamellipodium membrane,filopodium membrane,extracellular exosome",9,28,48,WLPAGTGPQAFSR.2|SSSSVTTSETQPC[CAM]TPSSSDYSDLQR.3|VKEEIIEAFVQELR.3|VKEEIIEAFVQELR.2|QQPGPSEHIER.3|QQPGPSEHIER.2|VKQELLEEVKK.3|VKQELLEEVKK.2|ATVMLYDDGNKR.3|ATVMLYDDGNKR.2|VKEEIIEAFVQELRK.4|VKEEIIEAFVQELRK.3|RQQPGPSEHIER.3|RQQPGPSEHIER.2|VPAQSESVR.2|VSKQEEASGGPTAPK.3|VSKQEEASGGPTAPK.2|RWLPAGTGPQAFSR.3|VQIYHNPTANSFR.3|VQIYHNPTANSFR.2|YNQATPNFHQWR.3|YNQATPNFHQWR.2|EEIIEAFVQELRK.3|KVSKQEEASGGPTAPK.3|KVSKQEEASGGPTAPK.2|SGGGGLMEEMNAMLAR.3|SGGGGLMEEMNAMLAR.2|SGGGGLM[Oxi]EEMNAMLAR.2|SGGGGLMEEMNAM[Oxi]LAR.2|QELLEEVKK.2|TPKDESANQEEPEAR.3|QVWGLNFGSK.2|QEEASGGPTAPK.2|MQPDQQVVINC[CAM]AIVR.3|M[Oxi]QPDQQVVINC[CAM]AIVR.2|MQPDQQVVINC[CAM]AIVR.2|ATQVGEKTPKDESANQEEPEAR.4|ATVMLYDDGNK.2|ATVM[Oxi]LYDDGNK.2|KMQPDQQVVINC[CAM]AIVR.3|KMQPDQQVVINC[CAM]AIVR.2|DESANQEEPEAR.2|EEIIEAFVQELR.2|EDAAQFAAGMASALEALEGGGPPPPPALPTWSVPNGPSPEEVEQQK.6|EDAAQFAAGMASALEALEGGGPPPPPALPTWSVPNGPSPEEVEQQK.5|EDAAQFAAGMASALEALEGGGPPPPPALPTWSVPNGPSPEEVEQQK.4|EDAAQFAAGMASALEALEGGGPPPPPALPTWSVPNGPSPEEVEQQKR.6|EDAAQFAAGMASALEALEGGGPPPPPALPTWSVPNGPSPEEVEQQKR.4
SEN / CTL,Cocaine esterase,CES2,O00748,0.84,0.09,3.50E-03,2.24E-03,2.65E+00,"xenobiotic metabolic process,catabolic process","methylumbelliferyl-acetate deacetylase activity,carboxylic ester hydrolase activity","extracellular space,endoplasmic reticulum,endoplasmic reticulum lumen",3,21,31,MIPGVVDGVFLPR.2|M[Oxi]IPGVVDGVFLPR.2|ADHGDELPFVFR.3|ADHGDELPFVFR.2|EMDREASQAALQK.3|SKEEILAINKPFK.3|SKEEILAINKPFK.2|APVYFYEFQHQPSWLK.4|APVYFYEFQHQPSWLK.3|APVYFYEFQHQPSWLK.2|SFFGGNYIK.2|TTHTGQVLGSLVHVK.3|GANAGVQTFLGIPFAKPPLGPLR.4|GANAGVQTFLGIPFAKPPLGPLR.3|GANAGVQTFLGIPFAKPPLGPLR.2|WVQQNIAHFGGNPDR.3|WVQQNIAHFGGNPDR.2|IQELEEPEERHTEL.3|HATGNWGYLDQVAALR.3|HATGNWGYLDQVAALR.2|LGVLGFFSTGDK.2|FTEEEEQLSR.2|IQELEEPEER.2|FTEEEEQLSRK.2|SFFGGNYIKFTEEEEQLSR.3|FAPPEPPESWSGVR.2|GANAGVQTFLGIPFAK.2|HPQELLASADFQPVPSIVGVNNNEFGWLIPK.4|HPQELLASADFQPVPSIVGVNNNEFGWLIPK.3|MLTLLMLPPTFGDLLR.2|NGNPNGEGLPHWPLFDQEEQYLQLNLQPAVGR.4
SEN / CTL,Transmembrane emp24 domain-containing protein 9,TMED9,Q9BVK6,0.84,0.52,4.25E-04,3.59E-04,3.44E+00,"ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,Golgi organization,positive regulation of organelle organization,COPI coating of Golgi vesicle,protein exit from endoplasmic reticulum,early endosome to Golgi transport",syntaxin binding,"Golgi membrane,endoplasmic reticulum,endoplasmic reticulum membrane,endoplasmic reticulum-Golgi intermediate compartment,Golgi apparatus,integral component of membrane,transport vesicle,trans-Golgi network transport vesicle,endoplasmic reticulum-Golgi intermediate compartment membrane,extracellular exosome",9,13,20,QLVEQVEQIQKEQNYQR.3|FSLFAGGMLR.2|FSLFAGGM[Oxi]LR.2|C[CAM]FIEEIPDETMVIGNYR.3|C[CAM]FIEEIPDETM[Oxi]VIGNYR.3|C[CAM]FIEEIPDETMVIGNYR.2|LSELQLR.2|VHLDIQVGEHANDYAEIAAK.4|VHLDIQVGEHANDYAEIAAK.3|VHLDIQVGEHANDYAEIAAK.2|EEYQPATPGLGMFVEVK.3|EEYQPATPGLGMFVEVK.2|VHLDIQVGEHANDYAEIAAKDKLSELQLR.5|QLVEQVEQIQK.2|QREEYQPATPGLGMFVEVKDPEDK.4|QREEYQPATPGLGMFVEVKDPEDK.3|KC[CAM]FIEEIPDETMVIGNYR.3|VRQLVEQVEQIQK.2|VRQLVEQVEQIQKEQNYQR.3|EEYQPATPGLGMFVEVKDPEDK.3
SEN / CTL,"Cytochrome c oxidase subunit 5B, mitochondrial",COX5B,P10606,0.83,0.69,1.35E-02,6.80E-03,2.17E+00,"mitochondrial electron transport, cytochrome c to oxygen,respiratory gaseous exchange,mitochondrial ATP synthesis coupled proton transport","cytochrome-c oxidase activity,protein binding,metal ion binding","mitochondrion,mitochondrial inner membrane,mitochondrial respiratory chain complex IV,extracellular exosome",6,10,16,KGLDPYNVLAPK.3|KGLDPYNVLAPK.2|GLDPYNVLAPK.2|EDPNLVPSISNKR.3|EDPNLVPSISNKR.2|GASGTREDPNLVPSISNKR.4|GASGTREDPNLVPSISNKR.3|GASGTREDPNLVPSISNKR.2|GASGTREDPNLVPSISNK.3|GASGTREDPNLVPSISNK.2|EDPNLVPSISNK.2|RIVGC[CAM]IC[CAM]EEDNTSVVWFWLHK.4|RIVGC[CAM]IC[CAM]EEDNTSVVWFWLHK.3|IVGC[CAM]IC[CAM]EEDNTSVVWFWLHKGEAQR.4|IVGC[CAM]IC[CAM]EEDNTSVVWFWLHK.3|SMASGGGVPTDEEQATGLER.2
SEN / CTL,Ras-related protein Rab-10,RAB10,P61026,0.83,0.37,8.13E-06,1.07E-05,4.97E+00,"Golgi to plasma membrane transport,small GTPase mediated signal transduction,axonogenesis,vesicle-mediated transport,endosomal transport,antigen processing and presentation,polarized epithelial cell differentiation,cellular response to insulin stimulus,Golgi to plasma membrane protein transport,establishment of neuroblast polarity,membrane organization,basolateral protein localization,endoplasmic reticulum tubular network organization,protein localization to plasma membrane,establishment of protein localization to membrane,establishment of protein localization to endoplasmic reticulum membrane,cell-cell adhesion","GTPase activity,GTP binding,GDP binding,myosin V binding,cadherin binding involved in cell-cell adhesion","Golgi membrane,endosome,endoplasmic reticulum membrane,Golgi apparatus,trans-Golgi network,cell-cell junction,cell-cell adherens junction,focal adhesion,cilium,cytoplasmic vesicle membrane,phagocytic vesicle membrane,insulin-responsive compartment,recycling endosome,recycling endosome membrane,extracellular exosome,endoplasmic reticulum tubular network,exocyst,plasma membrane",12,17,24,AFLTLAEDILR.2|LLLIGDSGVGK.2|LQIWDTAGQER.2|LQIWDTAGQER.3|IKLQIWDTAGQER.3|IKLQIWDTAGQER.2|ANINIEK.2|SFENISK.2|FHTITTSYYR.3|FHTITTSYYR.2|TYDLLFK.2|AFLTLAEDILRK.3|AFLTLAEDILRK.2|NIDEHANEDVER.3|NIDEHANEDVER.2|KTYDLLFK.2|GAMGIMLVYDITNGK.3|GAMGIMLVYDITNGK.2|KTPVKEPNSENVDISSGGGVTGWK.4|KTPVKEPNSENVDISSGGGVTGWK.3|ANINIEKAFLTLAEDILR.3|TPVKEPNSENVDISSGGGVTGWK.3|EPNSENVDISSGGGVTGWK.2|FSDDAFNTTFISTIGIDFK.2
SEN / CTL,Adenylate kinase isoenzyme 1,AK1,P00568,0.82,0.51,5.55E-08,1.20E-07,6.92E+00,"nucleoside diphosphate phosphorylation,ADP biosynthetic process,cell cycle arrest,nucleoside triphosphate biosynthetic process,nucleobase-containing small molecule interconversion,AMP metabolic process,ATP metabolic process","adenylate kinase activity,nucleoside diphosphate kinase activity,ATP binding","outer dense fiber,cytoplasm,cytosol,plasma membrane,extracellular exosome",21,16,23,IIFVVGGPGSGK.2|GQLVPLETVLDMLR.3|GQLVPLETVLDMLR.2|GQLVPLETVLDM[Oxi]LR.2|YGYTHLSTGDLLR.3|YGYTHLSTGDLLR.2|GFLIDGYPR.2|IGQPTLLLYVDAGPETMTQR.3|IGQPTLLLYVDAGPETMTQR.2|RIGQPTLLLYVDAGPETMTQR.3|EVQQGEEFERR.3|KLSEIMEK.2|VDDNEETIK.2|VNAEGSVDSVFSQVC[CAM]THLDALK.4|VNAEGSVDSVFSQVC[CAM]THLDALK.3|VNAEGSVDSVFSQVC[CAM]THLDALK.2|VDDNEETIKK.2|RGETSGRVDDNEETIK.3|IIFVVGGPGSGKGTQC[CAM]EK.3|EVQQGEEFER.2|KVNAEGSVDSVFSQVC[CAM]THLDALK.4|KVNAEGSVDSVFSQVC[CAM]THLDALK.3|ATEPVIAFYEK.2
SEN / CTL,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,P12268,0.81,0.34,2.15E-06,3.30E-06,5.48E+00,"GMP biosynthetic process,GTP biosynthetic process,purine ribonucleoside monophosphate biosynthetic process,lymphocyte proliferation,protein homotetramerization,oxidation-reduction process,retina development in camera-type eye,cellular response to interleukin-4","nucleotide binding,DNA binding,RNA binding,IMP dehydrogenase activity,metal ion binding","nucleus,cytoplasm,peroxisomal membrane,cytosol,membrane,extracellular exosome",12,39,77,NLIDAGVDALR.2|GKLPIVNEDDELVAIIAR.3|GKLPIVNEDDELVAIIAR.2|FVPYLIAGIQHSC[CAM]QDIGAK.3|FVPYLIAGIQHSC[CAM]QDIGAK.4|FVPYLIAGIQHSC[CAM]QDIGAK.2|RFGVPVIADGGIQNVGHIAK.4|RFGVPVIADGGIQNVGHIAK.3|RFGVPVIADGGIQNVGHIAK.2|ARHGFC[CAM]GIPITDTGR.4|ARHGFC[CAM]GIPITDTGR.3|RTSSAQVEGGVHSLHSYEK.5|RTSSAQVEGGVHSLHSYEK.4|RTSSAQVEGGVHSLHSYEK.3|TSSAQVEGGVHSLHSYEKR.5|TSSAQVEGGVHSLHSYEKR.4|TSSAQVEGGVHSLHSYEKR.3|KQLLC[CAM]GAAIGTHEDDKYR.5|KQLLC[CAM]GAAIGTHEDDKYR.4|LVGIISSR.2|PQATAVYK.2|KYEQGFITDPVVLSPK.4|KYEQGFITDPVVLSPK.3|KYEQGFITDPVVLSPK.2|FGVPVIADGGIQNVGHIAK.4|FGVPVIADGGIQNVGHIAK.3|FGVPVIADGGIQNVGHIAK.2|HGFC[CAM]GIPITDTGR.3|HGFC[CAM]GIPITDTGR.2|AM[Oxi]MYSGELKFEK.3|AMMYSGELKFEK.3|TSSAQVEGGVHSLHSYEK.4|TSSAQVEGGVHSLHSYEK.3|TSSAQVEGGVHSLHSYEK.2|EANEILQR.2|QLLC[CAM]GAAIGTHEDDKYR.4|QLLC[CAM]GAAIGTHEDDKYR.3|REDLVVAPAGITLK.3|REDLVVAPAGITLK.2|AMMYSGELK.2|AM[Oxi]MYSGELK.2|AMM[Oxi]YSGELK.2|GMGSLDAMDK.2|GM[Oxi]GSLDAMDK.2|GMGSLDAM[Oxi]DK.2|DKYPNLQVIGGNVVTAAQAK.4|DKYPNLQVIGGNVVTAAQAK.3|DKYPNLQVIGGNVVTAAQAK.2|KGKLPIVNEDDELVAIIAR.4|KGKLPIVNEDDELVAIIAR.3|NRDYPLASK.2|QLLC[CAM]GAAIGTHEDDK.3|QLLC[CAM]GAAIGTHEDDK.2|YEQGFITDPVVLSPK.3|YEQGFITDPVVLSPK.2|VAQGVSGAVQDK.2|LPIVNEDDELVAIIAR.3|LPIVNEDDELVAIIAR.2|EEEHDC[CAM]FLEEIMTK.3|EEEHDC[CAM]FLEEIMTK.2|GMGSLDAMDKHLSSQNR.3|YPNLQVIGGNVVTAAQAK.3|YPNLQVIGGNVVTAAQAK.2|YIKDKYPNLQVIGGNVVTAAQAK.4|DIDFLKEEEHDC[CAM]FLEEIMTK.4|DIDFLKEEEHDC[CAM]FLEEIMTK.3|EDLVVAPAGITLK.2|DIDFLKEEEHDC[CAM]FLEEIMTKR.4|YRGMGSLDAMDK.2|VKKYEQGFITDPVVLSPK.3|VGMGSGSIC[CAM]ITQEVLAC[CAM]GRPQATAVYK.4|VGM[Oxi]GSGSIC[CAM]ITQEVLAC[CAM]GRPQATAVYK.4|VGM[Oxi]GSGSIC[CAM]ITQEVLAC[CAM]GRPQATAVYK.3|VGMGSGSIC[CAM]ITQEVLAC[CAM]GRPQATAVYK.3|ALALGASTVMMGSLLAATTEAPGEYFFSDGIR.4|ALALGASTVMMGSLLAATTEAPGEYFFSDGIR.3|VGMGSGSIC[CAM]ITQEVLAC[CAM]GR.2
SEN / CTL,Dynein light chain roadblock-type 1,DYNLRB1,Q9NP97,0.81,0.19,4.50E-06,6.30E-06,5.20E+00,"transport,microtubule-based movement,visual behavior","microtubule motor activity,dynein intermediate chain binding","cytoplasm,centrosome,cytoplasmic dynein complex,microtubule,membrane,dynein complex,ciliary tip",9,6,12,STVRDIDPQNDLTFLR.3|DIDPQNDLTFLR.2|DIDPQNDLTFLR.3|GVQGIIVVNTEGIPIK.2|GVQGIIVVNTEGIPIK.3|KNEIMVAPDK.2|STMDNPTTTQYASLMHSFILK.4|STM[Oxi]DNPTTTQYASLMHSFILK.3|STMDNPTTTQYASLM[Oxi]HSFILK.3|STMDNPTTTQYASLMHSFILK.3|STMDNPTTTQYASLMHSFILK.2|KNEIMVAPDKDYFLIVIQNPTE.3
SEN / CTL,Kinesin-1 heavy chain,KIF5B,P33176,0.81,0.80,2.26E-03,1.54E-03,2.81E+00,"microtubule-based movement,cytoplasm organization,axon guidance,cytoskeleton-dependent intracellular transport,positive regulation of vesicle fusion,positive regulation of synaptic transmission, GABAergic,stress granule disassembly,positive regulation of insulin secretion involved in cellular response to glucose stimulus,regulation of membrane potential,positive regulation of potassium ion transport,vesicle transport along microtubule,plus-end-directed vesicle transport along microtubule,positive regulation of establishment of protein localization to plasma membrane,positive regulation of intracellular protein transport,cell-cell adhesion,positive regulation of voltage-gated sodium channel activity","microtubule motor activity,protein binding,ATP binding,microtubule binding,JUN kinase binding,ATP-dependent microtubule motor activity, plus-end-directed,cadherin binding involved in cell-cell adhesion","cytoplasm,microtubule organizing center,kinesin complex,microtubule,cell-cell adherens junction,membrane,endocytic vesicle,vesicle,ciliary rootlet,axonal growth cone,perinuclear region of cytoplasm",12,140,283,GLEETVAK.2|LYLVDLAGSEK.2|FQGEDTVVIASKPYAFDR.3|FQGEDTVVIASKPYAFDR.2|QLEESVDALSEELVQLR.3|QLEESVDALSEELVQLR.2|ALESALKEAKENASR.4|ALESALKEAKENASR.3|ALESALKEAKENASR.2|PGQHPAASPTHPSAIR.4|LHELTVMQDR.3|LHELTVM[Oxi]QDR.3|LHELTVMQDR.2|LHELTVM[Oxi]QDR.2|C[CAM]KQLESTQTESNKK.4|C[CAM]KQLESTQTESNKK.3|FRPLNESEVNRGDK.4|FRPLNESEVNRGDK.3|FRPLNESEVNRGDK.2|DNADLRC[CAM]ELPKLEK.4|DNADLRC[CAM]ELPKLEK.3|FRPLNESEVNRGDKYIAK.5|FRPLNESEVNRGDKYIAK.4|FRPLNESEVNRGDKYIAK.3|VKALESALKEAK.3|VKALESALKEAK.2|C[CAM]EEEIAK.2|QAVEQQIQSHR.3|QAVEQQIQSHR.2|TNLSVHEDKNR.3|TNLSVHEDKNR.2|DQDNMQAELNR.3|DQDNMQAELNR.2|DQDNM[Oxi]QAELNR.2|LHDPEGM[Oxi]GIIPR.3|LHDPEGMGIIPR.3|LHDPEGMGIIPR.2|LHDPEGM[Oxi]GIIPR.2|SATLASIDAELQK.3|SATLASIDAELQK.2|VQTANEVK.2|FRPLNESEVNR.3|FRPLNESEVNR.2|KLHELTVMQDR.3|KLHELTVM[Oxi]QDR.3|KLHELTVMQDR.2|KLHELTVM[Oxi]QDR.2|VHEMEKEHLNKVQTANEVK.5|VHEMEKEHLNKVQTANEVK.4|VHEM[Oxi]EKEHLNKVQTANEVK.4|VHEMEKEHLNKVQTANEVK.3|VHEM[Oxi]EKEHLNKVQTANEVK.3|AQEKVHEMEKEHLNK.4|AQEKVHEMEKEHLNK.3|GHSAQIAKPIRPGQHPAASPTHPSAIR.6|GHSAQIAKPIRPGQHPAASPTHPSAIR.5|GHSAQIAKPIRPGQHPAASPTHPSAIR.4|GHSAQIAKPIRPGQHPAASPTHPSAIR.3|KMEENEKELAAC[CAM]QLR.4|KM[Oxi]EENEKELAAC[CAM]QLR.4|KM[Oxi]EENEKELAAC[CAM]QLR.3|KMEENEKELAAC[CAM]QLR.3|KM[Oxi]EENEKELAAC[CAM]QLR.2|KMEENEKELAAC[CAM]QLR.2|QISSLRDEVEAK.3|QISSLRDEVEAK.2|QLESTQTESNKK.3|QLESTQTESNKK.2|SNRHVAVTNMNEHSSR.4|STLLFGQR.2|VHEMEKEHLNK.3|VHEM[Oxi]EKEHLNK.3|VHEM[Oxi]EKEHLNK.2|VHEMEKEHLNK.2|MMLEQER.2|M[Oxi]MLEQER.2|MM[Oxi]LEQER.2|M[Oxi]M[Oxi]LEQER.2|YQQEVDR.2|TNLSVHEDKNRVPYVK.4|TNLSVHEDKNRVPYVK.3|TNLSVHEDKNRVPYVK.2|ELAAC[CAM]QLR.2|KSAEIDSDDTGGSAAQKQK.4|SLTEYLQNVEQK.3|SLTEYLQNVEQK.2|VKALESALK.2|LQAENDASK.2|LQAENDASKEEVK.3|LQAENDASKEEVK.2|QAVEQQIQSHRETHQK.4|QAVEQQIQSHRETHQK.3|RGHSAQIAKPIRPGQHPAASPTHPSAIR.6|RGHSAQIAKPIRPGQHPAASPTHPSAIR.5|RGHSAQIAKPIRPGQHPAASPTHPSAIR.4|EYELLSDELNQK.3|EYELLSDELNQK.2|GGGAFVQNSQPVAVR.3|GGGAFVQNSQPVAVR.2|HVAVTNMNEHSSR.3|HVAVTNM[Oxi]NEHSSR.3|HVAVTNMNEHSSR.2|HVAVTNM[Oxi]NEHSSR.2|KC[CAM]EEEIAK.2|PIRPGQHPAASPTHPSAIR.4|PIRPGQHPAASPTHPSAIR.3|RDQDNM[Oxi]QAELNR.3|RDQDNMQAELNR.3|RDQDNMQAELNR.2|RDQDNM[Oxi]QAELNR.2|C[CAM]ELPKLEK.2|DLAEIGIAVGNNDVK.3|DLAEIGIAVGNNDVK.2|EHLNKVQTANEVK.3|KLHELTVMQDRR.3|KLHELTVMQDRR.2|LKTQMLDQEELLASTRR.4|LKTQMLDQEELLASTRR.3|LKTQMLDQEELLASTRR.2|NTIQWLENELNR.3|NTIQWLENELNR.2|ISFLENNLEQLTK.3|ISFLENNLEQLTK.2|VSYFEIYLDKIR.3|VSYFEIYLDKIR.2|C[CAM]KQLESTQTESNK.3|C[CAM]KQLESTQTESNK.2|GLEETVAKELQTLHNLRK.4|GLEETVAKELQTLHNLRK.3|GLEETVAKELQTLHNLRK.2|SAEIDSDDTGGSAAQK.3|SAEIDSDDTGGSAAQK.2|TNLSVHEDK.2|WRNGETVPIDEQFDKEK.4|WRNGETVPIDEQFDKEK.3|AAEMMASLLK.2|AAEM[Oxi]MASLLK.2|AAEMM[Oxi]ASLLK.2|AAEM[Oxi]M[Oxi]ASLLK.2|ALESALKEAK.2|IRDLLDVSK.2|LFVQDLATR.2|QLDDKDEEINQQSQLVEK.4|QLDDKDEEINQQSQLVEK.3|QLDDKDEEINQQSQLVEK.2|TGAEGAVLDEAKNINK.3|TGAEGAVLDEAKNINK.2|TQMLDQEELLASTR.3|TQM[Oxi]LDQEELLASTR.3|TQMLDQEELLASTR.2|TQM[Oxi]LDQEELLASTR.2|FVC[CAM]SPDEVMDTIDEGKSNR.4|FVC[CAM]SPDEVMDTIDEGKSNR.3|FVC[CAM]SPDEVM[Oxi]DTIDEGKSNR.3|FVC[CAM]SPDEVM[Oxi]DTIDEGKSNR.2|FVC[CAM]SPDEVMDTIDEGKSNR.2|RYQQEVDR.2|VQTANEVKQAVEQQIQSHR.4|VQTANEVKQAVEQQIQSHR.3|ANLEAFTVDK.2|KSAEIDSDDTGGSAAQK.3|KSAEIDSDDTGGSAAQK.2|ELQTLHNLR.2|IKSLTEYLQNVEQK.3|IKSLTEYLQNVEQK.2|KRQLEESVDALSEELVQLR.4|KRQLEESVDALSEELVQLR.3|KRQLEESVDALSEELVQLR.2|SHSIFLINVKQENTQTEQK.4|SHSIFLINVKQENTQTEQK.3|SHSIFLINVKQENTQTEQK.2|VQTANEVKQAVEQQIQSHRETHQK.5|MEENEKELAAC[CAM]QLR.3|M[Oxi]EENEKELAAC[CAM]QLR.3|MEENEKELAAC[CAM]QLR.2|M[Oxi]EENEKELAAC[CAM]QLR.2|SLSALGNVISALAEGSTYVPYR.4|SLSALGNVISALAEGSTYVPYR.3|SLSALGNVISALAEGSTYVPYR.2|TKEYELLSDELNQK.3|TKEYELLSDELNQK.2|SHSIFLINVK.2|TGAEGAVLDEAK.2|VSYFEIYLDKIRDLLDVSK.4|VSYFEIYLDKIRDLLDVSK.3|VSYFEIYLDKIRDLLDVSK.2|C[CAM]ELPKLEKR.2|NGETVPIDEQFDKEK.3|NGETVPIDEQFDKEK.2|QPEGTGMIDEEFTVAR.3|QPEGTGM[Oxi]IDEEFTVAR.3|QPEGTGM[Oxi]IDEEFTVAR.2|QPEGTGMIDEEFTVAR.2|YQQEVDRIK.2|KLFVQDLATR.2|NTVC[CAM]VNVELTAEQWK.3|NTVC[CAM]VNVELTAEQWK.2|QLDDKDEEINQQSQLVEKLK.4|QLDDKDEEINQQSQLVEKLK.3|TQMLDQEELLASTRR.3|TQM[Oxi]LDQEELLASTRR.3|TQMLDQEELLASTRR.2|QKISFLENNLEQLTK.3|QKISFLENNLEQLTK.2|SAEIDSDDTGGSAAQKQK.3|FVC[CAM]SPDEVMDTIDEGK.3|FVC[CAM]SPDEVM[Oxi]DTIDEGK.3|FVC[CAM]SPDEVM[Oxi]DTIDEGK.2|FVC[CAM]SPDEVMDTIDEGK.2|QDLKGLEETVAKELQTLHNLR.4|RAAEMMASLLK.2|EVLQALEELAVNYDQK.3|EVLQALEELAVNYDQK.2|ILQDSLGGNC[CAM]R.2|ELQTLHNLRK.2|LKTQM[Oxi]LDQEELLASTR.3|LKTQMLDQEELLASTR.3|LKTQMLDQEELLASTR.2|LKTQM[Oxi]LDQEELLASTR.2|QLESTQTESNK.2|SQEVEDKTKEYELLSDELNQK.4|SQEVEDKTKEYELLSDELNQK.3|VSYFEIYLDK.2|FQGEDTVVIASK.2|KIVKDVLEGYNGTIFAYGQTSSGK.4|KIVKDVLEGYNGTIFAYGQTSSGK.3|LYKQLDDKDEEINQQSQLVEK.4|LYKQLDDKDEEINQQSQLVEK.3|NTVC[CAM]VNVELTAEQWKK.3|NTVC[CAM]VNVELTAEQWKK.2|GLEETVAKELQTLHNLR.3|SLSALGNVISALAEGSTYVPYRDSK.4|SLSALGNVISALAEGSTYVPYRDSK.3|LITDLQDQNQK.2|SHSIFLINVKQENTQTEQKLSGK.4|DNADLRC[CAM]ELPK.2|LQAENDASKEEVKEVLQALEELAVNYDQK.5|LQAENDASKEEVKEVLQALEELAVNYDQK.4|LQAENDASKEEVKEVLQALEELAVNYDQK.3|QDLKGLEETVAK.2|VFQSSTSQEQVYNDC[CAM]AK.3|VFQSSTSQEQVYNDC[CAM]AK.2|DITLTNDKPATAIGVIGNFTDAERR.4|TTIVIC[CAM]C[CAM]SPSSYNESETK.3|TTIVIC[CAM]C[CAM]SPSSYNESETK.2|DVLEGYNGTIFAYGQTSSGK.3|DVLEGYNGTIFAYGQTSSGK.2|KC[CAM]EEEIAKLYK.2|LHELTVMQDRR.2|RQLEESVDALSEELVQLR.3|RQLEESVDALSEELVQLR.2|VFQSSTSQEQVYNDC[CAM]AKK.3|VFQSSTSQEQVYNDC[CAM]AKK.2|AAEMMASLLKDLAEIGIAVGNNDVKQPEGTGMIDEEFTVAR.6|AAEM[Oxi]MASLLKDLAEIGIAVGNNDVKQPEGTGMIDEEFTVAR.5|AAEMMASLLKDLAEIGIAVGNNDVKQPEGTGM[Oxi]IDEEFTVAR.5|AAEMMASLLKDLAEIGIAVGNNDVKQPEGTGMIDEEFTVAR.5|AAEM[Oxi]MASLLKDLAEIGIAVGNNDVKQPEGTGMIDEEFTVAR.4|AAEMMASLLKDLAEIGIAVGNNDVKQPEGTGM[Oxi]IDEEFTVAR.4|AAEMMASLLKDLAEIGIAVGNNDVKQPEGTGMIDEEFTVAR.4|ANLEAFTVDKDITLTNDKPATAIGVIGNFTDAER.5|ANLEAFTVDKDITLTNDKPATAIGVIGNFTDAER.4|QLESTQTESNKKMEENEK.3|ANLEAFTVDKDITLTNDKPATAIGVIGNFTDAERR.5|ANLEAFTVDKDITLTNDKPATAIGVIGNFTDAERR.4|NGETVPIDEQFDK.2|AKLITDLQDQNQK.2|DEEINQQSQLVEK.2|EEVKEVLQALEELAVNYDQK.3|EEVKEVLQALEELAVNYDQK.2|SLTEYLQNVEQKK.2|SATLASIDAELQKLK.2|IVKDVLEGYNGTIFAYGQTSSGK.3|PATAIGVIGNFTDAER.2|YQQEVDRIKEAVR.2|DLAEIGIAVGNNDVKQPEGTGMIDEEFTVAR.4|DLAEIGIAVGNNDVKQPEGTGM[Oxi]IDEEFTVAR.3|DLAEIGIAVGNNDVKQPEGTGMIDEEFTVAR.3|DITLTNDKPATAIGVIGNFTDAER.3|AAEMMASLLKDLAEIGIAVGNNDVK.3|IVQDIFNYIYSM[Oxi]DENLEFHIK.3|IVQDIFNYIYSMDENLEFHIK.3|NINKSLSALGNVISALAEGSTYVPYR.3
SEN / CTL,Cytoplasmic protein NCK2;Cytoplasmic protein NCK1,NCK2;NCK1,O43639;P16333,0.81,0.29,5.72E-02,2.26E-02,1.65E+00,"immunological synapse formation,actin filament organization,signal transduction,signal complex assembly,epidermal growth factor receptor signaling pathway,regulation of epidermal growth factor-activated receptor activity,negative regulation of cell proliferation,vesicle-mediated transport,cell migration,lamellipodium assembly,positive regulation of actin filament polymerization,negative regulation of peptidyl-serine phosphorylation,positive regulation of translation in response to endoplasmic reticulum stress,positive regulation of T cell proliferation,T cell activation,positive regulation of GTPase activity,positive regulation of transcription from RNA polymerase II promoter,vascular endothelial growth factor receptor signaling pathway,ephrin receptor signaling pathway,dendritic spine development,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,negative regulation of PERK-mediated unfolded protein response,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress;negative regulation of protein kinase activity,substrate-dependent cell migration, cell extension,actin filament organization,signal complex assembly,positive regulation of neuron projection development,vesicle-mediated transport,lamellipodium assembly,regulation of cell migration,positive regulation of actin filament polymerization,negative regulation of peptidyl-serine phosphorylation,positive regulation of translation in response to endoplasmic reticulum stress,Fc-gamma receptor signaling pathway involved in phagocytosis,positive regulation of T cell proliferation,T cell activation,positive regulation of GTPase activity,positive regulation of transcription from RNA polymerase II promoter,vascular endothelial growth factor receptor signaling pathway,ephrin receptor signaling pathway,T cell receptor signaling pathway,response to other organism,negative regulation of cell death,peptidyl-serine dephosphorylation,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,positive regulation of cap-dependent translational initiation,positive regulation of cap-independent translational initiation,negative regulation of PERK-mediated unfolded protein response,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress","SH3/SH2 adaptor activity,ARF guanyl-nucleotide exchange factor activity,protein binding,cytoskeletal adaptor activity,receptor signaling complex scaffold activity,protein complex binding,scaffold protein binding;protein kinase inhibitor activity,SH3/SH2 adaptor activity,ARF guanyl-nucleotide exchange factor activity,receptor binding,protein binding,cytoskeletal adaptor activity,protein domain specific binding,receptor signaling complex scaffold activity,protein binding, bridging,receptor tyrosine kinase binding,ephrin receptor binding,eukaryotic initiation factor eIF2 binding,cadherin binding involved in cell-cell adhesion","cytoplasm,endoplasmic reticulum,trans-Golgi network,cytosol,vesicle membrane,synapse;protein phosphatase type 1 complex,nucleus,cytoplasm,endoplasmic reticulum,trans-Golgi network,cytosol,ribosome,plasma membrane,cell-cell adherens junction,vesicle membrane",3,1,1,LWLLDDSK.2
SEN / CTL,Protein S100-A16,S100A16,Q96FQ6,0.80,0.65,4.47E-04,3.76E-04,3.42E+00,response to calcium ion,"calcium ion binding,protein binding,protein homodimerization activity,poly(A) RNA binding","nucleolus,cytoplasm,cytosol,plasma membrane,extracellular exosome",12,8,13,AVIVLVENFYK.2|AVIVLVENFYK.3|ISFDEYWTLIGGITGPIAK.3|ISFDEYWTLIGGITGPIAK.2|LIQNLDANHDGR.3|LIQNLDANHDGR.2|ELNHMLSDTGNRK.3|ELNHM[Oxi]LSDTGNRK.3|ELNHMLSDTGNRK.2|AADKLIQNLDANHDGR.3|KAADKLIQNLDANHDGR.3|LIHEQEQQSSS.2|ELNHMLSDTGNR.2
SEN / CTL,Copine-1,CPNE1,Q99829,0.80,0.27,2.12E-03,1.45E-03,2.84E+00,"transcription, DNA-templated,regulation of transcription, DNA-templated,proteolysis,lipid metabolic process,negative regulation of gene expression,vesicle-mediated transport,regulation of I-kappaB kinase/NF-kappaB signaling,negative regulation of DNA binding,positive regulation of neuron differentiation,glycerophospholipid biosynthetic process,positive regulation of protein kinase B signaling,cellular response to calcium ion,negative regulation of NIK/NF-kappaB signaling,positive regulation of tumor necrosis factor-mediated signaling pathway,neuron projection extension","phosphatidylserine binding,endopeptidase activity,transporter activity,calcium ion binding,protein binding,calcium-dependent phospholipid binding,protein homodimerization activity,NF-kappaB binding","nucleus,cytoplasm,cytosol,plasma membrane,membrane,extracellular exosome",6,23,37,SDPFLEFFR.2|EALAQTVLAEVPTQLVSYFR.3|EALAQTVLAEVPTQLVSYFR.4|EALAQTVLAEVPTQLVSYFR.2|DIVQFVPYRR.3|LRFGIYDIDNK.3|TLQLEYR.2|DNRVVTMEVEAR.3|NNLNPTWK.2|GTITVSAQELKDNR.3|SEVIKNNLNPTWK.3|VVTMEVEAR.2|VVTM[Oxi]EVEAR.2|AQGWAPLKPLPPSAK.3|AQGWAPLKPLPPSAK.2|NC[CAM]SSPEFSK.2|FGIYDIDNK.2|DIVQFVPYR.2|GTITVSAQELK.2|LYGPTNFAPIINHVAR.3|LYGPTNFAPIINHVAR.2|TPELRDDDFLGGAEC[CAM]SLGQIVSSQVLTLPLM[Oxi]LKPGKPAGR.6|TPELRDDDFLGGAEC[CAM]SLGQIVSSQVLTLPLMLKPGKPAGR.6|TPELRDDDFLGGAEC[CAM]SLGQIVSSQVLTLPLM[Oxi]LKPGKPAGR.5|TPELRDDDFLGGAEC[CAM]SLGQIVSSQVLTLPLMLKPGKPAGR.5|TPELRDDDFLGGAEC[CAM]SLGQIVSSQVLTLPLMLKPGKPAGR.4|DDDFLGGAEC[CAM]SLGQIVSSQVLTLPLMLKPGKPAGR.5|DDDFLGGAEC[CAM]SLGQIVSSQVLTLPLMLKPGKPAGR.4|DDDFLGGAEC[CAM]SLGQIVSSQVLTLPLM[Oxi]LKPGKPAGR.4|SDPLC[CAM]VLLQDVGGGSWAELGR.3|SDPLC[CAM]VLLQDVGGGSWAELGR.2|AQGWAPLKPLPPSAKDPAQAPQA.3|FAAQAAHQGTASQYFM[Oxi]LLLLTDGAVTDVEATR.4|FAAQAAHQGTASQYFMLLLLTDGAVTDVEATR.4|FAAQAAHQGTASQYFMLLLLTDGAVTDVEATR.3|ASNLPMSVIIVGVGGADFEAMEQLDADGGPLHTR.4|FAAQAAHQGTASQYFMLLLLTDGAVTDVEATREAVVR.4
SEN / CTL,40S ribosomal protein S3a,RPS3A,P61247,0.80,0.46,3.92E-06,5.63E-06,5.25E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,cell differentiation,negative regulation of apoptotic process","RNA binding,structural constituent of ribosome,protein binding,poly(A) RNA binding","nucleus,nucleoplasm,nucleolus,cytoplasm,cytosol,focal adhesion,cytosolic small ribosomal subunit,intracellular ribonucleoprotein complex,extracellular matrix,extracellular exosome",15,30,55,LFC[CAM]VGFTK.2|ADGYEPPVQESV.2|LIPDSIGKDIEK.3|LIPDSIGKDIEK.2|NC[CAM]LTNFHGMDLTR.3|NC[CAM]LTNFHGM[Oxi]DLTR.3|NC[CAM]LTNFHGMDLTR.2|NC[CAM]LTNFHGM[Oxi]DLTR.2|AC[CAM]QSIYPLHDVFVR.3|AC[CAM]QSIYPLHDVFVR.4|AC[CAM]QSIYPLHDVFVR.2|TSYAQHQQVR.3|TSYAQHQQVR.2|ATGDETGAKVER.3|ATGDETGAKVER.2|FKLITEDVQGK.3|FKLITEDVQGK.2|VVDPFSKKDWYDVK.4|KTSYAQHQQVR.3|KTSYAQHQQVR.2|LM[Oxi]ELHGEGSSSGK.3|LMELHGEGSSSGK.3|LMELHGEGSSSGK.2|LM[Oxi]ELHGEGSSSGK.2|MMEIMTR.2|M[Oxi]MEIMTR.2|MM[Oxi]EIMTR.2|AC[CAM]QSIYPLHDVFVRK.4|AC[CAM]QSIYPLHDVFVRK.3|AC[CAM]QSIYPLHDVFVRK.2|APAMFNIR.2|APAM[Oxi]FNIR.2|VVDPFSKK.2|TTDGYLLR.2|EVQTNDLK.2|KDWYDVK.2|LITEDVQGK.2|EVQTNDLKEVVNK.3|EVQTNDLKEVVNK.2|VFEVSLADLQNDEVAFRK.4|VFEVSLADLQNDEVAFRK.3|VFEVSLADLQNDEVAFRK.2|KWQTMIEAHVDVK.3|KWQTMIEAHVDVK.2|LM[Oxi]ELHGEGSSSGKATGDETGAK.4|LMELHGEGSSSGKATGDETGAK.4|GRVFEVSLADLQNDEVAFRK.4|GRVFEVSLADLQNDEVAFRK.3|NC[CAM]LTNFHGMDLTRDK.3|VFEVSLADLQNDEVAFR.3|VFEVSLADLQNDEVAFR.2|GRVFEVSLADLQNDEVAFR.3|WQTMIEAHVDVK.2|ATGDETGAKVERADGYEPPVQESV.3|VERADGYEPPVQESV.2
SEN / CTL,Prohibitin,PHB,P35232,0.80,0.74,9.02E-06,1.18E-05,4.93E+00,"negative regulation of transcription from RNA polymerase II promoter,osteoblast differentiation,regulation of transcription, DNA-templated,mitochondrion organization,signal transduction,negative regulation of cell proliferation,positive regulation of gene expression,positive regulation of cell death,negative regulation of transcription by competitive promoter binding,histone deacetylation,negative regulation of cell growth,negative regulation of protein catabolic process,regulation of apoptotic process,positive regulation of G-protein coupled receptor protein signaling pathway,negative regulation of transcription, DNA-templated,positive regulation of transcription, DNA-templated,positive regulation of complement activation,protein stabilization,progesterone receptor signaling pathway,negative regulation of androgen receptor signaling pathway,negative regulation of ERK1 and ERK2 cascade,positive regulation of ERK1 and ERK2 cascade,cellular response to interleukin-6,DNA biosynthetic process,negative regulation of glucocorticoid receptor signaling pathway","RNA polymerase II transcription factor activity, sequence-specific DNA binding,complement component C3a binding,complement component C3b binding,protein binding,protein C-terminus binding,enzyme binding,proteinase activated receptor binding,histone deacetylase binding,transcription regulatory region DNA binding","nucleus,nucleoplasm,cytoplasm,mitochondrion,mitochondrial inner membrane,early endosome,plasma membrane,integral component of plasma membrane,cell surface,membrane,myelin sheath,extracellular exosome",30,36,61,FDAGELITQR.2|DLQNVNITLR.2|VLPSITTEILK.2|VLPSITTEILK.3|KLEAAEDIAYQLSR.3|KLEAAEDIAYQLSR.2|IFTSIGEDYDER.2|IFTSIGEDYDER.3|ILFRPVASQLPR.3|ILFRPVASQLPR.2|AAIISAEGDSKAAELIANSLATAGDGLIELR.4|AAIISAEGDSKAAELIANSLATAGDGLIELR.3|NVPVITGSKDLQNVNITLR.3|NVPVITGSKDLQNVNITLR.2|AAELIANSLATAGDGLIELR.3|AAELIANSLATAGDGLIELR.4|AAELIANSLATAGDGLIELR.2|PVASQLPR.2|PIIFDC[CAM]R.2|LEAAEDIAYQLSR.3|LEAAEDIAYQLSR.2|EFTEAVEAK.2|AAIISAEGDSK.2|AATFGLILDDVSLTHLTFGK.4|AATFGLILDDVSLTHLTFGK.3|AATFGLILDDVSLTHLTFGK.2|QVAQQEAER.2|QVSDDLTER.2|GVQDIVVGEGTHFLIPWVQK.4|GVQDIVVGEGTHFLIPWVQK.3|GVQDIVVGEGTHFLIPWVQK.2|FDAGELITQRELVSR.3|FGLALAVAGGVVNSALYNVDAGHR.4|FGLALAVAGGVVNSALYNVDAGHR.3|FGLALAVAGGVVNSALYNVDAGHR.2|KAAIISAEGDSK.2|FVVEKAEQQK.2|NITYLPAGQSVLLQLPQ.3|NITYLPAGQSVLLQLPQ.2|GVQDIVVGEGTHFLIPWVQKPIIFDC[CAM]R.5|GVQDIVVGEGTHFLIPWVQKPIIFDC[CAM]R.4|GVQDIVVGEGTHFLIPWVQKPIIFDC[CAM]R.3|FRGVQDIVVGEGTHFLIPWVQK.4|FRGVQDIVVGEGTHFLIPWVQK.3|FVVEKAEQQKK.2|FRGVQDIVVGEGTHFLIPWVQKPIIFDC[CAM]R.5|FRGVQDIVVGEGTHFLIPWVQKPIIFDC[CAM]R.4|AVIFDRFRGVQDIVVGEGTHFLIPWVQKPIIFDC[CAM]R.6|AVIFDRFRGVQDIVVGEGTHFLIPWVQKPIIFDC[CAM]R.5|SRNITYLPAGQSVLLQLPQ.3|SRNITYLPAGQSVLLQLPQ.2|AAELIANSLATAGDGLIELRK.3|AAELIANSLATAGDGLIELRK.2|AATFGLILDDVSLTHLTFGKEFTEAVEAK.4|AATFGLILDDVSLTHLTFGKEFTEAVEAK.3|VFESIGKFGLALAVAGGVVNSALYNVDAGHR.4|VFESIGKFGLALAVAGGVVNSALYNVDAGHR.3|KAAIISAEGDSKAAELIANSLATAGDGLIELR.4|SVVARFDAGELITQR.2|QVSDDLTERAATFGLILDDVSLTHLTFGKEFTEAVEAK.5|IFTSIGEDYDERVLPSITTEILK.3
SEN / CTL,Membrane-associated progesterone receptor component 1,PGRMC1,O00264,0.79,0.63,3.91E-03,2.44E-03,2.61E+00,,"steroid binding,heme binding","nucleolus,endoplasmic reticulum,endoplasmic reticulum membrane,endomembrane system,membrane,integral component of membrane,organelle membrane,extracellular exosome",9,19,22,FYGPEGPYGVFAGR.2|IVRGDQPAASGDSDDDEPPPLPR.3|ILMAINGK.2|ILM[Oxi]AINGK.2|RRDFTPAELR.3|GRKFYGPEGPYGVFAGR.4|GRKFYGPEGPYGVFAGR.3|FDGVQDPR.2|ILMAINGKVFDVTK.3|KFYGPEGPYGVFAGRDASR.4|KFYGPEGPYGVFAGR.3|RDFTPAELR.2|EGEEPTVYSDEEEPKDESARK.4|FYGPEGPYGVFAGRDASR.3|LLKEGEEPTVYSDEEEPKDESAR.4|GDQPAASGDSDDDEPPPLPR.3|GDQPAASGDSDDDEPPPLPR.2|EGEEPTVYSDEEEPKDESAR.3|EGEEPTVYSDEEEPK.2|EALKDEYDDLSDLTAAQQETLSDWESQFTFK.4|DEYDDLSDLTAAQQETLSDWESQFTFK.3|GLATFC[CAM]LDKEALKDEYDDLSDLTAAQQETLSDWESQFTFK.4
SEN / CTL,Nuclease-sensitive element-binding protein 1,YBX1,P67809,0.79,0.39,1.61E-03,1.14E-03,2.94E+00,"negative regulation of transcription from RNA polymerase II promoter,mRNA splicing, via spliceosome,in utero embryonic development,regulation of transcription, DNA-templated,transcription from RNA polymerase II promoter,positive regulation of transcription from RNA polymerase II promoter,negative regulation of striated muscle cell differentiation,positive regulation of cell division,CRD-mediated mRNA stabilization,protein localization to cytoplasmic stress granule","RNA polymerase II core promoter proximal region sequence-specific DNA binding,transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,DNA binding,chromatin binding,double-stranded DNA binding,single-stranded DNA binding,transcription factor activity, sequence-specific DNA binding,RNA binding,protein binding,poly(A) RNA binding,GTPase binding","nucleus,nucleoplasm,U12-type spliceosomal complex,cytoplasm,cytoplasmic stress granule,intracellular ribonucleoprotein complex,nuclear membrane,intracellular membrane-bounded organelle,extracellular exosome,CRD-mediated mRNA stability complex,histone pre-mRNA 3'end processing complex",6,29,58,RPQYSNPPVQGEVMEGADNQGAGEQGRPVR.4|RPQYSNPPVQGEVM[Oxi]EGADNQGAGEQGRPVR.4|RPQYSNPPVQGEVMEGADNQGAGEQGRPVR.6|RPQYSNPPVQGEVM[Oxi]EGADNQGAGEQGRPVR.6|RPQYSNPPVQGEVMEGADNQGAGEQGRPVR.5|RPQYSNPPVQGEVMEGADNQGAGEQGRPVR.3|RPENPKPQDGKETK.4|RPENPKPQDGKETK.3|RPENPKPQDGK.3|RPENPKPQDGK.2|EDVFVHQTAIK.3|EDVFVHQTAIK.2|NDTKEDVFVHQTAIK.4|NDTKEDVFVHQTAIK.3|NDTKEDVFVHQTAIK.2|RRPENPKPQDGKETK.4|RRPENPKPQDGKETK.3|EDVFVHQTAIKK.3|EDVFVHQTAIKK.2|NDTKEDVFVHQTAIKK.4|NDTKEDVFVHQTAIKK.3|NDTKEDVFVHQTAIKK.2|NGYGFINR.2|NGYGFINRNDTK.3|NGYGFINRNDTK.2|RRPENPKPQDGK.3|FPPYYMR.2|NEGSESAPEGQAQQR.3|NEGSESAPEGQAQQR.2|NGYGFINRNDTKEDVFVHQTAIK.5|NGYGFINRNDTKEDVFVHQTAIK.4|GAEAANVTGPGGVPVQGSK.3|GAEAANVTGPGGVPVQGSK.2|NYQQNYQNSESGEK.3|NYQQNYQNSESGEK.2|ENQGDETQGQQPPQR.3|ENQGDETQGQQPPQR.2|SVGDGETVEFDVVEGEK.3|SVGDGETVEFDVVEGEK.2|ENQGDETQGQQPPQRR.3|AADPPAENSSAPEAEQGGAE.3|AADPPAENSSAPEAEQGGAE.2|EDGNEEDKENQGDETQGQQPPQR.4|EDGNEEDKENQGDETQGQQPPQR.3|PGTTGSGAGSGGPGGLTSAAPAGGDK.3|PGTTGSGAGSGGPGGLTSAAPAGGDK.2|EDGNEEDKENQGDETQGQQPPQRR.4|EDGNEEDKENQGDETQGQQPPQRR.3|RPQYSNPPVQGEVMEGADNQGAGEQGR.4|RPQYSNPPVQGEVM[Oxi]EGADNQGAGEQGR.3|RPQYSNPPVQGEVMEGADNQGAGEQGR.3|PGTTGSGAGSGGPGGLTSAAPAGGDKK.3|QPREDGNEEDKENQGDETQGQQPPQR.4|RPQYSNPPVQGEVMEGADNQGAGEQGRPVRQNMYR.5|NYQQNYQNSESGEKNEGSESAPEGQAQQR.4|NYQQNYQNSESGEKNEGSESAPEGQAQQR.3|SVGDGETVEFDVVEGEKGAEAANVTGPGGVPVQGSK.4|SVGDGETVEFDVVEGEKGAEAANVTGPGGVPVQGSK.3
SEN / CTL,Talin-1,TLN1,Q9Y490,0.79,0.65,5.75E-26,9.71E-25,2.40E+01,"platelet degranulation,movement of cell or subcellular component,muscle contraction,cytoskeletal anchoring at plasma membrane,cell-cell junction assembly,cell-substrate junction assembly,viral process,cortical actin cytoskeleton organization,IRE1-mediated unfolded protein response,platelet aggregation","integrin binding,structural constituent of cytoskeleton,protein binding,vinculin binding,LIM domain binding,actin filament binding,cadherin binding involved in cell-cell adhesion","ruffle,extracellular region,cytoplasm,microtubule organizing center,cytosol,plasma membrane,cell-cell junction,cell-cell adherens junction,focal adhesion,cell surface,ruffle membrane,extracellular exosome",225,186,355,GLAGAVSELLR.2|AVAEQIPLLVQGVR.2|AVAEQIPLLVQGVR.3|AVASAAAALVLK.2|NLGTALAELR.2|LAQAAQSSVATITR.2|LAQAAQSSVATITR.3|AVAAGNSC[CAM]RQEDVIATANLSR.3|SIAAATSALVK.2|TYGVSFFLVK.2|VGDDPAVWQLK.2|AVSSAIAQLLGEVAQGNENYAGIAAR.3|AVSSAIAQLLGEVAQGNENYAGIAAR.4|QVAASTAQLLVAC[CAM]K.3|QVAASTAQLLVAC[CAM]K.2|LASEAKPAAVAAENEEIGSHIK.4|LASEAKPAAVAAENEEIGSHIK.3|LASEAKPAAVAAENEEIGSHIK.2|TMLESAGGLIQTAR.2|TMLESAGGLIQTAR.3|TM[Oxi]LESAGGLIQTAR.2|TLAESALQLLYTAK.2|TLAESALQLLYTAK.3|LLAALLEDEGGSGRPLLQAAK.3|LLAALLEDEGGSGRPLLQAAK.4|LLAALLEDEGGSGRPLLQAAK.2|TLREQGVEEHETLLLR.4|TLREQGVEEHETLLLR.3|AAAFEEQENETVVVKEK.3|VMVTNVTSLLK.2|VM[Oxi]VTNVTSLLK.2|ALAVNPRDPPSWSVLAGHSR.4|ALAVNPRDPPSWSVLAGHSR.3|ALDYYMLR.2|ALDYYM[Oxi]LR.2|IGITNHDEYSLVR.3|IGITNHDEYSLVR.2|GTEWVDPEDPTVIAENELLGAAAAIEAAAK.3|AATAPLLEAVDNLSAFASNPEFSSIPAQISPEGR.4|AATAPLLEAVDNLSAFASNPEFSSIPAQISPEGR.5|AATAPLLEAVDNLSAFASNPEFSSIPAQISPEGR.3|VVAPTISSPVC[CAM]QEQLVEAGR.3|VVAPTISSPVC[CAM]QEQLVEAGR.4|VVAPTISSPVC[CAM]QEQLVEAGR.2|LNEAAAGLNQAATELVQASR.3|LNEAAAGLNQAATELVQASR.4|LNEAAAGLNQAATELVQASR.2|VGAIPANALDDGQWSQGLISAAR.3|VGAIPANALDDGQWSQGLISAAR.4|VGAIPANALDDGQWSQGLISAAR.2|AIAVTVQEMVTK.2|AIAVTVQEM[Oxi]VTK.2|EQGVEEHETLLLR.3|EQGVEEHETLLLR.2|AHATGAGPAGRYDQATDTILTVTENIFSSMGDAGEMVR.4|AHATGAGPAGRYDQATDTILTVTENIFSSMGDAGEM[Oxi]VR.4|VGKVEHGSVALPAIMR.4|VGKVEHGSVALPAIMR.3|LGAASLGAEDPETQVVLINAVKDVAK.3|LGAASLGAEDPETQVVLINAVKDVAK.4|AKPKEADESLNFEEQILEAAK.4|ALDGAFTEENRAQC[CAM]R.3|GVGAAATAVTQALNELLQHVK.3|GVGAAATAVTQALNELLQHVK.4|GVGAAATAVTQALNELLQHVK.2|ILAQATSDLVNAIKADAEGESDLENSR.4|ILAQATSDLVNAIKADAEGESDLENSR.3|NGNLPEFGDAISTASK.2|NGNLPEFGDAISTASK.3|QEDVIATANLSR.2|QEDVIATANLSR.3|QAAASATQTIAAAQHAASTPK.3|QAAASATQTIAAAQHAASTPK.2|AGFLDLKDFLPK.3|AGFLDLKDFLPK.2|VLGEAMTGISQNAK.2|VLGEAM[Oxi]TGISQNAK.2|ALSTDPAAPNLK.2|ALSTDPAAPNLK.3|VSQMAQYFEPLTLAAVGAASK.3|VSQMAQYFEPLTLAAVGAASK.4|VSQM[Oxi]AQYFEPLTLAAVGAASK.3|VSQM[Oxi]AQYFEPLTLAAVGAASK.2|VSQMAQYFEPLTLAAVGAASK.2|TMQFEPSTMVYDAC[CAM]R.2|TMQFEPSTMVYDAC[CAM]R.3|TM[Oxi]QFEPSTMVYDAC[CAM]R.2|LHTDDELNWLDHGR.4|LHTDDELNWLDHGR.3|LHTDDELNWLDHGR.2|DKAPGQLEC[CAM]ETAIAALNSC[CAM]LR.3|DKAPGQLEC[CAM]ETAIAALNSC[CAM]LR.4|DKAPGQLEC[CAM]ETAIAALNSC[CAM]LR.2|VQELGHGC[CAM]AALVTK.3|VQELGHGC[CAM]AALVTK.2|TLSHPQQMALLDQTK.3|TLSHPQQM[Oxi]ALLDQTK.3|TLSHPQQM[Oxi]ALLDQTK.2|TLSHPQQMALLDQTK.2|DLDQASLAAVSQQLAPR.3|DLDQASLAAVSQQLAPR.2|ILAQATSDLVNAIKADAEGESDLENSRK.4|ILAQATSDLVNAIKADAEGESDLENSRK.3|TEDSGLQTQVIAAATQC[CAM]ALSTSQLVAC[CAM]TK.4|TEDSGLQTQVIAAATQC[CAM]ALSTSQLVAC[CAM]TK.3|ISIGNVVK.2|FLPSELRDEH.3|FLPSELRDEH.2|MVGGIAQIIAAQEEMLRK.3|M[Oxi]VGGIAQIIAAQEEMLRK.3|MVGGIAQIIAAQEEM[Oxi]LRK.3|MVGGIAQIIAAQEEMLRK.2|EGISQEALHTQMLTAVQEISHLIEPLANAAR.4|EGISQEALHTQMLTAVQEISHLIEPLANAAR.5|EGISQEALHTQM[Oxi]LTAVQEISHLIEPLANAAR.4|EGISQEALHTQM[Oxi]LTAVQEISHLIEPLANAAR.3|EGISQEALHTQMLTAVQEISHLIEPLANAAR.3|EC[CAM]ANGYLELLDHVLLTLQKPSPELK.4|EC[CAM]ANGYLELLDHVLLTLQKPSPELK.5|EC[CAM]ANGYLELLDHVLLTLQKPSPELK.3|QKLHTDDELNWLDHGR.4|QKLHTDDELNWLDHGR.3|ASVPTIQDQASAMQLSQC[CAM]AK.3|ASVPTIQDQASAMQLSQC[CAM]AK.2|ASVPTIQDQASAM[Oxi]QLSQC[CAM]AK.3|ASVPTIQDQASAM[Oxi]QLSQC[CAM]AK.2|SNTSPEELGPLANQLTSDYGR.3|SNTSPEELGPLANQLTSDYGR.2|AVEGC[CAM]VSASQAATEDGQLLR.3|AVEGC[CAM]VSASQAATEDGQLLR.2|DVDNALR.2|HTSALC[CAM]NSC[CAM]R.3|HTSALC[CAM]NSC[CAM]R.2|MATNAAAQNAIK.3|MATNAAAQNAIK.2|M[Oxi]ATNAAAQNAIK.2|VLVEDTK.2|LKPLPGETMEK.3|LKPLPGETM[Oxi]EK.3|LKPLPGETMEK.2|VKADQDSEAM[Oxi]K.3|VKADQDSEAMK.3|VKADQDSEAMK.2|VLVQNAAGSQEK.3|VLVQNAAGSQEK.2|AC[CAM]KEAAYHPEVAPDVRLR.5|AQVVSNLK.2|AVEDEATK.2|AVTQALNR.2|GTPQDLAR.2|LQAAGNAVK.2|GIWLEAGK.2|AAGHPGDPESQQR.3|AAGHPGDPESQQR.2|HRVQELGHGC[CAM]AALVTK.4|MATNAAAQNAIKK.3|MATNAAAQNAIKK.2|VSHVLAALQAGNR.3|VSHVLAALQAGNR.2|AVAAGNSC[CAM]R.2|KSTVLQQQYNR.3|KSTVLQQQYNR.2|RASDNLVK.2|TIMVDDSK.2|TIM[Oxi]VDDSK.2|ADAEGESDLENSR.3|ADAEGESDLENSR.2|VEHGSVALPAIM[Oxi]R.3|VEHGSVALPAIMR.3|VEHGSVALPAIMR.2|VKADQDSEAMKR.3|VKADQDSEAMKR.2|AASAAQRELVAQGK.3|AASAAQRELVAQGK.2|AEASQLGHK.2|AGFLDLKDFLPKEYVK.4|AGFLDLKDFLPKEYVK.3|DPPSWSVLAGHSR.3|DPPSWSVLAGHSR.2|TKEVIQEWNLTNIKR.4|TVTDMLMTIC[CAM]AR.3|TVTDMLMTIC[CAM]AR.2|TVTDM[Oxi]LMTIC[CAM]AR.2|ASSLIEEAK.2|RAIADMLR.2|AHATGAGPAGR.2|RQFVQSAK.2|AGALQC[CAM]SPSDAYTK.3|AGALQC[CAM]SPSDAYTK.2|ASAGPQPLLVQSC[CAM]K.3|ASAGPQPLLVQSC[CAM]K.2|EAAYHPEVAPDVR.3|EAAYHPEVAPDVR.2|ILAQATSDLVNAIK.3|ILAQATSDLVNAIK.2|ALGDLISATK.2|EVIQEWNLTNIK.3|EVIQEWNLTNIK.2|KAAGHPGDPESQQR.3|KAAGHPGDPESQQR.2|NGDTMEYR.2|ADQDSEAMK.2|KFFYSDQNVDSR.3|KFFYSDQNVDSR.2|KGIWLEAGK.2|ADAEGESDLENSRK.3|ADAEGESDLENSRK.2|DPVQLNLLYVQAR.3|DPVQLNLLYVQAR.2|GAAAHPDSEEQQQR.3|GAAAHPDSEEQQQR.2|KLEQLKPR.2|LREAAEGLR.2|SAQPASAEPR.2|DDILNGSHPVSFDK.3|DDILNGSHPVSFDK.2|RLQAAGNAVK.2|KEEITGTLR.2|RQFVQSAKEVANSTANLVK.4|QELAVFC[CAM]SPEPPAK.3|QELAVFC[CAM]SPEPPAK.2|AGALQC[CAM]SPSDAYTKK.3|AGALQC[CAM]SPSDAYTKK.2|ASSLIEEAKK.2|C[CAM]VSC[CAM]LPGQR.2|EC[CAM]DNALRELETVR.3|TSTPEDFIR.2|ERIPEAPAGPPSDFGLFLSDDDPKK.5|ERIPEAPAGPPSDFGLFLSDDDPKK.4|ERIPEAPAGPPSDFGLFLSDDDPKK.3|PAAVAAENEEIGSHIK.3|PAAVAAENEEIGSHIK.2|VAGSVTELIQAAEAM[Oxi]K.3|VAGSVTELIQAAEAMK.3|VAGSVTELIQAAEAM[Oxi]K.2|VAGSVTELIQAAEAMK.2|EVIQEWNLTNIKR.3|EVIQEWNLTNIKR.2|LGAASLGAEDPETQVVLINAVK.4|LGAASLGAEDPETQVVLINAVK.3|LGAASLGAEDPETQVVLINAVK.2|AAAFEEQENETVVVK.3|AAAFEEQENETVVVK.2|EC[CAM]ANGYLELLDHVLLTLQK.4|EC[CAM]ANGYLELLDHVLLTLQK.3|EC[CAM]ANGYLELLDHVLLTLQK.2|AAMEPIVISAK.2|AAM[Oxi]EPIVISAK.2|C[CAM]TQDLGNSTK.2|ALEATTEHIR.2|EGTETFADHREGILK.3|EVANSTANLVK.2|TKEVIQEWNLTNIK.3|TKEVIQEWNLTNIK.2|ADQDSEAMKR.2|AVTDSINQLITMC[CAM]TQQAPGQK.4|AVTDSINQLITM[Oxi]C[CAM]TQQAPGQK.3|AVTDSINQLITMC[CAM]TQQAPGQK.3|AVTDSINQLITMC[CAM]TQQAPGQK.2|EGTETFADHR.2|AVEDEATKGTR.2|RVAGSVTELIQAAEAMK.3|RVAGSVTELIQAAEAM[Oxi]K.3|RVAGSVTELIQAAEAMK.2|AC[CAM]EFAGFQC[CAM]QIQFGPHNEQK.4|AC[CAM]EFAGFQC[CAM]QIQFGPHNEQK.3|AC[CAM]EFAGFQC[CAM]QIQFGPHNEQK.2|AC[CAM]KEAAYHPEVAPDVR.3|IPEAPAGPPSDFGLFLSDDDPKK.4|IPEAPAGPPSDFGLFLSDDDPKK.3|ALDGAFTEENR.2|M[Oxi]VGGIAQIIAAQEEMLR.3|MVGGIAQIIAAQEEM[Oxi]LR.3|MVGGIAQIIAAQEEMLR.3|MVGGIAQIIAAQEEMLR.2|M[Oxi]VGGIAQIIAAQEEMLR.2|MVGGIAQIIAAQEEM[Oxi]LR.2|AGALQC[CAM]SPSDAYTKKELIEC[CAM]AR.4|GVAALTSDPAVQAIVLDTASDVLDK.4|GVAALTSDPAVQAIVLDTASDVLDK.3|STVLQQQYNR.2|EC[CAM]ANGYLELLDHVLLTLQKPSPELKQQLTGHSK.6|MVAAATNNLC[CAM]EAANAAVQGHASQEK.4|M[Oxi]VAAATNNLC[CAM]EAANAAVQGHASQEK.3|MVAAATNNLC[CAM]EAANAAVQGHASQEK.3|NC[CAM]GQMSEIEAK.2|NC[CAM]GQM[Oxi]SEIEAK.2|SKDHFGLEGDEESTM[Oxi]LEDSVSPK.4|SKDHFGLEGDEESTMLEDSVSPK.4|SKDHFGLEGDEESTMLEDSVSPK.3|ANQAIQMAC[CAM]QSLGEPGC[CAM]TQAQVLSAATIVAK.5|ANQAIQMAC[CAM]QSLGEPGC[CAM]TQAQVLSAATIVAK.4|ANQAIQM[Oxi]AC[CAM]QSLGEPGC[CAM]TQAQVLSAATIVAK.3|ANQAIQMAC[CAM]QSLGEPGC[CAM]TQAQVLSAATIVAK.3|EADESLNFEEQILEAAK.3|EADESLNFEEQILEAAK.2|QFVQSAKEVANSTANLVK.3|ALSTDPAAPNLKSQLAAAAR.3|ALSTDPAAPNLKSQLAAAAR.2|ALEATTEHIRQELAVFC[CAM]SPEPPAK.4|ALEATTEHIRQELAVFC[CAM]SPEPPAK.3|VLVEDTKVLVQNAAGSQEK.3|FGQDFSTFLEAGVEMAGQAPSQEDR.4|FGQDFSTFLEAGVEM[Oxi]AGQAPSQEDR.3|FGQDFSTFLEAGVEMAGQAPSQEDR.3|LLSDSLPPSTGTFQEAQSR.3|LLSDSLPPSTGTFQEAQSR.2|APGQLEC[CAM]ETAIAALNSC[CAM]LR.3|APGQLEC[CAM]ETAIAALNSC[CAM]LR.2|FFYSDQNVDSR.2|GSQAQPDSPSAQLALIAASQSFLQPGGK.4|GSQAQPDSPSAQLALIAASQSFLQPGGK.3|QNLLQAAGNVGQASGELLQQIGESDTDPHFQDALMQLAK.6|QNLLQAAGNVGQASGELLQQIGESDTDPHFQDALMQLAK.5|QNLLQAAGNVGQASGELLQQIGESDTDPHFQDALM[Oxi]QLAK.4|QNLLQAAGNVGQASGELLQQIGESDTDPHFQDALMQLAK.4|LLAALLEDEGGSGR.2|FFYSDQNVDSRDPVQLNLLYVQAR.4|FFYSDQNVDSRDPVQLNLLYVQAR.3|RLLSDSLPPSTGTFQEAQSR.3|SGASGPENFQVGSMPPAQQQITSGQM[Oxi]HR.4|SGASGPENFQVGSMPPAQQQITSGQMHR.4|SGASGPENFQVGSM[Oxi]PPAQQQITSGQMHR.3|SGASGPENFQVGSMPPAQQQITSGQM[Oxi]HR.3|SGASGPENFQVGSMPPAQQQITSGQMHR.3|TLAESALQLLYTAKEAGGNPK.3|KFFYSDQNVDSRDPVQLNLLYVQAR.4|IPEAPAGPPSDFGLFLSDDDPK.3|IPEAPAGPPSDFGLFLSDDDPK.2|AQEAC[CAM]GPLEMDSALSVVQNLEKDLQEVK.4|AQEAC[CAM]GPLEMDSALSVVQNLEKDLQEVK.3|DHFGLEGDEESTMLEDSVSPK.3|DHFGLEGDEESTM[Oxi]LEDSVSPK.3|DHFGLEGDEESTMLEDSVSPK.2|ALC[CAM]GFTEAAAQAAYLVGVSDPNSQAGQQGLVEPTQFAR.5|ALC[CAM]GFTEAAAQAAYLVGVSDPNSQAGQQGLVEPTQFAR.4|ELLENPVQPINDMSYFGC[CAM]LDSVMENSK.4|ELLENPVQPINDM[Oxi]SYFGC[CAM]LDSVMENSK.3|ELLENPVQPINDMSYFGC[CAM]LDSVM[Oxi]ENSK.3|ELLENPVQPINDMSYFGC[CAM]LDSVMENSK.3|AQEAC[CAM]GPLEMDSALSVVQNLEK.3|AQEAC[CAM]GPLEMDSALSVVQNLEK.2|GHMPPLTSAQQALTGTINSSMQAVQAAQATLDDFDTLPPLGQDAASK.6|GHMPPLTSAQQALTGTINSSMQAVQAAQATLDDFDTLPPLGQDAASK.4|DHFGLEGDEESTMLEDSVSPKK.3|LADVVKLGAASLGAEDPETQVVLINAVKDVAK.4|ERIPEAPAGPPSDFGLFLSDDDPK.3|VLVEDTKVLVQNAAGSQEKLAQAAQSSVATITR.4|VLVQNAAGSQEKLAQAAQSSVATITR.3|ALEATTEHIRQELAVFC[CAM]SPEPPAKTSTPEDFIR.4|APGQLEC[CAM]ETAIAALNSC[CAM]LRDLDQASLAAVSQQLAPR.4|YDQATDTILTVTENIFSSM[Oxi]GDAGEMVR.3|YDQATDTILTVTENIFSSMGDAGEM[Oxi]VR.3|DKAPGQLEC[CAM]ETAIAALNSC[CAM]LRDLDQASLAAVSQQLAPR.4|LLSDSLPPSTGTFQEAQSRLNEAAAGLNQAATELVQASR.4
SEN / CTL,"40S ribosomal protein S4, X isoform",RPS4X,P62701,0.79,0.55,1.28E-04,1.26E-04,3.90E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,multicellular organism development,positive regulation of cell proliferation,viral transcription,positive regulation of translation","structural constituent of ribosome,protein binding,rRNA binding,poly(A) RNA binding","nucleoplasm,cytosol,ribosome,polysome,focal adhesion,small ribosomal subunit,membrane,cytosolic small ribosomal subunit,intracellular ribonucleoprotein complex,extracellular matrix,cytoplasmic ribonucleoprotein granule,extracellular exosome",12,30,47,LSNIFVIGK.2|LREC[CAM]LPLIIFLR.3|LREC[CAM]LPLIIFLR.2|EC[CAM]LPLIIFLR.2|FDTGNLC[CAM]MVTGGANLGR.2|FDTGNLC[CAM]MVTGGANLGR.3|FDTGNLC[CAM]M[Oxi]VTGGANLGR.3|FDTGNLC[CAM]M[Oxi]VTGGANLGR.2|GIPHLVTHDAR.3|GIPHLVTHDAR.2|TIRYPDPLIK.3|TIRYPDPLIK.2|HPGSFDVVHVK.3|HPGSFDVVHVK.2|LTIAEER.2|YPDPLIK.2|LTGVFAPR.2|LKYALTGDEVKK.3|LKYALTGDEVKK.2|HWMLDKLTGVFAPRPSTGPHK.5|HWM[Oxi]LDKLTGVFAPRPSTGPHK.5|ERHPGSFDVVHVK.3|ERHPGSFDVVHVK.2|YALTGDEVK.2|ERHPGSFDVVHVKDANGNSFATR.5|LTGVFAPRPSTGPHK.3|DANGNSFATR.2|LSNIFVIGKGNKPWISLPR.4|LSNIFVIGKGNKPWISLPR.3|LTIAEERDK.2|VRTDITYPAGFMDVISIDK.4|VRTDITYPAGFMDVISIDK.3|VRTDITYPAGFMDVISIDK.2|HWMLDKLTGVFAPR.3|YALTGDEVKK.2|GNKPWISLPR.2|LKYALTGDEVK.2|TDITYPAGFMDVISIDK.3|TDITYPAGFM[Oxi]DVISIDK.2|TDITYPAGFMDVISIDK.2|VRTDITYPAGFMDVISIDKTGENFR.4|VRTDITYPAGFMDVISIDKTGENFR.3|VNDTIQIDLETGK.2|VNDTIQIDLETGKITDFIK.3|VNDTIQIDLETGKITDFIK.2|ITDFIKFDTGNLC[CAM]MVTGGANLGR.3|TDITYPAGFMDVISIDKTGENFR.3
SEN / CTL,"Sulfide:quinone oxidoreductase, mitochondrial",SQRDL,Q9Y6N5,0.79,0.67,2.71E-08,6.21E-08,7.21E+00,"sulfide oxidation, using sulfide:quinone oxidoreductase,hydrogen sulfide metabolic process","quinone binding,sulfide:quinone oxidoreductase activity",mitochondrial inner membrane,30,39,63,YADALQEIIQER.2|TAAAVAAQSGILDR.2|TAAAVAAQSGILDR.3|HFYQPIWTLVGAGAK.3|HFYQPIWTLVGAGAK.2|ALQDFKEGNAIFTFPNTPVK.3|ALQDFKEGNAIFTFPNTPVK.4|ALQDFKEGNAIFTFPNTPVK.2|KYDGYTSC[CAM]PLVTGYNR.3|KYDGYTSC[CAM]PLVTGYNR.2|RYPNVFGIGDC[CAM]TNLPTSK.3|RYPNVFGIGDC[CAM]TNLPTSK.4|RYPNVFGIGDC[CAM]TNLPTSK.2|IMYLSEAYFR.2|IM[Oxi]YLSEAYFR.2|KYADALQEIIQER.3|KYADALQEIIQER.2|TSPVADAAGWVDVDKETLQHR.4|TSPVADAAGWVDVDKETLQHR.3|VTELNPDKNC[CAM]IHTDDDEKISYR.5|VTELNPDKNC[CAM]IHTDDDEKISYR.4|LFHLGMS.2|LFHLGM[Oxi]S.2|NC[CAM]IHTDDDEK.3|NC[CAM]IHTDDDEK.2|NLTVNYK.2|LSMYLMK.2|RKVGAENVAIVEPSER.4|RKVGAENVAIVEPSER.3|VTELNPDK.2|TSPVADAAGWVDVDKETLQHRR.5|ADKQEAVFENLDK.3|EGNAIFTFPNTPVK.3|EGNAIFTFPNTPVK.2|GLPEGFAHPK.2|KVGAENVAIVEPSER.3|KVGAENVAIVEPSER.2|VILAEFDYK.2|ANIIFNTSLGAIFGVK.3|ANIIFNTSLGAIFGVK.2|GYWGGPAFLR.2|ARVTELNPDK.2|SKANIIFNTSLGAIFGVK.3|YPNVFGIGDC[CAM]TNLPTSK.3|YPNVFGIGDC[CAM]TNLPTSK.2|VILAEFDYKAEPLETFPFDQSK.4|VILAEFDYKAEPLETFPFDQSK.3|NHYEVLVLGGGSGGITMAAR.3|NHYEVLVLGGGSGGITM[Oxi]AAR.3|NHYEVLVLGGGSGGITMAAR.2|ADKQEAVFENLDKPGETQVISYEMLHVTPPMSPPDVLK.6|ADKQEAVFENLDKPGETQVISYEMLHVTPPM[Oxi]SPPDVLK.5|ADKQEAVFENLDKPGETQVISYEMLHVTPPMSPPDVLK.5|VILAEFDYKAEPLETFPFDQSKER.4|QLSSSGRPTASVIPSGVEWIK.3|QLSSSGRPTASVIPSGVEWIK.2|VGAENVAIVEPSER.2|PTASVIPSGVEWIK.2|AEPLETFPFDQSK.2|TSPVADAAGWVDVDK.2|VGAENVAIVEPSERHFYQPIWTLVGAGAK.4|YDGYTSC[CAM]PLVTGYNR.2|QEAVFENLDKPGETQVISYEMLHVTPPMSPPDVLK.4
SEN / CTL,MICOS complex subunit MIC60,IMMT,Q16891,0.78,0.77,9.14E-03,4.97E-03,2.30E+00,"biological_process,cristae formation,mitochondrial calcium ion homeostasis","protein binding,poly(A) RNA binding","mitochondrion,mitochondrial inner membrane,membrane,myelin sheath,MICOS complex",12,79,130,VVSQYHELVVQAR.3|VVSQYHELVVQAR.2|LRGIEQAVQSHAVAEEEAR.4|LRGIEQAVQSHAVAEEEAR.3|TIPYSDKLFEMVLGPAAYNVPLPK.3|TIPYSDKLFEMVLGPAAYNVPLPK.4|TIPYSDKLFEM[Oxi]VLGPAAYNVPLPK.3|KAHQLWLSVEALK.3|KAHQLWLSVEALK.2|AFDSAVAK.2|QAAAHTDHLRDVLR.4|QAAAHTDHLRDVLR.3|SEIQAEQDRK.3|SEIQAEQDRK.2|SLEDALR.2|KAVDEAADALLK.3|KAVDEAADALLK.2|LHNM[Oxi]IVDLDNVVKK.4|LHNMIVDLDNVVKK.4|LHNM[Oxi]IVDLDNVVKK.3|LHNMIVDLDNVVKK.3|SIQSGPLK.2|LSTDDLNSLIAHAHR.4|LSTDDLNSLIAHAHR.3|LSTDDLNSLIAHAHR.2|RQAAAHTDHLR.3|KKEVAGAKPHITAAEGK.4|KKEVAGAKPHITAAEGK.3|VAQDWLK.2|VQEQELK.2|LRGIEQAVQSHAVAEEEARK.5|LRGIEQAVQSHAVAEEEARK.4|QPASQLQK.2|AAMDNSEIAGEKK.3|AAM[Oxi]DNSEIAGEKK.3|AAMDNSEIAGEKK.2|AAM[Oxi]DNSEIAGEKK.2|ALEHHRSEIQAEQDR.4|ALEHHRSEIQAEQDR.3|LSTDDLNSLIAHAHRR.4|LSTDDLNSLIAHAHRR.3|RIDQLNR.2|AHQLWLSVEALK.3|AHQLWLSVEALK.2|PHITAAEGK.2|RKAVDEAADALLK.3|VAMIDETR.2|VAM[Oxi]IDETR.2|VQAAQSEAK.2|KSIQSGPLK.2|RAFDSAVAK.2|GIEQAVQSHAVAEEEARK.4|GIEQAVQSHAVAEEEARK.3|ISSVSEVMK.2|ISSVSEVM[Oxi]K.2|EVAGAKPHITAAEGK.3|EVAGAKPHITAAEGK.2|LAQQEKQEQVKIESLAK.4|LAQQEKQEQVKIESLAK.3|DAMENEMR.2|DAM[Oxi]ENEMR.2|DAM[Oxi]ENEM[Oxi]R.2|LHNM[Oxi]IVDLDNVVK.3|LHNMIVDLDNVVK.3|LHNMIVDLDNVVK.2|LHNM[Oxi]IVDLDNVVK.2|RVAQDWLK.2|GMSVSDLADK.2|GM[Oxi]SVSDLADK.2|ELDSITPEVLPGWK.3|ELDSITPEVLPGWK.2|GVYSEETLR.2|QHITLALEK.2|GM[Oxi]SVSDLADKLSTDDLNSLIAHAHR.5|GMSVSDLADKLSTDDLNSLIAHAHR.5|GMSVSDLADKLSTDDLNSLIAHAHR.4|GM[Oxi]SVSDLADKLSTDDLNSLIAHAHR.4|GMSVSDLADKLSTDDLNSLIAHAHR.3|SEIQAEQDR.2|IEEVRDAMENEMR.3|IEEVRDAMENEMR.2|RVAMIDETR.2|AVDEAADALLK.2|QAAAHTDHLR.2|GMSVSDLADKLSTDDLNSLIAHAHRR.5|ERPPEEVAAR.2|LSEQELQFR.2|RELDSITPEVLPGWK.3|KIEEVRDAMENEMR.3|FVNQLKGESR.2|SEFEQNLSEK.2|GIEQAVQSHAVAEEEAR.3|GIEQAVQSHAVAEEEAR.2|AAMDNSEIAGEK.2|AAM[Oxi]DNSEIAGEK.2|LFEMVLGPAAYNVPLPK.3|LFEM[Oxi]VLGPAAYNVPLPK.3|LFEM[Oxi]VLGPAAYNVPLPK.2|LFEMVLGPAAYNVPLPK.2|YSTSGSSGLTTGK.2|TSSAETPTIPLGSAVEAIK.3|TSSAETPTIPLGSAVEAIK.2|QEQVKIESLAK.2|IAGAGLLFVGGGIGGTILYAK.3|IAGAGLLFVGGGIGGTILYAK.2|TDHPEIGEGKPTPALSEEASSSSIR.4|TDHPEIGEGKPTPALSEEASSSSIR.3|ISSVSEVMKESK.2|LAQQEKQEQVK.2|LFEMVLGPAAYNVPLPKK.3|VQEQELKSEFEQNLSEK.3|QTASVTLQAIAAQNAAVQAVNAHSNILK.4|QTASVTLQAIAAQNAAVQAVNAHSNILK.3|LLSYASYC[CAM]IEHGDLELAAK.3|LLSYASYC[CAM]IEHGDLELAAK.2|SLEDALRQTASVTLQAIAAQNAAVQAVNAHSNILK.5|SLEDALRQTASVTLQAIAAQNAAVQAVNAHSNILK.4|IDQLNRELAEQK.2|LSQEQVDNFTLDINTAYAR.3|LSQEQVDNFTLDINTAYAR.2|DDFKRELDSITPEVLPGWK.3|PTPALSEEASSSSIR.2|QKGDTPASATAPTEAAQIISAAGDTLSVPAPAVQPEESLK.5|QKGDTPASATAPTEAAQIISAAGDTLSVPAPAVQPEESLK.4|RLSQEQVDNFTLDINTAYAR.3|SEFEQNLSEKLSEQELQFR.3|QIVEILTAYASAVGIGTTQVQPE.3|ANC[CAM]SDNEFTQALTAAIPPESLTR.3|GDTPASATAPTEAAQIISAAGDTLSVPAPAVQPEESLK.4|TSSAETPTIPLGSAVEAIKANC[CAM]SDNEFTQALTAAIPPESLTR.4
SEN / CTL,Profilin-2,PFN2,P35080,0.78,0.35,9.19E-02,3.34E-02,1.48E+00,"negative regulation of epithelial cell migration,actin cytoskeleton organization,negative regulation of actin filament polymerization,positive regulation of actin filament polymerization,positive regulation of actin filament bundle assembly,positive regulation of ATPase activity,positive regulation of peptidyl-serine phosphorylation,protein stabilization,positive regulation of stress fiber assembly,negative regulation of ruffle assembly,regulation of synaptic vesicle exocytosis","adenyl-nucleotide exchange factor activity,actin monomer binding,phosphatidylinositol-4,5-bisphosphate binding","cytoplasm,cytoskeleton,terminal bouton,extracellular exosome",3,8,11,DREGFFTNGLTLGAK.3|DREGFFTNGLTLGAK.2|VLVFVM[Oxi]GK.2|EGVHGGGLNK.2|SQGGEPTYNVAVGR.3|SQGGEPTYNVAVGR.2|TKSQGGEPTYNVAVGR.3|EGFFTNGLTLGAK.2|DSLYVDGDC[CAM]TMDIR.2|DSLYVDGDC[CAM]TM[Oxi]DIR.2|YVWAATAGGVFQSITPIEIDMIVGK.3
SEN / CTL,Platelet-activating factor acetylhydrolase IB subunit beta,PAFAH1B2,P68402,0.77,0.32,7.12E-04,5.67E-04,3.25E+00,"lipid metabolic process,spermatogenesis,brain development,lipid catabolic process,positive regulation of macroautophagy","1-alkyl-2-acetylglycerophosphocholine esterase activity,phospholipase A2 activity,protein homodimerization activity,protein heterodimerization activity,platelet-activating factor acetyltransferase activity","nucleolus,cytoplasm,cytosol,plasma membrane,extracellular exosome",9,10,21,IIVLGLLPR.2|ELFSPLHALNFGIGGDTTR.3|ELFSPLHALNFGIGGDTTR.4|ELFSPLHALNFGIGGDTTR.2|LANVQLLDTDGGFVHSDGAISC[CAM]HDMFDFLHLTGGGYAK.5|LANVQLLDTDGGFVHSDGAISC[CAM]HDM[Oxi]FDFLHLTGGGYAK.5|LANVQLLDTDGGFVHSDGAISC[CAM]HDMFDFLHLTGGGYAK.4|LKNGELENIKPK.3|LKNGELENIKPK.2|IIVLGLLPRGEKPNPLR.4|PLHELIMQLLEETPEEK.4|PLHELIMQLLEETPEEK.3|PLHELIM[Oxi]QLLEETPEEK.3|PLHELIMQLLEETPEEK.2|NGELENIKPK.2|IC[CAM]KPLHELIMQLLEETPEEK.4|IC[CAM]KPLHELIM[Oxi]QLLEETPEEK.4|IC[CAM]KPLHELIMQLLEETPEEK.3|IC[CAM]KPLHELIM[Oxi]QLLEETPEEK.3|DKEPDVLFVGDSMVQLMQQYEIWR.3|IC[CAM]KPLHELIMQLLEETPEEKQTTIA.3
SEN / CTL,3-hydroxybutyrate dehydrogenase type 2,BDH2,Q9BUT1,0.77,0.37,2.39E-04,2.18E-04,3.66E+00,"fatty acid beta-oxidation,siderophore biosynthetic process,epithelial cell differentiation,heme metabolic process,ketone body biosynthetic process,iron ion homeostasis","3-hydroxybutyrate dehydrogenase activity,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,NAD binding","cytoplasm,cytosol,extracellular exosome,mitochondrion",9,13,19,SVAADFIQQGIR.2|VIILTAAAQGIGQAAALAFAR.3|VIILTAAAQGIGQAAALAFAR.2|VIATDINESKLQELEKYPGIQTR.4|VIATDINESKLQELEKYPGIQTR.3|KQIDQFANEVER.3|GRLDGKVIILTAAAQGIGQAAALAFAR.5|GRLDGKVIILTAAAQGIGQAAALAFAR.4|GRLDGKVIILTAAAQGIGQAAALAFAR.3|VIATDINESK.2|LDVLFNVAGFVHHGTVLDC[CAM]EEK.4|LDVLFNVAGFVHHGTVLDC[CAM]EEK.3|QIDQFANEVER.2|SGNIINM[Oxi]SSVASSVK.2|SGNIINMSSVASSVK.2|QIDQFANEVERLDVLFNVAGFVHHGTVLDC[CAM]EEK.5|LQELEKYPGIQTR.2|LDGKVIILTAAAQGIGQAAALAFAR.3|C[CAM]NC[CAM]VC[CAM]PGTVDTPSLQER.2
SEN / CTL,UDP-glucose 6-dehydrogenase,UGDH,O60701,0.77,0.80,2.32E-03,1.57E-03,2.81E+00,"gastrulation with mouth forming second,carbohydrate metabolic process,UDP-glucose metabolic process,glycosaminoglycan biosynthetic process,UDP-glucuronate biosynthetic process,oxidation-reduction process","UDP-glucose 6-dehydrogenase activity,electron carrier activity,NAD binding","nucleus,nucleoplasm,cytosol,extracellular exosome",15,46,76,ILTTNTWSSELSK.2|VTVVDVNESR.2|IAILGFAFK.2|LAANAFLAQR.2|IIDSLFNTVTDKK.3|IIDSLFNTVTDKK.2|MLKPAFIFDGR.3|RIPYAPSGEIPK.3|RIPYAPSGEIPK.2|AVQALC[CAM]AVYEHWVPR.4|AVQALC[CAM]AVYEHWVPR.3|AVQALC[CAM]AVYEHWVPR.2|AADLKYIEAC[CAM]AR.3|PAFIFDGR.2|ESSSIYISK.2|EADLVFISVNTPTK.3|EADLVFISVNTPTK.2|IVQNSNGYK.2|FSLQDPPNK.2|RVLDGLHNELQTIGFQIETIGKK.5|RVLDGLHNELQTIGFQIETIGKK.4|RVLDGLHNELQTIGFQIETIGKK.3|DTGDTRESSSIYISK.3|DTGDTRESSSIYISK.2|EQIVVDLSHPGVSEDDQVSR.4|EQIVVDLSHPGVSEDDQVSR.3|EQIVVDLSHPGVSEDDQVSR.2|IPYAPSGEIPK.2|VLDGLHNELQTIGFQIETIGK.4|VLDGLHNELQTIGFQIETIGK.3|VLDGLHNELQTIGFQIETIGK.2|RIVQNSNGYK.2|YLMDEGAHLHIYDPK.3|VLDGLHNELQTIGFQIETIGKK.4|VLDGLHNELQTIGFQIETIGKK.3|ASVGFGGSC[CAM]FQK.2|RVLDGLHNELQTIGFQIETIGK.4|RVLDGLHNELQTIGFQIETIGK.3|ILTTNTWSSELSKLAANAFLAQR.4|ILTTNTWSSELSKLAANAFLAQR.3|INAWNSPTLPIYEPGLK.3|INAWNSPTLPIYEPGLK.2|RIFDANTKPNLNLQVLSNPEFLAEGTAIK.5|RIFDANTKPNLNLQVLSNPEFLAEGTAIK.4|RIFDANTKPNLNLQVLSNPEFLAEGTAIK.3|VPREQIVVDLSHPGVSEDDQVSR.4|AVQALC[CAM]AVYEHWVPREK.3|IIDSLFNTVTDK.2|VLIGGDETPEGQR.2|IC[CAM]C[CAM]IGAGYVGGPTC[CAM]SVIAHMC[CAM]PEIR.4|IC[CAM]C[CAM]IGAGYVGGPTC[CAM]SVIAHM[Oxi]C[CAM]PEIR.3|IC[CAM]C[CAM]IGAGYVGGPTC[CAM]SVIAHMC[CAM]PEIR.3|INAWNSPTLPIYEPGLKEVVESC[CAM]R.4|INAWNSPTLPIYEPGLKEVVESC[CAM]R.3|DVLNLVYLC[CAM]EALNLPEVAR.3|DVLNLVYLC[CAM]EALNLPEVAR.2|KIC[CAM]C[CAM]IGAGYVGGPTC[CAM]SVIAHMC[CAM]PEIR.4|KIC[CAM]C[CAM]IGAGYVGGPTC[CAM]SVIAHMC[CAM]PEIR.3|NLFFSTNIDDAIK.2|PNLNLQVLSNPEFLAEGTAIK.3|PNLNLQVLSNPEFLAEGTAIK.2|IFDANTKPNLNLQVLSNPEFLAEGTAIK.4|IFDANTKPNLNLQVLSNPEFLAEGTAIK.3|ISSINSISALC[CAM]EATGADVEEVATAIGMDQR.4|ISSINSISALC[CAM]EATGADVEEVATAIGM[Oxi]DQR.3|ISSINSISALC[CAM]EATGADVEEVATAIGMDQR.3|IFDANTKPNLNLQVLSNPEFLAEGTAIKDLKNPDR.5|LVTISKDPYEAC[CAM]DGAHAVVIC[CAM]TEWDM[Oxi]FK.4|LVTISKDPYEAC[CAM]DGAHAVVIC[CAM]TEWDMFK.4|IFDANTKPNLNLQVLSNPEFLAEGTAIKDLK.4|DPYEAC[CAM]DGAHAVVIC[CAM]TEWDM[Oxi]FK.3|DPYEAC[CAM]DGAHAVVIC[CAM]TEWDMFK.3|YWQQVIDMNDYQR.2|YWQQVIDM[Oxi]NDYQR.2|NPDRVLIGGDETPEGQR.2|NLFFSTNIDDAIKEADLVFISVNTPTK.3
SEN / CTL,60S ribosomal protein L11,RPL11,P62913,0.77,0.33,2.79E-03,1.83E-03,2.74E+00,"ribosomal large subunit assembly,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,protein targeting,SRP-dependent cotranslational protein targeting to membrane,viral transcription,protein localization to nucleus,ribosomal large subunit biogenesis","RNA binding,structural constituent of ribosome,protein binding,rRNA binding,poly(A) RNA binding","nucleoplasm,nucleolus,cytoplasm,cytosol,membrane,cytosolic large ribosomal subunit,extracellular matrix,extracellular exosome",6,20,23,VLEQLTGQTPVFSK.2|VLEQLTGQTPVFSK.3|AEEILEK.2|HRISKEEAMR.3|PGFSIADK.2|NEKIAVHC[CAM]TVR.3|IAVHC[CAM]TVR.2|PGFSIADKK.2|VREYELR.2|ISKEEAM[Oxi]R.2|YDGIILPGK.2|GAKAEEILEK.2|KLC[CAM]LNIC[CAM]VGESGDR.3|KLC[CAM]LNIC[CAM]VGESGDR.2|WFQQKYDGIILPGK.3|AAKVLEQLTGQTPVFSK.3|LC[CAM]LNIC[CAM]VGESGDRLTR.3|KNNFSDTGNFGFGIQEHIDLGIK.4|KNNFSDTGNFGFGIQEHIDLGIK.3|LC[CAM]LNIC[CAM]VGESGDR.2|YDPSIGIYGLDFYVVLGRPGFSIADKK.4|NNFSDTGNFGFGIQEHIDLGIK.3|YDPSIGIYGLDFYVVLGRPGFSIADK.3
SEN / CTL,"NAD-dependent malic enzyme, mitochondrial",ME2,P23368,0.77,1.16,5.42E-02,2.15E-02,1.67E+00,"malate metabolic process,oxidation-reduction process,regulation of NADP metabolic process","malic enzyme activity,malate dehydrogenase (decarboxylating) (NAD+) activity,oxaloacetate decarboxylase activity,electron carrier activity,metal ion binding,NAD binding","mitochondrion,mitochondrial matrix,intracellular membrane-bounded organelle",12,35,55,VFTPGQGNNVYIFPGVALAVILC[CAM]NTR.3|LC[CAM]LYTAC[CAM]AGIRPDR.3|HISDSVFLEAAK.3|HISDSVFLEAAK.2|ILGLGDLGVYGMGIPVGK.3|ILGLGDLGVYGM[Oxi]GIPVGK.3|ILGLGDLGVYGMGIPVGK.2|ILGLGDLGVYGM[Oxi]GIPVGK.2|MAFRYPEPEDK.3|KMTSPLEK.2|LFTPDVIR.2|SIVDNWPENHVK.3|SIVDNWPENHVK.2|GLFISISDR.2|GMAFTLQER.2|GM[Oxi]AFTLQER.2|ALTSQLTDEELAQGR.3|ALTSQLTDEELAQGR.2|PSTIIGVAGAGR.2|TQQYDDLIDEFMK.3|TQQYDDLIDEFM[Oxi]K.2|TQQYDDLIDEFMK.2|VTEYLYANK.2|VISKPISEHK.2|IETQDIQALR.2|DPFYMGLYQK.2|C[CAM]LPVC[CAM]IDVGTDNIALLK.3|C[CAM]LPVC[CAM]IDVGTDNIALLK.2|DRTQQYDDLIDEFMK.3|DRTQQYDDLIDEFM[Oxi]K.3|DRTQQYDDLIDEFMK.2|NTLIQFEDFGNHNAFR.3|NTLIQFEDFGNHNAFR.2|YIYIMGIQER.2|YIYIM[Oxi]GIQER.2|QMLGLQGLLPPK.2|C[CAM]LFASGSPFGPVK.2|EKYC[CAM]TFNDDIQGTAAVALAGLLAAQK.4|EKYC[CAM]TFNDDIQGTAAVALAGLLAAQK.3|PVIFALSNPTAQAEC[CAM]TAEEAYTLTEGR.4|PVIFALSNPTAQAEC[CAM]TAEEAYTLTEGR.3|AMASINERPVIFALSNPTAQAEC[CAM]TAEEAYTLTEGR.5|AM[Oxi]ASINERPVIFALSNPTAQAEC[CAM]TAEEAYTLTEGR.4|AMASINERPVIFALSNPTAQAEC[CAM]TAEEAYTLTEGR.4|QMLGLQGLLPPKIETQDIQALR.3|AKIDSYQEPFTHSAPESIPDTFEDAVNILK.4|YC[CAM]TFNDDIQGTAAVALAGLLAAQK.3|ILQDDIESLM[Oxi]PIVYTPTVGLAC[CAM]SQYGHIFR.4|ILQDDIESLMPIVYTPTVGLAC[CAM]SQYGHIFR.4|ILQDDIESLMPIVYTPTVGLAC[CAM]SQYGHIFR.3|AKIDSYQEPFTHSAPESIPDTFEDAVNILKPSTIIGVAGAGR.5|SEYDSLLPDVYEWPESASSPPVITE.3|LYPPLANIQEVSINIAIK.2|C[CAM]LPVC[CAM]IDVGTDNIALLKDPFYMGLYQK.3|IDSYQEPFTHSAPESIPDTFEDAVNILKPSTIIGVAGAGR.4
SEN / CTL,Synaptic vesicle membrane protein VAT-1 homolog,VAT1,Q99536,0.77,0.56,1.62E-08,4.04E-08,7.39E+00,"negative regulation of mitochondrial fusion,oxidation-reduction process","zinc ion binding,oxidoreductase activity","mitochondrial outer membrane,integral component of membrane,extracellular exosome",33,28,53,TWWNQFSVTALQLLQANR.3|LQSRPAAPPAPGPGQLTLR.3|LQSRPAAPPAPGPGQLTLR.4|AC[CAM]GLNFADLMAR.2|AC[CAM]GLNFADLM[Oxi]AR.2|AVC[CAM]GFHLGYLDGEVELVSGVVAR.3|AVC[CAM]GFHLGYLDGEVELVSGVVAR.4|C[CAM]LVLTGFGGYDKVK.3|C[CAM]LVLTGFGGYDK.2|GVDIVMDPLGGSDTAK.2|GVDIVM[Oxi]DPLGGSDTAK.3|GVDIVMDPLGGSDTAK.3|GVDIVM[Oxi]DPLGGSDTAK.2|LLALYNQGHIKPHIDSVWPFEK.5|LLALYNQGHIKPHIDSVWPFEK.4|LLALYNQGHIKPHIDSVWPFEK.3|VLLVPGPEKEN.2|VLLVPGPEK.2|PAAPPAPGPGQLTLR.3|PAAPPAPGPGQLTLR.2|VVTYGMANLLTGPK.3|VVTYGMANLLTGPK.2|VVTYGM[Oxi]ANLLTGPK.2|ENGVTHPIDYHTTDYVDEIKK.5|ENGVTHPIDYHTTDYVDEIKK.4|ENGVTHPIDYHTTDYVDEIKK.3|HEALKENGVTHPIDYHTTDYVDEIKK.6|HEALKENGVTHPIDYHTTDYVDEIKK.5|HEALKENGVTHPIDYHTTDYVDEIKK.4|TVENVTVFGTASASKHEALK.4|TVENVTVFGTASASKHEALK.3|VKLQSRPAAPPAPGPGQLTLR.4|EVAEAATGEDASSPPPK.3|EVAEAATGEDASSPPPK.2|ENGVTHPIDYHTTDYVDEIK.4|ENGVTHPIDYHTTDYVDEIK.3|HEALKENGVTHPIDYHTTDYVDEIK.5|HEALKENGVTHPIDYHTTDYVDEIK.4|LLALYNQGHIK.2|TEAASDPQHPAASEGAAAAAASPPLLR.4|TEAASDPQHPAASEGAAAAAASPPLLR.3|LPPLPVTPGMEGAGVVIAVGEGVSDRK.4|LPPLPVTPGMEGAGVVIAVGEGVSDRK.3|PHIDSVWPFEK.2|QGLYDRLPPLPVTPGMEGAGVVIAVGEGVSDRK.5|QGLYDRLPPLPVTPGMEGAGVVIAVGEGVSDRK.4|QGLYDRLPPLPVTPGM[Oxi]EGAGVVIAVGEGVSDRK.4|TVENVTVFGTASASK.2|QGLYDRLPPLPVTPGMEGAGVVIAVGEGVSDR.4|QGLYDRLPPLPVTPGMEGAGVVIAVGEGVSDR.3|LPPLPVTPGM[Oxi]EGAGVVIAVGEGVSDR.3|LPPLPVTPGMEGAGVVIAVGEGVSDR.3|EVAEAATGEDASSPPPKTEAASDPQHPAASEGAAAAAASPPLLR.4
SEN / CTL,Spermatid perinuclear RNA-binding protein,STRBP,Q96SI9,0.76,0.52,1.41E-01,4.65E-02,1.33E+00,"multicellular organism development,spermatid development,mechanosensory behavior","DNA binding,double-stranded RNA binding,single-stranded RNA binding,protein binding,poly(A) RNA binding","nucleus,cytoplasm,microtubule cytoskeleton",3,24,25,SC[CAM]VIVLR.2|EDITHSAQHALR.3|RPFEDGLGDDKDPNKK.4|RPFEDGLGDDKDPNKK.3|ASAALAALEK.2|C[CAM]LNALASLR.2|KDGENVSM[Oxi]K.2|LSAFGQIYK.2|DNLPIQIQK.2|TQGPILTASGK.2|HVSDWLDETNKGTK.3|VILTSPLIRDELEK.3|SIGTC[CAM]NRPLGAGEALR.3|LFSGPNAANNK.2|AIDLMNALMR.2|VLEMDPLPSSKPFQK.3|DGENVSMKDPPDLLDR.3|GWPLELIC[CAM]EK.2|HVSDWLDETNK.2|DKPTETLLNTVK.2|TQGPILTASGKNPVMELNEK.3|VPTWAPLKGWPLELIC[CAM]EK.3|FPTYPVPHYSFF.2|YQVEQC[CAM]VNEASIIIR.2|HSTIYPSPEELEAVQNMVSTVEC[CAM]ALK.3
SEN / CTL,"Elongation factor Tu, mitochondrial",TUFM,P49411,0.76,1.63,8.17E-03,4.55E-03,2.34E+00,"translational elongation,response to ethanol,mitochondrial translational elongation","translation elongation factor activity,GTPase activity,protein binding,GTP binding,poly(A) RNA binding","mitochondrion,membrane,mitochondrial nucleoid,extracellular exosome",30,46,87,GITINAAHVEYSTAAR.3|GITINAAHVEYSTAAR.2|GITINAAHVEYSTAAR.4|DLEKPFLLPVEAVYSVPGR.3|DLEKPFLLPVEAVYSVPGR.4|DLEKPFLLPVEAVYSVPGR.2|SLERAEAGDNLGALVR.3|SLERAEAGDNLGALVR.2|GTVVTGTLER.2|ILAEGGGAK.2|QPMILEK.2|TVVTGIEMFHK.3|TVVTGIEM[Oxi]FHK.3|TVVTGIEMFHK.2|TVVTGIEM[Oxi]FHK.2|LLDAVDTYIPVPARDLEKPFLLPVEAVYSVPGR.4|LLDAVDTYIPVPARDLEKPFLLPVEAVYSVPGR.5|LLDAVDTYIPVPAR.2|LLDAVDTYIPVPAR.3|GLVMVKPGSIKPHQK.4|GLVMVKPGSIKPHQK.3|GDEC[CAM]ELLGHSK.3|GDEC[CAM]ELLGHSK.2|EHLLLAR.2|KYEEIDNAPEERAR.4|HYAHTDC[CAM]PGHADYVK.4|HYAHTDC[CAM]PGHADYVK.3|HYAHTDC[CAM]PGHADYVK.2|KGDEC[CAM]ELLGHSKNIR.4|DKPHVNVGTIGHVDHGK.4|DKPHVNVGTIGHVDHGK.3|DKPHVNVGTIGHVDHGKTTLTAAITK.6|DKPHVNVGTIGHVDHGKTTLTAAITK.5|KGDEC[CAM]ELLGHSK.3|KGDEC[CAM]ELLGHSK.2|TTLTAAITK.2|ARGITINAAHVEYSTAAR.4|ARGITINAAHVEYSTAAR.3|QIGVEHVVVYVNK.3|QIGVEHVVVYVNK.2|KYEEIDNAPEER.3|KYEEIDNAPEER.2|PHVNVGTIGHVDHGK.3|FNLILRQPMILEK.3|FNLILRQPMILEK.2|ELAMPGEDLK.2|ELAM[Oxi]PGEDLK.2|ELLTEFGYK.2|PFLLPVEAVYSVPGR.3|PFLLPVEAVYSVPGR.2|VEAQVYILSKEEGGR.3|VEAQVYILSKEEGGR.2|VEAQVYILSK.2|AEAGDNLGALVR.2|FKKYEEIDNAPEER.3|FKKYEEIDNAPEER.2|ELAMPGEDLKFNLILR.3|GEETPVIVGSALC[CAM]ALEGR.3|GEETPVIVGSALC[CAM]ALEGR.2|IILPPEKELAMPGEDLK.3|TIGTGLVTNTLAMTEEEK.3|TIGTGLVTNTLAM[Oxi]TEEEK.3|TIGTGLVTNTLAM[Oxi]TEEEK.2|TIGTGLVTNTLAMTEEEK.2|GEETPVIVGSALC[CAM]ALEGRDPELGLK.4|GEETPVIVGSALC[CAM]ALEGRDPELGLK.3|IILPPEKELAM[Oxi]PGEDLKFNLILR.4|IILPPEKELAMPGEDLKFNLILR.4|LLDAVDTYIPVPARDLEK.3|ADAVQDSEMVELVELEIR.3|ADAVQDSEM[Oxi]VELVELEIR.3|ADAVQDSEM[Oxi]VELVELEIR.2|ADAVQDSEMVELVELEIR.2|YEEIDNAPEER.2|NMITGTAPLDGC[CAM]ILVVAANDGPMPQTR.4|NMITGTAPLDGC[CAM]ILVVAANDGPMPQTR.3|NM[Oxi]ITGTAPLDGC[CAM]ILVVAANDGPMPQTR.3|NMITGTAPLDGC[CAM]ILVVAANDGPM[Oxi]PQTR.3|ELLTEFGYKGEETPVIVGSALC[CAM]ALEGR.4|ELLTEFGYKGEETPVIVGSALC[CAM]ALEGR.3|ELLTEFGYKGEETPVIVGSALC[CAM]ALEGRDPELGLK.5|ELLTEFGYKGEETPVIVGSALC[CAM]ALEGRDPELGLK.4|TIGTGLVTNTLAMTEEEKNIK.3|TIGTGLVTNTLAM[Oxi]TEEEKNIK.3|TIGTGLVTNTLAMTEEEKNIK.2|DLEKPFLLPVEAVYSVPGRGTVVTGTLER.4|LLDAVDTYIPVPARDLEKPFLLPVEAVYSVPGRGTVVTGTLER.5
SEN / CTL,General vesicular transport factor p115,USO1,O60763,0.76,0.61,2.34E-02,1.08E-02,1.97E+00,"intracellular protein transport,ER to Golgi vesicle-mediated transport,Golgi organization,transcytosis,COPII vesicle coating,Golgi vesicle docking,vesicle fusion with Golgi apparatus,membrane fusion,cell-cell adhesion","protein transporter activity,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","Golgi membrane,nucleolus,endoplasmic reticulum,Golgi apparatus,Golgi stack,cytosol,cell-cell adherens junction,ER to Golgi transport vesicle membrane,membrane,transport vesicle,perinuclear region of cytoplasm",9,49,72,VTNLHLMLQLVR.3|VTNLHLMLQLVR.2|EVIRNDGVLLLQALTR.3|EVIRNDGVLLLQALTR.2|QQENVTLLLSLLEEFDFHVR.3|TLEQHDNIVTHYK.4|TLEQHDNIVTHYK.3|TLEQHDNIVTHYK.2|VASSTLLDDRR.3|VASSTLLDDRR.2|LREEIEELKR.3|DQYNLLK.2|DKLELEITDSKK.3|DSMIENMK.2|LSALLQETK.2|DSEQVAELK.2|LMDLLADSR.2|LM[Oxi]DLLADSR.2|RNQELLQSQLTEK.3|RNQELLQSQLTEK.2|VASSTLLDDR.2|LEVGIQAMEHLIHVLQTDR.4|LEVGIQAMEHLIHVLQTDR.3|EQDDLLVLLADQDQK.3|EQDDLLVLLADQDQK.2|VLVSPTNPPGATSSC[CAM]QK.3|VLVSPTNPPGATSSC[CAM]QK.2|C[CAM]AVLYC[CAM]FQC[CAM]FLYK.3|C[CAM]AVLYC[CAM]FQC[CAM]FLYK.2|IVAFENAFER.2|DSEQVAELKQELATLK.3|SSQTSGTNEQSSAIVSAR.3|SSQTSGTNEQSSAIVSAR.2|NNNSNQNFFK.2|C[CAM]QNEQLQTAVTQQVSQIQQHK.4|C[CAM]QNEQLQTAVTQQVSQIQQHK.3|EQLDSSNSTIAILQTEK.3|EQLDSSNSTIAILQTEK.2|KEQDDLLVLLADQDQK.3|EQDLQLEELR.2|NMIREQDLQLEELRQQVSTLK.4|NDGVLLLQALTR.2|SQLNSQSVEITK.2|C[CAM]QNEQLQTAVTQQVSQIQQHKDQYNLLK.5|C[CAM]QNEQLQTAVTQQVSQIQQHKDQYNLLK.4|GVMGGQSAGPQHTEAETIQK.3|GVM[Oxi]GGQSAGPQHTEAETIQK.3|ASQKPQPNFPSPEYMIFDHEFTK.4|ASQKPQPNFPSPEYM[Oxi]IFDHEFTK.4|ASQKPQPNFPSPEYMIFDHEFTK.3|EQDLQLEELRQQVSTLK.3|LQTEKQELLQK.2|QLGPQVQQIILVSPMGVSR.3|QLGPQVQQIILVSPM[Oxi]GVSR.3|QLGPQVQQIILVSPM[Oxi]GVSR.2|QLGPQVQQIILVSPMGVSR.2|NNNSNQNFFKEGSYIQR.3|MKPWFEVGDENSGWSAQK.3|MKPWFEVGDENSGWSAQK.2|NQELLQSQLTEK.2|TAIKEQLDSSNSTIAILQTEK.3|PQPNFPSPEYMIFDHEFTK.3|IQLGKDNQHQGSYSEGAQMNGIQPEEIGR.4|NQELLQSQLTEKDSMIENMK.3|SVEVQGETETIIATK.2|DNQHQGSYSEGAQMNGIQPEEIGR.3|DNQHQGSYSEGAQM[Oxi]NGIQPEEIGR.3|QSEDLGSQFTEIFIK.2|PWFEVGDENSGWSAQK.2|GC[CAM]QVNQDYFASVNAPSNPPRPAIVVLLMSMVNER.4|VQLATSIGNPPVSLLQQC[CAM]TNILSQGSK.3|DLGHPVEEEDELESGDQEDEDDESEDPGK.3
SEN / CTL,Vitronectin,VTN,P04004,0.76,1.51,1.45E-01,4.77E-02,1.32E+00,"receptor-mediated endocytosis,immune response,cell adhesion,cell-matrix adhesion,positive regulation of cell-substrate adhesion,negative regulation of endopeptidase activity,positive regulation of smooth muscle cell migration,negative regulation of blood coagulation,extracellular matrix organization,regulation of complement activation,positive regulation of vascular endothelial growth factor receptor signaling pathway,positive regulation of protein binding,cell adhesion mediated by integrin,endodermal cell differentiation,positive regulation of receptor-mediated endocytosis,oligodendrocyte differentiation,positive regulation of peptidyl-tyrosine phosphorylation,protein polymerization,smooth muscle cell-matrix adhesion,positive regulation of wound healing,liver regeneration","scavenger receptor activity,integrin binding,protein binding,collagen binding,heparin binding,polysaccharide binding,identical protein binding,extracellular matrix binding","extracellular region,basement membrane,extracellular space,Golgi lumen,extracellular matrix,rough endoplasmic reticulum lumen,extracellular exosome,alphav-beta3 integrin-vitronectin complex,blood microparticle",12,22,33,LIRDVWGIEGPIDAAFTR.3|DVWGIEGPIDAAFTR.2|DVWGIEGPIDAAFTR.3|RVDTVDPPYPR.2|RVDTVDPPYPR.3|C[CAM]TEGFNVDKK.3|FEDGVLDPDYPR.3|FEDGVLDPDYPR.2|TSAGTRQPQFISR.3|IYISGMAPR.2|IYISGM[Oxi]APRPSLAK.3|PFDAFTDLK.2|C[CAM]TEGFNVDK.2|GQYC[CAM]YELDEKAVRPGYPK.4|GQYC[CAM]YELDEKAVRPGYPK.3|DWHGVPGQVDAAMAGR.3|DWHGVPGQVDAAM[Oxi]AGR.3|DWHGVPGQVDAAMAGR.2|SIAQYWLGC[CAM]PAPGHL.3|SIAQYWLGC[CAM]PAPGHL.2|VDTVDPPYPR.2|GQYC[CAM]YELDEK.2|PETLHPGRPQPPAEEELC[CAM]SGKPFDAFTDLK.5|PETLHPGRPQPPAEEELC[CAM]SGKPFDAFTDLK.4|GNPEQTPVLKPEEEAPAPEVGASKPEGIDSR.4|PQPPAEEELC[CAM]SGKPFDAFTDLK.3|QYWEYQFQHQPSQEEC[CAM]EGSSLSAVFEHFAMMQR.5|QYWEYQFQHQPSQEEC[CAM]EGSSLSAVFEHFAMM[Oxi]QR.4|M[Oxi]DWLVPATC[CAM]EPIQSVFFFSGDK.3|MDWLVPATC[CAM]EPIQSVFFFSGDK.3|C[CAM]QC[CAM]DELC[CAM]SYYQSC[CAM]C[CAM]TDYTAEC[CAM]KPQVTR.4|C[CAM]QC[CAM]DELC[CAM]SYYQSC[CAM]C[CAM]TDYTAEC[CAM]KPQVTR.3|KC[CAM]QC[CAM]DELC[CAM]SYYQSC[CAM]C[CAM]TDYTAEC[CAM]KPQVTR.4
SEN / CTL,Sorting nexin-2,SNX2,O60749,0.76,0.09,3.04E-03,1.97E-03,2.70E+00,"intracellular protein transport,endocytosis,vesicle organization,early endosome to Golgi transport,retrograde transport, endosome to Golgi,protein oligomerization,lamellipodium morphogenesis,cell-cell adhesion","epidermal growth factor receptor binding,insulin receptor binding,protein binding,phosphatidylinositol binding,protein homodimerization activity,protein heterodimerization activity,cadherin binding involved in cell-cell adhesion,transferrin receptor binding,leptin receptor binding","cytoplasm,cytosol,cell-cell adherens junction,endosome membrane,membrane,extrinsic component of membrane,lamellipodium,retromer complex,retromer, tubulation complex,early endosome membrane,protein complex,extracellular exosome",3,24,36,AVNTQALSGAGILR.2|AVNTQALSGAGILR.3|TVKHPTLLQDPDLR.4|TVKHPTLLQDPDLR.3|DFEQISK.2|HPTLLQDPDLR.3|HPTLLQDPDLR.2|LHVSVEALVC[CAM]HR.3|LHVSVEALVC[CAM]HR.2|QQQFENLDQQLR.3|QQQFENLDQQLR.2|VGKEDSSSTEFVEK.3|VGKEDSSSTEFVEK.2|VQQGERDFEQISK.3|YLHVGYIVPPAPEK.3|YLHVGYIVPPAPEK.2|SAAMLGNSEDHTALSR.3|SAAM[Oxi]LGNSEDHTALSR.3|SAAMLGNSEDHTALSR.2|QQQFENLDQQLRK.3|QQQFENLDQQLRK.2|ELSANTAAFAK.2|SMSAPVIFDR.2|YLESLVQTQQQLIK.3|YLESLVQTQQQLIK.2|FSDFLGLHSK.2|VKVGKEDSSSTEFVEK.3|QFLESSELPR.2|WEDAQITLLK.2|HPTLLQDPDLRQFLESSELPR.4|EDSSSTEFVEK.2|VGDGMNAYMAYR.2|MNESDAWFEEK.2|M[Oxi]NESDAWFEEK.2|TVKHPTLLQDPDLRQFLESSELPR.4|EPILSSEPSPAVTPVTPTTLIAPR.3
SEN / CTL,Serine protease HTRA1,HTRA1,Q92743,0.76,0.67,1.19E-01,4.10E-02,1.39E+00,"regulation of cell growth,placenta development,proteolysis,extracellular matrix disassembly,negative regulation of transforming growth factor beta receptor signaling pathway,negative regulation of BMP signaling pathway,positive regulation of epithelial cell proliferation,negative regulation of defense response to virus,chorionic trophoblast cell differentiation,dentinogenesis","serine-type endopeptidase activity,insulin-like growth factor binding,serine-type peptidase activity","extracellular region,extracellular space,cytosol,plasma membrane,extracellular matrix,extracellular exosome",6,2,2,IAPAVVHIELFR.3|SSELRPGEFVVAIGSPFSLQNTVTTGIVSTTQR.3
SEN / CTL,DDRGK domain-containing protein 1,DDRGK1,Q96HY6,0.76,0.39,9.55E-03,5.12E-03,2.29E+00,"regulation of intracellular estrogen receptor signaling pathway,response to endoplasmic reticulum stress,positive regulation of NF-kappaB transcription factor activity,positive regulation of proteasomal protein catabolic process,positive regulation of I-kappaB phosphorylation,protein K69-linked ufmylation","protein binding,ubiquitin-like protein ligase binding","endoplasmic reticulum,endoplasmic reticulum membrane",6,12,18,VVLLEDLASQVGLR.2|VVLLEDLASQVGLR.3|FIYITPEELAAVANFIR.3|FIYITPEELAAVANFIR.2|LRLEEEQKEEEER.4|LRLEEEQKEEEER.3|AREEQAQREHEEYLK.4|IQDLLAEGTITGVIDDR.3|IQDLLAEGTITGVIDDR.2|AASAGQEPLHNEELAGAGR.3|AASAGQEPLHNEELAGAGR.2|VSIAELAQASNSLIAWGR.3|VSIAELAQASNSLIAWGR.2|IQDLLAEGTITGVIDDRGK.3|GRVSIAELAQASNSLIAWGR.3|VAQPGPLEPEEPR.2|GKFIYITPEELAAVANFIR.3|VAWAEADENEEEAVILAQEEEGVEKPAETHLSGK.4
SEN / CTL,"ES1 protein homolog, mitochondrial",C21orf33,P30042,0.75,0.41,7.63E-03,4.27E-03,2.37E+00,,,mitochondrion,6,22,42,VLKEFHQAGKPIGLC[CAM]C[CAM]IAPVLAAK.4|VLKEFHQAGKPIGLC[CAM]C[CAM]IAPVLAAK.5|GKITDLANLSAANHDAAIFPGGFGAAK.4|GKITDLANLSAANHDAAIFPGGFGAAK.5|GKITDLANLSAANHDAAIFPGGFGAAK.3|KVLELTGK.2|GQPSEGESR.2|PIGLC[CAM]C[CAM]IAPVLAAK.3|PIGLC[CAM]C[CAM]IAPVLAAK.2|GVEVTVGHEQEEGGK.3|GVEVTVGHEQEEGGK.2|NLSTFAVDGK.2|HC[CAM]VKEVVEAHVDQK.3|EFHQAGKPIGLC[CAM]C[CAM]IAPVLAAK.4|EFHQAGKPIGLC[CAM]C[CAM]IAPVLAAK.3|EFHQAGKPIGLC[CAM]C[CAM]IAPVLAAK.2|EVVEAHVDQK.2|VVTTPAFMC[CAM]ETALHYIHDGIGAMVRK.5|VVTTPAFMC[CAM]ETALHYIHDGIGAMVRK.4|GGAEVQIFAPDVPQMHVIDHTK.4|GGAEVQIFAPDVPQM[Oxi]HVIDHTK.4|GGAEVQIFAPDVPQM[Oxi]HVIDHTK.3|GGAEVQIFAPDVPQMHVIDHTK.3|GGAEVQIFAPDVPQMHVIDHTK.2|GQPSEGESRNVLTESAR.3|NKVVTTPAFMC[CAM]ETALHYIHDGIGAMVR.5|NKVVTTPAFMC[CAM]ETALHYIHDGIGAMVR.4|WPYAGTAEAIK.2|ITDLANLSAANHDAAIFPGGFGAAK.4|ITDLANLSAANHDAAIFPGGFGAAK.3|VLRGVEVTVGHEQEEGGKWPYAGTAEAIK.5|VLRGVEVTVGHEQEEGGKWPYAGTAEAIK.4|HC[CAM]VKEVVEAHVDQKNK.3|GVEVTVGHEQEEGGKWPYAGTAEAIK.4|GVEVTVGHEQEEGGKWPYAGTAEAIK.3|VVTTPAFM[Oxi]C[CAM]ETALHYIHDGIGAMVR.4|VVTTPAFMC[CAM]ETALHYIHDGIGAM[Oxi]VR.4|VVTTPAFMC[CAM]ETALHYIHDGIGAMVR.4|VVTTPAFM[Oxi]C[CAM]ETALHYIHDGIGAMVR.3|VVTTPAFMC[CAM]ETALHYIHDGIGAMVR.3|NLSTFAVDGKDC[CAM]K.2|VALVLSGC[CAM]GVYDGTEIHEASAILVHLSR.4
SEN / CTL,Ras-related protein Rab-15,RAB15,P59190,0.75,0.45,6.01E-02,2.35E-02,1.63E+00,"small GTPase mediated signal transduction,protein transport,positive regulation of regulated secretory pathway","protein binding,GTP binding","cytoplasm,plasma membrane,endosome membrane,perinuclear region of cytoplasm,extracellular exosome",3,1,1,IQIWDTAGQER.2
SEN / CTL,Coronin-1B,CORO1B,Q9BR76,0.75,0.61,1.54E-06,2.47E-06,5.61E+00,"cell migration,actin cytoskeleton organization,ruffle organization,regulation of Arp2/3 complex-mediated actin nucleation,negative regulation of Arp2/3 complex-mediated actin nucleation,endothelial cell chemotaxis,cellular response to platelet-derived growth factor stimulus,wound healing,actin filament bundle assembly,negative regulation of smooth muscle cell chemotaxis,actin filament branching,cell-cell adhesion,protein localization to cell leading edge,positive regulation of lamellipodium morphogenesis","protein binding,identical protein binding,actin filament binding,Arp2/3 complex binding,cadherin binding involved in cell-cell adhesion","stress fiber,cytoplasm,cytosol,actin filament,plasma membrane,cell-cell adherens junction,focal adhesion,lamellipodium,cell leading edge,perinuclear region of cytoplasm,extracellular exosome,cell periphery",21,27,44,DADPILISLR.2|AGEAGKLEEVMQELR.3|AGEAGKLEEVMQELR.2|VTWDSTFC[CAM]AVNPK.2|VTWDSTFC[CAM]AVNPK.3|VGIIAWHPTAR.3|VGIIAWHPTAR.2|AIFLADGK.2|NVLSDSRPAMAPGSSHLGAPASTTTAADATPSGSLAR.4|NVLSDSRPAMAPGSSHLGAPASTTTAADATPSGSLAR.6|NVLSDSRPAMAPGSSHLGAPASTTTAADATPSGSLAR.5|NVLSDSRPAM[Oxi]APGSSHLGAPASTTTAADATPSGSLAR.4|NVLSDSRPAM[Oxi]APGSSHLGAPASTTTAADATPSGSLAR.3|NVLSDSRPAMAPGSSHLGAPASTTTAADATPSGSLAR.3|RNVLSDSRPAMAPGSSHLGAPASTTTAADATPSGSLAR.5|RNVLSDSRPAMAPGSSHLGAPASTTTAADATPSGSLAR.4|IC[CAM]RLEEQLGR.3|LEEQLGR.2|KC[CAM]EPIVMTVPR.3|KC[CAM]EPIVM[Oxi]TVPR.3|KC[CAM]EPIVMTVPR.2|HVFGQPVK.2|RGTLVAER.2|VFTTGFSR.2|NDQC[CAM]YEDIRVSR.3|HVFGQPVKNDQC[CAM]YEDIR.4|HVFGQPVKNDQC[CAM]YEDIR.3|LEEVMQELR.2|AIFLADGKVFTTGFSR.3|C[CAM]EPIVMTVPR.2|NDQC[CAM]YEDIR.2|LDSLHPDLIYNVSWNHNGSLFC[CAM]SAC[CAM]K.5|LDSLHPDLIYNVSWNHNGSLFC[CAM]SAC[CAM]K.4|LDSLHPDLIYNVSWNHNGSLFC[CAM]SAC[CAM]K.3|LDSLHPDLIYNVSWNHNGSLFC[CAM]SAC[CAM]KDK.5|PAMAPGSSHLGAPASTTTAADATPSGSLAR.4|PAMAPGSSHLGAPASTTTAADATPSGSLAR.3|YFEITEEPPYIHFLNTFTSKEPQR.4|YFEITEEPPYIHFLNTFTSKEPQR.3|KSDLFQDDLYPDTAGPEAALEAEEWVSGR.4|KSDLFQDDLYPDTAGPEAALEAEEWVSGR.3|YFEITEEPPYIHFLNTFTSK.3|SDLFQDDLYPDTAGPEAALEAEEWVSGR.3|QLALWDPENLEEPMALQELDSSNGALLPFYDPDTSVVYVC[CAM]GK.4
SEN / CTL,Integrin-linked protein kinase,ILK,Q13418,0.75,0.80,3.87E-03,2.42E-03,2.62E+00,"branching involved in ureteric bud morphogenesis,positive regulation of cell-matrix adhesion,outflow tract morphogenesis,protein phosphorylation,negative regulation of protein kinase activity,cell cycle arrest,cell-matrix adhesion,integrin-mediated signaling pathway,cell aging,cell proliferation,positive regulation of cell proliferation,negative regulation of cardiac muscle cell apoptotic process,fibroblast migration,negative regulation of smooth muscle cell migration,peptidyl-serine phosphorylation,nerve development,myelination in peripheral nervous system,positive regulation of cell migration,positive regulation of BMP signaling pathway,myelin assembly,regulation of actin cytoskeleton organization,cell junction assembly,substrate adhesion-dependent cell spreading,positive regulation of phosphorylation,extracellular fibril organization,positive regulation of MAP kinase activity,protein kinase B signaling,negative regulation of neuron apoptotic process,establishment or maintenance of epithelial cell apical/basal polarity,positive regulation of myoblast differentiation,positive regulation of osteoblast differentiation,positive regulation of axon extension,positive regulation of transcription, DNA-templated,negative regulation of smooth muscle cell proliferation,neuron projection morphogenesis,positive regulation of dendrite morphogenesis,protein heterooligomerization,positive regulation of protein kinase B signaling,platelet aggregation,positive regulation of canonical Wnt signaling pathway,negative regulation of neural precursor cell proliferation","protein serine/threonine kinase activity,signal transducer activity,integrin binding,protein binding,ATP binding,SH3 domain binding,protein kinase binding","stress fiber,nucleoplasm,cytoplasm,cytosol,plasma membrane,cell-cell junction,focal adhesion,membrane,sarcomere,lamellipodium,cell junction,extracellular matrix,neuronal cell body,costamere,terminal bouton,dendritic shaft,protein complex",12,21,36,FDMIVPILEK.2|FDM[Oxi]IVPILEK.2|SAVVEMLIMR.2|GMAFLHTLEPLIPR.3|GM[Oxi]AFLHTLEPLIPR.3|GMAFLHTLEPLIPR.2|SVMIDEDMTAR.2|SVM[Oxi]IDEDMTAR.2|HSGIDFK.2|EGNAVAVR.2|GRWQGNDIVVK.3|LNENHSGELWK.3|LNENHSGELWK.2|INVMNRGDDTPLHLAASHGHR.5|INVM[Oxi]NRGDDTPLHLAASHGHR.5|INVMNRGDDTPLHLAASHGHR.4|YGEMPVDK.2|FSFQC[CAM]PGR.2|GDDTPLHLAASHGHR.3|GDDTPLHLAASHGHR.2|MYAPAWVAPEALQK.3|MYAPAWVAPEALQK.2|M[Oxi]YAPAWVAPEALQK.2|WQGNDIVVK.2|DFNEEC[CAM]PR.2|IC[CAM]MNEDPAK.2|IC[CAM]M[Oxi]NEDPAK.2|VALEGLRPTIPPGISPHVC[CAM]K.4|VALEGLRPTIPPGISPHVC[CAM]K.3|VALEGLRPTIPPGISPHVC[CAM]K.2|EVPFADLSNMEIGMK.3|EVPFADLSNMEIGMK.2|SRDFNEEC[CAM]PR.2|LWLDNTENDLNQGDDHGFSPLHWAC[CAM]R.4|LWLDNTENDLNQGDDHGFSPLHWAC[CAM]R.3|ADINAVNEHGNVPLHYAC[CAM]FWGQDQVAEDLVANGALVSIC[CAM]NK.4
SEN / CTL,"Glucose 1,6-bisphosphate synthase",PGM2L1,Q6PCE3,0.75,0.18,2.87E-04,2.55E-04,3.59E+00,"glucose metabolic process,phosphorylation","intramolecular transferase activity, phosphotransferases,metal ion binding,glucose-1,6-bisphosphate synthase activity",cytosol,6,15,17,DVPVYLFSR.2|FC[CAM]GTFAILHVR.3|GFVVGYDTR.2|VFGFKPPIPVPEQK.3|LIDALIENFLQPSK.3|LIDALIENFLQPSK.2|KLIDALIENFLQPSK.3|KLIDALIENFLQPSK.2|VVLATDPDADR.2|GQVTSSC[CAM]SSQR.2|NVYMLATTVSSK.2|AVAGVMITASHNR.2|VFGFKPPIPVPEQKDPDPDFSTVK.4|YVPTPFVPYAVQK.2|TSYFLC[CAM]YEPPTIK.2|VVLATDPDADRLAAAELQENGC[CAM]WK.3|C[CAM]PNPEEGESVLELSLR.2
SEN / CTL,Tubulin alpha-4A chain,TUBA4A,P68366,0.74,0.63,6.77E-13,3.52E-12,1.15E+01,"G2/M transition of mitotic cell cycle,platelet degranulation,cytoskeleton organization,microtubule-based process","GTPase activity,structural constituent of cytoskeleton,protein binding,GTP binding,enzyme binding","extracellular region,cytosol,microtubule,extracellular exosome",42,16,28,LISQIVSSITASLR.2|LISQIVSSITASLR.3|AVFVDLEPTVIDEIR.2|AVFVDLEPTVIDEIR.3|DVNAAIAAIK.2|SIQFVDWC[CAM]PTGFK.2|SIQFVDWC[CAM]PTGFK.3|KLSDQC[CAM]TGLQGFLVFHSFGGGTGSGFTSLLMER.4|EIIDPVLDR.2|RSIQFVDWC[CAM]PTGFK.3|RSIQFVDWC[CAM]PTGFK.4|RSIQFVDWC[CAM]PTGFK.2|AVFVDLEPTVIDEIRNGPYR.3|AVFVDLEPTVIDEIRNGPYR.4|LSDQC[CAM]TGLQGFLVFHSFGGGTGSGFTSLLMER.4|LSDQC[CAM]TGLQGFLVFHSFGGGTGSGFTSLLM[Oxi]ER.4|LSDQC[CAM]TGLQGFLVFHSFGGGTGSGFTSLLMER.3|SIQFVDWC[CAM]PTGFKVGINYQPPTVVPGGDLAK.3|GHYTIGKEIIDPVLDRIR.4|GHYTIGKEIIDPVLDRIR.3|GHYTIGKEIIDPVLDR.4|GHYTIGKEIIDPVLDR.3|GHYTIGKEIIDPVLDR.2|GDVVPKDVNAAIAAIK.3|TIGGGDDSFTTFFC[CAM]ETGAGK.3|TIGGGDDSFTTFFC[CAM]ETGAGK.2|MREC[CAM]ISVHVGQAGVQMGNAC[CAM]WELYC[CAM]LEHGIQPDGQMPSDK.5|EC[CAM]ISVHVGQAGVQMGNAC[CAM]WELYC[CAM]LEHGIQPDGQMPSDK.4
SEN / CTL,GTP-binding nuclear protein Ran,RAN,P62826,0.74,0.41,5.96E-06,8.12E-06,5.09E+00,"ribosomal large subunit export from nucleus,ribosomal small subunit export from nucleus,protein import into nucleus, translocation,DNA metabolic process,tRNA export from nucleus,protein import into nucleus,protein export from nucleus,mitotic spindle organization,mitotic nuclear division,signal transduction,small GTPase mediated signal transduction,viral process,androgen receptor signaling pathway,gene silencing by RNA,positive regulation of protein binding,pre-miRNA export from nucleus,positive regulation of transcription, DNA-templated,cell division,protein transmembrane transport,intracellular transport of virus,cell-cell adhesion,protein localization to nucleolus","chromatin binding,transcription coactivator activity,GTPase activity,protein binding,GTP binding,GDP binding,poly(A) RNA binding,androgen receptor binding,cadherin binding involved in cell-cell adhesion,protein transmembrane transporter activity,pre-miRNA binding,pre-miRNA transporter activity","nucleus,nuclear pore,nucleoplasm,nucleolus,cytoplasm,centriole,cytosol,cell-cell adherens junction,membrane,midbody,extracellular matrix,melanosome,RNA nuclear export complex,recycling endosome,extracellular exosome,Flemming body,chromatin",15,19,35,GPIKFNVWDTAGQEK.3|GPIKFNVWDTAGQEK.2|LVLVGDGGTGK.2|SNYNFEKPFLWLAR.3|SNYNFEKPFLWLAR.4|SNYNFEKPFLWLAR.2|VC[CAM]ENIPIVLC[CAM]GNKVDIK.3|VC[CAM]ENIPIVLC[CAM]GNKVDIK.2|VC[CAM]ENIPIVLC[CAM]GNKVDIKDR.4|VC[CAM]ENIPIVLC[CAM]GNKVDIKDR.3|NLQYYDISAK.3|NLQYYDISAK.2|FNVWDTAGQEK.3|FNVWDTAGQEK.2|KYVATLGVEVHPLVFHTNR.5|KYVATLGVEVHPLVFHTNR.4|KYVATLGVEVHPLVFHTNR.3|KYVATLGVEVHPLVFHTNR.2|LVLVGDGGTGKTTFVKR.4|KNLQYYDISAK.3|KNLQYYDISAK.2|PFLWLAR.2|SNYNFEK.2|HLTGEFEK.2|KKNLQYYDISAK.3|KKNLQYYDISAK.2|VC[CAM]ENIPIVLC[CAM]GNK.3|VC[CAM]ENIPIVLC[CAM]GNK.2|YVATLGVEVHPLVFHTNR.4|YVATLGVEVHPLVFHTNR.3|YVATLGVEVHPLVFHTNR.2|HLTGEFEKK.2|RHLTGEFEK.2|DGYYIQAQC[CAM]AIIMFDVTSR.3|DGYYIQAQC[CAM]AIIMFDVTSR.2
SEN / CTL,Cysteine-rich protein 2,CRIP2,P52943,0.74,0.62,1.15E-07,2.29E-07,6.64E+00,"positive regulation of cell proliferation,hemopoiesis",zinc ion binding,"cell cortex,extracellular matrix",21,12,18,ASSVTTFTGEPNTC[CAM]PR.2|GVNIGGAGSYIYEKPLAEGPQVTGPIEVPAAR.4|GVNIGGAGSYIYEKPLAEGPQVTGPIEVPAAR.3|GVNIGGAGSYIYEKPLAEGPQVTGPIEVPAAR.5|TLTPGGHAEHDGQPYC[CAM]HKPC[CAM]YGILFGPK.5|TLTPGGHAEHDGQPYC[CAM]HKPC[CAM]YGILFGPK.6|GVNTGAVGSYIYDRDPEGK.3|GVNTGAVGSYIYDRDPEGK.2|TLTPGGHAEHDGKPFC[CAM]HKPC[CAM]YATLFGPK.5|TLTPGGHAEHDGKPFC[CAM]HKPC[CAM]YATLFGPK.6|KVYFAEK.2|PC[CAM]YATLFGPK.2|PC[CAM]YGILFGPK.2|PLAEGPQVTGPIEVPAAR.3|PLAEGPQVTGPIEVPAAR.2|GVNIGGAGSYIYEK.2|GVNTGAVGSYIYDR.2|GVNTGAVGSYIYDRDPEGKVQP.3
SEN / CTL,26S protease regulatory subunit 7,PSMC2,P35998,0.74,0.56,2.27E-04,2.08E-04,3.68E+00,"MAPK cascade,protein polyubiquitination,osteoblast differentiation,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,ubiquitin-dependent protein catabolic process,regulation of cellular amino acid metabolic process,viral process,ER-associated ubiquitin-dependent protein catabolic process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,positive regulation of proteasomal protein catabolic process","protein binding,ATP binding,ATPase activity,TBP-class protein binding,proteasome-activating ATPase activity","proteasome complex,cytoplasmic mRNA processing body,nucleus,nucleoplasm,cytoplasm,cytosol,proteasome regulatory particle, base subcomplex,membrane,proteasome accessory complex,nuclear proteasome complex,cytosolic proteasome complex,intracellular membrane-bounded organelle",15,40,63,ALDEGDIALLK.2|KIEFSLPDLEGR.3|KIEFSLPDLEGR.2|SVC[CAM]TEAGMFAIR.2|SVC[CAM]TEAGMFAIR.3|SVC[CAM]TEAGM[Oxi]FAIR.2|IINADSEDPKYIINVK.3|IINADSEDPKYIINVK.2|TMLELINQLDGFDPR.3|TM[Oxi]LELINQLDGFDPR.3|TMLELINQLDGFDPR.2|TM[Oxi]LELINQLDGFDPR.2|VLMATNR.2|YQIHIPLPPK.3|YQIHIPLPPK.2|LREVVETPLLHPER.4|LREVVETPLLHPER.3|LREVVETPLLHPER.2|INELTGIK.2|TDAC[CAM]FIR.2|FDDGAGGDNEVQR.3|FDDGAGGDNEVQR.2|DFLEAVNK.2|EVVETPLLHPER.3|EVVETPLLHPER.2|QVEDDIQQLLKK.3|VIGSELVQK.2|IATEKDFLEAVNK.3|IATEKDFLEAVNK.2|TKEDEKDDKPIR.3|TKEDEKDDKPIR.2|QTLQSEQPLQVAR.3|QTLQSEQPLQVAR.2|KINELTGIK.2|PDYLGADQR.2|TYGQSTYSR.2|KIATEKDFLEAVNK.3|IINADSEDPK.2|FVNLGIEPPK.2|FVNLGIEPPKGVLLFGPPGTGK.4|FVNLGIEPPKGVLLFGPPGTGK.3|GVLLFGPPGTGK.2|PDYLGADQRK.2|AC[CAM]LIFFDEIDAIGGAR.3|AC[CAM]LIFFDEIDAIGGAR.2|LC[CAM]PNSTGAEIR.2|ESDTGLAPPALWDLAADK.3|ESDTGLAPPALWDLAADK.2|IEFSLPDLEGR.2|KAC[CAM]LIFFDEIDAIGGAR.3|KAC[CAM]LIFFDEIDAIGGAR.2|QVEDDIQQLLK.2|FVVDLSDQVAPTDIEEGM[Oxi]R.3|FVVDLSDQVAPTDIEEGMR.3|FVVDLSDQVAPTDIEEGM[Oxi]R.2|FVVDLSDQVAPTDIEEGMR.2|YQIHIPLPPKIDPTVTMMQVEEKPDVTYSDVGGC[CAM]KEQIEK.6|YQIHIPLPPKIDPTVTMMQVEEKPDVTYSDVGGC[CAM]K.5|ESDTGLAPPALWDLAADKQTLQSEQPLQVAR.4|ESDTGLAPPALWDLAADKQTLQSEQPLQVAR.3|IDPTVTMMQVEEKPDVTYSDVGGC[CAM]KEQIEK.4|IDPTVTMMQVEEKPDVTYSDVGGC[CAM]K.3|INELTGIKESDTGLAPPALWDLAADKQTLQSEQPLQVAR.4
SEN / CTL,Leucine-rich repeat-containing protein 47,LRRC47,Q8N1G4,0.73,0.62,9.86E-03,5.26E-03,2.28E+00,phenylalanyl-tRNA aminoacylation,"poly(A) RNA binding,phenylalanine-tRNA ligase activity",phenylalanine-tRNA ligase complex,6,28,40,SILEYLR.2|DVRPYIVGAVVR.3|DVRPYIVGAVVR.2|AAGGQLPPR.2|RTAATLATHELR.3|RTAATLATHELR.2|QLQLEAEEQRK.3|ELSPDIAHLASLK.3|ELSPDIAHLASLK.2|ADLATAPPHVTVVR.3|ADLATAPPHVTVVR.2|APGPGLAQGLPQLHSLVLR.4|APGPGLAQGLPQLHSLVLR.3|APGPGLAQGLPQLHSLVLR.2|DVMDALILK.2|LHEDLC[CAM]EK.2|VLHVSENPVPLTVR.3|VLHVSENPVPLTVR.2|GPLLYC[CAM]ARPPQDLK.3|GPLLYC[CAM]ARPPQDLK.2|REGGDGEEQDVGDAGR.3|GMDLQPGNALK.2|LRELPADLAR.2|NALGPGLSPELGPLPALR.3|NALGPGLSPELGPLPALR.2|TAATLATHELR.2|QLQLEAEEQR.2|PGALPLLSELAAADNC[CAM]LR.3|PGALPLLSELAAADNC[CAM]LR.2|RNALGPGLSPELGPLPALR.3|DGPSLLVVEQVR.2|ELLLTGPGLEER.2|LFTLPLLHYLEVSGC[CAM]GSLR.3|LFTLPLLHYLEVSGC[CAM]GSLR.2|EGGDGEEQDVGDAGR.2|TLDLSNNQLSEIPAELADC[CAM]PK.3|TLDLSNNQLSEIPAELADC[CAM]PK.2|YLHLLDGNENYPC[CAM]LVDADGDVISFPPITNSEK.4|VLDLSGNALEALPPGQGLGPAEPPGLPQLQSLNLSGNR.4|LQSLNLTGNC[CAM]LDSFPAELFRPGALPLLSELAAADNC[CAM]LR.4
SEN / CTL,Tubulin beta-4A chain,TUBB4A,P04350,0.73,0.39,2.94E-04,2.60E-04,3.58E+00,"G2/M transition of mitotic cell cycle,cytoskeleton organization,microtubule-based process","GTPase activity,structural constituent of cytoskeleton,GTP binding","nucleus,cytosol,microtubule,cilium,internode region of axon,neuronal cell body,myelin sheath,extracellular exosome",12,4,7,M[Oxi]AATFIGNSTAIQELFKR.3|MAATFIGNSTAIQELFKR.3|M[Oxi]AATFIGNSTAIQELFK.3|M[Oxi]AATFIGNSTAIQELFK.2|MAATFIGNSTAIQELFK.2|EVDEQMLSVQSK.2|INVYYNEATGGNYVPR.2
SEN / CTL,Testin,TES,Q9UGI8,0.72,0.66,2.86E-05,3.24E-05,4.49E+00,"negative regulation of cell proliferation,cell-cell adhesion","protein binding,zinc ion binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,plasma membrane,cell-cell adherens junction,focal adhesion,cell junction,protein complex",18,33,47,C[CAM]EGFELHFWR.3|LSMKEGDPAIYAER.3|KNVSINTVTYEWAPPVQNQALAR.3|NVSINTVTYEWAPPVQNQALAR.3|YTTLIAK.2|FMPVEGMVFC[CAM]SVEC[CAM]K.2|FMPVEGMVFC[CAM]SVEC[CAM]K.3|QLPAHDQDPSK.3|QLPAHDQDPSK.2|KMGLGHEQGFGAPC[CAM]LK.4|KMGLGHEQGFGAPC[CAM]LK.3|SDGIPMYK.2|QPVAGSEGAQYRK.3|RNVMILTNPVAAK.3|SEALGVGDVK.2|QMNIPGGDR.2|EKQPVAGSEGAQYR.3|EKQPVAGSEGAQYR.2|C[CAM]GQEEHDVLLSNEEDRK.4|C[CAM]GQEEHDVLLSNEEDRK.3|LFEDTKYTTLIAK.3|QYMQMLPK.2|QLPAHDQDPSKC[CAM]HELSPR.4|MGLGHEQGFGAPC[CAM]LK.3|M[Oxi]GLGHEQGFGAPC[CAM]LK.3|MGLGHEQGFGAPC[CAM]LK.2|M[Oxi]GLGHEQGFGAPC[CAM]LK.2|NHAVVC[CAM]QGC[CAM]HNAIDPEVQR.4|NHAVVC[CAM]QGC[CAM]HNAIDPEVQR.3|NHAVVC[CAM]QGC[CAM]HNAIDPEVQR.2|EGDPAIYAER.2|STPAAVGAMEDK.2|STPAAVGAM[Oxi]EDK.2|LPC[CAM]EMDAQGPK.2|LPC[CAM]EM[Oxi]DAQGPK.2|NVMILTNPVAAK.2|NVM[Oxi]ILTNPVAAK.2|QPVAGSEGAQYR.2|TQYSC[CAM]YC[CAM]C[CAM]K.2|YKSEALGVGDVK.2|C[CAM]GQEEHDVLLSNEEDR.3|FMPVEGMVFC[CAM]SVEC[CAM]KK.3|VTYNNFSWHASTEC[CAM]FLC[CAM]SC[CAM]C[CAM]SK.4|VTYNNFSWHASTEC[CAM]FLC[CAM]SC[CAM]C[CAM]SK.3|SEALGVGDVKLPC[CAM]EMDAQGPK.3|YKSEALGVGDVKLPC[CAM]EMDAQGPK.3|C[CAM]AGC[CAM]DELIFSNEYTQAENQNWHLK.3
SEN / CTL,"Actin, alpha cardiac muscle 1",ACTC1,P68032,0.72,0.62,1.20E-16,8.78E-16,1.51E+01,"apoptotic process,positive regulation of gene expression,actin filament-based movement,muscle filament sliding,skeletal muscle thin filament assembly,actomyosin structure organization,actin-myosin filament sliding,response to drug,negative regulation of apoptotic process,response to ethanol,cardiac myofibril assembly,cardiac muscle tissue morphogenesis,heart contraction,cardiac muscle contraction,mesenchyme migration","ATP binding,ATPase activity,myosin binding","extracellular space,cytoplasm,cytosol,actin filament,focal adhesion,membrane,sarcomere,lamellipodium,filopodium,I band,actomyosin, actin portion,cell body,extracellular exosome,blood microparticle",81,12,42,EKLC[CAM]YVALDFENEM[Oxi]ATAASSSSLEK.3|MTQIMFETFNVPAMYVAIQAVLSLYASGR.3|VAPEEHPTLLTEAPLNPK.3|VAPEEHPTLLTEAPLNPK.4|VAPEEHPTLLTEAPLNPK.2|LC[CAM]YVALDFENEM[Oxi]ATAASSSSLEK.3|LC[CAM]YVALDFENEM[Oxi]ATAASSSSLEK.4|LC[CAM]YVALDFENEMATAASSSSLEK.4|LC[CAM]YVALDFENEMATAASSSSLEK.3|YPIEHGIITNWDDMEKIWHHTFYNELR.5|YPIEHGIITNWDDMEKIWHHTFYNELR.4|YPIEHGIITNWDDMEKIWHHTFYNELR.6|YPIEHGIITNWDDM[Oxi]EKIWHHTFYNELR.5|YPIEHGIITNWDDM[Oxi]EKIWHHTFYNELR.6|YPIEHGIITNWDDMEKIWHHTFYNELR.3|YPIEHGIITNWDDM[Oxi]EKIWHHTFYNELR.4|YPIEHGIITNWDDM[Oxi]EKIWHHTFYNELR.3|YPIEHGIITNWDDMEK.3|YPIEHGIITNWDDMEK.2|YPIEHGIITNWDDM[Oxi]EK.3|YPIEHGIITNWDDMEK.4|YPIEHGIITNWDDM[Oxi]EK.2|GILTLKYPIEHGIITNWDDMEKIWHHTFYNELR.5|GILTLKYPIEHGIITNWDDMEKIWHHTFYNELR.6|GILTLKYPIEHGIITNWDDMEKIWHHTFYNELR.7|GILTLKYPIEHGIITNWDDM[Oxi]EKIWHHTFYNELR.7|GILTLKYPIEHGIITNWDDM[Oxi]EKIWHHTFYNELR.6|GILTLKYPIEHGIITNWDDMEK.4|GILTLKYPIEHGIITNWDDMEK.3|GILTLKYPIEHGIITNWDDM[Oxi]EK.4|RGILTLKYPIEHGIITNWDDMEK.4|RGILTLKYPIEHGIITNWDDMEK.5|RGILTLKYPIEHGIITNWDDMEK.3|DLYANNVLSGGTTMYPGIADR.3|DLYANNVLSGGTTM[Oxi]YPGIADR.3|DLYANNVLSGGTTMYPGIADR.4|DLYANNVLSGGTTM[Oxi]YPGIADR.2|DLYANNVLSGGTTMYPGIADR.2|KDLYANNVLSGGTTMYPGIADR.3|KDLYANNVLSGGTTM[Oxi]YPGIADR.3|GYSFVTTAEREIVR.3|GYSFVTTAEREIVR.2
SEN / CTL,Small nuclear ribonucleoprotein E,SNRPE,P62304,0.72,0.47,1.36E-01,4.53E-02,1.34E+00,"spliceosomal complex assembly,spliceosomal snRNP assembly,mRNA splicing, via spliceosome,termination of RNA polymerase II transcription,histone mRNA metabolic process,hair cycle,nuclear import","RNA binding,protein binding","nucleus,nucleoplasm,spliceosomal complex,U5 snRNP,U7 snRNP,U1 snRNP,U2 snRNP,U4 snRNP,U12-type spliceosomal complex,cytosol,small nuclear ribonucleoprotein complex,methylosome,pICln-Sm protein complex,SMN-Sm protein complex,U4/U6 x U5 tri-snRNP complex,extracellular exosome,precatalytic spliceosome,catalytic step 2 spliceosome,telomerase holoenzyme complex",3,5,11,VMVQPINLIFR.2|VMVQPINLIFR.3|VM[Oxi]VQPINLIFR.3|VM[Oxi]VQPINLIFR.2|GDNITLLQSVSN.2|IEGC[CAM]IIGFDEYMNLVLDDAEEIHSK.4|IEGC[CAM]IIGFDEYMNLVLDDAEEIHSK.3|IQVWLYEQVNMR.2|IQVWLYEQVNM[Oxi]R.2|IM[Oxi]LKGDNITLLQSVSN.2|IMLKGDNITLLQSVSN.2
SEN / CTL,Calpain small subunit 1,CAPNS1,P04632,0.72,1.04,6.93E-04,5.57E-04,3.25E+00,"proteolysis,positive regulation of cell proliferation,regulation of macroautophagy,extracellular matrix disassembly","calcium-dependent cysteine-type endopeptidase activity,calcium ion binding","cytosol,plasma membrane,membrane,extracellular exosome",30,18,39,ILGGVISAISEAAAQYNPEPPPPR.4|ILGGVISAISEAAAQYNPEPPPPR.3|RLFAQLAGDDMEVSATELMNILNK.3|LFAQLAGDDMEVSATELMNILNK.3|LFAQLAGDDM[Oxi]EVSATELMNILNK.3|LFAQLAGDDMEVSATELM[Oxi]NILNK.3|THYSNIEANESEEVR.3|THYSNIEANESEEVR.2|VVTRHPDLKTDGFGIDTC[CAM]R.4|VVTRHPDLKTDGFGIDTC[CAM]R.5|VVTRHPDLKTDGFGIDTC[CAM]R.3|THYSNIEANESEEVRQFR.4|THYSNIEANESEEVRQFR.3|RYSDESGNMDFDNFISC[CAM]LVR.3|LGFEEFK.2|THYSNIEANESEEVRQFRR.5|THYSNIEANESEEVRQFRR.4|YLWNNIK.2|TDGFGIDTC[CAM]R.2|HPDLKTDGFGIDTC[CAM]R.3|GGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGGGGGGGGGGTAMR.6|GGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGGGGGGGGGGTAM[Oxi]R.5|GGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGGGGGGGGGGTAMR.5|GGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGGGGGGGGGGTAMR.4|GGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGGGGGGGGGGTAM[Oxi]R.4|GGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGGGGGGGGGGTAM[Oxi]R.3|GGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGGGGGGGGGGTAMR.3|SMVAVMDSDTTGK.2|SM[Oxi]VAVMDSDTTGK.2|SMVAVM[Oxi]DSDTTGK.2|SGTIC[CAM]SSELPGAFEAAGFHLNEHLYNMIIRR.5|SGTIC[CAM]SSELPGAFEAAGFHLNEHLYNMIIRR.4|SMVAVMDSDTTGKLGFEEFK.3|YSDESGNMDFDNFISC[CAM]LVR.3|YSDESGNM[Oxi]DFDNFISC[CAM]LVR.2|YSDESGNMDFDNFISC[CAM]LVR.2|SGTIC[CAM]SSELPGAFEAAGFHLNEHLYNM[Oxi]IIR.4|SGTIC[CAM]SSELPGAFEAAGFHLNEHLYNMIIR.4|SGTIC[CAM]SSELPGAFEAAGFHLNEHLYNMIIR.3
SEN / CTL,Transmembrane emp24 domain-containing protein 10,TMED10,P49755,0.71,0.37,2.42E-03,1.62E-03,2.79E+00,"kidney development,intracellular protein transport,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,Golgi organization,cargo loading into vesicle,COPI-coated vesicle budding,response to alkaloid,regulated exocytosis,vesicle targeting, to, from or within Golgi,COPI coating of Golgi vesicle,COPII vesicle coating,protein oligomerization,regulation of beta-amyloid formation","protein binding,syntaxin binding,protein complex binding","Golgi membrane,endoplasmic reticulum,endoplasmic reticulum membrane,endoplasmic reticulum-Golgi intermediate compartment,Golgi apparatus,cis-Golgi network,plasma membrane,ER to Golgi transport vesicle membrane,integral component of membrane,transport vesicle,COPI-coated vesicle,trans-Golgi network transport vesicle,secretory granule membrane,endoplasmic reticulum-Golgi intermediate compartment membrane,melanosome,zymogen granule membrane,extracellular exosome,gamma-secretase complex",6,11,23,RLEDLSESIVNDFAYMK.3|RLEDLSESIVNDFAYM[Oxi]K.3|RLEDLSESIVNDFAYM[Oxi]K.2|RLEDLSESIVNDFAYMK.2|GTGRIPDQLVILDMK.3|GTGRIPDQLVILDMK.2|ITDSAGHILYSK.3|ITDSAGHILYSK.2|ITDSAGHILYSKEDATK.4|ITDSAGHILYSKEDATK.3|LKPLEVELR.2|NYEEIAKVEK.2|LEDLSESIVNDFAYMK.3|LEDLSESIVNDFAYMK.2|LEDLSESIVNDFAYM[Oxi]K.2|IPDQLVILDMK.2|IPDQLVILDM[Oxi]K.2|EEIHKDLLVTGAYEISDQSGGAGGLR.4|EEIHKDLLVTGAYEISDQSGGAGGLR.3|DLLVTGAYEISDQSGGAGGLR.3|DLLVTGAYEISDQSGGAGGLR.2|C[CAM]LREEIHKDLLVTGAYEISDQSGGAGGLR.4|C[CAM]LREEIHKDLLVTGAYEISDQSGGAGGLR.3
SEN / CTL,"Myosin light chain kinase, smooth muscle",MYLK,Q15746,0.71,0.98,4.15E-02,1.71E-02,1.77E+00,"protein phosphorylation,muscle contraction,smooth muscle contraction,tonic smooth muscle contraction,positive regulation of cell migration,bleb assembly,positive regulation of calcium ion transport,aorta smooth muscle tissue morphogenesis,cellular hypotonic response,positive regulation of wound healing","actin binding,myosin light chain kinase activity,calmodulin binding,ATP binding,metal ion binding","stress fiber,cytoplasm,cytosol,lamellipodium,cleavage furrow,extracellular exosome",12,57,67,LIDFGLAR.2|LSSMAMISGLSGR.2|TSSSITLQAAR.2|TIRDLEVVEGSAAR.3|TIRDLEVVEGSAAR.2|QEISIMNC[CAM]LHHPK.4|VHSPQQVDFR.3|VHSPQQVDFR.2|PAETLKPMGNAK.3|ENIRQEISIMNC[CAM]LHHPK.5|ENIRQEISIMNC[CAM]LHHPK.3|QISEGVEYIHK.3|VRAGESVELFGK.3|VRAGESVELFGK.2|VPPPKPATPDFR.3|GYPEPQVTWHR.3|GYPEPQVTWHR.2|DFISNLLK.2|PAETLKPMGNAKPDENLK.4|RLENAGSLK.2|FESKPQSQEVKENQTVK.4|TVTINTEQK.2|AGESVELFGK.2|GNVPLQPSAR.2|QIQESEHMKVENSENGSK.4|QIQESEHMKVENSENGSK.3|NRLDC[CAM]TQC[CAM]LQHPWLMK.4|QGIVHLDLKPENIMC[CAM]VNK.4|QGIVHLDLKPENIMC[CAM]VNK.3|QGIVHLDLKPENIMC[CAM]VNK.2|LQDVHVAEGK.2|STSFNVQDLLPDHEYKFR.4|QIQESEHMK.2|SESQGTAPAFK.2|DLEVVEGSAAR.2|KLPAENGSSSAETLNAK.3|PLSNAQPSGPLKPVGNAK.3|QPGLGSQDVVSK.2|RQEGSIEVYEDAGSHYLC[CAM]LLK.4|STSFNVQDLLPDHEYK.3|STSFNVQDLLPDHEYK.2|RSESQGTAPAFK.2|VSDFYDIEER.2|LESEEDVSQAFLEAVAEEKPHVKPYFSK.5|QQEVEQLDFR.2|TQAVLTVQEPHDGTQPWFISKPR.4|TQAVLTVQEPHDGTQPWFISKPR.3|LVQC[CAM]VDAFEEK.2|APGLGVLSPSGEER.2|IIDEDFELTER.2|SSTGSPTSPLNAEK.2|KSEYLLPVAPSKPTAPIFLQGLSDLK.4|GREPASC[CAM]EDLC[CAM]GGGVGADGGGSDRYGSLRPGWPAR.5|IEGYPDPEVVWFKDDQSIR.3|NRVGEC[CAM]SC[CAM]QVSLMLQNSSAR.3|VTGTQPITC[CAM]TWMK.2|GREPASC[CAM]EDLC[CAM]GGGVGADGGGSDR.3|GTFSLVIHAVHEEDRGKYTC[CAM]EATNGSGAR.4|IEGYPDPEVVWFK.2|LAVMEVAPSFSSVLK.2|SSLPPVLGTESDATVK.2|LLLQC[CAM]QVSSDPPATIIWTLNGK.3|ITWLLNGQPIQYAR.2|QAQVNLTVVDKPDPPAGTPC[CAM]ASDIR.3|SEYLLPVAPSKPTAPIFLQGLSDLK.3|FIILSQEGSLC[CAM]SVSIEK.2|SVTASLGQSVLISC[CAM]AIAGDPFPTVHWLR.3
SEN / CTL,Flotillin-1,FLOT1,O75955,0.71,0.28,3.77E-07,6.84E-07,6.16E+00,"membrane raft assembly,positive regulation of cytokine production,positive regulation of protein phosphorylation,regulation of receptor internalization,axonogenesis,extracellular matrix disassembly,positive regulation of protein binding,positive regulation of synaptic transmission, dopaminergic,positive regulation of interferon-beta production,dsRNA transport,positive regulation of heterotypic cell-cell adhesion,positive regulation of toll-like receptor 3 signaling pathway,response to endoplasmic reticulum stress,regulation of Rho protein signal transduction,plasma membrane raft assembly,positive regulation of endocytosis,positive regulation of skeletal muscle tissue development,protein homooligomerization,positive regulation of cell adhesion molecule production,protein kinase C signaling,cellular response to exogenous dsRNA,establishment of protein localization to plasma membrane,positive regulation of myoblast fusion,positive regulation of cell junction assembly,protein localization to membrane raft,positive regulation of cell-cell adhesion mediated by cadherin,regulation of toll-like receptor 4 signaling pathway","protease binding,protein binding,ionotropic glutamate receptor binding,protein heterodimerization activity","uropod,lysosomal membrane,endosome,early endosome,microtubule organizing center,plasma membrane,caveola,cell-cell junction,cell-cell adherens junction,focal adhesion,membrane,integral component of membrane,basolateral plasma membrane,flotillin complex,lamellipodium,cytoplasmic vesicle,centriolar satellite,sarcolemma,melanosome,cell-cell contact zone,membrane raft,extracellular exosome,apical plasma membrane,COP9 signalosome,cortical actin cytoskeleton",15,31,45,AAYDIEVNTR.2|MRGEAEAFAIGAR.3|MRGEAEAFAIGAR.2|HGVPISVTGIAQVK.3|HGVPISVTGIAQVK.2|VTGEVLDILTRLPESVER.3|ITLVSSGSGTMGAAK.2|ITLVSSGSGTM[Oxi]GAAK.2|LTGVSISQVNHKPLR.4|LTGVSISQVNHKPLR.3|AIMAHMTVEEIYKDR.4|AIMAHMTVEEIYKDR.3|VQVQVVER.2|AQQVAVQEQEIAR.3|AQQVAVQEQEIAR.2|SPPVMVAGGR.2|TEAEIAHIALETLEGHQR.4|TEAEIAHIALETLEGHQR.3|TEAEIAHIALETLEGHQR.2|AIMAHMTVEEIYK.3|AIMAHMTVEEIYK.2|TKQQIEEQRVQVQVVER.4|SQLIMQAEAEAASVR.3|SQLIMQAEAEAASVR.2|AQQVAVQEQEIARR.3|GEAEAFAIGAR.2|ARAEAEQMAK.2|DIHDDQDYLHSLGK.3|DIHDDQDYLHSLGK.2|LPQVAEEISGPLTSANK.3|LPQVAEEISGPLTSANK.2|ISLNTLTLNVK.2|VTGEVLDILTR.2|KAAYDIEVNTR.2|VASSDLVNMGISVVSYTLK.3|VASSDLVNMGISVVSYTLK.2|MFFTC[CAM]GPNEAMVVSGFC[CAM]R.3|MFFTC[CAM]GPNEAMVVSGFC[CAM]R.2|AQADLAYQLQVAK.2|VASSDLVNMGISVVSYTLKDIHDDQDYLHSLGK.5|EMLAAAC[CAM]QMFLGK.2|VSAQYLSEIEMAK.2|VFVLPC[CAM]IQQIQR.2|KAEAFQLYQEAAQLDMLLEK.3|RAQADLAYQLQVAK.2
SEN / CTL,Myoferlin,MYOF,Q9NZM1,0.71,0.86,4.93E-05,5.26E-05,4.28E+00,"plasma membrane repair,muscle contraction,blood circulation,regulation of vascular endothelial growth factor receptor signaling pathway,cellular response to heat","protein binding,phospholipid binding","nuclear envelope,plasma membrane,caveola,integral component of membrane,cytoplasmic vesicle membrane,cytoplasmic vesicle,nuclear membrane,intracellular membrane-bounded organelle,extracellular exosome",30,117,143,WVTFLLK.2|FGSHC[CAM]GIPEEYC[CAM]VSGVNTWR.3|ANVTVLDTQIR.2|SLDGEGNFNWR.2|FKGFPQPILSEDGSR.3|ILVELATFLEK.2|LIGTATVALKDLTGDQSR.3|KVDNELNPVWNEILEFDLR.3|WLLLNDPEDTSSGSK.2|IYPLPDDPSVPAPPR.2|IYPLPDDPSVPAPPR.3|SLSQIHEAAVR.3|SLSQIHEAAVR.2|NNGPKVPVELR.3|TQTIFLK.2|GWEYGITIPPDHKPK.4|GWEYGITIPPDHKPK.3|GWEYGITIPPDHKPK.2|KPVVGQC[CAM]TIER.3|KPVVGQC[CAM]TIER.2|LLWHPVMNGDK.3|SIFSPVVK.2|ANVTVLDTQIRK.3|FGKPDPIVSVIFKDEK.4|FGKPDPIVSVIFKDEK.3|TQGLVPEHVETR.3|IPAHQVLYSTSGENASGK.4|IPAHQVLYSTSGENASGK.3|IPAHQVLYSTSGENASGK.2|LISLLNEK.2|TASLFEQK.2|DSFSDPYAHIC[CAM]FLHR.4|DSFSDPYAHIC[CAM]FLHR.3|DSFSDPYAHIC[CAM]FLHR.2|ILHQHLGAPEER.3|MAPSETHGAAAIFK.3|M[Oxi]APSETHGAAAIFK.3|MAPSETHGAAAIFK.2|C[CAM]YVYQAR.2|FGKPDPIVSVIFK.3|NDVVGTTYLHLSK.3|NDVVGTTYLHLSK.2|LIGTATVALK.2|MLSNKPQDFQIR.3|M[Oxi]LSNKPQDFQIR.3|MLSNKPQDFQIR.2|LQTNIEALK.2|YTLPLTEGK.2|TLHSTFQPNISQGK.3|TLHSTFQPNISQGK.2|DFETIGQNK.2|ADC[CAM]LMGEFK.2|ASLLSAPPC[CAM]R.2|EIFGGNADKK.2|DHYIPNTLNPVFGR.3|DQLRPTQLLQNVAR.3|DQLRPTQLLQNVAR.2|KVC[CAM]TNIIEK.2|NLVDPFVEVSFAGKK.3|PLASTTQYSR.2|KEHFWSIDQTEFR.3|KLEPISNDDLLVVEK.3|KLEPISNDDLLVVEK.2|LNSEMDITPK.2|DLTQTASSTAR.2|FYASSGEHEK.2|PVVGQC[CAM]TIER.2|VIVESASNIPK.2|ISVYDYDTFTRDEK.3|YGGRDYSLDEFEANK.3|GWWPC[CAM]YAEK.2|KVIEDRDHYIPNTLNPVFGR.4|KVIEDRDHYIPNTLNPVFGR.3|DIVIEMEDTKPLLASK.3|IDVGFVYDEPGHAVMR.3|LIDEVIEDTR.2|PVVTLTSYWEDISHR.3|FDTTC[CAM]KPLASTTQYSR.3|LIIQIWDNDK.2|VGETIIDLENR.2|VSMFVLGTGDEPPPERR.3|LQMWVDVFPK.2|VFLPKEELYMPPLVIK.3|GPVGTVSEAQLAR.2|DGSNLPILPPQR.2|EEEIVDWWSK.2|NLLALDKDSFSDPYAHIC[CAM]FLHR.4|NLLALDKDSFSDPYAHIC[CAM]FLHR.3|VEMTLEILNEK.2|DYSLDEFEANK.2|EELYMPPLVIK.2|IKLTIYDWDR.2|VNIWLGLSAVEK.2|TPNFPSSVLFMK.2|TPNFPSSVLFM[Oxi]K.2|GLELQPQDNNGLC[CAM]DPYIK.3|GLELQPQDNNGLC[CAM]DPYIK.2|ISVYDYDTFTR.2|LEGALGADTTEDGDEKSLEK.3|GFPQPILSEDGSR.2|IPANQLAELWLK.2|ASLLSAPPC[CAM]RDIVIEMEDTKPLLASK.4|ASLLSAPPC[CAM]RDIVIEMEDTKPLLASK.3|LDAVNTLLAMAER.2|STLAEIEDWLDK.2|FVFPFDYLPAEQLC[CAM]IVAK.3|FVFPFDYLPAEQLC[CAM]IVAK.2|SLGPPGPPFNITPR.2|HSATTVFGANTPIVSC[CAM]NFDR.3|HSATTVFGANTPIVSC[CAM]NFDR.2|LIDEVIEDTRYTLPLTEGK.3|NFQMASITSPSLVVEC[CAM]GGERVESVVIK.4|NFQMASITSPSLVVEC[CAM]GGERVESVVIK.3|SITGEEMSDIYVK.2|VNIWLGLSAVEKK.2|YPGGDWKPAEDTYTDANGDK.3|IYRAEDIPQMDDAFSQTVK.3|VIMELFDNDQVGKDEFLGR.3|VIEDRDHYIPNTLNPVFGR.3|ELPDSVPQEC[CAM]TVR.2|NLVDPFVEVSFAGK.2|GIPLDFSSSLGIIVK.2|SDENEDPSVVGEFK.2|LDLPNRPETSFLWFTNPC[CAM]K.3|MYELSC[CAM]YLPQEK.2|AMEELQDQEGWEYASLIGWK.3|EHFWSIDQTEFR.2|LEPISNDDLLVVEK.2|LEGALGADTTEDGDEK.2|QKHSATTVFGANTPIVSC[CAM]NFDR.3|VIIWNTKDVILDEK.2|EYTGFPDPYDELNTGKGEGVAYR.3|GIPLDFSSSLGIIVKDFETIGQNK.3|LMQLTEEPQNSMPDIIIWMIR.3|GKSDENEDPSVVGEFK.2|NANPEWNQVVNLQIKFPSVC[CAM]EK.3|SLLTEADAGHTEFTDEVYQNESR.3|GWEWEGEWIVDPER.2|NANPEWNQVVNLQIK.2|EYTGFPDPYDELNTGK.2|AASPSELTC[CAM]PPGWEWEDDAWSYDINR.3|NFQMASITSPSLVVEC[CAM]GGER.2|TTEIIHSTLNPTWDQTIIFDEVEIYGEPQTVLQNPPK.4
SEN / CTL,Ras-related protein Rab-6A;Ras-related protein Rab-6B,RAB6A;RAB6B,P20340;Q9NRW1,0.70,0.58,7.98E-04,6.26E-04,3.20E+00,"protein targeting to Golgi,retrograde vesicle-mediated transport, Golgi to ER,small GTPase mediated signal transduction,viral process,peptidyl-cysteine methylation,antigen processing and presentation,protein localization to Golgi apparatus,early endosome to Golgi transport,minus-end-directed organelle transport along microtubule;retrograde vesicle-mediated transport, Golgi to ER,intra-Golgi vesicle-mediated transport,small GTPase mediated signal transduction,protein transport,retrograde transport, endosome to Golgi","GTPase activity,protein binding,GTP binding,protein domain specific binding,myosin V binding;GTPase activity,protein binding,GTP binding,myosin V binding","Golgi membrane,endoplasmic reticulum membrane,Golgi apparatus,trans-Golgi network,cytosol,membrane,cytoplasmic vesicle,trans-Golgi network membrane,extracellular exosome,endosome to plasma membrane transport vesicle;Golgi membrane,endoplasmic reticulum-Golgi intermediate compartment,Golgi apparatus,cytosol,cytoplasmic, membrane-bounded vesicle",9,3,3,LQLWDTAGQER.2|LVFLGEQSVGK.2|FKLVFLGEQSVGK.3
SEN / CTL,26S proteasome non-ATPase regulatory subunit 7,PSMD7,P51665,0.70,0.38,2.09E-04,1.95E-04,3.71E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","protein binding,protein homodimerization activity","proteasome complex,nucleus,nucleoplasm,cytosol,proteasome regulatory particle,membrane,extracellular exosome",12,15,25,LHKNDIAINELMK.3|VVGVLLGSWQK.2|VVVHPLVLLSVVDHFNR.4|VVVHPLVLLSVVDHFNR.3|VVVHPLVLLSVVDHFNR.2|SVVALHNLINNK.3|SVVALHNLINNK.2|RVVGVLLGSWQK.3|DIKDTTVGTLSQR.3|DIKDTTVGTLSQR.2|ITNQVHGLK.2|DTTVGTLSQR.2|TNDQMVVVYLASLIR.3|TNDQM[Oxi]VVVYLASLIR.3|TNDQMVVVYLASLIR.2|TNDQM[Oxi]VVVYLASLIR.2|IVGWYHTGPK.2|NDIAINELMK.2|NDIAINELM[Oxi]K.2|YC[CAM]PNSVLVIIDVKPK.3|YC[CAM]PNSVLVIIDVKPK.2|TFEHVTSEIGAEEAEEVGVEHLLR.4|TFEHVTSEIGAEEAEEVGVEHLLR.3|DLGLPTEAYISVEEVHDDGTPTSK.3|VATGKLPINHQIIYQLQDVFNLLPDVSLQEFVK.4
SEN / CTL,Beta-actin-like protein 2,ACTBL2,Q562R1,0.70,0.36,7.98E-10,2.48E-09,8.61E+00,biological_process,"molecular_function,ATP binding","extracellular space,cytoplasm,cytoskeleton,extracellular exosome",24,9,17,VAPDEHPILLTEAPLNPK.3|VAPDEHPILLTEAPLNPK.4|KDLYANTVLSGGSTM[Oxi]YPGIADR.3|TTGIVM[Oxi]DSGDGVTHIVPIYEGYALPHAILR.4|TTGIVM[Oxi]DSGDGVTHIVPIYEGYALPHAILR.3|TTGIVM[Oxi]DSGDGVTHIVPIYEGYALPHAILR.5|DLYANTVLSGGSTM[Oxi]YPGIADR.3|DLYANTVLSGGSTM[Oxi]YPGIADR.2|HQGVMVGMGQKDC[CAM]YVGDEAQSKR.6|HQGVMVGMGQKDC[CAM]YVGDEAQSKR.5|HQGVM[Oxi]VGMGQKDC[CAM]YVGDEAQSKR.5|HQGVM[Oxi]VGMGQKDC[CAM]YVGDEAQSKR.4|IWYHTFYNELR.3|HQGVMVGMGQKDC[CAM]YVGDEAQSK.4|HQGVM[Oxi]VGMGQKDC[CAM]YVGDEAQSK.4|FRC[CAM]PEAIFQPSFLGIESSGIHETTFNSIMK.4|C[CAM]PEAIFQPSFLGIESSGIHETTFNSIMK.3
SEN / CTL,Stanniocalcin-2,STC2,O76061,0.69,1.41,4.56E-02,1.86E-02,1.73E+00,"cellular calcium ion homeostasis,response to oxidative stress,embryo implantation,negative regulation of gene expression,endoplasmic reticulum unfolded protein response,response to vitamin D,negative regulation of multicellular organism growth,response to peptide hormone,decidualization,regulation of hormone biosynthetic process,cellular response to hypoxia,regulation of store-operated calcium entry","hormone activity,enzyme binding,heme binding,protein homodimerization activity","extracellular space,endoplasmic reticulum,Golgi apparatus,perinuclear region of cytoplasm",6,2,2,HDLC[CAM]AAAQENTR.2|VIVEMIHFK.2
SEN / CTL,Tumor protein D54,TPD52L2,O43399,0.69,0.35,6.50E-08,1.36E-07,6.87E+00,,poly(A) RNA binding,,18,18,28,LGLSTLGELKQNLSR.3|LGLSTLGELK.2|TSAALSTVGSAISR.2|TSAALSTVGSAISR.3|TPAVEGLTEAEEEELRAELTKVEEEIVTLR.4|TPAVEGLTEAEEEELRAELTKVEEEIVTLR.5|TPAVEGLTEAEEEELRAELTKVEEEIVTLR.3|SWHDVQVSSAYVK.3|SWHDVQVSSAYVK.2|KTQETLSQAGQK.3|KTQETLSQAGQK.2|LGEWNEK.2|TSEKLGEWNEK.3|VTQSDLYK.2|TSAALSTVGSAISRK.3|VEEEIVTLR.2|VTQSDLYKK.2|TPAVEGLTEAEEEELR.3|TPAVEGLTEAEEEELR.2|TQETLSQAGQK.2|GLLSDSMTDVPVDTGVAAR.3|GLLSDSM[Oxi]TDVPVDTGVAAR.2|GLLSDSMTDVPVDTGVAAR.2|VVGDRENGSDNLPSSAGSGDK.3|VVGDRENGSDNLPSSAGSGDKPLSDPAPF.4|VVGDRENGSDNLPSSAGSGDKPLSDPAPF.3|TPAVEGLTEAEEEELRAELTK.3|TPAVEGLTEAEEEELRAELTK.2
SEN / CTL,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",SDHB,P21912,0.69,0.27,1.67E-03,1.19E-03,2.93E+00,"tricarboxylic acid cycle,succinate metabolic process,aerobic respiration,respiratory electron transport chain","succinate dehydrogenase activity,protein binding,succinate dehydrogenase (ubiquinone) activity,electron carrier activity,metal ion binding,ubiquinone binding,2 iron, 2 sulfur cluster binding,3 iron, 4 sulfur cluster binding,4 iron, 4 sulfur cluster binding","nucleoplasm,mitochondrion,mitochondrial inner membrane,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),plasma membrane,mitochondrial membrane,respiratory chain complex II,extracellular exosome",6,18,26,LQDPFSLYR.2|C[CAM]GPMVLDALIK.2|C[CAM]GPM[Oxi]VLDALIK.2|SIEPYLK.2|RIDTNLNKVSK.3|DDFTEER.2|AGDKPHMQTYEVDLNK.4|AGDKPHMQTYEVDLNK.3|AGDKPHM[Oxi]QTYEVDLNK.3|IYPLPHMYVIK.3|YLGPAVLMQAYR.3|YLGPAVLMQAYR.2|YLGPAVLM[Oxi]QAYR.2|IKNEVDSTLTFR.3|IKNEVDSTLTFR.2|LAKLQDPFSLYR.3|GAQTAAATAPR.2|QQYLQSIEEREK.3|DLVPDLSNFYAQYK.3|DLVPDLSNFYAQYK.2|NEVDSTLTFR.2|C[CAM]HTIMNC[CAM]TR.2|QQYLQSIEER.2|EGIC[CAM]GSC[CAM]AMNINGGNTLAC[CAM]TR.3|EGIC[CAM]GSC[CAM]AMNINGGNTLAC[CAM]TR.2|LDGLYEC[CAM]ILC[CAM]AC[CAM]C[CAM]STSC[CAM]PSYWWNGDK.3
SEN / CTL,PDZ and LIM domain protein 4,PDLIM4,P50479,0.68,0.56,6.65E-08,1.38E-07,6.86E+00,,"protein binding,zinc ion binding",,27,14,19,VKPPEGYDVVAVYPNAK.3|GYFFLDER.2|DFSAPLTISR.2|AALAALC[CAM]PGDLIQAINGESTELMTHLEAQNR.4|AALAALC[CAM]PGDLIQAINGESTELMTHLEAQNR.3|IHIDPEIQDGSPTTSR.3|IHIDPEIQDGSPTTSR.2|MLREPAEPVAAEPK.3|VDLGSEVYR.2|LGAPLSGLQGLPEC[CAM]TR.2|LGAPLSGLQGLPEC[CAM]TR.3|GC[CAM]HDHLTLSVSRPEGR.4|GC[CAM]HDHLTLSVSRPEGR.3|GPSPWGFR.2|LYC[CAM]ESHAK.2|SWPSAPDDSK.2|LYHPEC[CAM]FMC[CAM]SDC[CAM]GLNLK.3|YLQGMLEAGEGGDWPGPGGPR.3|YLQGMLEAGEGGDWPGPGGPR.2
SEN / CTL,Ubiquitin-conjugating enzyme E2 variant 1,UBE2V1,Q13404,0.68,0.64,9.73E-04,7.50E-04,3.12E+00,"protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,regulation of DNA repair,postreplication repair,regulation of transcription, DNA-templated,cell differentiation,Fc-epsilon receptor signaling pathway,positive regulation of I-kappaB kinase/NF-kappaB signaling,positive regulation of transcription, DNA-templated,T cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,nucleotide-binding oligomerization domain containing signaling pathway,protein K63-linked ubiquitination","protein binding,ubiquitin protein ligase binding,ubiquitin protein ligase activity","ubiquitin ligase complex,nucleus,cytoplasm,cytosol,ubiquitin conjugating enzyme complex,UBC13-UEV1A complex,protein complex,extracellular exosome",9,10,16,WTGMIIGPPR.2|WTGM[Oxi]IIGPPR.2|VVLQELR.2|IEC[CAM]GPKYPEAPPFVR.3|IEC[CAM]GPKYPEAPPFVR.2|YPEAPPFVR.2|INMNGVNSSNGVVDPR.3|INM[Oxi]NGVNSSNGVVDPR.2|INMNGVNSSNGVVDPR.2|LLEELEEGQK.2|LPQPPEGQC[CAM]YSN.2|GVGDGTVSWGLEDDEDMTLTR.3|GVGDGTVSWGLEDDEDM[Oxi]TLTR.2|GVGDGTVSWGLEDDEDMTLTR.2|ENMKLPQPPEGQC[CAM]YSN.2|LLEELEEGQKGVGDGTVSWGLEDDEDMTLTR.3
SEN / CTL,Dihydropyrimidinase-related protein 2,DPYSL2,Q16555,0.68,0.84,1.98E-05,2.33E-05,4.63E+00,"response to amphetamine,nucleobase-containing compound metabolic process,endocytosis,cytoskeleton organization,signal transduction,nervous system development,axon guidance,positive regulation of glutamate secretion,spinal cord development,olfactory bulb development,regulation of axon extension,response to cocaine,response to drug,synaptic vesicle transport","dihydropyrimidinase activity,protein binding,microtubule binding,protein kinase binding","mitochondrion,cytosol,dendrite,growth cone,neuronal cell body,terminal bouton,myelin sheath,protein complex,extracellular exosome,microtubule,membrane",45,34,71,QIGENLIVPGGVK.2|SSAEVIAQAR.2|IVLEDGTLHVTEGSGR.3|IVLEDGTLHVTEGSGR.2|FQLTDC[CAM]QIYEVLSVIR.3|FQLTDC[CAM]QIYEVLSVIR.2|GLYDGPVC[CAM]EVSVTPK.2|GLYDGPVC[CAM]EVSVTPK.3|AVGKDNFTLIPEGTNGTEER.3|AVGKDNFTLIPEGTNGTEER.2|AITIANQTNC[CAM]PLYITK.2|AITIANQTNC[CAM]PLYITK.3|MVIPGGIDVHTR.3|M[Oxi]VIPGGIDVHTR.3|MVIPGGIDVHTR.2|ILDLGITGPEGHVLSRPEEVEAEAVNR.4|ILDLGITGPEGHVLSRPEEVEAEAVNR.3|THNSSLEYNIFEGMEC[CAM]R.3|THNSSLEYNIFEGM[Oxi]EC[CAM]R.3|THNSSLEYNIFEGM[Oxi]EC[CAM]R.2|THNSSLEYNIFEGMEC[CAM]R.2|NLHQSGFSLSGAQIDDNIPR.3|NLHQSGFSLSGAQIDDNIPR.4|NLHQSGFSLSGAQIDDNIPR.2|KKGTVVYGEPITASLGTDGSHYWSK.4|KKGTVVYGEPITASLGTDGSHYWSK.5|FQMPDQGMTSADDFFQGTK.3|FQM[Oxi]PDQGMTSADDFFQGTK.3|FQMPDQGM[Oxi]TSADDFFQGTK.3|FQMPDQGM[Oxi]TSADDFFQGTK.2|FQMPDQGMTSADDFFQGTK.2|IAVGSDADLVIWDPDSVK.3|IAVGSDADLVIWDPDSVK.2|DRFQLTDC[CAM]QIYEVLSVIR.3|DRFQLTDC[CAM]QIYEVLSVIR.2|KPFPDFVYKR.3|VFNLYPR.2|DHGVNSFLVYMAFKDR.4|DHGVNSFLVYMAFKDR.3|SC[CAM]C[CAM]DYSLHVDISEWHK.4|SC[CAM]C[CAM]DYSLHVDISEWHK.3|SC[CAM]C[CAM]DYSLHVDISEWHK.2|DHGVNSFLVYMAFK.3|DHGVNSFLVYM[Oxi]AFK.3|DHGVNSFLVYMAFK.2|DHGVNSFLVYM[Oxi]AFK.2|GSPLVVISQGK.2|KPFPDFVYK.2|NLHQSGFSLSGAQIDDNIPRR.4|DIGAIAQVHAENGDIIAEEQQR.4|DIGAIAQVHAENGDIIAEEQQR.3|DIGAIAQVHAENGDIIAEEQQR.2|DNFTLIPEGTNGTEER.3|DNFTLIPEGTNGTEER.2|GTVVYGEPITASLGTDGSHYWSK.4|GTVVYGEPITASLGTDGSHYWSK.3|GIQEEMEALVK.2|KGTVVYGEPITASLGTDGSHYWSK.4|KGTVVYGEPITASLGTDGSHYWSK.3|GRIAVGSDADLVIWDPDSVK.3|AVVTGKM[Oxi]DENQFVAVTSTNAAK.3|AAAFVTSPPLSPDPTTPDFLNSLLSC[CAM]GDLQVTGSAHC[CAM]TFNTAQK.6|AAAFVTSPPLSPDPTTPDFLNSLLSC[CAM]GDLQVTGSAHC[CAM]TFNTAQK.4|AALAGGTTMIIDHVVPEPGTSLLAAFDQWREWADSK.5|AALAGGTTM[Oxi]IIDHVVPEPGTSLLAAFDQWREWADSK.4|AALAGGTTMIIDHVVPEPGTSLLAAFDQWREWADSK.4|AALAGGTTMIIDHVVPEPGTSLLAAFDQWR.4|AALAGGTTM[Oxi]IIDHVVPEPGTSLLAAFDQWR.3|AALAGGTTMIIDHVVPEPGTSLLAAFDQWR.3|IVNDDQSFYADIYMEDGLIK.3|IVNDDQSFYADIYMEDGLIK.2
SEN / CTL,Protein phosphatase 1 regulatory subunit 7,PPP1R7,Q15435,0.68,0.22,2.90E-03,1.90E-03,2.72E+00,"chromosome segregation,biological_process,positive regulation of protein dephosphorylation,regulation of catalytic activity","protein phosphatase type 1 regulator activity,enzyme regulator activity","nucleus,chromosome,cytoplasm,extracellular exosome",6,25,37,IEGLQNLVNLR.2|AIENIDTLTNLESLFLGK.3|AIENIDTLTNLESLFLGK.2|KHSSGIVADLSEQSLK.4|KHSSGIVADLSEQSLK.3|KHSSGIVADLSEQSLK.2|LFLVNNK.2|DAEDVDLNHYR.3|DAEDVDLNHYR.2|QIDATFVR.2|VMLALPSVR.2|VM[Oxi]LALPSVR.2|HSSGIVADLSEQSLK.3|HSSGIVADLSEQSLK.2|IENLSNLHQLQMLELGSNR.4|IENLSNLHQLQM[Oxi]LELGSNR.3|IENLSNLHQLQMLELGSNR.3|IENLSNLHQLQMLELGSNR.2|QIDATFVRF.2|SLETVYLER.2|LTMLDIASNR.2|GAGQQQSQEMMEVDRR.3|ELDLYDNQIK.2|ISKIENLSNLHQLQMLELGSNR.4|LQNLDALTNLTVLSMQSNR.3|LQNLDALTNLTVLSM[Oxi]QSNR.3|LQNLDALTNLTVLSMQSNR.2|C[CAM]IENLEELQSLR.2|DGEERGEEDPEEEHELPVDMETINLDRDAEDVDLNHYR.6|DGEERGEEDPEEEHELPVDMETINLDRDAEDVDLNHYR.5|IRAIENIDTLTNLESLFLGK.3|ELYLSHNGIEVIEGLENNNK.3|GAGQQQSQEMMEVDR.2|SLETVYLERNPLQK.2|GEEDPEEEHELPVDMETINLDR.3|C[CAM]IENLEELQSLRELDLYDNQIK.3|KIENISHLTELQEFWMNDNLLESWSDLDELK.4
SEN / CTL,Ubiquitin-like modifier-activating enzyme 1,UBA1,P22314,0.67,0.62,3.19E-15,1.87E-14,1.37E+01,"cellular response to DNA damage stimulus,protein ubiquitination,modification-dependent protein catabolic process","ubiquitin activating enzyme activity,ubiquitin-protein transferase activity,protein binding,ATP binding,poly(A) RNA binding","nucleus,cytoplasm,mitochondrion,cytosol,extracellular exosome,heterochromatin,lysosomal membrane,endosome membrane,desmosome,rough endoplasmic reticulum membrane",111,67,128,LQTSSVLVSGLR.2|LAGTQPLEVLEAVQR.3|LAGTQPLEVLEAVQR.2|NEEDAAELVALAQAVNAR.3|NEEDAAELVALAQAVNAR.2|NGSEADIDEGLYSR.2|SLVASLAEPDFVVTDFAK.2|SLVASLAEPDFVVTDFAK.3|ALPAVQQNNLDEDLIR.2|ALPAVQQNNLDEDLIR.3|QFLDYFK.2|NIILGGVK.2|IYDDDFFQNLDGVANALDNVDAR.3|IYDDDFFQNLDGVANALDNVDAR.4|QNRYDGQVAVFGSDLQEK.3|QNRYDGQVAVFGSDLQEK.2|AAVATFLQSVQVPEFTPK.3|AAVATFLQSVQVPEFTPK.2|AAVATFLQSVQVPEFTPK.4|RLQTSSVLVSGLR.3|RLQTSSVLVSGLR.2|YDGQVAVFGSDLQEK.2|YDGQVAVFGSDLQEK.3|LAYVAAGDLAPINAFIGGLAAQEVMK.3|LAYVAAGDLAPINAFIGGLAAQEVMK.4|LAYVAAGDLAPINAFIGGLAAQEVM[Oxi]K.4|LAYVAAGDLAPINAFIGGLAAQEVM[Oxi]K.3|YFLVGAGAIGC[CAM]ELLK.2|YFLVGAGAIGC[CAM]ELLK.3|ALPAVQQNNLDEDLIRK.3|ALPAVQQNNLDEDLIRK.4|ALPAVQQNNLDEDLIRK.2|VGPDTERIYDDDFFQNLDGVANALDNVDAR.4|VGPDTERIYDDDFFQNLDGVANALDNVDAR.3|RC[CAM]PHPLTFDVNNPLHLDYVMAAANLFAQTYGLTGSQDR.5|RC[CAM]PHPLTFDVNNPLHLDYVM[Oxi]AAANLFAQTYGLTGSQDR.5|RC[CAM]PHPLTFDVNNPLHLDYVMAAANLFAQTYGLTGSQDR.6|RC[CAM]PHPLTFDVNNPLHLDYVMAAANLFAQTYGLTGSQDR.4|QFLFRPWDVTK.3|QFLFRPWDVTK.2|LDQPMTEIVSR.2|LDQPM[Oxi]TEIVSR.2|VLGPYTFSIC[CAM]DTSNFSDYIR.3|VLGPYTFSIC[CAM]DTSNFSDYIR.2|ATLPSPDKLPGFK.3|ATLPSPDKLPGFK.2|KLAYVAAGDLAPINAFIGGLAAQEVMK.3|KLAYVAAGDLAPINAFIGGLAAQEVMK.4|KLAYVAAGDLAPINAFIGGLAAQEVM[Oxi]K.4|KLAYVAAGDLAPINAFIGGLAAQEVM[Oxi]K.3|QLDSYKNGFLNLALPFFGFSEPLAAPR.4|QLDSYKNGFLNLALPFFGFSEPLAAPR.3|GNVQVVIPFLTESYSSSQDPPEK.3|GNVQVVIPFLTESYSSSQDPPEK.4|QKYFLVGAGAIGC[CAM]ELLK.3|QKYFLVGAGAIGC[CAM]ELLK.2|ATLPSPDK.2|KPLLESGTLGTK.3|KPLLESGTLGTK.2|AENYDIPSADR.3|AENYDIPSADR.2|QLYVLGHEAM[Oxi]K.3|QLYVLGHEAMK.3|QLYVLGHEAMK.2|QLYVLGHEAM[Oxi]K.2|SDTAAAAVR.2|DNPGVVTC[CAM]LDEAR.3|DNPGVVTC[CAM]LDEAR.2|DEFEGLFK.2|AENYDIPSADRHK.3|AENYDIPSADRHK.2|VGEFC[CAM]HNR.2|MYPIDFEK.2|ERLDQPM[Oxi]TEIVSR.3|ERLDQPMTEIVSR.3|ERLDQPMTEIVSR.2|NRAEVSQPR.2|QPAENVNQYLTDPK.3|QPAENVNQYLTDPK.2|FSRPAQLHIGFQALHQFC[CAM]AQHGRPPRPR.6|FSRPAQLHIGFQALHQFC[CAM]AQHGRPPRPR.5|LKSDTAAAAVR.2|PLLESGTLGTK.2|NFPNAIEHTLQWAR.3|NFPNAIEHTLQWAR.2|NGFLNLALPFFGFSEPLAAPR.4|NGFLNLALPFFGFSEPLAAPR.3|NGFLNLALPFFGFSEPLAAPR.2|QNRYDGQVAVFGSDLQEKLGK.4|QNRYDGQVAVFGSDLQEKLGK.3|FEVQGLQPNGEEMTLK.3|FEVQGLQPNGEEM[Oxi]TLK.2|FEVQGLQPNGEEMTLK.2|HQYYNQEWTLWDR.3|HQYYNQEWTLWDR.2|AVTLHDQGTAQWADLSSQFYLR.4|AVTLHDQGTAQWADLSSQFYLR.3|SLVLQRPQTWADC[CAM]VTWAC[CAM]HHWHTQYSNNIR.6|SLVLQRPQTWADC[CAM]VTWAC[CAM]HHWHTQYSNNIR.5|SLVLQRPQTWADC[CAM]VTWAC[CAM]HHWHTQYSNNIR.4|QLLHNFPPDQLTSSGAPFWSGPK.4|QLLHNFPPDQLTSSGAPFWSGPK.3|YDGQVAVFGSDLQEKLGK.3|IHVSDQELQSANASVDDSRLEELK.4|IHVSDQELQSANASVDDSRLEELK.3|AVTLHDQGTAQWADLSSQFYLREEDIGKNR.5|AVTLHDQGTAQWADLSSQFYLREEDIGKNR.4|DDDSNFHMDFIVAASNLR.3|IHVSDQELQSANASVDDSR.3|IHVSDQELQSANASVDDSR.2|TEHKLEITMLSQGVSMLYSFFMPAAK.4|IIPAIATTTAAVVGLVC[CAM]LELYK.3|M[Oxi]YPIDFEKDDDSNFHMDFIVAASNLR.4|MYPIDFEKDDDSNFHMDFIVAASNLR.4|PQTWADC[CAM]VTWAC[CAM]HHWHTQYSNNIR.4|AVTLHDQGTAQWADLSSQFYLREEDIGK.4|AVTLHDQGTAQWADLSSQFYLREEDIGK.3|VSGPDPKPGSNC[CAM]SPAQSVLSEVPSVPTNGMAK.4|VSGPDPKPGSNC[CAM]SPAQSVLSEVPSVPTNGMAK.3|ALVLELC[CAM]C[CAM]NDESGEDVEVPYVR.3|DEFEGLFKQPAENVNQYLTDPK.3|NFAM[Oxi]IGLGC[CAM]GEGGEIIVTDMDTIEK.3|NFAMIGLGC[CAM]GEGGEIIVTDMDTIEK.3|HQYYNQEWTLWDRFEVQGLQPNGEEMTLK.4|C[CAM]PHPLTFDVNNPLHLDYVM[Oxi]AAANLFAQTYGLTGSQDR.4|C[CAM]PHPLTFDVNNPLHLDYVMAAANLFAQTYGLTGSQDR.4|HGFESGDFVSFSEVQGMVELNGNQPM[Oxi]EIK.3|HGFESGDFVSFSEVQGMVELNGNQPMEIK.3
SEN / CTL,Heat shock 70 kDa protein 1A;Heat shock 70 kDa protein 1B,HSPA1A;HSPA1B,P0DMV8;P0DMV9,0.67,0.90,3.39E-07,6.32E-07,6.20E+00,"positive regulation of gene expression,regulation of protein ubiquitination,negative regulation of protein ubiquitination,positive regulation of interleukin-8 production,cellular response to oxidative stress,cellular response to heat,protein refolding,regulation of mRNA stability,ATP metabolic process,viral entry into host cell,protein stabilization,positive regulation of NF-kappaB transcription factor activity,negative regulation of cell death,cellular heat acclimation,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,negative regulation of inclusion body assembly,cell-cell adhesion,regulation of cellular response to heat,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,positive regulation of endoribonuclease activity,positive regulation of tumor necrosis factor-mediated signaling pathway,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,regulation of cell death;positive regulation of gene expression,regulation of protein ubiquitination,negative regulation of protein ubiquitination,positive regulation of interleukin-8 production,cellular response to oxidative stress,cellular response to heat,protein refolding,ATP metabolic process,viral entry into host cell,protein stabilization,positive regulation of NF-kappaB transcription factor activity,negative regulation of cell death,cellular heat acclimation,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,negative regulation of inclusion body assembly,regulation of cellular response to heat,positive regulation of tumor necrosis factor-mediated signaling pathway,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,regulation of cell death","virus receptor activity,G-protein coupled receptor binding,receptor binding,protein binding,ATP binding,ATPase activity,enzyme binding,heat shock protein binding,ubiquitin protein ligase binding,ATPase activity, coupled,histone deacetylase binding,protein binding involved in protein folding,unfolded protein binding,C3HC4-type RING finger domain binding,cadherin binding involved in cell-cell adhesion;virus receptor activity,G-protein coupled receptor binding,receptor binding,protein binding,ATP binding,ATPase activity,enzyme binding,heat shock protein binding,ubiquitin protein ligase binding,ATPase activity, coupled,histone deacetylase binding,protein binding involved in protein folding,unfolded protein binding,C3HC4-type RING finger domain binding","nucleoplasm,cytoplasm,mitochondrion,centriole,cytosol,cell-cell adherens junction,focal adhesion,inclusion body,perinuclear region of cytoplasm,blood microparticle,ubiquitin ligase complex;nucleoplasm,cytoplasm,centriole,cytosol,focal adhesion,inclusion body,perinuclear region of cytoplasm,blood microparticle,ubiquitin ligase complex",90,60,132,TTPSYVAFTDTER.2|TTPSYVAFTDTER.3|IINEPTAAAIAYGLDR.3|IINEPTAAAIAYGLDR.2|ARFEELC[CAM]SDLFR.3|ARFEELC[CAM]SDLFR.2|LLQDFFNGR.2|AQIHDLVLVGGSTR.3|AQIHDLVLVGGSTR.2|QATKDAGVIAGLNVLR.3|QATKDAGVIAGLNVLR.2|FEELC[CAM]SDLFR.2|VEIIANDQGNR.2|VEIIANDQGNR.3|QTQIFTTYSDNQPGVLIQVYEGER.3|QTQIFTTYSDNQPGVLIQVYEGER.4|NQVALNPQNTVFDAK.2|NQVALNPQNTVFDAK.3|AFYPEEISSMVLTK.2|AFYPEEISSMVLTK.3|AFYPEEISSM[Oxi]VLTK.3|AFYPEEISSM[Oxi]VLTK.2|DAKLDKAQIHDLVLVGGSTR.4|DAKLDKAQIHDLVLVGGSTR.3|NQVALNPQNTVFDAKR.3|NQVALNPQNTVFDAKR.2|MKEIAEAYLGYPVTNAVITVPAYFNDSQR.3|MKEIAEAYLGYPVTNAVITVPAYFNDSQR.4|M[Oxi]KEIAEAYLGYPVTNAVITVPAYFNDSQR.4|M[Oxi]KEIAEAYLGYPVTNAVITVPAYFNDSQR.3|LLQDFFNGRDLNK.3|LLQDFFNGRDLNK.2|DAGVIAGLNVLR.2|DAGVIAGLNVLR.3|DAGVIAGLNVLR.1|NALESYAFNMK.2|NALESYAFNM[Oxi]K.3|NALESYAFNMK.3|NALESYAFNM[Oxi]K.2|ELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.3|ELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.5|ELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.4|KFGDPVVQSDMKHWPFQVINDGDKPK.5|KFGDPVVQSDMKHWPFQVINDGDKPK.6|KFGDPVVQSDM[Oxi]KHWPFQVINDGDKPK.5|KFGDPVVQSDMKHWPFQVINDGDKPK.4|KFGDPVVQSDM[Oxi]KHWPFQVINDGDKPK.4|KFGDPVVQSDMKHWPFQVINDGDKPK.3|LDKAQIHDLVLVGGSTR.3|LDKAQIHDLVLVGGSTR.4|LDKAQIHDLVLVGGSTR.2|TTPSYVAFTDTERLIGDAAK.3|TTPSYVAFTDTERLIGDAAK.2|ATAGDTHLGGEDFDNRLVNHFVEEFKR.6|ATAGDTHLGGEDFDNRLVNHFVEEFKR.5|ATAGDTHLGGEDFDNRLVNHFVEEFKR.4|HWPFQVINDGDKPK.4|HWPFQVINDGDKPK.3|HWPFQVINDGDKPK.2|GRLSKEEIER.3|GRLSKEEIER.2|LVNHFVEEFK.3|LVNHFVEEFK.2|MVQEAEK.2|M[Oxi]VQEAEK.2|AEDEVQR.2|ANKITITNDKGR.3|ANKITITNDKGR.2|KFGDPVVQSDMK.3|KFGDPVVQSDM[Oxi]K.3|KFGDPVVQSDMK.2|KFGDPVVQSDM[Oxi]K.2|STLEPVEK.2|LVNHFVEEFKR.3|LVNHFVEEFKR.2|SAVEDEGLK.2|YKAEDEVQRER.3|YKAEDEVQRER.2|MVQEAEKYKAEDEVQR.4|M[Oxi]VQEAEKYKAEDEVQR.4|MVQEAEKYKAEDEVQR.3|M[Oxi]VQEAEKYKAEDEVQR.3|MVQEAEKYKAEDEVQR.2|LSKEEIER.2|ITITNDKGR.2|ATAGDTHLGGEDFDNR.3|ATAGDTHLGGEDFDNR.2|AAAIGIDLGTTYSC[CAM]VGVFQHGK.4|AAAIGIDLGTTYSC[CAM]VGVFQHGK.3|AAAIGIDLGTTYSC[CAM]VGVFQHGK.2|C[CAM]QEVISWLDANTLAEKDEFEHKR.5|C[CAM]QEVISWLDANTLAEKDEFEHKR.4|C[CAM]QEVISWLDANTLAEKDEFEHKR.3|MVQEAEKYK.2|SAVEDEGLKGK.2|VQVSYKGETK.2|YKAEDEVQR.2|FGDPVVQSDM[Oxi]KHWPFQVINDGDKPK.5|FGDPVVQSDMKHWPFQVINDGDKPK.5|FGDPVVQSDMKHWPFQVINDGDKPK.4|FGDPVVQSDM[Oxi]KHWPFQVINDGDKPK.4|FGDPVVQSDMKHWPFQVINDGDKPK.3|ATAGDTHLGGEDFDNRLVNHFVEEFK.5|ATAGDTHLGGEDFDNRLVNHFVEEFK.4|ATAGDTHLGGEDFDNRLVNHFVEEFK.3|FELSGIPPAPR.2|GGSGSGPTIEEVD.2|FGDPVVQSDMK.2|FGDPVVQSDM[Oxi]K.2|AMTKDNNLLGR.2|C[CAM]QEVISWLDANTLAEK.3|C[CAM]QEVISWLDANTLAEK.2|VLDKC[CAM]QEVISWLDANTLAEKDEFEHK.5|VLDKC[CAM]QEVISWLDANTLAEKDEFEHK.4|C[CAM]QEVISWLDANTLAEKDEFEHK.4|C[CAM]QEVISWLDANTLAEKDEFEHK.3|RKELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.5|RKELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.4|RKELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.3|EIAEAYLGYPVTNAVITVPAYFNDSQR.4|EIAEAYLGYPVTNAVITVPAYFNDSQR.3|SINPDEAVAYGAAVQAAILM[Oxi]GDK.3|SINPDEAVAYGAAVQAAILMGDK.3|SINPDEAVAYGAAVQAAILM[Oxi]GDK.2|SINPDEAVAYGAAVQAAILMGDK.2|RTLSSSTQASLEIDSLFEGIDFYTSITR.4|RTLSSSTQASLEIDSLFEGIDFYTSITR.3|KELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.4|KELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.3|VEIIANDQGNRTTPSYVAFTDTER.3|DAGVIAGLNVLRIINEPTAAAIAYGLDR.3|TLSSSTQASLEIDSLFEGIDFYTSITR.3
SEN / CTL,rRNA 2'-O-methyltransferase fibrillarin,FBL,P22087,0.67,0.77,7.89E-02,2.95E-02,1.53E+00,"box C/D snoRNA 3'-end processing,osteoblast differentiation,rRNA processing,tRNA processing,rRNA methylation,snoRNA localization,histone glutamine methylation","TFIID-class transcription factor binding,RNA binding,protein binding,rRNA methyltransferase activity,poly(A) RNA binding,ATPase binding,histone-glutamine methyltransferase activity","dense fibrillar component,granular component,nucleus,nucleoplasm,chromosome,nucleolus,Cajal body,membrane,box C/D snoRNP complex,small-subunit processome,extracellular exosome",6,26,47,IVALNAHTFLR.3|IVALNAHTFLR.2|VSISEGDDKIEYR.3|VSISEGDDKIEYR.2|RVSISEGDDKIEYR.4|RVSISEGDDKIEYR.3|RVSISEGDDKIEYR.2|TNIIPVIEDARHPHK.4|LAAAILGGVDQIHIKPGAK.4|LAAAILGGVDQIHIKPGAK.3|LAAAILGGVDQIHIKPGAK.2|VSISEGDDK.2|GKEDALVTK.2|NLVPGESVYGEKR.3|NLVPGESVYGEKR.2|NVMVEPHR.2|NVMVEPHRHEGVFIC[CAM]R.4|NVM[Oxi]VEPHRHEGVFIC[CAM]R.4|NVMVEPHRHEGVFIC[CAM]R.3|NVM[Oxi]VEPHRHEGVFIC[CAM]R.3|HEGVFIC[CAM]R.2|LAAAILGGVDQIHIK.3|LAAAILGGVDQIHIK.2|DHAVVVGVYRPPPK.3|DHAVVVGVYRPPPK.2|SKLAAAILGGVDQIHIKPGAK.4|NGGHFVISIK.2|RVSISEGDDK.2|TNIIPVIEDAR.2|KMQQENMKPQEQLTLEPYER.4|KMQQENM[Oxi]KPQEQLTLEPYER.4|KMQQENMKPQEQLTLEPYER.3|NLVPGESVYGEK.2|ANC[CAM]IDSTASAEAVFASEVK.3|ANC[CAM]IDSTASAEAVFASEVK.2|KMQQENMKPQEQLTLEPYERDHAVVVGVYRPPPK.6|KMQQENMKPQEQLTLEPYERDHAVVVGVYRPPPK.5|VLYLGAASGTTVSHVSDIVGPDGLVYAVEFSHR.5|VLYLGAASGTTVSHVSDIVGPDGLVYAVEFSHR.4|VLYLGAASGTTVSHVSDIVGPDGLVYAVEFSHR.3|ANC[CAM]IDSTASAEAVFASEVKK.3|MLIAMVDVIFADVAQPDQTR.3|PQEQLTLEPYER.2|M[Oxi]QQENMKPQEQLTLEPYER.3|MQQENM[Oxi]KPQEQLTLEPYER.3|MQQENMKPQEQLTLEPYER.3|MQQENMKPQEQLTLEPYER.2
SEN / CTL,Microtubule-associated protein 4,MAP4,P27816,0.67,0.76,8.96E-07,1.52E-06,5.82E+00,"mitotic spindle organization,neuron projection development,microtubule sliding,establishment of spindle orientation,cell division,negative regulation of nonmotile primary cilium assembly","structural molecule activity,microtubule binding,poly(A) RNA binding","cytoplasm,microtubule,microtubule associated complex,plasma membrane,axoneme,microtubule cytoskeleton,neuron projection,extracellular exosome,mitotic spindle",36,68,96,NVVLPTETEVAPAKDVTLLKETER.4|ATPMPSRPSTTPFIDKKPTSAKPSSTTPR.6|NVVLPTETEVAPAKDVTLLK.3|NVC[CAM]LPPEMEVALTEDQVPALKTEAPLAK.3|TTTLSGTAPAAGVVPSR.2|TTTLSGTAPAAGVVPSR.3|VGSLDNVGHLPAGGAVK.3|VGSLDNVGHLPAGGAVK.2|DMESPTKLDVTLAK.3|DMESPTKLDVTLAK.2|NVC[CAM]LPPEMEVALTEDQVPALK.3|NVC[CAM]LPPEMEVALTEDQVPALK.2|LATNTSAPDLK.2|VALSSETEVALAR.2|VALSSETEVALAR.3|C[CAM]SLPAEEDSVLEK.2|ASPSKPASAPASR.3|SPSTLLPK.2|TTDMAPSK.2|VGSTENIK.2|MDLAPSKDMGPPKENK.4|HVPGGGNVQIQNK.3|KPTSAKPSSTTPR.3|PLATTQPAK.2|RASPSKPASAPASR.3|TTTAAAVASTGPSSR.3|TTTAAAVASTGPSSR.2|TAGPIASAQK.2|DMELPTEK.2|NVVLPTETEVAPAK.3|NVVLPTETEVAPAK.2|DKALPLEAEVAPVK.3|PSTTPFIDK.2|DMAQLPETEIAPAK.3|DM[Oxi]AQLPETEIAPAK.2|DMAQLPETEIAPAK.2|DVTPPPETEVVLIK.3|DVTPPPETEVVLIK.2|RPAVASARPSILPSK.3|KPMSLASGLVPAAPPK.3|KPM[Oxi]SLASGLVPAAPPK.3|KPMSLASGLVPAAPPK.2|DMEIAQTQK.2|DM[Oxi]EIAQTQK.2|SVPADLSRPK.2|KTTTLSGTAPAAGVVPSR.3|TKPLATTQPAK.2|TTDMAPSKETEMALAK.3|TTDMAPSKETEMALAK.2|ATPMPSRPSTTPFIDK.3|ATPMPSRPSTTPFIDK.2|DVKPKPIADAK.2|QPAPTTIGGLNK.2|WPTETDVSSAK.2|ALPLEAEVAPVK.2|KKPC[CAM]SETSQIEDTPSSK.3|KPC[CAM]NSQPSELSSETSGIAR.3|KPC[CAM]NSQPSELSSETSGIARPEEGRPVVSGTGNDITTPPNK.6|KPC[CAM]NSQPSELSSETSGIARPEEGRPVVSGTGNDITTPPNK.5|DGVLTLANNVTPAK.2|TDYIPLLDVDEK.2|PEEGRPVVSGTGNDITTPPNK.3|PMSLASGLVPAAPPK.2|DFIATLEAEAFDDVVGETVGK.3|DFIATLEAEAFDDVVGETVGK.2|DKALPLEAEVAPVKDMAQLPETEIAPAK.4|DMSPLSETEMALGK.2|DM[Oxi]SPLSETEMALGK.2|DMSPLSETEM[Oxi]ALGK.2|DMSPLSETEMALGKDVTPPPETEVVLIK.4|DMSPLSETEMALGKDVTPPPETEVVLIK.3|DM[Oxi]AQLPETEIAPAKDVAPSTVK.3|DMAQLPETEIAPAKDVAPSTVK.3|KKPC[CAM]SETSQIEDTPSSKPTLLANGGHGVEGSDTTGSPTEFLEEK.6|KKPC[CAM]SETSQIEDTPSSKPTLLANGGHGVEGSDTTGSPTEFLEEK.5|LGERKPC[CAM]NSQPSELSSETSGIARPEEGRPVVSGTGNDITTPPNK.6|DMQPSMESDMALVK.2|DM[Oxi]QPSMESDMALVK.2|DMQPSM[Oxi]ESDMALVK.2|DMQPSMESDM[Oxi]ALVK.2|DMTLPPETNVILTK.2|DM[Oxi]TLPPETNVILTK.2|EAQTLDSQIQETSI.2|RDFIATLEAEAFDDVVGETVGK.3|EIEMASEERPPAQALEIMMGLK.3|DVPPLSETEATPVPIK.2|MYHDDDLADLVFPSSATADTSIFAGQNDPLK.4|MYHDDDLADLVFPSSATADTSIFAGQNDPLK.3|ALPLEAEVAPVKDMAQLPETEIAPAKDVAPSTVK.4|ALPLEAEVAPVKDMAQLPETEIAPAK.3|DVPPLSETEATPVPIKDMEIAQTQK.3|GISEDSHLESLQDVGQSAAPTFM[Oxi]ISPETVTGTGKK.4|GISEDSHLESLQDVGQSAAPTFMISPETVTGTGKK.4|DGVLTLANNVTPAKDVPPLSETEATPVPIKDMEIAQTQK.4|GISEDSHLESLQDVGQSAAPTFMISPETVTGTGK.3|TEGGGSEAPLC[CAM]PGPPAGEEPAISEAAPEAGAPTSASGLNGHPTLSGGGDQR.4
SEN / CTL,Core histone macro-H2A.1,H2AFY,O75367,0.67,0.35,1.08E-07,2.16E-07,6.67E+00,"negative regulation of transcription from RNA polymerase II promoter,nucleosome assembly,chromatin silencing,dosage compensation,chromatin modification,regulation of lipid metabolic process,negative regulation of histone phosphorylation,positive regulation of maintenance of mitotic sister chromatid cohesion,regulation of gene expression, epigenetic,positive regulation of keratinocyte differentiation,negative regulation of gene expression, epigenetic,positive regulation of gene expression, epigenetic,negative regulation of histone H3-K4 methylation,negative regulation of histone H3-K27 methylation,establishment of protein localization to chromatin,negative regulation of protein serine/threonine kinase activity,negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,negative regulation of cell cycle G2/M phase transition,negative regulation of protein localization to chromosome, telomeric region,regulation of cell growth,regulation of chromatin silencing at rDNA","rDNA binding,RNA polymerase II regulatory region sequence-specific DNA binding,RNA polymerase II core promoter sequence-specific DNA binding,core promoter sequence-specific DNA binding,DNA binding,protein binding,double-stranded methylated DNA binding,enzyme binding,protein kinase binding,protein serine/threonine kinase inhibitor activity,chromatin DNA binding,nucleosomal DNA binding,transcription regulatory region DNA binding,protein heterodimerization activity","nuclear chromosome,nuclear chromosome, telomeric region,nucleosome,nuclear chromatin,condensed chromosome,sex chromatin,Barr body,nucleus,pericentric heterochromatin,nucleolus,extracellular exosome,ESC/E(Z) complex",18,23,38,HILLAVANDEELNQLLK.3|HILLAVANDEELNQLLK.2|KGGKEFVEAVLELR.3|KGGKEFVEAVLELR.2|AASADSTTEGTPADGFTVLSTK.2|AASADSTTEGTPADGFTVLSTK.3|GVTIASGGVLPNIHPELLAK.3|GVTIASGGVLPNIHPELLAK.4|GVTIASGGVLPNIHPELLAK.2|FVIHC[CAM]NSPVWGADKC[CAM]EELLEK.3|FVIHC[CAM]NSPVWGADKC[CAM]EELLEK.4|GKLEAIITPPPAK.3|GKLEAIITPPPAK.2|NGPLEVAGAAVSAGHGLPAK.4|NGPLEVAGAAVSAGHGLPAK.3|NGPLEVAGAAVSAGHGLPAK.2|AGVIFPVGR.2|C[CAM]EELLEK.2|NC[CAM]LALADDKKLK.3|GGKEFVEAVLELR.3|GKLEAIITPPPAKK.3|KNGPLEVAGAAVSAGHGLPAK.4|KNGPLEVAGAAVSAGHGLPAK.3|QTAAQLILK.2|DDLGNTLEK.2|NC[CAM]LALADDK.2|AISSYFVSTMSSSIK.3|AISSYFVSTMSSSIK.2|AISSYFVSTM[Oxi]SSSIK.2|FVIHC[CAM]NSPVWGADK.3|FVIHC[CAM]NSPVWGADK.2|SIAFPSIGSGR.2|NC[CAM]LALADDKK.2|LEAIITPPPAK.2|EFVEAVLELR.2|HILLAVANDEELNQLLKGVTIASGGVLPNIHPELLAK.6|HILLAVANDEELNQLLKGVTIASGGVLPNIHPELLAK.5|HILLAVANDEELNQLLKGVTIASGGVLPNIHPELLAK.4
SEN / CTL,60S ribosomal protein L14,RPL14,P50914,0.67,0.35,1.32E-02,6.68E-03,2.18E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,ribosomal large subunit biogenesis,cell-cell adhesion","RNA binding,structural constituent of ribosome,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","cytoplasm,cytosol,cell-cell adherens junction,membrane,cytosolic large ribosomal subunit,extracellular exosome",6,10,14,LVAIVDVIDQNR.2|LVAIVDVIDQNR.3|C[CAM]MQLTDFILK.2|C[CAM]M[Oxi]QLTDFILK.2|ALVDGPC[CAM]TQVR.3|ALVDGPC[CAM]TQVR.2|VAYVSFGPHAGK.3|VAYVSFGPHAGK.2|ADINTKWAATR.3|FPHSAHQK.2|GTAAAAAAAAAAK.2|APAQKVPAQK.2|C[CAM]MQLTDFILKFPHSAHQK.4|VAYVSFGPHAGKLVAIVDVIDQNR.4
SEN / CTL,"Splicing factor, proline- and glutamine-rich",SFPQ,P23246,0.67,0.88,8.20E-03,4.56E-03,2.34E+00,"negative regulation of transcription from RNA polymerase II promoter,alternative mRNA splicing, via spliceosome,double-strand break repair via homologous recombination,transcription, DNA-templated,mRNA processing,RNA splicing,regulation of circadian rhythm,negative regulation of circadian rhythm,positive regulation of sister chromatid cohesion,negative regulation of transcription, DNA-templated,rhythmic process,chromosome organization,histone H3 deacetylation,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway","nucleotide binding,transcription regulatory region sequence-specific DNA binding,RNA polymerase II distal enhancer sequence-specific DNA binding,core promoter binding,chromatin binding,protein binding,histone deacetylase binding,transcription regulatory region DNA binding,poly(A) RNA binding","chromatin,nucleus,nucleoplasm,cytoplasm,nuclear matrix,extracellular matrix,paraspeckles,RNA polymerase II transcription factor complex",12,49,90,NLSPYVSNELLEEAFSQFGPIER.3|NLSPYVSNELLEEAFSQFGPIER.4|FAQHGTFEYEYSQR.3|FAQHGTFEYEYSQR.2|ALAEIAKAELDDTPMR.3|ALAEIAKAELDDTPM[Oxi]R.3|ALAEIAKAELDDTPMR.2|LFVGNLPADITEDEFKR.3|LFVGNLPADITEDEFKR.2|RM[Oxi]EELHNQEM[Oxi]QK.4|RM[Oxi]EELHNQEMQK.3|RMEELHNQEM[Oxi]QK.3|RMEELHNQEMQK.3|RM[Oxi]EELHNQEM[Oxi]QK.3|RMEELHNQEMQK.2|RQREESYSR.3|QREMEEQMR.3|QREMEEQMR.2|GIVEFASKPAAR.3|GIVEFASKPAAR.2|RREEEMMIR.3|GIVEFASK.2|SLDEMEK.2|GGKMPGGPKPGGGPGLSTPGGHPKPPHR.6|GGKMPGGPKPGGGPGLSTPGGHPKPPHR.5|MGYMDPR.2|M[Oxi]GYMDPR.2|M[Oxi]GYM[Oxi]DPR.2|EEYEGPNKKPR.3|EEYEGPNKKPR.2|FGQGGAGPVGGQGPR.3|FGQGGAGPVGGQGPR.2|SEEKISDSEGFK.3|SEEKISDSEGFK.2|MEELHNQEMQK.3|M[Oxi]EELHNQEM[Oxi]QK.3|M[Oxi]EELHNQEMQK.3|MEELHNQEM[Oxi]QK.3|MEELHNQEMQK.2|VRFATHAAALSVR.3|EMEEQMR.2|MPGGPKPGGGPGLSTPGGHPKPPHR.5|MPGGPKPGGGPGLSTPGGHPKPPHR.4|EEYEGPNK.2|QHHPPYHQQHHQGPPPGGPGGR.5|QHHPPYHQQHHQGPPPGGPGGR.4|QHHPPYHQQHHQGPPPGGPGGRSEEK.6|YGEPGEVFINKGK.3|ALAEIAKAELDDTPMRGR.4|DKLESEMEDAYHEHQANLLR.5|DKLESEMEDAYHEHQANLLR.4|DKLESEM[Oxi]EDAYHEHQANLLR.4|DKLESEMEDAYHEHQANLLR.3|AELDDTPMR.2|AELDDTPM[Oxi]R.2|GREEYEGPNKKPR.3|QREESYSR.2|SEEKISDSEGFKANLSLLR.4|SEEKISDSEGFKANLSLLR.3|DAKDKLESEMEDAYHEHQANLLR.5|DAKDKLESEMEDAYHEHQANLLR.4|ISDSEGFKANLSLLR.3|ISDSEGFKANLSLLR.2|LESEMEDAYHEHQANLLR.4|LESEMEDAYHEHQANLLR.3|REEEMMIR.2|GMGPGTPAGYGR.2|GM[Oxi]GPGTPAGYGR.2|FATHAAALSVR.2|GREEYEGPNK.2|LFVGNLPADITEDEFK.3|LFVGNLPADITEDEFK.2|LFVGNLPADITEDEFKRLFAK.4|LFVGNLPADITEDEFKRLFAK.3|PGGGPGLSTPGGHPKPPHR.3|DKLESEMEDAYHEHQANLLRQDLMR.5|DKLESEMEDAYHEHQANLLRQDLMR.4|YGEPGEVFINK.2|SPPPGMGLNQNR.2|SPPPGM[Oxi]GLNQNR.2|PVIVEPLEQLDDEDGLPEK.3|PVIVEPLEQLDDEDGLPEK.2|C[CAM]SEGVFLLTTTPR.2|FPPLGGGGGIGYEANPGVPPATMSGSMMGSDMR.4|FPPLGGGGGIGYEANPGVPPATMSGSMMGSDMR.3|M[Oxi]GGGGAMNMGDPYGSGGQK.2|MGGGGAMNMGDPYGSGGQK.2|C[CAM]SEGVFLLTTTPRPVIVEPLEQLDDEDGLPEK.4|C[CAM]SEGVFLLTTTPRPVIVEPLEQLDDEDGLPEK.3|C[CAM]SEGVFLLTTTPRPVIVEPLEQLDDEDGLPEKLAQK.4
SEN / CTL,Protein transport protein Sec31A,SEC31A,O94979,0.67,1.05,1.48E-03,1.07E-03,2.97E+00,"antigen processing and presentation of peptide antigen via MHC class I,ER to Golgi vesicle-mediated transport,protein transport,antigen processing and presentation of exogenous peptide antigen via MHC class II,IRE1-mediated unfolded protein response,COPII vesicle coating,response to calcium ion","protein binding,calcium-dependent protein binding","Golgi membrane,cytoplasm,endoplasmic reticulum,endoplasmic reticulum membrane,cytosol,ER to Golgi transport vesicle membrane,vesicle coat,COPII vesicle coat,ER to Golgi transport vesicle,intracellular membrane-bounded organelle,perinuclear region of cytoplasm,endoplasmic reticulum exit site",18,51,78,NPAVLSAASFDGR.2|TTFEDLIQR.2|NVWSFLK.2|RPVGASFSFGGK.3|RPVGASFSFGGK.2|GILAIAWSMADPELLLSC[CAM]GK.3|GILAIAWSM[Oxi]ADPELLLSC[CAM]GK.3|MADAIILAIAGGQELLAR.3|M[Oxi]ADAIILAIAGGQELLAR.3|MADAIILAIAGGQELLAR.2|M[Oxi]ADAIILAIAGGQELLAR.2|AQGEPVAGHESPK.3|AQGEPVAGHESPK.2|ATVWDLR.2|KIDASQTEFEK.3|KIDASQTEFEK.2|KPIPDEHLILK.3|KPIPDEHLILK.2|VVLTQANK.2|LITAVVMK.2|LIWGPYK.2|VDGANVALK.2|C[CAM]LSSATDPQTKR.3|QVQHILASASPSGR.3|QVQHILASASPSGR.2|AQGEPVAGHESPKIPYEK.4|AQGEPVAGHESPKIPYEK.3|LVTFENVR.2|VNFEDDSR.2|EVVIAQNDK.2|YLELLGYR.2|LREQTLSPTITSGLHNIAR.4|LREQTLSPTITSGLHNIAR.3|IIAGDKEVVIAQNDK.3|IIAGDKEVVIAQNDK.2|RLEFLYDK.2|EIVESC[CAM]DLK.2|EVVIAQNDKHTGPVR.3|IIAGDKEVVIAQNDKHTGPVR.4|SC[CAM]ATFSSSHR.2|MPSHQGAEQQQQQHHVFISQVVTEK.5|M[Oxi]PSHQGAEQQQQQHHVFISQVVTEK.5|M[Oxi]PSHQGAEQQQQQHHVFISQVVTEK.4|MPSHQGAEQQQQQHHVFISQVVTEK.4|MPSHQGAEQQQQQHHVFISQVVTEK.3|AQDGSHPLSLQDLIEK.3|AQDGSHPLSLQDLIEK.2|IDASQTEFEK.2|VNFEDDSRGK.2|C[CAM]LSSATDPQTK.2|EQTLSPTITSGLHNIAR.3|EQTLSPTITSGLHNIAR.2|PNIEGAPGAPIGNTFQHVQSLPTK.4|PNIEGAPGAPIGNTFQHVQSLPTK.3|LSSSFGNLDPFGTGQPLPPLQIPQQTAQHSIVLPLK.6|LSSSFGNLDPFGTGQPLPPLQIPQQTAQHSIVLPLK.5|LSSSFGNLDPFGTGQPLPPLQIPQQTAQHSIVLPLK.4|TGPQNGWNDPPALNRVPK.3|AVQLTQAMDTSTVGVLLAAK.3|AVQLTQAMDTSTVGVLLAAK.2|EALAAVLTYAKPDEFSALC[CAM]DLLGTR.4|EALAAVLTYAKPDEFSALC[CAM]DLLGTR.3|KAVQLTQAMDTSTVGVLLAAK.3|QVDKLSSSFGNLDPFGTGQPLPPLQIPQQTAQHSIVLPLK.6|QVDKLSSSFGNLDPFGTGQPLPPLQIPQQTAQHSIVLPLK.4|SDQLQQAVQSQGFINYC[CAM]QK.3|SDQLQQAVQSQGFINYC[CAM]QK.2|GDVSGVLIAGGENGNIILYDPSK.3|GDVSGVLIAGGENGNIILYDPSK.2|ISVYSIMGGSTDGLR.2|ISVYSIM[Oxi]GGSTDGLR.2|MHC[CAM]SGLAWHPDVATQMVLASEDDRLPVIQMWDLR.5|PDEFSALC[CAM]DLLGTR.2|NYSEGLTMHTHIVSTSNFSETSAFMPVLK.4|TGPQNGWNDPPALNR.2|GILAIAWSMADPELLLSC[CAM]GKDAK.3|TQPPEDISC[CAM]IAWNR.2|LENEGDSLLQTQAC[CAM]LC[CAM]YIC[CAM]AGNVEK.3
SEN / CTL,Clathrin heavy chain 1,CLTC,Q00610,0.67,0.70,2.35E-28,5.29E-27,2.63E+01,"osteoblast differentiation,intracellular protein transport,receptor-mediated endocytosis,mitotic nuclear division,antigen processing and presentation of exogenous peptide antigen via MHC class II,receptor internalization,transferrin transport,retrograde transport, endosome to Golgi,Wnt signaling pathway, planar cell polarity pathway,regulation of mitotic spindle organization,negative regulation of hyaluronan biosynthetic process,negative regulation of protein localization to plasma membrane","double-stranded RNA binding,structural molecule activity,protein binding,protein kinase binding,clathrin light chain binding,poly(A) RNA binding","spindle,cytosol,plasma membrane,focal adhesion,membrane,clathrin coat,clathrin coat of trans-Golgi network vesicle,clathrin coat of coated pit,clathrin-coated vesicle,clathrin-coated endocytic vesicle membrane,extracellular matrix,trans-Golgi network membrane,endolysosome membrane,melanosome,intracellular membrane-bounded organelle,protein complex,extracellular exosome,clathrin complex,extracellular vesicle,mitotic spindle microtubule",234,154,302,LLLPWLEAR.2|SVDPTLALSVYLR.2|VANVELYYR.2|QKWLLLTGISAQQNR.3|KVGYTPDWIFLLR.3|KVGYTPDWIFLLR.2|LLYNNVSNFGR.2|WLLLTGISAQQNR.2|WLLLTGISAQQNR.3|YIEIYVQK.2|VGYTPDWIFLLR.2|ALEHFTDLYDIKR.3|ALEHFTDLYDIKR.4|ALEHFTDLYDIKR.2|GQFSTDELVAEVEKR.3|GQFSTDELVAEVEKR.2|LKLLLPWLEAR.2|LKLLLPWLEAR.3|TWKEVC[CAM]FAC[CAM]VDGKEFR.4|KFDVNTSAVQVLIEHIGNLDR.4|KFDVNTSAVQVLIEHIGNLDR.3|KFDVNTSAVQVLIEHIGNLDR.2|HSSLAGC[CAM]QIINYR.3|HSSLAGC[CAM]QIINYR.2|AFMTADLPNELIELLEK.2|AFM[Oxi]TADLPNELIELLEK.2|AFMTADLPNELIELLEK.3|AFM[Oxi]TADLPNELIELLEK.3|NNLAGAEELFAR.2|NNLAGAEELFAR.3|SVNESLNNLFITEEDYQALR.3|SVNESLNNLFITEEDYQALR.2|TSIDAYDNFDNISLAQR.2|TSIDAYDNFDNISLAQR.3|KGQVLSVC[CAM]VEEENIIPYITNVLQNPDLALR.4|KGQVLSVC[CAM]VEEENIIPYITNVLQNPDLALR.3|GQC[CAM]DLELINVC[CAM]NENSLFK.3|GQC[CAM]DLELINVC[CAM]NENSLFK.2|C[CAM]NEPAVWSQLAK.2|NLILVVR.2|TLQIFNIEMK.2|TLQIFNIEM[Oxi]K.2|VVGAMQLYSVDR.2|VVGAM[Oxi]QLYSVDR.2|NLQNLLILTAIK.2|NLQNLLILTAIK.3|NLQNLLILTAIKADR.3|NLQNLLILTAIKADR.2|WLKEDKLEC[CAM]SEELGDLVK.4|WLKEDKLEC[CAM]SEELGDLVK.3|WLKEDKLEC[CAM]SEELGDLVK.2|LASTLVHLGEYQAAVDGAR.3|LASTLVHLGEYQAAVDGAR.2|LASTLVHLGEYQAAVDGAR.4|IVLDNSVFSEHR.3|IVLDNSVFSEHR.2|ANVPNKVIQC[CAM]FAETGQVQK.3|KVSQPIEGHAASFAQFK.4|KVSQPIEGHAASFAQFK.3|MREHLELFWSR.3|M[Oxi]REHLELFWSR.3|VNPSRLPVVIGGLLDVDC[CAM]SEDVIKNLILVVR.4|LHIIEVGTPPTGNQPFPK.3|LHIIEVGTPPTGNQPFPK.2|LHIIEVGTPPTGNQPFPK.4|GQVLSVC[CAM]VEEENIIPYITNVLQNPDLALR.3|GQVLSVC[CAM]VEEENIIPYITNVLQNPDLALR.4|AVVHTHLLNPEWLVNYFGSLSVEDSLEC[CAM]LR.4|AVVHTHLLNPEWLVNYFGSLSVEDSLEC[CAM]LR.3|QLPLVKPYLR.3|QLPLVKPYLR.2|FLRENPYYDSR.3|FLRENPYYDSR.2|LLEMNLMHAPQVADAILGNQMFTHYDR.4|LLEM[Oxi]NLMHAPQVADAILGNQMFTHYDR.4|LLEMNLM[Oxi]HAPQVADAILGNQMFTHYDR.4|LLEMNLMHAPQVADAILGNQMFTHYDR.5|LLEM[Oxi]NLM[Oxi]HAPQVADAILGNQMFTHYDR.4|LLEM[Oxi]NLMHAPQVADAILGNQM[Oxi]FTHYDR.4|LLEMNLM[Oxi]HAPQVADAILGNQM[Oxi]FTHYDR.4|LLEMNLMHAPQVADAILGNQM[Oxi]FTHYDR.4|LLEM[Oxi]NLM[Oxi]HAPQVADAILGNQM[Oxi]FTHYDR.4|LLEMNLM[Oxi]HAPQVADAILGNQMFTHYDR.3|LLEMNLMHAPQVADAILGNQM[Oxi]FTHYDR.3|LLEMNLMHAPQVADAILGNQMFTHYDR.3|KFNALFAQGNYSEAAK.3|KFNALFAQGNYSEAAK.2|VSQPIEGHAASFAQFK.3|VSQPIEGHAASFAQFK.2|VVGAMQLYSVDRK.3|VVGAM[Oxi]QLYSVDRK.3|VVGAMQLYSVDRK.2|TWKEVC[CAM]FAC[CAM]VDGK.3|TWKEVC[CAM]FAC[CAM]VDGK.2|ARESYVETELIFALAK.3|ARESYVETELIFALAK.2|ISGETIFVTAPHEATAGIIGVNR.3|ISGETIFVTAPHEATAGIIGVNR.4|ISGETIFVTAPHEATAGIIGVNR.2|RPLIDQVVQTALSETQDPEEVSVTVK.3|RPLIDQVVQTALSETQDPEEVSVTVK.5|RPLIDQVVQTALSETQDPEEVSVTVK.4|ISGETIFVTAPHEATAGIIGVNRK.4|ISGETIFVTAPHEATAGIIGVNRK.5|ISGETIFVTAPHEATAGIIGVNRK.3|GQAGGKLHIIEVGTPPTGNQPFPK.4|GQAGGKLHIIEVGTPPTGNQPFPK.3|YIQAAC[CAM]K.2|IAAYLFK.2|AHTMTDDVTFWK.3|AHTM[Oxi]TDDVTFWK.3|AHTM[Oxi]TDDVTFWK.2|AHTMTDDVTFWK.2|AHMGMFTELAILYSK.3|AHM[Oxi]GMFTELAILYSK.3|AHMGM[Oxi]FTELAILYSK.3|AHM[Oxi]GM[Oxi]FTELAILYSK.3|AHM[Oxi]GMFTELAILYSK.2|AHMGM[Oxi]FTELAILYSK.2|AHMGMFTELAILYSK.2|AHM[Oxi]GM[Oxi]FTELAILYSK.2|HNIMDFAMPYFIQVMK.3|HNIMDFAMPYFIQVMK.4|HNIM[Oxi]DFAMPYFIQVMK.3|HNIMDFAM[Oxi]PYFIQVMK.3|HNIMDFAMPYFIQVM[Oxi]K.3|HNIM[Oxi]DFAM[Oxi]PYFIQVMK.3|HNIM[Oxi]DFAMPYFIQVMK.2|HNIMDFAM[Oxi]PYFIQVMK.2|HNIMDFAMPYFIQVM[Oxi]K.2|HNIMDFAMPYFIQVMK.2|VNPSRLPVVIGGLLDVDC[CAM]SEDVIK.3|VNPSRLPVVIGGLLDVDC[CAM]SEDVIK.4|LPVVIGGLLDVDC[CAM]SEDVIKNLILVVR.4|LPVVIGGLLDVDC[CAM]SEDVIKNLILVVR.3|ALEHFTDLYDIK.3|ALEHFTDLYDIK.2|EHLELFWSR.3|EHLELFWSR.2|AVNYFSK.2|VDKLDASESLR.3|VDKLDASESLR.2|YC[CAM]EKRDPHLAC[CAM]VAYER.5|YC[CAM]EKRDPHLAC[CAM]VAYER.4|YC[CAM]EKRDPHLAC[CAM]VAYER.3|IAAYLFKGNNR.3|AMLSANIR.2|AM[Oxi]LSANIR.2|AYEFAER.2|DPHLAC[CAM]VAYER.3|DPHLAC[CAM]VAYER.2|LEKHELIEFR.3|LEKHELIEFR.2|IHEGC[CAM]EEPATHNALAK.4|IHEGC[CAM]EEPATHNALAK.3|IHEGC[CAM]EEPATHNALAK.2|IYIDSNNNPER.3|IYIDSNNNPER.2|LDASESLR.2|NNRPSEGPLQTR.3|NNRPSEGPLQTR.2|VDKLDASESLRK.3|VDKLDASESLRK.2|FLRENPYYDSRVVGK.4|VMEYINR.2|VM[Oxi]EYINR.2|EAIDSYIK.2|HELIEFR.2|NNLAGAEELFARK.3|NNLAGAEELFARK.2|VKQLPLVKPYLR.3|QSVELC[CAM]KK.2|RDPHLAC[CAM]VAYER.3|RDPHLAC[CAM]VAYER.2|VIQC[CAM]FAETGQVQK.3|VIQC[CAM]FAETGQVQK.2|LDASESLRK.2|ENPYYDSR.2|GQFSTDELVAEVEK.3|GQFSTDELVAEVEK.2|LHIIEVGTPPTGNQPFPKK.4|LHIIEVGTPPTGNQPFPKK.3|LTDQLPLIIVC[CAM]DR.3|LTDQLPLIIVC[CAM]DR.2|MFDRHSSLAGC[CAM]QIINYR.4|RPISADSAIMNPASK.3|RPISADSAIM[Oxi]NPASK.3|RPISADSAIM[Oxi]NPASK.2|RPISADSAIMNPASK.2|PLLLNDLLMVLSPR.3|PLLLNDLLM[Oxi]VLSPR.3|PLLLNDLLM[Oxi]VLSPR.2|PLLLNDLLMVLSPR.2|TGQIKEVER.2|AHIAQLC[CAM]EK.2|ESYVETELIFALAK.3|ESYVETELIFALAK.2|HDVVFLITK.2|YESLELC[CAM]R.2|FNALFAQGNYSEAAK.3|FNALFAQGNYSEAAK.2|KDPELWGSVLLESNPYRR.4|RKDPELWGSVLLESNPYR.4|RKDPELWGSVLLESNPYR.3|RKDPELWGSVLLESNPYR.2|YHEQLSTQSLIELFESFK.4|YHEQLSTQSLIELFESFK.3|YHEQLSTQSLIELFESFK.2|DAMQYASESK.2|DAM[Oxi]QYASESK.2|FDFVHDLVLYLYR.3|FDFVHDLVLYLYR.2|DTELAEELLQWFLQEEKR.4|DTELAEELLQWFLQEEKR.3|MKAHTMTDDVTFWK.3|MKAHTMTDDVTFWK.2|ESNC[CAM]YDPER.2|EDKLEC[CAM]SEELGDLVK.3|EDKLEC[CAM]SEELGDLVK.2|EVC[CAM]FAC[CAM]VDGK.2|LAELEEFINGPNNAHIQQVGDR.4|LAELEEFINGPNNAHIQQVGDR.3|MEGNAEESTLFC[CAM]FAVR.3|M[Oxi]EGNAEESTLFC[CAM]FAVR.2|MEGNAEESTLFC[CAM]FAVR.2|YESLELC[CAM]RPVLQQGR.3|YESLELC[CAM]RPVLQQGR.2|DPELWGSVLLESNPYR.3|DPELWGSVLLESNPYR.2|KFDVNTSAVQVLIEHIGNLDRAYEFAER.5|KFDVNTSAVQVLIEHIGNLDRAYEFAER.4|AAEQAHLWAELVFLYDK.3|KDPELWGSVLLESNPYR.3|KDPELWGSVLLESNPYR.2|GMVKEAIDSYIK.2|LPVVIGGLLDVDC[CAM]SEDVIK.3|LPVVIGGLLDVDC[CAM]SEDVIK.2|PLIDQVVQTALSETQDPEEVSVTVK.4|PLIDQVVQTALSETQDPEEVSVTVK.3|IVLDNSVFSEHRNLQNLLILTAIK.4|IVLDNSVFSEHRNLQNLLILTAIK.3|LEC[CAM]SEELGDLVK.2|QNLQIC[CAM]VQVASK.2|ESNC[CAM]YDPERVK.2|PISADSAIMNPASK.2|DTELAEELLQWFLQEEK.3|TNRLAELEEFINGPNNAHIQQVGDR.4|TNRLAELEEFINGPNNAHIQQVGDR.3|TNRLAELEEFINGPNNAHIQQVGDRC[CAM]YDEK.5|VGEQAQVVIIDMNDPSNPIR.3|VGEQAQVVIIDM[Oxi]NDPSNPIR.3|VGEQAQVVIIDM[Oxi]NDPSNPIR.2|VGEQAQVVIIDMNDPSNPIR.2|FDVNTSAVQVLIEHIGNLDR.3|FDVNTSAVQVLIEHIGNLDR.2|KAVDVFFPPEAQNDFPVAMQISEKHDVVFLITK.5|KAVDVFFPPEAQNDFPVAMQISEKHDVVFLITK.4|FDVNTSAVQVLIEHIGNLDRAYEFAER.4|TSIDAYDNFDNISLAQRLEK.3|FQEHLQLQNLGINPANIGFSTLTM[Oxi]ESDK.4|FQEHLQLQNLGINPANIGFSTLTMESDK.4|FQEHLQLQNLGINPANIGFSTLTMESDK.3|FQEHLQLQNLGINPANIGFSTLTM[Oxi]ESDK.3|LAELEEFINGPNNAHIQQVGDRC[CAM]YDEK.4|LAELEEFINGPNNAHIQQVGDRC[CAM]YDEK.3|LAQMC[CAM]GLHIVVHADELEELINYYQDR.4|LAQMC[CAM]GLHIVVHADELEELINYYQDR.3|EKVGEQAQVVIIDMNDPSNPIRRPISADSAIMNPASK.5|FQSVPAQPGQTSPLLQYFGILLDQGQLNK.4|FQSVPAQPGQTSPLLQYFGILLDQGQLNK.3|WISLNTVALVTDNAVYHWSMEGESQPVK.4|WISLNTVALVTDNAVYHWSMEGESQPVK.3|YGYIHLYDLETGTC[CAM]IYM[Oxi]NR.3|YGYIHLYDLETGTC[CAM]IYMNR.3|YGYIHLYDLETGTC[CAM]IYMNR.2|EKVGEQAQVVIIDMNDPSNPIR.3|EKVGEQAQVVIIDM[Oxi]NDPSNPIR.3|LLYNNVSNFGRLASTLVHLGEYQAAVDGAR.4|REC[CAM]FGAC[CAM]LFTC[CAM]YDLLRPDVVLETAWR.4|REC[CAM]FGAC[CAM]LFTC[CAM]YDLLRPDVVLETAWR.3|YEEYDNAIITMMNHPTDAWK.3|SVQNHNNKSVNESLNNLFITEEDYQALR.4|DAMQYASESKDTELAEELLQWFLQEEKR.4|RFQSVPAQPGQTSPLLQYFGILLDQGQLNK.4|RFQSVPAQPGQTSPLLQYFGILLDQGQLNK.3|AVDVFFPPEAQNDFPVAMQISEK.3|DSLYKDAMQYASESK.2|AAEQAHLWAELVFLYDKYEEYDNAIITMMNHPTDAWK.5|AAEQAHLWAELVFLYDKYEEYDNAIITMMNHPTDAWK.4|ADDPSSYMEVVQAANTSGNWEELVK.3|ADDPSSYM[Oxi]EVVQAANTSGNWEELVK.3|EAIDSYIKADDPSSYMEVVQAANTSGNWEELVK.4|KAVDVFFPPEAQNDFPVAMQISEK.3|RAVVHTHLLNPEWLVNYFGSLSVEDSLEC[CAM]LR.4|VGEQAQVVIIDM[Oxi]NDPSNPIRRPISADSAIMNPASK.4|VGEQAQVVIIDMNDPSNPIRRPISADSAIMNPASK.4|FQEHLQLQNLGINPANIGFSTLTM[Oxi]ESDKFIC[CAM]IR.4|FQEHLQLQNLGINPANIGFSTLTMESDKFIC[CAM]IR.4|FQSVPAQPGQTSPLLQYFGILLDQGQLNKYESLELC[CAM]RPVLQQGR.5|EC[CAM]FGAC[CAM]LFTC[CAM]YDLLRPDVVLETAWR.3|FQSVPAQPGQTSPLLQYFGILLDQGQLNKYESLELC[CAM]RPVLQQGRK.5|DPELWGSVLLESNPYRRPLIDQVVQTALSETQDPEEVSVTVK.4
SEN / CTL,60S ribosomal protein L4,RPL4,P36578,0.67,0.42,8.82E-03,4.84E-03,2.32E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","RNA binding,structural constituent of ribosome,protein binding,poly(A) RNA binding","nucleus,nucleolus,cytoplasm,cytosol,focal adhesion,membrane,cytosolic large ribosomal subunit,intracellular ribonucleoprotein complex,extracellular exosome",6,42,74,NIPGITLLNVSK.2|NIPGITLLNVSK.3|FC[CAM]IWTESAFR.2|KPTTEEKKPAA.3|KPAPEKKPAEKKPTTEEK.5|KPAPEKKPAEKKPTTEEK.4|AAATKKPAPEKKPAEK.4|AAVAGKKPVVGKK.3|KLDELYGTWR.3|KLDELYGTWR.2|LAPGGHVGR.2|VDKAAAAAAALQAK.3|VDKAAAAAAALQAK.2|AWNDIKK.2|KPAEKKPTTEEKKPAA.4|EAVLLLKK.2|APIRPDIVNFVHTNLR.4|APIRPDIVNFVHTNLR.3|APIRPDIVNFVHTNLR.2|KLDELYGTWRK.3|MINTDLSR.2|M[Oxi]INTDLSR.2|AAAAAAALQAK.2|FC[CAM]IWTESAFRK.3|GHRIEEVPELPLVVEDK.4|GHRIEEVPELPLVVEDK.3|GHRIEEVPELPLVVEDK.2|NVTLPAVFK.2|NVTLPAVFKAPIRPDIVNFVHTNLRK.6|NVTLPAVFKAPIRPDIVNFVHTNLRK.5|NVTLPAVFKAPIRPDIVNFVHTNLRK.4|APIRPDIVNFVHTNLRK.4|APIRPDIVNFVHTNLRK.3|TKEAVLLLK.2|LRVDKAAAAAAALQAK.3|PLISVYSEK.2|PLISVYSEKGESSGK.3|PLISVYSEKGESSGK.2|GPC[CAM]IIYNEDNGIIK.3|GPC[CAM]IIYNEDNGIIK.2|IEEVPELPLVVEDK.3|IEEVPELPLVVEDK.2|AFRNIPGITLLNVSK.3|SNYNLPMHK.2|SNYNLPM[Oxi]HK.2|NVTLPAVFKAPIRPDIVNFVHTNLR.5|NVTLPAVFKAPIRPDIVNFVHTNLR.4|KNNRQPYAVSELAGHQTSAESWGTGR.5|KNNRQPYAVSELAGHQTSAESWGTGR.4|IEEVPELPLVVEDKVEGYKK.4|IEEVPELPLVVEDKVEGYKK.3|IEEVPELPLVVEDKVEGYKK.2|LDELYGTWR.2|QPYAVSELAGHQTSAESWGTGR.4|QPYAVSELAGHQTSAESWGTGR.3|QPYAVSELAGHQTSAESWGTGR.2|RGPC[CAM]IIYNEDNGIIK.3|RGPC[CAM]IIYNEDNGIIK.2|SGQGAFGNMC[CAM]R.2|SGQGAFGNM[Oxi]C[CAM]R.2|NIPGITLLNVSKLNILK.3|GHRIEEVPELPLVVEDKVEGYK.4|GHRIEEVPELPLVVEDKVEGYK.3|YAIC[CAM]SALAASALPALVMSK.3|YAIC[CAM]SALAASALPALVM[Oxi]SK.3|YAIC[CAM]SALAASALPALVMSK.2|YAIC[CAM]SALAASALPALVM[Oxi]SK.2|NNRQPYAVSELAGHQTSAESWGTGR.4|NNRQPYAVSELAGHQTSAESWGTGR.3|RYAIC[CAM]SALAASALPALVM[Oxi]SK.3|RYAIC[CAM]SALAASALPALVMSK.3|RYAIC[CAM]SALAASALPALVMSK.2|IEEVPELPLVVEDKVEGYK.3|IEEVPELPLVVEDKVEGYK.2
SEN / CTL,60S ribosomal protein L18a,RPL18A,Q02543,0.66,0.67,3.36E-02,1.44E-02,1.84E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","RNA binding,structural constituent of ribosome,protein binding,poly(A) RNA binding","cytosol,membrane,cytosolic large ribosomal subunit",6,17,25,EYRDLTTAGAVTQC[CAM]YR.3|DLTTAGAVTQC[CAM]YR.2|DLTTAGAVTQC[CAM]YR.3|VEEIAASK.2|AHSIQIM[Oxi]KVEEIAASK.4|AHSIQIMKVEEIAASK.4|AHSIQIMKVEEIAASK.3|AHSIQIM[Oxi]KVEEIAASK.3|AHSIQIMKVEEIAASK.2|FWYFVSQLKK.3|NFGIWLR.2|AHSIQIMK.2|AHSIQIM[Oxi]K.2|ASGTLREYKVVGR.3|SGTHNMYR.2|SRFWYFVSQLK.3|SRFWYFVSQLK.2|C[CAM]HTPPLYR.2|SRFWYFVSQLKK.3|IFAPNHVVAK.2|KSSGEIVYC[CAM]GQVFEK.3|KSSGEIVYC[CAM]GQVFEK.2|FWYFVSQLK.2|SSGEIVYC[CAM]GQVFEKSPLR.3|SSGEIVYC[CAM]GQVFEK.2
SEN / CTL,"ATP synthase subunit alpha, mitochondrial",ATP5A1,P25705,0.66,0.68,2.17E-15,1.36E-14,1.39E+01,"negative regulation of endothelial cell proliferation,lipid metabolic process,ATP biosynthetic process,embryo development,mitochondrial ATP synthesis coupled proton transport","protein binding,ATP binding,transmembrane transporter activity,MHC class I protein binding,poly(A) RNA binding,proton-transporting ATP synthase activity, rotational mechanism,ATPase activity","mitochondrion,mitochondrial inner membrane,mitochondrial proton-transporting ATP synthase complex,mitochondrial matrix,plasma membrane,membrane,extracellular matrix,myelin sheath,proton-transporting ATP synthase complex, catalytic core F(1),extracellular exosome,COP9 signalosome",87,55,105,TGAIVDVPVGEELLGR.2|TGAIVDVPVGEELLGR.3|EAYPGDVFYLHSR.3|EAYPGDVFYLHSR.2|HALIIYDDLSK.3|HALIIYDDLSK.2|AVDSLVPIGR.2|TSIAIDTIINQKR.3|TSIAIDTIINQKR.2|LYC[CAM]IYVAIGQK.2|GMSLNLEPDNVGVVVFGNDKLIK.3|GM[Oxi]SLNLEPDNVGVVVFGNDKLIK.3|GIRPAINVGLSVSR.3|GIRPAINVGLSVSR.2|VVDALGNAIDGKGPIGSK.3|VVDALGNAIDGKGPIGSK.2|ILGADTSVDLEETGR.2|ILGADTSVDLEETGR.3|TSIAIDTIINQK.2|TSIAIDTIINQK.3|EVAAFAQFGSDLDAATQQLLSR.3|EVAAFAQFGSDLDAATQQLLSR.4|EVAAFAQFGSDLDAATQQLLSR.2|FENAFLSHVVSQHQALLGTIR.4|FENAFLSHVVSQHQALLGTIR.3|FENAFLSHVVSQHQALLGTIR.2|ITKFENAFLSHVVSQHQALLGTIR.5|ITKFENAFLSHVVSQHQALLGTIR.4|ITKFENAFLSHVVSQHQALLGTIR.3|QGQYSPMAIEEQVAVIYAGVR.3|QGQYSPM[Oxi]AIEEQVAVIYAGVR.3|QGQYSPMAIEEQVAVIYAGVR.4|QGQYSPM[Oxi]AIEEQVAVIYAGVR.2|QGQYSPMAIEEQVAVIYAGVR.2|LKEIVTNFLAGFEA.2|LKEIVTNFLAGFEA.3|RTGAIVDVPVGEELLGR.3|RTGAIVDVPVGEELLGR.2|VLSIGDGIAR.2|GYLDKLEPSKITK.3|TGTAEMSSILEER.2|TGTAEMSSILEER.3|TGTAEM[Oxi]SSILEER.2|TGAIVDVPVGEELLGRVVDALGNAIDGKGPIGSK.4|TGAIVDVPVGEELLGRVVDALGNAIDGKGPIGSK.5|TGAIVDVPVGEELLGRVVDALGNAIDGKGPIGSK.3|RPPGREAYPGDVFYLHSR.5|RPPGREAYPGDVFYLHSR.4|EGDIVKR.2|ELIIGDRQTGK.3|ELIIGDRQTGK.2|ADGKISEQSDAK.3|ADGKISEQSDAK.2|DNGKHALIIYDDLSK.4|DNGKHALIIYDDLSK.3|DNGKHALIIYDDLSK.2|RVGLKAPGIIPR.3|STVAQLVK.2|ISEQSDAK.2|LTDADAM[Oxi]K.2|LELAQYR.2|AVDSLVPIGRGQR.3|FNDGSDEK.2|ISVREPMQTGIK.3|ISVREPM[Oxi]QTGIK.3|ISVREPMQTGIK.2|ISVREPM[Oxi]QTGIK.2|KLYC[CAM]IYVAIGQK.3|KLYC[CAM]IYVAIGQK.2|HALIIYDDLSKQAVAYR.4|HALIIYDDLSKQAVAYR.3|RSTVAQLVK.2|RLTDADAMK.2|RLTDADAM[Oxi]K.2|RPPGREAYPGDVFYLHSRLLER.5|QVAGTMKLELAQYR.3|QVAGTMKLELAQYR.2|RFNDGSDEK.2|FENAFLSHVVSQHQALLGTIRADGK.5|FENAFLSHVVSQHQALLGTIRADGK.4|FENAFLSHVVSQHQALLGTIRADGK.3|NVQAEEMVEFSSGLK.3|NVQAEEM[Oxi]VEFSSGLK.2|NVQAEEMVEFSSGLK.2|PAINVGLSVSR.2|VGLKAPGIIPR.2|GYLDKLEPSK.2|VVDALGNAIDGK.2|ISVREPM[Oxi]QTGIKAVDSLVPIGR.4|ISEQSDAKLKEIVTNFLAGFEA.4|ISEQSDAKLKEIVTNFLAGFEA.3|EIVTNFLAGFEA.2|GMSLNLEPDNVGVVVFGNDK.3|GM[Oxi]SLNLEPDNVGVVVFGNDK.3|GM[Oxi]SLNLEPDNVGVVVFGNDK.2|GMSLNLEPDNVGVVVFGNDK.2|LELAQYREVAAFAQFGSDLDAATQQLLSR.4|LELAQYREVAAFAQFGSDLDAATQQLLSR.3|YTIVVSATASDAAPLQYLAPYSGC[CAM]SMGEYFR.4|YTIVVSATASDAAPLQYLAPYSGC[CAM]SM[Oxi]GEYFR.4|YTIVVSATASDAAPLQYLAPYSGC[CAM]SM[Oxi]GEYFR.3|YTIVVSATASDAAPLQYLAPYSGC[CAM]SMGEYFR.3|ILGADTSVDLEETGRVLSIGDGIAR.3|QVAGTM[Oxi]KLELAQYREVAAFAQFGSDLDAATQQLLSR.4|QVAGTMKLELAQYREVAAFAQFGSDLDAATQQLLSR.4
SEN / CTL,Flotillin-2,FLOT2,Q14254,0.66,0.38,1.77E-03,1.25E-03,2.90E+00,"membrane raft assembly,cell adhesion,chemical synaptic transmission,epidermis development,negative regulation of gene expression,protein localization to plasma membrane raft,regulation of myoblast differentiation,protein stabilization,establishment of protein localization to plasma membrane,negative regulation of amyloid precursor protein catabolic process,positive regulation of establishment of T cell polarity,regulation of heterotypic cell-cell adhesion,regulation of toll-like receptor 3 signaling pathway","protease binding,protein binding,ionotropic glutamate receptor binding,protein heterodimerization activity","uropod,acrosomal membrane,endosome,plasma membrane,caveola,cell-cell adherens junction,focal adhesion,membrane,basolateral plasma membrane,flotillin complex,lamellipodium,endocytic vesicle,cytoplasmic vesicle,vesicle,cell-cell contact zone,perinuclear region of cytoplasm,extracellular exosome,apical plasma membrane,cortical actin cytoskeleton",12,26,30,SAFSEEVNIK.2|TAEAQLAYELQGAR.2|MALVLEALPQIAAK.2|M[Oxi]ALVLEALPQIAAK.2|QVLLAQAEAEK.2|TQTAVVQR.2|NVVLQTLEGHLR.3|NVVLQTLEGHLR.2|VDYLSSLGK.2|IQQIAEGEK.2|KIGEAEAAVIEAMGK.3|DADIGVAEAERDAGIR.3|IRQEEIEIEVVQR.3|DADIGVAEAER.2|SILGTLTVEQIYQDR.3|SILGTLTVEQIYQDR.2|LLAELPASVHALTGVDLSKIPLIK.4|MGIEILSFTIK.2|QIAVEAQEILR.2|LLAELPASVHALTGVDLSK.3|ISLEIMTLQPR.2|IAAPLTKVDEIVVLSGDNSK.3|IGEAEAAVIEAMGK.2|IMTEKELLAVAC[CAM]EQFLGK.3|NVQDIKNVVLQTLEGHLR.3|VDEIVVLSGDNSK.2|ELLAVAC[CAM]EQFLGK.2|SILGTLTVEQIYQDRDQFAK.3|SILGTLTVEQIYQDRDQFAK.2|DVYDKVDYLSSLGK.2
SEN / CTL,Cysteine and glycine-rich protein 1,CSRP1,P21291,0.65,0.96,2.16E-04,2.00E-04,3.70E+00,platelet aggregation,"zinc ion binding,poly(A) RNA binding","nucleus,focal adhesion,extracellular exosome",21,16,31,NLDSTTVAVHGEEIYC[CAM]K.3|NLDSTTVAVHGEEIYC[CAM]K.2|GFGFGQGAGALVHSE.2|GFGFGQGAGALVHSE.3|GLESTTLADKDGEIYC[CAM]K.3|GLESTTLADKDGEIYC[CAM]K.2|TVYFAEEVQC[CAM]EGNSFHK.3|TVYFAEEVQC[CAM]EGNSFHK.4|TVYFAEEVQC[CAM]EGNSFHK.2|GYGYGQGAGTLSTDKGESLGIKHEEAPGHRPTTNPNASK.6|GYGYGQGAGTLSTDKGESLGIKHEEAPGHRPTTNPNASK.5|GYGYGQGAGTLSTDKGESLGIKHEEAPGHRPTTNPNASK.7|GYGYGQGAGTLSTDKGESLGIKHEEAPGHRPTTNPNASK.4|DGEIYC[CAM]K.2|HEEAPGHRPTTNPNASK.4|HEEAPGHRPTTNPNASK.3|HEEAPGHRPTTNPNASK.2|GESLGIKHEEAPGHRPTTNPNASK.5|GESLGIKHEEAPGHRPTTNPNASK.4|GESLGIKHEEAPGHRPTTNPNASK.3|GLESTTLADK.2|C[CAM]SQAVYAAEKVIGAGK.3|C[CAM]SQAVYAAEK.2|SC[CAM]FLC[CAM]MVC[CAM]K.2|SC[CAM]FLC[CAM]M[Oxi]VC[CAM]K.2|GLESTTLADKDGEIYC[CAM]KGC[CAM]YAK.4|GLESTTLADKDGEIYC[CAM]KGC[CAM]YAK.3|KNLDSTTVAVHGEEIYC[CAM]K.3|GYGYGQGAGTLSTDKGESLGIK.3|GYGYGQGAGTLSTDKGESLGIK.2|GYGYGQGAGTLSTDK.2
SEN / CTL,Myosin regulatory light chain 12B;Myosin regulatory light chain 12A,MYL12B;MYL12A,O14950;P19105,0.65,0.46,3.80E-02,1.58E-02,1.80E+00,"muscle contraction,regulation of cell shape;muscle contraction,ephrin receptor signaling pathway,platelet aggregation","calcium ion binding,myosin heavy chain binding;calcium ion binding","stress fiber,cytosol,brush border,myosin II complex,Z disc,apical part of cell,extracellular exosome;cytosol,myosin complex,extracellular exosome",27,18,38,GNFNYIEFTR.2|LNGTDPEDVIR.2|NAFAC[CAM]FDEEATGTIQEDYLR.3|NAFAC[CAM]FDEEATGTIQEDYLR.2|ELLTTMGDRFTDEEVDELYR.3|ELLTTM[Oxi]GDRFTDEEVDELYR.3|ATSNVFAMFDQSQIQEFK.3|ATSNVFAMFDQSQIQEFK.2|ATSNVFAM[Oxi]FDQSQIQEFK.3|ATSNVFAM[Oxi]FDQSQIQEFK.2|FTDEEVDELYR.2|FTDEEVDELYR.3|KGNFNYIEFTR.3|KGNFNYIEFTR.2|ATSNVFAMFDQSQIQEFKEAFNMIDQNR.3|EDLHDMLASLGK.3|EDLHDMLASLGK.2|DGFIDKEDLHDMLASLGK.4|DGFIDKEDLHDM[Oxi]LASLGK.4|DGFIDKEDLHDMLASLGK.3|DGFIDKEDLHDMLASLGK.2|ELLTTMGDR.2|ELLTTM[Oxi]GDR.2|EAFNMIDQNR.2|EAFNM[Oxi]IDQNR.2|EAFNMIDQNRDGFIDK.3|EAFNMIDQNRDGFIDK.2|EAFNMIDQNRDGFIDKEDLHDMLASLGK.5|EAFNMIDQNRDGFIDKEDLHDMLASLGK.4|EAFNM[Oxi]IDQNRDGFIDKEDLHDMLASLGK.4|EAPIDKKGNFNYIEFTR.3|FTDEEVDELYREAPIDK.3|FTDEEVDELYREAPIDK.2|ELLTTM[Oxi]GDRFTDEEVDELYREAPIDK.4|ELLTTMGDRFTDEEVDELYREAPIDK.4|ELLTTMGDRFTDEEVDELYREAPIDK.3|LNGTDPEDVIRNAFAC[CAM]FDEEATGTIQEDYLR.4|LNGTDPEDVIRNAFAC[CAM]FDEEATGTIQEDYLR.3
SEN / CTL,Protein Niban,FAM129A,Q9BZQ8,0.65,0.41,1.48E-04,1.43E-04,3.84E+00,"negative regulation of protein phosphorylation,positive regulation of protein phosphorylation,response to endoplasmic reticulum stress,positive regulation of translation","molecular_function,protein binding","cytoplasm,plasma membrane,membrane,extracellular exosome",12,25,36,FSALLSDC[CAM]VR.2|EFPVYLWQPFFR.2|EFPVYLWQPFFR.3|QYSVAFC[CAM]NHVR.3|QYSVAFC[CAM]NHVR.2|FPHIDLVVQR.3|FPHIDLVVQR.2|HFPDPLASSEK.3|HFPDPLASSEK.2|ENTQPFVVLPK.3|ENTQPFVVLPK.2|HGYFC[CAM]FHEAADQKR.4|VNLLHER.2|ALASTC[CAM]KPELQK.3|ALASTC[CAM]KPELQK.2|AMVAQPAEK.2|DLTSQFLK.2|FRFPHIDLVVQR.3|VLTSEDEYNLLSDR.3|VLTSEDEYNLLSDR.2|SDMDQIVNSK.2|LMNLPLHSVK.2|IFQEALVQITLPTVQK.3|IFQEALVQITLPTVQK.2|HFPDPLASSEKENTQPFVVLPK.4|HFPDPLASSEKENTQPFVVLPK.3|QYDYDSSTIR.2|NDYAVESYENK.2|RFSALLSDC[CAM]VR.2|TKPPLAPGTILYEAELSQFSEDIK.4|TKPPLAPGTILYEAELSQFSEDIK.3|TKPPLAPGTILYEAELSQFSEDIKK.4|IHEC[CAM]QWVVEDAPNPDVLLSHKDDVK.4|EVNEVSQNFQTTK.2|GESLSLPGPSPPPDGTEQVIISR.3|GESLSLPGPSPPPDGTEQVIISR.2
SEN / CTL,Ras-related protein Rab-33B,RAB33B,Q9H082,0.64,0.46,1.29E-02,6.59E-03,2.18E+00,"protein targeting to Golgi,intra-Golgi vesicle-mediated transport,autophagy,small GTPase mediated signal transduction,skeletal system morphogenesis,regulation of Golgi organization,negative regulation of constitutive secretory pathway,regulation of retrograde vesicle-mediated transport, Golgi to ER,regulation of autophagosome assembly,regulation of cell growth,regulation of epithelial cell proliferation","GTPase activity,protein binding,GTP binding","Golgi membrane,Golgi apparatus,Golgi lumen,extracellular exosome",6,4,5,IQLWDTAGQER.2|IKIQLWDTAGQER.3|IKIQLWDTAGQER.2|QHLLANDIPR.2|SAIQVPTDLAQK.2
SEN / CTL,Plectin,PLEC,Q15149,0.64,0.91,9.66E-29,2.37E-27,2.66E+01,"hemidesmosome assembly,cell-cell adhesion","actin binding,protein binding,structural constituent of muscle,ankyrin binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","cytoplasm,cytosol,plasma membrane,brush border,cell-cell adherens junction,focal adhesion,sarcoplasm,hemidesmosome,extracellular matrix,sarcolemma,costamere,intermediate filament cytoskeleton,extracellular exosome",309,489,728,WQAVLAQTDVR.2|SQVEEELFSVR.2|VTLVQTLEIQR.2|IISLETYNLLR.2|SIQEELQQLR.2|LQLEAC[CAM]ETR.2|AEMEVLLASK.2|LSVAAQEAAR.2|HISDLYEDLRDGHNLISLLEVLSGDSLPR.4|HISDLYEDLRDGHNLISLLEVLSGDSLPR.5|LQEAGILSAEELQR.2|LQEAGILSAEELQR.3|LQNVQIALDYLR.2|LQNVQIALDYLR.3|TISLVIR.2|LSVYAALQR.2|QVEEEILALK.2|LLDPEDVDVPQPDEK.2|LLDPEDVDVPQPDEK.3|LAEVEAALEK.2|LGFHLPLEVAYQR.3|LGFHLPLEVAYQR.2|LREQLQLLEEQHR.4|LREQLQLLEEQHR.3|LREQLQLLEEQHR.2|YYRESADPLGAWLQDAR.3|AELELELGR.2|LLFNDVQTLK.2|LQLEATER.2|LAAEQELIR.2|SLVPAAELLESR.2|SLVPAAELLESR.3|SELELTLGKLEQVR.3|SELELTLGKLEQVR.2|QLEMSAEAER.2|QLEM[Oxi]SAEAER.2|AKLEQLFQDEVAK.3|AKLEQLFQDEVAK.2|LRLQAEEVAQQK.3|LRLQAEEVAQQK.2|SIITYVSSLYDAMPR.3|SIITYVSSLYDAMPR.2|SIITYVSSLYDAM[Oxi]PR.3|SIITYVSSLYDAM[Oxi]PR.2|VLALPEPSPAAPTLR.2|VLALPEPSPAAPTLR.3|GRLPLLAVC[CAM]DYK.3|GRLPLLAVC[CAM]DYK.2|LTAEDLFEAR.2|SWSLATFR.2|SLLAWQSLR.2|VLADPSDDTKGFFDPNTHENLTYR.4|SLQEEHVAVAQLREEAER.3|SLQEEHVAVAQLREEAER.4|LTVDEAVR.2|LAEVEAALEKQR.3|AALAHSEEVTASQVAATK.3|AALAHSEEVTASQVAATK.4|AALAHSEEVTASQVAATK.2|QYINAIKDYELQLVTYK.3|QYINAIKDYELQLVTYK.2|LKAEAELLQQQK.3|LKAEAELLQQQK.2|AQVEQELTTLR.2|AQVEQELTTLR.3|RQVEEEILALK.3|RQVEEEILALK.2|AGEVERDLDKADSMIR.3|AGEVERDLDKADSMIR.4|LTVEEAVR.2|RFPSSFEEIEILWSQFLK.3|AREEAERELER.3|AGVVGPELHEQLLSAEK.3|AGVVGPELHEQLLSAEK.2|C[CAM]RPDQLTGLSLLPLSEK.3|C[CAM]RPDQLTGLSLLPLSEK.2|AYSDPSTGEPATYGELQQR.3|AYSDPSTGEPATYGELQQR.2|C[CAM]VEDPETGLC[CAM]LLPLTDK.3|C[CAM]VEDPETGLC[CAM]LLPLTDK.2|C[CAM]ITDPQTGLC[CAM]LLPLKEK.3|C[CAM]ITDPQTGLC[CAM]LLPLKEK.2|VIDRELYQQLQR.3|VIDRELYQQLQR.2|VRAEMEVLLASK.3|VRAEMEVLLASK.2|RLQEDKEQMAQQLAEETQGFQR.4|RLQEDKEQM[Oxi]AQQLAEETQGFQR.4|RLQEDKEQMAQQLAEETQGFQR.3|LSAEAEKVLALPEPSPAAPTLR.3|LSAEAEKVLALPEPSPAAPTLR.4|LSAEAEKVLALPEPSPAAPTLR.2|SQVMDEATALQLR.2|SQVMDEATALQLR.3|SQVM[Oxi]DEATALQLR.2|ATTAALLLEAQAATGFLVDPVR.3|ATTAALLLEAQAATGFLVDPVR.2|YLQDLLAWVEENQHRVDGAEWGVDLPSVEAQLGSHR.5|YLQDLLAWVEENQHRVDGAEWGVDLPSVEAQLGSHR.4|ESADPLGAWLQDAR.2|ESADPLGAWLQDAR.3|AVTGYKDPYTGQQISLFQAMQK.3|AVTGYKDPYTGQQISLFQAM[Oxi]QK.3|ELIPTEEALR.2|QVQVALETAQR.2|LSFSGLRAPVPASELLASGVLSR.3|LISLFQAMK.2|LISLFQAM[Oxi]K.2|ARQEELYSELQAR.3|ARQEELYSELQAR.2|QTNLENLDQAFSVAERDLGVTR.3|LRAETEQGEQQRQLLEEELAR.4|GLLSAEVAR.2|AVTGYRDPYTGQSVSLFQALKK.4|AVTGYRDPYTGQSVSLFQALKK.3|ALQALEELR.2|LKAEAELLQQQKELAQEQAR.3|LKAEAELLQQQKELAQEQAR.4|QQEELLAEENQR.2|QQEELLAEENQR.3|GYLNKDTHDQLSEPSEVR.4|GYLNKDTHDQLSEPSEVR.3|GLVEDTLR.2|QAEVELASR.2|LKTEAEIALKEK.3|EQAELEAAR.2|LLEAQIATGGIIDPEESHRLPVEVAYKR.5|LLEAQIATGGIIDPEESHRLPVEVAYKR.6|LLEAQIATGGIIDPEESHRLPVEVAYKR.4|LLEAQIATGGIIDPEESHRLPVEVAYKR.3|LLEAQIATGGVIDPVHSHRVPVDVAYR.5|LLEAQIATGGVIDPVHSHRVPVDVAYR.4|LLEAQIATGGVIDPVHSHRVPVDVAYR.3|LLEAQIATGGIIDPVHSHRVPVDVAYQR.5|LLEAQIATGGIIDPVHSHRVPVDVAYQR.4|LLEAQIATGGIIDPVHSHRVPVDVAYQR.3|DDGTGQLLLPLSDAR.2|DDGTGQLLLPLSDAR.3|RDDGTGQLLLPLSDAR.3|RDDGTGQLLLPLSDAR.2|GIIRPGTAFELLEAQAATGYVIDPIKGLK.4|GIIRPGTAFELLEAQAATGYVIDPIKGLK.5|GIIRPGTAFELLEAQAATGYVIDPIKGLK.3|AQAEAQQPTFDALRDELR.3|AQAEAQQPTFDALRDELR.2|AGTLSITEFADMLSGNAGGFR.3|AGTLSITEFADM[Oxi]LSGNAGGFR.3|AGTLSITEFADMLSGNAGGFR.2|AAAGKAELELELGR.3|AAAGKAELELELGR.2|SLESLHSFVAAATK.3|SLESLHSFVAAATK.2|RLTAEDLFEAR.3|RLTAEDLFEAR.2|QALHSLELHYQAFLR.4|QALHSLELHYQAFLR.3|QALHSLELHYQAFLR.2|GLHQSIEEFR.3|GLHQSIEEFR.2|EGVVGPELHHK.3|EGVVGPELHHK.2|HKPLLIDMNK.3|HKPLLIDMNK.2|KGLVGPELHDR.3|KGLVGPELHDR.2|LREAIAELER.3|LREAIAELER.2|MGIVGPEFKDK.3|MGIVGPEFKDK.2|RLEEQAAQHK.3|RLEEQAAQHK.2|RPELEDSTLR.3|RPELEDSTLR.2|RQHEAEEGVR.3|VKAEAEAAREK.3|ERLSVYQAMK.3|ERLSVYQAMK.2|HGERDVEVER.3|LQLEETDHQK.3|LQLEETDHQK.2|QLQLAQEAAQK.3|QLQLAQEAAQK.2|QRELAEQELEKQR.4|QRELAEQELEKQR.3|RLAEDEAFQR.3|RLAEDEAFQR.2|SKEQAELEAAR.3|SKEQAELEAAR.2|VAQLLER.2|ARAEEAEAQKR.3|ARAEEAEAQKR.2|FLQEEAEKMK.3|FLQEEAEKMK.2|HISDLYEDLR.3|HISDLYEDLR.2|LPLDKEPAREC[CAM]AQR.4|RQVEEAERLK.3|AHEEQLK.2|ANELQLR.2|EDVRHYLQGR.3|EQLNEYKGHLSGLAK.4|GAQEVGER.2|HGEKVEEC[CAM]QR.3|KQEELQQLEQQRR.4|KQEELQQLEQQRR.3|KQEELQQLEQQRR.2|LDLQYAK.2|QYINAIK.2|RKQEELQQLEQQR.4|RKQEELQQLEQQR.3|RKQEELQQLEQQR.2|SALDQYR.2|AQFEQLK.2|AQQLREEQQR.3|AQQLREEQQR.2|AVTGYKDPYSGK.3|AVTGYKDPYSGK.2|FAEQTLR.2|FISETLR.2|KASDSELERQK.3|LRLPLDKEPAR.3|QTLSIYQALKK.3|QTLSIYQALKK.2|ALAEEAKR.2|ATVSAPFGK.2|GLVGPELHDRLLSAER.4|LHRTELATQEK.3|LHRTELATQEK.2|LTVNEAVK.2|QVAEEAAR.2|TEAEIALK.2|VAGMLMPR.2|LC[CAM]FEGLR.2|QRQLAEAHAQAK.3|QRQLAEAHAQAK.2|SVRDVAEVDTVR.3|SVRDVAEVDTVR.2|VPPGYHPLDVEK.3|VPPGYHPLDVEK.2|AGLVGPEFHEKLLSAEK.4|AGLVGPEFHEKLLSAEK.3|ASDSELER.2|AVVQLKPR.2|EAEGQLQK.2|ELQNAGDR.2|LAAIGEATR.2|LKQSAEEQAQAR.3|LKQSAEEQAQAR.2|QVEVTVHKGDEC[CAM]QLVGPAQPSHWK.6|QVEVTVHKGDEC[CAM]QLVGPAQPSHWK.5|QVEVTVHKGDEC[CAM]QLVGPAQPSHWK.4|QVEVTVHKGDEC[CAM]QLVGPAQPSHWK.3|RQHEAEEGVRR.3|SNAEDTLR.2|SSIAGLLLK.2|AALEEVER.2|AQAEVEGLGKGVAR.3|AQAEVEGLGKGVAR.2|ARSDEGQLSPATR.3|ARSDEGQLSPATR.2|EAIAELER.2|ELAEQELEKQR.3|LLLWSQR.2|LSIYNALK.2|QLQLAQEAAQKR.3|QRELAEQELEK.3|QRELAEQELEK.2|QRGGAEGELQALR.3|QRGGAEGELQALR.2|QRQLAEGTAQQR.3|REEAAVDAQQQK.3|REEAAVDAQQQK.2|SHRVPLDVAC[CAM]AR.3|SHRVPLDVAC[CAM]AR.2|TELATQEK.2|VPPGYHPLDVEKEWGK.4|VPVDVAYR.2|ELAQEQAR.2|EQLRQEQALLEEIERHGEK.5|LAQGHTTVDELAR.3|LAQGHTTVDELAR.2|LEDLLQDAQDEK.3|LEDLLQDAQDEK.2|LSVYQAMK.2|PLLIDMNK.2|RSIQEELQQLR.3|RSIQEELQQLR.2|TTVKDLSELGSVR.3|TTVKDLSELGSVR.2|VKAEAEAAR.2|EQLQLLEEQHR.3|EQLQLLEEQHR.2|GAYRDC[CAM]LGRLDLQYAK.4|GAYRDC[CAM]LGRLDLQYAK.3|IIITVVEEQEQK.3|IIITVVEEQEQK.2|KGLVGPELHDRLLSAER.4|LHVAILER.2|LQAEEAER.2|QLAAEEER.2|SLAQAEAEK.2|AQAEQAALR.2|ARIEAENR.2|ESYSALMR.2|LEAQHQALVTLWHQLHVDMK.5|LEAQHQALVTLWHQLHVDMK.4|LEAQHQALVTLWHQLHVDM[Oxi]K.4|LEAQHQALVTLWHQLHVDM[Oxi]K.3|LRAETEQGEQQR.3|LRAETEQGEQQR.2|LYVHEAVK.2|QRQLEMSAEAER.3|RLEEQAAQHKADIEER.4|RLEEQAAQHKADIEER.3|SAEAELQSK.2|SGRQYDIDDAIAK.3|VLAEKLAAIGEATR.3|VQMEELSK.2|VQM[Oxi]EELSK.2|VSIYEAMR.2|VSIYEAM[Oxi]R.2|AAEEAEEAR.2|ARQVQVALETAQR.3|ARQVQVALETAQR.2|DLSELGSVR.2|LREAIAELEREK.3|MGIVGPEFK.2|QQGLASYDYVRR.3|TLARPGPEPAPATDERDR.4|TLARPGPEPAPATDERDR.3|DGRHPQGEQMYR.3|DGRHPQGEQM[Oxi]YR.3|FPVTDAVNK.2|LFNAIIHR.2|QAADAEMEK.2|QAADAEM[Oxi]EK.2|QVQDESQR.2|SELELTLGK.2|SLQEEHVAVAQLR.3|SLQEEHVAVAQLR.2|VPDVQDGVR.2|AHAFAVQQK.2|AQAEVEGLGK.2|DVAEVDTVR.2|FLQEEAEK.2|LSYTQLLR.2|LVASMEEAR.2|LVASM[Oxi]EEAR.2|QLAEEDAAR.2|SVRDVAEVDTVRR.3|TLKPEEQR.2|VPLDVAC[CAM]AR.2|AIYEVLFR.2|DTHDQLSEPSEVR.3|DTHDQLSEPSEVR.2|ILITIVEEVETLR.3|ILITIVEEVETLR.2|LLEAQIATGGIIDPVHSHR.4|LLEAQIATGGIIDPVHSHR.3|LLEAQIATGGIIDPVHSHR.2|LLEAQIATGGVIDPVHSHR.4|LLEAQIATGGVIDPVHSHR.3|LLEAQIATGGVIDPVHSHR.2|REEAAVDAQQQKR.3|RQVEEAER.2|AQQQAEAER.2|FKEMELPAKEADK.3|LLDAQLATGGIVDPR.3|LLDAQLATGGIVDPR.2|LLEAAAQSTK.2|LLEAQIATGGVIDPVHSHRVPVDVAYRR.6|LLEAQIATGGVIDPVHSHRVPVDVAYRR.5|LLEAQIATGGVIDPVHSHRVPVDVAYRR.4|LTVDEAVRK.2|LTVNEAVKEGVVGPELHHK.4|LTVNEAVKEGVVGPELHHK.3|MQAVQEATR.2|M[Oxi]QAVQEATR.2|QRLEAEAGR.2|RLTVNEAVK.2|SLSAIYLEK.2|AAEEAEEARVQAER.3|APVPASELLASGVLSR.3|APVPASELLASGVLSR.2|AQAEREAKELQQR.3|ATNEKLSVYAALQR.3|ATNEKLSVYAALQR.2|IAEQQKAQAEVEGLGKGVAR.4|IAEQQKAQAEVEGLGKGVAR.3|KAALEEVER.2|KASDSELER.2|KGLLSAEVAR.2|KQEELQQLEQQR.3|KQEELQQLEQQR.2|LAQGHTTVDELARR.3|LRQLAEEDLAQQR.3|LRQLAEEDLAQQR.2|SLAAEEEAAR.2|VAQLLERWQAVLAQTDVR.4|VAQLLERWQAVLAQTDVR.3|VPLDEALQR.2|VPVDVAYQR.2|VSITEAMHR.2|GTQGAEEVLR.2|LKAEATEAAR.2|LRIEEEIR.2|MVEGYQGLR.2|M[Oxi]VEGYQGLR.2|NDDIADGNPK.2|QHEAEEGVR.2|RRQEQIQAMPLADSQAVR.4|RRQEQIQAMPLADSQAVR.3|RRQEQIQAMPLADSQAVR.2|VLADPSDDTK.2|VVIVDPETGK.2|ELYQQLQR.2|GC[CAM]LDEETSR.2|LAEDEAFQR.2|LLDAQLSTGGIVDPSK.3|LLDAQLSTGGIVDPSK.2|QLAEAHAQAK.2|QRSQVEEELFSVR.3|QRSQVEEELFSVR.2|SMVEEGTGLR.2|SM[Oxi]VEEGTGLR.2|TPHVQAVQGPLGSPPK.3|ELAEQELEK.2|ISYKDALDR.2|KESYSALMR.2|QSSEAEIQAK.2|YYRESADPLGAWLQDARR.4|AFC[CAM]GFEDPR.2|DPYTGQSVSLFQALK.3|DPYTGQSVSLFQALK.2|GGAEGELQALR.2|GLVGPELHDR.2|HHTAAFEER.2|IIITVVEEQEQKGR.3|LVNIRNDDIADGNPK.3|LVNIRNDDIADGNPK.2|QLAAEEERR.2|QLAEGTAQQR.2|QLLEEELAR.2|RLTVNEAVKEGVVGPELHHK.4|RQQEELLAEENQR.3|RQQEELLAEENQR.2|AQLEPVASPAK.2|EAQAVPATLPELEATK.3|EAQAVPATLPELEATK.2|GIYQSLEGAVQAGQLK.3|GIYQSLEGAVQAGQLK.2|QITMEELVR.2|QSAEEQAQAR.2|RAQAEQAALR.2|TLARPGPEPAPATDER.3|AGEVERDLDK.2|C[CAM]ISELKDIR.2|DALDGPAAEAEPEHSFDGLRR.4|DALDGPAAEAEPEHSFDGLRR.3|DDGTGQLLLPLSDARK.3|ESADPLGAWLQDARR.3|GYFSEEMNR.2|NLLDEELQR.2|NLVDNITGQR.2|QRELEQLGR.2|RAAEEAEEAR.2|RKELEEVSPETPVVPATTQR.4|SLQEEHVAVAQLREEAERR.4|SLQEEHVAVAQLREEAERR.3|TPVEVPVGGFK.2|EMSVYEAYR.2|GFFDPNTHENLTYR.3|GFFDPNTHENLTYR.2|HPQGEQMYR.2|IKELQNAGDR.2|KGIIRPGTAFELLEAQAATGYVIDPIK.5|KGIIRPGTAFELLEAQAATGYVIDPIK.4|KGIIRPGTAFELLEAQAATGYVIDPIK.3|LQAEEVAQQK.2|RAAEEAEEARVQAER.3|AEAELLQQQK.2|AVTGYRDPYTGQSVSLFQALK.4|AVTGYRDPYTGQSVSLFQALK.3|AVTGYRDPYTGQSVSLFQALK.2|C[CAM]ITDPQTGLC[CAM]LLPLK.3|C[CAM]ITDPQTGLC[CAM]LLPLK.2|DVAEVDTVRR.2|GFFDPNTHENLTYLQLLER.4|GFFDPNTHENLTYLQLLER.3|GFFDPNTHENLTYLQLLER.2|GYFDEEMNR.2|GYFDEEM[Oxi]NR.2|LRSLESLHSFVAAATK.3|LVASMEEARR.2|QYDIDDAIAK.2|RQAEVELASR.2|SDEGQLSPATR.2|SYVDPSTDERLSYTQLLRR.4|TLPNGRDALDGPAAEAEPEHSFDGLRR.5|TLPNGRDALDGPAAEAEPEHSFDGLRR.4|VVIVDPETGKEMSVYEAYRK.4|VVIVDPETGKEMSVYEAYRK.3|AETEQGEQQR.2|AQFEQLKDGK.2|C[CAM]DNFTSSWR.2|C[CAM]VEDPETGLR.2|IRSNAEDTLR.2|LRAQAEAQQPTFDALRDELR.4|LRAQAEAQQPTFDALRDELR.3|LRAQAEAQQPTFDALRDELR.2|QTLSIYQALK.2|SSSVGSSSSYPISPAVSR.3|SSSVGSSSSYPISPAVSR.2|SYVDPSTDER.2|AGLVGPEFHEK.2|DPYSGSTISLFQAMQK.3|DPYSGSTISLFQAMQK.2|DPYTGQSVSLFQALKK.3|DPYTGQSVSLFQALKK.2|EAIAELEREK.2|ETFEKTPVEVPVGGFK.3|ETFEKTPVEVPVGGFK.2|LLEAQIATGGIIDPEESHRLPVEVAYK.5|LLEAQIATGGIIDPEESHRLPVEVAYK.4|LLEAQIATGGIIDPEESHRLPVEVAYK.3|RAQQQAEAER.2|RGPLPTEEQR.2|RQELEAELAK.2|FRELAEEAAR.2|LLLEAQAATGFLLDPVK.3|LLLEAQAATGFLLDPVK.2|LPLLAVC[CAM]DYK.2|QEQIQAMPLADSQAVR.3|QEQIQAMPLADSQAVR.2|THYSELTTLTSQYIK.3|THYSELTTLTSQYIK.2|VAQLLERWQAVLAQTDVRQR.4|AQLMADFQAGR.2|AQLM[Oxi]ADFQAGR.2|AVTGYRDPYSGSTISLFQAMQK.4|AVTGYRDPYSGSTISLFQAM[Oxi]QK.3|AVTGYRDPYSGSTISLFQAMQK.3|AVTGYRDPYTEQTISLFQAMK.4|AVTGYRDPYTEQTISLFQAM[Oxi]K.3|AVTGYRDPYTEQTISLFQAMK.3|EGLTSIEEVTK.2|FLEGTSC[CAM]IAGVFVDATK.3|FLEGTSC[CAM]IAGVFVDATK.2|GDEC[CAM]QLVGPAQPSHWK.3|GDEC[CAM]QLVGPAQPSHWK.2|QQQQMEQER.2|SLAQAEAEKQKEEAER.3|VQSGSESVIQEYVDLR.3|VQSGSESVIQEYVDLR.2|EEAAVDAQQQK.2|QTNLENLDQAFSVAER.3|QTNLENLDQAFSVAER.2|DPYTGQQISLFQAMQK.3|DPYTGQQISLFQAM[Oxi]QK.2|DPYTGQQISLFQAMQK.2|GWLYYEAGQR.2|KQITMEELVR.2|LEDLLQDAQDEKEQLNEYKGHLSGLAK.5|LEDLLQDAQDEKEQLNEYKGHLSGLAK.4|LEDLLQDAQDEKEQLNEYKGHLSGLAK.3|QYLHLPPEIVPASLQR.3|QYLHLPPEIVPASLQR.2|RDDGTGQLLLPLSDARK.3|VQAEREAAQSR.2|AHEEQLKEAQAVPATLPELEATK.4|AHEEQLKEAQAVPATLPELEATK.3|EQELQQTLQQEQSVLDQLRGEAEAARR.5|EQELQQTLQQEQSVLDQLRGEAEAARR.4|EQLRQEQALLEEIER.3|EQLRQEQALLEEIER.2|SKGIYQSLEGAVQAGQLK.3|SKGIYQSLEGAVQAGQLK.2|AVTGYRDPYTEQTISLFQAMKK.4|DYELQLVTYK.2|EMSVYEAYRK.2|EQM[Oxi]AQQLAEETQGFQR.3|EQMAQQLAEETQGFQR.3|EQM[Oxi]AQQLAEETQGFQR.2|EQMAQQLAEETQGFQR.2|GGELVYTDSEARDVFEK.3|GGELVYTDSEARDVFEK.2|GTQGAEEVLRAHEEQLK.3|KGIIRPGTAFELLEAQAATGYVIDPIKGLK.5|KGIIRPGTAFELLEAQAATGYVIDPIKGLK.4|YLQDLLAWVEENQHR.3|YLQDLLAWVEENQHR.2|QRQLAEEDAAR.2|TLLQGSGC[CAM]LAGIYLEDTK.3|TLLQGSGC[CAM]LAGIYLEDTK.2|GGELVYTDSEAR.2|ILITIVEEVETLRQER.3|QLAEEDLAQQR.2|QQGLASYDYVR.2|RQEQIQAMPLADSQAVR.3|RQEQIQAMPLADSQAVR.2|ALQALEELRLQAEEAER.3|ATTAALLLEAQAATGFLVDPVRNQR.4|ATTAALLLEAQAATGFLVDPVRNQR.3|LEQLFQDEVAK.2|QAEEIGEKLHR.2|RGYFDEEMNR.2|AEQESARQLQLAQEAAQK.3|AGVAAPATQVAQVTLQSVQR.3|AGVAAPATQVAQVTLQSVQR.2|GANVIAGVWLEEAGQKLSIYNALKK.4|LLEAQAC[CAM]TGGIIDPSTGER.3|LLEAQAC[CAM]TGGIIDPSTGER.2|DSQDAGGFGPEDR.2|SATVTRLEDLLQDAQDEK.3|SATVTRLEDLLQDAQDEK.2|AEVVETTQVYTEEETRR.3|AEVVETTQVYTEEETRR.2|ASDSELERQKGLVEDTLR.3|DGHNLISLLEVLSGDSLPR.3|DGHNLISLLEVLSGDSLPR.2|EEAAVDAQQQKR.2|ERLAEVEAALEK.2|GIIRPGTAFELLEAQAATGYVIDPIK.4|GIIRPGTAFELLEAQAATGYVIDPIK.3|KGWLYYEAGQR.2|LLEAQIATGGIIDPEESHR.3|LLEAQIATGGIIDPEESHR.2|QEELYSELQAR.2|QEQALLEEIER.2|TLPNGRDALDGPAAEAEPEHSFDGLR.4|TLPNGRDALDGPAAEAEPEHSFDGLR.3|DALDGPAAEAEPEHSFDGLR.3|DALDGPAAEAEPEHSFDGLR.2|FLEGTSC[CAM]IAGVFVDATKER.3|FLEGTSC[CAM]IAGVFVDATKER.2|FLEVQYLTGGLIEPDTPGR.3|FLEVQYLTGGLIEPDTPGR.2|ELVLLLLQWMR.2|LLLEAQAATGFLLDPVKGER.3|LLLEAQAATGFLLDPVKGER.2|LMAEREYGSC[CAM]SHHYQQLLQSLEQGAQEESR.5|LMAEREYGSC[CAM]SHHYQQLLQSLEQGAQEESR.4|QEELQQLEQQR.2|SYVDPSTDERLSYTQLLR.3|AEQESARQLQLAQEAAQKR.3|AQAEAQQPTFDALRDELRGAQEVGER.4|GLFDEEMNEILTDPSDDTK.3|GLFDEEMNEILTDPSDDTK.2|TVTVWELISSEYFTAEQR.3|TVTVWELISSEYFTAEQR.2|AAEEAEEARVQAEREAAQSR.3|DLLPSDMAVALLEAQAGTGHIIDPATSAR.4|DLLPSDM[Oxi]AVALLEAQAGTGHIIDPATSAR.4|DLLPSDM[Oxi]AVALLEAQAGTGHIIDPATSAR.3|DLLPSDMAVALLEAQAGTGHIIDPATSAR.3|GYFDEEMNRVLADPSDDTK.3|QVEEAERLKQSAEEQAQAR.3|SATVTRLEDLLQDAQDEKEQLNEYK.4|TLLQGSGC[CAM]LAGIYLEDTKEK.3|TVTIWEIINSEYFTAEQR.3|TVTIWEIINSEYFTAEQR.2|VVIVDPETGKEMSVYEAYR.3|C[CAM]VEDPETGLC[CAM]LLPLTDKAAK.3|EYGSC[CAM]SHHYQQLLQSLEQGAQEESR.4|EYGSC[CAM]SHHYQQLLQSLEQGAQEESR.3|LKAGVAAPATQVAQVTLQSVQR.3|LLEAQAC[CAM]TGGIIDPSTGERFPVTDAVNK.4|LLEAQAC[CAM]TGGIIDPSTGERFPVTDAVNK.3|VDGAEWGVDLPSVEAQLGSHR.3|VDGAEWGVDLPSVEAQLGSHR.2|EEEEVGFDWSDR.2|EEEEVGFDWSDRNTNMTAK.3|EQELQQTLQQEQSVLDQLRGEAEAAR.4|EQELQQTLQQEQSVLDQLRGEAEAAR.3|GRTVTVWELISSEYFTAEQRQELLR.4|MQEEVVRREEAAVDAQQQK.3|VYRQTNLENLDQAFSVAER.3|YASGSSASLGGPESAVA.2|FIEQEKAKLEQLFQDEVAK.3|KDLLPSDMAVALLEAQAGTGHIIDPATSAR.4|AQAEAQQPTFDALR.2|EQELQQTLQQEQSVLDQLR.3|EQELQQTLQQEQSVLDQLR.2|GFFDPNTEENLTYLQLM[Oxi]ER.3|GFFDPNTEENLTYLQLMER.3|GFFDPNTEENLTYLQLMER.2|LEDLLQDAQDEKEQLNEYK.3|QKAQVEQELTTLR.2|RGLFDEEMNEILTDPSDDTK.3|RGLFDEEM[Oxi]NEILTDPSDDTK.3|RGLFDEEMNEILTDPSDDTK.2|SIQEELQQLRQSSEAEIQAK.3|FLEVQYLTGGLIEPDTPGRVPLDEALQR.4|FLEVQYLTGGLIEPDTPGRVPLDEALQR.3|GRTVTVWELISSEYFTAEQR.3|LQLEETDHQKNLLDEELQR.3|QALHSLELHYQAFLRDSQDAGGFGPEDR.4|VLALPEPSPAAPTLRSELELTLGKLEQVR.4|AHAFAVQQKEQELQQTLQQEQSVLDQLRGEAEAAR.5|ENAAYFQFFSDVR.2|QYINAIKDYELQLVTYKAQLEPVASPAK.4|SEEMQTVQQEQLLQETQALQQSFLSEK.4|SEEM[Oxi]QTVQQEQLLQETQALQQSFLSEK.3|SEEMQTVQQEQLLQETQALQQSFLSEK.3|VLSSSGSEAAVPSVC[CAM]FLVPPPNQEAQEAVTR.4|VLSSSGSEAAVPSVC[CAM]FLVPPPNQEAQEAVTR.3|ENAAYFQFFSDVREAEGQLQK.3|GANVIAGVWLEEAGQK.2|LQEDKEQMAQQLAEETQGFQR.3|RYASGSSASLGGPESAVA.2|VLADPSDDTKGFFDPNTHENLTYLQLLER.4|VLALPEPSPAAPTLRSELELTLGK.3|IAEQQKAQAEVEGLGK.2|SQVMDEATALQLREGLTSIEEVTK.3|ELIPTEEALRLLDAQLATGGIVDPR.3|GYYSPYSVSGSGSTAGSR.2|LQM[Oxi]EAGLC[CAM]EEQLNQADALLQSDVR.3|LQMEAGLC[CAM]EEQLNQADALLQSDVR.3|RGSFDATGSGFSMTFSSSSYSSSGYGR.3|TVTVWELISSEYFTAEQRQELLR.3|AEVVETTQVYTEEETR.2|EALEAESAWC[CAM]YLYGTGSVAGVYLPGSR.3|TQLASWSDPTEETGPVAGILDTETLEK.3|AFEETQIDIPGGGSHGGSTMSLWEVMQSDLIPEEQR.4|ELEEVSPETPVVPATTQR.2|SEEM[Oxi]QTVQQEQLLQETQALQQSFLSEKDSLLQR.4|SEEMQTVQQEQLLQETQALQQSFLSEKDSLLQR.4|SLREALEAESAWC[CAM]YLYGTGSVAGVYLPGSR.3
SEN / CTL,Protein S100-A11,S100A11,P31949,0.64,0.97,1.72E-02,8.28E-03,2.08E+00,"signal transduction,negative regulation of DNA replication,negative regulation of cell proliferation,cell-cell adhesion","calcium ion binding,protein homodimerization activity,S100 protein binding,calcium-dependent protein binding,cadherin binding involved in cell-cell adhesion","ruffle,extracellular space,nucleus,cytoplasm,cell-cell adherens junction,extracellular exosome",33,8,13,C[CAM]IESLIAVFQK.2|C[CAM]IESLIAVFQK.3|ISSPTETERC[CAM]IESLIAVFQK.3|KLDTNSDGQLDFSEFLNLIGGLAM[Oxi]AC[CAM]HDSFLK.4|KLDTNSDGQLDFSEFLNLIGGLAM[Oxi]AC[CAM]HDSFLK.3|TEFLSFMNTELAAFTK.2|TEFLSFMNTELAAFTK.3|TEFLSFM[Oxi]NTELAAFTK.2|YAGKDGYNYTLSK.3|YAGKDGYNYTLSK.2|DGYNYTLSK.2|ISSPTETER.2|NQKDPGVLDR.2
SEN / CTL,3-mercaptopyruvate sulfurtransferase,MPST,P25325,0.64,0.43,1.33E-01,4.46E-02,1.35E+00,"kidney development,liver development,cyanate catabolic process,response to toxic substance,transsulfuration,spinal cord development,hydrogen sulfide biosynthetic process","thiosulfate sulfurtransferase activity,3-mercaptopyruvate sulfurtransferase activity,identical protein binding","mitochondrion,cytosol,cell junction,neuron projection,synapse,extracellular exosome",3,17,26,ALVSAQWVAEALR.2|ALVSAQWVAEALR.3|ARPEDVISEGR.3|ARPEDVISEGR.2|FQVVDSR.2|QNLPLSSGK.2|AQLDPAFIK.2|SQPAPAEFR.2|TYEDIKENLESR.3|TYEDIKENLESR.2|SPEEIRHLFQEK.3|AFGHHAVSLLDGGLR.3|AFGHHAVSLLDGGLR.2|TSPYDHMLPGAEHFAEYAGR.4|TSPYDHMLPGAEHFAEYAGR.3|ALVSAQWVAEALRAPR.3|AGQPLQLLDASWYLPK.3|AGQPLQLLDASWYLPK.2|LGVGAATHVVIYDASDQGLYSAPR.4|LGVGAATHVVIYDASDQGLYSAPR.3|AQLDPAFIKTYEDIKENLESR.4|HIPGAAFFDIDQC[CAM]SDR.3|HIPGAAFFDIDQC[CAM]SDR.2|DGIEPGHIPGTVNIPFTDFLSQEGLEK.4|DGIEPGHIPGTVNIPFTDFLSQEGLEK.3|DGIEPGHIPGTVNIPFTDFLSQEGLEKSPEEIR.4
SEN / CTL,Glutathione S-transferase omega-1,GSTO1,P78417,0.64,0.73,2.55E-05,2.93E-05,4.53E+00,"glutathione metabolic process,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,L-ascorbic acid metabolic process,methylation,xenobiotic catabolic process,oxidation-reduction process,negative regulation of ryanodine-sensitive calcium-release channel activity,positive regulation of ryanodine-sensitive calcium-release channel activity,cellular response to arsenic-containing substance,cellular oxidant detoxification,glutathione derivative biosynthetic process","glutathione transferase activity,oxidoreductase activity,glutathione dehydrogenase (ascorbate) activity,methylarsonate reductase activity","cytoplasm,cytosol,extracellular exosome",18,28,41,VPSLVGSFIR.2|MILELFSK.2|M[Oxi]ILELFSK.2|GIRHEVININLK.3|LLPDDPYEK.2|MILELFSKVPSLVGSFIR.3|M[Oxi]ILELFSKVPSLVGSFIR.3|EFTKLEEVLTNKK.3|EFTKLEEVLTNKK.2|KLLPDDPYEK.3|KLLPDDPYEK.2|LNEC[CAM]VDHTPK.3|LNEC[CAM]VDHTPK.2|SQNKEDYAGLK.3|LWMAAMK.2|GSAPPGPVPEGSIR.3|GSAPPGPVPEGSIR.2|EDYAGLKEEFR.3|EDYAGLKEEFR.2|SQNKEDYAGLKEEFR.4|SQNKEDYAGLKEEFR.3|FC[CAM]PFAER.2|LEEVLTNK.2|LLPDDPYEKAC[CAM]QK.3|LEEVLTNKK.2|HEVININLK.2|NKPEWFFK.2|SLGKGSAPPGPVPEGSIR.3|LKLWMAAMKEDPTVSALLTSEK.4|EDPTVSALLTSEK.2|EFTKLEEVLTNK.2|LWMAAMKEDPTVSALLTSEK.3|LWM[Oxi]AAMKEDPTVSALLTSEK.3|LWMAAM[Oxi]KEDPTVSALLTSEK.3|LWMAAMKEDPTVSALLTSEK.2|NPFGLVPVLENSQGQLIYESAITC[CAM]EYLDEAYPGKK.5|NPFGLVPVLENSQGQLIYESAITC[CAM]EYLDEAYPGKK.4|KNPFGLVPVLENSQGQLIYESAITC[CAM]EYLDEAYPGKK.5|KNPFGLVPVLENSQGQLIYESAITC[CAM]EYLDEAYPGKK.4|NPFGLVPVLENSQGQLIYESAITC[CAM]EYLDEAYPGK.4|KNPFGLVPVLENSQGQLIYESAITC[CAM]EYLDEAYPGK.4
SEN / CTL,Guanylate kinase,GUK1,Q16774,0.63,0.33,3.47E-03,2.22E-03,2.65E+00,"purine nucleotide metabolic process,dGDP biosynthetic process,nucleobase-containing small molecule interconversion,GDP-mannose metabolic process,glycoprotein transport,ATP metabolic process,GMP metabolic process,dGMP metabolic process,dATP metabolic process,GDP biosynthetic process,nucleotide phosphorylation","guanylate kinase activity,ATP binding",cytosol,6,15,23,IC[CAM]VLDVDLQGVR.2|VAVQAVQAMNR.2|VAVQAVQAM[Oxi]NR.2|NTETEESLVKR.3|NTETEESLVKR.2|DYYFVTR.2|QRNTETEESLVK.3|ATDLRPIYISVQPPSLHVLEQR.5|ATDLRPIYISVQPPSLHVLEQR.4|ATDLRPIYISVQPPSLHVLEQR.3|LLQEHSGIFGFSVSHTTR.4|LLQEHSGIFGFSVSHTTR.3|LLQEHSGIFGFSVSHTTR.2|NPRPGEENGKDYYFVTR.4|NPRPGEENGKDYYFVTR.3|EALSEEIKK.2|PVVLSGPSGAGK.2|RLLQEHSGIFGFSVSHTTR.4|NTETEESLVK.2|LAAAQADMESSK.2|LAAAQADM[Oxi]ESSK.2|DIAAGDFIEHAEFSGNLYGTSK.3|RLAAAQADMESSKEPGLFDVVIINDSLDQAYAELK.4
SEN / CTL,Destrin,DSTN,P60981,0.63,0.67,8.27E-05,8.36E-05,4.08E+00,"actin polymerization or depolymerization,actin filament depolymerization,positive regulation of actin filament depolymerization,actin filament severing","protein binding,actin filament binding","actin cytoskeleton,cortical actin cytoskeleton,extracellular exosome",21,22,34,YALYDASFETK.2|AVIFC[CAM]LSADKK.3|AVIFC[CAM]LSADKK.2|ESRKEELMFFLWAPELAPLK.4|ESRKEELMFFLWAPELAPLK.3|KEELMFFLWAPELAPLK.3|KEELM[Oxi]FFLWAPELAPLK.3|KEELMFFLWAPELAPLK.2|KC[CAM]STPEEIKK.3|C[CAM]STPEEIKKR.3|KAVIFC[CAM]LSADKK.3|C[CAM]IIVEEGK.2|C[CAM]STPEEIK.2|HFVGMLPEKDC[CAM]R.3|HFVGM[Oxi]LPEKDC[CAM]R.3|HFVGMLPEKDC[CAM]R.2|HEC[CAM]QANGPEDLNR.3|HEC[CAM]QANGPEDLNR.2|FQGIKHEC[CAM]QANGPEDLNR.4|FQGIKHEC[CAM]QANGPEDLNR.3|HFVGMLPEK.2|HFVGM[Oxi]LPEK.2|KC[CAM]IIVEEGK.2|C[CAM]STPEEIKK.2|KC[CAM]STPEEIK.2|KFQGIKHEC[CAM]QANGPEDLNR.4|KFQGIKHEC[CAM]QANGPEDLNR.3|AVIFC[CAM]LSADK.2|EILVGDVGVTITDPFK.3|EILVGDVGVTITDPFK.2|EELMFFLWAPELAPLK.3|EELMFFLWAPELAPLK.2|LGGSLIVAFEGC[CAM]PV.2|C[CAM]IIVEEGKEILVGDVGVTITDPFK.3
SEN / CTL,Actin-related protein 2/3 complex subunit 1B,ARPC1B,O15143,0.63,0.30,1.54E-11,6.10E-11,1.02E+01,"movement of cell or subcellular component,Arp2/3 complex-mediated actin nucleation,Fc-gamma receptor signaling pathway involved in phagocytosis,response to estrogen,ephrin receptor signaling pathway","structural constituent of cytoskeleton,actin filament binding","cytosol,Arp2/3 protein complex,focal adhesion,actin cytoskeleton,tubulobulbar complex,extracellular exosome",30,22,41,TWKPTLVILR.3|VHELKEHNGQVTGIDWAPESNR.4|VHELKEHNGQVTGIDWAPESNR.5|IFSAYIKEVEERPAPTPWGSK.4|STVLSLDWHPNNVLLAAGSC[CAM]DFK.3|STVLSLDWHPNNVLLAAGSC[CAM]DFK.4|WAPNENKFAVGSGSR.3|VAWVSHDSTVC[CAM]LADADKK.4|VAWVSHDSTVC[CAM]LADADKK.3|VAWVSHDSTVC[CAM]LADADKK.2|NSVSQISVLSGGK.2|NSVSQISVLSGGK.3|TQIAIC[CAM]PNNHEVHIYEK.4|TQIAIC[CAM]PNNHEVHIYEK.3|TQIAIC[CAM]PNNHEVHIYEK.2|ASSEGGTAAGAGLDSLHKNSVSQISVLSGGK.4|KASSEGGTAAGAGLDSLHK.4|KASSEGGTAAGAGLDSLHK.3|KASSEGGTAAGAGLDSLHK.2|IVTC[CAM]GTDR.2|DRTQIAIC[CAM]PNNHEVHIYEK.5|DRTQIAIC[CAM]PNNHEVHIYEK.4|DRTQIAIC[CAM]PNNHEVHIYEK.3|DRTQIAIC[CAM]PNNHEVHIYEK.2|NAYVWTLK.2|EVEERPAPTPWGSK.3|EVEERPAPTPWGSK.2|ASSEGGTAAGAGLDSLHK.3|ASSEGGTAAGAGLDSLHK.2|SLESALKDLK.2|VAWVSHDSTVC[CAM]LADADK.3|VAWVSHDSTVC[CAM]LADADK.2|EHNGQVTGIDWAPESNR.3|EHNGQVTGIDWAPESNR.2|IVTC[CAM]GTDRNAYVWTLK.3|C[CAM]SQFC[CAM]TTGMDGGMSIWDVK.3|C[CAM]SQFC[CAM]TTGMDGGMSIWDVK.2|VISIC[CAM]YFEQENDWWVC[CAM]K.3|VISIC[CAM]YFEQENDWWVC[CAM]K.2|MPFGELMFESSSSC[CAM]GWVHGVC[CAM]FSASGSR.4|MPFGELMFESSSSC[CAM]GWVHGVC[CAM]FSASGSR.3
SEN / CTL,60S ribosomal protein L5,RPL5,P46777,0.62,0.46,9.81E-07,1.66E-06,5.78E+00,"ribosomal large subunit assembly,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,ribosomal large subunit biogenesis","RNA binding,structural constituent of ribosome,protein binding,5S rRNA binding,poly(A) RNA binding","nucleus,nucleolus,cytoplasm,cytosol,focal adhesion,membrane,cytosolic large ribosomal subunit,intracellular ribonucleoprotein complex,extracellular exosome",21,27,56,VGLTNYAAAYC[CAM]TGLLLAR.3|VGLTNYAAAYC[CAM]TGLLLAR.2|VTNRDIIC[CAM]QIAYAR.3|VTNRDIIC[CAM]QIAYAR.2|DIIC[CAM]QIAYAR.2|DIIC[CAM]QIAYAR.3|IEGDMIVC[CAM]AAYAHELPK.3|IEGDM[Oxi]IVC[CAM]AAYAHELPK.3|IEGDMIVC[CAM]AAYAHELPK.2|HIMGQNVADYMR.3|HIM[Oxi]GQNVADYMR.3|HIMGQNVADYM[Oxi]R.3|HIM[Oxi]GQNVADYM[Oxi]R.3|HIMGQNVADYMR.2|HIM[Oxi]GQNVADYM[Oxi]R.2|HIM[Oxi]GQNVADYMR.2|HIMGQNVADYM[Oxi]R.2|NSVTPDMMEEMYKK.3|NSVTPDM[Oxi]MEEMYKK.3|NSVTPDMM[Oxi]EEMYKK.3|NSVTPDMMEEM[Oxi]YKK.3|NSVTPDM[Oxi]MEEMYKK.2|NSVTPDMMEEMYKK.2|RLVIQDK.2|GAVDGGLSIPHSTK.3|GAVDGGLSIPHSTK.2|QFSQYIK.2|AHAAIRENPVYEK.3|AHAAIRENPVYEK.2|EFNAEVHR.2|GAVDGGLSIPHSTKR.3|GAVDGGLSIPHSTKR.2|FPGYDSESK.2|YLM[Oxi]EEDEDAYKK.3|YLMEEDEDAYKK.3|YLMEEDEDAYKK.2|YLM[Oxi]EEDEDAYKK.2|KHIMGQNVADYMR.3|KHIMGQNVADYMR.2|KAHAAIRENPVYEK.3|RFPGYDSESKEFNAEVHR.4|EGKTDYYAR.2|EFNAEVHRK.2|RFPGYDSESK.2|YLMEEDEDAYKKQFSQYIK.4|YLM[Oxi]EEDEDAYKKQFSQYIK.3|YLMEEDEDAYKKQFSQYIK.3|TTTGNKVFGALK.2|TTTGNKVFGALKGAVDGGLSIPHSTK.4|YLMEEDEDAYK.2|LVIQDKNKYNTPK.2|NSVTPDMMEEMYK.2|NSVTPDM[Oxi]MEEMYK.2|NSVTPDMM[Oxi]EEMYK.2|NSVTPDMMEEM[Oxi]YK.2|IYEGQVEVTGDEYNVESIDGQPGAFTC[CAM]YLDAGLAR.4
SEN / CTL,POTE ankyrin domain family member F,POTEF,A5A3E0,0.62,0.84,1.82E-03,1.28E-03,2.89E+00,retina homeostasis,,"extracellular space,cell cortex,extracellular exosome,blood microparticle",15,4,5,VAPEEHPVLLTEATLNPK.3|C[CAM]PEALFQPC[CAM]FLGMESC[CAM]GIHETTFNSIMK.4|FRC[CAM]PEALFQPC[CAM]FLGMESC[CAM]GIHETTFNSIMK.5|FRC[CAM]PEALFQPC[CAM]FLGMESC[CAM]GIHETTFNSIMK.4|LC[CAM]YVALDFEQEMATVASSSSLEK.3
SEN / CTL,Lysosomal alpha-glucosidase,GAA,P10253,0.62,1.07,2.01E-03,1.39E-03,2.86E+00,"maltose metabolic process,regulation of the force of heart contraction,diaphragm contraction,heart morphogenesis,glycogen catabolic process,sucrose metabolic process,glucose metabolic process,lysosome organization,locomotory behavior,tissue development,vacuolar sequestering,muscle cell cellular homeostasis,neuromuscular process controlling posture,neuromuscular process controlling balance,cardiac muscle contraction","alpha-1,4-glucosidase activity,oligo-1,6-glucosidase activity,carbohydrate binding,maltose alpha-glucosidase activity","lysosome,lysosomal membrane,membrane,lysosomal lumen,extracellular exosome",18,34,49,GAYTQVIFLAR.2|QQPMALAVALTK.2|WTQLGAFYPFMR.2|WTQLGAFYPFM[Oxi]R.2|TTPTFFPKDILTLR.3|AGYIIPLQGPGLTTTESR.2|AGYIIPLQGPGLTTTESR.3|VTSEGAGLQLQK.2|VTSEGAGLQLQK.3|RYEVPLETPHVHSR.4|RYEVPLETPHVHSR.3|LHFTIKDPANR.3|TTPTFFPK.2|PLFLEFPK.2|DGFRDFPAMVQELHQGGR.4|DGFRDFPAMVQELHQGGR.3|YALLPHLYTLFHQAHVAGETVAR.5|YALLPHLYTLFHQAHVAGETVAR.4|YALLPHLYTLFHQAHVAGETVAR.3|YEVPLETPHVHSR.3|DFPAMVQELHQGGR.3|DGFRDFPAMVQELHQGGRR.4|WGYSSTAITR.2|AHFPLDVQWNDLDYMDSRR.4|YALLPHLYTLFHQAHVAGETVARPLFLEFPK.6|YALLPHLYTLFHQAHVAGETVARPLFLEFPK.5|AITQEQC[CAM]EAR.2|LDVMMETENR.2|LDVM[Oxi]METENR.2|RYMMIVDPAISSSGPAGSYRPYDEGLRR.5|NHNSLLSLPQEPYSFSEPAQQAMR.4|NHNSLLSLPQEPYSFSEPAQQAMR.3|NHNSLLSLPQEPYSFSEPAQQAM[Oxi]R.3|EPAIHSEGQWVTLPAPLDTINVHLR.4|EPAIHSEGQWVTLPAPLDTINVHLR.3|NHNSLLSLPQEPYSFSEPAQQAMRK.4|AHFPLDVQWNDLDYMDSR.3|APSPLYSVEFSEEPFGVIVR.3|APSPLYSVEFSEEPFGVIVR.2|DSSTWTVDHQLLWGEALLITPVLQAGK.4|DSSTWTVDHQLLWGEALLITPVLQAGK.3|YMMIVDPAISSSGPAGSYRPYDEGLRR.4|VTVLGVATAPQQVLSNGVPVSNFTYSPDTK.4|VTVLGVATAPQQVLSNGVPVSNFTYSPDTK.3|APSPLYSVEFSEEPFGVIVRR.3|STGGILDVYIFLGPEPK.2|GELFWDDGESLEVLER.2|YMMIVDPAISSSGPAGSYRPYDEGLR.3|GSEDGC[CAM]PNNELENPPYVPGVVGGTLQAATIC[CAM]ASSHQFLSTHYNLHNLYGLTEAIASHR.6
SEN / CTL,DNA-directed RNA polymerase III subunit RPC3,POLR3C,Q9BUI4,0.62,0.20,3.04E-02,1.33E-02,1.88E+00,"regulation of transcription from RNA polymerase III promoter,transcription from RNA polymerase III promoter,positive regulation of type I interferon production,positive regulation of interferon-beta production,innate immune response,positive regulation of innate immune response,defense response to virus","DNA binding,DNA-directed RNA polymerase activity,protein binding,RNA polymerase III activity","nucleus,nucleoplasm,DNA-directed RNA polymerase III complex,cytosol",3,15,17,SLPVGYNISK.2|VIAHDTGTSLDQVK.3|VIAHDTGTSLDQVK.2|SGDSGGGMYVINLHK.3|LADTHFVQR.2|DQAIVSAVANR.2|ALASLATATLESVVQER.3|ALASLATATLESVVQER.2|MDQTSSEIVR.2|LC[CAM]SLLLQEHFGEIVEK.3|GVVEYEAQC[CAM]SR.2|RGVVEYEAQC[CAM]SR.2|QVLDQYLTLLADDPLEFVGK.3|TMDYAEVSNTFVR.2|TFYLYTVNILSAAR.2|YTTDNKEPIPDDGIYWQANLDR.3|TLYSDTGELIVEELLLNGK.2
SEN / CTL,UTP--glucose-1-phosphate uridylyltransferase,UGP2,Q16851,0.62,0.49,4.27E-06,6.06E-06,5.22E+00,"glycogen biosynthetic process,UDP-glucose metabolic process,UDP-glucuronate biosynthetic process,glucose 1-phosphate metabolic process","UTP:glucose-1-phosphate uridylyltransferase activity,protein binding,glucose binding,pyrimidine ribonucleotide binding,identical protein binding,metal ion binding","nucleus,cytosol,extracellular exosome",24,37,59,GLPDNISSVLNK.2|EFPTVPLVK.2|SFENSLGINVPR.2|SFENSLGINVPR.3|C[CAM]EFVMEVTNK.2|TLDGGLNVIQLETAVGAAIK.3|TLDGGLNVIQLETAVGAAIK.2|IQRPPEDSIQPYEK.3|IQRPPEDSIQPYEK.2|RC[CAM]EFVMEVTNK.3|RC[CAM]EFVM[Oxi]EVTNK.3|RC[CAM]EFVMEVTNK.2|ILTTASSHEFEHTK.4|ILTTASSHEFEHTK.3|ILTTASSHEFEHTK.2|INKESLLPVAK.3|INKESLLPVAK.2|AHVDEFK.2|GPSVDWGK.2|GTVIIIANHGDR.3|GTVIIIANHGDR.2|LRLVEIAQVPK.3|ILTTASSHEFEHTKK.4|ILTTASSHEFEHTKK.3|ARGLPDNISSVLNK.3|FLQEKGPSVDWGK.3|LVEIAQVPK.2|LGSSFTKVQDYLR.3|IYTFNQSR.2|GGTLTQYEGK.2|AMSQDGASQFQEVIR.3|AMSQDGASQFQEVIR.2|IFNTNNLWISLAAVK.3|IFNTNNLWISLAAVK.2|REFPTVPLVK.2|LNGGLGTSMGC[CAM]K.2|LNGGLGTSM[Oxi]GC[CAM]K.2|IFNTNNLWISLAAVKR.3|GTVIIIANHGDRIDIPPGAVLENK.4|GTVIIIANHGDRIDIPPGAVLENK.3|IDIPPGAVLENK.2|RLQEQNAIDM[Oxi]EIIVNAK.3|RLQEQNAIDMEIIVNAK.3|RLQEQNAIDMEIIVNAK.2|RFESIPDMLELDHLTVSGDVTFGK.4|RFESIPDM[Oxi]LELDHLTVSGDVTFGK.4|RFESIPDMLELDHLTVSGDVTFGK.3|TTSDLLLVMSNLYSLNAGSLTMSEK.4|TTSDLLLVMSNLYSLNAGSLTMSEK.3|TTSDLLLVMSNLYSLNAGSLTM[Oxi]SEK.3|AMSQDGASQFQEVIRQELELSVKK.4|SLIGVRNENTFLDLTVQQIEHLNK.4|SLIGVRNENTFLDLTVQQIEHLNK.3|NENTFLDLTVQQIEHLNK.3|NENTFLDLTVQQIEHLNK.2|TYNTDVPLVLMNSFNTDEDTK.3|AMSQDGASQFQEVIRQELELSVK.3|TYNTDVPLVLMNSFNTDEDTKK.3|LQEQNAIDMEIIVNAK.2
SEN / CTL,Vesicle-trafficking protein SEC22b,SEC22B,O75396,0.62,0.53,1.51E-02,7.46E-03,2.13E+00,"ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,protein transport,regulation of organelle organization,positive regulation of protein catabolic process,COPII vesicle coating,vesicle fusion with Golgi apparatus,exocytosis","SNARE binding,SNAP receptor activity,protein binding,syntaxin binding","Golgi membrane,endoplasmic reticulum membrane,endoplasmic reticulum-Golgi intermediate compartment,ER to Golgi transport vesicle membrane,integral component of membrane,transport vesicle,SNARE complex,endoplasmic reticulum-Golgi intermediate compartment membrane,melanosome",9,15,21,VLLTMIAR.2|VLLTM[Oxi]IAR.2|NLGSINTELQDVQR.2|IMVANIEEVLQR.2|IMVANIEEVLQR.3|IM[Oxi]VANIEEVLQR.2|ANNLSSLSK.2|LNEQSPTR.2|GEALSALDSK.2|KLNEQSPTR.2|RNLGSINTELQDVQR.3|RNLGSINTELQDVQR.2|DLQQYQSQAK.2|KVPTVSRPYSFIEFDTFIQK.4|KVPTVSRPYSFIEFDTFIQK.3|VADGLPLAASMQEDEQSGR.3|VADGLPLAASMQEDEQSGR.2|VPTVSRPYSFIEFDTFIQK.3|IMVANIEEVLQRGEALSALDSK.3|PYSFIEFDTFIQK.2|VADGLPLAASMQEDEQSGRDLQQYQSQAK.3
SEN / CTL,Phosphatidylinositol-binding clathrin assembly protein,PICALM,Q13492,0.62,0.41,1.27E-01,4.30E-02,1.37E+00,"protein complex assembly,receptor-mediated endocytosis,axonogenesis,cell proliferation,negative regulation of gene expression,synaptic vesicle maturation,vesicle-mediated transport,endosomal transport,hemopoiesis,regulation of endocytosis,receptor internalization,regulation of protein localization,cargo loading into vesicle,positive regulation of transcription, DNA-templated,negative regulation of receptor-mediated endocytosis,clathrin coat assembly,dendrite morphogenesis,iron ion homeostasis,clathrin-dependent endocytosis,iron ion import into cell,cell-cell adhesion,positive regulation of neuron death,positive regulation of beta-amyloid formation,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process","protein binding,1-phosphatidylinositol binding,clathrin binding,clathrin heavy chain binding,clathrin adaptor activity,cadherin binding involved in cell-cell adhesion","nucleus,Golgi apparatus,clathrin-coated pit,cell-cell adherens junction,membrane,vesicle,presynaptic membrane,neuronal cell body,postsynaptic membrane,neurofibrillary tangle,AP-2 adaptor complex,clathrin coat of coated pit,perinuclear region of cytoplasm",3,26,37,ATTLSNAVSSLASTGLSLTK.3|ATTLSNAVSSLASTGLSLTK.2|EKQAALEEEQAR.3|EKQAALEEEQAR.2|NTLFNLSNFLDK.3|NTLFNLSNFLDK.2|QVAFDFTK.2|ITAAQHSVTGSAVSK.3|ITAAQHSVTGSAVSK.2|VAEQVGIDR.2|FIQYLASR.2|ATTHEIMGPK.2|LFAAYNEGIINLLEK.3|LFAAYNEGIINLLEK.2|QAALEEEQAR.2|SLITTHHLMVYGNER.3|SLITTHHLM[Oxi]VYGNER.3|NDVNWSQPGEK.2|TTNSSWVVVFK.2|SSGDVHLSISSDVSTFTTR.3|GDIPDLSQAPSSLLDALEQHLASLEGK.4|GDIPDLSQAPSSLLDALEQHLASLEGK.3|GDIPDLSQAPSSLLDALEQHLASLEGKK.4|PTVASQNQNLPVAK.2|SGLQGYDMSTFIR.2|VAEQVGIDRGDIPDLSQAPSSLLDALEQHLASLEGK.5|VAEQVGIDRGDIPDLSQAPSSLLDALEQHLASLEGK.4|KPHTSLTTAASPVSTSAGGIMTAPAIDIFSTPSSSNSTSK.5|KPHTSLTTAASPVSTSAGGIMTAPAIDIFSTPSSSNSTSK.4|VAEQVGIDRGDIPDLSQAPSSLLDALEQHLASLEGKK.5|VAEQVGIDRGDIPDLSQAPSSLLDALEQHLASLEGKK.4|LVSDDLDSSLANLVGNLGIGNGTTK.3|STNVIVDSGGFDELGGLLKPTVASQNQNLPVAK.4|STNVIVDSGGFDELGGLLKPTVASQNQNLPVAK.3|TPTHEMFVGFTPSPVAQPHPSAGLNVDFESVFGNK.4|NTLFNLSNFLDKSGLQGYDMSTFIR.3|HLDYLIQC[CAM]TNEMNVNIPQLADSLFER.3
SEN / CTL,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5",MACF1,Q9UPN3,0.62,0.97,3.47E-04,3.03E-04,3.52E+00,"regulation of epithelial cell migration,Wnt signaling pathway,positive regulation of Wnt signaling pathway,regulation of microtubule-based process,wound healing,Golgi to plasma membrane protein transport,positive regulation of axon extension,regulation of focal adhesion assembly,cell-cell adhesion","actin binding,calcium ion binding,protein binding,microtubule binding,ATPase activity,poly(A) RNA binding,actin filament binding,cadherin binding involved in cell-cell adhesion","cytoplasm,Golgi apparatus,cytoskeleton,microtubule,plasma membrane,cell-cell adherens junction,ruffle membrane",18,251,298,ALLELVPWR.2|LVLDTVNEVSR.2|VIAQLEIR.2|C[CAM]DSFLHQSPSSSSVPTLR.3|YADITVTSSK.2|WQQVWLLALER.2|WQQVWLLALER.3|C[CAM]IVHQESGFK.3|C[CAM]IVHQESGFK.2|LEGIGQFHC[CAM]R.3|HLDALTLFSSK.3|HLDALTLFSSK.2|LRLEEYEQR.3|LRLEEYEQR.2|ATEVTVAR.2|ATHSSSTSWFR.3|IAQSAELADREK.3|IAQSAELADREK.2|LGGVLHER.2|SATVELEK.2|SSVASLVGR.2|IQQQIIR.2|YSC[CAM]DHNTSLSR.3|YSC[CAM]DHNTSLSR.2|TSQIFLAK.2|AISGVLDPR.2|ATSFATVVK.2|KATVDMLQAEGGR.3|NIEPTHAPFIEK.3|NIEPTHAPFIEK.2|RGEELIGR.2|AMLNEVEK.2|ARQEQLELTLGR.3|ARQEQLELTLGR.2|ESIAEHKPHIDK.3|ESIAEHKPHIDK.2|QLC[CAM]LC[CAM]VEQHVK.3|EFISIINPHNLK.3|AKEETYNQLLDK.3|AKEETYNQLLDK.2|KLANSEPVGTQTAK.3|KLANSEPVGTQTAK.2|LLHFQNAVEIEK.3|SDLDAVSMK.2|IAQLQEALLHC[CAM]GK.3|IAQLQEALLHC[CAM]GK.2|LRMPPLIPAEVDK.3|LVSDTIGQR.2|YTALVTLTTQHVK.3|RQGSFSEDVISHK.3|LIIEMLER.2|NLINPQMYQQLR.3|NLINPQMYQQLR.2|NLLVSVQSR.2|GQLQELSTR.2|DAYRPTTDADKIEDEVTR.4|DAYRPTTDADKIEDEVTR.3|LQQFMENK.2|SELNLLVEK.2|SLLDDWASK.2|ALFLPATTEILSWK.3|ALFLPATTEILSWK.2|IGLLDLMQR.2|LDNFLGEVR.2|AENMYAQIK.2|DIMEIEGEPAPDHR.3|IAQSAELADR.2|IKLPQGYHPNDVEEEWGK.4|LEC[CAM]TNLYR.2|LLPQAEMFEHLSGK.3|QHTILMSDK.2|VDSLIPWIK.2|EQVDPLQMK.2|GHFTSLELVPPSTLTTTHLK.4|GHFTSLELVPPSTLTTTHLK.3|ITRQEFIDGILASKFPTTK.4|SSQIDQAIVK.2|VLDMENSFK.2|LEEEVEAC[CAM]K.2|MDHVYGLSTVYLNK.3|MDHVYGLSTVYLNK.2|NDVLAHQATVETVNK.3|NDVLAHQATVETVNK.2|QPVYDTTIR.2|DLQDDIQNR.2|DSVLFSVADR.2|FRGALPDDTEALQSLIDTHK.4|FRGALPDDTEALQSLIDTHK.3|SIQDAELLVK.2|HHVLKNDVLAHQATVETVNK.4|HLWENLGEK.2|SVITYVSSIYDAFPK.3|SVITYVSSIYDAFPK.2|VDEIDAAIQR.2|AILEQQVLSEELTTK.3|AILEQQVLSEELTTK.2|ALFLPATTEILSWKK.3|DGHNLISLLEVLSGIK.3|DGHNLISLLEVLSGIK.2|LQQVNGLGQGLIQSAGK.3|LQQVNGLGQGLIQSAGK.2|MSQNFHTSYAETLGK.3|MSQNFHTSYAETLGK.2|EQLDTHMELYSQLK.3|GTLVEEINC[CAM]K.2|KLLPQAEMFEHLSGK.3|LELLLQIANK.2|NLQAHYEDFLQDSR.3|NLQAHYEDFLQDSR.2|SLISWNYLR.2|TGSLEEMTQR.2|VFANEVNAHR.2|LVSDANEQYK.2|QESLQAILNR.2|QLC[CAM]LEHDEK.2|FLDVLELAEK.2|HGLIGEDLAEK.2|HNLIDQDMAC[CAM]AILIR.3|LREFQESFK.2|QLQEELAEHQVPVEK.3|TLQNQLVELK.2|AGNELLESSAGDDASSLR.3|AGNELLESSAGDDASSLR.2|APLTVVQSIDR.2|FSQQYSTIVK.2|NQSDLKDLQDDIQNR.3|NQSDLKDLQDDIQNR.2|RNYFSELTMELEEK.3|ELEEAVTSALQQETEK.3|ELEEAVTSALQQETEK.2|AILEQQVLSEELTTKK.3|AILEQQVLSEELTTKK.2|ELQDALALISR.2|IAEQEHTQEDLQQLR.3|IAEQEHTQEDLQQLR.2|ELLGWVSTLAR.2|HMLEEEGTLDLLGLKR.3|ITGQLESLESR.2|QQLEETSEIR.2|RLETVALPLQGLEDLAADRINR.4|SLQDTAELLSLENHPAK.3|SLQDTAELLSLENHPAK.2|TEQSVALLEQK.2|TTQQDLSALQK.2|VNSGC[CAM]VMMENKLEGIGQFHC[CAM]R.4|VNSGC[CAM]VMMENKLEGIGQFHC[CAM]R.3|ALIAQLPSPAIDHEQLR.3|ATVDMLQAEGGR.2|HQLEIFDALGSQAC[CAM]SNK.3|HQLEIFDALGSQAC[CAM]SNK.2|IQNGALNC[CAM]EEK.2|TPEGLQESANVK.2|VLTLSQAIQLGK.2|VNSGC[CAM]VMMENK.2|ATAELIWLNEK.2|GALPDDTEALQSLIDTHK.3|GGSSPETLPSLLK.2|LDIEASEAEC[CAM]R.2|LETVALPLQGLEDLAADR.3|LETVALPLQGLEDLAADR.2|DYELQLMTYK.2|ISGTFSSGWTVR.2|MESQLSASKPTGGLPETAR.3|RVENLNIHQIFNPETK.3|SEIATQELTGEK.2|VKEALAGLLVTYPNSQEAENWKK.4|VLNQHTQLEGR.2|LANSEPVGTQTAK.2|QVSSLSSGVIQEALATNMK.3|QVSSLSSGVIQEALATNMK.2|SDLEQLDHEVK.2|SLGQVSLTHPYSEC[CAM]DFK.3|SLGQVSLTHPYSEC[CAM]DFK.2|AQQEVLQALEPQVDYLR.3|AQQEVLQALEPQVDYLR.2|DQEPIPQNIDR.2|GTSLENLIMEITAPDSQGK.3|GTSLENLIMEITAPDSQGK.2|HVQETTDSILSHFQSLSYSLAER.4|HVQETTDSILSHFQSLSYSLAER.3|LPEFQFSSQNK.2|QVQTLQDELQK.2|YLEVIPFSDIK.2|AFLAELEQNSPK.2|ARFEEVLTWAK.2|DC[CAM]DVQGLEHDMEEINAR.3|RFQVEQIGENK.2|RTLQNQLVELK.2|SLSQPTPPPMPILSQSEAK.3|SLSQPTPPPMPILSQSEAK.2|SLSSVSDTWNSR.2|SSAPGEC[CAM]HQIMK.2|TRYADITVTSSK.2|GHLLTIPPAEAEGVPLVVDK.3|QFHETAEPISDFLSVTEK.3|RLETVALPLQGLEDLAADR.3|SEIFGTC[CAM]GEEQK.2|VFANEVNAHRDQIIELDQTGNQLK.4|EANSVLQWLESK.2|EAQTLC[CAM]DELSVLIGEQYLKDELKK.4|EQYEALQEETR.2|GHFTSLELVPPSTLTTTHLKAEPLTK.4|LQNVQIALDFLK.2|LVSDTIGQRVDEIDAAIQR.3|QQVEAAETIKEETDGLHEELEFIR.4|TESLIQQYEAISLLNSER.3|TESLIQQYEAISLLNSER.2|YQWHVEDLVPWIEDC[CAM]K.3|ILGADLIFAC[CAM]GETEKPEVR.3|LFQVENQSAQEK.2|SQQYEQAADAELAWVAETK.3|C[CAM]TNFSSC[CAM]WSDGK.2|DIEGFMEENQTK.2|DTVHMLLEWLSEAEQTLR.3|EFANFDFDVWR.2|ENLEQAFEVAER.2|LEDLLQDSMDEK.2|ALALDEAVSQSTQITEFHDK.3|DTQDIVHDLESPGIDPSIIK.3|DTQDIVHDLESPGIDPSIIK.2|FEQLC[CAM]LQQQEK.2|IIASHQVLNGGIVDIFSDQR.3|LLSDTVASDPGVLQEQLATTK.3|LLSDTVASDPGVLQEQLATTK.2|NSVFSVLDEEIAK.2|TGSILPSVGSSVGSVNGYHTC[CAM]K.3|DLDLVQTWNLEK.2|GALDTTDGYMGVNQAPEKLDK.3|LQAALASTQQFQQMFDELR.3|LQAALASTQQFQQMFDELR.2|NDEC[CAM]VLEDNSQR.2|QTTGEEVLLIQEK.2|RVDVNSAVAMGEVILAVC[CAM]HPDC[CAM]ITTIK.4|VAQKELEEAVTSALQQETEK.3|DTDSLQSQIEDVR.2|LEDLLQDSMDEKEQLIQSK.3|LIDWLEDAESHLDSELEISNDPDKIK.4|SMENEDKEETVAK.2|VQIQSNRENLEQAFEVAER.3|ELNPEEGEMVEEK.2|LRAQQEVLQALEPQVDYLR.3|NNMGNDTNEEQEK.2|QLEESASHLAC[CAM]FQAAESQLRPWLMEK.4|QLEESASHLAC[CAM]FQAAESQLRPWLMEK.3|VEVYQQQIEMEK.2|AYHDLC[CAM]DGSANQLQQLQSQLAHQTEQK.4|AYHDLC[CAM]DGSANQLQQLQSQLAHQTEQK.3|ATSFATVVKDIEGFMEENQTK.3|FWYDMAALLTTIK.2|LDQMVFFWEDIK.2|LSVQSAISTQPEAVK.2|QIQPLELNLAELQDLLC[CAM]QAK.3|VTLDPVQLESSLLR.2|DASSC[CAM]QEQLDEFR.2|ENTAYFQFFSDAR.2|QLQTGGIIDTVTGQR.2|VPEGGEGISATEVDSR.2|ARHQELLSQQQNFILATQSAQAFLDQHGHNLTPEEQQMLQQK.6|DQIIELDQTGNQLK.2|FQSTYEELTGWLR.2|LEQDQTTAQLQVQK.2|LQSQLQENEEFQK.2|QVVDGGIIHHISGMR.2|FILPEGASQGMTPFR.2|LC[CAM]TMPPVGTDLNTVK.2|LLDAEDVDVPSPDEK.2|LMALGPIRLEQDQTTAQLQVQK.3|LSQEEVVLADLSALEAHWSTLR.3|VISPTGNEAMVPSVC[CAM]FLIPPPNK.3|AELVAISSSEDEGNLR.2|EQYSTSLAQSEAELK.2|FMETADSTTAAVLQGK.2|LC[CAM]TMPPVGTDLNTVKDQLNEMK.3|STQYQELLQDLSEK.2|QQNTC[CAM]HQQLEDLC[CAM]SWVGQAER.3|MSQNFHTSYAETLGKLETQYC[CAM]K.3|QSELESIQEVLGDYR.2|SSSSASQSNHSC[CAM]TSMPSSPATPASGTK.3|TSLAGDTSNSSSPASTGAK.2|DLTEIQC[CAM]DMSDVNLK.2|AGINQNMDAVTEELQAK.2|EVEEELATSGGQSPTGEQIPQFQQR.3|GALDTTDGYMGVNQAPEK.2|HQELLSQQQNFILATQSAQAFLDQHGHNLTPEEQQMLQQK.5|HQELLSQQQNFILATQSAQAFLDQHGHNLTPEEQQMLQQK.4|LQQVNGLGQGLIQSAGKDC[CAM]DVQGLEHDMEEINAR.4|MLSSSDAITQEFMDLR.2|NFTQGLVEDAPDGSDASQLLHQAEVAQQEFLEVK.4|TEEREQQLQSTLQQAQGFHSEIEDFLLELTR.4|ALALDEAVSQSTQITEFHDKIEPMLETLENLSSR.4|AQVLVNQFWETYEELSPWIEETR.3|AVAGVIDLGTVEIFPIFK.2|ATASQSENLLFQLMTHSYINVQNGQR.3|LGSHLNMLLGQYHQFQNSADSLQAWMQAC[CAM]EANVEK.4|QQHEQLNEAAQGILTGPGDVSLSTSQVQK.3|VLSEQLSQQTALFAEIER.2|EAQTLC[CAM]DELSVLIGEQYLK.2|EQQLQSTLQQAQGFHSEIEDFLLELTR.3
SEN / CTL,"Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial",DLST,P36957,0.61,0.96,1.25E-03,9.20E-04,3.04E+00,"generation of precursor metabolites and energy,tricarboxylic acid cycle,lysine catabolic process,L-lysine catabolic process to acetyl-CoA via saccharopine,glyoxylate metabolic process",dihydrolipoyllysine-residue succinyltransferase activity,"nucleus,mitochondrial matrix,membrane,myelin sheath,oxoglutarate dehydrogenase complex,extracellular exosome",18,27,40,LGFMSAFVK.2|LGFM[Oxi]SAFVK.2|GLVVPVIR.2|TPAFAESVTEGDVRWEK.3|TPAFAESVTEGDVRWEK.2|NVEAMNFADIER.2|NVEAM[Oxi]NFADIER.2|TITELGEK.2|VEVRPMMYVALTYDHR.4|VEVRPM[Oxi]MYVALTYDHR.4|VEVRPMM[Oxi]YVALTYDHR.4|VEVRPMMYVALTYDHR.3|VEVRPM[Oxi]MYVALTYDHR.3|VEVRPMM[Oxi]YVALTYDHR.3|VEGGTPLFTLRK.3|VEGGTPLFTLRK.2|LIDGREAVTFLR.3|EAVTFLRK.2|TPAFAESVTEGDVR.3|TPAFAESVTEGDVR.2|PAEAPAAAAPK.2|PMMYVALTYDHR.3|AKPAEAPAAAAPK.2|VEGGTPLFTLR.2|PVSAVKPTVAPPLAEPGAGK.3|PTVAPPLAEPGAGK.2|AAVEDPRVLLLDL.2|DYIDISVAVATPR.2|ASAFALQEQPVVNAVIDDTTK.3|ASAFALQEQPVVNAVIDDTTK.2|TSVQVPSPANGVIEALLVPDGGK.3|DDLVTVK.1|AEPTAAAVPPPAAPIPTQMPPVPSPSQPPSGKPVSAVKPTVAPPLAEPGAGK.6|AEPTAAAVPPPAAPIPTQMPPVPSPSQPPSGKPVSAVKPTVAPPLAEPGAGK.5|DDLVTVKTPAFAESVTEGDVRWEK.3|ASAFALQEQPVVNAVIDDTTKEVVYR.3|EAQNTC[CAM]AMLTTFNEIDMSNIQEMR.3|AVGDTVAEDEVVC[CAM]EIETDK.2|LKEAQNTC[CAM]AMLTTFNEIDM[Oxi]SNIQEMR.3|LKEAQNTC[CAM]AMLTTFNEIDMSNIQEMR.3
SEN / CTL,Serine/threonine-protein phosphatase PP1-alpha catalytic subunit,PPP1CA,P62136,0.61,0.42,6.01E-07,1.05E-06,5.98E+00,"glycogen metabolic process,regulation of glycogen biosynthetic process,regulation of glycogen catabolic process,protein dephosphorylation,cell cycle,dephosphorylation,lung development,negative regulation of protein binding,circadian regulation of gene expression,regulation of translational initiation by eIF2 alpha dephosphorylation,regulation of circadian rhythm,entrainment of circadian clock by photoperiod,branching morphogenesis of an epithelial tube,cell division,regulation of canonical Wnt signaling pathway,beta-catenin destruction complex disassembly,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand","phosphoprotein phosphatase activity,protein serine/threonine phosphatase activity,protein binding,protein phosphatase 1 binding,phosphatase activity,protein complex binding,ribonucleoprotein complex binding,metal ion binding","protein phosphatase type 1 complex,nucleus,nucleoplasm,nucleolus,cytoplasm,cytosol,plasma membrane,cell-cell junction,glycogen granule,dendritic spine,perikaryon,extracellular exosome,MLL5-L complex,PTW/PP1 phosphatase complex,nuclear chromosome, telomeric region",24,29,46,IKYPENFFLLR.3|AHQVVEDGYEFFAKR.3|AHQVVEDGYEFFAKR.4|GKQSLETIC[CAM]LLLAYK.3|TFTDC[CAM]FNC[CAM]LPIAAIVDEK.3|TFTDC[CAM]FNC[CAM]LPIAAIVDEK.2|YGQFSGLNPGGRPITPPR.3|AHQVVEDGYEFFAK.3|AHQVVEDGYEFFAK.2|IYGFYDEC[CAM]K.2|LNLDSIIGR.2|FLHKHDLDLIC[CAM]R.3|FLHKHDLDLIC[CAM]R.2|HDLDLIC[CAM]R.2|QSLETIC[CAM]LLLAYK.3|QSLETIC[CAM]LLLAYK.2|GKYGQFSGLNPGGRPITPPR.4|SREIFLSQPILLELEAPLK.4|SREIFLSQPILLELEAPLK.3|SREIFLSQPILLELEAPLK.2|IFC[CAM]C[CAM]HGGLSPDLQSMEQIR.4|IFC[CAM]C[CAM]HGGLSPDLQSM[Oxi]EQIR.3|IFC[CAM]C[CAM]HGGLSPDLQSMEQIR.3|IFC[CAM]C[CAM]HGGLSPDLQSMEQIR.2|IC[CAM]GDIHGQYYDLLR.3|IC[CAM]GDIHGQYYDLLR.2|GNHEC[CAM]ASINR.2|DVQGWGENDR.2|LLEVQGSRPGK.2|YPENFFLLR.2|IFC[CAM]C[CAM]HGGLSPDLQSM[Oxi]EQIRR.4|IFC[CAM]C[CAM]HGGLSPDLQSMEQIRR.4|IFC[CAM]C[CAM]HGGLSPDLQSMEQIRR.3|IFC[CAM]C[CAM]HGGLSPDLQSM[Oxi]EQIRR.3|NVQLTENEIR.2|YGQFSGLNPGGR.2|EIFLSQPILLELEAPLK.3|EIFLSQPILLELEAPLK.2|GVSFTFGAEVVAK.2|IMRPTDVPDQGLLC[CAM]DLLWSDPDK.4|IMRPTDVPDQGLLC[CAM]DLLWSDPDK.3|IMRPTDVPDQGLLC[CAM]DLLWSDPDKDVQGWGENDR.5|IMRPTDVPDQGLLC[CAM]DLLWSDPDKDVQGWGENDR.4|LFEYGGFPPESNYLFLGDYVDR.3|LFEYGGFPPESNYLFLGDYVDRGK.3|RQLVTLFSAPNYC[CAM]GEFDNAGAMMSVDETLMC[CAM]SFQILKPADK.4
SEN / CTL,Tubulin alpha-1C chain,TUBA1C,Q9BQE3,0.61,0.23,9.91E-04,7.56E-04,3.12E+00,"cytoskeleton organization,microtubule-based process,cytoskeleton-dependent intracellular transport,cell division","GTPase activity,structural molecule activity,structural constituent of cytoskeleton,protein binding,GTP binding","nucleus,cytoplasm,microtubule,vesicle",6,3,10,AVC[CAM]MLSNTTAVAEAWAR.3|AVC[CAM]MLSNTTAVAEAWAR.2|AVC[CAM]M[Oxi]LSNTTAVAEAWAR.3|AVC[CAM]M[Oxi]LSNTTAVAEAWAR.2|AYHEQLTVAEITNAC[CAM]FEPANQM[Oxi]VK.4|AYHEQLTVAEITNAC[CAM]FEPANQMVK.4|AYHEQLTVAEITNAC[CAM]FEPANQM[Oxi]VK.3|AYHEQLTVAEITNAC[CAM]FEPANQMVK.3|DYEEVGADSADGEDEGEEY.3|DYEEVGADSADGEDEGEEY.2
SEN / CTL,Decorin,DCN,P07585,0.61,0.48,1.45E-09,4.21E-09,8.38E+00,"kidney development,placenta development,negative regulation of protein kinase activity,skeletal muscle tissue development,aging,response to mechanical stimulus,animal organ morphogenesis,positive regulation of autophagy,negative regulation of endothelial cell migration,positive regulation of phosphatidylinositol 3-kinase signaling,positive regulation of macroautophagy,negative regulation of angiogenesis,cytokine-mediated signaling pathway,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,extracellular matrix disassembly,extracellular matrix organization,glycosaminoglycan metabolic process,chondroitin sulfate biosynthetic process,chondroitin sulfate catabolic process,dermatan sulfate biosynthetic process,response to lipopolysaccharide,wound healing,positive regulation of transcription from RNA polymerase II promoter,negative regulation of JAK-STAT cascade,positive regulation of mitochondrial depolarization,positive regulation of mitochondrial fission,negative regulation of vascular endothelial growth factor signaling pathway","protein kinase inhibitor activity,protein binding,collagen binding,glycosaminoglycan binding,poly(A) RNA binding,protein N-terminus binding,extracellular matrix binding","extracellular region,collagen type VI trimer,extracellular space,cytoplasm,Golgi lumen,lysosomal lumen,extracellular matrix",42,22,33,NLHALILVNNK.3|NLHALILVNNK.2|VSPGAFTPLVKLER.3|KVTFNGLNQMIVIELGTNPLK.3|ASYSGVSLFSNPVQYWEIQPSTFR.3|VSPGAFTPLVK.2|KASYSGVSLFSNPVQYWEIQPSTFR.3|KASYSGVSLFSNPVQYWEIQPSTFR.4|KASYSGVSLFSNPVQYWEIQPSTFR.5|VVQC[CAM]SDLGLDKVPK.3|VVQC[CAM]SDLGLDKVPK.2|NLHALILVNNKISK.3|VTFNGLNQMIVIELGTNPLK.3|VTFNGLNQM[Oxi]IVIELGTNPLK.3|VTFNGLNQM[Oxi]IVIELGTNPLK.2|VTFNGLNQMIVIELGTNPLK.2|YIQVVYLHNNNISVVGSSDFC[CAM]PPGHNTK.4|YIQVVYLHNNNISVVGSSDFC[CAM]PPGHNTK.3|LTRVPGGLAEHK.3|VPGGLAEHK.2|AHENEITK.2|VDAASLKGLNNLAK.3|VDAASLKGLNNLAK.2|ELHLDNNK.2|SAIQLGNYK.2|DLPPDTTLLDLQNNK.3|DLPPDTTLLDLQNNK.2|TLQELRAHENEITK.3|ITEIKDGDFK.2|VVQC[CAM]SDLGLDK.2|SSGIENGAFQGMK.2|SSGIENGAFQGM[Oxi]K.2|LGLSFNSISAVDNGSLANTPHLR.3
SEN / CTL,Glutaredoxin-1,GLRX,P35754,0.61,0.35,9.98E-07,1.67E-06,5.78E+00,"nucleobase-containing small molecule interconversion,cell redox homeostasis,positive regulation of membrane potential,oxidation-reduction process,protein deglutathionylation,positive regulation of sodium ion transmembrane transporter activity","electron carrier activity,glutathione disulfide oxidoreductase activity,protein N-terminus binding,glutathione oxidoreductase activity","nucleus,mitochondrion,cytosol,extracellular exosome",18,7,11,AQEILSQLPIK.2|RAQEILSQLPIK.3|RAQEILSQLPIK.2|QGLLEFVDITATNHTNEIQDYLQQLTGAR.4|QGLLEFVDITATNHTNEIQDYLQQLTGAR.3|VVVFIKPTC[CAM]PYC[CAM]R.3|VVVFIKPTC[CAM]PYC[CAM]R.2|VFIGKDC[CAM]IGGC[CAM]SDLVSLQQSGELLTR.3|LKQIGALQ.2|DC[CAM]IGGC[CAM]SDLVSLQQSGELLTR.3|DC[CAM]IGGC[CAM]SDLVSLQQSGELLTR.2
SEN / CTL,Carbonyl reductase [NADPH] 1,CBR1,P16152,0.61,0.36,9.94E-10,2.98E-09,8.53E+00,"drug metabolic process,cyclooxygenase pathway,epithelial cell differentiation,vitamin K metabolic process,oxidation-reduction process","carbonyl reductase (NADPH) activity,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,prostaglandin-E2 9-reductase activity","cytosol,extracellular exosome,extracellular vesicle",30,26,43,LFSGDVVLTAR.2|FHQLDIDDLQSIR.3|FHQLDIDDLQSIR.2|DVC[CAM]TELLPLIKPQGR.3|DVC[CAM]TELLPLIKPQGR.2|VVNVSSIMSVR.2|VVNVSSIM[Oxi]SVR.2|GIGLAIVR.2|GQAAVQQLQAEGLSPR.2|GQAAVQQLQAEGLSPR.3|IGVTVLSR.2|ILLNAC[CAM]C[CAM]PGWVR.2|ILLNAC[CAM]C[CAM]PGWVR.3|TNFFGTR.2|KGDKILLNAC[CAM]C[CAM]PGWVR.4|KGDKILLNAC[CAM]C[CAM]PGWVR.3|DVTRGQAAVQQLQAEGLSPR.4|DVTRGQAAVQQLQAEGLSPR.3|SC[CAM]SPELQQK.2|SETITEEELVGLMNK.3|SETITEEELVGLMNK.2|SETITEEELVGLM[Oxi]NK.2|EYGGLDVLVNNAGIAFK.3|EYGGLDVLVNNAGIAFK.2|VADPTPFHIQAEVTM[Oxi]K.3|VADPTPFHIQAEVTMK.3|VADPTPFHIQAEVTMK.2|VADPTPFHIQAEVTM[Oxi]K.2|GVHQKEGWPSSAYGVTK.3|KEYGGLDVLVNNAGIAFK.3|KEYGGLDVLVNNAGIAFK.2|SETITEEELVGLMNKFVEDTKK.4|EGWPSSAYGVTK.2|TNFFGTRDVC[CAM]TELLPLIKPQGR.4|DVC[CAM]TELLPLIK.2|FRSETITEEELVGLMNK.3|FRSETITEEELVGLM[Oxi]NK.3|FRSETITEEELVGLMNK.2|ALKSC[CAM]SPELQQK.2|SPEEGAETPVYLALLPPDAEGPHGQFVSEK.4|SPEEGAETPVYLALLPPDAEGPHGQFVSEK.3|SPEEGAETPVYLALLPPDAEGPHGQFVSEKR.4|ATKSPEEGAETPVYLALLPPDAEGPHGQFVSEK.4
SEN / CTL,60S ribosomal protein L7a,RPL7A,P62424,0.61,0.65,1.81E-04,1.72E-04,3.76E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,maturation of LSU-rRNA,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,cell-cell adhesion","RNA binding,structural constituent of ribosome,protein binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","nucleus,nucleolus,cytoplasm,cytosol,cell-cell adherens junction,focal adhesion,membrane,cytosolic large ribosomal subunit,polysomal ribosome,extracellular exosome",15,31,43,AQLVVIAHDVDPIELVVFLPALC[CAM]R.3|AQLVVIAHDVDPIELVVFLPALC[CAM]R.4|AGVNTVTTLVENK.2|AGVNTVTTLVENK.3|TC[CAM]TTVAFTQVNSEDKGALAK.3|TC[CAM]TTVAFTQVNSEDKGALAK.2|KAQLVVIAHDVDPIELVVFLPALC[CAM]R.4|KAQLVVIAHDVDPIELVVFLPALC[CAM]R.3|KMGVPYC[CAM]IIK.3|KMGVPYC[CAM]IIK.2|RHWGGNVLGPK.3|AAGKGDVPTKRPPVLR.4|VAPAPAVVK.2|VVNPLFEKRPK.3|QTATQLLK.2|VVNPLFEK.2|KVAPAPAVVK.2|KVVNPLFEKRPK.3|TNYNDRYDEIR.3|VAPAPAVVKK.2|AGVNTVTTLVENKK.3|AGVNTVTTLVENKK.2|VPPAINQFTQALDR.3|VPPAINQFTQALDR.2|HWGGNVLGPK.2|KVVNPLFEK.2|TNYNDRYDEIRR.3|MGVPYC[CAM]IIK.2|TC[CAM]TTVAFTQVNSEDK.3|TC[CAM]TTVAFTQVNSEDK.2|KTC[CAM]TTVAFTQVNSEDKGALAK.4|KTC[CAM]TTVAFTQVNSEDKGALAK.3|LKVPPAINQFTQALDR.3|LKVPPAINQFTQALDR.2|NFGIGQDIQPK.2|VPPAINQFTQALDRQTATQLLK.4|VPPAINQFTQALDRQTATQLLK.3|LKVPPAINQFTQALDRQTATQLLK.4|NFGIGQDIQPKR.2|AQLVVIAHDVDPIELVVFLPALC[CAM]RK.4|AQLVVIAHDVDPIELVVFLPALC[CAM]RK.3|KAQLVVIAHDVDPIELVVFLPALC[CAM]RK.4|KTC[CAM]TTVAFTQVNSEDK.2
SEN / CTL,Prostaglandin reductase 1,PTGR1,Q14914,0.61,0.25,7.18E-12,3.08E-11,1.05E+01,"leukotriene metabolic process,prostaglandin metabolic process,oxidation-reduction process","zinc ion binding,2-alkenal reductase [NAD(P)] activity,13-prostaglandin reductase activity,15-oxoprostaglandin 13-oxidase activity","cytoplasm,extracellular exosome",27,22,35,MEAFVVYR.2|IAIC[CAM]GAISTYNR.2|LGFDVVFNYK.2|HFVGYPTNSDFELK.3|HFVGYPTNSDFELK.2|VVGAVGSDEKVAYLQK.3|TGPLPPGPPPEIVIYQELR.3|TGPLPPGPPPEIVIYQELR.2|GGETVMVNAAAGAVGSVVGQIAK.3|GGETVMVNAAAGAVGSVVGQIAK.2|GTIVLASPGWTTHSISDGKDLEK.4|GTIVLASPGWTTHSISDGKDLEK.3|TVESLEETLKK.3|TVESLEETLKK.2|TAELPPLK.2|KHFVGYPTNSDFELK.4|KHFVGYPTNSDFELK.3|KHFVGYPTNSDFELK.2|VVGAVGSDEK.2|LKEGDTMMGQQVAK.3|LKEGDTM[Oxi]M[Oxi]GQQVAK.3|TVESLEETLK.2|VVESKNVALPK.2|LGFDVVFNYKTVESLEETLKK.4|GTIVLASPGWTTHSISDGK.3|GTIVLASPGWTTHSISDGK.2|EGDTMMGQQVAK.2|EGDTM[Oxi]MGQQVAK.2|EGDTMM[Oxi]GQQVAK.2|EGDTM[Oxi]M[Oxi]GQQVAK.2|NGEVLLEALFLTVDPYM[Oxi]R.3|EYIIEGFENMPAAFMGMLK.3|EYIIEGFENMPAAFMGMLK.2|IQYKEYIIEGFENMPAAFMGMLK.3|KASPDGYDC[CAM]YFDNVGGEFSNTVIGQMK.3
SEN / CTL,"Keratin, type II cuticular Hb6;Keratin, type II cuticular Hb3;Keratin, type II cuticular Hb1",KRT86;KRT83;KRT81,O43790;P78385;Q14533,0.61,2.27,4.62E-03,2.79E-03,2.55E+00,";aging,epidermis development,hair cycle;","structural molecule activity,protein binding;structural molecule activity,protein binding;structural molecule activity,protein binding","extracellular space,keratin filament,extracellular exosome;extracellular space,keratin filament;extracellular space,keratin filament",18,6,6,LGLDIEIATYR.2|DVDC[CAM]AYLR.2|ATAENEFVALKK.3|FAAFIDK.2|LTAEVENAK.2|ATAENEFVALK.2
SEN / CTL,Macrophage-capping protein,CAPG,P40121,0.59,0.80,6.74E-05,7.03E-05,4.15E+00,"protein complex assembly,barbed-end actin filament capping,cell-cell adhesion,extracellular matrix disassembly,positive regulation of podosome assembly","actin binding,protein binding,protein domain specific binding,protein complex binding,cadherin binding involved in cell-cell adhesion","nucleus,nucleoplasm,nucleolus,cytoplasm,centriole,cell-cell adherens junction,F-actin capping protein complex,melanosome,extracellular exosome,mitotic spindle,Flemming body",33,22,39,QAALQVAEGFISR.2|QAALQVAEGFISR.3|VADSSPFALELLISDDC[CAM]FVLDNGLC[CAM]GK.3|EVQGNESDLFMSYFPR.3|EVQGNESDLFMSYFPR.2|EVQGNESDLFM[Oxi]SYFPR.2|VSDATGQMNLTK.2|VSDATGQM[Oxi]NLTK.2|AQVEIVTDGEEPAEMIQVLGPKPALKEGNPEEDLTADKANAQAAALYK.5|DEQGAC[CAM]AVLAVHLNTLLGERPVQHR.5|DEQGAC[CAM]AVLAVHLNTLLGERPVQHR.4|DEQGAC[CAM]AVLAVHLNTLLGERPVQHR.3|YQEGGVESAFHK.3|YQEGGVESAFHK.2|EGNPEEDLTADKANAQAAALYK.3|GLKYQEGGVESAFHK.4|GLKYQEGGVESAFHK.3|GLKYQEGGVESAFHK.2|TSTGAPAAIK.2|ARDLALAIR.2|GLKYQEGGVESAFHKTSTGAPAAIK.5|ANAQAAALYK.2|TSTGAPAAIKK.2|ANEKERQAALQVAEGFISR.4|ANEKERQAALQVAEGFISR.3|AQVEIVTDGEEPAEMIQVLGPKPALK.5|AQVEIVTDGEEPAEMIQVLGPKPALK.4|AQVEIVTDGEEPAEMIQVLGPKPALK.3|ERQAALQVAEGFISR.3|ERQAALQVAEGFISR.2|MQYAPNTQVEILPQGHESPIFK.4|M[Oxi]QYAPNTQVEILPQGHESPIFK.3|MQYAPNTQVEILPQGHESPIFK.3|EGNPEEDLTADK.2|AQVEIVTDGEEPAEMIQVLGPK.3|AQVEIVTDGEEPAEMIQVLGPK.2|LKPVPVAQENQGVFFSGDSYLVLHNGPEEVSHLHLWIGQQSSR.6|LKPVPVAQENQGVFFSGDSYLVLHNGPEEVSHLHLWIGQQSSR.5|AQVEIVTDGEEPAEMIQVLGPKPALKEGNPEEDLTADK.4
SEN / CTL,POTE ankyrin domain family member J,POTEJ,P0CG39,0.59,0.12,1.38E-02,6.87E-03,2.16E+00,retina homeostasis,,"extracellular space,extracellular exosome",3,2,3,LC[CAM]YVALDFEQEMAMVASSSSLEK.3|LC[CAM]YVALDFEQEMAMVASSSSLEK.4|EKLC[CAM]YVALDFEQEMAMVASSSSLEK.4
SEN / CTL,Phosphotriesterase-related protein,PTER,Q96BW5,0.59,1.58,4.54E-02,1.85E-02,1.73E+00,"catabolic process,epithelial cell differentiation","molecular_function,zinc ion binding,hydrolase activity, acting on ester bonds",extracellular exosome,36,18,21,VQTVLGLVEPSKLGR.3|AMSVEQLTDVLMNEILHGADGTSIK.3|ILQEAGADISK.2|ANGGGALVENTTTGISR.2|VQTVLGLVEPSK.2|LLVEEGC[CAM]EDR.2|GITENVLDKILIENPKQWLTFK.4|GITENVLDKILIENPKQWLTFK.3|VLQATAHAQAQLGC[CAM]PVIIHPGR.4|VLQATAHAQAQLGC[CAM]PVIIHPGR.3|YGGHGYSHILTNVVPK.3|YGGHGYSHILTNVVPK.2|GITENVLDKILIENPK.3|APFQIIR.2|TVMSHLDR.2|GITENVLDK.2|C[CAM]GIIGEIGC[CAM]SWPLTESERK.3|RLAEETGVHIISGAGFYVDATHSSETR.4|ENLQLNQETEAIK.2|ENLQLNQETEAIKEELLYFK.3|TLTHEHLAMTFDC[CAM]C[CAM]YC[CAM]PPPPC[CAM]QEAISK.4
SEN / CTL,Nicastrin,NCSTN,Q92542,0.59,0.83,7.14E-02,2.70E-02,1.57E+00,"myeloid cell homeostasis,proteolysis,membrane protein ectodomain proteolysis,Notch signaling pathway,Notch receptor processing,protein processing,membrane protein intracellular domain proteolysis,T cell proliferation,amyloid precursor protein catabolic process,positive regulation of apoptotic process,positive regulation of catalytic activity,ephrin receptor signaling pathway,beta-amyloid metabolic process,epithelial cell proliferation","endopeptidase activity,protein binding","lysosomal membrane,endoplasmic reticulum,Golgi apparatus,plasma membrane,integral component of plasma membrane,focal adhesion,membrane,integral component of membrane,melanosome,extracellular exosome",6,10,12,LLYGFLIK.2|ALADVATVLGR.2|APDVTTLPR.2|ADVLFIAPR.2|SGAGVPAVILR.2|EQC[CAM]QDPSKVPSENK.3|GKFPVQLENVDSFVELGQVALR.4|GKFPVQLENVDSFVELGQVALR.3|NQVEDLLATLEK.2|FPVQLENVDSFVELGQVALR.3|IAGLAVSLTKPSPASGFSPSVQC[CAM]PNDGFGVYSNSYGPEFAHC[CAM]R.6|IAGLAVSLTKPSPASGFSPSVQC[CAM]PNDGFGVYSNSYGPEFAHC[CAM]R.4
SEN / CTL,Coatomer subunit gamma-1,COPG1,Q9Y678,0.58,0.39,4.03E-05,4.38E-05,4.36E+00,"intracellular protein transport,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,establishment of Golgi localization,organelle transport along microtubule",structural molecule activity,"Golgi membrane,endoplasmic reticulum membrane,Golgi apparatus,cytosol,COPI vesicle coat,transport vesicle",15,60,99,TLEEAVGNIVK.2|SIATLAITTLLK.2|SIATLAITTLLK.3|FGAQNEEMLPSILVLLKR.3|EMSC[CAM]IAEDVIIVTSSLTK.3|EMSC[CAM]IAEDVIIVTSSLTK.2|ELAPAVSVLQLFC[CAM]SSPK.3|ELAPAVSVLQLFC[CAM]SSPK.2|ILHLLGQEGPK.3|ILHLLGQEGPK.2|C[CAM]SFDVVK.2|DMTGKEDNYRGPAVR.4|DMTGKEDNYRGPAVR.3|GGHDILVR.2|LFQSNDPTLRR.3|NTHTLLLAGVFR.3|NTHTLLLAGVFR.2|KDEESGGGSNPFQHLEK.4|KDEESGGGSNPFQHLEK.3|KDEESGGGSNPFQHLEK.2|RC[CAM]VMDDDNEVR.3|RC[CAM]VMDDDNEVR.2|TGSESSIDR.2|EEGGFEYK.2|ALQQYTLEPSEKPFDLK.4|ALQQYTLEPSEKPFDLK.3|ALQQYTLEPSEKPFDLK.2|C[CAM]SFDVVKR.2|TESTPITAVKQPEK.3|TESTPITAVKQPEK.2|ALNAGYILNGLTVSIPGLER.4|ALNAGYILNGLTVSIPGLER.3|ALNAGYILNGLTVSIPGLER.2|SLEELPVDIILASVG.3|SLEELPVDIILASVG.2|TESTPITAVK.2|LLLLDTVTMQVTAR.3|LLLLDTVTMQVTAR.2|LLLLDTVTM[Oxi]QVTAR.2|DSPLFDFIESC[CAM]LR.3|DSPLFDFIESC[CAM]LR.2|QISSFMSEISDEFK.3|QISSFMSEISDEFK.2|RC[CAM]VMDDDNEVRDR.3|SDKVPDNKNTHTLLLAGVFR.4|VVLEHEEVR.2|FDKKDEESGGGSNPFQHLEK.4|FLGMHPC[CAM]ER.2|DEESGGGSNPFQHLEK.3|DEESGGGSNPFQHLEK.2|VPSVSSSALVSSLHLLK.3|VPSVSSSALVSSLHLLK.2|EETFTLSTIK.2|VFNETPINPR.2|LFQSNDPTLR.2|QAIVDKVPSVSSSALVSSLHLLK.4|QAIVDKVPSVSSSALVSSLHLLK.3|QEIFQEQLAAVPEFR.3|QEIFQEQLAAVPEFR.2|ALC[CAM]QITDSTMLQAIER.3|ALC[CAM]QITDSTMLQAIER.2|NKHEMVVYEAASAIVNLPGC[CAM]SAK.4|NKHEM[Oxi]VVYEAASAIVNLPGC[CAM]SAK.4|NKHEMVVYEAASAIVNLPGC[CAM]SAK.3|C[CAM]VMDDDNEVR.2|FGAQNEEMLPSILVLLK.3|FGAQNEEM[Oxi]LPSILVLLK.2|FGAQNEEMLPSILVLLK.2|LNFEAAWDEVGDEFEK.3|LNFEAAWDEVGDEFEK.2|SPFAYC[CAM]MMIR.2|SPFAYC[CAM]MM[Oxi]IR.2|AIVDC[CAM]IISIIEENSESK.3|AIVDC[CAM]IISIIEENSESK.2|ETGLSHLC[CAM]EFIEDC[CAM]EFTVLATR.4|ETGLSHLC[CAM]EFIEDC[CAM]EFTVLATR.3|ATFYLNVLEQK.2|SSPEPVALTESETEYVIR.3|SSPEPVALTESETEYVIR.2|SLPYNQPGTC[CAM]YTLVALPK.3|SLPYNQPGTC[CAM]YTLVALPK.2|SVPLATAPMAEQR.2|SVPLATAPM[Oxi]AEQR.2|RAIVDC[CAM]IISIIEENSESK.3|RAIVDC[CAM]IISIIEENSESK.2|VAMKHPSAVTAC[CAM]NLDLENLVTDSNR.4|ALQQYTLEPSEK.2|ILYLINQGEHLGTTEATEAFFAMTK.4|ILYLINQGEHLGTTEATEAFFAM[Oxi]TK.3|ILYLINQGEHLGTTEATEAFFAMTK.3|HEMVVYEAASAIVNLPGC[CAM]SAK.3|HEMVVYEAASAIVNLPGC[CAM]SAK.2|HPSAVTAC[CAM]NLDLENLVTDSNR.3|VAATRQEIFQEQLAAVPEFR.3|WVNEAQEAASSDNIMVQYHALGLLYHVR.4|EDPTAVAC[CAM]TFSC[CAM]MMK.2|QLEEEDGSRDSPLFDFIESC[CAM]LR.3|DC[CAM]DPTTGETDDEGYEDEYVLEDLEVTVADHIQK.4|LNFEAAWDEVGDEFEKEETFTLSTIK.3
SEN / CTL,Adseverin,SCIN,Q9Y6U3,0.58,0.93,3.86E-03,2.42E-03,2.62E+00,"negative regulation of cell proliferation,calcium ion regulated exocytosis,regulation of chondrocyte differentiation,sequestering of actin monomers,positive regulation of apoptotic process,actin nucleation,positive regulation of megakaryocyte differentiation,actin filament severing,positive regulation of secretion,positive regulation of actin nucleation,actin filament capping","phosphatidylserine binding,actin binding,calcium ion binding,1-phosphatidylinositol binding,phosphatidylinositol-4,5-bisphosphate binding,actin filament binding","cytoplasm,cytoskeleton,brush border,cell cortex,protein complex,extracellular exosome",12,34,43,LYMVSDASGSMR.2|GASQEEEKGAEYVASVLK.3|NTQIQVLPEGGETPIFK.2|NTQIQVLPEGGETPIFK.3|VLGEKPELPDGGDDDDIIADISNRK.4|ANQVATGIR.2|GGQAPAPPTR.2|AGGVASGLNHVLTNDLTAKR.4|AGGVASGLNHVLTNDLTAKR.3|SLGGQAVQIR.2|GAEYVASVLK.2|LHSSPQMAAQHNMVDDGSGK.4|LHSSPQMAAQHNMVDDGSGK.3|KGGQAPAPPTR.2|KDYQTSPLLETQAEDHPPR.4|LHSSPQMAAQHNMVDDGSGKVEIWR.5|LHSSPQMAAQHNMVDDGSGKVEIWR.4|VSQGKEPVHLLSLFK.3|VSQGKEPVHLLSLFK.2|MYLETDPSGR.2|EPVHLLSLFK.2|ELYHEEFAR.2|AGGVASGLNHVLTNDLTAK.3|AGGVASGLNHVLTNDLTAK.2|LPQNSGYIWVGK.2|GRSELIVVEEGSEPSELIK.3|IQEGEEPEEFWNSLGGKK.3|DYQTSPLLETQAEDHPPR.3|IVEVDVDANSLNSNDVFVLK.3|IVEVDVDANSLNSNDVFVLK.2|LELVPVPQSAHGDFYVGDAYLVLHTAK.4|LELVPVPQSAHGDFYVGDAYLVLHTAK.3|QGHEPPTFTGWFLGWDSSK.3|ATEVPLSWDSFNK.2|GQIIYTWQGANATR.2|QGHEPPTFTGWFLGWDSSKW.3|TAEEFLQQMNYSK.2|VTVVAEENPFSMAMLLSEEC[CAM]FILDHGAAK.4|VTVVAEENPFSMAMLLSEEC[CAM]FILDHGAAK.3|VLGEKPELPDGGDDDDIIADISNR.3|ELQGYESNDFVSYFK.2|SELIVVEEGSEPSELIK.2|IQEGEEPEEFWNSLGGK.2
SEN / CTL,T-complex protein 1 subunit alpha,TCP1,P17987,0.58,0.32,2.56E-10,8.86E-10,9.05E+00,"protein folding,tubulin complex assembly,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,translocation of peptides or proteins into host cell cytoplasm,protein stabilization,positive regulation of telomerase activity,scaRNA localization to Cajal body,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body,regulation of macrophage apoptotic process","protein binding,ATP binding,ubiquitin protein ligase binding,poly(A) RNA binding,unfolded protein binding","pericentriolar material,acrosomal vesicle,zona pellucida receptor complex,nuclear heterochromatin,Golgi apparatus,centrosome,cytosol,chaperonin-containing T-complex,microtubule,myelin sheath,cell body,extracellular exosome",48,42,75,EQLAIAEFAR.2|TSASIILR.2|IAC[CAM]LDFSLQK.2|IC[CAM]DDELILIK.2|VLC[CAM]ELADLQDKEVGDGTTSVVIIAAELLK.3|VLC[CAM]ELADLQDKEVGDGTTSVVIIAAELLK.4|FATEAAITILR.2|FATEAAITILR.3|LGVQVVITDPEKLDQIR.3|LGVQVVITDPEKLDQIR.2|GANDFMC[CAM]DEMER.2|GANDFM[Oxi]C[CAM]DEMER.2|GANDFMC[CAM]DEM[Oxi]ER.2|SLLVIPNTLAVNAAQDSTDLVAK.3|SLLVIPNTLAVNAAQDSTDLVAK.2|SLLVIPNTLAVNAAQDSTDLVAK.4|ASGATILSTLANLEGEETFEAAMLGQAEEVVQER.4|ASGATILSTLANLEGEETFEAAMLGQAEEVVQER.3|SVVPGGGAVEAALSIYLENYATSMGSR.3|SVVPGGGAVEAALSIYLENYATSMGSR.4|SVVPGGGAVEAALSIYLENYATSM[Oxi]GSR.3|YFVEAGAMAVR.2|YFVEAGAM[Oxi]AVR.2|YINENLIVNTDELGRDC[CAM]LINAAK.3|SQNVMAAASIANIVK.2|SQNVMAAASIANIVK.3|SQNVM[Oxi]AAASIANIVK.3|SQNVM[Oxi]AAASIANIVK.2|IHPTSVISGYR.3|LRAFHNEAQVNPER.4|LRAFHNEAQVNPER.3|SLHDALC[CAM]VVKR.3|DC[CAM]LINAAK.2|LRAFHNEAQVNPERK.4|LRAFHNEAQVNPERK.3|WIGLDLSNGKPR.3|WIGLDLSNGKPR.2|AFHNEAQVNPER.3|AFHNEAQVNPER.2|DDKHGSYEDAVHSGALND.4|DDKHGSYEDAVHSGALND.3|SSLGPVGLDK.2|AFHNEAQVNPERK.3|AFHNEAQVNPERK.2|DNKQAGVFEPTIVK.3|DNKQAGVFEPTIVK.2|HGSYEDAVHSGALND.3|HGSYEDAVHSGALND.2|LLEVEHPAAK.2|MKLGVQVVITDPEKLDQIR.4|SLHDALC[CAM]VVK.2|YPVNSVNILK.2|QAGVFEPTIVK.2|YINENLIVNTDELGR.3|YINENLIVNTDELGR.2|EVGDGTTSVVIIAAELLK.3|EVGDGTTSVVIIAAELLK.2|LGVQVVITDPEK.2|VLC[CAM]ELADLQDK.2|MLVDDIGDVTITNDGATILK.3|M[Oxi]LVDDIGDVTITNDGATILK.3|M[Oxi]LVDDIGDVTITNDGATILK.2|MLVDDIGDVTITNDGATILK.2|ILATGANVILTTGGIDDM[Oxi]C[CAM]LK.3|ILATGANVILTTGGIDDMC[CAM]LK.3|ILATGANVILTTGGIDDM[Oxi]C[CAM]LK.2|ILATGANVILTTGGIDDMC[CAM]LK.2|IIGINGDFFANM[Oxi]VVDAVLAIK.3|SQMESMLISGYALNC[CAM]VVGSQGMPK.3|SQM[Oxi]ESMLISGYALNC[CAM]VVGSQGMPK.3|SQMESM[Oxi]LISGYALNC[CAM]VVGSQGMPK.3|SQMESMLISGYALNC[CAM]VVGSQGM[Oxi]PK.3|LHPESKDDKHGSYEDAVHSGALND.3|SLLVIPNTLAVNAAQDSTDLVAKLR.3|SQMESMLISGYALNC[CAM]VVGSQGMPKR.3
SEN / CTL,Neuroblast differentiation-associated protein AHNAK,AHNAK,Q09666,0.58,0.75,1.22E-32,4.11E-31,3.04E+01,"regulation of RNA splicing,protein oligomerization,cell-cell adhesion,regulation of voltage-gated calcium channel activity","protein binding,S100 protein binding,poly(A) RNA binding,structural molecule activity conferring elasticity,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,lysosomal membrane,cytosol,plasma membrane,cell-cell adherens junction,focal adhesion,actin cytoskeleton,membrane,T-tubule,vesicle,sarcolemma,costamere,cell-cell contact zone,extracellular exosome,membrane raft",447,433,666,ISMPDLDLNLKGPK.3|ISMPDLDLNLKGPK.2|ISIPDVDLDLKGPK.3|VNVEAPDVNLEGLGGK.2|VNVEAPDVNLEGLGGK.3|ISMPEVDLNLKGPK.3|IEGEMQVPDVDIRGPK.3|IKGDVPSVGLEGPDVDLQGPEAK.3|VTAYTVDVTGR.2|VSAPGVQGDVKGPQVALK.3|ISMPDVNLNLKGPK.3|VDIKAPDVEGQGLDWSLK.3|FKMPFLSISSPK.3|ADVVVSGPKVDVEVPDVSLEGPEGK.3|ISAPNVDFNLEGPK.2|ISAPNVDFNLEGPK.3|ISMPDIDLNLTGPK.2|ISMPDIDLNLTGPK.3|TVIRLPSGSGAASPTGSAVDIR.3|VDINAPDVEVQGK.2|SSGC[CAM]DVNLPGVNVK.2|FSMPGFKGEGPEVDVKLPK.4|VKMPDVDISVPK.3|ISMPDIDLNLKGPK.3|ISMPDIDLNLKGPK.2|ISM[Oxi]PDIDLNLKGPK.3|ISMQDVDLSLGSPK.2|ISMQDVDLSLGSPK.3|ISM[Oxi]QDVDLSLGSPK.2|VSMPDVDLNLKGPK.3|VSMPDVDLNLKGPK.2|VDTNAPDLSLEGPEGK.2|VDTNAPDLSLEGPEGK.3|VDVEVPDVSLEGPEGK.2|VDVEVPDVSLEGPEGK.3|VDINAPDVDVHGPDWHLK.4|VDINAPDVDVHGPDWHLK.3|ADLGVSGPKVDIDVPDVNLEAPEGK.3|VSMPDVELNLKSPK.3|VGVEVPDVNIEGPEGK.2|VGVEVPDVNIEGPEGK.3|ISMPDVDLHLKGPK.3|ISMPDVDLHLKGPK.2|ISM[Oxi]PDVDLHLKGPK.3|MSLPDVDLDLKGPK.3|M[Oxi]SLPDVDLDLKGPK.3|VQANLGAPDINIEGLDAK.2|VQANLGAPDINIEGLDAK.3|HELTEISNVDVETQSGK.3|HELTEISNVDVETQSGK.2|ISMPDVDFNLKGPK.3|ISM[Oxi]PDVDFNLKGPK.3|ISMPDVDLHVK.3|ISMPDVDLHVK.2|VESEIKVPDVELK.3|VESEIKVPDVELK.2|VESDLKGPEVDIEGPEGK.3|VESDLKGPEVDIEGPEGK.2|MEGDLKGPEVDIKGPK.3|MEGDLKGPEVDIKGPK.4|ISMPDVDLNLKGPK.3|ISMPDVDLNLKGPK.2|ISM[Oxi]PDVDLNLKGPK.3|MDVNVGDIDIEGPEGK.2|M[Oxi]DVNVGDIDIEGPEGK.2|ADIDISGPNVDVDVPDVNIEGPDAK.3|VDVNAPDVQAPDWHLK.3|VDVNAPDVQAPDWHLK.2|LKSEDGVEGDLGETQSR.3|LKSEDGVEGDLGETQSR.2|VDIEAPDVSLEGPEGK.2|VDIEAPDVSLEGPEGK.3|ASLGSLEGEAEAEASSPK.2|ASLGSLEGEAEAEASSPK.3|ADLDVSGPKVDIDVPDVNIEGPDAK.3|ADLDVSGPKVDIDVPDVNIEGPEGK.3|ADIDVSGPKVDVEVPDVSLEGPEGK.3|ADIDVSGPKVDVDIPDVNIEGPDAK.3|ADIKSPSLDVTVPEAELNLETPEISVGGK.3|GLDLGGRGGVQVPAVDISSSLGGR.3|ADVDVSGPKVDVEVPDVSLEGPEGK.3|FSMPSLKGEGPEFDVNLSK.3|ADVVVSGPKVDIEAPDVSLEGPEGK.3|VDIKAPDVEGQGLDWSLKIPK.4|RVTAYTVDVTGR.3|RVTAYTVDVTGR.2|AEGPEVDVNLPK.2|AEGPEVDVNLPK.3|VDINAPDVDVR.2|GGLKGSEVGFHGAAPDISVK.4|FSMPGFKGEGPDGDVKLPK.4|GSRVDIETPNLEGTLTGPR.3|GSRVDIETPNLEGTLTGPR.2|LKGPQITGPSLEGDLGLK.3|LKGPQITGPSLEGDLGLK.2|LQVTMPGIK.2|LQVTM[Oxi]PGIK.2|SPQISMSDIDLNLKGPK.3|SPQISMSDIDLNLKGPK.2|VDINAPDVDVRGPDWHLK.4|VDINAPDVDVRGPDWHLK.3|VKGDLDIAGPNLEGDFKGPK.4|VKGDLDIAGPNLEGDFKGPK.3|VKGDLDIAGPNLEGDFKGPK.2|VDIETPNLEGTLTGPR.2|VDIETPNLEGTLTGPR.3|ISMPEIDLNLKGSK.3|VDIDAPDVSIEGPDAK.2|EGAKDIDISSPEFK.3|ANVDISAPKVDTNAPDLSLEGPEGK.3|VDVSAPDVEAHGPEWNLK.3|VDVSAPDVEAHGPEWNLK.2|VSMPDVELNLK.2|ADIDVSGPKVDVEC[CAM]PDVNIEGPEGK.3|VDINAPDVEVHGPDWHLK.4|VDINAPDVEVHGPDWHLK.3|VDINAPDVEVHGPDWHLK.2|MPSLEISAPK.2|ISMPDVGLNLK.2|VEGDLKGPEVDIKGPK.4|VEGDLKGPEVDIKGPK.3|ISMPDVDLHLK.3|ISM[Oxi]PDVDLHLK.3|ISMPDVDLHLK.2|ISM[Oxi]PDVDLHLK.2|VDINAPDVDVQGPDWHLK.3|VDINAPDVDVQGPDWHLK.4|VDINAPDVDVQGPDWHLK.2|GGVQVPAVDISSSLGGR.2|GGVQVPAVDISSSLGGR.3|ISMPDIDFNLKGPK.3|ISMPDIDFNLKGPK.2|VSGPDLDLNLKGPSLKGDLDASVPSMK.4|VSGPDLDLNLKGPSLKGDLDASVPSMK.3|DDGVFVQEVTQNSPAAR.2|DDGVFVQEVTQNSPAAR.3|FSMPGFKGEGPDVDVNLPK.3|FSM[Oxi]PGFKGEGPDVDVNLPK.3|FSMPGFKGEGPDVDVNLPK.2|MDIDVPDVEVQGPDWHLK.3|M[Oxi]DIDVPDVEVQGPDWHLK.3|VEGDLKGPEIDVK.3|VEGDLKGPEIDVK.2|IGFSGPKLEGGEVDLKGPK.4|IGFSGPKLEGGEVDLKGPK.3|VEGDLKGPEVDLKGPK.4|VEGDLKGPEVDLKGPK.3|VSVGAPDLSLEASEGSIKLPK.3|VSVGAPDLSLEASEGSIKLPK.4|VSVGAPDLSLEASEGSIKLPK.2|FSMPGFKAEGPEVDVNLPK.3|FSMPGFKAEGPEVDVNLPK.4|FSM[Oxi]PGFKAEGPEVDVNLPK.3|FSMPGFKAEGPEVDVNLPK.2|ISMPGFKGEGPEVDVNLPK.3|ISMPGFKGEGPEVDVNLPK.4|ISM[Oxi]PGFKGEGPEVDVNLPK.3|ISMPGFKGEGPEVDVNLPK.2|MDAEVPDVNIEGPDAK.2|MDAEVPDVNIEGPDAK.3|M[Oxi]DAEVPDVNIEGPDAK.2|ADIDVSGPKVDVDVPDVNIEGPDAK.3|ADLDVSGPKVDVDVPDVNIEGPDAK.3|VSAPEVSVGHKGGKPGLTIQAPQLEVSVPSANIEGLEGK.5|ADVDISGPKVDIEGPDVNIEGPEGK.3|LEGELQAPDLELSLPAIHVEGLDIK.3|LEGELQAPDLELSLPAIHVEGLDIK.4|IDVTAPDVSIEEPEGK.2|IDVTAPDVSIEEPEGK.3|IEGEMQVPDVDIR.2|IEGEM[Oxi]QVPDVDIR.2|FSMPGFKGEGPEVDVTLPK.3|FSMPGFKGEGPEVDVTLPK.4|FSM[Oxi]PGFKGEGPEVDVTLPK.3|ISMSEVDLNVAAPK.2|ISM[Oxi]SEVDLNVAAPK.2|FSVPGFKAEGPEVDVNLPKADVDISGPK.4|FSMPGFK.2|FSM[Oxi]PGFK.2|VDIKAPEVNLNAPDVDVHGPDWNLK.4|VEGDMQVPDLDIKGPK.3|VEGDMQVPDLDIKGPK.2|MDIDAPDVDVHGPDWHLK.4|MDIDAPDVDVHGPDWHLK.3|MDIDAPDVDVHGPDWHLK.2|VKGDMDVSVPKVEGEMK.4|APNISMPDVDLNLKGPK.3|APNISMPDVDLNLKGPK.2|LEGDLKGPEVDIK.3|VEGDLKGPEIDVKAPK.4|ISMPDVGLNLKAPK.3|VKGDVDVSLPK.2|IKGDVDVSVPEVEGKLEVPDMNIR.4|LPSGSGAASPTGSAVDIR.2|LPSGSGAASPTGSAVDIR.3|VDIDAPDVDVHGPDWHLK.4|VDIDAPDVDVHGPDWHLK.3|VDIDAPDVDVHGPDWHLK.2|VDIEGPDVNIEGPEGK.2|VDIEGPDVNIEGPEGK.3|FSMPGFKGEGPDVDVSLPK.3|FSM[Oxi]PGFKGEGPDVDVSLPK.3|VEGDLKGPEVDIK.3|VEGDLKGPEVDIK.2|ISMPDLDLNLK.2|ISM[Oxi]PDLDLNLK.2|ISMPDIDLNLK.2|ISMPDIDLNLK.3|ISM[Oxi]PDIDLNLK.2|TPSFGISAPQVSIPDVNVNLKGPK.3|TPSFGISAPQVSIPDVNVNLKGPK.4|VDISAPDVDVHGPDWHLK.4|VDISAPDVDVHGPDWHLK.3|VDISAPDVDVHGPDWHLK.2|FSVPGFKAEGPEVDVNLPK.3|FSVPGFKAEGPEVDVNLPK.2|VDVEC[CAM]PDVNIEGPEGK.2|VDVEC[CAM]PDVNIEGPEGK.3|VTAPDVDLHLKAPK.3|VTAPDVDLHLKAPK.2|ISMPDLDLHLK.3|ISM[Oxi]PDLDLHLK.3|ISMPDLDLHLK.2|ISMPGFKGEGPDVDVNLPK.3|ISMPGFKGEGPDVDVNLPK.4|ISM[Oxi]PGFKGEGPDVDVNLPK.3|ISMPGFKGEGPDVDVNLPK.2|ISMPDFDLHLKGPK.3|ISM[Oxi]PDFDLHLKGPK.4|ISMPDFDLHLKGPK.4|ISM[Oxi]PDFDLHLKGPK.3|AVEVQGPSLESGDHGK.4|AVEVQGPSLESGDHGK.3|AVEVQGPSLESGDHGK.2|FSMPGFKGEGR.3|FSMPGFKGEGR.2|IKGDMDISVPK.3|IKGDMDISVPK.2|IPMPDFDLHLKGPK.4|IPMPDFDLHLKGPK.3|LKTDVDVSLPK.3|LKTDVDVSLPK.2|MPDMHVNMPK.3|MPDMHVNMPK.2|VKGDMDISLPK.3|VKGDMDISLPK.2|VPDVDIR.2|VPDVEIK.2|VPDVELK.2|VTAPDVDLHLK.3|VTAPDVDLHLK.2|AGAISASGPELQGAGHSK.4|AGAISASGPELQGAGHSK.3|AGAISASGPELQGAGHSK.2|LEGGEVDLKGPK.3|VEGDLKGPEADIKGPK.4|VEGDLKGPEADIKGPK.3|VKGEYDVTVPK.3|VKGEYDVTVPK.2|MKGDYDVTVPK.3|MKGDYDVTVPK.2|ADLGVSGPK.2|GEGPDVHMTLPK.3|GEGPDVHMTLPK.2|GKKPDIDITGPK.3|GPDWHLK.2|VEGEIKAPDVDIKGPK.4|VEGTLKGPEVDLKGPR.4|VEGTLKGPEVDLKGPR.3|VKGEYDMTVPK.3|VKGEYDMTVPK.2|ADVVVSGPK.2|GPRLDFEGPDAK.3|ISMPDVDLHMK.3|ISMPDVDLHMK.2|MPEMNIK.2|M[Oxi]PEMNIK.2|MPEM[Oxi]NIK.2|VEGDMKVPDVDIKGPK.4|VEGEMKVPDVDIKGPK.4|VHAPGLNLSGVGGK.3|VHAPGLNLSGVGGK.2|ADVDVSGPK.2|GDISISGPK.2|GDVDVSAPK.2|GDVDVSGPK.2|IKGDVDVTGPKVEGDLK.4|IPMPDFDLHLK.3|IPM[Oxi]PDFDLHLK.3|IPMPDFDLHLK.2|ISMPDFDLHLK.3|ISM[Oxi]PDFDLHLK.3|ISMPDFDLHLK.2|ISM[Oxi]PDFDLHLK.2|ISMPDVDLHLKGPNVK.4|ISMPDVDLHLKGPNVK.3|LKGDVDVSGPKLEGDIK.4|LKGDVDVSGPKLEGDIK.3|VEGEMKVPDVEIKGPK.4|VEGEMKVPDVEIKGPK.3|VKVPEVDVRGPK.3|GNVDISAPK.2|GPGVDVNLK.2|IKGDVDVSAPKLEGELK.4|IKGDVDVSAPKLEGELK.3|MQVGGDGVK.2|ADIDVSGPK.2|ADLDVSGPK.2|ADVDISGPK.2|AEAPLPSPK.2|AKGEVDVDVPKLEGDLK.4|AKGEVDVDVPKLEGDLK.3|ANVDISAPK.2|EVDVNLPK.2|GDVVVSLPK.2|GGVDVTLPR.2|GPQVSGELK.2|LEVPDMNIRGPK.3|VEGDLKGPEADIK.3|VEGDLKGPEADIK.2|VPGIDATTK.2|ADIEISGPK.2|GDVDVSLPK.2|GDVDVSVPK.2|GEGPEVDVK.2|GPKVDIDAPDVDVHGPDWHLK.5|GPKVDIDAPDVDVHGPDWHLK.4|GPKVDIDAPDVDVHGPDWHLK.3|GPKVDIDAPDVDVHGPDWHLK.2|MPEMHFK.2|VEGTLKGPEVDLK.3|GDVDISLPK.2|GDVDVTLPK.2|GSLGATGEIK.2|LPQFGISTPGSDLHVNAK.4|LPQFGISTPGSDLHVNAK.3|LPQFGISTPGSDLHVNAK.2|VEGDLKGPEIDIK.3|VEGDLKGPEVDLK.3|VEGDLKGPEVDLK.2|GDMDVSVPK.2|GPKVDIDAPDVEVHDPDWHLK.5|LEGELKGPELDVK.3|MEGDLKGPEVDIK.3|VEGDLKGPEVDIR.3|VKGEYDVTVPKLEGELK.4|GDFDVSVPK.2|GDMDISVPK.2|GDMDVSLPK.2|GEVDVDVPK.2|GKGGVTGSPEASISGSKGDLK.4|GPHVDVSGPDIDIEGPEGK.4|GPHVDVSGPDIDIEGPEGK.3|GPHVDVSGPDIDIEGPEGK.2|LEGGEVDLK.2|LEGPDVSLK.2|MEGDLKAPEVDIK.3|M[Oxi]EGDLKAPEVDIK.3|TPEMIIQK.2|VEGDMKVPDVDIK.3|FGTFGGLGSK.2|GDMDISLPK.2|TDVDVSLPK.2|VEGEMKVPDVDIK.3|GDRSPEPGQTWTR.3|GDRSPEPGQTWTR.2|GPEVDVSGPK.2|ISIPDVGLHLKGPK.3|LDFEGPDAK.2|VEGEMKVPDVDIR.3|GDYDVTVPK.2|GHYEVTGSDDETGK.3|GHYEVTGSDDETGK.2|VGGSGVNVNAK.2|APDVEGQGLDWSLK.3|APDVEGQGLDWSLK.2|GEYDVTVPK.2|GKGGVTGSPEASISGSK.3|GKGGVTGSPEASISGSK.2|LKGPDVKLPDMSVK.3|VQTPEVDVK.2|GPNVKGEYDVTMPK.3|MDIDAPDVEVQGPDWHLK.4|M[Oxi]DIDAPDVEVQGPDWHLK.3|MDIDAPDVEVQGPDWHLK.3|MDIDAPDVEVQGPDWHLK.2|VDIDVPDVDVQGPDWHLK.4|VDIDVPDVDVQGPDWHLK.3|VDIDVPDVDVQGPDWHLK.2|VDINTPDVDVHGPDWHLK.4|VDINTPDVDVHGPDWHLK.3|APDVDIKGPK.2|GEYDMTVPK.2|GEYDVTMPK.2|GEYDVTM[Oxi]PK.2|GPEVDIKGPK.2|GSEVGFHGAAPDISVK.3|GSEVGFHGAAPDISVK.2|IKGDVDVSVPEVEGK.3|IKGDVDVSVPEVEGK.2|ISMPDVDLHMKGPK.3|ISMPDVDLHMKGPK.2|LQGSGVSLASK.2|MPTFSTPGAK.2|SPQISMSDIDLNLK.3|SPQISM[Oxi]SDIDLNLK.2|SPQISMSDIDLNLK.2|GPQVSGELKGPGVDVNLKGPR.4|ISMPDFDLNLKGPK.3|VDIDAPDVEVHDPDWHLK.4|VDIDAPDVEVHDPDWHLK.3|VSAPGVQGDVK.2|GEVDVDVPKLEGDLK.3|GPSLKGDLDASVPSMK.3|GPSLKGDLDASVPSMK.2|M[Oxi]KLPQFGISTPGSDLHVNAK.4|MKLPQFGISTPGSDLHVNAK.4|MKLPQFGISTPGSDLHVNAK.3|M[Oxi]KLPQFGISTPGSDLHVNAK.3|VPDVDIKGPK.2|ELLLPNWQGSGSHGLTIAQR.4|ELLLPNWQGSGSHGLTIAQR.3|ELLLPNWQGSGSHGLTIAQR.2|KPDIDITGPK.2|LEVPDMNIR.2|VDTNAPDLSLEGPEGKLKGPK.4|VGVEVPDVNIEGPEGKLKGPK.4|IGFSGPKLEGGEVDLK.3|MPDVDISVPK.2|MPFLSISSPK.2|M[Oxi]PFLSISSPK.2|SKGHYEVTGSDDETGKLQGSGVSLASK.5|VDVEGPDVNIEGPEGK.3|VDVEGPDVNIEGPEGK.2|VDVEVPDVSLEGPEGKLKGPK.4|FAGGLHFSGPK.2|FSMPGFKGEGPDGDVK.3|FSMPGFKGEGPDGDVK.2|GDLDASVPSMK.2|IDVTAPDVSIEEPEGKLKGPK.4|ISMPDVDLHLKGPNVKGEYDVTMPK.5|LKGDVDVSGPK.2|VDVDVPDVNIEGPDAK.3|VDVDVPDVNIEGPDAK.2|VGIDTPDIDIHGPEGK.3|VGIDTPDIDIHGPEGK.2|VKGDADVSVPK.2|VSAPEVSVGHK.2|GPKVDVSAPDVEAHGPEWNLK.4|GPKVDVSAPDVEAHGPEWNLK.3|IDVDAPDIDIHGPDAK.3|IDVDAPDIDIHGPDAK.2|IKGDVDVSAPK.2|IKGDVDVTGPK.2|IPRHELTEISNVDVETQSGK.4|IPRHELTEISNVDVETQSGK.3|VDIDTPDINIEGSEGKFKGPK.4|VDIDVPDVNIEGPDAK.3|VDIDVPDVNIEGPDAK.2|VDIDVPDVNIEGPEGK.3|VDIDVPDVNIEGPEGK.2|APSLDIKGPEVDVSGPK.3|APSLDIKGPEVDVSGPK.2|GPKVDISAPDVDVHGPDWHLK.4|GPQVDIDVPDVGVQGPDWHLK.4|GPQVDIDVPDVGVQGPDWHLK.3|LEGELKGPELDVKGPK.3|SKGHYEVTGSDDETGK.3|VDIDTPDIDIHGPEGK.3|VDIDTPDINIEGSEGK.3|VDIDTPDINIEGSEGK.2|VDIDVPDVNLEAPEGK.3|VDIDVPDVNLEAPEGK.2|VKGDVDVSVPK.2|VKGGVDVTLPR.2|AKGEVDVDVPK.2|DIDISSPEFK.2|EMGVDVHFPK.2|FSM[Oxi]PGFKGEGPEVDVK.3|FSMPGFKGEGPEVDVK.3|GPKVDINAPDVDVQGPDWHLK.4|GPKVDINAPDVEVHGPDWHLK.4|LNVGAPDVTLR.2|MEGDLKAPEVDIKGPK.3|MKGNVDISAPK.2|M[Oxi]KGNVDISAPK.2|MPTFSTPGAKGEGPDVHMTLPK.4|SPEPGQTWTR.2|GPKVDIDVPDVDVQGPDWHLK.4|GPKVDIDVPDVNVQGPDWHLK.4|GPKVDIDVPDVNVQGPDWHLK.3|MKGDVVVSLPK.2|M[Oxi]KGDVVVSLPK.2|QGFDLNVPGGEIDASLK.3|QGFDLNVPGGEIDASLK.2|VKGDMDVSVPK.2|VKGDM[Oxi]DVSVPK.2|VKGDVDISLPK.2|VKGDVDVTLPK.2|VSGPDLDLNLK.2|FKAEAPLPSPK.2|LEGDIKAPSLDIKGPEVDVSGPK.4|MKGDVDVSLPK.2|MPEMSIKPQK.2|MPSMNIQTHK.2|MQVGGDGVKVPGIDATTK.3|M[Oxi]QVGGDGVKVPGIDATTK.3|TPEMIIQKPK.2|VKGDMDVSLPK.2|EVDVNLPKADIDVSGPK.3|GPQVSGELKGPGVDVNLK.3|GPQVSGELKGPGVDVNLK.2|ISIPDVGLHLK.2|VKGDFDVSVPK.2|VKGDLDIAGPNLEGDFK.3|VKGDLDIAGPNLEGDFK.2|AEGPDVAVDLPK.2|GEGPDVDVSLPK.2|GGQIGLQAPGLSVSGPQGHLESGSGK.4|GGQIGLQAPGLSVSGPQGHLESGSGK.3|MKGEVDVSLANVEGDLK.3|VKGDVDVSVPKVEGEMK.3|GDLDIAGPNLEGDFKGPK.3|GEGPDVDVTLPK.2|GPEVDIEGPEGK.2|GPTVGGGLPGIGVQGLEGNLQMPGIK.4|GPTVGGGLPGIGVQGLEGNLQMPGIK.3|GPTVGGGLPGIGVQGLEGNLQM[Oxi]PGIK.3|IKGGADVSGGVSAPDISLGEGHLSVK.4|ISIPDVDLDLK.2|VSMPDVDLNLK.2|GEGPDVDVNLPK.2|GEGPEVDVTLPK.2|ISMPDVDLNLK.2|ISMPDVNLNLK.2|LPTGQISGPEIK.2|MSLPDVDLDLK.2|VEAPSLDVHMDSPDINIEGPDVK.4|VEAPSLDVHM[Oxi]DSPDINIEGPDVK.3|VEAPSLDVHMDSPDINIEGPDVK.3|VGIQLPEVELSVSTKKE.3|GEGPEVDVNLPK.2|GHYEVTGSDDETGKLQGSGVSLASK.4|GHYEVTGSDDETGKLQGSGVSLASK.3|ISMPEVDLNLK.2|KQGFDLNVPGGEIDASLK.3|KQGFDLNVPGGEIDASLK.2|M[Oxi]KGEVDVSLANVEGDLKGPALDIK.4|MKGEVDVSLANVEGDLKGPALDIK.4|MKGEVDVSLANVEGDLKGPALDIK.3|GPAFNMASPESDFGINLK.3|GPAFNM[Oxi]ASPESDFGINLK.2|GPAFNMASPESDFGINLK.2|ISMPDVDFNLK.2|ISMPEIDLNLK.2|FSVSGLKAEGPDVAVDLPK.3|GEGPEFDVNLSK.2|GEGPEVDMNLPK.2|GPKLDADMPEVAVEGPNGK.3|ISMPDFDLNLK.2|ISMPDIDFNLK.2|LKGEIDASVPELEGDLRGPQVDVK.4|M[Oxi]EGGGAEVHAQLPSLEGDLRGPDVK.4|MEGGGAEVHAQLPSLEGDLRGPDVK.4|SPSLDVTVPEAELNLETPEISVGGK.4|SPSLDVTVPEAELNLETPEISVGGK.3|ADIDVSGPKVDIDTPDIDIHGPEGK.4|ADIDVSGPKVDIDTPDIDIHGPEGK.3|GPSLDIDTPDVNIEGPEGK.3|GPSLDIDTPDVNIEGPEGK.2|LKGDVDVSLPEVEGEMKVPDVDIK.4|VDINAPDVGVQGPDWHLK.3|VDINAPDVGVQGPDWHLK.2|GKKPDIDITGPKVDINAPDVEVQGK.4|GKKPDIDITGPKVDINAPDVEVQGK.3|GDVDVSVPEVEGK.2|GGVTGSPEASISGSK.2|GPKVDIDTPDINIEGSEGK.3|VDVSAPDVEMQGPDWNLK.3|VDVSAPDVEMQGPDWNLK.2|FSMPGFKGEGPDVDVTLPK.3|FSM[Oxi]PGFKGEGPDVDVTLPK.3|GSLGATGEIKGPTVGGGLPGIGVQGLEGNLQMPGIK.5|GSLGATGEIKGPTVGGGLPGIGVQGLEGNLQMPGIK.4|GSLGATGEIKGPTVGGGLPGIGVQGLEGNLQMPGIK.3|VKTPSFGISAPQVSIPDVNVNLKGPK.4|FSMPGFKGEGPEVDVNLPK.3|FSM[Oxi]PGFKGEGPEVDVNLPK.2|FSMPGFKGEGPEVDVNLPK.2|FSMPSLKGEGPEVDVNLPK.3|FSM[Oxi]PSLKGEGPEVDVNLPK.3|VDIDVPDVNVQGPDWHLK.3|VDIDVPDVNVQGPDWHLK.2|AEASIQAGAGDGEWEESEVK.3|AEASIQAGAGDGEWEESEVK.2|FSMPGFKGEGPEVDMNLPK.3|FSMPGFKGEGPEVDM[Oxi]NLPK.3|GPFVEAEVPDVDLEC[CAM]PDAK.3|GPFVEAEVPDVDLEC[CAM]PDAK.2|MEGGGAEVHAQLPSLEGDLR.3|EETTRELLLPNWQGSGSHGLTIAQR.4|GGKPGLTIQAPQLEVSVPSANIEGLEGK.4|GGKPGLTIQAPQLEVSVPSANIEGLEGK.3|MEGGGAEVHAQLPSLEGDLRGPDVKLEGPDVSLK.5|MYFPDVEFDIK.2|M[Oxi]YFPDVEFDIK.2|VEAPSLDVHMDSPDINIEGPDVKIPK.4|GPQVSSALNLDTSK.2|GSGGEWKGPQVSSALNLDTSK.3|GSGGEWKGPQVSSALNLDTSK.2|TGVVKEGDQIVGATIYFDNLQSGEVTQLLNTMGHHTVGLK.6|TGVVKEGDQIVGATIYFDNLQSGEVTQLLNTMGHHTVGLK.5|TGVVKEGDQIVGATIYFDNLQSGEVTQLLNTMGHHTVGLK.4|AEGPEVDVNLPKADVDISGPK.3|AEGPEVDVNLPKADVDISGPK.2|FSMPSLKGEGPEVDVNLPKADVVVSGPK.4|FSMPSLKGEGPEVDVNLPKADVVVSGPK.3|GPAFNMASPESDFGINLKGPK.3|GPSLQGDLAVSGDIK.2|TPSFGISAPQVSIPDVNVNLK.3|TPSFGISAPQVSIPDVNVNLK.2|VEGDMQVPDLDIK.2|VEGEMKVPDVEIK.2|GGADVSGGVSAPDISLGEGHLSVK.3|GPGVDLPSVNLSMPK.2|GPGVDLPSVNLSM[Oxi]PK.2|APEVNLNAPDVDVHGPDWNLK.3|APEVNLNAPDVDVHGPDWNLK.2|APNISMPDVDLNLK.2|APNISM[Oxi]PDVDLNLK.2|EGDQIVGATIYFDNLQSGEVTQLLNTMGHHTVGLK.5|EGDQIVGATIYFDNLQSGEVTQLLNTMGHHTVGLK.4|GEIDASVPELEGDLRGPQVDVK.3|GEVDVSLANVEGDLK.2|APDVDVNIAGPDAALK.2|GAKPQGHIGVDASAPQIGGSITGPSVEVQAPDIDVQGPGSK.5|GAKPQGHIGVDASAPQIGGSITGPSVEVQAPDIDVQGPGSK.4|GDLDIAGPNLEGDFK.2|GPQITGPSLEGDLGLK.2|SEDGVEGDLGETQSR.2|GEIDASVPELEGDLR.2|VGIQLPEVELSVSTK.2|VKTPSFGISAPQVSIPDVNVNLK.3|EVFSSC[CAM]SSEVVLSGDDEEYQR.3|LEGPDVSLKGPGVDLPSVNLSMPK.3|LDADM[Oxi]PEVAVEGPNGK.2|LDADMPEVAVEGPNGK.2|ADIDVSGPSVDTDAPDLDIEGPEGK.3|ADVDVSGPKVDVEGPDVNIEGPEGK.3|EFSGPSTPTGTLEFEGGEVSLEGGK.3|VDVDIPDVNIEGPDAK.2|ADIDVSGPKVDIEGPDVNIEGPEGK.3|LNVGAPDVTLRGPSLQGDLAVSGDIK.3|PGLTIQAPQLEVSVPSANIEGLEGK.3|LEGDLTGPSVGVEVPDVELEC[CAM]PDAK.3|VSVGAPDLSLEASEGSIK.2|GEETGIDVTLPTGEVTVPGVSGDVSLPEIATGGLEGK.4|GEETGIDVTLPTGEVTVPGVSGDVSLPEIATGGLEGK.3|LEGDLTGPSVDVEVPDVELEC[CAM]PDAK.3|VKGSLGATGEIKGPTVGGGLPGIGVQGLEGNLQMPGIK.4|VKGDADVSVPKLEGDLTGPSVGVEVPDVELEC[CAM]PDAK.4|VKGDVDVSVPKLEGDLTGPSVGVEVPDVELEC[CAM]PDAK.4|VKGDVDVSLPKLEGDLTGPSVDVEVPDVELEC[CAM]PDAK.4|ELLLPNWQGSGSHGLTIAQRDDGVFVQEVTQNSPAAR.4|GDVPSVGLEGPDVDLQGPEAK.2|SNSFSDEREFSGPSTPTGTLEFEGGEVSLEGGK.3
SEN / CTL,V-type proton ATPase subunit G 1,ATP6V1G1,O75348,0.57,0.36,7.29E-05,7.51E-05,4.12E+00,"insulin receptor signaling pathway,regulation of macroautophagy,transferrin transport,ion transmembrane transport,phagosome acidification,hydrogen ion transmembrane transport","protein binding,hydrogen-exporting ATPase activity, phosphorylative mechanism,ATPase binding","lysosomal membrane,cytosol,plasma membrane,vacuolar proton-transporting V-type ATPase complex,extracellular exosome",9,8,13,MTILQTYFR.2|M[Oxi]TILQTYFR.2|QNRDEVLDNLLAFVC[CAM]DIRPEIHENYR.5|QNRDEVLDNLLAFVC[CAM]DIRPEIHENYR.4|QAKEEAQAEIEQYR.3|QAKEEAQAEIEQYR.2|EEAQAEIEQYR.3|EEAQAEIEQYR.2|AAEKVSEAR.2|GSC[CAM]STEVEK.2|GSC[CAM]STEVEKETQEK.3|GSC[CAM]STEVEKETQEK.2|DEVLDNLLAFVC[CAM]DIRPEIHENYR.4
SEN / CTL,Serine/threonine-protein phosphatase PP1-beta catalytic subunit,PPP1CB,P62140,0.57,0.31,1.15E-02,5.98E-03,2.22E+00,"G2/M transition of mitotic cell cycle,glycogen metabolic process,regulation of glycogen biosynthetic process,regulation of glycogen catabolic process,protein dephosphorylation,regulation of cell adhesion,circadian regulation of gene expression,regulation of circadian rhythm,entrainment of circadian clock by photoperiod,cell division","protein binding,phosphatase activity,myosin phosphatase activity,protein kinase binding,metal ion binding,myosin-light-chain-phosphatase activity","protein phosphatase type 1 complex,nucleus,nucleoplasm,nucleolus,cytosol,focal adhesion,glycogen granule,extracellular exosome,MLL5-L complex,PTW/PP1 phosphatase complex,nuclear chromosome, telomeric region",6,11,14,IVQMTEAEVR.2|IVQM[Oxi]TEAEVR.2|FLNRHDLDLIC[CAM]R.3|FLNRHDLDLIC[CAM]R.2|IC[CAM]GDIHGQYTDLLR.3|IC[CAM]GDIHGQYTDLLR.2|YQYGGLNSGRPVTPPR.3|GVSFTFGADVVSK.2|SREIFLSQPILLELEAPLKIC[CAM]GDIHGQYTDLLR.5|LFEYGGFPPEANYLFLGDYVDR.3|IMRPTDVPDTGLLC[CAM]DLLWSDPDK.3|LFEYGGFPPEANYLFLGDYVDRGK.3|IMRPTDVPDTGLLC[CAM]DLLWSDPDKDVQGWGENDR.4|RQLVTLFSAPNYC[CAM]GEFDNAGGMMSVDETLMC[CAM]SFQILKPSEK.4
SEN / CTL,Non-specific lipid-transfer protein,SCP2,P22307,0.57,0.96,3.41E-02,1.46E-02,1.84E+00,"bile acid biosynthetic process,peroxisome organization,sterol transport,positive regulation of intracellular cholesterol transport,fatty acid beta-oxidation using acyl-CoA oxidase,alpha-linolenic acid metabolic process,lipid hydroperoxide transport","fatty-acyl-CoA binding,receptor binding,protein binding,sterol transporter activity,cholesterol binding,propanoyl-CoA C-acyltransferase activity,long-chain fatty acyl-CoA binding,propionyl-CoA C2-trimethyltridecanoyltransferase activity,oleic acid binding","nucleoplasm,cytoplasm,mitochondrion,peroxisome,peroxisomal matrix,membrane,intracellular membrane-bounded organelle,protein complex,extracellular exosome",6,34,57,IGGIFAFK.2|EATWVVDVK.2|DYPDLAEEAGKK.3|DYPDLAEEAGKK.2|KLEEEGEQFVK.3|KLEEEGEQFVK.2|LEEEGEQFVKK.3|MVGFDMSK.2|GSVLPNSDK.2|HVDLLINK.2|FVKPGAENSRDYPDLAEEAGKK.5|FVKPGAENSRDYPDLAEEAGKK.4|KLEEEGEQFVKK.3|KLEEEGEQFVKK.2|KIGGIFAFK.2|ITGNMGLAMK.2|ITGNM[Oxi]GLAMK.2|ITGNMGLAM[Oxi]K.2|ITGNM[Oxi]GLAM[Oxi]K.2|VFVVGVGMTK.2|VFVVGVGM[Oxi]TK.2|FVKPGAENSRDYPDLAEEAGK.4|THQIEAVPTSSASDGFK.3|ANLVFKEIEK.2|MGFPEAASSFR.2|DYPDLAEEAGK.2|LEEEGEQFVK.2|MNPQSAFFQGK.2|M[Oxi]NPQSAFFQGK.2|WVINPSGGLISK.2|YGLSAHPVAPQM[Oxi]FGYAGK.3|YGLSAHPVAPQMFGYAGK.3|YGLSAHPVAPQMFGYAGK.2|QLIQGGVAEC[CAM]VLALGFEK.3|QLIQGGVAEC[CAM]VLALGFEK.2|VALQHNLGIGGAVVVTLYK.3|VALQHNLGIGGAVVVTLYK.2|LQNLQLQPGNAK.2|ADC[CAM]TITMADSDFLALMTGK.3|ADC[CAM]TITM[Oxi]ADSDFLALMTGK.2|ADC[CAM]TITMADSDFLALMTGK.2|LQNLQLQPGNAKL.2|KADC[CAM]TITM[Oxi]ADSDFLALMTGK.3|KADC[CAM]TITMADSDFLALMTGK.3|KADC[CAM]TITMADSDFLALMTGK.2|AVEILAQEMMTDLPSSFEEK.3|AVEILAQEMMTDLPSSFEEK.2|GHPLGATGLAQC[CAM]AELC[CAM]WQLR.3|GHPLGATGLAQC[CAM]AELC[CAM]WQLR.2|GSVLPNSDKKADC[CAM]TITMADSDFLALMTGK.4|GSVLPNSDKKADC[CAM]TITMADSDFLALMTGK.3|ALADAQIPYSAVDQAC[CAM]VGYVFGDSTC[CAM]GQR.4|ALADAQIPYSAVDQAC[CAM]VGYVFGDSTC[CAM]GQR.3|AIYHSLGMTGIPIINVNNNC[CAM]ATGSTALFMAR.4|AIYHSLGMTGIPIINVNNNC[CAM]ATGSTALFM[Oxi]AR.3|AIYHSLGMTGIPIINVNNNC[CAM]ATGSTALFMAR.3|HSVNNPYSQFQDEYSLDEVMASK.3
SEN / CTL,"Arginine--tRNA ligase, cytoplasmic",RARS,P54136,0.57,0.74,9.09E-06,1.19E-05,4.92E+00,"tRNA aminoacylation for protein translation,arginyl-tRNA aminoacylation,cell-cell adhesion","tRNA binding,arginine-tRNA ligase activity,protein binding,ATP binding,arginine binding,cadherin binding involved in cell-cell adhesion","nucleoplasm,cytoplasm,mitochondrion,cytosol,cell-cell adherens junction,membrane,aminoacyl-tRNA synthetase multienzyme complex,extracellular exosome",27,61,93,IVFVPGC[CAM]SIPLTIVK.2|IVFVPGC[CAM]SIPLTIVK.3|LMDLLGEGLKR.3|LMDLLGEGLKR.2|LFEFAGYDVLR.2|LLQQEEEIKSLTAEIDRLK.4|MLDDRGNTAAYLLYAFTR.3|M[Oxi]LDDRGNTAAYLLYAFTR.3|MLDDRGNTAAYLLYAFTR.2|STIIGESISR.2|AYQC[CAM]VVLLQGKNPDITK.3|SDGGYTYDTSDLAAIK.2|SDGGYTYDTSDLAAIK.3|VEIAGPGFINVHLRK.4|VEIAGPGFINVHLRK.3|VEIAGPGFINVHLRK.2|HLPDNEC[CAM]IEK.3|HLPDNEC[CAM]IEK.2|GFDILGIK.2|LIC[CAM]DVSR.2|FPEILQK.2|KRFDTEEEFK.3|RFDTEEEFKK.3|GFDILGIKPVQR.3|GFDILGIKPVQR.2|SLTAEIDR.2|MNDIVKEFEDR.3|MNDIVKEFEDR.2|MLLC[CAM]EAVAAVMAK.3|MLLC[CAM]EAVAAVMAK.2|M[Oxi]LLC[CAM]EAVAAVMAK.2|C[CAM]ILRFPEILQK.3|KVIVDFSSPNIAK.3|KVIVDFSSPNIAK.2|NMINIISR.2|NM[Oxi]INIISR.2|EMHVGHLR.2|GNTAAYLLYAFTR.3|GNTAAYLLYAFTR.2|YADLSHNR.2|GFVQVDDGR.2|VFHAGFGVVLGEDK.3|VFHAGFGVVLGEDK.2|GESFYQDR.2|VEIAGPGFINVHLR.3|VEIAGPGFINVHLR.2|FDTEEEFK.2|LMDLLGEGLK.2|LM[Oxi]DLLGEGLK.2|HLPDNEC[CAM]IEKVEIAGPGFINVHLR.5|HLPDNEC[CAM]IEKVEIAGPGFINVHLR.4|GFVQVDDGRK.2|LLQQEEEIK.2|LQEVFGHAIK.2|SLTAEIDRLK.2|HLPDNEC[CAM]IEKVEIAGPGFINVHLRK.5|VFHAGFGVVLGEDKKK.3|KIVFVPGC[CAM]SIPLTIVK.3|LNHVGDWGTQFGM[Oxi]LIAHLQDK.4|LNHVGDWGTQFGMLIAHLQDK.4|LNHVGDWGTQFGM[Oxi]LIAHLQDK.3|LNHVGDWGTQFGMLIAHLQDK.3|LNHVGDWGTQFGMLIAHLQDK.2|RFDTEEEFK.2|LNDYIFSFDK.2|AYQC[CAM]VVLLQGK.2|DFVSEQLTSLLVNGVQLPALGENK.4|DFVSEQLTSLLVNGVQLPALGENK.3|VIVDFSSPNIAK.2|LANIDEEMLQK.2|LANIDEEM[Oxi]LQK.2|ILLDHEKEWK.2|DFVSEQLTSLLVNGVQLPALGENKK.4|DFVSEQLTSLLVNGVQLPALGENKK.3|LLQQEEEIKSLTAEIDR.3|IYDALDVSLIER.2|KDFVSEQLTSLLVNGVQLPALGENKK.4|KDFVSEQLTSLLVNGVQLPALGENKK.3|VLTAEELNAAQTSVAYGC[CAM]IK.3|VLTAEELNAAQTSVAYGC[CAM]IK.2|AAYPDLENPPLLVTPSQQAK.3|AAYPDLENPPLLVTPSQQAK.2|RAYQC[CAM]VVLLQGK.2|FPDYLTVSPPIGDLQVFYK.3|FPDYLTVSPPIGDLQVFYK.2|NC[CAM]GC[CAM]LGASPNLEQLQEENLK.3|NC[CAM]GC[CAM]LGASPNLEQLQEENLK.2|DKVLTAEELNAAQTSVAYGC[CAM]IK.3|IYDALDVSLIERGESFYQDR.3|LKNC[CAM]GC[CAM]LGASPNLEQLQEENLK.3|KDFVSEQLTSLLVNGVQLPALGENK.3|FGDYQC[CAM]NSAM[Oxi]GISQMLK.2|FGDYQC[CAM]NSAMGISQMLK.2
SEN / CTL,Cytosolic acyl coenzyme A thioester hydrolase,ACOT7,O00154,0.57,0.30,1.71E-06,2.69E-06,5.57E+00,"coenzyme A biosynthetic process,long-chain fatty-acyl-CoA biosynthetic process,medium-chain fatty-acyl-CoA catabolic process,long-chain fatty-acyl-CoA catabolic process,medium-chain fatty acid biosynthetic process,palmitic acid biosynthetic process","fatty-acyl-CoA binding,protein binding,palmitoyl-CoA hydrolase activity,long-chain fatty acyl-CoA binding,protein homodimerization activity,acyl-CoA hydrolase activity,carboxylic ester hydrolase activity","nucleoplasm,cytoplasm,mitochondrion,cytosol,extracellular exosome",18,22,42,ATLWYVPLSLK.2|MIEEAGAIISTR.2|MIEEAGAIISTR.3|M[Oxi]IEEAGAIISTR.2|IMRPDDANVAGNVHGGTILK.4|IMRPDDANVAGNVHGGTILK.3|IM[Oxi]RPDDANVAGNVHGGTILK.4|IM[Oxi]RPDDANVAGNVHGGTILK.3|LMDEVAGIVAAR.2|LMDEVAGIVAAR.3|LM[Oxi]DEVAGIVAAR.2|TNIVTASVDAINFHDKIR.4|TNIVTASVDAINFHDKIR.3|TNIVTASVDAINFHDKIR.2|VLEVPPVVYSR.3|VLEVPPVVYSR.2|GC[CAM]VITISGR.2|SLPVPQLVPETEDEKKR.4|SLPVPQLVPETEDEKKR.3|RQGHAEPQP.2|KGC[CAM]VITISGR.2|SLPVPQLVPETEDEK.3|SLPVPQLVPETEDEK.2|NVDKVLEVPPVVYSR.3|AASAFFTYVSLSQEGR.3|AASAFFTYVSLSQEGR.2|TNIVTASVDAINFHDK.3|TNIVTASVDAINFHDK.2|SLPVPQLVPETEDEKK.3|HSVEVQVNVMSENILTGAK.3|HSVEVQVNVM[Oxi]SENILTGAK.3|HSVEVQVNVM[Oxi]SENILTGAK.2|HSVEVQVNVMSENILTGAK.2|ADLPPC[CAM]GAC[CAM]ITGR.2|SM[Oxi]EIEVLVDADPVVDSSQKR.3|SMEIEVLVDADPVVDSSQKR.3|SMEIEVLVDADPVVDSSQKR.2|NGDIVQPVLNPEPNTVSYSQSSLIHLVGPSDC[CAM]TLHGFVHGGVTMK.6|NGDIVQPVLNPEPNTVSYSQSSLIHLVGPSDC[CAM]TLHGFVHGGVTMK.5|WRNGDIVQPVLNPEPNTVSYSQSSLIHLVGPSDC[CAM]TLHGFVHGGVTMK.6|TDFLSPMC[CAM]IGEVAHVSAEITYTSK.3|SMEIEVLVDADPVVDSSQK.2
SEN / CTL,Arylsulfatase A,ARSA,P15289,0.57,0.26,3.60E-08,7.98E-08,7.10E+00,"glycosphingolipid metabolic process,post-translational protein modification","arylsulfatase activity,cerebroside-sulfatase activity,calcium ion binding,protein binding,sulfuric ester hydrolase activity","lysosome,endoplasmic reticulum lumen,lysosomal lumen,extracellular exosome",18,9,16,GGLPLEEVTVAEVLAAR.2|GGLPLEEVTVAEVLAAR.3|QSLFFYPSYPDEVR.2|YMAFAHDLMADAQR.3|YMAFAHDLMADAQR.2|AQLDAAVTFGPSQVAR.2|AQLDAAVTFGPSQVAR.3|MGMYPGVLVPSSR.2|M[Oxi]GMYPGVLVPSSR.2|WHLGVGPEGAFLPPHQGFHR.5|WHLGVGPEGAFLPPHQGFHR.4|WHLGVGPEGAFLPPHQGFHR.3|GEDPALQIC[CAM]C[CAM]HPGC[CAM]TPR.3|AHFFTQGSAHSDTTADPAC[CAM]HASSSLTAHEPPLLYDLSK.6|AHFFTQGSAHSDTTADPAC[CAM]HASSSLTAHEPPLLYDLSK.5|DPGENYNLLGGVAGATPEVLQALK.3
SEN / CTL,Mitogen-activated protein kinase 1,MAPK1,P28482,0.56,0.28,1.68E-04,1.61E-04,3.79E+00,"MAPK cascade,activation of MAPK activity,MAPK import into nucleus,transcription, DNA-templated,protein phosphorylation,apoptotic process,chemotaxis,response to stress,cellular response to DNA damage stimulus,cell cycle,signal transduction,chemical synaptic transmission,axon guidance,positive regulation of cell proliferation,fibroblast growth factor receptor signaling pathway,response to toxic substance,positive regulation of peptidyl-threonine phosphorylation,regulation of phosphatidylinositol 3-kinase signaling,viral process,peptidyl-serine phosphorylation,peptidyl-threonine phosphorylation,sensory perception of pain,cytosine metabolic process,platelet activation,regulation of ossification,positive regulation of cell migration,thyroid gland development,regulation of protein stability,lipopolysaccharide-mediated signaling pathway,positive regulation of telomere maintenance via telomerase,regulation of stress-activated MAPK cascade,mammary gland epithelial cell proliferation,Fc-epsilon receptor signaling pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,ERBB signaling pathway,outer ear morphogenesis,response to exogenous dsRNA,response to estrogen,negative regulation of cell differentiation,positive regulation of translation,positive regulation of transcription, DNA-templated,thymus development,T cell receptor signaling pathway,B cell receptor signaling pathway,regulation of sequence-specific DNA binding transcription factor activity,regulation of cytoskeleton organization,positive regulation of telomerase activity,Bergmann glial cell differentiation,long-term synaptic potentiation,face development,JAK-STAT cascade involved in growth hormone signaling pathway,lung morphogenesis,trachea formation,labyrinthine layer blood vessel development,cardiac neural crest cell development involved in heart development,ERK1 and ERK2 cascade,response to epidermal growth factor,caveolin-mediated endocytosis,regulation of Golgi inheritance,cellular response to granulocyte macrophage colony-stimulating factor stimulus,regulation of cellular response to heat,positive regulation of telomere capping,regulation of early endosome to late endosome transport","phosphotyrosine binding,DNA binding,protein serine/threonine kinase activity,MAP kinase activity,protein binding,ATP binding,transcription factor binding,RNA polymerase II carboxy-terminal domain kinase activity,kinase activity,phosphatase binding,mitogen-activated protein kinase kinase kinase binding,identical protein binding","nucleus,nucleoplasm,cytoplasm,mitochondrion,early endosome,late endosome,Golgi apparatus,microtubule organizing center,cytosol,cytoskeleton,caveola,focal adhesion,microtubule cytoskeleton,axon,pseudopodium,dendrite cytoplasm,perikaryon,protein complex,extracellular exosome,mitotic spindle",12,27,46,LKELIFEETAR.3|LKELIFEETAR.2|VADPDHDHTGFLTEYVATR.4|VADPDHDHTGFLTEYVATR.3|VADPDHDHTGFLTEYVATR.2|YIHSANVLHR.3|FRHENIIGINDIIR.4|FRHENIIGINDIIR.3|APTIEQMK.2|APTIEQM[Oxi]K.2|HENIIGINDIIR.3|HENIIGINDIIR.2|IC[CAM]DFGLAR.2|GQVFDVGPR.2|APEIMLNSK.2|APEIM[Oxi]LNSK.2|WYRAPEIMLNSK.3|ISPFEHQTYC[CAM]QR.3|ISPFEHQTYC[CAM]QR.2|NYLLSLPHK.2|ELIFEETAR.2|KISPFEHQTYC[CAM]QR.3|TQHLSNDHIC[CAM]YFLYQILR.4|TQHLSNDHIC[CAM]YFLYQILR.3|TQHLSNDHIC[CAM]YFLYQILR.2|DLKPSNLLLNTTC[CAM]DLK.3|DLKPSNLLLNTTC[CAM]DLK.2|DVYIVQDLMETDLYK.3|DVYIVQDLM[Oxi]ETDLYK.2|DVYIVQDLMETDLYK.2|FDMELDDLPK.2|FDM[Oxi]ELDDLPK.2|DLKPSNLLLNTTC[CAM]DLKIC[CAM]DFGLAR.4|PSNLLLNTTC[CAM]DLK.2|HYLDQLNHILGILGSPSQEDLNC[CAM]IINLK.4|HYLDQLNHILGILGSPSQEDLNC[CAM]IINLK.3|IEVEQALAHPYLEQYYDPSDEPIAEAPFK.4|IEVEQALAHPYLEQYYDPSDEPIAEAPFK.3|RIEVEQALAHPYLEQYYDPSDEPIAEAPFK.4|RIEVEQALAHPYLEQYYDPSDEPIAEAPFK.3|YTNLSYIGEGAYGMVC[CAM]SAYDNVNK.3|YTNLSYIGEGAYGM[Oxi]VC[CAM]SAYDNVNK.3|APTIEQMKDVYIVQDLMETDLYK.3|SIDIWSVGC[CAM]ILAEM[Oxi]LSNRPIFPGK.3|RIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPK.5|RIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPK.4
SEN / CTL,T-complex protein 1 subunit delta,CCT4,P50991,0.56,0.79,6.97E-05,7.23E-05,4.14E+00,"protein folding,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,protein stabilization,positive regulation of telomerase activity,scaRNA localization to Cajal body,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body","ATP binding,poly(A) RNA binding,unfolded protein binding","zona pellucida receptor complex,nucleoplasm,cytoplasm,centrosome,cytosol,chaperonin-containing T-complex,microtubule,melanosome,cell projection,cell body,extracellular exosome",51,44,86,VIDPATATSVDLRDIK.3|ALIAGGGAPEIELALR.2|ALIAGGGAPEIELALR.3|SILKIDDVVNTR.3|SILKIDDVVNTR.2|IGLIQFC[CAM]LSAPK.2|IGLIQFC[CAM]LSAPK.3|VIDPATATSVDLR.2|VIDPATATSVDLR.3|GIHPTIISESFQK.3|GIHPTIISESFQK.2|GSNKLVIEEAER.3|AFADAMEVIPSTLAENAGLNPISTVTELR.3|AFADAMEVIPSTLAENAGLNPISTVTELR.5|AFADAMEVIPSTLAENAGLNPISTVTELR.4|AFADAM[Oxi]EVIPSTLAENAGLNPISTVTELR.3|TLSGMESYC[CAM]VR.2|TLSGMESYC[CAM]VR.3|TLSGM[Oxi]ESYC[CAM]VR.2|MLVELSK.2|M[Oxi]LVELSK.2|VVSQYSSLLSPMSVNAVMK.3|VVSQYSSLLSPM[Oxi]SVNAVMK.3|VVSQYSSLLSPMSVNAVM[Oxi]K.3|VVSQYSSLLSPM[Oxi]SVNAVM[Oxi]K.3|VVSQYSSLLSPM[Oxi]SVNAVM[Oxi]K.2|VVSQYSSLLSPM[Oxi]SVNAVMK.2|VVSQYSSLLSPMSVNAVM[Oxi]K.2|VVSQYSSLLSPMSVNAVMK.2|KLGGTIDDC[CAM]ELVEGLVLTQK.3|KLGGTIDDC[CAM]ELVEGLVLTQK.4|KLGGTIDDC[CAM]ELVEGLVLTQK.2|MIQDGKGDVTITNDGATILK.3|M[Oxi]IQDGKGDVTITNDGATILK.3|MIQDGKGDVTITNDGATILK.2|LGGTIDDC[CAM]ELVEGLVLTQK.3|LGGTIDDC[CAM]ELVEGLVLTQK.2|DALSDLALHFLNK.3|DALSDLALHFLNK.2|VSNSGITR.2|KTGC[CAM]NVLLIQK.3|KTGC[CAM]NVLLIQK.2|SGATAGAAGGR.2|ITGC[CAM]ASPGK.2|AYILNLVK.2|IDDVVNTR.2|GDVTITNDGATILK.3|GDVTITNDGATILK.2|LVIEEAER.2|ETLLNSATTSLNSK.3|ETLLNSATTSLNSK.2|GAYQDRDKPAQIR.3|AKIGLIQFC[CAM]LSAPK.3|DIEREDIEFIC[CAM]K.3|DIEREDIEFIC[CAM]K.2|EDIEFIC[CAM]K.2|IMVIKDIEREDIEFIC[CAM]K.4|IMVIKDIEREDIEFIC[CAM]K.3|GIEILTDMSR.2|RALIAGGGAPEIELALR.3|TGC[CAM]NVLLIQK.2|QMQVLHPAAR.2|SIHDALC[CAM]VIR.2|VSNSGITRVEK.2|GIEILTDMSRPVELSDR.3|GIEILTDM[Oxi]SRPVELSDR.3|GIEILTDMSRPVELSDR.2|SILRDALSDLALHFLNK.3|TDMDNQIVVSDYAQMDR.3|TDM[Oxi]DNQIVVSDYAQM[Oxi]DR.3|TDM[Oxi]DNQIVVSDYAQMDR.3|TDMDNQIVVSDYAQM[Oxi]DR.3|TDMDNQIVVSDYAQMDR.2|TDM[Oxi]DNQIVVSDYAQMDR.2|TDMDNQIVVSDYAQM[Oxi]DR.2|TIGTKPVAHIDQFTADMLGSAELAEEVNLNGSGK.5|TIGTKPVAHIDQFTADM[Oxi]LGSAELAEEVNLNGSGK.4|TIGTKPVAHIDQFTADMLGSAELAEEVNLNGSGK.4|TIGTKPVAHIDQFTADMLGSAELAEEVNLNGSGK.3|PVELSDRETLLNSATTSLNSK.3|ALIAGGGAPEIELALRLTEYSR.3|GIEILTDMSRPVELSDRETLLNSATTSLNSK.4|GIEILTDM[Oxi]SRPVELSDRETLLNSATTSLNSK.4|GIEILTDMSRPVELSDRETLLNSATTSLNSK.3|AQDIEAGDGTTSVVIIAGSLLDSC[CAM]TK.3|PVAHIDQFTADMLGSAELAEEVNLNGSGK.3
SEN / CTL,"Trifunctional enzyme subunit beta, mitochondrial",HADHB,P55084,0.56,0.41,1.73E-05,2.07E-05,4.68E+00,"fatty acid beta-oxidation,cardiolipin acyl-chain remodeling","3-hydroxyacyl-CoA dehydrogenase activity,acetyl-CoA C-acyltransferase activity,enoyl-CoA hydratase activity,protein binding,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,poly(A) RNA binding","mitochondrion,mitochondrial envelope,mitochondrial outer membrane,mitochondrial inner membrane,endoplasmic reticulum,mitochondrial nucleoid,extracellular exosome",15,41,75,LAAAFAVSR.2|FNNWGGSLSLGHPFGATGC[CAM]R.3|FNNWGGSLSLGHPFGATGC[CAM]R.2|TSVPKEVVDYIIFGTVIQEVK.3|TSVPKEVVDYIIFGTVIQEVK.4|TSVPKEVVDYIIFGTVIQEVK.2|TPFLLSGTSYKDLMPHDLAR.4|TPFLLSGTSYKDLM[Oxi]PHDLAR.4|TPFLLSGTSYKDLMPHDLAR.3|TPFLLSGTSYKDLM[Oxi]PHDLAR.3|NVVVVDGVR.2|LMLDLNK.2|LVMAAANR.2|VGLPPLEK.2|AALTGLLHR.2|DQLLLGPTYATPK.3|DQLLLGPTYATPK.2|ALAMGYKPK.2|KAQDEGLLSDVVPFKVPGK.4|KAQDEGLLSDVVPFKVPGK.3|KAQDEGLLSDVVPFKVPGK.2|DNGIRPSSLEQMAK.3|DNGIRPSSLEQMAK.2|DLMPHDLAR.2|DLM[Oxi]PHDLAR.2|EAALGAGFSDK.2|TKVGLPPLEK.2|KAQDEGLLSDVVPFK.3|KAQDEGLLSDVVPFK.2|LEQDEYALR.2|AYLRDFMYVSQDPK.3|AMDSDWFAENYMGRK.3|AM[Oxi]DSDWFAENYMGRK.3|TPFLLSGTSYK.2|AQDEGLLSDVVPFKVPGKDTVTK.4|AQDEGLLSDVVPFKVPGKDTVTK.3|DFMYVSQDPK.2|DFM[Oxi]YVSQDPK.2|EVVDYIIFGTVIQEVK.3|EVVDYIIFGTVIQEVK.2|TLAKPNIRNVVVVDGVR.3|FRFNFLAPELPAVSEFSTSETMGHSADR.5|FRFNFLAPELPAVSEFSTSETM[Oxi]GHSADR.4|FRFNFLAPELPAVSEFSTSETMGHSADR.4|FRFNFLAPELPAVSEFSTSETMGHSADR.3|AQDEGLLSDVVPFKVPGK.3|TKVGLPPLEKFNNWGGSLSLGHPFGATGC[CAM]R.5|EGGQYGLVAAC[CAM]AAGGQGHAMIVEAYPK.4|EGGQYGLVAAC[CAM]AAGGQGHAM[Oxi]IVEAYPK.3|EGGQYGLVAAC[CAM]AAGGQGHAMIVEAYPK.3|LAAAFAVSRLEQDEYALR.3|PYGTVTAANSSFLTDGASAMLIMAEEK.4|PYGTVTAANSSFLTDGASAMLIMAEEK.3|FNFLAPELPAVSEFSTSETMGHSADR.4|FNFLAPELPAVSEFSTSETM[Oxi]GHSADR.3|FNFLAPELPAVSEFSTSETMGHSADR.3|KEGGQYGLVAAC[CAM]AAGGQGHAMIVEAYPK.4|KEGGQYGLVAAC[CAM]AAGGQGHAMIVEAYPK.3|LKPAFIKPYGTVTAANSSFLTDGASAMLIMAEEK.5|LKPAFIKPYGTVTAANSSFLTDGASAMLIM[Oxi]AEEK.4|LKPAFIKPYGTVTAANSSFLTDGASAMLIMAEEK.4|LKPAFIKPYGTVTAANSSFLTDGASAMLIMAEEK.3|VGLPPLEKFNNWGGSLSLGHPFGATGC[CAM]R.4|TSVPKEVVDYIIFGTVIQEVKTSNVAR.4|TSVPKEVVDYIIFGTVIQEVKTSNVAR.3|AQDEGLLSDVVPFK.2|AYLRDFM[Oxi]YVSQDPKDQLLLGPTYATPK.4|AYLRDFMYVSQDPKDQLLLGPTYATPK.4|AYLRDFM[Oxi]YVSQDPKDQLLLGPTYATPK.3|AYLRDFMYVSQDPKDQLLLGPTYATPK.3|AMDSDWFAENYMGR.2|AM[Oxi]DSDWFAENYMGR.2|AMDSDWFAENYM[Oxi]GR.2|DFMYVSQDPKDQLLLGPTYATPK.3|AGLTMNDIDAFEFHEAFSGQILANFK.3
SEN / CTL,"ATP synthase subunit gamma, mitochondrial",ATP5C1,P36542,0.56,1.45,4.46E-03,2.70E-03,2.57E+00,"oxidative phosphorylation,ATP biosynthetic process,mitochondrial ATP synthesis coupled proton transport","transmembrane transporter activity,poly(A) RNA binding,proton-transporting ATP synthase activity, rotational mechanism,ATPase activity","mitochondrial proton-transporting ATP synthase complex, catalytic core F(1),mitochondrion,mitochondrial inner membrane,mitochondrial proton-transporting ATP synthase complex,mitochondrial matrix,membrane,myelin sheath,extracellular exosome",15,21,34,IYGLGSLALYEK.2|IYGLGSLALYEK.3|EVMLVGIGDKIR.3|THSDQFLVAFK.3|THSDQFLVAFK.2|NASEMIDKLTLTFNR.3|NASEM[Oxi]IDKLTLTFNR.3|NASEMIDKLTLTFNR.2|NASEM[Oxi]IDKLTLTFNR.2|GLC[CAM]GAIHSSIAK.3|GLC[CAM]GAIHSSIAK.2|LTLTFNR.2|THSDQFLVAFKEVGR.4|THSDQFLVAFKEVGR.3|NASEM[Oxi]IDK.2|MTAMDNASK.2|MTAM[Oxi]DNASK.2|ADIKGPEDK.2|SEVATLTAAGK.2|EVMLVGIGDK.2|EVM[Oxi]LVGIGDK.2|ESTTSEQSAR.2|HLLIGVSSDR.2|EVGRKPPTFGDASVIALELLNSGYEFDEGSIIFNK.6|EVGRKPPTFGDASVIALELLNSGYEFDEGSIIFNK.4|QAVITKELIEIISGAAALD.3|ELIEIISGAAALD.2|KPPTFGDASVIALELLNSGYEFDEGSIIFNK.5|KPPTFGDASVIALELLNSGYEFDEGSIIFNK.4|KPPTFGDASVIALELLNSGYEFDEGSIIFNK.3|KPPTFGDASVIALELLNSGYEFDEGSIIFNKFR.5|KPPTFGDASVIALELLNSGYEFDEGSIIFNKFR.4|TRQAVITKELIEIISGAAALD.3|HLLIGVSSDRGLC[CAM]GAIHSSIAK.3
SEN / CTL,Nucleoside diphosphate kinase B,NME2,P22392,0.56,0.55,8.64E-02,3.19E-02,1.50E+00,"negative regulation of myeloid leukocyte differentiation,purine nucleotide metabolic process,nucleoside diphosphate phosphorylation,GTP biosynthetic process,pyrimidine nucleotide metabolic process,UTP biosynthetic process,CTP biosynthetic process,transcription, DNA-templated,regulation of transcription, DNA-templated,cell adhesion,integrin-mediated signaling pathway,nucleoside triphosphate biosynthetic process,positive regulation of neuron projection development,nucleobase-containing small molecule interconversion,peptidyl-histidine phosphorylation,positive regulation of cAMP biosynthetic process,cellular response to oxidative stress,negative regulation of apoptotic process,positive regulation of keratinocyte differentiation,regulation of epidermis development,positive regulation of transcription from RNA polymerase II promoter,protein autophosphorylation,positive regulation of epithelial cell proliferation,protein oligomerization,response to growth hormone,cellular response to glucose stimulus,cellular response to fatty acid","DNA binding,transcription factor activity, sequence-specific DNA binding,nucleoside diphosphate kinase activity,protein histidine kinase activity,protein serine/threonine kinase activity,fatty acid binding,protein binding,ATP binding,drug binding,intermediate filament binding,enzyme binding,metal ion binding","ruffle,nucleus,cytoplasm,cytosol,intermediate filament,lamellipodium,mitochondrial membrane,myelin sheath,perinuclear region of cytoplasm,extracellular exosome,cell periphery,focal adhesion",18,19,36,GDFC[CAM]IQVGR.2|SC[CAM]AHDWVYE.2|SAEKEISLWFKPEELVDYK.4|SAEKEISLWFKPEELVDYK.3|SAEKEISLWFKPEELVDYK.2|TFIAIKPDGVQR.3|TFIAIKPDGVQR.2|VMLGETNPADSKPGTIR.3|VM[Oxi]LGETNPADSKPGTIR.3|VMLGETNPADSKPGTIR.4|VMLGETNPADSKPGTIR.2|VM[Oxi]LGETNPADSKPGTIR.2|ASEEHLK.2|GLVGEIIK.2|GLVGEIIK.1|QHYIDLK.2|GLVGEIIKR.2|QHYIDLKDRPFFPGLVK.4|NIIHGSDSVK.2|ASEEHLKQHYIDLK.3|ASEEHLKQHYIDLKDRPFFPGLVK.5|DRPFFPGLVK.2|TGRVM[Oxi]LGETNPADSKPGTIRGDFC[CAM]IQVGR.5|VMLGETNPADSK.2|VM[Oxi]LGETNPADSK.2|EISLWFKPEELVDYK.3|EISLWFKPEELVDYK.2|YM[Oxi]NSGPVVAMVWEGLNVVK.3|YMNSGPVVAM[Oxi]VWEGLNVVK.3|YMNSGPVVAMVWEGLNVVK.3|YM[Oxi]NSGPVVAM[Oxi]VWEGLNVVK.3|YMNSGPVVAMVWEGLNVVK.2|YM[Oxi]NSGPVVAM[Oxi]VWEGLNVVK.2|YM[Oxi]NSGPVVAMVWEGLNVVK.2|YMNSGPVVAM[Oxi]VWEGLNVVK.2|SAEKEISLWFKPEELVDYKSC[CAM]AHDWVYE.4
SEN / CTL,Major vault protein,MVP,Q14764,0.55,0.75,7.90E-15,4.54E-14,1.33E+01,"protein transport,negative regulation of signaling,negative regulation of protein autophosphorylation,ERBB signaling pathway,mRNA transport,negative regulation of protein tyrosine kinase activity","protein binding,protein kinase binding,protein phosphatase binding","nucleus,nuclear pore,cytoplasm,cytoskeleton,membrane,intracellular ribonucleoprotein complex,perinuclear region of cytoplasm,extracellular exosome",168,78,128,SFFLQPGEQLEQGIQDVYVLSEQQGLLLR.3|SFFLQPGEQLEQGIQDVYVLSEQQGLLLR.4|LFSVPDFVGDAC[CAM]K.2|AQLELEVSK.2|ELELVYAR.2|IPPYHYIHVLDQNSNVSR.4|IPPYHYIHVLDQNSNVSR.3|ALC[CAM]LLLGPDFFTDVITIETADHAR.3|TAVFGFETSEAKGPDGMALPRPR.4|VASGPSPGEGISPQSAQAPQAPGDNHVVPVLR.4|VASGPSPGEGISPQSAQAPQAPGDNHVVPVLR.3|AQQLAEVEVK.2|VRGAVASVTFDDFHK.3|VRGAVASVTFDDFHK.4|GPLEYVPSAKVEVVEER.3|GAVASVTFDDFHK.3|GAVASVTFDDFHK.2|RALC[CAM]LLLGPDFFTDVITIETADHAR.4|RALC[CAM]LLLGPDFFTDVITIETADHAR.3|VVFGPELVSLGPEEQFTVLSLSAGRPK.3|VVFGPELVSLGPEEQFTVLSLSAGRPK.4|VVFGPELVSLGPEEQFTVLSLSAGRPK.5|VVSYRVPHNAAVQVYDYR.4|VVSYRVPHNAAVQVYDYR.3|LKAQALAIETEAELQR.3|LKAQALAIETEAELQR.2|LKAQALAIETEAELQR.4|LAQDPFPLYPGEVLEKDITPLQVVLPNTALHLK.4|LAQDPFPLYPGEVLEKDITPLQVVLPNTALHLK.5|LAQDPFPLYPGEVLEKDITPLQVVLPNTALHLK.6|STLITDGSTPINLFNTAFGLLGM[Oxi]GPEGQPLGR.3|STLITDGSTPINLFNTAFGLLGM[Oxi]GPEGQPLGR.4|QAIPLDENEGIYVQDVK.2|QAIPLDENEGIYVQDVK.3|ALQPLEEGEDEEKVSHQAGDHWLIR.5|ALQPLEEGEDEEKVSHQAGDHWLIR.4|ALQPLEEGEDEEKVSHQAGDHWLIR.3|GAVASVTFDDFHKNSAR.4|RVASGPSPGEGISPQSAQAPQAPGDNHVVPVLR.4|RVASGPSPGEGISPQSAQAPQAPGDNHVVPVLR.5|RVASGPSPGEGISPQSAQAPQAPGDNHVVPVLR.3|RVASGPSPGEGISPQSAQAPQAPGDNHVVPVLR.6|VRELELVYAR.3|VRELELVYAR.2|KEVEVVEIIQATIIR.3|KEVEVVEIIQATIIR.2|ALLDFEDKDGDKVVAGDEWLFEGPGTYIPR.4|ALLDFEDKDGDKVVAGDEWLFEGPGTYIPR.3|AEAARIEGEGSVLQAK.3|AEAARIEGEGSVLQAK.2|DAQGLVLFDVTGQVR.2|VRGAVASVTFDDFHKNSAR.4|VRGAVASVTFDDFHKNSAR.3|VPHNAAVQVYDYR.3|VPHNAAVQVYDYR.2|LLQSLGLK.2|AQALAIETEAELQR.2|AQALAIETEAELQR.3|HYC[CAM]TVANPVSR.3|HYC[CAM]TVANPVSR.2|ELLELEALSMAVESTGTAK.3|ELLELEALSM[Oxi]AVESTGTAK.3|ELLELEALSM[Oxi]AVESTGTAK.2|ELLELEALSMAVESTGTAK.2|RTGEEWLVTVQDTEAHVPDVHEEVLGVVPITTLGPHNYC[CAM]VILDPVGPDGK.6|RTGEEWLVTVQDTEAHVPDVHEEVLGVVPITTLGPHNYC[CAM]VILDPVGPDGK.5|DQAVFPQNGLVVSSVDVQSVEPVDQR.3|ELPPGVEELLNK.2|SVQLAIEITTNSQEAAAKHEAQRLEQEAR.5|SVQLAIEITTNSQEAAAKHEAQRLEQEAR.4|AQQLAEVEVKK.3|AQQLAEVEVKK.2|VLFAPMR.2|HADLEIR.2|VEVVEER.2|SLQPLAPR.2|VPHNAAVQVYDYREK.4|VPHNAAVQVYDYREK.3|GPDGMALPR.2|HEAQRLEQEAR.3|HEAQRLEQEAR.2|DITPLQVVLPNTALHLK.4|DITPLQVVLPNTALHLK.3|DITPLQVVLPNTALHLK.2|ALLDFEDK.2|VSHQAGDHWLIR.3|VSHQAGDHWLIR.2|ILDQSEAEK.2|FKQM[Oxi]TEAIGPSTIR.3|GPLEYVPSAK.2|EVEVVEIIQATIIR.3|EVEVVEIIQATIIR.2|GQDPLADRGEKDTAK.3|VVAGDEWLFEGPGTYIPRK.4|VVAGDEWLFEGPGTYIPRK.3|VVAGDEWLFEGPGTYIPRK.2|AQLELEVSKAQQLAEVEVKK.4|AQLELEVSKAQQLAEVEVKK.3|IEGEGSVLQAK.2|LRHADLEIR.2|GPDGMALPRPR.2|VVSYRVPHNAAVQVYDYREK.4|LAQDPFPLYPGEVLEK.3|LAQDPFPLYPGEVLEK.2|VSHQAGDHWLIRGPLEYVPSAK.4|DLAVAGPEMQVK.2|DLAVAGPEM[Oxi]QVK.2|SVQLAIEITTNSQEAAAK.3|SVQLAIEITTNSQEAAAK.2|TAVFGFETSEAK.2|QMTEAIGPSTIR.2|QM[Oxi]TEAIGPSTIR.2|VVAGDEWLFEGPGTYIPR.3|VVAGDEWLFEGPGTYIPR.2|ALLDFEDKDGDK.2|AVIGSTYMLTQDEVLWEK.3|AVIGSTYM[Oxi]LTQDEVLWEK.2|AVIGSTYMLTQDEVLWEK.2|IPPYHYIHVLDQNSNVSRVEVGPK.4|KELLELEALSMAVESTGTAK.3|ALQPLEEGEDEEK.2|VRAVIGSTYMLTQDEVLWEK.3|SVQLAIEITTNSQEAAAKHEAQR.3|QMTEAIGPSTIRDLAVAGPEMQVK.3|VVFGPELVSLGPEEQFTVLSLSAGR.3|TGEEWLVTVQDTEAHVPDVHEEVLGVVPITTLGPHNYC[CAM]VILDPVGPDGK.6|VEVVEERQAIPLDENEGIYVQDVK.3|ARVVFGPELVSLGPEEQFTVLSLSAGRPK.3
SEN / CTL,Staphylococcal nuclease domain-containing protein 1,SND1,Q7KZF4,0.55,0.55,2.72E-05,3.09E-05,4.51E+00,"osteoblast differentiation,transcription, DNA-templated,regulation of transcription, DNA-templated,RNA catabolic process,viral process,gene silencing by RNA,nucleic acid phosphodiester bond hydrolysis,cell-cell adhesion","transcription cofactor activity,nuclease activity,protein binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,mitochondrion,cell-cell adherens junction,membrane,RISC complex,melanosome,extracellular exosome,dense body",39,71,115,QFLPFLQR.2|ETC[CAM]LITFLLAGIEC[CAM]PR.3|ETC[CAM]LITFLLAGIEC[CAM]PR.2|SSHYDELLAAEAR.3|SSHYDELLAAEAR.2|MVLSGC[CAM]AIIVR.2|M[Oxi]VLSGC[CAM]AIIVR.2|LRPLYDIPYMFEAR.3|LRPLYDIPYM[Oxi]FEAR.3|LRPLYDIPYMFEAR.2|AGRSEAVVEYVFSGSR.3|AGRSEAVVEYVFSGSR.2|IHVFYIDYGNR.3|IHVFYIDYGNR.2|VMQVLNADAIVVK.2|VMQVLNADAIVVK.3|VM[Oxi]QVLNADAIVVK.2|EVC[CAM]FTIENKTPQGR.3|HFVDSHHQKPVNAIIEHVR.5|HFVDSHHQKPVNAIIEHVR.4|HFVDSHHQKPVNAIIEHVR.3|IHVFYIDYGNREVLPSTR.4|IHVFYIDYGNREVLPSTR.3|SEAVVEYVFSGSR.2|SEAVVEYVFSGSR.3|EVEVEVESMDK.2|EVEVEVESM[Oxi]DK.2|ADDADEFGYSR.3|ADDADEFGYSR.2|GDVGLGLVK.2|VHFTAER.2|YTIENPR.2|ANNPEQNR.2|DTPDEPWAFPAR.3|DTPDEPWAFPAR.2|GM[Oxi]WSEGNGSHTIR.3|GMWSEGNGSHTIR.3|GM[Oxi]WSEGNGSHTIR.2|GMWSEGNGSHTIR.2|KLRPLYDIPYMFEAR.4|KLRPLYDIPYMFEAR.3|QINLSNIR.2|TDAVDSVVR.2|VITEYLNAQESAK.3|VITEYLNAQESAK.2|RGEFC[CAM]IAK.2|SLLSAEEAAK.2|EGLVMVEVR.2|EGLVM[Oxi]VEVR.2|LEGENTQDK.2|VADISGDTQK.2|KGMWSEGNGSHTIR.3|DYVAPTANLDQKDK.3|DYVAPTANLDQKDK.2|EYGMIYLGK.2|FVDGEWYR.2|EADGSETPEPFAAEAK.3|EADGSETPEPFAAEAK.2|LSEC[CAM]EEQAK.2|HFVDSHHQK.2|EVC[CAM]FTIENK.2|NDIASHPPVEGSYAPR.3|NDIASHPPVEGSYAPR.2|PVNAIIEHVR.2|LGTLSPAFSTR.2|IWRDYVAPTANLDQK.3|RAAATQPDAKDTPDEPWAFPAR.4|RAAATQPDAKDTPDEPWAFPAR.3|READGSETPEPFAAEAK.3|VWAHYEEQPVEEVMPVLEEK.4|VWAHYEEQPVEEVMPVLEEK.3|LMENMRNDIASHPPVEGSYAPR.4|YGDFRADDADEFGYSR.3|TC[CAM]ATVTIGGINIAEALVSK.3|TC[CAM]ATVTIGGINIAEALVSK.2|YRQDDDQRSSHYDELLAAEAR.4|VLPAQATEYAFAFIQVPQDDDAR.4|VLPAQATEYAFAFIQVPQDDDAR.3|DTNGENIAESLVAEGLATR.3|DTNGENIAESLVAEGLATR.2|DIQNTQC[CAM]LLNVEHLSAGC[CAM]PHVTLQFADSK.5|DIQNTQC[CAM]LLNVEHLSAGC[CAM]PHVTLQFADSK.4|DIQNTQC[CAM]LLNVEHLSAGC[CAM]PHVTLQFADSK.3|VNVTVDYIRPASPATETVPAFSER.4|VNVTVDYIRPASPATETVPAFSER.3|DYVAPTANLDQK.2|ALLLPDYYLVTVM[Oxi]LSGIK.3|ANNPEQNRLSEC[CAM]EEQAK.3|EKVWAHYEEQPVEEVMPVLEEK.4|C[CAM]VDWSIAVYTR.2|VWAHYEEQPVEEVMPVLEEKER.4|AGNFIGWLHIDGANLSVLLVEHALSK.4|AGNFIGWLHIDGANLSVLLVEHALSK.3|DIQNTQC[CAM]LLNVEHLSAGC[CAM]PHVTLQFADSKGDVGLGLVK.6|DIQNTQC[CAM]LLNVEHLSAGC[CAM]PHVTLQFADSKGDVGLGLVK.5|DIQNTQC[CAM]LLNVEHLSAGC[CAM]PHVTLQFADSKGDVGLGLVK.4|KVNVTVDYIRPASPATETVPAFSER.4|KVNVTVDYIRPASPATETVPAFSER.3|DTNGENIAESLVAEGLATRR.3|VLPAQATEYAFAFIQVPQDDDARTDAVDSVVR.5|VLPAQATEYAFAFIQVPQDDDARTDAVDSVVR.4|VLPAQATEYAFAFIQVPQDDDARTDAVDSVVR.3|SASYKPVFVTEITDDLHFYVQDVETGTQLEK.5|SASYKPVFVTEITDDLHFYVQDVETGTQLEK.4|SASYKPVFVTEITDDLHFYVQDVETGTQLEK.3|AAATQPDAKDTPDEPWAFPAR.3|EYGMIYLGKDTNGENIAESLVAEGLATR.4|EYGMIYLGKDTNGENIAESLVAEGLATR.3|ERSASYKPVFVTEITDDLHFYVQDVETGTQLEK.5|NLPGLVQEGEPFSEEATLFTK.3|NLPGLVQEGEPFSEEATLFTK.2|PASPATETVPAFSER.2|EYGMIYLGKDTNGENIAESLVAEGLATRR.4|DVQIILESC[CAM]HNQNILGTILHPNGNITELLLK.4|DVQIILESC[CAM]HNQNILGTILHPNGNITELLLK.3
SEN / CTL,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2,GNB2,P62879,0.55,0.26,1.12E-03,8.34E-04,3.08E+00,"protein folding,G-protein coupled receptor signaling pathway,cellular response to glucagon stimulus","GTPase activity,signal transducer activity,calcium channel regulator activity,protein binding,protein complex binding,GTPase binding","extracellular space,lysosomal membrane,cytosol,plasma membrane,focal adhesion,membrane,vesicle,myelin sheath,protein complex,cell body,perinuclear region of cytoplasm,extracellular exosome",9,15,25,TFVSGAC[CAM]DASIK.2|KAC[CAM]GDSTLTQITAGLDPVGR.3|KAC[CAM]GDSTLTQITAGLDPVGR.2|LLLAGYDDFNC[CAM]NIWDAMKGDR.3|VHAIPLR.2|QEAEQLR.2|GDRAGVLAGHDNR.3|AGVLAGHDNR.2|ELPGHTGYLSC[CAM]C[CAM]R.3|ELPGHTGYLSC[CAM]C[CAM]R.2|AC[CAM]GDSTLTQITAGLDPVGR.3|AC[CAM]GDSTLTQITAGLDPVGR.2|ADQELLMYSHDNIIC[CAM]GITSVAFSR.4|ADQELLMYSHDNIIC[CAM]GITSVAFSR.3|ADQELLM[Oxi]YSHDNIIC[CAM]GITSVAFSR.3|LLLAGYDDFNC[CAM]NIWDAMK.3|LLLAGYDDFNC[CAM]NIWDAM[Oxi]K.2|LLLAGYDDFNC[CAM]NIWDAMK.2|VSC[CAM]LGVTDDGMAVATGSWDSFLK.3|VSC[CAM]LGVTDDGM[Oxi]AVATGSWDSFLK.3|LFDLRADQELLMYSHDNIIC[CAM]GITSVAFSR.4|SSWVMTC[CAM]AYAPSGNFVAC[CAM]GGLDNIC[CAM]SIYSLK.4|SSWVMTC[CAM]AYAPSGNFVAC[CAM]GGLDNIC[CAM]SIYSLK.3|QTFIGHESDINAVAFFPNGYAFTTGSDDATC[CAM]R.4|QTFIGHESDINAVAFFPNGYAFTTGSDDATC[CAM]R.3
SEN / CTL,Ras-related protein R-Ras,RRAS,P10301,0.54,0.69,1.46E-01,4.79E-02,1.32E+00,"leukocyte differentiation,Ras protein signal transduction,negative regulation of cell migration,positive regulation of angiogenesis,regulation of protein kinase B signaling,face morphogenesis,regulation of ERK1 and ERK2 cascade","GTPase activity,protein binding,GTP binding,GDP binding,protein complex binding","intracellular,plasma membrane,focal adhesion,extracellular exosome",9,13,15,LVVVGGGGVGK.2|LNVDEAFEQLVR.2|SEASAFGASHHVAYFEASAK.4|SEASAFGASHHVAYFEASAK.3|LFTQILR.2|DRDDFPVVLVGNK.3|GGGPGPGDPPPSETHK.3|IC[CAM]SVDGIPAR.2|LRLNVDEAFEQLVR.3|LRLNVDEAFEQLVR.2|AGHGFLLVFAINDRQSFNEVGKLFTQILR.5|AGHGFLLVFAINDR.2|LDILDTAGQEEFGAMREQYMR.3|LDILDTAGQEEFGAMR.2|IC[CAM]SVDGIPARLDILDTAGQEEFGAMR.3
SEN / CTL,Vimentin,VIM,P08670,0.54,1.17,2.04E-19,2.12E-18,1.77E+01,"movement of cell or subcellular component,positive regulation of gene expression,negative regulation of neuron projection development,astrocyte development,viral process,muscle filament sliding,intermediate filament organization,Bergmann glial cell differentiation,SMAD protein signal transduction,lens fiber cell development","glycoprotein binding,double-stranded RNA binding,structural constituent of cytoskeleton,structural constituent of eye lens,protein binding,protein C-terminus binding,identical protein binding,scaffold protein binding,keratin filament binding","cytoplasm,peroxisome,cytosol,cytoskeleton,intermediate filament,focal adhesion,extracellular matrix,cell leading edge,neuron projection,intermediate filament cytoskeleton,extracellular exosome,plasma membrane",336,92,187,ILLAELEQLKGQGK.3|ILLAELEQLKGQGK.2|ISLPLPNFSSLNLR.2|ISLPLPNFSSLNLR.3|KVESLQEEIAFLK.3|KVESLQEEIAFLK.2|QVQSLTC[CAM]EVDALKGTNESLER.3|QVQSLTC[CAM]EVDALKGTNESLER.2|QVQSLTC[CAM]EVDALKGTNESLER.4|KVESLQEEIAFLKK.3|KVESLQEEIAFLKK.4|KVESLQEEIAFLKK.2|MALDIEIATYR.2|M[Oxi]ALDIEIATYR.2|NLQEAEEWYK.2|NLQEAEEWYK.3|ILLAELEQLK.2|HLREYQDLLNVK.3|HLREYQDLLNVK.2|EYQDLLNVK.2|TNEKVELQELNDR.3|TNEKVELQELNDR.2|SRLGDLYEEEMRELR.4|SRLGDLYEEEMRELR.3|RQVQSLTC[CAM]EVDALKGTNESLER.4|RQVQSLTC[CAM]EVDALKGTNESLER.3|FADLSEAANR.2|SKFADLSEAANRNNDALR.4|SKFADLSEAANRNNDALR.3|FANYIDKVR.2|LQEEMLQREEAENTLQSFRQDVDNASLAR.4|LQEEM[Oxi]LQREEAENTLQSFRQDVDNASLAR.4|LQEEMLQREEAENTLQSFRQDVDNASLAR.5|LQEEMLQREEAENTLQSFRQDVDNASLAR.3|LQEEM[Oxi]LQREEAENTLQSFRQDVDNASLAR.3|QMREMEENFAVEAANYQDTIGR.3|EM[Oxi]EENFAVEAANYQDTIGR.3|EMEENFAVEAANYQDTIGR.3|EM[Oxi]EENFAVEAANYQDTIGR.2|EMEENFAVEAANYQDTIGR.2|EMEENFAVEAANYQDTIGR.4|MALDIEIATYRK.3|MALDIEIATYRK.2|M[Oxi]ALDIEIATYRK.3|M[Oxi]ALDIEIATYRK.2|ETNLDSLPLVDTHSKR.4|ETNLDSLPLVDTHSKR.3|ETNLDSLPLVDTHSKR.2|VEVERDNLAEDIMR.3|VEVERDNLAEDIMR.2|VEVERDNLAEDIM[Oxi]R.3|VEVERDNLAEDIM[Oxi]R.2|TNEKVELQELNDRFANYIDK.4|TNEKVELQELNDRFANYIDK.3|VELQELNDRFANYIDKVR.4|VELQELNDRFANYIDKVR.3|DGQVINETSQHHDDLE.3|DGQVINETSQHHDDLE.2|FADLSEAANRNNDALR.3|FADLSEAANRNNDALR.2|FADLSEAANRNNDALR.4|LGDLYEEEMRELRR.3|LGDLYEEEMRELRR.4|LGDLYEEEM[Oxi]RELRR.3|EKLQEEMLQREEAENTLQSFR.4|EKLQEEMLQREEAENTLQSFR.3|EKLQEEM[Oxi]LQREEAENTLQSFR.4|SRLGDLYEEEMR.3|SRLGDLYEEEMR.2|SRLGDLYEEEM[Oxi]R.3|SRLGDLYEEEM[Oxi]R.2|LGDLYEEEMR.2|LGDLYEEEM[Oxi]R.2|EEAENTLQSFRQDVDNASLAR.3|EEAENTLQSFRQDVDNASLAR.4|EEAENTLQSFRQDVDNASLAR.2|SYVTTSTR.2|QVQSLTC[CAM]EVDALK.2|QVQSLTC[CAM]EVDALK.3|DNLAEDIMR.2|DNLAEDIM[Oxi]R.2|LGDLYEEEMRELR.3|LGDLYEEEMRELR.2|LGDLYEEEM[Oxi]RELR.3|LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR.5|LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR.4|LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR.6|LQEEMLQREEAENTLQSFR.3|LQEEMLQREEAENTLQSFR.4|LQEEM[Oxi]LQREEAENTLQSFR.3|LQEEMLQREEAENTLQSFR.2|EMEENFAVEAANYQDTIGRLQDEIQNMKEEMAR.4|ETNLDSLPLVDTHSK.3|ETNLDSLPLVDTHSK.2|TYSLGSALRPSTSR.3|LQDEIQNMKEEMAR.3|LQDEIQNMKEEMAR.2|LQDEIQNM[Oxi]KEEMAR.2|LQDEIQNM[Oxi]KEEMAR.3|LQDEIQNMKEEM[Oxi]AR.3|LQDEIQNM[Oxi]KEEM[Oxi]AR.3|LQDEIQNMKEEM[Oxi]AR.2|ARVEVERDNLAEDIMR.4|ARVEVERDNLAEDIMR.3|ARVEVERDNLAEDIM[Oxi]R.4|ARVEVERDNLAEDIM[Oxi]R.3|ARVEVERDNLAEDIMR.2|KLHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR.5|KLHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR.6|KLHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR.4|KLHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR.7|ISLPLPNFSSLNLRETNLDSLPLVDTHSKR.5|ISLPLPNFSSLNLRETNLDSLPLVDTHSKR.4|ISLPLPNFSSLNLRETNLDSLPLVDTHSKR.6|SLYASSPGGVYATR.2|SLYASSPGGVYATR.3|FLEQQNKILLAELEQLKGQGK.4|FLEQQNKILLAELEQLKGQGK.3|LLQDSVDFSLADAINTEFKNTR.3|LLQDSVDFSLADAINTEFKNTR.4|LLQDSVDFSLADAINTEFK.3|LLQDSVDFSLADAINTEFK.2|LQEEMLQR.2|LQEEM[Oxi]LQR.2|EEAENTLQSFR.2|EEAENTLQSFR.3|QDVDNASLAR.2|SVSSSSYR.2|VESLQEEIAFLK.2|VESLQEEIAFLK.3|VESLQEEIAFLKK.3|VESLQEEIAFLKK.2|MFGGPGTASRPSSSR.3|M[Oxi]FGGPGTASRPSSSR.3|TVETRDGQVINETSQHHDDLE.4|TVETRDGQVINETSQHHDDLE.3|RQVDQLTNDK.3|RQVDQLTNDK.2|RMFGGPGTASRPSSSR.4|RMFGGPGTASRPSSSR.3|PDLTAALR.2|ARVEVER.2|FANYIDK.2|QVDQLTNDKAR.3|QVDQLTNDKAR.2|SKFADLSEAANR.3|SKFADLSEAANR.2|GTNESLER.2|DVRQQYESVAAK.3|DVRQQYESVAAK.2|QAKQESTEYRR.3|RQVDQLTNDKAR.3|TYSLGSALR.2|MFGGPGTASR.2|M[Oxi]FGGPGTASR.2|NLQEAEEWYKSK.3|NLQEAEEWYKSK.2|QQYESVAAK.2|KLLEGEESR.2|QVDQLTNDK.2|QESTEYRR.2|RQVQSLTC[CAM]EVDALK.3|RQVQSLTC[CAM]EVDALK.2|LQDEIQNMK.2|LQDEIQNM[Oxi]K.2|VELQELNDR.2|RMFGGPGTASR.2|ISLPLPNFSSLNLRETNLDSLPLVDTHSK.5|ISLPLPNFSSLNLRETNLDSLPLVDTHSK.4|ISLPLPNFSSLNLRETNLDSLPLVDTHSK.3|EKLQEEMLQR.2|KLLEGEESRISLPLPNFSSLNLR.4|KLLEGEESRISLPLPNFSSLNLR.3|NTRTNEKVELQELNDR.3|VELQELNDRFANYIDK.3|VELQELNDRFANYIDK.2|FLEQQNKILLAELEQLK.3|FADLSEAANRNNDALRQAK.3|LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALRDVR.6|LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALRDVR.5|KLHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALRDVR.6|KLHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALRDVR.5|SSVPGVRLLQDSVDFSLADAINTEFKNTR.4|LLEGEESRISLPLPNFSSLNLR.3|LLEGEESRISLPLPNFSSLNLRETNLDSLPLVDTHSK.5|TYSLGSALRPSTSRSLYASSPGGVYATR.3|EMEENFAVEAANYQDTIGRLQDEIQNMK.3
SEN / CTL,Peripheral plasma membrane protein CASK,CASK,O14936,0.54,0.80,6.94E-03,3.96E-03,2.40E+00,"negative regulation of cell-matrix adhesion,protein phosphorylation,cell adhesion,neurotransmitter secretion,negative regulation of keratinocyte proliferation,positive regulation of transcription from RNA polymerase II promoter,GMP metabolic process,GDP metabolic process,negative regulation of wound healing,calcium ion import,positive regulation of calcium ion import,negative regulation of cellular response to growth factor stimulus","guanylate kinase activity,protein serine/threonine kinase activity,protein binding,calmodulin binding,ATP binding,neurexin family protein binding","basement membrane,nuclear lamina,nucleolus,cytoplasm,cytosol,plasma membrane,cell-cell junction,focal adhesion,actin cytoskeleton,basolateral plasma membrane,nuclear matrix,vesicle,presynaptic membrane,ciliary membrane",9,32,43,ITVYEALNHPWLK.3|ITVYEALNHPWLK.2|IHEQGLIAILDVEPQALK.3|IHEQGLIAILDVEPQALK.2|FTSSPGLSTEDLKR.3|QGTLHVGDEIR.3|QGTLHVGDEIR.2|YC[CAM]HDNNIIHR.3|YC[CAM]HDNNIIHR.2|DVKPHC[CAM]VLLASK.3|MNELNHC[CAM]IVAR.3|MNELNHC[CAM]IVAR.2|VGTPHFMAPEVVK.3|VGTPHFMAPEVVK.2|IHLPETVEQLRK.3|NPPSDAVQR.2|ETGQQFAVK.2|RADAGFVYSEAVASHYMR.4|RADAGFVYSEAVASHYMR.3|GAVLAAVSSHK.2|MLMLDPAER.2|EASIC[CAM]HMLK.2|VGDIIQIISK.2|QWSHISESAK.2|DDHNWWQGK.2|NTDEPMGITLK.2|ADAGFVYSEAVASHYMR.3|EINGISVANQTVEQLQK.3|EINGISVANQTVEQLQK.2|AQFEYDPAKDDLIPC[CAM]K.3|EVLEEISC[CAM]YPENNDAK.3|EVLEEISC[CAM]YPENNDAK.2|FTSSPGLSTEDLK.2|DLDFLHSVFQDQHLHTLLDLYDK.4|DLDFLHSVFQDQHLHTLLDLYDK.3|HNAVFDQLDLVTYEEVVK.3|HNAVFDQLDLVTYEEVVK.2|QGTLHVGDEIREINGISVANQTVEQLQK.4|TYAHYFDLTIINNEIDETIR.3|HNAVFDQLDLVTYEEVVKLPAFK.3|NGTAGLIPSPELQEWR.2|LGGFGVAIQLGESGLVAGGR.2|TAEFAPFVVFIAAPTITPGLNEDESLQR.3
SEN / CTL,Sorting nexin-1,SNX1,Q13596,0.54,0.23,9.69E-04,7.50E-04,3.12E+00,"intracellular protein transport,vesicle organization,receptor internalization,early endosome to Golgi transport,retrograde transport, endosome to Golgi,positive regulation of protein catabolic process,lamellipodium morphogenesis,cell-cell adhesion","epidermal growth factor receptor binding,insulin receptor binding,protein binding,phosphatidylinositol binding,protein homodimerization activity,protein heterodimerization activity,cadherin binding involved in cell-cell adhesion,transferrin receptor binding,leptin receptor binding","cytoplasm,Golgi apparatus,cytosol,cell-cell adherens junction,endosome membrane,membrane,extrinsic component of membrane,lamellipodium,retromer complex,retromer, tubulation complex,early endosome membrane,vesicle,intracellular membrane-bounded organelle,protein complex",6,24,29,YWEAFLPEAK.2|AVGTQTLSGAGLLK.2|VKVGKEDSSSAEFLEK.4|VKVGKEDSSSAEFLEK.3|VTQYERDFER.3|LHAVVETLVNHR.3|VGKEDSSSAEFLEK.3|VGKEDSSSAEFLEK.2|HSQNGFIVPPPPEK.3|HSQNGFIVPPPPEK.2|IVNHPTMLQDPDVR.3|IVNHPTMLQDPDVR.2|IVNHPTMLQDPDVREFLEK.4|IVNHPTMLQDPDVREFLEKEELPR.5|LQQAKDEILEWESR.3|DEILEWESR.2|WQDAQATLQK.2|ELALNTAQFAK.2|ALSQLAEVEEK.2|FSDFLGLYEK.2|EDSSSAEFLEK.2|VTTQTSLPLFR.2|IGDGMNAYVAYK.2|LQEVEC[CAM]EEQR.2|ITTSLLPINNGSK.2|MNESDIWFEEK.2|SLAMLGSSEDNTALSR.2|SLAM[Oxi]LGSSEDNTALSR.2|YLETLLYSQQQLAK.2
SEN / CTL,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1,RPN1,P04843,0.54,1.21,8.17E-04,6.40E-04,3.19E+00,"cellular protein modification process,protein N-linked glycosylation via asparagine","protein binding,poly(A) RNA binding,dolichyl-diphosphooligosaccharide-protein glycotransferase activity","endoplasmic reticulum membrane,rough endoplasmic reticulum,oligosaccharyltransferase complex,membrane,integral component of membrane,extracellular matrix,melanosome",21,48,79,ALTSEIALLQSR.2|ALTSEIALLQSR.3|FFTVKLPVALDPGAK.3|IDHILDAL.2|YDYQRQPDSGISSIR.3|YDYQRQPDSGISSIR.2|FPLFGGWK.2|ATSFLLALEPELEAR.2|ATSFLLALEPELEAR.3|VTAEVVLAHLGGGSTSR.3|VTAEVVLAHLGGGSTSR.4|VTAEVVLAHLGGGSTSR.2|RTVDLSSHLAK.3|RTVDLSSHLAK.2|LKTEGSDLC[CAM]DR.3|LKTEGSDLC[CAM]DR.2|RQELVTK.2|APDELHYTYLDTFGRPVIVAYKK.6|APDELHYTYLDTFGRPVIVAYKK.5|APDELHYTYLDTFGRPVIVAYKK.4|LAHLGVQVK.2|NIEIDSPYEISR.3|NIEIDSPYEISR.2|LPVALDPGAK.2|TILPAAAQDVYYR.3|TILPAAAQDVYYR.2|VHYENNSPFLTITSMTR.4|VHYENNSPFLTITSM[Oxi]TR.3|VHYENNSPFLTITSMTR.3|VHYENNSPFLTITSMTR.2|VHYENNSPFLTITSM[Oxi]TR.2|DTYIENEK.2|DTYIENEKLISGK.3|DTYIENEKLISGK.2|HFDETVNR.2|LDFSITKDPAAEAR.3|DISTLNSGKK.2|QPDSGISSIR.2|TEGSDLC[CAM]DR.2|VAC[CAM]ITEQVLTLVNK.3|VAC[CAM]ITEQVLTLVNK.2|TVDLSSHLAK.2|NLVEQHIQDIVVHYTFNK.4|NLVEQHIQDIVVHYTFNK.3|NLVEQHIQDIVVHYTFNK.2|QFVVFEGNHYFYSPYPTK.4|QFVVFEGNHYFYSPYPTK.3|QFVVFEGNHYFYSPYPTK.2|KDTYIENEK.2|VIEVSHWGNIAVEENVDLKHTGAVLKGPFSR.6|KNLVEQHIQDIVVHYTFNK.4|TEGSDLC[CAM]DRVSEMQK.3|VAC[CAM]ITEQVLTLVNKR.3|VAC[CAM]ITEQVLTLVNKR.2|APDELHYTYLDTFGR.3|APDELHYTYLDTFGR.2|LAHLGVQVKGEDEEENNLEVR.4|LAHLGVQVKGEDEEENNLEVR.3|DVPAYSQDTFK.2|APDELHYTYLDTFGRPVIVAYK.4|APDELHYTYLDTFGRPVIVAYK.3|LGNPTRSEDLLDYGPFR.3|SEDLLDYGPFR.2|FVDHVFDEQVIDSLTVK.3|FVDHVFDEQVIDSLTVK.2|LKTEGSDLC[CAM]DRVSEMQK.3|NIEIDSPYEISRAPDELHYTYLDTFGRPVIVAYKK.6|NIEIDSPYEISRAPDELHYTYLDTFGRPVIVAYKK.4|GEDEEENNLEVR.2|ISVIVETVYTHVLHPYPTQITQSEK.4|ISVIVETVYTHVLHPYPTQITQSEK.3|VIEVSHWGNIAVEENVDLK.3|VIEVSHWGNIAVEENVDLK.2|THYIVGYNLPSYEYLYNLGDQYALK.4|THYIVGYNLPSYEYLYNLGDQYALK.3|NIEIDSPYEISRAPDELHYTYLDTFGRPVIVAYK.5|DVPAYSQDTFKVHYENNSPFLTITSMTR.4|DVPAYSQDTFKVHYENNSPFLTITSMTR.3|SEDLLDYGPFRDVPAYSQDTFK.3
SEN / CTL,"Dynein light chain 1, cytoplasmic;Dynein light chain 2, cytoplasmic",DYNLL1;DYNLL2,P63167;Q96FJ2,0.54,0.19,2.55E-02,1.16E-02,1.94E+00,"G2/M transition of mitotic cell cycle,transcription, DNA-templated,regulation of transcription, DNA-templated,ER to Golgi vesicle-mediated transport,apoptotic process,microtubule-based process,female gamete generation,anatomical structure morphogenesis,viral process,macroautophagy,antigen processing and presentation of exogenous peptide antigen via MHC class II,substantia nigra development,actin cytoskeleton organization,negative regulation of phosphorylation,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;ER to Golgi vesicle-mediated transport,microtubule-based process,synaptic target recognition,macroautophagy,antigen processing and presentation of exogenous peptide antigen via MHC class II,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway","motor activity,protein binding;motor activity,cytoskeletal protein binding","kinetochore,nucleus,cytoplasm,mitochondrion,centrosome,cytosol,cytoplasmic dynein complex,microtubule,plasma membrane,membrane,extracellular exosome,mitotic spindle,ciliary tip,COP9 signalosome;nucleus,mitochondrion,centrosome,cytosol,microtubule,plasma membrane,membrane,myosin complex,dynein complex,ciliary tip",3,1,2,YNPTWHC[CAM]IVGR.3|YNPTWHC[CAM]IVGR.2
SEN / CTL,Dual specificity protein phosphatase 3,DUSP3,P51452,0.54,0.33,1.13E-05,1.45E-05,4.84E+00,"inactivation of MAPK activity,in utero embryonic development,dephosphorylation,peptidyl-tyrosine dephosphorylation,negative regulation of MAPK cascade,positive regulation of mitotic cell cycle,negative regulation of JNK cascade,negative regulation of T cell receptor signaling pathway,negative regulation of T cell activation,negative regulation of ERK1 and ERK2 cascade","protein tyrosine phosphatase activity,protein tyrosine/serine/threonine phosphatase activity,phosphatase activity,protein kinase binding,MAP kinase phosphatase activity","immunological synapse,nucleus,nucleoplasm,cytoplasm,cytosol,extracellular exosome",12,10,15,LGITHVLNAAEGR.3|LGITHVLNAAEGR.2|SPTLVIAYLMMR.2|SPTLVIAYLMM[Oxi]R.3|SPTLVIAYLM[Oxi]MR.2|AADFIDQALAQK.2|IYVGNASVAQDIPK.2|SFMHVNTNANFYK.3|SFMHVNTNANFYK.2|DSGITYLGIK.2|IYVGNASVAQDIPKLQK.3|SFMHVNTNANFYKDSGITYLGIK.4|EIGPNDGFLAQLC[CAM]QLNDR.3|EIGPNDGFLAQLC[CAM]QLNDR.2|ANDTQEFNLSAYFER.2
SEN / CTL,Gamma-adducin,ADD3,Q9UEY8,0.53,0.47,2.33E-03,1.57E-03,2.80E+00,"cytoskeleton organization,transmembrane transport","actin binding,structural constituent of cytoskeleton,calmodulin binding","condensed nuclear chromosome,nucleoplasm,cytoplasm,cytosol,cytoskeleton,plasma membrane,brush border,cell-cell junction,cell cortex,membrane",9,31,36,GLSFSEATASNLVK.2|VGEIEFEGLMR.2|YFDRINENDPEYIRER.4|IDHTGFSPHAAIYSTRPDVK.5|IDHTGFSPHAAIYSTRPDVK.4|VNVPEESR.2|TLDNLGYR.2|ISKEQDHIIIIPR.3|WKVGEIEFEGLMR.3|WKVGEIEFEGLMR.2|VNIIGEVVDQGSTNLK.3|VNIIGEVVDQGSTNLK.2|QDFNMMEQR.2|C[CAM]VIHIHTLATAAVSSMK.3|EQDHIIIIPR.2|LEENHELFSK.2|VTQILQSPAFR.2|WLNSPNTYMK.2|INENDPEYIR.2|VNIIGEVVDQGSTNLKIDHTGFSPHAAIYSTRPDVK.6|AFTYTVAASGGGGVNMGSHQK.3|IEEVLSPEGSPSK.2|LVDLFGWAHLANTYISVR.3|RVTQILQSPAFREDLEC[CAM]LIQEQMK.4|RVTQILQSPAFREDLEC[CAM]LIQEQMK.3|VTQILQSPAFREDLEC[CAM]LIQEQMKK.4|SFISMEVPVMVVNGKDDMHDVEDELAK.4|VSGGTPIKIEDPNQFVPLNTNPNEVLEK.4|EDLEC[CAM]LIQEQMK.2|IEDPNQFVPLNTNPNEVLEK.3|IEDPNQFVPLNTNPNEVLEK.2|VSGGTPIKIEDPNQFVPLNTNPNEVLEKR.4|SFISMEVPVMVVNGK.2|LSTSTTIENIEITIK.2|SDVEIPATVTAFSFEDDTVPLSPLK.3|TAGPQSQLLAGIVVDKPPSTMQFEDDDHGPPAPPNPFSHLTEGELEEYKR.6
SEN / CTL,Isoamyl acetate-hydrolyzing esterase 1 homolog,IAH1,Q2TAA2,0.53,0.27,5.80E-04,4.74E-04,3.32E+00,lipid catabolic process,hydrolase activity,extracellular exosome,9,7,10,VSSLPLLLPYWR.2|DVAEAKPELSLLGDGDH.3|DVAEAKPELSLLGDGDH.2|GNEFLFSHLWPLIEK.3|GNEFLFSHLWPLIEK.2|QHIPLEEYAANLK.3|QHIPLEEYAANLK.2|GNSLDIPVAVTIFFGANDSALK.3|GNSLDIPVAVTIFFGANDSALKDENPK.3|VILITPTPLC[CAM]ETAWEEQC[CAM]IIQGC[CAM]K.3
SEN / CTL,UMP-CMP kinase,CMPK1,P30085,0.53,0.50,1.06E-06,1.76E-06,5.75E+00,"nucleoside diphosphate phosphorylation,'de novo' pyrimidine nucleobase biosynthetic process,UMP biosynthetic process,nucleoside triphosphate biosynthetic process,pyrimidine ribonucleotide biosynthetic process,nucleobase-containing small molecule interconversion,nucleoside monophosphate phosphorylation","cytidylate kinase activity,nucleoside diphosphate kinase activity,uridine kinase activity,ATP binding,uridylate kinase activity,nucleoside phosphate kinase activity","nucleus,cytoplasm,cytosol,extracellular exosome",30,19,38,FLIDGFPR.2|IVPVEITISLLKR.3|IVPVEITISLLKR.2|SVDEVFDEVVQIFDKEG.3|SVDEVFDEVVQIFDKEG.2|YGYTHLSAGELLRDER.3|YGYTHLSAGELLRDER.4|IVPVEITISLLK.2|MKPLVVFVLGGPGAGK.3|M[Oxi]KPLVVFVLGGPGAGK.3|MKPLVVFVLGGPGAGK.2|NKFLIDGFPR.3|PLVVFVLGGPGAGK.3|PLVVFVLGGPGAGK.2|YGYTHLSAGELLR.3|YGYTHLSAGELLR.2|REMDQTMAANAQK.3|REM[Oxi]DQTMAANAQK.3|REMDQTM[Oxi]AANAQK.3|REMDQTMAANAQK.2|YGYTHLSAGELLRDERK.4|KNPDSQYGELIEK.3|KNPDSQYGELIEK.2|SVDEVFDEVVQIFDK.3|SVDEVFDEVVQIFDK.2|NQDNLQGWNK.2|RIQTYLQSTKPIIDLYEEM[Oxi]GK.4|RIQTYLQSTKPIIDLYEEMGK.4|RIQTYLQSTKPIIDLYEEM[Oxi]GK.3|RIQTYLQSTKPIIDLYEEMGK.3|PIIDLYEEMGK.2|EMDQTMAANAQK.2|EM[Oxi]DQTMAANAQK.2|EMDQTM[Oxi]AANAQK.2|EM[Oxi]DQTM[Oxi]AANAQK.2|NPDSQYGELIEK.2|IQTYLQSTKPIIDLYEEMGK.3|IQTYLQSTKPIIDLYEEMGK.2
SEN / CTL,Calponin-2,CNN2,Q99439,0.52,0.47,1.92E-06,2.98E-06,5.53E+00,"cytoskeleton organization,actomyosin structure organization,regulation of actin filament-based process,cellular response to mechanical stimulus,cell-cell adhesion","actin binding,calmodulin binding,cadherin binding involved in cell-cell adhesion","stress fiber,cytoskeleton,cell-cell junction,cell-cell adherens junction,focal adhesion,membrane,extracellular exosome",24,17,33,TWIEGLTGLSIGPDFQK.2|TWIEGLTGLSIGPDFQK.3|GLKDGTILC[CAM]TLMNK.3|GLKDGTILC[CAM]TLMNK.2|AGQC[CAM]VIGLQMGTNK.2|AGQC[CAM]VIGLQM[Oxi]GTNK.2|TKGLQSGVDIGVK.3|TKGLQSGVDIGVK.2|LLSKYDPQKEAELR.4|SMQNWHQLENLSNFIK.3|SM[Oxi]QNWHQLENLSNFIK.3|SM[Oxi]QNWHQLENLSNFIK.2|SMQNWHQLENLSNFIK.2|GLQSGVDIGVK.2|C[CAM]ASQVGMTAPGTR.3|C[CAM]ASQVGMTAPGTR.2|C[CAM]ASQVGM[Oxi]TAPGTR.2|C[CAM]ASQSGMTAYGTR.3|C[CAM]ASQSGMTAYGTR.2|C[CAM]ASQSGM[Oxi]TAYGTR.2|NFDDATMK.2|C[CAM]ASQVGMTAPGTRR.3|GPSYGLSAEVK.2|NHILPPMDHSTISLQMGTNK.4|NHILPPM[Oxi]DHSTISLQMGTNK.4|NHILPPMDHSTISLQM[Oxi]GTNK.4|NHILPPMDHSTISLQMGTNK.3|NHILPPMDHSTISLQMGTNK.2|DGTILC[CAM]TLMNK.2|DGTILC[CAM]TLM[Oxi]NK.2|C[CAM]DNSSMSLQMGYTQGANQSGQVFGLGR.3|YC[CAM]PQGTVADGAPSGTGDC[CAM]PDPGEVPEYPPYYQEEAGY.4|LGTDKC[CAM]DNSSMSLQMGYTQGANQSGQVFGLGR.3
SEN / CTL,Guanine nucleotide-binding protein subunit alpha-13,GNA13,Q14344,0.52,0.26,4.18E-03,2.56E-03,2.59E+00,"patterning of blood vessels,in utero embryonic development,movement of cell or subcellular component,signal transduction,adenylate cyclase-activating G-protein coupled receptor signaling pathway,positive regulation of cytosolic calcium ion concentration,Rho protein signal transduction,regulation of cell shape,cell differentiation,platelet activation,regulation of cell migration,activation of phospholipase D activity","GTPase activity,signal transducer activity,protein binding,GTP binding,G-protein beta/gamma-subunit complex binding,type 1 angiotensin receptor binding,D5 dopamine receptor binding,metal ion binding","nucleus,cytoplasm,heterotrimeric G-protein complex,plasma membrane,focal adhesion,membrane,brush border membrane,melanosome,extracellular exosome",6,19,25,ILLLGAGESGK.2|VFLQYLPAIR.2|IIHGQDFDQR.3|IIHGQDFDQR.2|GIHEYDFEIKNVPFK.4|LHIPWGDNSNQQHGDK.4|LHIPWGDNSNQQHGDK.3|DVKDTILHDNLK.3|LVFRDVKDTILHDNLK.4|PLYHHFTTAINTENIR.4|PLYHHFTTAINTENIR.3|FLVEC[CAM]FR.2|DQQQKPLYHHFTTAINTENIR.5|DQQQKPLYHHFTTAINTENIR.4|DTILHDNLK.2|DYFLEFEGDPHC[CAM]LR.3|APMAAQGMVETR.2|GIHEYDFEIK.2|LGEPDYIPSQQDILLAR.3|LGEPDYIPSQQDILLAR.2|VQIVSIKDYFLEFEGDPHC[CAM]LR.4|VQIVSIKDYFLEFEGDPHC[CAM]LR.3|ALWADSGIQNAYDR.2|LTESLNIFETIVNNR.2|YFLDNLDKLGEPDYIPSQQDILLAR.3
SEN / CTL,Proteasome activator complex subunit 1,PSME1,Q06323,0.52,0.65,1.15E-06,1.89E-06,5.72E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,positive regulation of endopeptidase activity,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,regulation of proteasomal protein catabolic process,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,regulation of G1/S transition of mitotic cell cycle",endopeptidase activator activity,"proteasome complex,nucleoplasm,cytoplasm,cytosol,proteasome activator complex,extracellular exosome",42,26,39,IEDGNNFGVAVQEK.2|TENLLGSYFPK.2|IVVLLQR.2|QLVHELDEAEYRDIR.4|LKPEIKDVIEQLNLVTTWLQLQIPR.4|LKPEIKDVIEQLNLVTTWLQLQIPR.3|NAYAVLYDIILK.2|NAYAVLYDIILK.3|LMVMEIR.2|LM[Oxi]VMEIR.2|LMVM[Oxi]EIR.2|VDVFREDLC[CAM]TKTENLLGSYFPK.4|VDVFREDLC[CAM]TKTENLLGSYFPK.3|NAYAVLYDIILKNFEK.3|VFELMTSLHTK.3|VFELM[Oxi]TSLHTK.3|VFELMTSLHTK.2|VFELM[Oxi]TSLHTK.2|VDVFREDLC[CAM]TK.3|VDVFREDLC[CAM]TK.2|QLVHELDEAEYR.3|QLVHELDEAEYR.2|EPALNEANLSNLK.3|EPALNEANLSNLK.2|QPHVGDYR.2|APLDIPVPDPVKEK.3|ISELDAFLK.2|KGEDEDKGPPC[CAM]GPVNC[CAM]NEK.4|KGEDEDKGPPC[CAM]GPVNC[CAM]NEK.3|LEGFHTQISK.2|KISELDAFLK.2|APLDIPVPDPVK.2|KISELDAFLKEPALNEANLSNLK.4|KISELDAFLKEPALNEANLSNLK.3|YFSERGDAVTK.2|IEDGNNFGVAVQEKVFELMTSLHTKLEGFHTQISK.6|GEDEDKGPPC[CAM]GPVNC[CAM]NEK.3|GPPC[CAM]GPVNC[CAM]NEK.2|ISELDAFLKEPALNEANLSNLK.3
SEN / CTL,"Lon protease homolog, mitochondrial",LONP1,P36776,0.52,1.23,6.83E-03,3.92E-03,2.41E+00,"mitochondrial genome maintenance,response to hypoxia,misfolded or incompletely synthesized protein catabolic process,mitochondrion organization,aging,response to hormone,response to aluminum ion,mitochondrial DNA metabolic process,cellular response to oxidative stress,chaperone-mediated protein complex assembly,protein homooligomerization,proteolysis involved in cellular protein catabolic process,oxidation-dependent protein catabolic process,regulation of mitochondrial DNA replication","single-stranded DNA binding,single-stranded RNA binding,ATP-dependent peptidase activity,serine-type endopeptidase activity,protein binding,ATP binding,ADP binding,sequence-specific DNA binding,G-quadruplex DNA binding,DNA polymerase binding,mitochondrial light strand promoter anti-sense binding,mitochondrial heavy strand promoter anti-sense binding,mitochondrial light strand promoter sense binding,mitochondrial heavy strand promoter sense binding","nucleus,nucleoplasm,cytoplasm,mitochondrion,mitochondrial matrix,membrane,mitochondrial nucleoid",12,52,82,ILC[CAM]FYGPPGVGK.2|LSSDVLTLLIK.2|ILEFIAVSQLR.2|ILEFIAVSQLR.3|TIRDIIALNPLYR.3|TIRDIIALNPLYR.2|ALTAEIVK.2|ELGLEKDDKDAIEEK.4|ELGLEKDDKDAIEEK.3|ESVLQMMQAGQR.3|ESVLQMMQAGQR.2|ESVLQM[Oxi]M[Oxi]QAGQR.2|LAQPYVGVFLKR.3|TYVGAMPGK.2|TYVGAM[Oxi]PGK.2|RILEFIAVSQLR.3|RILEFIAVSQLR.2|ALC[CAM]GLDESK.2|AQAVLEEDHYGMEDVKK.4|AGVTC[CAM]IVLPAENKK.3|AGVTC[CAM]IVLPAENKK.2|EAEDELSAR.2|RAGVTC[CAM]IVLPAENK.3|TKTENPLILIDEVDKIGR.4|TKTENPLILIDEVDKIGR.3|TKTENPLILIDEVDKIGR.2|YLLQEQLK.2|AQAVLEEDHYGMEDVKKR.4|AQAVLEEDHYGMEDVKKR.3|NYLDWLTSIPWGK.3|NYLDWLTSIPWGK.2|AFLMQHAPANDYLVTSHIHLHVPEGATPK.6|AFLMQHAPANDYLVTSHIHLHVPEGATPK.5|AFLMQHAPANDYLVTSHIHLHVPEGATPK.4|AFLMQHAPANDYLVTSHIHLHVPEGATPK.3|DAKGDKDGSLEVTGQLGEVMK.4|QLEVEPEEPEAENKHKPR.4|QLEVEPEEPEAENK.3|QLEVEPEEPEAENK.2|RAGVTC[CAM]IVLPAENKK.3|LGLLDNHSSEFNVTR.3|LGLLDNHSSEFNVTR.2|TKTENPLILIDEVDK.3|TKTENPLILIDEVDK.2|KYLLQEQLK.2|VLFIC[CAM]TANVTDTIPEPLRDR.4|VLFIC[CAM]TANVTDTIPEPLRDR.3|DGPSAGC[CAM]TIVTALLSLAM[Oxi]GRPVR.4|DGPSAGC[CAM]TIVTALLSLAM[Oxi]GRPVR.3|DIIALNPLYR.2|YSNENLDLAR.2|AQAVLEEDHYGMEDVK.3|AQAVLEEDHYGM[Oxi]EDVK.3|AQAVLEEDHYGMEDVK.2|TENPLILIDEVDKIGR.3|GDKDGSLEVTGQLGEVMK.3|LAQPYVGVFLK.2|DFYDLAAFITEGLEVHFVEHYR.4|GKKEAEDELSAR.2|FSVGGMTDVAEIK.2|FSVGGM[Oxi]TDVAEIK.2|AGVTC[CAM]IVLPAENK.2|VLFIC[CAM]TANVTDTIPEPLR.3|VLFIC[CAM]TANVTDTIPEPLR.2|AKLSSDVLTLLIK.2|HVMDVVDEELSK.2|EIFDIAFPDEQAEALAVER.3|EIFDIAFPDEQAEALAVER.2|QNLAMTGEVSLTGK.2|QNLAM[Oxi]TGEVSLTGK.2|TENPLILIDEVDK.2|DGSLEVTGQLGEVMK.2|IVSGEAESVEVTPENLQDFVGK.3|IVSGEAESVEVTPENLQDFVGK.2|RDDSNESDVVESLDEIYHTGTFAQIHEMQDLGDK.5|RDDSNESDVVESLDEIYHTGTFAQIHEMQDLGDK.4|IVSGEAESVEVTPENLQDFVGKPVFTVER.4|IVSGEAESVEVTPENLQDFVGKPVFTVER.3|MEMINVSGYVAQEK.2|VVDNPIYLSDMGAALTGAESHELQDVLEETNIPK.4|VVDNPIYLSDM[Oxi]GAALTGAESHELQDVLEETNIPK.4|GYQGDPSSALLELLDPEQNANFLDHYLDVPVDLSK.4
SEN / CTL,Putative gamma-glutamyltranspeptidase 3;Gamma-glutamyltranspeptidase 1;Inactive gamma-glutamyltranspeptidase 2,GGT3P;GGT1;GGT2,A6NGU5;P19440;P36268,0.52,0.48,1.54E-03,1.11E-03,2.95E+00,"proteolysis,glutathione metabolic process,glutathione biosynthetic process,leukotriene biosynthetic process;regulation of immune system process,cellular amino acid metabolic process,glutamate metabolic process,leukotriene metabolic process,glutathione metabolic process,glutathione biosynthetic process,glutathione catabolic process,xenobiotic metabolic process,spermatogenesis,cysteine biosynthetic process,leukotriene biosynthetic process,zymogen activation,regulation of inflammatory response;glutathione metabolic process,glutathione biosynthetic process,xenobiotic metabolic process,leukotriene biosynthetic process,zymogen activation","gamma-glutamyltransferase activity,glutathione hydrolase activity;gamma-glutamyltransferase activity,protein binding,glutathione hydrolase activity;gamma-glutamyltransferase activity,glutathione hydrolase activity","integral component of membrane,anchored component of external side of plasma membrane,extracellular exosome;extracellular space,plasma membrane,integral component of membrane,anchored component of external side of plasma membrane,extracellular exosome;endoplasmic reticulum,plasma membrane,anchored component of external side of plasma membrane,perinuclear region of cytoplasm,extracellular exosome",9,3,3,LFQPSIQLAR.2|NIDQAVTAALETR.2|FVDVTEVVR.2
SEN / CTL,"Cytochrome c oxidase subunit 5A, mitochondrial",COX5A,P20674,0.52,0.42,1.79E-02,8.56E-03,2.07E+00,"mitochondrial electron transport, cytochrome c to oxygen,hydrogen ion transmembrane transport","cytochrome-c oxidase activity,electron carrier activity,metal ion binding","mitochondrial inner membrane,mitochondrial respiratory chain complex IV,myelin sheath,extracellular exosome",6,11,21,WVTYFNKPDIDAWELRK.4|WVTYFNKPDIDAWELRK.3|WVTYFNKPDIDAWELRK.2|GINTLVTYDMVPEPK.2|GINTLVTYDMVPEPK.3|GINTLVTYDM[Oxi]VPEPK.3|GINTLVTYDM[Oxi]VPEPK.2|LNDFASTVR.2|RLNDFASTVR.2|KGINTLVTYDMVPEPK.3|AGPHKEIYPYVIQELRPTLNELGISTPEELGLDKV.6|AGPHKEIYPYVIQELRPTLNELGISTPEELGLDKV.5|AGPHKEIYPYVIQELRPTLNELGISTPEELGLDKV.4|WVTYFNKPDIDAWELR.3|WVTYFNKPDIDAWELR.2|EIYPYVIQELRPTLNELGISTPEELGLDK.4|EIYPYVIQELRPTLNELGISTPEELGLDK.3|EIYPYVIQELRPTLNELGISTPEELGLDKV.4|EIYPYVIQELRPTLNELGISTPEELGLDKV.3|PTLNELGISTPEELGLDK.2|PTLNELGISTPEELGLDKV.2
SEN / CTL,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",SDHA,P31040,0.52,0.59,9.87E-02,3.54E-02,1.45E+00,"tricarboxylic acid cycle,succinate metabolic process,mitochondrial electron transport, succinate to ubiquinone,nervous system development,anaerobic respiration,respiratory electron transport chain,oxidation-reduction process","protein binding,succinate dehydrogenase (ubiquinone) activity,electron carrier activity,flavin adenine dinucleotide binding,succinate dehydrogenase activity","mitochondrion,mitochondrial inner membrane,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),myelin sheath",9,38,71,LGANSLLDLVVFGR.2|LGANSLLDLVVFGR.3|TYFSC[CAM]TSAHTSTGDGTAMITR.3|TYFSC[CAM]TSAHTSTGDGTAMITR.4|TYFSC[CAM]TSAHTSTGDGTAM[Oxi]ITR.3|TYFSC[CAM]TSAHTSTGDGTAMITR.2|GVIALC[CAM]IEDGSIHR.3|GVIALC[CAM]IEDGSIHR.2|AFGGQSLK.2|HTLSYVDVGTGK.3|HTLSYVDVGTGK.2|AKNTVVATGGYGR.3|AKNTVVATGGYGR.2|DHVYLQLHHLPPEQLATR.5|DHVYLQLHHLPPEQLATR.4|DHVYLQLHHLPPEQLATR.3|DHVYLQLHHLPPEQLATR.2|GEGGILINSQGER.3|GEGGILINSQGER.2|VTLEYRPVIDK.3|VTLEYRPVIDK.2|TGHSLLHTLYGR.3|TGHSLLHTLYGR.2|C[CAM]C[CAM]C[CAM]VADR.2|GC[CAM]GPEKDHVYLQLHHLPPEQLATR.6|GC[CAM]GPEKDHVYLQLHHLPPEQLATR.5|GC[CAM]GPEKDHVYLQLHHLPPEQLATR.4|KHTLSYVDVGTGK.3|VRIDEYDYSKPIQGQQK.4|VRIDEYDYSKPIQGQQK.3|TLNEADC[CAM]ATVPPAIR.3|TLNEADC[CAM]ATVPPAIR.2|NTVVATGGYGR.2|WHFYDTVK.2|TEDGKIYQR.2|AC[CAM]ALSIEESC[CAM]RPGDK.3|AC[CAM]ALSIEESC[CAM]RPGDK.2|VGSVLQEGC[CAM]GK.2|SMQNHAAVFR.2|SM[Oxi]QNHAAVFR.2|AAFGLSEAGFNTAC[CAM]VTK.3|AAFGLSEAGFNTAC[CAM]VTK.2|HVNGQDQIVPGLYAC[CAM]GEAAC[CAM]ASVHGANR.5|HVNGQDQIVPGLYAC[CAM]GEAAC[CAM]ASVHGANR.4|HVNGQDQIVPGLYAC[CAM]GEAAC[CAM]ASVHGANR.3|IDEYDYSKPIQGQQK.3|IDEYDYSKPIQGQQK.2|LPGISETAMIFAGVDVTK.3|LPGISETAMIFAGVDVTK.2|VPPIKPNAGEESVMNLDK.3|VPPIKPNAGEESVM[Oxi]NLDK.3|VRIDEYDYSK.2|AC[CAM]ALSIEESC[CAM]R.2|AC[CAM]ALSIEESC[CAM]RPGDKVPPIKPNAGEESVMNLDKLR.6|AC[CAM]ALSIEESC[CAM]RPGDKVPPIKPNAGEESVMNLDKLR.5|AC[CAM]ALSIEESC[CAM]RPGDKVPPIKPNAGEESVMNLDK.5|VSDSISAQYPVVDHEFDAVVVGAGGAGLR.4|VSDSISAQYPVVDHEFDAVVVGAGGAGLR.3|EPIPVLPTVHYNM[Oxi]GGIPTNYK.3|EPIPVLPTVHYNMGGIPTNYK.3|EPIPVLPTVHYNMGGIPTNYK.2|SHTVAAQGGINAALGNMEEDNWR.3|AGLPC[CAM]QDLEFVQFHPTGIYGAGC[CAM]LITEGC[CAM]R.4|AGLPC[CAM]QDLEFVQFHPTGIYGAGC[CAM]LITEGC[CAM]R.3|LPGISETAMIFAGVDVTKEPIPVLPTVHYNM[Oxi]GGIPTNYK.5|LPGISETAMIFAGVDVTKEPIPVLPTVHYNMGGIPTNYK.5|LPGISETAMIFAGVDVTKEPIPVLPTVHYNMGGIPTNYK.4|AGLPC[CAM]QDLEFVQFHPTGIYGAGC[CAM]LITEGC[CAM]RGEGGILINSQGER.5|AGLPC[CAM]QDLEFVQFHPTGIYGAGC[CAM]LITEGC[CAM]RGEGGILINSQGER.4|GSDWLGDQDAIHYMTEQAPAAVVELENYGMPFSR.4|VTLEYRPVIDKTLNEADC[CAM]ATVPPAIR.3
SEN / CTL,Cathepsin D,CTSD,P07339,0.51,0.81,9.27E-06,1.20E-05,4.92E+00,"proteolysis,autophagy,antigen processing and presentation of exogenous peptide antigen via MHC class II,protein catabolic process,collagen catabolic process","aspartic-type endopeptidase activity,cysteine-type endopeptidase activity,serine-type endopeptidase activity","extracellular region,extracellular space,lysosome,melanosome,lysosomal lumen,membrane raft,extracellular exosome,extracellular matrix",42,30,62,VSTLPAITLK.2|FDGILGMAYPR.2|FDGILGM[Oxi]AYPR.2|QVFGEATKQPGITFIAAK.3|QVFGEATKQPGITFIAAK.2|LLDIAC[CAM]WIHHK.3|LLDIAC[CAM]WIHHK.2|LSPEDYTLK.2|LVDQNIFSFYLSRDPDAQPGGELMLGGTDSK.4|LVDQNIFSFYLSRDPDAQPGGELM[Oxi]LGGTDSK.3|LVDQNIFSFYLSRDPDAQPGGELMLGGTDSK.3|AIGAVPLIQGEYMIPC[CAM]EK.3|AIGAVPLIQGEYMIPC[CAM]EK.2|AIGAVPLIQGEYM[Oxi]IPC[CAM]EK.3|AIGAVPLIQGEYM[Oxi]IPC[CAM]EK.2|TLC[CAM]LSGFM[Oxi]GM[Oxi]DIPPPSGPLWILGDVFIGR.3|ISVNNVLPVFDNLMQQK.3|ISVNNVLPVFDNLM[Oxi]QQK.3|ISVNNVLPVFDNLM[Oxi]QQK.2|ISVNNVLPVFDNLMQQK.2|GYKLSPEDYTLK.3|GYKLSPEDYTLK.2|DPDAQPGGELMLGGTDSK.2|DPDAQPGGELMLGGTDSK.3|DPDAQPGGELM[Oxi]LGGTDSK.2|TMSEVGGSVEDLIAK.2|TMSEVGGSVEDLIAK.3|TM[Oxi]SEVGGSVEDLIAK.2|VGFAEAAR.2|VGFAEAAR.1|LGGKGYKLSPEDYTLK.4|LGGKGYKLSPEDYTLK.3|YYTVFDR.2|YYTVFDRDNNR.3|YYTVFDRDNNR.2|GYKLSPEDYTLKVSQAGK.4|GYKLSPEDYTLKVSQAGK.3|QPGITFIAAK.2|LVDQNIFSFYLSR.3|LVDQNIFSFYLSR.2|LSPEDYTLKVSQAGK.3|LSPEDYTLKVSQAGK.2|YYTVFDRDNNRVGFAEAAR.4|YYTVFDRDNNRVGFAEAAR.3|AYWQVHLDQVEVASGLTLC[CAM]K.4|AYWQVHLDQVEVASGLTLC[CAM]K.3|AYWQVHLDQVEVASGLTLC[CAM]K.2|KAYWQVHLDQVEVASGLTLC[CAM]K.4|KAYWQVHLDQVEVASGLTLC[CAM]K.3|YSQAVPAVTEGPIPEVLK.3|YSQAVPAVTEGPIPEVLK.2|YNSDKSSTYVK.2|QPGITFIAAKFDGILGMAYPR.3|EGC[CAM]EAIVDTGTSLMVGPVDEVR.3|EGC[CAM]EAIVDTGTSLM[Oxi]VGPVDEVR.3|EGC[CAM]EAIVDTGTSLM[Oxi]VGPVDEVR.2|EGC[CAM]EAIVDTGTSLMVGPVDEVR.2|QVFGEATKQPGITFIAAKFDGILGMAYPR.4|QVFGEATKQPGITFIAAKFDGILGMAYPR.3|QVFGEATK.1|EGC[CAM]EAIVDTGTSLM[Oxi]VGPVDEVRELQK.3|EGC[CAM]EAIVDTGTSLMVGPVDEVRELQK.3
SEN / CTL,Peroxiredoxin-2,PRDX2,P32119,0.51,0.52,9.74E-10,2.98E-09,8.53E+00,"response to reactive oxygen species,response to oxidative stress,removal of superoxide radicals,cellular response to oxidative stress,hydrogen peroxide catabolic process,regulation of apoptotic process,negative regulation of apoptotic process,cell redox homeostasis,oxidation-reduction process","thioredoxin peroxidase activity,antioxidant activity","cytoplasm,cytosol,extracellular exosome",57,24,40,GLFIIDGK.2|LSEDYGVLKTDEGIAYR.3|KEGGLGPLNIPLLADVTR.3|KEGGLGPLNIPLLADVTR.2|ATAVVDGAFKEVK.3|ATAVVDGAFKEVK.2|GLFIIDGKGVLR.3|GLFIIDGKGVLR.2|KEGGLGPLNIPLLADVTRR.4|KEGGLGPLNIPLLADVTRR.3|RLSEDYGVLKTDEGIAYR.4|RLSEDYGVLKTDEGIAYR.3|RLSEDYGVLKTDEGIAYR.2|EGGLGPLNIPLLADVTR.2|EGGLGPLNIPLLADVTR.3|EGGLGPLNIPLLADVTRR.3|ATAVVDGAFK.2|ATAVVDGAFK.1|LVQAFQYTDEHGEVC[CAM]PAGWKPGSDTIKPNVDDSKEYFSK.6|LVQAFQYTDEHGEVC[CAM]PAGWKPGSDTIKPNVDDSKEYFSK.5|LVQAFQYTDEHGEVC[CAM]PAGWKPGSDTIKPNVDDSKEYFSK.4|LGC[CAM]EVLGVSVDSQFTHLAWINTPR.3|LGC[CAM]EVLGVSVDSQFTHLAWINTPR.4|IGKPAPDFKATAVVDGAFKEVK.5|TDEGIAYR.2|IGKPAPDFK.2|PGSDTIKPNVDDSK.3|PGSDTIKPNVDDSK.2|LSEDYGVLK.2|RLSEDYGVLK.2|GLFIIDGKGVLRQITVNDLPVGR.4|LVQAFQYTDEHGEVC[CAM]PAGWKPGSDTIKPNVDDSK.6|LVQAFQYTDEHGEVC[CAM]PAGWKPGSDTIKPNVDDSK.5|LVQAFQYTDEHGEVC[CAM]PAGWKPGSDTIKPNVDDSK.4|KLGC[CAM]EVLGVSVDSQFTHLAWINTPR.4|KLGC[CAM]EVLGVSVDSQFTHLAWINTPR.3|LGC[CAM]EVLGVSVDSQFTHLAWINTPRK.4|LGC[CAM]EVLGVSVDSQFTHLAWINTPRK.3|LVQAFQYTDEHGEVC[CAM]PAGWKPGSDTIK.4|LVQAFQYTDEHGEVC[CAM]PAGWK.3
SEN / CTL,"V-type proton ATPase subunit B, brain isoform",ATP6V1B2,P21281,0.51,0.47,1.87E-05,2.22E-05,4.65E+00,"insulin receptor signaling pathway,ATP hydrolysis coupled proton transport,proton transport,regulation of macroautophagy,transferrin transport,ion transmembrane transport,ATP metabolic process,phagosome acidification","ATP binding,hydrogen ion transmembrane transporter activity,proton-transporting ATPase activity, rotational mechanism","ruffle,lysosomal membrane,cytosol,plasma membrane,microvillus,endomembrane system,integral component of membrane,proton-transporting V-type ATPase, V1 domain,melanosome,myelin sheath,intracellular membrane-bounded organelle,extracellular exosome",24,28,43,IYPEEMIQTGISAIDGMNSIAR.3|TVFETLDIGWQLLR.2|TVFETLDIGWQLLR.3|AVVQVFEGTSGIDAK.2|AVVQVFEGTSGIDAK.3|GQKIPIFSAAGLPHNEIAAQIC[CAM]R.4|GQKIPIFSAAGLPHNEIAAQIC[CAM]R.3|YAEIVHLTLPDGTKR.4|YAEIVHLTLPDGTKR.3|LALTTAEFLAYQC[CAM]EK.3|LALTTAEFLAYQC[CAM]EK.2|AVVGEEALTSDDLLYLEFLQKFER.3|RSGQVLEVSGSK.3|RSGQVLEVSGSK.2|EQALAVSR.2|NYLSQPR.2|KTSC[CAM]EFTGDILR.3|KTSC[CAM]EFTGDILR.2|KDHADVSNQLYAC[CAM]YAIGK.4|KDHADVSNQLYAC[CAM]YAIGK.3|TVSGVNGPLVILDHVKFPR.4|YAEIVHLTLPDGTK.3|YAEIVHLTLPDGTK.2|RIPQSTLSEFYPR.3|RIPQSTLSEFYPR.2|SGQVLEVSGSK.2|AVVQVFEGTSGIDAKK.3|TVSGVNGPLVILDHVK.3|TVSGVNGPLVILDHVK.2|GPVVLAEDFLDIMGQPINPQC[CAM]R.4|GPVVLAEDFLDIMGQPINPQC[CAM]R.3|DHADVSNQLYAC[CAM]YAIGK.3|DHADVSNQLYAC[CAM]YAIGK.2|TSC[CAM]EFTGDILR.2|NFIAQGPYENR.2|GIVNGAAPELPVPTGGPAVGAR.3|GIVNGAAPELPVPTGGPAVGAR.2|IPQSTLSEFYPR.2|AVVGEEALTSDDLLYLEFLQK.3|AVVGEEALTSDDLLYLEFLQK.2|VFNGSGKPIDRGPVVLAEDFLDIMGQPINPQC[CAM]R.4|NFIAQGPYENRTVFETLDIGWQLLR.3|NGSITQIPILTMPNDDITHPIPDLTGYITEGQIYVDR.4
SEN / CTL,Septin-8,8-Sep,Q92599,0.51,0.58,1.34E-01,4.48E-02,1.35E+00,,"protein binding,GTP binding","cytoplasm,cytoskeleton,myelin sheath",9,17,23,VNIIPIIAK.2|LRPQTYDLQESNVQLK.3|LRPQTYDLQESNVQLK.2|AAVEALQSQALHATSQQPLRK.4|AAVEALQSQALHATSQQPLRK.3|EFLSELQR.2|FSNAEPEPR.2|RRELEEETNAFNR.3|SLFDYHDTR.2|KAAVEALQSQALHATSQQPLRK.4|IHVC[CAM]LYFITPTGHSLK.3|ELEEETNAFNR.2|VKETELELKEK.2|SLSLGGHVGFDSLPDQLVSK.3|SLSLGGHVGFDSLPDQLVSK.2|SVTQGFSFNILC[CAM]VGETGIGK.3|SVTQGFSFNILC[CAM]VGETGIGK.2|AAVEALQSQALHATSQQPLR.3|STLM[Oxi]NTLFNTTFETEEASHHEAC[CAM]VR.4|STLMNTLFNTTFETEEASHHEAC[CAM]VR.4|STLMNTLFNTTFETEEASHHEAC[CAM]VR.3|LTIVDAVGFGDQINK.2|DESYRPIVDYIDAQFENYLQEELK.3
SEN / CTL,Ragulator complex protein LAMTOR2,LAMTOR2,Q9Y2Q5,0.51,0.17,5.11E-02,2.04E-02,1.69E+00,"MAPK cascade,activation of MAPKK activity,cell cycle arrest,cell growth,macroautophagy,positive regulation of TOR signaling,cellular protein localization,positive regulation of GTPase activity,cellular response to amino acid stimulus","protein binding,guanyl-nucleotide exchange factor activity,protein complex scaffold","lysosomal membrane,late endosome,endosome membrane,extracellular exosome,Ragulator complex",3,9,12,FILMDC[CAM]MEGR.2|ETVGFGMLK.2|VTAAIASNIWAAYDR.3|VTAAIASNIWAAYDR.2|AQALVQYLEEPLTQVAAS.3|AQALVQYLEEPLTQVAAS.2|VANLLLC[CAM]MYAK.2|VANLLLC[CAM]M[Oxi]YAK.2|NGNQAFNEDNLK.2|ALTQVLSQANTGGVQSTLLLNNEGSLLAYSGYGDTDAR.4|VTAAIASNIWAAYDRNGNQAFNEDNLK.3|AKAQALVQYLEEPLTQVAAS.2
SEN / CTL,"Asparagine--tRNA ligase, cytoplasmic",NARS,O43776,0.51,0.79,1.70E-03,1.20E-03,2.92E+00,"tRNA aminoacylation for protein translation,asparaginyl-tRNA aminoacylation","nucleic acid binding,asparagine-tRNA ligase activity,ATP binding","cytoplasm,mitochondrion,cytosol,extracellular exosome",21,33,60,FLTWILNR.2|IFDSEEILAGYKR.3|IFDSEEILAGYKR.2|NLMFLVLR.2|NLM[Oxi]FLVLR.2|LMTDTINEPILLC[CAM]R.2|LMTDTINEPILLC[CAM]R.3|LM[Oxi]TDTINEPILLC[CAM]R.3|LM[Oxi]TDTINEPILLC[CAM]R.2|ALMTVGKEPFPTIYVDSQKENER.4|ALM[Oxi]TVGKEPFPTIYVDSQKENER.4|ALMTVGKEPFPTIYVDSQKENER.3|C[CAM]FRDHFFDR.3|IGALEGYR.2|VFGWVHR.2|DVC[CAM]LYPR.2|IFDSEEILAGYK.3|IFDSEEILAGYK.2|EPFPTIYVDSQK.3|EPFPTIYVDSQK.2|ITIKNDPSLPEPK.3|SPAGSIVHELNPNFQPPK.4|SPAGSIVHELNPNFQPPK.3|SPAGSIVHELNPNFQPPK.2|NDPSLPEPK.2|RMNYSDAIVWLK.3|RMNYSDAIVWLK.2|KITIKNDPSLPEPK.3|YGTC[CAM]PHGGYGLGLER.3|YGTC[CAM]PHGGYGLGLER.2|KEDGTFYEFGEDIPEAPER.4|KEDGTFYEFGEDIPEAPER.3|KEDGTFYEFGEDIPEAPER.2|EHDVKKEDGTFYEFGEDIPEAPER.5|EHDVKKEDGTFYEFGEDIPEAPER.4|EHDVKKEDGTFYEFGEDIPEAPER.3|VLAELYVSDR.2|KYGTC[CAM]PHGGYGLGLER.3|EGIDPTPYYWYTDQR.3|EGIDPTPYYWYTDQR.2|EPFPTIYVDSQKENER.3|EPFPTIYVDSQKENER.2|LEDLVC[CAM]DVVDR.2|EGIDPTPYYWYTDQRK.3|MNYSDAIVWLK.2|M[Oxi]NYSDAIVWLK.2|EDGTFYEFGEDIPEAPER.3|EDGTFYEFGEDIPEAPER.2|HLAEYTHVEAEC[CAM]PFLTFDDLLNR.4|HLAEYTHVEAEC[CAM]PFLTFDDLLNR.3|ALMTVGKEPFPTIYVDSQK.3|ALMTVGKEPFPTIYVDSQK.2|LTESVDVLMPNVGEIVGGSMR.3|LTESVDVLM[Oxi]PNVGEIVGGSMR.3|LTESVDVLMPNVGEIVGGSM[Oxi]R.3|LTESVDVLMPNVGEIVGGSMR.2|VLAELYVSDREGSDATGDGTK.3|VLAELYVSDREGSDATGDGTK.2|GYYEVTPPTLVQTQVEGGATLFK.3|C[CAM]PEDSRLTESVDVLMPNVGEIVGGSMR.3
SEN / CTL,"Diablo homolog, mitochondrial",DIABLO,Q9NR28,0.51,0.98,8.78E-02,3.22E-02,1.49E+00,"apoptotic process,activation of cysteine-type endopeptidase activity involved in apoptotic process,extrinsic apoptotic signaling pathway via death domain receptors,intrinsic apoptotic signaling pathway in response to oxidative stress,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,positive regulation of apoptotic process,neuron apoptotic process,intrinsic apoptotic signaling pathway",protein binding,"mitochondrion,mitochondrial intermembrane space,cytosol,cytoplasmic side of plasma membrane,CD40 receptor complex",12,12,19,AVYTLTSLYR.2|LQVEEVHQLSR.3|LQVEEVHQLSR.2|TQEEGEER.2|MNSEEEDEVWQVIIGAR.3|MNSEEEDEVWQVIIGAR.2|NHIQLVK.2|LAEAQIEELRQK.3|LAEAQIEELRQK.2|SEPHSLSSEALMR.3|SEPHSLSSEALM[Oxi]R.3|SEPHSLSSEALMR.2|SEPHSLSSEALM[Oxi]R.2|LAEAQIEELR.2|AESEQEAYLR.2|AESEQEAYLRED.2|TQEEGEERAESEQEAYLRED.3|LETTWMTAVGLSEMAAEAAYQTGADQASITAR.4|LETTWMTAVGLSEMAAEAAYQTGADQASITAR.3
SEN / CTL,40S ribosomal protein S23,RPS23,P62266,0.51,0.35,1.24E-01,4.22E-02,1.38E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","structural constituent of ribosome,protein binding,poly(A) RNA binding","nucleoplasm,nucleolus,cytoplasm,cytosol,ribosome,membrane,cytosolic small ribosomal subunit",3,11,14,VANVSLLALYK.2|AHLGTALK.2|KGHAVGDIPGVR.3|KGHAVGDIPGVR.2|AHLGTALKANPFGGASHAK.4|KAHLGTALK.2|ANPFGGASHAK.2|GHAVGDIPGVR.2|ITAFVPNDGC[CAM]LNFIEENDEVLVAGFGRK.4|ITAFVPNDGC[CAM]LNFIEENDEVLVAGFGRK.3|KITAFVPNDGC[CAM]LNFIEENDEVLVAGFGR.4|KITAFVPNDGC[CAM]LNFIEENDEVLVAGFGR.3|KITAFVPNDGC[CAM]LNFIEENDEVLVAGFGRK.4|ITAFVPNDGC[CAM]LNFIEENDEVLVAGFGR.3
SEN / CTL,Putative phospholipase B-like 2,PLBD2,Q8NHP8,0.51,1.72,5.02E-02,2.01E-02,1.70E+00,lipid catabolic process,hydrolase activity,"lysosomal lumen,extracellular exosome",15,15,20,YNDFLHDPLSLC[CAM]K.3|YNDFLHDPLSLC[CAM]K.2|LASDGATWADIFKR.3|LTLLQLK.2|GLEDSYEGR.2|GC[CAM]VLEWVR.2|IKPSLGSGSC[CAM]SALIK.3|AC[CAM]NPQPNGENAISAR.3|AC[CAM]NPQPNGENAISAR.2|AFIPGGPSPGSR.2|VLTILEQIPGMVVVADK.3|VLTILEQIPGMVVVADK.2|VLTILEQIPGMVVVADKTSELYQK.4|VLTILEQIPGMVVVADKTSELYQK.3|LLPGQSDLLVAHNTWNNYQHMLR.4|LLPGQSDLLVAHNTWNNYQHMLR.3|LASDGATWADIFK.2|RFNSGTYNNQWMIVDYK.3|EGPWGDYPLVPGNK.2|FNSGTYNNQWMIVDYK.2
SEN / CTL,26S proteasome non-ATPase regulatory subunit 12,PSMD12,O00232,0.50,0.73,2.49E-03,1.65E-03,2.78E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway",,"proteasome complex,nucleoplasm,cytoplasm,cytosol,proteasome regulatory particle,proteasome regulatory particle, lid subcomplex,membrane,proteasome accessory complex,nuclear proteasome complex,extracellular exosome",15,37,54,IYVEIER.2|LFTTMELMR.2|LQEVIETLLSLEK.2|LQEVIETLLSLEK.3|ERVEFILEQMR.3|ERVEFILEQMR.2|LAGIINFQRPK.3|LAGIINFQRPK.2|KLEEIPK.2|FFQEENTEKLK.3|TLATIKEQNGDVK.3|TLATIKEQNGDVK.2|DPNNLLNDWSQK.3|DPNNLLNDWSQK.2|EEMIHNLQ.2|LAGIINFQR.2|TASDMVSTSR.2|TASDM[Oxi]VSTSR.2|KGSLESPATDVFGSTEEGEKR.4|KGSLESPATDVFGSTEEGEKR.3|LNSLMSLVNK.2|LNSLM[Oxi]SLVNK.2|WSTLVEDYGMELRK.3|WSTLVEDYGMELRK.2|FFQEENTEK.2|VEFILEQMR.2|TTHLIAKEEMIHNLQ.3|TTHLIAKEEMIHNLQ.2|SVVLYVILAPFDNEQSDLVHR.4|SVVLYVILAPFDNEQSDLVHR.3|EGRLQEVIETLLSLEK.3|LAGIINFQRPKDPNNLLNDWSQK.4|LAGIINFQRPKDPNNLLNDWSQK.3|KGSLESPATDVFGSTEEGEK.3|GSLESPATDVFGSTEEGEKR.3|EAASILQELQVETYGSMEK.3|EAASILQELQVETYGSMEK.2|M[Oxi]EVDYSATVDQR.2|MEVDYSATVDQR.2|MVQQC[CAM]C[CAM]TYVEEITDLPIK.3|MVQQC[CAM]C[CAM]TYVEEITDLPIK.2|EAASILQELQVETYGSMEKK.3|AIYDTPC[CAM]IQAESEKWQQALK.3|WSTLVEDYGMELR.2|WSTLVEDYGM[Oxi]ELR.2|AIYDTPC[CAM]IQAESEK.2|MVQQC[CAM]C[CAM]TYVEEITDLPIKLR.3|YYNLMIQLDQHEGSYLSIC[CAM]K.3|MAQLLDLSVDESEAFLSNLVVNK.3|PKDPNNLLNDWSQK.2|EWDLLNENIMLLSK.2|RMAQLLDLSVDESEAFLSNLVVNK.3|RM[Oxi]AQLLDLSVDESEAFLSNLVVNK.3|GSLESPATDVFGSTEEGEK.2
SEN / CTL,40S ribosomal protein S2,RPS2,P15880,0.50,0.37,3.19E-02,1.39E-02,1.86E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,positive regulation of transferase activity,cell-cell adhesion","mRNA binding,structural constituent of ribosome,protein binding,fibroblast growth factor binding,enzyme binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","nucleus,nucleoplasm,cytoplasm,cytosol,cell-cell adherens junction,focal adhesion,membrane,cytosolic small ribosomal subunit,extracellular exosome,nucleolus",6,20,34,TYSYLTPDLWK.2|KLLMMAGIDDC[CAM]YTSAR.3|KLLMM[Oxi]AGIDDC[CAM]YTSAR.3|KLLM[Oxi]M[Oxi]AGIDDC[CAM]YTSAR.3|KLLMMAGIDDC[CAM]YTSAR.2|ATFDAISK.2|AFVAIGDYNGHVGLGVK.4|AFVAIGDYNGHVGLGVK.3|AFVAIGDYNGHVGLGVK.2|TQAPAVATT.2|AEDKEWM[Oxi]PVTK.3|AEDKEWMPVTK.3|AEDKEWMPVTK.2|LSIVPVRR.2|SPYQEFTDHLVK.3|SPYQEFTDHLVK.2|FKAFVAIGDYNGHVGLGVK.4|GTGIVSAPVPK.2|ESEIIDFFLGASLK.3|ESEIIDFFLGASLK.2|SLEEIYLFSLPIK.3|SLEEIYLFSLPIK.2|ETVFTKSPYQEFTDHLVK.4|GC[CAM]TATLGNFAK.2|IGKPHTVPC[CAM]K.2|LLMMAGIDDC[CAM]YTSAR.3|LLMMAGIDDC[CAM]YTSAR.2|LLM[Oxi]M[Oxi]AGIDDC[CAM]YTSAR.2|LLM[Oxi]MAGIDDC[CAM]YTSAR.2|IKSLEEIYLFSLPIK.3|TYSYLTPDLWKETVFTK.3|ESEIIDFFLGASLKDEVLK.3|ESEIIDFFLGASLKDEVLK.2|ATFDAISKTYSYLTPDLWKETVFTK.4
SEN / CTL,Programmed cell death protein 10,PDCD10,Q9BUL8,0.50,0.15,6.56E-04,5.30E-04,3.28E+00,"angiogenesis,positive regulation of cell proliferation,positive regulation of gene expression,negative regulation of gene expression,positive regulation of cell migration,positive regulation of stress-activated MAPK cascade,positive regulation of peptidyl-serine phosphorylation,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,response to hydrogen peroxide,negative regulation of apoptotic process,positive regulation of MAP kinase activity,wound healing, spreading of cells,positive regulation of Notch signaling pathway,protein stabilization,establishment of Golgi localization,positive regulation of protein serine/threonine kinase activity,negative regulation of cell migration involved in sprouting angiogenesis,Golgi reassembly,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,regulation of Rho protein signal transduction,stress fiber assembly","protein binding,protein kinase binding,protein homodimerization activity,protein N-terminus binding","Golgi membrane,cytoplasm,Golgi apparatus,cytosol,plasma membrane,extracellular exosome",6,12,17,VNLSAAQTLR.2|SVEVNFTESLLR.2|ELLDTVNNVFKK.3|ELLDTVNNVFKK.2|IPDEINDR.2|LIHQTNLILQTFK.3|LIHQTNLILQTFK.2|AINVFVSANR.2|AEKENPGLTQDIIMK.3|AEKENPGLTQDIIM[Oxi]K.3|ELLDTVNNVFK.2|ENPGLTQDIIMK.2|ENPGLTQDIIM[Oxi]K.2|KSVEVNFTESLLR.2|MAADDVEEYMIERPEPEFQDLNEK.3|M[Oxi]AADDVEEYMIERPEPEFQDLNEK.3|NEAETTSMVSMPLYAVMYPVFNELER.3
SEN / CTL,Myosin-10,MYH10,P35580,0.50,0.76,2.81E-06,4.20E-06,5.38E+00,"mitotic cytokinesis,in utero embryonic development,neuron migration,plasma membrane repair,cardiac septum development,exocytosis,substrate-dependent cell migration, cell extension,nuclear migration,cell adhesion,axon guidance,adult heart development,cell proliferation,regulation of cell shape,fourth ventricle development,lateral ventricle development,third ventricle development,cerebellar Purkinje cell layer development,actin filament-based movement,actomyosin structure organization,aorta development,neuromuscular process controlling balance,cardiac myofibril assembly,ventricular cardiac muscle cell development,retina development in camera-type eye,coronary vasculature development","microfilament motor activity,actin binding,protein binding,calmodulin binding,ATP binding,actin-dependent ATPase activity,ADP binding,actin filament binding","stress fiber,nucleus,cytoplasm,mitochondrion,spindle,cytosol,plasma membrane,brush border,cell cortex,actin cytoskeleton,myosin complex,myosin II complex,lamellipodium,axon,growth cone,midbody,neuromuscular junction,cleavage furrow,actomyosin,neuronal cell body,dendritic spine,extracellular exosome,myosin II filament",60,183,307,AGKLDPHLVLDQLR.3|AGKLDPHLVLDQLR.2|LDPHLVLDQLR.2|LDPHLVLDQLR.3|AGVLAHLEEER.3|AGVLAHLEEER.2|QLKDKADFC[CAM]IIHYAGK.4|QLKDKADFC[CAM]IIHYAGK.2|SLEAEILQLQEELASSER.3|SLEAEILQLQEELASSER.2|AGVLAHLEEERDLK.3|AGVLAHLEEERDLK.2|ADFC[CAM]IIHYAGK.3|ADFC[CAM]IIHYAGK.2|VDYKADEWLMK.3|VDYKADEWLMK.2|VDYKADEWLM[Oxi]K.2|ALEEALEAKEEFER.3|ALEEALEAKEEFER.2|IGQLEEQLEQEAKER.3|IGQLEEQLEQEAKER.2|ELDDATEANEGLSR.2|ELDDATEANEGLSR.3|ELEAELEDER.2|ELEAELEDERKQR.3|ELEAELEDERKQR.4|LQQELDDLTVDLDHQR.3|LQQELDDLTVDLDHQR.2|DLSEELEALKTELEDTLDTTAAQQELR.4|DLSEELEALKTELEDTLDTTAAQQELR.3|HATALEELSEQLEQAKR.4|HATALEELSEQLEQAKR.3|KEEELQGALAR.3|KEEELQGALAR.2|LLKDAEALSQR.3|LLKDAEALSQR.2|NHEAQIQDMR.3|NHEAQIQDM[Oxi]R.3|NHEAQIQDMR.2|NHEAQIQDM[Oxi]R.2|REQEVAELKK.3|ASRDEIFAQSK.3|ASRDEIFAQSK.2|LDAQVQELHAK.3|LDAQVQELHAK.2|LKEIFMQVEDERR.4|ASRDEIFAQSKESEK.4|KDHNIPGELER.3|KFDQLLAEEKSISAR.4|KQELEEILHDLESR.4|KQELEEILHDLESR.3|KQELEEILHDLESR.2|LLKDAEALSQRLEEK.4|LLKDAEALSQRLEEK.3|RAGKLDPHLVLDQLR.4|KMEIDLK.2|ADEWLMK.2|ADEWLM[Oxi]K.2|ADFC[CAM]IIHYAGKVDYK.4|ADFC[CAM]IIHYAGKVDYK.3|ADFC[CAM]IIHYAGKVDYK.2|DAEALSQR.2|LRLEVNMQAMK.3|QVASNLEK.2|VEGELEEMERK.3|ATISALEAK.2|ELEAELEDERK.3|ELEAELEDERK.2|TVGQLYKESLTK.3|DAEALSQRLEEK.3|DAEALSQRLEEK.2|HGFEAASIKEER.3|HGFEAASIKEER.2|KLDAQVQELHAK.3|KLDAQVQELHAK.2|QQQLSALK.2|RALEQQVEEMR.3|RALEQQVEEM[Oxi]R.3|RALEQQVEEMR.2|TGLEDPER.2|VEEEEER.2|DEIFAQSK.2|HADQYKEQMEK.3|HADQYKEQM[Oxi]EK.3|SALLDEKR.2|EQEVAELK.2|KKVDDDLGTIESLEEAK.4|KKVDDDLGTIESLEEAK.3|KKVDDDLGTIESLEEAK.2|DELADEITNSASGK.3|DELADEITNSASGK.2|EERGDEVMVELAENGKK.4|HEM[Oxi]PPHIYAISESAYR.4|HEM[Oxi]PPHIYAISESAYR.3|HEMPPHIYAISESAYR.3|HGFEAASIK.2|NTNPNFVR.2|SDLLLEGFNNYR.3|SDLLLEGFNNYR.2|RQLEEAEEEATR.3|RQLEEAEEEATR.2|VIQYLAHVASSHK.3|VIQYLAHVASSHK.2|LQELEGAVK.2|NKQGLETDNKELAC[CAM]EVK.4|NKQGLETDNKELAC[CAM]EVK.3|NKQGLETDNKELAC[CAM]EVK.2|NQILQNEK.2|TFHIFYQLLSGAGEHLK.4|TFHIFYQLLSGAGEHLK.3|DLQTRDEQNEEK.3|GGPISFSSSR.2|KKLDAQVQELHAK.3|LVWIPSER.2|ALEEALEAKEEFERQNK.4|ALEEALEAKEEFERQNK.3|GDEVMVELAENGKK.3|GDEVMVELAENGKK.2|IGQLEEQLEQEAK.3|IGQLEEQLEQEAK.2|VVSSVLQFGNISFK.3|VVSSVLQFGNISFK.2|ALEEETKNHEAQIQDM[Oxi]R.4|ALEEETKNHEAQIQDMR.4|ALEEETKNHEAQIQDMR.3|ALEEETKNHEAQIQDMR.2|DKADFC[CAM]IIHYAGK.3|DKADFC[CAM]IIHYAGK.2|DKADFC[CAM]IIHYAGKVDYK.4|HQQLLEEK.2|KMEIDLKDLEAQIEAANK.4|LKEIFMQVEDER.3|QRYEILTPNAIPK.3|QVLALQSQLADTKK.3|RHEMPPHIYAISESAYR.4|ATDKTFVEK.2|KQQQLSALK.2|YAEERDRAEAEAR.3|YAEERDRAEAEAR.2|ALAYDKLEK.2|KVIQYLAHVASSHK.3|LEVNMQAMK.2|LEVNMQAM[Oxi]K.2|NKQEVMISDLEER.3|NKQEVM[Oxi]ISDLEER.3|NKQEVMISDLEER.2|EQEVAELKK.2|NTDQASMPENTVAQK.3|NTDQASMPENTVAQK.2|NTDQASM[Oxi]PENTVAQK.2|ADMEDLM[Oxi]SSKDDVGK.3|ADMEDLMSSKDDVGK.3|ADMEDLMSSKDDVGK.2|AVIYNPATQADWTAK.3|AVIYNPATQADWTAK.2|HAEQERDELADEITNSASGK.4|HAEQERDELADEITNSASGK.3|HAEQERDELADEITNSASGK.2|NRLQQELDDLTVDLDHQR.4|VVSSVLQFGNISFKK.3|VVSSVLQFGNISFKK.2|EEELQGALAR.2|LVQEQGSHSK.2|QRHATALEELSEQLEQAKR.4|ADMEDLMSSK.2|ADMEDLM[Oxi]SSK.2|ADM[Oxi]EDLM[Oxi]SSK.2|KLVWIPSER.2|MEEEILLLEDQNSK.3|MEEEILLLEDQNSK.2|M[Oxi]EEEILLLEDQNSK.2|DLSEELEALK.2|LC[CAM]HLLGMNVMEFTR.3|LC[CAM]HLLGM[Oxi]NVMEFTR.3|LC[CAM]HLLGMNVM[Oxi]EFTR.3|LC[CAM]HLLGMNVMEFTR.2|QEEELQAKDEELLK.3|QEEELQAKDEELLK.2|TGLEDPERYLFVDR.3|VEDMAELTC[CAM]LNEASVLHNLK.4|VEDMAELTC[CAM]LNEASVLHNLK.3|VEDM[Oxi]AELTC[CAM]LNEASVLHNLK.3|VEDMAELTC[CAM]LNEASVLHNLK.2|AMVNKDDIQK.2|QGLETDNKELAC[CAM]EVK.3|QGLETDNKELAC[CAM]EVK.2|QLLQANPILESFGNAK.3|QLLQANPILESFGNAK.2|RGGPISFSSSR.2|KVDDDLGTIESLEEAK.3|KVDDDLGTIESLEEAK.2|NLPIYSENIIEMYR.3|NLPIYSENIIEM[Oxi]YR.3|NLPIYSENIIEMYR.2|NLPIYSENIIEM[Oxi]YR.2|NSLQEQQEEEEEARKNLEK.4|TTLQVDTLNAELAAER.3|TTLQVDTLNAELAAER.2|AKLQELEGAVK.2|ASKLQNELDNVSTLLEEAEKK.4|AVIYNPATQADWTAKK.3|DHNIPGELER.2|FKATISALEAK.2|KMQAHIQDLEEQLDEEEGAR.4|KMQAHIQDLEEQLDEEEGAR.3|LQNELDNVSTLLEEAEKKGIK.4|RHAEQERDELADEITNSASGK.4|RHAEQERDELADEITNSASGK.3|HATALEELSEQLEQAK.3|HATALEELSEQLEQAK.2|DLEAQIEAANK.2|IAEC[CAM]SSQLAEEEEKAK.3|IAEC[CAM]SSQLAEEEEKAK.2|KMEEEILLLEDQNSK.3|KM[Oxi]EEEILLLEDQNSK.3|KMEEEILLLEDQNSK.2|QLEEAEEEATRANASR.3|NSLQEQQEEEEEARK.3|TKNRLQQELDDLTVDLDHQR.4|VEGELEEMER.2|VEGELEEM[Oxi]ER.2|ALEQQVEEMR.2|ALEQQVEEM[Oxi]R.2|IRNKQEVMISDLEER.3|KTTLQVDTLNAELAAER.3|KTTLQVDTLNAELAAER.2|KVDDDLGTIESLEEAKK.3|VEEEEERNQILQNEK.3|YEILTPNAIPK.2|IAQLEEELEEEQSNMELLNDR.4|IAQLEEELEEEQSNMELLNDR.3|IAQLEEELEEEQSNM[Oxi]ELLNDR.3|VEDMAELTC[CAM]LNEASVLHNLKDR.4|VEDM[Oxi]AELTC[CAM]LNEASVLHNLKDR.4|VEDMAELTC[CAM]LNEASVLHNLKDR.3|AGKLDPHLVLDQLRC[CAM]NGVLEGIR.4|AGKLDPHLVLDQLRC[CAM]NGVLEGIR.3|ERNTDQASMPENTVAQK.3|MEIDLKDLEAQIEAANK.3|M[Oxi]EIDLKDLEAQIEAANK.3|TELEDTLDTTAAQQELR.3|TELEDTLDTTAAQQELR.2|EIFMQVEDER.2|LQNELDNVSTLLEEAEK.3|LQNELDNVSTLLEEAEK.2|QLEEAEEEATR.2|QLEEEKNSLQEQQEEEEEARK.4|RQLEEAEEEATRANASR.3|DAASLESQLQDTQELLQEETRQK.4|DAASLESQLQDTQELLQEETRQK.3|ELQAQIAELQEDFESEK.3|ELQAQIAELQEDFESEK.2|FSKVEDM[Oxi]AELTC[CAM]LNEASVLHNLK.4|FSKVEDMAELTC[CAM]LNEASVLHNLK.4|FSKVEDMAELTC[CAM]LNEASVLHNLK.3|VVRELQAQIAELQEDFESEKASR.4|VVRELQAQIAELQEDFESEKASR.3|QEVMISDLEER.2|QEVM[Oxi]ISDLEER.2|KLDGETTDLQDQIAELQAQIDELK.4|KLDGETTDLQDQIAELQAQIDELK.3|GDEVMVELAENGK.2|LQNELDNVSTLLEEAEKK.3|LQNELDNVSTLLEEAEKK.2|QLHLEGASLELSDDDTESK.3|IVGLDQVTGM[Oxi]TETAFGSAYK.3|IVGLDQVTGMTETAFGSAYK.3|IVGLDQVTGMTETAFGSAYK.2|IVGLDQVTGM[Oxi]TETAFGSAYK.2|NMDPLNDNVATLLHQSSDR.3|NM[Oxi]DPLNDNVATLLHQSSDR.3|NM[Oxi]DPLNDNVATLLHQSSDR.2|NMDPLNDNVATLLHQSSDR.2|QVLALQSQLADTK.2|PANPPGVLALLDEEC[CAM]WFPK.3|PANPPGVLALLDEEC[CAM]WFPK.2|RKLDGETTDLQDQIAELQAQIDELK.4|RKLDGETTDLQDQIAELQAQIDELK.3|TSDVNETQPPQSE.2|FSKVEDMAELTC[CAM]LNEASVLHNLKDR.4|GDDETLHKNNALK.2|DNFQETMEAMHIMGFSHEEILSMLK.4|DNFQETMEAMHIMGFSHEEILSMLK.3|IAQLEEELEEEQSNM[Oxi]ELLNDRFRK.4|QKKFDQLLAEEK.2|M[Oxi]QAHIQDLEEQLDEEEGAR.3|MQAHIQDLEEQLDEEEGAR.3|MQAHIQDLEEQLDEEEGAR.2|LKSLEAEILQLQEELASSER.3|ELQAQIAELQEDFESEKASR.3|C[CAM]M[Oxi]LQDREDQSILC[CAM]TGESGAGK.3|C[CAM]MLQDREDQSILC[CAM]TGESGAGK.3|C[CAM]MLQDREDQSILC[CAM]TGESGAGK.2|DAASLESQLQDTQELLQEETR.3|ITDIIIFFQAVC[CAM]R.2|IAEC[CAM]SSQLAEEEEK.2|KLDGETTDLQDQIAELQAQIDELKLQLAK.4|NILAEQLQAETELFAEAEEM[Oxi]R.3|NILAEQLQAETELFAEAEEMR.3|VDDDLGTIESLEEAK.2|DAASLESQLQDTQELLQEETRQKLNLSSR.4|QLEEEKNSLQEQQEEEEEAR.3|FLSNGYIPIPGQQDK.2|DVDRIVGLDQVTGMTETAFGSAYK.3|LDGETTDLQDQIAELQAQIDELK.3|NSLQEQQEEEEEAR.2|IRQLEEEKNSLQEQQEEEEEAR.3
SEN / CTL,Calpain-1 catalytic subunit,CAPN1,P07384,0.50,0.40,1.78E-08,4.36E-08,7.36E+00,"proteolysis,positive regulation of cell proliferation,regulation of macroautophagy,extracellular matrix disassembly,receptor catabolic process,mammary gland involution","calcium-dependent cysteine-type endopeptidase activity,calcium ion binding","cytoplasm,mitochondrion,lysosome,cytosol,plasma membrane,focal adhesion,membrane,extracellular exosome",54,51,72,EFTRLEIC[CAM]NLTPDALK.3|LYELIITR.2|DFFLANASR.2|YLGQDYEQLR.2|WNTTLYEGTWR.2|IRLDETDDPDDYGDRESGC[CAM]SFVLALMQK.4|KAPSDLYQIILK.3|KAPSDLYQIILK.2|NYPATFWVNPQFK.2|NYPATFWVNPQFK.3|LVFVHSAEGNEFWSALLEK.3|LVFVHSAEGNEFWSALLEK.2|WKRPTELLSNPQFIVDGATR.4|WKRPTELLSNPQFIVDGATR.3|WKRPTELLSNPQFIVDGATR.2|QLAGEDMEISVK.2|QLAGEDM[Oxi]EISVK.2|DMETIGFAVYEVPPELVGQPAVHLKR.4|LEIC[CAM]NLTPDALK.2|RPTELLSNPQFIVDGATR.3|RPTELLSNPQFIVDGATR.4|RPTELLSNPQFIVDGATR.2|LGLVEFNILWNR.2|NYLSIFR.2|YSEPDLAVDFDNFVC[CAM]C[CAM]LVR.3|YSEPDLAVDFDNFVC[CAM]C[CAM]LVR.2|RDFFLANASR.3|RDFFLANASR.2|GQVVSLIR.2|ARSEQFINLREVSTR.4|MAIESAGFK.2|GFSLESC[CAM]R.2|SMVNLMDR.2|GHAYSVTGAK.2|SEQFINLR.2|WLQLTMFA.2|C[CAM]LQSGTLFR.2|FRLPPGEYVVVPSTFEPNK.4|FRLPPGEYVVVPSTFEPNK.3|SGSMSAYEMR.2|SGSM[Oxi]SAYEMR.2|KLYELIITR.2|FRLPPGEYVVVPSTFEPNKEGDFVLR.5|FRLPPGEYVVVPSTFEPNKEGDFVLR.4|FRLPPGEYVVVPSTFEPNKEGDFVLR.3|IRLDETDDPDDYGDR.3|IRLDETDDPDDYGDR.2|ARSEQFINLR.2|APSDLYQIILK.2|LPPGEYVVVPSTFEPNK.3|LPPGEYVVVPSTFEPNK.2|C[CAM]LQSGTLFRDEAFPPVPQSLGYK.4|C[CAM]LQSGTLFRDEAFPPVPQSLGYK.3|ELGLGRHENAIK.2|LPPGEYVVVPSTFEPNKEGDFVLR.4|LPPGEYVVVPSTFEPNKEGDFVLR.3|DMETIGFAVYEVPPELVGQPAVHLK.4|DMETIGFAVYEVPPELVGQPAVHLK.3|DM[Oxi]ETIGFAVYEVPPELVGQPAVHLK.3|MEDGEFWMSFR.2|SMVNLMDRDGNGK.2|ESGC[CAM]SFVLALMQK.2|LDETDDPDDYGDR.2|DEAFPPVPQSLGYK.2|KWNTTLYEGTWR.2|GSLLGC[CAM]SIDISSVLDMEAITFKK.3|VKMEDGEFWMSFR.2|VNGSYEALSGGSTSEGFEDFTGGVTEWYELRK.4|VNGSYEALSGGSTSEGFEDFTGGVTEWYELRK.3|TLDTDLDGVVTFDLFK.2|MRNPWGEVEWTGAWSDSSSEWNNVDPYERDQLR.4|VNGSYEALSGGSTSEGFEDFTGGVTEWYELR.3
SEN / CTL,14 kDa phosphohistidine phosphatase,PHPT1,Q9NRX4,0.50,0.38,3.68E-02,1.54E-02,1.81E+00,"protein dephosphorylation,positive regulation of insulin secretion involved in cellular response to glucose stimulus,peptidyl-histidine dephosphorylation,negative regulation of T cell receptor signaling pathway,negative regulation of lyase activity,positive regulation of cell motility,regulation of actin cytoskeleton reorganization,negative regulation of ATP citrate synthase activity","phosphoprotein phosphatase activity,phosphohistidine phosphatase activity,calcium channel inhibitor activity,ion channel binding","cytosol,extracellular exosome",9,8,18,AKYPDYEVTWANDGY.2|IHVYGYSMAYGPAQHAISTEK.4|IHVYGYSM[Oxi]AYGPAQHAISTEK.4|IHVYGYSMAYGPAQHAISTEK.3|IHVYGYSM[Oxi]AYGPAQHAISTEK.3|IHVYGYSM[Oxi]AYGPAQHAISTEK.2|IHVYGYSMAYGPAQHAISTEK.2|SGAPAAESK.2|WAEYHADIYDK.3|WAEYHADIYDK.2|KIHVYGYSM[Oxi]AYGPAQHAISTEK.5|KIHVYGYSMAYGPAQHAISTEK.4|KIHVYGYSM[Oxi]AYGPAQHAISTEK.4|KIHVYGYSMAYGPAQHAISTEK.3|KIHVYGYSM[Oxi]AYGPAQHAISTEK.3|SGAPAAESKEIVR.2|QGC[CAM]DC[CAM]EC[CAM]LGGGR.2|YPDYEVTWANDGY.2
SEN / CTL,Heat shock cognate 71 kDa protein,HSPA8,P11142,0.49,0.89,2.44E-04,2.21E-04,3.66E+00,"mRNA splicing, via spliceosome,transcription, DNA-templated,protein folding,response to unfolded protein,neurotransmitter secretion,cellular response to starvation,viral process,regulation of protein stability,protein refolding,regulation of protein complex assembly,regulation of mRNA stability,negative regulation of transcription, DNA-templated,ATP metabolic process,positive regulation of mRNA splicing, via spliceosome,chaperone mediated protein folding requiring cofactor,regulation of cell cycle,regulation of protein complex stability,chaperone-mediated autophagy,late endosomal microautophagy,protein targeting to lysosome involved in chaperone-mediated autophagy,chaperone-mediated protein transport involved in chaperone-mediated autophagy,clathrin coat disassembly,cell-cell adhesion,regulation of cellular response to heat,negative regulation of fibril organization,regulation of protein import,chaperone-mediated autophagy translocation complex disassembly","G-protein coupled receptor binding,phosphatidylserine binding,protein binding,ATP binding,ATPase activity,enzyme binding,MHC class II protein complex binding,heat shock protein binding,ubiquitin protein ligase binding,ATPase activity, coupled,poly(A) RNA binding,unfolded protein binding,C3HC4-type RING finger domain binding,cadherin binding involved in cell-cell adhesion","Prp19 complex,extracellular space,intracellular,nucleus,nucleoplasm,spliceosomal complex,nucleolus,lysosomal membrane,late endosome,cytosol,plasma membrane,cell-cell adherens junction,focal adhesion,membrane,intracellular ribonucleoprotein complex,extracellular matrix,melanosome,lysosomal lumen,myelin sheath,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,extracellular exosome,blood microparticle,lumenal side of lysosomal membrane,presynapse,ubiquitin ligase complex",144,54,126,SQIHDIVLVGGSTR.3|SQIHDIVLVGGSTR.2|QATKDAGTIAGLNVLR.3|IINEPTAAAIAYGLDKK.3|IINEPTAAAIAYGLDKK.2|DAGTIAGLNVLR.2|DAGTIAGLNVLR.3|LDKSQIHDIVLVGGSTR.4|LDKSQIHDIVLVGGSTR.3|LDKSQIHDIVLVGGSTR.2|ARFEELNADLFR.3|ARFEELNADLFR.2|TVTNAVVTVPAYFNDSQR.3|TVTNAVVTVPAYFNDSQR.2|TVTNAVVTVPAYFNDSQR.4|DAKLDKSQIHDIVLVGGSTR.4|DAKLDKSQIHDIVLVGGSTR.3|DAKLDKSQIHDIVLVGGSTR.2|IINEPTAAAIAYGLDK.3|IINEPTAAAIAYGLDK.2|ARFEELNADLFRGTLDPVEK.4|ARFEELNADLFRGTLDPVEK.3|SFYPEEVSSMVLTK.2|SFYPEEVSSMVLTK.3|SFYPEEVSSM[Oxi]VLTK.3|SFYPEEVSSM[Oxi]VLTK.2|MKEIAEAYLGK.3|MKEIAEAYLGK.2|M[Oxi]KEIAEAYLGK.3|M[Oxi]KEIAEAYLGK.2|MVNHFIAEFK.3|MVNHFIAEFK.2|M[Oxi]VNHFIAEFK.3|M[Oxi]VNHFIAEFK.2|QTQTFTTYSDNQPGVLIQVYEGER.3|QTQTFTTYSDNQPGVLIQVYEGER.4|FEELNADLFR.2|FEELNADLFR.3|STAGDTHLGGEDFDNR.3|STAGDTHLGGEDFDNR.2|RFDDAVVQSDMKHWPFM[Oxi]VVNDAGRPK.5|RFDDAVVQSDMKHWPFMVVNDAGRPK.5|RFDDAVVQSDMKHWPFMVVNDAGRPK.6|RFDDAVVQSDMKHWPFM[Oxi]VVNDAGRPK.4|RFDDAVVQSDMKHWPFMVVNDAGRPK.4|RFDDAVVQSDM[Oxi]KHWPFMVVNDAGRPK.6|RFDDAVVQSDMKHWPFM[Oxi]VVNDAGRPK.6|RFDDAVVQSDM[Oxi]KHWPFM[Oxi]VVNDAGRPK.5|RFDDAVVQSDM[Oxi]KHWPFMVVNDAGRPK.5|RFDDAVVQSDM[Oxi]KHWPFMVVNDAGRPK.4|RFDDAVVQSDMKHWPFMVVNDAGRPK.3|NSLESYAFNMK.2|NSLESYAFNMK.3|NSLESYAFNM[Oxi]K.2|LLQDFFNGKELNK.3|LLQDFFNGKELNK.2|NQVAMNPTNTVFDAKR.3|NQVAMNPTNTVFDAKR.2|NQVAM[Oxi]NPTNTVFDAKR.3|LLQDFFNGK.2|LLQDFFNGK.1|NQVAMNPTNTVFDAK.2|NQVAMNPTNTVFDAK.3|NQVAM[Oxi]NPTNTVFDAK.3|NQVAM[Oxi]NPTNTVFDAK.2|HWPFMVVNDAGRPK.3|HWPFMVVNDAGRPK.4|HWPFM[Oxi]VVNDAGRPK.4|HWPFM[Oxi]VVNDAGRPK.3|HWPFMVVNDAGRPK.2|RFDDAVVQSDMK.3|RFDDAVVQSDM[Oxi]K.3|RFDDAVVQSDMK.2|RFDDAVVQSDM[Oxi]K.2|MVNHFIAEFKR.3|MVNHFIAEFKR.2|VC[CAM]NPIITK.2|FDDAVVQSDMKHWPFMVVNDAGRPK.5|FDDAVVQSDMKHWPFMVVNDAGRPK.4|FDDAVVQSDMKHWPFMVVNDAGRPK.3|GTLDPVEK.2|GTLDPVEK.1|GRLSKEDIER.3|GRLSKEDIER.2|FDDAVVQSDMK.3|FDDAVVQSDMK.2|FDDAVVQSDM[Oxi]K.2|NQTAEKEEFEHQQK.4|NQTAEKEEFEHQQK.3|NQTAEKEEFEHQQK.2|HWPFMVVNDAGR.3|LSKEDIER.2|EIAEAYLGK.2|EEFEHQQK.2|GPAVGIDLGTTYSC[CAM]VGVFQHGK.4|GPAVGIDLGTTYSC[CAM]VGVFQHGK.3|GPAVGIDLGTTYSC[CAM]VGVFQHGK.2|MVQEAEKYKAEDEK.3|MVQEAEKYKAEDEK.2|NQTAEKEEFEHQQKELEK.4|NQTAEKEEFEHQQKELEK.3|SINPDEAVAYGAAVQAAILSGDK.4|SINPDEAVAYGAAVQAAILSGDK.3|SINPDEAVAYGAAVQAAILSGDK.2|IINEPTAAAIAYGLDKKVGAER.4|YKAEDEKQR.2|ILDKC[CAM]NEIINWLDK.3|ILDKC[CAM]NEIINWLDK.2|FELTGIPPAPR.2|C[CAM]NEIINWLDKNQTAEKEEFEHQQK.5|C[CAM]NEIINWLDKNQTAEKEEFEHQQK.4|C[CAM]NEIINWLDKNQTAEKEEFEHQQK.3|ILDKC[CAM]NEIINWLDKNQTAEK.4|C[CAM]NEIINWLDK.2|DNNLLGKFELTGIPPAPR.3|C[CAM]NEIINWLDKNQTAEK.3|C[CAM]NEIINWLDKNQTAEK.2|ELEKVC[CAM]NPIITK.2|RTLSSSTQASIEIDSLYEGIDFYTSITR.4|RTLSSSTQASIEIDSLYEGIDFYTSITR.3|GVPQIEVTFDIDANGILNVSAVDK.3|LYQSAGGMPGGMPGGFPGGGAPPSGGASSGPTIEEVD.4|LYQSAGGMPGGMPGGFPGGGAPPSGGASSGPTIEEVD.3|NTTIPTKQTQTFTTYSDNQPGVLIQVYEGER.4|NTTIPTKQTQTFTTYSDNQPGVLIQVYEGER.3|TLSSSTQASIEIDSLYEGIDFYTSITR.3
SEN / CTL,DNA repair protein RAD50,RAD50,Q92878,0.49,0.13,1.19E-01,4.10E-02,1.39E+00,"regulation of mitotic recombination,telomere maintenance via recombination,telomere maintenance,double-strand break repair via homologous recombination,DNA double-strand break processing,DNA synthesis involved in DNA repair,strand displacement,DNA replication,DNA repair,double-strand break repair,double-strand break repair via nonhomologous end joining,DNA recombination,cellular response to DNA damage stimulus,telomere maintenance via telomerase,reciprocal meiotic recombination,viral process,telomeric 3' overhang formation,positive regulation of protein autophosphorylation,positive regulation of telomere maintenance,DNA duplex unwinding,positive regulation of kinase activity,nucleotide phosphorylation,chromosome organization involved in meiotic cell cycle,nucleic acid phosphodiester bond hydrolysis,regulation of signal transduction by p53 class mediator,negative regulation of telomere capping","DNA binding,double-stranded telomeric DNA binding,adenylate kinase activity,protein binding,ATP binding,protein binding, bridging,single-stranded telomeric DNA binding,metal ion binding,G-quadruplex DNA binding,single-stranded DNA endodeoxyribonuclease activity,ATP-dependent DNA helicase activity,3'-5' exonuclease activity","nuclear chromosome, telomeric region,nuclear chromatin,condensed nuclear chromosome,nucleoplasm,membrane,Mre11 complex,site of double-strand break",3,75,89,VLASLIIR.2|TTELVNK.2|LEENIDNIKR.3|GYEEEIIHFK.3|NHNLALGR.2|TLEGVITR.2|HSDELTSLLGYFPNKK.4|HSDELTSLLGYFPNKK.3|LDQEMEQLNHHTTTR.4|LQGIDLDR.2|SDADENVSASDKR.3|TLDQAIMK.2|VAQETDVR.2|NEELKEVEEER.3|TTIIEC[CAM]LK.2|ELASSEQNKNHINNELK.4|KLDQEMEQLNHHTTTR.4|KLDQEM[Oxi]EQLNHHTTTR.4|KLDQEMEQLNHHTTTR.3|NHINNELK.2|TQMEMLTK.2|GNTFVHDPK.2|RKEEQLSSYEDK.3|RKEEQLSSYEDK.2|SELLVEQGR.2|SRHSDELTSLLGYFPNKK.4|LQISTNLQR.2|TVQQVNQEK.2|FDEIFSATR.2|LEENIDNIK.2|LIQDQQEQIQHLK.3|ENIESLAHALVEIIK.3|VFQGTDEQLNDLYHNHQR.4|VFQGTDEQLNDLYHNHQR.3|SEHQKLEENIDNIK.3|SEHQKLEENIDNIK.2|HSDELTSLLGYFPNK.3|DEMLGLVPMR.2|WLQDNLTLR.2|KLIQDQQEQIQHLK.3|LLNQEKSELLVEQGR.3|VFQTEAELQEVISDLQSKLR.4|VFQTEAELQEVISDLQSKLR.3|NVKYELQQLEGSSDR.3|NVKYELQQLEGSSDR.2|VIAQLSEC[CAM]EK.2|C[CAM]AEIDREMISSLGVSK.3|C[CAM]AEIDREMISSLGVSK.2|DIENYIQDGK.2|MEVISLQNEK.2|C[CAM]SVSSLGFNVH.2|DVNGELIAVQR.2|ILELDQELIK.2|NIDQC[CAM]SEIVK.2|SYENELDPLK.2|EEQLSSYEDK.2|GQDIEYIEIR.2|SDADENVSASDK.2|SEHQKLEENIDNIKR.3|TANQLMNDFAEKETLK.3|LFDVC[CAM]GSQDFESDLDR.3|LFDVC[CAM]GSQDFESDLDR.2|AC[CAM]EIRDQITSK.2|SRHSDELTSLLGYFPNK.3|SRHSDELTSLLGYFPNK.2|EMGQMQVLQMK.2|VC[CAM]LTDVTIMER.2|DSLIQSLATQLELDGFER.3|KEEQLSSYEDK.2|EQVSPLETTLEK.2|LFDVC[CAM]GSQDFESDLDRLKEEIEK.4|NSNVETLKMEVISLQNEK.3|QIITFFSPLTILVGPNGAGK.3|QIITFFSPLTILVGPNGAGK.2|TANQLMNDFAEK.2|VFQTEAELQEVISDLQSK.3|VFQTEAELQEVISDLQSK.2|LFDVC[CAM]GSQDFESDLDRLK.3|YELQQLEGSSDR.2|ARDSLIQSLATQLELDGFERGPFSER.4|SYENELDPLKNR.2|ARDSLIQSLATQLELDGFER.3|QQLEEQTVELSTEVQSLYR.3|QQLEEQTVELSTEVQSLYR.2|SFGIEDKDKQIITFFSPLTILVGPNGAGK.4|RQQLEEQTVELSTEVQSLYR.3|AVLNNVIFC[CAM]HQEDSNWPLSEGK.3|LKNDIEEQETLLGTIMPEEESAK.3|DSLIQSLATQLELDGFERGPFSER.3
SEN / CTL,Filamin-C,FLNC,Q14315,0.49,1.01,2.70E-06,4.08E-06,5.39E+00,"cell junction assembly,muscle fiber development","protein binding,cytoskeletal protein binding,ankyrin binding,actin filament binding","cytoplasm,cytosol,cytoskeleton,plasma membrane,focal adhesion,sarcoplasm,Z disc,sarcolemma,costamere",36,144,206,YGGDEIPYSPFR.2|VAVGQEQAFSVNTR.2|GVAGVPAEFSIWTR.2|GVAGVPAEFSIWTR.3|EAMQQADDWLGVPQVIAPEEIVDPNVDEHSVMTYLSQFPK.4|EAMQQADDWLGVPQVIAPEEIVDPNVDEHSVMTYLSQFPK.5|LYAQDADGC[CAM]PIDIK.2|VYNVTYTVK.2|AFGPGLEPTGC[CAM]IVDKPAEFTIDAR.3|AFGPGLEPTGC[CAM]IVDKPAEFTIDAR.4|GAGTGGLGLAIEGPSEAK.2|GAGTGGLGLAIEGPSEAK.3|RDTVEVALEDKGDSTFR.4|RDTVEVALEDKGDSTFR.3|ARVPQTFTVDC[CAM]SQAGR.3|ARVPQTFTVDC[CAM]SQAGR.2|FVPQEMGPHTVAVK.3|FVPQEMGPHTVAVK.2|ATIRPVFDPSK.3|AKLDVQFAGTAK.3|LEPGGGAEAQAVR.3|LEPGGGAEAQAVR.2|SPFRVNVGEGSHPER.4|FNGAHIPGSPFK.3|FNGAHIPGSPFK.2|SLTATGGNHVTAR.3|SLTATGGNHVTAR.2|GELTGEVR.2|TGVEVGKPTHFTVLTK.4|TGVEVGKPTHFTVLTK.3|TGVEVGKPTHFTVLTK.2|VSGPGVEPHGVLR.3|VSGPGVEPHGVLR.2|GLHQMGIK.2|ITGDDSMR.2|ITGDDSM[Oxi]R.2|VHVQPAVDTSGVK.3|VHVQPAVDTSGVK.2|RLTDLQR.2|GDYILIVK.2|GSSYSSIPK.2|HVTNSPFK.2|YGGPQHIVGSPFK.3|YGGPQHIVGSPFK.2|LGSFGSITR.2|TARPNITDNKDGTITVR.4|TARPNITDNKDGTITVR.3|VLPAHDASK.2|AEIAFEDR.2|AGTNMMMVGVHGPK.3|AGTNMM[Oxi]MVGVHGPK.3|AGTNM[Oxi]M[Oxi]M[Oxi]VGVHGPK.3|RLTVTSLQETGLK.3|RLTVTSLQETGLK.2|VC[CAM]AYGPGLK.2|PATFTIVTK.2|YADQEVPR.2|APSGNEEPC[CAM]LLKR.3|HIGISFTPK.2|RPIPC[CAM]KLEPGGGAEAQAVR.4|RPIPC[CAM]KLEPGGGAEAQAVR.3|HTIIISWGGVNVPK.3|HTIIISWGGVNVPK.2|LENVSVALEFLER.3|LENVSVALEFLER.2|LENVSVALEFLEREHIK.4|C[CAM]SGPGLGAGVR.2|ITESDLSQLTASIR.3|ITESDLSQLTASIR.2|PAMEGPHTVHVAFAGAPITR.4|TYAVSYVPK.2|HVSAYGPGLSHGMVNKPATFTIVTK.5|HVSAYGPGLSHGMVNKPATFTIVTK.4|LSGGHSLHETSTVLVETVTK.4|LSGGHSLHETSTVLVETVTK.3|LSGGHSLHETSTVLVETVTK.2|VPQTFTVDC[CAM]SQAGR.3|VPQTFTVDC[CAM]SQAGR.2|VRAWGPGLETGQVGK.3|C[CAM]TYRPAM[Oxi]EGPHTVHVAFAGAPITR.5|C[CAM]TYRPAMEGPHTVHVAFAGAPITR.5|C[CAM]TYRPAMEGPHTVHVAFAGAPITR.4|C[CAM]TYRPAMEGPHTVHVAFAGAPITR.3|FIPHENGVHSIDVK.3|GAGGQGQLDVR.2|LDVQFAGTAK.2|NSFTVDC[CAM]SK.2|SPFVVNVAPPLDLSK.3|SPFVVNVAPPLDLSK.2|YRGQHVPGSPFQFTVGPLGEGGAHK.5|YRGQHVPGSPFQFTVGPLGEGGAHK.4|YRGQHVPGSPFQFTVGPLGEGGAHK.3|AEIAFEDRK.2|VIPNGDGTFR.2|HVSAYGPGLSHGMVNK.3|VHTPSGAVEEC[CAM]YVSELDSDKHTIR.5|VHTPSGAVEEC[CAM]YVSELDSDKHTIR.4|VVTRGPGLSQAFVGQK.3|VVTRGPGLSQAFVGQK.2|EVGEHVVSVR.2|IHALPTGDASK.2|IPGNWFQMVSAQER.3|IPGNWFQMVSAQER.2|TARPNITDNK.2|TPC[CAM]EEVYVK.2|YTIMVLFANQEIPASPFHIK.4|YTIMVLFANQEIPASPFHIK.3|YTIM[Oxi]VLFANQEIPASPFHIK.3|YTIMVLFANQEIPASPFHIK.2|DTVEVALEDKGDSTFR.3|DTVEVALEDKGDSTFR.2|EKGDYILIVK.2|GPGLSQAFVGQK.2|VNVGEGSHPER.2|C[CAM]SYVPTKPIK.2|QAPSIATIGSTC[CAM]DLNLK.3|QAPSIATIGSTC[CAM]DLNLK.2|VGVTEGC[CAM]DPTR.2|FGGEHIPNSPFHVLAC[CAM]DPLPHEEEPSEVPQLR.6|FGGEHIPNSPFHVLAC[CAM]DPLPHEEEPSEVPQLR.5|FGGEHIPNSPFHVLAC[CAM]DPLPHEEEPSEVPQLR.4|VEAAEIVEGEDSAYSVR.3|VEAAEIVEGEDSAYSVR.2|AFGPGLEGGLVNK.2|DNGDGTHTVHYTPATDGPYTVAVK.4|DNGDGTHTVHYTPATDGPYTVAVK.3|EAGAGGLSIAVEGPSKAEIAFEDRK.4|EVTTEFTVDAR.2|C[CAM]LVTVSIGGHGLGAC[CAM]LGPR.3|C[CAM]LVTVSIGGHGLGAC[CAM]LGPR.2|GLHQMGIKYDGNHIPGSPLQFYVDAINSR.5|ILVGPSEIGDASK.2|LTVTSLQETGLK.2|AWGPGLETGQVGK.2|DRTYAVSYVPK.2|RQAPSIATIGSTC[CAM]DLNLK.3|SPFPVHVSEAC[CAM]NPNAC[CAM]R.3|VPQLPITNFNR.2|WGDESVPGSPFK.2|APSGNEEPC[CAM]LLK.2|DAGEGLLTVQILDPEGKPK.3|DAGEGLLTVQILDPEGKPK.2|APLQVAVLGPTGVAEPVEVR.3|APLQVAVLGPTGVAEPVEVR.2|C[CAM]APGVVGPAEADIDFDIIK.3|GLSEGHTFQVAEFIVDTR.3|DGSC[CAM]TVEYIPFTPGDYDVNITFGGRPIPGSPFRVPVK.6|DGSC[CAM]TVEYIPFTPGDYDVNITFGGRPIPGSPFRVPVK.5|DGSC[CAM]TVEYIPFTPGDYDVNITFGGRPIPGSPFRVPVK.4|FNDEHIPDSPFVVPVASLSDDARR.4|VPQLPITNFNRDWQDGK.3|VTVLFAGQNIER.2|PFNLVIPFAVQK.2|VQYTAYEEGVHLVEVLYDEVAVPK.4|VQYTAYEEGVHLVEVLYDEVAVPK.3|ITESDLSQLTASIRAPSGNEEPC[CAM]LLK.4|ITESDLSQLTASIRAPSGNEEPC[CAM]LLK.3|QQEGEASSQDMTAQVTSPSGK.3|QQEGEASSQDMTAQVTSPSGK.2|DAGEGGLSLAVEGPSKAEITC[CAM]K.3|GGLVGTPAPFSIDTK.2|DAGEGGLSLAVEGPSK.2|VHTPSGAVEEC[CAM]YVSELDSDK.3|DGSC[CAM]GVSYVVQEPGDYEVSIK.3|DGSC[CAM]GVSYVVQEPGDYEVSIK.2|DGTC[CAM]TVSYLPTAPGDYSIIVR.3|DGTC[CAM]TVSYLPTAPGDYSIIVR.2|NAGYGGLGLSIEGPSK.2|VREAGDGVFEC[CAM]EYYPVVPGK.3|VREAGDGVFEC[CAM]EYYPVVPGK.2|TSQLNVGTSTDVSLK.2|VEESTQVGGDPFPAVFGDFLGR.3|VEESTQVGGDPFPAVFGDFLGR.2|ASGPGLNASGIPASLPVEFTIDAR.3|ASGPGLNASGIPASLPVEFTIDAR.2|FDDKHIPGSPFTAK.2|TDTYVTDNGDGTYR.2|VNQPASFAVQLNGAR.2|YDGNHIPGSPLQFYVDAINSR.3|SPFEVQVSPEAGVQK.2|YVVTITWGGYAIPR.2|AEVLIHNNADGTYHITYSPAFPGTYTITIK.4|AEVLIHNNADGTYHITYSPAFPGTYTITIK.3|QPYAPPRPGARPTHWATEEPVVPVEPMESMLRPFNLVIPFAVQK.6|SPFEVNVGMALGDANK.2|VQLDC[CAM]REC[CAM]PEGHVVTYTPMAPGNYLIAIK.4|ALGALVDNC[CAM]APGLC[CAM]PDWEAWDPNQPVENAR.4|ALGALVDNC[CAM]APGLC[CAM]PDWEAWDPNQPVENAR.3|FNDEHIPDSPFVVPVASLSDDAR.3|EC[CAM]PEGHVVTYTPM[Oxi]APGNYLIAIK.3|EC[CAM]PEGHVVTYTPMAPGNYLIAIK.3|DNKDGSC[CAM]TVEYIPFTPGDYDVNITFGGRPIPGSPFRVPVK.5|DNKDGTC[CAM]TVSYLPTAPGDYSIIVR.3|VRASGPGLNASGIPASLPVEFTIDAR.3|APLQVAVLGPTGVAEPVEVRDNGDGTHTVHYTPATDGPYTVAVK.5|DGSC[CAM]TVEYIPFTPGDYDVNITFGGRPIPGSPFR.4|EVRVEESTQVGGDPFPAVFGDFLGR.3|VTYC[CAM]PTEPGTYIINIK.2|YWPTEPGEYAVHVIC[CAM]DDEDIRDSPFIAHILPAPPDC[CAM]FPDK.5|ARVPQTFTVDC[CAM]SQAGRAPLQVAVLGPTGVAEPVEVR.4|PTHWATEEPVVPVEPMESMLRPFNLVIPFAVQK.4|YMPPEEGPYKVDITYDGHPVPGSPFAVEGVLPPDPSK.4|AIAYGPGIEPQGNTVLQPAHFTVQTVDAGVGEVLVYIEDPEGHTEEAK.5|EAGDGVFEC[CAM]EYYPVVPGK.2|GPGLEPVGNVANKPTYFDIYTAGAGTGDVAVVIVDPQGRR.4|IEC[CAM]QDNGDGSC[CAM]AVSYLPTEPGEYTINILFAEAHIPGSPFK.4
SEN / CTL,"Keratin, type I cytoskeletal 19",KRT19,P08727,0.49,0.60,6.17E-11,2.35E-10,9.63E+00,"Notch signaling pathway,viral process,response to estrogen,sarcomere organization,cell differentiation involved in embryonic placenta development","structural constituent of cytoskeleton,protein binding,structural constituent of muscle,protein complex binding","intermediate filament,plasma membrane,dystrophin-associated glycoprotein complex,Z disc,sarcolemma,costamere,extracellular exosome,cell periphery,terminal web",90,47,93,IVLQIDNAR.2|DAEAWFTSR.2|VLDELTLAR.2|FGAQLAHIQALISGIEAQLGDVR.3|FGAQLAHIQALISGIEAQLGDVR.4|AALEDTLAETEAR.2|AALEDTLAETEAR.3|DYSHYYTTIQDLR.3|DYSHYYTTIQDLR.2|DYSHYYTTIQDLRDK.3|DYSHYYTTIQDLRDK.4|SRLEQEIATYR.3|SRLEQEIATYR.2|ILGATIENSR.2|ALEAANGELEVK.2|ALEAANGELEVK.3|SLLEGQEDHYNNLSASK.3|SLLEGQEDHYNNLSASK.2|FGAQLAHIQALISGIEAQLGDVRADSER.4|FGAQLAHIQALISGIEAQLGDVRADSER.3|TEELNREVAGHTEQLQMSR.4|TEELNREVAGHTEQLQMSR.3|TEELNREVAGHTEQLQM[Oxi]SR.4|TEELNREVAGHTEQLQM[Oxi]SR.3|TEELNREVAGHTEQLQM[Oxi]SR.2|MSVEADINGLRR.3|M[Oxi]SVEADINGLRR.3|MSVEADINGLRR.2|FGAQLAHIQALISGIEAQLGDVRADSERQNQEYQR.5|FGAQLAHIQALISGIEAQLGDVRADSERQNQEYQR.6|FGAQLAHIQALISGIEAQLGDVRADSERQNQEYQR.4|DKILGATIENSR.2|TDLEMQIEGLKEELAYLKK.4|TDLEM[Oxi]QIEGLKEELAYLKK.4|TDLEM[Oxi]QIEGLKEELAYLKK.3|TDLEMQIEGLKEELAYLKK.3|TDLEMQIEGLKEELAYLKK.2|EVAGHTEQLQMSR.2|EVAGHTEQLQMSR.3|EVAGHTEQLQM[Oxi]SR.3|MSVEADINGLR.2|M[Oxi]SVEADINGLR.2|QGPGPSRDYSHYYTTIQDLR.4|QGPGPSRDYSHYYTTIQDLR.3|LTMQNLNDR.2|LTM[Oxi]QNLNDR.2|QSSATSSFGGLGGGSVR.2|QSSATSSFGGLGGGSVR.3|TLQGLEIELQSQLSMK.3|TLQGLEIELQSQLSM[Oxi]K.3|TLQGLEIELQSQLSM[Oxi]K.2|TLQGLEIELQSQLSMK.2|KDAEAWFTSR.3|KDAEAWFTSR.2|NHEEEISTLR.3|NHEEEISTLR.2|SEVTDLR.2|TKFETEQALR.3|TKFETEQALR.2|FGPGVAFR.2|KNHEEEISTLR.3|KNHEEEISTLR.2|SQYEVMAEQNR.3|SQYEVMAEQNR.2|SQYEVM[Oxi]AEQNR.2|QNQEYQR.2|SQYEVMAEQNRK.3|SQYEVM[Oxi]AEQNRK.3|SQYEVMAEQNRK.2|APSIHGGSGGR.2|FETEQALR.2|LAADDFRTKFETEQALR.4|LAADDFRTKFETEQALR.3|VRALEAANGELEVK.3|VRALEAANGELEVK.2|ADSERQNQEYQR.3|ADSERQNQEYQR.2|ALEAANGELEVKIRDWYQK.4|LTMQNLNDRLASYLDK.3|TDLEMQIEGLK.2|TDLEM[Oxi]QIEGLK.2|RTLQGLEIELQSQLSMK.3|RTLQGLEIELQSQLSMK.2|GQVGGQVSVEVDSAPGTDLAK.3|GQVGGQVSVEVDSAPGTDLAK.2|TDLEM[Oxi]QIEGLKEELAYLK.3|TDLEMQIEGLKEELAYLK.3|TDLEM[Oxi]QIEGLKEELAYLK.2|TDLEMQIEGLKEELAYLK.2|DYSHYYTTIQDLRDKILGATIENSR.4|KNHEEEISTLRGQVGGQVSVEVDSAPGTDLAK.4|FVSSSSSGAYGGGYGGVLTASDGLLAGNEK.3|VLDELTLARTDLEMQIEGLKEELAYLK.3
SEN / CTL,Coatomer subunit beta,COPB1,P53618,0.49,0.34,1.14E-05,1.45E-05,4.84E+00,"intracellular protein transport,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,intra-Golgi vesicle-mediated transport,viral process","structural molecule activity,protein binding","Golgi membrane,cytoplasm,endoplasmic reticulum membrane,endoplasmic reticulum-Golgi intermediate compartment,Golgi apparatus,Golgi-associated vesicle,cytosol,plasma membrane,membrane,COPI vesicle coat,transport vesicle,intracellular membrane-bounded organelle",15,73,120,LKEAELLEPLMPAIR.3|LKEAELLEPLM[Oxi]PAIR.3|VLQDLVMDILR.2|VLQDLVMDILR.3|VLQDLVM[Oxi]DILR.2|SIFGEDALANVSIEKPIHQGPDAAVTGHIR.5|SIFGEDALANVSIEKPIHQGPDAAVTGHIR.4|SIFGEDALANVSIEKPIHQGPDAAVTGHIR.3|EAGELKPEEEITVGPVQK.3|EAGELKPEEEITVGPVQK.2|LLHEMILVC[CAM]DAYRK.4|LLHEM[Oxi]ILVC[CAM]DAYRK.4|LLHEMILVC[CAM]DAYRK.3|LLHEMILVC[CAM]DAYRK.2|DLQHPNEFIR.3|DLQHPNEFIR.2|NVEELVIVLKK.3|NVEELVIVLKK.2|TNNVSEHEDTDKYR.4|TNNVSEHEDTDKYR.3|TNNVSEHEDTDKYR.2|RNAFMMLIHADQDR.4|RNAFMMLIHADQDR.3|RNAFMM[Oxi]LIHADQDR.3|FVLPLQDHTIK.3|EAADPLASK.2|AAAQC[CAM]YIDLIIK.3|AAAQC[CAM]YIDLIIK.2|TNNVSEHEDTDK.3|TNNVSEHEDTDK.2|KDLQHPNEFIR.3|KPITDDDVDRISLC[CAM]LK.4|KPITDDDVDRISLC[CAM]LK.3|YVALVQEK.2|KTLQLALDLVSSR.3|TLHSC[CAM]SVR.2|RNAVLAIYTIYR.3|EDIQSVMTEIRR.3|LIELKEHPAHER.3|GALWILGEYC[CAM]STK.3|GALWILGEYC[CAM]STK.2|KEAADPLASK.2|SLGEIPIVESEIKK.3|SLGEIPIVESEIKK.2|KEAGELKPEEEITVGPVQK.4|KEAGELKPEEEITVGPVQK.3|LVEKPSPLTLAPHDFANIK.4|LVEKPSPLTLAPHDFANIK.3|LVEKPSPLTLAPHDFANIK.2|NAFMMLIHADQDR.3|PIHQGPDAAVTGHIR.3|C[CAM]IYNLLQSSSPAVK.3|C[CAM]IYNLLQSSSPAVK.2|VC[CAM]HANPSER.2|EVIKTNNVSEHEDTDKYR.4|EVIKTNNVSEHEDTDKYR.3|LLHEMILVC[CAM]DAYR.3|MLEVFHAIK.2|PSPLTLAPHDFANIK.3|PSPLTLAPHDFANIK.2|QSLSHMLSAK.2|SQGMALSLGDK.2|SQGM[Oxi]ALSLGDK.2|LVTEMGTYATQSALSSSRPTK.4|LVTEMGTYATQSALSSSRPTK.3|LVTEM[Oxi]GTYATQSALSSSRPTK.3|VTVNTNMVDLNDYLQHILK.4|VTVNTNMVDLNDYLQHILK.3|VTVNTNM[Oxi]VDLNDYLQHILK.3|VTVNTNMVDLNDYLQHILK.2|LPGLLMTIIR.2|VIIMILNGEK.2|VLSTPDLEVR.2|NVEELVIVLK.2|KPITDDDVDR.2|ALSGYC[CAM]GFM[Oxi]AANLYAR.3|ALSGYC[CAM]GFMAANLYAR.3|ALSGYC[CAM]GFMAANLYAR.2|ALSGYC[CAM]GFM[Oxi]AANLYAR.2|LVTEMGTYATQSALSSSRPTKK.4|VLSEC[CAM]SPLMNDIFNK.3|VLSEC[CAM]SPLM[Oxi]NDIFNK.2|VLSEC[CAM]SPLMNDIFNK.2|SQGMALSLGDKINLSQK.3|SQGMALSLGDKINLSQK.2|YEAAGTLVTLSSAPTAIK.3|YEAAGTLVTLSSAPTAIK.2|LEEEKLSQKK.2|NFEHLIPDAPELIHDFLVNEK.4|NFEHLIPDAPELIHDFLVNEK.3|EDQFQLSLLAAMGNTQR.3|EDQFQLSLLAAMGNTQR.2|IYRGALWILGEYC[CAM]STK.3|NFEHLIPDAPELIHDFLVNEKDASC[CAM]KR.5|NFEHLIPDAPELIHDFLVNEKDASC[CAM]KR.4|NAVLAIYTIYR.2|EDIQSVMTEIR.2|TLQLALDLVSSR.2|NVTVQPDDPISFMQLTAK.3|NVTVQPDDPISFMQLTAK.2|LLLVFWEIVPK.2|SLGEIPIVESEIKKEAGELKPEEEITVGPVQK.5|SLGEIPIVESEIK.2|AAAQC[CAM]YIDLIIKESDNNVK.3|RNVTVQPDDPISFMQLTAK.3|RNVTVQPDDPISFMQLTAK.2|QNSFVAEAMLLM[Oxi]ATILHLGK.3|QNSFVAEAM[Oxi]LLM[Oxi]ATILHLGK.3|EAELLEPLMPAIR.2|EAELLEPLM[Oxi]PAIR.2|GALWILGEYC[CAM]STKEDIQSVMTEIRR.4|VLSEC[CAM]SPLMNDIFNKEC[CAM]R.3|QMWAEFEWENK.2|VIIMILNGEKLPGLLMTIIR.3|SIFGEDALANVSIEK.2|VASTENGIIFGNIVYDVSGAASDR.3|C[CAM]IYNLLQSSSPAVKYEAAGTLVTLSSAPTAIK.4|C[CAM]IYNLLQSSSPAVKYEAAGTLVTLSSAPTAIK.3|NEMNC[CAM]KEDQFQLSLLAAMGNTQR.3|LVTEMGTYATQSALSSSR.2
SEN / CTL,Omega-amidase NIT2,NIT2,Q9NQR4,0.48,0.37,1.33E-06,2.17E-06,5.66E+00,"oxaloacetate metabolic process,asparagine metabolic process,glutamine metabolic process",omega-amidase activity,"cytoplasm,mitochondrion,centrosome,extracellular exosome",30,28,39,FAELAQIYAQR.2|FAELAQIYAQR.3|VGLGIC[CAM]YDMR.2|IVSLPEC[CAM]FNSPYGAK.2|IVSLPEC[CAM]FNSPYGAK.3|LALIQLQISSIK.2|LALIQLQISSIK.3|TLSPGDSFSTFDTPYC[CAM]R.2|TLSPGDSFSTFDTPYC[CAM]R.3|AGTEEAIVYSDIDLKK.3|AGTEEAIVYSDIDLKK.2|AVDNQVYVATASPAR.2|AVDNQVYVATASPAR.3|IHLFDIDVPGK.3|IHLFDIDVPGK.2|ITFQESK.2|KIHLFDIDVPGK.3|LAEIRQQIPVFR.3|AC[CAM]SFIREAATQGAK.3|IHLFDIDVPGKITFQESK.4|YFPEYAEK.2|SDLYAVEMK.2|KIHLFDIDVPGKITFQESK.4|RSDLYAVEMK.2|SRAVDNQVYVATASPAR.3|LYNTC[CAM]AVFGPDGTLLAK.3|LYNTC[CAM]AVFGPDGTLLAK.2|YFPEYAEKIPGESTQK.3|YFPEYAEKIPGESTQK.2|AVDNQVYVATASPARDDK.3|DDKASYVAWGHSTVVNPWGEVLAK.4|LALIQLQISSIKSDNVTR.3|GC[CAM]QLLVYPGAFNLTTGPAHWELLQR.4|GC[CAM]QLLVYPGAFNLTTGPAHWELLQR.3|ASYVAWGHSTVVNPWGEVLAK.3|ASYVAWGHSTVVNPWGEVLAK.2|AGTEEAIVYSDIDLK.2|AVDNQVYVATASPARDDKASYVAWGHSTVVNPWGEVLAK.5|EC[CAM]SIYLIGGSIPEEDAGK.2
SEN / CTL,"Serine--tRNA ligase, cytoplasmic",SARS,P49591,0.48,1.29,3.03E-02,1.33E-02,1.88E+00,"translation,tRNA aminoacylation for protein translation,seryl-tRNA aminoacylation,tRNA processing,selenocysteine metabolic process,selenocysteinyl-tRNA(Sec) biosynthetic process","RNA binding,serine-tRNA ligase activity,ATP binding,selenocysteine-tRNA ligase activity","cytoplasm,cytosol,extracellular exosome",21,41,63,VLDLDLFR.2|LLIDEAILK.2|KLDLEAWFPGSGAFR.3|KLDLEAWFPGSGAFR.2|FKDPGLVDQLVK.3|FKDPGLVDQLVK.2|DVTLENR.2|TIC[CAM]AILENYQTEK.2|TIC[CAM]AILENYQTEK.3|ELVSC[CAM]SNC[CAM]TDYQAR.2|ELVSC[CAM]SNC[CAM]TDYQAR.3|GGDPALIR.2|PAPIEQEPSKK.3|VRLLIDEAILK.3|VDKGGDPALIRETQEK.4|VDKGGDPALIRETQEK.3|GYIPIYTPFFMR.3|GYIPIYTPFFMR.2|GYIPIYTPFFM[Oxi]R.2|IWGDC[CAM]TVR.2|DEWLRPEDLPIK.3|DEWLRPEDLPIK.2|IKLEAERFENLR.3|RFKDPGLVDQLVK.3|LQNMEVTDA.2|IEQFVYSSPHDNK.3|IEQFVYSSPHDNK.2|SDDNSYDEK.2|YAGLSTC[CAM]FR.2|DPGLVDQLVK.2|PAPIEQEPSK.2|YLIATSEQPIAALHR.3|YLIATSEQPIAALHR.2|EFMPPGLQELIPFVK.3|EFMPPGLQELIPFVK.2|MMDKVEFVHMLNATMC[CAM]ATTR.4|VEFVHMLNATMC[CAM]ATTR.3|VEFVHMLNATM[Oxi]C[CAM]ATTR.3|VEFVHMLNATMC[CAM]ATTR.2|LKEFMPPGLQELIPFVKPAPIEQEPSKK.5|LKEFM[Oxi]PPGLQELIPFVKPAPIEQEPSKK.4|LKEFMPPGLQELIPFVKPAPIEQEPSKK.4|YLIATSEQPIAALHRDEWLRPEDLPIK.5|YLIATSEQPIAALHRDEWLRPEDLPIK.4|YLIATSEQPIAALHRDEWLRPEDLPIK.3|YSHVDLVVMVDGFEGEK.3|EIGNLLHPSVPISNDEDVDNKVER.4|EIGNLLHPSVPISNDEDVDNKVER.3|EFMPPGLQELIPFVKPAPIEQEPSK.4|EFMPPGLQELIPFVKPAPIEQEPSK.3|GGDPALIRETQEK.2|EVMQEVAQLSQFDEELYK.3|EVM[Oxi]QEVAQLSQFDEELYK.2|EVMQEVAQLSQFDEELYK.2|EFMPPGLQELIPFVKPAPIEQEPSKK.4|EIGNLLHPSVPISNDEDVDNK.3|KEVMQEVAQLSQFDEELYK.3|LDLEAWFPGSGAFR.2|KKEPVGDDESVPENVLSFDDLTADALANLK.4|KKEPVGDDESVPENVLSFDDLTADALANLK.3|EPVGDDESVPENVLSFDDLTADALANLK.3|KEPVGDDESVPENVLSFDDLTADALANLK.3|KYSHVDLVVMVDGFEGEK.2
SEN / CTL,Inorganic pyrophosphatase,PPA1,Q15181,0.48,0.43,8.74E-07,1.49E-06,5.83E+00,"tRNA aminoacylation for protein translation,phosphate-containing compound metabolic process,diphosphate metabolic process","magnesium ion binding,inorganic diphosphatase activity","cytoplasm,cytosol,extracellular exosome",45,30,65,AAPFSLEYR.2|LKPGYLEATVDWFRR.3|LKPGYLEATVDWFRR.4|YVANLFPYK.2|LKPGYLEATVDWFR.3|LKPGYLEATVDWFR.2|AIVDALPPPC[CAM]ESAC[CAM]TVPTDVDKWFHHQKN.5|VLGILAMIDEGETDWK.2|VLGILAMIDEGETDWK.3|VLGILAM[Oxi]IDEGETDWK.2|MEIATKDPLNPIKQDVK.4|MEIATKDPLNPIKQDVK.3|M[Oxi]EIATKDPLNPIKQDVK.3|MEIATKDPLNPIKQDVK.2|GQYISPFHDIPIYADKDVFHMVVEVPR.5|GQYISPFHDIPIYADKDVFHMVVEVPR.4|GQYISPFHDIPIYADKDVFHM[Oxi]VVEVPR.5|GQYISPFHDIPIYADKDVFHM[Oxi]VVEVPR.4|GQYISPFHDIPIYADKDVFHMVVEVPR.3|VIAINVDDPDAANYNDINDVKR.3|VIAINVDDPDAANYNDINDVKR.4|GISC[CAM]MNTTLSESPFKC[CAM]DPDAAR.3|GISC[CAM]M[Oxi]NTTLSESPFKC[CAM]DPDAAR.3|DPLNPIKQDVK.3|DPLNPIKQDVK.2|DVFHMVVEVPR.3|DVFHM[Oxi]VVEVPR.3|DVFHMVVEVPR.2|DVFHM[Oxi]VVEVPR.2|STHDHWK.2|LRYVANLFPYK.3|RLKPGYLEATVDWFR.4|RLKPGYLEATVDWFR.3|DFAIDIIK.2|MEIATKDPLNPIK.3|MEIATKDPLNPIK.2|M[Oxi]EIATKDPLNPIK.2|VPDGKPENEFAFNAEFK.4|VPDGKPENEFAFNAEFK.3|VPDGKPENEFAFNAEFK.2|AIVDALPPPC[CAM]ESAC[CAM]TVPTDVDKWFHHQK.6|AIVDALPPPC[CAM]ESAC[CAM]TVPTDVDKWFHHQK.5|AIVDALPPPC[CAM]ESAC[CAM]TVPTDVDKWFHHQK.4|AIVDALPPPC[CAM]ESAC[CAM]TVPTDVDKWFHHQK.3|GISC[CAM]MNTTLSESPFK.3|GISC[CAM]M[Oxi]NTTLSESPFK.2|GISC[CAM]MNTTLSESPFK.2|YKVPDGKPENEFAFNAEFK.4|YKVPDGKPENEFAFNAEFK.3|YKVPDGKPENEFAFNAEFK.2|VIAINVDDPDAANYNDINDVK.4|VIAINVDDPDAANYNDINDVK.3|VIAINVDDPDAANYNDINDVK.2|AIVDALPPPC[CAM]ESAC[CAM]TVPTDVDK.4|AIVDALPPPC[CAM]ESAC[CAM]TVPTDVDK.3|AIVDALPPPC[CAM]ESAC[CAM]TVPTDVDK.2|DKDFAIDIIK.2|GQYISPFHDIPIYADK.3|GQYISPFHDIPIYADK.2|YKVPDGKPENEFAFNAEFKDK.4|HTGC[CAM]C[CAM]GDNDPIDVC[CAM]EIGSK.3|HTGC[CAM]C[CAM]GDNDPIDVC[CAM]EIGSK.2|PGYLEATVDWFR.2|GYIWNYGAIPQTWEDPGHNDK.3|GYIWNYGAIPQTWEDPGHNDKHTGC[CAM]C[CAM]GDNDPIDVC[CAM]EIGSK.5
SEN / CTL,ADP-ribosylation factor 3;ADP-ribosylation factor 1,ARF3;ARF1,P61204;P84077,0.48,0.47,4.35E-03,2.65E-03,2.58E+00,"phosphatidylinositol biosynthetic process,retrograde vesicle-mediated transport, Golgi to ER,small GTPase mediated signal transduction,protein transport;regulation of receptor internalization,phosphatidylinositol biosynthetic process,cellular copper ion homeostasis,post-Golgi vesicle-mediated transport,actin filament organization,small GTPase mediated signal transduction,protein transport,antigen processing and presentation of exogenous peptide antigen via MHC class II,regulation of Arp2/3 complex-mediated actin nucleation,very-low-density lipoprotein particle assembly,positive regulation of catalytic activity,positive regulation of endocytosis,positive regulation of calcium ion-dependent exocytosis,regulation of defense response to virus by virus,positive regulation of protein secretion,Golgi to transport vesicle transport,long term synaptic depression,positive regulation of dendritic spine development,synaptic vesicle budding,dendritic spine organization,lysosomal membrane organization,positive regulation of sodium ion transmembrane transport,positive regulation of late endosome to lysosome transport,positive regulation of ER to Golgi vesicle-mediated transport,regulation of phospholipid metabolic process","GTPase activity,GTP binding;magnesium ion binding,GTPase activity,receptor signaling protein activity,protein binding,GTP binding,GDP binding,poly(A) RNA binding,phospholipase D activator activity","Golgi membrane,perinuclear region of cytoplasm,extracellular exosome;Golgi membrane,late endosome,peroxisomal membrane,trans-Golgi network,cytosol,plasma membrane,focal adhesion,postsynaptic density,sarcomere,COPI-coated vesicle,cell leading edge,neuron projection,postsynaptic membrane,perinuclear region of cytoplasm,extracellular exosome",9,3,10,ILMVGLDAAGK.2|ILM[Oxi]VGLDAAGK.2|NISFTVWDVGGQDKIRPLWR.4|NISFTVWDVGGQDKIRPLWR.3|MLAEDELRDAVLLVFANK.3|M[Oxi]LAEDELRDAVLLVFANK.4|MLAEDELRDAVLLVFANK.4|M[Oxi]LAEDELRDAVLLVFANK.3|M[Oxi]LAEDELRDAVLLVFANK.2|MLAEDELRDAVLLVFANK.2
SEN / CTL,Hexokinase-1,HK1,P19367,0.48,0.48,1.05E-10,3.95E-10,9.40E+00,"cellular glucose homeostasis,glycolytic process,glucose transport,carbohydrate phosphorylation,glucose 6-phosphate metabolic process,canonical glycolysis,establishment of protein localization to mitochondrion,maintenance of protein location in mitochondrion","glucokinase activity,hexokinase activity,ATP binding,glucose binding,fructokinase activity,mannokinase activity","mitochondrion,mitochondrial outer membrane,cytosol,membrane raft,sperm principal piece",63,46,62,SANLVAATLGAILNR.2|SANLVAATLGAILNR.3|TTVGVDGSLYK.2|NILIDFTK.2|KLPVGFTFSFPC[CAM]QQSK.3|DMLLEVK.2|IDEAILITWTKR.3|IDEAILITWTKR.2|MISGMYLGEIVR.2|MISGM[Oxi]YLGEIVR.2|SIPDGSEKGDFIALDLGGSSFR.3|GAAMVTAVAYR.2|GAAM[Oxi]VTAVAYR.2|RTPDGTENGDFLALDLGGTNFR.3|GAALITAVGVR.2|ATDC[CAM]VGHDVVTLLR.3|ATDC[CAM]VGHDVVTLLR.2|EGLLFEGR.2|MVSGMYLGELVR.2|M[Oxi]VSGMYLGELVR.2|MVSGM[Oxi]YLGELVR.2|M[Oxi]VSGM[Oxi]YLGELVR.2|LSDETLIDIMTR.2|LSDETLIDIMTR.3|FLSQIESDRLALLQVR.3|IDEAILITWTK.2|TPDGTENGDFLALDLGGTNFR.3|TPDGTENGDFLALDLGGTNFR.2|HIDLVEGDEGR.3|HIDLVEGDEGR.2|LALLQVR.2|MLPTFVR.2|GQISETLK.2|TVC[CAM]GVVSR.2|LVPDSDVR.2|AEMELGLR.2|GKFNTSDVSAIEK.3|GKFNTSDVSAIEK.2|ITPELLTR.2|DFNPTATVK.2|ASGVEGADVVK.2|FLLSESGSGK.2|QIEETLAHFHLTK.3|RLVPDSDVR.2|RAAQLC[CAM]GAGMAAVVDK.3|FLSQIESDR.2|NILIDFTKK.2|FNTSDVSAIEK.2|LVDEYSLNAGK.2|LNVTVGVDGTLYK.2|AILQQLGLNSTC[CAM]DDSILVK.3|AILQQLGLNSTC[CAM]DDSILVK.2|AAQLC[CAM]GAGMAAVVDK.2|AAQLC[CAM]GAGM[Oxi]AAVVDK.2|GDFIALDLGGSSFR.2|C[CAM]NVSFLLSEDGSGK.2|MC[CAM]INTEWGAFGDDGSLEDIR.3|MC[CAM]INTEWGAFGDDGSLEDIR.2|LGVEPSDDDC[CAM]VSVQHVC[CAM]TIVSFR.3|LPVGFTFSFPC[CAM]QQSK.2|NQNVHMESEVYDTPENIVHGSGSQLFDHVAEC[CAM]LGDFMEK.5|NQNVHMESEVYDTPENIVHGSGSQLFDHVAEC[CAM]LGDFMEK.4
SEN / CTL,Protein kinase C and casein kinase substrate in neurons protein 2,PACSIN2,Q9UNF0,0.48,1.21,5.99E-02,2.35E-02,1.63E+00,"actin cytoskeleton organization,regulation of endocytosis,protein localization to endosome,negative regulation of endocytosis,cell projection morphogenesis,caveola assembly,caveolin-mediated endocytosis,membrane tubulation,cell-cell adhesion","transporter activity,protein binding,cytoskeletal protein binding,lipid binding,identical protein binding,phosphatidic acid binding,cadherin binding involved in cell-cell adhesion","nucleoplasm,cytoplasm,early endosome,cytosol,cytoskeleton,caveola,cell-cell adherens junction,focal adhesion,extrinsic component of membrane,cytoplasmic vesicle membrane,ruffle membrane,intracellular membrane-bounded organelle,recycling endosome membrane,extracellular exosome",21,22,29,AYAQQLTEWAR.2|AIYHDLEQSIR.3|AIYHDLEQSIR.2|HLDLSNVAGYK.3|HLDLSNVAGYK.2|AWMAFMSEAER.2|AWM[Oxi]AFMSEAER.2|EVLLEVQK.2|M[Oxi]EDEDEQGWC[CAM]K.2|MEDEDEQGWC[CAM]K.2|NVSSYEK.2|AADAVEDLR.2|AADAVEDLRWFR.3|RIDDGHRLC[CAM]SDLMNC[CAM]LHER.5|GPQYGTVEK.2|LC[CAM]SDLMNC[CAM]LHER.3|VSELHLEVK.2|ASLMNDDFEK.2|ASLM[Oxi]NDDFEK.2|ADPSLNPEQLK.2|ALYDYEGQEHDELSFK.3|ADPSLNPEQLKK.2|ATDGVTLTGINQTGDQSLPSK.3|ATDGVTLTGINQTGDQSLPSK.2|AGDELTKMEDEDEQGWC[CAM]K.3|GRLDNGQVGLYPANYVEAIQ.3|GRLDNGQVGLYPANYVEAIQ.2|ANHGPGMAMNWPQFEEWSADLNR.3|ELDQGTPQYMENMEQVFEQC[CAM]QQFEEK.3
SEN / CTL,Eukaryotic translation initiation factor 4E,EIF4E,P06730,0.48,0.51,9.68E-02,3.47E-02,1.46E+00,"G1/S transition of mitotic cell cycle,nuclear-transcribed mRNA poly(A) tail shortening,behavioral fear response,RNA export from nucleus,mRNA export from nucleus,translational initiation,regulation of translation,viral process,negative regulation of translation,stem cell population maintenance,lung development,negative regulation of neuron differentiation,positive regulation of mitotic cell cycle","RNA cap binding,translation initiation factor activity,protein binding,enzyme binding,eukaryotic initiation factor 4G binding,poly(A) RNA binding,repressing transcription factor binding","cytoplasmic mRNA processing body,cytoplasm,cytosol,mRNA cap binding complex,cytoplasmic stress granule,eukaryotic translation initiation factor 4F complex,RISC complex,chromatoid body,perinuclear region of cytoplasm,extracellular exosome",6,10,12,WLITLNK.2|IAIWTTEC[CAM]ENR.2|EAVTHIGR.2|TWQANLR.2|IVIGYQSHADTATK.3|IVIGYQSHADTATK.2|WALWFFK.2|LGLPPKIVIGYQSHADTATK.4|IAIWTTEC[CAM]ENREAVTHIGR.4|TESNQEVANPEHYIK.3|TESNQEVANPEHYIK.2|DGIEPMWEDEK.2
SEN / CTL,"Stomatin-like protein 2, mitochondrial",STOML2,Q9UJZ1,0.47,0.28,3.99E-04,3.41E-04,3.47E+00,"mitochondrial calcium ion transport,cellular calcium ion homeostasis,mitochondrion organization,lipid localization,positive regulation of mitochondrial membrane potential,interleukin-2 production,mitochondrial protein processing,CD4-positive, alpha-beta T cell activation,mitochondrial ATP synthesis coupled proton transport,T cell receptor signaling pathway,protein oligomerization,positive regulation of mitochondrial DNA replication,positive regulation of cardiolipin metabolic process,stress-induced mitochondrial fusion","receptor binding,protein binding,GTPase binding,cardiolipin binding","mitochondrial inner membrane,mitochondrial intermembrane space,cytoskeleton,extrinsic component of plasma membrane,membrane raft,immunological synapse,COP9 signalosome,actin cytoskeleton,T cell receptor complex",12,28,44,ILEPGLNILIPVLDR.2|ILEPGLNILIPVLDR.3|ESLNASIVDAINQAADC[CAM]WGIR.3|ESLNASIVDAINQAADC[CAM]WGIR.2|ESMQMQVEAER.2|RATVLESEGTR.3|RATVLESEGTR.2|DIHVPPR.2|YEIKDIHVPPR.3|APVPGTPDSLSSGSSR.3|APVPGTPDSLSSGSSR.2|ESAINVAEGK.2|VKESMQMQVEAER.3|ATVLESEGTR.2|ATVLESEGTRESAINVAEGKK.4|ATVLESEGTRESAINVAEGKK.3|AEQINQAAGEASAVLAK.3|AEQINQAAGEASAVLAK.2|DVQGTDASLDEELDR.3|DVQGTDASLDEELDR.2|RATVLESEGTRESAINVAEGK.4|RATVLESEGTRESAINVAEGK.3|ESAINVAEGKK.2|QAQILASEAEK.2|DVQGTDASLDEELDRVK.3|DVQGTDASLDEELDRVK.2|ILEPGLNILIPVLDRIR.3|KQAQILASEAEK.2|NTVVLFVPQQEAWVVER.3|NTVVLFVPQQEAWVVER.2|QAQILASEAEKAEQINQAAGEASAVLAK.4|QAQILASEAEKAEQINQAAGEASAVLAK.3|ILAAALTQHNGDAAASLTVAEQYVSAFSK.4|ILAAALTQHNGDAAASLTVAEQYVSAFSK.3|KQAQILASEAEKAEQINQAAGEASAVLAK.4|KQAQILASEAEKAEQINQAAGEASAVLAK.3|ASYGVEDPEYAVTQLAQTTMR.3|ASYGVEDPEYAVTQLAQTTM[Oxi]R.3|ASYGVEDPEYAVTQLAQTTMR.2|APVPGTPDSLSSGSSRDVQGTDASLDEELDRVK.4|ERESLNASIVDAINQAADC[CAM]WGIR.3|DSNTILLPSNPGDVTSMVAQAM[Oxi]GVYGALTK.3|DSNTILLPSNPGDVTSMVAQAMGVYGALTK.3|IMDPYKASYGVEDPEYAVTQLAQTTMR.3
SEN / CTL,Ras-related protein Rab-11A;Ras-related protein Rab-11B,RAB11A;RAB11B,P62491;Q15907,0.47,0.26,2.49E-03,1.65E-03,2.78E+00,"cytokinesis,renal water homeostasis,mitotic metaphase plate congression,small GTPase mediated signal transduction,positive regulation of epithelial cell migration,regulation of multivesicular body size,positive regulation of G2/M transition of mitotic cell cycle,protein transport,vesicle-mediated transport,astral microtubule organization,neuron projection development,melanosome transport,multivesicular body assembly,positive regulation of axon extension,regulation of long-term neuronal synaptic plasticity,plasma membrane to endosome transport,regulation of protein transport,establishment of vesicle localization,regulation of vesicle-mediated transport,establishment of protein localization to organelle,protein localization to plasma membrane,establishment of protein localization to membrane,mitotic spindle assembly,exosomal secretion;receptor recycling,small GTPase mediated signal transduction,melanosome transport,transferrin transport,insulin secretion involved in cellular response to glucose stimulus,regulation of anion transport,constitutive secretory pathway,regulated exocytosis,cellular response to acidic pH,establishment of protein localization to membrane,cell-cell adhesion,retrograde transport, endosome to plasma membrane,regulation of protein localization to cell surface,regulation of endocytic recycling","GTPase activity,protein binding,GTP binding,microtubule binding,syntaxin binding,myosin V binding;GTPase activity,protein binding,GTP binding,GDP binding,myosin V binding,cadherin binding involved in cell-cell adhesion","spindle pole,mitochondrion,multivesicular body,Golgi apparatus,trans-Golgi network,cytosol,plasma membrane,transport vesicle,axon,cytoplasmic vesicle membrane,cytoplasmic vesicle,vesicle,cleavage furrow,protein complex,phagocytic vesicle,perinuclear region of cytoplasm,recycling endosome,recycling endosome membrane,extracellular exosome,centrosome,kinetochore microtubule;mitochondrion,microtubule organizing center,plasma membrane,cell-cell adherens junction,synaptic vesicle,aggresome,cell junction,phagocytic vesicle membrane,synaptic vesicle membrane,phagocytic vesicle,recycling endosome,recycling endosome membrane,extracellular exosome",9,3,4,STIGVEFATR.2|VVLIGDSGVGK.2|GAVGALLVYDIAK.2|GAVGALLVYDIAK.3
SEN / CTL,Glycine--tRNA ligase,GARS,P41250,0.47,0.39,3.07E-08,6.98E-08,7.16E+00,"tRNA aminoacylation for protein translation,glycyl-tRNA aminoacylation,diadenosine tetraphosphate biosynthetic process","bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,glycine-tRNA ligase activity,ATP binding,protein dimerization activity","nucleoplasm,cytoplasm,mitochondrial matrix,cytosol,secretory granule,axon,extracellular exosome",27,46,82,LLEFNQGKLPFAAAQIGNSFR.3|TFFSFPAVVAPFK.2|TFFSFPAVVAPFK.3|LGDAVEQGVINNTVLGYFIGR.3|LGDAVEQGVINNTVLGYFIGR.2|TLYVEEVVPNVIEPSFGLGR.3|TLYVEEVVPNVIEPSFGLGR.4|TLYVEEVVPNVIEPSFGLGR.2|SPITGNDLSPPVSFNLMFK.3|SPITGNDLSPPVSFNLM[Oxi]FK.3|SPITGNDLSPPVSFNLM[Oxi]FK.2|SPITGNDLSPPVSFNLMFK.2|ELALQPKDDIVDR.3|ELALQPKDDIVDR.2|KSEMESVLAQLDNYGQQELADLFVNYNVK.4|KSEM[Oxi]ESVLAQLDNYGQQELADLFVNYNVK.3|KSEMESVLAQLDNYGQQELADLFVNYNVK.3|FRQHMENEMAHYAC[CAM]DC[CAM]WDAESK.4|FRQHMENEM[Oxi]AHYAC[CAM]DC[CAM]WDAESK.4|TSGHVDKFADFM[Oxi]VK.4|TSGHVDKFADFMVK.3|TSGHVDKFADFMVK.2|HGVSHKVDDSSGSIGR.4|IMYTVFEHTFHVR.4|IM[Oxi]YTVFEHTFHVR.4|IMYTVFEHTFHVR.3|IM[Oxi]YTVFEHTFHVR.3|IMYTVFEHTFHVR.2|SC[CAM]YDLSC[CAM]HAR.3|SC[CAM]YDLSC[CAM]HAR.2|APQVDVDK.2|ATKVPLVAEKPLKEPK.4|HGVSHKVDDSSGSIGRR.4|IYLYLTK.2|LPFAAAQIGNSFR.3|LPFAAAQIGNSFR.2|YPLFEGQETGKK.3|YPLFEGQETGKK.2|LLEFNQGK.2|EFTMAEIEHFVDPSEKDHPK.5|EFTMAEIEHFVDPSEKDHPK.4|VPLVAEKPLKEPK.3|VPLVAEKPLKEPK.2|APQVDVDKAVAELK.3|LKEDKAPQVDVDK.3|VDDSSGSIGR.2|NNIIQTWR.2|VREFTMAEIEHFVDPSEKDHPK.5|VREFTMAEIEHFVDPSEKDHPK.4|VREFTMAEIEHFVDPSEKDHPK.3|VREFTMAEIEHFVDPSEK.4|VREFTMAEIEHFVDPSEK.3|RLLEFNQGK.2|GEFTIETEGK.2|TVNVVQFEPSKGAIGK.3|FQNVADLHLYLYSAK.3|FQNVADLHLYLYSAK.2|RLLEFNQGKLPFAAAQIGNSFR.4|RLLEFNQGKLPFAAAQIGNSFR.3|QHMENEMAHYAC[CAM]DC[CAM]WDAESK.4|TVNVVQFEPSK.2|EFTMAEIEHFVDPSEK.3|EFTMAEIEHFVDPSEK.2|YPLFEGQETGK.2|YPLFEGQETGKKETIEE.3|C[CAM]SVLPLSQNQEFMPFVK.3|C[CAM]SVLPLSQNQEFM[Oxi]PFVK.3|C[CAM]SVLPLSQNQEFM[Oxi]PFVK.2|C[CAM]SVLPLSQNQEFMPFVK.2|AEISELPSIVQDLANGNITWADVEAR.4|AEISELPSIVQDLANGNITWADVEAR.3|TFIGPGGNM[Oxi]PGYLRPETAQGIFLNFK.4|TFIGPGGNMPGYLRPETAQGIFLNFK.4|TFIGPGGNM[Oxi]PGYLRPETAQGIFLNFK.3|TFIGPGGNMPGYLRPETAQGIFLNFK.3|NGEC[CAM]FRADHLLK.2|TFIGPGGNMPGYLRPETAQGIFLNFKR.4|SSMDGAGAEEVLAPLR.2|TSYGWIEIVGC[CAM]ADR.2|MRLGDAVEQGVINNTVLGYFIGR.3|QHFIQEEQILEIDC[CAM]TM[Oxi]LTPEPVLK.3|QHFIQEEQILEIDC[CAM]TMLTPEPVLK.3
SEN / CTL,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,P31930,0.47,0.97,6.65E-03,3.84E-03,2.42E+00,"oxidative phosphorylation,mitochondrial electron transport, ubiquinol to cytochrome c,aerobic respiration,response to activity,protein processing,response to alkaloid,oxidation-reduction process,hydrogen ion transmembrane transport","metalloendopeptidase activity,ubiquinol-cytochrome-c reductase activity,zinc ion binding,ubiquitin protein ligase binding,protein complex binding","mitochondrion,mitochondrial inner membrane,mitochondrial respiratory chain,mitochondrial respiratory chain complex III,myelin sheath",9,36,66,IAEVDASVVR.2|ADLTEYLSTHYKAPR.4|ADLTEYLSTHYKAPR.3|NALVSHLDGTTPVC[CAM]EDIGR.3|NALVSHLDGTTPVC[CAM]EDIGR.4|NALVSHLDGTTPVC[CAM]EDIGR.2|RIPLAEWESR.3|RIPLAEWESR.2|SGMFWLR.2|ADLTEYLSTHYK.3|ADLTEYLSTHYK.2|NRPGSALEK.2|EHTAYYIK.2|MVLAAAGGVEHQQLLDLAQK.4|M[Oxi]VLAAAGGVEHQQLLDLAQK.4|M[Oxi]VLAAAGGVEHQQLLDLAQK.3|MVLAAAGGVEHQQLLDLAQK.3|MVLAAAGGVEHQQLLDLAQK.2|NRPGSALEKEVESMGAHLNAYSTR.5|NRPGSALEKEVESMGAHLNAYSTR.4|SGMFWLRF.2|LSRADLTEYLSTHYKAPR.4|NNGAGYFLEHLAFK.3|NNGAGYFLEHLAFK.2|IPLAEWESR.2|EVESM[Oxi]GAHLNAYSTR.3|EVESMGAHLNAYSTR.3|EVESMGAHLNAYSTR.2|FETEKNNGAGYFLEHLAFK.4|IAEVDASVVREIC[CAM]SK.3|HLGGIPWTYAEDAVPTLTPC[CAM]R.4|HLGGIPWTYAEDAVPTLTPC[CAM]R.3|HLGGIPWTYAEDAVPTLTPC[CAM]R.2|IDDMMFVLQGQWMR.3|IDDMMFVLQGQWMR.2|LSRADLTEYLSTHYK.3|EMQENDASMR.2|EM[Oxi]QENDASMR.2|EMQENDASM[Oxi]R.2|EM[Oxi]QENDASM[Oxi]R.2|DVVFNYLHATAFQGTPLAQAVEGPSENVRK.5|DVVFNYLHATAFQGTPLAQAVEGPSENVRK.4|DVVFNYLHATAFQGTPLAQAVEGPSENVRK.3|AVELLGDIVQNC[CAM]SLEDSQIEKER.4|AVELLGDIVQNC[CAM]SLEDSQIEKER.3|LC[CAM]TSATESEVAR.2|M[Oxi]KIDDMMFVLQGQWMR.3|LC[CAM]QSFQTFSIC[CAM]YAETGLLGAHFVC[CAM]DR.4|LC[CAM]QSFQTFSIC[CAM]YAETGLLGAHFVC[CAM]DR.3|AVELLGDIVQNC[CAM]SLEDSQIEK.3|AVELLGDIVQNC[CAM]SLEDSQIEK.2|DVVFNYLHATAFQGTPLAQAVEGPSENVR.4|DVVFNYLHATAFQGTPLAQAVEGPSENVR.3|VASEQSSQPTC[CAM]TVGVWIDVGSR.3|VASEQSSQPTC[CAM]TVGVWIDVGSR.2|AVELLGDIVQNC[CAM]SLEDSQIEKERDVILR.4|AVELLGDIVQNC[CAM]SLEDSQIEKERDVILR.3|HRDDALPFAHVAIAVEGPGWASPDNVALQVANAIIGHYDC[CAM]TYGGGVHLSSPLASGAVANK.7|HRDDALPFAHVAIAVEGPGWASPDNVALQVANAIIGHYDC[CAM]TYGGGVHLSSPLASGAVANK.6|EM[Oxi]QENDASMRDVVFNYLHATAFQGTPLAQAVEGPSENVRK.5|EMQENDASM[Oxi]RDVVFNYLHATAFQGTPLAQAVEGPSENVRK.5|EMQENDASMRDVVFNYLHATAFQGTPLAQAVEGPSENVRK.5|YIYDQC[CAM]PAVAGYGPIEQLPDYNR.3|VASEQSSQPTC[CAM]TVGVWIDVGSRFETEK.3|YIYDQC[CAM]PAVAGYGPIEQLPDYNRIR.3|EMQENDASMRDVVFNYLHATAFQGTPLAQAVEGPSENVR.4
SEN / CTL,Histidine triad nucleotide-binding protein 1,HINT1,P49773,0.47,0.74,2.12E-03,1.45E-03,2.84E+00,"transcription, DNA-templated,regulation of transcription, DNA-templated,signal transduction,purine ribonucleotide catabolic process,positive regulation of calcium-mediated signaling,intrinsic apoptotic signaling pathway by p53 class mediator","nucleotide binding,protein kinase C binding,hydrolase activity","histone deacetylase complex,nucleus,cytoplasm,cytoskeleton,plasma membrane,extracellular exosome",21,13,35,AQVARPGGDTIFGK.3|AQVARPGGDTIFGK.2|IIFEDDRC[CAM]LAFHDISPQAPTHFLVIPK.4|IIFEDDRC[CAM]LAFHDISPQAPTHFLVIPK.5|IIFEDDRC[CAM]LAFHDISPQAPTHFLVIPK.6|KHISQISVAEDDDESLLGHLMIVGKK.5|KHISQISVAEDDDESLLGHLM[Oxi]IVGKK.5|KHISQISVAEDDDESLLGHLMIVGKK.4|MVVNEGSDGGQSVYHVHLHVLGGR.5|MVVNEGSDGGQSVYHVHLHVLGGR.4|M[Oxi]VVNEGSDGGQSVYHVHLHVLGGR.5|M[Oxi]VVNEGSDGGQSVYHVHLHVLGGR.4|M[Oxi]VVNEGSDGGQSVYHVHLHVLGGR.3|MVVNEGSDGGQSVYHVHLHVLGGR.3|C[CAM]LAFHDISPQAPTHFLVIPK.4|C[CAM]LAFHDISPQAPTHFLVIPK.5|C[CAM]LAFHDISPQAPTHFLVIPK.3|C[CAM]LAFHDISPQAPTHFLVIPK.2|C[CAM]AADLGLNKGYR.3|C[CAM]AADLGLNKGYR.2|PGGDTIFGK.2|IIFEDDR.2|C[CAM]AADLGLNK.2|KC[CAM]AADLGLNK.2|HISQISVAEDDDESLLGHLMIVGKK.5|HISQISVAEDDDESLLGHLMIVGKK.4|HISQISVAEDDDESLLGHLM[Oxi]IVGKK.4|KHISQISVAEDDDESLLGHLM[Oxi]IVGK.5|KHISQISVAEDDDESLLGHLMIVGK.5|KHISQISVAEDDDESLLGHLMIVGK.4|KHISQISVAEDDDESLLGHLM[Oxi]IVGK.4|KHISQISVAEDDDESLLGHLMIVGK.3|HISQISVAEDDDESLLGHLMIVGK.4|HISQISVAEDDDESLLGHLM[Oxi]IVGK.4|HISQISVAEDDDESLLGHLMIVGK.3
SEN / CTL,Myosin-9,MYH9,P35579,0.46,0.86,1.51E-19,1.69E-18,1.78E+01,"meiotic spindle organization,cytokinesis,angiogenesis,in utero embryonic development,establishment of T cell polarity,membrane protein ectodomain proteolysis,phagocytosis, engulfment,integrin-mediated signaling pathway,myoblast fusion,regulation of cell shape,protein transport,actin filament-based movement,platelet formation,monocyte differentiation,actomyosin structure organization,actin cytoskeleton reorganization,uropod organization,blood vessel endothelial cell migration,leukocyte migration,establishment of meiotic spindle localization,platelet aggregation,negative regulation of actin filament severing,positive regulation of protein processing in phagocytic vesicle","microfilament motor activity,motor activity,actin binding,protein binding,calmodulin binding,ATP binding,ATPase activity,protein domain specific binding,actin-dependent ATPase activity,protein homodimerization activity,protein anchor,ADP binding,poly(A) RNA binding,actin filament binding,cadherin binding involved in cell-cell adhesion","stress fiber,ruffle,uropod,nucleus,cytoplasm,spindle,actomyosin contractile ring,cytosol,plasma membrane,brush border,cell-cell adherens junction,actin cytoskeleton,membrane,myosin II complex,extracellular matrix,cell leading edge,neuromuscular junction,cleavage furrow,actomyosin,protein complex,extracellular exosome,myosin II filament,immunological synapse,focal adhesion,COP9 signalosome,integrin complex",609,240,477,LQQELDDLLVDLDHQR.3|LQQELDDLLVDLDHQR.2|VSHLLGINVTDFTR.3|VSHLLGINVTDFTR.2|ALELDSNLYR.2|LQVELDNVTGLLSQSDSK.3|LQVELDNVTGLLSQSDSK.2|ANLQIDQINTDLNLER.2|ANLQIDQINTDLNLER.3|VIQYLAYVASSHK.3|VIQYLAYVASSHK.2|TRLQQELDDLLVDLDHQR.3|TRLQQELDDLLVDLDHQR.4|IAQLEEQLDNETKER.3|IAQLEEQLDNETKER.2|IAEFTTNLTEEEEKSK.3|IAEFTTNLTEEEEKSK.2|DFSALESQLQDTQELLQEENRQK.3|DFSALESQLQDTQELLQEENRQK.4|QKHSQAVEELAEQLEQTKR.4|QKHSQAVEELAEQLEQTKR.5|QKHSQAVEELAEQLEQTKR.3|M[Oxi]EDSVGC[CAM]LETAEEVKR.3|MEDSVGC[CAM]LETAEEVKR.3|EQADFAIEALAK.2|DLGEELEALKTELEDTLDSTAAQQELR.3|DLGEELEALKTELEDTLDSTAAQQELR.4|RKLEGDSTDLSDQIAELQAQIAELK.4|RKLEGDSTDLSDQIAELQAQIAELK.3|QGFPNRVVFQEFR.3|ALEQQVEEMKTQLEELEDELQATEDAKLR.4|KLEGDSTDLSDQIAELQAQIAELK.3|KLEGDSTDLSDQIAELQAQIAELK.4|IAQLEEELEEEQGNTELINDRLK.3|IAQLEEELEEEQGNTELINDRLK.4|TDLLLEPYNKYR.3|TDLLLEPYNKYR.2|DQGELERQLLQANPILEAFGNAK.3|VEDMAELTC[CAM]LNEASVLHNLKER.4|NLPIYSEEIVEMYKGK.3|AQTKEQADFAIEALAK.3|GDLPFVVPR.2|LKSMEAEMIQLQEELAAAER.3|IRELESQISELQEDLESERASR.4|VVFQEFR.2|QLEEAEEEAQRANASR.3|YKASITALEAK.2|KQELEEIC[CAM]HDLEARVEEEEER.4|QRYEILTPNSIPK.3|QRYEILTPNSIPK.2|LTKDFSALESQLQDTQELLQEENR.3|LTKDFSALESQLQDTQELLQEENR.4|TFHIFYYLLSGAGEHLKTDLLLEPYNKYR.5|TFHIFYYLLSGAGEHLKTDLLLEPYNKYR.6|VISGVLQLGNIVFK.2|VISGVLQLGNIVFK.3|ASREEILAQAKENEK.4|ASREEILAQAKENEK.3|IAQLEEELEEEQGNTELINDR.3|IAQLEEELEEEQGNTELINDR.4|ELESQISELQEDLESER.3|ELESQISELQEDLESER.2|AKQTLENERGELANEVK.4|AKQTLENERGELANEVK.3|YEILTPNSIPK.2|FSKVEDMAELTC[CAM]LNEASVLHNLKER.5|FSKVEDMAELTC[CAM]LNEASVLHNLKER.4|AGVLAHLEEERDLKITDVIIGFQAC[CAM]C[CAM]R.4|ASITALEAK.2|RGDLPFVVPR.2|DLKITDVIIGFQAC[CAM]C[CAM]R.3|VISGVLQLGNIVFKK.3|VISGVLQLGNIVFKK.2|KLEEEQIILEDQNC[CAM]K.3|KLEEEQIILEDQNC[CAM]K.2|KANLQIDQINTDLNLER.3|KANLQIDQINTDLNLER.2|KANLQIDQINTDLNLER.4|LKKLEEEQIILEDQNC[CAM]K.3|LKKLEEEQIILEDQNC[CAM]K.4|LKKLEEEQIILEDQNC[CAM]K.2|KMQQNIQELEEQLEEEESAR.3|KM[Oxi]QQNIQELEEQLEEEESAR.3|KMQQNIQELEEQLEEEESAR.4|KVIQYLAYVASSHK.3|KVIQYLAYVASSHK.4|ALEEAMEQKAELER.3|ALEEAMEQKAELER.2|ALEEAM[Oxi]EQKAELER.2|ALEEAM[Oxi]EQKAELER.3|ALEQQVEEMKTQLEELEDELQATEDAK.4|ALEQQVEEMKTQLEELEDELQATEDAK.3|ALEQQVEEM[Oxi]KTQLEELEDELQATEDAK.3|HSQAVEELAEQLEQTKR.3|HSQAVEELAEQLEQTKR.4|HSQAVEELAEQLEQTKR.2|KAGKLDPHLVLDQLR.4|KAGKLDPHLVLDQLR.3|KAGKLDPHLVLDQLR.2|TFHIFYYLLSGAGEHLK.3|TFHIFYYLLSGAGEHLK.4|TFHIFYYLLSGAGEHLK.2|SMMQDREDQSILC[CAM]TGESGAGKTENTK.4|SMM[Oxi]QDREDQSILC[CAM]TGESGAGKTENTK.4|SMMQDREDQSILC[CAM]TGESGAGKTENTK.3|IAQLEEQLDNETK.2|IAQLEEQLDNETK.3|KMEDSVGC[CAM]LETAEEVKR.4|KMEDSVGC[CAM]LETAEEVKR.3|KM[Oxi]EDSVGC[CAM]LETAEEVKR.3|KM[Oxi]EDSVGC[CAM]LETAEEVKR.4|KMEDSVGC[CAM]LETAEEVKR.2|IRELESQISELQEDLESER.3|IRELESQISELQEDLESER.4|IRELESQISELQEDLESER.2|ELEDATETADAMNR.2|ELEDATETADAMNR.3|ELEDATETADAM[Oxi]NR.2|QAQQERDELADEIANSSGK.3|QAQQERDELADEIANSSGK.2|QAQQERDELADEIANSSGK.4|KQELEEIC[CAM]HDLEAR.4|KQELEEIC[CAM]HDLEAR.3|KQELEEIC[CAM]HDLEAR.2|ITDVIIGFQAC[CAM]C[CAM]R.2|LQLQEQLQAETELC[CAM]AEAEELRAR.3|EQEVNILK.2|FVSELWK.2|LRLEVNLQAMK.3|LRLEVNLQAMK.2|LRLEVNLQAM[Oxi]K.3|LRLEVNLQAM[Oxi]K.2|NMDPLNDNIATLLHQSSDKFVSELWKDVDR.4|NMDPLNDNIATLLHQSSDKFVSELWKDVDR.5|NM[Oxi]DPLNDNIATLLHQSSDKFVSELWKDVDR.4|NM[Oxi]DPLNDNIATLLHQSSDKFVSELWKDVDR.5|TLEEEAKTHEAQIQEMR.4|TLEEEAKTHEAQIQEMR.3|TLEEEAKTHEAQIQEM[Oxi]R.4|TLEEEAKTHEAQIQEM[Oxi]R.2|IIGLDQVAGMSETALPGAFK.3|IIGLDQVAGMSETALPGAFK.2|IIGLDQVAGM[Oxi]SETALPGAFK.3|IIGLDQVAGM[Oxi]SETALPGAFK.2|DFSALESQLQDTQELLQEENR.3|DFSALESQLQDTQELLQEENR.4|LEVNLQAMK.2|LEVNLQAM[Oxi]K.2|KTLEEEAKTHEAQIQEMR.4|KTLEEEAKTHEAQIQEMR.3|KTLEEEAKTHEAQIQEM[Oxi]R.4|NLPIYSEEIVEMYK.3|NLPIYSEEIVEMYK.2|NLPIYSEEIVEM[Oxi]YK.2|EMEAELEDER.2|EM[Oxi]EAELEDER.2|ELEDATETADAMNREVSSLK.3|ELEDATETADAM[Oxi]NREVSSLK.3|QIATLHAQVADMK.3|QIATLHAQVADMK.2|QIATLHAQVADM[Oxi]K.3|QIATLHAQVADM[Oxi]K.2|LTKDFSALESQLQDTQELLQEENRQK.4|LTKDFSALESQLQDTQELLQEENRQK.3|LKDVLLQVDDERR.4|LKDVLLQVDDERR.3|LKDVLLQVDDERR.2|LQRELEDATETADAMNR.3|LQRELEDATETADAMNR.4|QTLENERGELANEVK.3|QTLENERGELANEVK.2|DVLLQVDDERR.3|DVLLQVDDERR.2|KKVEAQLQELQVK.3|KKVEAQLQELQVK.2|RQLEEAEEEAQRANASR.4|RQLEEAEEEAQRANASR.3|INFDVNGYIVGANIETYLLEK.3|INFDVNGYIVGANIETYLLEK.2|HSQAVEELAEQLEQTK.3|HSQAVEELAEQLEQTK.2|IAEFTTNLTEEEEK.2|IAEFTTNLTEEEEK.3|RQAQQERDELADEIANSSGK.4|RQAQQERDELADEIANSSGK.3|QFRTEMEDLMSSKDDVGK.4|QFRTEMEDLMSSKDDVGK.3|GALALEEK.2|IMGIPEEEQMGLLR.2|IMGIPEEEQMGLLR.3|IM[Oxi]GIPEEEQMGLLR.2|IMGIPEEEQM[Oxi]GLLR.2|IM[Oxi]GIPEEEQM[Oxi]GLLR.2|SMEAEMIQLQEELAAAER.3|SMEAEMIQLQEELAAAER.2|SM[Oxi]EAEMIQLQEELAAAER.3|SMEAEM[Oxi]IQLQEELAAAER.3|SM[Oxi]EAEMIQLQEELAAAER.2|SMEAEM[Oxi]IQLQEELAAAER.2|DVDRIIGLDQVAGMSETALPGAFK.3|DVDRIIGLDQVAGMSETALPGAFK.4|DVDRIIGLDQVAGM[Oxi]SETALPGAFK.3|SMMQDREDQSILC[CAM]TGESGAGK.3|SMM[Oxi]QDREDQSILC[CAM]TGESGAGK.3|SM[Oxi]MQDREDQSILC[CAM]TGESGAGK.3|SMMQDREDQSILC[CAM]TGESGAGK.2|MQQNIQELEEQLEEEESAR.3|MQQNIQELEEQLEEEESAR.2|M[Oxi]QQNIQELEEQLEEEESAR.3|M[Oxi]QQNIQELEEQLEEEESAR.2|LTEMETLQSQLMAEK.3|LTEMETLQSQLMAEK.2|LTEM[Oxi]ETLQSQLMAEK.3|LTEM[Oxi]ETLQSQLMAEK.2|LTEMETLQSQLM[Oxi]AEK.2|SGFEPASLKEEVGEEAIVELVENGKK.4|SGFEPASLKEEVGEEAIVELVENGKK.3|KVEAQLQELQVK.3|KVEAQLQELQVK.2|LRRGDLPFVVPR.3|VKLQEMEGTVK.3|VKLQEM[Oxi]EGTVK.3|VKLQEMEGTVK.2|VKLQEM[Oxi]EGTVK.2|KMEDSVGC[CAM]LETAEEVK.3|KM[Oxi]EDSVGC[CAM]LETAEEVK.3|KMEDSVGC[CAM]LETAEEVK.2|KM[Oxi]EDSVGC[CAM]LETAEEVK.2|NFINNPLAQADWAAK.2|NFINNPLAQADWAAK.3|QAQQERDELADEIANSSGKGALALEEK.4|QAQQERDELADEIANSSGKGALALEEK.3|NMDPLNDNIATLLHQSSDKFVSELWK.4|NM[Oxi]DPLNDNIATLLHQSSDKFVSELWK.4|NMDPLNDNIATLLHQSSDKFVSELWK.3|QLEEAEEEAQR.2|QLEEAEEEAQR.3|FLSNGHVTIPGQQDKDMFQETMEAMR.4|FLSNGHVTIPGQQDKDMFQETMEAMR.3|FLSNGHVTIPGQQDKDM[Oxi]FQETMEAM[Oxi]R.4|FLSNGHVTIPGQQDKDM[Oxi]FQETMEAMR.4|FLSNGHVTIPGQQDKDMFQETM[Oxi]EAMR.4|FLSNGHVTIPGQQDKDMFQETMEAM[Oxi]R.4|TEMEDLMSSKDDVGK.3|TEM[Oxi]EDLMSSKDDVGK.3|TEMEDLM[Oxi]SSKDDVGK.3|TEM[Oxi]EDLM[Oxi]SSKDDVGK.3|TEMEDLMSSKDDVGK.2|HEMPPHIYAITDTAYR.4|HEMPPHIYAITDTAYR.3|HEM[Oxi]PPHIYAITDTAYR.4|HEM[Oxi]PPHIYAITDTAYR.3|HEMPPHIYAITDTAYR.2|MQQNIQELEEQLEEEESARQK.3|MQQNIQELEEQLEEEESARQK.4|M[Oxi]QQNIQELEEQLEEEESARQK.3|LKNKHEAMITDLEER.4|LKNKHEAM[Oxi]ITDLEER.4|LKNKHEAM[Oxi]ITDLEER.3|LKNKHEAMITDLEER.3|LKNKHEAMITDLEER.2|KRHEMPPHIYAITDTAYR.4|KRHEM[Oxi]PPHIYAITDTAYR.4|KRHEMPPHIYAITDTAYR.3|DELADEIANSSGK.2|DELADEIANSSGK.3|TVGQLYKEQLAK.3|TVGQLYKEQLAK.2|QLAAENRLTEMETLQSQLMAEK.3|QEEEMMAKEEELVK.3|QEEEM[Oxi]MAKEEELVK.3|QEEEMM[Oxi]AKEEELVK.3|QEEEMMAKEEELVK.2|LEEEQIILEDQNC[CAM]K.2|LEEEQIILEDQNC[CAM]K.3|QAC[CAM]VLMIK.2|QAC[CAM]VLM[Oxi]IK.2|EM[Oxi]EAELEDERK.3|EMEAELEDERK.3|EMEAELEDERK.2|EM[Oxi]EAELEDERK.2|KLKDVLLQVDDER.3|RHEMPPHIYAITDTAYR.4|RHEMPPHIYAITDTAYR.5|RHEM[Oxi]PPHIYAITDTAYR.4|RHEM[Oxi]PPHIYAITDTAYR.3|RHEMPPHIYAITDTAYR.3|RHEMPPHIYAITDTAYR.2|KFDQLLAEEKTISAK.3|KFDQLLAEEKTISAK.4|KFDQLLAEEKTISAK.2|QIATLHAQVADMKK.3|QIATLHAQVADM[Oxi]KK.3|QIATLHAQVADMKK.2|EQLEEEEEAKHNLEK.3|EQLEEEEEAKHNLEK.4|EQLEEEEEAKHNLEK.2|NKHEAMITDLEER.3|NKHEAM[Oxi]ITDLEER.4|NKHEAM[Oxi]ITDLEER.3|NKHEAM[Oxi]ITDLEER.2|NKHEAMITDLEER.2|ALEQQVEEMK.2|ALEQQVEEM[Oxi]K.2|LQRELEDATETADAMNREVSSLK.4|LQRELEDATETADAMNREVSSLK.3|LQEMEGTVK.2|LQEM[Oxi]EGTVK.2|VEAQLQELQVK.2|VEAQLQELQVK.3|ASREEILAQAK.3|ASREEILAQAK.2|DLEAHIDSANK.3|DLEAHIDSANK.2|QLAAENR.2|TDLLLEPYNK.3|TDLLLEPYNK.2|THEAQIQEMR.3|THEAQIQEM[Oxi]R.3|THEAQIQEMR.2|THEAQIQEM[Oxi]R.2|TLEEEAK.2|QVEDEKNSFR.3|QVEDEKNSFR.2|REQEVNILKK.3|SVHELEK.2|VRTELADKVTK.3|DQGELER.2|GELANEVK.2|NAEQYKDQADKASTR.4|NAEQYKDQADKASTR.3|DC[CAM]MRELDDTR.3|KLEMDLK.2|NAEQYKDQADK.3|NAEQYKDQADK.2|HEAMITDLEER.3|HEAM[Oxi]ITDLEER.3|HEAMITDLEER.2|HEAM[Oxi]ITDLEER.2|SKREQEVNILK.3|KGAGDGSDEEVDGK.3|RALEQQVEEMK.3|RALEQQVEEM[Oxi]K.3|RALEQQVEEMK.2|RALEQQVEEM[Oxi]K.2|VEEEAAQK.2|DLEGLSQR.2|LVWVPSDK.2|SGFEPASLK.2|SKYKASITALEAK.3|KTLEEEAK.2|QSAC[CAM]NLEK.2|ADGAEAKPAE.2|DLQGRDEQSEEK.3|DLQGRDEQSEEK.2|LKDVLLQVDDER.3|LKDVLLQVDDER.2|VNKDDIQK.2|KDQGELER.2|RNAEQYKDQADK.3|VLLQGKGDSEHKR.3|VLLQGKGDSEHKR.2|DLEAHIDSANKNR.3|GALALEEKR.2|LKQVEDEK.2|RQLEEAEEEAQR.3|RQLEEAEEEAQR.2|YRFLSNGHVTIPGQQDK.4|YRFLSNGHVTIPGQQDK.3|KKLEMDLK.2|LKQVEDEKNSFR.3|LKQVEDEKNSFR.2|QLEEAEEEAQRANASRR.4|TELADKVTK.2|C[CAM]QHLQAEK.2|ALEEAMEQK.2|ALEEAM[Oxi]EQK.2|KLEMDLKDLEAHIDSANK.4|QKHSQAVEELAEQLEQTK.4|QKHSQAVEELAEQLEQTK.3|QKHSQAVEELAEQLEQTK.2|VAAYDKLEK.2|VKPLLQVSR.2|FDQLLAEEKTISAK.3|KLVWVPSDK.2|KVEAQLQELQVKFNEGER.4|QFRTEMEDLMSSK.3|TENTKKVIQYLAYVASSHK.4|EQEVNILKK.2|FLSNGHVTIPGQQDK.3|FLSNGHVTIPGQQDK.2|QELEEIC[CAM]HDLEAR.3|QELEEIC[CAM]HDLEAR.2|REQEVNILK.2|C[CAM]IIPNHEKK.2|KGAGDGSDEEVDGKADGAEAKPAE.4|KGAGDGSDEEVDGKADGAEAKPAE.3|NSFREQLEEEEEAK.3|NSFREQLEEEEEAK.2|VMQEQGTHPK.2|VM[Oxi]QEQGTHPK.2|EEVGEEAIVELVENGK.3|EEVGEEAIVELVENGK.2|TEMEDLMSSK.2|TEM[Oxi]EDLMSSK.2|TEMEDLM[Oxi]SSK.2|TEM[Oxi]EDLM[Oxi]SSK.2|NSFREQLEEEEEAKHNLEK.4|VKVNKDDIQK.2|NFINNPLAQADWAAKK.3|DVLLQVDDER.2|KIRELESQISELQEDLESER.4|KIRELESQISELQEDLESER.3|TKTRLQQELDDLLVDLDHQR.4|EQLEEEEEAK.2|GAGDGSDEEVDGK.2|LEGDSTDLSDQIAELQAQIAELK.4|LEGDSTDLSDQIAELQAQIAELK.3|EEVGEEAIVELVENGKK.3|EEVGEEAIVELVENGKK.2|GAGDGSDEEVDGKADGAEAK.3|LLEDRIAEFTTNLTEEEEKSK.4|LLEDRIAEFTTNLTEEEEKSK.3|TRLQQELDDLLVDLDHQRQSAC[CAM]NLEK.5|TRLQQELDDLLVDLDHQRQSAC[CAM]NLEK.4|VEEEEERC[CAM]QHLQAEK.3|LQKDLEGLSQR.2|TELEDTLDSTAAQQELR.3|TELEDTLDSTAAQQELR.2|ELDDTRASREEILAQAK.3|KKMEDSVGC[CAM]LETAEEVK.3|KKM[Oxi]EDSVGC[CAM]LETAEEVK.3|KKM[Oxi]QQNIQELEEQLEEEESAR.4|KKM[Oxi]QQNIQELEEQLEEEESAR.3|VLLQGKGDSEHK.2|ASITALEAKIAQLEEQLDNETKER.4|KDQGELERQLLQANPILEAFGNAK.4|DLEAHIDSANKNRDEAIK.3|KMQQNIQELEEQLEEEESARQK.4|KMQQNIQELEEQLEEEESARQK.3|AQFERDLQGRDEQSEEK.3|DMFQETMEAMR.2|DMFQETM[Oxi]EAMR.2|DMFQETMEAM[Oxi]R.2|LEEEQIILEDQNC[CAM]KLAK.3|TVGQLYKEQLAKLMATLR.3|DVLLQVDDERRNAEQYK.3|PAGPPGILALLDEEC[CAM]WFPK.3|PAGPPGILALLDEEC[CAM]WFPK.2|IAQLEEELEEEQGNTELINDRLKK.4|IAQLEEELEEEQGNTELINDRLKK.3|KEEELQAALARVEEEAAQK.3|NM[Oxi]DPLNDNIATLLHQSSDK.3|NMDPLNDNIATLLHQSSDK.3|NM[Oxi]DPLNDNIATLLHQSSDK.2|NMDPLNDNIATLLHQSSDK.2|DLEGLSQRHEEK.2|GAGDGSDEEVDGKADGAEAKPAE.3|GAGDGSDEEVDGKADGAEAKPAE.2|LQQELDDLLVDLDHQRQSAC[CAM]NLEK.4|LQQELDDLLVDLDHQRQSAC[CAM]NLEK.3|KLEEEQIILEDQNC[CAM]KLAK.3|TELADKVTKLQVELDNVTGLLSQSDSK.4|TELADKVTKLQVELDNVTGLLSQSDSK.3|ELESQISELQEDLESERASR.3|NTDQASM[Oxi]PDNTAAQKVSHLLGINVTDFTR.4|NTDQASM[Oxi]PDNTAAQKVSHLLGINVTDFTR.3|RDLGEELEALKTELEDTLDSTAAQQELR.4|RDLGEELEALKTELEDTLDSTAAQQELR.3|YLYVDKNFINNPLAQADWAAK.3|RALEQQVEEMKTQLEELEDELQATEDAK.4|DFSALESQLQDTQELLQEENRQKLSLSTK.4|DFSALESQLQDTQELLQEENRQKLSLSTK.3|LQLQEQLQAETELC[CAM]AEAEELR.3|MEDSVGC[CAM]LETAEEVK.2|M[Oxi]EDSVGC[CAM]LETAEEVK.2|SGFEPASLKEEVGEEAIVELVENGK.3
SEN / CTL,LIM and SH3 domain protein 1,LASP1,Q14847,0.46,0.37,3.66E-07,6.72E-07,6.17E+00,"ion transport,positive regulation of signal transduction,ion transmembrane transport,cell-cell adhesion","SH3/SH2 adaptor activity,protein binding,zinc ion binding,ion transmembrane transporter activity,actin filament binding,cadherin binding involved in cell-cell adhesion","cytoplasm,cell-cell adherens junction,focal adhesion,cortical actin cytoskeleton,extracellular exosome",36,20,35,GKGFSVVADTPELQR.3|RPLEQQQPHHIPTSAPVYQQPQQQPVAQSYGGYKEPAAPVSIQR.6|RPLEQQQPHHIPTSAPVYQQPQQQPVAQSYGGYKEPAAPVSIQR.5|RPLEQQQPHHIPTSAPVYQQPQQQPVAQSYGGYKEPAAPVSIQR.7|GFSVVADTPELQR.2|GFSVVADTPELQR.3|TQDQISNIKYHEEFEK.4|TQDQISNIKYHEEFEK.3|QSFTMVADTPENLR.2|QSFTMVADTPENLR.3|QSFTM[Oxi]VADTPENLR.2|TGDTGMLPANYVEAI.2|TGDTGM[Oxi]LPANYVEAI.2|RPLEQQQPHHIPTSAPVYQQPQQQPVAQSYGGYK.4|RPLEQQQPHHIPTSAPVYQQPQQQPVAQSYGGYK.6|RPLEQQQPHHIPTSAPVYQQPQQQPVAQSYGGYK.5|AC[CAM]FHC[CAM]ETC[CAM]K.3|AC[CAM]FHC[CAM]ETC[CAM]K.2|KPYC[CAM]NAHYPK.3|KPYC[CAM]NAHYPK.2|LKQQSELQSQVR.3|LKQQSELQSQVR.2|YKEEFEK.2|YHEEFEK.2|M[Oxi]GPSGGEGMEPERR.3|MGPSGGEGM[Oxi]EPERR.3|MGPSGGEGMEPERR.3|M[Oxi]GPSGGEGM[Oxi]EPERR.3|DSQDGSSYR.2|TQDQISNIK.2|EPAAPVSIQR.2|KTQDQISNIK.2|QQSELQSQVR.2|MGPSGGEGMEPER.2|DSQDGSSYRRPLEQQQPHHIPTSAPVYQQPQQQPVAQSYGGYK.6
SEN / CTL,Integrin alpha-V,ITGAV,P06756,0.46,0.50,1.10E-03,8.27E-04,3.08E+00,"angiogenesis,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,cell adhesion,cell-matrix adhesion,integrin-mediated signaling pathway,positive regulation of cell proliferation,negative regulation of macrophage derived foam cell differentiation,negative regulation of lipid storage,cell growth,cell migration,extracellular matrix organization,positive regulation of cell migration,cell-substrate adhesion,negative regulation of lipid transport,cell adhesion mediated by integrin,positive regulation of osteoblast proliferation,heterotypic cell-cell adhesion,substrate adhesion-dependent cell spreading,endodermal cell differentiation,apolipoprotein A-I-mediated signaling pathway,apoptotic cell clearance,negative regulation of low-density lipoprotein particle receptor biosynthetic process,positive regulation of cell adhesion,viral entry into host cell,vascular endothelial growth factor receptor signaling pathway,negative regulation of lipoprotein metabolic process,regulation of phagocytosis,leukocyte migration,negative chemotaxis,entry of symbiont into host cell by promotion of host phagocytosis,ERK1 and ERK2 cascade,calcium ion transmembrane transport,extrinsic apoptotic signaling pathway in absence of ligand,regulation of apoptotic cell clearance,negative regulation of entry of bacterium into host cell,negative regulation of extrinsic apoptotic signaling pathway","virus receptor activity,fibronectin binding,protease binding,voltage-gated calcium channel activity,protein binding,coreceptor activity,metal ion binding,transforming growth factor beta binding,extracellular matrix binding,extracellular matrix protein binding,opsonin binding,protein kinase C binding,fibroblast growth factor binding,C-X3-C chemokine binding,insulin-like growth factor I binding,neuregulin binding","plasma membrane,integral component of plasma membrane,focal adhesion,integrin complex,external side of plasma membrane,cell surface,membrane,lamellipodium membrane,filopodium membrane,microvillus membrane,ruffle membrane,integrin alphav-beta3 complex,integrin alphav-beta5 complex,integrin alphav-beta8 complex,alphav-beta3 integrin-IGF-1-IGF1R complex,phagocytic vesicle,extracellular exosome",30,49,56,ILAC[CAM]APLYHWR.3|IYIGDDNPLTLIVK.2|GATDIDKNGYPDLIVGAFGVDR.3|LTPITIFMEYR.2|LNGFEVFAR.2|MFLLVGAPK.2|M[Oxi]FLLVGAPK.2|STGLNAVPSQILEGQWAAR.3|STGLNAVPSQILEGQWAAR.2|GSDGKLQEVGQVSVSLQR.3|SSASFNVIEFPYK.2|SSASFNVIEFPYK.3|DLALSEGDIHTLGC[CAM]GVAQC[CAM]LK.3|DLALSEGDIHTLGC[CAM]GVAQC[CAM]LK.2|LEVSVDSDQKK.3|LEVSVDSDQKK.2|ALFLYSR.2|AMLHLQWPYK.3|NNGPSSFSK.2|ASGDFQTTK.2|YNNQLATR.2|AGTQLLAGLR.2|QAHILLDC[CAM]GEDNVC[CAM]KPK.4|QAHILLDC[CAM]GEDNVC[CAM]KPK.3|SKQDKILAC[CAM]APLYHWR.4|TVEYAPC[CAM]R.2|GIVYIFNGR.2|TC[CAM]SLPGTALK.2|VSPVVSHKVDLAVLAAVEIR.4|YDPNVYSIK.2|LEVSVDSDQK.2|SHQWFGASVR.2|QAHILLDC[CAM]GEDNVC[CAM]K.3|TEMKQEREPVGTC[CAM]FLQDGTK.4|FDLQIQSSNLFDKVSPVVSHK.4|QEREPVGTC[CAM]FLQDGTK.3|QEREPVGTC[CAM]FLQDGTK.2|QVVC[CAM]DLGNPMK.2|TLGMVYIYDGK.2|ASGDFQTTKLNGFEVFAR.3|LNFQVELLLDK.2|DYAKDDPLEFK.2|SLLWTETFMNK.2|C[CAM]QPIEFDATGNR.2|LQEVGQVSVSLQR.2|EPVGTC[CAM]FLQDGTK.2|FDLQIQSSNLFDK.2|ENPETEEDVGPVVQHIYELR.3|NGYPDLIVGAFGVDR.2|FSVHQQSEMDTSVK.2|GGLMQC[CAM]EELIAYLR.2|EQLQPHENGEGNSET.2|KIYIGDDNPLTLIVK.2|VLLGGPGSFYWQGQLISDQVAEIVSK.3|FGSAIAPLGDLDQDGFNDIAIAAPYGGEDK.3|FGSAIAPLGDLDQDGFNDIAIAAPYGGEDKK.3
SEN / CTL,Coronin-1C,CORO1C,Q9ULV4,0.46,0.88,4.47E-03,2.70E-03,2.57E+00,"neural crest cell migration,regulation of protein phosphorylation,negative regulation of protein phosphorylation,phagocytosis,signal transduction,regulation of epithelial cell migration,negative regulation of epithelial cell migration,regulation of fibroblast migration,actin cytoskeleton organization,negative regulation of protein kinase activity by regulation of protein phosphorylation,establishment of protein localization,regulation of focal adhesion assembly,negative regulation of focal adhesion assembly,activation of GTPase activity,regulation of substrate adhesion-dependent cell spreading,negative regulation of substrate adhesion-dependent cell spreading,regulation of ruffle assembly,positive regulation of lamellipodium morphogenesis","protein binding,Rac GTPase binding,actin filament binding","cytoplasm,focal adhesion,actin cytoskeleton,lateral plasma membrane,flotillin complex,lamellipodium,vesicle",27,36,54,VTWDSSFC[CAM]AVNPR.2|NADPILISLK.2|AIFLADGNVFTTGFSR.3|AIFLADGNVFTTGFSR.2|YFEITDESPYVHYLNTFSSKEPQR.4|YFEITDESPYVHYLNTFSSKEPQR.3|VGIVAWHPTAR.3|VGIVAWHPTAR.2|HVFGQAVKNDQC[CAM]YDDIR.4|HVFGQAVKNDQC[CAM]YDDIR.3|SIKDTIC[CAM]NQDER.3|SIKDTIC[CAM]NQDER.2|KC[CAM]EPIIMTVPR.3|KC[CAM]EPIIM[Oxi]TVPR.3|KC[CAM]EPIIMTVPR.2|KC[CAM]EPIIM[Oxi]TVPR.2|KQEIVAEKEK.3|KQEIVAEKEK.2|NDQC[CAM]YDDIR.3|NDQC[CAM]YDDIR.2|NILDSKPTANK.3|NILDSKPTANK.2|GLDVNKC[CAM]EIAR.3|GLDVNKC[CAM]EIAR.2|LEQQMAK.2|HVFGQAVK.2|NILDSKPTANKK.3|RVGIVAWHPTAR.3|KTTDTASVQNEAK.3|KTTDTASVQNEAK.2|KQEIVAEK.2|C[CAM]DLISIPK.2|RGLDVNKC[CAM]EIAR.3|QLALWNPK.2|KTTDTASVQNEAKLDEILK.4|KTTDTASVQNEAKLDEILK.3|NGSLIC[CAM]TASK.2|C[CAM]DLISIPKK.2|KC[CAM]DLISIPK.2|DTIC[CAM]NQDER.2|TTDTASVQNEAKLDEILKEIK.4|ISKLEQQMAK.2|C[CAM]EPIIMTVPR.2|YFEITDESPYVHYLNTFSSK.4|YFEITDESPYVHYLNTFSSK.3|TTDTASVQNEAK.2|NGSLIC[CAM]TASKDK.2|FRHVFGQAVKNDQC[CAM]YDDIR.3|SDLFQDDLYPDTAGPEAALEAEEWFEGK.4|SDLFQDDLYPDTAGPEAALEAEEWFEGK.3|KSDLFQDDLYPDTAGPEAALEAEEWFEGK.4|KSDLFQDDLYPDTAGPEAALEAEEWFEGK.3|NM[Oxi]QEPIALHEMDTSNGVLLPFYDPDTSIIYLC[CAM]GK.4|NMQEPIALHEMDTSNGVLLPFYDPDTSIIYLC[CAM]GK.4
SEN / CTL,Torsin-1A-interacting protein 1,TOR1AIP1,Q5JTV8,0.46,0.35,2.74E-03,1.80E-03,2.75E+00,"positive regulation of ATPase activity,protein localization to nucleus,nuclear membrane organization","ATPase activator activity,lamin binding,cytoskeletal protein binding,ATPase binding","nucleus,nuclear inner membrane,integral component of membrane",9,21,26,SQPAILLLTAAR.2|SIQEAPVSEDLVIR.2|ISHLVLPVQPENALKR.4|YEATSVQQK.2|C[CAM]LSEQIADAYSSFR.3|C[CAM]LSEQIADAYSSFR.2|ISHLVLPVQPENALK.3|ISHLVLPVQPENALK.2|QPSVLSSGYQK.2|TPQEWAPQTAR.2|FTNSNTPNSYNHMDPDK.3|FTNSNTPNSYNHMDPDK.2|NGQNAAVVHRFESFPAGSTLIFYK.4|NGQNAAVVHRFESFPAGSTLIFYK.3|SELGNQSPSTSSR.2|LEVDQELSNGFK.2|FTNSNTPNSYNHMDPDKLNGLWSR.4|QVTGQPQNASFVK.2|LQQQHSEQPPLQPSPVMTR.3|LQQQHSEQPPLQPSPVMTR.2|ATQDSDTVKLEVDQELSNGFK.3|FESFPAGSTLIFYK.2|SSSQYIESFWQSSQSQNFTAHDK.3|VNFSEEGETEEDDQDSSHSSVTTVK.3|SSSQYIESFWQSSQSQNFTAHDKQPSVLSSGYQK.4|FSDEPPEVYGDFEPLVAK.2
SEN / CTL,Eukaryotic peptide chain release factor subunit 1,ETF1,P62495,0.46,0.42,5.19E-03,3.10E-03,2.51E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,translational termination,regulation of translational termination,protein methylation","RNA binding,translation release factor activity,protein binding,translation termination factor activity,translation release factor activity, codon specific,ribosome binding,poly(A) RNA binding","cytoplasm,cytosol,nucleus",9,35,53,LSVLGAITSVQQR.2|LSVLGAITSVQQR.3|GFGGIGGILR.2|FTVDLPK.2|KFGATLEIVTDK.3|KFGATLEIVTDK.2|GNGTSMISLIIPPK.3|GNGTSMISLIIPPK.2|TELSQSDMFDQR.3|TELSQSDM[Oxi]FDQR.2|TELSQSDMFDQR.2|VNVAGLVLAGSADFK.3|VNVAGLVLAGSADFK.2|ILYLTPEQEKDK.3|ILYLTPEQEKDK.2|VAETAVQLFISGDK.3|VAETAVQLFISGDK.2|YVLHC[CAM]QGTEEEK.3|YVLHC[CAM]QGTEEEK.2|SQEGSQFVK.2|KVAETAVQLFISGDK.3|FHTEALTALLSDDSK.3|FHTEALTALLSDDSK.2|KFGATLEIVTDKSQEGSQFVK.4|KFGATLEIVTDKSQEGSQFVK.3|FGATLEIVTDK.2|YC[CAM]FGVEDTLK.2|ILYLTPEQEK.2|YFDEISQDTGK.2|KVNIDFEPFKPINTSLYLC[CAM]DNK.4|KVNIDFEPFKPINTSLYLC[CAM]DNK.3|GNGTSMISLIIPPKDQISR.3|GNGTSM[Oxi]ISLIIPPKDQISR.3|VPPNGLVVYC[CAM]GTIVTEEGK.3|VPPNGLVVYC[CAM]GTIVTEEGK.2|ETGQEHELIESMPLLEWFANNYK.4|ETGQEHELIESMPLLEWFANNYK.3|LYNKVPPNGLVVYC[CAM]GTIVTEEGKEK.4|KVNIDFEPFKPINTSLYLC[CAM]DNKFHTEALTALLSDDSK.6|KVNIDFEPFKPINTSLYLC[CAM]DNKFHTEALTALLSDDSK.5|FGFIVIDGSGALFGTLQGNTR.3|LVDISYGGENGFNQAIELSTEVLSNVK.4|LVDISYGGENGFNQAIELSTEVLSNVK.3|PINTSLYLC[CAM]DNK.2|VNVAGLVLAGSADFKTELSQSDMFDQR.4|ETGQEHELIESMPLLEWFANNYKK.4|FGATLEIVTDKSQEGSQFVK.3|FGATLEIVTDKSQEGSQFVK.2|YVLHC[CAM]QGTEEEKILYLTPEQEKDK.4|KVAETAVQLFISGDKVNVAGLVLAGSADFK.4|VPPNGLVVYC[CAM]GTIVTEEGKEK.3|VNIDFEPFKPINTSLYLC[CAM]DNK.3|YFDEISQDTGKYC[CAM]FGVEDTLK.3
SEN / CTL,Dipeptidyl peptidase 2,DPP7,Q9UHL4,0.46,1.04,4.12E-02,1.70E-02,1.77E+00,proteolysis,"serine-type carboxypeptidase activity,serine-type peptidase activity,dipeptidyl-peptidase activity","lysosome,Golgi apparatus,cytosol,cytoplasmic, membrane-bounded vesicle,vesicle,intracellular membrane-bounded organelle,extracellular exosome",15,18,27,GHTELLTVEQALADFAELLR.3|DVTADFEGQSPK.2|KLEATIIGEWVK.3|KLEATIIGEWVK.2|ASHPEDPASVVEAR.3|ASHPEDPASVVEAR.2|LYHSC[CAM]ADPTGC[CAM]GTGPDAR.3|LYHSC[CAM]ADPTGC[CAM]GTGPDAR.4|LYHSC[CAM]ADPTGC[CAM]GTGPDAR.2|APDPGFQER.2|AASNIIFSNGNLDPWAGGGIR.4|AASNIIFSNGNLDPWAGGGIR.3|AASNIIFSNGNLDPWAGGGIR.2|LDHFNFER.2|NLSASVIAVTIQGGAHHLDLR.4|GALLVFAEHR.2|SLPFGAQSTQR.2|DLTQLFMFAR.2|DLTQLFM[Oxi]FAR.2|LEATIIGEWVK.2|DLFLQGAYDTVR.2|YC[CAM]LDTWGVWPR.2|YPHLVAGALAASAPVLAVAGLGDSNQFFR.4|YPHLVAGALAASAPVLAVAGLGDSNQFFR.3|NAFTVLAMMDYPYPTDFLGPLPANPVK.4|NAFTVLAMMDYPYPTDFLGPLPANPVK.3|WEFGTC[CAM]QPLSDEK.2
SEN / CTL,Inositol monophosphatase 1,IMPA1,P29218,0.46,1.30,6.58E-02,2.52E-02,1.60E+00,"inositol metabolic process,inositol biosynthetic process,phosphatidylinositol biosynthetic process,phosphate-containing compound metabolic process,signal transduction,inositol phosphate metabolic process,phosphatidylinositol phosphorylation,inositol phosphate dephosphorylation","magnesium ion binding,inositol monophosphate 1-phosphatase activity,manganese ion binding,lithium ion binding,protein homodimerization activity,inositol monophosphate 3-phosphatase activity,inositol monophosphate 4-phosphatase activity,inositol monophosphate phosphatase activity","cytoplasm,cytosol,extracellular exosome",9,16,22,LFC[CAM]IPVHGIR.3|LFC[CAM]IPVHGIR.2|EIQVIPLQRDDED.2|LQVSQQEDITK.2|MVLSNMEK.2|NEMNVMLK.2|EKYPSHSFIGEESVAAGEK.4|EKYPSHSFIGEESVAAGEK.3|EKYPSHSFIGEESVAAGEK.2|KIEFGVVYSC[CAM]VEGK.3|KIEFGVVYSC[CAM]VEGK.2|EIQVIPLQR.2|SSPVDLVTATDQKVEK.3|SLLVTELGSSR.2|QAGEVVC[CAM]EAIK.2|YPSHSFIGEESVAAGEK.3|YPSHSFIGEESVAAGEK.2|SILTDNPTWIIDPIDGTTNFVHR.4|SILTDNPTWIIDPIDGTTNFVHR.3|SSPVDLVTATDQK.2|QAGEVVC[CAM]EAIKNEMNVMLK.3|IEFGVVYSC[CAM]VEGK.2
SEN / CTL,26S proteasome non-ATPase regulatory subunit 1,PSMD1,Q99460,0.45,0.38,2.79E-06,4.18E-06,5.38E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","enzyme regulator activity,endopeptidase activity","proteasome complex,nucleus,nucleoplasm,cytosol,proteasome regulatory particle,proteasome regulatory particle, base subcomplex,membrane,proteasome accessory complex,proteasome storage granule,extracellular exosome",30,60,102,QAIGIALETR.2|VSTAVLSITAK.2|AAVESLGFILFR.2|AAVESLGFILFR.3|TNLYQDDAVTGEAAGLALGLVMLGSK.3|QDVYDLLK.2|FTATASLGVIHK.3|FTATASLGVIHK.2|HGGSLGLGLAAMGTAR.3|HGGSLGLGLAAMGTAR.2|HGGSLGLGLAAM[Oxi]GTAR.2|TPEQC[CAM]PSVVSLLSESYNPHVR.3|TPEQC[CAM]PSVVSLLSESYNPHVR.4|TPEQC[CAM]PSVVSLLSESYNPHVR.2|LLHVAVSDVNDDVRR.4|LLHVAVSDVNDDVRR.3|LLHVAVSDVNDDVRR.2|SNC[CAM]KPSTFAYPAPLEVPKEK.4|SNC[CAM]KPSTFAYPAPLEVPKEK.3|NASNDIVR.2|RLDVFEK.2|VINDKHDDVMAK.3|VINDKHDDVMAK.2|C[CAM]IDHYTK.2|RLLHVAVSDVNDDVRR.4|RLLHVAVSDVNDDVRR.3|KKEPEPNFQLLDNPAR.4|KKEPEPNFQLLDNPAR.3|KKEPEPNFQLLDNPAR.2|MEVDEAEK.2|TPEASPEPK.2|RAAVESLGFILFR.3|DNLEWLAR.2|TPEASPEPKDQTLK.3|LLHVAVSDVNDDVR.3|LLHVAVSDVNDDVR.2|VLTMPETC[CAM]R.2|QC[CAM]VENADLPEGEKKPIDQR.4|QC[CAM]VENADLPEGEKKPIDQR.3|LC[CAM]MSLMQNK.2|PLSIGGIIILK.2|RLLHVAVSDVNDDVR.3|YGAAMALGIC[CAM]C[CAM]AGTGNK.3|YGAAMALGIC[CAM]C[CAM]AGTGNK.2|TSSAFVGKTPEASPEPK.3|DSDSMETEEK.2|KEPEPNFQLLDNPAR.3|NNNTDLMILK.2|NSVC[CAM]HTATVIANSFMHC[CAM]GTTSDQFLR.5|NSVC[CAM]HTATVIANSFM[Oxi]HC[CAM]GTTSDQFLR.4|NSVC[CAM]HTATVIANSFMHC[CAM]GTTSDQFLR.4|NSVC[CAM]HTATVIANSFM[Oxi]HC[CAM]GTTSDQFLR.3|NSVC[CAM]HTATVIANSFMHC[CAM]GTTSDQFLR.3|YQPFKPLSIGGIIILK.3|SGMYTVAMAYC[CAM]GSGNNK.3|SGM[Oxi]YTVAMAYC[CAM]GSGNNK.2|SGMYTVAM[Oxi]AYC[CAM]GSGNNK.2|SGMYTVAMAYC[CAM]GSGNNK.2|GHEKEALQLMATYLPK.3|GHEKEALQLMATYLPK.2|TILESNDVPGMLAYSLK.3|TILESNDVPGMLAYSLK.2|GLAVGIALVMYGR.2|GLAVGIALVM[Oxi]YGR.2|SNC[CAM]KPSTFAYPAPLEVPK.3|SNC[CAM]KPSTFAYPAPLEVPK.2|DTSEDIEELVEPVAAHGPK.3|DTSEDIEELVEPVAAHGPK.2|IEVLYEDEGFR.2|LNAVVNDFWAEISESVDK.3|LNAVVNDFWAEISESVDK.2|EALQLMATYLPK.2|EALQLM[Oxi]ATYLPK.2|EAINLLEPMTNDPVNYVR.3|EAINLLEPMTNDPVNYVR.2|MITSAAGIISLLDEDEPQLK.3|M[Oxi]ITSAAGIISLLDEDEPQLK.2|MITSAAGIISLLDEDEPQLK.2|MITSAAGIISLLDEDEPQLKEFALHK.4|MITSAAGIISLLDEDEPQLKEFALHK.3|NAQAIEDMVGYAQETQHEK.3|NAQAIEDM[Oxi]VGYAQETQHEK.3|NAQAIEDMVGYAQETQHEK.2|TVGTPIASVPGSTNTGTVPGSEK.3|TVGTPIASVPGSTNTGTVPGSEK.2|QC[CAM]VENADLPEGEK.2|PSTFAYPAPLEVPK.2|QGALIASALIMIQQTEITC[CAM]PK.3|QGALIASALIMIQQTEITC[CAM]PK.2|YQPFKPLSIGGIIILKDTSEDIEELVEPVAAHGPK.5|M[Oxi]EEADALIESLC[CAM]R.2|MEEADALIESLC[CAM]R.2|NSVC[CAM]HTATVIANSFMHC[CAM]GTTSDQFLRDNLEWLAR.5|NSVC[CAM]HTATVIANSFM[Oxi]HC[CAM]GTTSDQFLRDNLEWLAR.4|NSVC[CAM]HTATVIANSFMHC[CAM]GTTSDQFLRDNLEWLAR.4|FGAILAQGILDAGGHNVTISLQSR.3|EPEPNFQLLDNPAR.2|TVGTPIASVPGSTNTGTVPGSEKDSDSMETEEK.4|TVGTPIASVPGSTNTGTVPGSEKDSDSMETEEK.3|DTSPGSAYQEGGGLYALGLIHANHGGDIIDYLLNQLK.4|IYMNLEKPDFINVC[CAM]QC[CAM]LIFLDDPQAVSDILEK.4|IEEEEQEPEPPEPFEYIDD.2
SEN / CTL,Peroxiredoxin-6,PRDX6,P30041,0.45,0.70,2.61E-04,2.35E-04,3.63E+00,"response to reactive oxygen species,lipid catabolic process,hydrogen peroxide catabolic process,cell redox homeostasis,oxidation-reduction process,cell-cell adhesion,cellular oxidant detoxification","glutathione peroxidase activity,protein binding,hydrolase activity,ubiquitin protein ligase binding,peroxiredoxin activity,cadherin binding involved in cell-cell adhesion","extracellular space,cytoplasm,lysosome,cytosol,cell-cell adherens junction,membrane,cytoplasmic, membrane-bounded vesicle,extracellular exosome",45,31,62,NFDEILR.2|FHDFLGDSWGILFSHPR.3|FHDFLGDSWGILFSHPR.4|FHDFLGDSWGILFSHPR.2|PGGLLLGDVAPNFEANTTVGR.3|PGGLLLGDVAPNFEANTTVGR.2|PGGLLLGDVAPNFEANTTVGR.4|DFTPVC[CAM]TTELGR.2|DFTPVC[CAM]TTELGR.3|IRFHDFLGDSWGILFSHPR.4|IRFHDFLGDSWGILFSHPR.3|LKLSILYPATTGR.3|LKLSILYPATTGR.2|VATPVDWKDGDSVMVLPTIPEEEAK.3|VATPVDWKDGDSVMVLPTIPEEEAK.4|LIALSIDSVEDHLAWSK.3|LIALSIDSVEDHLAWSK.2|VVISLQLTAEKR.3|VVISLQLTAEKR.2|ELAILLGMLDPAEKDEK.3|ELAILLGM[Oxi]LDPAEKDEK.3|ELAILLGM[Oxi]LDPAEKDEK.2|ELAILLGMLDPAEKDEK.2|DGDSVMVLPTIPEEEAK.2|DGDSVM[Oxi]VLPTIPEEEAK.3|DGDSVMVLPTIPEEEAK.3|DGDSVM[Oxi]VLPTIPEEEAK.2|NRELAILLGMLDPAEKDEK.4|NRELAILLGM[Oxi]LDPAEKDEK.3|NRELAILLGMLDPAEKDEK.3|LPFPIIDDRNR.3|VATPVDWK.2|ELAILLGMLDPAEK.3|ELAILLGMLDPAEK.2|ELAILLGM[Oxi]LDPAEK.2|VVFVFGPDK.2|DINAYNC[CAM]EEPTEK.3|DINAYNC[CAM]EEPTEK.2|RVATPVDWK.2|LPFPIIDDR.2|NFDEILRVVISLQLTAEKR.4|NFDEILRVVISLQLTAEKR.3|VVFVFGPDKK.2|NRELAILLGMLDPAEK.3|NRELAILLGM[Oxi]LDPAEK.3|NRELAILLGMLDPAEK.2|LSILYPATTGR.2|VVISLQLTAEK.2|IRFHDFLGDSWGILFSHPRDFTPVC[CAM]TTELGR.6|IRFHDFLGDSWGILFSHPRDFTPVC[CAM]TTELGR.5|IRFHDFLGDSWGILFSHPRDFTPVC[CAM]TTELGR.4|DGDSVMVLPTIPEEEAKK.3|DGDSVM[Oxi]VLPTIPEEEAKK.3|DGDSVMVLPTIPEEEAKK.2|DINAYNC[CAM]EEPTEKLPFPIIDDR.4|DINAYNC[CAM]EEPTEKLPFPIIDDR.3|FHDFLGDSWGILFSHPRDFTPVC[CAM]TTELGR.5|VATPVDWKDGDSVMVLPTIPEEEAKK.4|RVATPVDWKDGDSVM[Oxi]VLPTIPEEEAK.4|RVATPVDWKDGDSVMVLPTIPEEEAK.4|RVATPVDWKDGDSVMVLPTIPEEEAK.3|DINAYNC[CAM]EEPTEKLPFPIIDDRNR.4
SEN / CTL,Septin-9,9-Sep,Q9UHD8,0.45,1.55,2.68E-02,1.21E-02,1.92E+00,"cell cycle,protein heterooligomerization,cell division,cell-cell adhesion,positive regulation of nonmotile primary cilium assembly","GTPase activity,protein binding,GTP binding,cadherin binding involved in cell-cell adhesion","stress fiber,cytoplasm,microtubule,cell-cell adherens junction,axoneme,actin cytoskeleton,septin complex,perinuclear region of cytoplasm",30,46,76,YLQEEVNINR.2|STLINTLFK.2|ADTLTLEER.2|RTELSIDISSK.2|RVEIQMPKPAEAPTAPSPAQTLENSEPAPVSQLQSR.4|RVEIQMPKPAEAPTAPSPAQTLENSEPAPVSQLQSR.6|RVEIQMPKPAEAPTAPSPAQTLENSEPAPVSQLQSR.5|RVEIQM[Oxi]PKPAEAPTAPSPAQTLENSEPAPVSQLQSR.4|SFEVEEVETPNSTPPR.2|SFEVEEVETPNSTPPR.3|LEPKPQPPVAEATPR.3|LEPKPQPPVAEATPR.2|SQEATEAAPSC[CAM]VGDMADTPR.3|SQEATEAAPSC[CAM]VGDM[Oxi]ADTPR.3|SQEATEAAPSC[CAM]VGDMADTPR.2|SQEATEAAPSC[CAM]VGDM[Oxi]ADTPR.2|VHC[CAM]C[CAM]LYFIPATGHSLRPLDIEFMK.5|VHC[CAM]C[CAM]LYFIPATGHSLRPLDIEFM[Oxi]K.5|VHC[CAM]C[CAM]LYFIPATGHSLRPLDIEFM[Oxi]K.4|VHC[CAM]C[CAM]LYFIPATGHSLRPLDIEFMK.4|VHC[CAM]C[CAM]LYFIPATGHSLRPLDIEFMK.3|APVDFGYVGIDSILEQMR.3|APVDFGYVGIDSILEQM[Oxi]R.3|APVDFGYVGIDSILEQM[Oxi]R.2|APVDFGYVGIDSILEQMR.2|FQDLGVK.2|RTEITIVKPQESAHR.4|RTEITIVKPQESAHR.3|RVELSGPK.2|HVDSLSQR.2|LGDSSGPALK.2|YLQEEVNINRK.3|YLQEEVNINRK.2|DITSSIHFEAYR.3|DITSSIHFEAYR.2|VPEVPTAPATDAAPK.3|VPEVPTAPATDAAPK.2|SVQPTSEER.2|FINDQYEK.2|VVNIVPVIAK.2|RSFEVEEVETPNSTPPRR.4|RSFEVEEVETPNSTPPRR.3|SITHDIEEK.2|LGDSSGPALKR.2|EFDEDSEDR.2|THMQNIKDITSSIHFEAYR.4|EFDEDSEDRLVNEK.3|EFDEDSEDRLVNEK.2|ITADLLSNGIDVYPQK.3|ITADLLSNGIDVYPQK.2|QVENAGAIGPSR.2|FREMIPFAVVGSDHEYQVNGK.4|FREMIPFAVVGSDHEYQVNGK.3|TKWGTIEVENTTHC[CAM]EFAYLR.4|TKWGTIEVENTTHC[CAM]EFAYLR.3|RSFEVEEVETPNSTPPR.3|RSFEVEEVETPNSTPPR.2|SFEVEEVETPNSTPPRR.3|QRITADLLSNGIDVYPQK.3|QRITADLLSNGIDVYPQK.2|SVQPTSEERIPK.2|EM[Oxi]IPFAVVGSDHEYQVNGK.3|EMIPFAVVGSDHEYQVNGK.3|WGTIEVENTTHC[CAM]EFAYLR.3|WGTIEVENTTHC[CAM]EFAYLR.2|MKLTVIDTPGFGDHINNENC[CAM]WQPIMK.4|FINDQYEKYLQEEVNINR.3|LNEGSSAMANGMEEKEPEAPEM.3|NEKAPVDFGYVGIDSILEQMR.3|ITADLLSNGIDVYPQKEFDEDSEDRLVNEK.4|QGFEFNIM[Oxi]VVGQSGLGK.2|QGFEFNIMVVGQSGLGK.2|LTVIDTPGFGDHINNENC[CAM]WQPIM[Oxi]K.3|LTVIDTPGFGDHINNENC[CAM]WQPIMK.3|ITADLLSNGIDVYPQKEFDEDSEDR.3|PAEAPTAPSPAQTLENSEPAPVSQLQSR.3
SEN / CTL,26S protease regulatory subunit 10B,PSMC6,P62333,0.45,0.35,2.70E-06,4.08E-06,5.39E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,ubiquitin-dependent protein catabolic process,regulation of cellular amino acid metabolic process,ER-associated ubiquitin-dependent protein catabolic process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,positive regulation of proteasomal protein catabolic process","protein binding,ATP binding,ATPase activity,TBP-class protein binding,protein binding, bridging,proteasome-activating ATPase activity","proteasome complex,nucleus,nucleoplasm,cytosol,proteasome regulatory particle, base subcomplex,membrane,proteasome accessory complex,nuclear proteasome complex,cytosolic proteasome complex,extracellular exosome",21,28,44,ELREVIELPLTNPELFQR.3|VVSSSIVDKYIGESAR.3|HGEIDYEAIVK.3|HGEIDYEAIVK.2|ADHDFVVQEDFMK.3|ADHDFVVQEDFM[Oxi]K.3|ADHDFVVQEDFMK.2|ALQSVGQIVGEVLK.2|ALQSVGQIVGEVLK.3|VALDMTTLTIMR.2|VALDMTTLTIM[Oxi]R.2|NVC[CAM]TEAGMFAIR.2|NVC[CAM]TEAGM[Oxi]FAIR.2|LLEHKEIDGR.3|IHAGPITK.2|IHIDLPNEQAR.3|IHIDLPNEQAR.2|KLESKLDYKPV.3|VVSSSIVDK.2|KIHIDLPNEQAR.3|KIHIDLPNEQAR.2|FSEGTSADR.2|FSEGTSADREIQR.3|TLMELLNQMDGFDTLHR.4|TLM[Oxi]ELLNQMDGFDTLHR.3|TLMELLNQMDGFDTLHR.3|TLMELLNQMDGFDTLHR.2|RFSEGTSADREIQR.3|DHQPC[CAM]IIFMDEIDAIGGRR.4|DHQPC[CAM]IIFMDEIDAIGGRR.3|M[Oxi]IMATNRPDTLDPALLRPGR.4|RFSEGTSADR.2|LSDGFNGADLR.2|EVIELPLTNPELFQR.3|EVIELPLTNPELFQR.2|GC[CAM]LLYGPPGTGK.2|VGIIPPKGC[CAM]LLYGPPGTGK.3|AVASQLDC[CAM]NFLK.2|DHQPC[CAM]IIFMDEIDAIGGR.3|DHQPC[CAM]IIFMDEIDAIGGR.2|AVASQLDC[CAM]NFLKVVSSSIVDKYIGESAR.4|AVASQLDC[CAM]NFLKVVSSSIVDKYIGESAR.3|EVDPLVYNMSHEDPGNVSYSEIGGLSEQIR.4|EVDPLVYNMSHEDPGNVSYSEIGGLSEQIR.3
SEN / CTL,Protein NDRG1,NDRG1,Q92597,0.45,0.73,5.86E-03,3.45E-03,2.46E+00,"negative regulation of cell proliferation,response to metal ion,DNA damage response, signal transduction by p53 class mediator,peripheral nervous system myelin maintenance,regulation of apoptotic process,mast cell activation,cellular response to hypoxia,positive regulation of spindle checkpoint,cell-cell adhesion","protein binding,microtubule binding,Rab GTPase binding,gamma-tubulin binding,cadherin binding,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,centrosome,cytosol,microtubule,plasma membrane,cell-cell adherens junction,microtubule cytoskeleton,myelin sheath,perinuclear region of cytoplasm,recycling endosome membrane,extracellular exosome",15,18,49,SIIGMGTGAGAYILTR.2|SIIGMGTGAGAYILTR.3|SIIGM[Oxi]GTGAGAYILTR.3|SIIGM[Oxi]GTGAGAYILTR.2|SHTSEGAHLDITPNSGAAGNSAGPK.4|SHTSEGAHLDITPNSGAAGNSAGPK.3|SHTSEGAHLDITPNSGAAGNSAGPK.2|YFVQGMGYMPSASMTR.2|YFVQGMGYMPSASM[Oxi]TR.3|YFVQGM[Oxi]GYMPSASMTR.2|YFVQGMGYM[Oxi]PSASMTR.2|YFVQGMGYMPSASM[Oxi]TR.2|MADC[CAM]GGLPQISQPAK.2|MADC[CAM]GGLPQISQPAK.3|M[Oxi]ADC[CAM]GGLPQISQPAK.2|EEMQSNVEVVHTYR.4|EEMQSNVEVVHTYR.3|EEM[Oxi]QSNVEVVHTYR.3|EEMQSNVEVVHTYR.2|GNRPVILTYHDIGM[Oxi]NHK.4|GNRPVILTYHDIGMNHK.4|GNRPVILTYHDIGMNHK.3|SRSHTSEGAHLDITPNSGAAGNSAGPK.5|SRSHTSEGAHLDITPNSGAAGNSAGPK.4|SRSHTSEGAHLDITPNSGAAGNSAGPK.3|SRTASGSSVTSLDGTR.3|SRTASGSSVTSLDGTR.2|EMQDVDLAEVKPLVEK.3|EM[Oxi]QDVDLAEVKPLVEK.3|EMQDVDLAEVKPLVEK.2|QHIVNDM[Oxi]NPGNLHLFINAYNSR.4|QHIVNDMNPGNLHLFINAYNSR.4|QHIVNDM[Oxi]NPGNLHLFINAYNSR.3|QHIVNDMNPGNLHLFINAYNSR.3|TASGSSVTSLDGTR.2|ISGWTQALPDMVVSHLFGK.3|ISGWTQALPDM[Oxi]VVSHLFGK.3|ISGWTQALPDM[Oxi]VVSHLFGK.2|ISGWTQALPDMVVSHLFGK.2|ISGWTQALPDMVVSHLFGKEEMQSNVEVVHTYR.5|ISGWTQALPDMVVSHLFGKEEMQSNVEVVHTYR.4|LAEAFKYFVQGMGYMPSASMTR.3|DLEIERPMPGTHTVTLQC[CAM]PALLVVGDSSPAVDAVVEC[CAM]NSK.5|DLEIERPM[Oxi]PGTHTVTLQC[CAM]PALLVVGDSSPAVDAVVEC[CAM]NSK.4|DLEIERPMPGTHTVTLQC[CAM]PALLVVGDSSPAVDAVVEC[CAM]NSK.4|PMPGTHTVTLQC[CAM]PALLVVGDSSPAVDAVVEC[CAM]NSK.4|PMPGTHTVTLQC[CAM]PALLVVGDSSPAVDAVVEC[CAM]NSK.3|RDLEIERPMPGTHTVTLQC[CAM]PALLVVGDSSPAVDAVVEC[CAM]NSK.5|GETITGLLQEFDVQEQDIETLHGSVHVTLC[CAM]GTPK.4
SEN / CTL,182 kDa tankyrase-1-binding protein,TNKS1BP1,Q9C0C2,0.44,0.58,3.73E-03,2.38E-03,2.62E+00,"nuclear-transcribed mRNA poly(A) tail shortening,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,telomere maintenance via telomerase,cell-cell adhesion","enzyme binding,ankyrin binding,cadherin binding involved in cell-cell adhesion","nucleus,nucleoplasm,nuclear telomeric heterochromatin,cytoplasm,cytosol,cytoskeleton,plasma membrane,cell-cell adherens junction,CCR4-NOT complex",21,62,73,FAATTVEEILAK.2|SQEADVQDWEFR.2|EMEEELVPTGSEPGDTR.2|DVSLGDWEFGKR.3|DSLGAYASQDANEQGQDLGKR.3|GVGQADWTPDLGLR.2|NLEVSSC[CAM]VGSGGSSEAR.2|NLEVSSC[CAM]VGSGGSSEAR.3|HNGSLSPGLEAR.3|HNGSLSPGLEAR.2|SKDLAEVGEGGGHSQAR.4|SKDLAEVGEGGGHSQAR.3|KIPSVEDSLGEGSRDAGRPGER.5|DAELQDQEFGKR.3|GDAHLRPTSLVQR.3|DLAEVGEGGGHSQAR.3|DLAEVGEGGGHSQAR.2|DSLGTYSSR.2|KIPSVEDSLGEGSR.3|KIPSVEDSLGEGSR.2|GPLAELPSAR.2|VSGAGFSPSSK.2|DEDGSTLFR.2|DVSLGTYGSR.2|YGQGAGEGSTR.2|EHGVGGVSQC[CAM]PEPGLR.3|EHGVGGVSQC[CAM]PEPGLR.2|DFC[CAM]IEASER.2|LTFNHDGSSR.2|SAEEGELAESK.2|ELGVGQMDWGNNLGLR.3|ELGVGQMDWGNNLGLR.2|AASSELPADISK.2|RDVSLGTYGSR.2|VSAPGVLTAQDR.2|RFSEGVLQSPSQDQEK.3|RPLPFAPRPAVEASTGGEATQETGKEEAGKEEPPPLTPPAR.7|RPLPFAPRPAVEASTGGEATQETGKEEAGKEEPPPLTPPAR.6|RPLPFAPRPAVEASTGGEATQETGKEEAGKEEPPPLTPPAR.5|AAEPQEQEFGK.2|WSDQGPAQTSR.2|DVSLGDWEFGK.2|DAELQDQEFGK.2|SYQFGIIGNDR.2|HNGSLSPGLEARDPLEAR.3|SPAEC[CAM]REEHSKTPEER.3|TYGTTTAPRDEDGSTLFR.3|GSGGLFSPSTAHVPDGALGQR.3|GSGGLFSPSTAHVPDGALGQR.2|VNLFPGLSPSALK.2|YESQEPLAGQESPLPLATR.3|YESQEPLAGQESPLPLATR.2|NMAPGAVC[CAM]SPGESK.2|QQAGAQGPGSADLEDGEMGKR.3|SLPSDLAFNGDLAK.2|MNMLAGPQPYGGSK.2|EAAFSPGQQDWSR.2|DQSSWQNSDASQEVGGHQER.3|APVIRPGGTLGLSEAADSDAHLFQDSTEPR.4|TTAGSVDWTDQLGLR.2|C[CAM]PARPPPSGSQGLLEEMLAASSSK.3|SSGSEGSSPNWLQALK.2|FSEGVLQSPSQDQEK.2|WLDDLLASPPPSGGGAR.2|DLEVTC[CAM]DPDSGGSQGLR.2|YSSQDADEQDWEFQK.2|SFGTRPLSSGFSPEEAQQQDEEFEK.3|C[CAM]GIGQEEMEASSSQDQSK.2|DLQSEFGITGDPQPSSFSPSSWC[CAM]QGASQDYGLGGASPR.4|DTQSPSTC[CAM]SEGLLGWSQK.2|ESGVGQTDWSGVEAGEFLK.2|QQAGAQGPGSADLEDGEMGK.2|DSLGAYASQDANEQGQDLGK.2
SEN / CTL,40S ribosomal protein S5,RPS5,P46782,0.44,0.36,3.11E-04,2.74E-04,3.56E+00,"ribosomal small subunit assembly,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,regulation of translational fidelity,SRP-dependent cotranslational protein targeting to membrane,viral transcription","RNA binding,mRNA binding,structural constituent of ribosome,protein binding,rRNA binding,poly(A) RNA binding","nucleoplasm,cytosol,focal adhesion,membrane,cytosolic small ribosomal subunit,intracellular ribonucleoprotein complex,extracellular matrix,extracellular exosome",12,15,20,TIAEC[CAM]LADELINAAK.2|TIAEC[CAM]LADELINAAK.3|VNQAIWLLC[CAM]TGAR.2|VNQAIWLLC[CAM]TGAR.3|LTNSM[Oxi]M[Oxi]M[Oxi]HGR.3|LTNSMMMHGR.2|LTNSMM[Oxi]MHGR.2|YLPHSAGR.2|GSSNSYAIK.2|AQC[CAM]PIVER.2|QAVDVSPLR.2|KAQC[CAM]PIVER.2|RVNQAIWLLC[CAM]TGAR.3|RQAVDVSPLR.2|EAAFRNIKTIAEC[CAM]LADELINAAK.4|NIKTIAEC[CAM]LADELINAAK.3|NIKTIAEC[CAM]LADELINAAKGSSNSYAIK.4|WSTDDVQINDISLQDYIAVK.3|WSTDDVQINDISLQDYIAVK.2|IVKHAFEIIHLLTGENPLQVLVNAIINSGPREDSTR.5
SEN / CTL,Septin-2,2-Sep,Q15019,0.44,0.37,4.25E-14,2.25E-13,1.26E+01,"regulation of L-glutamate transport,mitotic nuclear division,smoothened signaling pathway,neuron projection development,regulation of protein localization,cilium assembly,regulation of catalytic activity,cell division,cell-cell adhesion","protein binding,GTP binding,enzyme regulator activity,protein complex scaffold,cadherin binding involved in cell-cell adhesion","exocyst,condensed chromosome kinetochore,nucleus,nucleolus,cytoplasm,spindle,cell-cell adherens junction,axoneme,actin cytoskeleton,midbody,septin complex,cleavage furrow,photoreceptor connecting cilium,myelin sheath,synapse,perinuclear region of cytoplasm,ciliary membrane,extracellular exosome,cell cortex",57,30,53,STLINSLFLTDLYPER.2|STLINSLFLTDLYPER.3|TIISYIDEQFER.2|ASIPFSVVGSNQLIEAK.2|ASIPFSVVGSNQLIEAK.3|GRLYPWGVVEVENPEHNDFLK.4|GRLYPWGVVEVENPEHNDFLK.3|LTVVDTPGYGDAINC[CAM]R.2|LTVVDTPGYGDAINC[CAM]R.3|TVQIEASTVEIEER.2|TVQIEASTVEIEER.3|LRLTVVDTPGYGDAINC[CAM]R.3|VHC[CAM]C[CAM]FYFISPFGHGLKPLDVAFMK.5|VHC[CAM]C[CAM]FYFISPFGHGLKPLDVAFMK.4|VHC[CAM]C[CAM]FYFISPFGHGLKPLDVAFM[Oxi]K.5|VHC[CAM]C[CAM]FYFISPFGHGLKPLDVAFM[Oxi]K.4|QQPTQFINPETPGYVGFANLPNQVHRK.4|VNIVPVIAK.2|TM[Oxi]LITHMQDLQEVTQDLHYENFR.4|TMLITHM[Oxi]QDLQEVTQDLHYENFR.4|TMLITHMQDLQEVTQDLHYENFR.4|TM[Oxi]LITHMQDLQEVTQDLHYENFR.3|TMLITHMQDLQEVTQDLHYENFR.3|ILDEIEEHNIK.3|ILDEIEEHNIK.2|YLHDESGLNR.3|YLHDESGLNR.2|DQILLEK.2|MQEMIAR.2|YLHDESGLNRR.3|YLHDESGLNRR.2|PLDVAFMK.2|KVENEDMNKDQILLEK.4|KVENEDMNKDQILLEK.3|VHC[CAM]C[CAM]FYFISPFGHGLK.4|VHC[CAM]C[CAM]FYFISPFGHGLK.3|RILDEIEEHNIK.3|AIHNKVNIVPVIAK.3|RMQEMIAR.2|KVENEDMNK.2|GRLYPWGVVEVENPEHNDFLKLR.5|LYPWGVVEVENPEHNDFLK.4|LYPWGVVEVENPEHNDFLK.3|LYPWGVVEVENPEHNDFLK.2|QQPTQFINPETPGYVGFANLPNQVHR.5|QQPTQFINPETPGYVGFANLPNQVHR.4|QQPTQFINPETPGYVGFANLPNQVHR.3|KGFEFTLMVVGESGLGK.3|VENEDMNKDQILLEK.3|LRTMLITHMQDLQEVTQDLHYENFR.5|M[Oxi]QAQMQMQMQGGDGDGGALGHHV.3|MQAQM[Oxi]QMQMQGGDGDGGALGHHV.3|MQAQMQMQMQGGDGDGGALGHHV.3
SEN / CTL,Apoptosis regulator BAX,BAX,Q07812,0.44,0.46,1.85E-02,8.84E-03,2.05E+00,"ovarian follicle development,neuron migration,T cell homeostatic proliferation,B cell homeostasis,B cell apoptotic process,kidney development,release of cytochrome c from mitochondria,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,blood vessel remodeling,myeloid cell homeostasis,B cell negative selection,B cell homeostatic proliferation,positive regulation of B cell apoptotic process,glycosphingolipid metabolic process,regulation of nitrogen utilization,apoptotic process,activation of cysteine-type endopeptidase activity involved in apoptotic process,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,activation of signaling protein activity involved in unfolded protein response,germ cell development,mitochondrial fusion,extrinsic apoptotic signaling pathway via death domain receptors,intrinsic apoptotic signaling pathway in response to DNA damage,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,apoptotic mitochondrial changes,fertilization,response to toxic substance,response to salt stress,establishment or maintenance of transmembrane electrochemical gradient,response to gamma radiation,viral process,hypothalamus development,cerebral cortex development,negative regulation of protein binding,positive regulation of protein oligomerization,endoplasmic reticulum calcium ion homeostasis,negative regulation of endoplasmic reticulum calcium ion concentration,release of matrix enzymes from mitochondria,negative regulation of peptidyl-serine phosphorylation,regulation of mammary gland epithelial cell proliferation,cellular response to UV,ectopic germ cell programmed cell death,odontogenesis of dentin-containing tooth,regulation of apoptotic process,positive regulation of apoptotic process,regulation of protein homodimerization activity,regulation of protein heterodimerization activity,negative regulation of neuron apoptotic process,positive regulation of neuron apoptotic process,mitochondrial fragmentation involved in apoptotic process,development of secondary sexual characteristics,retinal cell programmed cell death,positive regulation of developmental pigmentation,negative regulation of fibroblast proliferation,spermatid differentiation,post-embryonic camera-type eye morphogenesis,response to axon injury,homeostasis of number of cells within a tissue,protein oligomerization,protein homooligomerization,positive regulation of release of sequestered calcium ion into cytosol,neuron apoptotic process,regulation of mitochondrial membrane potential,Sertoli cell proliferation,retina development in camera-type eye,positive regulation of apoptotic process involved in mammary gland involution,vagina development,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,thymocyte apoptotic process,mitochondrion morphogenesis,intrinsic apoptotic signaling pathway by p53 class mediator,positive regulation of release of cytochrome c from mitochondria,apoptotic signaling pathway,extrinsic apoptotic signaling pathway,extrinsic apoptotic signaling pathway in absence of ligand,intrinsic apoptotic signaling pathway,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,positive regulation of endoplasmic reticulum unfolded protein response,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,apoptotic process involved in patterning of blood vessels,apoptotic process involved in embryonic digit morphogenesis,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,positive regulation of apoptotic DNA fragmentation,positive regulation of IRE1-mediated unfolded protein response,B cell receptor apoptotic signaling pathway,negative regulation of apoptotic signaling pathway,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,positive regulation of intrinsic apoptotic signaling pathway","protein binding,lipid binding,channel activity,identical protein binding,protein homodimerization activity,protein heterodimerization activity,BH3 domain binding","nucleus,nuclear envelope,cytoplasm,mitochondrion,mitochondrial outer membrane,mitochondrial permeability transition pore complex,endoplasmic reticulum,endoplasmic reticulum membrane,cytosol,membrane,pore complex,extracellular exosome,Bcl-2 family protein complex,BAX complex",9,8,14,TGALLLQGFIQDR.2|IGDELDSNMELQR.2|IGDELDSNM[Oxi]ELQR.2|MGGEAPELALDPVPQDASTK.3|M[Oxi]GGEAPELALDPVPQDASTK.2|MGGEAPELALDPVPQDASTK.2|RIGDELDSNMELQR.3|RIGDELDSNMELQR.2|TGALLLQGFIQDRAGR.3|MIAAVDTDSPR.2|M[Oxi]IAAVDTDSPR.2|GGGPTSSEQIMK.2|GGGPTSSEQIM[Oxi]K.2|TIMGWTLDFLR.2
SEN / CTL,Programmed cell death protein 6,PDCD6,O75340,0.44,0.69,1.77E-02,8.50E-03,2.07E+00,"angiogenesis,positive regulation of endothelial cell proliferation,proteolysis,intracellular protein transport,activation of cysteine-type endopeptidase activity involved in apoptotic process,positive regulation of endothelial cell migration,negative regulation of vascular endothelial growth factor receptor signaling pathway,negative regulation of TOR signaling,cellular response to heat,vascular endothelial growth factor receptor-2 signaling pathway,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,positive regulation of angiogenesis,response to calcium ion,negative regulation of protein kinase B signaling,apoptotic signaling pathway","calcium-dependent cysteine-type endopeptidase activity,calcium ion binding,protein binding,protein homodimerization activity,protein anchor,protein dimerization activity,calcium-dependent protein binding,binding, bridging","nucleus,cytoplasm,endosome,endoplasmic reticulum,endoplasmic reticulum membrane,cytoplasmic vesicle,nuclear membrane,extracellular exosome,endoplasmic reticulum exit site",9,13,19,AGVNFSEFTGVWK.2|LSDQFHDILIR.3|LSDQFHDILIR.2|SIISMFDRENK.3|SIISMFDRENK.2|DNSGMIDKNELK.3|TYDRDNSGMIDK.3|TYDRDNSGMIDKNELK.4|TYDRDNSGMIDKNELK.3|TYDRDNSGMIDKNELK.2|SIISMFDR.2|LSDQFHDILIRK.3|LSDQFHDILIRK.2|QALSGFGYR.2|YITDWQNVFR.2|DRSGVISDTELQQALSNGTWTPFNPVTVR.4|DRSGVISDTELQQALSNGTWTPFNPVTVR.3|PGPGAGPGPAAGAALPDQSFLWNVFQR.3|SGVISDTELQQALSNGTWTPFNPVTVR.3
SEN / CTL,T-complex protein 1 subunit gamma,CCT3,P49368,0.44,0.69,1.41E-07,2.74E-07,6.56E+00,"protein folding,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,pore complex assembly,protein stabilization,toxin transport,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body","protein binding,ATP binding,protein binding involved in protein folding,poly(A) RNA binding,unfolded protein binding","zona pellucida receptor complex,cytoplasm,cytosol,chaperonin-containing T-complex,cytoskeleton,microtubule,plasma membrane,myelin sheath,cell body,extracellular exosome",72,49,102,TAVETAVLLLR.2|IVLLDSSLEYK.2|AVAQALEVIPR.2|ELGIWEPLAVK.2|WSSLAC[CAM]NIALDAVK.2|WSSLAC[CAM]NIALDAVK.3|IVSRPEELREDDVGTGAGLLEIKK.4|IVSRPEELREDDVGTGAGLLEIKK.5|IVSRPEELREDDVGTGAGLLEIKK.3|VEKIPGGIIEDSC[CAM]VLR.3|VEKIPGGIIEDSC[CAM]VLR.2|IVSRPEELREDDVGTGAGLLEIK.4|IVSRPEELREDDVGTGAGLLEIK.5|IVSRPEELREDDVGTGAGLLEIK.3|SMIEISR.2|SM[Oxi]IEISR.2|ALDDMISTLK.2|ALDDM[Oxi]ISTLK.2|GISDLAQHYLMR.3|GISDLAQHYLM[Oxi]R.3|GISDLAQHYLMR.2|GISDLAQHYLM[Oxi]R.2|KGESQTDIEITREEDFTR.4|KGESQTDIEITREEDFTR.3|ILQMEEEYIQQLC[CAM]EDIIQLKPDVVITEK.4|ILQMEEEYIQQLC[CAM]EDIIQLKPDVVITEK.5|ILQM[Oxi]EEEYIQQLC[CAM]EDIIQLKPDVVITEK.4|ILQM[Oxi]EEEYIQQLC[CAM]EDIIQLKPDVVITEK.3|ILQMEEEYIQQLC[CAM]EDIIQLKPDVVITEK.3|AMTGVEQWPYR.2|AM[Oxi]TGVEQWPYR.2|GASKEILSEVER.3|GASKEILSEVER.2|ALDDMISTLKK.3|ALDDMISTLKK.2|AC[CAM]TILLR.2|MLLDPMGGIVMTNDGNAILR.3|M[Oxi]LLDPM[Oxi]GGIVMTNDGNAILR.3|M[Oxi]LLDPMGGIVM[Oxi]TNDGNAILR.3|M[Oxi]LLDPMGGIVMTNDGNAILR.3|MLLDPM[Oxi]GGIVMTNDGNAILR.3|MLLDPMGGIVM[Oxi]TNDGNAILR.3|MLLDPM[Oxi]GGIVMTNDGNAILR.2|MLLDPMGGIVM[Oxi]TNDGNAILR.2|MLLDPMGGIVMTNDGNAILR.2|ISIPVDISDSDMMLNIINSSITTK.3|ISIPVDISDSDM[Oxi]M[Oxi]LNIINSSITTK.3|ISIPVDISDSDM[Oxi]MLNIINSSITTK.3|ISIPVDISDSDMM[Oxi]LNIINSSITTK.3|IPGGIIEDSC[CAM]VLR.2|IPGGIIEDSC[CAM]VLR.3|TLIQNC[CAM]GASTIR.2|TLIQNC[CAM]GASTIR.3|TIADIIR.2|KALDDMISTLK.3|KALDDMISTLK.2|MVQFEENGRK.3|MVQFEENGRK.2|NLQDAMQVC[CAM]R.3|NLQDAMQVC[CAM]R.2|NLQDAM[Oxi]QVC[CAM]R.2|KALDDMISTLKK.3|KALDDMISTLKK.2|KGESQTDIEITR.3|KGESQTDIEITR.2|QGGAPDAGQE.2|IVLLDSSLEYKK.3|IVLLDSSLEYKK.2|EILSEVER.2|IDDIVSGHK.2|VQSGNINAAK.2|KIGDEYFTFITDC[CAM]KDPK.4|KIGDEYFTFITDC[CAM]KDPK.3|IGDEYFTFITDC[CAM]K.3|IGDEYFTFITDC[CAM]K.2|PVLVLSQNTK.2|EIQVQHPAAK.2|IDDIVSGHKK.2|MVQFEENGR.2|M[Oxi]VQFEENGR.2|KVQSGNINAAK.2|KIGDEYFTFITDC[CAM]K.3|KIGDEYFTFITDC[CAM]K.2|GESQTDIEITR.2|IGDEYFTFITDC[CAM]KDPK.3|IGDEYFTFITDC[CAM]KDPK.2|NVLLDPQLVPGGGASEM[Oxi]AVAHALTEK.4|NVLLDPQLVPGGGASEMAVAHALTEK.4|NVLLDPQLVPGGGASEM[Oxi]AVAHALTEK.3|NVLLDPQLVPGGGASEMAVAHALTEK.3|AKHTQENC[CAM]ETWGVNGETGTLVDMK.4|AKHTQENC[CAM]ETWGVNGETGTLVDMK.3|GESQTDIEITREEDFTR.3|KISIPVDISDSDMMLNIINSSITTK.4|KISIPVDISDSDM[Oxi]MLNIINSSITTK.3|KISIPVDISDSDMM[Oxi]LNIINSSITTK.3|KISIPVDISDSDMMLNIINSSITTK.3|KISIPVDISDSDM[Oxi]M[Oxi]LNIINSSITTK.3|EDDVGTGAGLLEIK.2|EILSEVERNLQDAMQVC[CAM]R.3|HTQENC[CAM]ETWGVNGETGTLVDM[Oxi]K.3|HTQENC[CAM]ETWGVNGETGTLVDMK.3
SEN / CTL,"Very long-chain specific acyl-CoA dehydrogenase, mitochondrial",ACADVL,P49748,0.43,1.03,2.33E-02,1.08E-02,1.97E+00,"temperature homeostasis,fatty acid beta-oxidation,energy derivation by oxidation of organic compounds,epithelial cell differentiation,fatty acid beta-oxidation using acyl-CoA dehydrogenase,IRE1-mediated unfolded protein response,very long-chain fatty acid catabolic process,negative regulation of fatty acid biosynthetic process,negative regulation of fatty acid oxidation,lipid homeostasis,regulation of cholesterol metabolic process","fatty-acyl-CoA binding,acyl-CoA dehydrogenase activity,long-chain-acyl-CoA dehydrogenase activity,electron carrier activity,very-long-chain-acyl-CoA dehydrogenase activity,flavin adenine dinucleotide binding,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor","nucleus,nucleolus,cytoplasm,mitochondrion,mitochondrial inner membrane,mitochondrial matrix,mitochondrial nucleoid",12,44,76,ITAFVVER.2|GIVNEQFLLQR.2|GIVNEQFLLQR.3|IFEGTNDILR.2|ALEQFATVVEAK.2|ALEQFATVVEAK.3|GFGGITHGPPEK.3|GFGGITHGPPEK.2|IHNFGLIQEK.3|IHNFGLIQEK.2|GFGGITHGPPEKK.3|SDSHPSDALTRK.3|SFAVGMFK.2|AGLGSGLSLSGLVHPELSR.4|AGLGSGLSLSGLVHPELSR.3|AGLGSGLSLSGLVHPELSR.2|ELVEPVSR.2|TPVTDPATGAVKEK.3|TPVTDPATGAVKEK.2|SLSEGHPTAQHEK.3|SLSEGHPTAQHEK.2|KGIVNEQFLLQR.3|KGIVNEQFLLQR.2|ELSGLGSALK.2|NPFGNAGLLLGEAGK.3|NPFGNAGLLLGEAGK.2|RAGLGSGLSLSGLVHPELSR.4|RAGLGSGLSLSGLVHPELSR.3|TSAVPSPC[CAM]GK.2|IFGSEAAWK.2|VPSENVLGEVGSGFK.3|VPSENVLGEVGSGFK.2|GGVVTSNPLGF.2|MLC[CAM]DTWC[CAM]IEAAAR.3|MLC[CAM]DTWC[CAM]IEAAAR.2|M[Oxi]LC[CAM]DTWC[CAM]IEAAAR.2|VAMHILNNGR.2|VAM[Oxi]HILNNGR.2|TPVTDPATGAVK.2|SDSHPSDALTR.2|FFEEVNDPAK.2|FGMAAALAGTMR.2|FGM[Oxi]AAALAGTMR.2|FGMAAALAGTM[Oxi]R.2|FGM[Oxi]AAALAGTM[Oxi]R.2|LADGAIDLYAMVVVLSR.3|LADGAIDLYAMVVVLSR.2|VTDEC[CAM]IQIMGGMGFMK.3|VTDEC[CAM]IQIMGGMGFMK.2|LWISNGGLADIFTVFAK.3|LWISNGGLADIFTVFAK.2|NDALEMVEETTWQGLK.3|NDALEMVEETTWQGLK.2|LFVALQGC[CAM]MDK.2|LFVALQGC[CAM]M[Oxi]DK.2|GKELSGLGSALKNPFGNAGLLLGEAGK.4|LVEIVGM[Oxi]HDLGVGITLGAHQSIGFK.4|LVEIVGMHDLGVGITLGAHQSIGFK.4|LVEIVGMHDLGVGITLGAHQSIGFK.3|LVEIVGM[Oxi]HDLGVGITLGAHQSIGFK.3|ELGAFGLQVPSELGGVGLC[CAM]NTQYAR.4|ELGAFGLQVPSELGGVGLC[CAM]NTQYAR.3|EGMAALQSDPWQQELYR.3|EGM[Oxi]AALQSDPWQQELYR.2|EGMAALQSDPWQQELYR.2|GQLTTDQVFPYPSVLNEEQTQFLK.4|GQLTTDQVFPYPSVLNEEQTQFLK.3|ASNTAEVFFDGVR.2|ASNTAEVFFDGVRVPSENVLGEVGSGFK.4|ASNTAEVFFDGVRVPSENVLGEVGSGFK.3|IREGMAALQSDPWQQELYR.3|IREGM[Oxi]AALQSDPWQQELYR.3|ELSGLGSALKNPFGNAGLLLGEAGK.3|LASGETVAAFC[CAM]LTEPSSGSDAASIR.3|VTDEC[CAM]IQIMGGMGFMKEPGVER.3|FFEEVNDPAKNDALEMVEETTWQGLK.3
SEN / CTL,Tubulin-folding cofactor B,TBCB,Q99426,0.43,0.52,2.97E-02,1.32E-02,1.88E+00,"nervous system development,cell differentiation",protein binding,"nucleoplasm,cytoplasm,microtubule,microtubule cytoskeleton",6,20,26,RGTVMYVGLTDFKPGYWIGVR.4|YTISQEAYDQRQDTVR.3|SLTIAEFK.2|LGEYEDVSRVEK.3|YDEPLGKNDGSVNGK.3|AQASSIPVGSR.2|LGEYEDVSR.2|AQQEAEAAQR.2|IHVIDHSGAR.2|LAEEKAQASSIPVGSR.3|LAEEKAQASSIPVGSR.2|RYFEC[CAM]QAK.2|LGRYNEEERAQQEAEAAQR.4|LGRYNEEERAQQEAEAAQR.3|YNEEERAQQEAEAAQR.3|LDQEDALLGSYPVDDGC[CAM]R.3|LDQEDALLGSYPVDDGC[CAM]R.2|PAVVTVGDFPEEDYGLDEI.3|PAVVTVGDFPEEDYGLDEI.2|YTISQEAYDQR.2|GTVMYVGLTDFKPGYWIGVR.3|GTVM[Oxi]YVGLTDFKPGYWIGVR.3|GTVMYVGLTDFKPGYWIGVR.2|FYSKLDQEDALLGSYPVDDGC[CAM]R.3|YGAFVKPAVVTVGDFPEEDYGLDEI.3|LELLVGSPASC[CAM]MELELYGVDDKFYSK.3
SEN / CTL,Poly(rC)-binding protein 2,PCBP2,Q15366,0.43,1.07,9.28E-02,3.36E-02,1.47E+00,"mRNA splicing, via spliceosome,gene expression,mRNA metabolic process,negative regulation of type I interferon production,viral RNA genome replication,proteasome-mediated ubiquitin-dependent protein catabolic process,innate immune response,negative regulation of defense response to virus,defense response to virus,IRES-dependent viral translational initiation","RNA binding,protein binding,enzyme binding,ubiquitin protein ligase binding,poly(A) RNA binding,C-rich single-stranded DNA binding","nucleus,nucleoplasm,cytoplasm,cytosol,focal adhesion,membrane,intracellular ribonucleoprotein complex,extracellular exosome",24,23,57,AITIAGIPQSIIEC[CAM]VK.2|AITIAGIPQSIIEC[CAM]VK.3|IITLAGPTNAIFK.2|IITLAGPTNAIFK.3|LVVPASQC[CAM]GSLIGK.2|LVVPASQC[CAM]GSLIGK.3|ESTGAQVQVAGDMLPNSTER.2|ESTGAQVQVAGDMLPNSTER.3|ESTGAQVQVAGDM[Oxi]LPNSTER.3|ESTGAQVQVAGDM[Oxi]LPNSTER.2|INISEGNC[CAM]PER.2|INISEGNC[CAM]PER.3|AFAMIIDKLEEDISSSMTNSTAASRPPVTLR.5|AFAMIIDKLEEDISSSMTNSTAASRPPVTLR.6|AFAM[Oxi]IIDKLEEDISSSM[Oxi]TNSTAASRPPVTLR.5|AFAM[Oxi]IIDKLEEDISSSMTNSTAASRPPVTLR.5|AFAMIIDKLEEDISSSM[Oxi]TNSTAASRPPVTLR.5|AFAM[Oxi]IIDKLEEDISSSM[Oxi]TNSTAASRPPVTLR.4|AFAM[Oxi]IIDKLEEDISSSMTNSTAASRPPVTLR.4|AFAMIIDKLEEDISSSM[Oxi]TNSTAASRPPVTLR.4|AFAMIIDKLEEDISSSMTNSTAASRPPVTLR.4|AFAMIIDKLEEDISSSMTNSTAASRPPVTLR.3|QMSGAQIK.2|AFAMIIDK.2|AFAM[Oxi]IIDK.2|PSSSPVIFAGGQDR.3|PSSSPVIFAGGQDR.2|LSSETGGMGSS.2|LSSETGGM[Oxi]GSS.2|PKPSSSPVIFAGGQDR.3|LHQLAMQQSHFPMTHGNTGFSGIESSSPEVK.6|LHQLAMQQSHFPMTHGNTGFSGIESSSPEVK.5|LHQLAM[Oxi]QQSHFPMTHGNTGFSGIESSSPEVK.5|LHQLAMQQSHFPM[Oxi]THGNTGFSGIESSSPEVK.5|LHQLAMQQSHFPMTHGNTGFSGIESSSPEVK.4|LHQLAM[Oxi]QQSHFPM[Oxi]THGNTGFSGIESSSPEVK.4|LHQLAM[Oxi]QQSHFPMTHGNTGFSGIESSSPEVK.4|LHQLAMQQSHFPM[Oxi]THGNTGFSGIESSSPEVK.4|LHQLAMQQSHFPMTHGNTGFSGIESSSPEVK.3|IANPVEGSTDR.2|GVTIPYRPKPSSSPVIFAGGQDR.4|GVTIPYRPKPSSSPVIFAGGQDR.3|LEEDISSSMTNSTAASRPPVTLR.4|LEEDISSSM[Oxi]TNSTAASRPPVTLR.3|LEEDISSSMTNSTAASRPPVTLR.3|LVVPASQC[CAM]GSLIGKGGC[CAM]K.3|QIC[CAM]VVMLETLSQSPPK.3|QIC[CAM]VVMLETLSQSPPK.2|IKEIRESTGAQVQVAGDM[Oxi]LPNSTER.4|QVTITGSAASISLAQYLINVR.3|QVTITGSAASISLAQYLINVR.2|GYWGLDASAQTTSHELTIPNDLIGC[CAM]IIGR.4|GYWGLDASAQTTSHELTIPNDLIGC[CAM]IIGR.3|EIRESTGAQVQVAGDMLPNSTER.3|IANPVEGSTDRQVTITGSAASISLAQYLINVR.4|IANPVEGSTDRQVTITGSAASISLAQYLINVR.3|YSTGSDSASFPHTTPSMC[CAM]LNPDLEGPPLEAYTIQGQYAIPQPDLTK.5
SEN / CTL,60S ribosomal protein L13,RPL13,P26373,0.43,0.49,8.61E-03,4.75E-03,2.32E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","RNA binding,structural constituent of ribosome,protein binding,poly(A) RNA binding","nucleus,cytosol,membrane,cytosolic large ribosomal subunit,cytosolic ribosome",9,22,35,TIGISVDPR.2|GFSLEELR.2|KGDSSAEELKLATQLTGPVMPVR.4|KGDSSAEELKLATQLTGPVMPVR.5|KGDSSAEELKLATQLTGPVM[Oxi]PVR.4|KGDSSAEELKLATQLTGPVM[Oxi]PVR.3|KGDSSAEELKLATQLTGPVMPVR.3|AKEAAEQDVEK.3|AKEAAEQDVEK.2|IAPRPASGPIRPIVR.4|IAPRPASGPIRPIVR.3|VITEEEKNFK.3|VITEEEKNFK.2|VITEEEK.2|NGMVLKPHFHK.3|NGMVLKPHFHK.2|VATWFNQPARK.3|AKEAAEQDVEKK.3|RVATWFNQPAR.3|RVATWFNQPAR.2|LATQLTGPVMPVR.3|LATQLTGPVMPVR.2|LATQLTGPVM[Oxi]PVR.2|RAKEAAEQDVEK.3|GDSSAEELK.2|VITEEEKNFKAFASLR.4|VITEEEKNFKAFASLR.2|NKSTESLQANVQR.3|NKSTESLQANVQR.2|EAAEQDVEK.2|KGDSSAEELK.2|EAAEQDVEKK.2|VATWFNQPAR.2|STESLQANVQR.2|EAAEQDVEKKK.2
SEN / CTL,SEC14-like protein 2;SEC14-like protein 3,SEC14L2;SEC14L3,O76054;Q9UDX4,0.43,0.10,1.54E-02,7.58E-03,2.12E+00,"transcription, DNA-templated,transport,regulation of cholesterol biosynthetic process,positive regulation of transcription, DNA-templated;transport","transporter activity,phospholipid binding,vitamin E binding;transporter activity,lipid binding","nucleus,cytoplasm,integral component of membrane,extracellular exosome;intracellular,integral component of membrane,extracellular exosome",3,1,1,FRENVQDVLPALPNPDDYFLLR.3
SEN / CTL,Heterogeneous nuclear ribonucleoprotein Q,SYNCRIP,O60506,0.43,0.77,1.47E-02,7.28E-03,2.14E+00,"mRNA splicing, via spliceosome,osteoblast differentiation,RNA processing,RNA splicing,viral process,negative regulation of translation,CRD-mediated mRNA stabilization,cellular response to interferon-gamma","nucleotide binding,RNA binding,poly(A) binding,poly(A) RNA binding","nucleus,nucleoplasm,endoplasmic reticulum,membrane,intracellular ribonucleoprotein complex,CRD-mediated mRNA stability complex,catalytic step 2 spliceosome,histone pre-mRNA 3'end processing complex,GAIT complex",33,48,77,GYAFVTFC[CAM]TK.2|DLFEDELVPLFEK.2|DLFEDELVPLFEK.3|TGYTLDVTTGQR.2|TGYTLDVTTGQR.3|HIGVC[CAM]ISVANNR.3|HIGVC[CAM]ISVANNR.2|NLANTVTEEILEK.2|NLANTVTEEILEK.3|LMMDPLTGLNR.2|LM[Oxi]MDPLTGLNR.2|LMM[Oxi]DPLTGLNR.2|TGYTLDVTTGQRK.3|TGYTLDVTTGQRK.2|GFC[CAM]FLEYEDHK.3|GFC[CAM]FLEYEDHK.2|AGPIWDLR.2|VADSSKGPDEAK.3|VADSSKGPDEAK.2|KADGYNQPDSK.3|KADGYNQPDSK.2|EAAQEAVK.2|LFVGSIPK.2|NRGFC[CAM]FLEYEDHK.4|NRGFC[CAM]FLEYEDHK.3|NRGFC[CAM]FLEYEDHK.2|DYAFIHFDER.3|DYAFIHFDER.2|DYAFIHFDERDGAVK.4|DYAFIHFDERDGAVK.3|AMEEMNGK.2|TKEQILEEFSK.3|TKEQILEEFSK.2|RKADGYNQPDSK.3|RKADGYNQPDSK.2|LKDYAFIHFDERDGAVK.4|SAFLC[CAM]GVMK.2|SAFLC[CAM]GVM[Oxi]K.2|LKDYAFIHFDER.3|VTEGLTDVILYHQPDDKK.4|LYNNHEIR.2|ADGYNQPDSK.2|VTEGLTDVILYHQPDDKKK.4|VTEGLTDVILYHQPDDKKK.3|KLKDYAFIHFDER.3|EQILEEFSK.2|DSDLSHVQNK.2|EFNEDGALAVLQQFK.3|EFNEDGALAVLQQFK.2|VAEKLDEIYVAGLVAHSDLDER.4|VAEKLDEIYVAGLVAHSDLDER.3|IPRDLFEDELVPLFEK.3|VTEGLTDVILYHQPDDK.3|VTEGLTDVILYHQPDDK.2|NLANTVTEEILEKAFSQFGKLER.4|LDEIYVAGLVAHSDLDER.3|LDEIYVAGLVAHSDLDER.2|DLEGENIEIVFAKPPDQK.3|DLEGENIEIVFAKPPDQK.2|SENQEFYQDTFGQQWK.3|SENQEFYQDTFGQQWK.2|AIEALKEFNEDGALAVLQQFKDSDLSHVQNK.5|AIEALKEFNEDGALAVLQQFKDSDLSHVQNK.4|AIEALKEFNEDGALAVLQQFKDSDLSHVQNK.3|EFNEDGALAVLQQFKDSDLSHVQNK.4|AMEEMNGKDLEGENIEIVFAKPPDQK.4|KYGGPPPDSVYSGQQPSVGTEIFVGKIPR.4|AIEALKEFNEDGALAVLQQFK.3|AIEALKEFNEDGALAVLQQFK.2|QTNNQNWGSQPIAQQPLQGGDHSGNYGYK.4|QTNNQNWGSQPIAQQPLQGGDHSGNYGYK.3|YGGPPPDSVYSGQQPSVGTEIFVGK.3|KYGGPPPDSVYSGQQPSVGTEIFVGK.3|VWGNVGTVEWADPIEDPDPEVM[Oxi]AK.3|VWGNVGTVEWADPIEDPDPEVMAK.3|VKVWGNVGTVEWADPIEDPDPEVMAK.3|YGGPPPDSVYSGQQPSVGTEIFVGKIPR.3
SEN / CTL,AP-2 complex subunit beta,AP2B1,P63010,0.43,0.43,1.01E-11,4.20E-11,1.04E+01,"ventricular septum development,intracellular protein transport,microtubule-based movement,antigen processing and presentation of exogenous peptide antigen via MHC class II,aorta development,negative regulation of epidermal growth factor receptor signaling pathway,ephrin receptor signaling pathway,clathrin coat assembly,regulation of defense response to virus by virus,Wnt signaling pathway, planar cell polarity pathway,coronary vasculature development,clathrin-dependent endocytosis","signal sequence binding,protein binding,protein transporter activity,clathrin binding,protein complex binding,clathrin adaptor activity","trans-Golgi network,cytosol,plasma membrane,membrane,AP-2 adaptor complex,endocytic vesicle membrane,clathrin-coated endocytic vesicle membrane,endolysosome membrane,intracellular membrane-bounded organelle",42,43,83,IQPGNPNYTLSLK.2|LASQANIAQVLAELKEYATEVDVDFVR.4|LASQANIAQVLAELKEYATEVDVDFVR.3|LVYLYLMNYAK.2|LVYLYLM[Oxi]NYAK.2|GLEISGTFTHR.3|GLEISGTFTHR.2|NVEGQDMLYQSLK.2|NVEGQDM[Oxi]LYQSLK.2|MEPLNNLQVAVK.2|M[Oxi]EPLNNLQVAVK.2|AVWLPAVK.2|VDKITEYLC[CAM]EPLRK.4|VDKITEYLC[CAM]EPLRK.3|VDKITEYLC[CAM]EPLRK.2|C[CAM]VSTLLDLIQTK.2|C[CAM]VSTLLDLIQTK.3|LTNGIWILAELR.2|KLVYLYLMNYAK.3|KLVYLYLM[Oxi]NYAK.3|KLVYLYLMNYAK.2|KLVYLYLM[Oxi]NYAK.2|LSHANSAVVLSAVK.3|LSHANSAVVLSAVK.2|ITEYLC[CAM]EPLRK.3|ITEYLC[CAM]EPLRK.2|RPEILKQEIK.3|RPEILKQEIK.2|FLELLPK.2|VIAAMTVGK.2|VIAAM[Oxi]TVGK.2|EC[CAM]HLNADTVSSK.3|EC[CAM]HLNADTVSSK.2|KLAPPLVTLLSGEPEVQYVALR.5|KLAPPLVTLLSGEPEVQYVALR.4|KLAPPLVTLLSGEPEVQYVALR.3|KLAPPLVTLLSGEPEVQYVALR.2|QVFLATWK.2|VNYVVQEAIVVIR.3|VNYVVQEAIVVIR.2|LLSTDPVTAK.2|DIPNENELQFQIK.3|DIPNENELQFQIK.2|QGHIYMEMNFTNK.3|QGHIYMEMNFTNK.2|SQPDMAIMAVNSFVK.3|SQPDMAIMAVNSFVK.2|ALQHM[Oxi]TDFAIQFNK.3|ALQHMTDFAIQFNK.3|ALQHMTDFAIQFNK.2|ALQHM[Oxi]TDFAIQFNK.2|LAPPLVTLLSGEPEVQYVALR.4|LAPPLVTLLSGEPEVQYVALR.3|LAPPLVTLLSGEPEVQYVALR.2|DSDYYNMLLK.2|LQNNNVYTIAK.2|NSFGVIPSTPLAIHTPLMPNQSIDVSLPLNTLGPVMK.6|NSFGVIPSTPLAIHTPLMPNQSIDVSLPLNTLGPVMK.5|NSFGVIPSTPLAIHTPLM[Oxi]PNQSIDVSLPLNTLGPVM[Oxi]K.4|NSFGVIPSTPLAIHTPLM[Oxi]PNQSIDVSLPLNTLGPVMK.4|NSFGVIPSTPLAIHTPLMPNQSIDVSLPLNTLGPVM[Oxi]K.4|NSFGVIPSTPLAIHTPLMPNQSIDVSLPLNTLGPVMK.4|APEVSQYIYQVYDSILK.3|APEVSQYIYQVYDSILK.2|APEVSQYIYQVYDSILKN.3|APEVSQYIYQVYDSILKN.2|PLISEETDLIEPTLLDELIC[CAM]HIGSLASVYHKPPNAFVEGSHGIHR.7|KPSETQELVQQVLSLATQDSDNPDLR.4|KPSETQELVQQVLSLATQDSDNPDLR.3|LHDINAQMVEDQGFLDSLR.3|LHDINAQMVEDQGFLDSLR.2|LFLKKPSETQELVQQVLSLATQDSDNPDLRDR.5|C[CAM]RAPEVSQYIYQVYDSILK.3|C[CAM]RAPEVSQYIYQVYDSILK.2|KPSETQELVQQVLSLATQDSDNPDLRDR.4|KPSETQELVQQVLSLATQDSDNPDLRDR.3|C[CAM]RAPEVSQYIYQVYDSILKN.3|DVSSLFPDVVNC[CAM]M[Oxi]QTDNLELK.3|DVSSLFPDVVNC[CAM]MQTDNLELK.3|DVSSLFPDVVNC[CAM]MQTDNLELKK.3|YPNKYESIIATLC[CAM]ENLDSLDEPDAR.3|LLTALNEC[CAM]TEWGQIFILDC[CAM]LSNYNPK.3|DLIADSNPMVVANAVAALSEISESHPNSNLLDLNPQNINK.4
SEN / CTL,Microtubule-associated protein 1B,MAP1B,P46821,0.43,0.51,3.60E-09,1.01E-08,8.00E+00,"microtubule bundle formation,cellular process,dendrite development,negative regulation of intracellular transport,positive regulation of axon extension,mitochondrion transport along microtubule,axon extension,establishment of monopolar cell polarity","structural molecule activity,protein binding,microtubule binding","photoreceptor outer segment,cytoplasm,cytosol,microtubule,microtubule associated complex,plasma membrane,postsynaptic density,cell junction,dendritic spine",63,110,158,TPEEGGYSYDISEK.2|AIGNIELGIR.2|SVNFSLTPNEIK.2|TPEDGDYSYEIIEK.2|AVLDALLEGK.2|SPPLIGSESAYESFLSADDKASGR.3|HSPTEDEESAKAEADAYIR.3|HSPTEDEESAKAEADAYIR.4|SSYYVVSGNDPAAEEPSR.2|SSYYVVSGNDPAAEEPSR.3|TATC[CAM]HSSSSPPIDAASAEPYGFR.3|TTSPPEVSGYSYEKTER.3|KTDDVEAMSSQPALALDER.3|KTDDVEAM[Oxi]SSQPALALDER.3|KTDDVEAMSSQPALALDER.2|DLTGQVPTPVVK.2|SVGNTIDPVILFQK.2|SVGNTIDPVILFQK.3|VLFPGNSTQYNILEGLEK.3|VLFPGNSTQYNILEGLEK.2|ASVLFDTMQHHLALNR.4|ASVLFDTM[Oxi]QHHLALNR.4|ASVLFDTMQHHLALNR.3|AAEAVAAAVGTGATTAAVMAAAGIAAIGPAKELEAER.4|AAEAVAAAVGTGATTAAVMAAAGIAAIGPAKELEAER.3|KIAELEEEQSQGSTTNSDWMK.3|ITSFPESEGYSYETSTK.2|ITSFPESEGYSYETSTK.3|SWDTNLIEC[CAM]NLDQELK.3|SWDTNLIEC[CAM]NLDQELK.2|HLDRVDSILLTHIGDDNLPGINSMLQR.4|HLDRVDSILLTHIGDDNLPGINSMLQR.5|HLDRVDSILLTHIGDDNLPGINSM[Oxi]LQR.4|HLDRVDSILLTHIGDDNLPGINSMLQR.3|LSMKPEPLFR.3|AEEVDVTK.2|LMITDAAR.2|ESLKPAAKPLPSK.3|HMDPPPAPVQDR.3|HM[Oxi]DPPPAPVQDR.3|HMDPPPAPVQDR.2|SKPLAASPKPAGLK.3|SSTPLSEAK.2|STDFAPIKEDFGQEKK.4|STDFAPIKEDFGQEKK.3|ESVASGDDR.2|KESKEETPEVTK.3|DAYC[CAM]SEVK.2|EVPSKEEPSPVKAEVAEK.4|FSPEVPGQK.2|SDISPLTPR.2|GAESPFEEK.2|DSISAVSSEK.2|LSKPC[CAM]C[CAM]YIFPGGR.3|DFEELKAEEVDVTK.3|DFEELKAEEVDVTK.2|LKETEPVEAYVIQK.3|LKETEPVEAYVIQK.2|TETKPSVTEK.2|TPDTSTYC[CAM]YETAEK.3|TPDTSTYC[CAM]YETAEK.2|DIKPQLELIEDEEK.3|DIKPQLELIEDEEK.2|M[Oxi]GVGKLEMYVLNPVK.3|MGVGKLEMYVLNPVK.2|AAKPTTTPEVK.2|STDFAPIKEDFGQEK.3|STDFAPIKEDFGQEK.2|MSISEGTVSDK.2|M[Oxi]SISEGTVSDK.2|LEMYVLNPVK.2|HSPTEDEESAK.2|PC[CAM]C[CAM]YIFPGGR.2|ASTTLDIKDSISAVSSEK.3|HNLQDFINIK.2|AEEDMDEAIEK.2|AEEDM[Oxi]DEAIEK.2|KLGDVSPTQIDVSQFGSFKEDTK.4|AETEEAEEPEEDGEEHVC[CAM]VSASK.4|AETEEAEEPEEDGEEHVC[CAM]VSASK.3|TSDVGGYYYEK.2|AAEAGGAEEQYGFLTTPTK.3|AAEAGGAEEQYGFLTTPTK.2|NSNLDRHNLQDFINIK.3|TDDVEAMSSQPALALDER.3|TDDVEAMSSQPALALDER.2|AAEAVAAAVGTGATTAAVMAAAGIAAIGPAK.4|AAEAVAAAVGTGATTAAVM[Oxi]AAAGIAAIGPAK.3|AAEAVAAAVGTGATTAAVMAAAGIAAIGPAK.3|SSAVPPGLPVYLDLC[CAM]YIPNHSNSK.4|SSAVPPGLPVYLDLC[CAM]YIPNHSNSK.3|DIKPQLELIEDEEKLKETEPVEAYVIQK.5|DIKPQLELIEDEEKLKETEPVEAYVIQK.4|TPGDFSYAYQKPEETTR.3|ASVSPM[Oxi]DEPVPDSESPIEK.3|ASVSPMDEPVPDSESPIEK.3|ASVSPMDEPVPDSESPIEK.2|DMSLYASLTSEK.2|DM[Oxi]SLYASLTSEK.2|SSHLPTEVIEKPPAVPVSFEFSDAKDENER.5|SSHLPTEVIEKPPAVPVSFEFSDAKDENER.4|KLGDVSPTQIDVSQFGSFK.3|PLTQSGGAPPPPGGK.2|SSHLPTEVIEKPPAVPVSFEFSDAK.4|SSHLPTEVIEKPPAVPVSFEFSDAK.3|NLISPDLGVVFLNVPENLK.3|NLISPDLGVVFLNVPENLK.2|ETEPVEAYVIQK.2|SALRDAYC[CAM]SEVK.2|SPPLIGSESAYESFLSADDK.3|SPPLIGSESAYESFLSADDK.2|SPSLSPSPPSPLEK.2|GDSALFAVNGFNMLINGGSER.3|GDSALFAVNGFNMLINGGSER.2|NLISPDLGVVFLNVPENLKNPEPNIK.4|NLISPDLGVVFLNVPENLKNPEPNIK.3|SPSDSGYSYETIGK.2|TLEVVSPSQSVTGSAGHTPYYQSPTDEK.4|TLEVVSPSQSVTGSAGHTPYYQSPTDEK.3|YESSLYSQEYSK.2|MEAEDYVMAVVDK.2|IAELEEEQSQGSTTNSDWMK.3|IAELEEEQSQGSTTNSDWMK.2|TDATDGKDYNASASTISPPSSMEEDKFSR.4|TPQASTYSYETSDLC[CAM]YTAEK.3|TPQASTYSYETSDLC[CAM]YTAEK.2|TTSPPEVSGYSYEK.2|SDVLETVVLINPSDEAVSTEVR.3|SDVLETVVLINPSDEAVSTEVR.2|VSAEAEVAPVSPEVTQEVVEEHC[CAM]ASPEDK.4|VSAEAEVAPVSPEVTQEVVEEHC[CAM]ASPEDK.3|AQWGSNMQVTLIPTHDSEVMR.3|LGDVSPTQIDVSQFGSFKEDTK.3|QGSPDQVSPVSEMTSTSLYQDK.3|QGSPDQVSPVSEMTSTSLYQDK.2|DYNASASTISPPSSMEEDKFSR.3|QSPDHPTVGAGVLHITENGPTEVDYSPSDMQDSSLSHK.5|TPQASTYSYETSDLC[CAM]YTAEKK.3|ASLTLFC[CAM]PEEGDWK.2|EEEYEPEKMEAEDYVMAVVDK.3|GPAESPDEGITTTEGEGEC[CAM]EQTPEELEPVEK.4|GPAESPDEGITTTEGEGEC[CAM]EQTPEELEPVEK.3|VDSILLTHIGDDNLPGINSMLQR.3|QDVDLC[CAM]LVSSC[CAM]EYK.2|SIEEAC[CAM]FTLQYLNK.2|EMQYFMQQWTGTNK.2|RLLDDISNGYDDSEDGGHTLGDPSYSYETTEK.4|SPDEEDYDYESYEK.2|DVMSDETNNEETESPSQEFVNITK.3|TDATDGKDYNASASTISPPSSMEEDK.3|AEFILPNGQEVDLPISYLTSVSSLIVWHPANPAEK.4|ESSPLYSPTFSDSTSAVK.2|EVTKGPAESPDEGITTTEGEGEC[CAM]EQTPEELEPVEK.4|LGDVSPTQIDVSQFGSFK.2|QGSPDQVSPVSEMTSTSLYQDKQEGK.3|YESSLYSQEYSKPADVTPLNGFSEGSK.3|DKAEFILPNGQEVDLPISYLTSVSSLIVWHPANPAEK.4|LLDDISNGYDDSEDGGHTLGDPSYSYETTEK.3
SEN / CTL,14-3-3 protein eta,YWHAH,Q04917,0.43,0.53,5.87E-02,2.31E-02,1.64E+00,"regulation of sodium ion transport,glucocorticoid catabolic process,intracellular protein transport,substantia nigra development,glucocorticoid receptor signaling pathway,regulation of neuron differentiation,positive regulation of transcription, DNA-templated,regulation of synaptic plasticity,negative regulation of dendrite morphogenesis,membrane organization,membrane depolarization during action potential,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,regulation of sodium ion transmembrane transporter activity","actin binding,insulin-like growth factor receptor binding,protein binding,sodium channel regulator activity,enzyme binding,protein domain specific binding,glucocorticoid receptor binding,ion channel binding,protein heterodimerization activity","cytoplasm,mitochondrion,cytosol,plasma membrane,intercalated disc,cytoplasmic vesicle membrane,extracellular exosome",18,18,35,AVTELNEPLSNEDRNLLSVAYK.3|LAEQAERYDDMASAMK.3|LAEQAERYDDMASAMK.2|QAFDDAIAELDTLNEDSYKDSTLIMQLLR.4|QAFDDAIAELDTLNEDSYKDSTLIM[Oxi]QLLR.4|QAFDDAIAELDTLNEDSYKDSTLIMQLLR.3|NSVVEASEAAYKEAFEISK.3|NSVVEASEAAYKEAFEISK.2|QAFDDAIAELDTLNEDSYK.3|QAFDDAIAELDTLNEDSYK.2|NSVVEASEAAYK.2|NSVVEASEAAYK.3|EQMQPTHPIR.3|EQM[Oxi]QPTHPIR.3|EQMQPTHPIR.2|EQM[Oxi]QPTHPIR.2|KNSVVEASEAAYK.3|KNSVVEASEAAYK.2|EAFEISKEQMQPTHPIR.4|YDDMASAMK.2|YDDM[Oxi]ASAMK.2|YDDMASAM[Oxi]K.2|YDDM[Oxi]ASAM[Oxi]K.2|AVTELNEPLSNEDR.3|AVTELNEPLSNEDR.2|YLAEVASGEK.2|KNSVVEASEAAYKEAFEISK.4|KNSVVEASEAAYKEAFEISK.3|ELETVC[CAM]NDVLSLLDK.3|ELETVC[CAM]NDVLSLLDK.2|YLAEVASGEKK.2|NC[CAM]NDFQYESK.2|DNLTLWTSDQQDEEAGEGN.3|DNLTLWTSDQQDEEAGEGN.2|IEKELETVC[CAM]NDVLSLLDK.3
SEN / CTL,60S ribosomal protein L7,RPL7,P18124,0.42,0.36,7.00E-04,5.61E-04,3.25E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),cytoplasmic translation,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,ribosomal large subunit biogenesis","DNA binding,RNA binding,mRNA binding,structural constituent of ribosome,protein binding,protein homodimerization activity,poly(A) RNA binding","nucleus,nucleolus,cytoplasm,cytosol,focal adhesion,membrane,cytosolic large ribosomal subunit,intracellular ribonucleoprotein complex,extracellular exosome",12,24,42,IALTDNALIAR.2|IVEPYIAWGYPNLK.2|IVEPYIAWGYPNLK.3|FKEANNFLWPFK.3|FKEANNFLWPFK.2|YGIIC[CAM]MEDLIHEIYTVGKR.4|YGIIC[CAM]M[Oxi]EDLIHEIYTVGKR.4|YGIIC[CAM]MEDLIHEIYTVGKR.3|ASINMLR.2|ASINM[Oxi]LR.2|EVPAVPETLKK.3|EVPAVPETLKK.2|LRQIFNGTFVKLNK.4|KAGNFYVPAEPK.3|KAGNFYVPAEPK.2|LRQIFNGTFVK.3|RIALTDNALIAR.3|RIALTDNALIAR.2|KKEVPAVPETLK.3|KTTHFVEGGDAGNREDQINR.5|KTTHFVEGGDAGNREDQINR.4|KTTHFVEGGDAGNREDQINR.3|TTHFVEGGDAGNR.3|TTHFVEGGDAGNR.2|SVNELIYK.2|KTTHFVEGGDAGNR.3|FKEANNFLWPFKLSSPR.4|FKEANNFLWPFKLSSPR.3|QIFNGTFVK.2|TTHFVEGGDAGNREDQINR.4|TTHFVEGGDAGNREDQINR.3|TTHFVEGGDAGNREDQINR.2|EVPAVPETLK.2|SLGKYGIIC[CAM]MEDLIHEIYTVGKR.5|SLGKYGIIC[CAM]MEDLIHEIYTVGKR.4|SVNELIYKR.2|AGNFYVPAEPK.2|EANNFLWPFK.2|YGIIC[CAM]M[Oxi]EDLIHEIYTVGK.3|YGIIC[CAM]MEDLIHEIYTVGK.3|YGIIC[CAM]M[Oxi]EDLIHEIYTVGK.2|YGIIC[CAM]MEDLIHEIYTVGK.2
SEN / CTL,60S ribosomal protein L9,RPL9,P32969,0.42,1.02,1.31E-01,4.43E-02,1.35E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,cytoplasmic translation,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","RNA binding,structural constituent of ribosome,protein binding,rRNA binding","nucleus,nucleolus,cytoplasm,cytosol,ribosome,focal adhesion,membrane,cytosolic large ribosomal subunit,extracellular matrix",6,15,30,FLDGIYVSEK.2|DFNHINVELSLLGK.3|DFNHINVELSLLGK.2|GTVQQADE.2|KFLDGIYVSEK.3|KFLDGIYVSEK.2|TIC[CAM]SHVQNMIK.3|TIC[CAM]SHVQNM[Oxi]IK.3|TIC[CAM]SHVQNMIK.2|TIC[CAM]SHVQNM[Oxi]IK.2|MRPGVAC[CAM]SVSQAQK.3|MRPGVAC[CAM]SVSQAQK.2|DFNHINVELSLLGKK.3|DFNHINVELSLLGKK.2|RDFNHINVELSLLGK.3|RDFNHINVELSLLGK.2|PGVAC[CAM]SVSQAQK.2|SVYAHFPINVVIQENGSLVEIR.4|SVYAHFPINVVIQENGSLVEIR.3|M[Oxi]KTILSNQTVDIPENVDITLKGR.4|TILSNQTVDIPENVDITLK.3|TILSNQTVDIPENVDITLK.2|M[Oxi]RPGVAC[CAM]SVSQAQKDELILEGNDIELVSNSAALIQQATTVK.6|MRPGVAC[CAM]SVSQAQKDELILEGNDIELVSNSAALIQQATTVK.6|M[Oxi]RPGVAC[CAM]SVSQAQKDELILEGNDIELVSNSAALIQQATTVK.5|MRPGVAC[CAM]SVSQAQKDELILEGNDIELVSNSAALIQQATTVK.5|M[Oxi]RPGVAC[CAM]SVSQAQKDELILEGNDIELVSNSAALIQQATTVK.4|MRPGVAC[CAM]SVSQAQKDELILEGNDIELVSNSAALIQQATTVK.4|MKTILSNQTVDIPENVDITLK.3|DELILEGNDIELVSNSAALIQQATTVK.3
SEN / CTL,MAM domain-containing protein 2,MAMDC2,Q7Z304,0.42,0.20,8.52E-02,3.15E-02,1.50E+00,,,"proteinaceous extracellular matrix,endoplasmic reticulum,membrane",3,1,1,AGDHTTGLGYYLLANTK.3
SEN / CTL,Prelamin-A/C,LMNA,P02545,0.41,1.29,1.28E-09,3.75E-09,8.43E+00,"mitotic nuclear envelope disassembly,mitotic nuclear envelope reassembly,regulation of cell migration,establishment or maintenance of microtubule cytoskeleton polarity,protein localization to nucleus,sterol regulatory element binding protein import into nucleus,IRE1-mediated unfolded protein response,ventricular cardiac muscle cell development,cellular response to hypoxia,negative regulation of mesenchymal cell proliferation,negative regulation of release of cytochrome c from mitochondria,positive regulation of cell aging,regulation of protein localization to nucleus,negative regulation of extrinsic apoptotic signaling pathway","structural molecule activity,protein binding","nucleus,nuclear envelope,lamin filament,nucleoplasm,cytoplasm,cytosol,nuclear speck,extracellular matrix,nuclear membrane",144,85,142,VAVEEVDEEGKFVR.3|VAVEEVDEEGKFVR.2|LADALQELR.2|EAALSTALSEK.2|LQEKEDLQELNDRLAVYIDR.4|LQLELSK.2|ITESEEVVSR.2|AAYEAELGDAR.2|TLEGELHDLRGQVAK.3|TLEGELHDLRGQVAK.4|TLEGELHDLRGQVAK.2|LKDLEALLNSK.3|LKDLEALLNSK.2|SVGGSGGGSFGDNLVTR.2|SVGGSGGGSFGDNLVTR.3|IRIDSLSAQLSQLQK.3|IRIDSLSAQLSQLQK.2|IRIDSLSAQLSQLQK.4|TLEGELHDLRGQVAKLEAALGEAK.4|TALINSTGEEVAMR.2|TALINSTGEEVAMR.3|TALINSTGEEVAM[Oxi]R.2|NSNLVGAAHEELQQSR.3|NSNLVGAAHEELQQSR.2|NSNLVGAAHEELQQSR.4|LRITESEEVVSR.3|LRITESEEVVSR.2|LAVYIDR.2|LAVYIDR.1|EAALSTALSEKR.3|EAALSTALSEKR.2|LQEKEDLQELNDR.3|LQEKEDLQELNDR.2|LQTMKEELDFQK.3|LQTMKEELDFQK.2|LQTM[Oxi]KEELDFQK.3|LQTM[Oxi]KEELDFQK.2|ITESEEVVSREVSGIK.3|SVTVVEDDEDEDGDDLLHHHHGSHC[CAM]SSSGDPAEYNLR.6|SLETENAGLR.2|MQQQLDEYQELLDIK.3|MQQQLDEYQELLDIK.2|M[Oxi]QQQLDEYQELLDIK.2|M[Oxi]QQQLDEYQELLDIK.3|AGQVVTIWAAGAGATHSPPTDLVWK.3|AGQVVTIWAAGAGATHSPPTDLVWK.4|TVLC[CAM]GTC[CAM]GQPADKASASGSGAQVGGPISSGSSASSVTVTR.4|TVLC[CAM]GTC[CAM]GQPADKASASGSGAQVGGPISSGSSASSVTVTR.6|TVLC[CAM]GTC[CAM]GQPADKASASGSGAQVGGPISSGSSASSVTVTR.5|LALDMEIHAYR.3|LALDM[Oxi]EIHAYR.3|LALDMEIHAYR.2|IDSLSAQLSQLQK.2|IDSLSAQLSQLQK.3|TALINSTGEEVAMRK.3|TALINSTGEEVAM[Oxi]RK.3|TALINSTGEEVAMRK.2|SGAQASSTPLSPTR.2|SGAQASSTPLSPTR.3|ASASGSGAQVGGPISSGSSASSVTVTR.3|ASASGSGAQVGGPISSGSSASSVTVTR.4|ASASGSGAQVGGPISSGSSASSVTVTR.2|EGDLIAAQAR.2|AQNTWGC[CAM]GNSLR.2|AQNTWGC[CAM]GNSLR.3|AQHEDQVEQYKKELEK.4|AQHEDQVEQYKKELEK.3|LALDMEIHAYRK.3|LALDM[Oxi]EIHAYRK.3|LALDMEIHAYRK.2|LQTMKEELDFQKNIYSEELR.4|LQTMKEELDFQKNIYSEELR.3|AAYEAELGDARK.3|AAYEAELGDARK.2|ASSHSSQTQGGGSVTKK.4|GRASSHSSQTQGGGSVTK.4|GRASSHSSQTQGGGSVTK.3|LVEIDNGK.2|RTLEGELHDLR.3|RTLEGELHDLR.2|LEAALGEAK.2|RTLEGELHDLRGQVAK.4|RTLEGELHDLRGQVAK.3|RTLEGELHDLRGQVAK.2|AQHEDQVEQYK.3|AQHEDQVEQYK.2|DLEDSLAR.2|NIYSEELRETK.3|NIYSEELRETK.2|SSFSQHAR.2|VAVEEVDEEGKFVRLR.4|KLESTESR.2|QREFESR.2|NKSNEDQSMGNWQIKR.4|NKSNEDQSM[Oxi]GNWQIKR.4|NKSNEDQSMGNWQIKR.3|NKSNEDQSM[Oxi]GNWQIKR.3|RQNGDDPLLTYR.3|RQNGDDPLLTYR.2|RQNGDDPLLTYRFPPK.4|RQNGDDPLLTYRFPPK.3|LSPSPTSQR.2|AQHEDQVEQYKK.3|AQHEDQVEQYKK.2|DLEALLNSK.2|LADALQELRAQHEDQVEQYKK.5|LADALQELRAQHEDQVEQYKK.4|LADALQELRAQHEDQVEQYKK.3|TSGRVAVEEVDEEGKFVR.4|TSGRVAVEEVDEEGKFVR.3|ASSHSSQTQGGGSVTK.3|ASSHSSQTQGGGSVTK.2|LRITESEEVVSREVSGIK.4|NTKKEGDLIAAQAR.3|TLDSVAKER.2|LEAALGEAKK.2|NIYSEELR.2|QLQDEMLR.2|SNEDQSMGNWQIK.3|SNEDQSM[Oxi]GNWQIK.2|SNEDQSMGNWQIK.2|EREMAEMR.2|IRIDSLSAQLSQLQKQLAAK.4|SRTVLC[CAM]GTC[CAM]GQPADK.3|SYLLGNSSPR.2|EDLQELNDR.2|SNEDQSMGNWQIKR.3|SNEDQSM[Oxi]GNWQIKR.3|KQLQDEMLR.2|KEGDLIAAQAR.2|LKDLEALLNSKEAALSTALSEK.4|LRDLEDSLAR.2|TLEGELHDLR.2|LVEIDNGKQREFESR.3|VAVEEVDEEGK.2|QNGDDPLLTYR.2|EDLQELNDRLAVYIDR.3|KLLEGEEERLR.2|GQVAKLEAALGEAK.2|TVLC[CAM]GTC[CAM]GQPADK.2|VDAENRLQTMKEELDFQK.3|NKSNEDQSMGNWQIK.2
SEN / CTL,Nucleosome assembly protein 1-like 4,NAP1L4,Q99733,0.41,0.26,9.88E-03,5.26E-03,2.28E+00,nucleosome assembly,"poly(A) RNA binding,unfolded protein binding","nucleus,cytoplasm",9,18,26,GIPEFWFTIFR.2|YAALYQPLFDK.2|NVDMLSELVQEYDEPILK.3|NVDM[Oxi]LSELVQEYDEPILK.3|NVDM[Oxi]LSELVQEYDEPILK.2|NVDMLSELVQEYDEPILK.2|VLAALQER.2|FYEEVHDLERK.3|FYEEVHDLERK.2|KYAALYQPLFDK.3|KYAALYQPLFDK.2|YAALYQPLFDKR.3|AAATAEEPDPK.2|LTDQVMQNPR.2|LTDQVM[Oxi]QNPR.2|QVPNESFFNFFNPLK.3|QVPNESFFNFFNPLK.2|LDNVPHTPSSYIETLPK.3|LDNVPHTPSSYIETLPK.2|SEPDKADPFSFEGPEIVDC[CAM]DGC[CAM]TIDWKK.4|ADPFSFEGPEIVDC[CAM]DGC[CAM]TIDWK.3|ADPFSFEGPEIVDC[CAM]DGC[CAM]TIDWKK.3|ASGDGESLDEDSEFTLASDFEIGHFFR.3|EFITGDVEPTDAESEWHSENEEEEK.3|NASNTEKLTDQVMQNPR.2|SEPDKADPFSFEGPEIVDC[CAM]DGC[CAM]TIDWK.3
SEN / CTL,40S ribosomal protein SA,RPSA,P08865,0.41,0.34,1.49E-05,1.80E-05,4.74E+00,"ribosomal small subunit assembly,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),rRNA processing,rRNA export from nucleus,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,cell adhesion,viral transcription,viral entry into host cell","virus receptor activity,structural constituent of ribosome,laminin receptor activity,protein binding,ribosome binding,laminin binding,poly(A) RNA binding","nucleus,nucleoplasm,cytoplasm,cytosol,plasma membrane,membrane,cytosolic small ribosomal subunit,90S preribosome,extracellular exosome",21,21,46,AIVAIENPADVSVISSR.2|AIVAIENPADVSVISSR.3|FTPGTFTNQIQAAFREPR.3|FTPGTFTNQIQAAFREPR.4|FTPGTFTNQIQAAFREPR.2|ADHQPLTEASYVNLPTIALC[CAM]NTDSPLR.3|ADHQPLTEASYVNLPTIALC[CAM]NTDSPLR.5|ADHQPLTEASYVNLPTIALC[CAM]NTDSPLR.4|GAHSVGLMWWMLAR.3|GAHSVGLM[Oxi]WWMLAR.3|GAHSVGLMWWM[Oxi]LAR.3|GAHSVGLM[Oxi]WWM[Oxi]LAR.3|GAHSVGLM[Oxi]WWMLAR.2|GAHSVGLMWWMLAR.2|GAHSVGLM[Oxi]WWM[Oxi]LAR.2|SDGIYIINLKR.3|EHPWEVMPDLYFYRDPEEIEKEEQAAAEK.5|EHPWEVM[Oxi]PDLYFYRDPEEIEKEEQAAAEK.5|EHPWEVMPDLYFYRDPEEIEKEEQAAAEK.4|EHPWEVM[Oxi]PDLYFYRDPEEIEKEEQAAAEK.4|FAAATGATPIAGR.3|FAAATGATPIAGR.2|KSDGIYIINLK.3|KSDGIYIINLK.2|DPEEIEK.2|LLVVTDPR.2|RKSDGIYIINLK.3|AVLKFAAATGATPIAGR.3|FTPGTFTNQIQAAFR.3|FTPGTFTNQIQAAFR.2|DPEEIEKEEQAAAEK.3|DPEEIEKEEQAAAEK.2|SDGIYIINLK.2|EHPWEVMPDLYFYR.3|EHPWEVMPDLYFYR.2|YVDIAIPC[CAM]NNK.2|FLAAGTHLGGTNLDFQMEQYIYK.4|FLAAGTHLGGTNLDFQM[Oxi]EQYIYK.3|FLAAGTHLGGTNLDFQMEQYIYK.3|EHPWEVM[Oxi]PDLYFYRDPEEIEK.4|EHPWEVMPDLYFYRDPEEIEK.4|EHPWEVMPDLYFYRDPEEIEK.3|FLAAGTHLGGTNLDFQMEQYIYKR.4|FLAAGTHLGGTNLDFQM[Oxi]EQYIYKR.4|FLAAGTHLGGTNLDFQMEQYIYKR.3|LLVVTDPRADHQPLTEASYVNLPTIALC[CAM]NTDSPLR.4
SEN / CTL,Transportin-1,TNPO1,Q92973,0.41,0.32,3.94E-03,2.44E-03,2.61E+00,"protein import into nucleus, docking,protein import into nucleus, translocation,NLS-bearing protein import into nucleus,ribosomal protein import into nucleus,viral process,regulation of mRNA stability","protein binding,nuclear localization sequence binding,Ran GTPase binding,protein transporter activity,poly(A) RNA binding","nucleus,cytoplasm,cytosol,nuclear membrane,nuclear periphery,extracellular exosome",9,43,65,TLLENTAITIGR.2|QSSFALLGDLTK.2|ALVMLLEVR.2|ATVGILITTIASK.3|ATVGILITTIASK.2|C[CAM]VNLVQK.2|RFSDQFPLPLK.3|RFSDQFPLPLK.2|DELLPHILPLLK.3|PLMTELLK.2|LLPHMHNIVEYMLQR.4|LLPHMHNIVEYM[Oxi]LQR.4|LLPHM[Oxi]HNIVEYMLQR.3|LLPHMHNIVEYM[Oxi]LQR.3|LLPHMHNIVEYMLQR.3|LLPHMHNIVEYMLQR.2|ELLFHHEWVVK.3|ELLFHHEWVVK.2|ERLAAFYGV.2|NIRDNEEKDSAFR.3|SHAVAC[CAM]VNQFIISR.3|SHAVAC[CAM]VNQFIISR.2|LIPVLVNGMK.2|GDVEEDETIPDSEQDIRPR.4|GDVEEDETIPDSEQDIRPR.3|GDVEEDETIPDSEQDIRPR.2|NQVGDENWR.2|SITC[CAM]WTLSR.2|AHFQNFPNGVTDFIK.3|AHFQNFPNGVTDFIK.2|YAHWVVSQPPDTYLKPLMTELLKR.5|YAHWVVSQPPDTYLKPLMTELLKR.4|SNILTLMYQC[CAM]MQDK.3|SNILTLMYQC[CAM]MQDK.2|FSDQFPLPLK.2|YSDIDIILLK.2|YAHWVVSQPPDTYLK.3|YAHWVVSQPPDTYLK.2|ESQSPDTTIQR.2|ATVGILITTIASKGELQNWPDLLPK.4|ATVGILITTIASKGELQNWPDLLPK.3|YAHWVVSQPPDTYLKPLMTELLK.4|YAHWVVSQPPDTYLKPLMTELLK.3|IC[CAM]EDSAEILDSDVLDRPLNIMIPK.4|IC[CAM]EDSAEILDSDVLDRPLNIMIPK.3|GELQNWPDLLPK.2|LGYVC[CAM]PQEVAPMLQQFIR.3|C[CAM]SAAALDVLANVYRDELLPHILPLLK.4|C[CAM]SAAALDVLANVYRDELLPHILPLLK.3|TLAQAMLNNAQPDQYEAPDK.3|TLAQAMLNNAQPDQYEAPDK.2|C[CAM]SAAALDVLANVYR.2|KC[CAM]SAAALDVLANVYRDELLPHILPLLK.4|LGYVC[CAM]PQEVAPMLQQFIRPWC[CAM]TSLR.4|LGYVC[CAM]PQEVAPM[Oxi]LQQFIRPWC[CAM]TSLR.3|LGYVC[CAM]PQEVAPMLQQFIRPWC[CAM]TSLR.3|SNILTLMYQC[CAM]MQDKMPEVR.3|LC[CAM]SLLDSEDYNTC[CAM]EGAFGALQK.3|LEQLNQYPDFNNYLIFVLTK.3|MEYEWKPDEQGLQQILQLLK.3|SEC[CAM]LNNIGDSSPLIR.2|IC[CAM]EDSAEILDSDVLDR.2|GDVEEDETIPDSEQDIR.2|TVAQQHDEDGIEEEDDDDDEIDDDDTISDWNLRK.4|TQDQDENVALEAC[CAM]EFWLTLAEQPIC[CAM]K.3
SEN / CTL,Putative heat shock protein HSP 90-beta 2,HSP90AB2P,Q58FF8,0.41,0.25,1.95E-03,1.35E-03,2.87E+00,"protein folding,response to stress,biological_process","molecular_function,ATP binding,unfolded protein binding","cytoplasm,extracellular exosome",9,2,6,HSQFLGYPITLYLEKER.4|HSQFLGYPITLYLEKER.3|HSQFLGYPITLYLEKER.2|HSQFLGYPITLYLEK.3|HSQFLGYPITLYLEK.4|HSQFLGYPITLYLEK.2
SEN / CTL,Dynactin subunit 1,DCTN1,Q14203,0.40,1.54,1.01E-02,5.36E-03,2.27E+00,"G2/M transition of mitotic cell cycle,ER to Golgi vesicle-mediated transport,mitotic nuclear division,nervous system development,centriole-centriole cohesion,transport along microtubule,antigen processing and presentation of exogenous peptide antigen via MHC class II,positive regulation of microtubule polymerization,melanosome transport,microtubule anchoring at centrosome,IRE1-mediated unfolded protein response,retrograde transport, endosome to Golgi,nuclear envelope disassembly,positive regulation of microtubule nucleation","motor activity,protein binding,microtubule binding,tubulin binding,dynein binding","kinetochore,spindle pole,nuclear envelope,cytoplasm,centrosome,centriole,spindle,cytosol,dynactin complex,microtubule,membrane,dynein complex,cell leading edge,microtubule plus-end,retromer complex",24,74,109,WVGVILDEAK.2|VTFSC[CAM]AAGFGQR.2|VTFSC[CAM]AAGFGQR.3|NLNLEEK.2|AFLQGGQEATDIALLLR.3|AFLQGGQEATDIALLLR.2|LATAMQEGEYDAERPPSKPPPVELR.4|LATAM[Oxi]QEGEYDAERPPSKPPPVELR.4|LATAMQEGEYDAERPPSKPPPVELR.3|QAQEKFELSENC[CAM]SERPGLR.4|ASLASLPPLHVAK.3|ASLASLPPLHVAK.2|LHISQLQHENSILK.4|LHISQLQHENSILK.3|LHISQLQHENSILK.2|MRDLSSSEKQEHVK.4|LVLTQEQLHQLHSR.4|LVLTQEQLHQLHSR.3|LVLTQEQLHQLHSR.2|AIEMELR.2|IQLEQVQEWK.3|IQLEQVQEWK.2|KYFTC[CAM]DEGHGIFVR.4|QLTAHLQDVNR.3|QLTAHLQDVNR.2|KLDSAAKDADER.3|SLDFLIELLHK.3|SLDFLIELLHK.2|SLSDTVEK.2|IKGEELSEANVR.3|IKGEELSEANVR.2|YEHALSQC[CAM]SVDVYKK.4|YEHALSQC[CAM]SVDVYKK.3|GTVAYVGATLFATGK.3|GTVAYVGATLFATGK.2|QLEEQNAR.2|VGSLYPEMSAHER.3|HKIQLEQVQEWK.3|QMEVAQANR.2|RVEAAQETVADYQQTIKK.4|RVEAAQETVADYQQTIKK.3|KTSQLLETLNQLSTHTHVVDITR.5|KTSQLLETLNQLSTHTHVVDITR.4|LEETQALLR.2|YFTC[CAM]DEGHGIFVR.3|YFTC[CAM]DEGHGIFVR.2|AESLQQEVEALKER.3|AESLQQEVEALKER.2|AKEEQQDDTVYMGK.3|AKEEQQDDTVYMGK.2|GEELSEANVR.2|ERVDELTTDLEILK.3|KNQELEVVR.2|AAALRAEITDAEGLGLK.3|FELSENC[CAM]SERPGLR.3|YEHALSQC[CAM]SVDVYK.3|YEHALSQC[CAM]SVDVYK.2|LSHEGPGSELPAGALYR.3|LSHEGPGSELPAGALYR.2|GSDGAASSYQLK.2|DLETSC[CAM]SDIR.2|VEAAQETVADYQQTIK.3|VEAAQETVADYQQTIK.2|AEITDAEGLGLK.2|LQEELSQAESTIDELK.3|LQEELSQAESTIDELK.2|MQEQQADLQR.2|M[Oxi]QEQQADLQR.2|TSQLLETLNQLSTHTHVVDITR.4|TSQLLETLNQLSTHTHVVDITR.3|VEAAQETVADYQQTIKK.3|YYQHLYSIHLAEQPEDC[CAM]TMQLADHIK.5|YYQHLYSIHLAEQPEDC[CAM]TMQLADHIK.4|RVEAAQETVADYQQTIK.3|RVEAAQETVADYQQTIK.2|AESLQQEVEALK.2|ETVSQRPGATVPTDFATFPSSAFLR.4|ETVSQRPGATVPTDFATFPSSAFLR.3|QLTAHLQDVNRELTNQQEASVER.4|QLTAHLQDVNRELTNQQEASVER.3|ASEQIYGTPSSSPYEC[CAM]LR.3|ASEQIYGTPSSSPYEC[CAM]LR.2|VDELTTDLEILK.2|ELTNQQEASVER.2|EQVDAALGAEEMVEMLTDR.3|LKDEVLKETVSQRPGATVPTDFATFPSSAFLR.5|QSC[CAM]NILISTMNK.2|VDELTTDLEILKAEIEEK.3|ERLQEELSQAESTIDELK.3|ERLQEELSQAESTIDELK.2|EEQQDDTVYMGK.2|EEQQDDTVYM[Oxi]GK.2|DSPLLLQQISAMR.2|DSPLLLQQISAM[Oxi]R.2|QQQPPPETFDFK.2|RMPGTDAPGIPAALAFGPQVSDTLLDC[CAM]RK.4|SPSAQLMEQVAQLK.2|SPSAQLM[Oxi]EQVAQLK.2|ERVDELTTDLEILKAEIEEK.3|DQLDETVNVEPLTK.2|ETVGDLEAMNEMNDELQENAR.3|ERYMEEMADTADAIEMATLDK.3|FTQSALDC[CAM]MSVEVGR.2|QSQIQVFEDGADTTSPETPDSSASK.3|EFEETMDALQADIDQLEAEKAELK.3|MPGTDAPGIPAALAFGPQVSDTLLDC[CAM]R.3|MPGTDAPGIPAALAFGPQVSDTLLDC[CAM]RK.3|RMPGTDAPGIPAALAFGPQVSDTLLDC[CAM]R.3|EFEETMDALQADIDQLEAEK.2
SEN / CTL,Plastin-1,PLS1,Q14651,0.40,0.36,7.37E-04,5.82E-04,3.24E+00,"intestinal D-glucose absorption,regulation of microvillus length,positive regulation of multicellular organism growth,actin filament bundle assembly,actin filament network formation,actin crosslink formation,positive regulation of establishment of protein localization to plasma membrane,terminal web assembly","structural constituent of cytoskeleton,calcium ion binding,actin filament binding","cytoplasm,actin filament,brush border,actin filament bundle,extracellular exosome,terminal web",15,37,50,SISTSLPVLDLIDAIAPNAVR.3|SISTSLPVLDLIDAIAPNAVR.2|MINLSEPDTIDER.2|M[Oxi]INLSEPDTIDER.2|GGEDGPAIAIDLSGINETNDLKR.3|IYALPDDLVEVKPK.3|SLADGILLC[CAM]K.2|RAGLMLQEADK.3|RAGLMLQEADK.2|VNDEIIIK.2|ILSVADSNK.2|ENLSDEDKLNNAK.3|AGLMLQEADKLGC[CAM]K.3|KIENC[CAM]NYAVELGK.3|KIENC[CAM]NYAVELGK.2|ALENDPDC[CAM]K.2|AGLMLQEADK.2|EASLPLPGYK.2|VAFVNWINK.2|HLIPM[Oxi]NPNDDSLFK.3|HLIPMNPNDDSLFK.3|HLIPM[Oxi]NPNDDSLFK.2|HLIPMNPNDDSLFK.2|RENLSDEDK.2|RENLSDEDKLNNAK.3|ISFEEFVSLMQELK.3|ISFEEFVSLMQELK.2|RYTLNVLSDLGEGEK.3|RYTLNVLSDLGEGEK.2|EGKPHLVLGLLWQIIK.3|VGLFADIEISR.2|ILSVADSNKDGK.2|IENC[CAM]NYAVELGK.2|LNLAFVANLFNTYPC[CAM]LHK.3|REGITAIGGTSTISSEGTQHSYSEEEK.4|REGITAIGGTSTISSEGTQHSYSEEEK.3|NEALIALLNEGEELEELM[Oxi]K.3|NEALIALLNEGEELEELMK.3|NEALIALLNEGEELEELMK.2|ILSVADSNKDGKISFEEFVSLMQELK.4|EELEELQEAFNK.2|IDIDNSGYVSDYELQDLFK.3|IDIDNSGYVSDYELQDLFK.2|PNNNDIDMNLLEGESKEER.3|YTLNVLSDLGEGEK.2|YTLNVLSDLGEGEKVNDEIIIK.3|WVNYHLTNAGWHTISNFSQDIK.3|EGITAIGGTSTISSEGTQHSYSEEEK.3|PNNNDIDMNLLEGESK.2|SISTSLPVLDLIDAIAPNAVRQEMIR.3
SEN / CTL,Heat shock protein HSP 90-alpha,HSP90AA1,P07900,0.40,0.80,1.44E-01,4.73E-02,1.33E+00,"G2/M transition of mitotic cell cycle,neuron migration,skeletal muscle contraction,mitochondrial transport,receptor-mediated endocytosis,response to unfolded protein,signal transduction,response to heat,response to cold,response to salt stress,positive regulation of lamellipodium assembly,cardiac muscle cell apoptotic process,peptidyl-tyrosine phosphorylation,regulation of protein ubiquitination,positive regulation of protein import into nucleus, translocation,Fc-gamma receptor signaling pathway involved in phagocytosis,ERBB2 signaling pathway,protein refolding,response to cocaine,response to drug,regulation of protein complex assembly,protein unfolding,response to estrogen,protein import into mitochondrial outer membrane,positive regulation of nitric oxide biosynthetic process,positive regulation of cell size,response to antibiotic,vascular endothelial growth factor receptor signaling pathway,protein stabilization,regulation of nitric-oxide synthase activity,chaperone-mediated protein complex assembly,positive regulation of cardiac muscle contraction,chaperone-mediated autophagy,regulation of cellular response to heat","nucleotide binding,glycoprotein binding,UTP binding,CTP binding,mRNA binding,protein tyrosine kinase activity,protein binding,ATP binding,GTP binding,ATPase activity,sulfonylurea receptor binding,protein kinase binding,protein phosphatase binding,MHC class II protein complex binding,nitric-oxide synthase regulator activity,TPR domain binding,dATP binding,identical protein binding,protein homodimerization activity,histone deacetylase binding,ion channel binding,poly(A) RNA binding,tau protein binding,GTPase binding,Rho GDP-dissociation inhibitor binding,unfolded protein binding","extracellular region,nucleus,nucleoplasm,cytoplasm,cytosol,plasma membrane,cell surface,membrane,basolateral plasma membrane,apical plasma membrane,extracellular matrix,brush border membrane,ruffle membrane,melanosome,neuron projection,neuronal cell body,lysosomal lumen,myelin sheath,protein complex,perinuclear region of cytoplasm,extracellular exosome,endocytic vesicle lumen,sperm mitochondrial sheath,sperm plasma membrane",105,69,151,ALLFVPR.2|NPDDITNEEYGEFYK.2|NPDDITNEEYGEFYK.3|ELISNSSDALDKIR.3|ELISNSSDALDKIR.2|RAPFDLFENR.3|RAPFDLFENR.2|KHLEINPDHSIIETLR.3|KHLEINPDHSIIETLR.4|KHLEINPDHSIIETLR.2|TKPIWTRNPDDITNEEYGEFYK.4|TKPIWTRNPDDITNEEYGEFYK.3|DQVANSAFVER.2|DQVANSAFVER.3|TLTIVDTGIGMTK.2|TLTIVDTGIGMTK.3|TLTIVDTGIGM[Oxi]TK.3|TLTIVDTGIGM[Oxi]TK.2|HIYYITGETKDQVANSAFVER.4|HIYYITGETKDQVANSAFVER.3|HLEINPDHSIIETLR.4|HLEINPDHSIIETLR.3|HLEINPDHSIIETLR.2|RVFIMDNC[CAM]EELIPEYLNFIR.3|RVFIMDNC[CAM]EELIPEYLNFIR.4|RVFIM[Oxi]DNC[CAM]EELIPEYLNFIR.4|RVFIM[Oxi]DNC[CAM]EELIPEYLNFIR.3|HGLEVIYMIEPIDEYC[CAM]VQQLKEFEGK.4|HGLEVIYM[Oxi]IEPIDEYC[CAM]VQQLKEFEGK.4|HGLEVIYMIEPIDEYC[CAM]VQQLKEFEGK.3|HGLEVIYM[Oxi]IEPIDEYC[CAM]VQQLKEFEGK.3|FYEQFSK.2|FYEQFSK.1|HSQFIGYPITLFVEKER.3|HSQFIGYPITLFVEKER.4|HSQFIGYPITLFVEKER.2|LVTSPC[CAM]C[CAM]IVTSTYGWTANMER.3|LVTSPC[CAM]C[CAM]IVTSTYGWTANMER.4|LVTSPC[CAM]C[CAM]IVTSTYGWTANM[Oxi]ER.3|YYTSASGDEMVSLKDYC[CAM]TR.3|YYTSASGDEM[Oxi]VSLKDYC[CAM]TR.3|YYTSASGDEMVSLKDYC[CAM]TR.2|C[CAM]LELFTELAEDKENYKK.4|C[CAM]LELFTELAEDKENYKK.3|C[CAM]LELFTELAEDKENYKK.2|TLTIVDTGIGMTKADLINNLGTIAK.3|TLTIVDTGIGMTKADLINNLGTIAK.4|TLTIVDTGIGM[Oxi]TKADLINNLGTIAK.3|HIYYITGETK.3|HIYYITGETK.2|VFIMDNC[CAM]EELIPEYLNFIR.3|VFIMDNC[CAM]EELIPEYLNFIR.4|VFIM[Oxi]DNC[CAM]EELIPEYLNFIR.4|VFIM[Oxi]DNC[CAM]EELIPEYLNFIR.3|HSQFIGYPITLFVEK.3|HSQFIGYPITLFVEK.4|HSQFIGYPITLFVEK.2|KHGLEVIYMIEPIDEYC[CAM]VQQLKEFEGK.4|KHGLEVIYMIEPIDEYC[CAM]VQQLKEFEGK.5|KHGLEVIYMIEPIDEYC[CAM]VQQLKEFEGK.3|IMKDILEK.2|IM[Oxi]KDILEK.2|APFDLFENRK.3|APFDLFENRK.2|LDSGKELHINLIPNKQDR.5|LDSGKELHINLIPNKQDR.4|LDSGKELHINLIPNKQDR.3|LDSGKELHINLIPNKQDR.2|LDSGKELHINLIPNK.4|LDSGKELHINLIPNK.3|LDSGKELHINLIPNK.2|KLSELLR.2|LGIHEDSQNRK.3|LGIHEDSQNRK.2|RAPFDLFENRK.3|RAPFDLFENRK.2|KHSQFIGYPITLFVEK.4|KHSQFIGYPITLFVEK.3|KHSQFIGYPITLFVEK.2|TDTGEPMGR.2|TDTGEPM[Oxi]GR.2|C[CAM]LELFTELAEDK.3|C[CAM]LELFTELAEDK.2|YYTSASGDEMVSLK.3|YYTSASGDEM[Oxi]VSLK.3|YYTSASGDEMVSLK.2|YYTSASGDEM[Oxi]VSLK.2|TKFENLC[CAM]K.2|ELHINLIPNKQDR.3|ELHINLIPNKQDR.2|KC[CAM]LELFTELAEDKENYK.4|KC[CAM]LELFTELAEDKENYK.3|KFYEQFSK.2|YESLTDPSKLDSGKELHINLIPNK.5|KHSQFIGYPITLFVEKER.4|KHSQFIGYPITLFVEKER.3|APFDLFENR.2|AQALRDNSTMGYMAAK.3|AQALRDNSTM[Oxi]GYM[Oxi]AAK.3|AQALRDNSTM[Oxi]GYMAAK.3|AQALRDNSTMGYM[Oxi]AAK.3|AQALRDNSTMGYMAAK.2|ENQKHIYYITGETK.3|ESEDKPEIEDVGSDEEEEKK.4|ESEDKPEIEDVGSDEEEEKK.3|EVSDDEAEEK.2|KTKFENLC[CAM]K.2|LGIHEDSQNR.2|QDRTLTIVDTGIGMTK.3|DNSTMGYMAAK.2|DNSTM[Oxi]GYMAAK.2|DNSTMGYM[Oxi]AAK.2|DNSTM[Oxi]GYM[Oxi]AAK.2|ELHINLIPNK.2|ELISNSSDALDK.2|ELISNSSDALDKIRYESLTDPSK.4|ELISNSSDALDKIRYESLTDPSK.3|HGLEVIYMIEPIDEYC[CAM]VQQLK.4|HGLEVIYM[Oxi]IEPIDEYC[CAM]VQQLK.4|HGLEVIYM[Oxi]IEPIDEYC[CAM]VQQLK.3|HGLEVIYMIEPIDEYC[CAM]VQQLK.3|EIFLRELISNSSDALDK.3|EIFLRELISNSSDALDK.2|C[CAM]LELFTELAEDKENYK.3|C[CAM]LELFTELAEDKENYK.2|KHGLEVIYMIEPIDEYC[CAM]VQQLK.4|KHGLEVIYM[Oxi]IEPIDEYC[CAM]VQQLK.4|KHGLEVIYM[Oxi]IEPIDEYC[CAM]VQQLK.3|KHGLEVIYMIEPIDEYC[CAM]VQQLK.3|ESEDKPEIEDVGSDEEEEKKDGDK.4|EVSDDEAEEKEDKEEEK.3|DKEVSDDEAEEK.2|LGIHEDSQNRKK.2|TLVSVTKEGLELPEDEEEK.3|VTVITKHNDDEQYAWESSAGGSFTVR.4|VTVITKHNDDEQYAWESSAGGSFTVR.3|ESEDKPEIEDVGSDEEEEK.3|DLVILLYETALLSSGFSLEDPQTHANR.4|DLVILLYETALLSSGFSLEDPQTHANR.3|SVKDLVILLYETALLSSGFSLEDPQTHANRIYR.5|SVKDLVILLYETALLSSGFSLEDPQTHANRIYR.4|NIKLGIHEDSQNR.2|KC[CAM]LELFTELAEDK.2|PIWTRNPDDITNEEYGEFYK.3|LGLGIDEDDPTADDTSAAVTEEMPPLEGDDDTSR.4|LGLGIDEDDPTADDTSAAVTEEM[Oxi]PPLEGDDDTSR.3|LGLGIDEDDPTADDTSAAVTEEMPPLEGDDDTSR.3|LGLGIDEDDPTADDTSAAVTEEM[Oxi]PPLEGDDDTSRM[Oxi]EEVD.4|LGLGIDEDDPTADDTSAAVTEEM[Oxi]PPLEGDDDTSRMEEVD.4|LGLGIDEDDPTADDTSAAVTEEMPPLEGDDDTSRM[Oxi]EEVD.4|LGLGIDEDDPTADDTSAAVTEEMPPLEGDDDTSRMEEVD.4
SEN / CTL,F-actin-capping protein subunit alpha-2,CAPZA2,P47755,0.40,0.27,3.59E-05,3.93E-05,4.41E+00,"protein complex assembly,movement of cell or subcellular component,blood coagulation,innate immune response,barbed-end actin filament capping",actin binding,"extracellular region,cytosol,brush border,F-actin capping protein complex,actin cytoskeleton,membrane,cortical cytoskeleton,extracellular exosome",15,16,29,FTITPSTTQVVGILK.2|FTITPSTTQVVGILK.3|EATDPRPC[CAM]EVENAVESWR.3|FIIHAPPGEFNEVFNDVR.3|FIIHAPPGEFNEVFNDVR.4|FIIHAPPGEFNEVFNDVR.2|KIDGQQTIIAC[CAM]IESHQFQAK.4|KIDGQQTIIAC[CAM]IESHQFQAK.5|KIDGQQTIIAC[CAM]IESHQFQAK.3|KIDGQQTIIAC[CAM]IESHQFQAK.2|TSVETALR.2|EHYPNGVC[CAM]TVYGK.3|EHYPNGVC[CAM]TVYGK.2|EGAAHAFAQYNLDQFTPVK.4|EGAAHAFAQYNLDQFTPVK.3|EGAAHAFAQYNLDQFTPVK.2|DIQDSLTVSNEVQTAK.3|DIQDSLTVSNEVQTAK.2|AYVKEHYPNGVC[CAM]TVYGK.3|IDGQQTIIAC[CAM]IESHQFQAK.3|IEGYEDQVLITEHGDLGNGK.3|IEGYEDQVLITEHGDLGNGK.2|PC[CAM]EVENAVESWR.2|IQVHYYEDGNVQLVSHKDIQDSLTVSNEVQTAK.5|IVEAAENEYQTAISENYQTMSDTTFK.4|IVEAAENEYQTAISENYQTMSDTTFK.3|FIIHAPPGEFNEVFNDVRLLLNNDNLLR.4|EGAAHAFAQYNLDQFTPVKIEGYEDQVLITEHGDLGNGK.5|EGAAHAFAQYNLDQFTPVKIEGYEDQVLITEHGDLGNGK.4
SEN / CTL,"Spectrin beta chain, non-erythrocytic 1",SPTBN1,Q01082,0.40,0.61,3.37E-23,5.35E-22,2.13E+01,"MAPK cascade,mitotic cytokinesis,ER to Golgi vesicle-mediated transport,plasma membrane organization,cytoskeleton organization,common-partner SMAD protein phosphorylation,SMAD protein import into nucleus,axon guidance,Golgi to plasma membrane protein transport,positive regulation of GTPase activity,actin filament capping,membrane assembly,protein targeting to plasma membrane,cell-cell adhesion,positive regulation of interleukin-2 secretion,regulation of protein localization to plasma membrane,positive regulation of protein localization to plasma membrane","actin binding,Ras guanyl-nucleotide exchange factor activity,structural constituent of cytoskeleton,protein binding,calmodulin binding,phospholipid binding,ankyrin binding,protein complex binding,poly(A) RNA binding,GTPase binding,cadherin binding involved in cell-cell adhesion","nucleolus,cytoplasm,cytosol,cell-cell adherens junction,spectrin,spectrin-associated cytoskeleton,axolemma,M band,cuticular plate,protein complex,extracellular exosome",294,217,362,SQNIVTDSSSLSAEAIR.3|SQNIVTDSSSLSAEAIR.2|LTTLELLEVR.2|QLWGLLIEETEKR.3|VQAVVAVAR.2|LWEYLLELLR.2|DLDDFQSWLSR.2|QALQDTLALYK.2|LTTLELLEVRR.3|EQWANLEQLSAIRK.3|EQWANLEQLSAIR.2|EQWANLEQLSAIR.3|FMELLEPLNER.2|FM[Oxi]ELLEPLNER.2|HQILEQAVEDYAETVHQLSK.4|HQILEQAVEDYAETVHQLSK.3|IDDIFERSQNIVTDSSSLSAEAIR.3|IDDIFER.2|DASVAEAWLLGQEPYLSSR.3|DASVAEAWLLGQEPYLSSR.2|VLVLSQDYGK.2|LADLKQLWGLLIEETEKR.3|LADLKQLWGLLIEETEKR.4|ITDLYTDLRDGR.3|TQETPSAQMEGFLNR.2|TQETPSAQMEGFLNR.3|TQETPSAQM[Oxi]EGFLNR.2|LSDLQKEAEKLESEHPDQAQAILSR.5|LSDLQKEAEKLESEHPDQAQAILSR.4|LSDLQKEAEKLESEHPDQAQAILSR.3|MHTTFEHDIQALGTQVR.4|MHTTFEHDIQALGTQVR.3|M[Oxi]HTTFEHDIQALGTQVR.3|M[Oxi]HTTFEHDIQALGTQVR.4|MHTTFEHDIQALGTQVR.2|KLPEELGRDQNTVETLQR.4|KLPEELGRDQNTVETLQR.3|KLPEELGRDQNTVETLQR.2|LILEVHQFSR.3|LILEVHQFSR.2|TKVIESTQDLGNDLAGVMALQR.3|DLMLWMEDVIR.2|TQILAASYELHK.2|TQILAASYELHK.3|MPLATSTDHGHNLQTVQLLIKK.4|AQTLPTSVVTITSESSPGKR.3|AQTLPTSVVTITSESSPGKR.2|ILSSDDYGKDLTSVMR.3|ILSSDDYGKDLTSVMR.2|LLDPEDISVDHPDEK.3|LLDPEDISVDHPDEK.2|QNLLSQSHAYQQFLR.3|QNLLSQSHAYQQFLR.2|SGHFEQAIKEGEDMIAEEHFGSEK.4|SGHFEQAIKEGEDMIAEEHFGSEK.5|SGHFEQAIKEGEDMIAEEHFGSEK.3|SNAHYNLQNAFNLAEQHLGLTK.4|SNAHYNLQNAFNLAEQHLGLTK.3|LPEELGRDQNTVETLQR.3|LPEELGRDQNTVETLQR.2|TALPAQSAATLPAR.2|TALPAQSAATLPAR.3|TAASGIPYHSEVPVSLK.3|TAASGIPYHSEVPVSLK.2|HLLGVEDLLQK.3|HLLGVEDLLQK.2|KHEAIETDIAAYEER.3|KHEAIETDIAAYEER.4|KHEAIETDIAAYEER.2|LAEISDVWEEMK.2|LAEISDVWEEM[Oxi]K.2|VSEEAESQQQWDTSKGEQVSQNGLPAEQGSPR.4|EAVC[CAM]EVALDYK.2|LLTQHENIKNEIDNYEEDYQK.4|LLTQHENIKNEIDNYEEDYQK.3|EIGQSVDEVEKLIK.3|VAVVNQIAR.2|EIHQFNRDVEDEILWVGER.4|EIHQFNRDVEDEILWVGER.3|EIHQFNRDVEDEILWVGER.2|DALLLWC[CAM]QMK.2|DALLLWC[CAM]QM[Oxi]K.2|VIESTQDLGNDLAGVMALQR.3|VIESTQDLGNDLAGVM[Oxi]ALQR.3|VIESTQDLGNDLAGVMALQR.2|LQALDTGWNELHK.3|LQALDTGWNELHK.2|EAEKLESEHPDQAQAILSR.4|EAEKLESEHPDQAQAILSR.3|MLTAQDMSYDEAR.2|M[Oxi]LTAQDMSYDEAR.2|MLTAQDM[Oxi]SYDEAR.2|VAHMEFC[CAM]YQELC[CAM]QLAAERR.4|VAHM[Oxi]EFC[CAM]YQELC[CAM]QLAAERR.4|LVSQDNFGFDLPAVEAATK.2|LVSQDNFGFDLPAVEAATK.3|DGMAFNALIHK.3|DGMAFNALIHK.2|DGM[Oxi]AFNALIHK.3|DGM[Oxi]AFNALIHK.2|VDKLYAGLKDLAEER.4|VDKLYAGLKDLAEER.3|VDKLYAGLKDLAEER.2|TAASGIPYHSEVPVSLKEAVC[CAM]EVALDYKK.5|GNLEVLLFTIQSK.2|GNLEVLLFTIQSK.3|QQMLENQMEVR.2|QQM[Oxi]LENQMEVR.2|IVSSSDVGHDEYSTQSLVKK.4|IVSSSDVGHDEYSTQSLVKK.3|MWEVLESTTQTK.2|MWEVLESTTQTK.3|M[Oxi]WEVLESTTQTK.2|FANSLVGVQQQLQAFNTYR.3|FANSLVGVQQQLQAFNTYR.2|EVVAGSHELGQDYEHVTMLQER.4|EVVAGSHELGQDYEHVTM[Oxi]LQER.4|EVVAGSHELGQDYEHVTM[Oxi]LQER.3|EVVAGSHELGQDYEHVTMLQER.3|TAGYPNVNIHNFTTSWR.3|TAGYPNVNIHNFTTSWR.2|SWHNVYC[CAM]VINNQEMGFYKDAK.4|SWHNVYC[CAM]VINNQEMGFYKDAK.3|LEMNLGLQK.2|LQQFLRDLDDFQSWLSR.3|HKDVAEEIANYRPTLDTLHEQASALPQEHAESPDVR.6|HKDVAEEIANYRPTLDTLHEQASALPQEHAESPDVR.5|KKEIEELQSQAQALSQEGK.3|KKEIEELQSQAQALSQEGK.4|NDSFTTC[CAM]IELGK.2|LLDPEDISVDHPDEKSIITYVVTYYHYFSK.5|LLDPEDISVDHPDEKSIITYVVTYYHYFSK.4|HQAFMAELASNKEWLDKIEK.4|TQTAIASEDMPNTLTEAEK.3|TQTAIASEDM[Oxi]PNTLTEAEK.3|TQTAIASEDM[Oxi]PNTLTEAEK.2|TQTAIASEDMPNTLTEAEK.2|MPLATSTDHGHNLQTVQLLIK.4|M[Oxi]PLATSTDHGHNLQTVQLLIK.4|M[Oxi]PLATSTDHGHNLQTVQLLIK.3|MPLATSTDHGHNLQTVQLLIK.3|MPLATSTDHGHNLQTVQLLIK.2|VAHMEFC[CAM]YQELC[CAM]QLAAER.3|VAHM[Oxi]EFC[CAM]YQELC[CAM]QLAAER.3|VAHMEFC[CAM]YQELC[CAM]QLAAER.2|FATDGEGYKPC[CAM]DPQVIR.3|FATDGEGYKPC[CAM]DPQVIR.2|HTLVEADIGIQAER.3|HTLVEADIGIQAER.2|HRPDLIDFDKLKK.4|LISDINK.2|LSGIEER.2|DLTSVMR.2|EVAELTR.2|HRPDLIDFDK.3|HRPDLIDFDK.2|LEDLEVIQHR.3|LEDLEVIQHR.2|LLEVLSGERLPKPTK.4|LLEVLSGERLPKPTK.3|LLEVLSGERLPKPTK.2|QLMHSGHPSEK.3|QLM[Oxi]HSGHPSEK.3|QLMHSGHPSEK.2|LLQLTEK.2|AKDEQSAVSMLK.3|AKDEQSAVSMLK.2|AKDEQSAVSM[Oxi]LK.2|LISDINKAWERLEK.4|VRLVDTGDKFR.3|ALVADSHPESER.3|ALVADSHPESER.2|LQAAYAGDKADDIQKR.4|LQAAYAGDKADDIQKR.3|NRETASELLMR.3|NRETASELLM[Oxi]R.3|NRETASELLMR.2|QRLEMNLGLQK.3|HQAFMAELASNK.3|HQAFM[Oxi]AELASNK.3|HQAFMAELASNK.2|HQAFM[Oxi]AELASNK.2|HRAFEDEM[Oxi]SGR.3|HRAFEDEMSGR.3|LISDINKAWER.3|RLVSDGNINSDR.3|RLVSDGNINSDR.2|ELEAENYHDIK.3|ELEAENYHDIK.2|KHNLLASK.2|QRLQALDTGWNELHK.4|QRLQALDTGWNELHK.3|RLEEAHR.2|AEHERELALRNELIR.4|FYHDAKEIFGR.3|KQALQDTLALYK.3|KQALQDTLALYK.2|RHEAFEK.2|EIHQFNR.2|LQAAYAGDK.2|SAATWDER.2|EAVC[CAM]EVALDYKK.3|EAVC[CAM]EVALDYKK.2|LSGIEERYKEVAELTR.4|LSGIEERYKEVAELTR.3|LSGIEERYKEVAELTR.2|EIQGHQPR.2|INAVVETGR.2|VHLENMGSHDIVDGNHR.4|VHLENM[Oxi]GSHDIVDGNHR.4|VHLENMGSHDIVDGNHR.3|DVEDEILWVGER.3|DVEDEILWVGER.2|HYASEEIK.2|DTGNIGQER.2|EMIDKWEDRWEWLR.4|EMIDKWEDRWEWLR.3|EVDDLEQWIAER.3|EVDDLEQWIAER.2|HRPDLIDFDKLK.3|ILSSDDYGK.2|ELEAENYHDIKR.3|ELEAENYHDIKR.2|FMELLEPLNERK.3|FMELLEPLNERK.2|LLEVLSGER.2|PRDVSSVELLMNNHQGIK.4|PRDVSSVELLM[Oxi]NNHQGIK.4|PRDVSSVELLMNNHQGIK.3|SGHFEQAIK.2|FQIQDISVETEDNKEKK.4|HEVSASTQSTPASSR.3|HEVSASTQSTPASSR.2|KQQMLENQMEVR.3|KQQMLENQMEVR.2|AFEDEMSGR.2|AFEDEM[Oxi]SGR.2|KSNAHYNLQNAFNLAEQHLGLTK.5|KSNAHYNLQNAFNLAEQHLGLTK.4|KSNAHYNLQNAFNLAEQHLGLTK.3|AAMRETWLSENQR.3|AAMRETWLSENQR.2|ETASELLMR.2|HEWEAHNK.2|SLLDAC[CAM]ESR.2|EGMQLISEKPETEAVVKEK.4|KHEAIETDIAAYEERVQAVVAVAR.5|KHEAIETDIAAYEERVQAVVAVAR.4|LQAAYAGDKADDIQK.3|KHYASEEIK.2|LLTQHENIK.2|QIEAQEKPR.2|SAATWDERFSALER.3|TQILAASYELHKFYHDAKEIFGR.5|TVEKPPKFTEKGNLEVLLFTIQSK.5|TVEKPPKFTEKGNLEVLLFTIQSK.4|TVEKPPKFTEKGNLEVLLFTIQSK.3|DEQSAVSMLK.2|DLTSVNILLK.2|EASLGEASKLQQFLR.3|EASLGEASKLQQFLR.2|ENEVLEAWK.2|IHC[CAM]LENVDKALQFLKEQR.4|INAVVETGRR.2|ITDLYTDLR.2|LRLNDGNEYLFQAK.3|LRLNDGNEYLFQAK.2|NQTLQKEIQGHQPR.3|IHC[CAM]LENVDK.2|LESEHPDQAQAILSR.3|LESEHPDQAQAILSR.2|LVSDGNINSDRIQEK.3|VLDNAIETEK.2|EGEDMIAEEHFGSEK.3|SWHNVYC[CAM]VINNQEMGFYK.4|SWHNVYC[CAM]VINNQEMGFYK.3|SWHNVYC[CAM]VINNQEM[Oxi]GFYK.3|DALLSALSIQNYHLEC[CAM]NETK.4|DALLSALSIQNYHLEC[CAM]NETK.3|DALLSALSIQNYHLEC[CAM]NETK.2|ETWLSENQR.2|NREASLGEASK.2|GEQVSQNGLPAEQGSPR.3|GEQVSQNGLPAEQGSPR.2|KHEWEAHNK.2|LVSDGNINSDR.2|DVSSVELLMNNHQGIK.3|DVSSVELLMNNHQGIK.2|DQNTVETLQR.2|KQEDFMTTMDANEEK.3|KQEDFMTTMDANEEK.2|SLLDAC[CAM]ESRR.2|RLVSDGNINSDRIQEK.3|DLTSVNILLKK.2|EIGQSVDEVEK.2|KHQILEQAVEDYAETVHQLSK.4|KHQILEQAVEDYAETVHQLSK.3|EGMQLISEKPETEAVVK.3|EGM[Oxi]QLISEKPETEAVVK.3|EGMQLISEKPETEAVVK.2|EIEELQSQAQALSQEGK.3|EIEELQSQAQALSQEGK.2|LAEISDVWEEMKTTLK.3|SIITYVVTYYHYFSK.3|SIITYVVTYYHYFSK.2|WLHGLESQIQSDDYGK.3|WLHGLESQIQSDDYGK.2|AQTLPTSVVTITSESSPGK.3|AQTLPTSVVTITSESSPGK.2|DRVAHMEFC[CAM]YQELC[CAM]QLAAER.4|DVAEEIANYRPTLDTLHEQASALPQEHAESPDVR.6|DVAEEIANYRPTLDTLHEQASALPQEHAESPDVR.5|DVAEEIANYRPTLDTLHEQASALPQEHAESPDVR.4|FLQDC[CAM]QELSLWINEK.3|FLQDC[CAM]QELSLWINEK.2|FQIQDISVETEDNKEK.3|KKDALLSALSIQNYHLEC[CAM]NETK.4|KKDALLSALSIQNYHLEC[CAM]NETK.3|MAETVDTSEMVNGATEQR.3|MAETVDTSEMVNGATEQR.2|HQAFMAELASNKEWLDK.3|ALADEREAVQKK.2|IVSSSDVGHDEYSTQSLVK.3|IVSSSDVGHDEYSTQSLVK.2|KHYASEEIKEK.2|EQWLNNMQIPEKLEDLEVIQHR.4|EQWLNNMQIPEKLEDLEVIQHR.3|LYAGLKDLAEER.2|SQNIVTDSSSLSAEAIRQR.3|KHKDVAEEIANYRPTLDTLHEQASALPQEHAESPDVR.6|LNDGNEYLFQAK.2|VDTVNHLADELINSGHSDAATIAEWK.4|VDTVNHLADELINSGHSDAATIAEWK.3|LVSQDNFGFDLPAVEAATKK.3|LFDANKAELFTQSC[CAM]ADLDK.3|QLWGLLIEETEK.2|DMGEMVTQGQTDAQYMFLR.3|DMGEMVTQGQTDAQYMFLR.2|IIYIREQWANLEQLSAIR.3|AELFTQSC[CAM]ADLDK.2|DDEEMNTWIQAISSAISSDK.3|DDEEMNTWIQAISSAISSDK.2|DTGNIGQERVDTVNHLADELINSGHSDAATIAEWK.5|EASLGEASKLQQFLRDLDDFQSWLSR.4|EQWLNNMQIPEK.2|TAASGIPYHSEVPVSLKEAVC[CAM]EVALDYK.4|KFANSLVGVQQQLQAFNTYR.3|NEIDNYEEDYQK.2|EVDDLEQWIAEREVVAGSHELGQDYEHVTMLQER.5|LFDANKAELFTQSC[CAM]ADLDKWLHGLESQIQSDDYGK.5|LFDANKAELFTQSC[CAM]ADLDKWLHGLESQIQSDDYGK.4|FESLEPEMNNQASR.2|FESLEPEM[Oxi]NNQASR.2|FQIQDISVETEDNK.2|QAEAFLNNQEYVLAHTEMPTTLEGAEAAIK.4|QAEAFLNNQEYVLAHTEMPTTLEGAEAAIK.3|QEDFMTTMDANEEK.2|FFWEMAEEEGWIR.2|WDVDDWDNENSSAR.2|VSEEAESQQQWDTSK.2|MFSEADAC[CAM]ELWIDEK.2|DDEEMNTWIQAISSAISSDKHEVSASTQSTPASSR.4
SEN / CTL,"Tryptophan--tRNA ligase, cytoplasmic",WARS,P23381,0.40,0.54,3.96E-07,7.13E-07,6.15E+00,"angiogenesis,translation,tRNA aminoacylation for protein translation,tryptophanyl-tRNA aminoacylation,negative regulation of cell proliferation,regulation of angiogenesis","tryptophan-tRNA ligase activity,protein binding,ATP binding","nucleus,cytoplasm,cytosol,extracellular exosome",36,36,61,GIFGFTDSDC[CAM]IGK.2|ALIEVLQPLIAEHQAR.3|ALIEVLQPLIAEHQAR.2|PNSEPASLLELFNSIATQGELVR.3|PNSEPASLLELFNSIATQGELVR.4|MSASDPNSSIFLTDTAK.2|M[Oxi]SASDPNSSIFLTDTAK.2|ISFPAIQAAPSFSNSFPQIFR.3|ISFPAIQAAPSFSNSFPQIFR.4|ISFPAIQAAPSFSNSFPQIFR.2|GIDYDKLIVR.2|DRTDIQC[CAM]LIPC[CAM]AIDQDPYFR.3|DRTDIQC[CAM]LIPC[CAM]AIDQDPYFR.4|IGYPKPALLHSTFFPALQGAQTK.4|IGYPKPALLHSTFFPALQGAQTK.3|KLSFDFQ.2|TDIQC[CAM]LIPC[CAM]AIDQDPYFR.3|TDIQC[CAM]LIPC[CAM]AIDQDPYFR.2|DYTSGAMLTGELKK.3|DYTSGAMLTGELKK.2|DMNQVLDAYENKKPFYLYTGR.4|DMNQVLDAYENKKPFYLYTGR.3|HAFSGGRDTIEEHR.4|RKEVTDEIVK.3|AAAGEDYK.2|KDYTSGAMLTGELKK.4|KDYTSGAMLTGELKK.3|ATGQRPHHFLR.3|DEIDSAVK.2|AGNASKDEIDSAVK.3|AGNASKDEIDSAVK.2|EVTDEIVK.2|KALIEVLQPLIAEHQAR.4|KALIEVLQPLIAEHQAR.3|PALLHSTFFPALQGAQTK.4|PALLHSTFFPALQGAQTK.3|PALLHSTFFPALQGAQTK.2|HVTFNQVK.2|IDKELINR.2|DMNQVLDAYENKK.3|GPSSEAM[Oxi]HVGHLIPFIFTK.4|GPSSEAMHVGHLIPFIFTK.4|GPSSEAM[Oxi]HVGHLIPFIFTK.3|GPSSEAMHVGHLIPFIFTK.3|GPSSEAMHVGHLIPFIFTK.2|EVTDEIVKEFMTPR.3|SLKAGNASKDEIDSAVK.3|DLTLDQAYSYAVENAK.3|DLTLDQAYSYAVENAK.2|DIIAC[CAM]GFDINK.2|DYTSGAMLTGELK.2|TFIFSDLDYMGMSSGFYK.3|TFIFSDLDYMGM[Oxi]SSGFYK.3|TFIFSDLDYMGMSSGFYK.2|DMNQVLDAYENK.2|DM[Oxi]NQVLDAYENK.2|WLQDVFNVPLVIQMTDDEK.3|WLQDVFNVPLVIQM[Oxi]TDDEK.3|WLQDVFNVPLVIQMTDDEK.2|ADC[CAM]PPGNPAPTSNHGPDATEAEEDFVDPWTVQTSSAK.4|AAAGEDYKADC[CAM]PPGNPAPTSNHGPDATEAEEDFVDPWTVQTSSAK.4
SEN / CTL,Quinone oxidoreductase,CRYZ,Q08257,0.39,1.08,2.25E-04,2.08E-04,3.68E+00,"visual perception,xenobiotic catabolic process,protein homotetramerization,oxidation-reduction process","mRNA 3'-UTR binding,NADPH:quinone reductase activity,zinc ion binding,NADPH binding,NADH binding","cytoplasm,cytosol,extracellular exosome",48,32,52,VFEFGGPEVLK.2|VHAC[CAM]GVNPVETYIR.3|VHAC[CAM]GVNPVETYIR.2|QGAAIGIPYFTAYR.2|QGAAIGIPYFTAYR.3|KPLLPYTPGSDVAGVIEAVGDNASAFK.3|KPLLPYTPGSDVAGVIEAVGDNASAFK.4|AGESVLVHGASGGVGLAAC[CAM]QIAR.3|AGESVLVHGASGGVGLAAC[CAM]QIAR.4|AGESVLVHGASGGVGLAAC[CAM]QIAR.2|LRSDIAVPIPKDHQVLIK.4|LRSDIAVPIPKDHQVLIK.5|LRSDIAVPIPKDHQVLIK.3|GIDIIIEMLANVNLSKDLSLLSHGGR.4|LRSDIAVPIPK.3|LRSDIAVPIPK.2|SDIAVPIPKDHQVLIK.4|SDIAVPIPK.2|GTIEINPR.2|IVLQNGAHEVFNHR.4|IVLQNGAHEVFNHR.3|IVLQNGAHEVFNHR.2|DHQVLIK.2|VAEAHENIIHGSGATGK.4|VAEAHENIIHGSGATGK.3|VAEAHENIIHGSGATGK.2|ALIHSAC[CAM]VK.2|VFEFGGPEVLKLR.3|AVRVFEFGGPEVLK.3|DLSLLSHGGR.2|ILGTAGTEEGQKIVLQNGAHEVFNHR.5|ILGTAGTEEGQKIVLQNGAHEVFNHR.4|ILGTAGTEEGQK.2|PVIGSQYPLEK.2|KPLLPYTPGSDVAGVIEAVGDNASAFKKGDR.5|VFTSSTISGGYAEYALAADHTVYK.4|VFTSSTISGGYAEYALAADHTVYK.3|LDFKQGAAIGIPYFTAYR.3|YVGEKGIDIIIEM[Oxi]LANVNLSKDLSLLSHGGR.5|YVGEKGIDIIIEMLANVNLSKDLSLLSHGGR.5|YVGEKGIDIIIEMLANVNLSKDLSLLSHGGR.4|VFTSSTISGGYAEYALAADHTVYKLPEKLDFK.5|VFTSSTISGGYAEYALAADHTVYKLPEKLDFK.4|KPLLPYTPGSDVAGVIEAVGDNASAFKK.4|KPLLPYTPGSDVAGVIEAVGDNASAFKK.3|ESSIIGVTLFSSTK.2|VFTSSTISGGYAEYALAADHTVYKLPEK.4|VFTSSTISGGYAEYALAADHTVYKLPEK.3|YVGEKGIDIIIEMLANVNLSK.3|PLLPYTPGSDVAGVIEAVGDNASAFK.3|EEFQQYAAALQAGMEIGWLKPVIGSQYPLEK.4|EEFQQYAAALQAGMEIGWLKPVIGSQYPLEK.3
SEN / CTL,LanC-like protein 1,LANCL1,O43813,0.39,0.38,1.12E-01,3.89E-02,1.41E+00,G-protein coupled receptor signaling pathway,"catalytic activity,G-protein coupled receptor activity,zinc ion binding,SH3 domain binding,glutathione binding,low-density lipoprotein particle receptor binding","cytoplasm,extracellular exosome,integral component of plasma membrane",9,22,31,SLAEGYFDAAGR.2|ARFPAFEL.2|IPQSHIQQIC[CAM]ETILTSGENLAR.3|IPQSHIQQIC[CAM]ETILTSGENLAR.4|LHSLVKPSVDYVC[CAM]QLK.4|LHSLVKPSVDYVC[CAM]QLK.3|QSLNC[CAM]LTK.2|LTPEFSQR.2|QAEDC[CAM]ITR.2|IDPHAPNEM[Oxi]LYGR.3|IDPHAPNEMLYGR.3|IDPHAPNEMLYGR.2|ELLQQMER.2|RSITFLC[CAM]GDAGPLAVAAVLYHK.4|RSITFLC[CAM]GDAGPLAVAAVLYHK.3|FAEWC[CAM]LEYGEHGC[CAM]R.3|FAEWC[CAM]LEYGEHGC[CAM]R.2|PSVDYVC[CAM]QLK.2|DLLVHWC[CAM]HGAPGVIYMLIQAYK.4|AFPNPYADYNK.2|IGYIYALLFVNKNFGVEK.3|IGYIYALLFVNK.2|SITFLC[CAM]GDAGPLAVAAVLYHK.3|KGYGLC[CAM]HGSAGNAYAFLTLYNLTQDMK.4|KGYGLC[CAM]HGSAGNAYAFLTLYNLTQDMK.3|YLC[CAM]DAYQC[CAM]ADVIWQYGLLK.3|YLC[CAM]DAYQC[CAM]ADVIWQYGLLK.2|AFPNPYADYNKSLAEGYFDAAGR.3|YLC[CAM]DAYQC[CAM]ADVIWQYGLLKK.3|GYGLC[CAM]HGSAGNAYAFLTLYNLTQDM[Oxi]K.3|GYGLC[CAM]HGSAGNAYAFLTLYNLTQDMK.3
SEN / CTL,Phosphoacetylglucosamine mutase,PGM3,O95394,0.39,0.04,6.00E-03,3.53E-03,2.45E+00,"carbohydrate metabolic process,glucosamine metabolic process,UDP-N-acetylglucosamine biosynthetic process,protein N-linked glycosylation,protein O-linked glycosylation,spermatogenesis,glucose 1-phosphate metabolic process,hemopoiesis","magnesium ion binding,phosphoacetylglucosamine mutase activity,phosphoglucomutase activity","cellular_component,cytosol",3,32,47,MGLLAVLR.2|AFVELTK.2|AFVELTK.1|AEHLDHVMFR.3|AEHLDHVM[Oxi]FR.3|AEHLDHVMFR.2|LNHLC[CAM]GADFVK.3|LNHLC[CAM]GADFVK.2|YLEEVMK.2|SHQKPPQGMEIK.3|VLIDISEK.2|AFVRPSGTEDVVR.3|AFVRPSGTEDVVR.2|PSGTEDVVR.2|SLKVDC[CAM]ANGIGALK.3|GKLNHLC[CAM]GADFVK.3|VISTTDAER.2|QSAEQLEDK.2|ATIEGYYQK.2|IATLISSFLK.2|VDC[CAM]ANGIGALK.2|IVYYYHDADGHFHLIDGDK.4|IVYYYHDADGHFHLIDGDK.3|IVYYYHDADGHFHLIDGDK.2|YSALHAKPNGLILQYGTAGFR.4|QASC[CAM]SGDEYR.2|YLEEVMKVPVYC[CAM]TK.3|QAVTPPGLQEAINDLVK.3|QAVTPPGLQEAINDLVK.2|C[CAM]C[CAM]SFDGDADR.2|IKQSAEQLEDK.2|QAVTPPGLQEAINDLVKK.3|GLTVQQWDALYTDLPNR.3|GLTVQQWDALYTDLPNR.2|STIGVMVTASHNPEEDNGVK.3|STIGVM[Oxi]VTASHNPEEDNGVK.3|STIGVMVTASHNPEEDNGVK.2|PNGLILQYGTAGFR.2|LSQSVIDGVTVLGGQFHDYGLLTTPQLHYMVYC[CAM]R.5|LSQSVIDGVTVLGGQFHDYGLLTTPQLHYMVYC[CAM]R.4|LSQSVIDGVTVLGGQFHDYGLLTTPQLHYM[Oxi]VYC[CAM]R.4|VYAEADSQESADHLAHEVSLAVFQLAGGIGERPQPGF.5|VYAEADSQESADHLAHEVSLAVFQLAGGIGERPQPGF.4|EAVNLQQDAFVVIGR.2|LREMEHYFSQGLSVQLFNDGSK.3|LVDPLGEMLAPSWEEHATC[CAM]LANAEEQDMQR.4|LVDPLGEMLAPSWEEHATC[CAM]LANAEEQDMQR.3
SEN / CTL,ATP-dependent RNA helicase DDX1,DDX1,Q92499,0.39,0.21,1.98E-03,1.37E-03,2.86E+00,"spliceosomal complex assembly,double-strand break repair,transcription, DNA-templated,regulation of transcription, DNA-templated,tRNA splicing, via endonucleolytic cleavage and ligation,regulation of translational initiation,multicellular organism development,response to virus,RNA secondary structure unwinding,DNA duplex unwinding,response to exogenous dsRNA,nucleic acid phosphodiester bond hydrolysis,protein localization to cytoplasmic stress granule","DNA binding,chromatin binding,transcription cofactor activity,RNA helicase activity,double-stranded RNA binding,ATP-dependent RNA helicase activity,nuclease activity,exonuclease activity,protein binding,ATP binding,ATP-dependent helicase activity,poly(A) binding,DNA/RNA helicase activity,poly(A) RNA binding","nucleus,nucleoplasm,cytoplasm,cytoplasmic stress granule,membrane,intracellular ribonucleoprotein complex,cleavage body,tRNA-splicing ligase complex",9,56,98,ELLIIGGVAAR.2|FLIC[CAM]TDVAAR.2|FLVLDEADGLLSQGYSDFINR.3|FLVLDEADGLLSQGYSDFINR.4|FLVLDEADGLLSQGYSDFINR.2|LNLSQVR.2|DGFVALSK.2|NQALFPAC[CAM]VLK.3|NQALFPAC[CAM]VLK.2|KGHQFSC[CAM]VC[CAM]LHGDR.4|SHIRTDDVHAK.3|SHIRTDDVHAK.2|APDGYIVK.2|ALIVEPSR.2|KYIDNPK.2|HYYEVSC[CAM]HDQGLC[CAM]R.4|HYYEVSC[CAM]HDQGLC[CAM]R.3|HYYEVSC[CAM]HDQGLC[CAM]R.2|IMHFPTWVDLK.3|IM[Oxi]HFPTWVDLK.3|IMHFPTWVDLK.2|LRELLIIGGVAAR.3|LRELLIIGGVAAR.2|SQHSGNAQVTQTK.3|SQHSGNAQVTQTK.2|LDDLVSTGK.2|DLGLAFEIPPHMK.3|DLGLAFEIPPHMK.2|FGFGFGGTGK.2|MHNQIPQVTSDGK.3|M[Oxi]HNQIPQVTSDGK.3|M[Oxi]HNQIPQVTSDGK.2|MHNQIPQVTSDGK.2|RLQVIVC[CAM]SATLHSFDVK.4|RLQVIVC[CAM]SATLHSFDVK.3|RLQVIVC[CAM]SATLHSFDVK.2|GKHYYEVSC[CAM]HDQGLC[CAM]R.4|GKHYYEVSC[CAM]HDQGLC[CAM]R.3|VPVDEFDGK.2|GEDSVPDTVHHVVVPVNPK.4|GEDSVPDTVHHVVVPVNPK.3|GHQFSC[CAM]VC[CAM]LHGDR.3|GHQFSC[CAM]VC[CAM]LHGDR.2|EAQTSFLHLGYLPNQLFR.4|EAQTSFLHLGYLPNQLFR.3|EAQTSFLHLGYLPNQLFR.2|FNFGEEEFKFPPK.3|MHNQIPQVTSDGKR.3|VPVDEFDGKVTYGQK.3|WQMNPYDR.2|GSAFAIGSDGLC[CAM]C[CAM]QSR.3|GSAFAIGSDGLC[CAM]C[CAM]QSR.2|IMHFPTWVDLKGEDSVPDTVHHVVVPVNPK.6|IM[Oxi]HFPTWVDLKGEDSVPDTVHHVVVPVNPK.6|IM[Oxi]HFPTWVDLKGEDSVPDTVHHVVVPVNPK.5|IMHFPTWVDLKGEDSVPDTVHHVVVPVNPK.5|IM[Oxi]HFPTWVDLKGEDSVPDTVHHVVVPVNPK.4|IMHFPTWVDLKGEDSVPDTVHHVVVPVNPK.4|FNFGEEEFK.2|VGWSTMQASLDLGTDK.3|VGWSTMQASLDLGTDK.2|GIDIHGVPYVINVTLPDEKQNYVHR.5|GIDIHGVPYVINVTLPDEKQNYVHR.4|MDQAIIFC[CAM]R.2|M[Oxi]DQAIIFC[CAM]R.2|EVKEWHGC[CAM]R.2|LQVIVC[CAM]SATLHSFDVK.3|LQVIVC[CAM]SATLHSFDVK.2|FNFGEEEFKFPPKDGFVALSK.4|MGLAISLVATEK.2|TGAFSIPVIQIVYETLK.3|TGAFSIPVIQIVYETLK.2|ELAEQTLNNIK.2|GHVDILAPTVQELAALEK.3|GHVDILAPTVQELAALEK.2|TKIDC[CAM]DNLEQYFIQQGGGPDKK.4|TKIDC[CAM]DNLEQYFIQQGGGPDKK.3|DQLSVLENGVDIVVGTPGR.3|DQLSVLENGVDIVVGTPGR.2|DNTRPGANSPEMWSEAIK.3|DNTRPGANSPEMWSEAIK.2|TGAFSIPVIQIVYETLKDQQEGKK.4|GIDIHGVPYVINVTLPDEK.3|GIDIHGVPYVINVTLPDEK.2|RAAGGGSYKGHVDILAPTVQELAALEK.4|VGWSTM[Oxi]QASLDLGTDKFGFGFGGTGKK.4|ALIVEPSRELAEQTLNNIK.3|ALIVEPSRELAEQTLNNIK.2|DQLSVLENGVDIVVGTPGRLDDLVSTGK.4|DQLSVLENGVDIVVGTPGRLDDLVSTGK.3|IDC[CAM]DNLEQYFIQQGGGPDK.3|IDC[CAM]DNLEQYFIQQGGGPDK.2|IDC[CAM]DNLEQYFIQQGGGPDKK.3|AAGGGSYKGHVDILAPTVQELAALEKEAQTSFLHLGYLPNQLFR.6|AAGGGSYKGHVDILAPTVQELAALEKEAQTSFLHLGYLPNQLFR.5|GHVDILAPTVQELAALEKEAQTSFLHLGYLPNQLFR.5|GHVDILAPTVQELAALEKEAQTSFLHLGYLPNQLFR.4|TGAFSIPVIQIVYETLKDQQEGK.3
SEN / CTL,Actin-related protein 2/3 complex subunit 4,ARPC4,P59998,0.39,0.34,1.02E-05,1.31E-05,4.88E+00,"actin filament polymerization,Arp2/3 complex-mediated actin nucleation,Fc-gamma receptor signaling pathway involved in phagocytosis,actin nucleation,ephrin receptor signaling pathway","structural constituent of cytoskeleton,protein binding,enzyme binding,protein binding, bridging,actin filament binding","cytosol,Arp2/3 protein complex,cell projection,extracellular exosome",21,12,18,VLIEGSINSVR.2|AENFFILR.2|IVAEEFLK.2|ELLLQPVTISR.2|ELLLQPVTISR.3|SSKELLLQPVTISR.3|ATLQAALC[CAM]LENFSSQVVER.3|ATLQAALC[CAM]LENFSSQVVER.2|ARIVAEEFLKNF.3|HNKPEVEVR.2|RKPVEGYDISFLITNFHTEQMYK.5|RKPVEGYDISFLITNFHTEQMYK.4|RKPVEGYDISFLITNFHTEQM[Oxi]YK.4|RKPVEGYDISFLITNFHTEQMYK.3|LVDFVIHFMEEIDK.3|LVDFVIHFMEEIDK.2|IVAEEFLKNF.2|KPVEGYDISFLITNFHTEQMYK.4
SEN / CTL,Tenascin,TNC,P24821,0.39,1.00,1.81E-02,8.65E-03,2.06E+00,"osteoblast differentiation,cell adhesion,negative regulation of cell adhesion,neuromuscular junction development,positive regulation of cell proliferation,response to wounding,response to mechanical stimulus,positive regulation of gene expression,peripheral nervous system axon regeneration,extracellular matrix organization,wound healing,odontogenesis of dentin-containing tooth,response to ethanol,bud outgrowth involved in lung branching,mesenchymal-epithelial cell signaling involved in prostate gland development,prostate gland epithelium morphogenesis,cellular response to retinoic acid,cellular response to vitamin D,response to fibroblast growth factor,cellular response to prostaglandin D stimulus",syndecan binding,"extracellular region,basement membrane,interstitial matrix,extracellular space,focal adhesion,membrane,extracellular matrix",18,77,105,VSIYGVIR.2|ITAQGQYELR.2|TAHISGLPPSTDFIVYLSGLAPSIR.3|TAHISGLPPSTDFIVYLSGLAPSIR.4|AGTPYTVTLHGEVR.3|AGTPYTVTLHGEVR.2|KQSEPLEITLLAPER.3|KQSEPLEITLLAPER.2|AVDIPGLK.2|STDLPGLK.2|RAC[CAM]GC[CAM]AAAPDVK.3|RPETSYR.2|AYAAGFGDR.2|VDLRDHGETAFAVYDK.4|VDLRDHGETAFAVYDK.3|GHEHSIQFAEMK.3|GHEHSIQFAEMK.2|IKYAPISGGDHAEVDVPK.4|AVDIPGLEAATPYR.3|AVDIPGLEAATPYR.2|IQALNGPLR.2|YGDNNHSQGVNWFHWK.4|YGDNNHSQGVNWFHWK.3|C[CAM]VC[CAM]EQGFK.2|VATYLPAPEGLKFK.3|FTTDLDSPR.2|VFAILENKK.2|REEFWLGLDNLNK.3|APTAQVESFR.2|LDAPSQIEVK.2|VTTTRLDAPSQIEVK.3|YAPISGGDHAEVDVPK.3|YAPISGGDHAEVDVPK.2|LIPGVEYLVSIIAM[Oxi]K.3|LIPGVEYLVSIIAM[Oxi]K.2|LIPGVEYLVSIIAMK.2|RGDM[Oxi]SSNPAKETFTTGLDAPR.4|RGDM[Oxi]SSNPAKETFTTGLDAPR.3|DLTATEVQSETALLTWRPPR.4|DLTATEVQSETALLTWRPPR.3|RVSQTDNSITLEWR.3|TPVLSAEASTAK.2|C[CAM]VNGQC[CAM]VC[CAM]HEGFMGK.3|C[CAM]VNGQC[CAM]VC[CAM]HEGFM[Oxi]GK.3|ESNPATINAATELDTPK.3|ESNPATINAATELDTPK.2|ETFTTGLDAPR.2|AATPYTVSIYGVIQGYR.3|AATPYTVSIYGVIQGYR.2|VPGDQTSTIIQELEPGVEYFIR.4|VPGDQTSTIIQELEPGVEYFIR.3|VATYLPAPEGLK.2|AYAAGFGDRREEFWLGLDNLNK.4|TRDITGLREATEYEIELYGISK.4|TVSGNTVEYALTDLEPATEYTLR.4|TVSGNTVEYALTDLEPATEYTLR.3|VDLRDHGETAFAVYDKFSVGDAK.4|GLEPGQEYNVLLTAEKGR.3|GLEPGQEYNVLLTAEKGR.2|IKYAPISGGDHAEVDVPKSQQATTK.4|EVIVGPDTTSYSLADLSPSTHYTAK.4|EVIVGPDTTSYSLADLSPSTHYTAK.3|QTGLAPGQEYEISLHIVK.3|QTGLAPGQEYEISLHIVK.2|DHGETAFAVYDK.2|TTLTGLRPGTEYGIGVSAVK.3|TTLTGLRPGTEYGIGVSAVK.2|ITYVPITGGTPSM[Oxi]VTVDGTK.3|ITYVPITGGTPSMVTVDGTK.3|ITYVPITGGTPSMVTVDGTK.2|LEELENLVSSLR.2|WQPAIATVDSYVISYTGEK.3|WQPAIATVDSYVISYTGEK.2|WQPAIATVDSYVISYTGEKVPEITR.4|WQPAIATVDSYVISYTGEKVPEITR.3|SNM[Oxi]IQTIFTTIGLLYPFPK.3|EEFWLGLDNLNK.2|DVTDTTALITWFK.2|SQTVSAIATTAMGSPK.2|SQTVSAIATTAM[Oxi]GSPK.2|VSQTDNSITLEWR.2|DLAPPSEPSESFQEHTVDGENQIVFTHR.4|DTDSAITNC[CAM]ALSYK.2|SFSTFDKDTDSAITNC[CAM]ALSYK.3|QSEPLEITLLAPER.2|YAPISGGDHAEVDVPKSQQATTK.3|C[CAM]VNGMC[CAM]VC[CAM]DDGYTGEDC[CAM]RDR.3|PLAEIDGIELTYGIK.2|FTTDLDSPRDLTATEVQSETALLTWRPPR.4|TTLTGLRPGTEYGIGVSAVKEDKESNPATINAATELDTPK.5|VTEYLVVYTPTHEGGLEM[Oxi]QFR.3|VTEYLVVYTPTHEGGLEMQFR.3|C[CAM]VNGQC[CAM]VC[CAM]DEGYTGEDC[CAM]SQLR.3|TTIDLTEDENQYSIGNLKPDTEYEVSLISR.4|TTIDLTEDENQYSIGNLKPDTEYEVSLISR.3|GHSTRPLAVEVVTEDLPQLGDLAVSEVGWDGLR.4|GLEPGQEYNVLLTAEK.2|EQC[CAM]TAGAGC[CAM]C[CAM]LQPATGR.2|LPVGSQC[CAM]SVDLESASGEK.2|LSWTADEGVFDNFVLK.2|C[CAM]VDGQC[CAM]IC[CAM]HEGFTGLDC[CAM]GQHSC[CAM]PSDC[CAM]NNLGQC[CAM]VSGR.4|DVPGDRTTIDLTEDENQYSIGNLKPDTEYEVSLISR.4|DVTDTTALITWFKPLAEIDGIELTYGIK.3|TPVLSAEASTGETPNLGEVVVAEVGWDALK.3|C[CAM]IC[CAM]NEGYSGEDC[CAM]SEVSPPK.2
SEN / CTL,Septin-7,7-Sep,Q16181,0.39,0.46,1.27E-05,1.58E-05,4.80E+00,"cytokinesis,mitotic nuclear division,regulation of embryonic cell shape,protein heterooligomerization,cilium morphogenesis,cell-cell adhesion,positive regulation of nonmotile primary cilium assembly","structural molecule activity,protein binding,GTP binding,cadherin binding involved in cell-cell adhesion","condensed chromosome kinetochore,stress fiber,nucleus,nucleolus,cytoplasm,spindle,cytosol,plasma membrane,cell-cell adherens junction,axoneme,actin cytoskeleton,microtubule cytoskeleton,midbody,septin complex,cleavage furrow,extracellular exosome,apical plasma membrane",27,39,59,VNIIPLIAK.2|THMQDLKDVTNNVHYENYR.4|STLINSLFLTDLYSPEYPGPSHR.3|STLINSLFLTDLYSPEYPGPSHR.4|IYEFPETDDEEENKLVK.3|NLEGYVGFANLPNQVYR.3|NLEGYVGFANLPNQVYR.2|KMEMEMEQVFEMK.3|IKIYEFPETDDEEENKLVK.4|IKIYEFPETDDEEENKLVK.3|THMQDLK.2|SPLAQMEEERR.3|SPLAQM[Oxi]EEERR.3|SPLAQMEEERR.2|TVQVEQSK.2|DSEAELQR.2|NLEAQHKELEEK.3|NLEAQHKELEEK.2|LHEKVNIIPLIAK.3|LHEKVNIIPLIAK.2|ANWEAQQR.2|KLAAVTYNGVDNNK.3|KLAAVTYNGVDNNK.2|DVTNNVHYENYR.3|DVTNNVHYENYR.2|NLEGYVGFANLPNQVYRK.4|NLEGYVGFANLPNQVYRK.3|NLEGYVGFANLPNQVYRK.2|ILEQQNSSR.2|LAAVTYNGVDNNKNK.3|IYEFPETDDEEENKLVKK.4|ADTLTPEEC[CAM]QQFKK.3|ADTLTPEEC[CAM]QQFKK.2|LPLAVVGSNTIIEVNGK.3|LPLAVVGSNTIIEVNGK.2|IYEFPETDDEEENK.3|IYEFPETDDEEENK.2|LKDSEAELQR.2|QFEDEKANWEAQQR.3|SPLAQMEEER.2|FEDYLNAESR.2|VQC[CAM]C[CAM]LYFIAPSGHGLK.3|LPLAVVGSNTIIEVNGKR.3|QIMKEIQEHK.2|SVNSSTMVAQQK.2|DRLPLAVVGSNTIIEVNGK.3|DRLPLAVVGSNTIIEVNGK.2|GRQYPWGVAEVENGEHC[CAM]DFTILR.4|GRQYPWGVAEVENGEHC[CAM]DFTILR.3|LAAVTYNGVDNNK.2|VQC[CAM]C[CAM]LYFIAPSGHGLKPLDIEFM[Oxi]K.4|VQC[CAM]C[CAM]LYFIAPSGHGLKPLDIEFMK.4|VQC[CAM]C[CAM]LYFIAPSGHGLKPLDIEFM[Oxi]K.3|VQC[CAM]C[CAM]LYFIAPSGHGLKPLDIEFMK.3|ADTLTPEEC[CAM]QQFK.2|MEMEMEQVFEMK.2|GFEFTLM[Oxi]VVGESGLGK.2|GFEFTLMVVGESGLGK.2|QYPWGVAEVENGEHC[CAM]DFTILR.3
SEN / CTL,Alpha/beta hydrolase domain-containing protein 14B,ABHD14B,Q96IU4,0.39,0.29,1.03E-05,1.32E-05,4.88E+00,"positive regulation of transcription from RNA polymerase II promoter,3'-phosphoadenosine 5'-phosphosulfate metabolic process","protein binding,hydrolase activity","nucleus,nucleolus,cytoplasm,cytosol,extracellular exosome",18,9,14,FSVLLLHGIR.2|FSSETWQNLGTLHR.3|FSSETWQNLGTLHR.2|AVAIDLPGLGHSK.3|AVAIDLPGLGHSK.2|TPALIVYGDQDPMGQTSFEHLK.3|TPALIVYGDQDPMGQTSFEHLK.4|TPALIVYGDQDPM[Oxi]GQTSFEHLK.3|EGTIQVQGQALFFR.2|EGTIQVQGQALFFR.3|EALPGSGQAR.2|INAANYASVK.2|TPALIVYGDQDPM[Oxi]GQTSFEHLKQLPNHR.5|GAGHPC[CAM]YLDKPEEWHTGLLDFLQGLQ.3
SEN / CTL,Extended synaptotagmin-1,ESYT1,Q9BSJ8,0.38,0.62,7.91E-07,1.37E-06,5.86E+00,lipid transport,"lipid binding,metal ion binding","plasma membrane,membrane,integral component of endoplasmic reticulum membrane,organelle membrane contact site",39,52,75,LTLWYYSEER.2|LTTVLNSGFLDEWLTLEDVPSGR.3|VQLDLAETDLSQGVAR.2|VQLDLAETDLSQGVAR.3|ALTLGALTLPLAR.2|ALTLGALTLPLAR.3|LLTAPELILDQWFQLSSSGPNSR.3|LLTAPELILDQWFQLSSSGPNSR.4|IHVLEAQDLIAK.3|IHVLEAQDLIAK.2|TISQTSAPVWDESASFLIR.3|TISQTSAPVWDESASFLIR.2|LTPRPTAAELEEVLQVNSLIQTQK.3|LTPRPTAAELEEVLQVNSLIQTQK.4|QLLDDEEQLTAK.2|HLSPYATLTVGDSSHK.3|HLSPYATLTVGDSSHK.4|HLSPYATLTVGDSSHK.2|AVYSTNC[CAM]PVWEEAFR.2|AVYSTNC[CAM]PVWEEAFR.3|LLVPLVPDLQDVAQLR.3|LLVPLVPDLQDVAQLR.2|SHVVREDLNPR.3|SDPYALVR.2|AEDLPLRK.2|KPHTESLELQVR.3|KPHTESLELQVR.2|LTHVDSPLEAPAGPLGQVK.4|LTHVDSPLEAPAGPLGQVK.3|LTHVDSPLEAPAGPLGQVK.2|GSNPHLQTFTFTR.3|GSNPHLQTFTFTR.2|GMQLHGVLR.2|LVSIVHGC[CAM]R.2|VELGEKPLR.2|LGTQTFC[CAM]SR.2|IHVLEAQDLIAKDR.3|WYDLMDNK.2|SAELAAALLSIYMER.3|SAELAAALLSIYMER.2|TLSPEFNER.2|QRLTHVDSPLEAPAGPLGQVK.4|QRLTHVDSPLEAPAGPLGQVK.3|QRLTHVDSPLEAPAGPLGQVK.2|GSSVDAPPRPC[CAM]HTTPDSQFGTEHVLR.5|GSSVDAPPRPC[CAM]HTTPDSQFGTEHVLR.4|LLAETVAPAVR.2|IHVLEAQDLIAKDRFLGGLVK.4|IVAQVWPFLGQYMEK.3|IVAQVWPFLGQYM[Oxi]EK.2|IVAQVWPFLGQYMEK.2|RTLSPEFNER.2|FFLQDPQSQELDVQVK.3|FFLQDPQSQELDVQVK.2|VLQASVLDDWFPLQGGQGQVHLR.4|VLQASVLDDWFPLQGGQGQVHLR.3|DPPDPYVSLLLLPDKNR.3|LEWLSLLSDAEK.2|QNGRDPPDPYVSLLLLPDK.3|LTLWYYSEERK.2|PTAAELEEVLQVNSLIQTQK.3|ELPAWVSFPDVEKAEWLNK.3|ELPAWVSFPDVEK.2|FEWELPLDEAQR.2|GNKEPNPMVQLSIQDVTQESK.3|FFLQDPQSQELDVQVKDDSR.3|WFTLSSGQGQVLLR.2|PDPGSGGQPAGPGAAGEALAVLTSFGR.3|SAELAAALLSIYMERAEDLPLR.3|AQLGILVSQHSGVEAHSHSYSHSSSSLSEEPELSGGPPHITSSAPELR.6|KGNKEPNPMVQLSIQDVTQESK.3|DPPDPYVSLLLLPDK.2|ILYLDSSEIC[CAM]FPTVPGC[CAM]PGAWDVDSENPQR.4|ILYLDSSEIC[CAM]FPTVPGC[CAM]PGAWDVDSENPQR.3|GEGTGVLGSLSLPLSELLVADQLC[CAM]LDR.3
SEN / CTL,60S ribosomal protein L24,RPL24,P83731,0.38,0.19,2.03E-04,1.90E-04,3.72E+00,"ribosomal large subunit assembly,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,mitotic cell cycle checkpoint,exit from mitosis,viral transcription,optic nerve development,retinal ganglion cell axon guidance,retina development in camera-type eye,cell-cell adhesion,assembly of large subunit precursor of preribosome","RNA binding,structural constituent of ribosome,protein binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","cytoplasm,cytosol,cell-cell adherens junction,membrane,cytosolic large ribosomal subunit,extracellular exosome",9,10,16,QINWTVLYR.2|AITGASLADIMAK.2|AITGASLADIMAK.3|AITGASLADIM[Oxi]AK.2|MKVELC[CAM]SFSGYK.3|M[Oxi]KVELC[CAM]SFSGYK.3|MKVELC[CAM]SFSGYK.2|KVELC[CAM]SFSGYK.3|KVELC[CAM]SFSGYK.2|TDGKVFQFLNAK.3|TDGKVFQFLNAK.2|GQSEEIQK.2|C[CAM]ESAFLSK.2|VFQFLNAK.2|KGQSEEIQK.2|VELC[CAM]SFSGYK.2
SEN / CTL,Serum amyloid A-2 protein,SAA2,P0DJI9,0.38,0.35,1.23E-01,4.20E-02,1.38E+00,"acute-phase response,positive chemotaxis,cell chemotaxis",chemoattractant activity,"extracellular space,high-density lipoprotein particle,extracellular exosome",3,2,3,RGPGGAWAAEVISNAR.3|RGPGGAWAAEVISNAR.2|GPGGAWAAEVISNAR.2
SEN / CTL,Fascin,FSCN1,Q16658,0.38,0.53,2.28E-04,2.08E-04,3.68E+00,"cell-cell junction assembly,cell proliferation,anatomical structure morphogenesis,positive regulation of lamellipodium assembly,cell migration,microspike assembly,actin cytoskeleton organization,regulation of microvillus assembly,regulation of actin cytoskeleton organization,establishment of apical/basal cell polarity,cell motility,actin filament bundle assembly,positive regulation of filopodium assembly,positive regulation of podosome assembly,positive regulation of extracellular matrix disassembly,cell-cell adhesion","actin binding,drug binding,protein binding, bridging,poly(A) RNA binding,actin filament binding,cadherin binding involved in cell-cell adhesion","stress fiber,ruffle,podosome,cytoplasm,cytosol,cytoskeleton,microvillus,cell-cell junction,cell-cell adherens junction,actin cytoskeleton,lamellipodium,filopodium,growth cone,cell projection membrane,filamentous actin,myelin sheath,microspike,extracellular exosome,invadopodium",48,44,69,YLTAEAFGFK.2|NASC[CAM]YFDIEWR.2|VGKDELFALEQSC[CAM]AQVVLQAANER.3|VGKDELFALEQSC[CAM]AQVVLQAANER.4|YLAPSGPSGTLK.2|YLAADKDGNVTC[CAM]EREVPGPDC[CAM]R.4|LINRPIIVFRGEHGFIGC[CAM]R.4|LINRPIIVFR.3|LINRPIIVFR.2|YAHLSARPADEIAVDRDVPWGVDSLITLAFQDQR.5|YAHLSARPADEIAVDRDVPWGVDSLITLAFQDQR.4|LVARPEPATGYTLEFR.3|LVARPEPATGYTLEFR.2|LVARPEPATGYTLEFR.4|YFGGTEDRLSC[CAM]FAQTVSPAEK.3|ASAETVDPASLWEY.2|KQIWTLEQPPDEAGSAAVC[CAM]LR.3|KQIWTLEQPPDEAGSAAVC[CAM]LR.4|KQIWTLEQPPDEAGSAAVC[CAM]LR.2|WSVHIAMHPQVNIYSVTR.4|WSVHIAM[Oxi]HPQVNIYSVTR.4|WSVHIAMHPQVNIYSVTR.3|WSVHIAM[Oxi]HPQVNIYSVTR.3|WSVHIAMHPQVNIYSVTR.2|QIWTLEQPPDEAGSAAVC[CAM]LR.3|QIWTLEQPPDEAGSAAVC[CAM]LR.2|YLKGDHAGVLK.3|YLKGDHAGVLK.2|VNASASSLK.2|YAHLSARPADEIAVDR.4|YAHLSARPADEIAVDR.3|YFGGTEDR.2|DGNVTC[CAM]ER.2|VTGTLDANR.2|LSC[CAM]FAQTVSPAEK.3|LSC[CAM]FAQTVSPAEK.2|RYAHLSARPADEIAVDR.4|RYAHLSARPADEIAVDR.3|PADEIAVDR.2|GEHGFIGC[CAM]R.2|KVTGTLDANR.2|YLAADKDGNVTC[CAM]ER.3|YLAADKDGNVTC[CAM]ER.2|YSVQTADHR.2|RYFGGTEDR.2|WSLQSEAHR.2|FLIVAHDDGR.2|VAFRDC[CAM]EGRYLAPSGPSGTLK.4|YWTLTATGGVQSTASSK.3|YWTLTATGGVQSTASSK.2|DGNVTC[CAM]EREVPGPDC[CAM]R.3|KKQIWTLEQPPDEAGSAAVC[CAM]LR.4|KKQIWTLEQPPDEAGSAAVC[CAM]LR.3|DVPWGVDSLITLAFQDQR.3|DVPWGVDSLITLAFQDQR.2|NGQLAASVETAGDSELFLMK.3|NGQLAASVETAGDSELFLMK.2|SSYDVFQLEFNDGAYNIK.3|SSYDVFQLEFNDGAYNIK.2|KNGQLAASVETAGDSELFLM[Oxi]K.3|KNGQLAASVETAGDSELFLMK.3|KNGQLAASVETAGDSELFLMK.2|PADEIAVDRDVPWGVDSLITLAFQDQR.4|PADEIAVDRDVPWGVDSLITLAFQDQR.3|THTGKYWTLTATGGVQSTASSK.3|DELFALEQSC[CAM]AQVVLQAANER.3|VGKDELFALEQSC[CAM]AQVVLQAANERNVSTR.4|QGMDLSANQDEETDQETFQLEIDRDTKK.4|QGMDLSANQDEETDQETFQLEIDRDTK.3
SEN / CTL,Rootletin,CROCC,Q5TZA2,0.37,0.08,1.67E-02,8.16E-03,2.09E+00,"cell cycle,protein localization,centriole-centriole cohesion,epithelial structure maintenance,ciliary basal body organization,protein localization to organelle,photoreceptor cell maintenance,centrosome organization,establishment of organelle localization","actin binding,structural molecule activity,protein binding,kinesin binding","photoreceptor inner segment,cytoplasm,centrosome,centriole,plasma membrane,actin cytoskeleton,ciliary rootlet,extracellular exosome",3,10,11,LALLEEAR.2|HSLATISLEMER.3|HSLATISLEMER.2|AEVAEALTK.2|TGLQEVER.2|TDGAMQAHEDAQR.3|AGTLQLTVER.2|DLLQLGGELAR.2|STVNALTSELR.2|EALEGSLFEVQR.2|TLTGAELELAEAQR.2
SEN / CTL,Non-POU domain-containing octamer-binding protein,NONO,Q15233,0.37,0.66,6.64E-02,2.54E-02,1.60E+00,"mRNA splicing, via spliceosome,DNA repair,DNA recombination,transcription, DNA-templated,regulation of transcription, DNA-templated,mRNA processing,circadian rhythm,RNA splicing,regulation of circadian rhythm,negative regulation of transcription, DNA-templated,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway","nucleotide binding,transcription regulatory region sequence-specific DNA binding,RNA polymerase II distal enhancer sequence-specific DNA binding,core promoter binding,chromatin binding,protein binding,poly(A) RNA binding","nucleus,nucleoplasm,nucleolus,membrane,nuclear matrix,nuclear speck,paraspeckles,RNA polymerase II transcription factor complex",12,43,99,NLPQYVSNELLEEAFSVFGQVER.3|FAC[CAM]HSASLTVR.3|FAC[CAM]HSASLTVR.2|FAQPGSFEYEYAMR.2|FAQPGSFEYEYAMR.3|FAQPGSFEYEYAM[Oxi]R.3|FAQPGSFEYEYAM[Oxi]R.2|TLAEIAKVELDNMPLRGK.4|TLAEIAKVELDNMPLRGK.3|HEHQVM[Oxi]LMR.3|HEHQVMLM[Oxi]R.3|HEHQVMLMR.2|AAPGAEFAPNKR.3|AAPGAEFAPNKR.2|GIVEFSGKPAAR.3|GIVEFSGKPAAR.2|RQQEGFKGTFPDAR.4|RQQEGFKGTFPDAR.3|ALIEMEK.2|ALIEM[Oxi]EK.2|GIVEFSGK.2|RMEELHNQEVQKR.4|RMEELHNQEVQKR.3|VELDNMPLRGK.3|VELDNMPLRGK.2|AVVIVDDR.2|AGEVFIHK.2|EKLEMEMEAAR.3|EKLEMEMEAAR.2|MEELHNQEVQK.3|M[Oxi]EELHNQEVQK.3|MEELHNQEVQK.2|QQEEMMR.2|QQEGFKGTFPDAR.3|QQQDQVDR.2|MGQMAMGGAMGINNR.3|M[Oxi]GQMAMGGAMGINNR.2|MGQM[Oxi]AMGGAMGINNR.2|MGQMAM[Oxi]GGAMGINNR.2|MGQMAMGGAM[Oxi]GINNR.2|MGQMAMGGAMGINNR.2|M[Oxi]GQM[Oxi]AMGGAMGINNR.2|M[Oxi]GQMAM[Oxi]GGAMGINNR.2|M[Oxi]GQMAMGGAM[Oxi]GINNR.2|MGQM[Oxi]AM[Oxi]GGAMGINNR.2|MGQM[Oxi]AMGGAM[Oxi]GINNR.2|MGQMAM[Oxi]GGAM[Oxi]GINNR.2|M[Oxi]GQM[Oxi]AM[Oxi]GGAM[Oxi]GINNR.2|M[Oxi]GQM[Oxi]AM[Oxi]GGAMGINNR.2|M[Oxi]GQM[Oxi]AMGGAM[Oxi]GINNR.2|M[Oxi]GQMAM[Oxi]GGAM[Oxi]GINNR.2|RMEELHNQEVQK.3|RM[Oxi]EELHNQEVQK.3|RMEELHNQEVQK.2|AAPGAEFAPNK.2|FGQAATMEGIGAIGGTPPAFNR.4|FGQAATMEGIGAIGGTPPAFNR.3|FGQAATM[Oxi]EGIGAIGGTPPAFNR.3|FGQAATM[Oxi]EGIGAIGGTPPAFNR.2|FGQAATMEGIGAIGGTPPAFNR.2|LEMEMEAAR.2|LEM[Oxi]EMEAAR.2|VELDNMPLR.2|VELDNM[Oxi]PLR.2|AVVIVDDRGR.2|RQQEEMMR.2|RQQEEM[Oxi]MR.2|RQQEEMM[Oxi]R.2|SRLFVGNLPPDITEEEMRK.4|AGEVFIHKDK.2|TLAEIAKVELDNMPLR.3|TLAEIAKVELDNM[Oxi]PLR.3|TLAEIAKVELDNMPLR.2|ALIEMEKQQQDQVDR.3|LFVGNLPPDITEEEMR.3|LFVGNLPPDITEEEM[Oxi]R.2|LFVGNLPPDITEEEMR.2|EKLEMEMEAARHEHQVMLMR.4|EREQPPRFAQPGSFEYEYAM[Oxi]R.4|EREQPPRFAQPGSFEYEYAMR.4|EREQPPRFAQPGSFEYEYAMR.3|LFVGNLPPDITEEEMRK.3|GAMPPAPVPAGTPAPPGPATMMPDGTLGLTPPTTER.5|GAMPPAPVPAGTPAPPGPATMMPDGTLGLTPPTTER.4|GAM[Oxi]PPAPVPAGTPAPPGPATMMPDGTLGLTPPTTER.3|GAMPPAPVPAGTPAPPGPATMMPDGTLGLTPPTTER.3|HHQHHHQQQHHQQQQQQPPPPPIPANGQQASSQNEGLTIDLK.7|HHQHHHQQQHHQQQQQQPPPPPIPANGQQASSQNEGLTIDLK.6|HHQHHHQQQHHQQQQQQPPPPPIPANGQQASSQNEGLTIDLK.5|KHHQHHHQQQHHQQQQQQPPPPPIPANGQQASSQNEGLTIDLK.7|KHHQHHHQQQHHQQQQQQPPPPPIPANGQQASSQNEGLTIDLK.6|KHHQHHHQQQHHQQQQQQPPPPPIPANGQQASSQNEGLTIDLK.5|PVTVEPMDQLDDEEGLPEK.3|PVTVEPM[Oxi]DQLDDEEGLPEK.3|PVTVEPMDQLDDEEGLPEK.2|C[CAM]SEGSFLLTTFPR.2|PVTVEPMDQLDDEEGLPEKLVIK.3|C[CAM]SEGSFLLTTFPRPVTVEPMDQLDDEEGLPEK.4|C[CAM]SEGSFLLTTFPRPVTVEPMDQLDDEEGLPEKLVIK.4
SEN / CTL,ERO1-like protein alpha,ERO1L,Q96HE7,0.37,0.53,8.61E-04,6.72E-04,3.17E+00,"response to reactive oxygen species,protein folding,cellular protein modification process,response to temperature stimulus,animal organ senescence,4-hydroxyproline metabolic process,protein maturation by protein folding,extracellular matrix organization,endoplasmic reticulum unfolded protein response,protein folding in endoplasmic reticulum,response to endoplasmic reticulum stress,cell redox homeostasis,brown fat cell differentiation,chaperone mediated protein folding requiring cofactor,release of sequestered calcium ion into cytosol,oxidation-reduction process,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,cellular response to hypoxia","protein disulfide isomerase activity,protein disulfide oxidoreductase activity,disulfide oxidoreductase activity,oxidoreductase activity,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor","endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum membrane,membrane,dendrite,intracellular membrane-bounded organelle",21,31,49,LLESDYFR.2|LGAVDESLSEETQK.2|YSEEANNLIEEC[CAM]EQAER.3|YSEEANNLIEEC[CAM]EQAER.2|LKNLYFLYLIELR.3|QEIVSLFNAFGR.2|QEIVSLFNAFGR.3|VLPFFERPDFQLFTGNK.3|VLPFFERPDFQLFTGNK.4|VLPFFERPDFQLFTGNK.2|AVLQWTK.2|NLLQNIH.2|YTGYKGPDAWK.3|YTGYKGPDAWK.2|MLLLEILHEIK.3|MLLLEILHEIK.2|FDGILTEGEGPRR.3|YLLQETWLEKK.3|SFPLHFDENSFFAGDKK.4|SFPLHFDENSFFAGDKK.3|SFPLHFDENSFFAGDKK.2|RDC[CAM]AVKPC[CAM]QSDEVPDGIK.4|RDC[CAM]AVKPC[CAM]QSDEVPDGIK.3|IWNVIYEENC[CAM]FKPQTIK.4|IWNVIYEENC[CAM]FKPQTIK.3|IWNVIYEENC[CAM]FKPQTIK.2|IMDC[CAM]VGC[CAM]FK.2|LISGLHASINVHLSAR.3|LQTQGLGTALK.2|RPC[CAM]PFWNDISQC[CAM]GR.3|RPC[CAM]PFWNDISQC[CAM]GR.2|SFPLHFDENSFFAGDK.3|DC[CAM]AVKPC[CAM]QSDEVPDGIK.3|DC[CAM]AVKPC[CAM]QSDEVPDGIK.2|FDGILTEGEGPR.2|YLLQETWLEK.2|LIANM[Oxi]PESGPSYEFHLTR.3|LIANMPESGPSYEFHLTR.3|LIANMPESGPSYEFHLTR.2|ISTSVKELENFR.2|NLYFLYLIELR.2|RPLNPLASGQGTSEENTFYSWLEGLC[CAM]VEK.4|RPLNPLASGQGTSEENTFYSWLEGLC[CAM]VEK.3|RPLNPLASGQGTSEENTFYSWLEGLC[CAM]VEKR.4|RPLNPLASGQGTSEENTFYSWLEGLC[CAM]VEKR.3|C[CAM]FC[CAM]QVSGYLDDC[CAM]TC[CAM]DVETIDR.3|HDDSSDNFC[CAM]EADDIQSPEAEYVDLLLNPER.4|HDDSSDNFC[CAM]EADDIQSPEAEYVDLLLNPER.3|C[CAM]FC[CAM]QVSGYLDDC[CAM]TC[CAM]DVETIDRFNNYR.3
SEN / CTL,60S ribosomal protein L6,RPL6,Q02878,0.37,0.54,6.81E-02,2.59E-02,1.59E+00,"ribosomal large subunit assembly,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,cytoplasmic translation,regulation of transcription, DNA-templated,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,cell-cell adhesion","DNA binding,RNA binding,structural constituent of ribosome,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","nucleus,cytosol,cell-cell adherens junction,focal adhesion,membrane,cytosolic large ribosomal subunit,cytoplasmic ribonucleoprotein granule",12,30,42,AIPQLQGYLR.2|IKAIPQLQGYLR.3|HQEGEIFDTEKEKYEITEQR.4|HQEGEIFDTEKEKYEITEQR.5|HQEGEIFDTEKEKYEITEQR.3|ASITPGTILIILTGR.2|ASITPGTILIILTGR.3|AGEKVEKPDTK.3|AGEKVEKPDTK.2|VLATVTKPVGGDK.3|VLATVTKPVGGDK.2|YYPTEDVPRK.3|YYPTEDVPRK.2|FVIATSTK.2|EKYEITEQRK.3|VLATVTKPVGGDKNGGTR.4|VLATVTKPVGGDKNGGTR.3|HQEGEIFDTEK.3|HQEGEIFDTEK.2|YEITEQR.2|SVFALTNGIYPHK.3|SVFALTNGIYPHK.2|AVDSQILPK.2|HLTDAYFK.2|KPFSQHVR.2|EKVLATVTKPVGGDK.3|HQEGEIFDTEKEK.3|HQEGEIFDTEKEK.2|PRHQEGEIFDTEK.3|PRHQEGEIFDTEK.2|HLTDAYFKK.2|YYPTEDVPR.2|QLASGLLLVTGPLVLNR.3|QLASGLLLVTGPLVLNR.2|EKYEITEQR.2|LRASITPGTILIILTGR.3|QLASGLLLVTGPLVLNRVPLRR.4|SVFALTNGIYPHKLVF.3|VVFLKQLASGLLLVTGPLVLNRVPLR.4|AIPQLQGYLRSVFALTNGIYPHKLVF.4|QLASGLLLVTGPLVLNRVPLR.3|VVFLKQLASGLLLVTGPLVLNR.3
SEN / CTL,Microtubule-associated protein RP/EB family member 1,MAPRE1,Q15691,0.37,0.38,1.85E-03,1.29E-03,2.89E+00,"G2/M transition of mitotic cell cycle,sister chromatid cohesion,mitotic nuclear division,cell proliferation,positive regulation of cell migration,negative regulation of microtubule polymerization,protein localization to microtubule,cell division,cell-cell adhesion,positive regulation of microtubule plus-end binding,negative regulation of microtubule binding","protein binding,protein C-terminus binding,identical protein binding,poly(A) RNA binding,microtubule plus-end binding,cadherin binding involved in cell-cell adhesion","cytoplasm,Golgi apparatus,centrosome,cytosol,microtubule,cytoplasmic microtubule,cell-cell adherens junction,cortical microtubule cytoskeleton,cell projection membrane,microtubule plus-end,spindle",18,24,48,FFDANYDGKDYDPVAAR.3|FFDANYDGKDYDPVAAR.2|NIELIC[CAM]QENEGENDPVLQR.3|NIELIC[CAM]QENEGENDPVLQR.2|QGQETAVAPSLVAPALNKPK.3|QGQETAVAPSLVAPALNKPK.4|QGQETAVAPSLVAPALNKPK.2|LTVEDLEKERDFYFGK.4|LTVEDLEKERDFYFGK.3|LTVEDLEKERDFYFGK.2|HDMLAWINESLQLNLTK.3|HDM[Oxi]LAWINESLQLNLTK.3|HDM[Oxi]LAWINESLQLNLTK.2|HDMLAWINESLQLNLTK.2|KFFDANYDGK.3|KFFDANYDGK.2|LTVEDLEKER.3|LTVEDLEKER.2|LEHEYIQNFK.3|LEHEYIQNFK.2|DYDPVAAR.2|LTVEDLEK.2|KPLTSSSAAPQRPISTQR.4|KPLTSSSAAPQRPISTQR.3|GKFQDNFEFVQWFKK.4|GKFQDNFEFVQWFKK.3|KFFDANYDGKDYDPVAAR.4|KFFDANYDGKDYDPVAAR.3|FFDANYDGK.2|FQDNFEFVQWFK.3|FQDNFEFVQWFK.2|FQDNFEFVQWFKK.3|QGQETAVAPSLVAPALNK.3|QGQETAVAPSLVAPALNK.2|GKFQDNFEFVQWFK.3|GKFQDNFEFVQWFK.2|KNPGVGNGDDEAAELMQQVNVLK.4|KNPGVGNGDDEAAELM[Oxi]QQVNVLK.3|KNPGVGNGDDEAAELMQQVNVLK.3|LRNIELIC[CAM]QENEGENDPVLQR.4|LRNIELIC[CAM]QENEGENDPVLQR.3|IEQLC[CAM]SGAAYC[CAM]QFMDMLFPGSIALKK.4|IEQLC[CAM]SGAAYC[CAM]QFMDMLFPGSIALKK.3|IVDILYATDEGFVIPDEGGPQEEQEEY.4|IVDILYATDEGFVIPDEGGPQEEQEEY.3|NPGVGNGDDEAAELMQQVNVLK.3|NPGVGNGDDEAAELMQQVNVLK.2|IEQLC[CAM]SGAAYC[CAM]QFMDMLFPGSIALK.3
SEN / CTL,Actin-related protein 3,ACTR3,P61158,0.37,0.47,1.21E-02,6.23E-03,2.21E+00,"movement of cell or subcellular component,establishment or maintenance of cell polarity,asymmetric cell division,meiotic chromosome movement towards spindle pole,meiotic cytokinesis,Arp2/3 complex-mediated actin nucleation,Fc-gamma receptor signaling pathway involved in phagocytosis,ephrin receptor signaling pathway,spindle localization,cilium morphogenesis","structural constituent of cytoskeleton,ATP binding,actin filament binding","cytosol,Arp2/3 protein complex,brush border,cell-cell junction,focal adhesion,actin cytoskeleton,membrane,lamellipodium,extracellular exosome",48,34,61,LKLSEELSGGR.2|LKPKPIDVQVITHHMQR.5|LKPKPIDVQVITHHMQR.4|LGYAGNTEPQFIIPSC[CAM]IAIK.3|LGYAGNTEPQFIIPSC[CAM]IAIK.2|EFSIDVGYER.2|YSYVC[CAM]PDLVK.2|HGIVEDWDLMER.3|HGIVEDWDLMER.2|HGIVEDWDLM[Oxi]ER.2|DITYFIQQLLR.2|DITYFIQQLLR.3|FMEQVIFK.2|FM[Oxi]EQVIFK.2|DYEEIGPSIC[CAM]R.2|DYEEIGPSIC[CAM]R.3|NIVLSGGSTMFR.2|NIVLSGGSTMFR.3|NIVLSGGSTM[Oxi]FR.2|TLTGTVIDSGDGVTHVIPVAEGYVIGSC[CAM]IK.4|TLTGTVIDSGDGVTHVIPVAEGYVIGSC[CAM]IK.5|TLTGTVIDSGDGVTHVIPVAEGYVIGSC[CAM]IK.3|GVDDLDFFIGDEAIEKPTYATK.3|GVDDLDFFIGDEAIEKPTYATK.4|LPAC[CAM]VVDC[CAM]GTGYTK.2|LPAC[CAM]VVDC[CAM]GTGYTK.3|QYTGINAISKK.3|QYTGINAISKK.2|EFNKYDTDGSK.3|EFNKYDTDGSK.2|KEFSIDVGYER.3|KEFSIDVGYER.2|LSEELSGGR.2|KDYEEIGPSIC[CAM]R.3|KDYEEIGPSIC[CAM]R.2|HNPVFGVMS.2|HNPVFGVM[Oxi]S.2|ERYSYVC[CAM]PDLVK.3|ERYSYVC[CAM]PDLVK.2|WPIRHGIVEDWDLMER.4|PIDVQVITHHM[Oxi]QR.3|PIDVQVITHHMQR.3|PIDVQVITHHMQR.2|HIPIAGRDITYFIQQLLR.4|QYTGINAISK.2|DREVGIPPEQSLETAK.3|DREVGIPPEQSLETAK.2|AEPEDHYFLLTEPPLNTPENR.4|AEPEDHYFLLTEPPLNTPENR.3|YSYVC[CAM]PDLVKEFNKYDTDGSK.4|YAVWFGGSMLASTPEFYQVC[CAM]HTK.4|YAVWFGGSM[Oxi]LASTPEFYQVC[CAM]HTK.3|YAVWFGGSMLASTPEFYQVC[CAM]HTK.3|YAVWFGGSMLASTPEFYQVC[CAM]HTKK.4|YAVWFGGSMLASTPEFYQVC[CAM]HTKK.3|YLRAEPEDHYFLLTEPPLNTPENR.4|YLRAEPEDHYFLLTEPPLNTPENR.3|EVGIPPEQSLETAK.2|GVDDLDFFIGDEAIEKPTYATKWPIR.4|LGYAGNTEPQFIIPSC[CAM]IAIKESAK.3|GVDDLDFFIGDEAIEK.2
SEN / CTL,T-complex protein 1 subunit zeta,CCT6A,P40227,0.37,0.71,1.55E-06,2.47E-06,5.61E+00,"protein folding,positive regulation of telomere maintenance via telomerase,protein stabilization,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body","protein binding,ATP binding,protein binding involved in protein folding,poly(A) RNA binding,unfolded protein binding,WD40-repeat domain binding","cytoplasm,cytosol,chaperonin-containing T-complex,microtubule,extracellular matrix,extracellular exosome",63,42,77,ALQFLEEVKVSR.3|VLAQNSGFDLQETLVK.3|VLAQNSGFDLQETLVK.2|GIDPFSLDALSK.2|VHAELADVLTEAVVDSILAIK.3|GLQDVLR.2|QADLYISEGLHPR.3|QADLYISEGLHPR.2|MLVSGAGDIK.2|M[Oxi]LVSGAGDIK.2|AQAALAVNISAAR.2|AQAALAVNISAAR.3|ALQFLEEVK.2|ALQFLEEVK.1|EMDRETLIDVAR.3|EM[Oxi]DRETLIDVAR.3|EMDRETLIDVAR.2|NAIDDGC[CAM]VVPGAGAVEVAMAEALIK.3|NAIDDGC[CAM]VVPGAGAVEVAMAEALIK.4|NAIDDGC[CAM]VVPGAGAVEVAM[Oxi]AEALIK.3|VATAQDDITGDGTTSNVLIIGELLK.3|VATAQDDITGDGTTSNVLIIGELLK.4|TKVHAELADVLTEAVVDSILAIK.4|TKVHAELADVLTEAVVDSILAIK.3|MLVSGAGDIKLTK.3|AQLGVQAFADALLIIPK.3|AQLGVQAFADALLIIPK.2|GIDPFSLDALSKEGIVALRR.4|KQDEPIDLFMIEIMEMK.3|KQDEPIDLFM[Oxi]IEIMEMK.3|KQDEPIDLFMIEIM[Oxi]EMK.3|KQDEPIDLFMIEIMEM[Oxi]K.3|KQDEPIDLFM[Oxi]IEIM[Oxi]EM[Oxi]K.3|DGNVLLHEMQIQHPTASLIAK.4|DGNVLLHEMQIQHPTASLIAK.3|DGNVLLHEM[Oxi]QIQHPTASLIAK.3|DGNVLLHEM[Oxi]QIQHPTASLIAK.2|DGNVLLHEMQIQHPTASLIAK.2|GPNKHTLTQIK.3|HTLTQIK.2|HKSETDTSLIR.3|HKSETDTSLIR.2|IITEGFEAAKEK.3|KVC[CAM]GDSDKGFVVINQK.4|KVC[CAM]GDSDKGFVVINQK.3|KVC[CAM]GDSDKGFVVINQK.2|GFVVINQK.2|GLVLDHGAR.2|GLVLDHGARHPDMK.3|GLVLDHGARHPDMK.2|SETDTSLIR.2|LTKDGNVLLHEMQIQHPTASLIAK.5|LTKDGNVLLHEMQIQHPTASLIAK.4|IITEGFEAAK.2|VC[CAM]GDSDKGFVVINQK.3|VC[CAM]GDSDKGFVVINQK.2|KRVEDAYILTC[CAM]NVSLEYEK.4|KRVEDAYILTC[CAM]NVSLEYEK.3|KRVEDAYILTC[CAM]NVSLEYEK.2|VHAELADVLTEAVVDSILAIKK.4|VHAELADVLTEAVVDSILAIKK.3|VHAELADVLTEAVVDSILAIKK.2|TEVNSGFFYK.2|KQLLHSC[CAM]TVIATNILLVDEIMR.4|KQLLHSC[CAM]TVIATNILLVDEIMR.3|TKVHAELADVLTEAVVDSILAIKK.4|GRAQLGVQAFADALLIIPK.3|VEDAYILTC[CAM]NVSLEYEK.3|VEDAYILTC[CAM]NVSLEYEK.2|RVEDAYILTC[CAM]NVSLEYEK.3|RVEDAYILTC[CAM]NVSLEYEK.2|QLLHSC[CAM]TVIATNILLVDEIM[Oxi]R.3|QLLHSC[CAM]TVIATNILLVDEIMR.3|RVEDAYILTC[CAM]NVSLEYEKTEVNSGFFYK.4|RVEDAYILTC[CAM]NVSLEYEKTEVNSGFFYK.3|LTLAC[CAM]GGVALNSFDDLSPDC[CAM]LGHAGLVYEYTLGEEK.4|VATAQDDITGDGTTSNVLIIGELLKQADLYISEGLHPR.4
SEN / CTL,Eukaryotic initiation factor 4A-I,EIF4A1,P60842,0.37,1.10,4.22E-02,1.73E-02,1.76E+00,"nuclear-transcribed mRNA poly(A) tail shortening,translational initiation,regulation of translational initiation,regulation of gene expression,RNA secondary structure unwinding,viral process","RNA cap binding,double-stranded RNA binding,mRNA binding,translation initiation factor activity,ATP-dependent RNA helicase activity,helicase activity,protein binding,ATP binding,translation factor activity, RNA binding,poly(A) RNA binding","cytoplasm,cytosol,membrane,eukaryotic translation initiation factor 4F complex,extracellular matrix,extracellular exosome,nucleus",51,39,86,VLITTDLLAR.2|AEVQKLQMEAPHIIVGTPGR.4|GIYAYGFEKPSAIQQR.3|GIYAYGFEKPSAIQQR.2|GFKDQIYDIFQK.3|GFKDQIYDIFQK.2|GYDVIAQAQSGTGK.2|GYDVIAQAQSGTGK.3|MFVLDEADEMLSR.2|MFVLDEADEMLSR.3|M[Oxi]FVLDEADEMLSR.3|MFVLDEADEM[Oxi]LSR.3|M[Oxi]FVLDEADEMLSR.2|MFVLDEADEM[Oxi]LSR.2|M[Oxi]FVLDEADEM[Oxi]LSR.2|LQMEAPHIIVGTPGR.3|LQM[Oxi]EAPHIIVGTPGR.3|LQM[Oxi]EAPHIIVGTPGR.2|LQMEAPHIIVGTPGR.2|KGVAINMVTEEDKR.3|KGVAINM[Oxi]VTEEDKR.4|KGVAINM[Oxi]VTEEDKR.3|KGVAINMVTEEDKR.2|GVAINMVTEEDKR.3|GVAINM[Oxi]VTEEDKR.3|GVAINMVTEEDKR.2|GVAINM[Oxi]VTEEDKR.2|TLRDIETFYNTSIEEMPLNVADLI.3|AILPC[CAM]IK.2|GIDVQQVSLVINYDLPTNR.3|GIDVQQVSLVINYDLPTNR.2|PSAIQQR.2|ILVKKEELTLEGIR.4|ILVKKEELTLEGIR.3|ILVKKEELTLEGIR.2|VDWLTEK.2|VFDMLNR.2|VFDM[Oxi]LNR.2|DFTVSAMHGDMDQKER.4|DFTVSAMHGDMDQKER.3|ELAQQIQK.2|KVDWLTEK.2|GIYAYGFEK.2|DFTVSAMHGDMDQK.3|DFTVSAM[Oxi]HGDM[Oxi]DQK.3|DFTVSAM[Oxi]HGDMDQK.3|DFTVSAMHGDM[Oxi]DQK.3|DFTVSAMHGDMDQK.2|DFTVSAM[Oxi]HGDMDQK.2|DFTVSAMHGDM[Oxi]DQK.2|EELTLEGIR.2|QFYINVER.2|QFYINVEREEWK.3|QFYINVEREEWK.2|ATQALVLAPTR.2|DQIYDIFQK.2|RKVDWLTEK.2|KEELTLEGIR.2|VVM[Oxi]ALGDYMGASC[CAM]HAC[CAM]IGGTNVR.4|VVMALGDYM[Oxi]GASC[CAM]HAC[CAM]IGGTNVR.4|VVMALGDYMGASC[CAM]HAC[CAM]IGGTNVR.4|VVM[Oxi]ALGDYM[Oxi]GASC[CAM]HAC[CAM]IGGTNVR.4|VVM[Oxi]ALGDYMGASC[CAM]HAC[CAM]IGGTNVR.3|VVMALGDYM[Oxi]GASC[CAM]HAC[CAM]IGGTNVR.3|VVMALGDYMGASC[CAM]HAC[CAM]IGGTNVR.3|VVM[Oxi]ALGDYM[Oxi]GASC[CAM]HAC[CAM]IGGTNVR.3|TATFAISILQQIELDLK.3|TATFAISILQQIELDLK.2|GVAINMVTEEDK.2|GVAINM[Oxi]VTEEDK.2|LNSNTQVVLLSATMPSDVLEVTKK.4|LNSNTQVVLLSATMPSDVLEVTKK.3|LNSNTQVVLLSATM[Oxi]PSDVLEVTKK.3|ATQALVLAPTRELAQQIQK.3|KGVAINMVTEEDK.2|GIDVQQVSLVINYDLPTNRENYIHR.4|GIDVQQVSLVINYDLPTNRENYIHR.3|VVMALGDYMGASC[CAM]HAC[CAM]IGGTNVRAEVQK.4|DIETFYNTSIEEM[Oxi]PLNVADLI.3|DIETFYNTSIEEMPLNVADLI.3|LNSNTQVVLLSATM[Oxi]PSDVLEVTK.3|LNSNTQVVLLSATMPSDVLEVTK.3|SRDNGPDGMEPEGVIESNWNEIVDSFDDMNLSESLLR.5|SRDNGPDGM[Oxi]EPEGVIESNWNEIVDSFDDMNLSESLLR.4|SRDNGPDGMEPEGVIESNWNEIVDSFDDM[Oxi]NLSESLLR.4|SRDNGPDGMEPEGVIESNWNEIVDSFDDMNLSESLLR.4
SEN / CTL,Septin-11,11-Sep,Q9NVA2,0.36,0.53,2.70E-04,2.42E-04,3.62E+00,"cell cycle,protein heterooligomerization,cell division","protein binding,GTP binding","stress fiber,cytoplasm,cell junction,axon,dendritic spine,extracellular exosome",18,27,44,STLMDTLFNTKFESDPATHNEPGVR.4|STLMDTLFNTKFESDPATHNEPGVR.3|STSQGFC[CAM]FNILC[CAM]VGETGIGK.3|STSQGFC[CAM]FNILC[CAM]VGETGIGK.2|NLSLSGHVGFDSLPDQLVNK.3|NLSLSGHVGFDSLPDQLVNK.2|IHAC[CAM]LYFIAPTGHSLK.4|IHAC[CAM]LYFIAPTGHSLK.3|IHAC[CAM]LYFIAPTGHSLK.2|ADTIAKNELHK.3|KKELEEEVNNFQK.4|KKELEEEVNNFQK.3|KKELEEEVNNFQK.2|RNEFLGELQK.3|RNEFLGELQK.2|EKEAELKEAEK.3|RSLFNYHDTR.3|VNMEDLR.2|VNM[Oxi]EDLR.2|SLDLVTMK.2|ELEEEVNNFQK.3|ELEEEVNNFQK.2|ARSYELQESNVR.3|AAAQLLQSQAQQSGAQQTKK.4|AAAQLLQSQAQQSGAQQTKK.3|FESDPATHNEPGVR.3|FESDPATHNEPGVR.2|LEEMGFKDTDPDSK.3|SLFNYHDTR.2|QYPWGVVQVENENHC[CAM]DFVK.4|QYPWGVVQVENENHC[CAM]DFVK.3|SYELQESNVR.2|STLMDTLFNTK.2|STLM[Oxi]DTLFNTK.2|ARQYPWGVVQVENENHC[CAM]DFVK.4|ARQYPWGVVQVENENHC[CAM]DFVK.3|AAAQLLQSQAQQSGAQQTK.3|AAAQLLQSQAQQSGAQQTK.2|PFSLQETYEAK.2|DTDPDSKPFSLQETYEAK.3|DTDPDSKPFSLQETYEAK.2|KAAAQLLQSQAQQSGAQQTK.3|LEEMGFKDTDPDSKPFSLQETYEAK.4|LTIVDTVGFGDQINK.2
SEN / CTL,Ubiquitin-associated protein 2-like,UBAP2L,Q14157,0.36,0.09,1.46E-01,4.79E-02,1.32E+00,"binding of sperm to zona pellucida,hematopoietic stem cell homeostasis","protein binding,poly(A) RNA binding","PcG protein complex,Ada2/Gcn5/Ada3 transcription activator complex",3,28,45,IDLAVLLGK.2|QRPQATAEQIR.3|QRPQATAEQIR.2|GFGDVGEAK.2|QLIDITGK.2|NPSDSAVHSPFTK.3|NPSDSAVHSPFTK.2|DGGQTESNEEGKENRDR.4|DGGQTESNEEGKENR.3|GNWEQPQNQNQTQHK.3|GNWEQPQNQNQTQHK.2|SAYNSYSWGAN.2|IFTASNVSSVPLPAENVTITAGQR.4|IFTASNVSSVPLPAENVTITAGQR.3|LAQMISDHNDADFEEK.3|LAQMISDHNDADFEEK.2|DGGQTESNEEGK.2|QTAISQPASGNTFSHHSMVSMLGK.4|QTAISQPASGNTFSHHSM[Oxi]VSMLGK.4|QTAISQPASGNTFSHHSMVSMLGK.3|SPAVATSTAAPPPPSSPLPSK.3|SPAVATSTAAPPPPSSPLPSK.2|QAFTPSSTMMEVFLQEK.3|QAFTPSSTMMEVFLQEK.2|NQDEC[CAM]VIALHDC[CAM]NGDVNR.3|NQDEC[CAM]VIALHDC[CAM]NGDVNR.2|RQAFTPSSTMMEVFLQEK.3|RQAFTPSSTMMEVFLQEK.2|EFRGQENGLDGTK.2|AINVLLEGNPDTHSWEMVGK.3|AINVLLEGNPDTHSWEMVGK.2|GGSTTGSQFLEQFK.2|DGSLASNPYSGDLTK.2|FPLDYYSIPFPTPTTPLTGR.3|FPLDYYSIPFPTPTTPLTGR.2|APPNLPPGVPPLLPNPYIMAPGLLHAYPPQVYGYDDLQMLQTR.6|APPNLPPGVPPLLPNPYIMAPGLLHAYPPQVYGYDDLQMLQTR.5|APPNLPPGVPPLLPNPYIMAPGLLHAYPPQVYGYDDLQMLQTR.4|TPSTMENDSSNLDPSQAPSLAQPLVFSNSK.4|TPSTMENDSSNLDPSQAPSLAQPLVFSNSK.3|STSAPQMSPGSSDNQSSSPQPAQQK.3|TAQALAQLAAQHSQSGSTTTSSWDMGSTTQSPSLVQYDLK.5|TAQALAQLAAQHSQSGSTTTSSWDMGSTTQSPSLVQYDLK.4|NGFSSVQATQLQTTQSVEGATGSAVK.3|TATEEWGTEDWNEDLSETK.2
SEN / CTL,Small nuclear ribonucleoprotein Sm D1,SNRPD1,P62314,0.36,0.42,7.28E-02,2.74E-02,1.56E+00,"spliceosomal complex assembly,spliceosomal snRNP assembly,mRNA splicing, via spliceosome,RNA splicing,nuclear import","RNA binding,protein binding,poly(A) RNA binding,U1 snRNP binding","commitment complex,nucleus,nucleoplasm,U5 snRNP,U1 snRNP,U2 snRNP,U4 snRNP,U12-type spliceosomal complex,cytosol,small nuclear ribonucleoprotein complex,methylosome,pICln-Sm protein complex,SMN-Sm protein complex,prespliceosome,precatalytic spliceosome,catalytic step 2 spliceosome,spliceosomal tri-snRNP complex",9,6,13,NREPVQLETLSIR.3|NREPVQLETLSIR.2|YFILPDSLPLDTLLVDVEPK.3|YFILPDSLPLDTLLVDVEPK.2|LSHETVTIELK.3|LSHETVTIELK.2|NREPVQLETLSIRGNNIR.4|NGTQVHGTITGVDVSMNTHLK.4|NGTQVHGTITGVDVSM[Oxi]NTHLK.4|NGTQVHGTITGVDVSM[Oxi]NTHLK.3|NGTQVHGTITGVDVSMNTHLK.3|NGTQVHGTITGVDVSMNTHLK.2|EPVQLETLSIR.2
SEN / CTL,Reticulon-4,RTN4,Q9NQC3,0.36,0.48,6.49E-05,6.84E-05,4.16E+00,"apoptotic process,axonal fasciculation,cerebral cortex radial glia guided migration,negative regulation of cell growth,negative regulation of axon extension,regulation of apoptotic process,negative regulation of axonogenesis,nuclear pore complex assembly,cardiac epithelial to mesenchymal transition,endoplasmic reticulum tubular network organization,endoplasmic reticulum tubular network assembly,cell-cell adhesion,regulation of branching morphogenesis of a nerve","protein binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","intracellular,nuclear envelope,endoplasmic reticulum,endoplasmic reticulum membrane,plasma membrane,cell-cell adherens junction,integral component of endoplasmic reticulum membrane,cell projection,extracellular exosome",21,18,28,KPAAGLSAAPVPTAPAAGAPLMDFGNDFVPPAPR.4|KPAAGLSAAPVPTAPAAGAPLMDFGNDFVPPAPR.3|KPAAGLSAAPVPTAPAAGAPLM[Oxi]DFGNDFVPPAPR.3|KPAAGLSAAPVPTAPAAGAPLM[Oxi]DFGNDFVPPAPR.4|KPAAGLSAAPVPTAPAAGAPLMDFGNDFVPPAPR.6|KPAAGLSAAPVPTAPAAGAPLMDFGNDFVPPAPR.5|GPLPAAPPVAPER.2|GPLPAAPPVAPER.3|HQAQIDHYLGLANK.4|HQAQIDHYLGLANK.3|HQAQIDHYLGLANK.2|GVIQAIQK.2|SDEGHPFR.2|SSAENMDLK.2|YSNSALGHVNC[CAM]TIK.3|YSNSALGHVNC[CAM]TIK.2|AESAVIVANPR.2|VAVEAPMREEYADFKPFER.4|AYLESEVAISEELVQK.3|AYLESEVAISEELVQK.2|LFLVDDLVDSLK.2|LVSNNILHNQQELPTALTK.3|VLLLPPDVSALATQAEIESIVKPK.3|QPSWDPSPVSSTVPAPSPLSAAAVSPSK.3|LSAEPAPDFSDYSEMAK.2|GPLPAAPPVAPERQPSWDPSPVSSTVPAPSPLSAAAVSPSK.4|EPEDEEEEEEEEEEDEDEDLEELEVLER.3|LPEDDEPPARPPPPPPASVSPQAEPVWTPPAPAPAAPPSTPAAPK.4
SEN / CTL,Filamin-B,FLNB,O75369,0.36,0.59,1.12E-17,9.14E-17,1.60E+01,"keratinocyte development,epithelial cell morphogenesis,cytoskeletal anchoring at plasma membrane,signal transduction,skeletal muscle tissue development,actin cytoskeleton organization,cell-cell adhesion","actin binding,protein binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","stress fiber,cytoplasm,cytosol,plasma membrane,brush border,cell-cell adherens junction,focal adhesion,cell cortex,actin cytoskeleton,integral component of membrane,Z disc,extracellular matrix,extracellular exosome",252,210,349,LIALLEVLSQK.2|SPFTVGVAAPLDLSK.2|SPFTVGVAAPLDLSK.3|IGNLQTDLSDGLR.2|SPFVVQVGEAC[CAM]NPNAC[CAM]R.3|SPFVVQVGEAC[CAM]NPNAC[CAM]R.2|RLPNNHIGISFIPR.3|RLPNNHIGISFIPR.4|VLQSFTVDSSK.2|LGSAADFLLDISETDLSSLTASIK.3|IKVFGPGIEGKDVFR.4|LIALLEVLSQKR.3|LIALLEVLSQKR.2|SGC[CAM]IVNNLAEFTVDPK.2|SGC[CAM]IVNNLAEFTVDPK.3|FADEHVPGSPFTVK.3|FADEHVPGSPFTVK.2|IFFAGDTIPK.2|TGEEVGFVVDAK.2|AHGPGLEGGLVGKPAEFTIDTK.4|AHGPGLEGGLVGKPAEFTIDTK.3|LLGWIQNK.2|IRETTDFKVDTK.3|VFGPGIEGKDVFR.3|C[CAM]LATGPGIASTVK.2|AIVHDNKDGTYAVTYIPDKTGR.4|AIVHDNKDGTYAVTYIPDKTGR.5|VTVLFAGQHISK.3|VTVLFAGQHISK.2|EATTDFTVDSRPLTQVGGDHIK.4|EATTDFTVDSRPLTQVGGDHIK.3|VHSPSGAVEEC[CAM]HVSELEPDKYAVR.5|VHSPSGAVEEC[CAM]HVSELEPDKYAVR.4|VHSPSGAVEEC[CAM]HVSELEPDKYAVR.6|VLFASQEIPASPFR.2|VLFASQEIPASPFR.3|LVSPGSANETSSILVESVTR.3|LVSPGSANETSSILVESVTR.2|VSYFPTVPGVYIVSTK.3|VSYFPTVPGVYIVSTK.2|VQAQGPGLKEAFTNKPNVFTVVTR.4|AGGPGLERGEAGVPAEFSIWTR.3|AGGPGLERGEAGVPAEFSIWTR.2|YGGELVPHFPAR.3|YGGELVPHFPAR.2|YMIGVTYGGDDIPLSPYR.2|YM[Oxi]IGVTYGGDDIPLSPYR.2|EAFTNKPNVFTVVTR.3|EAFTNKPNVFTVVTR.2|GAGIGGLGITVEGPSESK.2|GAGIGGLGITVEGPSESK.3|AAGSGELGVTMK.2|AAGSGELGVTM[Oxi]K.2|HVGNQQYNVTYVVK.3|HVGNQQYNVTYVVK.2|VVPC[CAM]LVTPVTGR.2|VVPC[CAM]LVTPVTGR.3|AGSNM[Oxi]LLIGVHGPTTPC[CAM]EEVSMK.3|AGSNMLLIGVHGPTTPC[CAM]EEVSMK.3|AGSNMLLIGVHGPTTPC[CAM]EEVSM[Oxi]K.3|QKDFLDGVYAFEYYPSTPGR.3|QKDFLDGVYAFEYYPSTPGR.2|SPFEVQVGPEAGMQK.2|SPFEVQVGPEAGMQK.3|SPFEVQVGPEAGM[Oxi]QK.2|AWGPGLHGGIVGR.3|AWGPGLHGGIVGR.2|WGEEHIPGSPFHVTVP.3|WGEEHIPGSPFHVTVP.2|GLHVVEVTYDDVPIPNSPFK.3|GLHVVEVTYDDVPIPNSPFK.2|GLHVVEVTYDDVPIPNSPFK.4|QMQLENVSVALEFLDRESIK.3|QM[Oxi]QLENVSVALEFLDRESIK.3|QMQLENVSVALEFLDRESIK.2|VTASGPGLSSYGVPASLPVDFAIDAR.3|VTASGPGLSSYGVPASLPVDFAIDAR.4|TFEMSDFIVDTR.2|TFEMSDFIVDTR.3|TFEM[Oxi]SDFIVDTR.2|HTIAVVWGGVNIPHSPYR.4|HTIAVVWGGVNIPHSPYR.3|HTIAVVWGGVNIPHSPYR.2|FNDEHIPESPYLVPVIAPSDDAR.3|FNDEHIPESPYLVPVIAPSDDAR.4|AGPGTLSVTIEGPSK.2|AGPGTLSVTIEGPSK.3|GEAGVPAEFSIWTR.2|IPYLPITNFNQNWQDGK.3|IPYLPITNFNQNWQDGK.2|VLQSFTVDSSKAGLAPLEVR.3|VLQSFTVDSSKAGLAPLEVR.2|GAGKAPLNVQFNSPLPGDAVK.3|ALGALVDSC[CAM]APGLC[CAM]PDWESWDPQKPVDNAR.4|ALGALVDSC[CAM]APGLC[CAM]PDWESWDPQKPVDNAR.3|GAGKAPLNVQFNSPLPGDAVKDLDIIDNYDYSHTVK.5|GAGKAPLNVQFNSPLPGDAVKDLDIIDNYDYSHTVK.6|GAGKAPLNVQFNSPLPGDAVKDLDIIDNYDYSHTVK.4|FVPQEMGVHTVSVK.3|FVPQEM[Oxi]GVHTVSVK.3|FVPQEM[Oxi]GVHTVSVK.2|FVPQEMGVHTVSVK.2|RLTVMSLQESGLK.3|RLTVMSLQESGLK.2|RLTVM[Oxi]SLQESGLK.2|EAMQQADDWLGVPQVITPEEIIHPDVDEHSVMTYLSQFPK.4|EAMQQADDWLGVPQVITPEEIIHPDVDEHSVMTYLSQFPK.5|YADEEIPRSPFK.3|YADEEIPRSPFK.2|GAGTGGLGLTVEGPC[CAM]EAK.2|GAGTGGLGLTVEGPC[CAM]EAK.3|DAGEGLLAVQITDQEGKPK.3|DAGEGLLAVQITDQEGKPK.2|MDGTYAC[CAM]SYTPVK.2|M[Oxi]DGTYAC[CAM]SYTPVK.2|LPNNHIGISFIPR.3|VFGPGVER.2|RLTVMSLQESGLKVNQPASFAIR.4|RLTVM[Oxi]SLQESGLKVNQPASFAIR.4|NTVELLVEDKGNQVYR.3|NTVELLVEDKGNQVYR.2|FIPHENGVHTIDVK.4|FIPHENGVHTIDVK.3|VAVTEGC[CAM]QPSR.3|VAVTEGC[CAM]QPSR.2|VKVEPAVDTSR.3|VKVEPAVDTSR.2|YAPTEVGLHEMHIK.4|YAPTEVGLHEM[Oxi]HIK.4|YAPTEVGLHEMHIK.3|YAPTEVGLHEM[Oxi]HIK.3|YAPTEVGLHEM[Oxi]HIK.2|AIVDGNLK.2|EVGEHLVSIKK.3|EVGEHLVSIKK.2|LDVTILSPSRK.3|LDVTILSPSRK.2|LNGLENR.2|AYGPGLEK.2|FNGSHVVGSPFK.3|FNGSHVVGSPFK.2|GDYVLAVK.2|PVTEKDLAEDAPWKK.4|PVTEKDLAEDAPWKK.3|AGVENGKPTHFTVYTK.4|AGVENGKPTHFTVYTK.3|APSGRDEPC[CAM]LLK.3|APSGRDEPC[CAM]LLK.2|GAGGQGKLDVTILSPSRK.4|GEITGEVHMPSGK.3|GEITGEVHMPSGK.2|VQAQGPGLK.2|VFGPGIEGK.2|AGLAPLEVR.2|GQHVTGSPFQFTVGPLGEGGAHK.5|GQHVTGSPFQFTVGPLGEGGAHK.4|GQHVTGSPFQFTVGPLGEGGAHK.3|YGGPNHIVGSPFK.3|YGGPNHIVGSPFK.2|KVVPC[CAM]LVTPVTGR.3|VDPSHDASK.2|YRGQHVTGSPFQFTVGPLGEGGAHKVR.6|YRGQHVTGSPFQFTVGPLGEGGAHKVR.5|KGEITGEVHMPSGK.3|KGEITGEVHM[Oxi]PSGK.3|VEPAVDTSR.2|IAGPGLGSGVR.2|IPEINSSDMSAHVTSPSGR.4|IPEINSSDM[Oxi]SAHVTSPSGR.3|IPEINSSDMSAHVTSPSGR.3|WC[CAM]NEHLK.2|YADEEIPR.2|AEVSIQNNK.2|VLPTYDASK.2|IQQNTFTR.2|SPFEVSVDK.2|KVVPC[CAM]LVTPVTGRENSTAK.4|NGNHVANSPVSIMVVQSEIGDARR.5|NGNHVANSPVSIMVVQSEIGDARR.4|NGNHVANSPVSIM[Oxi]VVQSEIGDARR.4|PAEFTIDTK.2|DLAEDAPWK.2|GIEPTGNMVK.2|GIEPTGNM[Oxi]VK.2|RIGNLQTDLSDGLR.3|RIGNLQTDLSDGLR.2|SSFLVDC[CAM]SK.2|AEISC[CAM]IDNK.2|AIVHDNKDGTYAVTYIPDK.4|AIVHDNKDGTYAVTYIPDK.3|DAGEGLLAVQITDQEGKPKR.4|DAGEGLLAVQITDQEGKPKR.3|VKMDC[CAM]QETPEGYK.3|VKMDC[CAM]QETPEGYK.2|YRGQHVTGSPFQFTVGPLGEGGAHK.5|YRGQHVTGSPFQFTVGPLGEGGAHK.4|YSIAITWGGHHIPK.3|YSIAITWGGHHIPK.2|AEITFDDHK.2|PGTYVIYVR.2|PVTEKDLAEDAPWK.3|ASSDASKVTSK.2|TATPEIVDNK.2|VDIQTEDLEDGTC[CAM]K.3|VDIQTEDLEDGTC[CAM]K.2|VEVGKDQEFTVDTR.3|VEVGKDQEFTVDTR.2|APSVATVGSIC[CAM]DLNLK.3|APSVATVGSIC[CAM]DLNLK.2|GAGGQGKLDVTILSPSR.3|GAGGQGKLDVTILSPSR.2|IEYNDQNDGSC[CAM]DVK.3|IEYNDQNDGSC[CAM]DVK.2|LDVTILSPSR.2|TYSVEYLPK.2|VHSPSGAVEEC[CAM]HVSELEPDK.4|VHSPSGAVEEC[CAM]HVSELEPDK.3|VNQPASFAIR.2|DQEFTVDTR.2|EVGEHLVSIK.2|IFAQDGEGQR.2|SPFEVSVDKAQGDASK.3|SPFEVSVDKAQGDASK.2|IKVFGPGIEGK.2|IRATQTGDASK.2|KIQQNTFTR.2|RAIVHDNKDGTYAVTYIPDK.4|AIKHTIAVVWGGVNIPHSPYR.4|DGTC[CAM]TVTYLPTLPGDYSILVK.4|DGTC[CAM]TVTYLPTLPGDYSILVK.3|DGTC[CAM]TVTYLPTLPGDYSILVK.2|DSPYMAFIHPATGGYNPDLVR.4|DSPYMAFIHPATGGYNPDLVR.3|DSPYM[Oxi]AFIHPATGGYNPDLVR.3|DSPYMAFIHPATGGYNPDLVR.2|DVFREATTDFTVDSRPLTQVGGDHIK.5|DVFREATTDFTVDSRPLTQVGGDHIK.4|ERGDYVLAVK.2|NTVELLVEDK.2|VVASGPGLEHGK.2|DLAEDAPWKK.2|DVFREATTDFTVDSR.3|NRMDGTYAC[CAM]SYTPVK.3|NRM[Oxi]DGTYAC[CAM]SYTPVK.3|NRMDGTYAC[CAM]SYTPVK.2|VNIGQGSHPQK.2|VTEAEIVPMGK.2|VTEAEIVPM[Oxi]GK.2|APLNVQFNSPLPGDAVK.3|APLNVQFNSPLPGDAVK.2|VKVDPSHDASK.2|VPVKDVVDPSK.2|ADIEMPFDPSKVVASGPGLEHGK.4|AHGPGLEGGLVGK.2|VMYTPM[Oxi]APGNYLISVK.3|VMYTPMAPGNYLISVK.3|VMYTPMAPGNYLISVK.2|VM[Oxi]YTPM[Oxi]APGNYLISVK.2|VM[Oxi]YTPMAPGNYLISVK.2|VMYTPM[Oxi]APGNYLISVK.2|DLDIIDNYDYSHTVK.3|DLDIIDNYDYSHTVK.2|TATPEIVDNKDGTVTVR.3|TATPEIVDNKDGTVTVR.2|VKAHGPGLEGGLVGKPAEFTIDTK.4|VKAHGPGLEGGLVGKPAEFTIDTK.3|EATTDFTVDSR.2|IFAQDGEGQRIDIQMK.3|ADIEMPFDPSK.2|ADIEM[Oxi]PFDPSK.2|EAGAGGLSIAVEGPSKAEITFDDHK.4|EAGAGGLSIAVEGPSKAEITFDDHK.3|KNGNHVANSPVSIMVVQSEIGDAR.4|QMQLENVSVALEFLDR.3|QM[Oxi]QLENVSVALEFLDR.3|QM[Oxi]QLENVSVALEFLDR.2|QMQLENVSVALEFLDR.2|VRAGGPGLERGEAGVPAEFSIWTR.4|PFDLVIPFAVR.2|VFGPGIEGKDVFREATTDFTVDSRPLTQVGGDHIK.6|VVPC[CAM]LVTPVTGRENSTAK.3|LTVMSLQESGLK.2|LTVM[Oxi]SLQESGLK.2|DGSC[CAM]SAEYIPFAPGDYDVNITYGGAHIPGSPFRVPVK.6|DGSC[CAM]SAEYIPFAPGDYDVNITYGGAHIPGSPFRVPVK.4|TSRAPSVATVGSIC[CAM]DLNLK.3|DGTYAVTYIPDK.2|EPGEYAVHIMC[CAM]DDEDIK.3|SSTETC[CAM]YSAIPK.2|FNDEHIPESPYLVPVIAPSDDARR.4|FNDEHIPESPYLVPVIAPSDDARR.3|M[Oxi]DC[CAM]QETPEGYK.2|MDC[CAM]QETPEGYK.2|IGNLQTDLSDGLRLIALLEVLSQKR.4|YTIKVLFASQEIPASPFR.3|DFLDGVYAFEYYPSTPGR.3|DFLDGVYAFEYYPSTPGR.2|AAGSGELGVTM[Oxi]KGPK.2|VGEAGLLSVDC[CAM]SEAGPGALGLEAVSDSGTK.4|VGEAGLLSVDC[CAM]SEAGPGALGLEAVSDSGTK.3|APSVATVGSIC[CAM]DLNLKIPEINSSDMSAHVTSPSGR.5|APSVATVGSIC[CAM]DLNLKIPEINSSDMSAHVTSPSGR.4|DNKDGSC[CAM]SAEYIPFAPGDYDVNITYGGAHIPGSPFRVPVK.6|DNKDGSC[CAM]SAEYIPFAPGDYDVNITYGGAHIPGSPFRVPVK.5|DNKDGSC[CAM]SAEYIPFAPGDYDVNITYGGAHIPGSPFRVPVK.4|EAGAGGLSIAVEGPSK.2|LLGWIQNKIPYLPITNFNQNWQDGK.4|LLGWIQNKIPYLPITNFNQNWQDGK.3|DAGYGGISLAVEGPSK.2|DGTYAVTYVPLTAGMYTLTMK.3|DGTYAVTYVPLTAGMYTLTM[Oxi]K.3|DGTYAVTYVPLTAGM[Oxi]YTLTMK.2|DGTYAVTYVPLTAGMYTLTMK.2|NGSC[CAM]GVSYIAQEPGNYEVSIK.3|NGSC[CAM]GVSYIAQEPGNYEVSIK.2|GLEELVKQKDFLDGVYAFEYYPSTPGR.4|TSRAPSVATVGSIC[CAM]DLNLKIPEINSSDMSAHVTSPSGR.5|YNDKHIPGSPFTAK.2|LTVMSLQESGLKVNQPASFAIR.3|NGNHVANSPVSIMVVQSEIGDAR.3|NGNHVANSPVSIMVVQSEIGDAR.2|YTPTQQGNMQVLVTYGGDPIPK.3|YTPTQQGNM[Oxi]QVLVTYGGDPIPK.3|LNGLENRVEVGKDQEFTVDTR.3|TATFTIVTEDAGEGGLDLAIEGPSK.3|ANEPTHFTVDC[CAM]TEAGEGDVSVGIK.3|EPGEYAVHIMC[CAM]DDEDIKDSPYMAFIHPATGGYNPDLVR.5|AHIANPSGASTEC[CAM]FVTDNADGTYQVEYTPFEK.4|AHIANPSGASTEC[CAM]FVTDNADGTYQVEYTPFEK.3|DGSC[CAM]SAEYIPFAPGDYDVNITYGGAHIPGSPFR.4|DGSC[CAM]SAEYIPFAPGDYDVNITYGGAHIPGSPFR.3|GLVEPVNVVDNGDGTHTVTYTPSQEGPYMVSVK.4|GLVEPVNVVDNGDGTHTVTYTPSQEGPYMVSVK.3|VLPTYDASKVTASGPGLSSYGVPASLPVDFAIDAR.4|ALGALVDSC[CAM]APGLC[CAM]PDWESWDPQK.3|APLNVQFNSPLPGDAVKDLDIIDNYDYSHTVK.4|SADFVVESIGSEVGSLGFAIEGPSQAK.3|IEC[CAM]SDNGDGTC[CAM]SVSYLPTKPGEYFVNILFEEVHIPGSPFK.5|IEC[CAM]SDNGDGTC[CAM]SVSYLPTKPGEYFVNILFEEVHIPGSPFK.4|VGEPGQAGNPALVSAYGTGLEGGTTGIQSEFFINTTR.4|VLSEDEEDVDFDIIHNANDTFTVK.3|LGSAADFLLDISETDLSSLTASIKAPSGRDEPC[CAM]LLK.4|FTVDTISAGQGDVMVFVEDPEGNKEEAQVTPDSDKNK.4|VRVGEPGQAGNPALVSAYGTGLEGGTTGIQSEFFINTTR.4|YM[Oxi]GSHIPESPLQFYVNYPNSGSVSAYGPGLVYGVANK.4|YMGSHIPESPLQFYVNYPNSGSVSAYGPGLVYGVANK.4|DAGYGGISLAVEGPSKVDIQTEDLEDGTC[CAM]K.3|AEISC[CAM]IDNKDGTC[CAM]TVTYLPTLPGDYSILVK.3|EEGLYAVDVTYDGHPVPGSPYTVEASLPPDPSK.3
SEN / CTL,CD2-associated protein,CD2AP,Q9Y5K6,0.36,0.46,9.67E-03,5.17E-03,2.29E+00,"protein complex assembly,substrate-dependent cell migration, cell extension,cytoskeleton organization,mitotic nuclear division,signal transduction,vesicle organization,single organismal cell-cell adhesion,negative regulation of transforming growth factor beta1 production,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of receptor-mediated endocytosis,cell division,positive regulation of protein localization to nucleus,regulation of actin cytoskeleton reorganization","vascular endothelial growth factor receptor binding,structural constituent of cytoskeleton,protein binding,beta-catenin binding,protein C-terminus binding,SH3 domain binding,protein complex binding,cadherin binding involved in cell-cell adhesion","ruffle,nucleolus,cytoplasm,plasma membrane,cell-cell adherens junction,actin cytoskeleton,endocytic vesicle,filamentous actin,perinuclear region of cytoplasm,extracellular exosome",12,47,57,SVDFDSLTVR.2|LGLFPSNFVK.2|ANTTAFLTPLEIK.2|ISTYGLPAGGIQPHPQTK.3|SSGTVYPK.2|APAPKPELIAAEK.3|APAPKPELIAAEK.2|ERHGNVASLVQR.3|PAAPQVPPK.2|TQSVEITK.2|FNGGHSPTHSPEK.3|FNGGHSPTHSPEK.2|FETEPVSK.2|APAPKPELIAAEKK.3|EEDSANLKPSELK.3|EEDSANLKPSELK.2|RPEKPVPPPPPIAK.3|TSSSETEEKKPEKPLILQSLGPK.5|TSSSETEEKKPEKPLILQSLGPK.4|YFSLKPEEKDEK.3|KPEKPLILQSLGPK.3|LKLDSEQLPLRPK.3|TQSVEITKTDTEGK.3|EEDSANLKPSELKK.3|ETEFKDDSLPIKR.3|GMFPDNFVK.2|PLILQSLGPK.2|ETGEAGWWR.2|HGNVASLVQR.2|SNLEMEIEK.2|INGEVSSISSK.2|AKVETDDVKK.2|EGEIIHLISK.2|YFSLKPEEK.2|AQIIELLC[CAM]IVEALKK.3|AQIIELLC[CAM]IVEALKK.2|KLQEEGWLEGELNGR.3|TSKETDVVNFDDIASSENLLHLTANRPK.5|TSKETDVVNFDDIASSENLLHLTANRPK.4|KLQEEGWLEGELNGRR.3|EGVFPDNFAVQINELDK.3|EGVFPDNFAVQINELDK.2|LDSEQLPLRPK.2|VLFEYIPQNEDELELK.3|VLFEYIPQNEDELELK.2|EGVFPDNFAVQINELDKDFPKPK.4|PSVYLSTPSSASK.2|INGEVSSISSKFETEPVSK.3|INGEVSSISSKFETEPVSK.2|ETDVVNFDDIASSENLLHLTANRPK.4|ETDVVNFDDIASSENLLHLTANRPK.3|DTC[CAM]YSPKPSVYLSTPSSASK.3|GIGFGDIFKEGSVK.2|TLFAYEGTNEDELTFKEGEIIHLISK.4|AQIIELLC[CAM]IVEALK.2|LQEEGWLEGELNGR.2|TLFAYEGTNEDELTFK.2
SEN / CTL,26S protease regulatory subunit 6A,PSMC3,P17980,0.36,0.91,3.77E-02,1.57E-02,1.80E+00,"MAPK cascade,protein polyubiquitination,blastocyst development,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,viral process,ER-associated ubiquitin-dependent protein catabolic process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,positive regulation of proteasomal protein catabolic process,negative regulation of nucleic acid-templated transcription","transcription coactivator activity,transcription corepressor activity,protein binding,ATP binding,ATPase activity,TBP-class protein binding,proteasome-activating ATPase activity","proteasome complex,cytoplasmic mRNA processing body,nucleus,nucleoplasm,cytosol,proteasome regulatory particle, base subcomplex,membrane,proteasome accessory complex,nuclear proteasome complex,cytosolic proteasome complex",15,35,62,VIAATNRVDILDPALLR.3|VIAATNRVDILDPALLR.2|LLDSEIK.2|KMNVSPDVNYEELAR.3|KM[Oxi]NVSPDVNYEELAR.3|KMNVSPDVNYEELAR.2|LAGPQLVQMFIGDGAK.2|LAGPQLVQMFIGDGAK.3|LAGPQLVQM[Oxi]FIGDGAK.2|ANLQYYA.2|VTHELQAMKDK.3|VTHELQAMKDK.2|EKFENLGIQPPK.3|EKFENLGIQPPK.2|AVC[CAM]VEAGMIALRR.3|KANLQYYA.2|KIEFPMPNEEAR.3|KIEFPM[Oxi]PNEEAR.3|KIEFPMPNEEAR.2|KIEFPM[Oxi]PNEEAR.2|VTHELQAMK.2|VTHELQAM[Oxi]K.2|MNVSPDVNYEELAR.3|MNVSPDVNYEELAR.2|MSTEEIIQR.2|M[Oxi]STEEIIQR.2|TMLELLNQLDGFQPNTQVK.4|TMLELLNQLDGFQPNTQVK.3|TMLELLNQLDGFQPNTQVK.2|QTYFLPVIGLVDAEK.3|QTYFLPVIGLVDAEK.2|VDILDPALLR.2|APSIIFIDELDAIGTK.3|APSIIFIDELDAIGTK.2|FENLGIQPPK.2|LKPGDLVGVNK.2|GVLMYGPPGTGK.2|GVLM[Oxi]YGPPGTGK.2|APSIIFIDELDAIGTKR.3|QIQELVEAIVLPMNHK.3|QIQELVEAIVLPM[Oxi]NHK.3|QIQELVEAIVLPMNHK.2|DSYLILETLPTEYDSR.3|DSYLILETLPTEYDSR.2|EKFENLGIQPPKGVLMYGPPGTGK.4|AVC[CAM]VEAGMIALR.2|AVC[CAM]VEAGM[Oxi]IALR.2|EKAPSIIFIDELDAIGTK.3|EKAPSIIFIDELDAIGTK.2|C[CAM]TDDFNGAQC[CAM]K.2|IEFPMPNEEAR.2|MATVWDEAEQDGIGEEVLK.3|MATVWDEAEQDGIGEEVLK.2|GATELTHEDYMEGILEVQAK.3|AMEVDERPTEQYSDIGGLDK.3|AM[Oxi]EVDERPTEQYSDIGGLDK.3|AMEVDERPTEQYSDIGGLDK.2|LKPGDLVGVNKDSYLILETLPTEYDSR.4|LKPGDLVGVNKDSYLILETLPTEYDSR.3|FENLGIQPPKGVLMYGPPGTGK.3|TLPYLVSNVIELLDVDPNDQEEDGANIDLDSQR.4|TLPYLVSNVIELLDVDPNDQEEDGANIDLDSQRK.4
SEN / CTL,RuvB-like 1,RUVBL1,Q9Y265,0.35,0.39,1.02E-02,5.39E-03,2.27E+00,"box C/D snoRNP assembly,DNA repair,DNA recombination,chromatin remodeling,transcription, DNA-templated,regulation of transcription from RNA polymerase II promoter,mitotic nuclear division,spermatogenesis,DNA duplex unwinding,CENP-A containing nucleosome assembly,regulation of growth,histone H4 acetylation,histone H2A acetylation,cell division,cell-cell adhesion,regulation of mitophagy,positive regulation of protein targeting to mitochondrion,beta-catenin-TCF complex assembly,positive regulation of telomerase RNA localization to Cajal body","DNA helicase activity,protein binding,ATP binding,ATPase activity,ATP-dependent 5'-3' DNA helicase activity,cadherin binding involved in cell-cell adhesion","Swr1 complex,nucleus,nucleoplasm,cytoplasm,Golgi apparatus,microtubule organizing center,cell-cell adherens junction,membrane,nuclear matrix,Ino80 complex,NuA4 histone acetyltransferase complex,intracellular membrane-bounded organelle,extracellular exosome,MLL1 complex,R2TP complex",12,35,55,EAC[CAM]GVIVELIK.2|YSVQLLTPANLLAK.2|YSVQLLTPANLLAK.3|ALESSIAPIVIFASNR.3|ALESSIAPIVIFASNR.2|KTEVLMENFR.3|KTEVLMENFR.2|QAASGLVGQENAR.3|QAASGLVGQENAR.2|ILADQQDK.2|TALALAIAQELGSK.3|TALALAIAQELGSK.2|GLGLDESGLAK.2|AVLLAGPPGTGK.2|TISHVIIGLK.2|QLKLDPSIFESLQK.3|QLKLDPSIFESLQK.2|DSIEKEHVEEISELFYDAK.4|DSIEKEHVEEISELFYDAK.3|EHVEEISELFYDAK.3|EHVEEISELFYDAK.2|TEVLMENFR.2|AQTEGINISEEALNHLGEIGTK.4|AQTEGINISEEALNHLGEIGTK.3|AQTEGINISEEALNHLGEIGTK.2|PQGGQDILSMMGQLMK.3|PQGGQDILSMMGQLMK.2|VEAGDVIYIEANSGAVK.3|VEAGDVIYIEANSGAVK.2|TMLYTPQEMK.2|TM[Oxi]LYTPQEMK.2|VEAGDVIYIEANSGAVKR.3|LDPSIFESLQK.2|EIIQDVTLHDLDVANAR.3|GTEDITSPHGIPLDLLDR.3|GTEDITSPHGIPLDLLDR.2|IRAQTEGINISEEALNHLGEIGTK.4|IRAQTEGINISEEALNHLGEIGTK.3|PQGGQDILSMMGQLMKPK.3|VPFC[CAM]PMVGSEVYSTEIK.3|VPFC[CAM]PM[Oxi]VGSEVYSTEIK.2|VPFC[CAM]PMVGSEVYSTEIK.2|ERVEAGDVIYIEANSGAVK.3|KKEIIQDVTLHDLDVANARPQGGQDILSMMGQLMKPK.6|KKEIIQDVTLHDLDVANARPQGGQDILSMMGQLMKPK.5|VPFC[CAM]PMVGSEVYSTEIKK.3|ERVEAGDVIYIEANSGAVKR.3|EIIQDVTLHDLDVANARPQGGQDILSMMGQLMKPK.5|EIIQDVTLHDLDVANARPQGGQDILSMMGQLMKPK.4|C[CAM]DTYATEFDLEAEEYVPLPK.3|C[CAM]DTYATEFDLEAEEYVPLPK.2|VPFC[CAM]PMVGSEVYSTEIKKTEVLMENFR.4|TALALAIAQELGSKVPFC[CAM]PMVGSEVYSTEIK.4|EVYEGEVTELTPC[CAM]ETENPMGGYGK.3|EIIQDVTLHDLDVANARPQGGQDILSMMGQLMK.4
SEN / CTL,Signal transducer and activator of transcription 1-alpha/beta,STAT1,P42224,0.35,0.53,9.36E-03,5.05E-03,2.30E+00,"negative regulation of transcription from RNA polymerase II promoter,negative regulation of endothelial cell proliferation,positive regulation of mesenchymal cell proliferation,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,transcription, DNA-templated,apoptotic process,JAK-STAT cascade,response to nutrient,blood circulation,response to mechanical stimulus,macrophage derived foam cell differentiation,negative regulation of angiogenesis,cellular response to insulin stimulus,tumor necrosis factor-mediated signaling pathway,response to cytokine,response to interferon-beta,cellular response to interferon-beta,response to drug,response to hydrogen peroxide,regulation of apoptotic process,negative regulation of I-kappaB kinase/NF-kappaB signaling,response to peptide hormone,positive regulation of transcription, DNA-templated,positive regulation of transcription from RNA polymerase II promoter,negative regulation by virus of viral protein levels in host cell,positive regulation of smooth muscle cell proliferation,response to cAMP,defense response to virus,interferon-gamma-mediated signaling pathway,regulation of interferon-gamma-mediated signaling pathway,type I interferon signaling pathway,regulation of type I interferon-mediated signaling pathway,renal tubule development,cellular response to organic cyclic compound,metanephric mesenchymal cell proliferation involved in metanephros development,metanephric mesenchymal cell differentiation,negative regulation of metanephric nephron tubule epithelial cell differentiation,cell-cell adhesion,endothelial cell migration","RNA polymerase II core promoter proximal region sequence-specific DNA binding,RNA polymerase II core promoter sequence-specific DNA binding,transcription factor activity, RNA polymerase II core promoter sequence-specific,double-stranded DNA binding,transcription factor activity, sequence-specific DNA binding,signal transducer activity,tumor necrosis factor receptor binding,protein binding,enzyme binding,CCR5 chemokine receptor binding,nuclear hormone receptor binding,protein homodimerization activity,protein phosphatase 2A binding,cadherin binding involved in cell-cell adhesion","nuclear chromatin,nucleus,nucleoplasm,nucleolus,cytoplasm,cytosol,cell-cell adherens junction,axon,dendrite,perinuclear region of cytoplasm",9,47,63,ELSAVTFPDIIR.2|NLSFFLTPPC[CAM]AR.2|FHDLLSQLDDQYSR.3|FHDLLSQLDDQYSR.2|YLYPNIDKDHAFGK.4|YLYPNIDKDHAFGK.3|ILENAQR.2|YTYEHDPITK.3|YTYEHDPITK.2|FSLENNFLLQHNIR.4|FSLENNFLLQHNIR.3|FSLENNFLLQHNIR.2|TGVQFTVK.2|FSLENNFLLQHNIRK.4|FSLENNFLLQHNIRK.3|SDQKQEQLLLKK.3|TELISVSEVHPSR.3|TELISVSEVHPSR.2|SQNGGEPDFHAVEPYTKK.4|KLEELEQK.2|FNILGTHTK.2|MYLMLDNK.2|YLYPNIDK.2|GTGYIKTELISVSEVHPSR.4|RGLNVDQLNMLGEK.3|RGLNVDQLNMLGEK.2|ALLKDQQPGTFLLR.3|LLGPNASPDGLIPWTR.3|LLGPNASPDGLIPWTR.2|LQELNYNLK.2|KMYLMLDNK.2|VMC[CAM]IEHEIK.2|DQQPGTFLLR.2|QYLAQWLEK.2|QDWEHAANDVSFATIR.3|QDWEHAANDVSFATIR.2|VLFDKDVNER.2|SQNGGEPDFHAVEPYTK.3|EAPEPMELDGPK.2|EAPEPM[Oxi]ELDGPK.2|EGAITFTWVER.2|HLLPLWNDGC[CAM]IMGFISK.3|HLLPLWNDGC[CAM]IM[Oxi]GFISK.3|HLLPLWNDGC[CAM]IMGFISK.2|SDQKQEQLLLK.2|TFSLFQQLIQSSFVVER.3|FNQAQSGNIQSTVMLDKQK.3|VMAAENIPENPLK.2|VM[Oxi]AAENIPENPLK.2|GLNVDQLNMLGEK.2|FLEQVHQLYDDSFPMEIR.3|FLEQVHQLYDDSFPMEIR.2|KLEELEQKYTYEHDPITK.3|SLEDLQDEYDFK.2|LQTTDNLLPMSPEEFDEVSR.3|LQTTDNLLPMSPEEFDEVSR.2|NLQDNFQEDPIQMSMIIYSC[CAM]LK.3|FNQAQSGNIQSTVMLDK.2|IIELLNVTELTQNALINDELVEWK.3|RNLQDNFQEDPIQMSMIIYSC[CAM]LK.3|RQQSAC[CAM]IGGPPNAC[CAM]LDQLQNWFTIVAESLQQVR.4|WAQLSEVLSWQFSSVTK.2|NLQDNFQEDPIQMSMIIYSC[CAM]LKEER.3
SEN / CTL,Isocitrate dehydrogenase [NADP] cytoplasmic,IDH1,O75874,0.35,0.50,4.09E-03,2.52E-03,2.60E+00,"glyoxylate cycle,tricarboxylic acid cycle,isocitrate metabolic process,2-oxoglutarate metabolic process,NADPH regeneration,glutathione metabolic process,response to oxidative stress,female gonad development,response to steroid hormone,regulation of phospholipid catabolic process,regulation of phospholipid biosynthetic process,cell-cell adhesion","magnesium ion binding,isocitrate dehydrogenase (NADP+) activity,receptor binding,protein homodimerization activity,NADP binding,NAD binding,(R)-2-hydroxyglutarate dehydrogenase activity,cadherin binding involved in cell-cell adhesion","cytoplasm,mitochondrion,peroxisome,peroxisomal matrix,cytosol,cell-cell adherens junction,extracellular exosome",30,28,53,GWPLYLSTK.2|IIWELIK.2|LVSGWVKPIIIGR.3|LVSGWVKPIIIGR.2|ISGGSVVEMQGDEMTR.2|ISGGSVVEM[Oxi]QGDEMTR.2|ISGGSVVEMQGDEM[Oxi]TR.2|KISGGSVVEMQGDEMTR.3|KISGGSVVEM[Oxi]QGDEMTR.3|KISGGSVVEM[Oxi]QGDEM[Oxi]TR.3|KISGGSVVEMQGDEMTR.2|FKDIFQEIYDKQYK.3|FKDIFQEIYDKQYK.4|LIDDMVAQAMK.2|LIDDM[Oxi]VAQAMK.2|LIDDMVAQAM[Oxi]K.2|LIDDM[Oxi]VAQAM[Oxi]K.2|GQETSTNPIASIFAWTR.3|GQETSTNPIASIFAWTR.2|DAAEAIKK.2|TVEAEAAHGTVTR.3|TVEAEAAHGTVTR.2|DATNDQVTKDAAEAIKK.4|FKDIFQEIYDK.3|FKDIFQEIYDK.2|VEITYTPSDGTQK.3|VEITYTPSDGTQK.2|DATNDQVTK.2|HAYGDQYR.2|SDYLNTFEFMDK.3|SDYLNTFEFMDK.2|SDYLNTFEFM[Oxi]DK.2|C[CAM]ATITPDEK.2|ATDFVVPGPGK.2|DATNDQVTKDAAEAIK.3|DATNDQVTKDAAEAIK.2|SEGGFIWAC[CAM]K.2|DIFQEIYDK.2|SIEDFAHSSFQMALSK.3|SIEDFAHSSFQM[Oxi]ALSK.3|SIEDFAHSSFQMALSK.2|LIFPYVELDLHSYDLGIENR.4|LIFPYVELDLHSYDLGIENR.3|ATDFVVPGPGKVEITYTPSDGTQK.4|ATDFVVPGPGKVEITYTPSDGTQK.3|VTYLVHNFEEGGGVAMGMYNQDK.4|VTYLVHNFEEGGGVAM[Oxi]GM[Oxi]YNQDK.3|VTYLVHNFEEGGGVAM[Oxi]GMYNQDK.3|VTYLVHNFEEGGGVAMGM[Oxi]YNQDK.3|VTYLVHNFEEGGGVAMGMYNQDK.3|SDYLNTFEFMDKLGENLK.3|DLAAC[CAM]IK.1|AKLDNNKELAFFANALEEVSIETIEAGFM[Oxi]TK.4
SEN / CTL,Dipeptidyl peptidase 4,DPP4,P27487,0.35,0.48,3.61E-04,3.14E-04,3.50E+00,"behavioral fear response,response to hypoxia,proteolysis,positive regulation of cell proliferation,negative regulation of extracellular matrix disassembly,T cell costimulation,regulation of cell-cell adhesion mediated by integrin,locomotory exploration behavior,psychomotor behavior,T cell activation,endothelial cell migration,viral entry into host cell","virus receptor activity,protease binding,serine-type endopeptidase activity,receptor binding,protein binding,serine-type peptidase activity,dipeptidyl-peptidase activity,identical protein binding,protein homodimerization activity","lysosomal membrane,plasma membrane,focal adhesion,cell surface,membrane,integral component of membrane,apical plasma membrane,lamellipodium,endocytic vesicle,lamellipodium membrane,membrane raft,intercellular canaliculus,extracellular exosome,invadopodium membrane",21,34,42,ISLQWLR.2|LNWATYLASTENIIVASFDGR.3|HSYTASYDIYDLNKR.3|HSYTASYDIYDLNKR.4|HSYTASYDIYDLNKR.2|WEYYDSVYTER.2|LGTFEVEDQIEAAR.2|C[CAM]QYYSVSFSK.2|AGAVNPTVK.2|WISDHEYLYK.3|WISDHEYLYK.2|IQLSDYTK.2|VTC[CAM]LSC[CAM]ELNPER.3|VTC[CAM]LSC[CAM]ELNPER.2|GTDDATADSR.2|C[CAM]GIAVAPVSR.2|FRPSEPHFTLDGNSFYK.4|FRPSEPHFTLDGNSFYK.3|RQLITEER.2|IEPNLPSYR.2|IISNEEGYR.2|TYTLTDYLKNTYR.3|VLEDNSALDK.2|TYTLTDYLK.2|HSYTASYDIYDLNK.3|HSYTASYDIYDLNK.2|FWYQMILPPHFDK.3|RLGTFEVEDQIEAAR.3|RLGTFEVEDQIEAAR.2|MLQNVQMPSK.2|KTYTLTDYLK.2|KYPLLLDVYAGPC[CAM]SQK.3|C[CAM]SGPGLPLYTLHSSVNDK.3|AENFKQVEYLLIHGTADDNVHFQQSAQISK.5|AENFKQVEYLLIHGTADDNVHFQQSAQISK.4|QVEYLLIHGTADDNVHFQQSAQISK.4|LAYVWNNDIYVK.2|QHIEMSTTGWVGR.2|C[CAM]GIAVAPVSRWEYYDSVYTER.3|LAYVWNNDIYVKIEPNLPSYR.3|YPLLLDVYAGPC[CAM]SQK.2|LNWATYLASTENIIVASFDGRGSGYQGDK.3
SEN / CTL,Polymerase I and transcript release factor,PTRF,Q6NZI2,0.35,0.74,3.59E-02,1.52E-02,1.82E+00,"regulation of transcription, DNA-templated,transcription initiation from RNA polymerase I promoter,termination of RNA polymerase I transcription","protein binding,rRNA primary transcript binding,poly(A) RNA binding","nucleus,nucleoplasm,cytoplasm,mitochondrion,endoplasmic reticulum,cytosol,caveola,protein complex,membrane raft",21,15,23,VMIYQDEVKLPAK.3|VM[Oxi]IYQDEVKLPAK.3|VMIYQDEVKLPAK.2|KLEVNEAELLR.3|KLEVNEAELLR.2|QAEMEGAVQSIQGELSK.3|QAEMEGAVQSIQGELSK.2|QAEM[Oxi]EGAVQSIQGELSK.2|ATEMVEVGADDDEGGAERGEAGDLR.3|SFTPDHVVYAR.3|SFTPDHVVYAR.2|EGQVEVLK.2|KLEVNEAELLRR.3|AHATTSNTVSK.2|VMIYQDEVK.2|VM[Oxi]IYQDEVK.2|IREGQVEVLK.2|LEVNEAELLR.2|IIGAVDQIQLTQAQLEER.3|IIGAVDQIQLTQAQLEER.2|SDQVNGVLVLSLLDK.2|ATEMVEVGADDDEGGAER.2|IIGAVDQIQLTQAQLEERQAEMEGAVQSIQGELSK.4
SEN / CTL,Guanine nucleotide-binding protein subunit beta-2-like 1,GNB2L1,P63244,0.34,0.58,7.48E-03,4.21E-03,2.38E+00,"positive regulation of protein phosphorylation,apoptotic process,activation of cysteine-type endopeptidase activity involved in apoptotic process,cell cycle,gastrulation,negative regulation of gene expression,regulation of tumor necrosis factor-mediated signaling pathway,viral process,negative regulation of translation,negative regulation of Wnt signaling pathway,negative regulation of cell growth,positive regulation of cell migration,positive regulation of cAMP catabolic process,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of protein homooligomerization,regulation of protein localization,negative regulation of peptidyl-serine phosphorylation,positive regulation of Golgi to plasma membrane protein transport,positive regulation of apoptotic process,positive regulation of GTPase activity,rhythmic process,negative regulation of phagocytosis,regulation of cell division,positive regulation of cyclic-nucleotide phosphodiesterase activity,regulation of cell cycle,negative regulation of protein kinase B signaling,positive regulation of mitochondrial depolarization,negative regulation of protein tyrosine kinase activity,cellular response to glucose stimulus,cellular response to growth factor stimulus,cell-cell adhesion,negative regulation of endoplasmic reticulum unfolded protein response,negative regulation of hydrogen peroxide-induced neuron death,regulation of establishment of cell polarity,positive regulation of ceramide biosynthetic process,positive regulation of gastrulation,positive regulation of intrinsic apoptotic signaling pathway","protein kinase C binding,receptor binding,protein binding,ion channel inhibitor activity,cysteine-type endopeptidase activator activity involved in apoptotic process,enzyme binding,protein phosphatase binding,protein tyrosine kinase inhibitor activity,receptor tyrosine kinase binding,protein complex scaffold,signaling adaptor activity,SH2 domain binding,protein homodimerization activity,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","phagocytic cup,nucleus,cytoplasm,mitochondrion,cytosol,cell-cell adherens junction,small ribosomal subunit,dendrite,midbody,neuronal cell body,perikaryon,perinuclear region of cytoplasm,extracellular exosome,IRE1-RACK1-PP2A complex",24,30,51,VWQVTIGTR.2|LWDLTTGTTTR.2|YWLC[CAM]AATGPSIK.2|YWLC[CAM]AATGPSIK.3|FSPNSSNPIIVSC[CAM]GWDK.2|FSPNSSNPIIVSC[CAM]GWDK.3|YTVQDESHSEWVSC[CAM]VR.3|YTVQDESHSEWVSC[CAM]VR.4|YTVQDESHSEWVSC[CAM]VR.2|LTRDETNYGIPQR.3|LTRDETNYGIPQR.2|DVLSVAFSSDNR.2|DVLSVAFSSDNR.3|IIVDELK.2|IWDLEGK.2|LWDLTTGTTTRR.3|QEVISTSSK.2|DGQAMLWDLNEGK.3|DGQAMLWDLNEGK.2|DGQAM[Oxi]LWDLNEGK.2|VWNLANC[CAM]K.2|GHNGWVTQIATTPQFPDMILSASR.5|GHNGWVTQIATTPQFPDMILSASR.4|GHNGWVTQIATTPQFPDM[Oxi]ILSASR.4|GHNGWVTQIATTPQFPDM[Oxi]ILSASR.3|GHNGWVTQIATTPQFPDMILSASR.3|LWNTLGVC[CAM]K.2|TNHIGHTGYLNTVTVSPDGSLC[CAM]ASGGK.5|TNHIGHTGYLNTVTVSPDGSLC[CAM]ASGGK.4|TNHIGHTGYLNTVTVSPDGSLC[CAM]ASGGK.3|HLYTLDGGDIINALC[CAM]FSPNR.4|HLYTLDGGDIINALC[CAM]FSPNR.3|HLYTLDGGDIINALC[CAM]FSPNR.2|DETNYGIPQR.2|IIVDELKQEVISTSSK.3|IIVDELKQEVISTSSK.2|IWDLEGKIIVDELKQEVISTSSK.4|TNHIGHTGYLNTVTVSPDGSLC[CAM]ASGGKDGQAMLWDLNEGK.6|TNHIGHTGYLNTVTVSPDGSLC[CAM]ASGGKDGQAMLWDLNEGK.5|GHNGWVTQIATTPQFPDMILSASRDK.4|GHSHFVSDVVISSDGQFALSGSWDGTLR.4|LKTNHIGHTGYLNTVTVSPDGSLC[CAM]ASGGKDGQAMLWDLNEGK.6|LKTNHIGHTGYLNTVTVSPDGSLC[CAM]ASGGKDGQAMLWDLNEGK.5|LKTNHIGHTGYLNTVTVSPDGSLC[CAM]ASGGK.4|GTLKGHNGWVTQIATTPQFPDMILSASR.4|GTLKGHNGWVTQIATTPQFPDMILSASR.3|AEPPQC[CAM]TSLAWSADGQTLFAGYTDNLVR.4|AEPPQC[CAM]TSLAWSADGQTLFAGYTDNLVR.3|HLYTLDGGDIINALC[CAM]FSPNRYWLC[CAM]AATGPSIK.4|DGQAMLWDLNEGKHLYTLDGGDIINALC[CAM]FSPNR.4|TNHIGHTGYLNTVTVSPDGSLC[CAM]ASGGKDGQAMLWDLNEGKHLYTLDGGDIINALC[CAM]FSPNR.6
SEN / CTL,Heterogeneous nuclear ribonucleoprotein D0,HNRNPD,Q14103,0.34,0.49,7.16E-03,4.05E-03,2.39E+00,"mRNA splicing, via spliceosome,liver development,transcription, DNA-templated,regulation of transcription, DNA-templated,RNA processing,RNA catabolic process,gene expression,cerebellum development,regulation of circadian rhythm,regulation of mRNA stability,positive regulation of translation,positive regulation of transcription, DNA-templated,mRNA stabilization,response to calcium ion,response to electrical stimulus,3'-UTR-mediated mRNA destabilization,cellular response to amino acid stimulus,cellular response to estradiol stimulus,cellular response to nitric oxide,circadian regulation of translation,response to rapamycin,response to sodium phosphate,cellular response to putrescine,hepatocyte dedifferentiation","nucleotide binding,AT DNA binding,chromatin binding,RNA binding,protein binding,transcription factor binding,mRNA 3'-UTR AU-rich region binding,telomeric DNA binding,histone deacetylase binding,poly(A) RNA binding","nucleus,nucleoplasm,cytosol,intracellular ribonucleoprotein complex,extracellular exosome",21,25,51,FGEVVDC[CAM]TLK.2|IFVGGLSPDTPEEK.2|IFVGGLSPDTPEEK.3|FGEVVDC[CAM]TLKLDPITGR.3|FGEVVDC[CAM]TLKLDPITGR.2|GFC[CAM]FITFKEEEPVKK.4|GFC[CAM]FITFKEEEPVKK.3|GFC[CAM]FITFKEEEPVKK.2|IFVGGLSPDTPEEKIR.3|MFIGGLSWDTTKK.3|M[Oxi]FIGGLSWDTTKK.3|MFIGGLSWDTTKK.2|M[Oxi]FIGGLSWDTTKK.2|ESESVDKVMDQKEHK.4|ESESVDKVMDQKEHK.3|ESESVDKVMDQKEHK.2|ESESVDKVMDQK.3|ESESVDKVM[Oxi]DQK.3|ESESVDKVM[Oxi]DQK.2|ESESVDKVMDQK.2|YHNVGLSK.2|NEEDEGHSNSSPR.3|NEEDEGHSNSSPR.2|IDASKNEEDEGHSNSSPR.4|IDASKNEEDEGHSNSSPR.3|IDASKNEEDEGHSNSSPR.2|GFC[CAM]FITFK.2|HSEAATAQREEWK.3|HSEAATAQREEWK.2|KYHNVGLSK.2|KIFVGGLSPDTPEEK.3|KIFVGGLSPDTPEEK.2|GFGFVLFKESESVDK.3|GFGFVLFKESESVDK.2|GFGFVLFKESESVDKVMDQK.4|GFC[CAM]FITFKEEEPVK.3|GFC[CAM]FITFKEEEPVK.2|RGFC[CAM]FITFKEEEPVK.3|M[Oxi]FIGGLSWDTTK.2|MFIGGLSWDTTK.2|IREYFGGFGEVESIELPMDNKTNK.4|IREYFGGFGEVESIELPM[Oxi]DNKTNK.4|IREYFGGFGEVESIELPMDNKTNK.3|EYFGGFGEVESIELPMDNK.3|EYFGGFGEVESIELPM[Oxi]DNK.3|EYFGGFGEVESIELPM[Oxi]DNK.2|EYFGGFGEVESIELPMDNK.2|EQYQQQQQWGSR.2|IREYFGGFGEVESIELPM[Oxi]DNK.3|IREYFGGFGEVESIELPMDNK.3|EYFGGFGEVESIELPMDNKTNK.3
SEN / CTL,26S proteasome non-ATPase regulatory subunit 14,PSMD14,O00487,0.34,0.34,8.08E-03,4.51E-03,2.35E+00,"MAPK cascade,protein polyubiquitination,double-strand break repair via homologous recombination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,double-strand break repair via nonhomologous end joining,ubiquitin-dependent protein catabolic process,regulation of cellular amino acid metabolic process,positive regulation of endopeptidase activity,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,response to ethanol,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,regulation of proteasomal protein catabolic process,protein K63-linked deubiquitination,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","protein binding,metallopeptidase activity,metal ion binding,endopeptidase activator activity,proteasome binding","proteasome complex,nucleus,nucleoplasm,cytosol,proteasome regulatory particle, lid subcomplex,proteasome accessory complex,cytosolic proteasome complex,extracellular exosome",12,12,25,AVAVVVDPIQSVK.2|AVAVVVDPIQSVK.3|LINANMMVLGHEPR.3|LINANMM[Oxi]VLGHEPR.3|LINANMMVLGHEPR.2|LGGGMPGLGQGPPTDAPAVDTAEQVYISSLALLK.3|LGGGMPGLGQGPPTDAPAVDTAEQVYISSLALLK.4|LGGGM[Oxi]PGLGQGPPTDAPAVDTAEQVYISSLALLK.3|HYYSITINYR.3|PSIQALIHGLNR.3|QTTSNLGHLNKPSIQALIHGLNR.5|QTTSNLGHLNKPSIQALIHGLNR.4|MTPEQLAIK.2|KSWMEGLTLQDYSEHC[CAM]KHNESVVK.5|KSWMEGLTLQDYSEHC[CAM]KHNESVVK.4|AVEEEDKM[Oxi]TPEQLAIK.3|AVEEEDKMTPEQLAIK.3|AVEEEDKMTPEQLAIK.2|SWM[Oxi]EGLTLQDYSEHC[CAM]K.3|SWMEGLTLQDYSEHC[CAM]K.3|SWMEGLTLQDYSEHC[CAM]K.2|VIDVFAMPQSGTGVSVEAVDPVFQAK.4|VIDVFAMPQSGTGVSVEAVDPVFQAK.3|VIDVFAM[Oxi]PQSGTGVSVEAVDPVFQAK.3|QTGRPEMVVGWYHSHPGFGC[CAM]WLSGVDINTQQSFEALSER.5
SEN / CTL,F-actin-capping protein subunit beta,CAPZB,P47756,0.34,0.35,4.66E-06,6.49E-06,5.19E+00,"movement of cell or subcellular component,cytoskeleton organization,blood coagulation,regulation of lamellipodium assembly,regulation of cell morphogenesis,actin cytoskeleton organization,barbed-end actin filament capping,negative regulation of filopodium assembly,cell-cell adhesion","actin binding,actin filament binding,cadherin binding involved in cell-cell adhesion","cytosol,cytoskeleton,actin filament,cell-cell adherens junction,F-actin capping protein complex,actin cytoskeleton,sarcomere,extracellular exosome,WASH complex",36,22,40,STLNEIYFGK.2|LVEDMENKIR.3|SGSGTMNLGGSLTR.2|SGSGTM[Oxi]NLGGSLTR.2|GC[CAM]WDSIHVVEVQEK.3|GC[CAM]WDSIHVVEVQEK.2|QMEKDETVSDC[CAM]SPHIANIGR.4|QMEKDETVSDC[CAM]SPHIANIGR.3|QMEKDETVSDC[CAM]SPHIANIGR.5|QM[Oxi]EKDETVSDC[CAM]SPHIANIGR.4|LTSTVMLWLQTNK.2|LTSTVM[Oxi]LWLQTNK.2|SPWSNKYDPPLEDGAMPSAR.3|SPWSNKYDPPLEDGAMPSAR.4|SPWSNKYDPPLEDGAM[Oxi]PSAR.3|DYLLC[CAM]DYNRDGDSYR.3|DYLLC[CAM]DYNRDGDSYR.2|DKVVGKDYLLC[CAM]DYNR.4|DKVVGKDYLLC[CAM]DYNR.3|LPPQQIEK.2|IKGC[CAM]WDSIHVVEVQEK.4|IKGC[CAM]WDSIHVVEVQEK.3|IRSTLNEIYFGK.3|IRSTLNEIYFGK.2|LVEDMENK.2|LVEDM[Oxi]ENK.2|YDPPLEDGAMPSAR.3|YDPPLEDGAMPSAR.2|YDPPLEDGAM[Oxi]PSAR.2|VVGKDYLLC[CAM]DYNR.3|VVGKDYLLC[CAM]DYNR.2|RLPPQQIEK.2|KLEVEANNAFDQYR.3|KLEVEANNAFDQYR.2|DETVSDC[CAM]SPHIANIGR.3|DETVSDC[CAM]SPHIANIGR.2|DYLLC[CAM]DYNR.2|VVGKDYLLC[CAM]DYNRDGDSYR.3|LEVEANNAFDQYR.2|RLPPQQIEKNLSDLIDLVPSLC[CAM]EDLLSSVDQPLK.4
SEN / CTL,Nicotinamide N-methyltransferase,NNMT,P40261,0.33,0.34,1.48E-02,7.35E-03,2.13E+00,"response to organonitrogen compound,animal organ regeneration,methylation,response to drug","nicotinamide N-methyltransferase activity,pyridine N-methyltransferase activity",cytosol,15,13,20,C[CAM]DVTQSQPLGAVPLPPADC[CAM]VLSTLC[CAM]LDAAC[CAM]PDLPTYC[CAM]R.4|NLGSLLKPGGFLVIMDALK.3|NLGSLLKPGGFLVIM[Oxi]DALK.3|NLGSLLKPGGFLVIMDALK.2|KEPEAFDWSPVVTYVC[CAM]DLEGNR.3|KEPEAFDWSPVVTYVC[CAM]DLEGNR.4|EPEAFDWSPVVTYVC[CAM]DLEGNR.3|SSYYMIGEQK.2|SSYYM[Oxi]IGEQK.2|DTYLSHFNPR.3|DTYLSHFNPR.2|IFC[CAM]LDGVK.2|HSAESQILK.2|GPEKEEKLR.2|PGGFLVIMDALK.2|EIVVTDYSDQNLQELEK.3|EIVVTDYSDQNLQELEK.2|KEPEAFDWSPVVTYVC[CAM]DLEGNRVK.4|KEPEAFDWSPVVTYVC[CAM]DLEGNRVK.3|GDLLIDIGSGPTIYQLLSAC[CAM]ESFK.3
SEN / CTL,Integrin alpha-3,ITGA3,P26006,0.33,0.54,3.89E-03,2.43E-03,2.61E+00,"neuron migration,cell-matrix adhesion,integrin-mediated signaling pathway,heart development,memory,positive regulation of gene expression,positive regulation of epithelial cell migration,positive regulation of cell-substrate adhesion,positive regulation of neuron projection development,regulation of transforming growth factor beta receptor signaling pathway,regulation of Wnt signaling pathway,extracellular matrix organization,lung development,regulation of BMP signaling pathway,negative regulation of cell projection organization,response to gonadotropin,negative regulation of Rho protein signal transduction,exploration behavior,response to drug,skin development,mesodermal cell differentiation,leukocyte migration,maternal process involved in female pregnancy,nephron development,positive regulation of establishment of protein localization to plasma membrane,dendritic spine maintenance,renal filtration","glycoprotein binding,fibronectin binding,protease binding,integrin binding,protein binding,collagen binding,protein domain specific binding,laminin binding,metal ion binding,protein heterodimerization activity","plasma membrane,focal adhesion,integrin complex,external side of plasma membrane,cell surface,basolateral plasma membrane,growth cone,filopodium membrane,integrin alpha3-beta1 complex,receptor complex,perinuclear region of cytoplasm,excitatory synapse,extracellular exosome,invadopodium membrane,cell periphery,synaptic membrane",33,26,39,YLLLAGAPR.2|VNGWATLFLR.2|EAGNPGSLFGYSVALHR.3|EAGNPGSLFGYSVALHR.2|LELLLMDNLRDK.3|YTQVLWSGSEDQRR.3|YTQVLWSGSEDQRR.2|SQPSETERLTDDY.2|SETVLTC[CAM]ATGR.2|NDPGHHIIEDMWLGVTVASQGPAGR.4|NDPGHHIIEDMWLGVTVASQGPAGR.3|FAGSESAVFHGFFSMPEMR.3|FAGSESAVFHGFFSMPEM[Oxi]R.3|FAGSESAVFHGFFSMPEMR.2|HMGAVFLLSQEAGGDLR.3|HM[Oxi]GAVFLLSQEAGGDLR.3|HMGAVFLLSQEAGGDLR.2|GLLRQPQQVIHGEK.4|GLLRQPQQVIHGEK.3|VLVC[CAM]AHR.2|TGAVYLC[CAM]PLTAHK.3|TGAVYLC[CAM]PLTAHK.2|GNSYMIQR.2|HMGAVFLLSQEAGGDLRR.4|HMGAVFLLSQEAGGDLRR.3|HM[Oxi]GAVFLLSQEAGGDLRR.3|C[CAM]ESNLQMR.2|TVEDVGSPLK.2|TGAVYLC[CAM]PLTAHKDDC[CAM]ER.4|AAFVSEQQQK.2|QPQQVIHGEK.2|EC[CAM]GPDNKC[CAM]ESNLQMR.3|EC[CAM]GPDNKC[CAM]ESNLQMR.2|LELLLMDNLR.2|AKSETVLTC[CAM]ATGR.2|YTQVLWSGSEDQR.2|LQSFFGGTVMGESGM[Oxi]K.2|LQSFFGGTVMGESGMK.2|QLDPGGGQGPPPVTLAAAK.2
SEN / CTL,Lysosomal alpha-mannosidase,MAN2B1,O00754,0.33,0.41,1.68E-02,8.18E-03,2.09E+00,"mannose metabolic process,cellular protein modification process,protein deglycosylation,oligosaccharide catabolic process","alpha-mannosidase activity,zinc ion binding,carbohydrate binding","extracellular space,lysosomal lumen,extracellular exosome",27,32,45,DLFSTFTITR.2|LQETTLVANQLR.2|FQVIVYNPLGR.2|ELVDYFLNVATAQGR.2|ELVDYFLNVATAQGR.3|DLPPSVHLLTLASWGPEMVLLR.3|DLPPSVHLLTLASWGPEM[Oxi]VLLR.3|TFLASVQWK.2|HDDFFPYADGPHQFWTGYFSSRPALK.5|HDDFFPYADGPHQFWTGYFSSRPALK.4|HDDFFPYADGPHQFWTGYFSSRPALK.3|HLVLLDTAQAAAAGHR.3|HLVLLDTAQAAAAGHR.2|GRFYTDSNGREILER.4|GRFYTDSNGREILER.3|RSWSPALTIENEHIR.4|GRHLVLLDTAQAAAAGHR.4|FDTPLETK.2|VAWHIDPFGHSR.3|LEHQFAVGEDSGR.3|LEHQFAVGEDSGR.2|WAQIHLVK.2|FLEDTFGNDGRPR.3|FLEDTFGNDGRPR.2|QHVANDYAR.2|LEMEQVWR.2|LPVSEGVFVVKDPNGR.3|LPVSEGVFVVK.2|TVDQYFYGIK.2|RDLPPSVHLLTLASWGPEMVLLR.4|HDDFFPYADGPHQFWTGYFSSR.4|HDDFFPYADGPHQFWTGYFSSR.3|QLAAGWGPC[CAM]EVLLSNALAR.3|QLAAGWGPC[CAM]EVLLSNALAR.2|DDGRGVSEPLMENGSGAWVR.3|HLELEWSVGPIPVGDTWGK.3|HLELEWSVGPIPVGDTWGK.2|NLC[CAM]WDVLC[CAM]VDQPLVEDPR.3|NLC[CAM]WDVLC[CAM]VDQPLVEDPR.2|GSSVHVLYSTPAC[CAM]YLWELNK.3|GSSVHVLYSTPAC[CAM]YLWELNK.2|GVSEPLMENGSGAWVR.2|ASTSLKPPTADLFTGVLPNGYNPPR.3|IYITDGNMQLTVLTDR.2|NLC[CAM]WDVLC[CAM]VDQPLVEDPRSPEYNAK.3
SEN / CTL,Annexin A11,ANXA11,P50995,0.33,0.54,5.18E-03,3.09E-03,2.51E+00,"phagocytosis,cell cycle,cell division,response to calcium ion","calcium ion binding,protein binding,calcium-dependent phospholipid binding,phosphatidylethanolamine binding,MHC class II protein complex binding,S100 protein binding,poly(A) RNA binding,calcium-dependent protein binding","nuclear envelope,nucleoplasm,cytoplasm,spindle,membrane,midbody,melanosome,specific granule,azurophil granule,phagocytic vesicle,extracellular exosome",21,29,45,SETDLLDIR.2|EAIKGVGTDEAC[CAM]LIEILASR.3|TPVLFDIYEIK.2|TPVLFDIYEIK.3|GVGTDEAC[CAM]LIEILASR.3|GVGTDEAC[CAM]LIEILASR.2|GTITDAPGFDPLRDAEVLRK.4|GTITDAPGFDPLRDAEVLRK.3|AHLVAVFNEYQR.3|AHLVAVFNEYQR.2|GFGTDEQAIIDC[CAM]LGSR.3|GFGTDEQAIIDC[CAM]LGSR.2|TLEEAIR.2|SRAHLVAVFNEYQR.4|SRAHLVAVFNEYQR.3|DAQELYAAGENR.3|DAQELYAAGENR.2|SLYHDISGDTSGDYRK.4|SLYHDISGDTSGDYRK.3|SLYHDISGDTSGDYRK.2|TLEEAIRSDTSGHFQR.4|TLEEAIRSDTSGHFQR.3|FNAVLC[CAM]SR.2|AYKAEFKK.2|SDTSGHFQR.2|SETDLLDIRSEYK.3|NTPAFFAER.2|LLISLSQGNR.2|LGTDESKFNAVLC[CAM]SR.3|LGTDESKFNAVLC[CAM]SR.2|SLYHDISGDTSGDYR.3|SLYHDISGDTSGDYR.2|TPVLFDIYEIKEAIK.3|LLISLSQGNRDESTNVDMSLAQR.4|LLISLSQGNRDESTNVDM[Oxi]SLAQR.3|LLISLSQGNRDESTNVDMSLAQR.3|DLKSELSGNFEK.2|GTITDAPGFDPLR.2|GTITDAPGFDPLRDAEVLR.3|DAQELYAAGENRLGTDESK.3|DESTNVDMSLAQR.2|EMSGDLEEGMLAVVK.2|EM[Oxi]SGDLEEGMLAVVK.2|EMSGDLEEGM[Oxi]LAVVK.2|TPVLFDIYEIKEAIKGVGTDEAC[CAM]LIEILASR.4
SEN / CTL,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,PPP2R1A,P30153,0.33,0.47,2.03E-04,1.90E-04,3.72E+00,"G2/M transition of mitotic cell cycle,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,inactivation of MAPK activity,regulation of DNA replication,regulation of transcription, DNA-templated,protein complex assembly,protein dephosphorylation,ceramide metabolic process,apoptotic process,chromosome segregation,mitotic nuclear envelope reassembly,female meiotic division,RNA splicing,response to organic substance,second-messenger-mediated signaling,regulation of Wnt signaling pathway,regulation of cell adhesion,negative regulation of cell growth,regulation of protein phosphatase type 2A activity,regulation of growth,negative regulation of tyrosine phosphorylation of Stat3 protein,regulation of cell differentiation,meiotic spindle elongation,mitotic sister chromatid separation,meiotic sister chromatid cohesion, centromeric,peptidyl-serine dephosphorylation,regulation of meiotic cell cycle process involved in oocyte maturation,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand","antigen binding,protein serine/threonine phosphatase activity,protein binding,protein phosphatase type 2A regulator activity,protein heterodimerization activity","protein phosphatase type 2A complex,chromosome, centromeric region,nucleus,mitochondrion,cytosol,microtubule cytoskeleton,membrane,extracellular exosome",42,41,75,QLSQSLLPAIVELAEDAKWR.3|TSAC[CAM]GLFSVC[CAM]YPR.2|AISHEHSPSDLEAHFVPLVKR.5|KLSTIALALGVER.3|KLSTIALALGVER.2|VLELDNVKSEIIPMFSNLASDEQDSVR.4|VLELDNVKSEIIPMFSNLASDEQDSVR.3|IGPILDNSTLQSEVKPILEK.3|IGPILDNSTLQSEVKPILEK.2|LNIISNLDC[CAM]VNEVIGIR.3|LNIISNLDC[CAM]VNEVIGIR.2|SALASVIMGLSPILGK.2|SALASVIMGLSPILGK.3|SALASVIM[Oxi]GLSPILGK.3|SALASVIM[Oxi]GLSPILGK.2|YMVADKFTELQK.3|YM[Oxi]VADKFTELQK.3|YMVADKFTELQK.2|LSTIALALGVER.2|LSTIALALGVER.3|DNTIEHLLPLFLAQLKDEC[CAM]PEVR.4|DNTIEHLLPLFLAQLKDEC[CAM]PEVR.3|AISHEHSPSDLEAHFVPLVK.5|AISHEHSPSDLEAHFVPLVK.4|AISHEHSPSDLEAHFVPLVK.3|AISHEHSPSDLEAHFVPLVK.2|ELVSDANQHVK.3|ELVSDANQHVK.2|DC[CAM]EAEVR.2|NEDVQLR.2|DEC[CAM]PEVR.2|VLELDNVK.2|DNTIEHLLPLFLAQLK.4|DNTIEHLLPLFLAQLK.3|DNTIEHLLPLFLAQLK.2|VLAM[Oxi]SGDPNYLHR.3|VLAMSGDPNYLHR.3|VLAMSGDPNYLHR.2|VLAM[Oxi]SGDPNYLHR.2|FGKEWAHATIIPK.3|FGKEWAHATIIPK.2|ENVIMSQILPC[CAM]IK.3|ENVIMSQILPC[CAM]IK.2|ENVIM[Oxi]SQILPC[CAM]IK.2|LNSLC[CAM]MAWLVDHVYAIR.4|LNSLC[CAM]M[Oxi]AWLVDHVYAIR.3|LNSLC[CAM]MAWLVDHVYAIR.3|LNSLC[CAM]MAWLVDHVYAIR.2|MAGDPVANVR.2|M[Oxi]AGDPVANVR.2|VKEFC[CAM]ENLSADC[CAM]R.3|VKEFC[CAM]ENLSADC[CAM]R.2|LAGGDWFTSR.2|LTQDQDVDVK.2|EWAHATIIPK.2|RLAGGDWFTSR.2|QLSQSLLPAIVELAEDAK.3|QLSQSLLPAIVELAEDAK.2|NLC[CAM]SDDTPMVR.2|NLC[CAM]SDDTPM[Oxi]VR.2|TDLVPAFQNLMK.2|TDLVPAFQNLM[Oxi]K.2|EFC[CAM]ENLSADC[CAM]R.2|SEIIPMFSNLASDEQDSVR.3|SEIIPM[Oxi]FSNLASDEQDSVR.2|SEIIPMFSNLASDEQDSVR.2|YFAQEALTVLSLA.2|AVGPEITKTDLVPAFQNLMK.3|AVGPEITKTDLVPAFQNLMK.2|TDLVPAFQNLMKDC[CAM]EAEVR.3|AVGPEITKTDLVPAFQNLMKDC[CAM]EAEVR.4|VKEFC[CAM]ENLSADC[CAM]RENVIMSQILPC[CAM]IK.4|IGPILDNSTLQSEVK.2|EFC[CAM]ENLSADC[CAM]RENVIMSQILPC[CAM]IK.3|LLAVEAC[CAM]VNIAQLLPQEDLEALVMPTLR.3
SEN / CTL,AP-2 complex subunit alpha-1,AP2A1,O95782,0.33,0.60,1.30E-01,4.39E-02,1.36E+00,"intracellular protein transport,Golgi to endosome transport,endocytosis,microtubule-based movement,antigen processing and presentation of exogenous peptide antigen via MHC class II,negative regulation of epidermal growth factor receptor signaling pathway,ephrin receptor signaling pathway,regulation of defense response to virus by virus,Wnt signaling pathway, planar cell polarity pathway,clathrin-dependent endocytosis,negative regulation of hyaluronan biosynthetic process","protein binding,protein C-terminus binding,protein transporter activity,protein kinase binding,protein complex binding,clathrin adaptor activity","cytosol,plasma membrane,membrane,basolateral plasma membrane,apical plasma membrane,AP-2 adaptor complex,clathrin coat of trans-Golgi network vesicle,endocytic vesicle membrane,clathrin-coated endocytic vesicle membrane,filopodium tip,endolysosome membrane",15,46,65,LVEC[CAM]LETVLNK.2|HLC[CAM]ELLAQQF.2|TC[CAM]VSLAVSR.2|EMGEAFAADIPR.2|EM[Oxi]GEAFAADIPR.2|LLGFGSALLDNVDPNPENFVGAGIIQTK.3|LLGFGSALLDNVDPNPENFVGAGIIQTK.4|ANHPMDAEVTK.3|ANHPM[Oxi]DAEVTK.3|ANHPMDAEVTK.2|ANHPM[Oxi]DAEVTK.2|THIDTVINALK.3|THIDTVINALK.2|ATIQGVLR.2|SSPPVQFSLLHSK.3|SSPPVQFSLLHSK.2|DDVQGYAAK.2|AC[CAM]NQLGQFLQHR.3|AC[CAM]NQLGQFLQHR.2|GLAVFISDIRNC[CAM]K.3|ALLLSTYIK.2|ALQVGC[CAM]LLR.2|GRLVEC[CAM]LETVLNK.3|GRLVEC[CAM]LETVLNK.2|QSAALC[CAM]LLR.2|MYLFYGNK.2|M[Oxi]YLFYGNK.2|GPGAGSALDDGR.2|LLQC[CAM]YPPPEDAAVK.3|LLQC[CAM]YPPPEDAAVK.2|NADVELQQR.2|THIDTVINALKTER.3|THIDTVINALKTER.2|FINLFPETK.2|YGGAPQALTLK.2|KGPGAGSALDDGR.2|NNGVLFENQLLQIGVK.3|NNGVLFENQLLQIGVK.2|LLQC[CAM]YPPPEDAAVKGR.3|YLETADYAIR.2|FFQPTEMAAQDFFQR.3|FFQPTEMAAQDFFQR.2|ILVAGDSMDSVK.2|DFLTPPLLSVR.2|VLQIVTNRDDVQGYAAK.3|VLQIVTNRDDVQGYAAK.2|QLSLPQQEAQK.2|AADLLYAMC[CAM]DR.2|TVFEALQAPAC[CAM]HENMVK.3|LEPNAQAQMYR.2|NDLASRNPTFMC[CAM]LALHC[CAM]IANVGSR.4|NPTFMC[CAM]LALHC[CAM]IANVGSR.3|NPTFMC[CAM]LALHC[CAM]IANVGSR.2|VVHLLNDQHMGVVTAAVSLITC[CAM]LC[CAM]K.4|VVHLLNDQHM[Oxi]GVVTAAVSLITC[CAM]LC[CAM]K.4|VVHLLNDQHM[Oxi]GVVTAAVSLITC[CAM]LC[CAM]K.3|TSVQFQNFSPTVVHPGDLQTQLAVQTK.4|TSVQFQNFSPTVVHPGDLQTQLAVQTK.3|ASPDLVPMGEWTAR.2|YLALESMC[CAM]TLASSEFSHEAVK.3|IAGDYVSEEVWYR.2|RVAAQVDGGAQVQQVLNIEC[CAM]LR.3|RVAAQVDGGAQVQQVLNIEC[CAM]LRDFLTPPLLSVR.4|IVSSASTDLQDYTYYFVPAPWLSVK.3|RDPSSNDINGGMEPTPSTVSTPSPSADLLGLR.3
SEN / CTL,Ragulator complex protein LAMTOR3,LAMTOR3,Q9UHA4,0.33,0.46,4.58E-02,1.86E-02,1.73E+00,"MAPK cascade,activation of MAPKK activity,cell cycle arrest,macroautophagy,positive regulation of TOR signaling,cellular protein localization,positive regulation of GTPase activity,cellular response to amino acid stimulus","protein binding,kinase activator activity,guanyl-nucleotide exchange factor activity,protein complex scaffold","lysosomal membrane,focal adhesion,endosome membrane,extracellular exosome,Ragulator complex",6,5,12,ELAPLFEELR.2|VANDNAPEHALRPGFLSTFALATDQGSK.4|VANDNAPEHALRPGFLSTFALATDQGSK.5|VANDNAPEHALRPGFLSTFALATDQGSK.3|KLPSVEGLHAIVVSDR.4|KLPSVEGLHAIVVSDR.3|KLPSVEGLHAIVVSDR.2|KLPSVEGLHAIVVSDRDGVPVIK.5|KLPSVEGLHAIVVSDRDGVPVIK.4|KLPSVEGLHAIVVSDRDGVPVIK.3|SIIC[CAM]YYNTYQVVQFNR.3|SIIC[CAM]YYNTYQVVQFNR.2
SEN / CTL,"2-oxoglutarate dehydrogenase, mitochondrial",OGDH,Q02218,0.33,1.34,3.33E-02,1.43E-02,1.84E+00,"generation of precursor metabolites and energy,glycolytic process,tricarboxylic acid cycle,2-oxoglutarate metabolic process,succinyl-CoA metabolic process,lysine catabolic process,NADH metabolic process,cerebellar cortex development,striatum development,hippocampus development,thalamus development,pyramidal neuron development,tangential migration from the subventricular zone to the olfactory bulb,glyoxylate metabolic process,olfactory bulb mitral cell layer development","oxoglutarate dehydrogenase (succinyl-transferring) activity,thiamine pyrophosphate binding,heat shock protein binding,oxoglutarate dehydrogenase (NAD+) activity,metal ion binding,chaperone binding","mitochondrion,mitochondrial matrix,mitochondrial membrane,oxoglutarate dehydrogenase complex,cytosol",9,77,124,QILLPFR.2|SWDIFFR.2|DMVGQVAITR.2|DM[Oxi]VGQVAITR.2|GRLNVLANVIR.3|GRLNVLANVIR.2|AKPVWYAGRDPAAAPATGNKK.5|AKPVWYAGRDPAAAPATGNKK.4|STRFEEFLQR.3|STRFEEFLQR.2|TKAEQFYC[CAM]GDTEGKK.4|TKAEQFYC[CAM]GDTEGKK.3|TKAEQFYC[CAM]GDTEGKK.2|ARDM[Oxi]VGQVAITR.3|ARDMVGQVAITR.2|HHVLHDQNVDK.3|HHVLHDQNVDK.2|GRLNVLANVIRK.3|LSGQDVER.2|PLIIFTPK.2|STFHKDVVVDLVC[CAM]YR.4|STFHKDVVVDLVC[CAM]YR.3|STFHKDVVVDLVC[CAM]YR.2|VYYDLTR.2|NQGYYDYVKPR.3|NQGYYDYVKPR.2|FEEFLQR.2|QILLPFRKPLIIFTPK.4|HHVLHDQNVDKR.3|IC[CAM]EEAFAR.2|LVEDHLAVQSLIR.3|LVEDHLAVQSLIR.2|THLTELQR.2|DPAAAPATGNK.2|LNVLANVIR.2|AEQFYC[CAM]GDTEGKK.3|AKPVWYAGRDPAAAPATGNK.4|QKFETPGIMQFTNEEKR.4|QKFETPGIMQFTNEEKR.3|RQILLPFRKPLIIFTPK.4|GSLAAVAHAQSLVEAQPNVDK.4|GSLAAVAHAQSLVEAQPNVDK.3|KPLIIFTPK.2|TKAEQFYC[CAM]GDTEGK.3|IEQLSPFPFDLLLK.3|IEQLSPFPFDLLLK.2|SSFDEMLPGTHFQR.3|SSFDEM[Oxi]LPGTHFQR.3|SSFDEMLPGTHFQR.2|SSFDEM[Oxi]LPGTHFQR.2|SSPYPTDVAR.2|VFHLPTTTFIGGQESALPLR.4|VFHLPTTTFIGGQESALPLR.3|VFHLPTTTFIGGQESALPLR.2|VIPEDGPAAQNPENVK.3|VIPEDGPAAQNPENVK.2|EVQKYPNAELAWC[CAM]QEEHK.4|EVQKYPNAELAWC[CAM]QEEHK.3|KTHLTELQR.2|QNGIVLLLPHGMEGMGPEHSSARPER.5|QNGIVLLLPHGMEGMGPEHSSARPER.4|QNGIVLLLPHGMEGMGPEHSSARPER.3|RFGLEGC[CAM]EVLIPALK.3|RFGLEGC[CAM]EVLIPALK.2|YPNAELAWC[CAM]QEEHK.3|YPNAELAWC[CAM]QEEHK.2|GSLAAVAHAQSLVEAQPNVDKLVEDHLAVQSLIR.6|GSLAAVAHAQSLVEAQPNVDKLVEDHLAVQSLIR.5|GSLAAVAHAQSLVEAQPNVDKLVEDHLAVQSLIR.4|LEAADEGSGDVK.2|SSENGVDYVIMGMPHR.3|SSENGVDYVIM[Oxi]GMPHR.3|SSENGVDYVIMGMPHR.2|EVQKYPNAELAWC[CAM]QEEHKNQGYYDYVKPR.6|EVQKYPNAELAWC[CAM]QEEHKNQGYYDYVKPR.5|FETPGIMQFTNEEKR.3|PVWYAGRDPAAAPATGNK.3|VIPEDGPAAQNPENVKR.3|VIPEDGPAAQNPENVKR.2|DVVVDLVC[CAM]YR.2|VVNAPIFHVNSDDPEAVMYVC[CAM]K.4|VVNAPIFHVNSDDPEAVMYVC[CAM]K.3|TVDWALAEYMAFGSLLK.3|TVDWALAEYM[Oxi]AFGSLLK.3|TVDWALAEYMAFGSLLK.2|QKFETPGIMQFTNEEK.3|QKFETPGIMQFTNEEK.2|TVDWALAEYM[Oxi]AFGSLLKEGIHIR.4|NTNAGAPPGTAYQSPLPLSR.3|NTNAGAPPGTAYQSPLPLSR.2|VFHLPTTTFIGGQESALPLREIIR.4|ILHIKHWLDSPWPGFFTLDGQPR.4|ILHIKHWLDSPWPGFFTLDGQPR.3|AEQFYC[CAM]GDTEGK.2|LLDTAFDLDVFK.2|VTDRNITLSLVANPSHLEAADPVVMGK.4|HWLDSPWPGFFTLDGQPR.3|HWLDSPWPGFFTLDGQPR.2|LGFYGLDESDLDK.2|NGHNEMDEPMFTQPLM[Oxi]YK.3|NGHNEMDEPMFTQPLMYK.3|NGHNEMDEPMFTQPLMYK.2|ELEQIFC[CAM]QFDSK.2|FGLEGC[CAM]EVLIPALK.2|SMSC[CAM]PSTGLTEDILTHIGNVASSVPVENFTIHGGLSR.5|SM[Oxi]SC[CAM]PSTGLTEDILTHIGNVASSVPVENFTIHGGLSR.4|SMSC[CAM]PSTGLTEDILTHIGNVASSVPVENFTIHGGLSR.4|WSSEKRFGLEGC[CAM]EVLIPALK.3|GHHVAQLDPLGILDADLDSSVPADIISSTDK.4|GHHVAQLDPLGILDADLDSSVPADIISSTDK.3|NITLSLVANPSHLEAADPVVM[Oxi]GK.3|NITLSLVANPSHLEAADPVVMGK.3|NITLSLVANPSHLEAADPVVMGK.2|FETPGIMQFTNEEK.2|KELEQIFC[CAM]QFDSK.2|YAELLVSQGVVNQPEYEEEISK.3|LLDTAFDLDVFKNFS.2|EANFDINQLYDC[CAM]NWVVVNC[CAM]STPGNFFHVLR.4|ELEQIFC[CAM]QFDSKLEAADEGSGDVK.3|LGFYGLDESDLDKVFHLPTTTFIGGQESALPLR.4|FLQM[Oxi]C[CAM]NDDPDVLPDLK.2|FLQMC[CAM]NDDPDVLPDLK.2|YAELLVSQGVVNQPEYEEEISKYDK.3|YAELLVSQGVVNQPEYEEEISKYDKIC[CAM]EEAFAR.4
SEN / CTL,Lysosome-associated membrane glycoprotein 1,LAMP1,P11279,0.33,0.83,2.34E-02,1.08E-02,1.97E+00,"autophagy,granzyme-mediated apoptotic signaling pathway,positive regulation of natural killer cell degranulation,positive regulation of natural killer cell mediated cytotoxicity,viral entry into host cell,autophagic cell death,protein stabilization,establishment of protein localization to organelle,Golgi to lysosome transport,regulation of organelle transport along microtubule","virus receptor activity,protein binding,enzyme binding,protein domain specific binding","cytoplasm,lysosome,lysosomal membrane,late endosome,multivesicular body,cytosol,plasma membrane,integral component of plasma membrane,synaptic vesicle,external side of plasma membrane,endosome membrane,membrane,dendrite,sarcolemma,melanosome,neuronal cell body,cytolytic granule,perinuclear region of cytoplasm,phagolysosome membrane,extracellular exosome,alveolar lamellar body",24,9,13,FFLQGIQLNTILPDARDPAFK.3|FFLQGIQLNTILPDARDPAFK.4|ALQATVGNSYK.2|TVESITDIR.2|TVESITDIRADIDKK.3|TVESITDIRADIDKK.4|TVESITDIRADIDKK.2|FFLQGIQLNTILPDAR.3|FFLQGIQLNTILPDAR.2|VWVQAFK.2|AFSVNIFK.2|C[CAM]NAEEHVR.2|TVESITDIRADIDK.3
SEN / CTL,Poly [ADP-ribose] polymerase 4,PARP4,Q9UKK3,0.33,1.10,2.59E-03,1.71E-03,2.77E+00,"DNA repair,cellular protein modification process,protein ADP-ribosylation,transport,inflammatory response,cellular response to DNA damage stimulus,cell death,response to drug","DNA binding,NAD+ ADP-ribosyltransferase activity,protein binding,enzyme binding","nucleus,cytoplasm,spindle microtubule,membrane,intracellular ribonucleoprotein complex,extracellular exosome",18,45,55,LGNVRPLLHGSPVQNIVGILC[CAM]R.4|QLLGLQPISTVSPLHR.3|SPVDVLQIFR.2|LLLIC[CAM]DVALGK.2|EVNLGLLAK.2|ISLNDVSKAEGILLLVK.3|YSHPGETDGTR.3|YSHPGETDGTR.2|QIALHALSLVGEK.3|QIALHALSLVGEK.2|AEGILLLVK.2|RTEGQYPSIC[CAM]PR.3|RDENESPFPDIPK.3|NHVHIANPDFIWK.3|NHVHIANPDFIWK.2|IEHVEQNTEEFLR.3|YLSLLYPAR.2|NGETAEQLQK.2|NILLVSDGHLQDESLTLQLVK.4|NILLVSDGHLQDESLTLQLVK.3|VNETTEFLSK.2|QVASFGSAAPPR.2|VEDYQLPDAK.2|ENSLITQFTSFVAVEK.3|ENSLITQFTSFVAVEK.2|LLDLSWTESC[CAM]KPTATEPLFKK.4|VNIIQFGTGYK.2|LFAC[CAM]GIGSTANR.2|LLVYGFIPHC[CAM]TQATLC[CAM]ALIQEK.4|LLVYGFIPHC[CAM]TQATLC[CAM]ALIQEK.3|IIDTVAQVIVFQTYTNK.3|IIDTVAQVIVFQTYTNK.2|VGMEGGQEAVVVELQC[CAM]SR.3|VGMEGGQEAVVVELQC[CAM]SR.2|AGLQDASGNLVPLEDVHIK.3|NYDPYKPLDITPPPDQK.3|LELGNDWDSATK.2|DFHPSDHTELEEYRPEFSNFSK.4|AAVC[CAM]GFEAFINGK.2|ALNENLQDTVEK.2|TTPVDLC[CAM]LLEESVGSLEGSR.3|TSEDASEYFENYIEELKK.3|DC[CAM]PFLISSHFLLDDGMETR.3|DC[CAM]PFLISSHFLLDDGMETR.2|LTPELGLILNLNTNGLHSFLK.3|LLDLSWTESC[CAM]KPTATEPLFK.3|VMGIFANC[CAM]IFC[CAM]LK.2|VM[Oxi]GIFANC[CAM]IFC[CAM]LK.2|LPMASALPEALC[CAM]SQSR.2|ILSQC[CAM]GAGVFEYFNAK.2|C[CAM]KIEHVEQNTEEFLR.2|VSPWETSTSSFFPILAPAVGSYLPPTAR.3|KVSPWETSTSSFFPILAPAVGSYLPPTAR.3|VSELIAKEDVDFLPYMSWQGEPQEAVR.3|FSFSLNPQC[CAM]THIILDNADVLSQYQLNSIQK.3
SEN / CTL,Gamma-enolase,ENO2,P09104,0.33,0.68,2.89E-02,1.28E-02,1.89E+00,"gluconeogenesis,canonical glycolysis","magnesium ion binding,phosphopyruvate hydratase activity","phosphopyruvate hydratase complex,photoreceptor inner segment,extracellular space,cytosol,plasma membrane,perikaryon,myelin sheath,extracellular exosome",39,20,33,VNQIGSVTEAIQAC[CAM]K.2|VNQIGSVTEAIQAC[CAM]K.3|LAMQEFMILPVGAESFR.3|LAMQEFMILPVGAESFR.2|AAVPSGASTGIYEALELRDGDKQR.4|GNPTVEVDLYTAK.2|IEEELGDEAR.2|YITGDQLGALYQDFVR.3|YITGDQLGALYQDFVR.2|DGKYDLDFKSPTDPSR.4|DGKYDLDFKSPTDPSR.3|AVDHINSTIAPALISSGLSVVEQEKLDNLMLELDGTENK.4|FTANVGIQIVGDDLTVTNPK.3|FTANVGIQIVGDDLTVTNPK.2|EAIDKAGYTEK.3|EAIDKAGYTEK.2|AGAAERELPLYR.3|LAQENGWGVMVSHR.3|LAQENGWGVM[Oxi]VSHR.3|LAQENGWGVMVSHR.2|LGAEVYHTLK.2|HIAQLAGNSDLILPVPAFNVINGGSHAGNK.5|HIAQLAGNSDLILPVPAFNVINGGSHAGNK.4|HIAQLAGNSDLILPVPAFNVINGGSHAGNK.3|AVDHINSTIAPALISSGLSVVEQEK.4|AVDHINSTIAPALISSGLSVVEQEK.3|IVIGMDVAASEFYR.2|IVIGM[Oxi]DVAASEFYR.2|LDNLMLELDGTENK.2|LDNLM[Oxi]LELDGTENK.2|DYPVVSIEDPFDQDDWAAWSK.3|DATNVGDEGGFAPNILENSEALELVK.3|EILDSRGNPTVEVDLYTAK.2
SEN / CTL,Laminin subunit gamma-2,LAMC2,Q13753,0.32,1.05,1.39E-01,4.60E-02,1.34E+00,"cell adhesion,positive regulation of cell proliferation,epidermis development,extracellular matrix disassembly,extracellular matrix organization,positive regulation of cell migration,hemidesmosome assembly",heparin binding,"extracellular region,laminin-2 complex,extracellular space,cell cortex,membrane,perinuclear region of cytoplasm",27,14,15,LDPVYFVAPAK.2|GGRHPSAHDVILEGAGLR.4|AQGGDGVVPDTELEGR.2|GHLHLLETSIDGILADVK.4|GHLHLLETSIDGILADVK.3|AGYFGDPLAPNPADK.2|NLGNWKEEAQQLLQNGK.3|EATQAEIEADR.2|LQGVSDQSFQVEEAK.2|KAEAEEAMK.2|ALGSAAADAQR.2|HQDVFSSAQR.2|TQINSQLRPMMSELEER.3|ALHEGVGSGSGSPDGAVVQGLVEK.3|PGFGGPNC[CAM]EHGAFSC[CAM]PAC[CAM]YNQVK.3
SEN / CTL,Ubiquitin-fold modifier-conjugating enzyme 1,UFC1,Q9Y3C8,0.32,0.70,1.04E-01,3.68E-02,1.43E+00,"response to endoplasmic reticulum stress,protein ufmylation,protein K69-linked ufmylation","protein binding,UFM1 transferase activity","cytoplasm,extracellular exosome",6,5,8,IC[CAM]LTDHFKPLWAR.3|IC[CAM]LTDHFKPLWAR.4|C[CAM]WYIHDLLK.3|C[CAM]WYIHDLLK.2|LKEEYQSLIR.3|LKEEYQSLIR.2|VVSEIPVLK.2|DRELWVQR.2
SEN / CTL,Target of Myb protein 1,TOM1,O60784,0.32,0.18,1.69E-02,8.18E-03,2.09E+00,"intracellular protein transport,endocytosis,protein transport,endosomal transport","protein binding,clathrin binding","cytoplasm,endosome,early endosome,cytosol,membrane,extracellular exosome",6,20,27,LRSELEMVSGNVR.3|LRSELEMVSGNVR.2|VLNLIQSWADAFR.2|VLNLIQSWADAFR.3|DDDMLFAL.2|GVTSEEFDK.2|AGLQSLEASGR.2|GVTSEEFDKFLEER.3|NNPPTIVHDK.2|KGLEFPMTDLDMLSPIHTPQR.4|SELEMVSGNVR.2|AADRLPNLSSPSAEGPPGPPSGPAPR.4|AADRLPNLSSPSAEGPPGPPSGPAPR.3|FHVLVASQDFVESVLVR.3|NFHEVMLALTVLETC[CAM]VK.3|NFHEVM[Oxi]LALTVLETC[CAM]VK.3|NFHEVMLALTVLETC[CAM]VK.2|EVKYEAPQATDGLAGALDAR.3|LEDEFDMFALTR.2|GLEFPMTDLDMLSPIHTPQR.3|GLEFPMTDLDMLSPIHTPQR.2|VMSEMLTELVPTQAEPADLELLQELNR.4|VMSEMLTELVPTQAEPADLELLQELNR.3|YEAPQATDGLAGALDAR.2|SSPDLTGVVTIYEDLR.2|QQSTGAIPVTQAC[CAM]LMEDIEQWLSTDVGNDAEEPK.4|APSEAEPAADLIDMGPDPAATGNLSSQLAGMNLGSSSVR.4
SEN / CTL,Ragulator complex protein LAMTOR5,LAMTOR5,O43504,0.32,0.12,6.22E-02,2.41E-02,1.62E+00,"cell cycle arrest,regulation of cell size,response to virus,macroautophagy,viral genome replication,positive regulation of TOR signaling,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,positive regulation of GTPase activity,protein localization to lysosome,cellular response to amino acid stimulus","protein binding,guanyl-nucleotide exchange factor activity,protein complex scaffold","lysosome,lysosomal membrane,cytosol,Ragulator complex",3,4,6,GTLSDEHAGVISVLAQQAAK.3|GTLSDEHAGVISVLAQQAAK.2|HDGITVAVHK.2|NPSIVGVLC[CAM]TDSQGLNLGC[CAM]R.3|NPSIVGVLC[CAM]TDSQGLNLGC[CAM]R.2|LTSDPTDIPVVC[CAM]LESDNGNIMIQK.3
SEN / CTL,Adenylyl cyclase-associated protein 1,CAP1,Q01518,0.32,0.63,3.70E-07,6.75E-07,6.17E+00,"cell morphogenesis,ameboidal-type cell migration,receptor-mediated endocytosis,establishment or maintenance of cell polarity,signal transduction,activation of adenylate cyclase activity,actin polymerization or depolymerization","actin binding,adenylate cyclase binding","plasma membrane,focal adhesion,cortical actin cytoskeleton,extracellular exosome",63,51,99,C[CAM]VNTTLQIK.2|NSLDC[CAM]EIVSAK.2|LSDLLAPISEQIKEVITFR.3|LVTTVTEIAG.2|LGLVFDDVVGIVEIINSKDVK.3|AGAAPYVQAFDSLLAGPVAEYLK.3|AGAAPYVQAFDSLLAGPVAEYLK.2|AGAAPYVQAFDSLLAGPVAEYLK.4|LGLVFDDVVGIVEIINSK.3|LGLVFDDVVGIVEIINSK.2|VPTISINKTDGC[CAM]HAYLSK.4|VPTISINKTDGC[CAM]HAYLSK.3|SSEMNVLIPTEGGDFNEFPVPEQFK.3|SSEMNVLIPTEGGDFNEFPVPEQFK.4|SSEM[Oxi]NVLIPTEGGDFNEFPVPEQFK.3|KLGLVFDDVVGIVEIINSK.3|KLGLVFDDVVGIVEIINSK.4|KLGLVFDDVVGIVEIINSK.2|KLGLVFDDVVGIVEIINSKDVK.4|KLGLVFDDVVGIVEIINSKDVK.3|ALLVTASQC[CAM]QQPAENKLSDLLAPISEQIKEVITFR.4|LFNHLSAVSESIQALGWVAMAPKPGPYVK.4|LFNHLSAVSESIQALGWVAMAPKPGPYVK.5|LFNHLSAVSESIQALGWVAM[Oxi]APKPGPYVK.5|LFNHLSAVSESIQALGWVAM[Oxi]APKPGPYVK.4|LFNHLSAVSESIQALGWVAM[Oxi]APKPGPYVK.3|LFNHLSAVSESIQALGWVAMAPKPGPYVK.3|TLWNGQK.2|GYADSPSK.2|EMNDAAMFYTNR.2|EMNDAAMFYTNR.3|EM[Oxi]NDAAMFYTNR.3|EMNDAAM[Oxi]FYTNR.3|EM[Oxi]NDAAMFYTNR.2|EMNDAAM[Oxi]FYTNR.2|EM[Oxi]NDAAM[Oxi]FYTNR.2|LSDLLAPISEQIK.2|LSDLLAPISEQIK.3|ALLVTASQC[CAM]QQPAENK.3|ALLVTASQC[CAM]QQPAENK.4|ALLVTASQC[CAM]QQPAENK.2|SGPKPFSAPKPQTSPSPK.4|SGPKPFSAPKPQTSPSPK.3|EPAVLELEGKK.3|KEPAVLELEGK.3|KEPAVLELEGK.2|HVSDDMK.2|EFHTTGLAWSK.3|EFHTTGLAWSK.2|EIGGDVQK.2|INSITVDNC[CAM]KK.3|INSITVDNC[CAM]KK.2|AVGRLEAVSHTSDMHR.4|AVGRLEAVSHTSDM[Oxi]HR.3|AVGRLEAVSHTSDMHR.3|QVAYIYK.2|GKINSITVDNC[CAM]K.3|GKINSITVDNC[CAM]K.2|KEPAVLELEGKK.3|KEPAVLELEGKK.2|KHVDWVK.2|LEAVSHTSDMHR.3|LEAVSHTSDM[Oxi]HR.3|LEAVSHTSDMHR.2|LEAVSHTSDM[Oxi]HR.2|PFSAPKPQTSPSPK.3|GKINSITVDNC[CAM]KK.3|GKINSITVDNC[CAM]KK.2|ATKKEPAVLELEGK.3|ATKKEPAVLELEGK.2|HAEMVHTGLKLER.3|VENQENVSNLVIEDTELK.4|VENQENVSNLVIEDTELK.3|VENQENVSNLVIEDTELK.2|EPAVLELEGK.2|HAEMVHTGLK.2|HAEM[Oxi]VHTGLK.2|TDGC[CAM]HAYLSK.2|INSITVDNC[CAM]K.2|ISKEIGGDVQK.2|LSDLLAPISEQIKEVITFREK.4|WRVENQENVSNLVIEDTELK.4|WRVENQENVSNLVIEDTELK.3|NRGSKLFNHLSAVSESIQALGWVAMAPKPGPYVK.6|NRGSKLFNHLSAVSESIQALGWVAMAPKPGPYVK.5|NRGSKLFNHLSAVSESIQALGWVAMAPKPGPYVK.4|LFNHLSAVSESIQALGWVAM[Oxi]APK.4|LFNHLSAVSESIQALGWVAMAPK.4|LFNHLSAVSESIQALGWVAM[Oxi]APK.3|LFNHLSAVSESIQALGWVAMAPK.3|KWRVENQENVSNLVIEDTELK.4|KWRVENQENVSNLVIEDTELK.3|EIGGDVQKHAEMVHTGLK.3|SSLFAQINQGESITHALK.3|SSLFAQINQGESITHALK.2|ALLVTASQC[CAM]QQPAENKLSDLLAPISEQIK.4|ALLVTASQC[CAM]QQPAENKLSDLLAPISEQIK.3|GSKLFNHLSAVSESIQALGWVAMAPKPGPYVK.4|AYLSIWTELQAYIK.2
SEN / CTL,Phosphoglycerate kinase 1,PGK1,P00558,0.32,0.66,1.03E-06,1.71E-06,5.77E+00,"gluconeogenesis,phosphorylation,epithelial cell differentiation,canonical glycolysis","phosphoglycerate kinase activity,ATP binding","cytosol,membrane,membrane raft,extracellular exosome",162,59,126,AC[CAM]ANPAAGSVILLENLR.3|AC[CAM]ANPAAGSVILLENLR.2|GC[CAM]ITIIGGGDTATC[CAM]C[CAM]AK.2|GC[CAM]ITIIGGGDTATC[CAM]C[CAM]AK.3|WNTEDKVSHVSTGGGASLELLEGK.4|WNTEDKVSHVSTGGGASLELLEGK.3|VLPGVDALSNI.2|SLLGKDVLFLK.3|SLLGKDVLFLK.2|ELNYFAK.2|DVLFLKDC[CAM]VGPEVEK.3|DVLFLKDC[CAM]VGPEVEK.2|LTLDKLDVK.2|VLNNMEIGTSLFDEEGAKIVKDLMSK.4|FC[CAM]LDNGAK.2|ALESPERPFLAILGGAK.3|ALESPERPFLAILGGAK.2|ALESPERPFLAILGGAK.4|LGDVYVNDAFGTAHR.3|LGDVYVNDAFGTAHR.2|LGDVYVNDAFGTAHR.4|SLLGKDVLFLKDC[CAM]VGPEVEK.4|SLLGKDVLFLKDC[CAM]VGPEVEK.3|SLLGKDVLFLKDC[CAM]VGPEVEK.2|VLNNMEIGTSLFDEEGAK.3|VLNNMEIGTSLFDEEGAK.2|VLNNM[Oxi]EIGTSLFDEEGAK.3|VLNNM[Oxi]EIGTSLFDEEGAK.2|VDFNVPMKNNQITNNQR.3|VDFNVPM[Oxi]KNNQITNNQR.3|VDFNVPMKNNQITNNQR.2|VDFNVPM[Oxi]KNNQITNNQR.2|QIVWNGPVGVFEWEAFAR.3|QIVWNGPVGVFEWEAFAR.2|TGQATVASGIPAGWMGLDC[CAM]GPESSKK.3|TGQATVASGIPAGWMGLDC[CAM]GPESSKK.4|TGQATVASGIPAGWM[Oxi]GLDC[CAM]GPESSKK.3|ITLPVDFVTADKFDENAK.3|ITLPVDFVTADKFDENAK.2|ITLPVDFVTADKFDENAK.4|AAVPSIKFC[CAM]LDNGAK.3|AAVPSIKFC[CAM]LDNGAK.2|SVVLMSHLGRPDGVPMPDKYSLEPVAVELK.5|SVVLMSHLGRPDGVPMPDKYSLEPVAVELK.4|SVVLMSHLGRPDGVPM[Oxi]PDKYSLEPVAVELK.5|SVVLM[Oxi]SHLGRPDGVPMPDKYSLEPVAVELK.5|SVVLM[Oxi]SHLGRPDGVPM[Oxi]PDKYSLEPVAVELK.5|SVVLMSHLGRPDGVPMPDKYSLEPVAVELK.6|SVVLM[Oxi]SHLGRPDGVPMPDKYSLEPVAVELK.4|SVVLMSHLGRPDGVPM[Oxi]PDKYSLEPVAVELK.4|SVVLMSHLGRPDGVPMPDKYSLEPVAVELK.3|AKQIVWNGPVGVFEWEAFAR.3|AKQIVWNGPVGVFEWEAFAR.4|AKQIVWNGPVGVFEWEAFAR.2|VADKIQLINNMLDKVNEM[Oxi]IIGGGMAFTFLK.4|VADKIQLINNMLDKVNEM[Oxi]IIGGGM[Oxi]AFTFLK.4|VADKIQLINNMLDKVNEMIIGGGM[Oxi]AFTFLK.4|VKAEPAKIEAFR.3|VKAEPAKIEAFR.2|AHSSMVGVNLPQK.3|AHSSMVGVNLPQK.2|AHSSM[Oxi]VGVNLPQK.3|AHSSM[Oxi]VGVNLPQK.2|TGQATVASGIPAGWMGLDC[CAM]GPESSK.3|TGQATVASGIPAGWMGLDC[CAM]GPESSK.4|TGQATVASGIPAGWM[Oxi]GLDC[CAM]GPESSK.3|VDFNVPMK.2|VDFNVPM[Oxi]K.2|VDFNVPMK.1|AEPAKIEAFR.2|ALMDEVVKATSR.3|ALM[Oxi]DEVVKATSR.3|ALM[Oxi]DEVVKATSR.2|ALMDEVVK.2|ALM[Oxi]DEVVK.2|YSLEPVAVELK.2|IKAAVPSIKFC[CAM]LDNGAK.4|IKAAVPSIKFC[CAM]LDNGAK.3|IKAAVPSIK.2|VSHVSTGGGASLELLEGK.3|VSHVSTGGGASLELLEGK.4|VSHVSTGGGASLELLEGK.2|VADKIQLINNMLDK.3|VADKIQLINNMLDK.2|YAEAVTR.2|AGGFLMKK.2|AGGFLMKKELNYFAK.4|AGGFLM[Oxi]KKELNYFAK.3|AGGFLMKKELNYFAK.2|FHVEEEGKGKDASGNK.4|FHVEEEGKGKDASGNK.3|KYAEAVTR.2|PDGVPMPDK.2|FHVEEEGK.2|PFLAILGGAK.2|KELNYFAK.2|SVVLMSHLGRPDGVPMPDK.4|SVVLM[Oxi]SHLGRPDGVPM[Oxi]PDK.4|SVVLM[Oxi]SHLGRPDGVPMPDK.4|SVVLMSHLGRPDGVPM[Oxi]PDK.4|SVVLM[Oxi]SHLGRPDGVPMPDK.3|SVVLMSHLGRPDGVPM[Oxi]PDK.3|SVVLMSHLGRPDGVPMPDK.3|SVVLMSHLGRPDGVPMPDK.2|DC[CAM]VGPEVEK.2|ASLSKLGDVYVNDAFGTAHR.4|AEPAKIEAFRASLSK.3|NNQITNNQR.2|FHVEEEGKGK.2|VNEMIIGGGMAFTFLK.3|VNEM[Oxi]IIGGGMAFTFLK.3|VNEMIIGGGM[Oxi]AFTFLK.3|VNEMIIGGGMAFTFLK.2|VNEM[Oxi]IIGGGM[Oxi]AFTFLK.2|VNEM[Oxi]IIGGGMAFTFLK.2|VNEMIIGGGM[Oxi]AFTFLK.2|AC[CAM]ANPAAGSVILLENLRFHVEEEGKGK.5|LGDVYVNDAFGTAHRAHSSM[Oxi]VGVNLPQK.5|IQLINNMLDK.2|IQLINNM[Oxi]LDK.2|NGVKITLPVDFVTADKFDENAK.4|VVM[Oxi]RVDFNVPM[Oxi]KNNQITNNQR.4|AKQIVWNGPVGVFEWEAFARGTK.4|ITLPVDFVTADK.2|QIVWNGPVGVFEWEAFARGTK.3|WNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI.4
SEN / CTL,Prolyl 4-hydroxylase subunit alpha-1,P4HA1,P13674,0.31,0.37,3.79E-03,2.40E-03,2.62E+00,"peptidyl-proline hydroxylation to 4-hydroxy-L-proline,collagen fibril organization,oxidation-reduction process","procollagen-proline 4-dioxygenase activity,iron ion binding,protein binding,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,L-ascorbic acid binding","mitochondrion,endoplasmic reticulum,endoplasmic reticulum lumen,membrane,procollagen-proline 4-dioxygenase complex,intracellular membrane-bounded organelle",24,32,47,LTSTATKDPEGFVGHPVNAFK.4|LTSTATKDPEGFVGHPVNAFK.3|SAWLSGYENPVVSR.2|SAWLSGYENPVVSR.3|FILAPAKQEDEWDKPR.4|FILAPAKQEDEWDKPR.3|FHDIISDAEIEIVKDLAKPR.4|FHDIISDAEIEIVKDLAKPR.3|FHDIISDAEIEIVK.3|FHDIISDAEIEIVK.2|SFLTAEDC[CAM]FELGK.2|LQDTYNLDTDTISK.2|QEDEWDKPR.3|LLELDPEHQR.3|LLELDPEHQR.2|AEEDKLEQIKK.3|KKGVAVDYLPER.3|KLLELDPEHQR.3|KLLELDPEHQR.2|KDEPDAFK.2|SASDDQSDQKTTPK.3|DPEGFVGHPVNAFK.3|DPEGFVGHPVNAFK.2|RATISNPITGDLETVHYR.4|RATISNPITGDLETVHYR.3|LDRLTSTATKDPEGFVGHPVNAFK.5|LDRLTSTATKDPEGFVGHPVNAFK.4|RPC[CAM]TLSELE.2|GVAVDYLPER.2|KDEPDAFKELGTGNR.3|KDEPDAFKELGTGNR.2|LNTEWSELENLVLK.3|LNTEWSELENLVLK.2|HAAC[CAM]PVLVGNK.2|RLNTEWSELENLVLK.3|RLNTEWSELENLVLK.2|ATISNPITGDLETVHYR.3|ATISNPITGDLETVHYR.2|DLVTSLKDYIK.2|QLDEGEISTIDK.2|FHDIISDAEIEIVKDLAK.3|VSVLDYLSYAVYQQGDLDK.3|VSVLDYLSYAVYQQGDLDK.2|KGTAVFWYNLFASGEGDYSTR.3|QYFPNDEDQVGAAK.2|VAYTEADYYHTELWMEQALR.3|IQDLTGLDVSTAEELQVANYGVGGQYEPHFDFAR.4
SEN / CTL,Ras-related protein Rab-2A,RAB2A,P61019,0.31,0.75,2.76E-02,1.24E-02,1.91E+00,"Golgi organization,small GTPase mediated signal transduction,protein transport,ER to Golgi vesicle-mediated transport","GTPase activity,protein binding,GTP binding,GDP binding","Golgi membrane,nucleus,lysosomal membrane,endoplasmic reticulum membrane,endoplasmic reticulum-Golgi intermediate compartment membrane,melanosome,extracellular exosome",12,17,32,LQIWDTAGQESFR.2|LQIWDTAGQESFR.3|GAAGALLVYDITRR.3|GAAGALLVYDITRR.2|DTFNHLTTWLEDAR.3|DTFNHLTTWLEDAR.2|SC[CAM]LLLQFTDKR.3|SC[CAM]LLLQFTDKR.2|GAAGALLVYDITR.3|GAAGALLVYDITR.2|EHGLIFMETSAK.3|EHGLIFM[Oxi]ETSAK.3|EHGLIFMETSAK.2|EHGLIFM[Oxi]ETSAK.2|EVKKEEGEAFAR.3|RDTFNHLTTWLEDAR.4|RDTFNHLTTWLEDAR.3|RDTFNHLTTWLEDAR.2|RFQPVHDLTIGVEFGAR.4|RFQPVHDLTIGVEFGAR.3|TASNVEEAFINTAK.3|TASNVEEAFINTAK.2|KEEGEAFAR.2|QHSNSNMVIMLIGNK.3|QHSNSNMVIMLIGNK.2|YIIIGDTGVGK.2|IQEGVFDINNEANGIK.3|IQEGVFDINNEANGIK.2|FQPVHDLTIGVEFGAR.3|FQPVHDLTIGVEFGAR.2|SC[CAM]LLLQFTDK.2|TASNVEEAFINTAKEIYEK.3
SEN / CTL,Cytosol aminopeptidase,LAP3,P28838,0.31,0.46,1.09E-01,3.80E-02,1.42E+00,proteolysis,"aminopeptidase activity,metalloexopeptidase activity,manganese ion binding","nucleus,nucleoplasm,cytoplasm,mitochondrion,trans-Golgi network,focal adhesion,extracellular exosome",15,44,80,GITFDSGGISIK.2|TLIEFLLR.2|LNLPINIIGLAPLC[CAM]ENMPSGK.3|LNLPINIIGLAPLC[CAM]ENM[Oxi]PSGK.3|LNLPINIIGLAPLC[CAM]ENM[Oxi]PSGK.2|LNLPINIIGLAPLC[CAM]ENMPSGK.2|LILADALC[CAM]YAHTFNPK.3|LILADALC[CAM]YAHTFNPK.4|LILADALC[CAM]YAHTFNPK.2|QVVDC[CAM]QLADVNNIGK.2|QVVDC[CAM]QLADVNNIGK.3|FAEIIEK.2|KAAGIDEQENWHEGK.4|KAAGIDEQENWHEGK.3|EFVTHPK.2|TIQVDNTDAEGR.3|TIQVDNTDAEGR.2|GLVLGIYSK.2|ANKPGDVVR.2|LRETLNISGPPLK.3|LRETLNISGPPLK.2|TEVHIRPK.2|WAHLDIAGVMTNK.3|WAHLDIAGVMTNK.2|TRTFYGLHQDFPSVVLVGLGKK.5|TRTFYGLHQDFPSVVLVGLGKK.4|WAHLDIAGVMTNKDEVPYLRK.5|WAHLDIAGVMTNKDEVPYLRK.4|WAHLDIAGVM[Oxi]TNKDEVPYLRK.4|WAHLDIAGVMTNKDEVPYLRK.3|SAGAC[CAM]TAAAFLKEFVTHPK.4|ASANMDLMR.2|ASANM[Oxi]DLMR.2|ASANMDLM[Oxi]R.2|GSPNANEPPLVFVGK.3|GSPNANEPPLVFVGK.2|AAGIDEQENWHEGKENIR.4|AAGIDEQENWHEGKENIR.3|AAGIDEQENWHEGKENIR.2|TFYGLHQDFPSVVLVGLGK.4|TFYGLHQDFPSVVLVGLGK.3|TFYGLHQDFPSVVLVGLGK.2|AAGIDEQENWHEGK.3|AAGIDEQENWHEGK.2|GSDEPPVFLEIHYK.3|GSDEPPVFLEIHYK.2|QLMETPANEMTPTR.3|QLM[Oxi]ETPANEMTPTR.2|QLMETPANEM[Oxi]TPTR.2|QLMETPANEMTPTR.2|TFYGLHQDFPSVVLVGLGKK.4|TFYGLHQDFPSVVLVGLGKK.3|KAAGIDEQENWHEGKENIR.4|ADMGGAATIC[CAM]SAIVSAAK.3|ADMGGAATIC[CAM]SAIVSAAK.2|ADM[Oxi]GGAATIC[CAM]SAIVSAAK.2|ETLNISGPPLK.2|SAGAC[CAM]TAAAFLK.2|TRTFYGLHQDFPSVVLVGLGK.4|TRTFYGLHQDFPSVVLVGLGK.3|WAHLDIAGVM[Oxi]TNKDEVPYLR.4|WAHLDIAGVMTNKDEVPYLR.4|WAHLDIAGVMTNKDEVPYLR.3|SWIEEQAMGSFLSVAK.3|SWIEEQAMGSFLSVAK.2|MPLFEHYTR.2|GVLFASGQNLAR.2|LFEASIETGDR.2|TIQVDNTDAEGRLILADALC[CAM]YAHTFNPK.5|TIQVDNTDAEGRLILADALC[CAM]YAHTFNPK.4|EKEDDVPQFTSAGENFDKLLAGK.4|EKEDDVPQFTSAGENFDKLLAGK.3|QVVDC[CAM]QLADVNNIGKYR.3|EKEDDVPQFTSAGENFDK.3|EKEDDVPQFTSAGENFDK.2|LYGSGDQEAWQK.2|LYGSGDQEAWQKGVLFASGQNLAR.3|EDDVPQFTSAGENFDK.2|QIQDLELSSVEVDPC[CAM]GDAQAAAEGAVLGLYEYDDLK.4|VILNAATLTGAMDVALGSGATGVFTNSSWLWNK.3
SEN / CTL,Cystatin-B,CSTB,P04080,0.31,0.35,1.75E-02,8.42E-03,2.07E+00,"adult locomotory behavior,negative regulation of peptidase activity,negative regulation of endopeptidase activity,negative regulation of proteolysis","protease binding,endopeptidase inhibitor activity,cysteine-type endopeptidase inhibitor activity,poly(A) RNA binding","extracellular space,nucleolus,cytoplasm,extracellular exosome",15,8,11,VHVGDEDFVHLR.3|VHVGDEDFVHLR.2|VFQSLPHENKPLTLSNYQTNK.4|VFQSLPHENKPLTLSNYQTNK.3|SQVVAGTNYFIK.2|SQVVAGTNYFIK.3|HDELTYF.2|AKHDELTYF.2|VFQSLPHENK.2|PLTLSNYQTNK.2|MC[CAM]GAPSATQPATAETQHIADQVR.3
SEN / CTL,Actin-related protein 2/3 complex subunit 2,ARPC2,O15144,0.31,0.66,3.26E-05,3.60E-05,4.44E+00,"movement of cell or subcellular component,positive regulation of lamellipodium assembly,Arp2/3 complex-mediated actin nucleation,Fc-gamma receptor signaling pathway involved in phagocytosis,ephrin receptor signaling pathway,positive regulation of substrate adhesion-dependent cell spreading","structural constituent of cytoskeleton,protein binding,actin filament binding","cytoplasm,endosome,Golgi apparatus,cytosol,Arp2/3 protein complex,focal adhesion,actin cytoskeleton,cell leading edge,muscle cell projection membrane,neuron projection,synapse,extracellular exosome",33,36,60,ASHTAPQVLFSHREPPLELKDTDAAVGDNIGYITFVLFPR.5|ASHTAPQVLFSHREPPLELKDTDAAVGDNIGYITFVLFPR.6|VYGSFLVNPESGYNVSLLYDLENLPASKDSIVHQAGMLKR.5|IIEETLALK.2|YFQFQEEGKEGENR.3|YFQFQEEGKEGENR.2|AVIHYRDDETMYVESK.4|AVIHYRDDETMYVESK.3|AVIHYRDDETM[Oxi]YVESK.4|AVIHYRDDETM[Oxi]YVESK.3|DNTINLIHTFR.3|DNTINLIHTFR.2|MILLEVNNR.2|M[Oxi]ILLEVNNR.2|FYKELQAHGADELLKR.3|DSIVHQAGMLK.3|DSIVHQAGMLK.2|DSIVHQAGM[Oxi]LK.2|RASHTAPQVLFSHR.4|RNC[CAM]FASVFEK.3|RNC[CAM]FASVFEK.2|ELQAHGADELLK.3|ELQAHGADELLK.2|DDETMYVESKK.3|VM[Oxi]VSISLK.2|ASHTAPQVLFSHREPPLELK.5|ASHTAPQVLFSHREPPLELK.4|ASHTAPQVLFSHREPPLELK.3|ASHTAPQVLFSHREPPLELK.2|DSIVHQAGMLKR.3|DSIVHQAGMLKR.2|VFMQEFK.2|ASHTAPQVLFSHR.3|ASHTAPQVLFSHR.2|RASHTAPQVLFSHREPPLELK.5|DDDDVVIGK.2|ELQAHGADELLKR.3|ELQAHGADELLKR.2|AVIHYRDDETMYVESKK.4|AVIHYRDDETMYVESKK.3|DYLHYHIK.2|NC[CAM]FASVFEK.2|VTVVFSTVFK.2|YFQFQEEGK.2|DNTINLIHTFRDYLHYHIK.4|DDETMYVESK.2|DDETM[Oxi]YVESK.2|VTVVFSTVFKDDDDVVIGK.3|NC[CAM]FASVFEKYFQFQEEGKEGENR.4|NC[CAM]FASVFEKYFQFQEEGKEGENR.3|DTDAAVGDNIGYITFVLFPR.3|DTDAAVGDNIGYITFVLFPR.2|FENAAAGNKPEAVEVTFADFDGVLYHISNPNGDK.5|FENAAAGNKPEAVEVTFADFDGVLYHISNPNGDK.4|FENAAAGNKPEAVEVTFADFDGVLYHISNPNGDKTK.5|FENAAAGNKPEAVEVTFADFDGVLYHISNPNGDKTK.4|RVYGSFLVNPESGYNVSLLYDLENLPASK.4|RVYGSFLVNPESGYNVSLLYDLENLPASK.3|EPPLELKDTDAAVGDNIGYITFVLFPR.3|VYGSFLVNPESGYNVSLLYDLENLPASK.3
SEN / CTL,Annexin A7,ANXA7,P20073,0.31,0.31,9.05E-05,9.08E-05,4.04E+00,"cellular calcium ion homeostasis,autophagy,hemostasis,cell proliferation,regulation of cell shape,response to salt stress,cellular water homeostasis,negative regulation of gene expression,response to organic cyclic compound,epithelial cell differentiation,social behavior,response to calcium ion,membrane fusion","integrin binding,calcium ion binding,protein binding,calcium-dependent phospholipid binding,poly(A) RNA binding,calcium-dependent protein binding","nucleus,nuclear envelope,endoplasmic reticulum membrane,cytosol,plasma membrane,membrane,extracellular exosome,chromaffin granule membrane",30,23,33,VLIEILC[CAM]TR.2|EFSGYVESGLK.2|GFGTDEQAIVDVVANR.3|GFGTDEQAIVDVVANR.2|SEIDLVQIK.2|TLGTMIAGDTSGDYRR.3|LGTDESC[CAM]FNMILATR.2|LGTDESC[CAM]FNM[Oxi]ILATR.2|LLVSM[Oxi]C[CAM]QGNRDENQSINHQMAQEDAQR.4|LLVSMC[CAM]QGNRDENQSINHQMAQEDAQR.4|LLVSMC[CAM]QGNRDENQSINHQM[Oxi]AQEDAQR.4|LLVSMC[CAM]QGNRDENQSINHQMAQEDAQR.3|TILQC[CAM]ALNRPAFFAER.3|TILQC[CAM]ALNRPAFFAER.4|TILQC[CAM]ALNRPAFFAER.2|LLLAIVGQ.2|DLLSSVSR.2|LYQAGEGR.2|PAANFDAIRDAEILRK.4|ATMEAYSR.2|PAANFDAIR.2|AMQGAGTQER.2|C[CAM]YQSEFGR.2|SDTSGHFER.2|GAGTDDSTLVR.2|QMFAQMYQK.2|QM[Oxi]FAQMYQK.2|QMFAQM[Oxi]YQK.2|LLVSMC[CAM]QGNR.2|LLVSM[Oxi]C[CAM]QGNR.2|DENQSINHQMAQEDAQR.3|C[CAM]YQSEFGRDLEK.2|TLGTMIAGDTSGDYR.2
SEN / CTL,Programmed cell death 6-interacting protein,PDCD6IP,Q8WUM4,0.31,0.35,2.87E-06,4.25E-06,5.37E+00,"cell separation after cytokinesis,apoptotic process,regulation of centrosome duplication,protein transport,viral life cycle,multivesicular body assembly,viral budding via host ESCRT complex,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,positive regulation of exosomal secretion,regulation of extracellular exosome assembly,positive regulation of extracellular exosome assembly,nucleus organization,mitotic metaphase plate congression,regulation of mitotic spindle assembly","protein binding,proteinase activated receptor binding,protein homodimerization activity,calcium-dependent protein binding","immunological synapse,cytoplasm,microtubule organizing center,cytosol,focal adhesion,membrane,melanosome,myelin sheath,extracellular exosome,endoplasmic reticulum exit site,extracellular vesicle",54,63,96,FYNELTEILVR.2|LANQAADYFGDAFK.2|FIQQTYPSGGEEQAQYC[CAM]R.3|FIQQTYPSGGEEQAQYC[CAM]R.2|TMQGSEVVNVLK.2|TM[Oxi]QGSEVVNVLK.2|MVPVSVQQSLAAYNQR.3|MVPVSVQQSLAAYNQR.2|M[Oxi]VPVSVQQSLAAYNQR.3|M[Oxi]VPVSVQQSLAAYNQR.2|AAVGRPLDKHEGALETLLR.4|AAVGRPLDKHEGALETLLR.3|NLATAYDNFVELVANLK.3|NLATAYDNFVELVANLK.2|YYDQIC[CAM]SIEPK.2|SVIEQGGIQTVDQLIKELPELLQR.4|SVIEQGGIQTVDQLIKELPELLQR.3|DAFDKGSLFGGSVK.3|DAFDKGSLFGGSVK.2|STPVNVPISQK.2|LALASLGYEK.2|HC[CAM]IMQANAEYHQSILAK.4|HC[CAM]IM[Oxi]QANAEYHQSILAK.3|HC[CAM]IMQANAEYHQSILAK.3|TPSNELYKPLRAEGTNFR.4|TPSNELYKPLRAEGTNFR.3|HYQFASGAFLHIK.3|HYQFASGAFLHIK.2|EREGLENDLK.3|EREGLENDLK.2|NREILDESLR.3|NREILDESLR.2|SLLSNLDEVKK.3|SLLSNLDEVKK.2|TSEVDLAK.2|TSEVDLAKPLVK.3|TSEVDLAKPLVK.2|KDNDFIYHDR.3|KDNDFIYHDR.2|NIQVSHQEFSK.3|NIQVSHQEFSK.2|TPSNELYKPLR.3|TPSNELYKPLR.2|FTDLFEK.2|AAVGRPLDK.2|AVQADGQVK.2|DLQQSIAR.2|EGLENDLK.2|KDNDFIYHDRVPDLK.4|KFGEEIAR.2|TPSNELYK.2|C[CAM]SDIVFAR.2|EILDESLR.2|ETVLSALSR.2|EVFPVLAAK.2|KTSEVDLAK.2|LLDEEEATDNDLR.3|LLDEEEATDNDLR.2|LQHAAELIK.2|SLLSNLDEVKKER.3|SVNFDMTSK.2|YDEYVNVK.2|QSNNEANLREEVLK.3|QSNNEANLREEVLK.2|SLLSNLDEVK.2|HEGALETLLR.2|LLDEEEATDNDLRAK.3|LLDEEEATDNDLRAK.2|SVIEQGGIQTVDQLIK.3|SVIEQGGIQTVDQLIK.2|EPSAPSIPTPAYQSSPAGGHAPTPPTPAPR.5|EPSAPSIPTPAYQSSPAGGHAPTPPTPAPR.4|EPSAPSIPTPAYQSSPAGGHAPTPPTPAPR.3|TM[Oxi]PPTKPQPPARPPPPVLPANR.4|TMPPTKPQPPARPPPPVLPANR.4|DNDFIYHDR.2|AVQADGQVKEC[CAM]YQSHR.3|MKQSNNEANLREEVLK.3|DTIVLLC[CAM]KPEPELNAAIPSANPAK.4|DTIVLLC[CAM]KPEPELNAAIPSANPAK.3|SRSVIEQGGIQTVDQLIK.3|SRSVIEQGGIQTVDQLIK.2|EC[CAM]YQSHRDTIVLLC[CAM]KPEPELNAAIPSANPAK.5|LANQAADYFGDAFKQC[CAM]QYKDTLPK.4|SC[CAM]VLFNC[CAM]AALASQIAAEQNLDNDEGLK.4|SC[CAM]VLFNC[CAM]AALASQIAAEQNLDNDEGLK.3|DLQQSIAREPSAPSIPTPAYQSSPAGGHAPTPPTPAPR.5|DLQQSIAREPSAPSIPTPAYQSSPAGGHAPTPPTPAPR.4|NLATAYDNFVELVANLKEGTK.3|TVASRYDEYVNVK.2|FLTALAQDGVINEEALSVTELDRVYGGLTTK.4|FLTALAQDGVINEEALSVTELDRVYGGLTTK.3|FLTALAQDGVINEEALSVTELDR.3|EATTLANGVLASLNLPAAIEDVSGDTVPQSILTK.4|EATTLANGVLASLNLPAAIEDVSGDTVPQSILTK.3|STPVNVPISQKFTDLFEK.2
SEN / CTL,"Thioredoxin-dependent peroxide reductase, mitochondrial",PRDX3,P30048,0.30,0.26,1.62E-06,2.58E-06,5.59E+00,"response to reactive oxygen species,maternal placenta development,apoptotic process,response to oxidative stress,mitochondrion organization,positive regulation of cell proliferation,peptidyl-cysteine oxidation,myeloid cell differentiation,response to lipopolysaccharide,negative regulation of kinase activity,cellular response to oxidative stress,cellular response to reactive oxygen species,response to hydrogen peroxide,hydrogen peroxide catabolic process,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,cell redox homeostasis,positive regulation of NF-kappaB transcription factor activity,regulation of mitochondrial membrane potential,cellular oxidant detoxification","protein binding,protein C-terminus binding,thioredoxin peroxidase activity,alkyl hydroperoxide reductase activity,kinase binding,protein kinase binding,identical protein binding,cysteine-type endopeptidase inhibitor activity involved in apoptotic process","cytoplasm,mitochondrion,mitochondrial matrix,early endosome,cytosol,myelin sheath,extracellular exosome,IkappaB kinase complex",30,19,41,GLFIIDPNGVIK.2|DYGVLLEGSGLALR.2|DYGVLLEGSGLALR.3|HLSVNDLPVGR.3|HLSVNDLPVGR.2|GTAVVNGEFKDLSLDDFKGK.4|GTAVVNGEFKDLSLDDFKGK.3|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASKEYFQK.5|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASKEYFQK.6|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASKEYFQK.4|NGGLGHMNIALLSDLTK.3|NGGLGHM[Oxi]NIALLSDLTK.3|NGGLGHMNIALLSDLTK.2|NGGLGHM[Oxi]NIALLSDLTK.2|QISRDYGVLLEGSGLALR.3|QISRDYGVLLEGSGLALR.4|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASK.4|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASK.6|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASK.5|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASK.3|SVEETLR.2|DLSLDDFK.2|KNGGLGHM[Oxi]NIALLSDLTK.4|KNGGLGHMNIALLSDLTK.3|KNGGLGHM[Oxi]NIALLSDLTK.3|KNGGLGHMNIALLSDLTK.2|GTAVVNGEFK.2|ANEFHDVNC[CAM]EVVAVSVDSHFSHLAWINTPR.6|ANEFHDVNC[CAM]EVVAVSVDSHFSHLAWINTPR.5|ANEFHDVNC[CAM]EVVAVSVDSHFSHLAWINTPR.4|ANEFHDVNC[CAM]EVVAVSVDSHFSHLAWINTPR.3|SVEETLRLVK.2|ANEFHDVNC[CAM]EVVAVSVDSHFSHLAWINTPRK.6|ANEFHDVNC[CAM]EVVAVSVDSHFSHLAWINTPRK.4|GLFIIDPNGVIKHLSVNDLPVGR.4|GLFIIDPNGVIKHLSVNDLPVGR.3|GTAVVNGEFKDLSLDDFK.3|GTAVVNGEFKDLSLDDFK.2|AFQYVETHGEVC[CAM]PANWTPDSPTIK.4|AFQYVETHGEVC[CAM]PANWTPDSPTIK.3|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASKEYFQKVNQ.6
SEN / CTL,T-complex protein 1 subunit beta,CCT2,P78371,0.30,0.66,3.36E-05,3.69E-05,4.43E+00,"protein folding,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,protein stabilization,chaperone mediated protein folding independent of cofactor,chaperone-mediated protein complex assembly,positive regulation of telomerase activity,scaRNA localization to Cajal body,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body","protein binding,ATP binding,ubiquitin protein ligase binding,protein binding involved in protein folding,unfolded protein binding","zona pellucida receptor complex,cytoplasm,cytosol,chaperonin-containing T-complex,microtubule,extracellular matrix,myelin sheath,cell body,extracellular exosome",54,49,108,LAVEAVLR.2|LTSFIGAIAIGDLVK.2|LTSFIGAIAIGDLVK.3|GATQQILDEAER.2|GATQQILDEAER.3|LIEEVMIGEDKLIHFSGVALGEAC[CAM]TIVLR.4|LIEEVMIGEDKLIHFSGVALGEAC[CAM]TIVLR.3|SLHDALC[CAM]VLAQTVK.3|SLHDALC[CAM]VLAQTVK.2|KIHPQTIIAGWR.3|M[Oxi]LPTIIADNAGYDSADLVAQLR.3|MLPTIIADNAGYDSADLVAQLR.3|MLPTIIADNAGYDSADLVAQLR.4|M[Oxi]LPTIIADNAGYDSADLVAQLR.2|MLPTIIADNAGYDSADLVAQLR.2|VQDDEVGDGTTSVTVLAAELLR.3|VQDDEVGDGTTSVTVLAAELLR.4|VQDDEVGDGTTSVTVLAAELLR.2|IHPQTIIAGWR.3|IHPQTIIAGWR.2|LKGSGNLEAIHIIK.3|FRQDLMNIAGTTLSSK.3|FRQDLM[Oxi]NIAGTTLSSK.3|FRQDLMNIAGTTLSSK.2|FRQDLM[Oxi]NIAGTTLSSK.2|LALVTGGEIASTFDHPELVK.3|LALVTGGEIASTFDHPELVK.4|LALVTGGEIASTFDHPELVK.2|SLHDALC[CAM]VLAQTVKDSR.4|SLHDALC[CAM]VLAQTVKDSR.3|SLHDALC[CAM]VLAQTVKDSR.2|VLVDMSR.2|VLVDM[Oxi]SR.2|ILIANTGMDTDKIK.3|ILIANTGM[Oxi]DTDKIK.3|ILIANTGMDTDKIK.2|TVYGGGC[CAM]SEMLMAHAVTQLANR.3|TVYGGGC[CAM]SEMLMAHAVTQLANR.4|TVYGGGC[CAM]SEM[Oxi]LMAHAVTQLANR.4|TVYGGGC[CAM]SEM[Oxi]LM[Oxi]AHAVTQLANR.3|TVYGGGC[CAM]SEM[Oxi]LMAHAVTQLANR.3|TVYGGGC[CAM]SEMLM[Oxi]AHAVTQLANR.3|TVYGGGC[CAM]SEM[Oxi]LMAHAVTQLANR.2|TVYGGGC[CAM]SEMLMAHAVTQLANR.2|LKGSGNLEAIHIIKK.4|GSGNLEAIHIIK.3|GSGNLEAIHIIK.2|AGADEERAETAR.3|AGADEERAETAR.2|VAEIEHAEKEK.3|VAEIEHAEKEK.2|KIGVNQPK.2|EALLSSAVDHGSDEVKFR.4|EALLSSAVDHGSDEVKFR.3|QDLMNIAGTTLSSK.3|QDLMNIAGTTLSSK.2|QDLM[Oxi]NIAGTTLSSK.2|TPGKEAVAMESYAK.3|TPGKEAVAMESYAK.2|NIGVDNPAAK.2|AAHSEGNTTAGLDM[Oxi]R.3|AAHSEGNTTAGLDMR.3|AAHSEGNTTAGLDMR.2|AAHSEGNTTAGLDM[Oxi]R.2|VAEIEHAEK.2|QVLLSAAEAAEVILR.3|QVLLSAAEAAEVILR.2|KLGGSLADSYLDEGFLLDKK.4|KLGGSLADSYLDEGFLLDKK.3|EALLSSAVDHGSDEVK.3|EALLSSAVDHGSDEVK.2|EAVAMESYAK.2|EAVAM[Oxi]ESYAK.2|HGINC[CAM]FINR.2|RQVLLSAAEAAEVILR.3|RQVLLSAAEAAEVILR.2|RQVLLSAAEAAEVILRVDNIIK.4|RQVLLSAAEAAEVILRVDNIIK.3|LGGSLADSYLDEGFLLDK.3|LGGSLADSYLDEGFLLDK.2|LIEEVMIGEDK.2|LIEEVM[Oxi]IGEDK.2|GATQQILDEAERSLHDALC[CAM]VLAQTVKDSR.5|GATQQILDEAERSLHDALC[CAM]VLAQTVKDSR.4|ILIANTGMDTDK.2|ILIANTGM[Oxi]DTDK.2|LIHFSGVALGEAC[CAM]TIVLR.3|LIHFSGVALGEAC[CAM]TIVLR.2|EGTIGDM[Oxi]AILGITESFQVK.3|EGTIGDMAILGITESFQVK.3|EGTIGDMAILGITESFQVK.2|EGTIGDM[Oxi]AILGITESFQVK.2|EALLSSAVDHGSDEVKFRQDLMNIAGTTLSSK.5|EALLSSAVDHGSDEVKFRQDLMNIAGTTLSSK.4|KLGGSLADSYLDEGFLLDK.3|KLGGSLADSYLDEGFLLDK.2|LGGSLADSYLDEGFLLDKK.3|LGGSLADSYLDEGFLLDKK.2|GSGNLEAIHIIKK.2|EGTIGDMAILGITESFQVKR.3|QVLLSAAEAAEVILRVDNIIK.3|DASLMVTNDGATILK.2|DASLM[Oxi]VTNDGATILK.2|QLIYNYPEQLFGAAGVMAIEHADFAGVER.4|QLIYNYPEQLFGAAGVM[Oxi]AIEHADFAGVER.4|QLIYNYPEQLFGAAGVM[Oxi]AIEHADFAGVER.3|QLIYNYPEQLFGAAGVMAIEHADFAGVER.3|VLVDM[Oxi]SRVQDDEVGDGTTSVTVLAAELLR.3
SEN / CTL,26S proteasome non-ATPase regulatory subunit 2,PSMD2,Q13200,0.30,0.95,6.04E-03,3.54E-03,2.45E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","protein binding,enzyme regulator activity,endopeptidase activity","proteasome complex,nucleus,nucleoplasm,cytosol,proteasome regulatory particle,proteasome regulatory particle, base subcomplex,membrane,proteasome accessory complex,proteasome storage granule,extracellular exosome",27,63,112,LNILDTLSK.2|MLVTFDEELRPLPVSVR.3|M[Oxi]LVTFDEELRPLPVSVR.3|LVGSQEELASWGHEYVR.3|LVGSQEELASWGHEYVR.2|TITGFQTHTTPVLLAHGERAELATEEFLPVTPILEGFVILR.5|AVPLALALISVSNPR.2|AVPLALALISVSNPR.3|RAVPLALALISVSNPR.3|AELATEEFLPVTPILEGFVILR.3|C[CAM]ALGVFR.2|HLAGEVAK.2|VPDDIYK.2|VPDDIYKTHLENNR.4|VPDDIYKTHLENNR.3|VQREPLLTLVK.3|VQREPLLTLVK.2|SETELKDTYAR.3|SETELKDTYAR.2|DKEQELSEEDK.3|DKEQELSEEDK.2|LKEIYENMAPGENKR.4|LKEIYENMAPGENKR.3|VQQLLHIC[CAM]SEHFDSK.4|VQQLLHIC[CAM]SEHFDSK.3|VQQLLHIC[CAM]SEHFDSK.2|GTLTLC[CAM]PYHSDR.3|GTLTLC[CAM]PYHSDR.2|WLPLGLGLNHLGK.3|WLPLGLGLNHLGK.2|ELDIMEPK.2|LLTDDGNKWLYK.3|LLTDDGNKWLYK.2|SSTTSMTSVPKPLK.3|SSTTSMTSVPKPLK.2|VGQAVDVVGQAGKPK.3|VGQAVDVVGQAGKPK.2|SGALLAC[CAM]GIVNSGVR.3|SGALLAC[CAM]GIVNSGVR.2|DIDENAYAK.2|DTSLYRPALEELR.3|LAQGLTHLGK.2|TITGFQTHTTPVLLAHGER.4|TITGFQTHTTPVLLAHGER.3|TITGFQTHTTPVLLAHGER.2|EDVLTLLLPVMGDSK.3|EDVLTLLLPVMGDSK.2|EDVLTLLLPVM[Oxi]GDSK.2|LKEIYENMAPGENK.3|LKEIYENM[Oxi]APGENK.3|DPNNLFMVR.2|DPNNLFM[Oxi]VR.2|APVQPQQSPAAAPGGTDEKPSGK.4|APVQPQQSPAAAPGGTDEKPSGK.3|APVQPQQSPAAAPGGTDEKPSGK.2|SSTTSMTSVPK.2|DTSLYRPALEELRR.3|SHYVLYGLVAAM[Oxi]QPR.3|SHYVLYGLVAAMQPR.3|SHYVLYGLVAAMQPR.2|YRLVGSQEELASWGHEYVR.4|YRLVGSQEELASWGHEYVR.3|FAADIISVLAMTMSGEREC[CAM]LK.4|FAADIISVLAMTMSGEREC[CAM]LK.3|FGGSGSQVDSAR.2|ELDIMEPKVPDDIYK.3|FAADIISVLAMTMSGER.3|FAADIISVLAMTMSGER.2|DAGDKDKEQELSEEDK.3|DKAPVQPQQSPAAAPGGTDEKPSGK.4|DKAPVQPQQSPAAAPGGTDEKPSGK.3|VGQAVDVVGQAGK.2|APVQPQQSPAAAPGGTDEK.3|APVQPQQSPAAAPGGTDEK.2|RFAADIISVLAMTMSGEREC[CAM]LK.4|RFAADIISVLAMTMSGEREC[CAM]LK.3|EWQELDDAEK.2|NEC[CAM]DPALALLSDYVLHNSNTMR.4|NEC[CAM]DPALALLSDYVLHNSNTMR.3|NEC[CAM]DPALALLSDYVLHNSNTM[Oxi]R.3|AELATEEFLPVTPILEGFVILRK.4|AELATEEFLPVTPILEGFVILRK.3|YLYSSEDYIK.2|RFAADIISVLAMTMSGER.3|RFAADIISVLAM[Oxi]TMSGER.3|RFAADIISVLAMTMSGER.2|SFANTLVDVC[CAM]AYAGSGNVLK.3|SFANTLVDVC[CAM]AYAGSGNVLK.2|EIYENM[Oxi]APGENK.2|EIYENMAPGENK.2|MNLASSFVNGFVNAAFGQDK.3|M[Oxi]NLASSFVNGFVNAAFGQDK.3|M[Oxi]NLASSFVNGFVNAAFGQDK.2|MNLASSFVNGFVNAAFGQDK.2|EIVPYNMAHNAEHEAC[CAM]DLLMEIEQVDMLEK.5|EIVPYNMAHNAEHEAC[CAM]DLLMEIEQVDMLEK.4|EIVPYNMAHNAEHEAC[CAM]DLLMEIEQVDMLEK.3|LALMLNDMELVEDIFTSC[CAM]KDVVVQK.4|LALMLNDMELVEDIFTSC[CAM]KDVVVQK.3|LALMLNDMELVEDIFTSC[CAM]K.3|LALMLNDMELVEDIFTSC[CAM]K.2|QLQDELEMLVER.2|EIYENMAPGENKR.2|TITGFQTHTTPVLLAHGERAELATEEFLPVTPILEGFVILRK.6|LGSIFGLGLAYAGSNR.2|LGSIFGLGLAYAGSNREDVLTLLLPVMGDSK.4|LGSIFGLGLAYAGSNREDVLTLLLPVMGDSK.3|SGALLAC[CAM]GIVNSGVRNEC[CAM]DPALALLSDYVLHNSNTMR.5|SGALLAC[CAM]GIVNSGVRNEC[CAM]DPALALLSDYVLHNSNTM[Oxi]R.4|SGALLAC[CAM]GIVNSGVRNEC[CAM]DPALALLSDYVLHNSNTMR.4|VC[CAM]LYLTSC[CAM]VNYVPEPENSALLR.3|FSHDADPEVSYNSIFAMGMVGSGTNNAR.3
SEN / CTL,6-phosphogluconolactonase,PGLS,O95336,0.30,0.30,6.20E-04,5.03E-04,3.30E+00,"carbohydrate metabolic process,pentose-phosphate shunt",6-phosphogluconolactonase activity,"cytosol,extracellular exosome",33,19,31,TVIFVATGEGK.2|LC[CAM]WFLDEAAAR.2|WTLGFC[CAM]DER.2|ELPAAVAPAGPASLAR.2|ELPAAVAPAGPASLAR.3|VTLTLPVLNAAR.2|VTLTLPVLNAAR.3|ILEDQEENPLPAALVQPHTGK.3|ILEDQEENPLPAALVQPHTGK.4|LVPFDHAESTYGLYR.3|LVPFDHAESTYGLYR.2|LPIPESQVITINPELPVEEAAEDYAK.3|LPIPESQVITINPELPVEEAAEDYAK.4|QAFQGDSIPVFDLLILGVGPDGHTC[CAM]SLFPDHPLLQER.4|FALGLSGGSLVSMLAR.2|FALGLSGGSLVSM[Oxi]LAR.3|FALGLSGGSLVSMLAR.3|FALGLSGGSLVSM[Oxi]LAR.2|EKIVAPISDSPKPPPQR.4|EKIVAPISDSPKPPPQR.3|AAC[CAM]C[CAM]LAGAR.2|LLTVPFEK.2|RILEDQEENPLPAALVQPHTGK.5|RILEDQEENPLPAALVQPHTGK.4|RILEDQEENPLPAALVQPHTGK.3|IVAPISDSPKPPPQR.3|IVAPISDSPKPPPQRVTLTLPVLNAAR.4|LRQAFQGDSIPVFDLLILGVGPDGHTC[CAM]SLFPDHPLLQER.5|LRQAFQGDSIPVFDLLILGVGPDGHTC[CAM]SLFPDHPLLQER.4|ILEDQEENPLPAALVQPHTGKLC[CAM]WFLDEAAAR.4|LPIPESQVITINPELPVEEAAEDYAKK.3
SEN / CTL,Tropomodulin-3,TMOD3,Q9NYL9,0.30,0.44,6.45E-02,2.48E-02,1.61E+00,"muscle contraction,actin filament organization,myofibril assembly,erythrocyte development,pointed-end actin filament capping,cell-cell adhesion,positive regulation of mitotic cell cycle phase transition","actin binding,tropomyosin binding,cadherin binding involved in cell-cell adhesion","striated muscle thin filament,cell-cell junction,cell-cell adherens junction",6,22,36,ILPVFDEPPNPTNVEESLKR.3|FGYQFTQQGPR.2|QKPVQTFTEEK.3|QKPVQTFTEEK.2|C[CAM]FSLAATR.2|AANAITKNNDLVR.3|TKENDAHLVEVNLNNIK.4|TKENDAHLVEVNLNNIK.3|TKENDAHLVEVNLNNIK.2|DREDYVPYTGEK.3|DREDYVPYTGEK.2|STTGPFDREHLLSYLEK.4|STTGPFDREHLLSYLEK.3|STTGPFDREHLLSYLEK.2|ALETNTHVK.2|DNETLAELK.2|EHLLSYLEK.2|ENDAHLVEVNLNNIK.3|ENDAHLVEVNLNNIK.2|QLETVLDDLDPENALLPAGFR.4|QLETVLDDLDPENALLPAGFR.3|QLETVLDDLDPENALLPAGFR.2|MLEENTNILK.2|DLDEDELLGNLSETELK.3|DLDEDELLGNLSETELK.2|ILPVFDEPPNPTNVEESLK.3|ILPVFDEPPNPTNVEESLK.2|QQLGTAVELEMAK.2|QQLGTAVELEM[Oxi]AK.2|EALEHKDREDYVPYTGEK.3|YKDLDEDELLGNLSETELK.3|YKDLDEDELLGNLSETELK.2|SNDPVATAFAEMLK.2|FC[CAM]NIMGSSNGVDQEHFSNVVK.3|FC[CAM]NIM[Oxi]GSSNGVDQEHFSNVVK.3|FC[CAM]NIMGSSNGVDQEHFSNVVKGEK.3
SEN / CTL,Cdc42-interacting protein 4,TRIP10,Q15642,0.29,0.49,1.00E-01,3.58E-02,1.45E+00,"endocytosis,cell communication,signal transduction,vesicle-mediated transport,actin cytoskeleton organization,positive regulation of GTPase activity,regulation of small GTPase mediated signal transduction","ARF guanyl-nucleotide exchange factor activity,GTPase activator activity,lipid binding,identical protein binding","phagocytic cup,nucleoplasm,cytoplasm,lysosome,trans-Golgi network,cytosol,cytoskeleton,cell cortex,cell projection,intracellular membrane-bounded organelle,perinuclear region of cytoplasm,extracellular exosome",6,25,32,ELVAENLSVR.2|LGAGYGLLSEAELEVVPIIAK.3|LGAGYGLLSEAELEVVPIIAK.2|NDSHVLIELHK.3|NDSHVLIELHK.2|ERTEVEQAYAK.3|ERTEVEQAYAK.2|VAANAVDPK.2|HTQWGLDLLDR.3|HTQWGLDLLDR.2|SHMAEESKNEYAAQLQR.4|LDQDINATK.2|LDQDINATKADVEK.3|NEYAAQLQR.2|RKEGGEGYVPTSYLR.3|AQQQLENGFK.2|AAQTAERLDQDINATK.3|AAQTAERLDQDINATK.2|RLQQQLEER.2|FNRDQAHFYFSQMPQIFDK.4|APSDSSLGTPSDGRPELR.3|HARPPDPPASAPPDSSSNSASQDTK.4|HARPPDPPASAPPDSSSNSASQDTK.3|RAQQQLENGFK.2|DQAHFYFSQMPQIFDK.3|DQAHFYFSQMPQIFDK.2|YEAWLAEAESR.2|EGGEGYVPTSYLR.2|LKLEVQKYEAWLAEAESR.3|SGFARPGDVEFEDFSQPMNR.3|FSQQQSFVQILQEVNDFAGQR.3|TPQMGDPASLEPQIAETLSNIER.3
SEN / CTL,Bifunctional purine biosynthesis protein PURH,ATIC,P31939,0.29,0.30,6.89E-06,9.21E-06,5.04E+00,"brainstem development,nucleobase-containing compound metabolic process,'de novo' IMP biosynthetic process,nucleoside metabolic process,purine ribonucleoside monophosphate biosynthetic process,response to inorganic substance,cerebellum development,cerebral cortex development,animal organ regeneration,dihydrofolate metabolic process,tetrahydrofolate biosynthetic process,cell-cell adhesion","IMP cyclohydrolase activity,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,protein homodimerization activity,cadherin binding involved in cell-cell adhesion","mitochondrion,cytosol,cell-cell adherens junction,membrane,extracellular exosome",27,53,87,LDFNLIR.2|TVASPGVTVEEAVEQIDIGGVTLLR.3|TVASPGVTVEEAVEQIDIGGVTLLR.4|SGVAYIAAPSGSAADKVVIEAC[CAM]DELGIILAHTNLR.4|SGVAYIAAPSGSAADKVVIEAC[CAM]DELGIILAHTNLR.5|RAEISNAIDQYVTGTIGEDEDLIKWK.4|RAEISNAIDQYVTGTIGEDEDLIKWK.3|VVAC[CAM]NLYPFVK.2|ELKEALGIPAAASFK.3|LPITVLNGAPGFINLC[CAM]DALNAWQLVK.3|LAGDKANYWWLR.3|AFTHTAQYDEAISDYFR.3|AFTHTAQYDEAISDYFR.2|DTSLETR.2|GVSQMPLR.2|GVSQM[Oxi]PLR.2|YTQSNSVC[CAM]YAK.3|YTQSNSVC[CAM]YAK.2|DLPESALR.2|TGLVEFAR.2|TLHPAVHAGILAR.3|TLHPAVHAGILAR.2|HVSPAGAAVGIPLSEDEAK.4|HVSPAGAAVGIPLSEDEAK.3|HVSPAGAAVGIPLSEDEAK.2|NGQVIGIGAGQQSR.3|NGQVIGIGAGQQSR.2|SLFSNVVTK.2|ANYWWLR.2|DLIVATIAVK.2|DVSELTGFPEMLGGR.3|DVSELTGFPEM[Oxi]LGGR.3|DVSELTGFPEMLGGR.2|DVSELTGFPEM[Oxi]LGGR.2|HHPQVLSMK.2|NLTALGLNLVASGGTAK.3|NLTALGLNLVASGGTAK.2|AFTHTAQYDEAISDYFRK.4|AFTHTAQYDEAISDYFRK.3|RSGVAYIAAPSGSAADK.3|RSGVAYIAAPSGSAADK.2|EVSDGIIAPGYEEEALTILSK.4|EVSDGIIAPGYEEEALTILSK.3|EVSDGIIAPGYEEEALTILSK.2|ALFEEVPELLTEAEK.3|ALFEEVPELLTEAEK.2|LTEVSISSDAFFPFR.3|LTEVSISSDAFFPFR.2|NKDLPESALR.2|TLFGLHLSQK.2|EALGIPAAASFK.2|TLTPISAAYAR.2|VC[CAM]MVYDLYK.2|VC[CAM]M[Oxi]VYDLYK.2|ALFEEVPELLTEAEKK.3|NIPEDNADMAR.2|NIPEDNADM[Oxi]AR.2|RSGVAYIAAPSGSAADKVVIEAC[CAM]DELGIILAHTNLR.6|RSGVAYIAAPSGSAADKVVIEAC[CAM]DELGIILAHTNLR.5|RSGVAYIAAPSGSAADKVVIEAC[CAM]DELGIILAHTNLR.4|ALFEEVPELLTEAEKKEWVEK.4|APGQLALFSVSDK.2|RAEISNAIDQYVTGTIGEDEDLIK.4|RAEISNAIDQYVTGTIGEDEDLIK.3|KNGNYC[CAM]VLQMDQSYKPDENEVR.4|KNGNYC[CAM]VLQMDQSYKPDENEVR.3|YGMNPHQTPAQLYTLQPK.3|YGM[Oxi]NPHQTPAQLYTLQPK.3|YGMNPHQTPAQLYTLQPK.2|KKNGNYC[CAM]VLQMDQSYKPDENEVR.4|VVIEAC[CAM]DELGIILAHTNLR.3|VVIEAC[CAM]DELGIILAHTNLR.2|M[Oxi]SSFGDFVALSDVC[CAM]DVPTAK.3|MSSFGDFVALSDVC[CAM]DVPTAK.3|M[Oxi]SSFGDFVALSDVC[CAM]DVPTAK.2|MSSFGDFVALSDVC[CAM]DVPTAK.2|APGQLALFSVSDKTGLVEFAR.3|MAPGQLALFSVSDK.2|SGVAYIAAPSGSAADK.2|LTEVSISSDAFFPFRDNVDR.3|AEISNAIDQYVTGTIGEDEDLIK.3|NGNYC[CAM]VLQM[Oxi]DQSYKPDENEVR.3|NGNYC[CAM]VLQMDQSYKPDENEVR.3|VTVVC[CAM]EPEDYVVVSTEMQSSESKDTSLETR.4|VTVVC[CAM]EPEDYVVVSTEMQSSESKDTSLETR.3|VTVVC[CAM]EPEDYVVVSTEMQSSESK.3|AEISNAIDQYVTGTIGEDEDLIKWK.3
SEN / CTL,40S ribosomal protein S14,RPS14,P62263,0.29,0.43,1.26E-03,9.28E-04,3.03E+00,"ribosomal small subunit assembly,negative regulation of transcription from RNA polymerase II promoter,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),rRNA processing,translation,translational initiation,regulation of translation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,erythrocyte differentiation,maturation of SSU-rRNA","RNA binding,structural constituent of ribosome,protein binding,poly(A) RNA binding,translation regulator activity,mRNA 5'-UTR binding,small ribosomal subunit rRNA binding","nucleoplasm,nucleolus,cytoplasm,mitochondrion,cytosol,focal adhesion,membrane,cytosolic small ribosomal subunit,extracellular matrix,extracellular exosome",15,15,31,IGRIEDVTPIPSDSTR.3|IGRIEDVTPIPSDSTR.2|VKADRDESSPYAAMLAAQDVAQR.4|VKADRDESSPYAAMLAAQDVAQR.3|VKADRDESSPYAAM[Oxi]LAAQDVAQR.4|VKADRDESSPYAAM[Oxi]LAAQDVAQR.3|IGRIEDVTPIPSDSTRR.4|IGRIEDVTPIPSDSTRR.3|ADRDESSPYAAMLAAQDVAQR.3|ADRDESSPYAAMLAAQDVAQR.4|ADRDESSPYAAM[Oxi]LAAQDVAQR.3|ADRDESSPYAAMLAAQDVAQR.2|TKTPGPGAQSALR.3|C[CAM]KELGITALHIK.3|C[CAM]KELGITALHIK.2|IEDVTPIPSDSTR.3|IEDVTPIPSDSTR.2|IEDVTPIPSDSTRR.3|IEDVTPIPSDSTRR.2|TPGPGAQSALR.2|ELGITALHIK.2|DESSPYAAMLAAQDVAQR.3|DESSPYAAMLAAQDVAQR.2|KEEQVISLGPQVAEGENVFGVC[CAM]HIFASFNDTFVHVTDLSGK.6|KEEQVISLGPQVAEGENVFGVC[CAM]HIFASFNDTFVHVTDLSGK.5|KEEQVISLGPQVAEGENVFGVC[CAM]HIFASFNDTFVHVTDLSGK.4|EKKEEQVISLGPQVAEGENVFGVC[CAM]HIFASFNDTFVHVTDLSGK.6|EKKEEQVISLGPQVAEGENVFGVC[CAM]HIFASFNDTFVHVTDLSGK.5|KEEQVISLGPQVAEGENVFGVC[CAM]HIFASFNDTFVHVTDLSGKETIC[CAM]R.6|KEEQVISLGPQVAEGENVFGVC[CAM]HIFASFNDTFVHVTDLSGKETIC[CAM]R.5|EEQVISLGPQVAEGENVFGVC[CAM]HIFASFNDTFVHVTDLSGK.4
SEN / CTL,"ATP synthase subunit beta, mitochondrial",ATP5B,P06576,0.29,0.44,5.75E-08,1.22E-07,6.91E+00,"angiogenesis,osteoblast differentiation,generation of precursor metabolites and energy,lipid metabolic process,ATP biosynthetic process,negative regulation of cell adhesion involved in substrate-bound cell migration,mitochondrion organization,proton transport,mitochondrial ATP synthesis coupled proton transport,regulation of intracellular pH","transporter activity,protein binding,ATP binding,transmembrane transporter activity,MHC class I protein binding,proton-transporting ATP synthase activity, rotational mechanism,proton-transporting ATPase activity, rotational mechanism,ATPase activity","nucleus,mitochondrion,mitochondrial proton-transporting ATP synthase complex,mitochondrial proton-transporting ATP synthase, catalytic core,mitochondrial matrix,plasma membrane,cell surface,membrane,extracellular matrix,mitochondrial membrane,mitochondrial nucleoid,myelin sheath,extracellular exosome",120,47,115,AIAELGIYPAVDPLDSTSR.2|AIAELGIYPAVDPLDSTSR.3|AHGGYSVFAGVGER.3|AHGGYSVFAGVGER.2|IGLFGGAGVGK.2|VVDLLAPYAK.2|LVLEVAQHLGESTVR.3|LVLEVAQHLGESTVR.2|FTQAGSEVSALLGR.2|FTQAGSEVSALLGR.3|VLDSGAPIKIPVGPETLGR.3|VLDSGAPIKIPVGPETLGR.2|VLDSGAPIKIPVGPETLGR.4|QFAPIHAEAPEFMEMSVEQEILVTGIK.3|QFAPIHAEAPEFMEM[Oxi]SVEQEILVTGIK.3|QFAPIHAEAPEFMEMSVEQEILVTGIK.4|QFAPIHAEAPEFM[Oxi]EM[Oxi]SVEQEILVTGIK.3|QFAPIHAEAPEFM[Oxi]EMSVEQEILVTGIK.3|TIAMDGTEGLVR.2|TIAM[Oxi]DGTEGLVR.2|TREGNDLYHEMIESGVINLK.4|TREGNDLYHEMIESGVINLK.3|TREGNDLYHEM[Oxi]IESGVINLK.4|TREGNDLYHEMIESGVINLK.2|IMNVIGEPIDERGPIKTK.4|IM[Oxi]NVIGEPIDERGPIKTK.4|TVLIMELINNVAK.2|TVLIMELINNVAK.3|TVLIM[Oxi]ELINNVAK.2|SLQDIIAILGMDELSEEDKLTVSR.3|SLQDIIAILGMDELSEEDKLTVSR.4|SLQDIIAILGM[Oxi]DELSEEDKLTVSR.4|SLQDIIAILGM[Oxi]DELSEEDKLTVSR.3|IMDPNIVGSEHYDVAR.3|IMDPNIVGSEHYDVAR.2|IM[Oxi]DPNIVGSEHYDVAR.2|IM[Oxi]DPNIVGSEHYDVAR.3|IMDPNIVGSEHYDVAR.4|KGSITSVQAIYVPADDLTDPAPATTFAHLDATTVLSR.4|KGSITSVQAIYVPADDLTDPAPATTFAHLDATTVLSR.5|KGSITSVQAIYVPADDLTDPAPATTFAHLDATTVLSR.6|IMNVIGEPIDER.2|IMNVIGEPIDER.3|IM[Oxi]NVIGEPIDER.2|GGKIGLFGGAGVGK.3|DQEGQDVLLFIDNIFR.3|DQEGQDVLLFIDNIFR.2|VALVYGQMNEPPGAR.2|VALVYGQMNEPPGAR.3|VALVYGQM[Oxi]NEPPGAR.3|VALVYGQM[Oxi]NEPPGAR.2|IMNVIGEPIDERGPIK.3|IM[Oxi]NVIGEPIDERGPIK.3|IM[Oxi]NVIGEPIDERGPIK.2|IMNVIGEPIDERGPIK.2|FLSQPFQVAEVFTGHMGK.3|FLSQPFQVAEVFTGHM[Oxi]GK.4|FLSQPFQVAEVFTGHMGK.4|FLSQPFQVAEVFTGHM[Oxi]GK.3|FLSQPFQVAEVFTGHM[Oxi]GK.2|FLSQPFQVAEVFTGHMGK.2|GFQQILAGEYDHLPEQAFYMVGPIEEAVAK.4|GFQQILAGEYDHLPEQAFYM[Oxi]VGPIEEAVAK.5|GFQQILAGEYDHLPEQAFYMVGPIEEAVAK.5|GFQQILAGEYDHLPEQAFYM[Oxi]VGPIEEAVAK.4|GFQQILAGEYDHLPEQAFYM[Oxi]VGPIEEAVAK.3|GFQQILAGEYDHLPEQAFYMVGPIEEAVAK.3|VALTGLTVAEYFR.2|VALTGLTVAEYFR.3|EGNDLYHEMIESGVINLK.3|EGNDLYHEM[Oxi]IESGVINLK.3|EGNDLYHEMIESGVINLK.2|IPSAVGYQPTLATDMGTMQER.3|IPSAVGYQPTLATDM[Oxi]GTM[Oxi]QER.3|IPSAVGYQPTLATDM[Oxi]GTMQER.3|IPSAVGYQPTLATDMGTM[Oxi]QER.3|IPSAVGYQPTLATDM[Oxi]GTM[Oxi]QER.2|IPSAVGYQPTLATDM[Oxi]GTMQER.2|IPSAVGYQPTLATDMGTM[Oxi]QER.2|IPSAVGYQPTLATDMGTMQER.2|TREGNDLYHEMIESGVINLKDATSK.5|TREGNDLYHEM[Oxi]IESGVINLKDATSK.5|TREGNDLYHEMIESGVINLKDATSK.4|TREGNDLYHEM[Oxi]IESGVINLKDATSK.4|TREGNDLYHEM[Oxi]IESGVINLKDATSK.3|VLDSGAPIK.2|ETRLVLEVAQHLGESTVR.4|ETRLVLEVAQHLGESTVR.3|ETRLVLEVAQHLGESTVR.2|IPVGPETLGR.2|TIAM[Oxi]DGTEGLVRGQK.3|TIAM[Oxi]DGTEGLVRGQK.2|ADKLAEEHSS.2|GQKVLDSGAPIKIPVGPETLGR.4|GGKIGLFGGAGVGKTVLIMELINNVAK.4|ILQDYKSLQDIIAILGMDELSEEDKLTVSR.5|ILQDYKSLQDIIAILGM[Oxi]DELSEEDKLTVSR.4|ILQDYKSLQDIIAILGMDELSEEDKLTVSR.4|SLQDIIAILGM[Oxi]DELSEEDK.3|SLQDIIAILGMDELSEEDK.3|SLQDIIAILGMDELSEEDK.2|IGLFGGAGVGKTVLIMELINNVAKAHGGYSVFAGVGER.5|IGLFGGAGVGKTVLIMELINNVAKAHGGYSVFAGVGER.4|IVAVIGAVVDVQFDEGLPPILNALEVQGR.4|IVAVIGAVVDVQFDEGLPPILNALEVQGR.3|LTPSASLPPAQLLLR.2|IGLFGGAGVGKTVLIMELINNVAK.3|TKQFAPIHAEAPEFMEMSVEQEILVTGIK.4|EGNDLYHEM[Oxi]IESGVINLKDATSK.3|LVPLKETIKGFQQILAGEYDHLPEQAFYMVGPIEEAVAK.5|GFQQILAGEYDHLPEQAFYMVGPIEEAVAKADKLAEEHSS.5|GFQQILAGEYDHLPEQAFYMVGPIEEAVAKADK.4|FTQAGSEVSALLGRIPSAVGYQPTLATDMGTMQER.4|GSITSVQAIYVPADDLTDPAPATTFAHLDATTVLSR.4|ETIKGFQQILAGEYDHLPEQAFYMVGPIEEAVAK.4
SEN / CTL,T-complex protein 1 subunit theta,CCT8,P50990,0.29,1.33,6.50E-02,2.50E-02,1.60E+00,"protein folding,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,pore complex assembly,protein stabilization,cell-cell adhesion,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body","protein binding,ATP binding,ATPase activity, coupled,unfolded protein binding,cadherin binding involved in cell-cell adhesion","zona pellucida receptor complex,nucleoplasm,cytoplasm,centrosome,cytosol,chaperonin-containing T-complex,microtubule,cell-cell adherens junction,cilium,cell body,intermediate filament cytoskeleton,extracellular exosome",60,59,110,FAEAFEAIPR.2|LATNAAVTVLR.2|DIDEVSSLLR.2|AIADTGANVVVTGGK.2|AIADTGANVVVTGGK.3|LFVTNDAATILR.2|LFVTNDAATILR.3|LVPGGGATEIELAK.2|LVPGGGATEIELAK.3|NLRDIDEVSSLLR.3|NLRDIDEVSSLLR.2|HFSGLEEAVYR.3|HFSGLEEAVYR.2|VADMALHYANKYNIMLVR.4|GSTDNLMDDIER.2|GSTDNLM[Oxi]DDIER.2|ILGSGISSSSVLHGMVFKK.4|ILGSGISSSSVLHGM[Oxi]VFKK.4|ILGSGISSSSVLHGMVFKK.3|LIAQAC[CAM]VSIFPDSGHFNVDNIR.3|LIAQAC[CAM]VSIFPDSGHFNVDNIR.4|IGLSVSEVIEGYEIAC[CAM]R.3|IGLSVSEVIEGYEIAC[CAM]R.2|TVGATALPR.2|LFVTNDAATILRELEVQHPAAK.4|IAVYSC[CAM]PFDGMITETK.2|IAVYSC[CAM]PFDGMITETK.3|IAVYSC[CAM]PFDGM[Oxi]ITETK.2|QITSYGETC[CAM]PGLEQYAIKK.3|QITSYGETC[CAM]PGLEQYAIKK.4|QITSYGETC[CAM]PGLEQYAIKK.2|ALAENSGVKANEVISK.3|ALAENSGVKANEVISK.2|VADMALHYANK.3|VADM[Oxi]ALHYANK.3|VADMALHYANK.2|VADM[Oxi]ALHYANK.2|KFAEAFEAIPR.3|KFAEAFEAIPR.2|KAHEILPNLVC[CAM]C[CAM]SAK.4|KAHEILPNLVC[CAM]C[CAM]SAK.3|KAHEILPNLVC[CAM]C[CAM]SAK.2|ALAENSGVK.2|ILGSGISSSSVLHGMVFK.4|ILGSGISSSSVLHGMVFK.3|ILGSGISSSSVLHGM[Oxi]VFK.3|ILGSGISSSSVLHGM[Oxi]VFK.2|ILGSGISSSSVLHGMVFK.2|YNIMLVR.2|YNIM[Oxi]LVR.2|ETEGDVTSVKDAK.3|ETEGDVTSVKDAK.2|VDQIIMAK.2|VDQIIM[Oxi]AK.2|VDQIIMAKPAGGPKPPSGK.4|VDQIIMAKPAGGPKPPSGK.3|APGFAQMLK.2|APGFAQM[Oxi]LK.2|NVGLDIEAEVPAVK.3|NVGLDIEAEVPAVK.2|MVINHLEK.2|M[Oxi]VINHLEK.2|PAGGPKPPSGK.2|RLVPGGGATEIELAK.3|RLVPGGGATEIELAK.2|DMLEAGILDTYLGK.3|DM[Oxi]LEAGILDTYLGK.3|DM[Oxi]LEAGILDTYLGK.2|DMLEAGILDTYLGK.2|NIQAC[CAM]KELAQTTR.3|NIQAC[CAM]KELAQTTR.2|HEKEDGAISTIVLR.3|HEKEDGAISTIVLR.2|ETEGDVTSVK.2|TAYGPNGMNK.2|TAYGPNGM[Oxi]NK.2|AHEILPNLVC[CAM]C[CAM]SAK.3|AHEILPNLVC[CAM]C[CAM]SAK.2|AVDDGVNTFK.2|ELEVQHPAAK.2|KDWDDDQND.2|LYAVHQEGNK.2|EDGAISTIVLR.2|QYGNEVFLAK.2|TAEELMNFSK.2|TAEELM[Oxi]NFSK.2|KETEGDVTSVK.2|GEENLMDAQVK.2|GEENLM[Oxi]DAQVK.2|LYAVHQEGNKNVGLDIEAEVPAVK.4|LYAVHQEGNKNVGLDIEAEVPAVK.3|IGLSVSEVIEGYEIAC[CAM]RK.3|IGLSVSEVIEGYEIAC[CAM]RK.2|LATNAAVTVLRVDQIIMAK.3|LATNAAVTVLRVDQIIM[Oxi]AK.3|QITSYGETC[CAM]PGLEQYAIK.3|QITSYGETC[CAM]PGLEQYAIK.2|DMLEAGILDTYLGKYWAIK.3|LTPPVLEEMGHC[CAM]DSVYLSEVGDTQVVVFKHEK.5|GSTDNLMDDIERAVDDGVNTFK.3|LTPPVLEEMGHC[CAM]DSVYLSEVGDTQVVVFKHEKEDGAISTIVLR.6|LTPPVLEEMGHC[CAM]DSVYLSEVGDTQVVVFKHEKEDGAISTIVLR.5|TAEELM[Oxi]NFSKGEENLMDAQVK.3|TAEELMNFSKGEENLM[Oxi]DAQVK.3|TAEELMNFSKGEENLMDAQVK.3|LTPPVLEEMGHC[CAM]DSVYLSEVGDTQVVVFK.4|LTPPVLEEM[Oxi]GHC[CAM]DSVYLSEVGDTQVVVFK.3|LTPPVLEEMGHC[CAM]DSVYLSEVGDTQVVVFK.3|LYAVHQEGNKNVGLDIEAEVPAVKDMLEAGILDTYLGK.5|NVGLDIEAEVPAVKDMLEAGILDTYLGK.3
SEN / CTL,"1,4-alpha-glucan-branching enzyme",GBE1,Q04446,0.29,0.46,9.97E-04,7.59E-04,3.12E+00,"glycogen metabolic process,glycogen biosynthetic process,generation of precursor metabolites and energy","1,4-alpha-glucan branching enzyme activity,hydrolase activity, hydrolyzing O-glycosyl compounds,carbohydrate binding,cation binding","cytosol,extracellular exosome",42,32,48,LITHGLGGEGYLNFM[Oxi]GNEFGHPEWLDFPR.4|LITHGLGGEGYLNFMGNEFGHPEWLDFPR.4|VALILQNVDLPN.2|LLEIDPYLKPYAVDFQR.3|LLEIDPYLKPYAVDFQR.2|IVLDSDAAEYGGHQR.3|IVLDSDAAEYGGHQR.2|LDHSTDFFSEAFEHNGRPYSLLVYIPSR.5|LDHSTDFFSEAFEHNGRPYSLLVYIPSR.4|NSADGLNMFDGTDSC[CAM]YFHSGPR.3|YGWLAAPQAYVSEKHEGNK.4|YGWLAAPQAYVSEKHEGNK.3|C[CAM]IAYAESHDQALVGDK.3|AGLLFIFNFHPSK.3|AGLLFIFNFHPSK.2|LAMAIPDKWIQLLK.3|LAM[Oxi]AIPDKWIQLLK.3|LAMAIPDKWIQLLK.2|YGTPEELQELVDTAHSMGIIVLLDVVHSHASK.5|YGTPEELQELVDTAHSM[Oxi]GIIVLLDVVHSHASK.5|EGDNVNYDWIHWDPEHSYEFK.4|EGDNVNYDWIHWDPEHSYEFK.3|NIGENEGGIDKFSR.3|NIGENEGGIDKFSR.2|GNNESYHYAR.3|SGEILYR.2|LAMAIPDK.2|QFSQILK.2|KGNNESYHYAR.3|KGNNESYHYAR.2|SVLVPHGSK.2|PYAVDFQR.2|RQFHLTDDDLLR.3|RQFHLTDDDLLR.2|IYESHVGISSHEGK.3|IYESHVGISSHEGK.2|C[CAM]ADGGLYC[CAM]K.2|WELYIPPK.2|GYESFGVHR.2|GTHDLWDSR.2|LLEIDPYLK.2|LITHGLGGEGYLNFMGNEFGHPEWLDFPRK.6|LITHGLGGEGYLNFMGNEFGHPEWLDFPRK.5|LITHGLGGEGYLNFMGNEFGHPEWLDFPRK.4|NIGENEGGIDK.2|EFKDEDWNMGDIVYTLTNR.3|YGWLAAPQAYVSEK.2|EWAPGAEGVFLTGDFNGWNPFSYPYK.3
SEN / CTL,"2,4-dienoyl-CoA reductase, mitochondrial",DECR1,Q16698,0.28,0.13,2.63E-02,1.19E-02,1.92E+00,"fatty acid beta-oxidation,protein homotetramerization","2,4-dienoyl-CoA reductase (NADPH) activity,oxidoreductase activity, acting on NAD(P)H,NADPH binding","nucleus,nucleoplasm,cytoplasm,mitochondrion,mitochondrial matrix,extracellular exosome",3,26,42,VAGHPNIVINNAAGNFISPTER.3|VAGHPNIVINNAAGNFISPTER.4|VAGHPNIVINNAAGNFISPTER.2|AGVEAM[Oxi]SK.2|LSPNAWK.2|LSPNAWK.1|FFSPLQK.2|SLAAEWGK.2|ATAEQISSQTGNK.3|ATAEQISSQTGNK.2|FNVIQPGPIKTK.3|VTKEQWDTIEELIRK.4|VTKEQWDTIEELIRK.3|GAFSRLDPTGTFEK.3|LDPTGTFEK.2|EQWDTIEELIRK.3|EQWDTIEELIRK.2|LDPTGTFEKEMIGR.3|VHAIQC[CAM]DVR.2|FNVIQPGPIK.2|VTKEQWDTIEELIR.3|VTKEQWDTIEELIR.2|VAFITGGGTGLGK.2|AMLPPNSFQGK.2|AM[Oxi]LPPNSFQGK.2|GMTTLLSSLGAQC[CAM]VIASR.3|GM[Oxi]TTLLSSLGAQC[CAM]VIASR.3|GM[Oxi]TTLLSSLGAQC[CAM]VIASR.2|GMTTLLSSLGAQC[CAM]VIASR.2|GAAFLSITTIYAETGSGFVVPSASAK.4|GAAFLSITTIYAETGSGFVVPSASAK.3|VHAIQC[CAM]DVRDPDMVQNTVSELIK.4|VHAIQC[CAM]DVRDPDM[Oxi]VQNTVSELIK.4|VHAIQC[CAM]DVRDPDM[Oxi]VQNTVSELIK.3|VHAIQC[CAM]DVRDPDMVQNTVSELIK.3|FDGGEEVLISGEFNDLRK.3|FDGGEEVLISGEFNDLRK.2|TITDIVLNGTAFVTLEIGKQLIKAQK.4|EQWDTIEELIR.2|VAGHPNIVINNAAGNFISPTERLSPNAWK.4|DPDMVQNTVSELIK.2|TITDIVLNGTAFVTLEIGKQLIK.3
SEN / CTL,60S ribosomal protein L23,RPL23,P62829,0.28,0.43,4.05E-03,2.50E-03,2.60E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,ribosomal protein import into nucleus,SRP-dependent cotranslational protein targeting to membrane,viral transcription","structural constituent of ribosome,poly(A) RNA binding,large ribosomal subunit rRNA binding","nucleolus,cytoplasm,cytosol,ribosome,focal adhesion,membrane,cytosolic large ribosomal subunit,extracellular matrix,extracellular exosome",12,14,27,NLYIISVK.2|ISLGLPVGAVINC[CAM]ADNTGAK.2|ISLGLPVGAVINC[CAM]ADNTGAK.3|LNRLPAAGVGDMVMATVK.3|LNRLPAAGVGDM[Oxi]VMATVK.3|LNRLPAAGVGDMVM[Oxi]ATVK.3|LNRLPAAGVGDM[Oxi]VM[Oxi]ATVK.3|LNRLPAAGVGDMVMATVK.2|IASNAGSIA.2|GSAITGPVAK.2|LPAAGVGDMVMATVK.3|LPAAGVGDMVMATVK.2|LPAAGVGDM[Oxi]VMATVK.2|LPAAGVGDMVM[Oxi]ATVK.2|LPAAGVGDM[Oxi]VM[Oxi]ATVK.2|KVHPAVVIR.2|EC[CAM]ADLWPR.2|LPAAGVGDMVMATVKK.3|LPAAGVGDM[Oxi]VMATVKK.3|LPAAGVGDMVM[Oxi]ATVKK.3|LPAAGVGDM[Oxi]VM[Oxi]ATVKK.3|LPAAGVGDMVMATVKK.2|RKDGVFLYFEDNAGVIVNNK.4|LNRLPAAGVGDMVMATVKK.3|KDGVFLYFEDNAGVIVNNK.3|FRISLGLPVGAVINC[CAM]ADNTGAK.3|DGVFLYFEDNAGVIVNNK.2
SEN / CTL,"Aconitate hydratase, mitochondrial",ACO2,Q99798,0.28,0.61,8.91E-03,4.88E-03,2.31E+00,"generation of precursor metabolites and energy,tricarboxylic acid cycle,citrate metabolic process,isocitrate metabolic process","aconitate hydratase activity,iron ion binding,3 iron, 4 sulfur cluster binding,4 iron, 4 sulfur cluster binding","nucleus,mitochondrion,mitochondrial matrix,myelin sheath",42,75,142,VAGILTVK.2|NAVTQEFGPVPDTAR.2|NAVTQEFGPVPDTAR.3|WVVIGDENYGEGSSR.2|WVVIGDENYGEGSSR.3|IVYGHLDDPASQEIER.3|IVYGHLDDPASQEIER.4|IVYGHLDDPASQEIER.2|AKDINQEVYNFLATAGAK.3|AKDINQEVYNFLATAGAK.4|AKDINQEVYNFLATAGAK.2|SQFTITPGSEQIR.2|SQFTITPGSEQIR.3|VGLIGSC[CAM]TNSSYEDMGR.2|VGLIGSC[CAM]TNSSYEDM[Oxi]GR.2|NDANPETHAFVTSPEIVTALAIAGTLK.3|NDANPETHAFVTSPEIVTALAIAGTLK.4|NFTGRNDANPETHAFVTSPEIVTALAIAGTLK.4|NFTGRNDANPETHAFVTSPEIVTALAIAGTLK.5|NFTGRNDANPETHAFVTSPEIVTALAIAGTLK.3|VAMQDATAQMAMLQFISSGLSK.3|VAM[Oxi]QDATAQM[Oxi]AMLQFISSGLSK.3|VAM[Oxi]QDATAQMAMLQFISSGLSK.3|VAMQDATAQM[Oxi]AMLQFISSGLSK.3|VAMQDATAQMAM[Oxi]LQFISSGLSK.3|VAM[Oxi]QDATAQMAMLQFISSGLSK.2|VAMQDATAQMAMLQFISSGLSK.2|WVVIGDENYGEGSSREHAALEPR.4|WVVIGDENYGEGSSREHAALEPR.3|VAEKEGWPLDIR.3|VAEKEGWPLDIR.2|DINQEVYNFLATAGAK.3|DINQEVYNFLATAGAK.2|ATIERDGYAQILR.3|ATIERDGYAQILR.2|QALAHGLK.2|IHETNLK.2|YGVGFWK.2|GKC[CAM]TTDHISAAGPWLK.4|GKC[CAM]TTDHISAAGPWLK.3|GKC[CAM]TTDHISAAGPWLK.2|LTIQGLKDFTPGKPLK.4|RLNRPLTLSEK.3|EHAALEPR.2|GEKNTIVTSYNR.3|DGYAQILR.2|VAVPSTIHC[CAM]DHLIEAQVGGEKDLRR.6|VAVPSTIHC[CAM]DHLIEAQVGGEKDLRR.5|VAVPSTIHC[CAM]DHLIEAQVGGEKDLRR.4|KRLNRPLTLSEK.3|EGWPLDIR.2|DFTPGKPLK.2|FRLEAPDADELPK.3|FRLEAPDADELPK.2|IVYGHLDDPASQEIERGK.4|IVYGHLDDPASQEIERGK.3|KGEKNTIVTSYNR.3|C[CAM]TTDHISAAGPWLK.3|C[CAM]TTDHISAAGPWLK.2|PHINGPFTPDLAHPVAEVGK.4|PHINGPFTPDLAHPVAEVGK.3|DLGGIVLANAC[CAM]GPC[CAM]IGQWDRKDIK.5|DLGGIVLANAC[CAM]GPC[CAM]IGQWDRKDIK.4|DLGGIVLANAC[CAM]GPC[CAM]IGQWDRKDIK.3|LQLLEPFDKWDGK.3|LQLLEPFDKWDGK.2|TGREDIANLADEFK.3|TGREDIANLADEFK.2|VAVPSTIHC[CAM]DHLIEAQVGGEKDLR.5|VAVPSTIHC[CAM]DHLIEAQVGGEKDLR.4|DSSGQHVDVSPTSQR.3|DSSGQHVDVSPTSQR.2|FRLEAPDADELPKGEFDPGQDTYQHPPK.6|FRLEAPDADELPKGEFDPGQDTYQHPPK.5|FRLEAPDADELPKGEFDPGQDTYQHPPK.4|NTIVTSYNR.2|KFRLEAPDADELPK.3|LQLLEPFDK.2|GHLDNISNNLLIGAINIENGK.4|GHLDNISNNLLIGAINIENGK.3|GHLDNISNNLLIGAINIENGK.2|FNPETDYLTGTDGKK.3|FNPETDYLTGTDGKK.2|VAVPSTIHC[CAM]DHLIEAQVGGEK.4|VAVPSTIHC[CAM]DHLIEAQVGGEK.3|VAVPSTIHC[CAM]DHLIEAQVGGEK.2|GEFDPGQDTYQHPPK.3|GEFDPGQDTYQHPPK.2|DLGGIVLANAC[CAM]GPC[CAM]IGQWDRK.4|DLGGIVLANAC[CAM]GPC[CAM]IGQWDRK.3|DLGGIVLANAC[CAM]GPC[CAM]IGQWDRK.2|C[CAM]KSQFTITPGSEQIR.3|C[CAM]KSQFTITPGSEQIR.2|LNRPLTLSEK.2|VAMSHFEPNEYIHYDLLEK.4|VAM[Oxi]SHFEPNEYIHYDLLEK.4|VAM[Oxi]SHFEPNEYIHYDLLEK.3|VAMSHFEPNEYIHYDLLEK.3|VAMSHFEPNEYIHYDLLEK.2|QGLLPLTFADPADYNK.3|QGLLPLTFADPADYNK.2|DLEDLQILIK.2|LEAPDADELPK.2|LNRPLTLSEKIVYGHLDDPASQEIER.5|LTGSLSGWSSPKDVILK.3|LTGSLSGWSSPKDVILK.2|FRGHLDNISNNLLIGAINIENGKANSVR.5|FRGHLDNISNNLLIGAINIENGKANSVR.4|FRGHLDNISNNLLIGAINIENGKANSVR.3|LTGSLSGWSSPK.2|QGLLPLTFADPADYNKIHPVDK.4|VAM[Oxi]SHFEPNEYIHYDLLEKNINIVR.5|FRGHLDNISNNLLIGAINIENGK.4|FRGHLDNISNNLLIGAINIENGK.3|KQGLLPLTFADPADYNK.3|KQGLLPLTFADPADYNK.2|RLNRPLTLSEKIVYGHLDDPASQEIER.5|RLNRPLTLSEKIVYGHLDDPASQEIER.4|EDIANLADEFK.2|QGLLPLTFADPADYNKIHPVDKLTIQGLK.5|DHLVPDPGC[CAM]HYDQLIEINLSELKPHINGPFTPDLAHPVAEVGK.7|DHLVPDPGC[CAM]HYDQLIEINLSELKPHINGPFTPDLAHPVAEVGK.6|DHLVPDPGC[CAM]HYDQLIEINLSELKPHINGPFTPDLAHPVAEVGK.5|C[CAM]IIKHPNGTQETILLNHTFNETQIEWFR.5|C[CAM]IIKHPNGTQETILLNHTFNETQIEWFR.4|GHLDNISNNLLIGAINIENGKANSVR.4|GHLDNISNNLLIGAINIENGKANSVR.3|LQLLEPFDKWDGKDLEDLQILIK.4|LQLLEPFDKWDGKDLEDLQILIK.3|DLGGIVLANAC[CAM]GPC[CAM]IGQWDR.3|DLGGIVLANAC[CAM]GPC[CAM]IGQWDR.2|LEAPDADELPKGEFDPGQDTYQHPPK.4|LEAPDADELPKGEFDPGQDTYQHPPK.3|HPNGTQETILLNHTFNETQIEWFR.4|HPNGTQETILLNHTFNETQIEWFR.3|LEAPDADELPKGEFDPGQDTYQHPPKDSSGQHVDVSPTSQR.6|LEAPDADELPKGEFDPGQDTYQHPPKDSSGQHVDVSPTSQR.5|FNPETDYLTGTDGK.2|DGYAQILRDLGGIVLANAC[CAM]GPC[CAM]IGQWDRK.4|NDANPETHAFVTSPEIVTALAIAGTLKFNPETDYLTGTDGKK.5|GGTGAIVEYHGPGVDSISC[CAM]TGMATIC[CAM]NMGAEIGATTSVFPYNHR.5|GGTGAIVEYHGPGVDSISC[CAM]TGMATIC[CAM]NMGAEIGATTSVFPYNHR.4
SEN / CTL,Deoxycytidylate deaminase,DCTD,P32321,0.28,0.34,1.34E-01,4.48E-02,1.35E+00,"pyrimidine nucleotide metabolic process,nucleotide biosynthetic process,pyrimidine nucleoside biosynthetic process","dCMP deaminase activity,protein binding,zinc ion binding","cytosol,extracellular exosome",9,11,17,LIIQAGIK.2|LLFNMAGVTFR.2|LLFNMAGVTFR.3|LLFNM[Oxi]AGVTFR.2|IVIDFDSINSRPSQK.3|YHDSDEATAAR.3|YHDSDEATAAR.2|LDTKYPYVC[CAM]HAELNAIMNK.4|LDTKYPYVC[CAM]HAELNAIMNK.3|YPYVC[CAM]HAELNAIMNK.3|YPYVC[CAM]HAELNAIMNK.2|SKDPNSQVGAC[CAM]IVNSENK.3|SKDPNSQVGAC[CAM]IVNSENK.2|IVGIGYNGMPNGC[CAM]SDDVLPWRR.3|DPNSQVGAC[CAM]IVNSENK.2|GC[CAM]SMYVALFPC[CAM]NEC[CAM]AK.2|IVGIGYNGMPNGC[CAM]SDDVLPWR.2
SEN / CTL,Xaa-Pro aminopeptidase 1,XPNPEP1,Q9NQW7,0.28,0.27,2.79E-05,3.17E-05,4.50E+00,"proteolysis,bradykinin catabolic process","aminopeptidase activity,manganese ion binding,protein homodimerization activity,metalloaminopeptidase activity","cytoplasm,extracellular exosome",21,33,49,VGVDPLIIPTDYWK.2|QEALEWLIR.2|MGLKDTPTQEDWLVSVLPEGSR.3|GSLTFEPLTLVPIQTK.2|GSLTFEPLTLVPIQTK.3|GHIAVSAAVFPTGTK.3|GHIAVSAAVFPTGTK.2|IENVVLVVPVK.2|IENVVLVVPVK.3|C[CAM]C[CAM]MPYTPIC[CAM]IAK.2|C[CAM]C[CAM]M[Oxi]PYTPIC[CAM]IAK.2|VTSELLR.2|SAGHHLIPVKENLVDK.4|GGVTEISAADKAEEFRR.4|GGVTEISAADKAEEFRR.3|TMHFGTPTAYEK.3|TM[Oxi]HFGTPTAYEK.3|TM[Oxi]HFGTPTAYEK.2|NSAESEGMR.2|ALC[CAM]ADLSPR.2|GHLLDSFAR.2|GGVTEISAADK.2|EC[CAM]FTYVLK.2|EHLLLDLGLEAEYR.3|EHLLLDLGLEAEYR.2|GGVTEISAADKAEEFR.3|GGVTEISAADKAEEFR.2|DAVALC[CAM]ELFNWLEK.3|DAVALC[CAM]ELFNWLEK.2|MIDVDSLTDK.2|ASYAVSETIPK.2|VGVDPLIIPTDYWKK.3|EC[CAM]DWLNNYHLTC[CAM]R.3|EC[CAM]DWLNNYHLTC[CAM]R.2|TMHFGTPTAYEKEC[CAM]FTYVLK.4|QMDSNWTLMK.2|DTPTQEDWLVSVLPEGSR.3|DTPTQEDWLVSVLPEGSR.2|MIDVDSLTDKEC[CAM]DWLNNYHLTC[CAM]R.4|SALWDSGLDYLHGTGHGVGSFLNVHEGPC[CAM]GISYK.5|SALWDSGLDYLHGTGHGVGSFLNVHEGPC[CAM]GISYK.4|NSEYVTEPIQAYIIPSGDAHQSEYIAPC[CAM]DC[CAM]R.4|NSEYVTEPIQAYIIPSGDAHQSEYIAPC[CAM]DC[CAM]R.3|QQADFVDLSFPTISSTGPNGAIIHYAPVPETNR.4|QQADFVDLSFPTISSTGPNGAIIHYAPVPETNR.3|AFVSGFDGSAGTAIITEEHAAMWTDGR.3|TLSLDEVYLIDSGAQYK.2|TFSDEPLEAGM[Oxi]IVTDEPGYYEDGAFGIR.3|TFSDEPLEAGMIVTDEPGYYEDGAFGIR.3
SEN / CTL,Coatomer subunit alpha,COPA,P53621,0.28,0.46,9.79E-04,7.51E-04,3.12E+00,"intracellular protein transport,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,intra-Golgi vesicle-mediated transport,pancreatic juice secretion","hormone activity,structural molecule activity","Golgi membrane,extracellular space,cytoplasm,endoplasmic reticulum membrane,cytosol,membrane,COPI vesicle coat,transport vesicle,extracellular exosome",30,92,167,SSGLTAVWVAR.2|VTTVTEIGKDVIGLR.3|VTTVTEIGKDVIGLR.2|TLDLPIYVTR.2|LLHDQVGVIQFGPYK.3|LLHDQVGVIQFGPYK.4|LLHDQVGVIQFGPYK.2|QLDFNSSKDVAVMQLR.3|GFFEGTIASK.2|VWDISGLR.2|GVNWAAFHPTMPLIVSGADDR.3|GVNWAAFHPTM[Oxi]PLIVSGADDR.3|GVNWAAFHPTMPLIVSGADDR.2|SILLSVPLLVVDNKQEIAEAQQLITIC[CAM]R.4|SILLSVPLLVVDNKQEIAEAQQLITIC[CAM]R.3|KLDALC[CAM]NIHENIR.4|KLDALC[CAM]NIHENIR.3|KLDALC[CAM]NIHENIR.2|TGVQTFR.2|GHYNNVSC[CAM]AVFHPR.4|GHYNNVSC[CAM]AVFHPR.3|GHYNNVSC[CAM]AVFHPR.2|GYPEVALHFVK.3|GYPEVALHFVK.2|MHSLLIK.2|ALDDKNC[CAM]WEK.3|ALDDKNC[CAM]WEK.2|FEEAVEK.2|ISPLQFR.2|KYDEVLHMVR.3|KYDEVLHMVR.2|KYDEVLHM[Oxi]VR.2|LNDLIQR.2|RSSGLTAVWVAR.3|YAVTTGDHGIIR.3|YAVTTGDHGIIR.2|KGYPEVALHFVKDEK.4|KGYPEVALHFVKDEK.3|KGYPEVALHFVKDEK.2|LVGQSIIAYLQK.3|LVGQSIIAYLQK.2|KGYPEVALHFVK.3|KGYPEVALHFVK.2|RLLELGPKPEVAQQTR.4|RLLELGPKPEVAQQTR.3|RLLELGPKPEVAQQTR.2|DVAVMQLR.2|DVAVM[Oxi]QLR.2|ERPAYAVHGNMLHYVK.4|ERPAYAVHGNMLHYVK.3|TALNLFFK.2|VTTVTEIGK.2|HVLEGHDR.2|MC[CAM]TLIDKFDEHDGPVR.4|M[Oxi]C[CAM]TLIDKFDEHDGPVR.4|MC[CAM]TLIDKFDEHDGPVR.3|M[Oxi]C[CAM]TLIDKFDEHDGPVR.3|MC[CAM]TLIDKFDEHDGPVR.2|VLTIDPTEFKFK.3|LDALC[CAM]NIHENIR.3|VWNWQSR.2|HAIVIC[CAM]NR.2|DADSQNPDAPEGKR.3|DADSQNPDAPEGKR.2|C[CAM]PLSGAC[CAM]YSPEFK.3|C[CAM]PLSGAC[CAM]YSPEFK.2|LSFLYLITGNLEK.3|LSFLYLITGNLEK.2|SILLSVPLLVVDNK.3|SILLSVPLLVVDNK.2|AWEVDTC[CAM]R.2|SLAYLTAATHGLDEEAESLK.4|SLAYLTAATHGLDEEAESLK.3|SLAYLTAATHGLDEEAESLK.2|FDEHDGPVR.2|C[CAM]LFTLLGHLDYIR.3|C[CAM]LFTLLGHLDYIR.2|DADSITLFDVQQKR.3|DADSITLFDVQQKR.2|DHDRFWVLAAHPNLNLFAAGHDGGMIVFK.6|DHDRFWVLAAHPNLNLFAAGHDGGM[Oxi]IVFK.5|DHDRFWVLAAHPNLNLFAAGHDGGMIVFK.5|KDMSGHYQNALYLGDVSER.4|KDMSGHYQNALYLGDVSER.3|GNNVYC[CAM]LDR.2|LLELGPKPEVAQQTR.3|LLELGPKPEVAQQTR.2|QEIAEAQQLITIC[CAM]R.3|QEIAEAQQLITIC[CAM]R.2|TKNFDKLSFLYLITGNLEK.4|TKNFDKLSFLYLITGNLEK.3|QLFLQTYAR.2|YDEVLHMVR.2|VKSGAWDESGVFIYTTSNHIK.4|VKSGAWDESGVFIYTTSNHIK.3|VLTIDPTEFK.2|LGEVALLQGNHQIVEMC[CAM]YQR.4|LGEVALLQGNHQIVEMC[CAM]YQR.3|LGEVALLQGNHQIVEMC[CAM]YQR.2|RPWILTSLHNGVIQLWDYR.4|RPWILTSLHNGVIQLWDYR.3|ETIPDIDPNAK.2|KVQVPNC[CAM]DEIFYAGTGNLLLR.4|KVQVPNC[CAM]DEIFYAGTGNLLLR.3|YVIWSADM[Oxi]SHVALLAK.3|YVIWSADMSHVALLAK.3|YVIWSADMSHVALLAK.2|ASNLENSTYDLYTIPK.3|ASNLENSTYDLYTIPK.2|LLQPPAPIMPLDTNWPLLTVSK.4|LLQPPAPIMPLDTNWPLLTVSK.3|LLQPPAPIM[Oxi]PLDTNWPLLTVSK.3|NLSPGAVESDVR.2|QELILSNSEDK.2|TTFFHHEYPWILSASDDQTIR.4|TTFFHHEYPWILSASDDQTIR.3|DADSQNPDAPEGK.2|NFDKLSFLYLITGNLEK.3|SGSKFPVFNMSYNPAENAVLLC[CAM]TR.4|SGSKFPVFNM[Oxi]SYNPAENAVLLC[CAM]TR.3|SGSKFPVFNMSYNPAENAVLLC[CAM]TR.3|DMSGHYQNALYLGDVSER.3|DM[Oxi]SGHYQNALYLGDVSER.3|DMSGHYQNALYLGDVSER.2|ETFDPEKETIPDIDPNAK.3|FWVLAAHPNLNLFAAGHDGGMIVFK.4|FWVLAAHPNLNLFAAGHDGGM[Oxi]IVFK.3|FWVLAAHPNLNLFAAGHDGGMIVFK.3|IC[CAM]EMAAYFTHSNLQPVHMILVLR.4|IC[CAM]EM[Oxi]AAYFTHSNLQPVHMILVLR.4|IC[CAM]EMAAYFTHSNLQPVHMILVLR.3|KNLSPGAVESDVR.2|EYIVGLSVETER.2|SGAWDESGVFIYTTSNHIK.3|SGAWDESGVFIYTTSNHIK.2|LLHDQVGVIQFGPYKQLFLQTYAR.4|LQLC[CAM]YQLTTVGK.2|TTYQALPC[CAM]LPSMYGYPNR.3|TTYQALPC[CAM]LPSM[Oxi]YGYPNR.3|TTYQALPC[CAM]LPSM[Oxi]YGYPNR.2|TTYQALPC[CAM]LPSMYGYPNR.2|KILSAC[CAM]EKNPTDAYQLNYDMHNPFDIC[CAM]AASYRPIYR.6|KILSAC[CAM]EKNPTDAYQLNYDMHNPFDIC[CAM]AASYRPIYR.5|QQPLFVSGGDDYK.2|DADSITLFDVQQK.2|SLAYLTAATHGLDEEAESLKETFDPEK.4|SLAYLTAATHGLDEEAESLKETFDPEK.3|LQLC[CAM]YQLTTVGKFEEAVEK.3|LQLC[CAM]YQLTTVGKFEEAVEK.2|EYIVGLSVETERK.2|VQVPNC[CAM]DEIFYAGTGNLLLR.3|VQVPNC[CAM]DEIFYAGTGNLLLR.2|FPVFNM[Oxi]SYNPAENAVLLC[CAM]TR.3|FPVFNMSYNPAENAVLLC[CAM]TR.3|FPVFNMSYNPAENAVLLC[CAM]TR.2|GRTTYQALPC[CAM]LPSM[Oxi]YGYPNR.3|GRTTYQALPC[CAM]LPSMYGYPNR.3|GITGVDLFGTTDAVVK.2|GTSPTQIWC[CAM]NNSQLPVDHILAGSFETAMR.4|GTSPTQIWC[CAM]NNSQLPVDHILAGSFETAMR.3|SLAYLTAATHGLDEEAESLKETFDPEKETIPDIDPNAK.5|SLAYLTAATHGLDEEAESLKETFDPEKETIPDIDPNAK.4|ILSAC[CAM]EKNPTDAYQLNYDMHNPFDIC[CAM]AASYRPIYR.5|NPTDAYQLNYDM[Oxi]HNPFDIC[CAM]AASYRPIYR.4|NPTDAYQLNYDMHNPFDIC[CAM]AASYRPIYR.4|NPTDAYQLNYDMHNPFDIC[CAM]AASYRPIYR.3|FSLALEC[CAM]GNIEIALEAAK.2
SEN / CTL,Adenosylhomocysteinase,AHCY,P23526,0.27,0.37,1.18E-01,4.07E-02,1.39E+00,"sulfur amino acid metabolic process,response to hypoxia,chronic inflammatory response to antigenic stimulus,one-carbon metabolic process,response to nutrient,S-adenosylhomocysteine catabolic process,methylation,S-adenosylmethionine cycle,circadian sleep/wake cycle,homocysteine biosynthetic process","adenosylhomocysteinase activity,protein binding,adenyl nucleotide binding,identical protein binding,NAD binding","nucleus,cytoplasm,cytosol,melanosome,neuron projection,extracellular exosome",30,34,62,VADIGLAAWGR.2|VAVVAGYGDVGKGC[CAM]AQALR.3|IILLAEGR.2|VAVVAGYGDVGK.2|YPQLLPGIR.2|KLDEAVAEAHLGKLNVK.4|KLDEAVAEAHLGKLNVK.3|GISEETTTGVHNLYK.3|GISEETTTGVHNLYK.2|VPAINVNDSVTK.2|VPAINVNDSVTK.3|ALDIAENEMPGLMR.2|ALDIAENEMPGLMR.3|ALDIAENEM[Oxi]PGLMR.2|ALDIAENEMPGLM[Oxi]R.2|ALDIAENEM[Oxi]PGLM[Oxi]R.2|QAQYLGMSC[CAM]DGPFKPDHYRY.4|QAQYLGM[Oxi]SC[CAM]DGPFKPDHYRY.4|QAQYLGMSC[CAM]DGPFKPDHYRY.3|LDEAVAEAHLGK.3|LDEAVAEAHLGK.2|SKFDNLYGC[CAM]R.3|SKFDNLYGC[CAM]R.2|VADIGLAAWGRK.3|MMANGILK.2|M[Oxi]MANGILK.2|MM[Oxi]ANGILK.2|YSASKPLK.2|ATDVMIAGK.2|ATDVM[Oxi]IAGK.2|KLDEAVAEAHLGK.3|KLDEAVAEAHLGK.2|AGIPVYAWK.2|FDNLYGC[CAM]R.2|RIILLAEGR.2|RATDVMIAGK.2|RATDVM[Oxi]IAGK.2|VNIKPQVDR.2|WLNENAVEK.2|DGPLNMILDDGGDLTNLIHTK.4|DGPLNM[Oxi]ILDDGGDLTNLIHTK.3|DGPLNMILDDGGDLTNLIHTK.3|DGPLNMILDDGGDLTNLIHTK.2|KALDIAENEMPGLMR.3|KALDIAENEMPGLMR.2|QAQYLGM[Oxi]SC[CAM]DGPFKPDHYR.4|QAQYLGMSC[CAM]DGPFKPDHYR.4|QAQYLGM[Oxi]SC[CAM]DGPFKPDHYR.3|QAQYLGMSC[CAM]DGPFKPDHYR.3|QAQYLGMSC[CAM]DGPFKPDHYR.2|HFEQM[Oxi]KDDAIVC[CAM]NIGHFDVEIDVK.5|HFEQMKDDAIVC[CAM]NIGHFDVEIDVK.4|YPVGVHFLPK.2|MMANGILKVPAINVNDSVTK.3|M[Oxi]MANGILKVPAINVNDSVTK.3|MM[Oxi]ANGILKVPAINVNDSVTK.3|GETDEEYLWC[CAM]IEQTLYFK.3|GETDEEYLWC[CAM]IEQTLYFK.2|VAVVAGYGDVGKGC[CAM]AQALRGFGAR.3|DGPLNMILDDGGDLTNLIHTKYPQLLPGIR.4|LVNLGC[CAM]AMGHPSFVMSNSFTNQVMAQIELWTHPDKYPVGVHFLPK.6|LVNLGC[CAM]AMGHPSFVMSNSFTNQVMAQIELWTHPDK.4
SEN / CTL,Elongation factor 1-gamma,EEF1G,P26641,0.27,0.37,3.42E-04,3.00E-04,3.52E+00,"translational elongation,glutathione metabolic process,response to virus,cell-cell adhesion","translation elongation factor activity,glutathione transferase activity,protein binding,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,cytosol,cell-cell adherens junction,membrane,extracellular exosome,endoplasmic reticulum",30,36,59,ILGLLDAYLK.2|ALIAAQYSGAQVR.2|ALIAAQYSGAQVR.3|STFVLDEFKR.3|STFVLDEFKR.2|KAAAPAPEEEMDEC[CAM]EQALAAEPK.3|KAAAPAPEEEM[Oxi]DEC[CAM]EQALAAEPK.3|VLSAPPHFHFGQTNR.4|VLSAPPHFHFGQTNR.3|VLSAPPHFHFGQTNR.2|KLDPGSEETQTLVR.3|KLDPGSEETQTLVR.2|EYFSWEGAFQHVGK.3|EYFSWEGAFQHVGK.4|EYFSWEGAFQHVGK.2|GQELAFPLSPDWQVDYESYTWR.3|FAETQPK.2|TFLVGER.2|QATENAKEEVR.3|QATENAKEEVR.2|RILGLLDAYLK.3|RILGLLDAYLK.2|TPEFLRK.2|DPFAHLPK.2|KFAETQPK.2|QAFPNTNR.2|QATENAKEEVRR.3|LDPGSEETQTLVR.3|LDPGSEETQTLVR.2|QVLEPSFR.2|VLSAPPHFHFGQTNRTPEFLR.5|WFLTC[CAM]INQPQFR.3|WFLTC[CAM]INQPQFR.2|STFVLDEFK.2|AKDPFAHLPK.2|YSNEDTLSVALPYFWEHFDK.4|YSNEDTLSVALPYFWEHFDK.3|FPEELTQTFMSC[CAM]NLITGMFQR.4|FPEELTQTFM[Oxi]SC[CAM]NLITGMFQR.3|FPEELTQTFMSC[CAM]NLITGMFQR.3|KYSNEDTLSVALPYFWEHFDK.4|KYSNEDTLSVALPYFWEHFDK.3|RKYSNEDTLSVALPYFWEHFDK.4|GSTPEAAAQVVQWVSFADSDIVPPASTWVFPTLGIM[Oxi]HHNK.6|GSTPEAAAQVVQWVSFADSDIVPPASTWVFPTLGIMHHNK.6|GSTPEAAAQVVQWVSFADSDIVPPASTWVFPTLGIMHHNK.5|GSTPEAAAQVVQWVSFADSDIVPPASTWVFPTLGIM[Oxi]HHNK.4|GSTPEAAAQVVQWVSFADSDIVPPASTWVFPTLGIMHHNK.4|DGWSLWYSEYR.2|AAAPAPEEEM[Oxi]DEC[CAM]EQALAAEPK.3|AAAPAPEEEMDEC[CAM]EQALAAEPK.3|AAAPAPEEEM[Oxi]DEC[CAM]EQALAAEPK.2|AAAPAPEEEMDEC[CAM]EQALAAEPK.2|KLDPGSEETQTLVREYFSWEGAFQHVGK.4|QAFPNTNRWFLTC[CAM]INQPQFR.3|NAFASVILFGTNNSSSISGVWVFR.3|GQELAFPLSPDWQVDYESYTWRK.3|KFPAGKVPAFEGDDGFC[CAM]VFESNAIAYYVSNEELR.4|VPAFEGDDGFC[CAM]VFESNAIAYYVSNEELR.3
SEN / CTL,Laminin subunit beta-3,LAMB3,Q13751,0.27,0.73,4.76E-02,1.92E-02,1.72E+00,"cell adhesion,epidermis development,extracellular matrix disassembly,extracellular matrix organization,hemidesmosome assembly,endodermal cell differentiation,brown fat cell differentiation","structural molecule activity,protein binding,protein complex binding","extracellular region,laminin-5 complex",6,11,11,AHAVEGQVEDVVGNLR.3|C[CAM]LC[CAM]LPNVVGPK.2|C[CAM]DQC[CAM]APYHWK.3|VAEVQQVLRPAEK.3|C[CAM]DC[CAM]NILGSR.2|SFNGLLTMYQR.2|EGFGGLMC[CAM]SAAAIR.2|C[CAM]APKPGASAGPSTAVQVHDVC[CAM]VC[CAM]QHNTAGPNC[CAM]ER.5|AAEESASQIQSSAQR.2|AGGAFLMAGQVAEQLR.2|AVLSSPAVTEQEVAQVASAILSLRR.3
SEN / CTL,Heat shock protein HSP 90-beta,HSP90AB1,P08238,0.26,0.85,4.98E-03,2.98E-03,2.53E+00,"placenta development,protein folding,response to unfolded protein,response to salt stress,virion attachment to host cell,regulation of protein ubiquitination,positive regulation of protein binding,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of phosphoprotein phosphatase activity,positive regulation of protein import into nucleus, translocation,cellular response to drug,Fc-gamma receptor signaling pathway involved in phagocytosis,response to cocaine,negative regulation of neuron apoptotic process,positive regulation of nitric oxide biosynthetic process,positive regulation of cell size,protein stabilization,regulation of interferon-gamma-mediated signaling pathway,regulation of type I interferon-mediated signaling pathway,cellular response to interleukin-4,cellular response to organic cyclic compound,positive regulation of protein serine/threonine kinase activity,fibril organization,cell-cell adhesion,regulation of cellular response to heat,negative regulation of complement-dependent cytotoxicity","glycoprotein binding,UTP binding,CTP binding,double-stranded RNA binding,protein binding,ATP binding,GTP binding,drug binding,sulfonylurea receptor binding,protein kinase regulator activity,kinase binding,protein kinase binding,MHC class II protein complex binding,nitric-oxide synthase regulator activity,TPR domain binding,dATP binding,histone deacetylase binding,ion channel binding,poly(A) RNA binding,unfolded protein binding,cadherin binding involved in cell-cell adhesion","nucleoplasm,cytoplasm,mitochondrion,lysosomal membrane,cytosol,cell-cell adherens junction,cell surface,membrane,inclusion body,basolateral plasma membrane,apical plasma membrane,brush border membrane,melanosome,extracellular exosome,sperm head plasma membrane,ooplasm,COP9 signalosome",186,84,175,GVVDSEDLPLNISR.2|GVVDSEDLPLNISR.3|ELISNASDALDKIR.3|ELISNASDALDKIR.2|SLTNDWEDHLAVK.3|SLTNDWEDHLAVK.2|ALLFIPR.2|HSQFIGYPITLYLEKER.4|HSQFIGYPITLYLEKER.3|NPDDITQEEYGEFYK.2|NPDDITQEEYGEFYK.3|SIYYITGESK.2|HFSVEGQLEFR.3|HFSVEGQLEFR.2|IDIIPNPQER.2|HLEINPDHPIVETLR.4|HLEINPDHPIVETLR.3|HLEINPDHPIVETLR.2|YIDQEELNKTKPIWTR.4|YIDQEELNKTKPIWTR.3|KHLEINPDHPIVETLR.4|KHLEINPDHPIVETLR.3|KHLEINPDHPIVETLR.2|ADLINNLGTIAK.2|ADLINNLGTIAK.3|VFIMDSC[CAM]DELIPEYLNFIR.3|VFIM[Oxi]DSC[CAM]DELIPEYLNFIR.2|VFIMDSC[CAM]DELIPEYLNFIR.2|VFIM[Oxi]DSC[CAM]DELIPEYLNFIR.3|VFIMDSC[CAM]DELIPEYLNFIR.4|TKPIWTRNPDDITQEEYGEFYK.4|TKPIWTRNPDDITQEEYGEFYK.3|TLTLVDTGIGMTK.2|TLTLVDTGIGMTK.3|TLTLVDTGIGM[Oxi]TK.3|TLTLVDTGIGM[Oxi]TK.2|ELKIDIIPNPQER.3|ELKIDIIPNPQER.2|C[CAM]LELFSELAEDKENYKK.4|C[CAM]LELFSELAEDKENYKK.3|C[CAM]LELFSELAEDKENYKK.2|RVFIMDSC[CAM]DELIPEYLNFIR.3|RVFIM[Oxi]DSC[CAM]DELIPEYLNFIR.3|RVFIMDSC[CAM]DELIPEYLNFIR.4|VILHLKEDQTEYLEER.3|VILHLKEDQTEYLEER.4|VILHLKEDQTEYLEER.2|EQVANSAFVER.2|EQVANSAFVER.3|ELISNASDALDK.2|ELISNASDALDK.3|LVSSPC[CAM]C[CAM]IVTSTYGWTANMER.3|LVSSPC[CAM]C[CAM]IVTSTYGWTANMER.4|LVSSPC[CAM]C[CAM]IVTSTYGWTANM[Oxi]ER.3|HNDDEQYAWESSAGGSFTVR.3|HNDDEQYAWESSAGGSFTVR.4|HNDDEQYAWESSAGGSFTVR.2|HSQFIGYPITLYLEK.3|HSQFIGYPITLYLEK.4|HSQFIGYPITLYLEK.2|RAPFDLFENK.3|RAPFDLFENK.2|VILHLKEDQTEYLEERR.4|VILHLKEDQTEYLEERR.5|VILHLKEDQTEYLEERR.3|YIDQEELNKTKPIWTRNPDDITQEEYGEFYK.5|YHTSQSGDEMTSLSEYVSR.3|YHTSQSGDEM[Oxi]TSLSEYVSR.3|YHTSQSGDEMTSLSEYVSR.4|YHTSQSGDEM[Oxi]TSLSEYVSR.2|YHTSQSGDEMTSLSEYVSR.2|DLVVLLFETALLSSGFSLEDPQTHSNR.4|DLVVLLFETALLSSGFSLEDPQTHSNR.3|SLTNDWEDHLAVKHFSVEGQLEFR.4|SLTNDWEDHLAVKHFSVEGQLEFR.3|TLTLVDTGIGMTKADLINNLGTIAK.3|TLTLVDTGIGMTKADLINNLGTIAK.4|SIYYITGESKEQVANSAFVER.3|SIYYITGESKEQVANSAFVER.4|SIYYITGESKEQVANSAFVER.2|GFEVVYMTEPIDEYC[CAM]VQQLK.3|GFEVVYMTEPIDEYC[CAM]VQQLK.4|GFEVVYM[Oxi]TEPIDEYC[CAM]VQQLK.3|FYEAFSK.2|FYEAFSK.1|YIDQEELNK.2|LGLGIDEDEVAAEEPNAAVPDEIPPLEGDEDASR.4|LGLGIDEDEVAAEEPNAAVPDEIPPLEGDEDASR.5|LGLGIDEDEVAAEEPNAAVPDEIPPLEGDEDASR.3|KHSQFIGYPITLYLEKER.4|KHSQFIGYPITLYLEKER.3|KRGFEVVYMTEPIDEYC[CAM]VQQLK.4|KRGFEVVYM[Oxi]TEPIDEYC[CAM]VQQLK.4|KRGFEVVYMTEPIDEYC[CAM]VQQLK.3|AQALRDNSTMGYMMAK.3|AQALRDNSTM[Oxi]GYMMAK.3|AQALRDNSTMGYM[Oxi]MAK.3|AQALRDNSTMGYMM[Oxi]AK.3|AQALRDNSTMGYMMAK.2|APFDLFENKK.3|APFDLFENKK.2|EGLELPEDEEEKKK.4|EGLELPEDEEEKKK.3|EGLELPEDEEEKKK.2|EMLQQSK.2|LGIHEDSTNRR.3|EDQTEYLEER.3|EDQTEYLEER.2|IRYESLTDPSK.3|IRYESLTDPSK.2|RLSELLR.2|GEKEEEDKDDEEKPK.4|GEKEEEDKDDEEKPK.3|IRYESLTDPSKLDSGK.4|IRYESLTDPSKLDSGK.3|IRYESLTDPSKLDSGK.2|RAPFDLFENKK.3|RAPFDLFENKK.2|EGLELPEDEEEK.3|EGLELPEDEEEK.2|EKYIDQEELNK.3|EKYIDQEELNK.2|IEDVGSDEEDDSGKDKK.4|IEDVGSDEEDDSGKDKK.3|ADHGEPIGR.2|YESLTDPSKLDSGKELK.4|YESLTDPSKLDSGKELK.3|YESLTDPSKLDSGKELK.2|EDQTEYLEERR.3|EDQTEYLEERR.2|KHSQFIGYPITLYLEK.4|KHSQFIGYPITLYLEK.3|KHSQFIGYPITLYLEK.2|LMKEILDK.2|NLKLGIHEDSTNR.3|AKFENLC[CAM]K.2|KFYEAFSK.2|EGLELPEDEEEKK.3|EGLELPEDEEEKK.2|YESLTDPSKLDSGK.3|YESLTDPSKLDSGK.2|YESLTDPSK.2|KC[CAM]LELFSELAEDKENYK.4|KC[CAM]LELFSELAEDKENYK.3|APFDLFENK.2|IKEKYIDQEELNK.3|SLVSVTKEGLELPEDEEEKK.4|LGIHEDSTNR.2|IEDVGSDEEDDSGKDK.3|DNSTMGYMMAK.2|DNSTM[Oxi]GYMMAK.2|DNSTMGYM[Oxi]MAK.2|DNSTMGYMM[Oxi]AK.2|DNSTM[Oxi]GYM[Oxi]MAK.2|DNSTM[Oxi]GYMM[Oxi]AK.2|DNSTMGYM[Oxi]M[Oxi]AK.2|DNSTM[Oxi]GYM[Oxi]M[Oxi]AK.2|EIFLRELISNASDALDK.3|EISDDEAEEEK.2|RGFEVVYMTEPIDEYC[CAM]VQQLK.4|RGFEVVYM[Oxi]TEPIDEYC[CAM]VQQLK.3|RGFEVVYMTEPIDEYC[CAM]VQQLK.3|C[CAM]LELFSELAEDKENYK.3|LDSGKELKIDIIPNPQER.3|SLVSVTKEGLELPEDEEEK.3|VVVITKHNDDEQYAWESSAGGSFTVR.4|VVVITKHNDDEQYAWESSAGGSFTVR.3|C[CAM]LELFSELAEDK.2|GFEVVYMTEPIDEYC[CAM]VQQLKEFDGK.4|GFEVVYMTEPIDEYC[CAM]VQQLKEFDGK.3|IEDVGSDEEDDSGK.2|KC[CAM]LELFSELAEDK.2|PIWTRNPDDITQEEYGEFYK.3|LGLGIDEDEVAAEEPNAAVPDEIPPLEGDEDASRM[Oxi]EEVD.4|LGLGIDEDEVAAEEPNAAVPDEIPPLEGDEDASRMEEVD.4
SEN / CTL,Actin-related protein 2/3 complex subunit 3,ARPC3,O15145,0.26,1.66,9.25E-02,3.36E-02,1.47E+00,"movement of cell or subcellular component,Arp2/3 complex-mediated actin nucleation,Fc-gamma receptor signaling pathway involved in phagocytosis,ephrin receptor signaling pathway,cellular response to nerve growth factor stimulus","structural constituent of cytoskeleton,protein binding,actin filament binding","cytosol,Arp2/3 protein complex,focal adhesion,actin cytoskeleton,membrane,lamellipodium,growth cone,extracellular exosome",18,16,27,AYLQQLR.2|PAYHSSLMDPDTKLIGNMALLPIR.4|ETKDTDIVDEAIYYFK.3|ETKDTDIVDEAIYYFK.2|LIGNMALLPIR.2|LIGNMALLPIR.3|LIGNM[Oxi]ALLPIR.2|VFDPQNDKPSKWWTC[CAM]FVK.4|PANKQEDEVMR.3|PANKQEDEVM[Oxi]R.3|PANKQEDEVMR.2|NYEIKNEADR.3|NYEIKNEADR.2|VFDPQNDKPSK.3|VFDPQNDKPSK.2|PAYHSSLMDPDTK.3|PAYHSSLM[Oxi]DPDTK.3|PAYHSSLMDPDTK.2|WWTC[CAM]FVK.2|AYLQQLRQETGLR.3|DTDIVDEAIYYFK.3|DTDIVDEAIYYFK.2|EM[Oxi]YTLGITNFPIPGEPGFPLNAIYAK.3|EMYTLGITNFPIPGEPGFPLNAIYAK.3|EMYTLGITNFPIPGEPGFPLNAIYAKPANKQEDEVMR.4|EMYTLGITNFPIPGEPGFPLNAIYAKPANK.3|SQGEKEMYTLGITNFPIPGEPGFPLNAIYAK.3
SEN / CTL,Aminopeptidase N,ANPEP,P15144,0.26,0.74,7.86E-05,8.01E-05,4.10E+00,"angiogenesis,proteolysis,cell differentiation,peptide catabolic process,viral entry into host cell","virus receptor activity,aminopeptidase activity,receptor activity,metallopeptidase activity,zinc ion binding,peptide binding,metalloaminopeptidase activity","extracellular space,lysosomal membrane,endoplasmic reticulum-Golgi intermediate compartment,cytosol,integral component of plasma membrane,external side of plasma membrane,extracellular exosome",102,60,99,ELWILNR.2|YRLPNTLKPDSYR.4|YRLPNTLKPDSYR.3|QQQDYWLIDVR.2|KQDATSTIISITNNVIGQGLVWDFVQSNWKK.4|GVGGSQPPDIDKTELVEPTEYLVVHLK.4|GVGGSQPPDIDKTELVEPTEYLVVHLK.3|GVGGSQPPDIDKTELVEPTEYLVVHLK.5|EVVLQWFTENSK.2|EVVLQWFTENSK.3|EATDVIIIHSK.3|EATDVIIIHSK.2|YLSYTLNPDLIR.2|YLSYTLNPDLIR.3|VMAVDALASSHPLSTPASEINTPAQISELFDAISYSK.4|VMAVDALASSHPLSTPASEINTPAQISELFDAISYSK.5|VM[Oxi]AVDALASSHPLSTPASEINTPAQISELFDAISYSK.4|VMAVDALASSHPLSTPASEINTPAQISELFDAISYSK.6|DLTALSNMLPK.2|DLTALSNM[Oxi]LPK.2|QWMENPNNNPIHPNLR.3|QWM[Oxi]ENPNNNPIHPNLR.3|DLMVLNDVYR.2|DLM[Oxi]VLNDVYR.2|LFNDYGGGSFSFSNLIQAVTR.3|LFNDYGGGSFSFSNLIQAVTR.2|ENSLLFDPLSSSSSNKER.3|ENSLLFDPLSSSSSNKER.2|QYMPWEAALSSLSYFK.3|QYMPWEAALSSLSYFK.2|QYM[Oxi]PWEAALSSLSYFK.3|QYM[Oxi]PWEAALSSLSYFK.2|ENKEVVLQWFTENSK.3|ENKEVVLQWFTENSK.2|VTLRPYLTPNDR.3|YLSYTLNPDLIRK.3|YLSYTLNPDLIRK.2|QVTPLFIHFR.3|QVTPLFIHFR.2|MLSSFLSEDVFK.2|M[Oxi]LSSFLSEDVFK.2|KLFNDYGGGSFSFSNLIQAVTR.3|FSTEYELQQLEQFKKDNEETGFGSGTR.4|VVATTQMQAADAR.2|VVATTQMQAADAR.3|VVATTQM[Oxi]QAADAR.2|VNYDEENWR.2|KVVATTQMQAADAR.3|KVVATTQM[Oxi]QAADAR.3|KVVATTQMQAADAR.2|KVVATTQM[Oxi]QAADAR.2|AQIINDAFNLASAHK.4|AQIINDAFNLASAHK.3|AQIINDAFNLASAHK.2|LPNTLKPDSYR.3|IQTQLQR.2|ALEQALEK.2|SEVYGPMK.2|VNYDEENWRK.3|VNYDEENWRK.2|KDNEETGFGSGTR.3|QASNGVLIR.2|VVATTQMQAADARK.3|SIQLPTTVR.2|RFSTEYELQQLEQFKK.4|RFSTEYELQQLEQFKK.3|VTLRPYLTPNDRGLYVFK.4|KVVATTQM[Oxi]QAADARK.3|KVVATTQMQAADARK.3|SEYMEGNVR.2|SEYM[Oxi]EGNVR.2|AALAC[CAM]SKELWILNR.3|ALEQALEKTK.2|DHSAIPVINR.2|WVKENKEVVLQWFTENSK.4|ENSLLFDPLSSSSSNK.3|ENSLLFDPLSSSSSNK.2|GVGGSQPPDIDK.2|TELVEPTEYLVVHLK.3|TELVEPTEYLVVHLK.2|DGRQQQDYWLIDVR.3|DNEETGFGSGTR.2|FSTEYELQQLEQFKK.3|FSTEYELQQLEQFKK.2|PSEFNYVWIVPITSIR.3|PSEFNYVWIVPITSIR.2|RFSTEYELQQLEQFK.3|RFSTEYELQQLEQFK.2|SFPC[CAM]FDEPAMK.2|AALAC[CAM]SKELWILNRYLSYTLNPDLIR.4|AALAC[CAM]SKELWILNRYLSYTLNPDLIR.3|ELWILNRYLSYTLNPDLIR.3|KQDATSTIISITNNVIGQGLVWDFVQSNWK.4|KQDATSTIISITNNVIGQGLVWDFVQSNWK.3|SDQIGLPDFNAGAMENWGLVTYR.3|DSQYEMDSEFEGELADDLAGFYR.3|FSTEYELQQLEQFK.2|STVYC[CAM]NAIAQGGEEEWDFAWEQFR.3|EIPENLMDQYSEVNAISTAC[CAM]SNGVPEC[CAM]EEMVSGLFK.4
SEN / CTL,"Keratin, type II cytoskeletal 8",KRT8,P05787,0.26,1.01,1.38E-01,4.58E-02,1.34E+00,"viral process,tumor necrosis factor-mediated signaling pathway,sarcomere organization,response to hydrostatic pressure,response to other organism,cell differentiation involved in embryonic placenta development,extrinsic apoptotic signaling pathway,hepatocyte apoptotic process","structural molecule activity,protein binding,protein complex binding,scaffold protein binding","nucleus,nucleoplasm,cytoplasm,intermediate filament,cell-cell junction,dystrophin-associated glycoprotein complex,nuclear matrix,Z disc,sarcolemma,costamere,keratin filament,extracellular exosome",105,65,157,LALDIEIATYR.2|LSELEAALQR.2|ASLEAAIADAEQRGELAIKDANAK.4|ASLEAAIADAEQRGELAIKDANAK.3|TLNNKFASFIDKVR.4|TLNNKFASFIDKVR.3|QLREYQELMNVK.3|QLREYQELMNVK.2|QLREYQELM[Oxi]NVK.3|LEGLTDEINFLR.2|LEGLTDEINFLR.3|ASLEAAIADAEQR.3|ASLEAAIADAEQR.2|AQYEDIANR.2|LALDIEIATYRK.3|LALDIEIATYRK.2|TEMENEFVLIKK.3|TEMENEFVLIKK.2|TEM[Oxi]ENEFVLIKK.3|TEM[Oxi]ENEFVLIKK.2|LQAEIEGLKGQR.3|LQAEIEGLKGQR.2|SLDMDSIIAEVK.2|SLDMDSIIAEVK.3|SLDM[Oxi]DSIIAEVK.2|DVDEAYMNKVELESRLEGLTDEINFLR.4|DVDEAYMNKVELESRLEGLTDEINFLR.3|DVDEAYMNKVELESR.3|DVDEAYM[Oxi]NKVELESR.3|DVDEAYMNKVELESR.2|GGLGGGYGGASGM[Oxi]GGITAVTVNQSLLSPLVLEVDPNIQAVR.4|GGLGGGYGGASGMGGITAVTVNQSLLSPLVLEVDPNIQAVR.4|GGLGGGYGGASGM[Oxi]GGITAVTVNQSLLSPLVLEVDPNIQAVR.6|GGLGGGYGGASGMGGITAVTVNQSLLSPLVLEVDPNIQAVR.6|GGLGGGYGGASGM[Oxi]GGITAVTVNQSLLSPLVLEVDPNIQAVR.5|GGLGGGYGGASGMGGITAVTVNQSLLSPLVLEVDPNIQAVR.5|QLYEEEIRELQSQISDTSVVLSMDNSR.4|QLYEEEIRELQSQISDTSVVLSM[Oxi]DNSR.4|QLYEEEIRELQSQISDTSVVLSM[Oxi]DNSR.3|QLYEEEIRELQSQISDTSVVLSMDNSR.3|KLLEGEESRLESGMQNMSIHTK.4|KLLEGEESRLESGMQNMSIHTK.5|KLLEGEESRLESGM[Oxi]QNM[Oxi]SIHTK.4|KLLEGEESRLESGMQNMSIHTK.3|DGKLVSESSDVLPK.3|DGKLVSESSDVLPK.2|SNMDNMFESYINNLRR.3|SNMDNMFESYINNLRR.4|SNM[Oxi]DNMFESYINNLRR.3|SNMDNM[Oxi]FESYINNLRR.3|SNM[Oxi]DNM[Oxi]FESYINNLRR.3|SNMDNMFESYINNLRR.2|SRAEAESMYQIKYEELQSLAGK.4|SRAEAESM[Oxi]YQIKYEELQSLAGK.4|SRAEAESMYQIKYEELQSLAGK.3|SRAEAESM[Oxi]YQIKYEELQSLAGK.3|LLEGEESR.2|FASFIDK.2|EYQELMNVK.2|EYQELM[Oxi]NVK.2|ASLEAAIADAEQRGELAIK.3|ASLEAAIADAEQRGELAIK.4|ASLEAAIADAEQRGELAIK.2|SRAEAESMYQIK.3|SRAEAESM[Oxi]YQIK.3|SRAEAESM[Oxi]YQIK.2|SRAEAESMYQIK.2|SNMDNMFESYINNLR.3|SNMDNM[Oxi]FESYINNLR.3|SNM[Oxi]DNM[Oxi]FESYINNLR.3|SNM[Oxi]DNM[Oxi]FESYINNLR.2|SNM[Oxi]DNMFESYINNLR.2|SNMDNM[Oxi]FESYINNLR.2|SNMDNMFESYINNLR.2|KDVDEAYMNK.3|KDVDEAYM[Oxi]NK.3|KDVDEAYMNK.2|RQLETLGQEK.3|RQLETLGQEK.2|TKTEISEMNR.3|TKTEISEM[Oxi]NR.3|TKTEISEMNR.2|TKTEISEM[Oxi]NR.2|RTEM[Oxi]ENEFVLIKK.4|RTEMENEFVLIKK.4|RTEMENEFVLIKK.3|RTEMENEFVLIKK.2|RTEM[Oxi]ENEFVLIKK.2|TKTEISEMNRNISR.4|TKTEISEM[Oxi]NRNISR.4|HGDDLRR.2|ISSSSFSR.2|NISRLQAEIEGLKGQR.4|RTKTEISEMNR.3|SYTSGPGSR.2|KDVDEAYMNKVELESR.4|TEISEMNR.2|TEISEM[Oxi]NR.2|LESGMQNMSIHTK.3|LESGM[Oxi]QNM[Oxi]SIHTK.3|LESGM[Oxi]QNMSIHTK.3|LESGMQNM[Oxi]SIHTK.3|LESGMQNMSIHTK.2|LESGM[Oxi]QNM[Oxi]SIHTK.2|LESGM[Oxi]QNMSIHTK.2|LESGMQNM[Oxi]SIHTK.2|LQAEIEGLK.2|RTEMENEFVLIK.3|RTEM[Oxi]ENEFVLIK.3|RTEMENEFVLIK.2|TQEKEQIK.2|YEELQSLAGKHGDDLRR.4|LKLEAELGNMQGLVEDFK.4|LKLEAELGNM[Oxi]QGLVEDFK.3|LKLEAELGNMQGLVEDFK.3|LKLEAELGNM[Oxi]QGLVEDFK.2|LKLEAELGNMQGLVEDFK.2|WSLLQQQK.2|QLETLGQEK.2|TQEKEQIKTLNNK.3|DANAKLSELEAALQR.3|DANAKLSELEAALQR.2|DVDEAYMNK.2|DVDEAYM[Oxi]NK.2|QLYEEEIR.2|SYKVSTSGPR.2|GELAIKDANAKLSELEAALQR.4|GELAIKDANAKLSELEAALQR.3|GELAIKDANAK.2|LKLEAELGNMQGLVEDFKNK.4|LKLEAELGNMQGLVEDFKNK.3|YEELQSLAGK.2|AEAESMYQIK.2|AEAESM[Oxi]YQIK.2|LVSESSDVLPK.2|LEAELGNMQGLVEDFK.3|LEAELGNMQGLVEDFK.2|LEAELGNM[Oxi]QGLVEDFK.2|LLEGEESRLESGMQNMSIHTK.4|LLEGEESRLESGMQNM[Oxi]SIHTK.3|LLEGEESRLESGMQNMSIHTK.3|TTSGYAGGLSSAYGGLTSPGLSYSLGSSFGSGAGSSSFSR.6|TTSGYAGGLSSAYGGLTSPGLSYSLGSSFGSGAGSSSFSR.5|TTSGYAGGLSSAYGGLTSPGLSYSLGSSFGSGAGSSSFSR.4|TEMENEFVLIK.2|TEM[Oxi]ENEFVLIK.2|ELQSQISDTSVVLSMDNSR.3|ELQSQISDTSVVLSM[Oxi]DNSR.3|ELQSQISDTSVVLSM[Oxi]DNSR.2|ELQSQISDTSVVLSMDNSR.2|VELESRLEGLTDEINFLR.3|AEAESMYQIKYEELQSLAGK.3|AEAESM[Oxi]YQIKYEELQSLAGK.3|AEAESM[Oxi]YQIKYEELQSLAGK.2|AEAESMYQIKYEELQSLAGK.2|SLDM[Oxi]DSIIAEVKAQYEDIANR.3|SLDMDSIIAEVKAQYEDIANR.3
SEN / CTL,Elongation factor 2,EEF2,P13639,0.25,1.02,8.58E-05,8.65E-05,4.06E+00,"hematopoietic progenitor cell differentiation,response to ischemia,skeletal muscle contraction,translational elongation,aging,glial cell proliferation,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,response to estradiol,response to endoplasmic reticulum stress,skeletal muscle cell differentiation,response to hydrogen peroxide,response to ethanol,positive regulation of translation,response to folic acid,cell-cell adhesion,cellular response to brain-derived neurotrophic factor stimulus,positive regulation of cytoplasmic translation","p53 binding,translation elongation factor activity,GTPase activity,protein binding,GTP binding,5S rRNA binding,protein kinase binding,ribosome binding,poly(A) RNA binding,actin filament binding,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,cytosol,plasma membrane,cell-cell adherens junction,membrane,aggresome,intracellular ribonucleoprotein complex,extracellular matrix,polysomal ribosome,membrane raft,extracellular exosome",144,84,183,VFSGLVSTGLK.2|EGIPALDNFLDKL.2|AYLPVNESFGFTADLR.3|AYLPVNESFGFTADLR.2|YLAEKYEWDVAEAR.3|YLAEKYEWDVAEAR.2|VNFTVDQIR.2|LM[Oxi]EPIYLVEIQC[CAM]PEQVVGGIYGVLNR.3|LMEPIYLVEIQC[CAM]PEQVVGGIYGVLNR.3|LMEPIYLVEIQC[CAM]PEQVVGGIYGVLNR.4|LM[Oxi]EPIYLVEIQC[CAM]PEQVVGGIYGVLNR.4|IMGPNYTPGKKEDLYLKPIQR.5|IM[Oxi]GPNYTPGKKEDLYLKPIQR.4|IMGPNYTPGKKEDLYLKPIQR.4|IMGPNYTPGKKEDLYLKPIQR.3|IM[Oxi]GPNYTPGKKEDLYLKPIQR.5|C[CAM]LYASVLTAQPR.2|C[CAM]LYASVLTAQPR.3|SDPVVSYRETVSEESNVLC[CAM]LSK.3|ALLELQLEPEELYQTFQR.3|ALLELQLEPEELYQTFQR.2|TFC[CAM]QLILDPIFK.2|TFC[CAM]QLILDPIFK.3|YVEPIEDVPC[CAM]GNIVGLVGVDQFLVK.3|YVEPIEDVPC[CAM]GNIVGLVGVDQFLVK.4|KIWC[CAM]FGPDGTGPNILTDITK.3|KIWC[CAM]FGPDGTGPNILTDITK.2|RC[CAM]LYASVLTAQPR.3|RC[CAM]LYASVLTAQPR.2|ETVSEESNVLC[CAM]LSK.2|ETVSEESNVLC[CAM]LSK.3|FAAKGEGQLGPAER.3|FAAKGEGQLGPAER.2|VFDAIMNFKKEETAK.4|VFDAIMNFKKEETAK.3|VFDAIMNFKKEETAK.2|STLTDSLVC[CAM]K.2|GGGQIIPTAR.2|ARPFPDGLAEDIDKGEVSAR.4|ARPFPDGLAEDIDKGEVSAR.3|ARPFPDGLAEDIDKGEVSAR.2|STAISLFYELSENDLNFIK.3|STAISLFYELSENDLNFIK.4|STAISLFYELSENDLNFIK.2|RWLPAGDALLQMITIHLPSPVTAQK.4|RWLPAGDALLQM[Oxi]ITIHLPSPVTAQK.4|RWLPAGDALLQMITIHLPSPVTAQK.3|GLKEGIPALDNFLDKL.3|GLKEGIPALDNFLDKL.2|QFAEMYVAK.2|QFAEM[Oxi]YVAK.2|FSVSPVVR.2|WLPAGDALLQMITIHLPSPVTAQK.3|WLPAGDALLQMITIHLPSPVTAQK.4|WLPAGDALLQM[Oxi]ITIHLPSPVTAQK.4|WLPAGDALLQM[Oxi]ITIHLPSPVTAQK.3|C[CAM]ELLYEGPPDDEAAMGIK.2|C[CAM]ELLYEGPPDDEAAM[Oxi]GIK.3|C[CAM]ELLYEGPPDDEAAMGIK.3|C[CAM]ELLYEGPPDDEAAM[Oxi]GIK.2|GVQYLNEIKDSVVAGFQWATK.3|GVQYLNEIKDSVVAGFQWATK.4|GVQYLNEIKDSVVAGFQWATK.2|GHVFEESQVAGTPMFVVK.3|GHVFEESQVAGTPMFVVK.4|GHVFEESQVAGTPM[Oxi]FVVK.3|GHVFEESQVAGTPM[Oxi]FVVK.2|GHVFEESQVAGTPMFVVK.2|TILMMGR.2|TILM[Oxi]MGR.2|TILMM[Oxi]GR.2|KRGHVFEESQVAGTPMFVVK.4|KRGHVFEESQVAGTPMFVVK.5|KRGHVFEESQVAGTPMFVVK.3|NMSVIAHVDHGKSTLTDSLVC[CAM]K.4|YRC[CAM]ELLYEGPPDDEAAMGIK.3|YRC[CAM]ELLYEGPPDDEAAMGIK.4|YRC[CAM]ELLYEGPPDDEAAM[Oxi]GIK.3|YRC[CAM]ELLYEGPPDDEAAM[Oxi]GIK.2|YRC[CAM]ELLYEGPPDDEAAMGIK.2|VFDAIMNFK.2|VFDAIM[Oxi]NFK.2|YLAEKYEWDVAEARK.4|YLAEKYEWDVAEARK.3|VAVEAKNPADLPK.3|VAVEAKNPADLPK.2|GPLMMYISK.2|GPLM[Oxi]MYISK.2|GPLMM[Oxi]YISK.2|GPLM[Oxi]M[Oxi]YISK.2|IMGPNYTPGKK.3|IMGPNYTPGKK.2|IM[Oxi]GPNYTPGKK.2|TGTITTFEHAHNMR.4|TGTITTFEHAHNM[Oxi]R.4|TGTITTFEHAHNMR.3|TGTITTFEHAHNM[Oxi]R.3|TGTITTFEHAHNM[Oxi]R.2|TGTITTFEHAHNMR.2|VFDAIMNFKK.3|VFDAIM[Oxi]NFKK.3|VFDAIMNFKK.2|KLWGDRYFDPANGK.4|KLWGDRYFDPANGK.3|EDLYLKPIQR.3|EDLYLKPIQR.2|YEWDVAEARK.3|YEWDVAEARK.2|LDSEDKDKEGKPLLK.4|LDSEDKDKEGKPLLK.3|NMSVIAHVDHGK.3|NM[Oxi]SVIAHVDHGK.3|NMSVIAHVDHGK.2|NM[Oxi]SVIAHVDHGK.2|DSVVAGFQWATK.3|DSVVAGFQWATK.2|FDVHDVTLHADAIHR.4|FDVHDVTLHADAIHR.3|FDVHDVTLHADAIHR.2|KVEDMMK.2|KVEDM[Oxi]MK.2|KVEDMM[Oxi]K.2|VFSGLVSTGLKVR.3|SDPVVSYR.2|KEDLYLKPIQR.3|KEDLYLKPIQR.2|FTDTRKDEQER.3|FTDTRKDEQER.2|LDIKLDSEDKDK.3|LDIKLDSEDKDK.2|DLEEDHAC[CAM]IPIK.3|DLEEDHAC[CAM]IPIK.2|IMGPNYTPGKKEDLYLK.4|IMGPNYTPGKKEDLYLK.3|PSQVVAETR.2|GEGQLGPAER.2|KVEDMMKK.2|ARPFPDGLAEDIDK.3|ARPFPDGLAEDIDK.2|LWGDRYFDPANGK.3|DLEEDHAC[CAM]IPIKK.3|DLEEDHAC[CAM]IPIKK.2|ARPFPDGLAEDIDKGEVSARQELK.5|ARPFPDGLAEDIDKGEVSARQELK.4|GVQYLNEIK.2|KSDPVVSYR.2|RGHVFEESQVAGTPMFVVK.4|RGHVFEESQVAGTPM[Oxi]FVVK.4|RGHVFEESQVAGTPM[Oxi]FVVK.3|RGHVFEESQVAGTPMFVVK.3|RGHVFEESQVAGTPM[Oxi]FVVK.2|RGHVFEESQVAGTPMFVVK.2|IMGPNYTPGK.2|IM[Oxi]GPNYTPGK.2|YEWDVAEAR.2|LDIKLDSEDK.2|EGALC[CAM]EENMR.2|EGALC[CAM]EENM[Oxi]R.2|MVNFTVDQIR.2|PFPDGLAEDIDKGEVSAR.3|VTDGALVVVDC[CAM]VSGVC[CAM]VQTETVLR.4|VTDGALVVVDC[CAM]VSGVC[CAM]VQTETVLR.3|KSDPVVSYRETVSEESNVLC[CAM]LSK.4|KSDPVVSYRETVSEESNVLC[CAM]LSK.3|PFPDGLAEDIDK.2|EGIPALDNFLDK.2|DGAGFLINLIDSPGHVDFSSEVTAALR.4|DGAGFLINLIDSPGHVDFSSEVTAALR.3|IWC[CAM]FGPDGTGPNILTDITK.3|IWC[CAM]FGPDGTGPNILTDITK.2|SNTGGQAFPQC[CAM]VFDHWQILPGDPFDNSSRPSQVVAETRK.6|SNTGGQAFPQC[CAM]VFDHWQILPGDPFDNSSRPSQVVAETRK.5|SNTGGQAFPQC[CAM]VFDHWQILPGDPFDNSSRPSQVVAETRK.4|LM[Oxi]EPIYLVEIQC[CAM]PEQVVGGIYGVLNRK.4|LMEPIYLVEIQC[CAM]PEQVVGGIYGVLNRK.4|LM[Oxi]EPIYLVEIQC[CAM]PEQVVGGIYGVLNRK.3|LMEPIYLVEIQC[CAM]PEQVVGGIYGVLNRK.3|QSKDGAGFLINLIDSPGHVDFSSEVTAALR.4|SDPMVQC[CAM]IIEESGEHIIAGAGELHLEIC[CAM]LK.4|SNTGGQAFPQC[CAM]VFDHWQILPGDPFDNSSRPSQVVAETR.5|SNTGGQAFPQC[CAM]VFDHWQILPGDPFDNSSRPSQVVAETR.4|STAISLFYELSENDLNFIKQSK.3|SNTGGQAFPQC[CAM]VFDHWQILPGDPFDNSSR.3
SEN / CTL,Poly(rC)-binding protein 1,PCBP1,Q15365,0.25,0.35,2.36E-04,2.15E-04,3.67E+00,"mRNA splicing, via spliceosome,gene expression,viral RNA genome replication,positive regulation of transcription from RNA polymerase II promoter,cell-cell adhesion","RNA polymerase II transcription factor activity, sequence-specific DNA binding,single-stranded DNA binding,RNA binding,mRNA binding,protein binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion,sequence-specific single stranded DNA binding","nucleoplasm,cytoplasm,cell-cell adherens junction,membrane,intracellular ribonucleoprotein complex,intracellular membrane-bounded organelle,extracellular exosome",30,15,49,AITIAGVPQSVTEC[CAM]VK.2|AITIAGVPQSVTEC[CAM]VK.3|IITLTGPTNAIFK.2|IITLTGPTNAIFK.3|VMTIPYQPM[Oxi]PASSPVIC[CAM]AGGQDR.3|VMTIPYQPMPASSPVIC[CAM]AGGQDR.3|VMTIPYQPMPASSPVIC[CAM]AGGQDR.4|VM[Oxi]TIPYQPMPASSPVIC[CAM]AGGQDR.3|VM[Oxi]TIPYQPM[Oxi]PASSPVIC[CAM]AGGQDR.3|LVVPATQC[CAM]GSLIGK.2|LVVPATQC[CAM]GSLIGK.3|QIC[CAM]LVMLETLSQSPQGR.3|QIC[CAM]LVM[Oxi]LETLSQSPQGR.2|QIC[CAM]LVMLETLSQSPQGR.2|AFAMIIDKLEEDINSSMTNSTAASRPPVTLR.4|AFAMIIDKLEEDINSSMTNSTAASRPPVTLR.5|AFAMIIDKLEEDINSSM[Oxi]TNSTAASRPPVTLR.6|AFAMIIDKLEEDINSSMTNSTAASRPPVTLR.6|AFAM[Oxi]IIDKLEEDINSSM[Oxi]TNSTAASRPPVTLR.5|AFAM[Oxi]IIDKLEEDINSSMTNSTAASRPPVTLR.5|AFAMIIDKLEEDINSSM[Oxi]TNSTAASRPPVTLR.5|AFAM[Oxi]IIDKLEEDINSSM[Oxi]TNSTAASRPPVTLR.4|AFAM[Oxi]IIDKLEEDINSSMTNSTAASRPPVTLR.4|AFAMIIDKLEEDINSSM[Oxi]TNSTAASRPPVTLR.4|AFAM[Oxi]IIDKLEEDINSSMTNSTAASRPPVTLR.3|AFAMIIDKLEEDINSSM[Oxi]TNSTAASRPPVTLR.3|AFAMIIDKLEEDINSSMTNSTAASRPPVTLR.3|QGANINEIR.2|QQSHFAMMHGGTGFAGIDSSSPEVK.5|QQSHFAMMHGGTGFAGIDSSSPEVK.4|QQSHFAM[Oxi]M[Oxi]HGGTGFAGIDSSSPEVK.4|QQSHFAMM[Oxi]HGGTGFAGIDSSSPEVK.4|QQSHFAM[Oxi]MHGGTGFAGIDSSSPEVK.3|QQSHFAMM[Oxi]HGGTGFAGIDSSSPEVK.3|QQSHFAMMHGGTGFAGIDSSSPEVK.3|IANPVEGSSGR.2|QVTITGSAASISLAQYLINAR.4|QVTITGSAASISLAQYLINAR.3|QVTITGSAASISLAQYLINAR.2|LVVPATQC[CAM]GSLIGKGGC[CAM]K.3|LEEDINSSMTNSTAASRPPVTLR.4|LEEDINSSMTNSTAASRPPVTLR.3|LEEDINSSM[Oxi]TNSTAASRPPVTLR.3|C[CAM]SDAAGYPHATHDLEGPPLDAYSIQGQHTISPLDLAK.6|C[CAM]SDAAGYPHATHDLEGPPLDAYSIQGQHTISPLDLAK.5|C[CAM]SDAAGYPHATHDLEGPPLDAYSIQGQHTISPLDLAK.4|GYWASLDASTQTTHELTIPNNLIGC[CAM]IIGR.4|GYWASLDASTQTTHELTIPNNLIGC[CAM]IIGR.3|AITIAGVPQSVTEC[CAM]VKQIC[CAM]LVMLETLSQSPQGR.4
SEN / CTL,"Spectrin alpha chain, non-erythrocytic 1",SPTAN1,Q13813,0.25,0.68,2.50E-09,7.10E-09,8.15E+00,"MAPK cascade,ER to Golgi vesicle-mediated transport,cytoskeleton organization,axon guidance,positive regulation of GTPase activity,actin filament capping,cell-cell adhesion","actin binding,Ras guanyl-nucleotide exchange factor activity,structural constituent of cytoskeleton,calcium ion binding,protein binding,calmodulin binding,cadherin binding involved in cell-cell adhesion","cytosol,cell-cell adherens junction,spectrin,microtubule cytoskeleton,membrane,intracellular membrane-bounded organelle,extracellular exosome,extracellular vesicle",225,282,447,ETENVKSSEEIESAFR.3|LQQLFRDVEDEETWIR.3|FLSDFRDLMSWINGIR.3|DVEDEETWIR.2|MTLVASEDYGDTLAAIQGLLK.3|MTLVASEDYGDTLAAIQGLLK.2|M[Oxi]TLVASEDYGDTLAAIQGLLK.3|SSLSSAQADFNQLAELDR.3|SSLSSAQADFNQLAELDR.2|QQVAPTDDETGKELVLALYDYQEK.3|ALSSEGKPYVTKEELYQNLTR.4|ALSSEGKPYVTKEELYQNLTR.3|DLAALGDKVNSLGETAER.3|DLAALGDKVNSLGETAER.2|LAALADQWQFLVQK.2|LAALADQWQFLVQK.3|HQAFEAELHANADRIR.4|VLETAEDIQER.2|VLETAEDIQER.3|KVEDLFLTFAK.3|KVEDLFLTFAK.2|SLQQLAEER.2|GVIDMGNSLIER.2|GVIDM[Oxi]GNSLIER.2|GRELPTAFDYVEFTR.3|GRELPTAFDYVEFTR.2|VASNPYTWFTMEALEETWR.3|VASNPYTWFTMEALEETWR.2|RQDLEDSLQAQQYFADANEAESWMR.3|RQDLEDSLQAQQYFADANEAESWM[Oxi]R.3|KLLVGSEDYGRDLTGVQNLR.4|KLLVGSEDYGRDLTGVQNLR.3|REELITNWEQIR.3|REELITNWEQIR.2|HQAFEAELSANQSR.3|HQAFEAELSANQSR.2|NQALNTDNYGHDLASVQALQR.3|NQALNTDNYGHDLASVQALQR.2|KGDILTLLNSTNKDWWK.4|KGDILTLLNSTNKDWWK.3|GKDLIGVQNLLK.2|GKDLIGVQNLLK.3|MNEVISLWK.2|M[Oxi]NEVISLWK.2|GLVSSDELAKDVTGAEALLER.3|GLVSSDELAKDVTGAEALLER.4|GLVSSDELAKDVTGAEALLER.2|LLVGSEDYGRDLTGVQNLR.3|LLVGSEDYGRDLTGVQNLR.4|QKLDILDQERADLEK.4|QKLDILDQERADLEK.3|VLETAEDIQERR.3|IAALQAFADQLIAAGHYAK.3|IAALQAFADQLIAAGHYAK.4|IAALQAFADQLIAAGHYAK.2|AGTFQAFEQFGQQLLAHGHYASPEIK.4|AGTFQAFEQFGQQLLAHGHYASPEIK.5|AGTFQAFEQFGQQLLAHGHYASPEIK.3|LIQSHPESAEDLQEKC[CAM]TELNQAWSSLGK.4|LIQSHPESAEDLQEKC[CAM]TELNQAWSSLGK.3|LIDVNHYAKDEVAAR.4|LIDVNHYAKDEVAAR.3|LIDVNHYAKDEVAAR.2|HQAFEAELHANADR.3|HQAFEAELHANADR.4|HQAFEAELHANADR.2|EQADYC[CAM]VSHMKPYVDGK.4|EQADYC[CAM]VSHMKPYVDGK.3|SSEEIESAFR.2|LIQEQHPEEELIKTKQDEVNAAWQR.4|NTTGVTEEALKEFSMMFK.3|NTTGVTEEALKEFSM[Oxi]MFK.3|NTTGVTEEALKEFSMM[Oxi]FK.3|NTTGVTEEALKEFSMMFK.2|ELPTAFDYVEFTR.2|ELPTAFDYVEFTR.3|GNAMVEEGHFAAEDVK.3|GNAM[Oxi]VEEGHFAAEDVK.3|GNAMVEEGHFAAEDVK.2|KVEDLFLTFAKK.3|KVEDLFLTFAKK.2|QETFDAGLQAFQQEGIANITALKDQLLAAK.4|QETFDAGLQAFQQEGIANITALKDQLLAAK.3|LSDDNTIGKEEIQQR.3|LSDDNTIGKEEIQQR.2|LMVHTVATFNSIKELNER.4|LMVHTVATFNSIKELNER.3|EKEPIVGSTDYGKDEDSAEALLK.3|EKEPIVGSTDYGKDEDSAEALLK.4|EANELQQWINEK.2|LMVHTVATFNSIK.3|LM[Oxi]VHTVATFNSIK.3|LMVHTVATFNSIK.2|LM[Oxi]VHTVATFNSIK.2|MQHNLEQQIQAR.3|M[Oxi]QHNLEQQIQAR.3|M[Oxi]QHNLEQQIQAR.2|MQHNLEQQIQAR.2|DLMSWINGIR.2|HQALQAEIAGHEPR.3|LQTASDESYKDPTNIQSK.3|LQTASDESYKDPTNIQSK.2|DLSSVQTLLTK.2|AALLELWELRR.3|AALLELWELRR.2|KHEALMSDLSAYGSSIQALR.4|KHEALM[Oxi]SDLSAYGSSIQALR.4|KHEALM[Oxi]SDLSAYGSSIQALR.3|KHEALMSDLSAYGSSIQALR.3|KHEALM[Oxi]SDLSAYGSSIQALR.2|KHEALMSDLSAYGSSIQALR.2|ASAFNSWFENAEEDLTDPVR.3|ASAFNSWFENAEEDLTDPVR.2|AKLDENSAFLQFNWK.3|AKLDENSAFLQFNWK.2|DADETKEWIEEKNQALNTDNYGHDLASVQALQR.5|DADETKEWIEEKNQALNTDNYGHDLASVQALQR.4|FLADFRDLTSWVTEMK.3|FLADFRDLTSWVTEM[Oxi]K.3|LGESQTLQQFSR.2|LGESQTLQQFSR.3|AQLADSFHLQQFFR.3|AQLADSFHLQQFFR.2|HQLLEADISAHEDR.4|HQLLEADISAHEDR.3|HQLLEADISAHEDR.2|EKEPIAASTNR.3|HQKHQAFEAELHANADR.5|LLEATELKGIK.3|AKLGDSHDLQR.3|AKLGDSHDLQR.2|KLLVGSEDYGR.3|KLLVGSEDYGR.2|DAEELEK.2|GEIDAHEDSFK.3|GEIDAHEDSFK.2|KHALLEADVAAHQDR.4|KHQALQAEIAGHEPR.4|KHQALQAEIAGHEPR.3|KHQALQAEIAGHEPR.2|ALSSEGKPYVTK.3|ALSSEGKPYVTK.2|KFDDFQKDLK.3|KFDDFQKDLK.2|DPTNLQGK.2|ENSLKTDDYGR.3|ENSLKTDDYGR.2|QGKLFGAAEVQR.3|YEALKEPMVAR.3|YEALKEPM[Oxi]VAR.3|DLAALEDK.2|DLAALEDK.1|KHQLLEADISAHEDR.4|KHQLLEADISAHEDR.3|LHELNQK.2|NNHHEENISSK.3|QFQDAGHFDAENIKK.4|QFQDAGHFDAENIKK.3|SQLLGSAHEVQR.3|SQLLGSAHEVQR.2|KLLEATELKGIK.3|ALC[CAM]AEADR.2|EQADYC[CAM]VSHMK.3|EQADYC[CAM]VSHMK.2|HQKHQAFEAELHANADRIR.5|HQKHQAFEAELHANADRIR.4|KHEGFER.2|KQEALVAR.2|RNEVLDR.2|RQQVLDR.2|AINVQEEK.2|HQEHRTEIDAR.3|KFDDFQK.2|KHEAFETDFTVHKDR.4|KHEDFDKAINVQEEK.4|LIQEQHPEEELIKTK.4|LLEATELK.2|LMELHRQWELLLEK.4|LNHQEFK.2|RWSQLLANSAAR.3|RWSQLLANSAAR.2|DRVNDVC[CAM]TNGQDLIKK.4|DRVNDVC[CAM]TNGQDLIKK.3|HQLLEADISAHEDRLK.4|HQLLEADISAHEDRLK.3|KFEEFQTDMAAHEER.4|KFEEFQTDMAAHEER.3|KFEEFQTDM[Oxi]AAHEER.3|KLSDDNTIGKEEIQQR.4|KLSDDNTIGKEEIQQR.3|RAQLADSFHLQQFFR.4|RAQLADSFHLQQFFR.3|RLEAELAAHEPAIQGVLDTGKK.5|RLEAELAAHEPAIQGVLDTGKK.4|RLEAELAAHEPAIQGVLDTGKK.3|GKDLIGVQNLLKK.3|GKDLIGVQNLLKK.2|HQEHKGEIDAHEDSFK.4|HQEHKGEIDAHEDSFK.3|KGDILTLLNSTNK.3|KGDILTLLNSTNK.2|LTVLSEER.2|DSDELKSWVNEK.3|DSDELKSWVNEK.2|EPIAASTNR.2|FHRDADETKEWIEEK.4|GNAM[Oxi]VEEGHFAAEDVKAK.4|LIQNNHYAMEDVATRR.4|LIQNNHYAM[Oxi]EDVATRR.4|LIQNNHYAMEDVATRR.3|LSDDNTIGK.2|TKQDEVNAAWQR.3|TKQDEVNAAWQR.2|HEAFETDFTVHK.3|C[CAM]NSLEEIK.2|ENLLEEQGSIALR.3|ENLLEEQGSIALR.2|IDGITIQAR.2|KIEDLGAAMEEALILDNK.4|KIEDLGAAMEEALILDNK.3|KIEDLGAAMEEALILDNK.2|LFGAAEVQR.2|DADETKEWIEEK.3|DADETKEWIEEK.2|KHQLLEADISAHEDRLK.4|KHQLLEADISAHEDRLK.3|LDILDQER.2|LHELNQKWEALK.3|LHELNQKWEALK.2|LRQEFAQHANAFHQWIQETR.5|LRQEFAQHANAFHQWIQETR.4|DLTGVQNLR.2|EKEQLMASDDFGR.3|GLVSSDELAK.2|LAQFVEHWKELK.3|ALC[CAM]AEADRLQQSHPLSATQIQVK.5|ALC[CAM]AEADRLQQSHPLSATQIQVK.4|ALC[CAM]AEADRLQQSHPLSATQIQVK.3|HALLEADVAAHQDR.3|HALLEADVAAHQDR.2|LREANQQQQFNR.3|LREANQQQQFNR.2|KLLEATELK.2|LDILDQERADLEK.3|LGDSHDLQR.2|GAC[CAM]AGSEDAVK.2|KHALLEADVAAHQDRIDGITIQAR.5|KHALLEADVAAHQDRIDGITIQAR.4|KHALLEADVAAHQDRIDGITIQAR.3|KHEAFETDFTVHK.3|QQNFNTGIK.2|QWELLLEK.2|KLDPAQSASR.2|LAQFVEHWKELKQLAAAR.4|LAQFVEHWKELKQLAAAR.3|LIDVNHYAK.2|LIQEQHPEEELIK.3|LIQEQHPEEELIK.2|SKLGESQTLQQFSR.3|SKLGESQTLQQFSR.2|VNDVC[CAM]TNGQDLIKK.3|VNSLGETAER.2|DEDSAEALLK.2|DLASVNNLLK.2|DLASVQALLR.2|FNRDVDETISWIK.3|FNRDVDETISWIK.2|KLSDDNTIGK.2|QFQDAGHFDAENIK.3|QFQDAGHFDAENIK.2|QGFVPAAYVK.2|DLAALEDKVK.2|LEAELAAHEPAIQGVLDTGKK.4|LLEAQSHFR.2|ALINADELASDVAGAEALLDRHQEHK.5|ALINADELASDVAGAEALLDRHQEHK.4|DLIGVQNLLK.2|ITALDEFATK.2|LLVGSEDYGR.2|LLVGSEDYGRDLTGVQNLRK.4|LLVGSEDYGRDLTGVQNLRK.3|LQQSHPLSATQIQVK.3|LQQSHPLSATQIQVK.2|QEFAQHANAFHQWIQETR.4|RLEAELAAHEPAIQGVLDTGK.4|RLEAELAAHEPAIQGVLDTGK.3|VNEVNQFAAK.2|QEQIDNQTR.2|ALINADELASDVAGAEALLDRHQEHKGEIDAHEDSFK.7|ALINADELASDVAGAEALLDRHQEHKGEIDAHEDSFK.6|LQTASDESYK.2|FEEFQTDMAAHEER.3|HEAFETDFTVHKDR.3|LAQFVEHWK.2|LIQSHPESAEDLQEK.3|LIQSHPESAEDLQEK.2|TATDEAYKDPSNLQGK.3|TATDEAYKDPSNLQGK.2|DLTNVQNLQK.2|DRVNDVC[CAM]TNGQDLIK.3|DRVNDVC[CAM]TNGQDLIK.2|DVTGAEALLER.2|EELYQNLTR.2|EPIVGSTDYGK.2|NTTGVTEEALK.2|EAIVTSEELGQDLEHVEVLQK.4|EAIVTSEELGQDLEHVEVLQK.3|EAIVTSEELGQDLEHVEVLQK.2|KFEEFQTDMAAHEERVNEVNQFAAK.5|KFEEFQTDMAAHEERVNEVNQFAAK.4|KFEEFQTDM[Oxi]AAHEERVNEVNQFAAK.4|LIQNNHYAMEDVATR.3|LIQNNHYAMEDVATR.2|LQIASDENYK.2|VEDLFLTFAK.2|HQAFEAEVQANSGAIVK.3|HQAFEAEVQANSGAIVK.2|QVEELYHSLLELGEK.3|QVEELYHSLLELGEK.2|SLQQLAEERSQLLGSAHEVQR.4|SLQQLAEERSQLLGSAHEVQR.3|VEVNDRQGFVPAAYVK.3|AALLELWELR.2|ADVVESWIGEKENSLK.3|DLTSWVTEMK.2|DVDETISWIK.2|KHEALMSDLSAYGSSIQALREQAQSC[CAM]R.5|KHEALMSDLSAYGSSIQALREQAQSC[CAM]R.4|KHEALMSDLSAYGSSIQALREQAQSC[CAM]R.3|SADESGQALLAAGHYASDEVREK.4|SADESGQALLAAGHYASDEVREK.3|HEDFDKAINVQEEKIAALQAFADQLIAAGHYAK.6|MMLDQC[CAM]LELQLFHR.3|MM[Oxi]LDQC[CAM]LELQLFHR.3|MMLDQC[CAM]LELQLFHR.2|QDEVNAAWQR.2|WSQLLANSAAR.2|ADVVESWIGEK.2|ARLAALADQWQFLVQK.3|DLIGVQNLLKK.2|DVEDEETWIREKEPIAASTNR.4|DVEDEETWIREKEPIAASTNR.3|ENSLKTDDYGRDLSSVQTLLTK.4|GDSLDSVEALIK.2|QETFDAGLQAFQQEGIANITALK.4|QETFDAGLQAFQQEGIANITALK.3|QQVAPTDDETGKELVLALYDYQEKSPR.5|QQVAPTDDETGKELVLALYDYQEKSPR.4|ADVVESWIGEKENSLKTDDYGR.4|DGHVSLQEYMAFMISR.3|HALLEADVAAHQDRIDGITIQAR.4|HALLEADVAAHQDRIDGITIQAR.3|QKLDILDQER.2|DMDDEESWIK.2|DM[Oxi]DDEESWIK.2|EANQQQQFNR.2|EQLMASDDFGR.2|EQLM[Oxi]ASDDFGR.2|GDILTLLNSTNKDWWK.3|GDILTLLNSTNKDWWK.2|KLDPAQSASRENLLEEQGSIALR.4|KLDPAQSASRENLLEEQGSIALR.3|TDDYGRDLSSVQTLLTK.3|GAC[CAM]AGSEDAVKAR.2|GDILTLLNSTNK.2|QQVAPTDDETGK.2|EKEQLMASDDFGRDLASVQALLR.4|VQKHQAFEAELSANQSR.3|MKTATDEAYKDPSNLQGK.3|RMMLDQC[CAM]LELQLFHR.3|SLSAQEEKITALDEFATK.3|SLSAQEEKITALDEFATK.2|DTEQVDNWMSK.2|HQEHKGEIDAHEDSFKSADESGQALLAAGHYASDEVR.6|HQEHKGEIDAHEDSFKSADESGQALLAAGHYASDEVR.5|LIQSHPESAEDLQEKC[CAM]TELNQAWSSLGKR.5|LIQSHPESAEDLQEKC[CAM]TELNQAWSSLGKR.4|NVEDIELWLYEVEGHLASDDYGK.4|NVEDIELWLYEVEGHLASDDYGK.3|ALC[CAM]AEADRLQQSHPLSATQIQVKR.4|HEALMSDLSAYGSSIQALR.3|HEALMSDLSAYGSSIQALR.2|LQIASDENYKDPTNLQGK.3|LQIASDENYKDPTNLQGK.2|MKQVEELYHSLLELGEK.3|M[Oxi]KQVEELYHSLLELGEK.3|M[Oxi]KQVEELYHSLLELGEK.2|TATDEAYKDPSNLQGKVQK.3|ALINADELASDVAGAEALLDR.3|ALINADELASDVAGAEALLDR.2|AINVQEEKIAALQAFADQLIAAGHYAK.4|AINVQEEKIAALQAFADQLIAAGHYAK.3|DVDEIEAWISEK.2|EELITNWEQIR.2|SADESGQALLAAGHYASDEVR.3|SADESGQALLAAGHYASDEVR.2|DC[CAM]EQAENWMAAR.2|ELVLALYDYQEK.2|LDETGNLM[Oxi]ISEGHFASETIR.3|LDETGNLMISEGHFASETIR.3|VNDVC[CAM]TNGQDLIK.2|C[CAM]TELNQAWSSLGK.2|DLNSQADSLM[Oxi]TSSAFDTSQVK.3|DLNSQADSLMTSSAFDTSQVK.3|DLNSQADSLM[Oxi]TSSAFDTSQVK.2|DLNSQADSLMTSSAFDTSQVK.2|EAALTSEEVGADLEQVEVLQK.3|EAALTSEEVGADLEQVEVLQK.2|EPIVGSTDYGKDEDSAEALLK.3|EPIVGSTDYGKDEDSAEALLK.2|HQAFEAELSANQSRIDALEK.3|DAEELEKWIQEK.2|EAFLNTEDKGDSLDSVEALIK.3|EAFLNTEDKGDSLDSVEALIK.2|EC[CAM]EDVMDWINDK.2|SSLSSAQADFNQLAELDRQIK.3|EQLM[Oxi]ASDDFGRDLASVQALLR.3|EQLMASDDFGRDLASVQALLR.3|MTLVASEDYGDTLAAIQGLLKK.3|DLAALGDK.1|EAALTSEEVGADLEQVEVLQKK.3|LDENSAFLQFNWK.2|NVEDIELWLYEVEGHLASDDYGKDLTNVQNLQKK.5|KASAFNSWFENAEEDLTDPVR.3|QEAFLLNEDLGDSLDSVEALLK.3|LKDLNSQADSLMTSSAFDTSQVK.3|LKDLNSQADSLM[Oxi]TSSAFDTSQVK.3|DVDEIEAWISEKLQTASDESYKDPTNIQSK.4|ENLLEEQGSIALRQEQIDNQTR.3|KASAFNSWFENAEEDLTDPVRC[CAM]NSLEEIK.4|QEAFLLNEDLGDSLDSVEALLKK.3|YTEHSTVGLAQQWDQLDQLGM[Oxi]R.3|YTEHSTVGLAQQWDQLDQLGMR.3|DLSSVQTLLTKQETFDAGLQAFQQEGIANITALKDQLLAAK.5|DLSSVQTLLTKQETFDAGLQAFQQEGIANITALKDQLLAAK.4|TYLLDGSC[CAM]MVEESGTLESQLEATK.3|EANELQQWINEKEAALTSEEVGADLEQVEVLQK.4|IEDLGAAMEEALILDNK.2|TYLLDGSC[CAM]MVEESGTLESQLEATKR.3|VASNPYTWFTMEALEETWRNLQK.3|NVEDIELWLYEVEGHLASDDYGKDLTNVQNLQK.4|QQYEQC[CAM]MDLQLFYR.2|LEESLEYQQFVANVEEEEAWINEK.3|ASAFNSWFENAEEDLTDPVRC[CAM]NSLEEIK.3|GQRLEESLEYQQFVANVEEEEAWINEK.3|SLGYDLPMVEEGEPDPEFEAILDTVDPNR.3|VAEDLESEGLMAEEVQAVQQQEVYGMMPR.3
SEN / CTL,Transitional endoplasmic reticulum ATPase,VCP,P55072,0.25,0.44,1.23E-05,1.53E-05,4.82E+00,"DNA repair,double-strand break repair,NADH metabolic process,ER to Golgi vesicle-mediated transport,autophagy,activation of cysteine-type endopeptidase activity involved in apoptotic process,cellular response to DNA damage stimulus,positive regulation of mitochondrial membrane potential,protein ubiquitination,protein N-linked glycosylation via asparagine,viral genome replication,translesion synthesis,ER-associated ubiquitin-dependent protein catabolic process,endoplasmic reticulum unfolded protein response,retrograde protein transport, ER to cytosol,positive regulation of protein complex assembly,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,protein hexamerization,ERAD pathway,regulation of apoptotic process,proteasome-mediated ubiquitin-dependent protein catabolic process,establishment of protein localization,positive regulation of protein catabolic process,ATP metabolic process,protein homooligomerization,aggresome assembly,error-free translesion synthesis,ER-associated misfolded protein catabolic process,flavin adenine dinucleotide catabolic process,autophagosome maturation,positive regulation of protein K63-linked deubiquitination,positive regulation of Lys63-specific deubiquitinase activity,regulation of aerobic respiration,positive regulation of oxidative phosphorylation,positive regulation of ubiquitin-specific protease activity,positive regulation of ATP biosynthetic process","protein binding,ATP binding,lipid binding,ATPase activity,protein phosphatase binding,protein domain specific binding,polyubiquitin binding,ubiquitin protein ligase binding,deubiquitinase activator activity,K48-linked polyubiquitin binding,MHC class I protein binding,identical protein binding,ADP binding,ubiquitin-like protein ligase binding,poly(A) RNA binding,BAT3 complex binding,ubiquitin-specific protease binding","proteasome complex,nucleus,nucleoplasm,cytoplasm,endoplasmic reticulum,endoplasmic reticulum membrane,lipid particle,cytosol,VCP-NPL4-UFD1 AAA ATPase complex,site of double-strand break,Derlin-1 retrotranslocation complex,myelin sheath,intracellular membrane-bounded organelle,perinuclear region of cytoplasm,extracellular exosome,VCP-NSFL1C complex",201,94,187,ELQELVQYPVEHPDKFLK.4|ELQELVQYPVEHPDKFLK.3|LDQLIYIPLPDEK.2|GILLYGPPGTGK.2|IVSQLLTLMDGLKQR.3|FGRFDREVDIGIPDATGR.4|GGNIGDGGGAADRVINQILTEMDGMSTKK.4|IHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIR.5|IHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIR.6|IHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIR.4|QAAPC[CAM]VLFFDELDSIAK.3|QAAPC[CAM]VLFFDELDSIAK.2|GGNIGDGGGAADRVINQILTEMDGMSTK.3|LADDVDLEQVANETHGHVGADLAALC[CAM]SEAALQAIR.4|LADDVDLEQVANETHGHVGADLAALC[CAM]SEAALQAIR.5|LADDVDLEQVANETHGHVGADLAALC[CAM]SEAALQAIR.6|WALSQSNPSALRETVVEVPQVTWEDIGGLEDVKR.4|AFEEAEKNAPAIIFIDELDAIAPK.3|MTNGFSGADLTEIC[CAM]QR.2|MTNGFSGADLTEIC[CAM]QR.3|M[Oxi]TNGFSGADLTEIC[CAM]QR.2|M[Oxi]TNGFSGADLTEIC[CAM]QR.3|LGDVISIQPC[CAM]PDVK.2|LGDVISIQPC[CAM]PDVK.3|IVSQLLTLMDGLK.2|IVSQLLTLMDGLK.3|IVSQLLTLM[Oxi]DGLK.2|LIVDEAINEDNSVVSLSQPK.3|LIVDEAINEDNSVVSLSQPK.2|AHVIVMAATNRPNSIDPALRR.5|AHVIVMAATNRPNSIDPALRR.4|AHVIVMAATNRPNSIDPALRR.3|AHVIVM[Oxi]AATNRPNSIDPALRR.5|MDELQLFR.2|M[Oxi]DELQLFR.2|ETVVEVPQVTWEDIGGLEDVKR.3|ETVVEVPQVTWEDIGGLEDVKR.4|KYEMFAQTLQQSR.3|KYEMFAQTLQQSR.2|KYEM[Oxi]FAQTLQQSR.3|KYEM[Oxi]FAQTLQQSR.2|VRLGDVISIQPC[CAM]PDVK.3|VRLGDVISIQPC[CAM]PDVK.2|WALSQSNPSALR.2|WALSQSNPSALR.3|ERQTNPSAMEVEEDDPVPEIR.3|ERQTNPSAM[Oxi]EVEEDDPVPEIR.3|EVDIGIPDATGRLEILQIHTK.4|EVDIGIPDATGRLEILQIHTK.3|AIANEC[CAM]QANFISIK.2|AIANEC[CAM]QANFISIK.3|ERQTNPSAMEVEEDDPVPEIRR.4|ERQTNPSAMEVEEDDPVPEIRR.3|NAPAIIFIDELDAIAPKR.3|NAPAIIFIDELDAIAPKR.2|KNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEK.6|KNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEK.5|NRPNRLIVDEAINEDNSVVSLSQPK.4|RIVSQLLTLMDGLK.3|RIVSQLLTLMDGLK.2|RIVSQLLTLM[Oxi]DGLK.2|EMVELPLRHPALFK.4|EMVELPLRHPALFK.3|EM[Oxi]VELPLRHPALFK.3|EM[Oxi]VELPLRHPALFK.4|EM[Oxi]VELPLRHPALFK.2|EMVELPLRHPALFK.2|VINQILTEMDGMSTK.2|VINQILTEMDGMSTK.3|VINQILTEMDGM[Oxi]STK.3|VINQILTEM[Oxi]DGMSTK.2|VINQILTEMDGM[Oxi]STK.2|VINQILTEM[Oxi]DGM[Oxi]STK.2|LADDVDLEQVANETHGHVGADLAALC[CAM]SEAALQAIRK.5|LADDVDLEQVANETHGHVGADLAALC[CAM]SEAALQAIRK.6|LADDVDLEQVANETHGHVGADLAALC[CAM]SEAALQAIRK.4|AFEEAEKNAPAIIFIDELDAIAPKR.4|AFEEAEKNAPAIIFIDELDAIAPKR.3|NVFIIGATNRPDIIDPAILRPGR.4|NVFIIGATNRPDIIDPAILRPGR.5|NVFIIGATNRPDIIDPAILRPGR.3|IHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIRK.6|IHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIRK.5|NAPAIIFIDELDAIAPK.3|NAPAIIFIDELDAIAPK.2|AVANETGAFFFLINGPEIMSK.3|AVANETGAFFFLINGPEIM[Oxi]SK.3|AVANETGAFFFLINGPEIM[Oxi]SK.2|AVANETGAFFFLINGPEIMSK.2|MDELQLFRGDTVLLK.3|M[Oxi]DELQLFRGDTVLLK.3|M[Oxi]DELQLFRGDTVLLK.2|MDELQLFRGDTVLLK.2|KAFEEAEKNAPAIIFIDELDAIAPK.4|KAFEEAEKNAPAIIFIDELDAIAPK.3|VINQILTEMDGMSTKK.3|VINQILTEMDGM[Oxi]STKK.3|VINQILTEMDGMSTKK.2|DVDLEFLAK.2|EVDIGIPDATGR.2|EAVC[CAM]IVLSDDTC[CAM]SDEKIR.3|GDIFLVR.2|NVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEK.5|NVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEK.6|NVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEK.4|GVLFYGPPGC[CAM]GK.2|GVLFYGPPGC[CAM]GK.3|RIHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIR.6|RIHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIR.5|LAGESESNLRK.3|LAGESESNLRK.2|RDHFEEAM[Oxi]R.3|RDHFEEAMR.2|AFEEAEK.2|AIGVKPPR.2|ARGGNIGDGGGAADR.3|ARGGNIGDGGGAADR.2|ELQELVQYPVEHPDK.4|ELQELVQYPVEHPDK.3|ELQELVQYPVEHPDK.2|SVSDNDIR.2|KGDIFLVR.2|PYFLEAYRPIR.3|ESIESEIR.2|EMVELPLR.2|RELQELVQYPVEHPDK.4|RELQELVQYPVEHPDK.3|RELQELVQYPVEHPDK.2|GDDLSTAILK.2|SPVAKDVDLEFLAK.3|DHFEEAMR.2|DHFEEAM[Oxi]R.2|KNVFIIGATNRPDIIDPAILRPGR.5|KNVFIIGATNRPDIIDPAILRPGR.4|RSVSDNDIR.2|AHVIVMAATNRPNSIDPALR.4|AHVIVM[Oxi]AATNRPNSIDPALR.4|AHVIVM[Oxi]AATNRPNSIDPALR.3|AHVIVMAATNRPNSIDPALR.3|LAGESESNLR.2|FDREVDIGIPDATGRLEILQIHTK.5|FDREVDIGIPDATGRLEILQIHTK.4|FDREVDIGIPDATGRLEILQIHTK.3|LEILQIHTK.2|ESIESEIRR.2|FDREVDIGIPDATGR.3|FDREVDIGIPDATGR.2|GGNIGDGGGAADR.2|QTNPSAMEVEEDDPVPEIRR.4|QTNPSAMEVEEDDPVPEIRR.3|LDQLIYIPLPDEKSR.3|EAVC[CAM]IVLSDDTC[CAM]SDEK.3|EAVC[CAM]IVLSDDTC[CAM]SDEK.2|NVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSR.7|NVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSR.6|NVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSR.5|REDEEESLNEVGYDDIGGC[CAM]RK.4|REDEEESLNEVGYDDIGGC[CAM]RK.3|GPELLTMWFGESEANVR.3|GPELLTM[Oxi]WFGESEANVR.3|GPELLTMWFGESEANVR.2|GPELLTM[Oxi]WFGESEANVR.2|IHVLPIDDTVEGITGNLFEVYLK.4|IHVLPIDDTVEGITGNLFEVYLK.3|REAVC[CAM]IVLSDDTC[CAM]SDEK.3|RIHVLPIDDTVEGITGNLFEVYLK.4|RIHVLPIDDTVEGITGNLFEVYLK.3|ARQAAPC[CAM]VLFFDELDSIAK.3|QTNPSAM[Oxi]EVEEDDPVPEIR.3|QTNPSAMEVEEDDPVPEIR.3|QTNPSAMEVEEDDPVPEIR.2|EDEEESLNEVGYDDIGGC[CAM]R.3|EDEEESLNEVGYDDIGGC[CAM]R.2|ARGGNIGDGGGAADRVINQILTEMDGM[Oxi]STK.4|ARGGNIGDGGGAADRVINQILTEMDGMSTK.4|YEMFAQTLQQSR.2|EDEEESLNEVGYDDIGGC[CAM]RK.3|EDEEESLNEVGYDDIGGC[CAM]RK.2|VVETDPSPYC[CAM]IVAPDTVIHC[CAM]EGEPIKR.4|ETVVEVPQVTWEDIGGLEDVK.3|ETVVEVPQVTWEDIGGLEDVK.2|REDEEESLNEVGYDDIGGC[CAM]R.3|REDEEESLNEVGYDDIGGC[CAM]R.2|GPELLTM[Oxi]WFGESEANVREIFDK.3|VVETDPSPYC[CAM]IVAPDTVIHC[CAM]EGEPIK.3|FPSGNQGGAGPSQGSGGGTGGSVYTEDNDDDLYG.3|AIANEC[CAM]QANFISIKGPELLTM[Oxi]WFGESEANVR.3
SEN / CTL,Serpin B8,SERPINB8,P50452,0.25,0.01,2.46E-03,1.64E-03,2.78E+00,negative regulation of endopeptidase activity,"serine-type endopeptidase inhibitor activity,protein binding","extracellular space,cytosol,extracellular exosome",3,13,14,ISEVLDAGTVDPLTK.2|RLGMIDAFDEAK.3|TGTQYLLR.2|LEESYDLEPFLR.3|LEESYDLEPFLR.2|ILGEEDNSR.2|ADFSGMSTEK.2|HINDWVAEK.2|TC[CAM]DFLPDFK.2|GSTAAQMSQALC[CAM]LYKDGDIHR.4|LGMIDAFDEAK.2|GFQSLLSEVNR.2|GSTAAQMSQALC[CAM]LYK.2|FYQAELEELSFAEDTEEC[CAM]RK.3
SEN / CTL,Gelsolin,GSN,P06396,0.25,1.24,3.16E-02,1.38E-02,1.86E+00,"phagocytosis, engulfment,positive regulation of gene expression,striated muscle atrophy,actin filament polymerization,protein destabilization,sequestering of actin monomers,cellular protein metabolic process,actin nucleation,negative regulation of viral entry into host cell,actin filament severing,barbed-end actin filament capping,positive regulation of actin nucleation,actin filament capping,cilium morphogenesis,regulation of podosome assembly,actin filament reorganization,renal protein absorption,hepatocyte apoptotic process,positive regulation of keratinocyte apoptotic process,regulation of wound healing, spreading of epidermal cells,regulation of establishment of T cell polarity,regulation of plasma membrane raft polarization,regulation of receptor clustering,positive regulation of protein processing in phagocytic vesicle,amyloid fibril formation,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,extracellular matrix disassembly","actin binding,calcium ion binding,protein binding,protein domain specific binding,myosin II binding","podosome,extracellular region,extracellular space,cytoplasm,cytosol,plasma membrane,focal adhesion,actin cytoskeleton,sarcoplasm,actin cap,cortical actin cytoskeleton,extracellular exosome,blood microparticle,nucleus",51,53,102,QTQVSVLPEGGETPLFK.2|QTQVSVLPEGGETPLFK.3|FDLVPVPTNLYGDFFTGDAYVILK.3|EVQGFESATFLGYFK.2|EVQGFESATFLGYFK.3|VEKFDLVPVPTNLYGDFFTGDAYVILK.3|VEKFDLVPVPTNLYGDFFTGDAYVILK.4|IEGSNKVPVDPATYGQFYGGDSYIILYNYR.3|IEGSNKVPVDPATYGQFYGGDSYIILYNYR.4|AGALNSNDAFVLK.2|AGALNSNDAFVLK.3|HVVPNEVVVQR.3|HVVPNEVVVQR.2|MDYPKQTQVSVLPEGGETPLFK.3|AQPVQVAEGSEPDGFWEALGGK.3|AQPVQVAEGSEPDGFWEALGGK.4|AQPVQVAEGSEPDGFWEALGGK.2|EGGQTAPASTR.2|TPSAAYLWVGTGASEAEKTGAQELLR.3|TPSAAYLWVGTGASEAEKTGAQELLR.4|GGVASGFKHVVPNEVVVQR.3|VPFDAATLHTSTAMAAQHGMDDDGTGQK.4|VPFDAATLHTSTAMAAQHGMDDDGTGQK.5|VPFDAATLHTSTAM[Oxi]AAQHGMDDDGTGQK.4|VPFDAATLHTSTAMAAQHGM[Oxi]DDDGTGQK.4|VPFDAATLHTSTAM[Oxi]AAQHGM[Oxi]DDDGTGQK.4|VPFDAATLHTSTAM[Oxi]AAQHGMDDDGTGQK.3|VPFDAATLHTSTAMAAQHGMDDDGTGQK.3|SEDC[CAM]FILDHGKDGK.4|SEDC[CAM]FILDHGKDGK.3|SEDC[CAM]FILDHGKDGK.2|RYIETDPANR.3|AGKEPGLQIWR.3|AGKEPGLQIWR.2|DSQEEEKTEALTSAK.4|DSQEEEKTEALTSAK.3|DSQEEEKTEALTSAK.2|KGGVASGFK.2|DSQEEEK.2|EPAHLM[Oxi]SLFGGK.3|EPAHLMSLFGGK.2|SEDC[CAM]FILDHGK.3|SEDC[CAM]FILDHGK.2|TASDFITK.2|TGAQELLR.2|VVQGKEPAHLMSLFGGK.4|VVQGKEPAHLMSLFGGK.3|RTPITVVK.2|KMDAHPPR.2|KM[Oxi]DAHPPR.2|PALPAGTEDTAKEDAANRK.4|PALPAGTEDTAKEDAANRK.3|EPGLQIWR.2|GASQAGAPQGR.2|RYIETDPANRDR.3|EPAHLMSLFGGKPMIIYK.4|EPAHLMSLFGGKPMIIYK.3|EPAHLMSLFGGKPMIIYK.2|PNSMVVEHPEFLK.3|PNSM[Oxi]VVEHPEFLK.3|PNSMVVEHPEFLK.2|VPEARPNSMVVEHPEFLK.4|VPEARPNSMVVEHPEFLK.3|VHVSEEGTEPEAMLQVLGPK.4|VHVSEEGTEPEAM[Oxi]LQVLGPK.3|VHVSEEGTEPEAMLQVLGPK.3|VHVSEEGTEPEAMLQVLGPK.2|YIETDPANR.2|NWRDPDQTDGLGLSYLSSHIANVER.5|NWRDPDQTDGLGLSYLSSHIANVER.4|NWRDPDQTDGLGLSYLSSHIANVER.3|AVQHREVQGFESATFLGYFK.4|PALPAGTEDTAK.2|ARVHVSEEGTEPEAMLQVLGPK.4|ARVHVSEEGTEPEAMLQVLGPK.3|DPDQTDGLGLSYLSSHIANVER.4|DPDQTDGLGLSYLSSHIANVER.3|DPDQTDGLGLSYLSSHIANVER.2|PALPAGTEDTAKEDAANR.3|TPSAAYLWVGTGASEAEK.3|TPSAAYLWVGTGASEAEK.2|VSNGAGTMSVSLVADENPFAQGALK.4|VSNGAGTM[Oxi]SVSLVADENPFAQGALK.3|VSNGAGTMSVSLVADENPFAQGALK.3|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANR.6|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANR.5|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANR.4|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAK.5|VHVSEEGTEPEAM[Oxi]LQVLGPKPALPAGTEDTAK.4|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAK.4|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAK.3|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANRK.6|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANRK.5|VPVDPATYGQFYGGDSYIILYNYR.4|VPVDPATYGQFYGGDSYIILYNYR.3|ARVHVSEEGTEPEAMLQVLGPKPALPAGTEDTAK.5|ARVHVSEEGTEPEAMLQVLGPKPALPAGTEDTAK.4|VSNGAGTMSVSLVADENPFAQGALKSEDC[CAM]FILDHGKDGK.5|NWRDPDQTDGLGLSYLSSHIANVERVPFDAATLHTSTAMAAQHGMDDDGTGQK.6|ATEVPVSWESFNNGDC[CAM]FILDLGNNIHQWC[CAM]GSNSNR.4|QGQIIYNWQGAQSTQDEVAASAILTAQLDEELGGTPVQSR.4|ATEVPVSWESFNNGDC[CAM]FILDLGNNIHQWC[CAM]GSNSNRYER.4
SEN / CTL,Peptidyl-prolyl cis-trans isomerase FKBP3,FKBP3,Q00688,0.25,0.30,3.46E-03,2.22E-03,2.65E+00,"protein peptidyl-prolyl isomerization,chaperone-mediated protein folding","peptidyl-prolyl cis-trans isomerase activity,receptor activity,FK506 binding,poly(A) RNA binding","nucleus,endoplasmic reticulum membrane",27,19,30,AWTVEQLRSEQLPK.3|ARLEIEPEWAYGK.3|ARLEIEPEWAYGK.2|VIRGWDEALLTMSK.3|FLQEHGSDSFLAEHK.4|FLQEHGSDSFLAEHK.3|FLQEHGSDSFLAEHK.2|GWDEALLTMSK.2|GWDEALLTM[Oxi]SK.2|TANKDHLVTAYNHLFETKR.4|TANKDHLVTAYNHLFETKR.5|ARLEIEPEWAYGKK.4|ARLEIEPEWAYGKK.3|TANKDHLVTAYNHLFETK.5|TANKDHLVTAYNHLFETK.4|TANKDHLVTAYNHLFETK.3|DHLVTAYNHLFETK.4|DHLVTAYNHLFETK.3|DHLVTAYNHLFETK.2|AWTVEQLRSEQLPKK.4|LEIEPEWAYGKK.3|AWTVEQLR.2|SEETLDEGPPKYTK.3|SEETLDEGPPK.2|LTFEVELVDID.2|KGDVVHC[CAM]WYTGTLQDGTVFDTNIQTSAKK.5|LEIEPEWAYGK.2|ETKSEETLDEGPPK.2|KGDVVHC[CAM]WYTGTLQDGTVFDTNIQTSAK.4|KGDVVHC[CAM]WYTGTLQDGTVFDTNIQTSAK.3
SEN / CTL,Cytosolic non-specific dipeptidase,CNDP2,Q96KP4,0.25,0.75,3.04E-05,3.39E-05,4.47E+00,"sulfur amino acid metabolic process,proteolysis,glutathione biosynthetic process,peptide catabolic process","carboxypeptidase activity,zinc ion binding,metallodipeptidase activity,cytosolic dipeptidase activity","nucleoplasm,cytoplasm,cytosol,extracellular exosome",114,44,84,TVFGVEPDLTR.2|WVAIQSVSAWPEK.2|WVAIQSVSAWPEK.3|EGGSIPVTLTFQEATGK.2|EGGSIPVTLTFQEATGK.3|QLGGSVELVDIGK.2|TGQEIPVNVR.2|LPDGSEIPLPPILLGR.3|LPDGSEIPLPPILLGR.2|WVAIQSVSAWPEKR.3|WVAIQSVSAWPEKR.2|WRYPSLSLHGIEGAFSGSGAK.4|WRYPSLSLHGIEGAFSGSGAK.3|WRYPSLSLHGIEGAFSGSGAK.2|DLHSGVYGGSVHEAMTDLILLMGSLVDKR.5|DLHSGVYGGSVHEAMTDLILLMGSLVDKR.4|QKLPDGSEIPLPPILLGR.3|QKLPDGSEIPLPPILLGR.4|QKLPDGSEIPLPPILLGR.2|QLGGSVELVDIGKQKLPDGSEIPLPPILLGR.4|QLGGSVELVDIGKQKLPDGSEIPLPPILLGR.3|VYMGHGGKPWVSDFSHPHYLAGR.5|VYMGHGGKPWVSDFSHPHYLAGR.6|VYMGHGGKPWVSDFSHPHYLAGR.4|GSTDDKGPVAGWINALEAYQK.3|GSTDDKGPVAGWINALEAYQK.2|TVC[CAM]IYGHLDVQPAALEDGWDSEPFTLVER.3|TVC[CAM]IYGHLDVQPAALEDGWDSEPFTLVER.4|FC[CAM]LEGMEESGSEGLDELIFAR.3|FC[CAM]LEGMEESGSEGLDELIFAR.2|MLAAYLYEVSQLKD.3|MLAAYLYEVSQLKD.2|M[Oxi]LAAYLYEVSQLKD.3|M[Oxi]LAAYLYEVSQLKD.2|MMEVAAADVK.2|M[Oxi]MEVAAADVK.2|M[Oxi]M[Oxi]EVAAADVK.2|TVFGVEPDLTREGGSIPVTLTFQEATGK.3|LVPNMTPEVVGEQVTSYLTK.3|LVPNM[Oxi]TPEVVGEQVTSYLTK.3|LVPNMTPEVVGEQVTSYLTK.2|LVPNM[Oxi]TPEVVGEQVTSYLTK.2|KDTFFKDVDYVC[CAM]ISDNYWLGK.4|KDTFFKDVDYVC[CAM]ISDNYWLGK.3|YNYIEGTK.2|RMMEVAAADVK.3|RM[Oxi]M[Oxi]EVAAADVK.3|YPSLSLHGIEGAFSGSGAK.3|YPSLSLHGIEGAFSGSGAK.4|YPSLSLHGIEGAFSGSGAK.2|GNILIPGINEAVAAVTEEEHK.3|GNILIPGINEAVAAVTEEEHK.4|GNILIPGINEAVAAVTEEEHK.2|YIDENQDRYIK.3|YIDENQDRYIK.2|KKPC[CAM]ITYGLR.3|DVGAQILLHSHK.3|DVGAQILLHSHK.2|PWVSDFSHPHYLAGR.4|PWVSDFSHPHYLAGR.3|LNRYNYIEGTK.3|LNRYNYIEGTK.2|YIDENQDR.2|GPVAGWINALEAYQK.3|GPVAGWINALEAYQK.2|LYDDIDFDIEEFAK.3|LYDDIDFDIEEFAK.2|RGNILIPGINEAVAAVTEEEHK.4|RGNILIPGINEAVAAVTEEEHK.3|FAELRSPNEFK.2|NVMLLPVGSADDGAHSQNEK.3|NVM[Oxi]LLPVGSADDGAHSQNEK.3|NVMLLPVGSADDGAHSQNEK.2|NVM[Oxi]LLPVGSADDGAHSQNEKLNRYNYIEGTK.5|DVGAQILLHSHKK.2|DLHSGVYGGSVHEAM[Oxi]TDLILLMGSLVDK.4|DLHSGVYGGSVHEAMTDLILLMGSLVDK.3|MLAAYLYEVSQLK.2|LVPNMTPEVVGEQVTSYLTKK.3|GSTDDKGPVAGWINALEAYQKTGQEIPVNVR.4|GSTDDKGPVAGWINALEAYQKTGQEIPVNVR.3|GIC[CAM]YFFIEVEC[CAM]SNK.2|TVC[CAM]IYGHLDVQPAALEDGWDSEPFTLVERDGK.4|DVDYVC[CAM]ISDNYWLGK.2
SEN / CTL,"Aldehyde dehydrogenase X, mitochondrial",ALDH1B1,P30837,0.25,0.41,5.90E-02,2.31E-02,1.64E+00,"carbohydrate metabolic process,ethanol catabolic process,ethanol oxidation",aldehyde dehydrogenase (NAD) activity,"nucleoplasm,mitochondrion,mitochondrial matrix,intracellular membrane-bounded organelle",21,31,51,YGLAAAVFTR.2|LAPALATGNTVVMK.2|LAPALATGNTVVM[Oxi]K.2|VLGYIQLGQK.2|LLNLLADLVERDR.3|GFFIKPTVFGGVQDDMR.3|GFFIKPTVFGGVQDDM[Oxi]R.3|GFFIKPTVFGGVQDDMR.2|IAKEEIFGPVQPLFK.3|IAKEEIFGPVQPLFK.2|VAEQTPLSALYLASLIK.3|VAEQTPLSALYLASLIK.2|LLC[CAM]GGER.2|IEEVVER.2|KIEEVVER.2|VAFTGSTEVGHLIQK.3|VAFTGSTEVGHLIQK.2|TIPMDGQHFC[CAM]FTR.3|TIPM[Oxi]DGQHFC[CAM]FTR.3|TIPMDGQHFC[CAM]FTR.2|KTFPTVNPTTGEVIGHVAEGDRADVDR.5|KTFPTVNPTTGEVIGHVAEGDRADVDR.4|KTFPTVNPTTGEVIGHVAEGDR.4|KTFPTVNPTTGEVIGHVAEGDR.3|TFVEESIYNEFLER.3|TFVEESIYNEFLER.2|LLNLLADLVER.2|VGNPFELDTQQGPQVDKEQFER.4|VGNPFELDTQQGPQVDKEQFER.3|KVGNPFELDTQQGPQVDK.3|HEPVGVC[CAM]GQIIPWNFPLVM[Oxi]QGWK.4|HEPVGVC[CAM]GQIIPWNFPLVMQGWK.4|HEPVGVC[CAM]GQIIPWNFPLVMQGWK.3|HEPVGVC[CAM]GQIIPWNFPLVM[Oxi]QGWK.3|KVGNPFELDTQQGPQVDKEQFER.4|KVGNPFELDTQQGPQVDKEQFER.3|TFPTVNPTTGEVIGHVAEGDRADVDR.4|TFPTVNPTTGEVIGHVAEGDRADVDR.3|EEIFGPVQPLFK.2|VYLASLETLDNGK.2|ESGNGRELGEDGLK.2|TFPTVNPTTGEVIGHVAEGDR.3|EAGFPPGVVNIITGYGPTAGAAIAQHVDVDK.4|EAGFPPGVVNIITGYGPTAGAAIAQHVDVDK.3|SPSIVLADADMEHAVEQC[CAM]HEALFFNMGQC[CAM]C[CAM]C[CAM]AGSR.5|SPSIVLADADMEHAVEQC[CAM]HEALFFNMGQC[CAM]C[CAM]C[CAM]AGSR.4|VYLASLETLDNGKPFQESYALDLDEVIK.4|VYLASLETLDNGKPFQESYALDLDEVIK.3|AMYFTQALQAGTVWVNTYNIVTC[CAM]HTPFGGFK.4|PFQESYALDLDEVIK.2|VGNPFELDTQQGPQVDK.2
SEN / CTL,Chloride intracellular channel protein 5,CLIC5,Q9NZA1,0.25,0.46,5.47E-02,2.17E-02,1.66E+00,"diet induced thermogenesis,transport,chloride transport,female pregnancy,sensory perception of sound,protein localization,regulation of ion transmembrane transport,neuromuscular process controlling balance,auditory receptor cell stereocilium organization,chloride transmembrane transport,glutathione metabolic process","voltage-gated ion channel activity,chloride channel activity,protein binding,glutathione transferase activity","Golgi apparatus,microtubule organizing center,cell cortex,actin cytoskeleton,stereocilium,chloride channel complex,extracellular exosome,nucleus",15,13,16,FLDGDELTLADC[CAM]NLLPK.2|FLDGDELTLADC[CAM]NLLPK.3|LFMILWLK.2|LFM[Oxi]ILWLK.2|NYDIPAEMTGLWR.2|QQNNAALER.2|RKPADLHNLAPGTHPPFLTFNGDVK.5|RKPADLHNLAPGTHPPFLTFNGDVK.4|TDVNKIEEFLEETLTPEKYPK.4|ESNTAGIDIFSK.2|GVVFNVTTVDLK.2|TDVNKIEEFLEETLTPEK.3|HRESNTAGIDIFSK.2|DEFTNTC[CAM]AADSEIELAYADVAK.3|AGIDGESIGNC[CAM]PFSQR.2|KLDDYLNTPLPEEIDANTC[CAM]GEDK.3
SEN / CTL,Filamin-A,FLNA,P21333,0.25,1.06,4.38E-02,1.79E-02,1.75E+00,"platelet degranulation,adenylate cyclase-inhibiting dopamine receptor signaling pathway,negative regulation of transcription from RNA polymerase I promoter,platelet activation,regulation of cell migration,actin cytoskeleton reorganization,cell junction assembly,protein localization to cell surface,negative regulation of protein catabolic process,cilium assembly,mRNA transcription from RNA polymerase II promoter,positive regulation of transcription factor import into nucleus,negative regulation of apoptotic process,receptor clustering,positive regulation of I-kappaB kinase/NF-kappaB signaling,negative regulation of sequence-specific DNA binding transcription factor activity,wound healing, spreading of cells,establishment of protein localization,protein stabilization,cytoplasmic sequestering of protein,actin crosslink formation,platelet aggregation,semaphorin-plexin signaling pathway,mitotic spindle assembly,positive regulation of substrate adhesion-dependent cell spreading,positive regulation of integrin-mediated signaling pathway","G-protein coupled receptor binding,glycoprotein binding,signal transducer activity,protein binding,transcription factor binding,Rho GTPase binding,Ral GTPase binding,kinase binding,small GTPase binding,mu-type opioid receptor binding,Fc-gamma receptor I complex binding,protein homodimerization activity,poly(A) RNA binding,SMAD binding,Rac GTPase binding,actin filament binding,GTPase binding,cadherin binding involved in cell-cell adhesion","extracellular region,nucleus,nucleolus,cytoplasm,cytosol,plasma membrane,cell-cell junction,cell-cell adherens junction,focal adhesion,actin cytoskeleton,membrane,cortical cytoskeleton,extracellular matrix,Myb complex,neuronal cell body,dendritic shaft,perinuclear region of cytoplasm,extracellular exosome,apical dendrite,filamentous actin",453,207,388,YGGDEIPFSPYR.2|EATTEFSVDAR.2|FGGEHVPNSPFQVTALAGDQPSVQPPLR.3|FGGEHVPNSPFQVTALAGDQPSVQPPLR.4|FGGEHVPNSPFQVTALAGDQPSVQPPLR.5|AEAGVPAEFSIWTR.2|AEAGVPAEFSIWTR.3|IVGPSGAAVPC[CAM]KVEPGLGADNSVVR.3|IVGPSGAAVPC[CAM]KVEPGLGADNSVVR.4|GAGTGGLGLAVEGPSEAK.2|GAGTGGLGLAVEGPSEAK.3|IANLQTDLSDGLR.2|IANLQTDLSDGLR.3|LYSVSYLLK.2|TGVAVNKPAEFTVDAK.3|TGVAVNKPAEFTVDAK.2|LPQLPITNFSR.2|LPQLPITNFSR.3|VGSAADIPINISETDLSLLTATVVPPSGREEPC[CAM]LLKR.4|VGSAADIPINISETDLSLLTATVVPPSGREEPC[CAM]LLKR.5|VGSAADIPINISETDLSLLTATVVPPSGREEPC[CAM]LLKR.6|AWGPGLEGGVVGK.2|WGDEHIPGSPYR.3|WGDEHIPGSPYR.2|LIALLEVLSQKK.3|LIALLEVLSQKK.2|EGPYSISVLYGDEEVPR.2|EGPYSISVLYGDEEVPR.3|VTVLFAGQHIAK.3|VTVLFAGQHIAK.2|LSPFMADIRDAPQDFHPDRVK.5|VANPSGNLTETYVQDR.3|VANPSGNLTETYVQDR.2|YGGQPVPNFPSKLQVEPAVDTSGVQC[CAM]YGPGIEGQGVFR.4|VHGPGIQSGTTNKPNKFTVETR.5|VHGPGIQSGTTNKPNKFTVETR.4|SPYTVTVGQAC[CAM]NPSAC[CAM]R.3|SPYTVTVGQAC[CAM]NPSAC[CAM]R.2|TPC[CAM]EEILVK.2|ENGVYLIDVK.2|MDC[CAM]QEC[CAM]PEGYRVTYTPMAPGSYLISIK.3|KTHIQDNHDGTYTVAYVPDVTGR.4|KTHIQDNHDGTYTVAYVPDVTGR.5|KTHIQDNHDGTYTVAYVPDVTGR.3|SPFSVAVSPSLDLSK.2|SPFSVAVSPSLDLSK.3|SPFEVYVDKSQGDASKVTAQGPGLEPSGNIANK.4|AEFTVETR.2|VSGLGEKVDVGKDQEFTVK.4|VSGLGEKVDVGKDQEFTVK.3|DKGEYTLVVK.2|ALGALVDSC[CAM]APGLC[CAM]PDWDSWDASKPVTNAR.3|ALGALVDSC[CAM]APGLC[CAM]PDWDSWDASKPVTNAR.4|ALGALVDSC[CAM]APGLC[CAM]PDWDSWDASKPVTNAR.5|VRVHGPGIQSGTTNKPNKFTVETR.5|VRVHGPGIQSGTTNKPNKFTVETR.6|VRVHGPGIQSGTTNKPNKFTVETR.4|VRVHGPGIQSGTTNKPNKFTVETR.3|TFSVWYVPEVTGTHK.3|TFSVWYVPEVTGTHK.2|YNEQHVPGSPFTAR.3|YNEQHVPGSPFTAR.2|YGGPYHIGGSPFK.3|YGGPYHIGGSPFK.2|EAGAGGLAIAVEGPSKAEISFEDRK.4|EAGAGGLAIAVEGPSKAEISFEDRK.3|TGVELGKPTHFTVNAK.4|TGVELGKPTHFTVNAK.3|TGVELGKPTHFTVNAK.2|GKLDVQFSGLTK.3|GKLDVQFSGLTK.2|YGGQPVPNFPSK.2|VDVGKDQEFTVK.3|VDVGKDQEFTVK.2|LVSNHSLHETSSVFVDSLTK.4|LVSNHSLHETSSVFVDSLTK.3|LVSNHSLHETSSVFVDSLTK.2|ASGPGLNTTGVPASLPVEFTIDAK.3|ASGPGLNTTGVPASLPVEFTIDAK.2|VHSPSGALEEC[CAM]YVTEIDQDKYAVR.4|VHSPSGALEEC[CAM]YVTEIDQDKYAVR.3|VHSPSGALEEC[CAM]YVTEIDQDKYAVR.5|VAQPTITDNKDGTVTVR.3|VAQPTITDNKDGTVTVR.2|DGSC[CAM]GVAYVVQEPGDYEVSVK.3|DGSC[CAM]GVAYVVQEPGDYEVSVK.2|LDVQFSGLTK.2|DAEMPATEKDLAEDAPWKK.4|DAEMPATEKDLAEDAPWKK.3|VKETADFKVYTK.3|C[CAM]SYQPTM[Oxi]EGVHTVHVTFAGVPIPR.4|C[CAM]SYQPTMEGVHTVHVTFAGVPIPR.4|C[CAM]SYQPTMEGVHTVHVTFAGVPIPR.3|C[CAM]SYQPTMEGVHTVHVTFAGVPIPR.5|C[CAM]SYQPTM[Oxi]EGVHTVHVTFAGVPIPR.3|AGNNMLLVGVHGPR.3|AGNNMLLVGVHGPR.2|AGNNM[Oxi]LLVGVHGPR.3|AGNNM[Oxi]LLVGVHGPR.2|FNEEHIPDSPFVVPVASPSGDAR.3|FNEEHIPDSPFVVPVASPSGDAR.4|FLPREEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSK.4|FLPREEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSK.5|FLPREEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSK.6|VGSAADIPINISETDLSLLTATVVPPSGR.3|VGSAADIPINISETDLSLLTATVVPPSGR.4|YTPVQQGPVGVNVTYGGDPIPK.3|YTPVQQGPVGVNVTYGGDPIPK.2|LQVEPAVDTSGVQC[CAM]YGPGIEGQGVFR.3|LQVEPAVDTSGVQC[CAM]YGPGIEGQGVFR.4|EGPYSISVLYGDEEVPRSPFK.3|EGPYSISVLYGDEEVPRSPFK.2|ANLPQSFQVDTSK.2|ANLPQSFQVDTSK.3|YWPQEAGEYAVHVLC[CAM]NSEDIR.3|YWPQEAGEYAVHVLC[CAM]NSEDIR.4|LSPFMADIR.2|LSPFM[Oxi]ADIR.2|RIANLQTDLSDGLR.3|RIANLQTDLSDGLR.2|AFGPGLQGGSAGSPAR.2|AFGPGLQGGSAGSPAR.3|SPFEVYVDKSQGDASK.3|SPFEVYVDKSQGDASK.2|VQVQDNEGC[CAM]PVEALVK.2|VQVQDNEGC[CAM]PVEALVK.3|AHVVPC[CAM]FDASK.3|AHVVPC[CAM]FDASK.2|RLTVSSLQESGLK.3|RLTVSSLQESGLK.2|DVDIIDHHDNTYTVK.3|DVDIIDHHDNTYTVK.4|DVDIIDHHDNTYTVK.2|GLVEPVDVVDNADGTQTVNYVPSR.3|GLVEPVDVVDNADGTQTVNYVPSR.4|AGGPGLERAEAGVPAEFSIWTR.3|GDAVRDVDIIDHHDNTYTVK.4|GDAVRDVDIIDHHDNTYTVK.5|GDAVRDVDIIDHHDNTYTVK.3|GDAVRDVDIIDHHDNTYTVK.2|DAGEGLLAVQITDPEGKPK.2|DAGEGLLAVQITDPEGKPK.3|DAGEGLLAVQITDPEGKPK.4|LLGWIQNKLPQLPITNFSR.3|LLGWIQNKLPQLPITNFSR.4|LLGWIQNKLPQLPITNFSR.2|LSPFMADIRDAPQDFHPDR.4|LSPFM[Oxi]ADIRDAPQDFHPDR.4|LSPFMADIRDAPQDFHPDR.3|VRAWGPGLEGGVVGK.3|VRAWGPGLEGGVVGK.2|EAGAGGLAIAVEGPSK.2|EAGAGGLAIAVEGPSK.3|VTAQGPGLEPSGNIANK.2|VTAQGPGLEPSGNIANK.3|GAGSYTIMVLFADQATPTSPIR.3|GAGSYTIMVLFADQATPTSPIR.2|GAGSYTIM[Oxi]VLFADQATPTSPIR.3|GAGSYTIM[Oxi]VLFADQATPTSPIR.2|VKASGPGLNTTGVPASLPVEFTIDAK.3|VKASGPGLNTTGVPASLPVEFTIDAK.4|SAGQGEVLVYVEDPAGHQEEAK.3|SAGQGEVLVYVEDPAGHQEEAK.4|SAGQGEVLVYVEDPAGHQEEAK.2|FNGTHIPGSPFK.3|FNGTHIPGSPFK.2|ANLPQSFQVDTSKAGVAPLQVK.3|ANLPQSFQVDTSKAGVAPLQVK.2|GTVEPQLEAR.2|SSFTVDC[CAM]SK.2|HTAMVSWGGVSIPNSPFR.3|HTAM[Oxi]VSWGGVSIPNSPFR.3|HTAM[Oxi]VSWGGVSIPNSPFR.2|HTAMVSWGGVSIPNSPFR.2|VTYTPMAPGSYLISIK.2|VTYTPMAPGSYLISIK.3|VTYTPM[Oxi]APGSYLISIK.3|VTYTPM[Oxi]APGSYLISIK.2|RLTVSSLQESGLKVNQPASFAVSLNGAK.4|RLTVSSLQESGLKVNQPASFAVSLNGAK.3|THEAEIVEGENHTYC[CAM]IR.4|THEAEIVEGENHTYC[CAM]IR.3|THEAEIVEGENHTYC[CAM]IR.2|EAMQQADDWLGIPQVITPEEIVDPNVDEHSVMTYLSQFPK.4|EAMQQADDWLGIPQVITPEEIVDPNVDEHSVMTYLSQFPK.6|EAMQQADDWLGIPQVITPEEIVDPNVDEHSVMTYLSQFPK.5|EAM[Oxi]QQADDWLGIPQVITPEEIVDPNVDEHSVMTYLSQFPK.4|AYGPGIEPTGNMVK.2|AYGPGIEPTGNMVK.3|AYGPGIEPTGNM[Oxi]VK.2|THIQDNHDGTYTVAYVPDVTGR.4|THIQDNHDGTYTVAYVPDVTGR.3|FNEEHIPDSPFVVPVASPSGDARR.4|SAGQGEVLVYVEDPAGHQEEAKVTANNDKNR.5|SAGQGEVLVYVEDPAGHQEEAKVTANNDKNR.4|AHEPTYFTVDC[CAM]AEAGQGDVSIGIK.3|AGVAPLQVK.2|VKAFGPGLQGGSAGSPAR.3|YAPSEAGLHEMDIR.3|YAPSEAGLHEM[Oxi]DIR.3|YAPSEAGLHEMDIR.2|VGSAADIPINISETDLSLLTATVVPPSGREEPC[CAM]LLK.4|VGSAADIPINISETDLSLLTATVVPPSGREEPC[CAM]LLK.5|C[CAM]SGPGLSPGMVR.2|C[CAM]SGPGLSPGM[Oxi]VR.2|VNQPASFAVSLNGAK.2|VNQPASFAVSLNGAK.3|GKLDVQFSGLTKGDAVR.3|GKLDVQFSGLTKGDAVR.4|DAPQDFHPDR.3|DAPQDFHPDR.2|VKVEPSHDASK.3|VKVEPSHDASK.2|KRAEFTVETR.3|VHGPGIQSGTTNKPNK.4|VHGPGIQSGTTNKPNK.3|VHGPGIQSGTTNKPNK.2|ETGEHLVHVKK.3|ETGEHLVHVKK.2|VNVGAGSHPNKVK.3|VNVGAGSHPNKVK.2|C[CAM]SGPGLER.2|MSC[CAM]MDNK.2|VEPGLGADNSVVR.3|VEPGLGADNSVVR.2|VTGDDSMR.2|ATC[CAM]APQHGAPGPGPADASK.4|ATC[CAM]APQHGAPGPGPADASK.3|ATC[CAM]APQHGAPGPGPADASK.2|RAPSVANVGSHC[CAM]DLSLK.4|RAPSVANVGSHC[CAM]DLSLK.3|RAPSVANVGSHC[CAM]DLSLK.2|AGVAPLQVKVQGPK.3|VKETADFK.2|LRNGHVGISFVPK.3|VRVHGPGIQSGTTNKPNK.4|VRVHGPGIQSGTTNKPNK.3|YKGQHVPGSPFQFTVGPLGEGGAHKVR.6|YKGQHVPGSPFQFTVGPLGEGGAHKVR.5|YKGQHVPGSPFQFTVGPLGEGGAHKVR.4|AEISFEDR.2|AGQSAAGAAPGGGVDTR.3|AGQSAAGAAPGGGVDTR.2|MDC[CAM]QEC[CAM]PEGYR.3|MDC[CAM]QEC[CAM]PEGYR.2|M[Oxi]DC[CAM]QEC[CAM]PEGYR.2|VLPTHDASK.2|PAEFTVDAK.2|PATFTVNTK.2|DAEMPATEK.2|DAEM[Oxi]PATEK.2|KGEITGEVR.2|RRAPSVANVGSHC[CAM]DLSLK.4|VGTEC[CAM]GNQK.2|DAGEGGLSLAIEGPSK.3|DAGEGGLSLAIEGPSK.2|FVPAEMGTHTVSVK.3|FVPAEM[Oxi]GTHTVSVK.3|FVPAEMGTHTVSVK.2|FVPAEM[Oxi]GTHTVSVK.2|FADQHVPGSPFSVK.3|FADQHVPGSPFSVK.2|NRTFSVWYVPEVTGTHK.4|VKAEGPGLSR.2|DAGEGLLAVQITDPEGKPKK.4|DAGEGLLAVQITDPEGKPKK.3|DAGEGLLAVQITDPEGKPKK.2|DNGNGTYSC[CAM]SYVPRKPVK.4|YKGQHVPGSPFQFTVGPLGEGGAHK.5|YKGQHVPGSPFQFTVGPLGEGGAHK.4|YKGQHVPGSPFQFTVGPLGEGGAHK.3|NDNDTFTVK.2|LKPGAPLRPK.2|IEC[CAM]DDKGDGSC[CAM]DVR.3|IEC[CAM]DDKGDGSC[CAM]DVR.2|SPFEVYVDK.2|VAQPTITDNK.2|VDINTEDLEDGTC[CAM]R.3|VDINTEDLEDGTC[CAM]R.2|VNVGAGSHPNK.2|VRVSGQGLHEGHTFEPAEFIIDTR.5|VRVSGQGLHEGHTFEPAEFIIDTR.4|AEISFEDRK.2|APSVANVGSHC[CAM]DLSLK.3|APSVANVGSHC[CAM]DLSLK.2|KTHIQDNHDGTYTVAYVPDVTGRYTILIK.6|KTHIQDNHDGTYTVAYVPDVTGRYTILIK.4|YGGDEIPFSPYRVR.3|ALTQTGGPHVK.2|FIPRENGVYLIDVK.3|RAEFTVETR.2|SPFEVKVGTEC[CAM]GNQK.3|SPFEVKVGTEC[CAM]GNQK.2|VKMDC[CAM]QEC[CAM]PEGYR.3|VKMDC[CAM]QEC[CAM]PEGYR.2|ETGEHLVHVK.2|GAGSGELKVTVK.2|VHSPSGALEEC[CAM]YVTEIDQDK.4|VHSPSGALEEC[CAM]YVTEIDQDK.3|VHSPSGALEEC[CAM]YVTEIDQDK.2|EEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSK.6|EEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSK.5|EEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSK.4|EEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSK.3|GQHVPGSPFQFTVGPLGEGGAHK.4|GQHVPGSPFQFTVGPLGEGGAHK.3|GQHVPGSPFQFTVGPLGEGGAHK.2|IVGPSGAAVPC[CAM]K.2|NGHVGISFVPK.2|VPVHDVTDASK.2|SPFSVAVSPSLDLSKIK.3|SPFSVAVSPSLDLSKIK.2|NGQHVASSPIPVVISQSEIGDASR.4|NGQHVASSPIPVVISQSEIGDASR.3|VSGQGLHEGHTFEPAEFIIDTR.4|VSGQGLHEGHTFEPAEFIIDTR.3|LTVSSLQESGLK.2|QRLLGWIQNKLPQLPITNFSR.4|VGTEC[CAM]GNQKVR.2|VTYC[CAM]PTEPGNYIINIK.3|VTYC[CAM]PTEPGNYIINIK.2|RAPSVANVGSHC[CAM]DLSLKIPEISIQDMTAQVTSPSGK.6|RAPSVANVGSHC[CAM]DLSLKIPEISIQDMTAQVTSPSGK.5|RAPSVANVGSHC[CAM]DLSLKIPEISIQDMTAQVTSPSGK.4|KNGQHVASSPIPVVISQSEIGDASR.4|KNGQHVASSPIPVVISQSEIGDASR.3|ALGALVDSC[CAM]APGLC[CAM]PDWDSWDASK.4|ALGALVDSC[CAM]APGLC[CAM]PDWDSWDASK.3|ARVANPSGNLTETYVQDR.3|GAIDAKVHSPSGALEEC[CAM]YVTEIDQDKYAVR.5|IPEISIQDMTAQVTSPSGK.3|IPEISIQDMTAQVTSPSGK.2|IPEISIQDM[Oxi]TAQVTSPSGK.2|C[CAM]APGVVGPAEADIDFDIIR.3|C[CAM]APGVVGPAEADIDFDIIR.2|DAEMPATEKDLAEDAPWK.3|DAEMPATEKDLAEDAPWK.2|IANLQTDLSDGLRLIALLEVLSQKK.4|DAPQDFHPDRVK.2|VASKIVGPSGAAVPC[CAM]KVEPGLGADNSVVR.4|VEYTPYEEGLHSVDVTYDGSPVPSSPFQVPVTEGC[CAM]DPSR.6|VEYTPYEEGLHSVDVTYDGSPVPSSPFQVPVTEGC[CAM]DPSR.4|AHVVPC[CAM]FDASKVK.2|YDNM[Oxi]HIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNKPATFTVNTK.7|YDNMHIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNKPATFTVNTK.7|YDNMHIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNKPATFTVNTK.6|YDNM[Oxi]HIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNKPATFTVNTK.6|YDNM[Oxi]HIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNKPATFTVNTK.5|YDNMHIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNKPATFTVNTK.5|APLRVQVQDNEGC[CAM]PVEALVK.3|LLGWIQNKLPQLPITNFSRDWQSGR.4|SQQLAPQYTYAQGGQQTWAPERPLVGVNGLDVTSLRPFDLVIPFTIK.7|SQQLAPQYTYAQGGQQTWAPERPLVGVNGLDVTSLRPFDLVIPFTIK.6|SQQLAPQYTYAQGGQQTWAPERPLVGVNGLDVTSLRPFDLVIPFTIK.5|C[CAM]APGVVGPAEADIDFDIIRNDNDTFTVK.4|C[CAM]APGVVGPAEADIDFDIIRNDNDTFTVK.3|DAGYGGLSLSIEGPSK.2|DGSC[CAM]SVEYIPYEAGTYSLNVTYGGHQVPGSPFKVPVHDVTDASK.6|DGSC[CAM]SVEYIPYEAGTYSLNVTYGGHQVPGSPFKVPVHDVTDASK.5|DGSC[CAM]SVEYIPYEAGTYSLNVTYGGHQVPGSPFKVPVHDVTDASK.4|EAGAGGLAIAVEGPSKAEISFEDR.3|EAGAGGLAIAVEGPSKAEISFEDR.2|AGQSAAGAAPGGGVDTRDAEMPATEK.3|DNGNGTYSC[CAM]SYVPR.2|KDGSC[CAM]GVAYVVQEPGDYEVSVK.3|KDGSC[CAM]GVAYVVQEPGDYEVSVK.2|VANPSGNLTETYVQDRGDGMYK.3|VGEPGHGGDPGLVSAYGAGLEGGVTGNPAEFVVNTSNAGAGALSVTIDGPSK.6|AEISC[CAM]TDNQDGTC[CAM]SVSYLPVLPGDYSILVK.4|AEISC[CAM]TDNQDGTC[CAM]SVSYLPVLPGDYSILVK.3|IEC[CAM]DDKGDGSC[CAM]DVRYWPQEAGEYAVHVLC[CAM]NSEDIR.5|IEC[CAM]DDKGDGSC[CAM]DVRYWPQEAGEYAVHVLC[CAM]NSEDIR.4|YDNM[Oxi]HIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNK.5|YDNMHIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNK.5|YDNMHIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNK.4|DAGEGLLAVQITDPEGK.2|VKMDC[CAM]QEC[CAM]PEGYRVTYTPMAPGSYLISIK.4|DGSC[CAM]SVEYIPYEAGTYSLNVTYGGHQVPGSPFK.4|DGSC[CAM]SVEYIPYEAGTYSLNVTYGGHQVPGSPFK.3|SADFVVEAIGDDVGTLGFSVEGPSQAK.3|APSVANVGSHC[CAM]DLSLKIPEISIQDMTAQVTSPSGK.4|LTVSSLQESGLKVNQPASFAVSLNGAK.3|LQVEPAVDTSGVQC[CAM]YGPGIEGQGVFREATTEFSVDAR.4|ASGPGLNTTGVPASLPVEFTIDAKDAGEGLLAVQITDPEGKPK.4|DAGYGGLSLSIEGPSKVDINTEDLEDGTC[CAM]R.3|MSC[CAM]MDNKDGSC[CAM]SVEYIPYEAGTYSLNVTYGGHQVPGSPFK.4|MSC[CAM]MDNKDGSC[CAM]SVEYIPYEAGTYSLNVTYGGHQVPGSPFKVPVHDVTDASK.5|VQVQDNEGC[CAM]PVEALVKDNGNGTYSC[CAM]SYVPR.3
SEN / CTL,Dynactin subunit 2,DCTN2,Q13561,0.24,0.37,7.65E-03,4.28E-03,2.37E+00,"G2/M transition of mitotic cell cycle,ER to Golgi vesicle-mediated transport,microtubule-based process,mitotic spindle organization,mitotic nuclear division,cell proliferation,antigen processing and presentation of exogenous peptide antigen via MHC class II,melanosome transport,protein localization to centrosome","motor activity,protein binding,spectrin binding","kinetochore,cytoplasm,centrosome,cytosol,dynactin complex,microtubule,membrane,dynein complex,growth cone,vesicle,extracellular exosome",36,28,43,LLLQLEATK.2|WSPIASTLPELVQR.2|LLGPDAAINLTDPDGALAKR.3|LLHEVQELTTEVEK.3|LLHEVQELTTEVEK.2|VSALDLAVLDQVEAR.2|VSALDLAVLDQVEAR.3|LLHEVQELTTEVEKIK.3|LLHEVQELTTEVEKIK.4|LTELETAVR.2|YADLPGIAR.2|TGYESGEYEMLGEGLGVK.2|TGYESGEYEMLGEGLGVK.3|TGYESGEYEM[Oxi]LGEGLGVK.2|ENLATVEGNFASIDER.2|ENLATVEGNFASIDER.3|LTPVLLAK.2|VHQLYETIQR.3|VHQLYETIQR.2|HKASVEDADTQSK.3|DNTTLLTQVQTTMR.3|DNTTLLTQVQTTMR.2|ASVEDADTQSK.2|QQLVASHLEK.2|RLLLQLEATK.2|RLTELETAVR.2|TTVKESATEEK.2|LLGPDAAINLTDPDGALAK.3|LLGPDAAINLTDPDGALAK.2|TTGTPPDSSLVTYELHSRPEQDKFSQAAK.5|TTGTPPDSSLVTYELHSRPEQDKFSQAAK.4|TTGTPPDSSLVTYELHSRPEQDK.4|TTGTPPDSSLVTYELHSRPEQDK.3|RTGYESGEYEMLGEGLGVK.3|RTGYESGEYEMLGEGLGVK.2|LQSVLGKVNEIAK.2|VSALDLAVLDQVEARLQSVLGK.3|QLHEQAM[Oxi]QFGQLLTHLDTTQQMIANSLK.4|QLHEQAMQFGQLLTHLDTTQQM[Oxi]IANSLK.4|QLHEQAMQFGQLLTHLDTTQQMIANSLK.4|QLHEQAMQFGQLLTHLDTTQQMIANSLK.3|C[CAM]DQDAQNPLSAGLQGAC[CAM]LMETVELLQAK.3|DNTTLLTQVQTTMRENLATVEGNFASIDER.3
SEN / CTL,"Alanine--tRNA ligase, cytoplasmic",AARS,P49588,0.24,0.27,8.64E-03,4.76E-03,2.32E+00,"hair follicle development,tRNA modification,tRNA aminoacylation for protein translation,alanyl-tRNA aminoacylation,regulation of translational fidelity,protein folding,tRNA processing,cerebellar Purkinje cell layer development,endoplasmic reticulum unfolded protein response,response to amino acid,negative regulation of neuron apoptotic process,neuromuscular process controlling balance","tRNA binding,aminoacyl-tRNA editing activity,alanine-tRNA ligase activity,ATP binding,zinc ion binding,amino acid binding","cytoplasm,cytosol,membrane,extracellular exosome,mitochondrion",18,62,112,NVGC[CAM]LQEALQLATSFAQLR.3|NVGC[CAM]LQEALQLATSFAQLR.4|NVGC[CAM]LQEALQLATSFAQLR.2|VGAEDADGIDMAYR.2|VGAEDADGIDMAYR.3|VGAEDADGIDM[Oxi]AYR.2|MALELLTQEFGIPIER.3|M[Oxi]ALELLTQEFGIPIER.3|M[Oxi]ALELLTQEFGIPIER.2|MALELLTQEFGIPIER.2|AVFDETYPDPVR.2|GLVVDMDGFEEER.2|GLVVDM[Oxi]DGFEEER.2|GGYVLHIGTIYGDLK.3|GGYVLHIGTIYGDLK.2|GSLVAPDR.2|RIVAVTGAEAQK.3|RIVAVTGAEAQK.2|PIFLNTIDPSHPMAK.4|PIFLNTIDPSHPMAK.3|PIFLNTIDPSHPM[Oxi]AK.3|PIFLNTIDPSHPMAK.2|DVSAQATGK.2|LVSVLQNK.2|AVYTQDC[CAM]PLAAAK.3|AVYTQDC[CAM]PLAAAK.2|C[CAM]LSVMEAK.2|SVLGEADQK.2|GAMSTQQIK.2|GAM[Oxi]STQQIK.2|KIQSLGDSK.2|GTGARPYTGK.2|HNDLDDVGK.2|KAEEIANEMIEAAK.3|KAEEIANEM[Oxi]IEAAK.3|KAEEIANEMIEAAK.2|RPIMSNHTATHILNFALR.4|RPIMSNHTATHILNFALR.3|GLEVTDDSPK.2|VGDQVWLFIDEPR.3|VGDQVWLFIDEPR.2|SIDTGMGLER.2|SIDTGM[Oxi]GLER.2|VDDSSEDKTEFTVK.3|VDDSSEDKTEFTVK.2|ASEWVQQVSGLMDGK.3|ASEWVQQVSGLMDGK.2|ASEWVQQVSGLM[Oxi]DGK.2|GLVVDMDGFEEERK.3|GLVVDM[Oxi]DGFEEERK.3|GLVVDMDGFEEERK.2|IVAVTGAEAQK.2|ITC[CAM]LC[CAM]QVPQNAANR.3|ITC[CAM]LC[CAM]QVPQNAANR.2|KDPDMVKDIINEEEVQFLK.4|KDPDMVKDIINEEEVQFLK.3|TITVALADGGRPDNTGR.3|TITVALADGGRPDNTGR.2|SVLGEADQKGSLVAPDR.3|VGDQVWLFIDEPRR.3|YNYHLDSSGSYVFENTVATVMALRR.5|YNYHLDSSGSYVFENTVATVMALRR.4|YNYHLDSSGSYVFENTVATVM[Oxi]ALRR.4|EADGILKPLPK.2|GGGKDVSAQATGK.2|KSIDTGMGLER.2|NSSHAGAFVIVTEEAIAK.3|NSSHAGAFVIVTEEAIAK.2|EIADLGEALATAVIPQWQKDELR.4|EIADLGEALATAVIPQWQKDELR.3|MFVEEVSTGQEC[CAM]GVVLDK.3|M[Oxi]FVEEVSTGQEC[CAM]GVVLDK.2|MFVEEVSTGQEC[CAM]GVVLDK.2|SVLGEADQKGSLVAPDRLR.3|EIADLGEALATAVIPQWQK.3|EIADLGEALATAVIPQWQK.2|YNYHLDSSGSYVFENTVATVMALR.4|YNYHLDSSGSYVFENTVATVM[Oxi]ALR.3|YNYHLDSSGSYVFENTVATVMALR.3|GAGGEDLIMLDIYAIEELR.3|M[Oxi]HSPQTSAMLFTVDNEAGK.3|MHSPQTSAM[Oxi]LFTVDNEAGK.3|MHSPQTSAMLFTVDNEAGK.3|MHSPQTSAMLFTVDNEAGK.2|VVSIGVPVSELLDDPSGPAGSLTSVEFC[CAM]GGTHLR.5|VVSIGVPVSELLDDPSGPAGSLTSVEFC[CAM]GGTHLR.4|VVSIGVPVSELLDDPSGPAGSLTSVEFC[CAM]GGTHLR.3|AEEIANEMIEAAK.2|QIWQNLGLDDTK.2|M[Oxi]SNYDTDLFVPYFEAIQK.3|MSNYDTDLFVPYFEAIQK.3|M[Oxi]SNYDTDLFVPYFEAIQK.2|MSNYDTDLFVPYFEAIQK.2|DIINEEEVQFLK.2|MHSPQTSAMLFTVDNEAGKITC[CAM]LC[CAM]QVPQNAANR.5|MHSPQTSAMLFTVDNEAGKITC[CAM]LC[CAM]QVPQNAANR.4|TC[CAM]FYAEQGGQIYDEGYLVK.3|TC[CAM]FYAEQGGQIYDEGYLVK.2|EIADLGEALATAVIPQWQKDELRETLK.4|EKMFVEEVSTGQEC[CAM]GVVLDK.3|LYVTYFGGDEAAGLEADLEC[CAM]K.3|LYVTYFGGDEAAGLEADLEC[CAM]K.2|NEHTYVHSSATIPLDDPTLLFANAGMNQFKPIFLNTIDPSHPMAK.6|NEHTYVHSSATIPLDDPTLLFANAGMNQFKPIFLNTIDPSHPMAK.5|QFIDSNPNQPLVILEMESGASAK.3|RNEHTYVHSSATIPLDDPTLLFANAGMNQFKPIFLNTIDPSHPMAK.6|RNEHTYVHSSATIPLDDPTLLFANAGMNQFKPIFLNTIDPSHPMAK.5|DNFWEMGDTGPC[CAM]GPC[CAM]SEIHYDR.3|TKQFIDSNPNQPLVILEMESGASAK.3|GLEVTDDSPKYNYHLDSSGSYVFENTVATVMALR.4|DAAHLVNQDDPNVLEIWNLVFIQYNR.3|TIPGDTAWLLYDTYGFPVDLTGLIAEEK.3
SEN / CTL,Coatomer subunit delta,ARCN1,P48444,0.24,0.28,1.64E-04,1.58E-04,3.80E+00,"intracellular protein transport,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,adult locomotory behavior,cerebellar Purkinje cell layer maturation,pigmentation",poly(A) RNA binding,"Golgi membrane,cytoplasm,endoplasmic reticulum membrane,Golgi apparatus,cytosol,membrane,COPI vesicle coat,transport vesicle,intracellular membrane-bounded organelle",21,40,66,VLLAAAVC[CAM]TK.2|LYMVLITTK.2|LFTAESLIGLKNPEK.3|LFTAESLIGLKNPEK.2|NSNILEDLETLR.2|NSNILEDLETLR.3|NTLEWC[CAM]LPVIDAK.2|NTLEWC[CAM]LPVIDAK.3|TRIEGLLAAFPK.3|TRIEGLLAAFPK.2|RNTLEWC[CAM]LPVIDAK.3|RNTLEWC[CAM]LPVIDAK.2|ITLTC[CAM]GR.2|M[Oxi]HAPPINMESVHMK.4|MHAPPINMESVHMK.3|M[Oxi]HAPPINMESVHMK.3|MHAPPINM[Oxi]ESVHMK.3|MHAPPINMESVHM[Oxi]K.3|VAPAPARPSGPSK.3|IRLHVENEDK.3|KNYC[CAM]NIQVTK.3|KLFTAESLIGLK.3|KLFTAESLIGLK.2|GVQLQTHPNVDK.3|GVQLQTHPNVDK.2|QHTFVETESVR.3|QHTFVETESVR.2|TFTEM[Oxi]DSHEEK.3|TFTEMDSHEEK.3|TFTEMDSHEEK.2|GKEVDNFVDKLK.3|GKEVDNFVDKLK.2|IRLHVENEDKK.3|EVDNFVDK.2|GVQLQTHPNVDKK.3|GVQLQTHPNVDKK.2|KGVQLQTHPNVDK.3|KGVQLQTHPNVDK.2|LHVENEDK.2|ENVNLAQIR.2|IEGLLAAFPK.2|LKSEGETIMSSSMGK.3|LKSEGETIMSSSMGK.2|YVYQPMEK.2|LHVENEDKK.2|NYC[CAM]NIQVTK.2|GKEVDNFVDK.2|VTQVDGNSPVR.2|KLFTAESLIGLKNPEK.3|LFTAESLIGLK.2|DGGLQNMELHGMIMLR.3|DGGLQNMELHGMIM[Oxi]LR.3|DGGLQNMELHGMIMLR.2|SFPVNSDVGVLK.2|FSTETTFLVDK.2|KAPGFGGFGSSAVSGGSTAAMITETIIETDKPK.5|KAPGFGGFGSSAVSGGSTAAMITETIIETDKPK.4|KAPGFGGFGSSAVSGGSTAAM[Oxi]ITETIIETDKPK.4|KAPGFGGFGSSAVSGGSTAAMITETIIETDKPK.3|SEGETIMSSSMGK.2|SEGETIM[Oxi]SSSMGK.2|SEGETIMSSSM[Oxi]GK.2|APGFGGFGSSAVSGGSTAAMITETIIETDKPK.4|APGFGGFGSSAVSGGSTAAMITETIIETDKPK.3|SGSLEFSIAGQPNDFFPVQVSFVSK.3|FSTETTFLVDKYEIL.2
SEN / CTL,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,P05023,0.24,0.77,1.06E-04,1.05E-04,3.98E+00,"regulation of the force of heart contraction,regulation of sodium ion transport,cellular sodium ion homeostasis,regulation of blood pressure,potassium ion import,establishment or maintenance of transmembrane electrochemical gradient,ATP hydrolysis coupled proton transport,dephosphorylation,cellular potassium ion homeostasis,negative regulation of glucocorticoid biosynthetic process,ion transmembrane transport,sodium ion export from cell,response to drug,negative regulation of heart contraction,positive regulation of heart contraction,positive regulation of striated muscle contraction,relaxation of cardiac muscle,cardiac muscle contraction,membrane hyperpolarization,cellular response to mechanical stimulus,cellular response to steroid hormone stimulus,regulation of cardiac muscle cell contraction,membrane repolarization,membrane repolarization during cardiac muscle cell action potential,cell communication by electrical coupling involved in cardiac conduction,response to glycoside,regulation of cardiac conduction,potassium ion import across plasma membrane","sodium:potassium-exchanging ATPase activity,protein binding,ATP binding,phosphatase activity,protein kinase binding,protein domain specific binding,ankyrin binding,potassium ion binding,sodium ion binding,ADP binding,phosphatidylinositol 3-kinase binding,chaperone binding,steroid hormone binding","endosome,endoplasmic reticulum,Golgi apparatus,plasma membrane,sodium:potassium-exchanging ATPase complex,caveola,intercalated disc,membrane,integral component of membrane,basolateral plasma membrane,apical plasma membrane,T-tubule,sarcolemma,melanosome,myelin sheath,intracellular membrane-bounded organelle,protein complex,extracellular exosome,extracellular vesicle",39,62,112,IISANGC[CAM]KVDNSSLTGESEPQTR.3|AVAGDASESALLK.2|AVAGDASESALLK.3|LIIVEGC[CAM]QR.2|SPDFTNENPLETR.2|SPDFTNENPLETR.3|EQPLDEELKDAFQNAYLELGGLGER.3|EQPLDEELKDAFQNAYLELGGLGER.4|C[CAM]SSILLHGKEQPLDEELKDAFQNAYLELGGLGER.4|C[CAM]SSILLHGKEQPLDEELKDAFQNAYLELGGLGER.5|GVGIISEGNETVEDIAAR.3|GVGIISEGNETVEDIAAR.2|AVFQANQENLPILKR.3|AVFQANQENLPILKR.4|AVFQANQENLPILKR.2|NMVPQQALVIR.2|NMVPQQALVIR.3|NM[Oxi]VPQQALVIR.2|GIVVYTGDR.2|LNIPVSQVNPR.2|LNIPVSQVNPR.3|NIAFFSTNC[CAM]VEGTAR.2|NIAFFSTNC[CAM]VEGTAR.3|AAVPDAVGK.2|DKYEPAAVSEQGDKK.4|DKYEPAAVSEQGDKK.3|DKYEPAAVSEQGDKK.2|LIFDNLK.2|TGTLTQNR.2|YQLSIHK.2|RAVAGDASESALLK.3|RAVAGDASESALLK.2|RPGGWVEK.2|VIMVTGDHPITAK.3|VIM[Oxi]VTGDHPITAK.3|VIMVTGDHPITAK.2|VIM[Oxi]VTGDHPITAK.2|YEPAAVSEQGDKK.3|YEPAAVSEQGDKK.2|QGAIVAVTGDGVNDSPALKK.4|QGAIVAVTGDGVNDSPALKK.3|LIFDNLKK.2|LSLDELHR.2|YQLSIHKNPNTSEPQHLLVMK.5|YQLSIHKNPNTSEPQHLLVMK.4|ADIGVAM[Oxi]GIAGSDVSK.3|ADIGVAMGIAGSDVSK.3|ADIGVAMGIAGSDVSK.2|ADIGVAM[Oxi]GIAGSDVSK.2|C[CAM]SSILLHGK.2|GIVVYTGDRTVMGR.3|DKYEPAAVSEQGDK.3|DKYEPAAVSEQGDK.2|NSVFQQGMK.2|NSVFQQGM[Oxi]K.2|AVFQANQENLPILK.3|AVFQANQENLPILK.2|IVEIPFNSTNKYQLSIHK.4|IVEIPFNSTNKYQLSIHK.3|NPNTSEPQHLLVMK.3|NPNTSEPQHLLVM[Oxi]K.3|NPNTSEPQHLLVMK.2|NPNTSEPQHLLVM[Oxi]K.2|AC[CAM]VVHGSDLK.2|KADIGVAM[Oxi]GIAGSDVSK.3|KADIGVAMGIAGSDVSK.3|KADIGVAMGIAGSDVSK.2|VDNSSLTGESEPQTR.3|VDNSSLTGESEPQTR.2|EQPLDEELK.2|TSATWLALSR.2|LSLDELHRK.2|YHTEIVFAR.2|DAFQNAYLELGGLGER.3|DAFQNAYLELGGLGER.2|AC[CAM]VVHGSDLKDMTSEQLDDILKYHTEIVFAR.6|AC[CAM]VVHGSDLKDM[Oxi]TSEQLDDILKYHTEIVFAR.6|AC[CAM]VVHGSDLKDM[Oxi]TSEQLDDILKYHTEIVFAR.5|AC[CAM]VVHGSDLKDMTSEQLDDILKYHTEIVFAR.5|AC[CAM]VVHGSDLKDMTSEQLDDILKYHTEIVFAR.4|QGAIVAVTGDGVNDSPALK.3|QGAIVAVTGDGVNDSPALK.2|C[CAM]IELC[CAM]C[CAM]GSVK.2|M[Oxi]SINAEEVVVGDLVEVK.3|MSINAEEVVVGDLVEVK.3|MSINAEEVVVGDLVEVK.2|M[Oxi]SINAEEVVVGDLVEVK.2|SAGIKVIMVTGDHPITAK.3|AC[CAM]VVHGSDLKDMTSEQLDDILK.4|AC[CAM]VVHGSDLKDMTSEQLDDILK.3|IVEIPFNSTNKYQLSIHKNPNTSEPQHLLVM[Oxi]K.6|IVEIPFNSTNKYQLSIHKNPNTSEPQHLLVM[Oxi]K.5|IVEIPFNSTNK.2|NLEAVETLGSTSTIC[CAM]SDK.3|NLEAVETLGSTSTIC[CAM]SDK.2|YEPAAVSEQGDK.2|DMTSEQLDDILK.2|DM[Oxi]TSEQLDDILK.2|NLEAVETLGSTSTIC[CAM]SDKTGTLTQNR.4|NLEAVETLGSTSTIC[CAM]SDKTGTLTQNR.3|MSINAEEVVVGDLVEVKGGDRIPADLR.4|DGPNALTPPPTTPEWIKFC[CAM]R.3|GVGIISEGNETVEDIAARLNIPVSQVNPR.4|GVGIISEGNETVEDIAARLNIPVSQVNPR.3|WINDVEDSYGQQWTYEQR.3|MTVAHMWFDNQIHEADTTENQSGVSFDK.4|QAADM[Oxi]ILLDDNFASIVTGVEEGR.3|QAADMILLDDNFASIVTGVEEGR.3|QAADM[Oxi]ILLDDNFASIVTGVEEGRLIFDNLKK.4|QAADMILLDDNFASIVTGVEEGRLIFDNLKK.4|DGPNALTPPPTTPEWIK.2|SPDFTNENPLETRNIAFFSTNC[CAM]VEGTAR.3
SEN / CTL,V-type proton ATPase subunit d 1,ATP6V0D1,P61421,0.24,0.95,1.11E-02,5.81E-03,2.24E+00,"vacuolar transport,vacuolar acidification,brain development,insulin receptor signaling pathway,ATP hydrolysis coupled proton transport,proton transport,regulation of macroautophagy,transferrin transport,ion transmembrane transport,IRE1-mediated unfolded protein response,cilium assembly,phagosome acidification","protein binding,hydrogen-exporting ATPase activity, phosphorylative mechanism,protein complex binding,proton-transporting ATPase activity, rotational mechanism","lysosomal membrane,early endosome,synaptic vesicle,endosome membrane,membrane,apical plasma membrane,vacuolar proton-transporting V-type ATPase complex,phagocytic vesicle membrane,proton-transporting V-type ATPase, V0 domain,plasma membrane proton-transporting V-type ATPase complex,axon terminus,extracellular exosome,centrosome",18,16,21,LYPEGLAQLAR.2|LYPEGLAQLAR.3|AKIDNYIPIF.2|NIVWIAEC[CAM]IAQR.2|NIVWIAEC[CAM]IAQR.3|ADDYEQVKNVADYYPEYK.3|SIAELVPK.2|ADDYEQVK.2|IDNYIPIF.2|AYLESFYK.2|AFIITINSFGTELSK.3|AFIITINSFGTELSK.2|NVADYYPEYK.2|LLFEGAGSNPGDK.2|AFIITINSFGTELSKEDR.3|FC[CAM]TLLGGTTADAMC[CAM]PILEFEADRR.4|FC[CAM]TLLGGTTADAMC[CAM]PILEFEADRR.3|LHLQSTDYGNFLANEASPLTVSVIDDR.4|LHLQSTDYGNFLANEASPLTVSVIDDR.3|LHLQSTDYGNFLANEASPLTVSVIDDRLK.4|AGVLSQADYLNLVQC[CAM]ETLEDLK.3
SEN / CTL,Leukocyte elastase inhibitor,SERPINB1,P30740,0.24,0.37,3.84E-04,3.31E-04,3.48E+00,negative regulation of endopeptidase activity,serine-type endopeptidase inhibitor activity,"extracellular space,cytoplasm,membrane,extracellular exosome",30,24,41,LGVQDLFNSSK.2|TFHFNTVEEVHSR.4|TFHFNTVEEVHSR.3|TYNFLPEFLVSTQK.2|TYNFLPEFLVSTQK.3|FKLEESYTLNSDLAR.3|FKLEESYTLNSDLAR.2|FAYGYIEDLKC[CAM]R.3|LHEWTKPENLDFIEVNVSLPR.4|LHEWTKPENLDFIEVNVSLPR.3|HNSSGSILFLGR.3|HNSSGSILFLGR.2|TYGADLASVDFQHASEDAR.3|TYGADLASVDFQHASEDAR.2|GQTEGKIPELLASGMVDNMTK.3|GQTEGKIPELLASGM[Oxi]VDNMTK.3|GQTEGKIPELLASGMVDNM[Oxi]TK.3|GQTEGKIPELLASGMVDNMTK.2|KIEEQLTLEK.3|KIEEQLTLEK.2|FQSLNADINKR.3|FQSLNADINKR.2|GNTAAQLSK.2|KFAYGYIEDLK.3|KFAYGYIEDLK.2|ADLSGMSGAR.2|ADLSGM[Oxi]SGAR.2|EATTNAPFR.2|IPELLASGMVDNMTK.3|IPELLASGMVDNMTK.2|TYGADLASVDFQHASEDARK.4|TYGADLASVDFQHASEDARK.3|TYGADLASVDFQHASEDARK.2|IEEQLTLEK.2|FQSLNADINK.2|FAYGYIEDLK.2|LGVQDLFNSSKADLSGMSGAR.3|LEESYTLNSDLAR.2|VLELPYQGEELSMVILLPDDIEDESTGLKK.4|VLELPYQGEELSMVILLPDDIEDESTGLKK.3|VLELPYQGEELSMVILLPDDIEDESTGLK.3
SEN / CTL,26S proteasome non-ATPase regulatory subunit 3,PSMD3,O43242,0.24,0.29,1.24E-03,9.20E-04,3.04E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,ubiquitin-dependent protein catabolic process,regulation of cellular amino acid metabolic process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","protein binding,enzyme regulator activity","proteasome complex,nucleus,nucleoplasm,cytoplasm,cytosol,proteasome regulatory particle, lid subcomplex,membrane,proteasome accessory complex,extracellular exosome",18,43,64,VYEFLDKLDVVR.3|VYEFLDKLDVVR.2|HDADGQATLLNLLLR.3|HDADGQATLLNLLLR.2|SLMPYFLLTQAVR.2|SLMPYFLLTQAVR.3|SLM[Oxi]PYFLLTQAVR.2|SVFPEQANNNEWAR.2|SVFPEQANNNEWAR.3|ISFC[CAM]LDIHNMSVK.3|ISFC[CAM]LDIHNM[Oxi]SVK.3|ISFC[CAM]LDIHNM[Oxi]SVK.2|ISFC[CAM]LDIHNMSVK.2|DFLLPFLEEPMDTEADLQFRPR.3|DFLLPFLEEPMDTEADLQFRPR.4|ALDLVAAK.2|RLNHYVLYK.3|SYNKDLESAEERR.4|AIRDGVIEASINHEK.4|AIRDGVIEASINHEK.3|DGVIEASINHEK.3|DGVIEASINHEK.2|ELDTVTLEDIKEHVK.4|ELDTVTLEDIKEHVK.3|ELDTVTLEDIKEHVK.2|AIQLEYSEARR.3|AIQLEYSEARR.2|VYEFLDK.2|EREQQDLEFAK.3|EREQQDLEFAK.2|DLESAEER.2|ISDDLMQK.2|ISLADIAQK.2|MISLSYSR.2|RALDLVAAK.2|SYNKDLESAEER.3|SYNKDLESAEER.2|C[CAM]YYYHAR.2|REREQQDLEFAK.3|APQHTAVGFK.2|LNHYVLYK.2|NYLHYSLYDQAEK.3|NYLHYSLYDQAEK.2|TATLRHDADGQATLLNLLLR.4|TATLRHDADGQATLLNLLLR.3|EMIDIYSTREPQLAFHQR.4|EMIDIYSTREPQLAFHQR.3|EQQDLEFAK.2|LQLDSPEDAEFIVAK.3|LQLDSPEDAEFIVAK.2|TAAAAAEHSQR.2|EMIDIYSTR.2|EPQLAFHQR.2|RSLMPYFLLTQAVR.3|AIQLEYSEAR.2|TAAAAAEHSQRELDTVTLEDIK.4|TAAAAAEHSQRELDTVTLEDIK.3|ELDTVTLEDIK.2|FNQVLDQFGEK.2|FQADGTYTLIIR.2|AVQGFFTSNNATR.2|EEAATGGGSTGEADGK.2|AKPPPGGGEQEPPPPPAPQDVEMK.3|AKPPPGGGEQEPPPPPAPQDVEMKEEAATGGGSTGEADGK.4
SEN / CTL,Elongation factor 1-delta,EEF1D,P29692,0.23,0.39,1.71E-02,8.28E-03,2.08E+00,"transcription, DNA-templated,regulation of transcription, DNA-templated,translational elongation,signal transduction,positive regulation of I-kappaB kinase/NF-kappaB signaling,cellular response to ionizing radiation,cell-cell adhesion","DNA binding,translation elongation factor activity,signal transducer activity,translation factor activity, RNA binding,cadherin binding involved in cell-cell adhesion","nucleus,nucleolus,cytoplasm,cytosol,eukaryotic translation elongation factor 1 complex,cell-cell adherens junction,endoplasmic reticulum",18,24,46,LVPVGYGIR.2|SIQLDGLVWGASK.2|SIQLDGLVWGASK.3|IASLEVENQSLR.2|IASLEVENQSLR.3|GVVQELQQAISK.2|GVVQELQQAISK.3|SLAGSSGPGASSGTSGDHGELVVR.3|SLAGSSGPGASSGTSGDHGELVVR.4|SLAGSSGPGASSGTSGDHGELVVR.2|GVVQELQQAISKLEAR.3|GVVQELQQAISKLEAR.2|FKYDDAERR.3|LQIQC[CAM]VVEDDK.3|LQIQC[CAM]VVEDDK.2|ATAPQTQHVSPMR.3|ATAPQTQHVSPM[Oxi]R.3|ATAPQTQHVSPMR.2|ATAPQTQHVSPM[Oxi]R.2|KLQIQC[CAM]VVEDDK.3|KLQIQC[CAM]VVEDDK.2|FYEQMNGPVAGASR.3|FYEQMNGPVAGASR.2|FYEQM[Oxi]NGPVAGASR.2|QENGASVILR.2|RFYEQMNGPVAGASR.3|RFYEQMNGPVAGASR.2|FEEHVQSVDIAAFNK.3|FEEHVQSVDIAAFNK.2|FEEHVQSVDIAAFNKI.3|FEEHVQSVDIAAFNKI.2|IASLEVENQSLRGVVQELQQAISK.4|IASLEVENQSLRGVVQELQQAISK.3|VGTDLLEEEITK.2|SSILLDVKPWDDETDMAQLEAC[CAM]VR.4|SSILLDVKPWDDETDMAQLEAC[CAM]VR.3|LQIQC[CAM]VVEDDKVGTDLLEEEITKFEEHVQSVDIAAFNK.6|LQIQC[CAM]VVEDDKVGTDLLEEEITKFEEHVQSVDIAAFNK.5|LQIQC[CAM]VVEDDKVGTDLLEEEITKFEEHVQSVDIAAFNK.4|VGTDLLEEEITKFEEHVQSVDIAAFNK.4|VGTDLLEEEITKFEEHVQSVDIAAFNK.3|IASLEVENQSLRGVVQELQQAISKLEAR.4|VGTDLLEEEITKFEEHVQSVDIAAFNKI.4|VGTDLLEEEITKFEEHVQSVDIAAFNKI.3|LQIQC[CAM]VVEDDKVGTDLLEEEITK.3|KPATPAEDDEDDDIDLFGSDNEEEDK.3
SEN / CTL,"Adenylate kinase 2, mitochondrial",AK2,P54819,0.23,0.35,7.12E-04,5.67E-04,3.25E+00,"ADP biosynthetic process,nucleobase-containing small molecule interconversion,AMP metabolic process,ATP metabolic process,nucleotide phosphorylation","adenylate kinase activity,ATP binding","mitochondrial inner membrane,mitochondrial intermembrane space,extracellular exosome,sperm mitochondrial sheath",39,28,55,NGFLLDGFPR.2|GIHSAIDASQTPDVVFASILAAFSK.3|GIHSAIDASQTPDVVFASILAAFSK.4|EKLDSVIEFSIPDSLLIRR.4|SYHEEFNPPKEPMKDDITGEPLIR.5|SYHEEFNPPKEPM[Oxi]KDDITGEPLIR.4|SYHEEFNPPKEPMKDDITGEPLIR.4|SYHEEFNPPKEPM[Oxi]KDDITGEPLIR.5|SYHEEFNPPKEPMKDDITGEPLIR.3|EKLDSVIEFSIPDSLLIR.3|EKLDSVIEFSIPDSLLIR.2|LQAYHTQTTPLIEYYR.3|LQAYHTQTTPLIEYYR.4|LQAYHTQTTPLIEYYR.2|QAEMLDDLMEK.2|QAEM[Oxi]LDDLMEK.2|QAEMLDDLM[Oxi]EK.2|QAEM[Oxi]LDDLM[Oxi]EK.2|LAENFC[CAM]VC[CAM]HLATGDMLR.3|LAENFC[CAM]VC[CAM]HLATGDM[Oxi]LR.3|LAENFC[CAM]VC[CAM]HLATGDMLR.2|LAENFC[CAM]VC[CAM]HLATGDM[Oxi]LR.2|LDSVIEFSIPDSLLIR.2|LDSVIEFSIPDSLLIR.3|APSVPAAEPEYPKGIR.4|APSVPAAEPEYPKGIR.3|SYHEEFNPPK.3|SYHEEFNPPK.2|SYHEEFNPPKEPMK.4|APSVPAAEPEYPK.3|APSVPAAEPEYPK.2|IRLQAYHTQTTPLIEYYRK.5|IRLQAYHTQTTPLIEYYRK.4|AVLLGPPGAGK.2|NLETPLC[CAM]K.2|LVSDEMVVELIEK.3|LVSDEMVVELIEK.2|LVSDEM[Oxi]VVELIEK.2|AMVASGSELGK.2|AM[Oxi]VASGSELGK.2|AVLLGPPGAGKGTQAPR.3|LQAYHTQTTPLIEYYRK.4|LQAYHTQTTPLIEYYRK.3|RGIHSAIDASQTPDVVFASILAAFSK.5|RGIHSAIDASQTPDVVFASILAAFSK.4|RGIHSAIDASQTPDVVFASILAAFSK.3|DDITGEPLIR.2|IRLQAYHTQTTPLIEYYR.4|IRLQAYHTQTTPLIEYYR.3|AMVASGSELGKK.2|AM[Oxi]VASGSELGKK.2|LDSVIEFSIPDSLLIRR.3|KRGIHSAIDASQTPDVVFASILAAFSK.4|EPMKDDITGEPLIR.2|LVSDEMVVELIEKNLETPLC[CAM]K.3
SEN / CTL,5'-nucleotidase,NT5E,P21589,0.23,0.56,8.89E-02,3.26E-02,1.49E+00,"purine nucleotide catabolic process,AMP catabolic process,DNA metabolic process,leukocyte cell-cell adhesion,dephosphorylation,adenosine biosynthetic process,pyrimidine nucleoside catabolic process,negative regulation of inflammatory response","nucleotide binding,5'-nucleotidase activity,metal ion binding","cytoplasm,plasma membrane,cell surface,membrane,anchored component of membrane,extracellular exosome",30,28,42,TIVYLDGSSQSC[CAM]R.2|EVPAGKYPFIVTSDDGR.3|VLPVGDEVVGIVGYTSK.3|VLPVGDEVVGIVGYTSK.2|FPILSANIK.2|YDAMALGNHEFDNGVEGLIEPLLK.3|YDAM[Oxi]ALGNHEFDNGVEGLIEPLLK.3|GAEVAHFMNALR.3|GAEVAHFMNALR.2|GAEVAHFM[Oxi]NALR.2|ETPFLSNPGTNLVFEDEITALQPEVDKLK.3|ETPFLSNPGTNLVFEDEITALQPEVDKLK.4|FREC[CAM]NMGNLIC[CAM]DAMINNNLR.3|IIALGHSGFEMDKLIAQK.4|IIALGHSGFEMDKLIAQK.3|C[CAM]RVPSYDPLK.3|MKVIYPAVEGR.3|KVPVVQAYAFGK.3|IIALGHSGFEMDK.3|IIALGHSGFEMDK.2|AFEHSVHR.2|VIYPAVEGR.2|GPLASQISGLYLPYK.3|GPLASQISGLYLPYK.2|GVDVVVGGHSNTFLYTGNPPSK.4|GVDVVVGGHSNTFLYTGNPPSK.3|GVDVVVGGHSNTFLYTGNPPSK.2|LEQTSEDSSK.2|VPSYDPLKMDEVYK.3|VPVVQAYAFGK.2|HDSGDQDINVVSTYISK.3|HDSGDQDINVVSTYISK.2|YPFIVTSDDGR.2|VILPNFLANGGDGFQMIK.3|VILPNFLANGGDGFQMIK.2|VILPNFLANGGDGFQMIKDELLR.4|VILPNFLANGGDGFQM[Oxi]IKDELLR.3|VILPNFLANGGDGFQMIKDELLR.3|C[CAM]RVPSYDPLKMDEVYK.3|YPFIVTSDDGRK.2|YGQSTGEFLQVGGIHVVYDLSR.3|ETPFLSNPGTNLVFEDEITALQPEVDK.3
SEN / CTL,Protein CYR61,CYR61,O00622,0.23,1.11,5.20E-02,2.07E-02,1.68E+00,"regulation of cell growth,osteoblast differentiation,positive regulation of protein phosphorylation,intussusceptive angiogenesis,atrioventricular valve morphogenesis,apoptotic process involved in heart morphogenesis,ventricular septum development,chemotaxis,cell adhesion,cell-cell signaling,cell proliferation,anatomical structure morphogenesis,positive regulation of phospholipase activity,positive regulation of cell-substrate adhesion,extracellular matrix organization,positive regulation of cell migration,positive regulation of BMP signaling pathway,positive regulation of osteoblast proliferation,negative regulation of apoptotic process,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,wound healing, spreading of cells,positive regulation of osteoblast differentiation,positive regulation of protein kinase activity,positive regulation of transcription from RNA polymerase II promoter,atrial septum morphogenesis,negative regulation of cell death,chondroblast differentiation,chorio-allantoic fusion,labyrinthine layer blood vessel development,positive regulation of cartilage development,regulation of ERK1 and ERK2 cascade,reactive oxygen species metabolic process,positive regulation of ceramide biosynthetic process","integrin binding,insulin-like growth factor binding,heparin binding,extracellular matrix binding","proteinaceous extracellular matrix,extracellular matrix",36,17,20,GLEC[CAM]NFGASSTALK.2|C[CAM]APGVGLVR.2|HQC[CAM]TC[CAM]IDGAVGC[CAM]IPLC[CAM]PQELSLPNLGC[CAM]PNPR.4|HQC[CAM]TC[CAM]IDGAVGC[CAM]IPLC[CAM]PQELSLPNLGC[CAM]PNPR.3|HQC[CAM]TC[CAM]IDGAVGC[CAM]IPLC[CAM]PQELSLPNLGC[CAM]PNPR.5|FTYAGC[CAM]LSVK.2|C[CAM]NYNC[CAM]PHANEAAFPFYR.3|IC[CAM]EVRPC[CAM]GQPVYSSLK.3|NNELIAVGK.2|ELGFDASEVELTR.2|IYQNGESFQPNC[CAM]K.2|C[CAM]IVQTTSWSQC[CAM]SK.2|AQSEGRPC[CAM]EYNSR.3|C[CAM]C[CAM]TPQLTR.2|C[CAM]EDGETFSK.2|YC[CAM]GSC[CAM]VDGR.2|VTNDNPEC[CAM]R.2|NVMMIQSC[CAM]K.2|NVMM[Oxi]IQSC[CAM]K.2|FRC[CAM]EDGETFSK.2
SEN / CTL,Proteasome activator complex subunit 2,PSME2,Q9UL46,0.23,0.96,1.02E-01,3.63E-02,1.44E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,positive regulation of endopeptidase activity,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,regulation of proteasomal protein catabolic process,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,regulation of G1/S transition of mitotic cell cycle",endopeptidase activator activity,"proteasome complex,nucleoplasm,cytoplasm,cytosol,proteasome activator complex,membrane,extracellular exosome",36,23,36,QNLFQEAEEFLYR.2|QNLFQEAEEFLYR.3|ALVHERDEAAYGELR.4|ALVHERDEAAYGELR.3|ALVHERDEAAYGELR.2|AFYAELYHIISSNLEK.3|AFYAELYHIISSNLEK.2|IIYLNQLLQEDSLNVADLTSLR.3|IIYLNQLLQEDSLNVADLTSLR.4|AMVLDLR.2|AM[Oxi]VLDLR.2|IEDGNDFGVAIQEK.2|VLSLLALVKPEVWTLKEK.4|VLSLLALVKPEVWTLKEK.3|VLSLLALVKPEVWTLK.3|VLSLLALVKPEVWTLK.4|VLSLLALVKPEVWTLK.2|C[CAM]ILVITWIQHLIPK.3|C[CAM]ILVITWIQHLIPK.2|ASKETHVMDYR.3|TKVEAFQTTISK.3|TKVEAFQTTISK.2|GEEKPSMY.2|C[CAM]GFLPGNEK.2|DEAAYGELR.2|ETHVMDYR.2|ETHVM[Oxi]DYR.2|VEAFQTTISK.2|AFYAELYHIISSNLEKIVNPK.4|YFSERGDAVAK.2|KQVEVFRQNLFQEAEEFLYR.4|APLDIPIPDPPPK.2|APLDIPIPDPPPKDDEMETDKQEK.4|APLDIPIPDPPPKDDEMETDKQEK.3|APLDIPIPDPPPKDDEMETDK.3|QVEVFRQNLFQEAEEFLYR.3
SEN / CTL,RuvB-like 2,RUVBL2,Q9Y230,0.23,0.76,8.56E-02,3.17E-02,1.50E+00,"box C/D snoRNP assembly,DNA repair,DNA recombination,chromatin remodeling,transcription, DNA-templated,protein folding,DNA duplex unwinding,cellular response to UV,positive regulation of histone acetylation,regulation of growth,histone H4 acetylation,histone H2A acetylation,positive regulation of transcription from RNA polymerase II promoter,establishment of protein localization to chromatin,cellular response to estradiol stimulus,transcriptional activation by promoter-enhancer looping,negative regulation of estrogen receptor binding,positive regulation of telomerase RNA localization to Cajal body","RNA polymerase II core promoter sequence-specific DNA binding,RNA polymerase II distal enhancer sequence-specific DNA binding,DNA helicase activity,ATP-dependent DNA helicase activity,protein binding,ATP binding,chromatin DNA binding,identical protein binding,ATP-dependent 5'-3' DNA helicase activity,unfolded protein binding,ATPase activity","Swr1 complex,intracellular,nucleus,nucleoplasm,nuclear euchromatin,cytoplasm,membrane,nuclear matrix,Ino80 complex,NuA4 histone acetyltransferase complex,extracellular exosome,MLL1 complex,R2TP complex",24,42,67,GLGLDDALEPR.2|IGLETSLR.2|ALESDMAPVLIMATNR.3|ALESDMAPVLIMATNR.2|RAAGVVLEMIR.3|RAAGVVLEMIR.2|AAGVVLEMIR.2|AAGVVLEM[Oxi]IR.2|IRGTSYQSPHGIPIDLLDR.4|IRGTSYQSPHGIPIDLLDR.3|MIESLTK.2|IRC[CAM]EEEDVEMSEDAYTVLTR.3|IRC[CAM]EEEDVEM[Oxi]SEDAYTVLTR.3|GTEVQVDDIKR.3|GTEVQVDDIKR.2|ARDYDAMGSQTK.3|ARDYDAMGSQTK.2|IGAHSHIR.2|RKEVVHTVSLHEIDVINSR.5|RKEVVHTVSLHEIDVINSR.4|RKEVVHTVSLHEIDVINSR.3|KGTEVQVDDIKR.3|KGTEVQVDDIKR.2|RKGTEVQVDDIK.3|RVYSLFLDESR.3|RVYSLFLDESR.2|DKVQAGDVITIDK.3|DKVQAGDVITIDK.2|EVVHTVSLHEIDVINSR.4|EVVHTVSLHEIDVINSR.3|EVVHTVSLHEIDVINSR.2|FVQC[CAM]PDGELQKR.3|TTEMETIYDLGTK.3|TTEMETIYDLGTK.2|TTEM[Oxi]ETIYDLGTK.2|EYQDAFLFNELK.3|EYQDAFLFNELK.2|KEVVHTVSLHEIDVINSR.4|TEALTQAFR.2|YAIQLITAASLVC[CAM]R.3|YAIQLITAASLVC[CAM]R.2|GTEVQVDDIK.2|VAEWREEGK.2|AVLIAGQPGTGK.2|DYDAMGSQTK.2|DYDAM[Oxi]GSQTK.2|LLIVSTTPYSEKDTK.3|LLIVSTTPYSEKDTK.2|TQGFLALFSGDTGEIK.3|TQGFLALFSGDTGEIK.2|YAIQLITAASLVC[CAM]RK.3|VQAGDVITIDK.2|KGTEVQVDDIK.2|VYSLFLDESR.2|GTSYQSPHGIPIDLLDR.3|GTSYQSPHGIPIDLLDR.2|FVQC[CAM]PDGELQK.2|QASQGMVGQLAAR.2|QASQGM[Oxi]VGQLAAR.2|LLIVSTTPYSEK.2|IRGTSYQSPHGIPIDLLDRLLIVSTTPYSEK.5|TQGFLALFSGDTGEIKSEVR.3|TQGFLALFSGDTGEIKSEVR.2|IKEETEIIEGEVVEIQIDRPATGTGSK.4|IKEETEIIEGEVVEIQIDRPATGTGSK.3|TAIAMGMAQALGPDTPFTAIAGSEIFSLEMSK.3|EYQDAFLFNELKGETMDTS.2
SEN / CTL,V-type proton ATPase catalytic subunit A,ATP6V1A,P38606,0.23,0.43,8.21E-07,1.41E-06,5.85E+00,"transport,insulin receptor signaling pathway,ATP hydrolysis coupled proton transport,regulation of macroautophagy,transferrin transport,ion transmembrane transport,ATP metabolic process,phagosome acidification","ATP binding,proton-transporting ATPase activity, rotational mechanism","mitochondrion,lysosomal membrane,cytosol,plasma membrane,integral component of plasma membrane,microvillus,apical plasma membrane,proton-transporting two-sector ATPase complex,proton-transporting V-type ATPase, V1 domain,myelin sheath,extracellular exosome",42,53,91,QVRPVTEKLPANHPLLTGQR.4|AKEILQEEEDLAEIVQLVGK.3|AKEILQEEEDLAEIVQLVGK.4|VLDALFPC[CAM]VQGGTTAIPGAFGC[CAM]GK.3|VLDALFPC[CAM]VQGGTTAIPGAFGC[CAM]GK.4|VGSHITGGDIYGIVSENSLIK.3|VGSHITGGDIYGIVSENSLIK.4|VGSHITGGDIYGIVSENSLIK.2|IKSDYAQLLEDMQNAFR.3|IKSDYAQLLEDMQNAFR.4|IKSDYAQLLEDMQNAFR.2|FTMVQVWPVR.2|FTMVQVWPVR.3|FTM[Oxi]VQVWPVR.2|LAEMPADSGYPAYLGAR.2|LAEMPADSGYPAYLGAR.3|LAEM[Oxi]PADSGYPAYLGAR.2|TGKPLSVELGPGIMGAIFDGIQRPLSDISSQTQSIYIPR.4|TGKPLSVELGPGIMGAIFDGIQRPLSDISSQTQSIYIPR.5|TGKPLSVELGPGIMGAIFDGIQRPLSDISSQTQSIYIPR.6|ALDEYYDKHFTEFVPLR.4|ALDEYYDKHFTEFVPLR.3|ALDEYYDKHFTEFVPLR.2|DMGYHVSMMADSTSR.3|DM[Oxi]GYHVSMMADSTSR.3|DMGYHVSMMADSTSR.2|DM[Oxi]GYHVSMMADSTSR.2|TVGMLSNMIAFYDMAR.3|TVGMLSNMIAFYDMAR.2|EILQEEEDLAEIVQLVGK.3|EILQEEEDLAEIVQLVGK.2|ASLAETDK.2|FKDPLKDGEAK.3|FKDPLKDGEAK.2|KHFPSVNWLISYSK.4|KHFPSVNWLISYSK.3|KHFPSVNWLISYSK.2|DIKWDFTPC[CAM]K.3|LASFYER.2|LPANHPLLTGQR.3|LPANHPLLTGQR.2|RAVETTAQSDNK.3|RAVETTAQSDNK.2|VGHSELVGEIIR.3|VGHSELVGEIIR.2|ITWSIIR.2|GVNVSALSR.2|WDFTPC[CAM]K.2|QVRPVTEK.2|TVISQSLSK.2|ALDEYYDK.2|TALVANTSNMPVAAR.3|TALVANTSNM[Oxi]PVAAR.2|TALVANTSNMPVAAR.2|GNEMSEVLR.2|GNEM[Oxi]SEVLR.2|ASLAETDKITLEVAK.3|ASLAETDKITLEVAK.2|HFPSVNWLISYSK.3|HFPSVNWLISYSK.2|EHMGDILYK.2|EHM[Oxi]GDILYK.2|RAVETTAQSDNKITWSIIR.4|RTALVANTSNMPVAAR.3|RTALVANTSNM[Oxi]PVAAR.3|HFTEFVPLR.2|AVETTAQSDNK.2|SDYAQLLEDMQNAFR.3|SDYAQLLEDMQNAFR.2|PLSDISSQTQSIYIPR.3|PLSDISSQTQSIYIPR.2|AVETTAQSDNKITWSIIR.3|DFPELTMEVDGK.2|LIKDDFLQQNGYTPYDR.3|LIKDDFLQQNGYTPYDR.2|PLSVELGPGIMGAIFDGIQR.3|LIKDDFLQQNGYTPYDRFC[CAM]PFYK.4|PLSVELGPGIMGAIFDGIQRPLSDISSQTQSIYIPR.5|PLSVELGPGIMGAIFDGIQRPLSDISSQTQSIYIPR.4|TGKPLSVELGPGIMGAIFDGIQR.3|ESTFGYVHGVSGPVVTAC[CAM]DMAGAAMYELVR.4|ESTFGYVHGVSGPVVTAC[CAM]DMAGAAMYELVR.3|GNEMSEVLRDFPELTMEVDGK.3|DDFLQQNGYTPYDR.2|EASIYTGITLSEYFR.2|YSNSDVIIYVGC[CAM]GER.2|LEGDM[Oxi]ATIQVYEETSGVSVGDPVLR.3|LEGDMATIQVYEETSGVSVGDPVLR.3|GTVTYIAPPGNYDTSDVVLELEFEGVK.3|ILDEDKESTFGYVHGVSGPVVTAC[CAM]DMAGAAMYELVR.4|GTVTYIAPPGNYDTSDVVLELEFEGVKEK.3
SEN / CTL,Ribonuclease inhibitor,RNH1,P13489,0.23,0.70,1.31E-01,4.43E-02,1.35E+00,"mRNA catabolic process,negative regulation of catalytic activity,regulation of angiogenesis","protein binding,ribonuclease inhibitor activity","nucleoplasm,cytoplasm,angiogenin-PRI complex,extracellular exosome",84,31,55,VNPALAELNLR.2|VNPALAELNLR.3|WAELLPLLQQC[CAM]QVVR.2|WAELLPLLQQC[CAM]QVVR.3|TLPTLQELHLSDNLLGDAGLQLLC[CAM]EGLLDPQC[CAM]R.4|TLWIWEC[CAM]GITAK.2|VLC[CAM]QGLKDSPC[CAM]QLEALKLESC[CAM]GVTSDNC[CAM]R.4|DSPC[CAM]QLEALKLESC[CAM]GVTSDNC[CAM]R.3|LDDC[CAM]GLTEAR.2|ELC[CAM]QGLGQPGSVLR.2|ELC[CAM]QGLGQPGSVLR.3|LEDAGVRELC[CAM]QGLGQPGSVLR.3|LSLQNC[CAM]C[CAM]LTGAGC[CAM]GVLSSTLR.3|LSLQNC[CAM]C[CAM]LTGAGC[CAM]GVLSSTLR.2|LSLQNC[CAM]C[CAM]LTGAGC[CAM]GVLSSTLR.4|ESLKELSLAGNELGDEGAR.3|ESLKELSLAGNELGDEGAR.2|ELDLSNNC[CAM]LGDAGILQLVESVR.3|ELDLSNNC[CAM]LGDAGILQLVESVR.4|ELSLAGNELGDEGAR.2|ELSLAGNELGDEGAR.3|ELTVSNNDINEAGVR.2|ELTVSNNDINEAGVR.3|AKESLKELSLAGNELGDEGAR.4|AKESLKELSLAGNELGDEGAR.3|LLC[CAM]ETLLEPGC[CAM]QLESLWVK.3|LLC[CAM]ETLLEPGC[CAM]QLESLWVK.4|LLC[CAM]ETLLEPGC[CAM]QLESLWVK.2|SC[CAM]SFTAAC[CAM]C[CAM]SHFSSVLAQNR.3|SC[CAM]SFTAAC[CAM]C[CAM]SHFSSVLAQNR.4|SC[CAM]SFTAAC[CAM]C[CAM]SHFSSVLAQNR.2|LQLEYC[CAM]SLSAASC[CAM]EPLASVLR.3|LQLEYC[CAM]SLSAASC[CAM]EPLASVLR.4|LQLEYC[CAM]SLSAASC[CAM]EPLASVLR.2|LGDVGMAELC[CAM]PGLLHPSSR.3|LGDVGMAELC[CAM]PGLLHPSSR.4|LGDVGM[Oxi]AELC[CAM]PGLLHPSSR.3|LGDVGMAELC[CAM]PGLLHPSSR.2|SNELGDVGVHC[CAM]VLQGLQTPSC[CAM]K.3|SNELGDVGVHC[CAM]VLQGLQTPSC[CAM]K.4|SNELGDVGVHC[CAM]VLQGLQTPSC[CAM]K.2|VLWLADC[CAM]DVSDSSC[CAM]SSLAATLLANHSLR.3|VLWLADC[CAM]DVSDSSC[CAM]SSLAATLLANHSLR.5|VLWLADC[CAM]DVSDSSC[CAM]SSLAATLLANHSLR.4|QPGC[CAM]LLEQLVLYDIYWSEEMEDRLQALEKDKPSLR.5|DLC[CAM]GIVASK.2|ASLRELALGSNK.3|GC[CAM]GDLC[CAM]R.2|LESC[CAM]GVTSDNC[CAM]R.3|LESC[CAM]GVTSDNC[CAM]R.2|AKPDFKELTVSNNDINEAGVR.4|DSPC[CAM]QLEALK.2|VLC[CAM]QGLKDSPC[CAM]QLEALK.3|FLLELQISNNR.2|LESC[CAM]GVTSDNC[CAM]RDLC[CAM]GIVASK.3
SEN / CTL,Lipoma-preferred partner,LPP,Q93052,0.22,0.69,2.46E-02,1.13E-02,1.95E+00,"cell adhesion,biological_process","protein binding,zinc ion binding","nucleus,cytoplasm,plasma membrane,focal adhesion",21,28,50,KTYITDPVSAPC[CAM]APPLQPK.3|METTHSFGNPSISVSTQQPPKK.4|SLDGIPFTVDAGGLIHC[CAM]IEDFHKK.5|SLDGIPFTVDAGGLIHC[CAM]IEDFHKK.4|METTHSFGNPSISVSTQQPPK.3|METTHSFGNPSISVSTQQPPK.4|M[Oxi]ETTHSFGNPSISVSTQQPPK.3|METTHSFGNPSISVSTQQPPK.2|IVALDRDFHVHC[CAM]YR.4|IVALDRDFHVHC[CAM]YR.3|GGHSGQLGPSSVAPSFRPEDELEHLTKK.5|GGHSGQLGPSSVAPSFRPEDELEHLTKK.6|GGHSGQLGPSSVAPSFRPEDELEHLTKK.4|YYEGYYAAGPGYGGR.2|YYEGYYAAGPGYGGR.3|STGEPLGHVPAR.3|STGEPLGHVPAR.2|LRGQPFYAVEK.3|AYHPHC[CAM]FTC[CAM]VMC[CAM]HR.4|GQPFYAVEK.2|NDSDPTYGQQGHPNTWKR.4|NDSDPTYGQQGHPNTWKR.3|GGHSGQLGPSSVAPSFRPEDELEHLTK.5|GGHSGQLGPSSVAPSFRPEDELEHLTK.4|GGHSGQLGPSSVAPSFRPEDELEHLTK.3|SLDGIPFTVDAGGLIHC[CAM]IEDFHK.4|SLDGIPFTVDAGGLIHC[CAM]IEDFHK.3|MLYDMENPPADEYFGR.3|MLYDM[Oxi]ENPPADEYFGR.2|MLYDMENPPADEYFGR.2|NDSDPTYGQQGHPNTWK.3|TYITDPVSAPC[CAM]APPLQPK.3|TYITDPVSAPC[CAM]APPLQPK.2|MVIPNQPPLTATK.2|SAQPSPHYMAAPSSGQIYGSGPQGYNTQPVPVSGQC[CAM]PPPSTR.6|SAQPSPHYMAAPSSGQIYGSGPQGYNTQPVPVSGQC[CAM]PPPSTR.4|C[CAM]SVC[CAM]KEPIMPAPGQEETVR.3|C[CAM]SVC[CAM]KEPIMPAPGQEETVR.2|AYC[CAM]EPC[CAM]YINTLEQC[CAM]NVC[CAM]SKPIM[Oxi]ER.4|AYC[CAM]EPC[CAM]YINTLEQC[CAM]NVC[CAM]SKPIMER.4|AYC[CAM]EPC[CAM]YINTLEQC[CAM]NVC[CAM]SKPIM[Oxi]ER.3|AYC[CAM]EPC[CAM]YINTLEQC[CAM]NVC[CAM]SKPIMER.3|EPIMPAPGQEETVR.2|EPIM[Oxi]PAPGQEETVR.2|EPGYTPPGAGNQNPPGMYPVTGPK.3|EPGYTPPGAGNQNPPGMYPVTGPKK.3|REPGYTPPGAGNQNPPGMYPVTGPK.3|YYEGYYAAGPGYGGRNDSDPTYGQQGHPNTWK.4|GGMDYAYIPPPGLQPEPGYGYAPNQGR.3|C[CAM]EDC[CAM]GGLLSEGDNQGC[CAM]YPLDGHILC[CAM]K.3
SEN / CTL,T-complex protein 1 subunit eta,CCT7,Q99832,0.22,0.75,1.52E-01,4.93E-02,1.31E+00,"protein folding,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,protein stabilization,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body","protein binding,ATP binding,identical protein binding,unfolded protein binding","zona pellucida receptor complex,cytoplasm,mitochondrion,cytosol,chaperonin-containing T-complex,microtubule,cell body,extracellular exosome",30,48,102,INALTAASEAAC[CAM]LIVSVDETIKNPR.3|INALTAASEAAC[CAM]LIVSVDETIKNPR.4|C[CAM]QVFEETQIGGER.2|C[CAM]QVFEETQIGGER.3|QQLLIGAYAK.2|QVKPYVEEGLHPQIIIR.4|QVKPYVEEGLHPQIIIR.3|QVKPYVEEGLHPQIIIR.2|SQDAEVGDGTTSVTLLAAEFLK.3|SQDAEVGDGTTSVTLLAAEFLK.4|SQDAEVGDGTTSVTLLAAEFLK.2|TIPGKQQLLIGAYAK.3|TIPGKQQLLIGAYAK.2|QLC[CAM]DNAGFDATNILNK.3|QLC[CAM]DNAGFDATNILNK.2|TC[CAM]TFILR.2|ALEIIPR.2|VPEEDLK.2|GGAEQFMEETER.3|GGAEQFMEETER.2|GGAEQFM[Oxi]EETER.2|GKATISNDGATILK.3|GKATISNDGATILK.2|TFSYAGFEMQPK.3|TFSYAGFEMQPK.2|TFSYAGFEM[Oxi]QPK.2|TATQLAVNK.2|C[CAM]AMTALSSK.2|C[CAM]AM[Oxi]TALSSK.2|VQGGALEDSQLVAGVAFKK.4|VQGGALEDSQLVAGVAFKK.3|VQGGALEDSQLVAGVAFKK.2|VPEEDLKR.2|IKEIAVTVK.2|KTFSYAGFEM[Oxi]QPK.3|KTFSYAGFEMQPK.3|KTFSYAGFEMQPK.2|KVQGGALEDSQLVAGVAFKK.4|KVQGGALEDSQLVAGVAFKK.3|LPIGDVATQYFADR.3|LPIGDVATQYFADR.2|STVDAPTAAGR.2|IALLNVELELKAEK.3|LLDVVHPAAK.2|RAIKNDSVVAGGGAIEMELSK.4|RAIKNDSVVAGGGAIEMELSK.3|DMFC[CAM]AGRVPEEDLK.3|DMFC[CAM]AGRVPEEDLK.2|PYVEEGLHPQIIIR.3|PYVEEGLHPQIIIR.2|YNFFTGC[CAM]PK.2|IALLNVELELKAEKDNAEIR.4|IALLNVELELKAEKDNAEIR.3|SLHDAIMIVR.2|SLHDAIM[Oxi]IVR.2|VQGGALEDSQLVAGVAFK.3|VQGGALEDSQLVAGVAFK.2|ATISNDGATILK.2|DMFC[CAM]AGRVPEEDLKR.3|M[Oxi]VVDAVM[Oxi]MLDDLLQLK.3|M[Oxi]VVDAVMM[Oxi]LDDLLQLK.3|M[Oxi]VVDAVMMLDDLLQLK.3|MVVDAVM[Oxi]M[Oxi]LDDLLQLK.3|MVVDAVM[Oxi]MLDDLLQLK.3|MVVDAVMMLDDLLQLK.2|M[Oxi]VVDAVM[Oxi]M[Oxi]LDDLLQLK.2|M[Oxi]VVDAVM[Oxi]MLDDLLQLK.2|M[Oxi]VVDAVMMLDDLLQLK.2|MVVDAVM[Oxi]M[Oxi]LDDLLQLK.2|MVVDAVM[Oxi]MLDDLLQLK.2|IALLNVELELK.2|RTMMAC[CAM]GGSIQTSVNALSADVLGR.4|RTMMAC[CAM]GGSIQTSVNALSADVLGR.3|RTM[Oxi]M[Oxi]AC[CAM]GGSIQTSVNALSADVLGR.3|RTM[Oxi]MAC[CAM]GGSIQTSVNALSADVLGR.3|RTMM[Oxi]AC[CAM]GGSIQTSVNALSADVLGR.3|VHTVEDYQAIVDAEWNILYDK.4|VHTVEDYQAIVDAEWNILYDK.3|KVQGGALEDSQLVAGVAFK.3|KVQGGALEDSQLVAGVAFK.2|AIKNDSVVAGGGAIEM[Oxi]ELSK.3|AIKNDSVVAGGGAIEMELSK.3|AIKNDSVVAGGGAIEMELSK.2|EGTDSSQGIPQLVSNISAC[CAM]QVIAEAVR.4|EGTDSSQGIPQLVSNISAC[CAM]QVIAEAVR.3|VHTVEDYQAIVDAEWNILYDKLEK.4|VHTVEDYQAIVDAEWNILYDKLEK.3|INALTAASEAAC[CAM]LIVSVDETIK.3|INALTAASEAAC[CAM]LIVSVDETIK.2|TM[Oxi]M[Oxi]AC[CAM]GGSIQTSVNALSADVLGR.3|TM[Oxi]MAC[CAM]GGSIQTSVNALSADVLGR.3|TMM[Oxi]AC[CAM]GGSIQTSVNALSADVLGR.3|TMMAC[CAM]GGSIQTSVNALSADVLGR.3|TM[Oxi]MAC[CAM]GGSIQTSVNALSADVLGR.2|TMMAC[CAM]GGSIQTSVNALSADVLGR.2|LPIGDVATQYFADRDMFC[CAM]AGR.3|LPIGDVATQYFADRDM[Oxi]FC[CAM]AGR.3|LPIGDVATQYFADRDMFC[CAM]AGRVPEEDLK.4|NDSVVAGGGAIEM[Oxi]ELSK.2|NDSVVAGGGAIEMELSK.2|C[CAM]QVFEETQIGGERYNFFTGC[CAM]PK.3|HAQGGTWYGVDINNEDIADNFEAFVWEPAMVR.4
SEN / CTL,Complement C3,C3,P01024,0.22,0.59,1.18E-07,2.33E-07,6.63E+00,"positive regulation of type IIa hypersensitivity,positive regulation of protein phosphorylation,positive regulation of activation of membrane attack complex,proteolysis,fatty acid metabolic process,inflammatory response,immune response,complement activation,complement activation, alternative pathway,complement activation, classical pathway,signal transduction,G-protein coupled receptor signaling pathway,positive regulation of vascular endothelial growth factor production,positive regulation of glucose transport,regulation of triglyceride biosynthetic process,positive regulation of lipid storage,negative regulation of endopeptidase activity,regulation of complement activation,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of angiogenesis,regulation of immune response,positive regulation of apoptotic cell clearance","serine-type endopeptidase activity,endopeptidase inhibitor activity,receptor binding,protein binding,C5L2 anaphylatoxin chemotactic receptor binding","extracellular region,extracellular space,plasma membrane,extracellular exosome,blood microparticle",153,130,202,LVAYYTLIGASGQR.3|LVAYYTLIGASGQR.2|QVREPGQDLVVLPLSITTDFIPSFR.3|QVREPGQDLVVLPLSITTDFIPSFR.4|VYAYYNLEESC[CAM]TR.2|VYAYYNLEESC[CAM]TR.3|VFLDC[CAM]C[CAM]NYITELRR.3|GQGTLSVVTMYHAK.3|EPGQDLVVLPLSITTDFIPSFR.3|VRVELLHNPAFC[CAM]SLATTK.4|VRVELLHNPAFC[CAM]SLATTK.3|YYGGGYGSTQATFMVFQALAQYQK.3|RIPIEDGSGEVVLSRK.3|RIPIEDGSGEVVLSRK.4|RIPIEDGSGEVVLSR.3|RIPIEDGSGEVVLSR.2|LSINTHPSQKPLSITVR.4|LSINTHPSQKPLSITVR.3|LSINTHPSQKPLSITVR.2|IHWESASLLR.3|IHWESASLLR.2|DFDFVPPVVR.2|LMNIFLK.2|VPVAVQGEDTVQSLTQGDGVAK.3|VPVAVQGEDTVQSLTQGDGVAK.2|TELRPGETLNVNFLLR.3|TELRPGETLNVNFLLR.2|SGIPIVTSPYQIHFTK.3|SGIPIVTSPYQIHFTK.2|GLEVTITAR.2|SEETKENEGFTVTAEGK.3|SEETKENEGFTVTAEGK.2|TIYTPGSTVLYR.2|VHQYFNVELIQPGAVK.3|VHQYFNVELIQPGAVK.4|VHQYFNVELIQPGAVK.2|NTMILEIC[CAM]TR.2|NTM[Oxi]ILEIC[CAM]TR.2|IPIEDGSGEVVLSR.2|IPIEDGSGEVVLSR.3|VVLVAVDKGVFVLNKK.4|VVLVAVDKGVFVLNKK.3|VFLDC[CAM]C[CAM]NYITELR.2|VFLDC[CAM]C[CAM]NYITELR.3|ILLQGTPVAQMTEDAVDAER.3|ILLQGTPVAQM[Oxi]TEDAVDAER.3|ILLQGTPVAQM[Oxi]TEDAVDAER.2|ILLQGTPVAQMTEDAVDAER.2|VQLSNDFDEYIMAIEQTIK.3|VQLSNDFDEYIM[Oxi]AIEQTIK.3|VQLSNDFDEYIM[Oxi]AIEQTIK.2|VQLSNDFDEYIMAIEQTIK.2|AGDFLEANYMNLQR.2|AGDFLEANYMNLQR.3|AGDFLEANYM[Oxi]NLQR.3|AGDFLEANYM[Oxi]NLQR.2|KVEGTAFVIFGIQDGEQR.3|KVEGTAFVIFGIQDGEQR.2|SSLSVPYVIVPLKTGLQEVEVK.3|ISLPESLK.2|KVFLDC[CAM]C[CAM]NYITELRR.4|TFISPIK.2|SVQLTEK.2|NNNEKDMALTAFVLISLQEAKDIC[CAM]EEQVNSLPGSITK.4|NNNEKDM[Oxi]ALTAFVLISLQEAKDIC[CAM]EEQVNSLPGSITK.4|ILLQGTPVAQMTEDAVDAERLK.3|ILLQGTPVAQM[Oxi]TEDAVDAERLK.3|IRYYTYLIMNK.3|IRYYTYLIM[Oxi]NK.3|DIC[CAM]EEQVNSLPGSITK.2|DIC[CAM]EEQVNSLPGSITK.3|SSLSVPYVIVPLK.3|SSLSVPYVIVPLK.2|SYTVAIAGYALAQMGR.3|SYTVAIAGYALAQM[Oxi]GR.3|SYTVAIAGYALAQM[Oxi]GR.2|SYTVAIAGYALAQMGR.2|AAVYHHFISDGVRK.4|AAVYHHFISDGVRK.3|FYHPEKEDGKLNK.4|FYHPEKEDGKLNK.3|KGYTQQLAFR.3|KGYTQQLAFR.2|VTIKPAPETEK.3|VTIKPAPETEK.2|ASHLGLAR.2|KVLLDGVQNPR.3|KVLLDGVQNPR.2|FYHPEKEDGK.3|VVLVAVDK.2|TRFISLGEAC[CAM]K.3|QGALELIK.2|QLANGVDR.2|SGSDEVQVGQQR.3|SGSDEVQVGQQR.2|NEQVEIR.2|APSTWLTAYVVK.3|APSTWLTAYVVK.2|AVLYNYR.2|IWDVVEK.2|KLVLSSEK.2|KQELSEAEQATR.3|KQELSEAEQATR.2|TRFISLGEAC[CAM]KK.3|TRFISLGEAC[CAM]KK.2|VSHSEDDC[CAM]LAFK.3|VSHSEDDC[CAM]LAFK.2|VTIKPAPETEKRPQDAK.4|VTIKPAPETEKRPQDAK.3|EALKLEEK.2|KVLLDGVQNPRAEDLVGK.4|KVLLDGVQNPRAEDLVGK.3|AAVYHHFISDGVR.3|AAVYHHFISDGVR.2|PNLSYIIGK.2|RAPSTWLTAYVVK.3|RAPSTWLTAYVVK.2|TGLQEVEVK.2|FISLGEAC[CAM]K.2|LKGPLLNKFLTTAK.3|RQGALELIK.2|ADIGC[CAM]TPGSGK.2|DSC[CAM]VGSLVVK.2|KC[CAM]C[CAM]EDGMR.2|IPIEDGSGEVVLSRK.3|VVLVAVDKGVFVLNK.3|GYTQQLAFR.2|TKKQELSEAEQATR.3|FVTVQATFGTQVVEK.3|FVTVQATFGTQVVEK.2|LDKAC[CAM]EPGVDYVYK.3|NTLIIYLDK.2|TVMVNIENPEGIPVK.3|TVM[Oxi]VNIENPEGIPVK.2|TVMVNIENPEGIPVK.2|VLLDGVQNPR.2|LESEETMVLEAHDAQGDVPVTVTVHDFPGKK.6|LESEETMVLEAHDAQGDVPVTVTVHDFPGKK.5|LSINTHPSQK.2|FYYIYNEK.2|QPSSAFAAFVK.2|KGYTQQLAFRQPSSAFAAFVK.4|GYTQQLAFRQPSSAFAAFVKR.4|SDDKVTLEER.2|VELLHNPAFC[CAM]SLATTK.3|VELLHNPAFC[CAM]SLATTK.2|SNLDEDIIAEENIVSR.3|SNLDEDIIAEENIVSR.2|VLLDGVQNPRAEDLVGK.3|YYTYLIMNK.2|YYTYLIM[Oxi]NK.2|KVFLDC[CAM]C[CAM]NYITELR.3|HYLMWGLSSDFWGEK.3|EYVLPSFEVIVEPTEK.3|EYVLPSFEVIVEPTEK.2|QELSEAEQATR.2|SYTVAIAGYALAQMGRLKGPLLNK.4|DSITTWEILAVSMSDKK.3|ENEGFTVTAEGK.2|QKPDGVFQEDAPVIHQEM[Oxi]IGGLR.4|QKPDGVFQEDAPVIHQEMIGGLR.4|QKPDGVFQEDAPVIHQEMIGGLR.3|TMQALPYSTVGNSNNYLHLSVLR.4|TM[Oxi]QALPYSTVGNSNNYLHLSVLR.4|TM[Oxi]QALPYSTVGNSNNYLHLSVLR.3|TMQALPYSTVGNSNNYLHLSVLR.3|AC[CAM]EPGVDYVYK.2|C[CAM]AEENC[CAM]FIQK.2|LESEETMVLEAHDAQGDVPVTVTVHDFPGK.5|LESEETMVLEAHDAQGDVPVTVTVHDFPGK.4|SGQSEDRQPVPGQQMTLK.3|EVVADSVWVDVK.2|EGVQKEDIPPADLSDQVPDTESETR.4|EGVQKEDIPPADLSDQVPDTESETR.3|AYYENSPQQVFSTEFEVK.3|AYYENSPQQVFSTEFEVK.2|DAPDHQELNLDVSLQLPSR.3|QLYNVEATSYALLALLQLK.3|QLYNVEATSYALLALLQLK.2|SEFPESWLWNVEDLKEPPKNGISTK.4|AEDLVGKSLYVSATVILHSGSDMVQAER.4|EDIPPADLSDQVPDTESETR.3|EDIPPADLSDQVPDTESETR.2|GYTQQLAFRQPSSAFAAFVK.3|KHYLMWGLSSDFWGEKPNLSYIIGK.4|VFSLAVNLIAIDSQVLC[CAM]GAVK.3|VFSLAVNLIAIDSQVLC[CAM]GAVK.2|SLYVSATVILHSGSDMVQAER.3|PGMPFDLMVFVTNPDGSPAYR.3|SEFPESWLWNVEDLKEPPK.3|NNNEKDMALTAFVLISLQEAK.3|IRAYYENSPQQVFSTEFEVK.3|DYAGVFSDAGLTFTSSSGQQTAQR.3|DMALTAFVLISLQEAK.2|DTWVEHWPEEDEC[CAM]QDEENQK.3|YFKPGMPFDLMVFVTNPDGSPAYR.3|SEFPESWLWNVEDLK.2|VVLVSLQSGYLFIQTDK.2|HLIVTPSGC[CAM]GEQNMIGM[Oxi]TPTVIAVHYLDETEQWEK.4|HLIVTPSGC[CAM]GEQNMIGMTPTVIAVHYLDETEQWEK.4|QDSLSSQNQLGVLPLSWDIPELVNM[Oxi]GQWK.3|QDSLSSQNQLGVLPLSWDIPELVNMGQWK.3
SEN / CTL,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",DDAH1,O94760,0.21,0.36,1.32E-01,4.44E-02,1.35E+00,"citrulline metabolic process,regulation of systemic arterial blood pressure,arginine catabolic process,nitric oxide mediated signal transduction,positive regulation of nitric oxide biosynthetic process,positive regulation of angiogenesis,regulation of nitric-oxide synthase activity","catalytic activity,dimethylargininase activity,amino acid binding,metal ion binding","mitochondrion,cytosol,extracellular exosome",9,21,37,QHQLYVGVLGSK.3|QHQLYVGVLGSK.2|GAEILADTFKDYAVSTVPVADGLHLK.4|GAEILADTFKDYAVSTVPVADGLHLK.3|AERQHQLYVGVLGSK.4|AERQHQLYVGVLGSK.3|ALPESLGQHALR.3|ALPESLGQHALR.2|GEEVDVAR.2|LKDHMLIPVSMSELEK.4|LKDHMLIPVSMSELEK.3|IMQQMSDHRYDK.3|GAEILADTFK.2|VDGLLTC[CAM]C[CAM]SVLINK.3|VDGLLTC[CAM]C[CAM]SVLINK.2|DHMLIPVSMSELEK.3|DHM[Oxi]LIPVSMSELEK.3|DHMLIPVSM[Oxi]SELEK.3|DHMLIPVSMSELEK.2|LQLNIVEMK.2|TPEEYPESAKVYEK.3|DYAVSTVPVADGLHLK.3|DYAVSTVPVADGLHLK.2|IMQQMSDHR.2|SAKGEEVDVAR.2|TPEEYPESAK.2|LTVPDDIAANC[CAM]IYLNIPNKGHVLLHR.5|LTVPDDIAANC[CAM]IYLNIPNKGHVLLHR.4|LQLNIVEMKDENATLDGGDVLFTGR.4|LQLNIVEMKDENATLDGGDVLFTGR.3|LTVPDDIAANC[CAM]IYLNIPNK.3|LTVPDDIAANC[CAM]IYLNIPNK.2|SFC[CAM]SM[Oxi]AGPNLIAIGSSESAQK.3|SFC[CAM]SMAGPNLIAIGSSESAQK.3|SFC[CAM]SM[Oxi]AGPNLIAIGSSESAQK.2|SFC[CAM]SMAGPNLIAIGSSESAQK.2|DENATLDGGDVLFTGR.2
SEN / CTL,Latent-transforming growth factor beta-binding protein 4,LTBP4,Q8N2S1,0.21,0.36,9.47E-02,3.41E-02,1.47E+00,"regulation of cell growth,protein folding,transmembrane receptor protein serine/threonine kinase signaling pathway,multicellular organism development,regulation of transforming growth factor beta receptor signaling pathway,regulation of proteolysis,growth hormone secretion,regulation of cell differentiation","transforming growth factor beta-activated receptor activity,integrin binding,calcium ion binding,protein binding,glycosaminoglycan binding,transforming growth factor beta binding","extracellular region,proteinaceous extracellular matrix,extracellular space,extracellular matrix,extracellular exosome",15,10,11,GGYTC[CAM]VC[CAM]PDGFLLDSSR.2|IQQC[CAM]PGTETAEYQSLC[CAM]PHGR.3|GAGLAWGVHDC[CAM]QLC[CAM]SER.3|VSGPWEEADAEAVAR.2|C[CAM]ISRPSGYTC[CAM]AC[CAM]DSGFR.3|SSC[CAM]ISQHVISEAK.3|SSC[CAM]ISQHVISEAK.2|NPQVC[CAM]GPGR.2|SRGPGAPC[CAM]QDVDEC[CAM]AR.3|EIC[CAM]PAGPGYHYSASDLR.3|GPGAPC[CAM]QDVDEC[CAM]AR.2
SEN / CTL,"Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial",ECH1,Q13011,0.21,0.35,3.02E-02,1.33E-02,1.88E+00,"fatty acid beta-oxidation,fatty acid catabolic process","receptor binding,isomerase activity","mitochondrion,peroxisome,membrane,extracellular exosome",24,26,53,YQETFNVIER.2|VIGNQSLVNELAFTAR.2|VIGNQSLVNELAFTAR.3|YC[CAM]AQDAFFQVK.2|YC[CAM]AQDAFFQVK.3|VFPDKEVMLDAALALAAEISSK.3|VFPDKEVMLDAALALAAEISSK.4|VFPDKEVM[Oxi]LDAALALAAEISSK.3|KMMADEALGSGLVSR.3|KM[Oxi]M[Oxi]ADEALGSGLVSR.3|KMMADEALGSGLVSR.2|KM[Oxi]M[Oxi]ADEALGSGLVSR.2|MMADEALGSGLVSR.2|MMADEALGSGLVSR.3|M[Oxi]M[Oxi]ADEALGSGLVSR.2|M[Oxi]MADEALGSGLVSR.2|MM[Oxi]ADEALGSGLVSR.2|EVDVGLAADVGTLQR.2|EVDVGLAADVGTLQR.3|AVVISGAGK.2|HVLHVQLNRPNKR.4|VNLLYSR.2|SVQATTENKELK.3|SVQATTENKELK.2|SPVAVQSTK.2|DADC[CAM]RAVVISGAGK.3|HVLHVQLNRPNK.3|SVQATTENK.2|EMVEC[CAM]FNK.2|C[CAM]PKPVIAAVHGGC[CAM]IGGGVDLVTAC[CAM]DIR.5|C[CAM]PKPVIAAVHGGC[CAM]IGGGVDLVTAC[CAM]DIR.4|C[CAM]PKPVIAAVHGGC[CAM]IGGGVDLVTAC[CAM]DIR.3|EVMLDAALALAAEISSK.3|EVMLDAALALAAEISSK.2|SPVAVQSTKVNLLYSR.3|PVIAAVHGGC[CAM]IGGGVDLVTAC[CAM]DIR.4|PVIAAVHGGC[CAM]IGGGVDLVTAC[CAM]DIR.3|VIGNQSLVNELAFTARK.3|VIGNQSLVNELAFTARK.2|VFPDKEVMLDAALALAAEISSKSPVAVQSTK.5|VFPDKEVMLDAALALAAEISSKSPVAVQSTK.4|VFPDKEVM[Oxi]LDAALALAAEISSKSPVAVQSTK.4|ISWYLRDIITRYQETFNVIER.4|LTGSSAQEEASGVALGEAPDHSYESLR.4|LTGSSAQEEASGVALGEAPDHSYESLR.3|M[Oxi]FTAGIDLMDMASDILQPK.3|MFTAGIDLM[Oxi]DMASDILQPK.3|MFTAGIDLMDM[Oxi]ASDILQPK.3|MFTAGIDLMDMASDILQPK.3|MFTAGIDLMDMASDILQPK.2|M[Oxi]FTAGIDLMDMASDILQPK.2|DHSVAESLNYVASWNM[Oxi]SMLQTQDLVK.3|DHSVAESLNYVASWNMSMLQTQDLVK.3
SEN / CTL,Toll-interacting protein,TOLLIP,Q9H0E2,0.21,0.77,3.60E-02,1.52E-02,1.82E+00,"autophagy,inflammatory response,signal transduction,cell-cell signaling,phosphorylation,epithelial cell differentiation,positive regulation of protein sumoylation,intracellular signal transduction,protein localization to endosome,innate immune response,leukocyte activation","signal transducer activity,interleukin-1, Type I receptor binding,protein binding,kinase binding,ubiquitin conjugating enzyme binding,ubiquitin protein ligase binding,SUMO binding,Toll-like receptor binding","cytoplasm,cytosol,nuclear body,interleukin-18 receptor complex,interleukin-1 receptor complex,perinuclear region of cytoplasm,extracellular exosome",9,10,12,GPVYIGELPQDFLR.2|LNITVVQAK.2|IAWTHITIPESLR.3|IAWTHITIPESLR.2|ITPTQQQR.2|LGYAVYETPTAHNGAK.3|LGYAVYETPTAHNGAK.2|DAAINSLLQMGEEP.2|VIHC[CAM]TVPPGVDSFYLEIFDER.3|GNKDAAINSLLQMGEEP.2|AIQDMFPNMDQEVIR.2|QVQLDAQAAQQLQYGGAVGTVGR.2
SEN / CTL,60S ribosomal protein L30,RPL30,P62888,0.21,0.24,1.10E-02,5.74E-03,2.24E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","RNA binding,structural constituent of ribosome,protein binding,poly(A) RNA binding","nucleus,cytoplasm,cytosol,focal adhesion,membrane,cytosolic large ribosomal subunit,extracellular matrix,extracellular exosome",12,10,19,VC[CAM]TLAIIDPGDSDIIR.2|VC[CAM]TLAIIDPGDSDIIR.3|LVILANNC[CAM]PALR.2|LVILANNC[CAM]PALR.3|KSEIEYYAMLAK.3|KSEIEYYAM[Oxi]LAK.3|KSEIEYYAMLAK.2|KSEIEYYAM[Oxi]LAK.2|SLESINSR.2|LVILANNC[CAM]PALRK.3|LVILANNC[CAM]PALRK.2|SMPEQTGEK.2|TGVHHYSGNNIELGTAC[CAM]GK.4|TGVHHYSGNNIELGTAC[CAM]GK.3|TGVHHYSGNNIELGTAC[CAM]GK.2|KSLESINSR.2|AKLVILANNC[CAM]PALR.3|SEIEYYAMLAK.2|SEIEYYAM[Oxi]LAK.2
SEN / CTL,Protein disulfide-isomerase A5,PDIA5,Q14554,0.21,1.25,1.04E-01,3.70E-02,1.43E+00,"protein folding,response to endoplasmic reticulum stress,IRE1-mediated unfolded protein response,cell redox homeostasis,oxidation-reduction process","protein disulfide isomerase activity,oxidoreductase activity","endoplasmic reticulum lumen,endoplasmic reticulum membrane",6,26,32,GFPTIC[CAM]YFEK.2|FHISEFPTLK.3|FHISEFPTLK.2|VIPHFTATADAFK.3|VIPHFTATADAFK.2|KVIPHFTATADAFKDDR.4|DKKVELFHYQDGAFHTEYNR.5|LLSTVAQAVK.2|DVVHLDSEK.2|DKNQDLC[CAM]QQEAVK.3|NNVLVLYSK.2|EHSSVLVM[Oxi]FHAPWC[CAM]GHC[CAM]K.4|IAC[CAM]AAVDC[CAM]VK.2|KVELFHYQDGAFHTEYNR.4|KVELFHYQDGAFHTEYNR.3|SEVAAENHLR.2|GPPLWEEDPGAKDVVHLDSEK.4|FAEKYDSDRTELGFTNYIR.4|YDSDRTELGFTNYIR.3|GQGTIC[CAM]WVDC[CAM]GDAESRK.3|GQGTIC[CAM]WVDC[CAM]GDAESRK.2|GPPLWEEDPGAK.2|NQDLC[CAM]QQEAVK.2|GHAVLAGMNVYSSEFENIK.3|GHAVLAGMNVYSSEFENIKEEYSVR.4|GHAVLAGMNVYSSEFENIKEEYSVR.3|AAEALHGEADSSGVLAAVDATVNK.3|AAEALHGEADSSGVLAAVDATVNK.2|GYPTFHYYHYGK.2|FLFQYDNYGSTAEDIVEWLK.3|NPQPPQPQVPETPWADEGGSVYHLTDEDFDQFVK.4|FLEWMQNPEAPPPPEPTWEEQQTSVLHLVGDNFR.4
SEN / CTL,Heterogeneous nuclear ribonucleoprotein R,HNRNPR,O43390,0.21,0.69,8.87E-02,3.25E-02,1.49E+00,"mRNA splicing, via spliceosome,mRNA processing,circadian rhythm,gene expression,negative regulation of catalytic activity,positive regulation of mRNA catabolic process,mRNA destabilization","nucleotide binding,RNA binding,mRNA 3'-UTR binding,poly(A) RNA binding","nucleoplasm,spliceosomal complex,endoplasmic reticulum,dendrite,growth cone,intracellular ribonucleoprotein complex,axon terminus,catalytic step 2 spliceosome,nucleolus",12,33,51,GYAFITFC[CAM]GK.2|NLATTVTEEILEK.2|NLATTVTEEILEK.3|HLGVC[CAM]ISVANNR.3|HLGVC[CAM]ISVANNR.2|KLKDYAFVHFEDR.4|DYAFVHFEDR.3|DYAFVHFEDR.2|VQESTKGPDEAK.3|VQESTKGPDEAK.2|LC[CAM]DSYEIRPGK.3|LC[CAM]DSYEIRPGK.2|TKENILEEFSK.3|TKENILEEFSK.2|EIEGEEIEIVLAKPPDKK.4|EIEGEEIEIVLAKPPDKK.3|LKDYAFVHFEDR.3|LKDYAFVHFEDR.2|VTEGLVDVILYHQPDDKK.4|VTEGLVDVILYHQPDDKK.3|DLYEDELVPLFEK.3|DLYEDELVPLFEK.2|EEEEPMDTSSVTHTEHYK.4|EEEEPMDTSSVTHTEHYK.3|TLIEAGLPQK.2|EAAQEAVKLC[CAM]DSYEIRPGK.4|VTEGLVDVILYHQPDDKKK.4|ENILEEFSK.2|EFNEEGALSVLQQFK.3|EFNEEGALSVLQQFK.2|ESDLSHVQNK.2|STAYEDYYYHPPPR.3|AIDALREFNEEGALSVLQQFK.4|AIDALREFNEEGALSVLQQFK.3|AIDALREFNEEGALSVLQQFK.2|SFSEFGKLER.2|LMMDPLSGQNR.2|LM[Oxi]MDPLSGQNR.2|LMM[Oxi]DPLSGQNR.2|EIEGEEIEIVLAKPPDK.3|EIEGEEIEIVLAKPPDK.2|VTEGLVDVILYHQPDDK.3|VTEGLVDVILYHQPDDK.2|IPRDLYEDELVPLFEK.3|NLATTVTEEILEKSFSEFGKLER.4|AIDALREFNEEGALSVLQQFKESDLSHVQNK.5|KYGGPPPDSVYSGVQPGIGTEVFVGKIPR.4|YGGPPPDSVYSGVQPGIGTEVFVGK.3|KYGGPPPDSVYSGVQPGIGTEVFVGK.3|VWGNVVTVEWADPVEEPDPEVMAK.3|YGGPPPDSVYSGVQPGIGTEVFVGKIPR.3
SEN / CTL,Laminin subunit beta-2,LAMB2,P55268,0.21,0.49,9.96E-03,5.29E-03,2.28E+00,"cell adhesion,axon guidance,neuromuscular junction development,visual perception,astrocyte development,Schwann cell development,extracellular matrix organization,axon extension involved in regeneration,retina development in camera-type eye,metanephric glomerular visceral epithelial cell development,metanephric glomerular basement membrane development","integrin binding,structural molecule activity","extracellular region,basement membrane,basal lamina,laminin-3 complex,laminin-11 complex,synapse,extracellular exosome,extracellular matrix",15,53,60,SLADVDAILAR.2|TGGSAQPETPYSGPGLLIDSLVLLPR.3|GAVADTRDTEQTLYQVQER.3|VLDPAIPIPDPYSSR.2|VLDPAIPIPDPYSSR.3|QLDALLEALK.2|ARHTQAELQR.3|VVQDLAAR.2|AETVQAALEEAQR.3|AETVQAALEEAQR.2|DLLQAAQDKLQR.3|C[CAM]EAC[CAM]APGHFGDPSRPGGR.4|AQGIAQGAIR.2|AQGVLAAQAR.2|HTQAELQR.2|TSGQC[CAM]LC[CAM]R.2|DLLQAAQDK.2|GQVLDVVER.2|HRTEALMDAQKEDFNSK.4|HFATSC[CAM]HQDEYSQQIVC[CAM]HC[CAM]R.5|HFATSC[CAM]HQDEYSQQIVC[CAM]HC[CAM]R.4|AAQLDGLEAR.2|AEQLLQDAR.2|ALAEGGSILSR.2|LGIVQGIVGAR.2|KAQGVLAAQAR.2|GPTC[CAM]NEFTGQC[CAM]HC[CAM]R.3|LQEGQTLEFLVASVPK.3|LQEGQTLEFLVASVPK.2|RAEQLLQDAR.2|DGFFGLSISDR.2|GPLGDQYQTVK.2|VLELSIPASAEQIQHLAGAIAER.4|VLELSIPASAEQIQHLAGAIAER.3|AGNSLAASTAEETAGSAQGR.3|AGNSLAASTAEETAGSAQGR.2|SWAEDEKQKAETVQAALEEAQR.4|YLIFPNPVC[CAM]LEPGISYKLHLK.4|DLPWRPAEDGHSHAC[CAM]R.3|RAGNSLAASTAEETAGSAQGR.3|VLELSIPASAEQIQHLAGAIAERVR.4|GQVEQANQELQELIQSVK.3|GQVEQANQELQELIQSVK.2|IQNVVTSFAPQR.2|HSNFLGAYDSIR.2|GNC[CAM]FC[CAM]YGHASEC[CAM]APAPGAPAHAEGMVHGAC[CAM]IC[CAM]K.5|GQWGFPSC[CAM]RPC[CAM]VC[CAM]NGHADEC[CAM]NTHTGAC[CAM]LGC[CAM]R.5|GSC[CAM]YPATGDLLVGR.2|YYYALYELVVR.2|DTEQTLYQVQER.2|GLNC[CAM]EQC[CAM]QDFYR.2|LQELEGTYEENER.2|GFSGIFPAC[CAM]HPC[CAM]HAC[CAM]FGDWDR.3|AQELQQTGVLGAFESSFWHMQEK.3|LVTPGETPSWTGSGFVR.2|VLVLEMFSGGDAAALER.2|YSEIEPSTEGEVIYR.2|EIGEATEHLTQLEADLTDVQDENFNANHALSGLER.4|YLIFPNPVC[CAM]LEPGISYK.2|AQEAEQLLRGPLGDQYQTVK.2
SEN / CTL,40S ribosomal protein S10,RPS10,P46783,0.20,0.39,1.00E-01,3.58E-02,1.45E+00,"ribosomal small subunit assembly,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","structural constituent of ribosome,protein binding,poly(A) RNA binding","nucleoplasm,nucleolus,cytosol,ribosome,focal adhesion,membrane,cytosolic small ribosomal subunit,extracellular matrix,extracellular exosome",6,15,25,IAIYELLFK.2|KAEAGAGSATEFQFR.3|KAEAGAGSATEFQFR.2|HPELADK.2|DVHMPKHPELADKNVPNLHVMK.6|DYLHLPPEIVPATLR.4|DYLHLPPEIVPATLR.3|DYLHLPPEIVPATLR.2|HPELADKNVPNLHVMK.4|HPELADKNVPNLHVMK.3|HPELADKNVPNLHVM[Oxi]K.3|NRIAIYELLFK.3|DYLHLPPEIVPATLRR.4|DYLHLPPEIVPATLRR.3|AEAGAGSATEFQFR.3|AEAGAGSATEFQFR.2|GLEGERPAR.2|HFYWYLTNEGIQYLR.4|HFYWYLTNEGIQYLR.3|HFYWYLTNEGIQYLR.2|DVHMPKHPELADK.3|NVPNLHVMK.2|SAVPPGADKKAEAGAGSATEFQFR.4|SAVPPGADKKAEAGAGSATEFQFR.3|IAIYELLFKEGVMVAK.3
SEN / CTL,Peptidyl-prolyl cis-trans isomerase FKBP2,FKBP2,P26885,0.20,0.22,1.24E-02,6.40E-03,2.19E+00,"protein peptidyl-prolyl isomerization,chaperone-mediated protein folding","peptidyl-prolyl cis-trans isomerase activity,FK506 binding","endoplasmic reticulum,endoplasmic reticulum membrane,extracellular exosome",12,13,21,LVIPSELGYGER.2|GAPPKIPGGATLVFEVELLKIER.4|KLVIPSELGYGER.3|KLVIPSELGYGER.2|GAPPKIPGGATLVFEVELLK.3|GDVLHMHYTGK.3|GDVLHM[Oxi]HYTGK.3|GDVLHMHYTGK.2|GDVLHM[Oxi]HYTGK.2|VDHC[CAM]PIK.2|KGDVLHMHYTGK.3|KGDVLHMHYTGK.2|RVDHC[CAM]PIK.2|IPGGATLVFEVELLK.3|IPGGATLVFEVELLK.2|LEDGTEFDSSLPQNQPFVFSLGTGQVIK.4|LEDGTEFDSSLPQNQPFVFSLGTGQVIK.3|GWDQGLLGMC[CAM]EGEK.2|GWDQGLLGM[Oxi]C[CAM]EGEK.2|GDVLHMHYTGKLEDGTEFDSSLPQNQPFVFSLGTGQVIK.5|KGDVLHMHYTGKLEDGTEFDSSLPQNQPFVFSLGTGQVIK.5
SEN / CTL,60S ribosomal protein L35,RPL35,P42766,0.20,0.22,4.78E-02,1.93E-02,1.71E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","mRNA binding,structural constituent of ribosome,poly(A) RNA binding","nucleolus,cytoplasm,cytosol,membrane,cytosolic large ribosomal subunit",6,8,10,QLDDLKVELSQLR.3|QLDDLKVELSQLR.2|KYKPLDLRPK.3|RLNKHEENLK.3|VELSQLR.2|VLTVINQTQKENLRK.4|VLTVINQTQKENLRK.3|VLTVINQTQKENLR.3|LNKHEENLK.2|VLTVINQTQK.2
SEN / CTL,Sialic acid synthase,NANS,Q9NR45,0.20,0.31,6.04E-02,2.36E-02,1.63E+00,lipopolysaccharide biosynthetic process,"N-acylneuraminate cytidylyltransferase activity,N-acylneuraminate-9-phosphate synthase activity,N-acetylneuraminate synthase activity","cytoplasm,cytosol,extracellular exosome",6,23,39,GSDHSASLEPGELAELVR.3|GSDHSASLEPGELAELVR.2|PLELELC[CAM]PGR.2|VISEYQK.2|HLEFSHDQYR.3|HLEFSHDQYR.2|RHLEFSHDQYR.3|RHLEFSHDQYR.2|QLLPC[CAM]EMAC[CAM]NEK.3|QLLPC[CAM]EM[Oxi]AC[CAM]NEK.2|QLLPC[CAM]EMAC[CAM]NEK.2|RHLEFSHDQYRELQR.4|VGSGDTNNFPYLEK.3|VGSGDTNNFPYLEK.2|ALERPYTSK.2|GYPPEDIFNLVGKK.3|GYPPEDIFNLVGKK.2|TWKGSDHSASLEPGELAELVR.4|TWKGSDHSASLEPGELAELVR.3|WVGGQHPC[CAM]FIIAEIGQNHQGDLDVAKR.5|WVGGQHPC[CAM]FIIAEIGQNHQGDLDVAKR.4|GRPMVISSGMQSMDTMK.3|GRPM[Oxi]VISSGMQSMDTMK.3|VKIPEGTILTMDMLTVK.3|VLVTVEEDDTIMEELVDNHGKK.4|VLVTVEEDDTIMEELVDNHGKK.3|LFPDIPIGYSGHETGIAISVAAVALGAK.4|LFPDIPIGYSGHETGIAISVAAVALGAK.3|GYPPEDIFNLVGK.2|WVGGQHPC[CAM]FIIAEIGQNHQGDLDVAK.4|WVGGQHPC[CAM]FIIAEIGQNHQGDLDVAK.3|PLNPNFC[CAM]FLQC[CAM]TSAYPLQPEDVNLR.4|PLNPNFC[CAM]FLQC[CAM]TSAYPLQPEDVNLR.3|QVYQIVKPLNPNFC[CAM]FLQC[CAM]TSAYPLQPEDVNLR.5|QVYQIVKPLNPNFC[CAM]FLQC[CAM]TSAYPLQPEDVNLR.4|VLVTVEEDDTIMEELVDNHGK.3|IPEGTILTMDMLTVK.2|IPEGTILTMDM[Oxi]LTVK.2|PMVISSGMQSMDTMK.2
SEN / CTL,Cytoplasmic aconitate hydratase,ACO1,P21399,0.20,0.68,1.94E-02,9.14E-03,2.04E+00,"tricarboxylic acid cycle,citrate metabolic process,regulation of translation,cellular iron ion homeostasis,post-embryonic development,response to iron(II) ion,intestinal absorption","RNA binding,aconitate hydratase activity,protein binding,iron-responsive element binding,metal ion binding,4 iron, 4 sulfur cluster binding","cytoplasm,mitochondrion,endoplasmic reticulum,Golgi apparatus,cytosol,extracellular exosome",54,42,66,VLLEAAIR.2|FVEFFGPGVAQLSIADR.2|FVEFFGPGVAQLSIADR.3|DIWPTRDEIQAVER.3|YQQAGLPLIVLAGK.2|YQQAGLPLIVLAGK.3|ANYLASPPLVIAYAIAGTIR.3|ANYLASPPLVIAYAIAGTIR.2|QAPQTIHLPSGEILDVFDAAER.3|QAPQTIHLPSGEILDVFDAAER.4|KAVDAGLNVMPYIK.3|KAVDAGLNVM[Oxi]PYIK.3|LMGKPHPLVTSTDIVLTITK.4|LMGKPHPLVTSTDIVLTITK.3|QYVIPGMFK.2|VILQDFTGVPAVVDFAAMR.3|VILQDFTGVPAVVDFAAM[Oxi]R.3|VILQDFTGVPAVVDFAAMR.2|YLQAVGMFR.2|YLQAVGM[Oxi]FR.2|AVLAESYER.2|YTIIIPENLKPQMK.3|YTIIIPENLKPQMK.2|IIPPGSGIIHQVNLEYLAR.3|IIPPGSGIIHQVNLEYLAR.4|IIPPGSGIIHQVNLEYLAR.2|SPPFFENLTLDLQPPK.3|SPPFFENLTLDLQPPK.2|KQDIENILHWNVTQHK.4|KQDIENILHWNVTQHK.5|KQDIENILHWNVTQHK.3|GPFLLGIK.2|FFNLNKLEDSR.3|FFNLNKLEDSR.2|EFNSYGSR.2|IDFEKEPLGVNAK.3|IDFEKEPLGVNAK.2|RGNDAVMAR.2|GFQVAPEHHNDHK.3|GFQVAPEHHNDHK.2|DFESC[CAM]LGAK.2|NC[CAM]DEFLVK.2|KQDIENILHWNVTQHKNIEVPFKPAR.6|NQDLEFER.2|TVVPC[CAM]C[CAM]SGPK.2|PHPLVTSTDIVLTITK.3|PHPLVTSTDIVLTITK.2|NIEVPFKPAR.2|IETVNESWNALATPSDK.3|IETVNESWNALATPSDK.2|GQQVFLKDIWPTRDEIQAVER.4|AVDAGLNVMPYIK.2|AVDAGLNVM[Oxi]PYIK.2|SIVDAYVLLNLGDSVTTDHISPAGNIAR.4|SIVDAYVLLNLGDSVTTDHISPAGNIAR.3|YQQAGLPLIVLAGKEYGAGSSR.3|DFNDPSQDPDFTQVVELDLK.3|DFNDPSQDPDFTQVVELDLK.2|INPVC[CAM]PADLVIDHSIQVDFNR.3|EVYQKIETVNESWNALATPSDKLFFWNSK.4|IETVNESWNALATPSDKLFFWNSK.3|QAPQTIHLPSGEILDVFDAAERYQQAGLPLIVLAGKEYGAGSSR.5|QAPQTIHLPSGEILDVFDAAERYQQAGLPLIVLAGK.4|ATIANMC[CAM]PEYGATAAFFPVDEVSITYLVQTGRDEEK.4|SNLVGMGVIPLEYLPGENADALGLTGQER.3|SNLVGM[Oxi]GVIPLEYLPGENADALGLTGQER.3
SEN / CTL,"Glycogen phosphorylase, brain form",PYGB,P11216,0.19,0.76,3.33E-05,3.67E-05,4.44E+00,glycogen catabolic process,"protein binding,glycogen phosphorylase activity,pyridoxal phosphate binding","cytoplasm,membrane,extracellular exosome",42,65,111,VIFLENYR.2|VLYPNDNFFEGK.2|LAAC[CAM]FLDSMATLGLAAYGYGIR.3|LAAC[CAM]FLDSM[Oxi]ATLGLAAYGYGIR.3|LKQEYFVVAATLQDIIR.3|LKQEYFVVAATLQDIIR.2|LVTSIGDVVNHDPVVGDRLK.4|LVTSIGDVVNHDPVVGDRLK.3|LKQEYFVVAATLQDIIRR.4|LKQEYFVVAATLQDIIRR.3|ILVDVEK.2|ARPEYMLPVHFYGR.4|ARPEYM[Oxi]LPVHFYGR.4|ARPEYMLPVHFYGR.3|ARPEYMLPVHFYGR.2|VLYPNDNFFEGKELR.3|LLPLVSDEVFIRDVAK.3|LLPLVSDEVFIRDVAK.2|NLAENISR.2|HLEIIYAINQR.3|HLEIIYAINQR.2|HLDHVAALFPGDVDR.3|HLDHVAALFPGDVDR.4|HLDHVAALFPGDVDR.2|QLLNC[CAM]LHVVTLYNR.3|QLLNC[CAM]LHVVTLYNR.2|IHSEIVK.2|FSAFLEK.2|GLAGLGDVAEVRK.3|GLAGLGDVAEVRK.2|EYYDHLPELK.3|EYYDHLPELK.2|MSVIEEGDC[CAM]KR.3|M[Oxi]SVIEEGDC[CAM]KR.2|DYFFALAHTVR.3|DYFFALAHTVR.2|RM[Oxi]SVIEEGDC[CAM]K.3|RMSVIEEGDC[CAM]K.2|INPSSM[Oxi]FDVHVK.3|INPSSMFDVHVK.3|INPSSM[Oxi]FDVHVK.2|INPSSMFDVHVK.2|LLPLVSDEVFIR.3|LLPLVSDEVFIR.2|NNTVNTMR.2|NNTVNTM[Oxi]R.2|HLDHVAALFPGDVDRLR.4|HLDHVAALFPGDVDRLR.3|ILVDVEKVDWDK.3|ILVDVEKVDWDK.2|KLLPLVSDEVFIRDVAK.4|KLLPLVSDEVFIRDVAK.3|VEHTPDGVK.2|IGEEFLTDLSQLK.3|IGEEFLTDLSQLK.2|KTC[CAM]AYTNHTVLPEALER.4|KTC[CAM]AYTNHTVLPEALER.3|INMAHLC[CAM]VIGSHAVNGVAR.4|INMAHLC[CAM]VIGSHAVNGVAR.3|INMAHLC[CAM]VIGSHAVNGVAR.2|KLLPLVSDEVFIR.3|KLLPLVSDEVFIR.2|QAVDQISSGFFSPK.3|QAVDQISSGFFSPK.2|WPVSMFEK.2|VEDVEALDR.2|EPDC[CAM]FKDIVNMLMHHDR.4|IGEEFLTDLSQLKK.3|IGEEFLTDLSQLKK.2|RINMAHLC[CAM]VIGSHAVNGVAR.4|ILVDVEKVDWDKAWEITK.4|QSVFKDFYELEPEKFQNK.4|QSVFKDFYELEPEKFQNK.3|TC[CAM]FETFPDK.2|GLAGLGDVAEVR.2|DFYELEPEK.2|MSVIEEGDC[CAM]K.2|M[Oxi]SVIEEGDC[CAM]K.2|VEDVEALDRK.2|IVNGWQVEEADDWLR.3|IVNGWQVEEADDWLR.2|QAVDQISSGFFSPKEPDC[CAM]FKDIVNMLMHHDR.6|VIPAADLSQQISTAGTEASGTGNMK.4|VIPAADLSQQISTAGTEASGTGNMK.3|VIPAADLSQQISTAGTEASGTGNM[Oxi]K.3|WLLLC[CAM]NPGLADTIVEK.3|WLLLC[CAM]NPGLADTIVEK.2|LQDFNVGDYIEAVLDR.3|LQDFNVGDYIEAVLDR.2|FSAFLEKEYK.2|LVTSIGDVVNHDPVVGDR.3|LVTSIGDVVNHDPVVGDR.2|RWLLLC[CAM]NPGLADTIVEK.3|RWLLLC[CAM]NPGLADTIVEK.2|DYFFALAHTVRDHLVGR.3|VAIQLNDTHPALSIPELM[Oxi]R.3|VAIQLNDTHPALSIPELMR.3|VAIQLNDTHPALSIPELMR.2|RMSVIEEGDC[CAM]KR.2|EIWGVEPSDLQIPPPNIPRD.3|EIWGVEPSDLQIPPPNIPRD.2|QAVDQISSGFFSPKEPDC[CAM]FK.3|WLDTQVVLAMPYDTPVPGYK.3|WLDTQVVLAMPYDTPVPGYK.2|TC[CAM]FETFPDKVAIQLNDTHPALSIPELMR.4|TC[CAM]FETFPDKVAIQLNDTHPALSIPELMR.3|VFADYEAYMQC[CAM]QAQVDQLYR.3|APNDFKLQDFNVGDYIEAVLDR.3|APNDFKLQDFNVGDYIEAVLDRNLAENISR.4|LQDFNVGDYIEAVLDRNLAENISR.3|VFADYEAYMQC[CAM]QAQVDQLYRNPK.3
SEN / CTL,T-complex protein 1 subunit epsilon,CCT5,P48643,0.19,0.61,1.22E-01,4.19E-02,1.38E+00,"protein folding,binding of sperm to zona pellucida,response to virus,positive regulation of telomere maintenance via telomerase,protein stabilization,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body","protein binding,ATP binding,G-protein beta-subunit binding,beta-tubulin binding,unfolded protein binding","zona pellucida receptor complex,nucleolus,cytoplasm,centrosome,cytosol,chaperonin-containing T-complex,microtubule,myelin sheath,cell body,extracellular exosome",45,49,103,AVTIFIR.2|WVGGPEIELIAIATGGR.2|WVGGPEIELIAIATGGR.3|DVDFELIKVEGK.3|DVDFELIKVEGK.2|AFADALEVIPMALSENSGMNPIQTMTEVR.3|AFADALEVIPM[Oxi]ALSENSGMNPIQTMTEVR.3|AFADALEVIPMALSENSGM[Oxi]NPIQTMTEVR.3|AFADALEVIPMALSENSGMNPIQTMTEVR.4|AFADALEVIPM[Oxi]ALSENSGMNPIQTMTEVR.4|AFADALEVIPMALSENSGM[Oxi]NPIQTMTEVR.4|AFADALEVIPMALSENSGMNPIQTM[Oxi]TEVR.3|LGFAGLVQEISFGTTKDK.3|IAILTC[CAM]PFEPPKPK.3|IAILTC[CAM]PFEPPKPK.4|IAILTC[CAM]PFEPPKPK.2|LGFAGLVQEISFGTTK.2|LGFAGLVQEISFGTTK.3|LMVELSK.2|LM[Oxi]VELSK.2|MIIEEAK.2|GVIVDKDFSHPQMPK.4|GVIVDKDFSHPQM[Oxi]PK.4|GVIVDKDFSHPQMPK.3|GVIVDKDFSHPQM[Oxi]PK.3|TKHKLDVTSVEDYK.4|TKHKLDVTSVEDYK.3|QQHVIETLIGK.3|QQHVIETLIGK.2|LM[Oxi]GLEALK.2|RSLHDALC[CAM]VIR.3|RSLHDALC[CAM]VIR.2|FSELTAEK.2|IDDIRKPGESEE.3|IDDIRKPGESEE.2|QQHVIETLIGKK.3|QQHVIETLIGKK.2|VAIEHLDK.2|HKLDVTSVEDYKALQK.4|HKLDVTSVEDYKALQK.3|KQQISLATQMVR.3|KQQISLATQMVR.2|EKFEEMIQQIK.3|EKFEEMIQQIK.2|EKFEEM[Oxi]IQQIK.2|GTNDMKQQHVIETLIGK.4|GTNDMKQQHVIETLIGK.3|HKLDVTSVEDYK.3|HKLDVTSVEDYK.2|MIIEEAKR.2|EMNPALGIDC[CAM]LHK.3|EM[Oxi]NPALGIDC[CAM]LHK.3|EMNPALGIDC[CAM]LHK.2|EM[Oxi]NPALGIDC[CAM]LHK.2|TSLGPNGLDK.2|MLVIEQC[CAM]K.2|M[Oxi]LVIEQC[CAM]K.2|EMNPALGIDC[CAM]LHKGTNDMK.4|DFSHPQMPK.2|DFSHPQM[Oxi]PK.2|ISDSVLVDIK.2|IADGYEQAAR.2|ISDSVLVDIKDTEPLIQTAK.4|ISDSVLVDIKDTEPLIQTAK.3|ISDSVLVDIKDTEPLIQTAK.2|DTEPLIQTAK.2|RDVDFELIK.2|FEEMIQQIK.2|FEEM[Oxi]IQQIK.2|LDVTSVEDYK.2|SLHDALC[CAM]VIR.2|VAIEHLDKISDSVLVDIKDTEPLIQTAK.5|VAIEHLDKISDSVLVDIKDTEPLIQTAK.4|VAIEHLDKISDSVLVDIKDTEPLIQTAK.3|C[CAM]PTLEQYAMR.2|C[CAM]PTLEQYAM[Oxi]R.2|QQISLATQMVR.2|QQISLATQM[Oxi]VR.2|QM[Oxi]AEIAVNAVLTVADMER.3|QMAEIAVNAVLTVADM[Oxi]ER.3|QMAEIAVNAVLTVADMER.3|QM[Oxi]AEIAVNAVLTVADM[Oxi]ER.3|QMAEIAVNAVLTVADMER.2|DGDVTVTNDGATILSMMDVDHQIAK.4|DGDVTVTNDGATILSMMDVDHQIAK.3|DGDVTVTNDGATILSMM[Oxi]DVDHQIAK.3|QMAEIAVNAVLTVADMERR.3|VVYGGGAAEISC[CAM]ALAVSQEADK.3|VVYGGGAAEISC[CAM]ALAVSQEADK.2|M[Oxi]MVDKDGDVTVTNDGATILSMMDVDHQIAK.4|MM[Oxi]VDKDGDVTVTNDGATILSMMDVDHQIAK.4|MMVDKDGDVTVTNDGATILSM[Oxi]MDVDHQIAK.4|MMVDKDGDVTVTNDGATILSMMDVDHQIAK.4|M[Oxi]M[Oxi]VDKDGDVTVTNDGATILSMMDVDHQIAK.4|MMVDKDGDVTVTNDGATILSMMDVDHQIAK.3|ETGANLAIC[CAM]QWGFDDEANHLLLQNNLPAVR.4|ETGANLAIC[CAM]QWGFDDEANHLLLQNNLPAVR.3|FSELTAEKLGFAGLVQEISFGTTK.3|VVYGGGAAEISC[CAM]ALAVSQEADKC[CAM]PTLEQYAMR.4|VVYGGGAAEISC[CAM]ALAVSQEADKC[CAM]PTLEQYAM[Oxi]R.4|VVYGGGAAEISC[CAM]ALAVSQEADKC[CAM]PTLEQYAM[Oxi]R.3|VVYGGGAAEISC[CAM]ALAVSQEADKC[CAM]PTLEQYAMR.3|YEKEKFEEMIQQIK.2
SEN / CTL,40S ribosomal protein S9,RPS9,P46781,0.19,0.42,1.29E-01,4.38E-02,1.36E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,positive regulation of cell proliferation,viral transcription,positive regulation of translational fidelity","structural constituent of ribosome,protein binding,rRNA binding,poly(A) RNA binding,translation regulator activity","nucleus,nucleoplasm,nucleolus,cytoplasm,cytosol,ribosome,focal adhesion,membrane,cytosolic small ribosomal subunit,intracellular ribonucleoprotein complex,extracellular exosome",9,19,26,QVVNIPSFIVR.2|QVVNIPSFIVR.3|KQVVNIPSFIVR.3|KQVVNIPSFIVR.2|LIGEYGLR.2|M[Oxi]KLDYILGLK.3|MKLDYILGLK.2|M[Oxi]KLDYILGLK.2|IGVLDEGK.2|LQTQVFK.2|ELLTLDEKDPR.3|ELLTLDEKDPR.2|HIDFSLR.2|IEDFLER.2|LDYILGLK.2|LDYILGLK.1|SRLDQELKLIGEYGLR.4|SRLDQELKLIGEYGLR.3|ELLTLDEK.2|LDSQKHIDFSLR.3|RLQTQVFK.2|LFEGNALLR.2|RLFEGNALLR.2|GQGGAGAGDDEEED.2|IGVLDEGKMKLDYILGLK.3|KGQGGAGAGDDEEED.2
SEN / CTL,Prolyl 4-hydroxylase subunit alpha-2,P4HA2,O15460,0.19,0.33,8.77E-03,4.82E-03,2.32E+00,"peptidyl-proline hydroxylation,oxidation-reduction process","procollagen-proline 4-dioxygenase activity,iron ion binding,electron carrier activity,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,L-ascorbic acid binding","nucleus,cytoplasm,endoplasmic reticulum,endoplasmic reticulum lumen,intracellular membrane-bounded organelle",18,21,24,SSWLEEDDDPVVAR.2|YYDVMSDEEIER.2|KGTAVFWYNLLR.3|SAADAEGYLAHPVNAYK.3|QFFPTDEDEIGAAK.2|YFEQLLEEEREK.3|HAAC[CAM]PVLVGC[CAM]K.3|HAAC[CAM]PVLVGC[CAM]K.2|LDPGTISR.2|RLLSLDPSHER.3|TGVLTVASYR.2|APQLLIAPFK.2|SQVLDYLSYAVFQLGDLHR.4|SQVLDYLSYAVFQLGDLHR.3|MQHITGLTVK.2|LLSLDPSHER.2|QLDAGEEATTTK.2|APQLLIAPFKEEDEWDSPHIVR.4|APQLLIAPFKEEDEWDSPHIVR.3|GTAVFWYNLLR.2|YFEQLLEEER.2|GQEFLRPC[CAM]GSTEVD.2|SAYNEGDYYHTVLWMEQVLK.3|TAELLQVANYGVGGQYEPHFDFSR.3
SEN / CTL,Annexin A4,ANXA4,P09525,0.19,0.73,1.12E-02,5.86E-03,2.23E+00,"regulation of transcription from RNA polymerase II promoter,signal transduction,Notch signaling pathway,epithelial cell differentiation,negative regulation of NF-kappaB transcription factor activity,negative regulation of apoptotic process,negative regulation of catalytic activity,negative regulation of interleukin-8 secretion","phospholipase inhibitor activity,calcium ion binding,calcium-dependent phospholipid binding,identical protein binding,calcium-dependent protein binding,NF-kappaB binding","nucleus,cytoplasm,plasma membrane,cell surface,vesicle membrane,nuclear membrane,perinuclear region of cytoplasm,extracellular exosome",96,45,70,GLGTDEDAIISVLAYR.2|GLGTDEDAIISVLAYR.3|GAGTDEGC[CAM]LIEILASR.2|GAGTDEGC[CAM]LIEILASR.3|SLEDDIRSDTSFMFQR.3|ISQKDIEQSIKSETSGSFEDALLAIVK.4|SLYSFIKGDTSGDYRK.3|SLYSFIKGDTSGDYRK.4|FLTVLC[CAM]SR.2|GLGTDDNTLIR.2|SLYSFIK.2|SETSGSFEDALLAIVK.2|SETSGSFEDALLAIVK.3|DIEQSIKSETSGSFEDALLAIVK.3|DLIDDLK.2|VLLVLC[CAM]GGDD.2|NHLLHVFDEYKR.3|AASGFNAMEDAQTLR.2|AASGFNAMEDAQTLR.3|AASGFNAM[Oxi]EDAQTLR.2|NRNHLLHVFDEYKR.4|NRNHLLHVFDEYKR.3|AEIDMLDIR.2|AEIDM[Oxi]LDIR.2|WGTDEVKFLTVLC[CAM]SR.3|WGTDEVKFLTVLC[CAM]SR.2|SLEDDIR.2|AASGFNAMEDAQTLRK.3|AASGFNAMEDAQTLRK.2|AASGFNAM[Oxi]EDAQTLRK.3|AASGFNAM[Oxi]EDAQTLRK.2|VLVSLSAGGRDEGNYLDDALVR.3|VLVSLSAGGRDEGNYLDDALVR.4|VLVSLSAGGRDEGNYLDDALVR.2|VLVSLSAGGR.2|ISQTYQQQYGR.2|ISQTYQQQYGR.3|AM[Oxi]KGAGTDEGC[CAM]LIEILASR.3|AM[Oxi]KGAGTDEGC[CAM]LIEILASR.2|ISQKDIEQSIK.3|ISQKDIEQSIK.2|KWGTDEVKFLTVLC[CAM]SR.3|SAYFAEKLYK.3|SAYFAEKLYK.2|NRNHLLHVFDEYK.4|NRNHLLHVFDEYK.3|NRNHLLHVFDEYK.2|STIGRDLIDDLK.3|QDAQDLYEAGEK.3|QDAQDLYEAGEK.2|NHLLHVFDEYK.3|NHLLHVFDEYK.2|KWGTDEVK.2|GDTSGDYRK.2|QDAQDLYEAGEKK.3|RISQTYQQQYGR.3|RISQTYQQQYGR.2|SM[Oxi]KGLGTDDNTLIR.3|SDTSFMFQR.2|GAGTDEGC[CAM]LIEILASRTPEEIRR.4|DEGNYLDDALVR.2|GLGTDEDAIISVLAYRNTAQR.3|GAGTDEGC[CAM]LIEILASRTPEEIR.3|SELSGNFEQVIVGMMTPTVLYDVQELRR.4|SELSGNFEQVIVGM[Oxi]MTPTVLYDVQELRR.4|SELSGNFEQVIVGMMTPTVLYDVQELRR.3|DIEQSIK.1|DEGNYLDDALVRQDAQDLYEAGEK.3|VLVSLSAGGRDEGNYLDDALVRQDAQDLYEAGEK.4|SELSGNFEQVIVGMMTPTVLYDVQELR.3
SEN / CTL,Stress-induced-phosphoprotein 1,STIP1,P31948,0.18,0.31,7.98E-04,6.26E-04,3.20E+00,response to stress,"protein C-terminus binding,Hsp70 protein binding,poly(A) RNA binding,chaperone binding","nucleus,Golgi apparatus,myelin sheath,protein complex",30,71,131,TLLSDPTYRELIEQLR.3|LMDVGLIAIR.2|LM[Oxi]DVGLIAIR.2|ALDLDSSC[CAM]KEAADGYQR.3|ALDLDSSC[CAM]KEAADGYQR.2|LAYINPDLALEEK.2|LAYINPDLALEEK.3|ALSVGNIDDALQC[CAM]YSEAIKLDPHNHVLYSNR.5|ALSVGNIDDALQC[CAM]YSEAIKLDPHNHVLYSNR.6|ALSVGNIDDALQC[CAM]YSEAIKLDPHNHVLYSNR.4|LILEQMQKDPQALSEHLKNPVIAQK.5|LILEQMQKDPQALSEHLKNPVIAQK.4|LILEQM[Oxi]QKDPQALSEHLKNPVIAQK.5|LILEQM[Oxi]QKDPQALSEHLKNPVIAQK.4|TYEEGLK.2|AMADPEVQQIMSDPAMR.2|AMADPEVQQIMSDPAMR.3|AM[Oxi]ADPEVQQIMSDPAMR.3|AMADPEVQQIMSDPAM[Oxi]R.3|AM[Oxi]ADPEVQQIMSDPAMR.2|AMADPEVQQIM[Oxi]SDPAMR.2|AMADPEVQQIMSDPAM[Oxi]R.2|AAALEAMK.2|AAALEAM[Oxi]K.2|IGNSYFKEEK.3|IGNSYFKEEK.2|TPDVLKK.2|HDSPEDVKRR.3|KETKPEPMEEDLPENKK.5|KETKPEPM[Oxi]EEDLPENKK.4|KETKPEPMEEDLPENKK.4|KETKPEPMEEDLPENKK.3|AYEDGC[CAM]K.2|AMDVYQK.2|AM[Oxi]DVYQK.2|HYTEAIK.2|YKDAIHFYNK.3|YKDAIHFYNK.2|AAALEAMKDYTK.3|AAALEAMKDYTK.2|AAALEFLNRFEEAKR.4|AAALEFLNRFEEAKR.3|GNEC[CAM]FQK.2|EAADGYQR.2|ELGNDAYK.2|GDYPQAMK.2|GDYPQAM[Oxi]K.2|GDYPQAMK.1|HDSPEDVK.2|DPQALSEHLKNPVIAQK.4|DPQALSEHLKNPVIAQK.3|KAAALEAMK.2|KDFDTALK.2|TYEEGLKHEANNPQLK.4|TYEEGLKHEANNPQLK.3|TYEEGLKHEANNPQLK.2|ETKPEPM[Oxi]EEDLPENKK.4|ETKPEPMEEDLPENKK.4|ETKPEPMEEDLPENKK.3|ETKPEPM[Oxi]EEDLPENKK.3|ETKPEPMEEDLPENKK.2|KAAALEAMKDYTK.3|KAAALEAMKDYTK.2|KETKPEPMEEDLPENK.4|KETKPEPMEEDLPENK.3|LDPHNHVLYSNR.3|LDPHNHVLYSNR.2|C[CAM]MMAQYNRHDSPEDVK.4|C[CAM]MMAQYNRHDSPEDVK.3|AAALEFLNR.2|LILEQMQK.2|LILEQM[Oxi]QK.2|RTYEEGLK.2|ALDLDSSC[CAM]K.2|DAIHFYNK.2|NKGNEC[CAM]FQKGDYPQAMK.4|NKGNEC[CAM]FQKGDYPQAM[Oxi]K.3|NKGNEC[CAM]FQKGDYPQAMK.3|NKGNEC[CAM]FQKGDYPQAMK.2|RTYEEGLKHEANNPQLK.4|RTYEEGLKHEANNPQLK.3|EGLQNMEAR.2|EGLQNM[Oxi]EAR.2|HEANNPQLK.2|LILEQMQKDPQALSEHLK.4|AAALEFLNRFEEAK.3|AAALEFLNRFEEAK.2|AIEVGRENREDYR.3|C[CAM]MMAQYNR.2|C[CAM]M[Oxi]MAQYNR.2|C[CAM]MM[Oxi]AQYNR.2|C[CAM]M[Oxi]M[Oxi]AQYNR.2|KKDFDTALK.2|LLEFQLALK.2|TLLSDPTYR.2|HDSPEDVKR.2|FM[Oxi]NPFNMPNLYQK.3|FMNPFNM[Oxi]PNLYQK.3|FMNPFNMPNLYQK.3|FM[Oxi]NPFNMPNLYQK.2|FMNPFNM[Oxi]PNLYQK.2|FMNPFNMPNLYQK.2|FM[Oxi]NPFNM[Oxi]PNLYQK.2|KAAALEFLNR.2|NKGNEC[CAM]FQK.2|DPQALSEHLK.2|KAAALEFLNRFEEAK.3|TVDLKPDWGK.2|DC[CAM]EEC[CAM]IQLEPTFIK.3|DC[CAM]EEC[CAM]IQLEPTFIK.2|KFMNPFNMPNLYQK.3|KFM[Oxi]NPFNMPNLYQK.3|ETKPEPM[Oxi]EEDLPENK.3|ETKPEPMEEDLPENK.3|ETKPEPMEEDLPENK.2|LAYINPDLALEEKNKGNEC[CAM]FQK.4|AYEDGC[CAM]KTVDLKPDWGK.3|DFDTALKHYDK.2|RAMADPEVQQIMSDPAMR.3|SLAEHRTPDVLK.2|ALSVGNIDDALQC[CAM]YSEAIK.3|ALSVGNIDDALQC[CAM]YSEAIK.2|TYEEGLKHEANNPQLKEGLQNMEAR.4|AKELDPTNMTYITNQAAVYFEKGDYNK.4|ELDPTNM[Oxi]TYITNQAAVYFEK.3|ELDPTNMTYITNQAAVYFEK.3|ELDPTNM[Oxi]TYITNQAAVYFEK.2|ELDPTNMTYITNQAAVYFEK.2|AKELDPTNMTYITNQAAVYFEK.3|LLEFQLALKDC[CAM]EEC[CAM]IQLEPTFIK.3|ELDPTNMTYITNQAAVYFEKGDYNK.3
SEN / CTL,Transgelin-2,TAGLN2,P37802,0.18,0.56,3.95E-02,1.63E-02,1.79E+00,"epithelial cell differentiation,cell-cell adhesion",cadherin binding involved in cell-cell adhesion,"cell-cell adherens junction,vesicle,extracellular exosome",84,26,53,QYDADLEQILIQWITTQC[CAM]R.3|QYDADLEQILIQWITTQC[CAM]R.2|YGINTTDIFQTVDLWEGK.2|YGINTTDIFQTVDLWEGK.3|TLMNLGGLAVARDDGLFSGDPNWFPKK.4|QYDADLEQILIQWITTQC[CAM]RK.3|IEKQYDADLEQILIQWITTQC[CAM]R.3|DDGLFSGDPNWFPKK.3|DDGLFSGDPNWFPKK.2|QMEQISQFLQAAER.2|QMEQISQFLQAAER.3|QM[Oxi]EQISQFLQAAER.2|DDGLFSGDPNWFPK.2|DDGLFSGDPNWFPK.3|DVGRPQPGRENFQNWLK.3|DVGRPQPGRENFQNWLK.4|NFSDNQLQEGKNVIGLQMGTNR.3|NFSDNQLQEGKNVIGLQM[Oxi]GTNR.3|NVIGLQMGTNR.2|NVIGLQMGTNR.3|NVIGLQM[Oxi]GTNR.2|DGTVLC[CAM]ELINALYPEGQAPVKK.3|DGTVLC[CAM]ELINALYPEGQAPVKK.5|DGTVLC[CAM]ELINALYPEGQAPVKK.4|DGTVLC[CAM]ELINALYPEGQAPVK.3|DGTVLC[CAM]ELINALYPEGQAPVK.4|DGTVLC[CAM]ELINALYPEGQAPVK.2|TLMNLGGLAVARDDGLFSGDPNWFPK.3|TLMNLGGLAVARDDGLFSGDPNWFPK.4|TLMNLGGLAVAR.2|TLMNLGGLAVAR.3|TLM[Oxi]NLGGLAVAR.3|TLM[Oxi]NLGGLAVAR.2|GASQAGMTGYGMPR.2|GASQAGMTGYGMPR.3|GASQAGM[Oxi]TGYGMPR.3|GASQAGM[Oxi]TGYGMPR.2|GASQAGMTGYGM[Oxi]PR.2|GASQAGM[Oxi]TGYGM[Oxi]PR.2|IQASTMAFK.2|IQASTM[Oxi]AFK.2|NFSDNQLQEGK.2|NFSDNQLQEGK.3|GPAYGLSR.2|NMAC[CAM]VQR.2|NM[Oxi]AC[CAM]VQR.2|DVGRPQPGR.2|ENFQNWLK.2|KIQASTMAFK.2|KIQASTM[Oxi]AFK.2|ENPRNFSDNQLQEGK.3|NVIGLQM[Oxi]GTNRGASQAGMTGYGMPR.3|YGINTTDIFQTVDLWEGKNMAC[CAM]VQR.3
SEN / CTL,Guanine nucleotide-binding protein G(i) subunit alpha-2,GNAI2,P04899,0.18,0.41,8.03E-08,1.63E-07,6.79E+00,"activation of MAPKK activity,adenosine receptor signaling pathway,protein folding,cell cycle,signal transduction,G-protein coupled receptor signaling pathway,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,negative regulation of adenylate cyclase activity,G-protein coupled acetylcholine receptor signaling pathway,gamma-aminobutyric acid signaling pathway,response to nutrient,cell proliferation,positive regulation of cell proliferation,intracellular signal transduction,negative regulation of synaptic transmission,cell division,regulation of calcium ion transport","G-protein coupled receptor binding,GTPase activity,signal transducer activity,protein binding,GTP binding,G-protein beta/gamma-subunit complex binding,metal ion binding","nucleoplasm,cytoplasm,centrosome,cytosol,heterotrimeric G-protein complex,plasma membrane,membrane,dendrite,midbody,cell body,membrane raft,extracellular exosome,extracellular vesicle",33,27,44,IAQSDYIPTQQDVLR.2|IAQSDYIPTQQDVLR.3|AMGNLQIDFADPSRADDAR.3|RLWADHGVQAC[CAM]FGR.4|RLWADHGVQAC[CAM]FGR.3|RLWADHGVQAC[CAM]FGR.2|EIYTHFTC[CAM]ATDTK.3|EIYTHFTC[CAM]ATDTK.2|SREYQLNDSAAYYLNDLER.3|SREYQLNDSAAYYLNDLER.2|LWADHGVQAC[CAM]FGR.3|LWADHGVQAC[CAM]FGR.2|ITHSPLTIC[CAM]FPEYTGANKYDEAASYIQSK.4|ITHSPLTIC[CAM]FPEYTGANKYDEAASYIQSK.3|AVVYSNTIQSIMAIVK.3|AVVYSNTIQSIM[Oxi]AIVK.2|AVVYSNTIQSIMAIVK.2|TTGIVETHFTFK.3|TTGIVETHFTFK.2|MFDVGGQR.2|M[Oxi]FDVGGQR.2|DTKEIYTHFTC[CAM]ATDTK.4|DTKEIYTHFTC[CAM]ATDTK.3|MIDKNLREDGEK.3|AMGNLQIDFADPSR.3|AMGNLQIDFADPSR.2|IIHEDGYSEEEC[CAM]RQYR.4|VKTTGIVETHFTFK.3|IIHEDGYSEEEC[CAM]R.3|IIHEDGYSEEEC[CAM]R.2|NNLKDC[CAM]GLF.2|LFDSIC[CAM]NNK.2|NVQFVFDAVTDVIIK.3|NVQFVFDAVTDVIIK.2|WFTDTSIILFLNKK.3|YDEAASYIQSK.2|ITHSPLTIC[CAM]FPEYTGANK.3|ITHSPLTIC[CAM]FPEYTGANK.2|EYQLNDSAAYYLNDLER.3|EYQLNDSAAYYLNDLER.2|NVQFVFDAVTDVIIKNNLK.3|WFTDTSIILFLNK.2|QLFALSC[CAM]TAEEQGVLPDDLSGVIR.3|QLFALSC[CAM]TAEEQGVLPDDLSGVIRR.3
SEN / CTL,Actin-related protein 2,ACTR2,P61160,0.17,0.51,6.78E-03,3.91E-03,2.41E+00,"movement of cell or subcellular component,establishment or maintenance of cell polarity,asymmetric cell division,meiotic chromosome movement towards spindle pole,cytosolic transport,meiotic cytokinesis,Arp2/3 complex-mediated actin nucleation,Fc-gamma receptor signaling pathway involved in phagocytosis,cilium assembly,ephrin receptor signaling pathway,spindle localization","structural constituent of cytoskeleton,ATP binding,actin filament binding","cytoplasm,cytosol,Arp2/3 protein complex,focal adhesion,actin cytoskeleton,membrane,actin cap,cell projection,extracellular exosome",54,23,52,VGNIEIKDLMVGDEASELR.3|GYAFNHSADFETVR.3|GYAFNHSADFETVR.2|HMVFLGGAVLADIMKDKDNFWMTR.4|HMVFLGGAVLADIM[Oxi]KDKDNFWMTR.4|LC[CAM]YVGYNIEQEQK.2|LC[CAM]YVGYNIEQEQK.3|VVVC[CAM]DNGTGFVK.2|VVVC[CAM]DNGTGFVK.3|KVVVC[CAM]DNGTGFVK.3|KVVVC[CAM]DNGTGFVK.2|C[CAM]GYAGSNFPEHIFPALVGRPIIR.4|C[CAM]GYAGSNFPEHIFPALVGRPIIR.3|C[CAM]GYAGSNFPEHIFPALVGRPIIR.5|HIVLSGGSTMYPGLPSRLER.4|HIVLSGGSTMYPGLPSRLER.3|HLWDYTFGPEK.3|HLWDYTFGPEK.2|HIVLSGGSTMYPGLPSR.3|HIVLSGGSTMYPGLPSR.4|HIVLSGGSTM[Oxi]YPGLPSR.3|HIVLSGGSTM[Oxi]YPGLPSR.2|HIVLSGGSTMYPGLPSR.2|SMLEVNYPMENGIVR.2|SMLEVNYPMENGIVR.3|SM[Oxi]LEVNYPMENGIVR.2|SMLEVNYPM[Oxi]ENGIVR.2|ILLTEPPMNPTK.2|ILLTEPPM[Oxi]NPTK.3|ILLTEPPMNPTK.3|ILLTEPPM[Oxi]NPTK.2|DLMVGDEASELR.2|DLM[Oxi]VGDEASELR.2|HMVFLGGAVLADIMK.3|HM[Oxi]VFLGGAVLADIM[Oxi]K.3|HM[Oxi]VFLGGAVLADIMK.3|HMVFLGGAVLADIM[Oxi]K.3|HMVFLGGAVLADIMK.2|HM[Oxi]VFLGGAVLADIMK.2|HMVFLGGAVLADIM[Oxi]K.2|RLDIAGRDITR.3|DNFWMTR.2|C[CAM]GYAGSNFPEHIFPALVGR.4|C[CAM]GYAGSNFPEHIFPALVGR.3|C[CAM]GYAGSNFPEHIFPALVGR.2|DKDNFWMTR.2|VLKGDVEKLSK.2|HMVFLGGAVLADIMKDK.3|EKLC[CAM]YVGYNIEQEQK.3|LALETTVLVESYTLPDGR.3|LALETTVLVESYTLPDGR.2|HLWDYTFGPEKLNIDTR.3
SEN / CTL,40S ribosomal protein S8,RPS8,P62241,0.17,0.44,9.47E-03,5.09E-03,2.29E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","structural constituent of ribosome,poly(A) RNA binding","nucleus,nucleoplasm,cytoplasm,cytosol,focal adhesion,membrane,cytosolic small ribosomal subunit,intracellular ribonucleoprotein complex,extracellular exosome",21,23,39,ELEFYLR.2|IIDVVYNASNNELVR.3|IIDVVYNASNNELVR.2|ISSLLEEQFQQGK.2|ISSLLEEQFQQGK.3|NC[CAM]IVLIDSTPYR.2|NC[CAM]IVLIDSTPYR.3|NC[CAM]IVLIDSTPYRQWYESHYALPLGR.4|NC[CAM]IVLIDSTPYRQWYESHYALPLGR.3|QWYESHYALPLGR.3|QWYESHYALPLGR.2|LTPEEEEILNKKR.4|LTPEEEEILNKKR.3|LTPEEEEILNKKR.2|YELGRPAANTK.3|YELGRPAANTK.2|LTPEEEEILNK.3|LTPEEEEILNK.2|KYELGRPAANTK.3|KYELGRPAANTK.2|LLAC[CAM]IASR.2|ADGYVLEGK.2|LTPEEEEILNKK.3|LTPEEEEILNKK.2|LLAC[CAM]IASRPGQC[CAM]GR.3|LLAC[CAM]IASRPGQC[CAM]GR.2|ELEFYLRK.2|ALRLDVGNFSWGSEC[CAM]C[CAM]TRK.4|LDVGNFSWGSEC[CAM]C[CAM]TR.3|LDVGNFSWGSEC[CAM]C[CAM]TR.2|LDVGNFSWGSEC[CAM]C[CAM]TRK.3|LDVGNFSWGSEC[CAM]C[CAM]TRK.2|TRIIDVVYNASNNELVR.3|TRIIDVVYNASNNELVR.2|ADGYVLEGKELEFYLRK.3|ALRLDVGNFSWGSEC[CAM]C[CAM]TR.3|ALRLDVGNFSWGSEC[CAM]C[CAM]TR.2|ISSLLEEQFQQGKLLAC[CAM]IASRPGQC[CAM]GR.4|ADGYVLEGKELEFYLR.2
SEN / CTL,Protein CutA,CUTA,O60888,0.17,0.21,1.26E-03,9.23E-04,3.03E+00,"protein localization,response to metal ion","copper ion binding,enzyme binding","membrane,extracellular exosome",21,7,14,TQSSLVPALTDFVR.2|TQSSLVPALTDFVR.3|LAAC[CAM]VNLIPQITSIYEWK.3|LAAC[CAM]VNLIPQITSIYEWK.2|GKIEEDSEVLMMIK.3|GKIEEDSEVLMMIK.2|SVHPYEVAEVIALPVEQGNFPYLQWVR.4|SVHPYEVAEVIALPVEQGNFPYLQWVR.5|SVHPYEVAEVIALPVEQGNFPYLQWVR.3|RLAAC[CAM]VNLIPQITSIYEWK.4|RLAAC[CAM]VNLIPQITSIYEWK.3|RLAAC[CAM]VNLIPQITSIYEWK.2|IEEDSEVLMMIK.2|QVTESVSDSITVLP.2
SEN / CTL,Insulin-like growth factor-binding protein 3,IGFBP3,P17936,0.17,0.41,3.30E-02,1.43E-02,1.85E+00,"regulation of cell growth,osteoblast differentiation,negative regulation of protein phosphorylation,protein phosphorylation,apoptotic process,negative regulation of cell proliferation,negative regulation of signal transduction,regulation of glucose metabolic process,negative regulation of smooth muscle cell migration,regulation of apoptotic process,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of MAPK cascade,regulation of insulin-like growth factor receptor signaling pathway,positive regulation of insulin-like growth factor receptor signaling pathway,cellular protein metabolic process,type B pancreatic cell proliferation,positive regulation of myoblast differentiation,negative regulation of smooth muscle cell proliferation","fibronectin binding,protein binding,insulin-like growth factor binding,protein tyrosine phosphatase activator activity,insulin-like growth factor I binding,insulin-like growth factor II binding,metal ion binding","extracellular region,extracellular space,nucleus,insulin-like growth factor binding protein complex,insulin-like growth factor ternary complex,extracellular exosome",9,10,13,C[CAM]QPSPDEARPLQALLDGR.3|FLNVLSPR.2|EMEDTLNHLK.3|EM[Oxi]EDTLNHLK.3|SAGSVESPSVSSTHR.3|SAGSVESPSVSSTHR.2|GKEDVHC[CAM]YSMQSK.3|GFC[CAM]WC[CAM]VDK.2|ALAQC[CAM]APPPAVC[CAM]AELVR.3|ALAQC[CAM]APPPAVC[CAM]AELVR.2|YGQPLPGYTTK.2|YKVDYESQSTDTQNFSSESK.3|EPGC[CAM]GC[CAM]C[CAM]LTC[CAM]ALSEGQPC[CAM]GIYTER.3
SEN / CTL,Four and a half LIM domains protein 2,FHL2,Q14192,0.17,0.75,5.79E-02,2.28E-02,1.64E+00,"negative regulation of transcription from RNA polymerase II promoter,osteoblast differentiation,transcription, DNA-templated,response to hormone,androgen receptor signaling pathway,negative regulation of apoptotic process,positive regulation of transcription, DNA-templated,atrial cardiac muscle cell development,ventricular cardiac muscle cell development,heart trabecula formation","transcription coactivator activity,protein binding,transcription factor binding,zinc ion binding,androgen receptor binding","nucleus,nucleoplasm,focal adhesion,actin cytoskeleton,Z disc,M band",21,26,39,GFLTERDDILC[CAM]PDC[CAM]GKDI.3|SFIPKDNQNFC[CAM]VPC[CAM]YEK.3|YISFEER.2|DNQNFC[CAM]VPC[CAM]YEK.2|NSLVDKPFAAKEDQLLC[CAM]TDC[CAM]YSNEYSSK.4|NSLVDKPFAAKEDQLLC[CAM]TDC[CAM]YSNEYSSK.3|C[CAM]SLSLVGR.2|GSSWHETC[CAM]FIC[CAM]HR.4|GSSWHETC[CAM]FIC[CAM]HR.3|GSSWHETC[CAM]FIC[CAM]HR.2|FDC[CAM]HHC[CAM]NESLFGK.4|FDC[CAM]HHC[CAM]NESLFGK.3|DRHWHEAC[CAM]FHC[CAM]SQC[CAM]R.5|DRHWHEAC[CAM]FHC[CAM]SQC[CAM]R.4|QHAM[Oxi]QC[CAM]VQC[CAM]K.3|QHAMQC[CAM]VQC[CAM]K.3|QHAMQC[CAM]VQC[CAM]K.2|QHAM[Oxi]QC[CAM]VQC[CAM]K.2|FDC[CAM]HHC[CAM]NESLFGKK.4|FDC[CAM]HHC[CAM]NESLFGKK.3|HWHEAC[CAM]FHC[CAM]SQC[CAM]R.4|C[CAM]QQPIGTK.2|QWHNDC[CAM]FNC[CAM]K.3|QWHNDC[CAM]FNC[CAM]K.2|KC[CAM]AGC[CAM]TNPISGLGGTK.3|DDILC[CAM]PDC[CAM]GK.2|KPITTGGVTYR.2|NSLVDKPFAAK.2|EC[CAM]FVC[CAM]TAC[CAM]R.2|GFLTERDDILC[CAM]PDC[CAM]GK.3|GFLTERDDILC[CAM]PDC[CAM]GK.2|EC[CAM]FVC[CAM]TAC[CAM]RK.2|DDFAYC[CAM]LNC[CAM]FC[CAM]DLYAK.3|DDFAYC[CAM]LNC[CAM]FC[CAM]DLYAK.2|EDQLLC[CAM]TDC[CAM]YSNEYSSK.3|EDQLLC[CAM]TDC[CAM]YSNEYSSK.2|C[CAM]AGC[CAM]TNPISGLGGTK.2|EESPYC[CAM]VVC[CAM]FETLFANTC[CAM]EEC[CAM]GKPIGC[CAM]DC[CAM]K.4|YILREESPYC[CAM]VVC[CAM]FETLFANTC[CAM]EEC[CAM]GKPIGC[CAM]DC[CAM]K.4
SEN / CTL,"3'(2'),5'-bisphosphate nucleotidase 1",BPNT1,O95861,0.16,0.36,1.09E-01,3.83E-02,1.42E+00,"nucleobase-containing compound metabolic process,nervous system development,dephosphorylation,phosphatidylinositol phosphorylation,3'-phosphoadenosine 5'-phosphosulfate metabolic process","magnesium ion binding,3'(2'),5'-bisphosphate nucleotidase activity","cytoplasm,cytosol,extracellular exosome",15,19,27,RVIAEGDLGIVEK.3|RVIAEGDLGIVEK.2|LAQMSIC[CAM]SSLAR.2|LAQM[Oxi]SIC[CAM]SSLAR.2|VIAEGDLGIVEK.2|HMNSAGVLATLR.3|HMNSAGVLATLR.2|LVASAYSIAQK.2|IIQLIEGK.2|KWDTC[CAM]APEVILHAVGGK.4|KWDTC[CAM]APEVILHAVGGK.3|KWDTC[CAM]APEVILHAVGGK.2|LTDIHGNVLQYHK.3|LTDIHGNVLQYHK.2|TC[CAM]ATDLQTK.2|NYDYYASR.2|LVTDC[CAM]VAAMNPDAVLR.3|LVTDC[CAM]VAAM[Oxi]NPDAVLR.2|LVTDC[CAM]VAAMNPDAVLR.2|WDTC[CAM]APEVILHAVGGK.3|ASAYVFASPGC[CAM]K.2|QPC[CAM]PSQYSAIK.2|AIAGVINQPYYNYEAGPDAVLGR.3|EEDLVVWVDPLDGTK.2|TIWGVLGLGAFGFQLK.2|QPC[CAM]PSQYSAIKEEDLVVWVDPLDGTK.3|LTIIGEEDLPSEEVDQELIEDSQWEEILK.3
SEN / CTL,Alpha-soluble NSF attachment protein,NAPA,P54920,0.16,0.31,8.94E-02,3.27E-02,1.49E+00,"intracellular protein transport,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,intra-Golgi vesicle-mediated transport,brain development,regulation of synaptic vesicle priming,neuron differentiation,synaptic transmission, glutamatergic,SNARE complex disassembly,apical protein localization,COPII vesicle coating,membrane fusion","soluble NSF attachment protein activity,protein binding,syntaxin binding","Golgi membrane,vacuolar membrane,cytosol,membrane,SNARE complex,terminal bouton,myelin sheath,synaptobrevin 2-SNAP-25-syntaxin-1a complex,extracellular exosome",18,24,43,IEEAC[CAM]EIYAR.2|LAVQKYEELFPAFSDSR.3|LAVQKYEELFPAFSDSR.2|AIEIYTDMGR.2|AIEIYTDM[Oxi]GR.2|KADPQEAINC[CAM]LMR.3|KADPQEAINC[CAM]LMR.2|HDAATC[CAM]FVDAGNAFK.3|HDAATC[CAM]FVDAGNAFK.2|AIDIYEQVGTNAMDSPLLK.3|AIDIYEQVGTNAMDSPLLK.2|KTIQGDEEDLR.3|KTIQGDEEDLR.2|HDAATC[CAM]FVDAGNAFKK.4|HDAATC[CAM]FVDAGNAFKK.3|HDAATC[CAM]FVDAGNAFKK.2|VAGYAALLEQYQK.3|VAGYAALLEQYQK.2|EAEAMALLAEAERK.3|NSQSFFSGLFGGSSK.3|NSQSFFSGLFGGSSK.2|AIAHYEQSADYYK.3|AIAHYEQSADYYK.2|HHISIAEIYETELVDIEK.4|HHISIAEIYETELVDIEK.3|AALC[CAM]HFC[CAM]IDM[Oxi]LNAK.3|AALC[CAM]HFC[CAM]IDMLNAK.3|AALC[CAM]HFC[CAM]IDMLNAK.2|KLLEAHEEQNVDSYTESVK.4|KLLEAHEEQNVDSYTESVK.3|TIQGDEEDLR.2|NWSAAGNAFC[CAM]QAAQLHLQLQSK.4|NWSAAGNAFC[CAM]QAAQLHLQLQSK.3|AIAHYEQSADYYKGEESNSSANK.4|AIAHYEQSADYYKGEESNSSANK.3|LDQWLTTMLLR.2|LDQWLTTM[Oxi]LLR.2|EAEAMALLAEAER.2|LLEAHEEQNVDSYTESVK.3|LLEAHEEQNVDSYTESVK.2|ADPQEAINC[CAM]LMR.2|LLEAHEEQNVDSYTESVKEYDSISR.4|YEELFPAFSDSR.2
SEN / CTL,Hsc70-interacting protein,ST13,P50502,0.16,0.42,4.15E-03,2.55E-03,2.59E+00,"protein folding,protein homooligomerization,negative regulation of protein refolding,chaperone cofactor-dependent protein refolding","protein domain specific binding,Hsp70 protein binding,protein binding, bridging,protein complex binding,dATP binding,identical protein binding,unfolded protein binding,chaperone binding","cytoplasm,cytosol,protein complex,extracellular exosome",18,19,33,AIDLFTDAIK.2|AIDLFTDAIKLNPR.3|VAAIEALNDGELQK.2|AIEINPDSAQPYKWR.3|AIEINPDSAQPYKWR.2|FLREWVESMGGK.3|FLREWVESM[Oxi]GGK.3|FLREWVESMGGK.2|VMNLISK.2|VM[Oxi]NLISK.2|RASVFVK.2|KVEEDLK.2|MC[CAM]KQDPSVLHTEEMR.4|MC[CAM]KQDPSVLHTEEMR.3|AIEINPDSAQPYK.3|AIEINPDSAQPYK.2|LLGHWEEAAHDLALAC[CAM]K.4|LLGHWEEAAHDLALAC[CAM]K.3|LLGHWEEAAHDLALAC[CAM]K.2|QDPSVLHTEEMR.3|QDPSVLHTEEM[Oxi]R.3|QDPSVLHTEEMR.2|QDPSVLHTEEM[Oxi]R.2|LQKPNAAIR.2|EWVESMGGK.2|EWVESM[Oxi]GGK.2|KVAAIEALNDGELQK.3|KVAAIEALNDGELQK.2|LDYDEDASAMLK.2|LDYDEDASAM[Oxi]LK.2|VAAIEALNDGELQKAIDLFTDAIKLNPR.4|LLGHWEEAAHDLALAC[CAM]KLDYDEDASAMLK.4|VAAIEALNDGELQKAIDLFTDAIK.3
SEN / CTL,Sorting nexin-6,SNX6,Q9UNH7,0.16,0.67,3.64E-02,1.53E-02,1.81E+00,"intracellular protein transport,endocytosis,negative regulation of epidermal growth factor-activated receptor activity,vesicle organization,regulation of macroautophagy,negative regulation of transforming growth factor beta receptor signaling pathway,retrograde transport, endosome to Golgi,negative regulation of transcription, DNA-templated,regulation of histamine secretion by mast cell","protein binding,dynactin binding,phosphatidylinositol binding,protein homodimerization activity,protein heterodimerization activity","intracellular,nucleus,cytoplasm,cytosol,cytoplasmic, membrane-bounded vesicle,extrinsic component of membrane,retromer complex,retromer, tubulation complex,early endosome membrane,tubular endosome",9,25,36,NLVELAELELK.2|SADGVIVSGVKDVDDFFEHER.4|SADGVIVSGVKDVDDFFEHER.3|TVAMHEVFLC[CAM]R.3|TVAM[Oxi]HEVFLC[CAM]R.3|TVAMHEVFLC[CAM]R.2|TVAM[Oxi]HEVFLC[CAM]R.2|DVDDFFEHER.3|DVDDFFEHER.2|VAAHPILR.2|VSADEDLK.2|QELIDFK.2|SAADDYNR.2|MKQELEAEYLAIFKK.4|MKQELEAEYLAIFKK.3|QNEFSVVR.2|ISESAKQELIDFK.3|ISESAKQELIDFK.2|LGEGEGSMTK.2|LGEGEGSM[Oxi]TK.2|SADGVIVSGVK.2|LGEGEGSMTKEEFTK.3|MKQELEAEYLAIFK.3|MKQELEAEYLAIFK.2|SLVDYENANK.2|SSLPNFKQNEFSVVR.3|TFLLEYHNR.2|DVLQAETSQQLC[CAM]C[CAM]QK.3|DVLQAETSQQLC[CAM]C[CAM]QK.2|GNLQLLQNC[CAM]LAVLNGDT.3|GNLQLLQNC[CAM]LAVLNGDT.2|NKDVLQAETSQQLC[CAM]C[CAM]QKFEK.4|NKDVLQAETSQQLC[CAM]C[CAM]QK.3|QELEAEYLAIFK.2|VSADEDLKLSDLLK.2|IGSSLYALGTQDSTDIC[CAM]K.2
SEN / CTL,"Aspartate--tRNA ligase, cytoplasmic",DARS,P14868,0.15,1.07,1.15E-01,3.99E-02,1.40E+00,"translation,tRNA aminoacylation for protein translation,aspartyl-tRNA aminoacylation,protein complex assembly","aminoacylase activity,aspartate-tRNA ligase activity,protein binding,ATP binding,poly(A) RNA binding","cytoplasm,cytosol,membrane,extracellular exosome",24,43,70,IYVISLAEPR.2|IGSC[CAM]TQQDVELHVQK.3|IGSC[CAM]TQQDVELHVQK.2|LEYC[CAM]EALAMLR.2|LEYC[CAM]EALAM[Oxi]LR.2|VTMLFLGLHNVR.3|VTM[Oxi]LFLGLHNVR.3|VTMLFLGLHNVR.2|VTM[Oxi]LFLGLHNVR.2|VFSIGPVFR.2|QMC[CAM]IC[CAM]ADFEK.2|AYIDSFR.2|EAGVEMGDEDDLSTPNEK.2|EAGVEM[Oxi]GDEDDLSTPNEK.3|EAGVEM[Oxi]GDEDDLSTPNEK.2|IHDPQLLTER.3|IHDPQLLTER.2|LQSGIC[CAM]HLFR.3|LQSGIC[CAM]HLFR.2|ESIVDVEGVVRK.3|ESIVDVEGVVRK.2|FLEPTLR.2|ATVNQDTR.2|FGAPPHAGGGIGLER.3|FGAPPHAGGGIGLER.2|VRDLTIQKADEVVWVR.4|VRDLTIQKADEVVWVR.3|ADEVVWVR.2|QQQFNVQALVAVGDHASK.4|QQQFNVQALVAVGDHASK.3|QQQFNVQALVAVGDHASK.2|PREIMDAAEDYAK.3|PREIMDAAEDYAK.2|TSTSQAVFR.2|ERYGISSMIQSQEKPDR.4|ERYGISSMIQSQEKPDR.3|GFVEIQTPK.2|NNAYLAQSPQLYK.3|NNAYLAQSPQLYK.2|EIMDAAEDYAKER.3|EIMDAAEDYAKER.2|EKYDTDFYILDK.3|EKYDTDFYILDK.2|FAANINKESIVDVEGVVRK.4|GEEILSGAQR.2|QFPC[CAM]EPFK.2|LPLQLDDAVRPEAEGEEEGR.4|LPLQLDDAVRPEAEGEEEGR.3|ALHHGIDLEK.2|PFYTMPDPR.2|YGISSMIQSQEKPDR.3|YGISSM[Oxi]IQSQEKPDR.3|YGISSMIQSQEKPDR.2|ESIVDVEGVVR.2|FQTEIQTVNK.2|YPLAVRPFYTMPDPR.3|YPLAVRPFYTM[Oxi]PDPR.3|YPLAVRPFYTMPDPR.2|EIMDAAEDYAK.2|EIM[Oxi]DAAEDYAK.2|QSNSYDMFMR.2|QSNSYDMFM[Oxi]R.2|YDTDFYILDK.2|FAANINKESIVDVEGVVR.3|IISAASEGGANVFTVSYFK.3|IISAASEGGANVFTVSYFK.2|EKYDTDFYILDKYPLAVRPFYTMPDPR.5|FLEPTLRLEYC[CAM]EALAMLR.3|LPLQLDDAVRPEAEGEEEGRATVNQDTR.4|QSNSYDMFMRGEEILSGAQR.3
SEN / CTL,A-kinase anchor protein 12,AKAP12,Q02952,0.15,1.01,6.85E-03,3.93E-03,2.41E+00,"protein targeting,G-protein coupled receptor signaling pathway,positive regulation of protein kinase A signaling,positive regulation of cAMP biosynthetic process,regulation of protein kinase C signaling","adenylate cyclase binding,protein kinase A binding","cytoplasm,cytoskeleton,plasma membrane,focal adhesion,cell cortex",81,84,109,VKEESQLPGTGGPEDVLQPVQR.3|LVQNIIQTAVDQFVR.2|LVQNIIQTAVDQFVR.3|LKETC[CAM]VSGEDPTQGADLSPDEK.3|SPEQPPEGSSTPAEPEPSGGGPSAEAAPDTTADPAIAASDPATK.4|EMVVQVER.2|EVSSLEGSPPPC[CAM]LGQEEAVC[CAM]TK.3|TQEVLQAVAEK.2|FFTQGWAGWR.2|WKSDEVDEQVAC[CAM]QEVK.3|SLVEPKEDEKGDDVDDPENQNSALADTDASGGLTK.4|STPVIVSATTK.2|VLSKPPEGVVSEVEMLSSQER.3|VLSKPPEGVVSEVEM[Oxi]LSSQER.3|SSEKNEDFAAHPGEDAVPTGPDC[CAM]QAK.4|SSEKNEDFAAHPGEDAVPTGPDC[CAM]QAK.3|QLLQTVNVPIIDGAK.2|QLLQTVNVPIIDGAK.3|SEDSIAGSGVEHSTPDTEPGKEESWVSIKK.5|ERPPAPSSFVFQEETKEQSK.4|ERPPAPSSFVFQEETKEQSK.3|EKTEAEPTHVNEEKLEHETAVTVSEEVSK.5|EKTEAEPTHVNEEKLEHETAVTVSEEVSK.4|GLAEVQQDGEAEEGATSDGEK.3|GLAEVQQDGEAEEGATSDGEK.2|AATIIEER.2|SDEVDEQVAC[CAM]QEVK.2|VHSESDKAITPQAQEELQKQER.4|SVPEDDGHALLAER.3|SVPEDDGHALLAER.2|RTQEVLQAVAEK.3|RTQEVLQAVAEK.2|DKTEKPDTVQLLTVK.4|DKTEKPDTVQLLTVK.3|GSVEEPKPEEPK.3|GSVEEPKPEEPK.2|KDDALELQSHAK.3|AEAERPEEQAEASGLKK.4|AEAERPEEQAEASGLKK.3|KPKEDEVEASEK.3|TEAEPTHVNEEK.3|TEAEPTHVNEEK.2|QSTEKPEETLKR.3|GLSSDLEGEK.2|VHSESDKAITPQAQEELQK.4|EKEDAQEVELQEGK.3|EKEDAQEVELQEGK.2|EQEPEKVDTEEDGK.3|ESAKSELTES.2|LEHETAVTVSEEVSK.3|LEHETAVTVSEEVSK.2|LTASEQAHPQEPAESAHEPR.4|LTASEQAHPQEPAESAHEPR.3|VDAQEAKTEPFTQGK.3|EGVTPWASFK.2|AEAERPEEQAEASGLK.3|IEVHQEEVVAEVHVSTVEER.4|IEVHQEEVVAEVHVSTVEER.3|EQEPEKVDTEEDGKAEVASEK.4|KGLSSDLEGEK.2|AITPQAQEELQKQER.3|EESESTAVGQAHSDISK.3|KDEGEGAAGAGDHKDPSLGAGEAASK.4|KDEGEGAAGAGDHKDPSLGAGEAASK.3|GEGTEEAEC[CAM]KKDDALELQSHAK.4|MEDTLEHTDK.2|ERPPAPSSFVFQEETK.3|VTEVALKGEGTEEAEC[CAM]K.3|ADSQDAGQETEK.2|EVSVETVSILSK.2|SAESPTSPVTSETGSTFKK.3|PAPLATEVFDEK.2|ELSESQVHMMAAAVADGTR.3|VVGQTTPESFEK.2|AITPQAQEELQK.2|SATLSSTESTASEMQEEMK.3|SATLSSTESTASEMQEEMK.2|EDAQEVELQEGK.2|SEDSIAGSGVEHSTPDTEPGK.3|DVPFFEGLEGSIDTGITVSR.3|ETC[CAM]VSGEDPTQGADLSPDEK.3|ETC[CAM]VSGEDPTQGADLSPDEK.2|VLGETANILETGETLEPAGAHLVLEEK.4|VLGETANILETGETLEPAGAHLVLEEK.3|EVIAEEEPPTVTEPLPENR.3|EVIAEEEPPTVTEPLPENR.2|DEGEGAAGAGDHKDPSLGAGEAASK.3|SEDSIAGSGVEHSTPDTEPGKEESWVSIK.4|NEDFAAHPGEDAVPTGPDC[CAM]QAK.3|NEDFAAHPGEDAVPTGPDC[CAM]QAK.2|TEETATEMLTSELQTQAHVIK.3|TEETATEM[Oxi]LTSELQTQAHVIK.3|TKDVPFFEGLEGSIDTGITVSR.3|TEGTQEADQYADEK.2|VELPSEEQVSGSQGPSEEKPAPLATEVFDEK.4|VELPSEEQVSGSQGPSEEKPAPLATEVFDEK.3|GALNGQGALNSQEEEEVIVTEVGQR.3|GGGDEESGEHTQVPADSPDSQEEQK.3|APQVTESIESSELVTTC[CAM]QAETLAGVK.3|QEQAPVEDAGPTGANEDDSDVPAVVPLSEYDAVER.4|SAESPTSPVTSETGSTFK.2|VDTSVSWEALIC[CAM]VGSSK.2|EDEKGDDVDDPENQNSALADTDASGGLTK.3|GESSASSPEEPEEITC[CAM]LEK.2|TEEQKTEVEETAGSVPAEELVEMDAEPQEAEPAKELVK.4|VELPSEEQVSGSQGPSEEK.2|EESQLPGTGGPEDVLQPVQR.2|IQVQSSEASFTLTAAAEEEK.2|VSVAIEDLEPENGILELETK.2
SEN / CTL,"Malate dehydrogenase, mitochondrial",MDH2,P40926,0.15,0.41,1.22E-01,4.19E-02,1.38E+00,"gluconeogenesis,tricarboxylic acid cycle,oxaloacetate metabolic process,malate metabolic process,internal protein amino acid acetylation,NADH metabolic process","L-malate dehydrogenase activity,protein self-association,poly(A) RNA binding,malate dehydrogenase (NADP+) activity","nucleus,nucleoplasm,mitochondrion,mitochondrial inner membrane,mitochondrial matrix,plasma membrane,myelin sheath,extracellular exosome",93,31,62,SQETEC[CAM]TYFSTPLLLGK.2|SQETEC[CAM]TYFSTPLLLGK.3|ANTFVAELK.2|GLDPARVNVPVIGGHAGK.4|GLDPARVNVPVIGGHAGK.3|TIIPLISQC[CAM]TPK.2|TIIPLISQC[CAM]TPK.3|VDFPQDQLTALTGR.2|VDFPQDQLTALTGR.3|GYLGPEQLPDC[CAM]LKGC[CAM]DVVVIPAGVPR.3|GYLGPEQLPDC[CAM]LKGC[CAM]DVVVIPAGVPR.4|GC[CAM]DVVVIPAGVPR.2|GC[CAM]DVVVIPAGVPR.3|VAVLGASGGIGQPLSLLLK.2|VAVLGASGGIGQPLSLLLK.3|VAVLGASGGIGQPLSLLLK.4|LTLYDIAHTPGVAADLSHIETK.4|LTLYDIAHTPGVAADLSHIETK.3|LTLYDIAHTPGVAADLSHIETK.2|GYLGPEQLPDC[CAM]LK.2|GYLGPEQLPDC[CAM]LK.3|MISDAIPELK.2|M[Oxi]ISDAIPELK.2|IFGVTTLDIVR.2|IFGVTTLDIVR.3|AGAGSATLSMAYAGAR.3|AGAGSATLSMAYAGAR.2|AGAGSATLSM[Oxi]AYAGAR.3|AGAGSATLSM[Oxi]AYAGAR.2|HGVYNPNKIFGVTTLDIVR.4|HGVYNPNKIFGVTTLDIVR.3|HGVYNPNKIFGVTTLDIVR.2|SQETEC[CAM]TYFSTPLLLGKK.3|SQETEC[CAM]TYFSTPLLLGKK.4|SQETEC[CAM]TYFSTPLLLGKK.2|ANTFVAELKGLDPAR.3|ANTFVAELKGLDPAR.2|AAVKGYLGPEQLPDC[CAM]LKGC[CAM]DVVVIPAGVPR.4|FVFSLVDAMNGK.2|FVFSLVDAMNGK.3|FVFSLVDAM[Oxi]NGK.3|FVFSLVDAM[Oxi]NGK.2|AKAGAGSATLSMAYAGAR.3|AKAGAGSATLSM[Oxi]AYAGAR.3|FVFSLVDAMNGKEGVVEC[CAM]SFVK.3|FVFSLVDAMNGKEGVVEC[CAM]SFVK.4|FVFSLVDAM[Oxi]NGKEGVVEC[CAM]SFVK.4|FVFSLVDAM[Oxi]NGKEGVVEC[CAM]SFVK.3|KGEDFVK.2|IQEAGTEVVKAK.3|HGVYNPNK.2|IQEAGTEVVK.2|ANTFVAELKGLDPARVNVPVIGGHAGK.5|ANTFVAELKGLDPARVNVPVIGGHAGK.4|VNVPVIGGHAGK.2|EGVVEC[CAM]SFVK.2|VSSFEEKM[Oxi]ISDAIPELK.3|VSSFEEKMISDAIPELK.3|TIIPLISQC[CAM]TPKVDFPQDQLTALTGR.4|TIIPLISQC[CAM]TPKVDFPQDQLTALTGR.3|VDFPQDQLTALTGRIQEAGTEVVK.3|DDLFNTNATIVATLTAAC[CAM]AQHC[CAM]PEAMIC[CAM]VIANPVNSTIPITAEVFKK.5
SEN / CTL,26S proteasome non-ATPase regulatory subunit 13,PSMD13,Q9UNM6,0.15,0.72,1.10E-01,3.83E-02,1.42E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,ubiquitin-dependent protein catabolic process,regulation of cellular amino acid metabolic process,meiosis I,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,proteasome assembly,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway",structural molecule activity,"proteasome complex,nucleus,nucleoplasm,cytosol,proteasome regulatory particle,proteasome regulatory particle, lid subcomplex,membrane,proteasome accessory complex,extracellular exosome",18,35,52,FLGC[CAM]VDIKDLPVSEQQER.3|ITVNEVELLVMK.2|ITVNEVELLVM[Oxi]K.2|QLTFEEIAK.2|NTDRQWLIDTLYAFNSGNVER.3|NTDRQWLIDTLYAFNSGNVER.4|VNPLSLVEIILHVVR.3|TAWGQQPDLAANEAQLLRK.3|TAWGQQPDLAANEAQLLRK.2|GSIDEVDK.2|LEELYTK.2|VKSSDEAVILC[CAM]K.3|VKSSDEAVILC[CAM]K.2|FLGC[CAM]VDIK.2|DVPGFLQQSQNSGPGQPAVWHR.5|DVPGFLQQSQNSGPGQPAVWHR.3|VLDLQQIK.2|DRLEFWC[CAM]TDVK.3|DRLEFWC[CAM]TDVK.2|GSIDEVDKR.2|LEELYTKK.2|YYQTIGNHASYYKDALR.4|LYENFISEFEHR.3|LYENFISEFEHR.2|YYQTIGNHASYYK.3|YYQTIGNHASYYK.2|LNIGDLQVTK.2|IQLLC[CAM]LMEMTFTRPANHR.4|IQLLC[CAM]LMEM[Oxi]TFTRPANHR.4|SSDEAVILC[CAM]K.2|VHMTWVQPR.2|VHM[Oxi]TWVQPR.2|SMEMLVEHQAHDILT.3|SMEMLVEHQAHDILT.2|DLPVSEQQER.2|GMKDRLEFWC[CAM]TDVK.3|LEFWC[CAM]TDVK.2|ETIEDVEEMLNNLPGVTSVHSR.4|ETIEDVEEM[Oxi]LNNLPGVTSVHSR.3|ETIEDVEEMLNNLPGVTSVHSR.3|MKDVPGFLQQSQNSGPGQPAVWHR.4|TAWGQQPDLAANEAQLLR.3|TAWGQQPDLAANEAQLLR.2|QWLIDTLYAFNSGNVER.3|QWLIDTLYAFNSGNVER.2|LWHQLTLQVLDFVQDPC[CAM]FAQGDGLIK.4|LWHQLTLQVLDFVQDPC[CAM]FAQGDGLIK.3|KLWHQLTLQVLDFVQDPC[CAM]FAQGDGLIK.4|QMTDPNVALTFLEK.2|QM[Oxi]TDPNVALTFLEK.2|IQLLC[CAM]LMEMTFTR.2|LNIGDLQVTKETIEDVEEMLNNLPGVTSVHSR.4
SEN / CTL,Galectin-3,LGALS3,P17931,0.15,0.33,1.06E-03,8.02E-04,3.10E+00,"monocyte chemotaxis,mRNA processing,RNA splicing,neutrophil chemotaxis,epithelial cell differentiation,regulation of T cell proliferation,innate immune response,negative regulation of endocytosis,eosinophil chemotaxis,macrophage chemotaxis,negative regulation of T cell receptor signaling pathway,positive chemotaxis,regulation of T cell apoptotic process,mononuclear cell migration,positive regulation of mononuclear cell migration,positive regulation of calcium ion import,regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of immunological synapse formation,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,negative regulation of extrinsic apoptotic signaling pathway,positive regulation of dendritic cell differentiation","protein binding,IgE binding,carbohydrate binding,chemoattractant activity,laminin binding,poly(A) RNA binding","immunological synapse,extracellular space,nucleus,spliceosomal complex,cytoplasm,mitochondrial inner membrane,plasma membrane,membrane,extracellular exosome,extracellular matrix",21,12,19,IALDFQR.2|MLITILGTVKPNANR.3|M[Oxi]LITILGTVKPNANR.3|QSVFPFESGKPFK.3|QSVFPFESGKPFK.2|GNDVAFHFNPR.3|GNDVAFHFNPR.2|IQVLVEPDHFK.3|IQVLVEPDHFK.2|VAVNDAHLLQYNHR.4|VAVNDAHLLQYNHR.3|VAVNDAHLLQYNHR.2|KLNEISK.2|VIVC[CAM]NTK.2|LDNNWGR.2|RVIVC[CAM]NTK.2|MLITILGTVK.2|M[Oxi]LITILGTVK.2|QSVFPFESGK.2
SEN / CTL,UDP-glucose:glycoprotein glucosyltransferase 1,UGGT1,Q9NYU2,0.15,0.71,1.23E-01,4.21E-02,1.38E+00,"protein N-linked glycosylation via asparagine,endoplasmic reticulum unfolded protein response,'de novo' posttranslational protein folding,ER-associated misfolded protein catabolic process,UDP-glucosylation,endoplasmic reticulum mannose trimming","UDP-glucose:glycoprotein glucosyltransferase activity,protein binding,unfolded protein binding","endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum-Golgi intermediate compartment,endoplasmic reticulum quality control compartment,extracellular exosome",12,68,110,LGIEGLSLHNVLK.3|LGIEGLSLHNVLK.2|ILETTTFFQR.2|IVPEWQDYDQEIK.2|IYSHDGTDSPPDADEVVIVLNNFK.3|IYSHDGTDSPPDADEVVIVLNNFK.4|LSDMPLK.2|SGYWASHLAGR.3|SGYWASHLAGR.2|VMEGLHR.2|DLHPDLEGQLK.3|DLHPDLEGQLK.2|TAVSSELR.2|VKVEHVVSVLEK.3|VKVEHVVSVLEK.2|IMMLSVLK.2|HYIFNPR.2|QLLYDAIK.2|HLVESTNEMAPLK.3|HLVESTNEM[Oxi]APLK.3|HLVESTNEMAPLK.2|HLVESTNEM[Oxi]APLK.2|ILASPVELALVVMK.3|ILASPVELALVVMK.2|ILASPVELALVVM[Oxi]K.2|ISMINNPAK.2|FTILDSQGK.2|M[Oxi]DFILSHAVYC[CAM]R.3|MDFILSHAVYC[CAM]R.3|MDFILSHAVYC[CAM]R.2|M[Oxi]DFILSHAVYC[CAM]R.2|LRDLHPDLEGQLK.3|VDALLSAQPK.2|AIWAALQTQTSNAAK.3|AIWAALQTQTSNAAK.2|DLSQNFPTK.2|WLHQQTEK.2|TC[CAM]ESDTLEALLLTASERPKPLLFK.5|TC[CAM]ESDTLEALLLTASERPKPLLFK.4|TC[CAM]ESDTLEALLLTASERPKPLLFK.3|VWQLQDLSFQTAAR.3|VWQLQDLSFQTAAR.2|KTC[CAM]ESDTLEALLLTASERPK.4|KTC[CAM]ESDTLEALLLTASERPK.3|SPAISWVNNLEVDSR.3|SPAISWVNNLEVDSR.2|KTC[CAM]ESDTLEALLLTASERPKPLLFK.5|KTC[CAM]ESDTLEALLLTASERPKPLLFK.4|LNIQPSEADYAVDIR.3|LNIQPSEADYAVDIR.2|VEHVVSVLEK.2|QDKDDIINIFSVASGHLYER.4|TEEVKQDKDDIINIFSVASGHLYER.5|TEEVKQDKDDIINIFSVASGHLYER.4|KEPVYLSGYGVELAIK.3|KEPVYLSGYGVELAIK.2|EQLDPDELETITMHK.3|EQLDPDELETITMHK.2|TAVSSELRTEVEENQK.3|YNSWPSSLQELLRPTFPGVIR.4|YNSWPSSLQELLRPTFPGVIR.3|IEYQFFEDR.2|EGETYFDVVAVVDPVTR.3|EGETYFDVVAVVDPVTR.2|TC[CAM]ESDTLEALLLTASER.3|TC[CAM]ESDTLEALLLTASER.2|TIDLC[CAM]NNPMTK.2|FLFVDADQIVR.2|VEEDVASDLVMK.2|VEEDVASDLVM[Oxi]K.2|EISYENTQISR.2|GQYQGLSQDPNSLSNLDQDLPNNMIHQVPIK.5|GQYQGLSQDPNSLSNLDQDLPNNMIHQVPIK.4|GQYQGLSQDPNSLSNLDQDLPNNMIHQVPIK.3|TAAVANSMNYLTK.2|TAAVANSM[Oxi]NYLTK.2|DFNLDGAPYGYTPFC[CAM]DSR.3|DFNLDGAPYGYTPFC[CAM]DSR.2|TC[CAM]ESDTLEALLLTASERPK.3|GDHRYPSSNPESPVVIFYSEIGSEEFSNFHR.5|GDHRYPSSNPESPVVIFYSEIGSEEFSNFHR.4|AYNYVAQEVDDYHAFQTLTHIYNK.4|AYNYVAQEVDDYHAFQTLTHIYNK.3|IIGPLEDSELFNQDDFHLLENIILK.4|IIGPLEDSELFNQDDFHLLENIILK.3|KYPYVEVNSILGIDSAYDR.3|KYPYVEVNSILGIDSAYDR.2|AVYLGELPHDQDVVEYIMNQPNVVPR.4|AVYLGELPHDQDVVEYIMNQPNVVPR.3|TAVSSELRTEVEENQKYFK.3|SLPQEWLWC[CAM]ETWC[CAM]DDASK.3|SLPQEWLWC[CAM]ETWC[CAM]DDASK.2|NLHNM[Oxi]VFIVDPAHETTAELMNTAEMFLSNHIPLR.5|NLHNMVFIVDPAHETTAELMNTAEMFLSNHIPLR.5|NLHNMVFIVDPAHETTAELMNTAEMFLSNHIPLR.4|EPVYLSGYGVELAIK.2|WFSTPLLLEASEFLAEDSQEK.3|ELRDFNLDGAPYGYTPFC[CAM]DSR.3|TIDLC[CAM]NNPMTKEPK.2|SYSATIQAFQQIAADEPPPEGC[CAM]NSFFSVHGK.4|SYSATIQAFQQIAADEPPPEGC[CAM]NSFFSVHGK.3|GYYEQTGVGPLPVVLFNGMPFER.3|ILTAERDYLDLTASNNFFVDDYAR.3|EIYDDSFIRPVTFWIVGDFDSPSGR.3|KADMVNEDLLSDGTSENESGFWDSFK.3|YVLEPEISFTSDNSFAK.2|FLDM[Oxi]PQSPLFTLNLNTPESWMVESVR.3|FLDMPQSPLFTLNLNTPESWMVESVR.3|HLVESTNEMAPLKVWQLQDLSFQTAAR.3|YPSSNPESPVVIFYSEIGSEEFSNFHR.3
SEN / CTL,Serpin B9,SERPINB9,P50453,0.14,0.34,9.38E-02,3.38E-02,1.47E+00,"mast cell mediated immunity,apoptotic process,immune response,response to bacterium,positive regulation of gene expression,negative regulation of endopeptidase activity,negative regulation by symbiont of host apoptotic process,protection from natural killer cell mediated cytotoxicity,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,cellular response to estrogen stimulus","protease binding,serine-type endopeptidase inhibitor activity,protein binding,cysteine-type endopeptidase inhibitor activity involved in apoptotic process","extracellular space,intracellular,nucleus,cytoplasm,cytosol,membrane,extracellular exosome",15,21,29,LVLVNAIYFK.2|AQLLELPYAR.2|FC[CAM]ADHPFLFFIR.3|FC[CAM]ADHPFLFFIR.2|STEVEVLLPK.2|HLGIVDAFQQGK.3|HLGIVDAFQQGK.2|LTAWTKPDC[CAM]MK.3|AGTQYLLR.2|HINTWVSK.2|ESC[CAM]LQFYHAELK.3|ESC[CAM]LQFYHAELK.2|ANSILFC[CAM]GR.2|ADLSAMSAER.2|GKWNEPFDETYTR.3|GKWNEPFDETYTR.2|TC[CAM]QFLSTFK.2|GNTATQMAQALSLNTEEDIHR.4|GNTATQMAQALSLNTEEDIHR.3|AFQSLLTEVNK.2|KTEGKIEELLPGSSIDAETR.3|LQEDYDMESVLR.2|LQEDYDM[Oxi]ESVLR.2|INQEEQRPVQMMYQEATFK.3|IEELLPGSSIDAETR.2|ILC[CAM]QDNPSHNVFC[CAM]SPVSISSALAMVLLGAK.4|ILC[CAM]QDNPSHNVFC[CAM]SPVSISSALAM[Oxi]VLLGAK.3|ILC[CAM]QDNPSHNVFC[CAM]SPVSISSALAMVLLGAK.3|ELSLLVLLPDDGVELSTVEK.2
SEN / CTL,F-actin-capping protein subunit alpha-1,CAPZA1,P52907,0.14,0.46,4.25E-05,4.59E-05,4.34E+00,"protein complex assembly,movement of cell or subcellular component,blood coagulation,innate immune response,barbed-end actin filament capping,cell-cell adhesion","actin binding,cadherin binding involved in cell-cell adhesion","extracellular region,cytosol,cytoskeleton,cell-cell adherens junction,F-actin capping protein complex,actin cytoskeleton,extracellular exosome,WASH complex",24,20,42,FTITPPTAQVVGVLK.2|FTITPPTAQVVGVLK.3|EASDPQPEEADGGLKSWR.3|LLLNNDNLLR.2|LLLNNDNLLR.3|FITHAPPGEFNEVFNDVR.3|FITHAPPGEFNEVFNDVR.4|FITHAPPGEFNEVFNDVR.2|AYVKDHYSNGFC[CAM]TVYAK.4|AYVKDHYSNGFC[CAM]TVYAK.3|TIDGQQTIIAC[CAM]IESHQFQPK.3|TIDGQQTIIAC[CAM]IESHQFQPK.4|TIDGQQTIIAC[CAM]IESHQFQPK.2|SWRESC[CAM]DSALR.3|SWRESC[CAM]DSALR.2|ESC[CAM]DSALR.2|TKIDWNKILSYK.3|IQVHYYEDGNVQLVSHK.4|IQVHYYEDGNVQLVSHK.3|IQVHYYEDGNVQLVSHK.2|EASDPQPEEADGGLK.3|EASDPQPEEADGGLK.2|DHYSNGFC[CAM]TVYAK.3|DHYSNGFC[CAM]TVYAK.2|EGAAHAFAQYNMDQFTPVK.4|EGAAHAFAQYNM[Oxi]DQFTPVK.3|EGAAHAFAQYNMDQFTPVK.3|EGAAHAFAQYNMDQFTPVK.2|KEASDPQPEEADGGLK.3|IEGYEDQVLITEHGDLGNSR.4|IEGYEDQVLITEHGDLGNSR.3|IEGYEDQVLITEHGDLGNSR.2|DVQDSLTVSNEAQTAK.3|DVQDSLTVSNEAQTAK.2|IQVHYYEDGNVQLVSHKDVQDSLTVSNEAQTAK.5|IQVHYYEDGNVQLVSHKDVQDSLTVSNEAQTAK.4|IIENAENEYQTAISENYQTMSDTTFK.4|IIENAENEYQTAISENYQTM[Oxi]SDTTFK.3|IIENAENEYQTAISENYQTMSDTTFK.3|FITHAPPGEFNEVFNDVRLLLNNDNLLR.4|EGAAHAFAQYNMDQFTPVKIEGYEDQVLITEHGDLGNSR.5|EGAAHAFAQYNMDQFTPVKIEGYEDQVLITEHGDLGNSR.4
SEN / CTL,Cofilin-1,CFL1,P23528,0.14,0.73,7.35E-02,2.76E-02,1.56E+00,"cytoskeleton organization,Rho protein signal transduction,response to virus,regulation of cell morphogenesis,actin cytoskeleton organization,actin filament depolymerization,negative regulation of apoptotic process,positive regulation by host of viral process,regulation of dendritic spine morphogenesis","protein binding,actin filament binding","extracellular space,nucleus,cytoplasm,focal adhesion,actin cytoskeleton,membrane,nuclear matrix,extracellular matrix,lamellipodium membrane,vesicle,ruffle membrane,extracellular exosome",42,22,40,LGGSAVISLEGKPL.2|LGGSAVISLEGKPL.3|NIILEEGKEILVGDVGQTVDDPYATFVK.3|NIILEEGKEILVGDVGQTVDDPYATFVK.4|NIILEEGKEILVGDVGQTVDDPYATFVK.5|LTGIKHELQANC[CAM]YEEVKDR.4|LTGIKHELQANC[CAM]YEEVKDR.5|LTGIKHELQANC[CAM]YEEVKDR.3|AVLFC[CAM]LSEDKK.3|AVLFC[CAM]LSEDKK.2|HELQANC[CAM]YEEVKDR.4|HELQANC[CAM]YEEVKDR.3|HELQANC[CAM]YEEVKDR.2|KAVLFC[CAM]LSEDKK.3|KAVLFC[CAM]LSEDKK.2|EILVGDVGQTVDDPYATFVK.3|EILVGDVGQTVDDPYATFVK.4|EILVGDVGQTVDDPYATFVK.2|KAVLFC[CAM]LSEDK.3|SSTPEEVK.2|NIILEEGK.2|DRC[CAM]TLAEK.2|KSSTPEEVK.2|SSTPEEVKK.2|HELQANC[CAM]YEEVK.3|HELQANC[CAM]YEEVK.2|LTGIKHELQANC[CAM]YEEVK.4|LTGIKHELQANC[CAM]YEEVK.3|LTGIKHELQANC[CAM]YEEVK.2|KNIILEEGK.2|MLPDKDC[CAM]R.2|M[Oxi]LPDKDC[CAM]R.2|KLTGIKHELQANC[CAM]YEEVK.4|KLTGIKHELQANC[CAM]YEEVK.3|KLTGIKHELQANC[CAM]YEEVK.2|AVLFC[CAM]LSEDKKNIILEEGK.4|LGGSAVISLEGK.2|AVLFC[CAM]LSEDK.2|KNIILEEGKEILVGDVGQTVDDPYATFVK.4|KNIILEEGKEILVGDVGQTVDDPYATFVK.3
SEN / CTL,60S ribosomal protein L27,RPL27,P61353,0.13,0.27,1.33E-01,4.46E-02,1.35E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","structural constituent of ribosome,poly(A) RNA binding","nucleus,cytosol,ribosome,focal adhesion,membrane,cytosolic large ribosomal subunit,intracellular ribonucleoprotein complex,extracellular matrix,extracellular exosome",6,11,19,VVLVLAGR.2|NIDDGTSDRPYSHALVAGIDRYPR.5|NIDDGTSDRPYSHALVAGIDRYPR.4|NIDDGTSDRPYSHALVAGIDRYPR.3|DVFRDPALKR.3|KVTAAMGK.2|TVVNKDVFRDPALK.4|TVVNKDVFRDPALK.3|PYSHALVAGIDR.3|VYNYNHLMPTR.3|VYNYNHLM[Oxi]PTR.3|VYNYNHLMPTR.2|VYNYNHLM[Oxi]PTR.2|DVFRDPALK.2|YSVDIPLDK.2|YSVDIPLDKTVVNK.3|NIDDGTSDRPYSHALVAGIDR.4|NIDDGTSDRPYSHALVAGIDR.3|NIDDGTSDRPYSHALVAGIDR.2
SEN / CTL,Integrin beta-1,ITGB1,P05556,0.12,0.57,1.03E-02,5.43E-03,2.26E+00,"G1/S transition of mitotic cell cycle,in utero embryonic development,cell fate specification,cell migration involved in sprouting angiogenesis,cellular defense response,homophilic cell adhesion via plasma membrane adhesion molecules,leukocyte cell-cell adhesion,cell-matrix adhesion,calcium-independent cell-matrix adhesion,integrin-mediated signaling pathway,positive regulation of cell proliferation,germ cell migration,visual learning,regulation of collagen catabolic process,cell migration,formation of radial glial scaffolds,B cell differentiation,extracellular matrix organization,cell-substrate adhesion,receptor internalization,cell adhesion mediated by integrin,cell-cell adhesion mediated by integrin,heterotypic cell-cell adhesion,negative regulation of Rho protein signal transduction,positive regulation of apoptotic process,positive regulation of GTPase activity,sarcomere organization,negative regulation of cell differentiation,viral entry into host cell,mesodermal cell differentiation,axon extension,dendrite morphogenesis,regulation of immune response,leukocyte migration,leukocyte tethering or rolling,regulation of cell cycle,cardiac muscle cell differentiation,cellular response to low-density lipoprotein particle stimulus,positive regulation of establishment of protein localization to plasma membrane,negative regulation of anoikis,transforming growth factor beta receptor signaling pathway,stress fiber assembly","virus receptor activity,fibronectin binding,protease binding,actin binding,integrin binding,protein binding,coreceptor activity,protein complex binding,laminin binding,metal ion binding,protein heterodimerization activity,cell adhesion molecule binding,collagen binding involved in cell-matrix adhesion,cadherin binding involved in cell-cell adhesion,C-X3-C chemokine binding","ruffle,cytoplasm,plasma membrane,cell-cell adherens junction,focal adhesion,integrin complex,external side of plasma membrane,cell surface,intercalated disc,membrane,lamellipodium,filopodium,neuromuscular junction,cleavage furrow,ruffle membrane,integrin alpha1-beta1 complex,integrin alpha2-beta1 complex,integrin alpha3-beta1 complex,integrin alpha7-beta1 complex,integrin alpha8-beta1 complex,integrin alpha10-beta1 complex,integrin alpha11-beta1 complex,myelin sheath abaxonal region,sarcolemma,melanosome,dendritic spine,receptor complex,membrane raft,perinuclear region of cytoplasm,recycling endosome,extracellular exosome,invadopodium membrane,synaptic membrane",45,36,53,LKPEDITQIQPQQLVLR.3|LKPEDITQIQPQQLVLR.2|LKPEDITQIQPQQLVLR.4|IGFGSFVEK.2|WDTGENPIYK.2|LSENNIQTIFAVTEEFQPVYK.3|LSEGVTISYK.2|NVLSLTNKGEVFNELVGK.3|NVLSLTNKGEVFNELVGK.2|LLVFSTDAGFHFAGDGK.3|LLVFSTDAGFHFAGDGK.2|RAEDYPIDLYYLMDLSYSMKDDLENVK.4|SLGTDLMNEMR.2|SLGTDLM[Oxi]NEMR.2|SLGTDLMNEM[Oxi]R.2|TVMPYISTTPAK.2|TVM[Oxi]PYISTTPAK.2|LGGIVLPNDGQC[CAM]HLENNMYTMSHYYDYPSIAHLVQK.5|LGGIVLPNDGQC[CAM]HLENNMYTMSHYYDYPSIAHLVQK.6|LGGIVLPNDGQC[CAM]HLENNM[Oxi]YTM[Oxi]SHYYDYPSIAHLVQK.5|LGGIVLPNDGQC[CAM]HLENNMYTMSHYYDYPSIAHLVQK.4|HC[CAM]EC[CAM]STDEVNSEDM[Oxi]DAYC[CAM]R.3|HC[CAM]EC[CAM]STDEVNSEDMDAYC[CAM]R.3|NVLSLTNK.2|DKLPQPVQPDPVSHC[CAM]K.4|DKLPQPVQPDPVSHC[CAM]K.3|DKLPQPVQPDPVSHC[CAM]K.2|LRSGEPQTFTLK.3|KGC[CAM]PPDDIENPR.3|KGC[CAM]PPDDIENPR.2|KRDNTNEIYSGK.3|KRDNTNEIYSGK.2|C[CAM]DDLEALK.2|SAVTTVVNPKYEGK.3|SAVTTVVNPK.2|LPQPVQPDPVSHC[CAM]K.3|LPQPVQPDPVSHC[CAM]K.2|C[CAM]DDLEALKK.2|GEVFNELVGK.2|GIC[CAM]EC[CAM]GVC[CAM]K.2|KGC[CAM]PPDDIENPRGSK.3|SGEPQTFTLK.2|DNTNEIYSGK.2|GTAEKLKPEDITQIQPQQLVLR.4|GC[CAM]PPDDIENPR.2|RDNTNEIYSGK.2|SNGLIC[CAM]GGNGVC[CAM]K.2|LSENNIQTIFAVTEEFQPVYKELK.4|LSENNIQTIFAVTEEFQPVYKELK.3|FC[CAM]EC[CAM]DNFNC[CAM]DR.2|FQGQTC[CAM]EMC[CAM]QTC[CAM]LGVC[CAM]AEHK.3|RAEDYPIDLYYLMDLSYSMK.3|LSENNIQTIFAVTEEFQPVYKELKNLIPK.4
SEN / CTL,Plasma alpha-L-fucosidase,FUCA2,Q9BTY2,0.12,0.30,7.52E-02,2.82E-02,1.55E+00,"fucose metabolic process,response to bacterium,glycoside catabolic process,regulation of entry of bacterium into host cell",alpha-L-fucosidase activity,"extracellular space,extracellular exosome",21,12,14,LVYAIFLK.2|EAGISDYLTIEELVK.2|WPTSGQLFLGHPK.3|WPTSGQLFLGHPK.2|FFNANQWADIFQASGAK.3|FFNANQWADIFQASGAK.2|FDPTWESLDAR.2|VNGEAIYETHTWR.3|AILGATEVK.2|GTVVTNDRWGAGSIC[CAM]K.3|HGGFYTC[CAM]SDR.2|WENC[CAM]MTIDK.2|YEDFGPLFTAK.2|LLGHGQPLNWISLEQNGIMVELPQLTIHQMPC[CAM]K.4
SEN / CTL,Prosaposin,PSAP,P07602,0.12,1.36,9.10E-02,3.32E-02,1.48E+00,"platelet degranulation,glycosphingolipid metabolic process,lipid transport,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,regulation of autophagy,regulation of lipid metabolic process,positive regulation of catalytic activity,positive regulation of MAPK cascade,prostate gland growth,epithelial cell differentiation involved in prostate gland development,cellular response to organic substance,negative regulation of hydrogen peroxide-induced cell death","G-protein coupled receptor binding,protein binding,enzyme activator activity,lipid binding","extracellular region,extracellular space,cytoplasm,mitochondrion,lysosome,lysosomal membrane,integral component of membrane,lysosomal lumen,extracellular exosome",51,30,59,SDVYC[CAM]EVC[CAM]EFLVK.2|SDVYC[CAM]EVC[CAM]EFLVK.3|EIVDSYLPVILDIIK.2|EIVDSYLPVILDIIK.3|LVGYLDR.2|EILDAFDKMC[CAM]SK.3|GC[CAM]SFLPDPYQK.2|GC[CAM]SFLPDPYQK.3|C[CAM]IWGPSYWC[CAM]QNTETAAQC[CAM]NAVEHC[CAM]KR.4|DGGFC[CAM]EVC[CAM]K.2|LGPGMADIC[CAM]K.2|LGPGM[Oxi]ADIC[CAM]K.2|NVIPALELVEPIKK.3|NVIPALELVEPIKK.2|EILDAFDK.2|SLPC[CAM]DIC[CAM]KDVVTAAGDMLK.3|KLVGYLDR.2|NYISQYSEIAIQMMMHMQPK.3|NYISQYSEIAIQMMMHMQPK.4|NYISQYSEIAIQM[Oxi]MMHMQPK.4|NYISQYSEIAIQMM[Oxi]MHMQPK.4|NYISQYSEIAIQMMM[Oxi]HMQPK.4|NYISQYSEIAIQMMMHM[Oxi]QPK.4|NYISQYSEIAIQM[Oxi]MM[Oxi]HMQPK.4|NYISQYSEIAIQMM[Oxi]MHM[Oxi]QPK.4|NYISQYSEIAIQM[Oxi]M[Oxi]MHM[Oxi]QPK.3|NYISQYSEIAIQM[Oxi]M[Oxi]MHMQPK.3|NYISQYSEIAIQM[Oxi]MM[Oxi]HM[Oxi]QPK.3|NYISQYSEIAIQM[Oxi]MM[Oxi]HMQPK.3|NYISQYSEIAIQM[Oxi]MMHM[Oxi]QPK.3|NYISQYSEIAIQM[Oxi]MMHMQPK.3|NYISQYSEIAIQMM[Oxi]MHM[Oxi]QPK.3|NYISQYSEIAIQMM[Oxi]MHMQPK.3|NYISQYSEIAIQMMM[Oxi]HM[Oxi]QPK.3|NYISQYSEIAIQMMM[Oxi]HMQPK.3|NYISQYSEIAIQMMMHM[Oxi]QPK.3|DGGFC[CAM]EVC[CAM]KK.3|DGGFC[CAM]EVC[CAM]KK.2|IGAC[CAM]PSAHKPLLGTEK.4|IGAC[CAM]PSAHKPLLGTEK.3|IGAC[CAM]PSAHKPLLGTEK.2|LPALTVHVTQPK.3|LPALTVHVTQPK.2|LVGYLDRNLEK.3|LVGYLDRNLEK.2|KLVGYLDRNLEK.3|SLPC[CAM]DIC[CAM]K.2|QEILAALEK.2|HLAELNHQK.2|DVVTAAGDMLK.2|DVVTAAGDM[Oxi]LK.2|GSAVWC[CAM]QNVK.2|HEVPAKSDVYC[CAM]EVC[CAM]EFLVK.4|EEC[CAM]DRLGPGMADIC[CAM]K.3|EMPMQTLVPAK.2|NVIPALELVEPIK.2|EIC[CAM]ALVGFC[CAM]DEVK.2|GEMSRPGEVC[CAM]SALNLC[CAM]ESLQK.3|C[CAM]IWGPSYWC[CAM]QNTETAAQC[CAM]NAVEHC[CAM]K.3
SEN / CTL,Eukaryotic translation initiation factor 6,EIF6,P56537,0.12,0.40,3.39E-02,1.45E-02,1.84E+00,"ribosomal subunit export from nucleus,maturation of 5.8S rRNA,maturation of LSU-rRNA,regulation of glycolytic process,translational initiation,response to insulin,gene silencing by miRNA,miRNA mediated inhibition of translation,mature ribosome assembly,regulation of fatty acid biosynthetic process,regulation of megakaryocyte differentiation,positive regulation of translation,assembly of large subunit precursor of preribosome,regulation of reactive oxygen species metabolic process","translation initiation factor activity,protein binding,ribosome binding,ribosomal large subunit binding","nucleus,nucleoplasm,nucleolus,cytoplasm,cytosol,preribosome, large subunit precursor,extracellular exosome",24,13,23,HGLLVPNNTTDQELQHIR.4|HGLLVPNNTTDQELQHIR.3|TSIEDQDELSSLLQVPLVAGTVNR.3|TSIEDQDELSSLLQVPLVAGTVNR.4|ASFENNC[CAM]EIGC[CAM]FAK.2|ASFENNC[CAM]EIGC[CAM]FAK.3|LSALGNVTTC[CAM]NDYVALVHPDLDRETEEILADVLKVEVFR.5|LSALGNVTTC[CAM]NDYVALVHPDLDRETEEILADVLKVEVFR.4|NSLPDTVQIR.2|QTVADQVLVGSYC[CAM]VFSNQGGLVHPK.3|QTVADQVLVGSYC[CAM]VFSNQGGLVHPK.4|QTVADQVLVGSYC[CAM]VFSNQGGLVHPK.5|DSLIDSLT.2|LNEAQPSTIATSMR.3|LNEAQPSTIATSMR.2|LNEAQPSTIATSM[Oxi]R.2|ETEEILADVLK.2|LSALGNVTTC[CAM]NDYVALVHPDLDR.4|LSALGNVTTC[CAM]NDYVALVHPDLDR.3|LSALGNVTTC[CAM]NDYVALVHPDLDRETEEILADVLK.5|LSALGNVTTC[CAM]NDYVALVHPDLDRETEEILADVLK.4|LTNTYC[CAM]LVAIGGSENFYSVFEGELSDTIPVVHASIAGC[CAM]R.4|LNEAQPSTIATSMRDSLIDSLT.2
SEN / CTL,Eukaryotic translation initiation factor 3 subunit C,EIF3C,Q99613,0.11,0.76,5.04E-02,2.01E-02,1.70E+00,"formation of translation preinitiation complex,translational initiation,regulation of translational initiation","translation initiation factor binding,poly(A) RNA binding,translation initiation factor activity","cytosol,eukaryotic translation initiation factor 3 complex,eukaryotic 43S preinitiation complex,eukaryotic 48S preinitiation complex",12,47,79,GC[CAM]ILTLVER.2|AKELLGQGLLLR.3|AKELLGQGLLLR.2|RLDEEEEDNEGGEWER.3|RLDEEEEDNEGGEWER.2|DLM[Oxi]LMSHLQDNIQHADPPVQILYNR.4|DLMLM[Oxi]SHLQDNIQHADPPVQILYNR.4|DLMLMSHLQDNIQHADPPVQILYNR.4|DLM[Oxi]LM[Oxi]SHLQDNIQHADPPVQILYNR.4|DLM[Oxi]LMSHLQDNIQHADPPVQILYNR.3|DLMLM[Oxi]SHLQDNIQHADPPVQILYNR.3|DLMLMSHLQDNIQHADPPVQILYNR.3|DFESHITSYK.3|DFESHITSYK.2|EHVVAASK.2|TC[CAM]HSFIINEK.3|TC[CAM]HSFIINEK.2|YNRDFESHITSYK.4|YNRDFESHITSYK.3|YNRDFESHITSYK.2|GTEITHAVVIKK.3|GTEITHAVVIKK.2|RFEELTNLIR.3|RFEELTNLIR.2|MDEEFTK.2|APTTDEDKKAAEK.3|ILHTYYK.2|GTTEEVC[CAM]R.2|LNEILQAR.2|VWDLFPEADKVR.3|DAHNALLDIQSSGR.3|DAHNALLDIQSSGR.2|KIQEESLR.2|VGERQPLLGPPESMREHVVAASK.5|VGERQPLLGPPESMREHVVAASK.4|IMQNTDPHSQEYVEHLK.4|IMQNTDPHSQEYVEHLK.3|QGTYGGYFR.2|QLTPPEGSSK.2|KLNEILQAR.2|SIVDKEGVPR.2|ELLGQGLLLR.2|QPLLLSEDEEDTKR.3|VGERQPLLGPPESMR.3|LGSLVENNER.2|FEELTNLIR.2|GTEITHAVVIK.2|TEPTAQQNLALQLAEK.3|TEPTAQQNLALQLAEK.2|QPLLGPPESMR.2|QPLLGPPESM[Oxi]R.2|VWDLFPEADK.2|C[CAM]LEEFELLGK.2|MIINEELMASLDQPTQTVVMHR.4|M[Oxi]IINEELMASLDQPTQTVVMHR.4|M[Oxi]IINEELMASLDQPTQTVVM[Oxi]HR.3|M[Oxi]IINEELMASLDQPTQTVVMHR.3|MIINEELM[Oxi]ASLDQPTQTVVMHR.3|MIINEELMASLDQPTQTVVM[Oxi]HR.3|MIINEELMASLDQPTQTVVMHR.3|DEAQVC[CAM]AIIER.2|TMVQLGIC[CAM]AFR.2|TM[Oxi]VQLGIC[CAM]AFR.2|ILADLEDYLNELWEDK.3|ILADLEDYLNELWEDK.2|IMQNTDPHSQEYVEHLKDEAQVC[CAM]AIIER.5|IM[Oxi]QNTDPHSQEYVEHLKDEAQVC[CAM]AIIER.4|IMQNTDPHSQEYVEHLKDEAQVC[CAM]AIIER.4|IMQNTDPHSQEYVEHLKDEAQVC[CAM]AIIER.3|QGLTKDAHNALLDIQSSGR.3|QPLLGPPESMREHVVAASK.3|SEQDQAENEGEDSAVLMER.3|SEQDQAENEGEDSAVLM[Oxi]ER.3|SEQDQAENEGEDSAVLMER.2|ILADLEDYLNELWEDKEGK.3|QPLLLSEDEEDTK.2|LDEEEEDNEGGEWER.2|FNIIASLYDYNPNLATYMKPEMWGK.3|QLTPPEGSSKSEQDQAENEGEDSAVLMER.3
SEN / CTL,Ezrin,EZR,P15311,0.11,0.52,8.97E-03,4.90E-03,2.31E+00,"negative regulation of transcription from RNA polymerase II promoter,intestinal D-glucose absorption,sphingosine-1-phosphate signaling pathway,cytoskeletal anchoring at plasma membrane,leukocyte cell-cell adhesion,axon guidance,regulation of cell shape,positive regulation of gene expression,protein kinase A signaling,membrane to membrane docking,microvillus assembly,astral microtubule organization,actin cytoskeleton reorganization,receptor internalization,regulation of microvillus length,cellular protein complex localization,positive regulation of multicellular organism growth,cortical microtubule organization,filopodium assembly,phosphatidylinositol-mediated signaling,positive regulation of protein secretion,negative regulation of T cell receptor signaling pathway,actin filament bundle assembly,establishment of centrosome localization,establishment of endothelial barrier,negative regulation of ERK1 and ERK2 cascade,cellular response to cAMP,protein localization to cell cortex,establishment of protein localization to plasma membrane,positive regulation of establishment of protein localization to plasma membrane,negative regulation of interleukin-2 secretion,regulation of organelle assembly,terminal web assembly,positive regulation of protein localization to early endosome,positive regulation of cellular protein catabolic process,negative regulation of p38MAPK cascade,positive regulation of early endosome to late endosome transport,regulation of cell size,gland morphogenesis,regulation of actin cytoskeleton organization,establishment of epithelial cell apical/basal polarity,regulation of NIK/NF-kappaB signaling","actin binding,protein binding,microtubule binding,protein domain specific binding,protein kinase A catalytic subunit binding,protein kinase A regulatory subunit binding,S100 protein binding,poly(A) RNA binding,cell adhesion molecule binding,actin filament binding,ATPase binding,cadherin binding involved in cell-cell adhesion","ruffle,immunological synapse,uropod,extracellular space,nucleolus,cytoplasm,endosome,cytosol,actin filament,plasma membrane,microvillus,brush border,cell-cell adherens junction,focal adhesion,actin cytoskeleton,membrane,basolateral plasma membrane,apical plasma membrane,extrinsic component of membrane,filopodium,T-tubule,cortical cytoskeleton,microvillus membrane,vesicle,ruffle membrane,ciliary basal body,cell projection,myelin sheath,cell body,microspike,plasma membrane raft,apical part of cell,perinuclear region of cytoplasm,cell tip,extracellular exosome,cell periphery,astrocyte projection,Schwann cell microvillus,cytoplasmic side of apical plasma membrane,TCR signalosome",72,50,90,QRIDEFEAL.2|GMLKDNAMLEYLK.3|GMLKDNAMLEYLK.2|SQEQLAAELAEYTAK.3|SQEQLAAELAEYTAK.2|QLLTLSSELSQARDENKR.4|QLLTLSSELSQAR.2|QLLTLSSELSQAR.3|IALLEEAR.2|DQWEDRIQVWHAEHR.4|DQWEDRIQVWHAEHR.3|AKFYPEDVAEELIQDITQK.3|AKFYPEDVAEELIQDITQK.4|AKFYPEDVAEELIQDITQK.2|AQEEAERLEADRMAALR.4|ELSEQIQR.2|EGILSDEIYC[CAM]PPETAVLLGSYAVQAK.3|EGILSDEIYC[CAM]PPETAVLLGSYAVQAK.4|FYPEDVAEELIQDITQK.3|FYPEDVAEELIQDITQK.2|QAVDQIKSQEQLAAELAEYTAK.3|QAVDQIKSQEQLAAELAEYTAK.4|GTDLWLGVDALGLNIYEKDDKLTPK.4|GTDLWLGVDALGLNIYEKDDKLTPK.3|EVWYFGLHYVDNK.3|EVWYFGLHYVDNK.2|ILQLC[CAM]MGNHELYMR.3|ILQLC[CAM]MGNHELYMR.2|ILQLC[CAM]M[Oxi]GNHELYMR.3|ILQLC[CAM]MGNHELYM[Oxi]R.3|ILQLC[CAM]M[Oxi]GNHELYMR.2|QQLETEK.2|DNAMLEYLK.2|DNAM[Oxi]LEYLK.2|LTRDQWEDR.3|QAVDQIK.2|AKEELERQAVDQIK.4|AKEELERQAVDQIK.3|RKEDEVEEWQHR.4|RKEDEVEEWQHR.3|RTHNDIIHNENMR.4|RTHNDIIHNENM[Oxi]R.4|RTHNDIIHNENMR.3|RTHNDIIHNENM[Oxi]R.3|RTHNDIIHNENMR.2|RITEAEKNER.3|RITEAEKNER.2|ALQLEEERKR.3|SGYLSSER.2|AERELSEQIQR.3|AERELSEQIQR.2|EDEVEEWQHR.3|EDEVEEWQHR.2|KVSAQEVR.2|LQDYEEK.2|AQEEAERLEADR.3|AQEEAERLEADR.2|RILQLC[CAM]MGNHELYMR.4|RILQLC[CAM]M[Oxi]GNHELYMR.4|RILQLC[CAM]MGNHELYMR.3|RILQLC[CAM]M[Oxi]GNHELYMR.3|RILQLC[CAM]MGNHELYM[Oxi]R.3|ALQLEEER.2|KAERELSEQIQR.3|KEDEVEEWQHR.3|KEDEVEEWQHR.2|SGYLSSERLIPQR.3|THNDIIHNENMR.3|THNDIIHNENM[Oxi]R.3|THNDIIHNENM[Oxi]R.2|THNDIIHNENMR.2|RAQEEAERLEADR.3|IALLEEARR.2|ITEAEKNER.2|AKEAQDDLVK.2|ALQLEEERK.2|IQVWHAEHR.2|FGDYNKEVHK.2|QLLTLSSELSQARDENK.3|IAQDLEMYGINYFEIK.3|IAQDLEM[Oxi]YGINYFEIK.3|IAQDLEM[Oxi]YGINYFEIK.2|IAQDLEMYGINYFEIK.2|GTDLWLGVDALGLNIYEK.3|GTDLWLGVDALGLNIYEK.2|KGTDLWLGVDALGLNIYEK.3|KGTDLWLGVDALGLNIYEK.2|GTDLWLGVDALGLNIYEKDDK.3|GTDLWLGVDALGLNIYEKDDK.2|KGTDLWLGVDALGLNIYEKDDK.3
SEN / CTL,"Glycogen phosphorylase, liver form",PYGL,P06737,0.10,0.28,1.13E-03,8.38E-04,3.08E+00,"glycogen metabolic process,glycogen catabolic process,5-phosphoribose 1-diphosphate biosynthetic process,glucose homeostasis,necroptotic process","purine nucleobase binding,protein binding,ATP binding,glucose binding,drug binding,glycogen phosphorylase activity,AMP binding,vitamin binding,pyridoxal phosphate binding,bile acid binding,protein homodimerization activity","cytoplasm,cytosol,plasma membrane,extracellular exosome",36,51,80,LHSFLGDDVFLR.3|LHSFLGDDVFLR.2|IFVDIEKLPWSK.3|IFVDIEKLPWSK.2|IRDGWQVEEADDWLR.3|IRDGWQVEEADDWLR.2|SRPEFMLPVHFYGK.4|SRPEFMLPVHFYGK.3|SRPEFM[Oxi]LPVHFYGK.3|VIPATDLSEQISTAGTEASGTGNMK.3|VIPATDLSEQISTAGTEASGTGNM[Oxi]K.3|IGEDYVKDLSQLTK.3|LITSVADVVNNDPMVGSK.3|LITSVADVVNNDPMVGSK.2|LITSVADVVNNDPM[Oxi]VGSK.3|LITSVADVVNNDPM[Oxi]VGSK.2|GIVGVENVAELKK.3|GIVGVENVAELKK.2|QLLNC[CAM]LHVITMYNR.3|QLLNC[CAM]LHVITMYNR.2|TIKEYAQNIWNVEPSDLK.3|TIKEYAQNIWNVEPSDLK.2|IHSDIVK.2|IGEDYVK.2|IVALFPKDVDR.3|AWELTQK.2|LHSFLGDDVFLRELAK.4|LHSFLGDDVFLRELAK.3|HLEIIYEINQK.3|HLEIIYEINQK.2|APNDFNLR.2|AWNTMVLK.2|DIINMLFYHDR.3|DIINMLFYHDR.2|IDDVAALDK.2|RMSLIEEEGSKR.3|ISLSNESNK.2|VFKDFSELEPDKFQNK.4|VFKDFSELEPDKFQNK.3|WPVDLVEK.2|INMAHLC[CAM]IVGSHAVNGVAK.4|INMAHLC[CAM]IVGSHAVNGVAK.3|INMAHLC[CAM]IVGSHAVNGVAK.2|LVIDQIDNGFFSPK.3|LVIDQIDNGFFSPK.2|DFSELEPDKFQNK.3|DFSELEPDKFQNK.2|DFNVGDYIQAVLDR.3|DFNVGDYIQAVLDR.2|DFSELEPDK.2|DGWQVEEADDWLR.3|DGWQVEEADDWLR.2|VSQLYMNPK.2|VSQLYM[Oxi]NPK.2|MSLIEEEGSK.2|YEYGIFNQK.2|YEYGIFNQK.1|EYAQNIWNVEPSDLK.3|EYAQNIWNVEPSDLK.2|VFADYEAYVK.2|GIVGVENVAELK.2|WLLLC[CAM]NPGLAELIAEK.3|WLLLC[CAM]NPGLAELIAEK.2|TFAYTNHTVLPEALER.3|TFAYTNHTVLPEALER.2|EYYEALPELK.2|MSLIEEEGSKR.2|RMSLIEEEGSK.2|FSQFLETEYK.2|RWLLLC[CAM]NPGLAELIAEK.3|RWLLLC[CAM]NPGLAELIAEK.2|INPSSMFDVQVK.2|ISLSNESNKVNGN.2|TFAYTNHTVLPEALERWPVDLVEK.4|C[CAM]QDKVSQLYMNPK.2|GAGTVFDAFPDQVAIQLNDTHPALAIPELMR.4|GAGTVFDAFPDQVAIQLNDTHPALAIPELMR.3|APNDFNLRDFNVGDYIQAVLDR.3|APNDFNLRDFNVGDYIQAVLDRNLAENISR.4|WIDTQVVLALPYDTPVPGYMNNTVNTMR.3
SEN / CTL,Vacuolar protein sorting-associated protein 35,VPS35,Q96QK1,0.10,0.63,9.09E-02,3.32E-02,1.48E+00,"intracellular protein transport,Wnt signaling pathway,regulation of macroautophagy,regulation of protein stability,retrograde transport, endosome to Golgi,transcytosis,positive regulation of dopamine receptor signaling pathway,positive regulation of Wnt protein secretion,positive regulation of canonical Wnt signaling pathway,neurotransmitter receptor transport, endosome to plasma membrane,negative regulation of late endosome to lysosome transport,retrograde transport, endosome to plasma membrane","protein binding,protein transporter activity,D1 dopamine receptor binding","lysosomal membrane,endosome,early endosome,late endosome,cytosol,endosome membrane,retromer complex,retromer, cargo-selective complex,extracellular exosome,tubular endosome",27,41,64,NIIIALIDR.2|IRFTLPPLVFAAYQLAFR.3|SEDPDQQYLILNTAR.2|SEDPDQQYLILNTAR.3|AVSTC[CAM]AHLFWSGR.3|AVSTC[CAM]AHLFWSGR.2|LFDIFSQQVATVIQSR.3|LFDIFSQQVATVIQSR.2|LLKIPVDTYNNILTVLK.3|LLKIPVDTYNNILTVLK.2|YKQIVLTGILEQVVNC[CAM]R.3|KDILKDLVEMC[CAM]R.3|LSQLEGVNVER.3|LSQLEGVNVER.2|HFHNTLEHLR.3|HFHNTLEHLR.2|VQSFQMK.2|AC[CAM]AELHQNVNVK.3|AC[CAM]AELHQNVNVK.2|HFHPLFEYFDYESR.4|HFHPLFEYFDYESR.3|HFHPLFEYFDYESR.2|C[CAM]FSEENHEPLR.3|C[CAM]FSEENHEPLR.2|TQC[CAM]ALAASK.2|LALFAHREDGPGIPADIK.4|LALFAHREDGPGIPADIK.3|LNLEHIATSSAVSK.3|LNLEHIATSSAVSK.2|ILVGTNLVR.2|AELAELPLR.2|HFHPLFEYFDYESRK.4|HFHPLFEYFDYESRK.3|KVADLYELVQYAGNIIPR.4|KVADLYELVQYAGNIIPR.3|IFSFAHQTISALIK.3|IFSFAHQTISALIK.2|AQLAAITLIIGTFER.3|AQLAAITLIIGTFER.2|IPVDTYNNILTVLK.3|IPVDTYNNILTVLK.2|NYLLQC[CAM]TR.2|LLDEAIQAVK.2|EDGPGIPADIK.2|HASNMLGELR.2|HASNM[Oxi]LGELR.2|QIVLTGILEQVVNC[CAM]R.3|QIVLTGILEQVVNC[CAM]R.2|C[CAM]FSEENHEPLRTQC[CAM]ALAASK.4|IREDLPNLESSEETEQINKHFHNTLEHLR.6|IREDLPNLESSEETEQINKHFHNTLEHLR.5|ENDAVTIQVLNQLIQK.3|ENDAVTIQVLNQLIQK.2|VADLYELVQYAGNIIPR.3|VADLYELVQYAGNIIPR.2|VLETTVEIFNK.2|VLETTVEIFNKLNLEHIATSSAVSK.4|IREDLPNLESSEETEQINK.3|IREDLPNLESSEETEQINK.2|PTTQQSPQDEQEK.2|QDMPSEDVVSLQVSLINLAMK.3|ESPESEGPIYEGLIL.2|PTTQQSPQDEQEKLLDEAIQAVK.3|EDLPNLESSEETEQINK.2
SEN / CTL,Basement membrane-specific heparan sulfate proteoglycan core protein,HSPG2,P98160,0.09,0.82,9.15E-03,4.97E-03,2.30E+00,"retinoid metabolic process,angiogenesis,glycosaminoglycan biosynthetic process,glycosaminoglycan catabolic process,extracellular matrix disassembly,extracellular matrix organization,glycosaminoglycan metabolic process,lipoprotein metabolic process,cellular protein metabolic process","calcium ion binding,protein binding,protein C-terminus binding","extracellular region,basement membrane,extracellular space,Golgi lumen,plasma membrane,focal adhesion,extracellular matrix,lysosomal lumen,extracellular exosome",390,163,239,LLSGPYFWSLPSR.2|LLSGPYFWSLPSR.3|AGLSSGFIGC[CAM]VR.2|LLQVTPADSGEYVC[CAM]R.2|LLQVTPADSGEYVC[CAM]R.3|LHLVSPADSGEYVC[CAM]R.3|LHLVSPADSGEYVC[CAM]R.2|IAHVELADAGQYR.3|IAHVELADAGQYR.2|FLGDKVTSYGGELR.3|FLGDKVTSYGGELR.2|LPAVEPTDQAQYLC[CAM]R.2|LPAVEPTDQAQYLC[CAM]R.3|LYIFQASPADAGQYVC[CAM]R.2|LYIFQASPADAGQYVC[CAM]R.3|AAGVPSATITWR.2|YELGSGLAVLR.2|HLISTHFAPGDFQGFALVNPQR.4|HLISTHFAPGDFQGFALVNPQR.3|LYQASPADSGEYVC[CAM]R.3|LYQASPADSGEYVC[CAM]R.2|EHLLMALAGIDTLLIR.3|EHLLMALAGIDTLLIR.2|EHLLM[Oxi]ALAGIDTLLIR.3|VISSGSVASYVTSPQGFQFR.3|VISSGSVASYVTSPQGFQFR.2|FSSGITGC[CAM]VK.2|C[CAM]LC[CAM]LPGFSGPR.2|C[CAM]LIHDGAAPISLEWK.3|FLVHDSFWALPEQFLGNKVDSYGGSLR.4|SIGASVEFHC[CAM]AVPSDR.3|SIGASVEFHC[CAM]AVPSDR.2|LRSPVISIDPPSSTVQQGQDASFK.3|AVTLEC[CAM]VSAGEPR.2|SGPVEDFVSLAMVGGHLEFR.3|IQNLDQSC[CAM]QGTYIC[CAM]QAHGPWGK.3|LVSEDPINDGEWHR.3|VPAGSAAVFPC[CAM]IASGYPTPDISWSK.3|SPLPWQHRLEGDTLIIPR.4|TPSGLYLGTC[CAM]ER.2|LEGDTLIIPR.2|LRLPQVSPADSGEYVC[CAM]RVENGSGPK.4|VAEGQTLDLK.2|HPTPLALGHFHTVTLLR.4|SPAYTLVWTR.2|LRSPLPWQHRLEGDTLIIPR.5|QPQAIITWYK.2|QVQFSEEHWVHESGRPVQR.4|C[CAM]PIGYSGLSC[CAM]ESC[CAM]DAHFTR.3|EFREVSEAVVDTLESEYLK.3|IPGDQVVSVVFIK.2|RGSIQVDGEELVSGR.2|EHLLMALADLDELLIR.3|EHLLMALADLDELLIR.2|EHLLM[Oxi]ALADLDELLIR.3|VVPYFTQTPYSFLPLPTIK.3|VVPYFTQTPYSFLPLPTIK.2|VGGHLRPGIVQSGGVVR.4|VGGHLRPGIVQSGGVVR.3|VVGSSGTQEASVLVTIQQR.3|VVGSSGTQEASVLVTIQQR.2|AMDFNGILTIR.2|AM[Oxi]DFNGILTIR.2|LGTVPQFPR.2|AHSVEEC[CAM]RC[CAM]PIGYSGLSC[CAM]ESC[CAM]DAHFTR.5|AHSVEEC[CAM]RC[CAM]PIGYSGLSC[CAM]ESC[CAM]DAHFTR.4|QPDFISFGLVGGRPEFR.3|RFSDTC[CAM]FLDTDGQATC[CAM]DAC[CAM]APGYTGRR.4|ATATSC[CAM]RPC[CAM]PC[CAM]PYIDASR.3|ESDQGAYTC[CAM]EAMNAR.2|LRIPQVTPADSGEYVC[CAM]HVSNGAGSR.4|LRIPQVTPADSGEYVC[CAM]HVSNGAGSR.3|SQSVRPGADVTFIC[CAM]TAK.3|SQSVRPGADVTFIC[CAM]TAK.2|LC[CAM]NEC[CAM]ADGSFHLSTR.3|LC[CAM]NEC[CAM]ADGSFHLSTR.2|SKSPAYTLVWTR.3|SKSPAYTLVWTR.2|RFLVHDSFWALPEQFLGNKVDSYGGSLR.5|RFLVHDSFWALPEQFLGNKVDSYGGSLR.4|AQLHGASEEPGHFSLTNAASTHTTNEGIFSPTPGELGFSSFHR.6|AQLHGASEEPGHFSLTNAASTHTTNEGIFSPTPGELGFSSFHR.5|AQLHGASEEPGHFSLTNAASTHTTNEGIFSPTPGELGFSSFHR.7|AQLHGASEEPGHFSLTNAASTHTTNEGIFSPTPGELGFSSFHR.4|VLGSSVPLEASVLVTIEPAGSVPALGVTPTVR.4|VLGSSVPLEASVLVTIEPAGSVPALGVTPTVR.3|HQGSELHFPSVQPSDAGVYIC[CAM]TC[CAM]R.4|HQGSELHFPSVQPSDAGVYIC[CAM]TC[CAM]R.3|ALEVEEC[CAM]RC[CAM]PPGYIGLSC[CAM]QDC[CAM]APGYTR.3|FQGLDLNEELYLGGYPDYGAIPK.3|SIGASVEFHC[CAM]AVPSDRGTQLR.4|SIGASVEFHC[CAM]AVPSDRGTQLR.3|SIVPQGGSHSLR.3|RC[CAM]ESC[CAM]APGYEGNPIQPGGK.3|AQASAQLVIQALPSVLINIR.3|AQASAQLVIQALPSVLINIR.2|RVPGSPTNLANRQPDFISFGLVGGRPEFR.5|RVPGSPTNLANRQPDFISFGLVGGRPEFR.4|AQIHGGILRLPAVEPTDQAQYLC[CAM]R.4|AQIHGGILRLPAVEPTDQAQYLC[CAM]R.3|C[CAM]VASNAYGVAQSVVNLSVHGPPTVSVLPEGPVWVK.4|C[CAM]VASNAYGVAQSVVNLSVHGPPTVSVLPEGPVWVK.5|LDVEFKPLAPDGVLLFSGGK.3|LDVEFKPLAPDGVLLFSGGK.2|SQPGSTPLHGQPLVVLQGNNIILEHHVAQEPSPGQPSTFIVPFR.5|SQPGSTPLHGQPLVVLQGNNIILEHHVAQEPSPGQPSTFIVPFR.6|SQPGSTPLHGQPLVVLQGNNIILEHHVAQEPSPGQPSTFIVPFR.4|ITFRPDSADGMLLYNGQK.3|ITFRPDSADGM[Oxi]LLYNGQK.3|C[CAM]QVSGSPPHYFYWSR.3|C[CAM]QVSGSPPHYFYWSR.2|LRLPQVSPADSGEYVC[CAM]R.3|LRLPQVSPADSGEYVC[CAM]R.2|SPVISIDPPSSTVQQGQDASFK.3|SPVISIDPPSSTVQQGQDASFK.2|AAGVPSATITWRK.3|AAGVPSATITWRK.2|C[CAM]SATGSPTPTLEWTGGPGGQLPAK.3|C[CAM]SATGSPTPTLEWTGGPGGQLPAK.2|FDAGSGMATIR.2|FDAGSGM[Oxi]ATIR.2|LHQMSVADSGEYVC[CAM]R.3|LHQMSVADSGEYVC[CAM]R.2|LHQM[Oxi]SVADSGEYVC[CAM]R.2|GMVFGIPDGVLELVPQR.3|GM[Oxi]VFGIPDGVLELVPQR.3|GMVFGIPDGVLELVPQR.2|GM[Oxi]VFGIPDGVLELVPQR.2|LRLLQVTPADSGEYVC[CAM]R.3|TC[CAM]ESLGAGGYR.2|LRLHHVSPADSGEYVC[CAM]R.4|LRLHHVSPADSGEYVC[CAM]R.3|LRLHHVSPADSGEYVC[CAM]R.5|MASVGLSDIAMDTTVTHATSHGR.4|M[Oxi]ASVGLSDIAMDTTVTHATSHGR.4|M[Oxi]ASVGLSDIAM[Oxi]DTTVTHATSHGR.4|C[CAM]TATNAAGTTQSHVLLLVQALPQISMPQEVR.4|C[CAM]TATNAAGTTQSHVLLLVQALPQISMPQEVR.5|C[CAM]TATNAAGTTQSHVLLLVQALPQISMPQEVR.3|SIEYSPQLEDAGSR.2|SIEYSPQLEDAGSR.3|GQTVTFTC[CAM]VAIGVPTPIINWR.3|GQTVTFTC[CAM]VAIGVPTPIINWR.2|VVPYFTQTPYSFLPLPTIKDAYR.3|AELLVTEAPSKPITVTVEEQR.3|AELLVTEAPSKPITVTVEEQR.4|AELLVTEAPSKPITVTVEEQR.2|RFSDTC[CAM]FLDTDGQATC[CAM]DAC[CAM]APGYTGR.3|VKAFAHLQVPER.3|VISSGSVASYVTSPQGFQFRR.3|VISSGSVASYVTSPQGFQFRR.4|C[CAM]APGYYGNPSQGQPC[CAM]QR.2|SAEPLALGR.2|C[CAM]FC[CAM]MGVSR.2|IQVVVLSASDASPPPVK.3|IQVVVLSASDASPPPVK.2|LHHVSPADSGEYVC[CAM]R.4|LHHVSPADSGEYVC[CAM]R.3|EVSEAVVDTLESEYLK.3|EVSEAVVDTLESEYLK.2|RGGSLPAR.2|ISSTPAKLEQR.3|ISSTPAKLEQR.2|VQVSPER.2|C[CAM]RPVNQEIVR.3|RVPGSPTNLANR.3|RVPGSPTNLANR.2|LNWGHIPSHPR.3|RGGSLPSHHQTR.3|VTVTSEGGR.2|GHTPTQPGALNQR.3|GHTPTQPGALNQR.2|RGGSLPVRHQTHGSLLR.4|EDGRPVPSGTQQR.3|VDSYGGSLR.2|AGFFGDAM[Oxi]K.2|AQIHGGILR.2|GGSLPSRHQIVGSR.3|LSGSHSQGVAYPVR.3|LSGSHSQGVAYPVR.2|VAEGQTLDLKC[CAM]VVPGQAHAQVTWHKR.6|VAEGQTLDLKC[CAM]VVPGQAHAQVTWHKR.4|RPEEVC[CAM]GPTQFR.3|VTSYGGELR.2|ALEVEEC[CAM]R.2|RPDGQPATR.2|EGGSLPPQAR.2|PGAPPPQPLDLQHR.3|HQTHGSLLR.2|LDGSLPPDSR.2|RGGSLPPHTQVHGSR.3|C[CAM]SATGSPAPTIHWSK.3|C[CAM]SATGSPAPTIHWSK.2|EQAWQRPDGQPATR.3|GC[CAM]VGEVSVNGK.2|WFKEGGQLPPGHSVQDGVLR.4|AHSSAGQQVAR.2|HC[CAM]TSSSWSR.2|VAEGQTLDLKC[CAM]VVPGQAHAQVTWHK.5|GSM[Oxi]GTSGEAC[CAM]R.2|DFISLGLQDGHLVFR.3|GGSLPVRHQTHGSLLR.3|RPDGQPATREHLLM[Oxi]ALADLDELLIR.5|RPDGQPATREHLLMALADLDELLIR.4|RPDGQPATREHLLM[Oxi]ALADLDELLIR.4|SYEIM[Oxi]FREEFWR.3|AELLVTEAPSK.2|AVLHVHGGGGPR.2|RFLVHDSFWALPEQFLGNK.4|RFLVHDSFWALPEQFLGNK.3|AFAHLQVPER.2|EGGQLPPGHSVQDGVLR.3|ASYAQQPAESR.2|EASITVSVLHGTHSGPSYTPVPGSTRPIR.5|AQAGANTRPC[CAM]PS.2|IEPSSSHVAEGQTLDLNC[CAM]VVPGQAHAQVTWHKR.6|LRFDQPDDFK.2|IEPSSSHVAEGQTLDLNC[CAM]VVPGQAHAQVTWHK.5|IEPSSSHVAEGQTLDLNC[CAM]VVPGQAHAQVTWHK.4|VVPYFTQTPYSFLPLPTIKDAYRK.4|FLVHDSFWALPEQFLGNK.3|ATARNELLHFER.2|ATFSSVPLAASISAVSLEVAQPGPSNRPR.4|ATFSSVPLAASISAVSLEVAQPGPSNRPR.3|FLGDKVTSYGGELRFTVTQR.3|GPSC[CAM]QDC[CAM]DTGYTR.2|VPGSPTNLANRQPDFISFGLVGGRPEFR.4|AFAHLQVPERVVPYFTQTPYSFLPLPTIKDAYR.5|IESSSPTVVEGQTLDLNC[CAM]VVAR.3|IESSSPTVVEGQTLDLNC[CAM]VVAR.2|ETSLIVTIQGSGSSHVPSVSPPIR.3|TSVQTVVVGHAVEFEC[CAM]LALGDPKPQVTWSK.4|AASGPGPEQEASFTVTVPPSEGSSYR.3|C[CAM]EQC[CAM]QPGYYGDAQR.2|IESSSASLANGHTLDLNC[CAM]LVASQAPHTITWYK.4|GPC[CAM]PDGHFYLEHSAAC[CAM]LPC[CAM]FC[CAM]FGITSVC[CAM]QSTR.4|TYGLMDSHAVLQISSAKPSDAGTYVC[CAM]LAQNALGTAQK.4|LENNMLMLPSVRPQDAGTYVC[CAM]TATNR.3|LTGEFTVEPVPEGAQLSFGNFAQLGHESFYWQLPETYQGDK.4
SEN / CTL,Protein disulfide-isomerase A6,PDIA6,Q15084,0.09,0.23,3.97E-04,3.40E-04,3.47E+00,"protein folding,response to endoplasmic reticulum stress,IRE1-mediated unfolded protein response,apoptotic cell clearance,cell redox homeostasis","protein disulfide isomerase activity,protein binding","endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum membrane,endoplasmic reticulum-Golgi intermediate compartment,plasma membrane,endoplasmic reticulum chaperone complex,melanosome,extracellular exosome",69,32,56,TGEAIVDAALSALR.2|TGEAIVDAALSALR.3|NSYLEVLLK.2|GSFSEQGINEFLR.2|GSFSEQGINEFLR.3|VKLAAVDATVNQVLASR.3|VKLAAVDATVNQVLASR.2|TC[CAM]EEHQLC[CAM]VVAVLPHILDTGAAGR.4|TC[CAM]EEHQLC[CAM]VVAVLPHILDTGAAGR.3|ALDLFSDNAPPPELLEIINEDIAKR.3|ALDLFSDNAPPPELLEIINEDIAKR.4|VGAVDADKHHSLGGQYGVQGFPTIK.4|VGAVDADKHHSLGGQYGVQGFPTIK.5|VGAVDADKHHSLGGQYGVQGFPTIK.3|VGAVDADKHHSLGGQYGVQGFPTIK.6|LAAVDATVNQVLASR.2|LAAVDATVNQVLASR.3|NLEPEWAAAASEVKEQTK.3|NLEPEWAAAASEVKEQTK.2|ALDLFSDNAPPPELLEIINEDIAK.3|ALDLFSDNAPPPELLEIINEDIAK.4|NLEPEWAAAASEVK.2|NLEPEWAAAASEVK.3|IFQKGESPVDYDGGR.3|IFQKGESPVDYDGGR.2|RTC[CAM]EEHQLC[CAM]VVAVLPHILDTGAAGR.4|RTC[CAM]EEHQLC[CAM]VVAVLPHILDTGAAGR.5|RTC[CAM]EEHQLC[CAM]VVAVLPHILDTGAAGR.3|NRPEDYQGGRTGEAIVDAALSALR.4|NSYLEVLLKLADKYK.4|NSYLEVLLKLADKYK.3|HHSLGGQYGVQGFPTIK.4|HHSLGGQYGVQGFPTIK.3|HHSLGGQYGVQGFPTIK.2|AATALKDVVK.2|KDVIELTDDSFDK.3|KDVIELTDDSFDK.2|TGEAIVDAALSALRQLVKDR.4|GSTAPVGGGAFPTIVER.3|GSTAPVGGGAFPTIVER.2|GESPVDYDGGR.2|GSTAPVGGGAFPTIVEREPWDGR.4|GSTAPVGGGAFPTIVEREPWDGR.3|NRPEDYQGGR.2|TGEAIVDAALSALRQLVK.3|DVIELTDDSFDK.2|SDSSSKKDVIELTDDSFDK.3|EVIQSDSLWLVEFYAPWC[CAM]GHC[CAM]QR.4|EVIQSDSLWLVEFYAPWC[CAM]GHC[CAM]QR.3|GSFSEQGINEFLRELSFGR.3|DGELPVEDDIDLSDVELDDLGK.3|EPWDGRDGELPVEDDIDLSDVELDDLGKDEL.4|EPWDGRDGELPVEDDIDLSDVELDDLGKDEL.3|NVLDSEDVWMVEFYAPWC[CAM]GHC[CAM]K.3|NVLDSEDVWM[Oxi]VEFYAPWC[CAM]GHC[CAM]K.3|DGELPVEDDIDLSDVELDDLGKDEL.3
SEN / CTL,Rho GDP-dissociation inhibitor 1,ARHGDIA,P52565,0.09,0.40,3.23E-04,2.84E-04,3.55E+00,"movement of cell or subcellular component,negative regulation of cell adhesion,regulation of Rho protein signal transduction,negative regulation of apoptotic process,positive regulation of GTPase activity,negative regulation of axonogenesis,positive regulation of axonogenesis,regulation of small GTPase mediated signal transduction,semaphorin-plexin signaling pathway,regulation of actin cytoskeleton reorganization","Rho GDP-dissociation inhibitor activity,GTPase activator activity,protein binding","cytosol,cytoskeleton,extracellular exosome",57,15,29,AEEYEFLTPVEEAPK.2|AEEYEFLTPVEEAPK.3|SIQEIQELDKDDESLR.3|SIQEIQELDKDDESLR.2|QSFVLKEGVEYR.3|QSFVLKEGVEYR.2|SIQEIQELDKDDESLRK.4|SIQEIQELDKDDESLRK.3|SIQEIQELDKDDESLRK.2|VAVSADPNVPNVVVTGLTLVC[CAM]SSAPGPLELDLTGDLESFKK.5|VAVSADPNVPNVVVTGLTLVC[CAM]SSAPGPLELDLTGDLESFKK.4|VAVSADPNVPNVVVTGLTLVC[CAM]SSAPGPLELDLTGDLESFKK.6|IDKTDYMVGSYGPR.3|IDKTDYMVGSYGPR.2|IDKTDYM[Oxi]VGSYGPR.3|SRFTDDDKTDHLSWEWNLTIK.5|SRFTDDDKTDHLSWEWNLTIK.4|IDKTDYMVGSYGPRAEEYEFLTPVEEAPK.4|GVKIDKTDYMVGSYGPR.4|FTDDDKTDHLSWEWNLTIK.4|FTDDDKTDHLSWEWNLTIK.3|FTDDDKTDHLSWEWNLTIK.2|YIQHTYR.2|FTDDDKTDHLSWEWNLTIKK.5|FTDDDKTDHLSWEWNLTIKK.4|SIQEIQELDK.2|TDYMVGSYGPR.2|TDYM[Oxi]VGSYGPR.2|AEEYEFLTPVEEAPKGM[Oxi]LAR.3
SEN / CTL,Collagen alpha-1(XVIII) chain,COL18A1,P39060,0.08,0.36,1.11E-01,3.86E-02,1.41E+00,"angiogenesis,endothelial cell morphogenesis,cell adhesion,visual perception,positive regulation of cell proliferation,negative regulation of cell proliferation,animal organ morphogenesis,extracellular matrix organization,positive regulation of cell migration,collagen catabolic process,response to drug,response to hydrostatic pressure,positive regulation of endothelial cell apoptotic process","structural molecule activity,metal ion binding","extracellular region,collagen trimer,basement membrane,extracellular space,endoplasmic reticulum lumen,extracellular matrix,extracellular exosome",60,31,46,LQDLYSIVR.2|IFSFDGKDVLR.3|DELLFPSWEALFSGSEGPLKPGAR.3|TEAPSATGQASSLLGGR.2|TEAPSATGQASSLLGGR.3|GLELEPGAGLFVAQAGGADPDKFQGVIAELK.3|GLELEPGAGLFVAQAGGADPDKFQGVIAELK.4|AVGLAGTFR.2|ISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVAR.4|ELLREETGAALKPR.3|LTESYC[CAM]ETWR.2|RLTESYC[CAM]ETWRTEAPSATGQASSLLGGR.4|AAVPIVNLKDELLFPSWEALFSGSEGPLKPGAR.4|AAVPIVNLKDELLFPSWEALFSGSEGPLKPGAR.5|AAVPIVNLKDELLFPSWEALFSGSEGPLKPGAR.6|AAVPIVNLKDELLFPSWEALFSGSEGPLKPGAR.3|GTDNEVAALQPPVVQLHDSNPYPR.3|GTDNEVAALQPPVVQLHDSNPYPR.4|GADFQC[CAM]FQQAR.2|GADFQC[CAM]FQQAR.3|DFQPVLHLVALNSPLSGGMR.3|DFQPVLHLVALNSPLSGGM[Oxi]R.3|DFQPVLHLVALNSPLSGGMR.2|QAMLGQVHEVPEGWLIFVAEQEELYVR.3|SVWHGSDPNGR.3|SVWHGSDPNGR.2|YHFPSLFFR.3|HPTWPQK.2|AAVPIVNLK.2|FQGVIAELK.2|ADDILASPPR.2|EETGAALKPR.2|GIRGADFQC[CAM]FQQAR.3|AFLSSRLQDLYSIVR.3|LSGVQDGHQDISLLYTEPGAGQTHTAASFR.5|LSGVQDGHQDISLLYTEPGAGQTHTAASFR.4|LSGVQDGHQDISLLYTEPGAGQTHTAASFR.3|GTDNEVAALQPPVVQLHDSNPYPRR.4|GLELEPGAGLFVAQAGGADPDK.3|GLELEPGAGLFVAQAGGADPDK.2|LTESYC[CAM]ETWRTEAPSATGQASSLLGGR.4|LTESYC[CAM]ETWRTEAPSATGQASSLLGGR.3|RLTESYC[CAM]ETWR.2|GPPGPQGPPGPPGPSFR.2|GLELEPGAGLFVAQAGGADPDKFQGVIAELKVR.4|GLELEPGAGLFVAQAGGADPDKFQGVIAELKVR.3
SEN / CTL,26S proteasome non-ATPase regulatory subunit 11,PSMD11,O00231,0.08,0.61,2.20E-03,1.50E-03,2.82E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,ubiquitin-dependent protein catabolic process,regulation of cellular amino acid metabolic process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,proteasome assembly,regulation of mRNA stability,stem cell differentiation,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway",structural molecule activity,"proteasome complex,nucleus,nucleoplasm,cytosol,proteasome regulatory particle, lid subcomplex,membrane,proteasome accessory complex,extracellular exosome",27,33,53,YQEALHLGSQLLR.3|YQEALHLGSQLLR.2|AQSLLSTDREASIDILHSIVKR.4|AQSLLSTDREASIDILHSIVKR.5|AQSLLSTDREASIDILHSIVKR.3|LYDNLLEQNLIR.2|LYDNLLEQNLIR.3|ALTDYRAELRDDPIISTHLAK.4|ALTDYRAELRDDPIISTHLAK.3|VQIEHISSLIK.3|VQIEHISSLIK.2|EQSILELGSLLAK.2|TGQAAELGGLLK.2|SLADFEK.2|KLSQMILDKK.3|AELRDDPIISTHLAK.4|AELRDDPIISTHLAK.3|RYQEALHLGSQLLR.4|RYQEALHLGSQLLR.3|RYQEALHLGSQLLR.2|EASIDILHSIVK.3|EASIDILHSIVK.2|YVRPFLNSISK.3|ALLVEVQLLESK.3|ALLVEVQLLESK.2|VVDSLYNK.2|LSQMILDK.2|LSQM[Oxi]ILDK.2|AQSLLSTDR.2|EASIDILHSIVKR.3|EASIDILHSIVKR.2|KLSQMILDK.2|TYEAALETIQNMSK.3|TYEAALETIQNMSK.2|LVSLYFDTK.2|RDIQENDEEAVQVK.3|RDIQENDEEAVQVK.2|AQSLLSTDREASIDILHSIVK.4|AQSLLSTDREASIDILHSIVK.3|IMLNTPEDVQALVSGK.3|IMLNTPEDVQALVSGK.2|IM[Oxi]LNTPEDVQALVSGK.2|TYHALSNLPK.2|LQATLDMQSGIIHAAEEKDWK.4|DDPIISTHLAK.2|TTANAIYC[CAM]PPK.2|KFHGILDQGEGVLIIFDEPPVDK.4|LQATLDMQSGIIHAAEEK.3|LQATLDMQSGIIHAAEEK.2|DIQENDEEAVQVK.2|TAYSYFYEAFEGYDSIDSPK.3|TAYSYFYEAFEGYDSIDSPK.2|FHGILDQGEGVLIIFDEPPVDK.3
SEN / CTL,Urokinase-type plasminogen activator,PLAU,P00749,0.07,0.24,1.21E-01,4.17E-02,1.38E+00,"response to hypoxia,proteolysis,chemotaxis,signal transduction,blood coagulation,regulation of receptor activity,smooth muscle cell migration,regulation of smooth muscle cell migration,positive regulation of cell migration,regulation of cell adhesion mediated by integrin,regulation of cell proliferation,fibrinolysis,regulation of wound healing,regulation of smooth muscle cell-matrix adhesion","serine-type endopeptidase activity,protein binding","extracellular region,extracellular space,plasma membrane,focal adhesion,cell surface,extracellular exosome",12,6,7,IIGGEFTTIENQPWFAAIYR.3|VSHFLPWIR.2|DYSADTLAHHNDIALLK.4|DYSADTLAHHNDIALLK.3|SRLNSNTQGEMKFEVENLILHK.5|SHTKEENGLAL.2|YFSNIHWC[CAM]NC[CAM]PK.2
SEN / CTL,Plastin-3,PLS3,P13797,0.05,0.49,5.61E-02,2.22E-02,1.65E+00,"actin filament bundle assembly,actin filament network formation,actin crosslink formation,bone development","calcium ion binding,actin filament binding","cytoplasm,actin filament,actin filament bundle",33,45,74,AYFHLLNQIAPK.3|AYFHLLNQIAPK.2|VYALPEDLVEVKPK.3|VYALPEDLVEVKPK.2|MVMTVFAC[CAM]LMGR.2|M[Oxi]VMTVFAC[CAM]LMGR.2|MINLSVPDTIDER.2|MINLSVPDTIDER.3|M[Oxi]INLSVPDTIDER.2|TISSSLAVVDLIDAIQPGC[CAM]INYDLVK.3|TISSSLAVVDLIDAIQPGC[CAM]INYDLVK.4|QFVTPADVVSGNPK.2|QFVTPADVVSGNPK.3|NWMNSLGVNPHVNHLYADLQDALVILQLYER.4|LTPFIIQENLNLALNSASAIGC[CAM]HVVNIGAEDLR.4|LTPFIIQENLNLALNSASAIGC[CAM]HVVNIGAEDLR.3|LMLDGDR.2|RAESMLQQADK.3|RAESMLQQADK.2|RAESM[Oxi]LQQADK.2|STSIQSFK.2|INNFSADIKDSK.3|INNFSADIKDSK.2|LENC[CAM]NYAVELGKHPAK.4|LENC[CAM]NYAVELGKHPAK.3|NEALAALLR.2|SGNLTEDDK.2|KLENC[CAM]NYAVELGKHPAK.4|KLENC[CAM]NYAVELGKHPAK.3|AVGDGIVLC[CAM]K.2|INNFSADIK.2|SGNLTEDDKHNNAK.3|AESMLQQADKLGC[CAM]R.3|WANFHLENSGWQK.3|WANFHLENSGWQK.2|HVIPM[Oxi]NPNTDDLFK.3|HVIPMNPNTDDLFK.3|HVIPMNPNTDDLFK.2|AESMLQQADK.2|AESM[Oxi]LQQADK.2|EANMPLPGYK.2|EANM[Oxi]PLPGYK.2|IDINMSGFNETDDLK.3|IDINMSGFNETDDLK.2|RYTLNVLEDLGDGQK.3|RYTLNVLEDLGDGQK.2|DGETLEELMK.2|DGETLEELM[Oxi]K.2|ISFDEFVYIFQEVK.3|ISFDEFVYIFQEVK.2|AGKPHLVLGLLWQIIK.3|IDINMSGFNETDDLKR.3|IDINM[Oxi]SGFNETDDLKR.3|IDINMSGFNETDDLKR.2|LNLAFVANLFNK.2|EGIC[CAM]ALGGTSELSSEGTQHSYSEEEK.4|EGIC[CAM]ALGGTSELSSEGTQHSYSEEEK.3|NEALAALLRDGETLEELMK.3|ANDDIIVNWVNR.2|KLTPFIIQENLNLALNSASAIGC[CAM]HVVNIGAEDLR.5|KLTPFIIQENLNLALNSASAIGC[CAM]HVVNIGAEDLR.4|YPALTKPENQDIDWTLLEGETREER.4|KKLTPFIIQENLNLALNSASAIGC[CAM]HVVNIGAEDLR.5|KKLTPFIIQENLNLALNSASAIGC[CAM]HVVNIGAEDLR.4|VDLNSNGFIC[CAM]DYELHELFK.3|VDLNSNGFIC[CAM]DYELHELFK.2|RYTLNVLEDLGDGQKANDDIIVNWVNR.4|RYTLNVLEDLGDGQKANDDIIVNWVNR.3|YTLNVLEDLGDGQK.2|YPALTKPENQDIDWTLLEGETR.3|PENQDIDWTLLEGETR.2|EGIC[CAM]ALGGTSELSSEGTQHSYSEEEKYAFVNWINK.4|YTLNVLEDLGDGQKANDDIIVNWVNR.3|DKTISSSLAVVDLIDAIQPGC[CAM]INYDLVK.3
SEN / CTL,Coatomer subunit beta',COPB2,P35606,0.03,0.56,6.88E-02,2.62E-02,1.58E+00,"intracellular protein transport,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,intra-Golgi vesicle-mediated transport,toxin transport",structural molecule activity,"Golgi membrane,endoplasmic reticulum membrane,cytosol,COPI vesicle coat,transport vesicle",15,61,94,TFEVC[CAM]DLPVR.2|TFEVC[CAM]DLPVR.3|KNWVVTGADDMQIR.3|KNWVVTGADDMQIR.2|DNNQFASASLDR.2|TGRLPEAAFLAR.3|TGRLPEAAFLAR.2|TMYLLGYIPK.3|TMYLLGYIPK.2|TM[Oxi]YLLGYIPK.2|AMGDAEIK.2|VAHFLEK.2|AMGDAEIKDGER.3|RIEIQPK.2|IWDYQNK.2|QLAELAISK.2|RDFSMADK.2|LPEAAFLAR.2|QQALTVSTDPEHR.3|QQALTVSTDPEHR.2|VWC[CAM]VASLR.2|VHMFEAHSDYIR.3|VHM[Oxi]FEAHSDYIR.3|VHMFEAHSDYIR.2|NNVAFMSYFLQGK.3|NNVAFMSYFLQGK.2|NNVAFM[Oxi]SYFLQGK.2|NVMEEGKDFQPSR.3|NVM[Oxi]EEGKDFQPSR.3|IAYQLAVEAESEQK.3|IAYQLAVEAESEQK.2|IWHSSTYR.2|PASPTPVIVASHTANK.3|TYLPSQVSR.2|LGREEPAMSMDANGK.3|LGREEPAMSM[Oxi]DANGK.3|SFGSAQEFAWAHDSSEYAIR.4|SFGSAQEFAWAHDSSEYAIR.3|SFGSAQEFAWAHDSSEYAIR.2|KSFKPDFGAESIYGGFLLGVR.4|KSFKPDFGAESIYGGFLLGVR.3|GSNNVALGYDEGSIIVK.3|GSNNVALGYDEGSIIVK.2|HSEVQQANLK.2|VFNYNTLER.2|ETHADLWPAK.2|EAFVVEEWVKETHADLWPAK.4|DGKNNVAFMSYFLQGK.3|STAQQELDGKPASPTPVIVASHTANKEEK.5|STAQQELDGKPASPTPVIVASHTANKEEK.4|VDAC[CAM]LELLIR.2|EAFVVEEWVK.2|FELALQLGELK.2|IAYQLAVEAESEQKWK.3|AMGDAEIKDGERLPLAVK.3|EEPAMSMDANGK.2|LNYYVGGEIVTIAHLDR.3|LNYYVGGEIVTIAHLDR.2|LESTLNYGMER.2|LESTLNYGM[Oxi]ER.2|STAQQELDGKPASPTPVIVASHTANK.4|QYPLVTPNEER.2|SVNGLAFYDWDNTELIR.3|SVNGLAFYDWDNTELIR.2|VWQLGSSSPNFTLEGHEK.3|VWQLGSSSPNFTLEGHEK.2|QQALTVSTDPEHRFELALQLGELK.4|QQALTVSTDPEHRFELALQLGELK.3|AAESLADPTEYENLFPGLK.3|AAESLADPTEYENLFPGLK.2|KWSC[CAM]SQVFEGHTHYVMQIVINPK.4|GVNC[CAM]IDYYSGGDK.2|SFKPDFGAESIYGGFLLGVR.3|SFKPDFGAESIYGGFLLGVR.2|C[CAM]QFGLAQEC[CAM]LHHAQDYGGLLLLATASGNANMVNK.5|C[CAM]QFGLAQEC[CAM]LHHAQDYGGLLLLATASGNANM[Oxi]VNK.4|C[CAM]QFGLAQEC[CAM]LHHAQDYGGLLLLATASGNANMVNK.4|DM[Oxi]GSC[CAM]EIYPQTIQHNPNGR.3|DMGSC[CAM]EIYPQTIQHNPNGR.3|SVDLHPTEPWMLASLYNGSVC[CAM]VWNHETQTLVK.5|SVDLHPTEPWMLASLYNGSVC[CAM]VWNHETQTLVK.4|NWVVTGADDMQIR.2|TC[CAM]VQTLEGHAQNVSC[CAM]ASFHPELPIIITGSEDGTVR.5|TC[CAM]VQTLEGHAQNVSC[CAM]ASFHPELPIIITGSEDGTVR.4|C[CAM]IAVHPTQPFILTSSDDM[Oxi]LIK.3|C[CAM]IAVHPTQPFILTSSDDMLIK.3|C[CAM]IAVHPTQPFILTSSDDMLIK.2|QGFKQQALTVSTDPEHRFELALQLGELK.4|GVNC[CAM]IDYYSGGDKPYLISGADDR.3|VLAAQETHEGVTEDGIEDAFEVLGEIQEIVK.4|VLAAQETHEGVTEDGIEDAFEVLGEIQEIVK.3|WSC[CAM]SQVFEGHTHYVMQIVINPK.3|GVNC[CAM]IDYYSGGDKPYLISGADDRLVK.3|TGLWVGDC[CAM]FIYTSSVNR.2
SEN / CTL,Ras suppressor protein 1,RSU1,Q15404,0.03,0.53,6.57E-02,2.52E-02,1.60E+00,"signal transduction,positive regulation of cell-substrate adhesion,positive regulation of GTPase activity,regulation of cell-substrate adhesion",protein binding,"cytosol,focal adhesion,extracellular exosome",18,19,28,LQILSLRDNDLISLPK.3|LQILSLRDNDLISLPK.2|NLEVLNFFNNQIEELPTQISSLQK.3|NLEVLNFFNNQIEELPTQISSLQK.4|LTVLPPELGNLDLTGQK.2|LTVLPPELGNLDLTGQK.3|ALYLSDNDFEILPPDIGKLTK.3|LQILSLR.2|HMQANPEPPKK.3|HMQANPEPPKK.2|HMQANPEPPKKNNDK.4|HLNLGMNR.2|ELHIQGNR.2|DNDLISLPK.2|EIGELTQLK.2|HMQANPEPPK.2|NQPEVDMSDR.2|NQPEVDM[Oxi]SDR.2|LTMVPPNIAELK.2|ALYLSDNDFEILPPDIGK.3|ALYLSDNDFEILPPDIGK.2|GISNMLDVNGLFTLSHITQLVLSHNK.4|GISNM[Oxi]LDVNGLFTLSHITQLVLSHNK.4|GISNMLDVNGLFTLSHITQLVLSHNK.3|AENNPWVTPIADQFQLGVSHVFEYIR.4|AENNPWVTPIADQFQLGVSHVFEYIR.3|NQPEVDMSDRGISNMLDVNGLFTLSHITQLVLSHNK.5|QVFKAENNPWVTPIADQFQLGVSHVFEYIR.4
SEN / CTL,Spermine synthase,SMS,P52788,0.03,0.72,1.46E-01,4.80E-02,1.32E+00,"methionine metabolic process,polyamine metabolic process,spermine biosynthetic process",spermine synthase activity,"cytosol,extracellular exosome",24,28,36,LILDLSMK.2|TC[CAM]GDVLDNLKGDC[CAM]YQVLIEDC[CAM]IPVLKR.4|EGREFDYVINDLTAVPISTSPEEDSTWEFLR.4|IYPHGLVLLDLQSYDGDAQGKEEIDSILNKVEER.5|IYPHGLVLLDLQSYDGDAQGKEEIDSILNKVEER.4|LVEYDIDEVVYDEDSPYQNIK.3|YFTQGNC[CAM]VNLTEALSLYEEQLGR.3|MVTMVEIDQMVIDGC[CAM]KK.3|HSTLDFMLGAK.3|HSTLDFMLGAK.2|HSTLDFM[Oxi]LGAK.2|ADGETILK.2|M[Oxi]KELSQDSTGR.3|AIMGSGKEDYTGK.3|AIMGSGKEDYTGK.2|GGAIDRYWPTADGR.3|EEIDSILNK.2|EEIDSILNKVEER.3|TC[CAM]GDVLDNLK.2|LYC[CAM]PVEFSK.2|DVLILGGGDGGILC[CAM]EIVK.3|DVLILGGGDGGILC[CAM]EIVK.2|GDC[CAM]YQVLIEDC[CAM]IPVLK.3|GDC[CAM]YQVLIEDC[CAM]IPVLK.2|TC[CAM]GDVLDNLKGDC[CAM]YQVLIEDC[CAM]IPVLK.4|TC[CAM]GDVLDNLKGDC[CAM]YQVLIEDC[CAM]IPVLK.3|IYPHGLVLLDLQSYDGDAQGK.3|AIMGSGKEDYTGKDVLILGGGDGGILC[CAM]EIVK.4|KTC[CAM]GDVLDNLKGDC[CAM]YQVLIEDC[CAM]IPVLK.4|EDYTGKDVLILGGGDGGILC[CAM]EIVK.3|IYPHGLVLLDLQSYDGDAQGKEEIDSILNK.4|QFGNILILSGDVNLAESDLAYTR.3|GLQSIFQEQGMAESVHTWQDHGYLATYTNK.4|GLQSIFQEQGMAESVHTWQDHGYLATYTNK.3|MVTMVEIDQMVIDGC[CAM]K.2|EFDYVINDLTAVPISTSPEEDSTWEFLR.3
SEN / CTL,Peptidyl-prolyl cis-trans isomerase FKBP4,FKBP4,Q02790,0.03,0.51,1.08E-01,3.78E-02,1.42E+00,"protein peptidyl-prolyl isomerization,protein folding,steroid hormone receptor complex assembly,copper ion transport,embryo implantation,negative regulation of neuron projection development,androgen receptor signaling pathway,prostate gland development,negative regulation of microtubule polymerization or depolymerization,negative regulation of microtubule polymerization,protein complex localization,male sex differentiation,chaperone-mediated protein folding,regulation of cellular response to heat","peptidyl-prolyl cis-trans isomerase activity,protein binding,ATP binding,GTP binding,FK506 binding,protein binding, bridging,heat shock protein binding,copper-dependent protein binding,glucocorticoid receptor binding,poly(A) RNA binding,tau protein binding,phosphoprotein binding","nucleoplasm,cytoplasm,mitochondrion,endoplasmic reticulum membrane,cytosol,microtubule,neuronal cell body,protein complex,axonal growth cone,perinuclear region of cytoplasm,extracellular exosome",15,58,112,RGEAHLAVNDFELAR.3|RGEAHLAVNDFELAR.4|RGEAHLAVNDFELAR.2|AWDIAIATMK.2|AWDIAIATM[Oxi]K.2|LQAFSAAIESC[CAM]NK.2|LQAFSAAIESC[CAM]NK.3|LASHLNLAMC[CAM]HLK.3|LASHLNLAM[Oxi]C[CAM]HLK.3|LASHLNLAMC[CAM]HLK.2|LAEEENK.2|QALLQYK.2|AKAEASSGDHPTDTEMK.4|AKAEASSGDHPTDTEMK.3|FSFDLGKGEVIK.3|FSFDLGKGEVIK.2|AKAEASSGDHPTDTEMKEEQK.5|AKAEASSGDHPTDTEMKEEQK.4|AKAEASSGDHPTDTEM[Oxi]KEEQK.4|AKAEASSGDHPTDTEMKEEQK.3|LEQSTIVK.2|FDSSLDRK.2|AKESWEMNSEEK.3|AKESWEM[Oxi]NSEEK.3|AKESWEMNSEEK.2|FQIPPNAELKYELHLK.4|FQIPPNAELKYELHLK.3|FQIPPNAELKYELHLK.2|MEKGEHSIVYLKPSYAFGSVGK.5|MEKGEHSIVYLKPSYAFGSVGK.4|M[Oxi]EKGEHSIVYLKPSYAFGSVGK.4|MEKGEHSIVYLKPSYAFGSVGK.3|VGEVC[CAM]HITC[CAM]KPEYAYGSAGSPPK.5|VGEVC[CAM]HITC[CAM]KPEYAYGSAGSPPK.4|VGEVC[CAM]HITC[CAM]KPEYAYGSAGSPPK.3|GEHSIVYLKPSYAFGSVGK.4|GEHSIVYLKPSYAFGSVGK.3|GEHSIVYLKPSYAFGSVGK.2|PSYAFGSVGK.2|GEAHLAVNDFELAR.3|GEAHLAVNDFELAR.2|GEDLTEEEDGGIIR.3|GEDLTEEEDGGIIR.2|REGTGTEMPMIGDR.3|REGTGTEMPMIGDR.2|VFVHYTGWLLDGTKFDSSLDRK.5|VFVHYTGWLLDGTKFDSSLDRK.4|VFVHYTGWLLDGTKFDSSLDRK.3|AEASSGDHPTDTEMKEEQK.4|AEASSGDHPTDTEM[Oxi]KEEQK.4|AEASSGDHPTDTEMKEEQK.3|AEASSGDHPTDTEMKEEQK.2|GEHSIVYLK.2|LYANMFER.2|LYANM[Oxi]FER.2|AEASSGDHPTDTEM[Oxi]K.3|AEASSGDHPTDTEMK.3|AEASSGDHPTDTEMK.2|DKFSFDLGK.2|DKFSFDLGKGEVIK.3|DKFSFDLGKGEVIK.2|ALELDSNNEKGLFR.3|VFVHYTGWLLDGTK.3|VFVHYTGWLLDGTK.2|VLQLYPNNK.2|TQLAVC[CAM]QQR.2|ALELDSNNEK.2|GEDLTEEEDGGIIRR.3|FQIPPNAELK.2|YKQALLQYK.2|KLYANMFER.2|KLYANM[Oxi]FER.2|AKESWEMNSEEKLEQSTIVK.4|AKESWEM[Oxi]NSEEKLEQSTIVK.4|AKESWEMNSEEKLEQSTIVK.3|AKESWEM[Oxi]NSEEKLEQSTIVK.3|GEGYAKPNEGAIVEVALEGYYK.4|GEGYAKPNEGAIVEVALEGYYK.3|GEGYAKPNEGAIVEVALEGYYK.2|VGEVC[CAM]HITC[CAM]K.2|VFVHYTGWLLDGTKFDSSLDR.4|ESWEMNSEEK.2|ESWEM[Oxi]NSEEK.2|FEIGEGENLDLPYGLER.3|FEIGEGENLDLPYGLER.2|GEGYAKPNEGAIVEVALEGYYKDK.4|GEGYAKPNEGAIVEVALEGYYKDK.3|IPPNATLVFEVELFEFK.3|IPPNATLVFEVELFEFK.2|PEYAYGSAGSPPK.2|ATESGAQSAPLPMEGVDISPK.3|ATESGAQSAPLPM[Oxi]EGVDISPK.3|ATESGAQSAPLPM[Oxi]EGVDISPK.2|ATESGAQSAPLPMEGVDISPK.2|EGTGTEM[Oxi]PMIGDR.2|EGTGTEMPMIGDR.2|EGTGTEM[Oxi]PM[Oxi]IGDR.2|SNTAGSQSQVETEA.2|EKFQIPPNAELK.2|IQTRGEGYAKPNEGAIVEVALEGYYK.4|ESWEMNSEEKLEQSTIVK.3|ESWEM[Oxi]NSEEKLEQSTIVK.3|ESWEMNSEEKLEQSTIVK.2|IVSWLEYESSFSNEEAQK.3|IVSWLEYESSFSNEEAQK.2|KIVSWLEYESSFSNEEAQK.3|KIVSWLEYESSFSNEEAQK.2|ELRFEIGEGENLDLPYGLER.3|PNEGAIVEVALEGYYK.2|IPPNATLVFEVELFEFKGEDLTEEEDGGIIRR.4|TAEEMKATESGAQSAPLPMEGVDISPK.3|ATESGAQSAPLPMEGVDISPKQDEGVLK.3
SEN / CTL,Interleukin enhancer-binding factor 3,ILF3,Q12906,0.02,0.69,1.88E-02,8.92E-03,2.05E+00,"transcription, DNA-templated,protein phosphorylation,negative regulation of translation,negative regulation of viral genome replication,negative regulation of transcription, DNA-templated,positive regulation of transcription, DNA-templated,defense response to virus","DNA binding,RNA binding,double-stranded RNA binding,protein binding,poly(A) RNA binding","nucleus,nucleoplasm,nucleolus,cytoplasm,mitochondrion,membrane,intracellular ribonucleoprotein complex",21,70,118,SC[CAM]VIVIR.2|C[CAM]LAALASLR.2|HSSVYPTQEELEAVQNMVSHTER.4|HSSVYPTQEELEAVQNMVSHTER.3|HSSVYPTQEELEAVQNMVSHTER.5|HSSVYPTQEELEAVQNM[Oxi]VSHTER.4|HSSVYPTQEELEAVQNM[Oxi]VSHTER.3|VLQDMGLPTGAEGR.2|VLQDMGLPTGAEGR.3|VLQDM[Oxi]GLPTGAEGR.2|AYAALAALEK.2|IFVNDDR.2|EATDAIGHLDR.3|EATDAIGHLDR.2|RPMEEDGEEK.3|RPMEEDGEEK.2|RPMEEDGEEKSPSK.4|RPMEEDGEEKSPSK.3|LNQLKPGLQYK.3|LNQLKPGLQYK.2|PTTALLDK.2|AEPPQAMNALMR.3|AEPPQAMNALMR.2|AEPPQAMNALM[Oxi]R.2|EPPLSLTIHLTSPVVR.4|EPPLSLTIHLTSPVVR.3|EPPLSLTIHLTSPVVR.2|SIGTANRPMGAGEALRR.4|QQREDITQSAQHALR.4|QQREDITQSAQHALR.3|QQREDITQSAQHALR.2|EDITQSAQHALR.3|EDITQSAQHALR.2|HGKNPVMELNEK.3|HGKNPVM[Oxi]ELNEK.3|HGKNPVMELNEK.2|KEEKAEPPQAMNALMR.4|VPTWGPLR.2|FNYSGSGGR.2|NADHSM[Oxi]NYQYR.3|NADHSMNYQYR.3|NADHSMNYQYR.2|NADHSM[Oxi]NYQYR.2|GLKYELISETGGSHDKR.4|GLKYELISETGGSHDKR.3|IFVNDDRHVMAK.3|IFVNDDRHVMAK.2|RFVMEVEVDGQK.3|RFVMEVEVDGQK.2|YELISETGGSHDK.3|YELISETGGSHDK.2|EGAGEQKTEHMTR.3|LAAFGQLHK.2|LFPDTPLALDANKK.3|LFPDTPLALDANKK.2|DSSKGEDSAEETEAK.3|NTKEPPLSLTIHLTSPVVR.4|NTKEPPLSLTIHLTSPVVR.3|VLGMDPLPSK.2|VLGM[Oxi]DPLPSK.2|YELISETGGSHDKR.3|YELISETGGSHDKR.2|NPVMELNEK.2|SIGTANRPM[Oxi]GAGEALR.3|SIGTANRPMGAGEALR.3|SIGTANRPMGAGEALR.2|NTKEPPLSLTIHLTSPVVREEMEK.5|NTKEPPLSLTIHLTSPVVREEMEK.4|EKPTTALLDK.2|EEKAEPPQAMNALMR.3|GLKYELISETGGSHDK.3|RPMEEDGEEKSPSKK.3|EPPLSLTIHLTSPVVREEM[Oxi]EK.4|EPPLSLTIHLTSPVVREEMEK.4|EPPLSLTIHLTSPVVREEMEK.3|GWPLELLC[CAM]EK.2|VLEC[CAM]LASGIVMPDGSGIYDPC[CAM]EK.4|VLEC[CAM]LASGIVM[Oxi]PDGSGIYDPC[CAM]EK.3|VLEC[CAM]LASGIVMPDGSGIYDPC[CAM]EK.3|AYAALAALEKLFPDTPLALDANKK.4|VLAGETLSVNDPPDVLDR.3|VLAGETLSVNDPPDVLDR.2|FVMEVEVDGQK.2|AVSDWIDEQEK.2|GDLDLELVLLC[CAM]K.2|GSSEQAESDNMDVPPEDDSK.3|GSSEQAESDNMDVPPEDDSK.2|LFPDTPLALDANK.2|VLAGETLSVNDPPDVLDRQK.3|KQPHGGQQKPSYGSGYQSHQGQQQSYNQSPYSNYGPPQGK.6|KQPHGGQQKPSYGSGYQSHQGQQQSYNQSPYSNYGPPQGK.5|EKPTTALLDKVADNLAIQLAAVTEDKYEILQSVDDAAIVIK.6|EKPTTALLDKVADNLAIQLAAVTEDKYEILQSVDDAAIVIK.5|AYAALAALEKLFPDTPLALDANK.3|LVSQTGPVHAPIFTMSVEVDGNSFEASGPSK.4|LVSQTGPVHAPIFTM[Oxi]SVEVDGNSFEASGPSK.3|LVSQTGPVHAPIFTMSVEVDGNSFEASGPSK.3|LVSQTGPVHAPIFTMSVEVDGNSFEASGPSKK.4|LVSQTGPVHAPIFTMSVEVDGNSFEASGPSKK.3|PAVVAPAPVVEAVSTPSAAFPSDATAEQGPILTK.4|PAVVAPAPVVEAVSTPSAAFPSDATAEQGPILTK.3|VADNLAIQLAAVTEDKYEILQSVDDAAIVIK.4|VADNLAIQLAAVTEDKYEILQSVDDAAIVIK.3|VADNLAIQLAAVTEDK.2|YEILQSVDDAAIVIK.2|NENPVDYTVQIPPSTTYAITPMK.3|PSYGSGYQSHQGQQQSYNQSPYSNYGPPQGK.4|PSYGSGYQSHQGQQQSYNQSPYSNYGPPQGK.3|QGGYSQSNYNSPGSGQNYSGPPSSYQSSQGGYGR.4|QGGYSQSNYNSPGSGQNYSGPPSSYQSSQGGYGR.3|QKGYNHGQGSYSYSNSYNSPGGGGGSDYNYESK.4|RVLEC[CAM]LASGIVMPDGSGIYDPC[CAM]EK.3|VLEC[CAM]LASGIVMPDGSGIYDPC[CAM]EKEATDAIGHLDR.4|GSSEQAESDNMDVPPEDDSKEGAGEQK.3|DSSKGEDSAEETEAKPAVVAPAPVVEAVSTPSAAFPSDATAEQGPILTK.5|SGGNSYGSGGASYNPGSHGGYGGGSGGGSSYQGK.3|GEDSAEETEAKPAVVAPAPVVEAVSTPSAAFPSDATAEQGPILTK.4|GYNHGQGSYSYSNSYNSPGGGGGSDYNYESK.3
SEN / CTL,Protein disulfide-isomerase,P4HB,P07237,0.01,0.82,1.37E-02,6.86E-03,2.16E+00,"response to reactive oxygen species,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,response to endoplasmic reticulum stress,lipoprotein biosynthetic process,cell redox homeostasis,positive regulation of viral entry into host cell,cellular response to hypoxia,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway","protein disulfide isomerase activity,integrin binding,protein binding,enzyme binding,poly(A) RNA binding,protein heterodimerization activity,procollagen-proline 4-dioxygenase activity","extracellular region,endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum-Golgi intermediate compartment,focal adhesion,external side of plasma membrane,procollagen-proline 4-dioxygenase complex,extracellular matrix,endoplasmic reticulum chaperone complex,melanosome,extracellular exosome",156,62,113,ILFIFIDSDHTDNQR.3|ILFIFIDSDHTDNQR.2|VDATEESDLAQQYGVR.3|VDATEESDLAQQYGVR.2|ILEFFGLKKEEC[CAM]PAVR.4|ILEFFGLKKEEC[CAM]PAVR.3|EADDIVNWLK.2|ILEFFGLK.2|FFPASADRTVIDYNGER.3|THILLFLPK.2|YQLDKDGVVLFK.3|YQLDKDGVVLFK.2|NFEDVAFDEK.2|ENLLDFIK.2|EYTAGREADDIVNWLK.3|EYTAGREADDIVNWLK.2|HNQLPLVIEFTEQTAPK.3|HNQLPLVIEFTEQTAPK.2|HNQLPLVIEFTEQTAPK.4|ILEFFGLKK.2|SVSDYDGKLSNFK.3|SVSDYDGKLSNFK.2|LAKVDATEESDLAQQYGVR.3|LAKVDATEESDLAQQYGVR.2|LITLEEEMTKYKPESEELTAER.4|LITLEEEMTKYKPESEELTAER.3|FDEGRNNFEGEVTKENLLDFIK.4|FDEGRNNFEGEVTKENLLDFIK.3|ALAPEYAK.2|TVIDYNGER.2|TGPAATTLPDGAAAESLVESSEVAVIGFFK.3|TGPAATTLPDGAAAESLVESSEVAVIGFFK.4|LITLEEEMTK.2|LITLEEEM[Oxi]TK.2|QFLQAAEAIDDIPFGITSNSDVFSK.3|QFLQAAEAIDDIPFGITSNSDVFSK.4|MDSTANEVEAVKVHSFPTLK.4|MDSTANEVEAVKVHSFPTLK.3|M[Oxi]DSTANEVEAVKVHSFPTLK.4|M[Oxi]DSTANEVEAVKVHSFPTLK.3|YQLDKDGVVLFKK.3|YQLDKDGVVLFKK.2|YKPESEELTAER.3|YKPESEELTAER.2|QLAPIWDKLGETYKDHENIVIAK.5|QLAPIWDKLGETYKDHENIVIAK.4|QLAPIWDKLGETYKDHENIVIAK.3|YKPESEELTAERITEFC[CAM]HR.4|YKPESEELTAERITEFC[CAM]HR.5|IKPHLMSQELPEDWDKQPVK.4|IKPHLMSQELPEDWDKQPVK.5|IKPHLMSQELPEDWDKQPVK.3|IKPHLM[Oxi]SQELPEDWDKQPVK.4|IKPHLM[Oxi]SQELPEDWDKQPVK.5|IKPHLM[Oxi]SQELPEDWDKQPVK.3|EADDIVNWLKK.3|EADDIVNWLKK.2|NNFEGEVTKENLLDFIK.3|NNFEGEVTKENLLDFIK.2|RTGPAATTLPDGAAAESLVESSEVAVIGFFKDVESDSAK.4|RTGPAATTLPDGAAAESLVESSEVAVIGFFKDVESDSAK.5|FFPASADR.2|LGETYKDHENIVIAK.4|LGETYKDHENIVIAK.3|LGETYKDHENIVIAK.2|MDSTANEVEAVK.2|MDSTANEVEAVK.3|M[Oxi]DSTANEVEAVK.2|TLDGFKK.2|KSNFAEALAAHK.3|KSNFAEALAAHK.2|KFDEGRNNFEGEVTK.4|KFDEGRNNFEGEVTK.3|KFDEGRNNFEGEVTK.2|NFEDVAFDEKK.3|NFEDVAFDEKK.2|IFGGEIKTHILLFLPK.4|IFGGEIKTHILLFLPK.3|VHSFPTLK.2|TAAESFKGK.2|ITEFC[CAM]HR.2|NGDTASPKEYTAGR.3|NGDTASPKEYTAGR.2|QLAPIWDK.2|IKPHLM[Oxi]SQELPEDWDK.4|IKPHLMSQELPEDWDK.4|IKPHLMSQELPEDWDK.3|IKPHLM[Oxi]SQELPEDWDK.3|IKPHLMSQELPEDWDK.2|KEEC[CAM]PAVR.2|LKAEGSEIR.2|KNVFVEFYAPWC[CAM]GHC[CAM]K.4|KNVFVEFYAPWC[CAM]GHC[CAM]K.3|KNVFVEFYAPWC[CAM]GHC[CAM]K.2|DHENIVIAK.2|NNFEGEVTK.2|FDEGRNNFEGEVTK.3|FDEGRNNFEGEVTK.2|SNFAEALAAHK.2|NVFVEFYAPWC[CAM]GHC[CAM]K.3|NVFVEFYAPWC[CAM]GHC[CAM]K.2|YLLVEFYAPWC[CAM]GHC[CAM]K.3|YLLVEFYAPWC[CAM]GHC[CAM]K.2|AAGKLKAEGSEIR.2|LAKVDATEESDLAQQYGVRGYPTIK.4|ENLLDFIKHNQLPLVIEFTEQTAPK.4|PHLMSQELPEDWDKQPVK.3|RTGPAATTLPDGAAAESLVESSEVAVIGFFK.4|RTGPAATTLPDGAAAESLVESSEVAVIGFFK.3|NNFEGEVTKENLLDFIKHNQLPLVIEFTEQTAPK.5|KRTGPAATTLPDGAAAESLVESSEVAVIGFFK.4|KRTGPAATTLPDGAAAESLVESSEVAVIGFFK.3|VDATEESDLAQQYGVRGYPTIK.3
SEN / CTL,Caspase-3,CASP3,P42574,0.00,0.72,1.30E-01,4.40E-02,1.36E+00,"response to hypoxia,apoptotic DNA fragmentation,proteolysis,apoptotic process,activation of cysteine-type endopeptidase activity involved in apoptotic process,cellular component disassembly involved in execution phase of apoptosis,learning or memory,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,response to glucose,response to X-ray,regulation of macroautophagy,hippocampus development,neuron differentiation,keratinocyte differentiation,erythrocyte differentiation,platelet formation,response to cobalt ion,response to estradiol,response to lipopolysaccharide,glial cell apoptotic process,response to tumor necrosis factor,response to nicotine,hippo signaling,wound healing,response to drug,response to hydrogen peroxide,negative regulation of apoptotic process,response to amino acid,positive regulation of neuron apoptotic process,response to antibiotic,neurotrophin TRK receptor signaling pathway,response to glucocorticoid,cellular response to organic cyclic compound,apoptotic signaling pathway,extrinsic apoptotic signaling pathway in absence of ligand,execution phase of apoptosis","protease binding,aspartic-type endopeptidase activity,cysteine-type endopeptidase activity,death receptor binding,protein binding,peptidase activity,cysteine-type endopeptidase activator activity involved in apoptotic process,phospholipase A2 activator activity,protein complex binding,cysteine-type endopeptidase activity involved in apoptotic process,cysteine-type endopeptidase activity involved in execution phase of apoptosis","nucleus,nucleoplasm,cytosol,plasma membrane,death-inducing signaling complex,membrane raft",12,16,19,LFIIQAC[CAM]R.2|QYADKLEFMHILTR.3|QYADKLEFMHILTR.4|KQIPC[CAM]IVSMLTK.3|EEIVELMR.2|SGTDVDAANLR.2|LEFMHILTR.2|RSSFVC[CAM]VLLSHGEEGIIFGTNGPVDLKK.5|RSSFVC[CAM]VLLSHGEEGIIFGTNGPVDLKK.4|NKNDLTREEIVELMR.3|QIPC[CAM]IVSMLTK.2|VATEFESFSFDATFHAK.3|VATEFESFSFDATFHAK.2|IIHGSESMDSGISLDNSYK.3|SSFVC[CAM]VLLSHGEEGIIFGTNGPVDLKK.4|GTELDC[CAM]GIETDSGVDDDMAC[CAM]HK.3|NDLTREEIVELMR.2|DGSWFIQSLC[CAM]AMLK.2|IPVEADFLYAYSTAPGYYSWR.3
SEN / CTL,Ubiquitin carboxyl-terminal hydrolase 5,USP5,P45974,-0.01,1.26,1.49E-04,1.44E-04,3.84E+00,"ubiquitin-dependent protein catabolic process,protein deubiquitination,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,protein K48-linked deubiquitination","cysteine-type endopeptidase activity,thiol-dependent ubiquitin-specific protease activity,zinc ion binding,ubiquitin binding",lysosome,30,54,78,DGLGGLPDIVR.2|DGLGGLPDIVRDR.3|SAADSISESVPVGPK.2|SAADSISESVPVGPK.3|FASFPDYLVIQIKK.3|QQDAQEFFLHLINMVER.3|QQDAQEFFLHLINM[Oxi]VER.3|QQDAQEFFLHLINMVER.2|EELLEYEEK.2|DRVTSAVEALLSADSASR.3|DRVTSAVEALLSADSASR.2|GHPEFSTNR.2|KLDVSIEMPEELDISQLR.3|KLDVSIEM[Oxi]PEELDISQLR.3|KLDVSIEMPEELDISQLR.2|LGHGLLSGEYSKPVPESGDGERVPEQKEVQDGIAPR.5|LGHGLLSGEYSKPVPESGDGERVPEQKEVQDGIAPR.6|RPKEEDPATGTGDPPR.4|RPKEEDPATGTGDPPR.3|KFTFGLDWVPK.3|KFTFGLDWVPK.2|ATNNSLER.2|YFDGSGGNNHAVEHYR.4|YFDGSGGNNHAVEHYR.3|MALPELVR.2|KQEVQAWDGEVR.3|KQEVQAWDGEVR.2|EEDPATGTGDPPRK.3|EVQDGIAPR.2|RYFDGSGGNNHAVEHYR.4|TRRPKEEDPATGTGDPPR.4|FELDEDVK.2|VC[CAM]ASEKPPK.2|FASFPDYLVIQIK.3|FASFPDYLVIQIK.2|VTSAVEALLSADSASR.3|VTSAVEALLSADSASR.2|WVIYNDQK.2|LGHGLLSGEYSKPVPESGDGER.4|LGHGLLSGEYSKPVPESGDGER.3|LGHGLLSGEYSKPVPESGDGERVPEQK.5|LGHGLLSGEYSKPVPESGDGERVPEQK.4|LGHGLLSGEYSKPVPESGDGERVPEQK.3|VTSAVEALLSADSASRK.3|PLFGPGYTGIR.2|SSENPNEVFR.2|FTFGLDWVPK.2|ENLWLNLTDGSILC[CAM]GR.3|ENLWLNLTDGSILC[CAM]GR.2|LGHGLLSGEYSK.2|VDYIMQLPVPMDAALNK.3|VDYIMQLPVPMDAALNK.2|QEVQAWDGEVR.2|DLGYIYFYQR.2|LDVSIEMPEELDISQLR.3|EEDPATGTGDPPR.2|YFDGSGGNNHAVEHYRETGYPLAVK.4|IFQNAPTDPTQDFSTQVAK.3|IFQNAPTDPTQDFSTQVAK.2|IGEWELIQESGVPLKPLFGPGYTGIR.4|IGEWELIQESGVPLKPLFGPGYTGIR.3|IVILPDYLEIAR.2|DGLGGLPDIVRDRVTSAVEALLSADSASR.4|TMTELEIDMNQR.2|TM[Oxi]TELEIDMNQR.2|VDYIMQLPVPMDAALNKEELLEYEEK.4|VDYIM[Oxi]QLPVPMDAALNKEELLEYEEK.3|VDYIMQLPVPMDAALNKEELLEYEEK.3|LAIGVEGGFDLSEEKFELDEDVK.3|IGEWELIQESGVPLK.2|GTGLQPGEEELPDIAPPLVTPDEPK.3|AVDWIFSHIDDLDAEAAM[Oxi]DISEGR.3|AVDWIFSHIDDLDAEAAMDISEGR.3|NLGNSC[CAM]YLNSVVQVLFSIPDFQR.3|YTQRVDYIMQLPVPMDAALNKEELLEYEEK.4|NLGNSC[CAM]YLNSVVQVLFSIPDFQRK.3|LGTITPDGADVYSYDEDDMVLDPSLAEHLSHFGIDMLK.4|AQVPFSSC[CAM]LEAYGAPEQVDDFWSTALQAK.3
SEN / CTL,Proteasome subunit beta type-3,PSMB3,P49720,-0.01,0.28,1.37E-01,4.54E-02,1.34E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,viral process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","threonine-type endopeptidase activity,protein binding","proteasome complex,nucleus,nucleoplasm,cytoplasm,mitochondrion,Golgi apparatus,cytosol,proteasome core complex,actin cytoskeleton,proteasome core complex, beta-subunit complex,extracellular exosome",18,13,31,FGPYYTEPVIAGLDPK.2|FGPYYTEPVIAGLDPK.3|LYIGLAGLATDVQTVAQR.3|LYIGLAGLATDVQTVAQR.2|FGIQAQMVTTDFQK.2|FGIQAQMVTTDFQK.3|FGIQAQM[Oxi]VTTDFQK.2|QIKPYTLMSMVANLLYEKR.4|QIKPYTLM[Oxi]SMVANLLYEKR.4|QIKPYTLMSM[Oxi]VANLLYEKR.4|QIKPYTLMSMVANLLYEK.3|QIKPYTLM[Oxi]SM[Oxi]VANLLYEK.3|QIKPYTLM[Oxi]SMVANLLYEK.3|QIKPYTLMSM[Oxi]VANLLYEK.3|QIKPYTLMSMVANLLYEK.2|DAVSGMGVIVHIIEKDK.4|DAVSGMGVIVHIIEKDK.3|NC[CAM]VAIAADR.2|DAVSGMGVIVHIIEK.3|DAVSGMGVIVHIIEK.2|DAVSGM[Oxi]GVIVHIIEK.2|NC[CAM]VAIAADRR.2|PYTLMSMVANLLYEK.3|PYTLMSM[Oxi]VANLLYEK.3|PYTLM[Oxi]SMVANLLYEK.2|PYTLMSM[Oxi]VANLLYEK.2|PYTLMSMVANLLYEK.2|RFGIQAQMVTTDFQK.3|FRLNLYELK.2|RFGPYYTEPVIAGLDPK.3|RFGPYYTEPVIAGLDPK.2
SEN / CTL,Obg-like ATPase 1,OLA1,Q9NTK5,-0.03,0.52,8.10E-02,3.01E-02,1.52E+00,"ATP metabolic process,cell-cell adhesion","ATP binding,GTP binding,ATPase activity,ribosome binding,ribosomal large subunit binding,metal ion binding,cadherin binding involved in cell-cell adhesion","nucleolus,cytoplasm,centrosome,cell-cell adherens junction,membrane,extracellular exosome",9,38,62,IPAFLNVVDIAGLVK.2|IPAFLNVVDIAGLVK.3|NYIVEDGDIIFFK.2|NYIVEDGDIIFFK.3|VPVPDER.2|FDFLC[CAM]QYHKPASK.4|FDFLC[CAM]QYHKPASK.3|EIEVLNK.2|GGDGIKPPPIIGR.3|HLFLTSK.2|LKPEYDIMC[CAM]K.3|LKPEYDIMC[CAM]K.2|SWVIDQK.2|IHTDFEK.2|KGGDGIKPPPIIGR.3|GAHNGQGLGNAFLSHISAC[CAM]DGIFHLTR.6|GAHNGQGLGNAFLSHISAC[CAM]DGIFHLTR.5|GAHNGQGLGNAFLSHISAC[CAM]DGIFHLTR.4|GAHNGQGLGNAFLSHISAC[CAM]DGIFHLTR.3|KLKPEYDIMC[CAM]K.3|KLKPEYDIMC[CAM]K.2|FNTPQQPK.2|FYHDWNDKEIEVLNK.4|FYHDWNDKEIEVLNK.3|FYHDWNDKEIEVLNK.2|VPVPDERFDFLC[CAM]QYHKPASK.5|VPVPDERFDFLC[CAM]QYHKPASK.4|YLEANMTQSALPK.3|YLEANMTQSALPK.2|YLEANM[Oxi]TQSALPK.2|GFIMAEVMK.2|GFIMAEVM[Oxi]K.2|GFIM[Oxi]AEVM[Oxi]K.2|HLFLTSKPMVYLVNLSEK.4|HLFLTSKPMVYLVNLSEK.3|IGIVGLPNVGK.2|LQELSAEER.2|YEDFKEEGSENAVK.3|YEDFKEEGSENAVK.2|FYHDWNDK.2|YDPGALVIPFSGALELK.3|YDPGALVIPFSGALELK.2|PMVYLVNLSEKDYIR.3|DEEMIGPIIDK.2|DEEM[Oxi]IGPIIDK.2|PMVYLVNLSEK.2|PM[Oxi]VYLVNLSEK.2|GFIMAEVMKYEDFKEEGSENAVK.4|HLFLTSKPMVYLVNLSEKDYIR.4|AFEDDDITHVEGSVDPIR.3|IKEWVDKYDPGALVIPFSGALELK.4|IKEWVDKYDPGALVIPFSGALELK.3|AFEDDDITHVEGSVDPIRDIEIIHEELQLK.5|AFEDDDITHVEGSVDPIRDIEIIHEELQLK.4|AGFAALQLEYFFTAGPDEVR.3|AGFAALQLEYFFTAGPDEVR.2|DIEIIHEELQLK.2|AFEDDDITHVEGSVDPIRDIEIIHEELQLKDEEMIGPIIDK.6|STFFNVLTNSQASAENFPFC[CAM]TIDPNESR.4|STFFNVLTNSQASAENFPFC[CAM]TIDPNESR.3|EWVDKYDPGALVIPFSGALELK.3|QKYLEANMTQSALPK.2
SEN / CTL,NEDD8,NEDD8,Q15843,-0.03,0.59,4.74E-02,1.92E-02,1.72E+00,"regulation of transcription from RNA polymerase II promoter,cellular protein modification process,proteolysis,ubiquitin-dependent protein catabolic process,transforming growth factor beta receptor signaling pathway,protein localization,anatomical structure morphogenesis,response to organic cyclic compound,protein neddylation","protein binding,ubiquitin protein ligase binding","nucleus,cytosol,extracellular exosome",15,4,7,ILGGSVLHLVLALR.3|ILGGSVLHLVLALR.2|TLTGKEIEIDIEPTDKVER.4|TLTGKEIEIDIEPTDKVER.3|EIEIDIEPTDKVER.3|EIEIDIEPTDKVER.2|EIEIDIEPTDK.2
SEN / CTL,Eukaryotic translation initiation factor 5A-1;Eukaryotic translation initiation factor 5A-1-like,EIF5A;EIF5AL1,P63241;Q6IS14,-0.03,0.52,1.16E-01,4.01E-02,1.40E+00,"mRNA export from nucleus,translational frameshifting,protein export from nucleus,nucleocytoplasmic transport,apoptotic process,positive regulation of cell proliferation,peptidyl-lysine modification to peptidyl-hypusine,positive regulation of translational elongation,positive regulation of translational termination;translational frameshifting,protein transport,positive regulation of translational elongation,positive regulation of translational termination,mRNA transport","RNA binding,translation elongation factor activity,protein binding,U6 snRNA binding,ribosome binding,poly(A) RNA binding,protein N-terminus binding;translation elongation factor activity,ribosome binding","nucleus,annulate lamellae,nuclear pore,cytoplasm,endoplasmic reticulum membrane,cytosol,membrane,extracellular exosome;nuclear pore,endoplasmic reticulum membrane",36,7,21,VHLVGIDIFTGK.3|VHLVGIDIFTGK.2|YDC[CAM]GEEILITVLSAMTEEAAVAIK.3|KYEDIC[CAM]PSTHNMDVPNIKR.5|KYEDIC[CAM]PSTHNMDVPNIKR.4|KYEDIC[CAM]PSTHNM[Oxi]DVPNIKR.4|KYEDIC[CAM]PSTHNM[Oxi]DVPNIKR.5|KYEDIC[CAM]PSTHNM[Oxi]DVPNIKR.3|KYEDIC[CAM]PSTHNMDVPNIKR.3|KYEDIC[CAM]PSTHNMDVPNIK.4|KYEDIC[CAM]PSTHNM[Oxi]DVPNIK.4|KYEDIC[CAM]PSTHNMDVPNIK.3|KYEDIC[CAM]PSTHNM[Oxi]DVPNIK.3|KYEDIC[CAM]PSTHNMDVPNIK.2|VHLVGIDIFTGKK.3|VHLVGIDIFTGKK.2|VHLVGIDIFTGKKYEDIC[CAM]PSTHNMDVPNIK.6|VHLVGIDIFTGKKYEDIC[CAM]PSTHNMDVPNIK.5|YEDIC[CAM]PSTHNMDVPNIKR.4|YEDIC[CAM]PSTHNM[Oxi]DVPNIKR.4|YEDIC[CAM]PSTHNMDVPNIKR.3
SEN / CTL,Gamma-glutamylcyclotransferase,GGCT,O75223,-0.05,0.06,1.07E-01,3.78E-02,1.42E+00,"release of cytochrome c from mitochondria,glutathione biosynthetic process","gamma-glutamylcyclotransferase activity,protein homodimerization activity","cytosol,extracellular exosome",3,15,18,NPSAAFFC[CAM]VAR.2|NPSAAFFC[CAM]VAR.3|VSEEIEDIIKK.3|VATQEGKEITC[CAM]R.3|LDFGNSQGK.2|LQDFKLDFGNSQGK.3|AIEPNDYTGK.2|SGMYVVIEVK.2|VSEEIEDIIK.2|ENGLPLEYQEK.2|SYLMTNYESAPPSPQYK.3|SYLMTNYESAPPSPQYK.2|SYLMTNYESAPPSPQYKK.3|SNLNSLDEQEGVK.2|TSQTWHGGIATIFQSPGDEVWGVVWK.4|TSQTWHGGIATIFQSPGDEVWGVVWK.3|AIEPNDYTGKVSEEIEDIIK.3|DVTGPDEESFLYFAYGSNLLTER.3
SEN / CTL,EH domain-containing protein 4,EHD4,Q9H223,-0.05,0.42,2.80E-02,1.25E-02,1.90E+00,"pinocytosis,regulation of endocytosis,endocytic recycling,positive regulation of peptidyl-tyrosine phosphorylation,protein homooligomerization,cellular response to growth factor stimulus,cell-cell adhesion","nucleic acid binding,calcium ion binding,protein binding,ATP binding,GTP binding,cadherin binding involved in cell-cell adhesion","nucleus,endoplasmic reticulum,plasma membrane,cell-cell adherens junction,membrane,early endosome membrane,perinuclear region of cytoplasm,recycling endosome membrane,extracellular exosome",9,32,46,EYQISAGDFPEVK.2|EYQISAGDFPEVK.3|YLLEQDFPGMR.2|VYGALMWSLGK.2|VYGALM[Oxi]WSLGK.2|AGGADAVQTVTGGLR.3|AGGADAVQTVTGGLR.2|DIQSLPQK.2|FGNAFLNR.2|IKLDGYELPSSLPPHLVPPSHR.5|IKLDGYELPSSLPPHLVPPSHR.4|IKLDGYELPSSLPPHLVPPSHR.3|RLFEAEAQDLFR.3|VINTPEVLR.2|VLPLEEAYR.2|LDGYELPSSLPPHLVPPSHR.4|LDGYELPSSLPPHLVPPSHR.3|LDGYELPSSLPPHLVPPSHRK.4|GYDFC[CAM]QVLQWFAER.3|GYDFC[CAM]QVLQWFAER.2|IILLFDAHKLDISDEFSEAIK.4|LPEIYIQLQR.2|ADQVDTQQLMR.2|ADQVDTQQLM[Oxi]R.2|LFEAEAQDLFR.2|LIEAVDNMLSNK.2|LIEAVDNM[Oxi]LSNK.2|EGADEEEWVVAK.2|FHEFHSPALEDADFENKPMILLVGQYSTGK.5|FHEFHSPALEDADFENKPMILLVGQYSTGK.4|LDISDEFSEAIK.2|DKPVYDELFYTLSPINGK.3|DKPVYDELFYTLSPINGK.2|PMILLVGQYSTGK.2|VYIGSFWAQPLQNTDNRR.3|FMC[CAM]SQLPNQVLK.2|FM[Oxi]C[CAM]SQLPNQVLK.2|LADC[CAM]DC[CAM]DGMLDEEEFALAK.3|LADC[CAM]DC[CAM]DGMLDEEEFALAK.2|LFEAEAQDLFRDIQSLPQK.3|SISVIDSPGILSGEK.2|AM[Oxi]QEQLENYDFTK.2|AMQEQLENYDFTK.2|ISPLMNLISQEETSTPTQLVQGGAFDGTTEGPFNQGYGEGAK.5|VYIGSFWAQPLQNTDNR.2|IGPEPTTDSFIAVMYGETEGSTPGNALVVDPK.3
SEN / CTL,Signal recognition particle 9 kDa protein,SRP9,P49458,-0.06,0.24,1.02E-01,3.62E-02,1.44E+00,"SRP-dependent cotranslational protein targeting to membrane,SRP-dependent cotranslational protein targeting to membrane, translocation,negative regulation of translational elongation","RNA binding,signal recognition particle binding,protein binding,7S RNA binding","signal recognition particle receptor complex,signal recognition particle, endoplasmic reticulum targeting,cytosol,extracellular exosome",12,8,11,VTDDLVC[CAM]LVYK.2|PQYQTWEEFSR.2|PQYQTWEEFSR.3|VTDDLVC[CAM]LVYKTDQAQDVK.3|VTDDLVC[CAM]LVYKTDQAQDVK.2|YRHSDGNLC[CAM]VK.3|TDQAQDVK.2|FHSQLMR.2|LYLADPMK.2|LYLADPM[Oxi]K.2|HSDGNLC[CAM]VK.2
SEN / CTL,Glyoxalase domain-containing protein 4,GLOD4,Q9HC38,-0.06,0.32,1.51E-01,4.90E-02,1.31E+00,cell-cell adhesion,cadherin binding involved in cell-cell adhesion,"mitochondrion,cell-cell adherens junction,extracellular exosome",15,22,35,ILTPLVSLDTPGK.2|ILTPLVSLDTPGK.3|SLNYWC[CAM]NLLGMK.2|SLNYWC[CAM]NLLGM[Oxi]K.2|VTLAVSDLQK.2|ALLGYADNQC[CAM]KLELQGVK.3|ALHFVFK.2|SDEWFAK.2|IYEKDEEKQR.3|IYEKDEEKQR.2|IAFSC[CAM]PQK.2|GGVDHAAAFGR.2|LLDDAMAADK.2|LLDDAM[Oxi]AADK.2|LLDDAMAADK.1|SLPQSDPVLK.2|IAFSC[CAM]PQKELPDLEDLMKR.4|ELPDLEDLMK.2|ELPDLEDLM[Oxi]K.2|ALLGYADNQC[CAM]K.2|KLEWPLTEVAEGVFETEAPGGYK.4|KLEWPLTEVAEGVFETEAPGGYK.3|LLDDAMAADKSDEWFAK.3|LLDDAMAADKSDEWFAK.2|LGNDFMGITLASSQAVSNAR.3|LGNDFM[Oxi]GITLASSQAVSNAR.3|LGNDFMGITLASSQAVSNAR.2|TMVGFGPEDDHFVAELTYNYGVGDYK.4|TM[Oxi]VGFGPEDDHFVAELTYNYGVGDYK.3|TMVGFGPEDDHFVAELTYNYGVGDYK.3|ALLGYADNQC[CAM]KLELQGVKGGVDHAAAFGR.4|LEWPLTEVAEGVFETEAPGGYK.3|KLEWPLTEVAEGVFETEAPGGYKFYLQNR.4|KLEWPLTEVAEGVFETEAPGGYKFYLQNR.3|ATVQVVILADPDGHEIC[CAM]FVGDEAFR.3
SEN / CTL,Putative nascent polypeptide-associated complex subunit alpha-like protein,NACAP1,Q9BZK3,-0.07,0.13,1.87E-02,8.92E-03,2.05E+00,,,,12,3,7,IEDLSQEAQLAAAEK.2|IEDLSQEAQLAAAEK.3|NILFVITKPDVYK.3|NILFVITKPDVYK.2|SKNILFVITKPDVYK.4|SKNILFVITKPDVYK.3|SKNILFVITKPDVYK.2
SEN / CTL,Heat shock 70 kDa protein 4,HSPA4,P34932,-0.07,0.34,1.77E-06,2.76E-06,5.56E+00,"response to unfolded protein,protein import into mitochondrial outer membrane,chaperone-mediated protein complex assembly","protein binding,ATP binding","cytosol,extracellular exosome",66,85,157,EFSITDVVPYPISLR.2|EFSITDVVPYPISLR.3|AFSDPFVEAEKSNLAYDIVQLPTGLTGIK.3|AFSDPFVEAEKSNLAYDIVQLPTGLTGIK.4|GC[CAM]ALQC[CAM]AILSPAFK.2|GC[CAM]ALQC[CAM]AILSPAFK.3|VLATAFDTTLGGR.2|VLATAFDTTLGGR.3|AGGIETIANEYSDR.2|AGGIETIANEYSDR.3|ELSTTLNADEAVTR.2|ELSTTLNADEAVTR.3|NAVEEYVYEMR.2|NAVEEYVYEMR.3|NAVEEYVYEM[Oxi]R.2|LM[Oxi]NETTAVALAYGIYKQDLPALEEKPR.4|LMNETTAVALAYGIYKQDLPALEEKPR.4|LMNETTAVALAYGIYKQDLPALEEKPR.5|LMNETTAVALAYGIYKQDLPALEEKPR.3|SVMDATQIAGLNC[CAM]LR.2|SVMDATQIAGLNC[CAM]LR.3|SVM[Oxi]DATQIAGLNC[CAM]LR.3|SVM[Oxi]DATQIAGLNC[CAM]LR.2|GKFLEMC[CAM]NDLLAR.3|LFEELGK.2|VREFSITDVVPYPISLR.3|VREFSITDVVPYPISLR.4|VREFSITDVVPYPISLR.2|FLEMC[CAM]NDLLAR.2|FLEM[Oxi]C[CAM]NDLLAR.2|LMSANASDLPLSIEC[CAM]FMNDVDVSGTMNR.3|LMSANASDLPLSIEC[CAM]FMNDVDVSGTMNR.4|LKKEDIYAVEIVGGATR.3|LKKEDIYAVEIVGGATR.4|LKKEDIYAVEIVGGATR.2|IKELTSTC[CAM]SPIISKPKPK.5|IKELTSTC[CAM]SPIISKPKPK.4|IKELTSTC[CAM]SPIISKPKPK.3|SVLEQTK.2|LSGEYEK.2|NHAAPFSK.2|QDLPALEEKPR.3|QDLPALEEKPR.2|ETAESVLK.2|ELTSTC[CAM]SPIISKPKPK.4|ELTSTC[CAM]SPIISKPKPK.3|MDQPPQAK.2|M[Oxi]DQPPQAK.2|QIQQYMK.2|QIQQYM[Oxi]K.2|IRFQESEERPK.3|IRFQESEERPK.2|NKEDQYDHLDAADMTK.4|NKEDQYDHLDAADM[Oxi]TK.4|NKEDQYDHLDAADM[Oxi]TK.3|NKEDQYDHLDAADMTK.3|NKEDQYDHLDAADMTK.2|KLPEMDID.2|KLPEM[Oxi]DID.2|VLATAFDTTLGGRK.3|AESEEMETSQAGSK.3|AESEEMETSQAGSK.2|AESEEM[Oxi]ETSQAGSK.2|EDIYAVEIVGGATR.3|EDIYAVEIVGGATR.2|KFDEVLVNHFC[CAM]EEFGK.4|KFDEVLVNHFC[CAM]EEFGK.3|KFDEVLVNHFC[CAM]EEFGK.2|VNVHGIFSVSSASLVEVHK.4|VNVHGIFSVSSASLVEVHK.3|VNVHGIFSVSSASLVEVHK.2|ELTSTC[CAM]SPIISKPK.3|FVSEDDRNSFTLK.3|FVSEDDRNSFTLK.2|KMDQPPQAK.2|QDLPALEEK.2|IKELTSTC[CAM]SPIISK.3|IKELTSTC[CAM]SPIISK.2|KFDEVLVNHFC[CAM]EEFGKK.4|KFDEVLVNHFC[CAM]EEFGKK.3|NFTTEQVTAMLLSK.3|NFTTEQVTAMLLSK.2|NFTTEQVTAM[Oxi]LLSK.2|VTYMEEER.2|VTYM[Oxi]EEER.2|DKLSGEYEK.2|KEDIYAVEIVGGATR.3|KEDIYAVEIVGGATR.2|EDQYDHLDAADMTK.3|EDQYDHLDAADMTK.2|VTPQSDGSSSK.2|LKETAESVLK.2|QSLTMDPVVK.2|QSLTM[Oxi]DPVVK.2|MIMQDKLEK.2|M[Oxi]IMQDKLEK.2|FQESEERPK.2|LMNETTAVALAYGIYK.3|LM[Oxi]NETTAVALAYGIYK.3|LMNETTAVALAYGIYK.2|LM[Oxi]NETTAVALAYGIYK.2|SEENEEPM[Oxi]ETDQNAK.3|SEENEEPM[Oxi]ETDQNAK.2|SEENEEPMETDQNAK.2|KPVVDC[CAM]VVSVPC[CAM]FYTDAERR.4|KPVVDC[CAM]VVSVPC[CAM]FYTDAERR.3|KPVVDC[CAM]VVSVPC[CAM]FYTDAERR.2|NVVFVDMGHSAYQVSVC[CAM]AFNR.4|NVVFVDM[Oxi]GHSAYQVSVC[CAM]AFNR.3|NVVFVDMGHSAYQVSVC[CAM]AFNR.3|RSVMDATQIAGLNC[CAM]LR.3|AFSDPFVEAEK.2|C[CAM]TPAC[CAM]ISFGPK.2|FDEVLVNHFC[CAM]EEFGK.3|FDEVLVNHFC[CAM]EEFGK.2|SNLAYDIVQLPTGLTGIK.3|SNLAYDIVQLPTGLTGIK.2|WNSPAEEGSSDC[CAM]EVFSK.3|WNSPAEEGSSDC[CAM]EVFSK.2|ETAESVLKKPVVDC[CAM]VVSVPC[CAM]FYTDAERR.5|EDIYAVEIVGGATRIPAVK.3|ELTSTC[CAM]SPIISK.2|FFGKELSTTLNADEAVTR.3|LKETAESVLKKPVVDC[CAM]VVSVPC[CAM]FYTDAER.5|LKETAESVLKKPVVDC[CAM]VVSVPC[CAM]FYTDAER.4|LEDTENWLYEDGEDQPK.3|LEDTENWLYEDGEDQPK.2|LMNETTAVALAYGIYKQDLPALEEK.4|MIMQDKLEKER.2|TSTVDLPIENQLLWQIDR.3|TSTVDLPIENQLLWQIDR.2|VNVHGIFSVSSASLVEVHKSEENEEPMETDQNAKEEEK.6|VNVHGIFSVSSASLVEVHKSEENEEPMETDQNAKEEEK.5|STNEAMEWMNNKLNLQNK.3|EM[Oxi]LNLYIENEGK.2|EMLNLYIENEGK.2|STNEAM[Oxi]EWMNNK.2|STNEAMEWM[Oxi]NNK.2|STNEAMEWMNNK.2|KPVVDC[CAM]VVSVPC[CAM]FYTDAER.3|KPVVDC[CAM]VVSVPC[CAM]FYTDAER.2|SEENEEPMETDQNAKEEEK.3|VKTSTVDLPIENQLLWQIDR.3|EPFTLEAYYSSPQDLPYPDPAIAQFSVQK.4|EPFTLEAYYSSPQDLPYPDPAIAQFSVQK.3|KEPFTLEAYYSSPQDLPYPDPAIAQFSVQK.4|KEPFTLEAYYSSPQDLPYPDPAIAQFSVQK.3|M[Oxi]QVDQEEPHVEEQQQQTPAENK.3|MQVDQEEPHVEEQQQQTPAENK.3|MQVDQEEPHVEEQQQQTPAENKAESEEMETSQAGSKDK.5|VTYMEEERNFTTEQVTAMLLSK.3|VKTSTVDLPIENQLLWQIDREMLNLYIENEGK.4|MQVDQEEPHVEEQQQQTPAENKAESEEMETSQAGSK.4|KLMSANASDLPLSIEC[CAM]FMNDVDVSGTMNR.3|VEPPKEEQKNAEQNGPVDGQGDNPGPQAAEQGTDTAVPSDSDK.4|NAEQNGPVDGQGDNPGPQAAEQGTDTAVPSDSDK.3|TSTVDLPIENQLLWQIDREMLNLYIENEGK.3
SEN / CTL,Proteasome subunit beta type-1,PSMB1,P20618,-0.07,0.32,3.61E-02,1.52E-02,1.82E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,viral process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","threonine-type endopeptidase activity,protein binding","proteasome complex,nucleus,nucleoplasm,cytosol,proteasome core complex,extracellular exosome",24,17,37,LVKDVFISAAERDVYTGDALR.4|LVKDVFISAAERDVYTGDALR.3|LSEGFSIHTR.2|AMTTGAIAAMLSTILYSR.3|AMTTGAIAAMLSTILYSR.2|AM[Oxi]TTGAIAAMLSTILYSR.3|AMTTGAIAAM[Oxi]LSTILYSR.3|AM[Oxi]TTGAIAAM[Oxi]LSTILYSR.3|AM[Oxi]TTGAIAAMLSTILYSR.2|AMTTGAIAAM[Oxi]LSTILYSR.2|AGGSASAMLQPLLDNQVGFK.3|AGGSASAM[Oxi]LQPLLDNQVGFK.3|AGGSASAMLQPLLDNQVGFK.2|AGGSASAM[Oxi]LQPLLDNQVGFK.2|RFFPYYVYNIIGGLDEEGKGAVYSFDPVGSYQR.4|LTDKTVIGC[CAM]SGFHGDC[CAM]LTLTK.4|LTDKTVIGC[CAM]SGFHGDC[CAM]LTLTK.3|AAGPLQLR.2|DVFISAAER.2|DVYTGDALR.2|GAVYSFDPVGSYQR.3|GAVYSFDPVGSYQR.2|NMQNVEHVPLSLDR.3|NM[Oxi]QNVEHVPLSLDR.3|NMQNVEHVPLSLDR.2|NM[Oxi]QNVEHVPLSLDR.2|RFFPYYVYNIIGGLDEEGK.4|RFFPYYVYNIIGGLDEEGK.3|RFFPYYVYNIIGGLDEEGK.2|TVIGC[CAM]SGFHGDC[CAM]LTLTK.3|TVIGC[CAM]SGFHGDC[CAM]LTLTK.2|EGIREETVSLR.2|DVFISAAERDVYTGDALR.3|DVFISAAERDVYTGDALR.2|LVKDVFISAAER.2|FFPYYVYNIIGGLDEEGK.3|FFPYYVYNIIGGLDEEGK.2
SEN / CTL,Adapter molecule crk,CRK,P46108,-0.07,0.34,6.21E-02,2.41E-02,1.62E+00,"activation of MAPKK activity,regulation of transcription from RNA polymerase II promoter,regulation of actin cytoskeleton organization,regulation of Rac protein signal transduction,Fc-gamma receptor signaling pathway involved in phagocytosis,regulation of GTPase activity,vascular endothelial growth factor receptor signaling pathway,ephrin receptor signaling pathway,positive regulation of substrate adhesion-dependent cell spreading","SH3/SH2 adaptor activity,protein binding,enzyme binding,SH2 domain binding,protein phosphorylated amino acid binding,ephrin receptor binding","nucleus,cytoplasm,cytosol,plasma membrane,actin cytoskeleton,extracellular exosome",21,23,29,VSHYIINSSGPRPPVPPSPAQPPPGVSPSR.4|LSRQEAVALLQGQR.3|QGSGVILRQEEAEYVR.3|DSSTSPGDYVLSVSENSR.2|IHYLDTTTLIEPVSR.3|IHYLDTTTLIEPVSR.2|IHYLDTTTLIEPVSR.4|IGDQEFDSLPALLEFYK.3|IGDQEFDSLPALLEFYK.2|HGVFLVR.2|RGMIPVPYVEK.3|RGMIPVPYVEK.2|SSWYWGR.2|GMIPVPYVEK.2|INVSGQWEGEC[CAM]NGKR.3|IRDKPEEQWWNAEDSEGKR.4|QEAVALLQGQR.2|ALFDFNGNDEEDLPFK.3|ALFDFNGNDEEDLPFK.2|TALALEVGELVK.2|DKPEEQWWNAEDSEGK.3|ALFDFNGNDEEDLPFKK.3|DKPEEQWWNAEDSEGKR.3|LLDQQNPDEDFS.2|IRDKPEEQWWNAEDSEGK.3|LRIGDQEFDSLPALLEFYK.3|YRPASASVSALIGGNQEGSHPQPLGGPEPGPYAQPSVNTPLPNLQNGPIYAR.7|YRPASASVSALIGGNQEGSHPQPLGGPEPGPYAQPSVNTPLPNLQNGPIYAR.5|INVSGQWEGEC[CAM]NGK.2
SEN / CTL,"6-phosphogluconate dehydrogenase, decarboxylating",PGD,P52209,-0.08,0.40,1.06E-01,3.73E-02,1.43E+00,"pentose-phosphate shunt,pentose-phosphate shunt, oxidative branch,pentose biosynthetic process,D-gluconate metabolic process,oxidation-reduction process",phosphogluconate dehydrogenase (decarboxylating) activity,"nucleus,cytosol,extracellular exosome",42,36,73,GILFVGSGVSGGEEGAR.2|GILFVGSGVSGGEEGAR.3|GTGKWTAISALEYGVPVTLIGEAVFAR.3|GTGKWTAISALEYGVPVTLIGEAVFAR.4|WTAISALEYGVPVTLIGEAVFAR.3|WTAISALEYGVPVTLIGEAVFAR.4|AKGILFVGSGVSGGEEGAR.3|TIFQGIAAK.2|VGTGEPC[CAM]C[CAM]DWVGDEGAGHFVK.3|VGTGEPC[CAM]C[CAM]DWVGDEGAGHFVK.4|VGTGEPC[CAM]C[CAM]DWVGDEGAGHFVK.2|LVPLLDTGDIIIDGGNSEYRDTTRR.4|LVPLLDTGDIIIDGGNSEYRDTTRR.3|AGQAVDDFIEK.2|TVSKVDDFLANEAK.3|TVSKVDDFLANEAK.2|IKDAFDRNPELQNLLLDDFFK.4|IKDAFDRNPELQNLLLDDFFK.3|IISYAQGFMLLR.2|IISYAQGFMLLR.3|IISYAQGFM[Oxi]LLR.2|LVPLLDTGDIIIDGGNSEYR.3|LVPLLDTGDIIIDGGNSEYR.2|EAWPHIK.2|SFLEDIR.2|SAVENC[CAM]QDSWR.3|SAVENC[CAM]QDSWR.2|FQDTDGKHLLPK.3|FQFDGDKK.2|HEMLPASLIQAQR.3|HEM[Oxi]LPASLIQAQR.3|HEM[Oxi]LPASLIQAQR.2|HEMLPASLIQAQR.2|SAVENC[CAM]QDSWRR.3|SAVENC[CAM]QDSWRR.2|DYFGAHTYELLAK.3|DYFGAHTYELLAK.2|SFLEDIRK.2|C[CAM]LSSLKDER.2|VDDFLANEAK.2|YGPSLMPGGNK.2|YGPSLM[Oxi]PGGNK.2|NPELQNLLLDDFFK.3|NPELQNLLLDDFFK.2|DAFDRNPELQNLLLDDFFK.4|DAFDRNPELQNLLLDDFFK.3|DAFDRNPELQNLLLDDFFK.2|PGQFIHTNWTGHGGTVSSSSYNA.4|PGQFIHTNWTGHGGTVSSSSYNA.3|LVPLLDTGDIIIDGGNSEYRDTTR.4|LVPLLDTGDIIIDGGNSEYRDTTR.3|M[Oxi]VHNGIEYGDMQLIC[CAM]EAYHLMK.4|MVHNGIEYGDM[Oxi]QLIC[CAM]EAYHLMK.4|MVHNGIEYGDMQLIC[CAM]EAYHLM[Oxi]K.4|MVHNGIEYGDMQLIC[CAM]EAYHLMK.4|M[Oxi]VHNGIEYGDMQLIC[CAM]EAYHLMK.3|MVHNGIEYGDMQLIC[CAM]EAYHLMK.3|VVGAQSLKEMVSK.2|AVSTGVQAGIPMPC[CAM]FTTALSFYDGYR.4|AVSTGVQAGIPMPC[CAM]FTTALSFYDGYR.3|AVSTGVQAGIPM[Oxi]PC[CAM]FTTALSFYDGYR.3|DVLGMAQDEMAQAFEDWNK.3|DVLGM[Oxi]AQDEM[Oxi]AQAFEDWNK.3|DVLGM[Oxi]AQDEMAQAFEDWNK.3|DVLGMAQDEM[Oxi]AQAFEDWNK.3|DVLGM[Oxi]AQDEMAQAFEDWNK.2|DVLGMAQDEMAQAFEDWNK.2|DYFGAHTYELLAKPGQFIHTNWTGHGGTVSSSSYNA.5|DYFGAHTYELLAKPGQFIHTNWTGHGGTVSSSSYNA.4|RAVSTGVQAGIPMPC[CAM]FTTALSFYDGYRHEMLPASLIQAQR.5|RAVSTGVQAGIPM[Oxi]PC[CAM]FTTALSFYDGYR.3|RAVSTGVQAGIPMPC[CAM]FTTALSFYDGYR.3|AVSTGVQAGIPMPC[CAM]FTTALSFYDGYRHEMLPASLIQAQR.4
SEN / CTL,Nuclear transport factor 2,NUTF2,P61970,-0.08,0.20,4.06E-02,1.68E-02,1.78E+00,"protein import into nucleus, translocation,protein import into nucleus,protein export from nucleus,positive regulation of protein import into nucleus,protein transmembrane transport,protein localization to nuclear pore,negative regulation of vascular endothelial growth factor production","protein binding,protein transmembrane transporter activity,Ran GTPase binding","nuclear outer membrane,nucleoplasm,cytosol,nuclear membrane,nuclear pore central transport channel,extracellular exosome",12,8,20,NINDAWVC[CAM]TNDMFR.2|NINDAWVC[CAM]TNDMFR.3|NINDAWVC[CAM]TNDM[Oxi]FR.2|IQHSITAQDHQPTPDSC[CAM]IISMVVGQLK.4|IQHSITAQDHQPTPDSC[CAM]IISMVVGQLK.5|IQHSITAQDHQPTPDSC[CAM]IISM[Oxi]VVGQLK.4|IQHSITAQDHQPTPDSC[CAM]IISMVVGQLK.3|IQHSITAQDHQPTPDSC[CAM]IISM[Oxi]VVGQLK.3|IQHSITAQDHQPTPDSC[CAM]IISMVVGQLKADEDPIMGFHQMFLLK.6|IQHSITAQDHQPTPDSC[CAM]IISMVVGQLKADEDPIMGFHQM[Oxi]FLLK.6|IQHSITAQDHQPTPDSC[CAM]IISMVVGQLKADEDPIMGFHQMFLLK.5|LSSLPFQK.2|AAIVEKLSSLPFQK.3|AAIVEKLSSLPFQK.2|ADEDPIMGFHQMFLLK.3|ADEDPIM[Oxi]GFHQMFLLK.3|ADEDPIMGFHQM[Oxi]FLLK.3|ADEDPIMGFHQMFLLK.2|TQLGAIYIDASC[CAM]LTWEGQQFQGK.3|PIWEQIGSSFIQHYYQLFDNDR.3
SEN / CTL,"Nascent polypeptide-associated complex subunit alpha, muscle-specific form;Nascent polypeptide-associated complex subunit alpha",NACA,E9PAV3;Q13765,-0.08,0.13,4.87E-02,1.96E-02,1.71E+00,"transcription, DNA-templated,regulation of transcription, DNA-templated;",DNA binding;,"nucleus,cytoplasm;",9,2,4,IEDLSQQAQLAAAEK.3|IEDLSQQAQLAAAEK.2|SPASDTYIVFGEAK.2|SPASDTYIVFGEAK.3
SEN / CTL,Fructose-bisphosphate aldolase C,ALDOC,P09972,-0.08,0.27,1.57E-03,1.13E-03,2.95E+00,"fructose metabolic process,gluconeogenesis,fructose 1,6-bisphosphate metabolic process,epithelial cell differentiation,canonical glycolysis","fructose-bisphosphate aldolase activity,protein binding,cytoskeletal protein binding","mitochondrion,cytosol,cytoskeleton,extracellular exosome",30,27,42,VDKGVVPLAGTDGETTTQGLDGLSER.3|VDKGVVPLAGTDGETTTQGLDGLSER.4|TPSALAILENANVLAR.2|TPSALAILENANVLAR.3|C[CAM]PLPRPWALTFSYGR.3|ALQASALNAWR.2|GVVPLAGTDGETTTQGLDGLSER.3|GVVPLAGTDGETTTQGLDGLSER.4|GVVPLAGTDGETTTQGLDGLSER.2|GILAADESVGSMAK.2|GILAADESVGSM[Oxi]AK.2|DNAGAATEEFIK.2|PHSYPALSAEQK.3|PHSYPALSAEQK.2|RLSQIGVENTEENRR.4|RLSQIGVENTEENRR.3|ELSDIALR.2|PNMVTPGHAC[CAM]PIK.3|DDNGVPFVR.2|ALSDHHVYLEGTLLKPNMVTPGHAC[CAM]PIK.6|ALSDHHVYLEGTLLKPNM[Oxi]VTPGHAC[CAM]PIK.6|ALSDHHVYLEGTLLKPNM[Oxi]VTPGHAC[CAM]PIK.5|ALSDHHVYLEGTLLKPNMVTPGHAC[CAM]PIK.5|ALSDHHVYLEGTLLKPNMVTPGHAC[CAM]PIK.4|ALSDHHVYLEGTLLKPNM[Oxi]VTPGHAC[CAM]PIK.4|AEVNGLAAQGK.2|QVLFSADDR.2|LSQIGVENTEENRR.3|RLSQIGVENTEENR.3|YTPEEIAMATVTALR.3|YTPEEIAMATVTALR.2|ALSDHHVYLEGTLLK.3|C[CAM]IGGVIFFHETLYQK.3|C[CAM]IGGVIFFHETLYQK.2|RAEVNGLAAQGK.2|YTPEEIAMATVTALRR.3|DNAGAATEEFIKR.2|ISERTPSALAILENANVLAR.3|LSQIGVENTEENR.2|YEGSGEDGGAAAQSLYIANHAY.3|YEGSGEDGGAAAQSLYIANHAY.2|ALSDHHVYLEGTLLKPNMVTPGHAC[CAM]PIKYTPEEIAMATVTALR.6
SEN / CTL,Heat shock 70 kDa protein 4L,HSPA4L,O95757,-0.09,0.10,1.41E-01,4.67E-02,1.33E+00,"protein folding,response to unfolded protein",ATP binding,"nucleus,cytoplasm,cytosol",3,48,66,SGGIETIANEYSDR.2|QDLPPLDEKPR.3|SSGEM[Oxi]EVD.2|MQVDQEEGHQK.3|MQVDQEEGHQK.2|NHPAPFSK.2|SQIVTNVR.2|YDHLDPTEMEK.3|YDHLDPTEMEK.2|NAVEEYVYDFR.3|NAVEEYVYDFR.2|YGQPIQMK.2|LYQEC[CAM]EK.2|C[CAM]HAEHTPEEEIDHTGAK.4|C[CAM]HAEHTPEEEIDHTGAK.3|DISTTLNADEAVAR.3|DISTTLNADEAVAR.2|ELDNFC[CAM]NPIIYKPKPK.4|AQFEQLC[CAM]ASLLAR.3|AQFEQLC[CAM]ASLLAR.2|AEVPEDKPK.2|FITPEDLSK.2|LSLTQDPVVK.2|SKELDNFC[CAM]NPIIYKPKPK.4|AVMEQANLQR.2|AVM[Oxi]EQANLQR.2|KPVADC[CAM]VISIPSFFTDAERR.4|KPVADC[CAM]VISIPSFFTDAERR.3|ELDNFC[CAM]NPIIYKPK.3|VNIHGIFSVASASVIEK.3|VNIHGIFSVASASVIEK.2|NVVFIDMGHSAYQVLVC[CAM]AFNK.4|NVVFIDMGHSAYQVLVC[CAM]AFNK.3|QLGQDLLNSYIENEGK.3|QLGQDLLNSYIENEGK.2|C[CAM]TPAC[CAM]ISLGSR.2|YMEHEERPK.2|ANSEHNGPMDGQSGTETK.3|ANSEHNGPM[Oxi]DGQSGTETK.3|ANSEHNGPMDGQSGTETK.2|NFDEALVDYFC[CAM]DEFK.3|NFDEALVDYFC[CAM]DEFK.2|SFDDPIVQTER.2|VRYLEEERPFAIEQVTGMLLAK.4|VRYLEEERPFAIEQVTGMLLAK.3|KEPFELEAFYTNLHEVPYPDAR.4|KEPFELEAFYTNLHEVPYPDAR.3|IGSFTIQNVFPQSDGDSSK.3|IGSFTIQNVFPQSDGDSSK.2|VREFSITDLVPYSITLR.3|SIDLPIQSSLC[CAM]R.2|C[CAM]ISDAMSWLNSK.2|VLATTFDPYLGGR.2|QNLEGDHSDAPMETETSFK.3|EDISSIEIVGGATR.2|KPVADC[CAM]VISIPSFFTDAER.3|KPVADC[CAM]VISIPSFFTDAER.2|LMNETTAVALAYGIYKQDLPPLDEKPR.4|SVMAAAQVAGLNC[CAM]LR.2|YLEEERPFAIEQVTGMLLAK.3|LSAVLEDTENWLYEDGEDQPK.3|EPFELEAFYTNLHEVPYPDAR.3|EFSITDLVPYSITLR.2|TSFEDGSGEC[CAM]EVFC[CAM]K.2|LMSANASDLPLNIEC[CAM]FMNDLDVSSK.3|KLMSANASDLPLNIEC[CAM]FMNDLDVSSK.3
SEN / CTL,Annexin A6,ANXA6,P08133,-0.10,0.34,3.66E-03,2.34E-03,2.63E+00,"calcium ion transport,regulation of muscle contraction,ion transmembrane transport,protein homooligomerization,mitochondrial calcium ion homeostasis,apoptotic signaling pathway","calcium ion binding,protein binding,GTP binding,calcium-dependent phospholipid binding,lipid binding,ligand-gated ion channel activity,cholesterol binding,protein homodimerization activity,calcium-dependent protein binding","mitochondrion,lysosomal membrane,focal adhesion,membrane,late endosome membrane,melanosome,perinuclear region of cytoplasm,extracellular exosome",96,72,121,GFGSDKEAILDIITSR.3|GFGSDKEAILDIITSR.2|ALIEILATR.2|LVFDEYLK.2|C[CAM]LIEILASR.2|DAFVAIVQSVK.2|SEIDLLNIRR.3|LSGGDDDAAGQFFPEAAQVAYQMWELSAVAR.3|LSGGDDDAAGQFFPEAAQVAYQMWELSAVAR.4|ALLALC[CAM]GGED.2|ALLALC[CAM]GGED.1|GLGTDEDTIIDIITHR.3|GLGTDEDTIIDIITHR.2|EIKDAISGIGTDEKC[CAM]LIEILASR.4|EIKDAISGIGTDEKC[CAM]LIEILASR.3|SLEDALSSDTSGHFRR.4|SLEDALSSDTSGHFRR.3|SLEDALSSDTSGHFRR.2|AM[Oxi]EGAGTDEKALIEILATR.3|SLHQAIEGDTSGDFLK.3|SLHQAIEGDTSGDFLK.2|VELKGTVRPANDFNPDADAK.4|VELKGTVRPANDFNPDADAK.3|SELDMLDIR.2|SELDM[Oxi]LDIR.2|FMTILC[CAM]TR.2|FM[Oxi]TILC[CAM]TR.2|SELDMLDIREIFR.3|SELDM[Oxi]LDIREIFR.3|EMSGDVRDAFVAIVQSVK.3|EM[Oxi]SGDVRDAFVAIVQSVK.3|SEIDLLNIR.2|LIVGLMRPPAYC[CAM]DAK.3|LIVGLM[Oxi]RPPAYC[CAM]DAK.3|LIVGLM[Oxi]RPPAYC[CAM]DAK.2|DLMTDLKSEISGDLAR.3|DLM[Oxi]TDLKSEISGDLAR.3|DLMTDLKSEISGDLAR.2|YRGSIHDFPGFDPNQDAEALYTAMK.4|YRGSIHDFPGFDPNQDAEALYTAM[Oxi]K.3|YRGSIHDFPGFDPNQDAEALYTAMK.3|WGTDEAQFIYILGNR.3|WGTDEAQFIYILGNR.2|LILGLMMPPAHYDAK.3|LILGLMMPPAHYDAK.4|LILGLM[Oxi]MPPAHYDAK.3|LILGLMM[Oxi]PPAHYDAK.3|LILGLMMPPAHYDAK.2|DLEADIIGDTSGHFQK.3|DLEADIIGDTSGHFQK.2|DLMTDLK.2|PLFFADK.2|SLYSMIK.2|QRQEVC[CAM]QSYK.3|QRQEVC[CAM]QSYK.2|MTNYDVEHTIK.3|MTNYDVEHTIK.2|SLYGKDLIADLK.3|SLYGKDLIADLK.2|VFQEFIK.2|SEISGDLAR.2|AINEAYKEDYHK.3|DLIADLKYELTGK.3|DLIADLKYELTGK.2|EIKDAISGIGTDEK.3|EIKDAISGIGTDEK.2|GELSGDFEK.2|MTNYDVEHTIKK.3|M[Oxi]TNYDVEHTIKK.3|MTNYDVEHTIKK.2|M[Oxi]TNYDVEHTIKK.2|AMEGAGTDEK.2|SLYGKDLIADLKYELTGK.4|SLYGKDLIADLKYELTGK.3|TNEQM[Oxi]HQLVAAYK.3|TNEQMHQLVAAYK.3|TNEQMHQLVAAYK.2|TNEQM[Oxi]HQLVAAYK.2|QEVC[CAM]QSYK.2|RVFQEFIK.2|TTGKPIEASIRGELSGDFEK.4|TTGKPIEASIRGELSGDFEK.3|ILISLATGHR.2|NKPLFFADK.2|SLEDALSSDTSGHFR.3|SLEDALSSDTSGHFR.2|TNEQMHQLVAAYKDAYER.4|TNEQMHQLVAAYKDAYER.3|DAISGIGTDEK.2|STPEYFAER.2|EAILDIITSR.2|GTVRPANDFNPDADAK.3|GTVRPANDFNPDADAK.2|MLVVLLQGTR.2|M[Oxi]LVVLLQGTR.2|GAGTDEKTLTR.2|ILISLATGHREEGGENLDQAR.4|ILISLATGHREEGGENLDQAR.3|KAMEGAGTDEK.2|TTGKPIEASIRGELSGDFEKLMLAVVK.5|TTGKPIEASIR.2|DAYERDLEADIIGDTSGHFQK.4|DAYERDLEADIIGDTSGHFQK.3|EEGGENLDQAR.2|DLIADLKYELTGKFER.3|GSIHDFPGFDPNQDAEALYTAMK.4|GSIHDFPGFDPNQDAEALYTAM[Oxi]K.3|GSIHDFPGFDPNQDAEALYTAMK.3|PANDFNPDADAK.2|TNEQMHQLVAAYKDAYERDLEADIIGDTSGHFQK.6|TNEQMHQLVAAYKDAYERDLEADIIGDTSGHFQK.4|EDAQVAAEILEIADTPSGDK.3|EDAQVAAEILEIADTPSGDK.2|EDAQVAAEILEIADTPSGDKTSLETR.4|EDAQVAAEILEIADTPSGDKTSLETR.3|DAISGIGTDEKC[CAM]LIEILASR.3|ILISLATGHREEGGENLDQAREDAQVAAEILEIADTPSGDK.5|EEDDVVSEDLVQQDVQDLYEAGELK.3|EEGGENLDQAREDAQVAAEILEIADTPSGDKTSLETR.4|M[Oxi]LVVLLQGTREEDDVVSEDLVQQDVQDLYEAGELK.4|EEGGENLDQAREDAQVAAEILEIADTPSGDK.3
SEN / CTL,"Single-stranded DNA-binding protein, mitochondrial",SSBP1,Q04837,-0.11,0.35,5.61E-02,2.22E-02,1.65E+00,"DNA replication,mitochondrion organization,positive regulation of helicase activity,mitochondrion morphogenesis","chromatin binding,single-stranded DNA binding,poly(A) RNA binding","nucleus,mitochondrion,mitochondrial matrix,mitochondrial nucleoid,extracellular exosome",12,10,18,QVEGKNPVTIFSLATNEMWR.3|NPVTIFSLATNEMWR.3|NPVTIFSLATNEMWR.2|NPVTIFSLATNEM[Oxi]WR.3|NPVTIFSLATNEM[Oxi]WR.2|SGDSEVYQLGDVSQK.2|SGDSEVYQLGDVSQK.3|VGQDPVLR.2|DVAYQYVK.2|IDYGEYMDKNNVR.3|IDYGEYMDKNNVR.2|IDYGEYMDK.2|IDYGEYM[Oxi]DK.2|QATTIIADNIIFLSDQTK.3|QATTIIADNIIFLSDQTK.2|RQATTIIADNIIFLSDQTK.3|RQATTIIADNIIFLSDQTK.2|QATTIIADNIIFLSDQTKEKE.3
SEN / CTL,Rab GDP dissociation inhibitor alpha,GDI1,P31150,-0.12,0.38,4.72E-02,1.91E-02,1.72E+00,"signal transduction,protein transport,Rab protein signal transduction,positive regulation of GTPase activity,negative regulation of axonogenesis,regulation of small GTPase mediated signal transduction,response to calcium ion,oxidation-reduction process,negative regulation of protein targeting to membrane","GDP-dissociation inhibitor activity,Rab GDP-dissociation inhibitor activity,GTPase activator activity,protein binding,oxidoreductase activity,Rab GTPase binding","cytoplasm,Golgi apparatus,cytosol,midbody,neuron projection,myelin sheath,protein complex",36,28,53,IIC[CAM]ILSHPIKNTNDANSC[CAM]QIIIPQNQVNR.4|TDDYLDQPC[CAM]LETVNR.2|TDDYLDQPC[CAM]LETVNR.3|QLIC[CAM]DPSYIPDR.2|VLHMDRNPYYGGESSSITPLEELYKR.5|VLHMDRNPYYGGESSSITPLEELYKR.4|VVEGSFVYK.2|FQLLEGPPESMGR.2|FQLLEGPPESM[Oxi]GR.2|IYKVPSTETEALASNLMGMFEK.3|IYKVPSTETEALASNLMGMFEK.4|IYKVPSTETEALASNLMGM[Oxi]FEK.3|KSDIYVC[CAM]MISYAHNVAAQGK.4|KSDIYVC[CAM]MISYAHNVAAQGK.3|MAGTAFDFENMKR.3|M[Oxi]AGTAFDFENMKR.3|MAGTAFDFENMKR.2|YIAIASTTVETTDPEKEVEPALELLEPIDQK.4|YIAIASTTVETTDPEKEVEPALELLEPIDQK.3|RMAGTAFDFENMK.3|RMAGTAFDFENMK.2|RFQLLEGPPESMGR.3|RFQLLEGPPESM[Oxi]GR.3|RFQLLEGPPESMGR.2|EVEPALELLEPIDQK.3|EVEPALELLEPIDQK.2|QNDVFGEAEQ.2|YIAIASTTVETTDPEK.3|YIAIASTTVETTDPEK.2|IIC[CAM]ILSHPIK.2|KQNDVFGEAEQ.2|TFEGVDPQTTSMRDVYR.3|MAGTAFDFENMK.2|M[Oxi]AGTAFDFENMK.2|MAGTAFDFENM[Oxi]K.2|VPSTETEALASNLMGMFEK.3|VPSTETEALASNLM[Oxi]GMFEK.3|VPSTETEALASNLMGM[Oxi]FEK.3|VPSTETEALASNLMGMFEK.2|RKQNDVFGEAEQ.2|SDIYVC[CAM]M[Oxi]ISYAHNVAAQGK.3|SDIYVC[CAM]MISYAHNVAAQGK.3|SDIYVC[CAM]MISYAHNVAAQGK.2|NPYYGGESSSITPLEELYK.3|NPYYGGESSSITPLEELYK.2|VLHMDRNPYYGGESSSITPLEELYK.4|VLHMDRNPYYGGESSSITPLEELYK.3|TFEGVDPQTTSMR.2|TFEGVDPQTTSM[Oxi]R.2|NPYYGGESSSITPLEELYKR.3|FLVFVANFDENDPK.2|LSAIYGGTYMLNKPVDDIIMENGK.3|LSAIYGGTYM[Oxi]LNKPVDDIIM[Oxi]ENGK.3
SEN / CTL,Rab GDP dissociation inhibitor beta,GDI2,P50395,-0.12,0.71,3.33E-02,1.43E-02,1.84E+00,"signal transduction,small GTPase mediated signal transduction,protein transport,vesicle-mediated transport,positive regulation of GTPase activity,regulation of small GTPase mediated signal transduction,oxidation-reduction process","Rab GDP-dissociation inhibitor activity,GTPase activator activity,protein binding,oxidoreductase activity,small GTPase binding,poly(A) RNA binding","cytoplasm,Golgi apparatus,cytosol,focal adhesion,membrane,vesicle,myelin sheath,extracellular exosome",105,56,113,DLGTESQIFISR.2|TDDYLDQPC[CAM]YETINR.2|TDDYLDQPC[CAM]YETINR.3|GRDWNVDLIPK.2|GRDWNVDLIPK.3|FKIPGSPPESMGR.3|YGKSPYLYPLYGLGELPQGFAR.3|TYDATTHFETTC[CAM]DDIKNIYKR.4|TYDATTHFETTC[CAM]DDIKNIYKR.5|VLHMDRNPYYGGESASITPLEDLYKR.5|VLHMDRNPYYGGESASITPLEDLYKR.4|VLHM[Oxi]DRNPYYGGESASITPLEDLYKR.5|SPYLYPLYGLGELPQGFAR.3|SPYLYPLYGLGELPQGFAR.4|SPYLYPLYGLGELPQGFAR.2|KFDLGQDVIDFTGHALALYR.3|KFDLGQDVIDFTGHALALYR.4|KFDLGQDVIDFTGHALALYR.2|MLLYTEVTR.2|M[Oxi]LLYTEVTR.2|FVSISDLLVPK.2|FVSISDLLVPK.3|YLDFKVTEGSFVYK.3|IYKVPSTEAEALASSLMGLFEK.3|IYKVPSTEAEALASSLMGLFEK.4|IYKVPSTEAEALASSLM[Oxi]GLFEK.4|IYKVPSTEAEALASSLM[Oxi]GLFEK.3|IYKVPSTEAEALASSLMGLFEK.2|VIC[CAM]ILSHPIKNTNDANSC[CAM]QIIIPQNQVNR.4|VIC[CAM]ILSHPIKNTNDANSC[CAM]QIIIPQNQVNR.3|VIC[CAM]ILSHPIKNTNDANSC[CAM]QIIIPQNQVNR.5|TYDATTHFETTC[CAM]DDIK.3|TYDATTHFETTC[CAM]DDIK.2|KSDIYVC[CAM]MISFAHNVAAQGK.4|KSDIYVC[CAM]MISFAHNVAAQGK.3|KSDIYVC[CAM]M[Oxi]ISFAHNVAAQGK.4|KSDIYVC[CAM]M[Oxi]ISFAHNVAAQGK.3|KSDIYVC[CAM]MISFAHNVAAQGK.2|FDLGQDVIDFTGHALALYR.3|FDLGQDVIDFTGHALALYR.4|FDLGQDVIDFTGHALALYR.2|LSAIYGGTYMLNKPIEEIIVQNGK.3|LSAIYGGTYMLNKPIEEIIVQNGK.4|LSAIYGGTYM[Oxi]LNKPIEEIIVQNGK.3|LYSESLAR.2|MTGSEFDFEEMKR.3|M[Oxi]TGSEFDFEEMKR.3|MTGSEFDFEEM[Oxi]KR.3|MTGSEFDFEEMKR.2|VPSTEAEALASSLMGLFEK.3|VPSTEAEALASSLM[Oxi]GLFEK.3|VPSTEAEALASSLM[Oxi]GLFEK.2|VPSTEAEALASSLMGLFEK.2|YIAIVSTTVETKEPEKEIRPALELLEPIEQK.5|YIAIVSTTVETKEPEKEIRPALELLEPIEQK.4|NPYYGGESASITPLEDLYKR.3|NPYYGGESASITPLEDLYKR.2|FLVYVANFDEKDPR.3|FLVYVANFDEKDPR.2|VTEGSFVYKGGK.3|KFDLGQDVIDFTGHALALYRTDDYLDQPC[CAM]YETINR.5|KFDLGQDVIDFTGHALALYRTDDYLDQPC[CAM]YETINR.4|TFEGIDPK.2|KNDIYGED.2|QLIC[CAM]DPSYVKDR.3|VTEGSFVYK.2|RMTGSEFDFEEMK.3|RMTGSEFDFEEMK.2|KKNDIYGED.2|DWNVDLIPK.2|FLMANGQLVK.2|FLM[Oxi]ANGQLVK.2|EPEKEIRPALELLEPIEQK.4|EPEKEIRPALELLEPIEQK.3|IPGSPPESMGR.2|IPGSPPESM[Oxi]GR.2|NTNDANSC[CAM]QIIIPQNQVNRK.4|NTNDANSC[CAM]QIIIPQNQVNRK.3|NTNDANSC[CAM]QIIIPQNQVNRK.2|RMTGSEFDFEEMKR.3|RM[Oxi]TGSEFDFEEMKR.3|RMTGSEFDFEEM[Oxi]KR.3|EIRPALELLEPIEQK.3|EIRPALELLEPIEQK.2|VIC[CAM]ILSHPIK.2|YIAIVSTTVETKEPEK.3|YIAIVSTTVETKEPEK.2|QLIC[CAM]DPSYVK.2|TYDATTHFETTC[CAM]DDIKNIYK.4|TYDATTHFETTC[CAM]DDIKNIYK.3|PIEEIIVQNGK.2|YIAIVSTTVETK.2|FLVYVANFDEK.2|PALELLEPIEQK.2|NPYYGGESASITPLEDLYK.3|NPYYGGESASITPLEDLYK.2|SDIYVC[CAM]MISFAHNVAAQGK.3|SDIYVC[CAM]M[Oxi]ISFAHNVAAQGK.3|SDIYVC[CAM]M[Oxi]ISFAHNVAAQGK.2|SDIYVC[CAM]MISFAHNVAAQGK.2|LSAIYGGTYMLNK.2|VLHM[Oxi]DRNPYYGGESASITPLEDLYK.4|VLHMDRNPYYGGESASITPLEDLYK.4|VLHM[Oxi]DRNPYYGGESASITPLEDLYK.3|VLHMDRNPYYGGESASITPLEDLYK.3|M[Oxi]TGSEFDFEEMK.2|MTGSEFDFEEM[Oxi]K.2|MTGSEFDFEEMK.2|NTNDANSC[CAM]QIIIPQNQVNR.3|NTNDANSC[CAM]QIIIPQNQVNR.2|EIRPALELLEPIEQKFVSISDLLVPK.4|KVLHMDRNPYYGGESASITPLEDLYK.4|FVSISDLLVPKDLGTESQIFISR.3
SEN / CTL,Glycogenin-1,GYG1,P46976,-0.12,0.47,1.47E-01,4.80E-02,1.32E+00,"glycogen biosynthetic process,glycogen catabolic process","protein binding,glycogenin glucosyltransferase activity,metal ion binding","cytosol,membrane,lysosomal lumen,extracellular exosome",9,11,16,GALVLGSSLK.2|LVVLATPQVSDSMR.2|LVVLATPQVSDSMR.3|WEQGQADYMGADSFDNIKR.3|VKPWNYTYDPK.3|VKPWNYTYDPK.2|LHC[CAM]WSLTQYSK.3|LHC[CAM]WSLTQYSK.2|LVVLATPQVSDSMRK.3|RLVVLATPQVSDSMR.3|RLVVLATPQVSDSMR.2|RPELGVTLTK.2|ERWEQGQADYMGADSFDNIKR.4|ERWEQGQADYMGADSFDNIKR.3|ERWEQGQADYMGADSFDNIK.3|VLETVFDEVIMVDVLDSGDSAHLTLMK.3
SEN / CTL,X-ray repair cross-complementing protein 6,XRCC6,P12956,-0.13,0.51,1.12E-01,3.89E-02,1.41E+00,"telomere maintenance,DNA ligation,double-strand break repair via nonhomologous end joining,DNA recombination,transcription, DNA-templated,brain development,positive regulation of type I interferon production,DNA duplex unwinding,negative regulation of transcription, DNA-templated,positive regulation of transcription, DNA-templated,positive regulation of transcription from RNA polymerase II promoter,regulation of smooth muscle cell proliferation,protein heterotetramerization,cellular hyperosmotic salinity response,cellular response to gamma radiation,cellular response to X-ray,establishment of integrated proviral latency,double-strand break repair via classical nonhomologous end joining","DNA binding,damaged DNA binding,double-stranded DNA binding,ATP-dependent DNA helicase activity,protein binding,ATP binding,protein C-terminus binding,transcription regulatory region DNA binding,poly(A) RNA binding,macromolecular complex binding,5'-deoxyribose-5-phosphate lyase activity,double-stranded telomeric DNA binding","nuclear telomere cap complex,nuclear chromosome, telomeric region,nucleus,nucleoplasm,transcription factor complex,nucleolus,cytosol,membrane,Ku70:Ku80 complex,nonhomologous end joining complex",42,66,122,DSLIFLVDASK.2|SDSFENPVLQQHFR.3|SDSFENPVLQQHFR.2|NIYVLQELDNPGAKR.3|NIYVLQELDNPGAKR.2|LGSLVDEFKELVYPPDYNPEGK.3|LGSLVDEFKELVYPPDYNPEGK.4|KPGGFDISLFYR.3|KPGGFDISLFYR.2|NLEALALDLMEPEQAVDLTLPK.3|NLEALALDLMEPEQAVDLTLPK.4|NLEALALDLM[Oxi]EPEQAVDLTLPK.3|ILELDQFK.2|VEYSEEELKTHISK.4|VEYSEEELKTHISK.3|TFNTSTGGLLLPSDTKR.3|TFNTSTGGLLLPSDTKR.2|NIYVLQELDNPGAK.2|NIYVLQELDNPGAK.3|AGDLRDTGIFLDLMHLK.3|AGDLRDTGIFLDLMHLK.4|AGDLRDTGIFLDLM[Oxi]HLK.4|DTGIFLDLMHLK.3|DTGIFLDLM[Oxi]HLK.3|DTGIFLDLMHLK.2|DTGIFLDLM[Oxi]HLK.2|EVAALC[CAM]R.2|FTVPMLK.2|LYRETNEPVK.3|LYRETNEPVK.2|VHFEESSKLEDLLR.4|VHFEESSKLEDLLR.3|VHFEESSKLEDLLR.2|ALKPPPIK.2|QIILEKEETEELKR.4|QIILEKEETEELKR.3|C[CAM]LEKEVAALC[CAM]R.3|ILELDQFKGQQGQKR.4|DIISIAEDEDLR.3|DIISIAEDEDLR.2|VHFEESSKLEDLLRK.4|VHFEESSKLEDLLRK.3|RSQIYGSR.2|VHFEESSK.2|LYRETNEPVKTK.3|ELVYPPDYNPEGK.3|ELVYPPDYNPEGK.2|IISSDRDLLAVVFYGTEK.4|IISSDRDLLAVVFYGTEK.3|IISSDRDLLAVVFYGTEK.2|LGSLVDEFK.2|RFDDPGLMLMGFK.3|RFDDPGLMLMGFK.2|RIMLFTNEDNPHGNDSAK.4|RIM[Oxi]LFTNEDNPHGNDSAK.4|RIMLFTNEDNPHGNDSAK.3|TRTFNTSTGGLLLPSDTKR.4|QELLEALTK.2|SGLKKQELLEALTK.3|SGLKKQELLEALTK.2|IMATPEQVGK.2|IM[Oxi]ATPEQVGK.2|QIILEKEETEELK.3|TKAGDLRDTGIFLDLMHLK.4|FDDPGLM[Oxi]LMGFKPLVLLKK.4|FDDPGLMLM[Oxi]GFKPLVLLKK.4|FDDPGLMLMGFKPLVLLKK.4|FDDPGLMLMGFKPLVLLKK.3|ILELDQFKGQQGQK.3|ILELDQFKGQQGQK.2|RFDDPGLM[Oxi]LMGFKPLVLLK.4|RFDDPGLMLM[Oxi]GFKPLVLLK.4|RFDDPGLMLMGFKPLVLLK.4|RFDDPGLM[Oxi]LM[Oxi]GFKPLVLLK.4|RFDDPGLM[Oxi]LMGFKPLVLLK.3|RFDDPGLMLM[Oxi]GFKPLVLLK.3|RFDDPGLMLMGFKPLVLLK.3|RFDDPGLM[Oxi]LM[Oxi]GFKPLVLLK.3|TFNTSTGGLLLPSDTK.3|TFNTSTGGLLLPSDTK.2|YSGRDSLIFLVDASK.3|YSGRDSLIFLVDASK.2|VEYSEEELK.2|FTYRSDSFENPVLQQHFR.4|IISSDRDLLAVVFYGTEKDK.4|IISSDRDLLAVVFYGTEKDK.3|IQVTPPGFQLVFLPFADDKR.4|IQVTPPGFQLVFLPFADDKR.3|RFDDPGLMLMGFKPLVLLKK.4|RILELDQFK.2|KQELLEALTK.2|NIPPYFVALVPQEEELDDQK.4|NIPPYFVALVPQEEELDDQK.3|NIPPYFVALVPQEEELDDQK.2|RLGSLVDEFK.2|IQVTPPGFQLVFLPFADDKRK.4|IM[Oxi]LFTNEDNPHGNDSAK.3|IMLFTNEDNPHGNDSAK.3|IMLFTNEDNPHGNDSAK.2|LNKDIVISVGIYNLVQK.3|LNKDIVISVGIYNLVQK.2|TRTFNTSTGGLLLPSDTK.3|RLGSLVDEFKELVYPPDYNPEGK.4|RLGSLVDEFKELVYPPDYNPEGK.3|DLLAVVFYGTEK.2|FDDPGLMLMGFK.2|FDDPGLM[Oxi]LMGFKPLVLLK.3|FDDPGLMLM[Oxi]GFKPLVLLK.3|FDDPGLMLMGFKPLVLLK.3|FDDPGLM[Oxi]LM[Oxi]GFKPLVLLK.3|FDDPGLMLMGFKPLVLLK.2|HHYLRPSLFVYPEESLVIGSSTLFSALLIK.5|HHYLRPSLFVYPEESLVIGSSTLFSALLIK.4|IQVTPPGFQLVFLPFADDK.3|IQVTPPGFQLVFLPFADDK.2|KHHYLRPSLFVYPEESLVIGSSTLFSALLIK.5|KHHYLRPSLFVYPEESLVIGSSTLFSALLIK.4|DIISIAEDEDLRVHFEESSKLEDLLR.4|DIVISVGIYNLVQK.2|RNIPPYFVALVPQEEELDDQK.3|TEGDEEAEEEQEENLEASGDYK.3|AMFESQSEDELTPFDMSIQC[CAM]IQSVYISK.3
SEN / CTL,Prefoldin subunit 2,PFDN2,Q9UHV9,-0.13,0.23,1.47E-01,4.80E-02,1.32E+00,"protein folding,positive regulation of cytoskeleton organization","protein binding,protein binding involved in protein folding,unfolded protein binding","nucleus,nucleoplasm,nucleolus,cytoplasm,mitochondrion,prefoldin complex,extracellular exosome",12,9,15,GAVSAEQVIAGFNR.3|GAVSAEQVIAGFNR.2|IIETLTQQLQAK.2|IIETLTQQLQAK.3|LM[Oxi]GEDEKPAAK.3|LMGEDEKPAAK.2|MVGGVLVER.2|M[Oxi]VGGVLVER.2|EVLPALENNK.2|EVLPALENNKEQIQK.3|AAELEMELNEHSLVIDTLKEVDETRK.5|AAELEMELNEHSLVIDTLKEVDETRK.4|TVKEVLPALENNKEQIQK.3|AAELEM[Oxi]ELNEHSLVIDTLK.3|AAELEMELNEHSLVIDTLK.3
SEN / CTL,Alpha-N-acetylglucosaminidase,NAGLU,P54802,-0.13,0.39,3.24E-02,1.40E-02,1.85E+00,"glycosaminoglycan catabolic process,lysosome organization,nervous system development,cerebellar Purkinje cell layer development,middle ear morphogenesis,locomotor rhythm,retinal rod cell development,inner ear receptor cell development",alpha-N-acetylglucosaminidase activity,"lysosome,lysosomal lumen,extracellular exosome",30,21,31,ALAAKPGLDTYSLGGGGAAR.3|FLLGSWLEQAR.2|KDPVPDLAAWVTSFAAR.3|YDLLDLTR.2|AGGVLAYELLPALDEVLASDSR.3|AGGVLAYELLPALDEVLASDSR.2|AAAVSEAEADFYEQNSR.3|AAAVSEAEADFYEQNSR.2|LLVLDLFAESQPVYTR.3|LLVLDLFAESQPVYTR.2|LLGPGPAADFSVSVER.2|QLAGLVANYYTPR.2|QLAGLVANYYTPR.3|SFGMTPVLPAFAGHVPEAVTR.3|SFGM[Oxi]TPVLPAFAGHVPEAVTR.3|SFGMTPVLPAFAGHVPEAVTR.2|YGVSHPDAGAAWR.3|LLLTSAPSLATSPAFR.3|LLLTSAPSLATSPAFR.2|GSTGVAAAAGLHR.2|DFC[CAM]GC[CAM]HVAWSGSQLR.3|DFC[CAM]GC[CAM]HVAWSGSQLR.2|LFLEALVDSVAQGIPFQQHQFDK.4|LFLEALVDSVAQGIPFQQHQFDK.3|LPRPLPAVPGELTEATPNR.3|GRLLVLDLFAESQPVYTR.3|PGLDTYSLGGGGAAR.2|YQLTLWGPEGNILDYANK.3|YQLTLWGPEGNILDYANK.2|NVFQLEQAFVLSK.2|DPVPDLAAWVTSFAAR.2
SEN / CTL,Puromycin-sensitive aminopeptidase,NPEPPS,P55786,-0.13,0.55,2.51E-03,1.66E-03,2.78E+00,"protein polyubiquitination,proteolysis,peptide catabolic process,cellular response to hypoxia,positive regulation of protein targeting to mitochondrion","aminopeptidase activity,zinc ion binding,peptide binding,metalloaminopeptidase activity","nucleus,cytosol,plasma membrane,extracellular exosome",102,55,85,LNLGTVGFYR.2|LGLQNDLFSLAR.2|AGIISTVEVLK.2|AFPC[CAM]WDEPAIK.2|ATFDISLVVPK.2|TIQQC[CAM]C[CAM]ENILLNAAWLKR.3|ATFDISLVVPKDR.3|VLGATLLPDLIQK.2|VLGATLLPDLIQK.3|DAESIHQYLLQR.3|DAESIHQYLLQR.2|VALSNMNVIDRKPYPDDENLVEVK.4|LGWDPKPGEGHLDALLR.4|LGWDPKPGEGHLDALLR.3|LGWDPKPGEGHLDALLR.2|QMGFPLIYVEAEQVEDDRLLR.3|SPVYLTVLK.2|YAAVTQFEATDARR.3|YAAVTQFEATDARR.2|ILMDKPEMNVVLK.3|ILMDKPEMNVVLK.2|LSVEGFAVDK.2|LSVEGFAVDK.1|HGDGTTLDIMLK.3|HGDGTTLDIMLK.2|HGDGTTLDIM[Oxi]LK.3|HGDGTTLDIM[Oxi]LK.2|TLPFYKDYFNVPYPLPK.3|TLPFYKDYFNVPYPLPK.2|TQYSSAMLESLLPGIR.3|TQYSSAMLESLLPGIR.2|TQYSSAM[Oxi]LESLLPGIR.2|YAAVTQFEATDAR.2|YAAVTQFEATDAR.3|YQGGFLISR.2|FIKDNWEELYNR.3|FIKDNWEELYNR.2|NAATEDLWESLENASGKPIAAVMNTWTK.4|NAATEDLWESLENASGKPIAAVMNTWTK.3|IDFVGELNDK.2|VLTFALSEEVRPQDTVSVIGGVAGGSK.3|VLTFALSEEVRPQDTVSVIGGVAGGSK.4|TIQQC[CAM]C[CAM]ENILLNAAWLK.3|TIQQC[CAM]C[CAM]ENILLNAAWLK.2|DYFNVPYPLPK.2|AFFESHPAPSAER.3|AFFESHPAPSAER.2|RDAESIHQYLLQR.4|RDAESIHQYLLQR.3|RDAESIHQYLLQR.2|LEAAAQVR.2|QILSADLR.2|GMNMYLTK.2|DRVALSNMNVIDR.3|DRVALSNMNVIDR.2|ETALLIDPK.2|RAFPC[CAM]WDEPAIK.3|RAFPC[CAM]WDEPAIK.2|DLSLPPVDR.2|DVFSPIGER.2|YTTPSGEVR.2|KPYPDDENLVEVK.3|KPYPDDENLVEVK.2|MLHDYIGDK.2|NVKPDQWVK.2|VTLSFPSTLQTGTGTLK.3|VTLSFPSTLQTGTGTLK.2|PGEGHLDALLR.2|DRVALSNMNVIDRKPYPDDENLVEVK.5|DRVALSNMNVIDRKPYPDDENLVEVK.4|PIAAVMNTWTK.2|SKYTTPSGEVR.2|VALSNMNVIDR.2|VALSNM[Oxi]NVIDR.2|DNWEELYNR.2|FIKDNWEELYNRYQGGFLISR.4|QMGFPLIYVEAEQVEDDR.3|QM[Oxi]GFPLIYVEAEQVEDDR.2|QMGFPLIYVEAEQVEDDR.2|LPADVSPINYSLC[CAM]LKPDLLDFTFEGK.4|LPADVSPINYSLC[CAM]LKPDLLDFTFEGK.3|DNWEELYNRYQGGFLISR.3|MLHDYIGDKDFKK.2|AQELDALDNSHPIEVSVGHPSEVDEIFDAISYSK.4|KFC[CAM]AGGSYVGEDC[CAM]PQWMVPITISTSEDPNQAK.3
SEN / CTL,Splicing factor 3A subunit 1,SF3A1,Q15459,-0.14,0.06,2.08E-02,9.69E-03,2.01E+00,"regulation of alternative mRNA splicing, via spliceosome,mRNA 3'-splice site recognition,mRNA splicing, via spliceosome,mRNA processing","RNA binding,protein binding,poly(A) RNA binding","nucleoplasm,spliceosomal complex,U2-type spliceosomal complex,U2 snRNP,U2-type prespliceosome,catalytic step 2 spliceosome",3,50,82,LTAQFVAR.2|GLVPEDDTKEK.3|IRQNEINNPK.3|IRQNEINNPK.2|RTDIFGVEETAIGKK.4|RTDIFGVEETAIGKK.3|VTWDGHSGSMAR.3|VTWDGHSGSM[Oxi]AR.3|VTWDGHSGSMAR.2|LVEQYTK.2|NIVDKTASFVAR.3|NIVDKTASFVAR.2|VKIHEATGMPAGK.3|QKLQYEGIFIK.3|QKLQYEGIFIK.2|NGPEFEAR.2|AKGLVPEDDTKEK.3|IGEEEIQKPEEK.3|IGEEEIQKPEEK.2|PVVGIIYPPPEVR.3|PVVGIIYPPPEVR.2|QNEINNPK.2|GLVPEDDTK.2|VQAQVIQETIVPK.3|VQAQVIQETIVPK.2|LKTEDSLMPEEEFLRR.4|TDIFGVEETAIGKK.3|AQEPSAAIPK.2|RTDIFGVEETAIGK.3|RTDIFGVEETAIGK.2|KIGEEEIQKPEEK.3|KIGEEEIQKPEEK.2|VQVPNMQDK.2|IHEATGMPAGK.2|IHEATGM[Oxi]PAGK.2|LQYEGIFIK.2|TQQAAQANITLQEQIEAIHK.4|TQQAAQANITLQEQIEAIHK.3|TQQAAQANITLQEQIEAIHK.2|DSNSLAYYNMANGAVIHLALK.4|DSNSLAYYNMANGAVIHLALK.3|DSNSLAYYNM[Oxi]ANGAVIHLALK.3|DSNSLAYYNMANGAVIHLALK.2|QFLTQLMQK.2|QFLTQLM[Oxi]QK.2|TEDSLMPEEEFLRR.3|ASKPLPPAPAPDEYLVSPITGEK.4|ASKPLPPAPAPDEYLVSPITGEK.3|ASKPLPPAPAPDEYLVSPITGEK.2|EVLDQVC[CAM]YR.2|QPTEEEASSKEDSAPSK.3|LKTEDSLMPEEEFLR.3|NYQFDFLRPQHSLFNYFTK.4|NYQFDFLRPQHSLFNYFTK.3|EAENPREVLDQVC[CAM]YR.3|IRQNEINNPKFNFLNPNDPYHAYYR.5|PAGPVQAVPPPPPVPTEPK.3|PAGPVQAVPPPPPVPTEPK.2|FNFLNPNDPYHAYYR.3|FNFLNPNDPYHAYYR.2|VM[Oxi]QQQQQTTQQQLPQK.3|VMQQQQQTTQQQLPQK.3|VM[Oxi]QQQQQTTQQQLPQK.2|VMQQQQQTTQQQLPQK.2|QSDDEVYAPGLDIESSLK.3|QSDDEVYAPGLDIESSLK.2|TDIFGVEETAIGK.2|PLPPAPAPDEYLVSPITGEK.3|PLPPAPAPDEYLVSPITGEK.2|ASKPLPPAPAPDEYLVSPITGEKIPASK.4|EDSAPSKPVVGIIYPPPEVR.3|EDSAPSKPVVGIIYPPPEVR.2|LNGQVLVFTLPLTDQVSVIK.3|LNGQVLVFTLPLTDQVSVIK.2|EKQSDDEVYAPGLDIESSLK.3|EKQSDDEVYAPGLDIESSLK.2|TEDSLM[Oxi]PEEEFLR.2|TEDSLMPEEEFLR.2|VQVPNMQDKTEWK.2|QPTEEEASSKEDSAPSKPVVGIIYPPPEVR.4|EPPPEFEFIADPPSISAFDLDVVK.3|VQAQVIQETIVPKEPPPEFEFIADPPSISAFDLDVVK.4
SEN / CTL,THO complex subunit 4,ALYREF,Q86V81,-0.14,0.18,1.23E-01,4.20E-02,1.38E+00,"regulation of DNA recombination,mRNA splicing, via spliceosome,osteoblast differentiation,termination of RNA polymerase II transcription,RNA export from nucleus,mRNA export from nucleus,mRNA 3'-end processing,replication fork processing,positive regulation of DNA-templated transcription, elongation,viral mRNA export from host cell nucleus","nucleotide binding,protein binding,poly(A) RNA binding","transcription export complex,nucleus,nucleoplasm,cytosol,membrane,nuclear speck,intracellular membrane-bounded organelle,extracellular exosome,catalytic step 2 spliceosome,nuclear chromosome, telomeric region,exon-exon junction complex",6,12,20,SLGTADVHFER.3|SLGTADVHFER.2|LLVSNLDFGVSDADIQELFAEFGTLKK.3|LLVSNLDFGVSDADIQELFAEFGTLKK.4|AAVHYDR.2|GAGGFGGGGGTR.2|PMNIQLVTSQIDAQR.3|PM[Oxi]NIQLVTSQIDAQR.3|PMNIQLVTSQIDAQR.2|MDMSLDDIIK.2|QLPDKWQHDLFDSGFGGGAGVETGGK.4|QLPDKWQHDLFDSGFGGGAGVETGGK.3|QQLSAEELDAQLDAYNAR.3|QQLSAEELDAQLDAYNAR.2|SLGTADVHFERK.2|QYNGVPLDGRPMNIQLVTSQIDAQR.4|QYNGVPLDGRPMNIQLVTSQIDAQR.3|WQHDLFDSGFGGGAGVETGGK.3|WQHDLFDSGFGGGAGVETGGK.2|NSKQQLSAEELDAQLDAYNAR.3
SEN / CTL,Far upstream element-binding protein 2,KHSRP,Q92945,-0.14,0.35,6.66E-03,3.84E-03,2.42E+00,"RNA splicing, via transesterification reactions,transcription, DNA-templated,regulation of transcription, DNA-templated,mRNA processing,mRNA catabolic process,RNA splicing,regulation of mRNA stability,negative regulation of nitric oxide biosynthetic process,mRNA transport,positive regulation of mRNA catabolic process,3'-UTR-mediated mRNA destabilization,cellular response to cytokine stimulus,regulation of miRNA metabolic process","DNA binding,protein binding,mRNA 3'-UTR AU-rich region binding,poly(A) RNA binding","nucleoplasm,cytosol,cytoplasmic stress granule,membrane,exosome (RNase complex)",18,42,79,IINDLLQSLR.2|IGGGIDVPVPR.2|MMLDDIVSR.2|M[Oxi]MLDDIVSR.2|MM[Oxi]LDDIVSR.2|M[Oxi]M[Oxi]LDDIVSR.2|TSMTEEYRVPDGMVGLIIGR.3|TSMTEEYRVPDGMVGLIIGR.4|TSM[Oxi]TEEYRVPDGM[Oxi]VGLIIGR.3|TSM[Oxi]TEEYRVPDGMVGLIIGR.3|TSMTEEYRVPDGM[Oxi]VGLIIGR.3|DAFADAVQR.2|KLASQGDSISSQLGPIHPPPR.4|KLASQGDSISSQLGPIHPPPR.3|IIGDPYK.2|VQISPDSGGLPER.3|VQISPDSGGLPER.2|ERDQGGFGDRNEYGSR.4|ERDQGGFGDRNEYGSR.3|HSVGVVIGR.2|QLEDGDQPESKK.3|RQLEDGDQPESK.3|RQLEDGDQPESK.2|IQFKQDDGTGPEK.3|RQLEDGDQPESKK.3|TSMTEEYR.2|TSM[Oxi]TEEYR.2|AINQQTGAFVEISR.3|AINQQTGAFVEISR.2|LASQGDSISSQLGPIHPPPR.4|LASQGDSISSQLGPIHPPPR.3|LASQGDSISSQLGPIHPPPR.2|MILIQDGSQNTNVDKPLR.4|M[Oxi]ILIQDGSQNTNVDKPLR.3|MILIQDGSQNTNVDKPLR.3|MILIQDGSQNTNVDKPLR.2|DQGGFGDRNEYGSR.3|DQGGFGDRNEYGSR.2|GQGNWGPPGGEMTFSIPTHK.4|GQGNWGPPGGEM[Oxi]TFSIPTHK.3|GQGNWGPPGGEMTFSIPTHK.3|GQGNWGPPGGEMTFSIPTHK.2|VQQAC[CAM]EMVMDILR.3|VQQAC[CAM]EM[Oxi]VMDILR.2|VQQAC[CAM]EMVM[Oxi]DILR.2|VQQAC[CAM]EMVMDILR.2|GSPQQIDHAK.2|IAHIMGPPDR.2|KDAFADAVQR.2|MILIQDGSQNTNVDK.3|MILIQDGSQNTNVDK.2|GGGGPGGGGPGGGSAGGPSQPPGGGGPGIR.4|GGGGPGGGGPGGGSAGGPSQPPGGGGPGIR.3|GGGGPGGGGPGGGSAGGPSQPPGGGGPGIR.2|GGGGPGGGGPGGGSAGGPSQPPGGGGPGIRK.4|GGGGPGGGGPGGGSAGGPSQPPGGGGPGIRK.3|QLPPNGDPNFK.2|VPDGMVGLIIGR.2|QLEDGDQPESK.2|SVSLTGAPESVQK.2|IGQQPQQPGAPPQQDYTK.3|IGQQPQQPGAPPQQDYTK.2|GGPPGQFHDNANGGQNGTVQEIMIPAGK.4|GGPPGQFHDNANGGQNGTVQEIM[Oxi]IPAGK.3|GGPPGQFHDNANGGQNGTVQEIMIPAGK.3|KIGQQPQQPGAPPQQDYTK.3|KIGQQPQQPGAPPQQDYTK.2|IGGDAATTVNNSTPDFGFGGQK.3|IGGDAATTVNNSTPDFGFGGQK.2|SGPPGPPGGPGMPPGGR.2|SGPPGPPGGPGM[Oxi]PPGGR.2|GRGGPPGQFHDNANGGQNGTVQEIM[Oxi]IPAGK.4|GRGGPPGQFHDNANGGQNGTVQEIMIPAGK.4|IGGDAATTVNNSTPDFGFGGQKR.3|AAAAAADPNAAWAAYYSHYYQQPPGPVPGPAPAPAAPPAQGEPPQPPPTGQSDYTK.7|IIGDPYKVQQAC[CAM]EMVMDILR.3|IIGDPYKVQQAC[CAM]EMVMDILR.2|QAQVATGGGPGAPPGSQPDYSAAWAEYYR.3|KQAQVATGGGPGAPPGSQPDYSAAWAEYYR.3
SEN / CTL,60S acidic ribosomal protein P2,RPLP2,P05387,-0.15,0.76,7.46E-02,2.80E-02,1.55E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,cytoplasmic translation,rRNA processing,translation,translational initiation,translational elongation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","structural constituent of ribosome,large ribosomal subunit rRNA binding","cytosol,focal adhesion,membrane,cytosolic large ribosomal subunit,preribosome, large subunit precursor,extracellular exosome",45,13,30,NIEDVIAQGIGK.2|NIEDVIAQGIGK.3|ILDSVGIEADDDRLNK.3|ILDSVGIEADDDRLNK.2|YVASYLLAALGGNSSPSAK.3|YVASYLLAALGGNSSPSAK.2|YVASYLLAALGGNSSPSAK.4|VISELNGKNIEDVIAQGIGK.3|VISELNGKNIEDVIAQGIGK.2|ILDSVGIEADDDRLNKVISELNGK.4|ILDSVGIEADDDRLNKVISELNGK.3|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEKKDEK.4|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEKKDEK.6|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEKKDEK.5|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEKKDEK.3|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEK.3|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEK.4|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEK.5|KILDSVGIEADDDRLNK.4|KILDSVGIEADDDRLNK.3|KILDSVGIEADDDRLNK.2|MRYVASYLLAALGGNSSPSAK.3|M[Oxi]RYVASYLLAALGGNSSPSAK.3|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEKK.3|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEKK.4|ILDSVGIEADDDR.3|ILDSVGIEADDDR.2|KILDSVGIEADDDR.3|RYVASYLLAALGGNSSPSAK.3|RYVASYLLAALGGNSSPSAK.2
SEN / CTL,Growth factor receptor-bound protein 2,GRB2,P62993,-0.15,0.41,2.07E-02,9.66E-03,2.01E+00,"MAPK cascade,epidermal growth factor receptor signaling pathway,Ras protein signal transduction,cell-cell signaling,axon guidance,aging,insulin receptor signaling pathway,fibroblast growth factor receptor signaling pathway,positive regulation of signal transduction,regulation of phosphatidylinositol 3-kinase signaling,viral process,positive regulation of actin filament polymerization,T cell costimulation,receptor internalization,phosphatidylinositol-3-phosphate biosynthetic process,Fc-epsilon receptor signaling pathway,Fc-gamma receptor signaling pathway involved in phagocytosis,ERBB2 signaling pathway,negative regulation of epidermal growth factor receptor signaling pathway,signal transduction in response to DNA damage,regulation of MAPK cascade,positive regulation of GTPase activity,phosphatidylinositol phosphorylation,phosphatidylinositol-mediated signaling,anatomical structure formation involved in morphogenesis,leukocyte migration,protein heterooligomerization,branching involved in labyrinthine layer morphogenesis,cellular response to ionizing radiation,positive regulation of reactive oxygen species metabolic process","phosphotyrosine binding,SH3/SH2 adaptor activity,Ras guanyl-nucleotide exchange factor activity,epidermal growth factor receptor binding,neurotrophin TRKA receptor binding,protein binding,1-phosphatidylinositol-3-kinase activity,SH3 domain binding,protein kinase binding,protein phosphatase binding,identical protein binding,insulin receptor substrate binding,poly(A) RNA binding,ephrin receptor binding,phosphatidylinositol-4,5-bisphosphate 3-kinase activity","nucleus,nucleoplasm,nucleolus,cytoplasm,endosome,Golgi apparatus,cytosol,plasma membrane,cell-cell junction,COP9 signalosome,vesicle membrane,extracellular exosome,Grb2-EGFR complex",12,19,28,YFLWVVK.2|FNSLNELVDYHR.3|FNSLNELVDYHR.2|RGDFIHVMDNSDPNWWK.4|RGDFIHVM[Oxi]DNSDPNWWK.4|RGDFIHVMDNSDPNWWK.3|NYIEMKPHPWFFGK.4|NYIEMKPHPWFFGK.3|NYIEMKPHPWFFGK.2|AEEMLSK.2|QRHDGAFLIR.3|ATADDELSFKR.3|GAC[CAM]HGQTGMFPR.3|GAC[CAM]HGQTGM[Oxi]FPR.3|GAC[CAM]HGQTGMFPR.2|GAC[CAM]HGQTGM[Oxi]FPR.2|HDGAFLIR.2|NQQIFLR.2|NYVTPVNR.2|AKAEEMLSK.2|FGNDVQHFK.2|ATADDELSFK.2|GDFIHVMDNSDPNWWK.3|ESESAPGDFSLSVK.2|VLNEEC[CAM]DQNWYKAELNGK.3|VLNEEC[CAM]DQNWYK.2|DIEQVPQQPTYVQALFDFDPQEDGELGFR.4|DIEQVPQQPTYVQALFDFDPQEDGELGFR.3
SEN / CTL,Secernin-1,SCRN1,Q12765,-0.15,0.48,8.58E-02,3.17E-02,1.50E+00,"proteolysis,exocytosis","molecular_function,dipeptidase activity","nucleus,cytoplasm,nuclear membrane",15,21,30,C[CAM]IC[CAM]SQLSLTTK.2|SIFKPFIFVDDVK.3|SIFKPFIFVDDVK.2|SSPC[CAM]IHYFTGTPDPSR.3|SSPC[CAM]IHYFTGTPDPSR.2|SIFKPFIFVDDVKLVPK.4|SIFKPFIFVDDVKLVPK.3|EPAAEIEALLGMDLVR.2|EPAAEIEALLGM[Oxi]DLVR.3|EPAAEIEALLGMDLVR.3|DGLVVFGK.2|AIIESDQEQGRK.3|AIIESDQEQGRK.2|STMLELEK.2|TYAIMISR.2|TQSPC[CAM]FGDDDPAKKEPR.4|TQSPC[CAM]FGDDDPAKKEPR.3|TQSPC[CAM]FGDDDPAKK.3|VEC[CAM]TYISIDQVPR.3|VEC[CAM]TYISIDQVPR.2|PFIFVDDVK.2|MDAEHPELR.2|AIIESDQEQGR.2|DEAWVLETIGK.2|TQSPC[CAM]FGDDDPAK.2|DEVQEVVYFSAADHEPESK.3|DEVQEVVYFSAADHEPESK.2|QEESITVQTMMNTLR.2|PAWLWGAEMGANEHGVC[CAM]IANEAINTR.3|QGLEAMEEILTSSEPLDPAEVGDLFYDC[CAM]VDTEIK.4
SEN / CTL,"Solute carrier family 2, facilitated glucose transporter member 1",SLC2A1,P11166,-0.16,0.31,3.59E-02,1.52E-02,1.82E+00,"lactose biosynthetic process,protein complex assembly,response to osmotic stress,glucose transport,L-ascorbic acid metabolic process,cellular response to glucose starvation,xenobiotic transport,regulation of insulin secretion,dehydroascorbic acid transport,glucose transmembrane transport","glucose transmembrane transporter activity,protein binding,kinase binding,dehydroascorbic acid transporter activity,xenobiotic transporter activity,protein self-association,D-glucose transmembrane transporter activity","Golgi membrane,female pronucleus,cytosol,plasma membrane,integral component of plasma membrane,caveola,cell-cell junction,membrane,basolateral plasma membrane,apical plasma membrane,midbody,cortical actin cytoskeleton,melanosome,extracellular exosome,blood microparticle",9,10,17,TFDEIASGFR.2|VTILELFR.2|LRGTADVTHDLQEMKEESR.4|LRGTADVTHDLQEMKEESR.5|LRGTADVTHDLQEM[Oxi]KEESR.4|LRGTADVTHDLQEM[Oxi]KEESR.3|LRGTADVTHDLQEMKEESR.3|GTADVTHDLQEMK.3|GTADVTHDLQEMK.2|GTADVTHDLQEMKEESR.4|GTADVTHDLQEMKEESR.3|GTADVTHDLQEM[Oxi]KEESR.3|SFEMLILGR.2|KVTILELFR.2|GRTFDEIASGFR.2|QGGASQSDKTPEELFHPLGADSQV.3|TPEELFHPLGADSQV.2
SEN / CTL,Sialate O-acetylesterase,SIAE,Q9HAT2,-0.16,0.30,3.89E-02,1.62E-02,1.79E+00,"regulation of immune system process,carbohydrate metabolic process",sialate O-acetylesterase activity,"extracellular space,lysosome,extracellular exosome",12,18,31,WHQTADFGYVPNPK.3|WHQTADFGYVPNPK.2|YMSAVC[CAM]WLFGR.2|YM[Oxi]SAVC[CAM]WLFGR.2|HLYDTLQYPIGLIASSWGGTPIEAWSSGR.3|HLYDTLQYPIGLIASSWGGTPIEAWSSGR.4|YAWTTWPC[CAM]EYK.2|ELSNTAAYQSVR.3|ELSNTAAYQSVR.2|PTSENLGHGYFK.3|PTSENLGHGYFK.2|IFEISC[CAM]C[CAM]SDHR.3|IFEISC[CAM]C[CAM]SDHR.2|AHSDTWMVVLDPMK.3|SSDDGFPQIR.2|FFPFGLVQLSSDLSK.3|FFPFGLVQLSSDLSK.2|MPNTFMAVAMDLC[CAM]DRDSPFGSIHPR.5|MPNTFMAVAMDLC[CAM]DRDSPFGSIHPR.4|MPNTFMAVAMDLC[CAM]DRDSPFGSIHPR.3|FFPFGLVQLSSDLSKK.3|KSSDDGFPQIR.2|FASYINNDMVLQK.2|WLPASMNTVSTQSLTLAIDSC[CAM]HGTVVALR.4|WLPASM[Oxi]NTVSTQSLTLAIDSC[CAM]HGTVVALR.3|WLPASMNTVSTQSLTLAIDSC[CAM]HGTVVALR.3|AHSDTWMVVLDPMKPGGPFEVM[Oxi]AQQTLEK.4|AHSDTWMVVLDPMKPGGPFEVMAQQTLEK.4|ILSVSPIQAEQELEDLVAVDLQWSKPTSENLGHGYFK.5|ILSVSPIQAEQELEDLVAVDLQWSKPTSENLGHGYFK.4|QC[CAM]PLYHPSSALPAPPFIAFITDQGPGHQSNVAK.4
SEN / CTL,Heterogeneous nuclear ribonucleoprotein A3,HNRNPA3,P51991,-0.16,0.28,3.02E-02,1.33E-02,1.88E+00,"mRNA splicing, via spliceosome,gene expression,mRNA transport","nucleotide binding,RNA binding,mRNA binding,protein binding,poly(A) RNA binding,RNA transmembrane transporter activity","nucleus,nucleoplasm,cytoplasm,intracellular ribonucleoprotein complex,ribonucleoprotein granule,neuron projection,catalytic step 2 spliceosome,messenger ribonucleoprotein complex",12,32,62,YGKIETIEVMEDR.3|YGKIETIEVMEDR.2|IETIEVMEDR.2|IETIEVM[Oxi]EDR.2|GFAFVTFDDHDTVDKIVVQK.4|GFAFVTFDDHDTVDKIVVQK.3|IFVGGIKEDTEEYNLRDYFEK.4|IFVGGIKEDTEEYNLRDYFEK.3|GEEGHDPKEPEQLR.4|GEEGHDPKEPEQLR.3|YHTINGHNC[CAM]EVKK.4|YHTINGHNC[CAM]EVKK.3|YHTINGHNC[CAM]EVKK.2|GEEGHDPKEPEQLRK.4|GEEGHDPKEPEQLRK.3|AVSREDSVKPGAHLTVK.4|RGEEGHDPKEPEQLR.4|RGEEGHDPKEPEQLR.3|WGTLTDC[CAM]VVMR.3|WGTLTDC[CAM]VVMR.2|WGTLTDC[CAM]VVM[Oxi]R.2|EDSVKPGAHLTVK.3|EDSVKPGAHLTVK.2|RGFAFVTFDDHDTVDK.4|RGFAFVTFDDHDTVDK.3|RGFAFVTFDDHDTVDK.2|RGFAFVTFDDHDTVDKIVVQK.5|YGKIETIEVMEDRQSGK.4|YHTINGHNC[CAM]EVK.3|YHTINGHNC[CAM]EVK.2|EDSVKPGAHLTVKK.3|EDSVKPGAHLTVKK.2|KIFVGGIKEDTEEYNLR.4|KIFVGGIKEDTEEYNLR.3|KRGFAFVTFDDHDTVDK.4|KLFIGGLSFETTDDSLREHFEK.5|KLFIGGLSFETTDDSLREHFEK.4|KLFIGGLSFETTDDSLREHFEK.3|QEMQSAGSQR.2|GFAFVTFDDHDTVDK.3|GFAFVTFDDHDTVDK.2|SRGFGFVTYSC[CAM]VEEVDAAMC[CAM]ARPHK.5|EDTEEYNLR.2|LFIGGLSFETTDDSLR.3|LFIGGLSFETTDDSLR.2|GFGFVTYSC[CAM]VEEVDAAMC[CAM]ARPHKVDGR.5|GFGFVTYSC[CAM]VEEVDAAMC[CAM]ARPHKVDGR.4|LFIGGLSFETTDDSLREHFEK.4|LFIGGLSFETTDDSLREHFEK.3|EDTEEYNLRDYFEK.3|IFVGGIKEDTEEYNLR.3|IFVGGIKEDTEEYNLR.2|KLFIGGLSFETTDDSLR.3|SSGSPYGGGYGSGGGSGGYGSR.3|SSGSPYGGGYGSGGGSGGYGSR.2|WGTLTDC[CAM]VVMRDPQTK.3|WGTLTDC[CAM]VVM[Oxi]RDPQTK.3|WGTLTDC[CAM]VVM[Oxi]RDPQTK.2|WGTLTDC[CAM]VVMRDPQTK.2|GFGFVTYSC[CAM]VEEVDAAMC[CAM]ARPHK.4|GFGFVTYSC[CAM]VEEVDAAM[Oxi]C[CAM]ARPHK.4|GFGFVTYSC[CAM]VEEVDAAMC[CAM]ARPHK.3
SEN / CTL,14-3-3 protein beta/alpha,YWHAB,P31946,-0.16,0.74,3.17E-03,2.05E-03,2.69E+00,"MAPK cascade,protein targeting,viral process,negative regulation of protein dephosphorylation,hippo signaling,positive regulation of catalytic activity,regulation of mRNA stability,negative regulation of G-protein coupled receptor protein signaling pathway,negative regulation of transcription, DNA-templated,cytoplasmic sequestering of protein,protein heterooligomerization,membrane organization,cell-cell adhesion,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway","transcription corepressor activity,protein binding,protein C-terminus binding,enzyme binding,protein domain specific binding,protein complex binding,histone deacetylase binding,phosphoserine binding,phosphoprotein binding,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,mitochondrion,cytosol,cell-cell adherens junction,focal adhesion,membrane,transcriptional repressor complex,cytoplasmic vesicle membrane,melanosome,perinuclear region of cytoplasm,extracellular exosome",57,37,87,NLLSVAYK.2|NLLSVAYK.1|NLLSVAYKNVVGAR.3|NLLSVAYKNVVGAR.2|QTTVSNSQQAYQEAFEISKK.3|QTTVSNSQQAYQEAFEISKK.2|QTTVSNSQQAYQEAFEISKK.4|VISSIEQK.2|LAEQAERYDDMAAAMK.3|LAEQAERYDDMAAAMK.2|LAEQAERYDDMAAAM[Oxi]K.3|LAEQAERYDDM[Oxi]AAAMK.2|LAEQAERYDDM[Oxi]AAAMK.3|LAEQAERYDDM[Oxi]AAAM[Oxi]K.3|LAEQAERYDDMAAAM[Oxi]K.2|LAEQAERYDDM[Oxi]AAAM[Oxi]K.2|TAFDEAIAELDTLNEESYKDSTLIMQLLR.4|TAFDEAIAELDTLNEESYKDSTLIM[Oxi]QLLR.4|TAFDEAIAELDTLNEESYKDSTLIM[Oxi]QLLR.3|TAFDEAIAELDTLNEESYKDSTLIMQLLR.3|YLSEVASGDNKQTTVSNSQQAYQEAFEISKK.4|YLSEVASGDNKQTTVSNSQQAYQEAFEISKK.3|YLSEVASGDNKQTTVSNSQQAYQEAFEISKK.5|DSTLIMQLLR.2|DSTLIM[Oxi]QLLR.2|DSTLIMQLLR.1|LGLALNFSVFYYEILNSPEK.3|LGLALNFSVFYYEILNSPEK.2|AKLAEQAERYDDMAAAMK.4|AKLAEQAERYDDMAAAM[Oxi]K.3|AKLAEQAERYDDMAAAMK.3|AKLAEQAERYDDM[Oxi]AAAM[Oxi]K.3|AKLAEQAERYDDM[Oxi]AAAM[Oxi]K.2|AKLAEQAERYDDM[Oxi]AAAMK.2|AKLAEQAERYDDMAAAM[Oxi]K.2|AKLAEQAERYDDMAAAMK.2|KEMQPTHPIR.3|KEM[Oxi]QPTHPIR.3|KEMQPTHPIR.2|KEM[Oxi]QPTHPIR.2|LAEQAER.2|VISSIEQKTERNEK.4|VISSIEQKTERNEK.3|VISSIEQKTERNEK.2|YLIPNATQPESK.3|YLIPNATQPESK.2|MKGDYFR.2|M[Oxi]KGDYFR.2|AKLAEQAER.2|YDDMAAAMK.2|YDDM[Oxi]AAAMK.2|YDDMAAAM[Oxi]K.2|YDDM[Oxi]AAAM[Oxi]K.2|VFYLKMKGDYFR.3|AVTEQGHELSNEER.3|AVTEQGHELSNEER.2|NLLSVAYKNVVGARR.3|EMQPTHPIR.2|EM[Oxi]QPTHPIR.2|TMDKSELVQK.2|YLSEVASGDNK.2|YLSEVASGDNK.1|EKIEAELQDIC[CAM]NDVLELLDK.4|EKIEAELQDIC[CAM]NDVLELLDK.3|EKIEAELQDIC[CAM]NDVLELLDK.2|AVTEQGHELSNEERNLLSVAYK.4|AVTEQGHELSNEERNLLSVAYK.3|AVTEQGHELSNEERNLLSVAYKNVVGAR.5|AVTEQGHELSNEERNLLSVAYKNVVGAR.4|AVTEQGHELSNEERNLLSVAYKNVVGAR.3|VISSIEQKTER.2|YDDM[Oxi]AAAM[Oxi]KAVTEQGHELSNEER.4|EYREKIEAELQDIC[CAM]NDVLELLDK.4|EYREKIEAELQDIC[CAM]NDVLELLDK.3|IEAELQDIC[CAM]NDVLELLDK.3|IEAELQDIC[CAM]NDVLELLDK.2|QTTVSNSQQAYQEAFEISK.3|QTTVSNSQQAYQEAFEISK.2|TAFDEAIAELDTLNEESYK.3|TAFDEAIAELDTLNEESYK.2|DNLTLWTSENQGDEGDAGEGEN.3|YLSEVASGDNKQTTVSNSQQAYQEAFEISK.4|YLSEVASGDNKQTTVSNSQQAYQEAFEISK.3|IEAELQDIC[CAM]NDVLELLDKYLIPNATQPESK.4|IEAELQDIC[CAM]NDVLELLDKYLIPNATQPESK.3|EKIEAELQDIC[CAM]NDVLELLDKYLIPNATQPESK.4|LGLALNFSVFYYEILNSPEKAC[CAM]SLAK.3
SEN / CTL,Argininosuccinate lyase,ASL,P04424,-0.17,0.48,3.55E-02,1.51E-02,1.82E+00,"urea cycle,internal protein amino acid acetylation,arginine biosynthetic process,arginine catabolic process,arginine biosynthetic process via ornithine,protein tetramerization","argininosuccinate lyase activity,protein binding","cytoplasm,cytosol,extracellular exosome",12,29,36,FNASIAYDR.2|MAEDLILYC[CAM]TK.2|INVLPLGSGAIAGNPLGVDRELLR.3|QTC[CAM]STLSGLLWELIR.3|QTC[CAM]STLSGLLWELIR.2|ALLQAQQA.2|HLWEVDVQGSK.3|HLWEVDVQGSK.2|SRNDQVVTDLR.3|SRNDQVVTDLR.2|GLPSTYNK.2|AEMDQILHGLDK.3|AVFM[Oxi]AETK.2|DVLFPGYTHLQR.3|DVLFPGYTHLQR.2|SSVDWQIR.2|AEAERDVLFPGYTHLQR.4|AEAERDVLFPGYTHLQR.3|C[CAM]AGLLMTLK.2|NPDSLELIR.2|LNSNDEDIHTANER.3|LNSNDEDIHTANER.2|LKELIGATAGK.2|WSHWILSHAVALTR.3|KNPDSLELIR.2|LNSNDEDIHTANERR.3|FVGAVDPIMEK.2|RLKELIGATAGK.2|VAEEWAQGTFK.2|INVLPLGSGAIAGNPLGVDR.3|INVLPLGSGAIAGNPLGVDR.2|RINVLPLGSGAIAGNPLGVDRELLR.4|TMVDRAEAERDVLFPGYTHLQR.4|RINVLPLGSGAIAGNPLGVDR.3|AEMDQILHGLDKVAEEWAQGTFK.3|EFSFVQLSDAYSTGSSLMPQK.2
SEN / CTL,Vinculin,VCL,P18206,-0.17,0.90,1.13E-02,5.89E-03,2.23E+00,"morphogenesis of an epithelium,platelet degranulation,movement of cell or subcellular component,muscle contraction,cell adhesion,cell-matrix adhesion,lamellipodium assembly,negative regulation of cell migration,adherens junction assembly,protein localization to cell surface,apical junction assembly,axon extension,platelet aggregation,epithelial cell-cell adhesion","dystroglycan binding,actin binding,structural molecule activity,protein binding,beta-catenin binding,ubiquitin protein ligase binding,alpha-catenin binding,cadherin binding,cadherin binding involved in cell-cell adhesion","extracellular region,cytosol,cytoskeleton,plasma membrane,cell-cell junction,adherens junction,cell-cell adherens junction,fascia adherens,focal adhesion,actin cytoskeleton,cell-substrate junction,costamere,protein complex,extracellular exosome,extracellular vesicle",198,102,192,AIPDLTAPVAAVQAAVSNLVR.3|AIPDLTAPVAAVQAAVSNLVR.2|GWLRDPSASPGDAGEQAIR.3|GWLRDPSASPGDAGEQAIR.2|WIDNPTVDDRGVGQAAIR.3|ALASQLQDSLKDLK.3|ALASQLQDSLKDLK.2|STVEGIQASVK.2|AQQVSQGLDVLTAK.2|AQQVSQGLDVLTAK.3|VLQLTSWDEDAWASKDTEAMKR.4|TDAGFTLR.2|ILLRNPGNQAAYEHFETMK.4|ELTPQVVSAAR.2|AAVHLEGKIEQAQR.3|TNLLQVC[CAM]ER.2|QILDEAGKVGELC[CAM]AGKER.4|QILDEAGKVGELC[CAM]AGKER.3|VGKETVQTTEDQILKR.4|VGKETVQTTEDQILKR.3|VGKETVQTTEDQILKR.2|GILSGTSDLLLTFDEAEVR.3|GILSGTSDLLLTFDEAEVR.2|AAAVGTANKSTVEGIQASVK.3|LVQAAQMLQSDPYSVPARDYLIDGSR.3|LVQAAQMLQSDPYSVPARDYLIDGSR.4|LVQAAQM[Oxi]LQSDPYSVPARDYLIDGSR.3|LLAVAATAPPDAPNREEVFDER.3|LLAVAATAPPDAPNREEVFDER.4|LLAVAATAPPDAPNREEVFDER.2|IPTISTQLK.2|ELLPVLISAMK.2|ELLPVLISAM[Oxi]K.2|MSAEINEIIR.2|M[Oxi]SAEINEIIR.2|QILDEAGKVGELC[CAM]AGK.3|QILDEAGKVGELC[CAM]AGK.2|C[CAM]DRVDQLTAQLADLAARGEGESPQAR.4|C[CAM]DRVDQLTAQLADLAARGEGESPQAR.3|AVAGNISDPGLQK.2|AVAGNISDPGLQK.3|SLLDASEEAIKK.3|SLLDASEEAIKK.2|TNLLQVC[CAM]ERIPTISTQLK.3|VLQLTSWDEDAWASK.2|VLQLTSWDEDAWASK.3|MLGQMTDQVADLR.2|MLGQMTDQVADLR.3|M[Oxi]LGQMTDQVADLR.2|M[Oxi]LGQM[Oxi]TDQVADLR.2|MLGQM[Oxi]TDQVADLR.2|MTGLVDEAIDTK.2|MTGLVDEAIDTK.3|M[Oxi]TGLVDEAIDTK.2|MALLMAEMSR.2|M[Oxi]ALLMAEMSR.2|MALLM[Oxi]AEMSR.2|C[CAM]DRVDQLTAQLADLAAR.3|C[CAM]DRVDQLTAQLADLAAR.4|C[CAM]DRVDQLTAQLADLAAR.2|TIESILEPVAQQISHLVIMHEEGEVDGK.4|TIESILEPVAQQISHLVIM[Oxi]HEEGEVDGK.4|TIESILEPVAQQISHLVIMHEEGEVDGK.3|VAMANIQPQMLVAGATSIAR.3|VAMANIQPQMLVAGATSIAR.2|VAMANIQPQM[Oxi]LVAGATSIAR.3|VAM[Oxi]ANIQPQMLVAGATSIAR.3|VAM[Oxi]ANIQPQM[Oxi]LVAGATSIAR.3|VAM[Oxi]ANIQPQM[Oxi]LVAGATSIAR.2|VAM[Oxi]ANIQPQMLVAGATSIAR.2|VAMANIQPQM[Oxi]LVAGATSIAR.2|MQEAMTQEVSDVFSDTTTPIK.3|MQEAMTQEVSDVFSDTTTPIK.2|M[Oxi]QEAMTQEVSDVFSDTTTPIK.3|M[Oxi]QEAMTQEVSDVFSDTTTPIK.2|MQEAM[Oxi]TQEVSDVFSDTTTPIK.2|SFLDSGYR.2|RMALLMAEMSR.3|RMALLMAEMSR.2|ETVREAEAASIK.3|ETVREAEAASIK.2|IRTDAGFTLR.2|LVQAAQMLQSDPYSVPAR.3|LVQAAQMLQSDPYSVPAR.2|LVQAAQMLQSDPYSVPAR.4|LVQAAQM[Oxi]LQSDPYSVPAR.3|LVQAAQM[Oxi]LQSDPYSVPAR.2|LANVMMGPYRQDLLAK.3|LANVM[Oxi]MGPYRQDLLAK.3|LANVMM[Oxi]GPYRQDLLAK.3|LANVMMGPYRQDLLAK.2|VMLVNSMNTVK.2|VM[Oxi]LVNSMNTVK.2|VMLVNSM[Oxi]NTVK.2|VM[Oxi]LVNSM[Oxi]NTVK.2|GILSGTSDLLLTFDEAEVRK.3|GILSGTSDLLLTFDEAEVRK.4|GILSGTSDLLLTFDEAEVRK.2|AGEVINQPMMMAAR.2|AGEVINQPMMMAAR.3|AGEVINQPM[Oxi]MMAAR.2|AGEVINQPMM[Oxi]MAAR.2|AGEVINQPMMM[Oxi]AAR.2|AGEVINQPM[Oxi]M[Oxi]M[Oxi]AAR.2|ALASQLQDSLK.2|DYLIDGSR.2|ALIQC[CAM]AK.2|ETVQTTEDQILKR.3|ETVQTTEDQILKR.2|AAAVGTANK.2|ALASIDSK.2|REVENSEDPK.3|REVENSEDPK.2|AAVHLEGK.2|ALIQC[CAM]AKDIAK.3|NLGPGMTK.2|GLVAEGHR.2|VGELC[CAM]AGK.2|NQGIEEALKNR.3|NQGIEEALKNR.2|GNDIIAAAK.2|QQELTHQEHR.3|QQELTHQEHR.2|AANFENHSGKLGATAEK.4|AANFENHSGKLGATAEK.3|ALASQLQDSLKDLKAR.4|ALASQLQDSLKDLKAR.3|EVENSEDPKFR.3|EVENSEDPKFR.2|IAELC[CAM]DDPKER.3|IAELC[CAM]DDPKER.2|ALASIDSKLNQAK.3|ALASIDSKLNQAK.2|EEVFDER.2|GEGESPQAR.2|RALASIDSK.2|RALIQC[CAM]AK.2|IAELC[CAM]DDPKERDDILR.4|IAELC[CAM]DDPKERDDILR.3|MIDERQQELTHQEHR.4|DPSASPGDAGEQAIR.3|DPSASPGDAGEQAIR.2|KIAELC[CAM]DDPKER.3|KIAELC[CAM]DDPKER.2|LLAVAATAPPDAPNR.3|LLAVAATAPPDAPNR.2|VDQLTAQLADLAAR.3|VDQLTAQLADLAAR.2|NQGIEEALK.2|DEEFPEQK.2|KLEAMTNSK.2|EVENSEDPK.2|IAELC[CAM]DDPK.2|AANFENHSGK.2|GQGSSPVAMQK.2|GQGSSPVAM[Oxi]QK.2|SLGEISALTSK.2|TISPMVMDAK.2|NQWIDNVEK.2|LANVMMGPYR.2|LANVM[Oxi]MGPYR.2|LANVMM[Oxi]GPYR.2|NPGNQAAYEHFETMK.3|NPGNQAAYEHFETM[Oxi]K.3|NPGNQAAYEHFETMK.2|KIAELC[CAM]DDPK.2|SLLDASEEAIK.2|SLLDASEEAIKKDLDK.3|WIDNPTVDDR.2|KIDAAQNWLADPNGGPEGEEQIR.4|KIDAAQNWLADPNGGPEGEEQIR.3|QVATALQNLQTK.2|LTDELAPPKPPLPEGEVPPPRPPPPEEKDEEFPEQK.6|LTDELAPPKPPLPEGEVPPPRPPPPEEKDEEFPEQK.5|LTDELAPPKPPLPEGEVPPPRPPPPEEKDEEFPEQK.4|VREAFQPQEPDFPPPPPDLEQLR.4|VREAFQPQEPDFPPPPPDLEQLR.3|LLAVAATAPPDAPNREEVFDERAANFENHSGK.5|AQQVSQGLDVLTAKVENAAR.3|AQQVSQGLDVLTAKVENAAR.2|ETVQTTEDQILK.2|LTDELAPPKPPLPEGEVPPPRPPPPEEK.4|LTDELAPPKPPLPEGEVPPPRPPPPEEK.3|TNISDEESEQATEMLVHNAQNLMQSVK.4|TNISDEESEQATEM[Oxi]LVHNAQNLMQSVK.3|TNISDEESEQATEMLVHNAQNLM[Oxi]QSVK.3|TNISDEESEQATEMLVHNAQNLMQSVK.3|IDAAQNWLADPNGGPEGEEQIR.3|IDAAQNWLADPNGGPEGEEQIR.2|KIDAAQNWLADPNGGPEGEEQIRGALAEAR.4|EAFQPQEPDFPPPPPDLEQLR.3|VLQLTSWDEDAWASKDTEAMK.3
SEN / CTL,Elongation factor 1-beta,EEF1B2,P24534,-0.17,0.39,1.22E-01,4.19E-02,1.38E+00,"translational elongation,response to ethanol","translation elongation factor activity,protein binding","cytoplasm,cytosol,eukaryotic translation elongation factor 1 complex,nucleus,endoplasmic reticulum",18,13,25,LVPVGYGIK.2|SIQADGLVWGSSK.2|SIQADGLVWGSSK.3|SSILLDVKPWDDETDMAKLEEC[CAM]VR.4|SSILLDVKPWDDETDMAKLEEC[CAM]VR.3|SSILLDVKPWDDETDM[Oxi]AKLEEC[CAM]VR.4|GFGDLKSPAGLQVLNDYLADK.3|LAQYESK.2|LAQYESKK.2|SPAGLQVLNDYLADK.3|SPAGLQVLNDYLADK.2|YGPADVEDTTGSGATDSK.3|YGPADVEDTTGSGATDSK.2|SSILLDVKPWDDETDM[Oxi]AK.3|SSILLDVKPWDDETDMAK.3|SSILLDVKPWDDETDM[Oxi]AK.2|SSILLDVKPWDDETDMAK.2|SYIEGYVPSQADVAVFEAVSSPPPADLC[CAM]HALR.5|SYIEGYVPSQADVAVFEAVSSPPPADLC[CAM]HALR.4|SYIEGYVPSQADVAVFEAVSSPPPADLC[CAM]HALR.3|VGTDMLEEQITAFEDYVQSM[Oxi]DVAAFNKI.4|VGTDMLEEQITAFEDYVQSM[Oxi]DVAAFNKI.3|SPAGLQVLNDYLADKSYIEGYVPSQADVAVFEAVSSPPPADLC[CAM]HALR.5|VGTDM[Oxi]LEEQITAFEDYVQSMDVAAFNK.3|VGTDMLEEQITAFEDYVQSM[Oxi]DVAAFNK.3
SEN / CTL,WD repeat-containing protein 1,WDR1,O75083,-0.17,0.90,2.67E-02,1.21E-02,1.92E+00,"platelet degranulation,sensory perception of sound,regulation of actin filament depolymerization,positive regulation of actin filament depolymerization,apical junction assembly,maintenance of epithelial cell apical/basal polarity,sarcomere organization,regulation of oligodendrocyte differentiation,regulation of ventricular cardiac muscle cell membrane repolarization",actin filament binding,"podosome,extracellular region,cytoplasm,cytosol,actin filament,cell-cell junction,cell projection,myelin sheath,extracellular exosome",87,47,76,LYSILGTTLKDEGK.3|LYSILGTTLKDEGK.2|VFASLPQVER.2|YAPSGFYIASGDVSGK.2|YAPSGFYIASGDVSGK.3|LATGSDDNC[CAM]AAFFEGPPFK.3|LATGSDDNC[CAM]AAFFEGPPFK.2|NIDNPALADIYTEHAHQVVVAK.4|NIDNPALADIYTEHAHQVVVAK.3|AHDGGIYAISWSPDSTHLLSASGDKTSK.5|AHDGGIYAISWSPDSTHLLSASGDKTSK.4|AHDGGIYAISWSPDSTHLLSASGDKTSK.3|YTSLMLR.2|MTVDESGQLISC[CAM]SMDDTVR.3|MTVDESGQLISC[CAM]SMDDTVR.2|M[Oxi]TVDESGQLISC[CAM]SMDDTVR.3|MTVDESGQLISC[CAM]SM[Oxi]DDTVR.3|KC[CAM]FSIDNPGYEPEVVAVHPGGDTVAIGGVDGNVR.4|KC[CAM]FSIDNPGYEPEVVAVHPGGDTVAIGGVDGNVR.3|SYIYSGSHDGHINYWDSETGENDSFAGK.4|SYIYSGSHDGHINYWDSETGENDSFAGK.3|C[CAM]FSIDNPGYEPEVVAVHPGGDTVAIGGVDGNVR.4|C[CAM]FSIDNPGYEPEVVAVHPGGDTVAIGGVDGNVR.3|YAPSGFYIASGDVSGKLR.3|GPVTDVAYSHDGAFLAVC[CAM]DASK.3|GPVTDVAYSHDGAFLAVC[CAM]DASK.4|GPVTDVAYSHDGAFLAVC[CAM]DASK.2|VVTVFSVADGYSENNVFYGHHAK.4|VVTVFSVADGYSENNVFYGHHAK.3|VVTVFSVADGYSENNVFYGHHAK.5|AHDGGIYAISWSPDSTHLLSASGDK.4|AHDGGIYAISWSPDSTHLLSASGDK.3|IWDTTQKEHLLKYEYQPFAGK.5|IWDTTQKEHLLKYEYQPFAGK.4|LHHVSSLAWLDEHTLVTTSHDASVKEWTITY.5|VINSVDIK.2|FGAVFLWDSGSSVGEITGHNK.3|FGAVFLWDSGSSVGEITGHNK.2|DHLLSVSLSGYINYLDRNNPSKPLHVIK.6|DHLLSVSLSGYINYLDRNNPSKPLHVIK.5|IAVVGEGR.2|TGEKVC[CAM]ALGGSK.3|KVFASLPQVER.3|KVFASLPQVER.2|IKDIAWTEDSK.3|IKDIAWTEDSK.2|IWDTTQK.2|LHHVSSLAWLDEHTLVTTSHDASVK.6|LHHVSSLAWLDEHTLVTTSHDASVK.5|LHHVSSLAWLDEHTLVTTSHDASVK.4|LHHVSSLAWLDEHTLVTTSHDASVK.3|FTIGDHSR.2|DYSGQGVVK.2|PYEIKKVFASLPQVER.4|RIAVVGEGR.2|IKDIAWTEDSKR.3|IKDIAWTEDSKR.2|IWDTTQKEHLLK.3|DIAWTEDSK.2|SIQC[CAM]LTVHK.2|YEYQPFAGK.2|LYSILGTTLK.2|GNNFLYTNGK.2|EHLLKYEYQPFAGK.3|EHLLKYEYQPFAGK.2|DIAWTEDSKR.2|EKFGAVFLWDSGSSVGEITGHNK.4|NNPSKPLHVIK.2|DHLLSVSLSGYINYLDRNNPSK.4|DHLLSVSLSGYINYLDR.3|C[CAM]VAVGPGGYAVVVC[CAM]IGQIVLLKDQRK.4|C[CAM]VAVGPGGYAVVVC[CAM]IGQIVLLK.3|C[CAM]VAVGPGGYAVVVC[CAM]IGQIVLLK.2|FATASADGQIYIYDGK.2|IWDVSVNSVVSTFPMGSTVLDQQLGC[CAM]LWQK.4|IWDVSVNSVVSTFPMGSTVLDQQLGC[CAM]LWQK.3
SEN / CTL,Spliceosome RNA helicase DDX39B,DDX39B,Q13838,-0.17,0.39,9.58E-02,3.44E-02,1.46E+00,"spliceosomal complex assembly,mRNA splicing, via spliceosome,liver development,termination of RNA polymerase II transcription,RNA export from nucleus,mRNA export from nucleus,RNA splicing,RNA secondary structure unwinding,mRNA 3'-end processing,positive regulation of DNA-templated transcription, elongation,positive regulation of translation,viral mRNA export from host cell nucleus,positive regulation of cell growth involved in cardiac muscle cell development,positive regulation of vascular smooth muscle cell proliferation,negative regulation of DNA damage checkpoint,positive regulation of DNA biosynthetic process","ATP-dependent RNA helicase activity,protein binding,ATP binding,RNA-dependent ATPase activity,ATPase activity,U6 snRNA binding,U4 snRNA binding,protein complex binding,identical protein binding,ATP-dependent protein binding,poly(A) RNA binding","transcription export complex,nucleus,nucleoplasm,spliceosomal complex,nuclear matrix,nuclear speck,U4 snRNP,U6 snRNP,cytoplasm",18,15,31,VAVFFGGLSIK.2|C[CAM]IALAQLLVEQNFPAIAIHR.3|C[CAM]IALAQLLVEQNFPAIAIHR.4|C[CAM]IALAQLLVEQNFPAIAIHR.5|C[CAM]IALAQLLVEQNFPAIAIHR.2|QVMMFSATLSK.2|QVM[Oxi]MFSATLSK.2|QVMM[Oxi]FSATLSK.2|QVM[Oxi]M[Oxi]FSATLSK.2|TAVFVLATLQQLEPVTGQVSVLVMC[CAM]HTR.4|TAVFVLATLQQLEPVTGQVSVLVMC[CAM]HTR.3|VNIAFNYDMPEDSDTYLHR.3|VNIAFNYDMPEDSDTYLHR.4|VNIAFNYDM[Oxi]PEDSDTYLHR.3|VNIAFNYDMPEDSDTYLHR.2|VAVFFGGLSIKK.3|NC[CAM]PHIVVGTPGR.3|NC[CAM]PHIVVGTPGR.2|KNC[CAM]PHIVVGTPGR.3|VAVFFGGLSIKKDEEVLK.4|HFILDEC[CAM]DK.2|FMQDPMEIFVDDETK.3|FM[Oxi]QDPMEIFVDDETK.3|FM[Oxi]QDPMEIFVDDETK.2|FMQDPMEIFVDDETK.2|KFMQDPMEIFVDDETK.3|KFMQDPMEIFVDDETKLTLHGLQQYYVK.5|KFM[Oxi]QDPMEIFVDDETKLTLHGLQQYYVK.4|KFMQDPMEIFVDDETKLTLHGLQQYYVK.4|FMQDPMEIFVDDETKLTLHGLQQYYVK.4|FEVNISELPDEIDISSYIEQTR.3
SEN / CTL,Leukotriene A-4 hydrolase,LTA4H,P09960,-0.17,0.70,1.26E-02,6.44E-03,2.19E+00,"proteolysis,leukotriene metabolic process,leukotriene biosynthetic process,peptide catabolic process","aminopeptidase activity,epoxide hydrolase activity,leukotriene-A4 hydrolase activity,peptidase activity,zinc ion binding,peptide binding,poly(A) RNA binding,metalloaminopeptidase activity","nucleus,nucleoplasm,cytoplasm,cytosol,plasma membrane,extracellular exosome",48,45,79,PEIVDTC[CAM]SLASPASVC[CAM]R.3|PEIVDTC[CAM]SLASPASVC[CAM]R.2|WEDAIPLALK.2|QSYKGSPMEISLPIALSK.3|LTYTAEVSVPK.2|AILPC[CAM]QDTPSVK.2|TLTGTAALTVQSQEDNLR.3|TLTGTAALTVQSQEDNLR.2|WITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQR.5|WITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQR.4|HFNALGGWGELQNSVK.3|HFNALGGWGELQNSVK.2|SAYEFSETESMLK.2|SAYEFSETESM[Oxi]LK.2|LC[CAM]IQSKWEDAIPLALK.3|LVVDLTDIDPDVAYSSVPYEK.3|LVVDLTDIDPDVAYSSVPYEK.4|LVVDLTDIDPDVAYSSVPYEK.2|GSPMEISLPIALSK.2|GSPMEISLPIALSK.3|GSPM[Oxi]EISLPIALSK.2|TWDHFWLNEGHTVYLER.4|TWDHFWLNEGHTVYLER.3|SLVLDTKDLTIEK.3|TLVWSEK.2|ASMHPVTAMLVGK.3|ASM[Oxi]HPVTAMLVGK.3|ASMHPVTAM[Oxi]LVGK.3|ASMHPVTAMLVGK.2|ASM[Oxi]HPVTAMLVGK.2|ASMHPVTAM[Oxi]LVGK.2|APLPLGHIK.2|DGETPDPEDPSRK.3|DGETPDPEDPSRK.2|SITTDDWK.2|EHPYLFSQC[CAM]QAIHC[CAM]R.4|EHPYLFSQC[CAM]QAIHC[CAM]R.3|EHPYLFSQC[CAM]QAIHC[CAM]R.2|VVINGQEVK.2|DLSSHQLNEFLAQTLQR.4|DLSSHQLNEFLAQTLQR.3|DLSSHQLNEFLAQTLQR.2|FRHFNALGGWGELQNSVK.4|FRHFNALGGWGELQNSVK.3|DLAAFDKSHDQAVR.3|DLAAFDKSHDQAVR.2|DFLYSYFK.2|SSALQWLTPEQTSGK.3|SSALQWLTPEQTSGK.2|ELVALMSAIR.2|ELVALM[Oxi]SAIR.2|SITTDDWKDFLYSYFKDK.4|SITTDDWKDFLYSYFKDK.3|TFGETHPFTK.2|SLSNVIAHEISHSWTGNLVTNK.4|SLSNVIAHEISHSWTGNLVTNK.3|ELVALM[Oxi]SAIRDGETPDPEDPSRK.4|ELVALMSAIRDGETPDPEDPSRK.4|M[Oxi]QEVYNFNAINNSEIR.3|MQEVYNFNAINNSEIR.3|M[Oxi]QEVYNFNAINNSEIR.2|MQEVYNFNAINNSEIR.2|DGETPDPEDPSR.2|VPIPC[CAM]YLIALVVGALESR.3|SITTDDWKDFLYSYFK.3|RTLTGTAALTVQSQEDNLR.3|WITAKEDDLNSFNATDLK.3|RM[Oxi]QEVYNFNAINNSEIR.3|RMQEVYNFNAINNSEIR.3|RMQEVYNFNAINNSEIR.2|SSALQWLTPEQTSGKEHPYLFSQC[CAM]QAIHC[CAM]R.5|SSALQWLTPEQTSGKEHPYLFSQC[CAM]QAIHC[CAM]R.4|EDDLNSFNATDLK.2|TLVWSEKEQVEK.2|DLAAFDK.1|ELVALMSAIRDGETPDPEDPSR.3|EDDLNSFNATDLKDLSSHQLNEFLAQTLQR.4|EDDLNSFNATDLKDLSSHQLNEFLAQTLQR.3|PNYDMTLTNAC[CAM]IALSQR.2
SEN / CTL,Fructose-bisphosphate aldolase A,ALDOA,P04075,-0.18,0.88,7.20E-05,7.44E-05,4.13E+00,"platelet degranulation,fructose metabolic process,gluconeogenesis,glycolytic process,ATP biosynthetic process,striated muscle contraction,actin filament organization,regulation of cell shape,fructose 1,6-bisphosphate metabolic process,muscle cell cellular homeostasis,protein homotetramerization,canonical glycolysis,cell-cell adhesion","actin binding,fructose-bisphosphate aldolase activity,cytoskeletal protein binding,tubulin binding,identical protein binding,poly(A) RNA binding,fructose binding,cadherin binding involved in cell-cell adhesion","extracellular region,extracellular space,nucleus,cytosol,cell-cell adherens junction,actin cytoskeleton,membrane,platelet alpha granule lumen,M band,I band,extracellular exosome",153,51,110,VDKGVVPLAGTNGETTTQGLDGLSER.3|VDKGVVPLAGTNGETTTQGLDGLSER.4|GILAADESTGSIAKR.3|GILAADESTGSIAKR.2|ADDGRPFPQVIK.3|ADDGRPFPQVIK.2|ALANSLAC[CAM]QGK.2|QLLLTADDR.2|YASIC[CAM]QQNGIVPIVEPEILPDGDHDLKR.4|YASIC[CAM]QQNGIVPIVEPEILPDGDHDLKR.3|YASIC[CAM]QQNGIVPIVEPEILPDGDHDLKR.5|YASIC[CAM]QQNGIVPIVEPEILPDGDHDLKR.6|C[CAM]PLLKPWALTFSYGR.3|C[CAM]PLLKPWALTFSYGR.2|PYQYPALTPEQKKELSDIAHR.5|TVPPAVTGITFLSGGQSEEEASINLNAINKC[CAM]PLLKPWALTFSYGR.6|TVPPAVTGITFLSGGQSEEEASINLNAINKC[CAM]PLLKPWALTFSYGR.5|GVVPLAGTNGETTTQGLDGLSER.3|GVVPLAGTNGETTTQGLDGLSER.2|GVVPLAGTNGETTTQGLDGLSER.4|ALSDHHIYLEGTLLKPNM[Oxi]VTPGHAC[CAM]TQK.5|ALSDHHIYLEGTLLKPNMVTPGHAC[CAM]TQK.5|ALSDHHIYLEGTLLKPNMVTPGHAC[CAM]TQK.6|ALSDHHIYLEGTLLKPNMVTPGHAC[CAM]TQK.4|ALSDHHIYLEGTLLKPNM[Oxi]VTPGHAC[CAM]TQK.4|ALSDHHIYLEGTLLKPNMVTPGHAC[CAM]TQK.3|ALSDHHIYLEGTLLKPNM[Oxi]VTPGHAC[CAM]TQK.6|ALSDHHIYLEGTLLKPNM[Oxi]VTPGHAC[CAM]TQK.3|GILAADESTGSIAK.2|GILAADESTGSIAK.3|PYQYPALTPEQKK.3|PYQYPALTPEQKK.2|FSHEEIAMATVTALRR.4|FSHEEIAMATVTALRR.3|FSHEEIAMATVTALRR.2|FSHEEIAM[Oxi]ATVTALRR.4|FSHEEIAM[Oxi]ATVTALRR.3|YTPSGQAGAAASESLFVSNHAY.3|YTPSGQAGAAASESLFVSNHAY.2|FSHEEIAMATVTALR.3|FSHEEIAMATVTALR.2|FSHEEIAMATVTALR.4|FSHEEIAM[Oxi]ATVTALR.3|FSHEEIAM[Oxi]ATVTALR.2|GGVVGIKVDKGVVPLAGTNGETTTQGLDGLSER.4|GGVVGIKVDKGVVPLAGTNGETTTQGLDGLSER.3|LQSIGTENTEENRR.3|LQSIGTENTEENRR.2|IGEHTPSALAIMENANVLAR.3|IGEHTPSALAIMENANVLAR.4|IGEHTPSALAIMENANVLAR.2|IGEHTPSALAIM[Oxi]ENANVLAR.3|IGEHTPSALAIM[Oxi]ENANVLAR.4|IGEHTPSALAIM[Oxi]ENANVLAR.2|QLLLTADDRVNPC[CAM]IGGVILFHETLYQK.4|QLLLTADDRVNPC[CAM]IGGVILFHETLYQK.3|QLLLTADDRVNPC[CAM]IGGVILFHETLYQK.5|IVAPGKGILAADESTGSIAK.3|IVAPGKGILAADESTGSIAK.2|IVAPGKGILAADESTGSIAK.4|PYQYPALTPEQK.2|PYQYPALTPEQK.3|ELSDIAHR.2|ENLKAAQEEYVKR.3|ALQASALK.2|ALSDHHIYLEGTLLK.4|ALSDHHIYLEGTLLK.3|ALSDHHIYLEGTLLK.2|KDGADFAK.2|ALQASALKAWGGK.3|ALQASALKAWGGK.2|RALANSLAC[CAM]QGK.3|RALANSLAC[CAM]QGK.2|RLQSIGTENTEENRR.4|RLQSIGTENTEENRR.3|RLQSIGTENTEENRR.2|C[CAM]QYVTEK.2|AAQEEYVK.2|ALQASALKAWGGKK.3|ENLKAAQEEYVK.3|ENLKAAQEEYVK.2|PNMVTPGHAC[CAM]TQK.3|PNM[Oxi]VTPGHAC[CAM]TQK.3|PNMVTPGHAC[CAM]TQK.2|GGVVGIKVDK.2|LQSIGTENTEENR.3|LQSIGTENTEENR.2|VNPC[CAM]IGGVILFHETLYQK.4|VNPC[CAM]IGGVILFHETLYQK.3|VNPC[CAM]IGGVILFHETLYQK.2|DGADFAKWR.2|KELSDIAHR.2|RC[CAM]QYVTEK.2|AAQEEYVKR.2|RLQSIGTENTEENR.3|RLQSIGTENTEENR.2|C[CAM]QYVTEKVLAAVYK.3|AWGGKKENLK.2|SKGGVVGIKVDK.2|PWALTFSYGR.2|YASIC[CAM]QQNGIVPIVEPEILPDGDHDLK.5|YASIC[CAM]QQNGIVPIVEPEILPDGDHDLK.4|YASIC[CAM]QQNGIVPIVEPEILPDGDHDLK.3|RTVPPAVTGITFLSGGQSEEEASINLNAINK.5|RTVPPAVTGITFLSGGQSEEEASINLNAINK.4|RTVPPAVTGITFLSGGQSEEEASINLNAINK.3|TVPPAVTGITFLSGGQSEEEASINLNAINK.4|TVPPAVTGITFLSGGQSEEEASINLNAINK.3|ALANSLAC[CAM]QGKYTPSGQAGAAASESLFVSNHAY.4|ALANSLAC[CAM]QGKYTPSGQAGAAASESLFVSNHAY.3
SEN / CTL,S-adenosylmethionine synthase isoform type-2,MAT2A,P31153,-0.18,0.27,2.65E-02,1.20E-02,1.92E+00,"S-adenosylmethionine biosynthetic process,one-carbon metabolic process,methylation,protein hexamerization,protein heterooligomerization","methionine adenosyltransferase activity,protein binding,ATP binding,metal ion binding","cytosol,methionine adenosyltransferase complex",15,24,40,NFDLRPGVIVR.3|FVIGGPQGDAGLTGR.2|FVIGGPQGDAGLTGR.3|YLDEDTIYHLQPSGR.3|YLDEDTIYHLQPSGR.4|YLDEDTIYHLQPSGR.2|TQVTVQYMQDR.2|TQVTVQYM[Oxi]QDR.2|TGMILLAGEITSR.2|TGMILLAGEITSR.3|TGM[Oxi]ILLAGEITSR.2|DSFPWEVPKK.3|ELLEIVK.2|VAC[CAM]ETVAK.2|DLDLKKPIYQR.3|NGTLPWLRPDSK.3|NGTLPWLRPDSK.2|ELLEIVKK.2|IIVDTYGGWGAHGGGAFSGK.4|IIVDTYGGWGAHGGGAFSGK.3|IIVDTYGGWGAHGGGAFSGK.2|TAAYGHFGR.2|HIGYDDSSK.2|KIIVDTYGGWGAHGGGAFSGK.4|KIIVDTYGGWGAHGGGAFSGK.3|FVIGGPQGDAGLTGRK.3|FVIGGPQGDAGLTGRK.2|HIGYDDSSKGFDYK.3|DSFPWEVPK.2|IC[CAM]DQISDAVLDAHLQQDPDAK.4|IC[CAM]DQISDAVLDAHLQQDPDAK.3|IC[CAM]DQISDAVLDAHLQQDPDAK.2|VHTIVISVQHDEEVC[CAM]LDEMR.4|VHTIVISVQHDEEVC[CAM]LDEMR.3|TC[CAM]NVLVALEQQSPDIAQGVHLDR.4|TC[CAM]NVLVALEQQSPDIAQGVHLDR.3|VHTIVISVQHDEEVC[CAM]LDEMRDALK.4|VLVQVSYAIGVSHPLSISIFHYGTSQK.4|VLVQVSYAIGVSHPLSISIFHYGTSQK.3|RVLVQVSYAIGVSHPLSISIFHYGTSQK.4
SEN / CTL,Macrophage migration inhibitory factor,MIF,P14174,-0.18,0.33,1.35E-01,4.49E-02,1.35E+00,"prostaglandin biosynthetic process,negative regulation of mature B cell apoptotic process,inflammatory response,cell surface receptor signaling pathway,cell aging,cell proliferation,negative regulation of gene expression,positive regulation of protein kinase A signaling,carboxylic acid metabolic process,DNA damage response, signal transduction by p53 class mediator,positive regulation of B cell proliferation,positive regulation of lipopolysaccharide-mediated signaling pathway,negative regulation of cellular protein metabolic process,negative regulation of myeloid cell apoptotic process,positive regulation of peptidyl-serine phosphorylation,positive regulation of phosphorylation,regulation of macrophage activation,negative regulation of apoptotic process,positive regulation of MAP kinase activity,negative regulation of DNA damage response, signal transduction by p53 class mediator,innate immune response,positive regulation of fibroblast proliferation,positive regulation of cytokine secretion,positive regulation of peptidyl-tyrosine phosphorylation,leukocyte migration,positive chemotaxis,positive regulation of prostaglandin secretion involved in immune response,positive regulation of myeloid leukocyte cytokine production involved in immune response,protein homotrimerization,positive regulation of ERK1 and ERK2 cascade,negative regulation of cell cycle arrest,positive regulation of arachidonic acid secretion,negative regulation of cell aging,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,positive regulation of chemokine (C-X-C motif) ligand 2 production","dopachrome isomerase activity,receptor binding,cytokine activity,cytokine receptor binding,protein binding,chemoattractant activity,phenylpyruvate tautomerase activity","extracellular region,extracellular space,nucleoplasm,cytoplasm,cell surface,vesicle,myelin sheath,extracellular exosome",30,10,22,PMFIVNTNVPR.2|PMFIVNTNVPR.3|PM[Oxi]FIVNTNVPR.2|PM[Oxi]FIVNTNVPR.3|LLC[CAM]GLLAER.2|ASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPC[CAM]ALC[CAM]SLHSIGK.5|ASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPC[CAM]ALC[CAM]SLHSIGK.6|ASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLM[Oxi]AFGGSSEPC[CAM]ALC[CAM]SLHSIGK.7|ASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPC[CAM]ALC[CAM]SLHSIGK.7|ASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLM[Oxi]AFGGSSEPC[CAM]ALC[CAM]SLHSIGK.6|LLC[CAM]GLLAERLR.3|SYSKLLC[CAM]GLLAERLR.4|SYSKLLC[CAM]GLLAERLR.3|SYSKLLC[CAM]GLLAER.3|SYSKLLC[CAM]GLLAER.2|MPMFIVNTNVPR.2|MPM[Oxi]FIVNTNVPR.2|ASVPDGFLSELTQQLAQATGK.3|ASVPDGFLSELTQQLAQATGK.2|VYINYYDM[Oxi]NAANVGWNNSTFA.3|VYINYYDMNAANVGWNNSTFA.3|ISPDRVYINYYDMNAANVGWNNSTFA.3
SEN / CTL,cAMP-dependent protein kinase type II-alpha regulatory subunit,PRKAR2A,P13861,-0.19,1.19,1.34E-01,4.48E-02,1.35E+00,"renal water homeostasis,blood coagulation,activation of protein kinase A activity,intracellular signal transduction,cellular response to glucagon stimulus,negative regulation of cAMP-dependent protein kinase activity","cAMP-dependent protein kinase inhibitor activity,protein binding,cAMP-dependent protein kinase regulator activity,cAMP binding,ubiquitin protein ligase binding,protein kinase A catalytic subunit binding","cytoplasm,centrosome,cytosol,plasma membrane,focal adhesion,cAMP-dependent protein kinase complex,membrane,nucleotide-activated protein kinase complex,plasma membrane raft,extracellular exosome,ciliary base",18,23,31,SLEVSER.2|NLDQEQLSQVLDAMFER.3|NLDQEQLSQVLDAMFER.2|GQYFGELALVTNKPR.3|GQYFGELALVTNKPR.2|ADEHVIDQGDDGDNFYVIER.3|SVGQYDNR.2|QQPPDLVEFAVEYFTR.3|QQPPDLVEFAVEYFTR.2|QSLGHPPPEPGPDR.3|GTYDILVTK.2|RNISHYEEQLVK.3|RNISHYEEQLVK.2|SNKDGGNQEVEIAR.3|MFESFIESVPLLK.3|M[Oxi]FESFIESVPLLK.2|MFESFIESVPLLK.2|AASAYAVGDVK.2|GTYDILVTKDNQTR.3|KMFESFIESVPLLK.3|APASVLPAATPR.2|DGGNQEVEIAR.2|LLGPC[CAM]MDIMK.2|MFGSSVDLGNLGQ.2|M[Oxi]FGSSVDLGNLGQ.2|C[CAM]LVMDVQAFER.2|NISHYEEQLVK.2|VSVC[CAM]AETYNPDEEEEDTDPR.3|VSVC[CAM]AETYNPDEEEEDTDPR.2|RVSVC[CAM]AETYNPDEEEEDTDPR.3|AATIVATSEGSLWGLDR.2
SEN / CTL,Proteasome subunit alpha type-7,PSMA7,O14818,-0.19,0.74,7.28E-02,2.74E-02,1.56E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,viral process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","threonine-type endopeptidase activity,protein binding","proteasome complex,nucleus,nucleoplasm,cytosol,proteasome core complex,proteasome core complex, alpha-subunit complex,extracellular exosome",39,16,28,LTVEDPVTVEYITR.2|LTVEDPVTVEYITR.3|KIC[CAM]ALDDNVC[CAM]MAFAGLTADAR.3|RPFGISALIVGFDFDGTPR.3|ALLEVVQSGGK.2|NIELAVMR.2|NIELAVM[Oxi]R.2|AITVFSPDGHLFQVEYAQEAVKK.4|AITVFSPDGHLFQVEYAQEAVKK.3|NYTDEAIETDDLTIK.2|NYTDEAIETDDLTIK.3|AITVFSPDGHLFQVEYAQEAVK.3|AITVFSPDGHLFQVEYAQEAVK.4|DIVVLGVEK.2|YVAEIEK.2|LYQTDPSGTYHAWK.3|LYQTDPSGTYHAWK.4|LYQTDPSGTYHAWK.2|IC[CAM]ALDDNVC[CAM]MAFAGLTADAR.3|IC[CAM]ALDDNVC[CAM]M[Oxi]AFAGLTADAR.3|IC[CAM]ALDDNVC[CAM]M[Oxi]AFAGLTADAR.2|IC[CAM]ALDDNVC[CAM]MAFAGLTADAR.2|YVAEIEKEKEENEK.4|YVAEIEKEKEENEK.3|YVAEIEKEKEENEK.2|GRDIVVLGVEKK.3|ILNPEEIEK.2|GRDIVVLGVEK.2
SEN / CTL,"Keratin, type II cytoskeletal 1",KRT1,P04264,-0.19,0.72,1.49E-05,1.80E-05,4.74E+00,"complement activation, lectin pathway,retina homeostasis,response to oxidative stress,fibrinolysis,regulation of angiogenesis,negative regulation of inflammatory response,establishment of skin barrier","receptor activity,structural molecule activity,protein binding,carbohydrate binding","extracellular space,nucleus,cytoskeleton,plasma membrane,membrane,extracellular matrix,keratin filament,extracellular exosome,blood microparticle",87,64,116,LALDLEIATYR.2|SLNNQFASFIDKVR.3|SLNNQFASFIDKVR.2|WELLQQVDTSTR.2|WELLQQVDTSTR.3|SISISVAR.2|FSSC[CAM]GGGGGSFGAGGGFGSR.3|FSSC[CAM]GGGGGSFGAGGGFGSR.2|SKAEAESLYQSKYEELQITAGR.4|SKAEAESLYQSKYEELQITAGR.3|THNLEPYFESFINNLRR.4|THNLEPYFESFINNLRR.3|SLVNLGGSK.2|NKLNDLEDALQQAKEDLAR.4|NKLNDLEDALQQAKEDLAR.3|NKLNDLEDALQQAKEDLAR.2|SLDLDSIIAEVK.2|SLDLDSIIAEVK.3|YEELQITAGR.2|YEELQITAGR.1|LLRDYQELMNTK.3|LLRDYQELMNTK.2|LLRDYQELM[Oxi]NTK.3|LLRDYQELM[Oxi]NTK.2|QISNLQQSISDAEQRGENALKDAK.4|QISNLQQSISDAEQRGENALKDAK.3|MSGEC[CAM]APNVSVSVSTSHTTISGGGSR.3|M[Oxi]SGEC[CAM]APNVSVSVSTSHTTISGGGSR.3|MSGEC[CAM]APNVSVSVSTSHTTISGGGSR.4|GGGGGGYGSGGSSYGSGGGSYGSGGGGGGGR.3|GGGGGGYGSGGSSYGSGGGSYGSGGGGGGGR.2|THNLEPYFESFINNLR.3|THNLEPYFESFINNLR.4|THNLEPYFESFINNLR.2|AEAESLYQSKYEELQITAGR.3|AEAESLYQSKYEELQITAGR.2|TLLEGEESR.2|SLNNQFASFIDK.2|SLNNQFASFIDK.3|NSKIEISELNR.3|NSKIEISELNR.2|SGGGFSSGSAGIINYQR.2|SGGGFSSGSAGIINYQR.3|LRSEIDNVKK.3|LRSEIDNVKK.2|SDQSRLDSELK.3|SDQSRLDSELK.2|TNAENEFVTIK.3|TNAENEFVTIK.2|RVDQLKSDQSR.3|SKAEAESLYQSK.3|SKAEAESLYQSK.2|LNDLEDALQQAK.3|LNDLEDALQQAK.2|TNAENEFVTIKK.3|TNAENEFVTIKK.2|SEIDNVKK.2|GENALKDAK.2|RTNAENEFVTIK.3|DVDGAYMTK.2|DVDGAYM[Oxi]TK.2|GGSGGGGGGSSGGR.2|RTNAENEFVTIKK.3|AQYEDIAQK.2|EQIKSLNNQFASFIDKVR.4|EQIKSLNNQFASFIDKVR.3|LRSEIDNVK.2|NKLNDLEDALQQAK.3|NKLNDLEDALQQAK.2|GSGGGSSGGSIGGR.2|AEAESLYQSK.2|KDVDGAYMTK.2|KDVDGAYM[Oxi]TK.2|SLVNLGGSKSISISVAR.3|SLVNLGGSKSISISVAR.2|DYQELMNTK.2|DYQELM[Oxi]NTK.2|QISNLQQSISDAEQR.3|QISNLQQSISDAEQR.2|GSGGGSSGGSIGGRGSSSGGVK.3|SLDLDSIIAEVKAQYEDIAQK.4|SLDLDSIIAEVKAQYEDIAQK.3|SLDLDSIIAEVKAQYEDIAQK.2|TNAENEFVTIKKDVDGAYMTK.4|TNAENEFVTIKKDVDGAYMTK.3|SGGGFSSGSAGIINYQRR.3|FVSTTYSGVTR.2|KQISNLQQSISDAEQR.3|KQISNLQQSISDAEQR.2|KQISNLQQSISDAEQRGENALK.4|VDQLKSDQSRLDSELK.3|SDQSRLDSELKNMQDMVEDYR.4|SLDLDSIIAEVKAQYEDIAQKSK.4|LNDLEDALQQAKEDLAR.3|LNDLEDALQQAKEDLAR.2|NMQDMVEDYR.2|NM[Oxi]QDMVEDYR.2|NMQDM[Oxi]VEDYR.2|NM[Oxi]QDM[Oxi]VEDYR.2|LDSELKNM[Oxi]QDMVEDYR.3|LDSELKNMQDM[Oxi]VEDYR.3|LDSELKNMQDMVEDYR.3|LDSELKNM[Oxi]QDM[Oxi]VEDYR.3|LDSELKNM[Oxi]QDMVEDYR.2|LDSELKNMQDM[Oxi]VEDYR.2|LDSELKNMQDMVEDYR.2|LDSELKNM[Oxi]QDM[Oxi]VEDYR.2|GGSGGGGGGSSGGRGSGGGSSGGSIGGRGSSSGGVK.4|GGSGGGGGGSSGGRGSGGGSSGGSIGGR.3|FLEQQNQVLQTKWELLQQVDTSTR.4|FLEQQNQVLQTKWELLQQVDTSTR.3|SGGGGGRFSSC[CAM]GGGGGSFGAGGGFGSR.3|QISNLQQSISDAEQRGENALK.3|GSYGSGGSSYGSGGGSYGSGGGGGGHGSYGSGSSSGGYR.4|GSYGSGGSSYGSGGGSYGSGGGGGGHGSYGSGSSSGGYR.3|GSYGSGGSSYGSGGGSYGSGGGGGGHGSYGSGSSSGGYRGGSGGGGGGSSGGR.4
SEN / CTL,Vacuolar protein sorting-associated protein 26A,VPS26A,O75436,-0.19,0.41,1.03E-01,3.65E-02,1.44E+00,"intracellular protein transport,Wnt signaling pathway,regulation of macroautophagy,retrograde transport, endosome to Golgi,retrograde transport, endosome to plasma membrane","protein binding,protein transporter activity","endosome,early endosome,cytosol,endosome membrane,retromer complex,retromer, cargo-selective complex,vesicle,intracellular membrane-bounded organelle,extracellular exosome,tubular endosome",21,22,31,YFLNLVLVDEEDRR.3|ELALPGELTQSR.2|LFLAGYDPTPTMR.2|LFLAGYDPTPTM[Oxi]R.2|HYLFYDGESVSGK.3|HYLFYDGESVSGK.2|QQEIILWR.2|IYFLLVR.2|YEIMDGAPVKGESIPIR.3|YEIM[Oxi]DGAPVKGESIPIR.3|IQHMELQLIK.3|IQHMELQLIK.2|SNTHEFVNLVK.3|SNTHEFVNLVK.2|RLEHQGIR.2|YEIMDGAPVK.2|EITGIGPSTTTETETIAK.3|EITGIGPSTTTETETIAK.2|PYESYIGANVR.2|RLTDLVKEYDLIVHQLATYPDVNNSIK.5|RLTDLVKEYDLIVHQLATYPDVNNSIK.4|KEITGIGPSTTTETETIAK.3|IEFVGQIELFNDKSNTHEFVNLVK.4|SYDFEFMQVEK.2|LTDLVKEYDLIVHQLATYPDVNNSIK.4|LTDLVKEYDLIVHQLATYPDVNNSIK.3|EYDLIVHQLATYPDVNNSIK.3|EYDLIVHQLATYPDVNNSIK.2|IEFVGQIELFNDK.2|FESPESQASAEQPEM.2|SYDFEFMQVEKPYESYIGANVR.3
SEN / CTL,Proteasome subunit alpha type-2,PSMA2,P25787,-0.19,0.18,4.17E-04,3.54E-04,3.45E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,response to virus,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","threonine-type endopeptidase activity,protein binding","proteasome complex,cytoplasmic mRNA processing body,nucleus,nucleoplasm,cytosol,proteasome core complex,proteasome core complex, alpha-subunit complex,extracellular exosome",24,15,31,RLTPTEVKDYLAAIA.3|KLAQQYYLVYQEPIPTAQLVQR.3|KLAQQYYLVYQEPIPTAQLVQR.4|HIGLVYSGMGPDYR.3|HIGLVYSGMGPDYR.2|HIGLVYSGM[Oxi]GPDYR.3|HIGLVYSGM[Oxi]GPDYR.2|LVQIEYALAAVAGGAPSVGIK.3|LVQIEYALAAVAGGAPSVGIK.4|LVQIEYALAAVAGGAPSVGIK.2|GYSFSLTTFSPSGK.2|GYSFSLTTFSPSGK.3|LAQQYYLVYQEPIPTAQLVQR.3|LAQQYYLVYQEPIPTAQLVQR.4|AANGVVLATEKK.3|AANGVVLATEKK.2|AANGVVLATEK.2|YNEDLELEDAIHTAILTLK.4|YNEDLELEDAIHTAILTLK.3|YNEDLELEDAIHTAILTLK.2|SVHKVEPITK.2|RYNEDLELEDAIHTAILTLK.4|RYNEDLELEDAIHTAILTLK.3|RYNEDLELEDAIHTAILTLK.2|PYLFQSDPSGAYFAWK.3|PYLFQSDPSGAYFAWK.2|ESFEGQMTEDNIEVGIC[CAM]NEAGFRR.4|ESFEGQMTEDNIEVGIC[CAM]NEAGFRR.3|LTPTEVKDYLAAIA.2|ESFEGQM[Oxi]TEDNIEVGIC[CAM]NEAGFR.3|ESFEGQMTEDNIEVGIC[CAM]NEAGFR.3
SEN / CTL,Cytochrome c oxidase subunit 6B1,COX6B1,P14854,-0.20,0.20,3.14E-02,1.37E-02,1.86E+00,"mitochondrial electron transport, cytochrome c to oxygen,substantia nigra development,hydrogen ion transmembrane transport",cytochrome-c oxidase activity,"mitochondrion,mitochondrial inner membrane,mitochondrial intermembrane space",9,9,12,GGDISVC[CAM]EWYQR.2|NC[CAM]WQNYLDFHR.3|NC[CAM]WQNYLDFHR.2|AEGTFPGK.2|AEGTFPGKI.2|FPNQNQTR.2|TAPFDSRFPNQNQTR.3|VYQSLC[CAM]PTSWVTDWDEQR.3|VYQSLC[CAM]PTSWVTDWDEQR.2|VYQSLC[CAM]PTSWVTDWDEQRAEGTFPGKI.4|VYQSLC[CAM]PTSWVTDWDEQRAEGTFPGKI.3|VYQSLC[CAM]PTSWVTDWDEQRAEGTFPGK.3
SEN / CTL,Acid ceramidase,ASAH1,Q13510,-0.20,0.12,4.23E-03,2.58E-03,2.59E+00,"ceramide metabolic process,glycosphingolipid metabolic process","catalytic activity,ceramidase activity","extracellular space,lysosomal lumen,extracellular exosome",9,24,34,LTVYTTLIDVTK.2|ESLDVYELDAK.2|TSQENISFETMYDVLSTKPVLNK.3|TSQENISFETM[Oxi]YDVLSTKPVLNK.4|TSQENISFETMYDVLSTKPVLNK.4|TSQENISFETM[Oxi]YDVLSTKPVLNK.3|HPFFLDDRR.3|RWHELM[Oxi]LDK.3|RWHELMLDK.3|RWHELMLDK.2|WKHPFFLDDR.3|IMQVVDEK.2|GQFETYLR.2|HPFFLDDR.2|WHELMLDKAPVLK.3|WYVVQTNYDRWK.3|WYVVQTNYDRWK.2|DRKESLDVYELDAK.3|DRKESLDVYELDAK.2|NMINTFVPSGK.2|NM[Oxi]INTFVPSGK.2|PLTVNLDFQR.2|GAVPWYTINLDLPPYK.3|GAVPWYTINLDLPPYK.2|STYPPSGPTYR.2|PGLFSLTLNER.2|GAVPWYTINLDLPPYKR.3|FSINGGYLGILEWILGKK.3|WYVVQTNYDR.2|ILAPAYFILGGNQSGEGC[CAM]VITR.3|ASSFAGYVGMLTGFKPGLFSLTLNER.3|IMQVVDEKLPGLLGNFPGPFEEEMK.3|LPGLLGNFPGPFEEEMK.2|LPGLLGNFPGPFEEEM[Oxi]K.2
SEN / CTL,Phosphoglucomutase-2,PGM2,Q96G03,-0.21,0.44,3.01E-02,1.33E-02,1.88E+00,"glycogen biosynthetic process,glycogen catabolic process,glucose metabolic process,pentose-phosphate shunt,galactose catabolic process,deoxyribose phosphate catabolic process","magnesium ion binding,phosphoglucomutase activity,phosphopentomutase activity","cytosol,extracellular exosome",15,36,58,LAATTFISQGIPVYLFSDITPTPFVPFTVSHLK.4|LAATTFISQGIPVYLFSDITPTPFVPFTVSHLK.6|LAATTFISQGIPVYLFSDITPTPFVPFTVSHLK.5|GIVISFDAR.2|FEISAIR.2|MNDLTIIQTTQGFC[CAM]R.2|MNDLTIIQTTQGFC[CAM]R.3|M[Oxi]NDLTIIQTTQGFC[CAM]R.2|IVLANDPDADRLAVAEK.3|IVLANDPDADRLAVAEK.2|AAMGPGISR.2|AAM[Oxi]GPGISR.2|ASYFIC[CAM]HDQETIKK.4|ASYFIC[CAM]HDQETIKK.3|ASYFIC[CAM]HDQETIKK.2|YPNPEEGK.2|AIYVEYGYHITK.3|AIYVEYGYHITK.2|NSLTLEAVK.2|MEFGTAGLR.2|AFDLVPPEAVPEQK.3|AFDLVPPEAVPEQK.2|EGFHFEETLTGFK.3|EGFHFEETLTGFK.2|NLSLSQQLK.2|FVHTSVHGVGHSFVQSAFK.4|FVHTSVHGVGHSFVQSAFK.3|FVHTSVHGVGHSFVQSAFK.2|DLTTGYDDSQPDKK.3|DLTTGYDDSQPDKK.2|ASYFIC[CAM]HDQETIK.3|ASYFIC[CAM]HDQETIK.2|ELNELVSAIEEHFFQPQK.4|ELNELVSAIEEHFFQPQK.3|ELNELVSAIEEHFFQPQK.2|DPDPEFPTVK.2|SALKDTYMLSSTVSSK.3|SALKDTYMLSSTVSSK.2|VYWDNGAQIISPHDK.3|VYWDNGAQIISPHDK.2|IVLANDPDADR.2|IKYYAELC[CAM]APPGNSDPEQLKK.4|DGVSAAVISAELASFLATK.3|DGVSAAVISAELASFLATK.2|GVLTLSFALADK.2|LDQETAQWLR.2|LIAEGNKEELR.2|SSQMITFTFANGGVATMR.3|SSQMITFTFANGGVATMR.2|DTYMLSSTVSSK.2|AFDLVPPEAVPEQKDPDPEFPTVK.4|AFDLVPPEAVPEQKDPDPEFPTVK.3|LIAEGNKEELRK.2|YPNPEEGKGVLTLSFALADK.3|DLTTGYDDSQPDK.2|YYAELC[CAM]APPGNSDPEQLKK.3|LC[CAM]AGIMITASHNPK.2|YYAELC[CAM]APPGNSDPEQLK.2
SEN / CTL,Lamin-B2,LMNB2,Q03252,-0.21,0.62,2.52E-02,1.15E-02,1.94E+00,biological_process,"molecular_function,structural molecule activity","nuclear inner membrane,lamin filament",24,59,82,LQIEIGK.2|GLESDVAELR.2|ALELENDRLLLK.3|ALELENDRLLLK.2|C[CAM]QSLQEELDFRK.3|C[CAM]QSLQEELDFRK.2|SEVELAAALSDKR.2|SEVELAAALSDKR.3|MRLESLSYQLSGLQK.3|M[Oxi]RLESLSYQLSGLQK.3|MRLESLSYQLSGLQK.2|LALDMEINAYRK.3|LALDM[Oxi]EINAYRK.3|LALDMEINAYRK.2|LLEGEEERLK.3|IRELEEAMAGERDK.4|IRELEEAMAGERDK.3|LSPSPSSR.2|RGLESDVAELR.3|RGLESDVAELR.2|LAHYIDR.2|KLLEGEEERLK.3|KREGELTVAQGR.3|KREGELTVAQGR.2|ISEKEEVTTREVSGIK.4|LVEVDSSR.2|AELDEVNK.2|ALYESELADARR.3|ALYESELADARR.2|ALELENDR.2|RQVLEGEEIAYK.3|RQVLEGEEIAYK.2|RVLDETAR.2|DQSLGNWR.2|LESLSYQLSGLQK.3|LESLSYQLSGLQK.2|LLEGEEER.2|SVFEEEVR.2|DLESLFHR.2|MAQALEELRSQHDEQVR.4|MAQALEELRSQHDEQVR.3|NNSDKDQSLGNWR.3|NNSDKDQSLGNWR.2|AASAAREELK.2|EGELTVAQGR.2|MAQALEELR.2|M[Oxi]AQALEELR.2|RLVEVDSSR.2|EQEM[Oxi]TEM[Oxi]R.2|LYKLELEQTYQAK.3|LYKLELEQTYQAK.2|KLLEGEEER.2|LQEKEELRELNDR.3|AGGPATPLSPTR.2|ELEEAMAGER.2|QVLEGEEIAYKFTPK.3|LRAELDEVNK.2|DLESLFHRSEVELAAALSDKR.4|ISEKEEVTTR.2|LELEQTYQAK.2|ALYESELADAR.2|SEVELAAALSDK.2|AGQMVTVWAAGAGVAHSPPSTLVWK.4|AGQM[Oxi]VTVWAAGAGVAHSPPSTLVWK.4|AGQM[Oxi]VTVWAAGAGVAHSPPSTLVWK.3|AGQMVTVWAAGAGVAHSPPSTLVWK.3|ATSSSSGSLSATGR.2|QVLEGEEIAYK.2|RQVLEGEEIAYKFTPK.3|GQSSWGTGESFR.2|LALDMEINAYR.2|RLVEVDSSRQQEYDFK.3|DVMQQQLAEYQELLDVK.3|DVMQQQLAEYQELLDVK.2|IRELEEAMAGER.2|C[CAM]QSLQEELDFR.2|DLESLFHRSEVELAAALSDK.3|TVLVNADGEEVAMR.2|TVLVNADGEEVAM[Oxi]R.2|EQEMTEMRDVMQQQLAEYQELLDVK.4|EQEMTEMRDVMQQQLAEYQELLDVK.3|ENENGEEEEEEAEFGEEDLFHQQGDPR.3
SEN / CTL,"Oligoribonuclease, mitochondrial",REXO2,Q9Y3B8,-0.21,0.12,5.92E-04,4.81E-04,3.32E+00,"nucleobase-containing compound metabolic process,nucleotide metabolic process,RNA phosphodiester bond hydrolysis, exonucleolytic","3'-5'-exoribonuclease activity,nucleic acid binding,3'-5' exonuclease activity","nucleus,nucleolus,mitochondrion,mitochondrial intermembrane space,mitochondrial matrix,focal adhesion",9,14,18,ESTITLQQAEYEFLSFVR.3|ESTITLQQAEYEFLSFVR.2|ALDDISESIKELQFYR.3|ALDDISESIKELQFYR.2|RWYPEEYEFAPK.3|RWYPEEYEFAPK.2|IIDVSTVK.2|IIENGENEK.2|ALDDISESIK.2|QQTPPGLC[CAM]PLAGNSVHEDKK.4|QQTPPGLC[CAM]PLAGNSVHEDKK.3|KIIENGENEK.2|QQTPPGLC[CAM]PLAGNSVHEDK.3|EGGAAMAAGESMAQR.2|WYPEEYEFAPK.2|AVKESTITLQQAEYEFLSFVR.3|QPDELLDSMSDWC[CAM]K.2|MVWVDLEMTGLDIEK.2
SEN / CTL,Dipeptidyl peptidase 1,CTSC,P53634,-0.21,0.39,1.83E-03,1.28E-03,2.89E+00,"T cell mediated cytotoxicity,proteolysis,ER to Golgi vesicle-mediated transport,apoptotic process,immune response,aging,response to organic substance,COPII vesicle coating,proteolysis involved in cellular protein catabolic process,positive regulation of proteolysis involved in cellular protein catabolic process,positive regulation of apoptotic signaling pathway","cysteine-type endopeptidase activity,serine-type endopeptidase activity,cysteine-type peptidase activity,peptidase activator activity involved in apoptotic process,phosphatase binding,chloride ion binding,identical protein binding,protein self-association,chaperone binding","Golgi membrane,extracellular space,lysosome,endoplasmic reticulum lumen,membrane,ER to Golgi transport vesicle,endoplasmic reticulum-Golgi intermediate compartment membrane,extracellular exosome",24,16,31,GTDEC[CAM]AIESIAVAATPIPKL.2|NSWGTGWGENGYFR.2|RGTDEC[CAM]AIESIAVAATPIPKL.3|NVHGINFVSPVR.3|NVHGINFVSPVR.2|YAQDFGLVEEAC[CAM]FPYTGTDSPC[CAM]K.3|YAQDFGLVEEAC[CAM]FPYTGTDSPC[CAM]K.4|ILHLPTSWDWR.3|ILHLPTSWDWR.2|VVVYLQK.2|RGTDEC[CAM]AIESIAVAATPIPK.3|RGTDEC[CAM]AIESIAVAATPIPK.4|RGTDEC[CAM]AIESIAVAATPIPK.2|LELVHHGPMAVAFEVYDDFLHYKK.6|LELVHHGPMAVAFEVYDDFLHYKK.5|LELVHHGPM[Oxi]AVAFEVYDDFLHYKK.5|LELVHHGPMAVAFEVYDDFLHYKK.4|LELVHHGPM[Oxi]AVAFEVYDDFLHYKK.4|LELVHHGPMAVAFEVYDDFLHYKK.3|KVVVYLQK.2|PAPLTAEIQQK.2|GTDEC[CAM]AIESIAVAATPIPK.3|GTDEC[CAM]AIESIAVAATPIPK.2|LELVHHGPMAVAFEVYDDFLHYK.4|LELVHHGPMAVAFEVYDDFLHYK.3|NQASC[CAM]GSC[CAM]YSFASMGMLEAR.3|NQASC[CAM]GSC[CAM]YSFASMGMLEAR.2|YYSSEYHYVGGFYGGC[CAM]NEALM[Oxi]K.3|YYSSEYHYVGGFYGGC[CAM]NEALMK.3|DPFNPFELTNHAVLLVGYGTDSASGMDYWIVK.4|DPFNPFELTNHAVLLVGYGTDSASGMDYWIVK.3
SEN / CTL,Laminin subunit alpha-5,LAMA5,O15230,-0.21,0.59,3.62E-07,6.69E-07,6.17E+00,"angiogenesis,branching involved in ureteric bud morphogenesis,morphogenesis of a polarized epithelium,neural crest cell migration,hair follicle development,cytoskeleton organization,integrin-mediated signaling pathway,muscle organ development,cell recognition,cell proliferation,embryo development,morphogenesis of embryonic epithelium,cell migration,cell differentiation,regulation of cell adhesion,extracellular matrix organization,lung development,regulation of cell migration,substrate adhesion-dependent cell spreading,regulation of cell proliferation,cilium assembly,odontogenesis of dentin-containing tooth,endothelial cell differentiation,regulation of embryonic development,focal adhesion assembly,branching involved in salivary gland morphogenesis,establishment of protein localization to plasma membrane","integrin binding,structural molecule activity","extracellular region,basement membrane,basal lamina,laminin-5 complex,extracellular space,nucleus,extracellular matrix,laminin-10 complex,laminin-11 complex,extracellular exosome",123,77,89,LGLVWAALQGAR.2|ILQAVQAAEDAAGQALQQADHTWATVVR.3|ILQAVQAAEDAAGQALQQADHTWATVVR.4|FFLHGVTLVPIEEFSPEFVEPR.3|FFLHGVTLVPIEEFSPEFVEPR.4|GALDQLC[CAM]GAGGLC[CAM]R.2|AIQVFLLGGSR.2|DLGAPQAAAEAELAAAQR.3|DLGAPQAAAEAELAAAQR.2|GQLQLVEGNFR.2|GFGEPFVLNPGTWALR.2|DQASQLLAGTEATLGHAK.3|FANSPRPDLWVLER.3|FGFNPLEFENFSWR.2|DLADLAAYTALK.2|ISFDSQISTTK.2|TPPYLQLQVTEK.2|AGALLPAIHEQLR.3|TFQLDTAVDRPC[CAM]AR.3|QATGDYMGVSLR.2|ITRDDAAIC[CAM]TTEYSR.3|VQSQLQAMQENVER.2|LLHSLDQAKEELER.3|LLHSLDQAKEELER.4|LC[CAM]DELTGQC[CAM]IC[CAM]PPR.2|LVSYSGVLFFLK.2|ASPDGLC[CAM]QVSLQQGR.2|TLQFGHMSVTVER.3|VHWVYQLGEAGPAVLSIDEDIGEQFAAVSLDR.4|YAFLLHGYQPAHPTFPVEVLINAGR.4|YAFLLHGYQPAHPTFPVEVLINAGR.3|HVPEAVPEAFPELYWQAPPSYLGDR.3|SKSTGDPWLTDGSYLDGTGFAR.3|TYQPWQFFASSK.2|DTLASVFR.2|GQDLGQAVLDAGHSVSTLEK.3|LPVTVGFSGC[CAM]VK.2|C[CAM]KPGFWGLSPSNPEGC[CAM]TR.3|C[CAM]ATGYWGFPNC[CAM]RPC[CAM]DC[CAM]GAR.3|C[CAM]DIGGALGQSC[CAM]EPR.2|TLAEVER.2|VQEQLSSLWEENQALATQTR.3|VQEQLSSLWEENQALATQTR.2|LGGQAVGTR.2|LAASLDGAR.2|QEVGVAVHTPQR.3|QEVGVAVHTPQR.2|AHPASNAIDGTER.3|AHPASNAIDGTER.2|NQERLEEALQR.3|C[CAM]YC[CAM]RPNFSGER.3|C[CAM]VPC[CAM]QC[CAM]HGHSDR.3|SPNHPLDSPHVC[CAM]R.3|LLHSLDQAK.2|GPPPELQPQPEGPPR.3|GPPPELQPQPEGPPR.2|AIEASNAYSR.2|LELEEAATPEGHAVR.3|VGFEGATC[CAM]DR.2|WQGQYEGLR.2|C[CAM]RPNTQGPTC[CAM]SEPAR.3|AVAAEAQDTATR.2|GYAQMAPVQPR.2|GYAQM[Oxi]APVQPR.2|AHPASNAIDGTERWWQSPPLSR.4|TQC[CAM]LC[CAM]KPGYAGASC[CAM]ER.3|LLHSLDQAKEELERLAASLDGAR.4|HETAQQLEVLEQQSTSLGQDARR.4|LGGQAVGTRDQASQLLAGTEATLGHAK.4|IAASATC[CAM]GEEAPAR.2|RLGGQAVGTRDQASQLLAGTEATLGHAK.4|STGDPWLTDGSYLDGTGFAR.3|STGDPWLTDGSYLDGTGFAR.2|YALVVEYANEDARQEVGVAVHTPQR.4|SYDFISHC[CAM]AAQGYHISPSSSSLFC[CAM]R.4|SYDFISHC[CAM]AAQGYHISPSSSSLFC[CAM]R.3|APQQGLLSLHPC[CAM]LYSTLC[CAM]R.3|AVPLQPPPPLTSASK.2|C[CAM]DTC[CAM]SQQHQVPVPGGPVGHSIHC[CAM]EVC[CAM]DHC[CAM]VVLLLDDLER.6|EAQELNSRNQERLEEALQR.3|LVGGPVAGGDPNQTIR.2|NAAASLSLFYNNGARPC[CAM]GC[CAM]HEVGATGPTC[CAM]EPFGGQC[CAM]PC[CAM]HAHVIGR.6|HETAQQLEVLEQQSTSLGQDAR.3|DGFFGLDQADYFGC[CAM]R.2|FYLQGPEPEPGQGTEDR.2|HVPEAVPEAFPELYWQAPPSYLGDRVSSYGGTLR.4|GDTVAPGAEGLLNLRPDDFVFYVGGYPSTFTPPPLLR.4|LALSNVAPLTGNVYSGFGFHSAQDSALLYYR.3|VTEAC[CAM]TYRPSAQQSGDNC[CAM]LLYTHLPLDGFPSAAGLEALC[CAM]R.4
SEN / CTL,Annexin A3,ANXA3,P12429,-0.21,0.35,4.06E-06,5.79E-06,5.24E+00,"phagocytosis,positive regulation of endothelial cell migration,hippocampus development,animal organ regeneration,defense response to bacterium,negative regulation of catalytic activity,neutrophil degranulation,positive regulation of angiogenesis,positive regulation of DNA metabolic process,positive regulation of sequence-specific DNA binding transcription factor activity,response to glucocorticoid,response to growth factor","calcium ion binding,calcium-dependent phospholipid binding,phospholipase A2 inhibitor activity,calcium-dependent protein binding","cytoplasm,plasma membrane,membrane,axon,dendrite,phagocytic vesicle membrane,specific granule,neuronal cell body,extracellular exosome",66,31,45,MLISILTER.2|GAGTNEDALIEILTTR.2|GAGTNEDALIEILTTR.3|SEIDLLDIR.2|SDTSGDYEITLLK.2|GIGTDEFTLNR.2|ALKGIGTDEFTLNR.3|WGTDEDKFTEILC[CAM]LR.3|SMKGAGTNEDALIEILTTR.3|NTPAFLAER.2|LTFDEYR.2|SLGDDISSETSGDFRK.3|SLGDDISSETSGDFRK.2|SLGDDISSETSGDFRK.4|HYGYSLYSAIK.3|HYGYSLYSAIK.2|DYPDFSPSVDAEAIQK.2|DYPDFSPSVDAEAIQK.3|GTVRDYPDFSPSVDAEAIQK.3|GTVRDYPDFSPSVDAEAIQK.2|GELSGHFEDLLLAIVNC[CAM]VR.3|GELSGHFEDLLLAIVNC[CAM]VR.2|ELKDDLKGDLSGHFEHLMVALVTPPAVFDAK.5|ELKDDLKGDLSGHFEHLMVALVTPPAVFDAK.4|ELKDDLKGDLSGHFEHLMVALVTPPAVFDAK.6|ELKDDLKGDLSGHFEHLMVALVTPPAVFDAK.3|SLGDDISSETSGDFR.2|AGENRWGTDEDK.3|ALLTLADGR.2|DESLKVDEHLAK.3|EYQAAYGK.2|QDAQILYK.2|DISQAYYTVYKK.3|DISQAYYTVYKK.2|RDESLKVDEHLAK.3|RDESLKVDEHLAK.2|FTEILC[CAM]LR.2|QMKDISQAYYTVYK.3|QMKDISQAYYTVYK.2|GDLSGHFEHLMVALVTPPAVFDAK.4|GDLSGHFEHLMVALVTPPAVFDAK.3|DISQAYYTVYK.2|NISQKDIVDSIK.2|KHYGYSLYSAIK.2|DDLKGDLSGHFEHLMVALVTPPAVFDAK.4
SEN / CTL,Calpastatin,CAST,P20810,-0.21,1.10,3.74E-02,1.56E-02,1.81E+00,"negative regulation of endopeptidase activity,cell-cell adhesion,negative regulation of type B pancreatic cell apoptotic process","endopeptidase inhibitor activity,cysteine-type endopeptidase inhibitor activity,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","cytoplasm,endoplasmic reticulum,cytosol,cell-cell adherens junction,membrane",15,48,69,C[CAM]GEDDETIPSEYR.2|SESELIDELSEDFDRSEC[CAM]K.3|GTVPDDAVEALADSLGKK.3|GTVPDDAVEALADSLGKK.2|LKPATDKDGKPLLPEPEEKPKPR.5|LKPATDKDGKPLLPEPEEKPKPR.6|DTMSDQALEALSASLGTR.3|DTMSDQALEALSASLGTR.2|TTEETSKPKDD.3|LEEVKDKDGKPLLPK.4|LEEVKDKDGKPLLPK.3|AAAPAPVSEAVC[CAM]R.3|AAAPAPVSEAVC[CAM]R.2|TEKEESTEVLK.3|TEKEESTEVLK.2|LSDSLGQR.2|DGKPLLPEPEEKPKPR.4|DGKPLLPEPEEKPKPR.3|SLTPAVPVESKPDKPSGK.4|SLTPAVPVESKPDKPSGK.3|EADPEDGKPVMDK.3|EADPEDGKPVM[Oxi]DK.3|EADPEDGKPVMDK.2|HLLDDNGQDKPVKPPTK.4|HLLDDNGQDKPVKPPTK.3|KTEKEESTEVLK.3|KTEKEESTEVLK.2|KSLTPAVPVESKPDKPSGK.4|SAEQQPSEK.2|HLLDDNGQDKPVKPPTKK.4|SIKEVDEAK.2|QPDPDENKPMEDK.3|QPDPDENKPM[Oxi]EDK.3|KEADPEDGKPVMDK.3|LGERDDTIPPEYR.3|QAEPELDLR.2|GTVPDDAVEALADSLGK.3|GTVPDDAVEALADSLGK.2|DTSQSDKDLDDALDK.3|EETIPPDYR.2|HLLDDNGQDK.2|AIPVSQQMEGPHLPNK.3|AIPVSQQMEGPHLPNK.2|SESELIDELSEDFDR.3|SESELIDELSEDFDR.2|LSDSLGQRQPDPDENKPMEDK.4|TSMC[CAM]SIQSAPPEPATLK.3|TSM[Oxi]C[CAM]SIQSAPPEPATLK.2|TSMC[CAM]SIQSAPPEPATLK.2|DTSQSDKDLDDALDKLSDSLGQR.4|PRSESELIDELSEDFDRSEC[CAM]K.4|TKPQDM[Oxi]ISAGGESVAGITAISGKPGDK.4|TKPQDMISAGGESVAGITAISGKPGDK.4|TKPQDMISAGGESVAGITAISGKPGDK.3|QASDTGSNDAHNKK.2|TKPQDMISAGGESVAGITAISGK.3|VEKDTMSDQALEALSASLGTR.3|LAAAISEVVSQTPASTTQAGAPPR.3|LAAAISEVVSQTPASTTQAGAPPR.2|KVEKDTMSDQALEALSASLGTR.3|PIGPDDAIDALSSDFTC[CAM]GSPTAAGK.3|PIGPDDAIDALSSDFTC[CAM]GSPTAAGKK.3|EGITGPPADSSKPIGPDDAIDALSSDFTC[CAM]GSPTAAGK.4|EQLPPMSEDFLLDALSEDFSGPQNASSLKFEDAK.4|KEGITGPPADSSKPIGPDDAIDALSSDFTC[CAM]GSPTAAGK.4|SEDSKKPADDQDPIDALSGDLDSC[CAM]PSTTETSQNTAK.4|LAAAISEVVSQTPASTTQAGAPPRDTSQSDK.3|EQLPPMSEDFLLDALSEDFSGPQNASSLK.3|KPADDQDPIDALSGDLDSC[CAM]PSTTETSQNTAK.3
SEN / CTL,Chloride intracellular channel protein 4,CLIC4,Q9Y696,-0.21,0.36,2.72E-04,2.43E-04,3.61E+00,"angiogenesis,endothelial cell morphogenesis,chloride transport,apoptotic process,vacuolar acidification,fertilization,cell differentiation,keratinocyte differentiation,negative regulation of cell migration,regulation of ion transmembrane transport,establishment or maintenance of apical/basal cell polarity,multicellular organism growth,branching morphogenesis of an epithelial tube,regulation of cytoskeleton organization,retina vasculature morphogenesis in camera-type eye,cellular response to calcium ion,chloride transmembrane transport,glutathione metabolic process","voltage-gated ion channel activity,chloride channel activity,protein binding,glutathione transferase activity","intracellular,cytoplasm,mitochondrion,centrosome,cytosol,plasma membrane,microvillus,cell-cell junction,cell surface,actin cytoskeleton,nuclear matrix,midbody,cytoplasmic vesicle membrane,chloride channel complex,apical part of cell,perinuclear region of cytoplasm,extracellular exosome,microtubule cytoskeleton",30,24,43,GVVFSVTTVDLK.2|YLTNAYSRDEFTNTC[CAM]PSDKEVEIAYSDVAK.4|GVVFSVTTVDLKR.3|LSPKHPESNTAGMDIFAK.4|LSPKHPESNTAGMDIFAK.3|LSPKHPESNTAGM[Oxi]DIFAK.4|LSPKHPESNTAGMDIFAK.2|KFLDGNEMTLADC[CAM]NLLPK.3|KFLDGNEM[Oxi]TLADC[CAM]NLLPK.3|KFLDGNEMTLADC[CAM]NLLPK.2|TDVNKIEEFLEEVLC[CAM]PPK.3|TDVNKIEEFLEEVLC[CAM]PPK.4|TDVNKIEEFLEEVLC[CAM]PPK.2|AGSDGESIGNC[CAM]PFSQR.2|AGSDGESIGNC[CAM]PFSQR.3|RKPADLQNLAPGTHPPFITFNSEVK.4|RKPADLQNLAPGTHPPFITFNSEVK.5|RKPADLQNLAPGTHPPFITFNSEVK.3|DEFTNTC[CAM]PSDKEVEIAYSDVAK.3|DEFTNTC[CAM]PSDK.3|DEFTNTC[CAM]PSDK.2|NSRPEANEALER.3|NSRPEANEALER.2|YLTNAYSR.2|HPESNTAGMDIFAK.3|HPESNTAGM[Oxi]DIFAK.3|HPESNTAGM[Oxi]DIFAK.2|HPESNTAGMDIFAK.2|EEDKEPLIELFVK.3|EEDKEPLIELFVK.2|IEEFLEEVLC[CAM]PPK.3|IEEFLEEVLC[CAM]PPK.2|NFDIPKEM[Oxi]TGIWR.3|EVEIAYSDVAK.2|TDVNKIEEFLEEVLC[CAM]PPKYLK.4|FLDGNEMTLADC[CAM]NLLPK.3|FLDGNEMTLADC[CAM]NLLPK.2|KPADLQNLAPGTHPPFITFNSEVK.4|KPADLQNLAPGTHPPFITFNSEVK.3|FSAYIKNSRPEANEALER.3|YLTNAYSRDEFTNTC[CAM]PSDK.3|KPADLQNLAPGTHPPFITFNSEVKTDVNKIEEFLEEVLC[CAM]PPK.6|LDEYLNSPLPDEIDENSMEDIK.3
SEN / CTL,Cystatin-C,CST3,P01034,-0.21,0.52,1.02E-02,5.41E-03,2.27E+00,"eye development,response to hypoxia,cell activation,apoptotic process,defense response,brain development,salivary gland development,embryo implantation,positive regulation of cell proliferation,response to toxic substance,response to carbohydrate,negative regulation of peptidase activity,negative regulation of collagen catabolic process,negative regulation of extracellular matrix disassembly,response to nutrient levels,response to estradiol,regulation of tissue remodeling,response to drug,circadian sleep/wake cycle, REM sleep,regulation of programmed cell death,extracellular fibril organization,cellular protein metabolic process,positive regulation of DNA replication,negative regulation of proteolysis,response to axon injury,Sertoli cell development,negative regulation of elastin catabolic process,negative regulation of blood vessel remodeling,negative regulation of cell death,cellular response to hydrogen peroxide,negative regulation of cysteine-type endopeptidase activity","beta-amyloid binding,protease binding,endopeptidase inhibitor activity,cysteine-type endopeptidase inhibitor activity,protein binding,identical protein binding","extracellular region,basement membrane,extracellular space,lysosome,multivesicular body,endoplasmic reticulum,axon,nuclear membrane,neuronal cell body,contractile fiber,perinuclear region of cytoplasm,extracellular exosome",27,7,11,ALDFAVGEYNK.2|KQIVAGVNYFLDVELGR.3|TQPNLDNC[CAM]PFHDQPHLK.4|TQPNLDNC[CAM]PFHDQPHLK.3|LVGGPMDASVEEEGVR.2|LVGGPMDASVEEEGVRR.3|LVGGPM[Oxi]DASVEEEGVRR.3|AFC[CAM]SFQIYAVPWQGTMTLSK.3|AFC[CAM]SFQIYAVPWQGTMTLSK.2|AFC[CAM]SFQIYAVPWQGTM[Oxi]TLSK.3|ASNDMYHSR.2
SEN / CTL,Beta-enolase,ENO3,P13929,-0.22,0.30,1.03E-02,5.43E-03,2.26E+00,"gluconeogenesis,aging,response to drug,skeletal muscle tissue regeneration,canonical glycolysis","magnesium ion binding,phosphopyruvate hydratase activity,protein homodimerization activity,protein heterodimerization activity","phosphopyruvate hydratase complex,extracellular space,cytoplasm,cytosol,plasma membrane,extracellular exosome",9,14,19,VNQIGSVTESIQAC[CAM]K.2|VNQIGSVTESIQAC[CAM]K.3|YGKDATNVGDEGGFAPNILENNEALELLK.4|NGKYDLDFKSPDDPAR.4|AC[CAM]NC[CAM]LLLK.2|LAQSNGWGVMVSHR.3|LAQSNGWGVM[Oxi]VSHR.3|LAQSNGWGVM[Oxi]VSHR.2|KLSVVDQEK.2|TAIQAAGYPDK.2|IGAEVYHHLK.2|LAMQEFMILPVGASSFK.3|LAMQEFMILPVGASSFK.2|GNPTVEVDLHTAK.2|AAVPSGASTGIYEALELRDGDK.3|HIADLAGNPDLILPVPAFNVINGGSHAGNK.4|HIADLAGNPDLILPVPAFNVINGGSHAGNK.3|AVENINNTLGPALLQK.2|DATNVGDEGGFAPNILENNEALELLK.3
SEN / CTL,Protein deglycase DJ-1,PARK7,Q99497,-0.22,0.40,2.38E-08,5.64E-08,7.25E+00,"negative regulation of protein phosphorylation,negative regulation of protein kinase activity,proteolysis,protein deglycosylation,autophagy,inflammatory response,mitochondrion organization,Ras protein signal transduction,single fertilization,adult locomotory behavior,methylglyoxal metabolic process,detoxification of copper ion,positive regulation of gene expression,negative regulation of gene expression,enzyme active site formation via L-cysteine sulfinic acid,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,lactate biosynthetic process,negative regulation of protein ubiquitination,negative regulation of protein binding,activation of protein kinase B activity,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of interleukin-8 production,positive regulation of peptidyl-serine phosphorylation,negative regulation of protein sumoylation,cellular response to oxidative stress,cellular response to glyoxal,peptidyl-cysteine deglycation,peptidyl-arginine deglycation,peptidyl-lysine deglycation,protein deglycation, glyoxal removal,protein deglycation, methylglyoxal removal,glutathione deglycation,hydrogen peroxide metabolic process,negative regulation of apoptotic process,regulation of neuron apoptotic process,negative regulation of neuron apoptotic process,positive regulation of transcription from RNA polymerase II promoter,glycolate biosynthetic process,negative regulation of protein export from nucleus,regulation of inflammatory response,detoxification of mercury ion,protein stabilization,positive regulation of sequence-specific DNA binding transcription factor activity,negative regulation of ubiquitin-protein transferase activity,dopamine uptake involved in synaptic transmission,regulation of mitochondrial membrane potential,positive regulation of protein kinase B signaling,membrane depolarization,membrane hyperpolarization,negative regulation of cell death,regulation of androgen receptor signaling pathway,cellular response to hydrogen peroxide,positive regulation of protein homodimerization activity,cell-cell adhesion,cellular oxidant detoxification,positive regulation of protein localization to nucleus,negative regulation of neuron death,positive regulation of superoxide dismutase activity,negative regulation of protein acetylation,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,regulation of fibril organization,positive regulation of mitochondrial electron transport, NADH to ubiquinone,negative regulation of death-inducing signaling complex assembly,negative regulation of protein K48-linked deubiquitination,negative regulation of TRAIL-activated apoptotic signaling pathway,positive regulation of pyrroline-5-carboxylate reductase activity,positive regulation of tyrosine 3-monooxygenase activity,positive regulation of dopamine biosynthetic process,glyoxal metabolic process,glyoxal catabolic process,positive regulation of L-dopa biosynthetic process,positive regulation of L-dopa decarboxylase activity,negative regulation of oxidative stress-induced cell death,negative regulation of hydrogen peroxide-induced cell death,negative regulation of hydrogen peroxide-induced neuron death,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,positive regulation of reactive oxygen species biosynthetic process,positive regulation of mitophagy,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,negative regulation of ubiquitin-specific protease activity,positive regulation of oxidative phosphorylation uncoupler activity,positive regulation of transcription regulatory region DNA binding,positive regulation of androgen receptor activity,negative regulation of extrinsic apoptotic signaling pathway,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,regulation of TRAIL receptor biosynthetic process","transcription coactivator activity,mRNA binding,receptor binding,copper ion binding,protein binding,transcription factor binding,peptidase activity,superoxide dismutase copper chaperone activity,oxidoreductase activity, acting on peroxide as acceptor,glyoxalase III activity,enzyme binding,kinase binding,cytokine binding,tyrosine 3-monooxygenase activator activity,L-dopa decarboxylase activator activity,protein deglycase activity,identical protein binding,protein homodimerization activity,small protein activating enzyme binding,ubiquitin-like protein conjugating enzyme binding,mercury ion binding,androgen receptor binding,peroxiredoxin activity,repressing transcription factor binding,scaffold protein binding,cadherin binding involved in cell-cell adhesion,cupric ion binding,cuprous ion binding,ubiquitin-specific protease binding,glyoxalase (glycolic acid-forming) activity,core promoter binding,double-stranded DNA binding,single-stranded DNA binding","chromatin,nucleus,cytoplasm,mitochondrion,mitochondrial intermembrane space,mitochondrial matrix,endoplasmic reticulum,cytosol,plasma membrane,cell-cell adherens junction,PML body,axon,cell body,membrane raft,perinuclear region of cytoplasm,extracellular exosome,presynapse,mitochondrial respiratory chain complex I",45,27,55,DGLILTSR.2|GPGTSFEFALAIVEALNGKEVAAQVK.3|GPGTSFEFALAIVEALNGKEVAAQVK.4|AGIKVTVAGLAGKDPVQC[CAM]SR.4|AGIKVTVAGLAGKDPVQC[CAM]SR.3|DVVIC[CAM]PDASLEDAKK.3|DVVIC[CAM]PDASLEDAKK.2|DVVIC[CAM]PDASLEDAKK.4|DVVIC[CAM]PDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVK.4|KGLIAAIC[CAM]AGPTALLAHEIGFGSK.4|KGLIAAIC[CAM]AGPTALLAHEIGFGSK.3|GPGTSFEFALAIVEALNGK.3|GPGTSFEFALAIVEALNGK.2|VTVAGLAGKDPVQC[CAM]SR.3|VTVAGLAGKDPVQC[CAM]SR.2|VTVAGLAGKDPVQC[CAM]SR.4|GAEEMETVIPVDVMR.2|GAEEMETVIPVDVMR.3|GAEEMETVIPVDVM[Oxi]R.3|GAEEM[Oxi]ETVIPVDVMR.2|GAEEMETVIPVDVM[Oxi]R.2|GAEEM[Oxi]ETVIPVDVM[Oxi]R.2|GLIAAIC[CAM]AGPTALLAHEIGFGSK.3|GLIAAIC[CAM]AGPTALLAHEIGFGSK.4|GLIAAIC[CAM]AGPTALLAHEIGFGSK.2|VTVAGLAGK.2|DPVQC[CAM]SR.2|VTTHPLAK.2|RALVILAK.2|DKMMNGGHYTYSENR.4|DKMMNGGHYTYSENR.3|M[Oxi]MNGGHYTYSENRVEK.4|MMNGGHYTYSENRVEK.3|M[Oxi]MNGGHYTYSENRVEK.3|MM[Oxi]NGGHYTYSENRVEK.3|DVVIC[CAM]PDASLEDAK.3|DVVIC[CAM]PDASLEDAK.2|MMNGGHYTYSENR.3|M[Oxi]M[Oxi]NGGHYTYSENR.3|M[Oxi]MNGGHYTYSENR.3|MM[Oxi]NGGHYTYSENR.3|M[Oxi]MNGGHYTYSENR.2|MMNGGHYTYSENR.2|EILKEQENR.2|GAEEMETVIPVDVMRR.3|GAEEM[Oxi]ETVIPVDVM[Oxi]RR.3|GAEEMETVIPVDVM[Oxi]RR.3|VEKDGLILTSR.2|EGPYDVVVLPGGNLGAQNLSESAAVK.4|EGPYDVVVLPGGNLGAQNLSESAAVK.3|MMNGGHYTYSENRVEKDGLILTSR.4|DGLILTSRGPGTSFEFALAIVEALNGKEVAAQVK.4|KEGPYDVVVLPGGNLGAQNLSESAAVK.3|EGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENR.4|EGPYDVVVLPGGNLGAQNLSESAAVKEILK.3
SEN / CTL,EGF-containing fibulin-like extracellular matrix protein 2,EFEMP2,O95967,-0.22,0.42,9.58E-02,3.44E-02,1.46E+00,,"extracellular matrix structural constituent,calcium ion binding,protein binding","extracellular region,basement membrane,extracellular exosome,extracellular vesicle",6,6,6,C[CAM]INHYGGYLC[CAM]LPR.3|LC[CAM]QDIDEC[CAM]ESGAHQC[CAM]SEAQTC[CAM]VNFHGGYR.4|AGNSQGDFYIR.2|C[CAM]LC[CAM]PASNPLC[CAM]R.2|DVNEC[CAM]LTIPEAC[CAM]K.2|SC[CAM]VDVNEC[CAM]DMGAPC[CAM]EQR.2
SEN / CTL,Heme-binding protein 2,HEBP2,Q9Y5Z4,-0.22,0.59,9.49E-02,3.42E-02,1.47E+00,"negative regulation of mitochondrial membrane potential,positive regulation of necrotic cell death,positive regulation of mitochondrial membrane permeability,regulation of response to reactive oxygen species",protein binding,"cytoplasm,mitochondrion,extracellular exosome",9,10,11,AEMTVFVR.2|NQEQLLTLASILR.2|NQEQLLTLASILR.3|VYYTAGYNSPVK.2|LNSYIQGK.2|SFDGFSSAQK.2|NNEVWLIQK.2|NQEQLLTLASILREDGKVFDEK.4|NQEQLLTLASILREDGK.3|WVSTSVESMDWDSAIQTGFTK.3|APEDAGPQPGSYEIR.2
SEN / CTL,60S acidic ribosomal protein P1,RPLP1,P05386,-0.23,0.24,9.21E-03,4.98E-03,2.30E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,cytoplasmic translation,rRNA processing,translation,translational initiation,translational elongation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,activation of protein kinase activity,positive regulation of protein kinase activity","structural constituent of ribosome,protein binding,protein kinase activator activity,large ribosomal subunit rRNA binding","cytoplasm,cytosol,focal adhesion,cytosolic large ribosomal subunit,preribosome, large subunit precursor,extracellular exosome",15,5,12,AAGVNVEPFWPGLFAK.2|AAGVNVEPFWPGLFAK.3|ALANVNIGSLIC[CAM]NVGAGGPAPAAGAAPAGGPAPSTAAAPAEEK.4|ALANVNIGSLIC[CAM]NVGAGGPAPAAGAAPAGGPAPSTAAAPAEEK.5|ALANVNIGSLIC[CAM]NVGAGGPAPAAGAAPAGGPAPSTAAAPAEEK.6|ALANVNIGSLIC[CAM]NVGAGGPAPAAGAAPAGGPAPSTAAAPAEEKKVEAK.7|ALANVNIGSLIC[CAM]NVGAGGPAPAAGAAPAGGPAPSTAAAPAEEKKVEAK.6|ALANVNIGSLIC[CAM]NVGAGGPAPAAGAAPAGGPAPSTAAAPAEEKKVEAK.5|ALANVNIGSLIC[CAM]NVGAGGPAPAAGAAPAGGPAPSTAAAPAEEKKVEAK.4|ALANVNIGSLIC[CAM]NVGAGGPAPAAGAAPAGGPAPSTAAAPAEEKK.4|KEESEESDDDM[Oxi]GFGLFD.2|KEESEESDDDMGFGLFD.2
SEN / CTL,ATP-dependent RNA helicase DDX39A,DDX39A,O00148,-0.23,0.39,1.08E-01,3.78E-02,1.42E+00,"mRNA splicing, via spliceosome,termination of RNA polymerase II transcription,RNA export from nucleus,mRNA export from nucleus,cellular response to DNA damage stimulus,regulation of gene expression,RNA secondary structure unwinding,mRNA 3'-end processing","ATP-dependent RNA helicase activity,protein binding,ATP binding,ATPase activity,poly(A) RNA binding","nucleus,nucleoplasm,spliceosomal complex,membrane,cytoplasm",27,28,52,ILVATNLFGR.2|GLAITFVSDENDAK.2|GLAITFVSDENDAK.3|DFLLKPELLR.3|DFLLKPELLR.2|GSYVSIHSSGFRDFLLKPELLR.5|GSYVSIHSSGFRDFLLKPELLR.4|GSYVSIHSSGFRDFLLKPELLR.3|ELAFQISKEYER.3|ELAFQISKEYER.2|AIVDC[CAM]GFEHPSEVQHEC[CAM]IPQAILGMDVLC[CAM]QAK.4|AIVDC[CAM]GFEHPSEVQHEC[CAM]IPQAILGMDVLC[CAM]QAK.5|AIVDC[CAM]GFEHPSEVQHEC[CAM]IPQAILGM[Oxi]DVLC[CAM]QAK.4|C[CAM]MALAQLLVEQNFPAIAIHR.3|C[CAM]MALAQLLVEQNFPAIAIHR.4|C[CAM]M[Oxi]ALAQLLVEQNFPAIAIHR.4|C[CAM]M[Oxi]ALAQLLVEQNFPAIAIHR.3|C[CAM]M[Oxi]ALAQLLVEQNFPAIAIHR.2|C[CAM]MALAQLLVEQNFPAIAIHR.2|GSYVSIHSSGFR.3|GSYVSIHSSGFR.2|KDEEVLK.2|NC[CAM]PHVVVGTPGR.3|NC[CAM]PHVVVGTPGR.2|DVQEIFR.2|KNC[CAM]PHVVVGTPGR.3|ILNDVQDR.2|LTLHGLQQYYVK.3|LTLHGLQQYYVK.2|KDEEVLKK.2|VSVFFGGLSIKKDEEVLK.4|VSVFFGGLSIKKDEEVLK.3|MLEQLDMR.2|M[Oxi]LEQLDMR.2|MLEQLDM[Oxi]R.2|RDVQEIFR.2|HFVLDEC[CAM]DK.2|VSVFFGGLSIK.2|FMQDPMEVFVDDETK.3|FMQDPMEVFVDDETK.2|RILVATNLFGR.2|QC[CAM]MMFSATLSK.2|QC[CAM]M[Oxi]MFSATLSK.2|QC[CAM]MM[Oxi]FSATLSK.2|KFMQDPMEVFVDDETKLTLHGLQQYYVK.5|KFMQDPMEVFVDDETKLTLHGLQQYYVK.4|HFVLDEC[CAM]DKMLEQLDMR.3|VNIVFNYDMPEDSDTYLHR.3|VNIVFNYDM[Oxi]PEDSDTYLHR.3|VNIVFNYDMPEDSDTYLHR.2|FMQDPMEVFVDDETKLTLHGLQQYYVK.4|FEVNVAELPEEIDISTYIEQSR.3
SEN / CTL,Cathepsin B,CTSB,P07858,-0.23,0.44,2.19E-03,1.50E-03,2.82E+00,"toll-like receptor signaling pathway,proteolysis,collagen catabolic process,epithelial cell differentiation,regulation of apoptotic process,decidualization,viral entry into host cell,regulation of catalytic activity,proteolysis involved in cellular protein catabolic process,cellular response to thyroid hormone stimulus","cysteine-type endopeptidase activity,serine-type endopeptidase activity,protein binding,collagen binding,peptidase activity,cysteine-type peptidase activity,proteoglycan binding","extracellular region,extracellular space,intracellular,nucleolus,mitochondrion,lysosome,endolysosome lumen,melanosome,intracellular membrane-bounded organelle,perinuclear region of cytoplasm,extracellular exosome",39,22,46,VMFTEDLKLPASFDAR.3|EQWPQC[CAM]PTIK.2|GQDHC[CAM]GIESEVVAGIPR.3|GQDHC[CAM]GIESEVVAGIPR.2|GQDHC[CAM]GIESEVVAGIPR.4|ILRGQDHC[CAM]GIESEVVAGIPR.4|ILRGQDHC[CAM]GIESEVVAGIPR.3|ILRGQDHC[CAM]GIESEVVAGIPR.5|NGPVEGAFSVYSDFLLYK.3|NGPVEGAFSVYSDFLLYK.2|LC[CAM]GTFLGGPKPPQR.3|IC[CAM]EPGYSPTYK.2|SGVYQHVTGEMMGGHAIR.4|SGVYQHVTGEMMGGHAIR.3|SGVYQHVTGEM[Oxi]MGGHAIR.4|SGVYQHVTGEMM[Oxi]GGHAIR.4|SGVYQHVTGEM[Oxi]M[Oxi]GGHAIR.4|SGVYQHVTGEM[Oxi]MGGHAIR.3|SGVYQHVTGEMM[Oxi]GGHAIR.3|SGVYQHVTGEM[Oxi]M[Oxi]GGHAIR.3|SGVYQHVTGEMMGGHAIR.2|SGVYQHVTGEMM[Oxi]GGHAIR.2|DQGSC[CAM]GSC[CAM]WAFGAVEAISDR.3|DQGSC[CAM]GSC[CAM]WAFGAVEAISDR.2|LPASFDAR.2|DIMAEIYK.2|DIM[Oxi]AEIYK.2|QDKHYGYNSYSVSNSEK.4|QDKHYGYNSYSVSNSEK.3|PSFHPLSDELVNYVNKR.4|PSFHPLSDELVNYVNKR.3|GLVSGGLYESHVGC[CAM]R.3|GLVSGGLYESHVGC[CAM]R.2|HYGYNSYSVSNSEK.3|HYGYNSYSVSNSEK.2|IC[CAM]EPGYSPTYKQDK.3|IC[CAM]EPGYSPTYKQDK.2|QDKHYGYNSYSVSNSEKDIMAEIYK.5|QDKHYGYNSYSVSNSEKDIMAEIYK.4|HYGYNSYSVSNSEKDIM[Oxi]AEIYK.4|HYGYNSYSVSNSEKDIMAEIYK.4|HYGYNSYSVSNSEKDIMAEIYK.3|SRPSFHPLSDELVNYVNK.3|LPASFDAREQWPQC[CAM]PTIK.3|EIRDQGSC[CAM]GSC[CAM]WAFGAVEAISDR.3|ILGWGVENGTPYWLVANSWNTDWGDNGFFK.3
SEN / CTL,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2",PLOD2,O00469,-0.24,0.59,1.43E-01,4.71E-02,1.33E+00,"response to hypoxia,cellular protein modification process,oxidation-reduction process","iron ion binding,procollagen-lysine 5-dioxygenase activity,L-ascorbic acid binding","endoplasmic reticulum,endoplasmic reticulum membrane,rough endoplasmic reticulum membrane,extracellular exosome",33,33,47,SEDYVDIVQGNR.2|VLGQGEEWRGGDGINSIGGGQK.3|IFTENIVEQPC[CAM]PDVFWFPIFSEK.3|AC[CAM]DELVEEMEHYGK.3|QVDLENVWLHFIR.3|EFIAPVTLK.2|LLVITVATK.2|IVGPEENLSQAEAR.2|IVGPEENLSQAEAR.3|GFALLNFVVK.2|VGVWNVPYMANVYLIK.3|VGVWNVPYM[Oxi]ANVYLIK.3|VGVWNVPYM[Oxi]ANVYLIK.2|VGVWNVPYMANVYLIK.2|LWSNFWGALSPDGYYAR.3|LWSNFWGALSPDGYYAR.2|LTHLHEGLPVK.3|LTHLHEGLPVK.2|DKLDPDMALC[CAM]R.3|VFAGYYTK.2|VYIDPLKR.2|NMGMDFC[CAM]R.2|YIAVSFIDP.2|VVFAADGILWPDKR.3|VLGQGEEWR.2|IFQTLNGAVDEVVLK.3|IFQTLNGAVDEVVLK.2|GGDGINSIGGGQK.2|ISGGYENVPTDDIHMK.3|ISGGYENVPTDDIHM[Oxi]K.3|ISGGYENVPTDDIHMK.2|C[CAM]KIFQTLNGAVDEVVLKFENGK.4|NTFYETLPVAINGNGPTK.3|NTFYETLPVAINGNGPTK.2|RYLNSGGFIGYAPYVNR.3|RYLNSGGFIGYAPYVNR.2|SLRPHHDASTFTINIALNNVGEDFQGGGC[CAM]K.5|SLRPHHDASTFTINIALNNVGEDFQGGGC[CAM]K.4|AKNTFYETLPVAINGNGPTK.3|VVFAADGILWPDK.2|FLDILLTLDYPK.2|IFQTLNGAVDEVVLKFENGK.3|IFQTLNGAVDEVVLKFENGK.2|NMGMDFC[CAM]RQDEK.2|IVQQWNLQDNDDDQLFYTK.3|IVQQWNLQDNDDDQLFYTK.2|YLNSGGFIGYAPYVNR.2
SEN / CTL,78 kDa glucose-regulated protein,HSPA5,P11021,-0.24,1.05,2.02E-02,9.50E-03,2.02E+00,"ER overload response,activation of signaling protein activity involved in unfolded protein response,cerebellum structural organization,cerebellar Purkinje cell layer development,substantia nigra development,positive regulation of cell migration,ER-associated ubiquitin-dependent protein catabolic process,negative regulation of transforming growth factor beta receptor signaling pathway,endoplasmic reticulum unfolded protein response,positive regulation of protein ubiquitination,protein folding in endoplasmic reticulum,maintenance of protein localization in endoplasmic reticulum,IRE1-mediated unfolded protein response,PERK-mediated unfolded protein response,ATF6-mediated unfolded protein response,cellular response to glucose starvation,negative regulation of apoptotic process,regulation of protein folding in endoplasmic reticulum,cellular response to antibiotic,cellular response to manganese ion,cellular response to interleukin-4,negative regulation of protein homodimerization activity,cell-cell adhesion,toxin transport,regulation of ATF6-mediated unfolded protein response,regulation of IRE1-mediated unfolded protein response,regulation of PERK-mediated unfolded protein response,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress","glycoprotein binding,calcium ion binding,protein binding,ATP binding,ATPase activity,enzyme binding,protein domain specific binding,ubiquitin protein ligase binding,ribosome binding,unfolded protein binding,chaperone binding,misfolded protein binding,cadherin binding involved in cell-cell adhesion","nucleus,mitochondrion,endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum membrane,smooth endoplasmic reticulum,endoplasmic reticulum-Golgi intermediate compartment,plasma membrane,cell-cell adherens junction,focal adhesion,cell surface,membrane,integral component of endoplasmic reticulum membrane,midbody,extracellular matrix,endoplasmic reticulum chaperone complex,melanosome,myelin sheath,extracellular exosome,COP9 signalosome",165,68,133,IINEPTAAAIAYGLDKR.3|IINEPTAAAIAYGLDKR.2|VLEDSDLKKSDIDEIVLVGGSTR.4|VLEDSDLKKSDIDEIVLVGGSTR.3|ITPSYVAFTPEGER.2|ITPSYVAFTPEGER.3|IDTRNELESYAYSLK.3|IDTRNELESYAYSLK.2|KKELEEIVQPIISK.3|KKELEEIVQPIISK.4|KKELEEIVQPIISK.2|ITPSYVAFTPEGERLIGDAAK.3|NQLTSNPENTVFDAK.2|NQLTSNPENTVFDAK.3|AVEEKIEWLESHQDADIEDFKAK.4|AVEEKIEWLESHQDADIEDFKAK.5|ELEEIVQPIISK.2|ELEEIVQPIISK.3|ITITNDQNRLTPEEIER.3|VTHAVVTVPAYFNDAQR.3|VTHAVVTVPAYFNDAQR.2|VTHAVVTVPAYFNDAQR.4|TWNDPSVQQDIK.2|TWNDPSVQQDIK.3|SQIFSTASDNQPTVTIK.3|SQIFSTASDNQPTVTIK.2|SQIFSTASDNQPTVTIK.4|TKPYIQVDIGGGQTK.3|TKPYIQVDIGGGQTK.2|TKPYIQVDIGGGQTK.4|KSDIDEIVLVGGSTR.3|KSDIDEIVLVGGSTR.2|NQLTSNPENTVFDAKR.3|NQLTSNPENTVFDAKR.2|AKFEELNMDLFR.3|AKFEELNMDLFR.2|AKFEELNM[Oxi]DLFR.3|AKFEELNM[Oxi]DLFR.2|TFAPEEISAMVLTK.2|TFAPEEISAMVLTK.3|TFAPEEISAM[Oxi]VLTK.3|TFAPEEISAM[Oxi]VLTK.2|DAGTIAGLNVMR.2|DAGTIAGLNVMR.3|DAGTIAGLNVM[Oxi]R.2|NELESYAYSLK.2|NELESYAYSLK.3|NGRVEIIANDQGNR.3|NGRVEIIANDQGNR.2|FEELNMDLFR.2|FEELNM[Oxi]DLFR.2|KTKPYIQVDIGGGQTK.3|KTKPYIQVDIGGGQTK.4|KTKPYIQVDIGGGQTK.2|DNHLLGTFDLTGIPPAPR.3|DNHLLGTFDLTGIPPAPR.4|DNHLLGTFDLTGIPPAPR.2|LYGSAGPPPTGEEDTAEKDEL.3|LYGSAGPPPTGEEDTAEKDEL.2|IEWLESHQDADIEDFKAK.4|IEWLESHQDADIEDFKAK.3|IEWLESHQDADIEDFKAK.2|MKETAEAYLGK.3|MKETAEAYLGK.2|M[Oxi]KETAEAYLGK.2|KSQIFSTASDNQPTVTIK.3|KSQIFSTASDNQPTVTIK.4|KSQIFSTASDNQPTVTIK.2|VYEGERPLTKDNHLLGTFDLTGIPPAPR.5|VYEGERPLTKDNHLLGTFDLTGIPPAPR.4|KVTHAVVTVPAYFNDAQR.3|KVTHAVVTVPAYFNDAQR.5|KVTHAVVTVPAYFNDAQR.4|KVTHAVVTVPAYFNDAQR.2|LTPEEIER.2|ETAEAYLGK.2|MKETAEAYLGKK.3|M[Oxi]KETAEAYLGKK.3|MKETAEAYLGKK.2|M[Oxi]KETAEAYLGKK.2|EFFNGKEPSR.3|EFFNGKEPSR.2|MVNDAEKFAEEDKK.4|M[Oxi]VNDAEKFAEEDKK.4|MVNDAEKFAEEDKK.3|M[Oxi]VNDAEKFAEEDKK.3|MVNDAEKFAEEDKK.2|FAEEDKK.2|LSSEDKETMEK.3|LSSEDKETMEK.2|LSSEDKETM[Oxi]EK.2|NKITITNDQNR.3|NKITITNDQNR.2|NTVVPTKK.2|VMEHFIK.2|VM[Oxi]EHFIK.2|STMKPVQK.2|VLEDSDLK.2|IQQLVKEFFNGKEPSR.4|SDIDEIVLVGGSTR.3|SDIDEIVLVGGSTR.2|ALSSQHQAR.2|KELEEIVQPIISK.3|MVNDAEKFAEEDK.3|MVNDAEKFAEEDK.2|TWNDPSVQQDIKFLPFK.4|TWNDPSVQQDIKFLPFK.3|TWNDPSVQQDIKFLPFK.2|ERIDTRNELESYAYSLK.4|ERIDTRNELESYAYSLK.3|VLEDSDLKK.2|ITITNDQNR.2|LGGKLSSEDKETMEK.3|QATKDAGTIAGLNVMR.3|ETAEAYLGKK.2|IINEPTAAAIAYGLDKREGEK.4|VYEGERPLTK.2|LYGSAGPPPTGEEDTAEK.3|LYGSAGPPPTGEEDTAEK.2|LIGDAAKNQLTSNPENTVFDAKR.4|AVEEKIEWLESHQDADIEDFK.4|AVEEKIEWLESHQDADIEDFK.3|IEWLESHQDADIEDFK.3|IEWLESHQDADIEDFK.2|GVPQIEVTFEIDVNGILR.3|PYIQVDIGGGQTK.2|IEIESFYEGEDFSETLTR.3|IEIESFYEGEDFSETLTR.2|NELESYAYSLKNQIGDKEK.3|NKITITNDQNRLTPEEIER.3|LIGDAAKNQLTSNPENTVFDAK.3|MVNDAEK.1|KEDVGTVVGIDLGTTYSC[CAM]VGVFK.3
SEN / CTL,Transketolase,TKT,P29401,-0.24,0.69,3.26E-08,7.34E-08,7.13E+00,"xylulose biosynthetic process,pentose-phosphate shunt,pentose-phosphate shunt, non-oxidative branch,regulation of growth,glyceraldehyde-3-phosphate biosynthetic process","transketolase activity,protein homodimerization activity,metal ion binding,cofactor binding","nucleus,nucleoplasm,peroxisome,cytosol,vesicle,myelin sheath,extracellular exosome",150,53,103,TVPFC[CAM]STFAAFFTR.2|TVPFC[CAM]STFAAFFTR.3|VLDPFTIKPLDR.3|VLDPFTIKPLDR.2|TSRPENAIIYNNNEDFQVGQAK.3|TSRPENAIIYNNNEDFQVGQAK.4|LGQSDPAPLQHQMDIYQKR.4|GHAAPILYAVWAEAGFLAEAELLNLRK.3|IIALDGDTKNSTFSEIFKK.4|VLDPFTIKPLDRK.3|VLDPFTIKPLDRK.2|IIALDGDTK.2|SVPTSTVFYPSDGVATEKAVELAANTK.3|ILATPPQEDAPSVDIANIR.3|ILATPPQEDAPSVDIANIR.4|ILATPPQEDAPSVDIANIR.2|MFGIDRDAIAQAVR.3|MFGIDRDAIAQAVR.2|M[Oxi]FGIDRDAIAQAVR.3|MAAISESNINLC[CAM]GSHC[CAM]GVSIGEDGPSQMALEDLAMFR.4|MAAISESNINLC[CAM]GSHC[CAM]GVSIGEDGPSQM[Oxi]ALEDLAMFR.4|MAAISESNINLC[CAM]GSHC[CAM]GVSIGEDGPSQMALEDLAMFR.5|ILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPR.5|ILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPR.6|ILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPR.4|ILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPR.7|QAFTDVATGSLGQGLGAAC[CAM]GMAYTGK.3|QAFTDVATGSLGQGLGAAC[CAM]GMAYTGK.4|QAFTDVATGSLGQGLGAAC[CAM]GM[Oxi]AYTGK.3|RC[CAM]EAFGWHAIIVDGHSVEELC[CAM]K.5|RC[CAM]EAFGWHAIIVDGHSVEELC[CAM]K.4|RC[CAM]EAFGWHAIIVDGHSVEELC[CAM]K.3|NMAEQIIQEIYSQIQSK.3|NMAEQIIQEIYSQIQSK.2|NM[Oxi]AEQIIQEIYSQIQSK.3|NM[Oxi]AEQIIQEIYSQIQSK.2|GITGVEDKESWHGKPLPK.4|GITGVEDKESWHGKPLPK.3|SVPTSTVFYPSDGVATEK.2|SVPTSTVFYPSDGVATEK.3|LDNLVAILDINR.2|LDNLVAILDINR.3|SKDDQVTVIGAGVTLHEALAAAELLKK.4|SKDDQVTVIGAGVTLHEALAAAELLKK.5|SKDDQVTVIGAGVTLHEALAAAELLKK.6|SKDDQVTVIGAGVTLHEALAAAELLKK.3|KILATPPQEDAPSVDIANIR.3|KILATPPQEDAPSVDIANIR.2|LGHASDRIIALDGDTK.4|LGHASDRIIALDGDTK.3|AVELAANTK.2|ISSDLDGHPVPK.3|ISSDLDGHPVPK.2|ISSIQATTAAGSGHPTSC[CAM]C[CAM]SAAEIM[Oxi]AVLFFHTMR.4|ISSIQATTAAGSGHPTSC[CAM]C[CAM]SAAEIMAVLFFHTMR.4|ISSIQATTAAGSGHPTSC[CAM]C[CAM]SAAEIMAVLFFHTMR.5|ISSIQATTAAGSGHPTSC[CAM]C[CAM]SAAEIMAVLFFHTM[Oxi]R.6|ISSIQATTAAGSGHPTSC[CAM]C[CAM]SAAEIMAVLFFHTMR.6|ISSIQATTAAGSGHPTSC[CAM]C[CAM]SAAEIM[Oxi]AVLFFHTM[Oxi]R.4|ISSIQATTAAGSGHPTSC[CAM]C[CAM]SAAEIMAVLFFHTM[Oxi]R.4|C[CAM]EAFGWHAIIVDGHSVEELC[CAM]K.4|C[CAM]EAFGWHAIIVDGHSVEELC[CAM]K.3|ILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNR.4|ILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNR.6|ILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNR.5|MPSLPSYK.2|M[Oxi]PSLPSYK.2|LGQSDPAPLQHQMDIYQK.3|LGQSDPAPLQHQM[Oxi]DIYQK.3|LGQSDPAPLQHQM[Oxi]DIYQK.2|LGQSDPAPLQHQMDIYQK.2|VYC[CAM]LLGDGELSEGSVWEAMAFASIYK.3|EHPDRFIEC[CAM]YIAEQNMVSIAVGC[CAM]ATR.4|EHPDRFIEC[CAM]YIAEQNMVSIAVGC[CAM]ATR.3|SKDDQVTVIGAGVTLHEALAAAELLK.4|SKDDQVTVIGAGVTLHEALAAAELLK.5|SKDDQVTVIGAGVTLHEALAAAELLK.3|NSTFSEIFKK.3|NSTFSEIFKK.2|AYGQALAK.2|GITGVEDK.2|DAIAQAVR.2|GRGITGVEDKESWHGKPLPK.5|NPHNDRFVLSK.3|KISSDLDGHPVPK.3|KISSDLDGHPVPK.2|KLILDSAR.2|SGKPAELLK.2|VLDPFTIK.2|KAYGQALAK.2|HQPTAIIAK.2|GRGITGVEDK.2|NSTFSEIFK.2|LQALKDTANR.2|ESWHGKPLPK.2|NRTVPFC[CAM]STFAAFFTR.3|GRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNR.6|GRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNR.5|GRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNR.4|GRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPR.6|GRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPR.5|DDQVTVIGAGVTLHEALAAAELLK.3|FIEC[CAM]YIAEQNMVSIAVGC[CAM]ATR.3
SEN / CTL,Annexin A5,ANXA5,P08758,-0.25,0.74,3.69E-04,3.19E-04,3.50E+00,"signal transduction,blood coagulation,response to organic substance,negative regulation of apoptotic process,negative regulation of catalytic activity,negative regulation of coagulation","phospholipase inhibitor activity,calcium ion binding,phospholipid binding,calcium-dependent phospholipid binding","intracellular,cytoplasm,focal adhesion,external side of plasma membrane,membrane,extracellular exosome,endothelial microparticle",108,45,70,GLGTDEESILTLLTSR.3|GLGTDEESILTLLTSR.2|VLTEIIASR.2|GTVTDFPGFDERADAETLRK.4|GTVTDFPGFDERADAETLRK.3|WGTDEEKFITIFGTR.3|WGTDEEKFITIFGTR.2|SEIDLFNIR.2|ALLLLC[CAM]GEDD.2|GTVTDFPGFDERADAETLR.3|SEIDLFNIRK.3|SEIDLFNIRK.2|AIKQVYEEEYGSSLEDDVVGDTSGYYQR.3|LYDAYELK.2|VLTEIIASRTPEELR.3|VFDKYMTISGFQIEETIDRETSGNLEQLLLAVVK.4|NFATSLYSMIKGDTSGDYKK.4|FITIFGTR.2|AM[Oxi]KGLGTDEESILTLLTSR.3|QEISAAFK.2|DLLDDLK.2|KALLLLC[CAM]GEDD.2|MLVVLLQANRDPDAGIDEAQVEQDAQALFQAGELK.4|MLVVLLQANRDPDAGIDEAQVEQDAQALFQAGELK.5|M[Oxi]LVVLLQANRDPDAGIDEAQVEQDAQALFQAGELK.4|DLLDDLKSELTGKFEK.3|DLLDDLKSELTGKFEK.4|DLLDDLKSELTGKFEK.2|LIVALMKPSR.2|SIPAYLAETLYYAMK.2|SIPAYLAETLYYAMK.3|SIPAYLAETLYYAM[Oxi]K.3|SIPAYLAETLYYAM[Oxi]K.2|GTVTDFPGFDER.2|GTVTDFPGFDER.3|SNAQRQEISAAFK.3|SNAQRQEISAAFK.2|KNFATSLYSMIK.3|KNFATSLYSMIK.2|QVYEEEYGSSLEDDVVGDTSGYYQR.3|QVYEEEYGSSLEDDVVGDTSGYYQR.4|NFATSLYSMIK.2|NFATSLYSMIK.3|NFATSLYSM[Oxi]IK.3|NFATSLYSM[Oxi]IK.2|TLFGRDLLDDLKSELTGK.3|DLLDDLKSELTGK.3|DLLDDLKSELTGK.2|WGTDEEK.2|ADAETLRK.2|LYDAYELKHALK.3|SELTGKFEK.2|LYDAYELKHALKGAGTNEK.4|LYDAYELKHALKGAGTNEK.3|ETSGNLEQLLLAVVK.3|ETSGNLEQLLLAVVK.2|GAGTNEKVLTEIIASR.3|GAGTNEKVLTEIIASR.2|HALKGAGTNEK.2|GAGTDDHTLIR.2|MLVVLLQANR.2|M[Oxi]LVVLLQANR.2|GAGTNEKVLTEIIASRTPEELR.4|YMTISGFQIEETIDR.3|YMTISGFQIEETIDR.2|DPDAGIDEAQVEQDAQALFQAGELK.4|DPDAGIDEAQVEQDAQALFQAGELK.3|TLFGRDLLDDLK.2|SIPAYLAETLYYAMKGAGTDDHTLIR.4|MLVVLLQANRDPDAGIDEAQVEQDAQALFQAGELKWGTDEEK.5
SEN / CTL,Integral membrane protein 2B,ITM2B,Q9Y287,-0.26,0.66,3.16E-02,1.38E-02,1.86E+00,"nervous system development,negative regulation of amyloid precursor protein biosynthetic process,cellular protein metabolic process","beta-amyloid binding,protein binding,ATP binding","Golgi membrane,extracellular region,extracellular space,Golgi apparatus,plasma membrane,endosome membrane,membrane,Golgi-associated vesicle membrane,integral component of organelle membrane,intracellular membrane-bounded organelle,extracellular exosome",6,6,6,NLLELLINIK.2|FAVETLIC[CAM]S.2|VTFNSALAQK.2|IENIDHLGFFIYR.3|AGTYLPQSYLIHEHMVITDR.4|IFEEEEVEFISVPVPEFADSDPANIVHDFNK.3
SEN / CTL,Protein FAM49B,FAM49B,Q9NUQ9,-0.26,0.32,3.23E-03,2.08E-03,2.68E+00,,,"cilium,membrane,extracellular exosome",12,23,41,VLKDQPPNSVEGLLNALR.3|VLKDQPPNSVEGLLNALR.2|INNVPAEGENEVNNELANR.3|INNVPAEGENEVNNELANR.2|VMVGVIILYDHVHPVGAFAK.4|VM[Oxi]VGVIILYDHVHPVGAFAK.4|VMVGVIILYDHVHPVGAFAK.3|VMVGVIILYDHVHPVGAFAK.2|MSLFYAEATPMLK.2|MSLFYAEATPMLK.3|M[Oxi]SLFYAEATPMLK.2|MSLFYAEATPM[Oxi]LK.2|QFAEILHFTLR.3|QFAEILHFTLR.2|FYEFSQR.2|DAEGILEDLQSYR.3|DAEGILEDLQSYR.2|GLLGALTSTPYSPTQHLER.4|GLLGALTSTPYSPTQHLER.3|GLLGALTSTPYSPTQHLER.2|HLNDETTSK.2|DQPPNSVEGLLNALR.3|DQPPNSVEGLLNALR.2|EAIQHPADEKLQEK.3|AWGAVVPLVGK.2|DAEGILEDLQSYRGAGHEIR.4|EAIQHPADEK.2|MTNPAIQNDFSYYR.3|MTNPAIQNDFSYYR.2|M[Oxi]TNPAIQNDFSYYR.2|VMLETPEYR.2|VM[Oxi]LETPEYR.2|MTNPAIQNDFSYYRR.3|EIYNQVNVVLK.2|GLLGALTSTPYSPTQHLEREQALAK.4|NLPIENTTDC[CAM]LSTMASVC[CAM]R.3|NLPIENTTDC[CAM]LSTMASVC[CAM]R.2|FTNEETVSFC[CAM]LR.2|VLTC[CAM]TDLEQGPNFFLDFENAQPTESEK.4|VLTC[CAM]TDLEQGPNFFLDFENAQPTESEK.3|FVSENKNLPIENTTDC[CAM]LSTMASVC[CAM]R.3
SEN / CTL,Synembryn-B,RIC8B,Q9NVN3,-0.27,0.19,1.21E-01,4.16E-02,1.38E+00,"regulation of G-protein coupled receptor protein signaling pathway,positive regulation of GTPase activity","G-protein alpha-subunit binding,guanyl-nucleotide exchange factor activity,GTPase activator activity","cytoplasm,centrosome,cytosol,plasma membrane,cell cortex",3,1,1,GSSYREGLTPVLSLLTEC[CAM]SR.3
SEN / CTL,Protein phosphatase 1 regulatory subunit 14B,PPP1R14B,Q96C90,-0.27,0.28,7.34E-04,5.81E-04,3.24E+00,"regulation of protein dephosphorylation,regulation of phosphorylation,negative regulation of catalytic activity,innate immune response",protein serine/threonine phosphatase inhibitor activity,cytoplasm,15,9,14,VKELLVDC[CAM]YKPTEAFISGLLDKIR.4|VYFQSPPGAAGEGPGGADDEGPVRR.3|LNLEEWILEQLTR.2|LNLEEWILEQLTR.3|RLNLEEWILEQLTR.3|RLNLEEWILEQLTR.2|VYFQSPPGAAGEGPGGADDEGPVR.3|VYFQSPPGAAGEGPGGADDEGPVR.2|VKELLVDC[CAM]YKPTEAFISGLLDK.4|PTEAFISGLLDK.2|ELLVDC[CAM]YKPTEAFISGLLDK.3|ELLVDC[CAM]YKPTEAFISGLLDK.2|LYDC[CAM]QEEEIPELEIDVDELLDM[Oxi]ESDDAR.3|LYDC[CAM]QEEEIPELEIDVDELLDMESDDAR.3
SEN / CTL,Nicotinate-nucleotide pyrophosphorylase [carboxylating],QPRT,Q15274,-0.27,0.27,7.34E-06,9.76E-06,5.01E+00,"NAD biosynthetic process,NAD metabolic process,quinolinate catabolic process,protein oligomerization","nicotinate-nucleotide diphosphorylase (carboxylating) activity,protein homodimerization activity","cytoplasm,cytosol,extracellular exosome",18,11,15,C[CAM]SGIASAAAAAVEAAR.3|C[CAM]SGIASAAAAAVEAAR.2|YDLGGLVMVK.2|VALNTLAR.2|YGLLVGGAASHR.3|YGLLVGGAASHR.2|GPAHC[CAM]LLLGER.3|GPAHC[CAM]LLLGER.2|GAGWTGHVAGTR.2|VAEVRGPAHC[CAM]LLLGER.3|DNHVVAAGGVEK.2|GAGWTGHVAGTRK.2|EDC[CAM]PGLNYAALVSGAGPSQAALWAK.3|VEVEC[CAM]SSLQEAVQAAEAGADLVLLDNFKPEELHPTATVLK.5|VEVEC[CAM]SSLQEAVQAAEAGADLVLLDNFKPEELHPTATVLK.4
SEN / CTL,14-3-3 protein zeta/delta,YWHAZ,P63104,-0.28,1.42,6.92E-03,3.96E-03,2.40E+00,"protein targeting,signal transduction,platelet activation,negative regulation of apoptotic process,regulation of mRNA stability,establishment of Golgi localization,membrane organization,Golgi reassembly,cell-cell adhesion,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway","protein binding,transcription factor binding,protein kinase binding,protein domain specific binding,ubiquitin protein ligase binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","extracellular space,nucleus,nucleoplasm,cytoplasm,mitochondrion,cytosol,cell-cell adherens junction,focal adhesion,cytoplasmic vesicle membrane,melanosome,extracellular exosome,blood microparticle",84,22,53,IETELRDIC[CAM]NDVLSLLEK.3|IETELRDIC[CAM]NDVLSLLEK.2|IETELRDIC[CAM]NDVLSLLEK.4|EKIETELRDIC[CAM]NDVLSLLEK.4|EKIETELRDIC[CAM]NDVLSLLEK.3|SVTEQGAELSNEER.2|SVTEQGAELSNEER.3|SVTEQGAELSNEERNLLSVAYK.3|YLAEVAAGDDK.2|GIVDQSQQAYQEAFEISKK.3|GIVDQSQQAYQEAFEISKK.2|GIVDQSQQAYQEAFEISKK.4|FLIPNASQAESK.2|FLIPNASQAESK.3|DIC[CAM]NDVLSLLEK.2|DIC[CAM]NDVLSLLEK.3|LAEQAERYDDMAAC[CAM]MK.3|LAEQAERYDDMAAC[CAM]MK.2|LAEQAERYDDMAAC[CAM]M[Oxi]K.2|LAEQAERYDDM[Oxi]AAC[CAM]MK.2|LAEQAERYDDM[Oxi]AAC[CAM]MK.3|LAEQAERYDDMAAC[CAM]M[Oxi]K.3|LAEQAERYDDM[Oxi]AAC[CAM]M[Oxi]K.3|TAFDEAIAELDTLSEESYK.3|TAFDEAIAELDTLSEESYK.2|YLAEVAAGDDKK.3|YLAEVAAGDDKK.2|AKLAEQAERYDDMAAC[CAM]MK.4|AKLAEQAERYDDMAAC[CAM]MK.3|AKLAEQAERYDDM[Oxi]AAC[CAM]MK.3|AKLAEQAERYDDMAAC[CAM]M[Oxi]K.3|YLAEVAAGDDKKGIVDQSQQAYQEAFEISK.4|YLAEVAAGDDKKGIVDQSQQAYQEAFEISK.3|KGIVDQSQQAYQEAFEISKK.4|KGIVDQSQQAYQEAFEISKK.3|GIVDQSQQAYQEAFEISK.3|GIVDQSQQAYQEAFEISK.2|VVSSIEQKTEGAEK.3|VVSSIEQKTEGAEK.2|VVSSIEQKTEGAEKK.4|VVSSIEQKTEGAEKK.3|VVSSIEQKTEGAEKK.2|VVSSIEQK.2|KGIVDQSQQAYQEAFEISK.4|KGIVDQSQQAYQEAFEISK.3|KGIVDQSQQAYQEAFEISK.2|YDDMAAC[CAM]MK.2|YDDM[Oxi]AAC[CAM]MK.2|YDDMAAC[CAM]M[Oxi]K.2|YDDM[Oxi]AAC[CAM]M[Oxi]K.2|SVTEQGAELSNEERNLLSVAYKNVVGAR.4|SVTEQGAELSNEERNLLSVAYKNVVGAR.3|DNLTLWTSDTQGDEAEAGEGGEN.3
SEN / CTL,Proteasome subunit alpha type-4,PSMA4,P25789,-0.28,0.91,2.63E-03,1.73E-03,2.76E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,viral process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","threonine-type endopeptidase activity,protein binding","proteasome complex,cytoplasmic mRNA processing body,nucleus,nucleoplasm,cytoplasm,cytosol,proteasome core complex,proteasome core complex, alpha-subunit complex,intracellular membrane-bounded organelle,extracellular exosome",36,18,30,LLDEVFFSEK.2|IYKLNEDMAC[CAM]SVAGITSDANVLTNELR.3|YLLQYQEPIPC[CAM]EQLVTALC[CAM]DIK.3|LSAEKVEIATLTR.3|LSAEKVEIATLTR.2|LYQVEYAMEAIGHAGTC[CAM]LGILANDGVLLAAERR.4|LYQVEYAMEAIGHAGTC[CAM]LGILANDGVLLAAERR.5|LYQVEYAM[Oxi]EAIGHAGTC[CAM]LGILANDGVLLAAERR.4|RPFGVSLLYIGWDK.3|RPFGVSLLYIGWDK.2|LNEDMAC[CAM]SVAGITSDANVLTNELR.3|LNEDM[Oxi]AC[CAM]SVAGITSDANVLTNELR.3|EVEQLIK.2|LYQVEYAMEAIGHAGTC[CAM]LGILANDGVLLAAER.4|LYQVEYAM[Oxi]EAIGHAGTC[CAM]LGILANDGVLLAAER.4|LYQVEYAMEAIGHAGTC[CAM]LGILANDGVLLAAER.3|ATC[CAM]IGNNSAAAVSMLK.3|ATC[CAM]IGNNSAAAVSMLK.2|ATC[CAM]IGNNSAAAVSM[Oxi]LK.2|HEEEEAKAER.3|QDYKEGEMTLK.3|VEIATLTR.2|QAYTQFGGK.2|TTIFSPEGR.2|HYGFQLYQSDPSGNYGGWK.4|HYGFQLYQSDPSGNYGGWK.3|HYGFQLYQSDPSGNYGGWK.2|ATC[CAM]IGNNSAAAVSMLKQDYK.3|ATC[CAM]IGNNSAAAVSMLKQDYKEGEMTLK.4|ATC[CAM]IGNNSAAAVSMLKQDYKEGEMTLK.3
SEN / CTL,Ephrin-B1,EFNB1,P98172,-0.28,0.19,1.12E-01,3.89E-02,1.41E+00,"neural crest cell migration,cell adhesion,cell-cell signaling,axon guidance,embryonic pattern specification,T cell costimulation,positive regulation of T cell proliferation,ephrin receptor signaling pathway","protein binding,ephrin receptor binding","nucleus,cytoplasm,plasma membrane,integral component of plasma membrane,membrane raft,synapse,extracellular exosome",3,4,4,LYLVRPEQAAAC[CAM]STVLDPNVLVTC[CAM]NRPEQEIR.4|AAALSLSTLASPK.2|AEAGRPYEYYK.2|GGSGTAGTEPSDIIIPLR.2
SEN / CTL,BUB3-interacting and GLEBS motif-containing protein ZNF207,ZNF207,O43670,-0.28,0.10,2.31E-02,1.07E-02,1.97E+00,"mitotic sister chromatid segregation,microtubule bundle formation,regulation of transcription, DNA-templated,mitotic spindle assembly checkpoint,attachment of spindle microtubules to kinetochore,microtubule polymerization,protein stabilization,cell division,regulation of chromosome segregation,mitotic spindle assembly","DNA binding,transcription factor activity, sequence-specific DNA binding,protein binding,microtubule binding,heparin binding,zinc ion binding,poly(A) RNA binding","kinetochore,condensed chromosome kinetochore,nucleus,nucleolus,cytoplasm,spindle,microtubule,spindle matrix",3,10,12,LIHPDEDISLEER.3|LIHPDEDISLEER.2|LIHPDEDISLEERR.4|LYTGPGLAIHC[CAM]MQVHK.4|LYTGPGLAIHC[CAM]MQVHK.3|PATLTTTSATSK.2|LYTGPGLAIHC[CAM]MQVHKETIDAVPNAIPGR.5|PAASITSKPATLTTTSATSK.3|ETIDAVPNAIPGR.2|TDIELEIYGMEGIPEKDMDER.3|TDIELEIYGMEGIPEK.2|ETIDAVPNAIPGRTDIELEIYGMEGIPEK.3
SEN / CTL,Growth arrest-specific protein 6,GAS6,Q14393,-0.28,0.62,1.90E-02,9.03E-03,2.04E+00,"neuron migration,positive regulation of protein phosphorylation,positive regulation of cytokine-mediated signaling pathway,platelet degranulation,positive regulation of glomerular filtration,signal peptide processing,protein phosphorylation,ER to Golgi vesicle-mediated transport,phagocytosis,apoptotic process,cell cycle arrest,cell adhesion,signal transduction,enzyme linked receptor protein signaling pathway,cell proliferation,cellular response to starvation,positive regulation of gene expression,negative regulation of tumor necrosis factor-mediated signaling pathway,macrophage cytokine production,cell migration,peptidyl-serine phosphorylation,fusion of virus membrane with host plasma membrane,viral genome replication,platelet activation,animal organ regeneration,cell-substrate adhesion,positive regulation of TOR signaling,activation of protein kinase B activity,negative regulation of interferon-gamma production,negative regulation of interleukin-6 production,negative regulation of tumor necrosis factor production,positive regulation of natural killer cell differentiation,positive regulation of peptidyl-serine phosphorylation,negative regulation of protein import into nucleus, translocation,cellular response to interferon-alpha,cellular response to drug,B cell chemotaxis,regulation of growth,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,apoptotic cell clearance,negative regulation of sequence-specific DNA binding transcription factor activity,protein kinase B signaling,positive regulation of protein kinase activity,negative regulation of transcription, DNA-templated,viral entry into host cell,receptor-mediated virion attachment to host cell,positive regulation of protein export from nucleus,positive regulation of fibroblast proliferation,negative regulation of interleukin-1 secretion,positive regulation of phagocytosis,leukocyte migration,positive regulation of protein kinase B signaling,positive regulation of protein tyrosine kinase activity,negative regulation of biomineral tissue development,positive regulation of ERK1 and ERK2 cascade,platelet aggregation,calcium ion transmembrane transport,cellular response to vitamin K,cellular response to glucose stimulus,cellular response to growth factor stimulus,protein targeting to plasma membrane,extracellular matrix assembly,dendritic cell differentiation,hematopoietic stem cell migration to bone marrow,negative regulation of oligodendrocyte apoptotic process,negative regulation of interleukin-6 secretion,negative regulation of fibroblast apoptotic process,negative regulation of endothelial cell apoptotic process,positive regulation of dendritic cell chemotaxis,negative regulation of renal albumin absorption,negative regulation of dendritic cell apoptotic process","phosphatidylserine binding,receptor binding,voltage-gated calcium channel activity,calcium ion binding,protein binding,protein tyrosine kinase activator activity,receptor tyrosine kinase binding,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,receptor agonist activity,binding, bridging","extracellular region,extracellular space,cytoplasm,endoplasmic reticulum lumen,Golgi lumen,platelet alpha granule lumen,extracellular exosome",15,11,13,SPVLTFAGGLPDVPVTSAPVTAFYR.3|AVPLSVALVDYHSTK.3|AVPLSVALVDYHSTK.2|TC[CAM]QDIDEC[CAM]ADSEAC[CAM]GEAR.3|TC[CAM]QDIDEC[CAM]ADSEAC[CAM]GEAR.2|QLVVLAVEHTALALMEIK.3|DGEATLEVDGTR.2|AFQVFEEAK.2|DVDEC[CAM]LQGR.2|HSDITAHSC[CAM]PPVEPAAA.3|GQSEVSAAQLQER.2|NSGFATC[CAM]VQNLPDQC[CAM]TPNPC[CAM]DRK.3|GTQAC[CAM]QDLMGNFFC[CAM]LC[CAM]K.2
SEN / CTL,Thioredoxin,TXN,P10599,-0.28,0.27,5.16E-04,4.30E-04,3.37E+00,"sulfate assimilation,negative regulation of transcription from RNA polymerase II promoter,response to reactive oxygen species,transcription, DNA-templated,protein folding,glycerol ether metabolic process,movement of cell or subcellular component,signal transduction,cell-cell signaling,cell proliferation,response to radiation,nucleobase-containing small molecule interconversion,protein repair,activation of protein kinase B activity,positive regulation of peptidyl-serine phosphorylation,regulation of protein import into nucleus, translocation,positive regulation of DNA binding,cell redox homeostasis,negative regulation of protein export from nucleus,positive regulation of protein kinase B signaling,oxidation-reduction process,negative regulation of hydrogen peroxide-induced cell death","protein binding,protein disulfide oxidoreductase activity,peptide disulfide oxidoreductase activity,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,poly(A) RNA binding","nucleus,nucleoplasm,cytoplasm,mitochondrion,cytosol,extracellular exosome",24,12,20,TAFQEALDAAGDKLVVVDFSATWC[CAM]GPC[CAM]K.4|TAFQEALDAAGDKLVVVDFSATWC[CAM]GPC[CAM]K.3|EKLEATINELV.2|C[CAM]MPTFQFFK.2|C[CAM]M[Oxi]PTFQFFK.2|VGEFSGANKEKLEATINELV.3|VGEFSGANKEKLEATINELV.2|LEATINELV.2|TAFQEALDAAGDK.2|TAFQEALDAAGDK.3|MIKPFFHSLSEK.3|M[Oxi]IKPFFHSLSEK.3|MIKPFFHSLSEK.2|M[Oxi]IKPFFHSLSEK.2|C[CAM]MPTFQFFKK.3|VGEFSGANK.2|PFFHSLSEK.2|LVVVDFSATWC[CAM]GPC[CAM]K.3|LVVVDFSATWC[CAM]GPC[CAM]K.2|VGEFSGANKEK.2
SEN / CTL,Protein disulfide-isomerase A3,PDIA3,P30101,-0.28,0.98,2.33E-06,3.55E-06,5.45E+00,"antigen processing and presentation of peptide antigen via MHC class I,protein folding,proteolysis,protein import into nucleus,protein retention in ER lumen,signal transduction,protein folding in endoplasmic reticulum,response to endoplasmic reticulum stress,cell redox homeostasis,oxidation-reduction process,positive regulation of extrinsic apoptotic signaling pathway","protein disulfide isomerase activity,cysteine-type endopeptidase activity,phospholipase C activity,protein binding,disulfide oxidoreductase activity,poly(A) RNA binding","nucleus,endoplasmic reticulum,endoplasmic reticulum lumen,focal adhesion,cell surface,melanosome,myelin sheath,extracellular exosome",120,62,120,FLQDYFDGNLKR.3|FLQDYFDGNLKR.2|KTFSHELSDFGLESTAGEIPVVAIR.4|KTFSHELSDFGLESTAGEIPVVAIR.3|KTFSHELSDFGLESTAGEIPVVAIR.5|KYEGGRELSDFISYLQR.4|KYEGGRELSDFISYLQR.3|FLDAGHKLNFAVASR.4|FLDAGHKLNFAVASR.3|FVMQEEFSRDGK.3|VDC[CAM]TANTNTC[CAM]NKYGVSGYPTLK.3|YGVSGYPTLK.2|LAPEYEAAATR.2|ELSDFISYLQR.2|ELSDFISYLQR.3|MDATANDVPSPYEVR.2|MDATANDVPSPYEVR.3|M[Oxi]DATANDVPSPYEVR.2|GFPTIYFSPANK.2|GFPTIYFSPANK.3|LNFAVASR.2|TFSHELSDFGLESTAGEIPVVAIR.3|TFSHELSDFGLESTAGEIPVVAIR.5|TFSHELSDFGLESTAGEIPVVAIR.4|GFPTIYFSPANKK.3|GFPTIYFSPANKK.2|FISDKDASIVGFFDDSFSEAHSEFLK.4|FISDKDASIVGFFDDSFSEAHSEFLK.3|FVMQEEFSR.2|FVM[Oxi]QEEFSR.2|KFLDAGHKLNFAVASR.4|KFLDAGHKLNFAVASR.3|IFRDGEEAGAYDGPR.3|IFRDGEEAGAYDGPR.2|DLLIAYYDVDYEK.2|FLQDYFDGNLK.2|QAGPASVPLRTEEEFKK.3|QAGPASVPLRTEEEFKK.2|FIQENIFGIC[CAM]PHMTEDNKDLIQGK.4|FIQENIFGIC[CAM]PHM[Oxi]TEDNKDLIQGK.4|FIQENIFGIC[CAM]PHMTEDNKDLIQGK.3|FAHTNVESLVNEYDDNGEGIILFRPSHLTNKFEDKTVAYTEQK.6|FAHTNVESLVNEYDDNGEGIILFRPSHLTNKFEDKTVAYTEQK.7|EATNPPVIQEEKPK.3|EATNPPVIQEEKPK.2|LSKDPNIVIAK.3|LSKDPNIVIAK.2|LKGIVPLAK.2|RLAPEYEAAATR.3|RLAPEYEAAATR.2|DGEEAGAYDGPR.3|DGEEAGAYDGPR.2|EATNPPVIQEEKPKK.4|EATNPPVIQEEKPKK.3|DPNIVIAK.2|PSHLTNKFEDK.3|PSHLTNKFEDK.2|SEPIPESNDGPVK.3|SEPIPESNDGPVK.2|TEEEFKK.2|KFLDAGHK.2|KQAGPASVPLRTEEEFK.4|KQAGPASVPLRTEEEFK.3|TVAYTEQK.2|VDC[CAM]TANTNTC[CAM]NK.3|VDC[CAM]TANTNTC[CAM]NK.2|RYLKSEPIPESNDGPVK.4|RYLKSEPIPESNDGPVK.3|FEDKTVAYTEQK.3|FEDKTVAYTEQK.2|QAGPASVPLR.2|TADGIVSHLK.2|FIQENIFGIC[CAM]PHMTEDNK.4|FIQENIFGIC[CAM]PHMTEDNK.3|FIQENIFGIC[CAM]PHM[Oxi]TEDNK.3|FIQENIFGIC[CAM]PHM[Oxi]TEDNK.2|FIQENIFGIC[CAM]PHMTEDNK.2|PSHLTNKFEDKTVAYTEQK.4|KQAGPASVPLR.2|FAHTNVESLVNEYDDNGEGIILFRPSHLTNKFEDK.7|FAHTNVESLVNEYDDNGEGIILFRPSHLTNKFEDK.6|FAHTNVESLVNEYDDNGEGIILFRPSHLTNKFEDK.5|FAHTNVESLVNEYDDNGEGIILFRPSHLTNKFEDK.4|KFIQENIFGIC[CAM]PHMTEDNK.4|KFIQENIFGIC[CAM]PHM[Oxi]TEDNK.4|KFIQENIFGIC[CAM]PHMTEDNK.3|KFIQENIFGIC[CAM]PHM[Oxi]TEDNK.3|KFIQENIFGIC[CAM]PHMTEDNK.2|DASIVGFFDDSFSEAHSEFLK.4|DASIVGFFDDSFSEAHSEFLK.3|DASIVGFFDDSFSEAHSEFLK.2|QAGPASVPLRTEEEFK.3|QAGPASVPLRTEEEFK.2|TADGIVSHLKK.2|FAHTNVESLVNEYDDNGEGIILFRPSHLTNK.6|FAHTNVESLVNEYDDNGEGIILFRPSHLTNK.5|FAHTNVESLVNEYDDNGEGIILFRPSHLTNK.4|FAHTNVESLVNEYDDNGEGIILFRPSHLTNK.3|YLKSEPIPESNDGPVK.3|YLKSEPIPESNDGPVK.2|KFIQENIFGIC[CAM]PHMTEDNKDLIQGK.5|KFIQENIFGIC[CAM]PHMTEDNKDLIQGK.4|KFIQENIFGIC[CAM]PHMTEDNKDLIQGK.3|KFISDKDASIVGFFDDSFSEAHSEFLK.5|KFISDKDASIVGFFDDSFSEAHSEFLK.4|VVVAENFDEIVNNENK.3|VVVAENFDEIVNNENK.2|ISDTGSAGLMLVEFFAPWC[CAM]GHC[CAM]K.4|ISDTGSAGLM[Oxi]LVEFFAPWC[CAM]GHC[CAM]K.4|ISDTGSAGLMLVEFFAPWC[CAM]GHC[CAM]K.3|ISDTGSAGLM[Oxi]LVEFFAPWC[CAM]GHC[CAM]K.3|YEGGRELSDFISYLQR.3|EATNPPVIQEEK.2|ISDTGSAGLMLVEFFAPWC[CAM]GHC[CAM]KR.4|ISDTGSAGLM[Oxi]LVEFFAPWC[CAM]GHC[CAM]KR.4|ISDTGSAGLMLVEFFAPWC[CAM]GHC[CAM]KR.3|GEKFVMQEEFSR.2|FAHTNVESLVNEYDDNGEGIILFR.3|VVVAENFDEIVNNENKDVLIEFYAPWC[CAM]GHC[CAM]K.4|SEPIPESNDGPVKVVVAENFDEIVNNENK.3
SEN / CTL,Kunitz-type protease inhibitor 1,SPINT1,O43278,-0.28,0.19,1.50E-01,4.88E-02,1.31E+00,"neural tube closure,negative regulation of endopeptidase activity,extracellular matrix organization,positive regulation of glial cell differentiation,branching involved in labyrinthine layer morphogenesis,placenta blood vessel development,cellular response to BMP stimulus,negative regulation of neural precursor cell proliferation",serine-type endopeptidase inhibitor activity,"extracellular region,extracellular space,plasma membrane,membrane,extracellular exosome",6,11,13,EGFINYLTR.2|WYYNPFSEHC[CAM]AR.3|GHC[CAM]VDLPDTGLC[CAM]K.3|GHC[CAM]VDLPDTGLC[CAM]K.2|DVENTDWR.2|FTYGGC[CAM]YGNK.2|SFVYGGC[CAM]LGNK.2|YTSGFDELQR.2|NNYLREEEC[CAM]ILAC[CAM]R.3|NNYLREEEC[CAM]ILAC[CAM]R.2|QTEDYC[CAM]LASNK.2|WYYDPTEQIC[CAM]K.2|NNFEEEQQC[CAM]LESC[CAM]R.2
SEN / CTL,Heterogeneous nuclear ribonucleoprotein D-like,HNRNPDL,O14979,-0.28,0.30,8.07E-05,8.19E-05,4.09E+00,"transcription, DNA-templated,regulation of transcription, DNA-templated","nucleotide binding,DNA binding,poly(A) RNA binding","nucleoplasm,cytoplasm,extracellular exosome",18,22,35,DLTEYLSR.2|FGEVVDC[CAM]TIK.2|GFGFVLFK.2|GFGFVLFK.1|RGFC[CAM]FITYTDEEPVKK.4|RGFC[CAM]FITYTDEEPVKK.3|FGEVVDC[CAM]TIKTDPVTGR.3|FGEVVDC[CAM]TIKTDPVTGR.2|YHQIGSGK.2|YHQIGSGKC[CAM]EIK.3|MFIGGLSWDTSKK.3|M[Oxi]FIGGLSWDTSKK.3|MFIGGLSWDTSKK.2|M[Oxi]FIGGLSWDTSKK.2|VFVGGLSPDTSEEQIK.3|VFVGGLSPDTSEEQIK.2|GFC[CAM]FITYTDEEPVKK.3|GFC[CAM]FITYTDEEPVKK.2|KVFVGGLSPDTSEEQIK.3|RGFC[CAM]FITYTDEEPVK.3|RGFC[CAM]FITYTDEEPVK.2|DAASVDKVLELK.2|LSHVPPPLFPSAPATLASR.3|GGGNHQNNYQPY.2|MFIGGLSWDTSK.2|M[Oxi]FIGGLSWDTSK.2|EVYRQQQQQQK.2|EYFGAFGEIENIELPMDTK.3|EYFGAFGEIENIELPM[Oxi]DTK.3|EYFGAFGEIENIELPM[Oxi]DTK.2|EYFGAFGEIENIELPMDTK.2|NQQDDGKMFIGGLSWDTSKK.3|QLAPLLPSLAPSSAR.2|GFC[CAM]FITYTDEEPVK.2|VFVGGLSPDTSEEQIKEYFGAFGEIENIELPMDTK.4
SEN / CTL,Alpha-enolase,ENO1,P06733,-0.29,0.83,7.16E-10,2.25E-09,8.65E+00,"gluconeogenesis,transcription, DNA-templated,response to virus,negative regulation of cell growth,negative regulation of transcription, DNA-templated,canonical glycolysis,cell-cell adhesion","magnesium ion binding,DNA binding,phosphopyruvate hydratase activity,protein binding,poly(A) RNA binding,GTPase binding,cadherin binding involved in cell-cell adhesion","phosphopyruvate hydratase complex,extracellular space,nucleus,cytoplasm,cytosol,plasma membrane,cell-cell adherens junction,membrane,M band,extracellular exosome",228,56,121,VNQIGSVTESLQAC[CAM]K.2|VNQIGSVTESLQAC[CAM]K.3|YISPDQLADLYK.2|YISPDQLADLYK.3|GNPTVEVDLFTSK.2|GNPTVEVDLFTSK.3|SGKYDLDFKSPDDPSR.4|SGKYDLDFKSPDDPSR.3|SGKYDLDFKSPDDPSR.2|AAVPSGASTGIYEALELRDNDKTR.4|AAVPSGASTGIYEALELRDNDKTR.3|SFIKDYPVVSIEDPFDQDDWGAWQK.3|SFIKDYPVVSIEDPFDQDDWGAWQK.4|FGANAILGVSLAVC[CAM]K.2|FGANAILGVSLAVC[CAM]K.3|AAVPSGASTGIYEALELR.3|AAVPSGASTGIYEALELR.2|FTASAGIQVVGDDLTVTNPKR.3|FTASAGIQVVGDDLTVTNPKR.4|FTASAGIQVVGDDLTVTNPKR.2|YNQLLRIEEELGSK.3|YNQLLRIEEELGSK.2|DATNVGDEGGFAPNILENKEGLELLK.3|DATNVGDEGGFAPNILENKEGLELLK.4|TIAPALVSK.2|SC[CAM]NC[CAM]LLLK.2|YGKDATNVGDEGGFAPNILENK.3|LMIEMDGTENKSK.3|IGAEVYHNLK.2|HIADLAGNSEVILPVPAFNVINGGSHAGNKLAMQEFMILPVGAANFR.5|HIADLAGNSEVILPVPAFNVINGGSHAGNKLAM[Oxi]QEFM[Oxi]ILPVGAANFR.5|HIADLAGNSEVILPVPAFNVINGGSHAGNKLAM[Oxi]QEFMILPVGAANFR.5|IGAEVYHNLKNVIK.3|IGAEVYHNLKNVIK.4|DYPVVSIEDPFDQDDWGAWQK.3|LNVTEQEKIDKLMIEMDGTENK.4|YGKDATNVGDEGGFAPNILENKEGLELLK.4|YGKDATNVGDEGGFAPNILENKEGLELLK.3|YGKDATNVGDEGGFAPNILENKEGLELLK.5|LAMQEFMILPVGAANFR.3|LAMQEFMILPVGAANFR.2|LAMQEFM[Oxi]ILPVGAANFR.3|LAM[Oxi]QEFMILPVGAANFR.3|LAM[Oxi]QEFMILPVGAANFR.2|LAMQEFMILPVGAANFR.4|LAMQEFM[Oxi]ILPVGAANFR.2|LAM[Oxi]QEFM[Oxi]ILPVGAANFR.3|LAM[Oxi]QEFM[Oxi]ILPVGAANFR.2|YDLDFKSPDDPSR.3|YDLDFKSPDDPSR.2|DATNVGDEGGFAPNILENK.3|DATNVGDEGGFAPNILENK.2|IGAEVYHNLKNVIKEK.4|IGAEVYHNLKNVIKEK.3|SGETEDTFIADLVVGLC[CAM]TGQIK.3|SGETEDTFIADLVVGLC[CAM]TGQIK.2|SGETEDTFIADLVVGLC[CAM]TGQIK.4|HIADLAGNSEVILPVPAFNVINGGSHAGNK.4|HIADLAGNSEVILPVPAFNVINGGSHAGNK.3|HIADLAGNSEVILPVPAFNVINGGSHAGNK.5|NFRNPLAK.2|LAQANGWGVMVSHR.3|LAQANGWGVMVSHR.2|LAQANGWGVM[Oxi]VSHR.3|LAQANGWGVM[Oxi]VSHR.2|FTASAGIQVVGDDLTVTNPK.3|FTASAGIQVVGDDLTVTNPK.2|SPDDPSRYISPDQLADLYK.3|SPDDPSRYISPDQLADLYK.2|EIFDSRGNPTVEVDLFTSK.3|EIFDSRGNPTVEVDLFTSK.2|EIFDSRGNPTVEVDLFTSK.4|AGYTDKVVIGMDVAASEFFR.4|AGYTDKVVIGMDVAASEFFR.3|AGYTDKVVIGM[Oxi]DVAASEFFR.3|AGYTDKVVIGM[Oxi]DVAASEFFR.2|AGYTDKVVIGMDVAASEFFR.2|SKFGANAILGVSLAVC[CAM]K.3|SKFGANAILGVSLAVC[CAM]K.2|LMIEMDGTENK.2|LM[Oxi]IEMDGTENK.2|LMIEM[Oxi]DGTENK.2|LM[Oxi]IEM[Oxi]DGTENK.2|AAVPSGASTGIYEALELRDNDK.3|AAVPSGASTGIYEALELRDNDK.4|AAVPSGASTGIYEALELRDNDK.2|IEEELGSK.2|EGLELLK.2|EGLELLK.1|IDKLMIEMDGTENK.3|IDKLM[Oxi]IEMDGTENK.3|IDKLMIEM[Oxi]DGTENK.3|IDKLM[Oxi]IEM[Oxi]DGTENK.3|IDKLMIEMDGTENK.2|VVIGMDVAASEFFR.2|VVIGMDVAASEFFR.3|VVIGM[Oxi]DVAASEFFR.3|VVIGM[Oxi]DVAASEFFR.2|LNVTEQEKIDK.3|LNVTEQEKIDK.2|AVEHINK.2|AGAVEKGVPLYR.3|AVEHINKTIAPALVSK.4|AVEHINKTIAPALVSK.3|AVEHINKTIAPALVSK.2|YNQLLRIEEELGSKAK.4|YNQLLRIEEELGSKAK.3|YNQLLRIEEELGSKAK.2|KLNVTEQEKIDK.3|KLNVTEQEKIDK.2|LNVTEQEK.2|LAKYNQLLRIEEELGSK.4|LAKYNQLLRIEEELGSK.3|AVNEKSC[CAM]NC[CAM]LLLK.3|SGKYDLDFK.2|KLNVTEQEK.2|YISPDQLADLYKSFIK.3|EKYGKDATNVGDEGGFAPNILENK.4|YDLDFKSPDDPSRYISPDQLADLYK.4|DATNVGDEGGFAPNILENKEGLELLKTAIGK.4|IHAREIFDSRGNPTVEVDLFTSK.3
SEN / CTL,L-lactate dehydrogenase A chain,LDHA,P00338,-0.29,1.05,1.29E-04,1.26E-04,3.90E+00,"response to hypoxia,lactate metabolic process,pyruvate metabolic process,glycolytic process,response to nutrient,response to glucose,NAD metabolic process,response to drug,response to hydrogen peroxide,positive regulation of apoptotic process,response to estrogen,post-embryonic animal organ development,response to cAMP,oxidation-reduction process,cell-cell adhesion","L-lactate dehydrogenase activity,protein binding,kinase binding,identical protein binding,NAD binding,cadherin binding involved in cell-cell adhesion","nucleus,cytosol,cell-cell adherens junction,membrane,extracellular exosome",123,38,92,LVIITAGAR.2|VTLTSEEEAR.2|QVVESAYEVIK.2|QVVESAYEVIK.3|SADTLWGIQKELQF.2|SADTLWGIQK.2|VTLTSEEEARLK.3|LGVHPLSC[CAM]HGWVLGEHGDSSVPVWSGMNVAGVSLK.5|LGVHPLSC[CAM]HGWVLGEHGDSSVPVWSGMNVAGVSLK.4|LGVHPLSC[CAM]HGWVLGEHGDSSVPVWSGM[Oxi]NVAGVSLK.6|LGVHPLSC[CAM]HGWVLGEHGDSSVPVWSGMNVAGVSLK.6|LGVHPLSC[CAM]HGWVLGEHGDSSVPVWSGM[Oxi]NVAGVSLK.5|LGVHPLSC[CAM]HGWVLGEHGDSSVPVWSGM[Oxi]NVAGVSLK.4|LLIVSNPVDILTYVAWK.3|LLIVSNPVDILTYVAWK.2|QQEGESRLNLVQR.3|EVHKQVVESAYEVIK.3|EVHKQVVESAYEVIK.4|EVHKQVVESAYEVIK.2|FIIPNVVK.2|FIIPNVVK.1|DQLIYNLLK.2|VIGSGC[CAM]NLDSAR.2|VIGSGC[CAM]NLDSAR.3|IVSGKDYNVTANSK.3|IVSGKDYNVTANSK.2|DLADELALVDVIEDK.2|DLADELALVDVIEDK.3|GLYGIKDDVFLSVPC[CAM]ILGQNGISDLVK.4|GLYGIKDDVFLSVPC[CAM]ILGQNGISDLVK.3|NRVIGSGC[CAM]NLDSAR.3|NRVIGSGC[CAM]NLDSAR.2|DQLIYNLLKEEQTPQNK.3|DQLIYNLLKEEQTPQNK.2|DQLIYNLLKEEQTPQNK.4|LKGYTSWAIGLSVADLAESIMK.3|LKGYTSWAIGLSVADLAESIM[Oxi]K.3|LKGYTSWAIGLSVADLAESIMK.2|GYTSWAIGLSVADLAESIMK.3|GYTSWAIGLSVADLAESIMK.2|GYTSWAIGLSVADLAESIM[Oxi]K.3|GYTSWAIGLSVADLAESIM[Oxi]K.2|DLADELALVDVIEDKLK.3|DLADELALVDVIEDKLK.2|ITVVGVGAVGMAC[CAM]AISILMK.3|ITVVGVGAVGMAC[CAM]AISILMK.2|ITVVGVGAVGM[Oxi]AC[CAM]AISILMK.3|ITVVGVGAVGMAC[CAM]AISILM[Oxi]K.3|ITVVGVGAVGM[Oxi]AC[CAM]AISILM[Oxi]K.3|ITVVGVGAVGM[Oxi]AC[CAM]AISILMK.2|ITVVGVGAVGMAC[CAM]AISILM[Oxi]K.2|ITVVGVGAVGM[Oxi]AC[CAM]AISILM[Oxi]K.2|EEQTPQNK.2|LKGEMMDLQHGSLFLR.4|LKGEM[Oxi]M[Oxi]DLQHGSLFLR.4|LKGEM[Oxi]MDLQHGSLFLR.4|LKGEMM[Oxi]DLQHGSLFLR.4|LKGEM[Oxi]MDLQHGSLFLR.3|LKGEMM[Oxi]DLQHGSLFLR.3|LKGEMMDLQHGSLFLR.3|LKGEM[Oxi]M[Oxi]DLQHGSLFLR.3|LKGEMMDLQHGSLFLR.2|LKGEMM[Oxi]DLQHGSLFLR.2|GEMMDLQHGSLFLR.3|GEMMDLQHGSLFLR.4|GEM[Oxi]MDLQHGSLFLR.3|GEMM[Oxi]DLQHGSLFLR.3|GEM[Oxi]M[Oxi]DLQHGSLFLR.3|GEMMDLQHGSLFLR.2|GEM[Oxi]MDLQHGSLFLR.2|GEMM[Oxi]DLQHGSLFLR.2|KSADTLWGIQK.3|KSADTLWGIQK.2|TLHPDLGTDKDK.3|TLHPDLGTDKDK.2|TLHPDLGTDKDKEQWK.4|TLHPDLGTDKDKEQWK.3|TLHPDLGTDKDKEQWK.2|DYNVTANSK.2|VHPVSTMIK.2|NVNIFKFIIPNVVK.3|NVNIFKFIIPNVVK.2|TLHPDLGTDK.2|DDVFLSVPC[CAM]ILGQNGISDLVK.4|DDVFLSVPC[CAM]ILGQNGISDLVK.3|DDVFLSVPC[CAM]ILGQNGISDLVK.2|IVSGKDYNVTANSKLVIITAGAR.4|IVSGKDYNVTANSKLVIITAGAR.3|LLIVSNPVDILTYVAWKISGFPKNR.4|NVNIFKFIIPNVVKYSPNC[CAM]K.3|YSPNC[CAM]KLLIVSNPVDILTYVAWKISGFPK.4|YSPNC[CAM]KLLIVSNPVDILTYVAWK.3
SEN / CTL,Proteasome subunit alpha type-6,PSMA6,P60900,-0.29,0.39,9.79E-04,7.51E-04,3.12E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,regulation of inflammatory response,T cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,proteolysis involved in cellular protein catabolic process,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","RNA binding,endopeptidase activity,threonine-type endopeptidase activity,protein binding,purine ribonucleoside triphosphate binding,NF-kappaB binding","proteasome complex,cytoplasmic mRNA processing body,nucleus,nucleoplasm,cytoplasm,cytosol,proteasome core complex,polysome,nuclear matrix,proteasome core complex, alpha-subunit complex,myofibril,sarcomere,extracellular exosome",30,20,30,LYQVEYAFK.2|KVPDKLLDSSTVTHLFK.4|KVPDKLLDSSTVTHLFK.3|GSSAGFDRHITIFSPEGR.4|ITENIGC[CAM]VMTGMTADSR.3|ITENIGC[CAM]VMTGMTADSR.2|ITENIGC[CAM]VM[Oxi]TGMTADSR.2|AINQGGLTSVAVR.2|AINQGGLTSVAVR.3|ILTEAEIDAHLVALAERD.3|ILTEAEIDAHLVALAERD.2|C[CAM]DPAGYYC[CAM]GFK.2|LLDSSTVTHLFK.3|LLDSSTVTHLFK.2|GKDC[CAM]AVIVTQK.3|GKDC[CAM]AVIVTQK.2|YEAANWK.2|DC[CAM]AVIVTQK.2|HITIFSPEGR.2|QTESTSFLEK.2|ILTEAEIDAHLVALAER.3|ILTEAEIDAHLVALAER.2|RIADISQVYTQNAEMR.3|YGYEIPVDMLC[CAM]K.2|YGYEIPVDM[Oxi]LC[CAM]K.2|PSEIEVGVVTVENPK.2|RIADISQVYTQNAEMRPLGC[CAM]C[CAM]MILIGIDEEQGPQVYK.5|RIADISQVYTQNAEMRPLGC[CAM]C[CAM]MILIGIDEEQGPQVYK.4|IADISQVYTQNAEMR.2|YKYGYEIPVDMLC[CAM]K.2
SEN / CTL,28 kDa heat- and acid-stable phosphoprotein,PDAP1,Q13442,-0.29,0.31,2.00E-04,1.89E-04,3.72E+00,"signal transduction,cell proliferation",poly(A) RNA binding,,12,15,23,KGVEGLIDIENPNR.3|KGVEGLIDIENPNR.2|GVEGLIDIENPNR.2|GVEGLIDIENPNR.3|QYTSPEEIDAQLQAEKQK.3|QYTSPEEIDAQLQAEK.2|QYTSPEEIDAQLQAEK.3|KVTQLDLDGPK.3|KVTQLDLDGPK.2|KVTQLDLDGPKELSR.4|KVTQLDLDGPKELSR.3|MQSLSLNK.2|M[Oxi]QSLSLNK.2|EEEEQKEGGDGAAGDPKK.4|AREEEEQKEGGDGAAGDPK.4|AREEEEQKEGGDGAAGDPK.3|AKDDATLSGK.2|RMQSLSLNK.2|VTQLDLDGPK.2|RKGVEGLIDIENPNR.3|RKGVEGLIDIENPNR.2|EEEEQKEGGDGAAGDPK.3|GVEGLIDIENPNRVAQTTK.3
SEN / CTL,Triosephosphate isomerase,TPI1,P60174,-0.29,0.74,1.29E-04,1.26E-04,3.90E+00,"gluconeogenesis,glycolytic process,pentose-phosphate shunt,multicellular organism development,glycerol catabolic process,glyceraldehyde-3-phosphate biosynthetic process,canonical glycolysis","triose-phosphate isomerase activity,ubiquitin protein ligase binding","extracellular space,nucleus,cytosol,extracellular exosome",156,37,70,VVLAYEPVWAIGTGK.2|VVLAYEPVWAIGTGK.3|VPADTEVVC[CAM]APPTAYIDFAR.3|VPADTEVVC[CAM]APPTAYIDFAR.2|VPADTEVVC[CAM]APPTAYIDFAR.4|IIYGGSVTGATC[CAM]K.2|IIYGGSVTGATC[CAM]K.3|KQSLGELIGTLNAAK.3|KQSLGELIGTLNAAK.2|KQSLGELIGTLNAAKVPADTEVVC[CAM]APPTAYIDFAR.4|KQSLGELIGTLNAAKVPADTEVVC[CAM]APPTAYIDFAR.5|HVFGESDELIGQK.3|HVFGESDELIGQK.2|FFVGGNWK.2|DC[CAM]GATWVVLGHSER.3|DC[CAM]GATWVVLGHSER.2|QSLGELIGTLNAAK.2|QSLGELIGTLNAAK.3|VAHALAEGLGVIAC[CAM]IGEKLDER.4|VAHALAEGLGVIAC[CAM]IGEKLDER.3|VIADNVKDWSK.3|VIADNVKDWSK.2|QSLGELIGTLNAAKVPADTEVVC[CAM]APPTAYIDFAR.4|QSLGELIGTLNAAKVPADTEVVC[CAM]APPTAYIDFAR.3|IAVAAQNC[CAM]YK.2|VTNGAFTGEISPGMIKDC[CAM]GATWVVLGHSER.4|VVFEQTK.2|VAHALAEGLGVIAC[CAM]IGEK.3|VAHALAEGLGVIAC[CAM]IGEK.2|VAHALAEGLGVIAC[CAM]IGEK.4|ELASQPDVDGFLVGGASLKPEFVDIINAKQ.4|ELASQPDVDGFLVGGASLKPEFVDIINAKQ.3|IIYGGSVTGATC[CAM]KELASQPDVDGFLVGGASLKPEFVDIINAKQ.6|LDEREAGITEKVVFEQTK.4|ELASQPDVDGFLVGGASLKPEFVDIINAK.4|ELASQPDVDGFLVGGASLKPEFVDIINAK.3|VAHALAEGLGVIAC[CAM]IGEKLDEREAGITEK.4|VAHALAEGLGVIAC[CAM]IGEKLDEREAGITEK.5|VAHALAEGLGVIAC[CAM]IGEKLDEREAGITEK.3|RHVFGESDELIGQK.3|RHVFGESDELIGQK.4|RHVFGESDELIGQK.2|DC[CAM]GATWVVLGHSERR.4|DC[CAM]GATWVVLGHSERR.3|DC[CAM]GATWVVLGHSERR.2|SNVSDAVAQSTR.2|SNVSDAVAQSTR.3|VTNGAFTGEISPGMIK.2|VTNGAFTGEISPGMIK.3|VTNGAFTGEISPGM[Oxi]IK.3|VTNGAFTGEISPGM[Oxi]IK.2|VTNGAFTGEISPGMIKDC[CAM]GATWVVLGHSERR.5|VTNGAFTGEISPGM[Oxi]IKDC[CAM]GATWVVLGHSERR.5|TATPQQAQEVHEKLR.4|TATPQQAQEVHEKLR.3|HVFGESDELIGQKVAHALAEGLGVIAC[CAM]IGEK.5|HVFGESDELIGQKVAHALAEGLGVIAC[CAM]IGEK.4|LDEREAGITEK.3|LDEREAGITEK.2|TATPQQAQEVHEKLRGWLK.5|TATPQQAQEVHEKLRGWLK.4|TATPQQAQEVHEK.3|TATPQQAQEVHEK.2|KFFVGGNWK.2|GWLKSNVSDAVAQSTR.3|PEFVDIINAK.2|RHVFGESDELIGQKVAHALAEGLGVIAC[CAM]IGEK.5|RHVFGESDELIGQKVAHALAEGLGVIAC[CAM]IGEK.4|VIADNVKDWSKVVLAYEPVWAIGTGK.4|SNVSDAVAQSTRIIYGGSVTGATC[CAM]K.3
SEN / CTL,Endoplasmic reticulum resident protein 29,ERP29,P30040,-0.30,0.37,1.15E-04,1.14E-04,3.94E+00,"activation of MAPK activity,positive regulation of protein phosphorylation,protein folding,intracellular protein transport,protein secretion,positive regulation of gene expression,negative regulation of gene expression,protein unfolding,negative regulation of protein secretion,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway","protein homodimerization activity,chaperone binding,protein disulfide isomerase activity","endoplasmic reticulum,endoplasmic reticulum lumen,smooth endoplasmic reticulum,cell surface,membrane,transport vesicle,melanosome,extracellular exosome",30,22,35,SLNILTAFQK.2|DGDFENPVPYTGAVK.2|DGDFENPVPYTGAVK.3|YKLDKESYPVFYLFR.3|YKLDKESYPVFYLFR.4|GALPLDTVTFYK.2|GALPLDTVTFYK.3|FDTQYPYGEKQDEFKR.4|FDTQYPYGEKQDEFKR.3|GQGVYLGMPGC[CAM]LPVYDALAGEFIR.3|GQGVYLGM[Oxi]PGC[CAM]LPVYDALAGEFIR.3|GQGVYLGMPGC[CAM]LPVYDALAGEFIR.4|ILDQGEDFPASEMTR.2|ILDQGEDFPASEMTR.3|ILDQGEDFPASEM[Oxi]TR.2|QGQDNLSSVKETQKK.4|QGQDNLSSVKETQKK.3|WAEQYLK.2|LNMELSEK.2|LNM[Oxi]ELSEK.2|QGQDNLSSVKETQK.3|KWAEQYLK.2|QGQDNLSSVK.2|LDKESYPVFYLFR.3|FDTQYPYGEK.2|FDTQYPYGEKQDEFK.3|FDTQYPYGEKQDEFK.2|MSDGKKEELQK.2|ESYPVFYLFR.2|LAENSASSDDLLVAEVGISDYGDK.3|LAENSASSDDLLVAEVGISDYGDKLNM[Oxi]ELSEK.4|LAENSASSDDLLVAEVGISDYGDKLNMELSEK.4|LAENSASSDDLLVAEVGISDYGDKLNMELSEK.3|RLAENSASSDDLLVAEVGISDYGDK.3|ESYPVFYLFRDGDFENPVPYTGAVK.3
SEN / CTL,Far upstream element-binding protein 1,FUBP1,Q96AE4,-0.30,0.99,5.39E-02,2.15E-02,1.67E+00,"regulation of transcription, DNA-templated,transcription from RNA polymerase II promoter,positive regulation of gene expression","single-stranded DNA binding,transcription factor activity, sequence-specific DNA binding,poly(A) RNA binding","nucleus,nucleoplasm",21,39,63,FAVGIVIGR.2|IGGNEGIDVPIPR.2|IGGNEGIDVPIPR.3|C[CAM]QHAAEIITDLLR.3|C[CAM]QHAAEIITDLLR.2|IQIAPDSGGLPER.2|IQIAPDSGGLPER.3|EMVLELIR.2|SVMTEEYKVPDGMVGFIIGR.3|SVM[Oxi]TEEYKVPDGMVGFIIGR.3|SVMTEEYKVPDGMVGFIIGR.2|AWEEYYKK.2|IQNDAGVR.2|GRPAPGFHHGDGPGNAVQEIMIPASK.6|GRPAPGFHHGDGPGNAVQEIM[Oxi]IPASK.5|GRPAPGFHHGDGPGNAVQEIMIPASK.5|GRPAPGFHHGDGPGNAVQEIMIPASK.4|GRPAPGFHHGDGPGNAVQEIM[Oxi]IPASK.4|GRPAPGFHHGDGPGNAVQEIMIPASK.3|ITGDPYKVQQAK.3|RPLEDGDQPDAK.3|RPLEDGDQPDAK.2|SISQQSGAR.2|IQQESGC[CAM]K.2|LLDQIVEK.2|RPLEDGDQPDAKK.3|AWEEYYK.2|MVMIQDGPQNTGADKPLR.4|MVMIQDGPQNTGADKPLR.3|M[Oxi]VM[Oxi]IQDGPQNTGADKPLR.3|M[Oxi]VMIQDGPQNTGADKPLR.3|MVM[Oxi]IQDGPQNTGADKPLR.3|SVMTEEYK.2|SVM[Oxi]TEEYK.2|IQFKPDDGTTPER.3|IQFKPDDGTTPER.2|KIQNDAGVR.2|IAQITGPPDR.2|EMVLELIRDQGGFR.3|RLLDQIVEK.2|GTPQQIDYAR.2|SC[CAM]MLTGTPESVQSAKR.3|NPPPNADPNMK.2|NPPPNADPNM[Oxi]K.2|KVAPQNDSFGTQLPPMHQQQSR.4|VPDGMVGFIIGR.2|VPDGM[Oxi]VGFIIGR.2|QQAAYYAQTSPQGMPQHPPAPQGQ.4|QQAAYYAQTSPQGMPQHPPAPQGQ.3|QQAAYYAQTSPQGM[Oxi]PQHPPAPQGQ.3|IGGDAGTSLNSNDYGYGGQK.3|IGGDAGTSLNSNDYGYGGQK.2|SVQAGNPGGPGPGGR.2|VAPQNDSFGTQLPPMHQQQSR.3|MVMIQDGPQNTGADK.2|SC[CAM]M[Oxi]LTGTPESVQSAK.2|SC[CAM]MLTGTPESVQSAK.2|IGGDAGTSLNSNDYGYGGQKRPLEDGDQPDAK.4|GQGNWNMGPPGGLQEFNFIVPTGK.3|GRGQGNWNMGPPGGLQEFNFIVPTGK.3|MGQAVPAPTGAPPGGQPDYSAAWAEYYR.3|M[Oxi]GQAVPAPTGAPPGGQPDYSAAWAEYYR.3|KMGQAVPAPTGAPPGGQPDYSAAWAEYYR.3
SEN / CTL,Ubiquitin-fold modifier 1,UFM1,P61960,-0.30,0.40,9.38E-02,3.38E-02,1.47E+00,"regulation of intracellular estrogen receptor signaling pathway,response to endoplasmic reticulum stress,protein ufmylation,protein K69-linked ufmylation",,"nucleus,cytoplasm,extracellular exosome",9,5,9,VLSVPESTPFTAVLK.2|VLSVPESTPFTAVLK.3|FAAEEFKVPAATSAIITNDGIGINPAQTAGNVFLK.4|FAAEEFKVPAATSAIITNDGIGINPAQTAGNVFLK.3|FAAEEFKVPAATSAIITNDGIGINPAQTAGNVFLK.5|FAAEEFK.2|ITLTSDPR.2|VPAATSAIITNDGIGINPAQTAGNVFLK.4|VPAATSAIITNDGIGINPAQTAGNVFLK.3
SEN / CTL,Protein archease,ZBTB8OS,Q8IWT0,-0.31,0.16,6.38E-02,2.46E-02,1.61E+00,"tRNA splicing, via endonucleolytic cleavage and ligation",metal ion binding,"nucleoplasm,extracellular exosome,tRNA-splicing ligase complex",3,2,2,FSADEFFIPR.2|SIGWGEEFSLSK.2
SEN / CTL,Importin-5,IPO5,O00410,-0.31,0.60,4.53E-04,3.80E-04,3.42E+00,"protein import into nucleus, docking,protein import into nucleus, translocation,NLS-bearing protein import into nucleus,ribosomal protein import into nucleus,viral process,negative regulation of GTPase activity,positive regulation of protein import into nucleus,cellular response to amino acid stimulus","GTPase inhibitor activity,protein binding,nuclear localization sequence binding,Ran GTPase binding,protein transporter activity,poly(A) RNA binding","nucleus,nuclear pore,nucleoplasm,nucleolus,cytoplasm,Golgi apparatus,membrane,nuclear membrane,nuclear periphery,intracellular membrane-bounded organelle",39,61,119,ITFLLQAIR.2|VIAALLQTMEDQGNQR.2|VIAALLQTMEDQGNQR.3|VIAALLQTM[Oxi]EDQGNQR.2|LMVPLLK.2|LM[Oxi]VPLLK.2|VAAAESMPLLLEC[CAM]AR.2|VAAAESMPLLLEC[CAM]AR.3|VAAAESM[Oxi]PLLLEC[CAM]AR.2|AIGTEPDSDVLSEIMHSFAK.3|AIGTEPDSDVLSEIMHSFAK.2|FMQDASDVMQLLLK.3|FMQDASDVMQLLLK.2|FM[Oxi]QDASDVMQLLLK.3|FM[Oxi]QDASDVMQLLLK.2|FLFDSVSSQNVGLR.2|FLFDSVSSQNVGLR.3|VQAHAAAALINFTEDC[CAM]PK.3|VQAHAAAALINFTEDC[CAM]PK.4|VQAHAAAALINFTEDC[CAM]PK.2|ATAAFILANEHNVALFK.3|ATAAFILANEHNVALFK.4|ATAAFILANEHNVALFK.2|ELKEGFVEYTEQVVK.3|ELKEGFVEYTEQVVK.2|LVLPMIK.2|AKLEEHFKNQELR.4|AKLEEHFKNQELR.3|KVC[CAM]DIAAELAR.3|KVC[CAM]DIAAELAR.2|LQELIQK.2|VSDILHSIFSSYKEK.4|VSDILHSIFSSYKEK.3|SLLIPYLDNLVK.3|SLLIPYLDNLVK.2|HIVENAVQKELR.3|NTTAAEEAR.2|STAC[CAM]QMLVC[CAM]YAK.3|STAC[CAM]QM[Oxi]LVC[CAM]YAK.2|STAC[CAM]QMLVC[CAM]YAK.2|TIEC[CAM]ISLIGLAVGK.3|TIEC[CAM]ISLIGLAVGK.2|VSDILHSIFSSYK.3|VSDILHSIFSSYK.2|IFSIIAEGEMHEAIKHEDPC[CAM]AK.5|IFSIIAEGEMHEAIKHEDPC[CAM]AK.4|IFSIIAEGEMHEAIKHEDPC[CAM]AK.3|RMLVQC[CAM]MQDQEHPSIR.4|FYFHDGVR.2|HIVENAVQK.2|QAEETYENIPGQSK.3|QAEETYENIPGQSK.2|FVPYYDLFMPSLK.3|FVPYYDLFM[Oxi]PSLK.2|FVPYYDLFMPSLK.2|EHIMQMLQNPDWK.3|EHIMQM[Oxi]LQNPDWK.3|EHIM[Oxi]QMLQNPDWK.2|EHIMQM[Oxi]LQNPDWK.2|EHIMQMLQNPDWK.2|VC[CAM]DIAAELAR.2|IFSIIAEGEMHEAIK.3|KQAEETYENIPGQSK.3|KQAEETYENIPGQSK.2|SLVEIADTVPK.2|EFQQYLPVVMGPLMK.3|EFQQYLPVVM[Oxi]GPLMK.2|EFQQYLPVVMGPLM[Oxi]K.2|EFQQYLPVVMGPLMK.2|YLRPHLEATLQLSLK.3|YLRPHLEATLQLSLK.2|NLIDEDGNNQWPEGLK.3|NLIDEDGNNQWPEGLK.2|SLLIPYLDNLVKHLHSIMVLK.4|TKENVNATENC[CAM]ISAVGK.3|TKENVNATENC[CAM]ISAVGK.2|FKPDC[CAM]VNVEEVLPHWLSWLPLHEDK.5|FKPDC[CAM]VNVEEVLPHWLSWLPLHEDK.4|LVLPMIKEHIMQMLQNPDWK.4|LVLPMIKEHIMQMLQNPDWK.3|MLVQC[CAM]MQDQEHPSIR.3|MLVQC[CAM]MQDQEHPSIR.2|VRGPEYLTQM[Oxi]WHFMC[CAM]DALIK.4|VRGPEYLTQMWHFM[Oxi]C[CAM]DALIK.4|VRGPEYLTQMWHFMC[CAM]DALIK.4|VRGPEYLTQMWHFMC[CAM]DALIK.3|SELLMIIQMETQSSMR.3|YAEYFLRPMLQYVC[CAM]DNSPEVR.4|YAEYFLRPM[Oxi]LQYVC[CAM]DNSPEVR.3|YAEYFLRPMLQYVC[CAM]DNSPEVR.3|LC[CAM]GDTSLNNMQR.2|LC[CAM]GDTSLNNM[Oxi]QR.2|LVLEQVVTSIASVADTAEEK.3|LVLEQVVTSIASVADTAEEK.2|YAAC[CAM]NAVGQM[Oxi]ATDFAPGFQK.3|YAAC[CAM]NAVGQMATDFAPGFQK.3|YAAC[CAM]NAVGQMATDFAPGFQK.2|ILGKEFQQYLPVVMGPLMK.3|HFADLLPGFLQAVNDSC[CAM]YQNDDSVLK.4|HFADLLPGFLQAVNDSC[CAM]YQNDDSVLK.3|GPEYLTQMWHFMC[CAM]DALIK.3|EAALHIFWNFPGIFGNQQQHYLDVIK.4|EAALHIFWNFPGIFGNQQQHYLDVIK.3|LLSSAFDEVYPALPSDVQTAIK.3|LLSSAFDEVYPALPSDVQTAIK.2|ENVNATENC[CAM]ISAVGK.2|QWGLC[CAM]IFDDVIEHC[CAM]SPASFK.3|RQDEDYDEQVEESLQDEDDNDVYILTK.4|RQDEDYDEQVEESLQDEDDNDVYILTK.3|RLLSSAFDEVYPALPSDVQTAIK.3|PMLQYVC[CAM]DNSPEVR.2|QAAAYGLGVMAQYGGDNYRPFC[CAM]TEALPLLVR.4|QAAAYGLGVMAQYGGDNYRPFC[CAM]TEALPLLVR.3|C[CAM]IEVMGDGC[CAM]LNNEHFEELGGILK.3|C[CAM]IEVM[Oxi]GDGC[CAM]LNNEHFEELGGILK.3|EEAVQTFNYLC[CAM]DLIESNHPIVLGPNNTNLPK.4|EEAVQTFNYLC[CAM]DLIESNHPIVLGPNNTNLPK.3|TQTDFNDMEDDDPQISYMISAWAR.3|TASIKPEVALLDTQDMENMSDDDGWEFVNLGDQQSFGIK.4
SEN / CTL,Heterogeneous nuclear ribonucleoprotein A1,HNRNPA1,P09651,-0.31,0.37,1.11E-08,2.83E-08,7.55E+00,"mRNA splicing, via spliceosome,mRNA processing,RNA export from nucleus,fibroblast growth factor receptor signaling pathway,gene expression,viral process,negative regulation of telomere maintenance via telomerase,positive regulation of telomere maintenance via telomerase,mRNA transport,nuclear export,nuclear import","nucleotide binding,single-stranded DNA binding,RNA binding,single-stranded RNA binding,protein binding,poly(A) RNA binding,telomeric repeat-containing RNA binding,G-rich strand telomeric DNA binding","nucleus,nucleoplasm,spliceosomal complex,cytoplasm,membrane,intracellular ribonucleoprotein complex,extracellular exosome,catalytic step 2 spliceosome",42,41,92,LFIGGLSFETTDESLR.2|LFIGGLSFETTDESLR.3|KLFIGGLSFETTDESLR.3|KLFIGGLSFETTDESLR.2|GFAFVTFDDHDSVDKIVIQK.4|GFAFVTFDDHDSVDKIVIQK.3|GFAFVTFDDHDSVDKIVIQK.2|IEVIEIMTDR.2|IEVIEIMTDR.3|IEVIEIM[Oxi]TDR.2|GFGFVTYATVEEVDAAMNARPHKVDGR.5|GFGFVTYATVEEVDAAM[Oxi]NARPHKVDGR.5|GFGFVTYATVEEVDAAMNARPHKVDGR.4|GFGFVTYATVEEVDAAMNARPHKVDGR.3|SHFEQWGTLTDC[CAM]VVMRDPNTKR.5|SHFEQWGTLTDC[CAM]VVMRDPNTKR.4|SHFEQWGTLTDC[CAM]VVM[Oxi]RDPNTKR.5|SHFEQWGTLTDC[CAM]VVM[Oxi]RDPNTKR.4|SHFEQWGTLTDC[CAM]VVM[Oxi]RDPNTKR.3|SHFEQWGTLTDC[CAM]VVMRDPNTKR.3|RGFAFVTFDDHDSVDKIVIQK.4|RGFAFVTFDDHDSVDKIVIQK.5|RGFAFVTFDDHDSVDKIVIQK.3|SRGFGFVTYATVEEVDAAMNARPHKVDGR.6|SRGFGFVTYATVEEVDAAMNARPHKVDGR.5|GFGFVTYATVEEVDAAMNARPHK.4|GFGFVTYATVEEVDAAMNARPHK.5|GFGFVTYATVEEVDAAM[Oxi]NARPHK.4|GFGFVTYATVEEVDAAMNARPHK.3|GFAFVTFDDHDSVDK.3|GFAFVTFDDHDSVDK.2|KIFVGGIKEDTEEHHLR.5|KIFVGGIKEDTEEHHLR.4|KIFVGGIKEDTEEHHLR.3|YHTVNGHNC[CAM]EVRK.4|YHTVNGHNC[CAM]EVRK.3|YHTVNGHNC[CAM]EVRK.2|PGAHLTVK.2|SESPKEPEQLR.3|SESPKEPEQLR.2|EPEQLRK.2|SGSGNFGGGR.2|AVSREDSQRPGAHLTVK.4|RGFAFVTFDDHDSVDK.4|RGFAFVTFDDHDSVDK.3|RGFAFVTFDDHDSVDK.2|SSGPYGGGGQYFAK.3|SSGPYGGGGQYFAK.2|IFVGGIKEDTEEHHLR.4|IFVGGIKEDTEEHHLR.3|SESPKEPEQLRK.3|SESPKEPEQLRK.2|EDSQRPGAHLTVK.3|EDSQRPGAHLTVK.2|IFVGGIKEDTEEHHLRDYFEQYGK.6|IFVGGIKEDTEEHHLRDYFEQYGK.5|IFVGGIKEDTEEHHLRDYFEQYGK.4|IFVGGIKEDTEEHHLRDYFEQYGK.3|KRGFAFVTFDDHDSVDK.4|KRGFAFVTFDDHDSVDK.3|YHTVNGHNC[CAM]EVR.3|YHTVNGHNC[CAM]EVR.2|IEVIEIMTDRGSGK.3|EDSQRPGAHLTVKK.3|EDSQRPGAHLTVKK.2|DYFEQYGK.2|SSGPYGGGGQYFAKPR.3|SSGPYGGGGQYFAKPR.2|EDTEEHHLRDYFEQYGK.4|EDTEEHHLRDYFEQYGK.3|SRGFGFVTYATVEEVDAAMNARPHK.5|SRGFGFVTYATVEEVDAAMNARPHK.4|NQGGYGGSSSSSSYGSGR.3|NQGGYGGSSSSSSYGSGR.2|GGGFGGNDNFGR.2|EDTEEHHLR.2|QEMASASSSQR.2|SHFEQWGTLTDC[CAM]VVMRDPNTK.4|SHFEQWGTLTDC[CAM]VVM[Oxi]RDPNTK.4|SHFEQWGTLTDC[CAM]VVM[Oxi]RDPNTK.3|SHFEQWGTLTDC[CAM]VVMRDPNTK.3|PRNQGGYGGSSSSSSYGSGR.3|SHFEQWGTLTDC[CAM]VVMR.3|SHFEQWGTLTDC[CAM]VVM[Oxi]R.3|SHFEQWGTLTDC[CAM]VVM[Oxi]R.2|SHFEQWGTLTDC[CAM]VVMR.2|GFGFVTYATVEEVDAAM[Oxi]NAR.3|GFGFVTYATVEEVDAAMNAR.3|GFGFVTYATVEEVDAAM[Oxi]NAR.2|GFGFVTYATVEEVDAAMNAR.2|LFIGGLSFETTDESLRSHFEQWGTLTDC[CAM]VVMRDPNTK.5|GGGGYGGSGDGYNGFGNDGGYGGGGPGYSGGSR.3
SEN / CTL,von Willebrand factor A domain-containing protein 1,VWA1,Q6PCB0,-0.32,0.24,3.61E-02,1.52E-02,1.82E+00,"extracellular matrix organization,behavioral response to pain",identical protein binding,"basement membrane,interstitial matrix,extracellular space,extracellular exosome",6,15,25,EQLFAEASGARPGVPK.3|EQLFAEASGARPGVPK.2|VREFVGQLVAPLPLGTGALR.3|VREFVGQLVAPLPLGTGALR.4|GNFLELSAAASAPAEK.3|GNFLELSAAASAPAEK.2|APTPGTASREP.2|HLHFVDVDDLHIIVQELR.4|PQQLHATEITSSGFR.3|EFVGQLVAPLPLGTGALR.3|EFVGQLVAPLPLGTGALR.2|GSILDAMRPQQLHATEITSSGFR.4|GSILDAM[Oxi]RPQQLHATEITSSGFR.4|GSILDAMRPQQLHATEITSSGFR.3|ASLVHVGSRPYTEFPFGQHSSGEAAQDAVR.5|ASLVHVGSRPYTEFPFGQHSSGEAAQDAVR.4|SLRVSWAPALGSAAALGYHVQFGPLR.4|LAWPPLLTADSGYYVLELVPSAQPGAAR.4|LAWPPLLTADSGYYVLELVPSAQPGAAR.3|MGDTHTGLALVYAK.2|M[Oxi]GDTHTGLALVYAK.2|PYTEFPFGQHSSGEAAQDAVR.3|VLVWVTDGGSSDPVGPPMQELK.3|VLVWVTDGGSSDPVGPPMQELK.2|VSWAPALGSAAALGYHVQFGPLR.3
SEN / CTL,Polypyrimidine tract-binding protein 1,PTBP1,P26599,-0.32,0.48,2.67E-02,1.21E-02,1.92E+00,"alternative mRNA splicing, via spliceosome,regulation of alternative mRNA splicing, via spliceosome,mRNA splicing, via spliceosome,mRNA processing,RNA splicing,fibroblast growth factor receptor signaling pathway,gene expression,negative regulation of RNA splicing,negative regulation of mRNA splicing, via spliceosome,negative regulation of muscle cell differentiation,IRES-dependent viral translational initiation","nucleotide binding,RNA binding,protein binding,poly-pyrimidine tract binding,pre-mRNA binding,poly(A) RNA binding","nucleoplasm,nucleolus,membrane,extracellular exosome",18,35,87,VTPQSLFILFGVYGDVQR.3|VTPQSLFILFGVYGDVQR.2|KLPIDVTEGEVISLGLPFGK.3|KLPIDVTEGEVISLGLPFGK.4|KLPIDVTEGEVISLGLPFGK.2|VLFSSNGGVVK.2|LSLDGQNIYNAC[CAM]C[CAM]TLR.2|LSLDGQNIYNAC[CAM]C[CAM]TLR.3|GKNQAFIEMNTEEAANTMVNYYTSVTPVLR.4|GKNQAFIEM[Oxi]NTEEAANTMVNYYTSVTPVLR.3|GKNQAFIEMNTEEAANTMVNYYTSVTPVLR.3|ELKTDSSPNQAR.3|ELKTDSSPNQAR.2|GQPIYIQFSNHKELK.4|VTNLLMLK.2|VTNLLM[Oxi]LK.2|GQPIYIQFSNHK.3|GQPIYIQFSNHK.2|TDSSPNQAR.2|HQNVQLPR.2|ENALVQMADGNQAQLAMSHLNGHK.5|ENALVQMADGNQAQLAMSHLNGHK.4|ENALVQM[Oxi]ADGNQAQLAM[Oxi]SHLNGHK.4|ENALVQM[Oxi]ADGNQAQLAMSHLNGHK.4|ENALVQMADGNQAQLAM[Oxi]SHLNGHK.4|ENALVQM[Oxi]ADGNQAQLAMSHLNGHK.3|ENALVQMADGNQAQLAM[Oxi]SHLNGHK.3|ENALVQMADGNQAQLAMSHLNGHK.3|ENALVQM[Oxi]ADGNQAQLAM[Oxi]SHLNGHK.3|HQNVQLPREGQEDQGLTK.4|HQNVQLPREGQEDQGLTK.3|DYGNSPLHR.2|EGQEDQGLTKDYGNSPLHR.4|EGQEDQGLTKDYGNSPLHR.3|KENALVQMADGNQAQLAM[Oxi]SHLNGHK.5|KENALVQMADGNQAQLAMSHLNGHK.5|KENALVQMADGNQAQLAMSHLNGHK.4|EGQEDQGLTK.2|NNQFQALLQYADPVSAQHAK.4|NNQFQALLQYADPVSAQHAK.3|NNQFQALLQYADPVSAQHAK.2|IAIPGLAGAGNSVLLVSNLNPER.4|IAIPGLAGAGNSVLLVSNLNPER.3|IAIPGLAGAGNSVLLVSNLNPER.2|M[Oxi]ALIQM[Oxi]GSVEEAVQALIDLHNHDLGENHHLR.6|M[Oxi]ALIQMGSVEEAVQALIDLHNHDLGENHHLR.6|MALIQM[Oxi]GSVEEAVQALIDLHNHDLGENHHLR.6|MALIQMGSVEEAVQALIDLHNHDLGENHHLR.6|M[Oxi]ALIQM[Oxi]GSVEEAVQALIDLHNHDLGENHHLR.5|M[Oxi]ALIQMGSVEEAVQALIDLHNHDLGENHHLR.5|MALIQM[Oxi]GSVEEAVQALIDLHNHDLGENHHLR.5|MALIQMGSVEEAVQALIDLHNHDLGENHHLR.5|M[Oxi]ALIQMGSVEEAVQALIDLHNHDLGENHHLR.4|MALIQM[Oxi]GSVEEAVQALIDLHNHDLGENHHLR.4|MALIQMGSVEEAVQALIDLHNHDLGENHHLR.4|MALIQMGSVEEAVQALIDLHNHDLGENHHLR.3|KMALIQMGSVEEAVQALIDLHNHDLGENHHLR.6|KMALIQMGSVEEAVQALIDLHNHDLGENHHLR.5|AQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQSPVLR.6|AQAALQAVNSVQSGNLALAASAAAVDAGM[Oxi]AMAGQSPVLR.5|AQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQSPVLR.5|AQAALQAVNSVQSGNLALAASAAAVDAGM[Oxi]AMAGQSPVLR.4|AQAALQAVNSVQSGNLALAASAAAVDAGMAM[Oxi]AGQSPVLR.4|AQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQSPVLR.4|HQNVQLPREGQEDQGLTKDYGNSPLHR.5|LPIDVTEGEVISLGLPFGK.3|LPIDVTEGEVISLGLPFGK.2|IDFSKLTSLNVK.2|DYTRPDLPSGDSQPSLDQTMAAAFGLSVPNVHGALAPLAIPSAAAAAAAAGR.7|DYTRPDLPSGDSQPSLDQTMAAAFGLSVPNVHGALAPLAIPSAAAAAAAAGR.6|DYTRPDLPSGDSQPSLDQTMAAAFGLSVPNVHGALAPLAIPSAAAAAAAAGR.5|NFQNIFPPSATLHLSNIPPSVSEEDLK.4|NFQNIFPPSATLHLSNIPPSVSEEDLK.3|SRDYTRPDLPSGDSQPSLDQTMAAAFGLSVPNVHGALAPLAIPSAAAAAAAAGR.7|SRDYTRPDLPSGDSQPSLDQTMAAAFGLSVPNVHGALAPLAIPSAAAAAAAAGR.6|SRDYTRPDLPSGDSQPSLDQTM[Oxi]AAAFGLSVPNVHGALAPLAIPSAAAAAAAAGR.5|SRDYTRPDLPSGDSQPSLDQTMAAAFGLSVPNVHGALAPLAIPSAAAAAAAAGR.5|NQAFIEMNTEEAANTMVNYYTSVTPVLR.4|NQAFIEM[Oxi]NTEEAANTMVNYYTSVTPVLR.3|NQAFIEMNTEEAANTMVNYYTSVTPVLR.3|IIVENLFYPVTLDVLHQIFSK.3|RGSDELFSTC[CAM]VTNGPFIMSSNSASAANGNDSK.4|RGSDELFSTC[CAM]VTNGPFIMSSNSASAANGNDSK.3|RGSDELFSTC[CAM]VTNGPFIMSSNSASAANGNDSKK.4|GQPIYIQFSNHKELKTDSSPNQAR.3|GSDELFSTC[CAM]VTNGPFIMSSNSASAANGNDSK.3|GSDELFSTC[CAM]VTNGPFIMSSNSASAANGNDSKK.3
SEN / CTL,Serpin B6,SERPINB6,P35237,-0.32,0.30,5.51E-07,9.73E-07,6.01E+00,"sensory perception of sound,negative regulation of endopeptidase activity,cellular response to osmotic stress","protease binding,serine-type endopeptidase inhibitor activity","extracellular space,cytoplasm,cytosol,protein complex,extracellular exosome,nucleus",45,28,44,LVLVNAVYFR.2|SC[CAM]DFLSSFR.2|IAELLSPGSVDPLTR.2|IAELLSPGSVDPLTR.3|NLGMTDAFELGK.2|NLGM[Oxi]TDAFELGK.2|GNTAAQMAQILSFNK.2|GNTAAQMAQILSFNK.3|GNTAAQM[Oxi]AQILSFNK.2|TYIGEIFTQILVLPYVGK.3|TYIGEIFTQILVLPYVGK.2|NVFFSPMSMSC[CAM]ALAMVYMGAK.3|FC[CAM]ADHPFLFFIQHSK.4|FC[CAM]ADHPFLFFIQHSK.3|FC[CAM]ADHPFLFFIQHSK.2|FKLEESYDMESVLR.3|FKLEESYDMESVLR.2|SGGGGDIHQGFQSLLTEVNKTGTQYLLR.4|SGGGGDIHQGFQSLLTEVNKTGTQYLLR.3|ADFSGMSQTDLSLSK.2|ADFSGMSQTDLSLSK.3|ADFSGM[Oxi]SQTDLSLSK.2|GNWDEQFDKENTEER.3|GNWDEQFDKENTEER.2|NEEKPVQMMFK.3|HINTWVAEKTEGK.3|SGGGGDIHQGFQSLLTEVNK.4|SGGGGDIHQGFQSLLTEVNK.3|SGGGGDIHQGFQSLLTEVNK.2|TNGILFC[CAM]GR.2|HINTWVAEK.2|KHINTWVAEKTEGK.3|GNWDEQFDK.2|KHINTWVAEK.2|TVEKELTYEK.2|FYQAEMEELDFISAVEK.3|FYQAEMEELDFISAVEK.2|KTYIGEIFTQILVLPYVGK.3|LEESYDMESVLR.2|LEESYDM[Oxi]ESVLR.2|ELNMIIMLPDETTDLRTVEK.3|SFVEVNEEGTEAAAATAAIMMMR.3|LDMMDEEEVEVSLPR.2|ELNMIIMLPDETTDLR.2
SEN / CTL,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",CPOX,P36551,-0.33,0.50,7.43E-03,4.19E-03,2.38E+00,"protoporphyrinogen IX biosynthetic process,heme biosynthetic process,response to iron ion,response to lead ion,response to insecticide,response to arsenic-containing substance,response to methylmercury,oxidation-reduction process","coproporphyrinogen oxidase activity,structural constituent of eye lens,protein homodimerization activity","cytoplasm,mitochondrion,mitochondrial inner membrane,mitochondrial intermembrane space",9,29,42,AVVPSYIPLVK.2|IESILMSLPLTAR.2|IESILMSLPLTAR.3|IESILM[Oxi]SLPLTAR.2|KWC[CAM]DDYFFIAHR.4|KWC[CAM]DDYFFIAHR.3|FVQSC[CAM]AR.2|HC[CAM]DDSFTPQEK.3|HC[CAM]DDSFTPQEK.2|ATSLGRPEEEEDELAHR.4|ATSLGRPEEEEDELAHR.3|DGKLPFC[CAM]AMGVSSVIHPK.4|DGKLPFC[CAM]AMGVSSVIHPK.3|NPHAPTIHFNYR.3|FGLFTPGSR.2|KHC[CAM]DDSFTPQEK.3|KHC[CAM]DDSFTPQEK.2|WEYMHSPSENSK.3|EAC[CAM]DQHGPDLYPK.3|EAC[CAM]DQHGPDLYPK.2|WC[CAM]DDYFFIAHR.3|EAEILEVLR.2|LPFC[CAM]AM[Oxi]GVSSVIHPK.3|LPFC[CAM]AMGVSSVIHPK.3|RGIGGIFFDDLDSPSK.3|AGVSISVVHGNLSEEAAK.3|AGVSISVVHGNLSEEAAK.2|RGIGGIFFDDLDSPSKEEVFR.4|QWWFGGGC[CAM]DLTPTYLNQEDAVHFHR.5|QWWFGGGC[CAM]DLTPTYLNQEDAVHFHR.4|QWWFGGGC[CAM]DLTPTYLNQEDAVHFHR.3|C[CAM]SSFMAPPVTDLGELRR.3|YFEVEEADGNK.2|YVEFNLLYDR.2|KEGGGGISC[CAM]VLQDGC[CAM]VFEK.3|KEGGGGISC[CAM]VLQDGC[CAM]VFEK.2|GIGGIFFDDLDSPSKEEVFR.3|GRYVEFNLLYDR.2|GIGGIFFDDLDSPSK.2|TKMELLILETQAQVC[CAM]QALAQVDGGANFSVDR.4|C[CAM]SSFMAPPVTDLGELR.2|EGGGGISC[CAM]VLQDGC[CAM]VFEK.2
SEN / CTL,Protein canopy homolog 2,CNPY2,Q9Y2B0,-0.33,0.33,6.30E-05,6.70E-05,4.17E+00,"enzyme linked receptor protein signaling pathway,tissue development,negative regulation of gene expression,regulation of low-density lipoprotein particle clearance,positive regulation of low-density lipoprotein particle receptor biosynthetic process",protein binding,"endoplasmic reticulum,integral component of plasma membrane",21,15,27,INPDGSQSVVEVPYAR.2|INPDGSQSVVEVPYAR.3|SEAHLTELLEEIC[CAM]DR.3|SEAHLTELLEEIC[CAM]DR.2|ALVDELEWEIAQVDPKK.3|RTDLC[CAM]DHALHISHDEL.4|RTDLC[CAM]DHALHISHDEL.3|RTDLC[CAM]DHALHISHDEL.2|ALVDELEWEIAQVDPK.3|ALVDELEWEIAQVDPK.2|IDSDISGTLK.2|SQDLHC[CAM]GAC[CAM]R.3|SQDLHC[CAM]GAC[CAM]R.2|MKEYGEQIDPSTHR.4|MKEYGEQIDPSTHR.3|MKEYGEQIDPSTHRK.4|MKEYGEQIDPSTHRK.3|TIQMGSFR.2|NGESSELDLQGIR.3|NGESSELDLQGIR.2|EYGEQIDPSTHR.3|EYGEQIDPSTHR.2|EYGEQIDPSTHRK.3|EYGEQIDPSTHRK.2|TDLC[CAM]DHALHISHDEL.3|TDLC[CAM]DHALHISHDEL.2|NGESSELDLQGIRIDSDISGTLK.3
SEN / CTL,"Complement component 1 Q subcomponent-binding protein, mitochondrial",C1QBP,Q07021,-0.33,0.18,1.87E-03,1.30E-03,2.88E+00,"negative regulation of transcription from RNA polymerase II promoter,transcription, DNA-templated,mRNA processing,apoptotic process,immune response,complement activation, classical pathway,blood coagulation, intrinsic pathway,RNA splicing,phosphatidylinositol 3-kinase signaling,viral process,regulation of complement activation,negative regulation of interferon-gamma production,negative regulation of interleukin-12 production,negative regulation of MDA-5 signaling pathway,negative regulation of RIG-I signaling pathway,mature ribosome assembly,positive regulation of apoptotic process,innate immune response,positive regulation of cell adhesion,negative regulation of mRNA splicing, via spliceosome,negative regulation of defense response to virus,positive regulation of protein kinase B signaling,positive regulation of mitochondrial translation,positive regulation of neutrophil chemotaxis,positive regulation of substrate adhesion-dependent cell spreading,positive regulation of trophoblast cell migration,positive regulation of dendritic cell chemotaxis","complement component C1q binding,transcription corepressor activity,mRNA binding,protein kinase C binding,protein binding,hyaluronic acid binding,transcription factor binding,kininogen binding,adrenergic receptor binding,mitochondrial ribosome binding","extracellular space,nucleus,nucleolus,cytoplasm,mitochondrion,mitochondrial matrix,cytosol,plasma membrane,cell surface,membrane",6,12,21,ALVLDC[CAM]HYPEDEVGQEDEAESDIFSIR.3|ALVLDC[CAM]HYPEDEVGQEDEAESDIFSIR.4|ALVLDC[CAM]HYPEDEVGQEDEAESDIFSIR.5|AFVDFLSDEIKEERK.4|AFVDFLSDEIKEERK.3|EVSFQSTGESEWK.3|EVSFQSTGESEWK.2|AFVDFLSDEIKEER.3|AFVDFLSDEIKEER.2|AFVDFLSDEIK.2|VEEQEPELTSTPNFVVEVIKNDDGKK.4|VEEQEPELTSTPNFVVEVIKNDDGKK.3|VEEQEPELTSTPNFVVEVIK.3|VEEQEPELTSTPNFVVEVIK.2|KALVLDC[CAM]HYPEDEVGQEDEAESDIFSIR.4|M[Oxi]SGGWELELNGTEAK.2|MSGGWELELNGTEAK.2|VEEQEPELTSTPNFVVEVIKNDDGK.3|ITVTFNINNSIPPTFDGEEEPSQGQK.3|DTNYTLNTDSLDWALYDHLM[Oxi]DFLADR.3|DTNYTLNTDSLDWALYDHLMDFLADR.3
SEN / CTL,Myeloid-derived growth factor,MYDGF,Q969H8,-0.33,0.36,6.89E-04,5.55E-04,3.26E+00,"angiogenesis,positive regulation of protein phosphorylation,positive regulation of endothelial cell proliferation,apoptotic process,positive regulation of phosphatidylinositol 3-kinase signaling,IRE1-mediated unfolded protein response,negative regulation of apoptotic process,positive regulation of MAPK cascade,positive regulation of angiogenesis,positive regulation of transcription from RNA polymerase II promoter,positive regulation of protein kinase B signaling",protein binding,"extracellular space,endoplasmic reticulum lumen,endoplasmic reticulum-Golgi intermediate compartment,extracellular exosome",18,8,13,SYLYFTQFK.2|ESDVPLKTEEFEVTK.3|ESDVPLKTEEFEVTK.2|AAFERESDVPLKTEEFEVTK.4|AAFERESDVPLKTEEFEVTK.3|GAEIEYAMAYSK.2|GAEIEYAM[Oxi]AYSK.2|PGGVVHSFSHNVGPGDK.4|PGGVVHSFSHNVGPGDK.3|PGGVVHSFSHNVGPGDK.2|TEEFEVTK.2|TAVAHRPGAFK.2|YTC[CAM]MFTYASQGGTNEQWQMSLGTSEDHQHFTC[CAM]TIWRPQGK.5
SEN / CTL,40S ribosomal protein S28,RPS28,P62857,-0.33,0.59,6.26E-02,2.43E-02,1.62E+00,"ribosomal small subunit assembly,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,maturation of SSU-rRNA,ribosome biogenesis,ribosomal small subunit biogenesis","RNA binding,structural constituent of ribosome,poly(A) RNA binding","nucleoplasm,cytoplasm,cytosol,small ribosomal subunit,cytosolic small ribosomal subunit,extracellular exosome",21,8,13,EGDVLTLLESEREAR.3|NVKGPVREGDVLTLLESER.3|GPVREGDVLTLLESEREAR.4|GPVREGDVLTLLESEREAR.3|GPVREGDVLTLLESER.3|GPVREGDVLTLLESER.2|EGDVLTLLESER.2|EGDVLTLLESER.3|TGSQGQC[CAM]TQVRVEFMDDTSR.3|VEFMDDTSR.2|VEFM[Oxi]DDTSR.2|TGSQGQC[CAM]TQVR.3|TGSQGQC[CAM]TQVR.2
SEN / CTL,Lactoylglutathione lyase,GLO1,Q04760,-0.34,0.25,2.23E-05,2.59E-05,4.59E+00,"carbohydrate metabolic process,pyruvate metabolic process,regulation of transcription from RNA polymerase II promoter,glutathione metabolic process,methylglyoxal metabolic process,osteoclast differentiation,negative regulation of apoptotic process","lactoylglutathione lyase activity,zinc ion binding","cytoplasm,cytosol,extracellular exosome",18,16,31,GFGHIGIAVPDVYSAC[CAM]KR.4|GFGHIGIAVPDVYSAC[CAM]KR.3|GFGHIGIAVPDVYSAC[CAM]KR.2|VLGMTLIQK.2|VLGM[Oxi]TLIQK.2|GFGHIGIAVPDVYSAC[CAM]K.3|GFGHIGIAVPDVYSAC[CAM]K.2|GFGHIGIAVPDVYSAC[CAM]K.4|GLAFIQDPDGYWIEILNPNK.3|GLAFIQDPDGYWIEILNPNK.2|FEELGVK.2|IAWALSR.2|DFLLQQTMLR.3|DFLLQQTMLR.2|DFLLQQTM[Oxi]LR.2|C[CAM]DFPIMK.2|C[CAM]DFPIM[Oxi]K.2|SLDFYTR.2|RFEELGVK.2|FSLYFLAYEDKNDIPKEK.4|FSLYFLAYEDKNDIPKEK.3|ATLELTHNWGTEDDETQSYHNGNSDPR.5|ATLELTHNWGTEDDETQSYHNGNSDPR.4|ATLELTHNWGTEDDETQSYHNGNSDPR.3|KATLELTHNWGTEDDETQSYHNGNSDPR.5|KATLELTHNWGTEDDETQSYHNGNSDPR.4|KATLELTHNWGTEDDETQSYHNGNSDPR.3|FSLYFLAYEDKNDIPK.3|FSLYFLAYEDKNDIPK.2|GFGHIGIAVPDVYSAC[CAM]KRFEELGVK.4|FSLYFLAYEDK.2
SEN / CTL,ADP-sugar pyrophosphatase,NUDT5,Q9UKK9,-0.34,0.39,6.12E-03,3.58E-03,2.45E+00,"chromatin remodeling,nucleotide metabolic process,ribonucleoside diphosphate catabolic process,D-ribose catabolic process,nucleobase-containing small molecule catabolic process,ATP generation from poly-ADP-D-ribose","magnesium ion binding,protein binding,nucleotidyltransferase activity,ADP-sugar diphosphatase activity,snoRNA binding,protein homodimerization activity,8-oxo-dGDP phosphatase activity,ADP-ribose diphosphatase activity,m7G(5')pppN diphosphatase activity","intracellular,nucleus,cytosol,extracellular exosome",21,17,27,VYSYALALK.2|TLHYEC[CAM]IVLVK.3|TLHYEC[CAM]IVLVK.2|EQTADGVAVIPVLQR.2|EQTADGVAVIPVLQR.3|HANAKPFEVPFLKF.3|HANAKPFEVPFLKF.4|HANAKPFEVPFLKF.2|PFEVPFLK.2|HANAKPFEVPFLK.3|HANAKPFEVPFLK.2|TTYMDPTGK.2|TTRKEQTADGVAVIPVLQR.4|ELEEETGYK.2|LDALVAEEHLTVDAR.3|LDALVAEEHLTVDAR.2|PFEVPFLKF.2|PKPGDGEFVEVISLPK.3|PKPGDGEFVEVISLPK.2|KEQTADGVAVIPVLQR.3|KEQTADGVAVIPVLQR.2|NDLLQRLDALVAEEHLTVDAR.4|NDLLQRLDALVAEEHLTVDAR.3|PGDGEFVEVISLPK.2|QYIISEELISEGK.2|QFRPPMGGYC[CAM]IEFPAGLIDDGETPEAAALR.4|QFRPPMGGYC[CAM]IEFPAGLIDDGETPEAAALR.3
SEN / CTL,Protein PBDC1,PBDC1,Q9BVG4,-0.35,0.14,1.90E-04,1.80E-04,3.74E+00,biological_process,molecular_function,cellular_component,9,12,17,IQFFAIEIAR.2|LISSVDPQFLK.2|FNGIVEDFNYGTLLR.2|AMQHAEVYYK.3|AM[Oxi]QHAEVYYK.3|AMQHAEVYYK.2|VDDQIYSEFRK.3|VDDQIYSEFRK.2|AVYISVQDKEGEK.3|AVYISVQDKEGEK.2|AVYISVQDK.2|AVYISVQDKEGEKGVNNGGEK.4|IDVLDPEELKSESAK.3|IDVLDPEELK.2|VDDQIYSEFR.2|LDC[CAM]SQGYTEENTIFAPR.3|LDC[CAM]SQGYTEENTIFAPR.2
SEN / CTL,Fatty acid synthase,FASN,P49327,-0.35,0.88,5.70E-04,4.67E-04,3.33E+00,"osteoblast differentiation,acetyl-CoA metabolic process,fatty acid metabolic process,fatty acid biosynthetic process,pantothenate metabolic process,mammary gland development,positive regulation of cellular metabolic process,long-chain fatty-acyl-CoA biosynthetic process,oxidation-reduction process,cellular response to interleukin-4,cell-cell adhesion","fatty acid synthase activity,[acyl-carrier-protein] S-acetyltransferase activity,[acyl-carrier-protein] S-malonyltransferase activity,3-oxoacyl-[acyl-carrier-protein] synthase activity,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,oleoyl-[acyl-carrier-protein] hydrolase activity,protein binding,drug binding,myristoyl-[acyl-carrier-protein] hydrolase activity,palmitoyl-[acyl-carrier-protein] hydrolase activity,phosphopantetheine binding,protein homodimerization activity,poly(A) RNA binding,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,NADPH binding,cadherin binding involved in cell-cell adhesion,3-oxo-pimeloyl-[acp] methyl ester reductase activity","cytoplasm,mitochondrion,Golgi apparatus,cytosol,plasma membrane,cell-cell adherens junction,membrane,melanosome,glycogen granule,extracellular exosome",57,162,312,TGTVSLEVR.2|SEGVVAVLLTK.2|FC[CAM]FTPHTEEGC[CAM]LSER.3|FC[CAM]FTPHTEEGC[CAM]LSER.2|TLLEGSGLESIISIIHSSLAEPR.3|TLLEGSGLESIISIIHSSLAEPR.4|LHLSGIDANPNALFPPVEFPAPR.3|LHLSGIDANPNALFPPVEFPAPR.5|LHLSGIDANPNALFPPVEFPAPR.4|LQVVDQPLPVR.2|LQVVDQPLPVR.3|AC[CAM]LDTAVENMPSLK.2|AC[CAM]LDTAVENMPSLK.3|AC[CAM]LDTAVENM[Oxi]PSLK.2|SLLVNPEGPTLMR.2|SLLVNPEGPTLMR.3|SLLVNPEGPTLM[Oxi]R.3|SLLVNPEGPTLM[Oxi]R.2|WLSTSIPEAQWHSSLAR.3|WLSTSIPEAQWHSSLAR.4|WLSTSIPEAQWHSSLAR.2|LSIPTYGLQC[CAM]TR.2|LSIPTYGLQC[CAM]TR.3|AALQEELQLC[CAM]K.2|FPQLDSTSFANSR.2|FPQLDSTSFANSR.3|ELNLVLSVR.2|SEGVVAVLLTKK.3|HSQDLAFLSMLNDIAAVPATAMPFR.3|HSQDLAFLSM[Oxi]LNDIAAVPATAMPFR.4|HSQDLAFLSMLNDIAAVPATAM[Oxi]PFR.4|HSQDLAFLSMLNDIAAVPATAMPFR.4|HSQDLAFLSM[Oxi]LNDIAAVPATAM[Oxi]PFR.3|HSQDLAFLSM[Oxi]LNDIAAVPATAMPFR.3|HSQDLAFLSMLNDIAAVPATAM[Oxi]PFR.3|VLLSLEHGLWAPNLHFHSPNPEIPALLDGR.5|VLLSLEHGLWAPNLHFHSPNPEIPALLDGR.4|VLLSLEHGLWAPNLHFHSPNPEIPALLDGR.3|VVVQVLAEEPEAVLK.2|VVVQVLAEEPEAVLK.3|ALGLGVEQLPVVFEDVVLHQATILPK.3|ALGLGVEQLPVVFEDVVLHQATILPK.4|VTVAGGVHISGLHTESAPR.4|VTVAGGVHISGLHTESAPR.3|VTVAGGVHISGLHTESAPR.2|QAHTM[Oxi]DPQLR.3|QAHTMDPQLR.3|QAHTMDPQLR.2|RGLKPSC[CAM]TIIPLMK.4|RGLKPSC[CAM]TIIPLMK.3|VMGLVPAK.2|VM[Oxi]GLVPAK.2|FDASFFGVHPK.3|FDASFFGVHPK.2|VSVHVIEGDHR.3|VSVHVIEGDHR.2|AGLYGLPR.2|DIMLATGK.2|QRC[CAM]PPGVVPAC[CAM]HNSK.4|QRC[CAM]PPGVVPAC[CAM]HNSK.3|AKYHGNVMLLR.3|DTSFEQHVLWHTGGK.4|DTSFEQHVLWHTGGK.3|DTSFEQHVLWHTGGK.2|GMGLSLMR.2|GM[Oxi]GLSLMR.2|GMGLSLM[Oxi]R.2|SHQGLDRQELSFAAR.4|SHQGLDRQELSFAAR.3|SHQGLDRQELSFAAR.2|VYQWDDPDPR.3|VYQWDDPDPR.2|DGAWGAFR.2|DGVVRPLK.2|DHRDNLEFFLAGIGR.4|DHRDNLEFFLAGIGR.3|DHRDNLEFFLAGIGR.2|LYTLQDK.2|RAYLQAR.2|VTAIHIDPATHR.3|VTAIHIDPATHR.2|LSPDAIPGK.2|MKVVEVLAGHGHLYSR.4|AAEQYTPK.2|DNLEFFLAGIGR.3|DNLEFFLAGIGR.2|EGGFLLLHTLLR.3|EGGFLLLHTLLR.2|M[Oxi]VVPGLDGAQIPR.3|MVVPGLDGAQIPR.2|M[Oxi]VVPGLDGAQIPR.2|WVC[CAM]SSLR.2|ADEASELAC[CAM]PTPK.3|ADEASELAC[CAM]PTPK.2|GVDLVLNSLAEEK.3|GVDLVLNSLAEEK.2|GYAVLGGER.2|RVYATILNAGTNTDGFK.4|RVYATILNAGTNTDGFK.3|RVYATILNAGTNTDGFK.2|DLVEAVAHILGIR.3|DLVEAVAHILGIR.2|KDHRDNLEFFLAGIGR.4|KDHRDNLEFFLAGIGR.3|KLQELSSK.2|VLQGDLVMNVYR.3|VLQGDLVMNVYR.2|VLQGDLVM[Oxi]NVYR.2|C[CAM]PPGVVPAC[CAM]HNSK.3|C[CAM]PPGVVPAC[CAM]HNSK.2|GLVQALQTK.2|HGLYLPTR.2|GLKPSC[CAM]TIIPLMK.3|GLKPSC[CAM]TIIPLM[Oxi]K.3|GLKPSC[CAM]TIIPLMK.2|RQQEQQVPILEK.3|RQQEQQVPILEK.2|VLEALLPLK.2|VAAAVDLIIK.2|AFEVSENGNLVVSGK.3|AFEVSENGNLVVSGK.2|VVEVLAGHGHLYSR.3|VVEVLAGHGHLYSR.2|AQVADVVVSR.2|GTPLISPLIK.2|VFTTVGSAEK.2|YSGTLNLDR.2|GILADEDSSR.2|PNTSVQFLR.2|VLEALLPLKGLEER.3|VLEALLPLKGLEER.2|VLFPATGYLSIVWK.3|VLFPATGYLSIVWK.2|AAPLDSIHSLAAYYIDC[CAM]IR.4|AAPLDSIHSLAAYYIDC[CAM]IR.3|AAPLDSIHSLAAYYIDC[CAM]IR.2|DPSQQELPR.2|EAHLPPGAMAAVGLSWEEC[CAM]K.4|EAHLPPGAM[Oxi]AAVGLSWEEC[CAM]K.3|EAHLPPGAMAAVGLSWEEC[CAM]K.3|EAHLPPGAMAAVGLSWEEC[CAM]K.2|EDGLAQQQTQLNLR.3|EDGLAQQQTQLNLR.2|HFLLEEDKPEEPTAHAFVSTLTR.5|HFLLEEDKPEEPTAHAFVSTLTR.4|HFLLEEDKPEEPTAHAFVSTLTR.3|LSFFFDFR.2|QVQPEGPYR.2|TGGMAFHSYFMEAIAPPLLQELKK.5|TGGM[Oxi]AFHSYFMEAIAPPLLQELKK.4|TGGMAFHSYFM[Oxi]EAIAPPLLQELKK.4|TGGMAFHSYFMEAIAPPLLQELKK.4|TGGM[Oxi]AFHSYFM[Oxi]EAIAPPLLQELKK.4|TGGM[Oxi]AFHSYFMEAIAPPLLQELKK.3|TGGMAFHSYFM[Oxi]EAIAPPLLQELKK.3|TGGMAFHSYFMEAIAPPLLQELKK.3|C[CAM]TVFHGAQVEDAFR.3|C[CAM]TVFHGAQVEDAFR.2|QEPLLIGSTK.2|IPGLLSPHPLLQLSYTATDR.4|IPGLLSPHPLLQLSYTATDR.3|IPGLLSPHPLLQLSYTATDR.2|LNSVQSSERPLFLVHPIEGSTTVFHSLASR.6|LNSVQSSERPLFLVHPIEGSTTVFHSLASR.5|LNSVQSSERPLFLVHPIEGSTTVFHSLASR.4|LNSVQSSERPLFLVHPIEGSTTVFHSLASR.3|RPTPQDSPIFLPVDDTSFR.4|RPTPQDSPIFLPVDDTSFR.3|RPTPQDSPIFLPVDDTSFR.2|SNMGHPEPASGLAALAK.3|SNM[Oxi]GHPEPASGLAALAK.3|SNMGHPEPASGLAALAK.2|SNM[Oxi]GHPEPASGLAALAK.2|YHGNVMLLR.2|AQVADVVVSRWLRVTVAGGVHISGLHTESAPR.6|AQVADVVVSRWLRVTVAGGVHISGLHTESAPR.5|DGLLENQTPEFFQDVC[CAM]KPK.4|DGLLENQTPEFFQDVC[CAM]KPK.3|DGLLENQTPEFFQDVC[CAM]KPK.2|GILADEDSSRPVWLK.3|GILADEDSSRPVWLK.2|VYATILNAGTNTDGFK.3|VYATILNAGTNTDGFK.2|DLSRFDASFFGVHPK.3|DPETLVGYSMVGC[CAM]QR.3|DPETLVGYSM[Oxi]VGC[CAM]QR.2|DPETLVGYSMVGC[CAM]QR.2|QKLYTLQDK.2|KLQELSSKADEASELAC[CAM]PTPK.4|KLQELSSKADEASELAC[CAM]PTPK.3|PLFLVHPIEGSTTVFHSLASR.4|PLFLVHPIEGSTTVFHSLASR.3|PSC[CAM]TIIPLMK.2|PSC[CAM]TIIPLM[Oxi]K.2|WTSQDSLLGM[Oxi]EFSGR.3|WTSQDSLLGM[Oxi]EFSGR.2|WTSQDSLLGMEFSGR.2|ALC[CAM]ATRQEPLLIGSTK.3|PNTQPPPAPAPHATLPR.3|DTVTISGPQAPVFEFVEQLRK.4|DTVTISGPQAPVFEFVEQLRK.3|DTVTISGPQAPVFEFVEQLRK.2|LPEDPLLSGLLDSPALK.3|LPEDPLLSGLLDSPALK.2|LQLNGNLQLELAQVLAQERPK.4|LQLNGNLQLELAQVLAQERPK.3|LQLNGNLQLELAQVLAQERPK.2|VRPGETLLIHSGSGGVGQAAIAIALSLGC[CAM]R.5|VRPGETLLIHSGSGGVGQAAIAIALSLGC[CAM]R.4|VRPGETLLIHSGSGGVGQAAIAIALSLGC[CAM]R.3|LGMLSPEGTC[CAM]K.2|LGM[Oxi]LSPEGTC[CAM]K.2|SDEAVKPFGLK.2|VFTTVGSAEKR.2|AINC[CAM]ATSGVVGLVNC[CAM]LR.3|AINC[CAM]ATSGVVGLVNC[CAM]LR.2|MVVPGLDGAQIPRDPSQQELPR.4|MVVPGLDGAQIPRDPSQQELPR.3|AFDTAGNGYC[CAM]R.2|FDLSQNHPLGM[Oxi]AIFLK.3|FDLSQNHPLGMAIFLK.3|FDLSQNHPLGMAIFLK.2|FDLSQNHPLGM[Oxi]AIFLK.2|EVWALVQAGIR.2|DSQRDLVEAVAHILGIR.3|FLEIGKFDLSQNHPLGMAIFLK.4|FLEIGKFDLSQNHPLGM[Oxi]AIFLK.4|FLEIGKFDLSQNHPLGMAIFLK.3|EQGVTFPSGDIQEQLIR.3|EQGVTFPSGDIQEQLIR.2|HAQPTC[CAM]PGAQLC[CAM]TVYYASLNFR.4|HAQPTC[CAM]PGAQLC[CAM]TVYYASLNFR.3|SLYQSAGVAPESFEYIEAHGTGTK.4|SLYQSAGVAPESFEYIEAHGTGTK.3|TGGMAFHSYFMEAIAPPLLQELK.4|TGGM[Oxi]AFHSYFMEAIAPPLLQELK.3|TGGMAFHSYFM[Oxi]EAIAPPLLQELK.3|TGGMAFHSYFMEAIAPPLLQELK.3|GGNVGINSFGFGGSNVHIILRPNTQPPPAPAPHATLPR.6|GGNVGINSFGFGGSNVHIILRPNTQPPPAPAPHATLPR.5|GGNVGINSFGFGGSNVHIILRPNTQPPPAPAPHATLPR.4|AINC[CAM]ATSGVVGLVNC[CAM]LRR.3|QGVQVQVSTSNISSLEGAR.3|QGVQVQVSTSNISSLEGAR.2|VGDPQELNGITR.2|LRGYDYGPHFQGILEASLEGDSGR.4|LRGYDYGPHFQGILEASLEGDSGR.3|C[CAM]VLLSNLSSTSHVPEVDPGSAELQK.4|C[CAM]VLLSNLSSTSHVPEVDPGSAELQK.3|GGPEVQQVPAGER.2|PKLPEDPLLSGLLDSPALK.3|QQEQQVPILEK.2|SFYGSTLFLC[CAM]R.2|DGLLENQTPEFFQDVC[CAM]K.3|DGLLENQTPEFFQDVC[CAM]K.2|GVDLVLNSLAEEKLQASVR.3|GTHTGVWVGVSGSETSEALSR.3|GTHTGVWVGVSGSETSEALSR.2|RQGVQVQVSTSNISSLEGAR.3|RQGVQVQVSTSNISSLEGAR.2|LFDHPESPTPNPTEPLFLAQAEVYK.4|LFDHPESPTPNPTEPLFLAQAEVYK.3|LQELSSKADEASELAC[CAM]PTPK.3|DTVTISGPQAPVFEFVEQLR.3|DTVTISGPQAPVFEFVEQLR.2|EAC[CAM]PELDYFVVFSSVSC[CAM]GR.3|EAC[CAM]PELDYFVVFSSVSC[CAM]GR.2|C[CAM]PPGVVPAC[CAM]HNSKDTVTISGPQAPVFEFVEQLRK.5|GLIAEAAQLGPVGGVFNLAVVLR.3|RVYATILNAGTNTDGFKEQGVTFPSGDIQEQLIR.5|RVYATILNAGTNTDGFKEQGVTFPSGDIQEQLIR.4|VLQGDLVMNVYRDGAWGAFR.3|GGPEVQQVPAGERPLWFIC[CAM]SGMGTQWR.4|GGPEVQQVPAGERPLWFIC[CAM]SGM[Oxi]GTQWR.3|GGPEVQQVPAGERPLWFIC[CAM]SGMGTQWR.3|LLLEVTYEAIVDGGINPDSLR.3|LLLEVTYEAIVDGGINPDSLR.2|TGGAYGEDLGADYNLSQVC[CAM]DGK.3|TGGAYGEDLGADYNLSQVC[CAM]DGK.2|VLLSLEHGLWAPNLHFHSPNPEIPALLDGRLQVVDQPLPVR.6|GYDYGPHFQGILEASLEGDSGR.3|GYDYGPHFQGILEASLEGDSGR.2|LPESENLQEFWDNLIGGVDMVTDDDRR.4|LPESENLQEFWDNLIGGVDM[Oxi]VTDDDRR.4|LPESENLQEFWDNLIGGVDMVTDDDRR.3|LFDHPESPTPNPTEPLFLAQAEVYKELR.4|LFDHPESPTPNPTEPLFLAQAEVYKELR.3|NVTFHGVLLDAFFNESSADWR.3|LQLNGNLQLELAQVLAQERPKLPEDPLLSGLLDSPALK.5|LQLNGNLQLELAQVLAQERPKLPEDPLLSGLLDSPALK.4|LTPGC[CAM]EAEAETEAIC[CAM]FFVQQFTDMEHNR.4|LTPGC[CAM]EAEAETEAIC[CAM]FFVQQFTDM[Oxi]EHNR.4|LTPGC[CAM]EAEAETEAIC[CAM]FFVQQFTDM[Oxi]EHNR.3|LTPGC[CAM]EAEAETEAIC[CAM]FFVQQFTDMEHNR.3|HAQPTC[CAM]PGAQLC[CAM]TVYYASLNFRDIMLATGK.4|TSSAEYNVNNLVSPVLFQEALWHVPEHAVVLEIAPHALLQAVLKR.6|LQVVDQPLPVRGGNVGINSFGFGGSNVHIILRPNTQPPPAPAPHATLPR.6|LSPDAIPGKWTSQDSLLGMEFSGR.3|AKLTPGC[CAM]EAEAETEAIC[CAM]FFVQQFTDMEHNR.4|GNAGQSNYGFANSAM[Oxi]ER.2|GNAGQSNYGFANSAMER.2|GPSIALDTAC[CAM]SSSLMALQNAYQAIHSGQC[CAM]PAAIVGGINVLLKPNTSVQFLR.6|GPSIALDTAC[CAM]SSSLMALQNAYQAIHSGQC[CAM]PAAIVGGINVLLKPNTSVQFLR.5|VYATILNAGTNTDGFKEQGVTFPSGDIQEQLIR.4|VYATILNAGTNTDGFKEQGVTFPSGDIQEQLIR.3|HSQDLAFLSMLNDIAAVPATAMPFRGYAVLGGER.4|GHPLGDIVAFLTSTEPQYGQGILSQDAWESLFSR.4|GTHTGVWVGVSGSETSEALSRDPETLVGYSM[Oxi]VGC[CAM]QR.4|GTHTGVWVGVSGSETSEALSRDPETLVGYSMVGC[CAM]QR.4|TSSAEYNVNNLVSPVLFQEALWHVPEHAVVLEIAPHALLQAVLK.5|ADEASELAC[CAM]PTPKEDGLAQQQTQLNLR.3|WDHSLAWDVPAAEDFPNGSGSPSAAIYNIDTSSESPDHYLVDHTLDGR.5
SEN / CTL,Proteasome subunit beta type-2,PSMB2,P49721,-0.35,0.92,1.54E-02,7.58E-03,2.12E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,response to organonitrogen compound,response to organic cyclic compound,viral process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway",threonine-type endopeptidase activity,"proteasome complex,nucleus,nucleoplasm,cytosol,proteasome core complex,membrane,extracellular exosome",18,21,33,FILNLPTFSVR.2|IIDKNGIHDLDNISFPK.4|NGYELSPTAAANFTR.2|NGYELSPTAAANFTR.3|NLADC[CAM]LR.2|VAASNIVQMKDDHDKMFK.5|MRNGYELSPTAAANFTR.3|M[Oxi]RNGYELSPTAAANFTR.3|MRNGYELSPTAAANFTR.2|AVELLRK.2|VAASNIVQMKDDHDK.4|VAASNIVQM[Oxi]KDDHDK.4|VAASNIVQMKDDHDK.3|C[CAM]LEELQK.2|NGIHDLDNISFPK.3|NGIHDLDNISFPK.2|RFILNLPTFSVR.3|YYTPTISR.2|RNLADC[CAM]LR.2|KC[CAM]LEELQK.2|VAASNIVQMK.2|VAASNIVQM[Oxi]K.2|IIDKNGIHDLDNISFPKQGS.4|APFAAHGYGAFLTLSILDR.3|APFAAHGYGAFLTLSILDR.2|APFAAHGYGAFLTLSILDRYYTPTISR.4|SRTPYHVNLLLAGYDEHEGPALYYM[Oxi]DYLAALAK.5|SRTPYHVNLLLAGYDEHEGPALYYMDYLAALAK.5|SRTPYHVNLLLAGYDEHEGPALYYMDYLAALAK.4|ILLLC[CAM]VGEAGDTVQFAEYIQK.3|ILLLC[CAM]VGEAGDTVQFAEYIQK.2|TPYHVNLLLAGYDEHEGPALYYM[Oxi]DYLAALAK.4|TPYHVNLLLAGYDEHEGPALYYMDYLAALAK.4
SEN / CTL,LDLR chaperone MESD,MESDC2,Q14696,-0.35,0.27,1.91E-02,9.04E-03,2.04E+00,"protein folding,mesoderm development,Wnt signaling pathway,protein localization to cell surface","molecular_function,low-density lipoprotein particle receptor binding","cellular_component,endoplasmic reticulum,plasma membrane",6,15,22,DGSYAWEIKDFLVGQDR.3|DGSYAWEIKDFLVGQDR.2|IDPSKPESILK.3|IDPSKPESILK.2|DFLVGQDR.2|LLEQWEK.2|DIRDYNDADMAR.3|DIRDYNDADM[Oxi]AR.3|DIRDYNDADM[Oxi]AR.2|DIRDYNDADMAR.2|DDDIEEGDLPEHK.3|DDDIEEGDLPEHK.2|DGSYAWEIK.2|DYNDADMAR.2|RPSAPVDFSK.2|LLEQWEKDDDIEEGDLPEHK.4|LLEQWEKDDDIEEGDLPEHK.3|DDDIEEGDLPEHKRPSAPVDFSK.4|LLEQWEKDDDIEEGDLPEHKRPSAPVDFSK.5|C[CAM]ADVTLEGQVYPGK.2|TLMMFVTVSGSPTEK.2|ETEEITSLWQGSLFNANYDVQR.3
SEN / CTL,Neurosecretory protein VGF,VGF,O15240,-0.35,0.26,1.33E-01,4.46E-02,1.35E+00,"ovarian follicle development,response to dietary excess,generation of precursor metabolites and energy,response to cold,sexual reproduction,insulin secretion,response to insulin,carbohydrate homeostasis,glucose homeostasis,defense response to bacterium,regulation of synaptic plasticity,response to cAMP","molecular_function,hormone activity,neuropeptide hormone activity,growth factor activity","extracellular space,transport vesicle,cytoplasmic vesicle,intracellular membrane-bounded organelle",3,10,11,LADLASDLLLQYLLQGGAR.3|LADLASDLLLQYLLQGGAR.2|RAQEEAEAEER.3|RQQETAAAETETR.3|AYQGVAAPFPK.2|AQEEAEAEER.2|ARRPESALLGGSEAGER.3|THLGEALAPLSK.2|QQETAAAETETR.2|LHLPADDVVSIIEEVEEK.3|RLQEQEELENYIEHVLLR.3
SEN / CTL,Protein arginine N-methyltransferase 1,PRMT1,Q99873,-0.35,0.32,1.60E-03,1.14E-03,2.94E+00,"regulation of transcription, DNA-templated,protein methylation,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,cell surface receptor signaling pathway,histone methylation,peptidyl-arginine methylation,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,neuron projection development,histone H4-R3 methylation,positive regulation of erythrocyte differentiation,negative regulation of megakaryocyte differentiation,positive regulation of hemoglobin biosynthetic process,positive regulation of p38MAPK cascade","protein binding,methyltransferase activity,N-methyltransferase activity,protein methyltransferase activity,methyl-CpG binding,protein-arginine N-methyltransferase activity,enzyme binding,protein-arginine omega-N asymmetric methyltransferase activity,histone methyltransferase activity,histone methyltransferase activity (H4-R3 specific),poly(A) RNA binding,mitogen-activated protein kinase p38 binding","nucleus,nucleoplasm,cytoplasm,cytosol,methylosome",15,32,48,DKWLAPDGLIFPDR.3|DKWLAPDGLIFPDR.2|KVIGIEC[CAM]SSISDYAVK.3|KVIGIEC[CAM]SSISDYAVK.2|TGEEIFGTIGMRPNAK.3|TGEEIFGTIGM[Oxi]RPNAK.3|TGEEIFGTIGMRPNAK.2|ATLYVTAIEDR.2|IHWWENVYGFDMSC[CAM]IKDVAIKEPLVDVVDPK.5|IHWWENVYGFDMSC[CAM]IKDVAIKEPLVDVVDPK.4|ANKLDHVVTIIK.3|ANKLDHVVTIIK.2|GKVEEVELPVEK.3|GKVEEVELPVEK.2|NSMFHNR.2|RTGFSTSPESPYTHWK.4|RTGFSTSPESPYTHWK.3|EVDIYTVK.2|LDHVVTIIK.2|DVAIKEPLVDVVDPK.3|DVAIKEPLVDVVDPK.2|EPLVDVVDPK.2|QLVTNAC[CAM]LIK.2|TGFSTSPESPYTHWK.3|TGFSTSPESPYTHWK.2|VEEVELPVEK.2|VEDLTFTSPFC[CAM]LQVK.3|VEDLTFTSPFC[CAM]LQVK.2|VVLDVGSGTGILC[CAM]MFAAK.3|VVLDVGSGTGILC[CAM]M[Oxi]FAAK.2|VVLDVGSGTGILC[CAM]MFAAK.2|TGEEIFGTIGMR.2|DKVVLDVGSGTGILC[CAM]MFAAK.3|DKVVLDVGSGTGILC[CAM]MFAAK.2|DYYFDSYAHFGIHEEMLKDEVR.4|IHWWENVYGFDMSC[CAM]IK.3|IHWWENVYGFDM[Oxi]SC[CAM]IK.3|IHWWENVYGFDMSC[CAM]IK.2|NDYVHALVAYFNIEFTR.3|QLVTNAC[CAM]LIKEVDIYTVK.3|WLAPDGLIFPDR.2|RNDYVHALVAYFNIEFTR.3|DYYFDSYAHFGIHEEMLK.3|GQLC[CAM]ELSC[CAM]STDYR.2|QTVFYMEDYLTVK.2|VIGIEC[CAM]SSISDYAVK.2|WLAPDGLIFPDRATLYVTAIEDR.3|EVDIYTVKVEDLTFTSPFC[CAM]LQVK.3
SEN / CTL,C-type mannose receptor 2,MRC2,Q9UBG0,-0.36,0.33,2.04E-02,9.56E-03,2.02E+00,"osteoblast differentiation,endocytosis,signal transduction,collagen catabolic process","transmembrane signaling receptor activity,protein binding,collagen binding,carbohydrate binding","integral component of plasma membrane,focal adhesion,membrane",12,30,39,TLGDQLSLLLGAR.2|DC[CAM]SIALPYVC[CAM]K.2|GAWLGMNFNPK.2|WSDGVGFSYHNFDR.3|WSDGVGFSYHNFDR.2|FFEHHSTWAQAQR.4|FFEHHSTWAQAQR.3|FFEHHSTWAQAQR.2|AGQLSQGAAEEDHGC[CAM]RK.4|C[CAM]VYMTASR.2|GTDVREPDDSPQGR.3|GTDVREPDDSPQGR.2|SC[CAM]TEETHGFIC[CAM]QK.3|SC[CAM]TEETHGFIC[CAM]QK.2|TPLWIGLAGEEGSRR.3|TESSGGWQNR.2|AGQLSQGAAEEDHGC[CAM]R.3|LC[CAM]TDHGSQLVTITNR.3|YDNQWFHGC[CAM]TSTGR.3|YDNQWFHGC[CAM]TSTGR.2|KAGQLSQGAAEEDHGC[CAM]R.3|RISYHGSC[CAM]PQGLADSAWIPFR.4|C[CAM]LTALPYIC[CAM]K.2|KAGQLSQGAAEEDHGC[CAM]RK.3|IFGESEPEIHEQHWFWIGLNR.4|IFGESEPEIHEQHWFWIGLNR.3|VEC[CAM]EPSWQPFQGHC[CAM]YR.3|C[CAM]FQVQGQEPQSR.2|TPLWIGLAGEEGSR.2|ISYHGSC[CAM]PQGLADSAWIPFR.3|ISYHGSC[CAM]PQGLADSAWIPFR.2|IYGSEEDLC[CAM]ALPYHEVYTIQGNSHGKPC[CAM]TIPFK.5|LQGAVC[CAM]GVSSGPPPPR.2|IC[CAM]TWFQAELTSVHSQAELDFLSHNLQK.4|IC[CAM]TWFQAELTSVHSQAELDFLSHNLQK.3|YLNWESDQPDNPSEENC[CAM]GVIR.3|DSLEDC[CAM]VTIWGPEGR.2|ETQPPDLPTTALGGC[CAM]PSDWIQFLNK.3|GWTWHSPSC[CAM]YWLGEDQVTYSEAR.3
SEN / CTL,Prefoldin subunit 4,PFDN4,Q9NQP4,-0.36,0.50,7.27E-02,2.74E-02,1.56E+00,protein folding,"protein binding,unfolded protein binding,chaperone binding","nucleus,cytoplasm,mitochondrion,cytosol,prefoldin complex",9,7,10,ITELKEEIEVK.3|ITELKEEIEVK.2|NLQEEIDALESR.2|NLQEEIDALESR.3|KAAAEDVNVTFEDQQK.3|KAAAEDVNVTFEDQQK.2|AAAEDVNVTFEDQQKINKFAR.4|FGSNINLEADES.2|KNLQEEIDALESR.2|AAAEDVNVTFEDQQK.2
SEN / CTL,Sulfhydryl oxidase 1,QSOX1,O00391,-0.36,0.79,1.00E-01,3.58E-02,1.45E+00,"platelet degranulation,negative regulation of macroautophagy,cell redox homeostasis,oxidation-reduction process","protein disulfide isomerase activity,flavin-linked sulfhydryl oxidase activity","extracellular region,extracellular space,Golgi apparatus,integral component of Golgi membrane,platelet alpha granule lumen,intracellular membrane-bounded organelle,intercellular bridge,extracellular exosome",51,23,29,DFNIPGFPTVR.2|VGSPNAAVLWLWSSHNR.3|SFYTAYLQR.2|NNEEYLALIFEK.2|KFGVTDFPSC[CAM]YLLFR.3|FGVTDFPSC[CAM]YLLFR.2|LAGAPSEDPQFPK.2|GYVHYFFGC[CAM]R.3|DC[CAM]ASHFEQMAAASMHR.4|DC[CAM]ASHFEQMAAASMHR.3|DC[CAM]ASHFEQMAAASM[Oxi]HR.3|AWRPALYLAALDC[CAM]AEETNSAVC[CAM]R.3|AWRPALYLAALDC[CAM]AEETNSAVC[CAM]R.4|SALYSPSDPLTLLQADTVR.3|SALYSPSDPLTLLQADTVR.2|AHFSPSNIILDFPAAGSAAR.3|AHFSPSNIILDFPAAGSAAR.4|AHFSPSNIILDFPAAGSAAR.2|NGSGAVFPVAGADVQTLR.2|VLNTEANVVR.2|VPVLMESR.2|ELC[CAM]SAC[CAM]HNER.3|KVNWIGC[CAM]QGSEPHFR.4|DTGAALLAESR.2|LEEIDGFFAR.2|RVLNTEANVVR.2|DVQNVAAAPELAMGALELESR.3|AAPGQEPPEHMAELQR.2|LDVPVWDVEATLNFLK.2
SEN / CTL,Glutathione S-transferase P,GSTP1,P09211,-0.37,0.63,5.41E-04,4.45E-04,3.35E+00,"response to reactive oxygen species,negative regulation of acute inflammatory response,negative regulation of protein kinase activity,glutathione metabolic process,xenobiotic metabolic process,central nervous system development,negative regulation of biosynthetic process,negative regulation of tumor necrosis factor-mediated signaling pathway,oligodendrocyte development,animal organ regeneration,response to estradiol,negative regulation of interleukin-1 beta production,negative regulation of tumor necrosis factor production,cellular response to insulin stimulus,regulation of stress-activated MAPK cascade,negative regulation of stress-activated MAPK cascade,positive regulation of superoxide anion generation,response to L-ascorbic acid,common myeloid progenitor cell proliferation,nitric oxide storage,negative regulation of apoptotic process,negative regulation of I-kappaB kinase/NF-kappaB signaling,response to amino acid,negative regulation of MAP kinase activity,negative regulation of MAPK cascade,negative regulation of JUN kinase activity,linoleic acid metabolic process,response to ethanol,negative regulation of fibroblast proliferation,negative regulation of nitric-oxide synthase biosynthetic process,regulation of ERK1 and ERK2 cascade,negative regulation of ERK1 and ERK2 cascade,negative regulation of leukocyte proliferation,cellular response to lipopolysaccharide,cellular response to epidermal growth factor stimulus,cellular response to glucocorticoid stimulus,cellular response to cell-matrix adhesion,negative regulation of monocyte chemotactic protein-1 production,negative regulation of smooth muscle cell chemotaxis,cellular oxidant detoxification,glutathione derivative biosynthetic process,negative regulation of vascular smooth muscle cell proliferation,negative regulation of extrinsic apoptotic signaling pathway","glutathione transferase activity,glutathione peroxidase activity,protein binding,drug binding,JUN kinase binding,kinase regulator activity,S-nitrosoglutathione binding,dinitrosyl-iron complex binding,glutathione binding,nitric oxide binding","extracellular space,intracellular,nucleus,cytoplasm,mitochondrion,cytosol,plasma membrane,vesicle,extracellular exosome,TRAF2-GSTP1 complex",48,20,44,ALPGQLKPFETLLSQNQGGK.3|ALPGQLKPFETLLSQNQGGK.2|ALPGQLKPFETLLSQNQGGK.4|FQDGDLTLYQSNTILR.2|FQDGDLTLYQSNTILR.3|PPYTVVYFPVR.2|PPYTVVYFPVR.3|TLGLYGKDQQEAALVDMVNDGVEDLRC[CAM]K.4|ASC[CAM]LYGQLPK.2|TLGLYGKDQQEAALVDMVNDGVEDLR.3|TLGLYGKDQQEAALVDMVNDGVEDLR.4|TLGLYGKDQQEAALVDM[Oxi]VNDGVEDLR.3|MLLADQGQSWKEEVVTVETWQEGSLK.3|MLLADQGQSWKEEVVTVETWQEGSLK.4|M[Oxi]LLADQGQSWKEEVVTVETWQEGSLK.3|DQQEAALVDMVNDGVEDLR.3|DQQEAALVDMVNDGVEDLR.2|DQQEAALVDMVNDGVEDLR.4|DQQEAALVDM[Oxi]VNDGVEDLR.3|DQQEAALVDM[Oxi]VNDGVEDLR.2|MPPYTVVYFPVR.3|M[Oxi]PPYTVVYFPVR.3|MPPYTVVYFPVR.2|M[Oxi]PPYTVVYFPVR.2|MLLADQGQSWK.3|MLLADQGQSWK.2|M[Oxi]LLADQGQSWK.2|YISLIYTNYEAGKDDYVK.4|YISLIYTNYEAGKDDYVK.3|YISLIYTNYEAGKDDYVK.2|EEVVTVETWQEGSLK.3|EEVVTVETWQEGSLK.2|AFLASPEYVNLPINGNGK.3|AFLASPEYVNLPINGNGK.2|AFLASPEYVNLPINGNGKQ.3|AFLASPEYVNLPINGNGKQ.2|PFETLLSQNQGGK.2|LKAFLASPEYVNLPINGNGK.3|ASC[CAM]LYGQLPKFQDGDLTLYQSNTILR.4|ASC[CAM]LYGQLPKFQDGDLTLYQSNTILR.3|LKAFLASPEYVNLPINGNGKQ.3|LKAFLASPEYVNLPINGNGKQ.2|YISLIYTNYEAGK.2|DQQEAALVDMVNDGVEDLRC[CAM]K.3
SEN / CTL,Enolase-phosphatase E1,ENOPH1,Q9UHY7,-0.38,0.34,1.36E-02,6.82E-03,2.17E+00,"dephosphorylation,L-methionine biosynthetic process from methylthioadenosine","magnesium ion binding,acireductone synthase activity","nucleus,cytosol,extracellular exosome",9,11,14,LLFGHSTEGDILELVDGHFDTK.4|LLFGHSTEGDILELVDGHFDTK.3|VYIYSSGSVEAQK.2|IADSIGC[CAM]STNNILFLTDVTR.3|IADSIGC[CAM]STNNILFLTDVTR.2|AEFFADVVPAVRK.3|AEFFADVVPAVRK.2|MKAEFFADVVPAVR.3|PGNAGLTDDEK.2|AEFFADVVPAVR.2|EYLQTHWEEEEC[CAM]QQDVSLLRK.4|DILFPYIEENVK.2|KIADSIGC[CAM]STNNILFLTDVTR.3|EYLQTHWEEEEC[CAM]QQDVSLLR.3
SEN / CTL,Ubiquitin carboxyl-terminal hydrolase isozyme L3,UCHL3,P15374,-0.38,0.36,7.04E-03,4.00E-03,2.40E+00,"ubiquitin-dependent protein catabolic process,protein deubiquitination,protein catabolic process","thiol-dependent ubiquitin-specific protease activity,peptidase activity,ubiquitin binding","nucleus,cytoplasm,extracellular exosome",12,15,26,FLEESVSMSPEER.2|FLEESVSM[Oxi]SPEER.2|SQGQDVTSSVYFMK.2|SQGQDVTSSVYFM[Oxi]K.2|YLENYDAIR.2|WLPLEANPEVTNQFLK.2|WLPLEANPEVTNQFLK.3|MHFESGSTLKK.3|FNAIALSAA.2|KFMERDPDELR.3|PVC[CAM]AVLLLFPITEK.3|PVC[CAM]AVLLLFPITEK.2|VTHETSAHEGQTEAPSIDEK.4|VTHETSAHEGQTEAPSIDEK.3|VTHETSAHEGQTEAPSIDEK.2|KFLEESVSMSPEER.3|KFLEESVSMSPEER.2|KPFPINHGETSDETLLEDAIEVC[CAM]KK.5|KPFPINHGETSDETLLEDAIEVC[CAM]KK.4|KPFPINHGETSDETLLEDAIEVC[CAM]KK.3|MHFESGSTLK.2|KPFPINHGETSDETLLEDAIEVC[CAM]K.4|KPFPINHGETSDETLLEDAIEVC[CAM]K.3|QTISNAC[CAM]GTIGLIHAIANNK.3|QTISNAC[CAM]GTIGLIHAIANNK.2|QTISNAC[CAM]GTIGLIHAIANNKDK.3
SEN / CTL,Proteasome subunit alpha type-3,PSMA3,P25788,-0.38,1.23,3.30E-02,1.43E-02,1.85E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,viral process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,regulation of endopeptidase activity,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","threonine-type endopeptidase activity,protein binding","proteasome complex,nucleus,nucleoplasm,cytoplasm,cytosol,proteasome core complex,proteasome core complex, alpha-subunit complex,extracellular exosome",24,15,25,AVENSSTAIGIR.2|LFNVDRHVGMAVAGLLADAR.4|VFQVEYAMK.2|VFQVEYAM[Oxi]K.2|SLADIAREEASNFR.3|SLADIAREEASNFR.2|SNFGYNIPLK.2|HVGMAVAGLLADAR.3|HVGMAVAGLLADAR.2|HVGM[Oxi]AVAGLLADAR.3|HVGM[Oxi]AVAGLLADAR.2|C[CAM]KDGVVFGVEK.3|C[CAM]KDGVVFGVEK.2|IIYIVHDEVK.3|IIYIVHDEVK.2|DIREEAEKYAK.3|DIREEAEKYAK.2|RLFNVDR.2|DGVVFGVEK.2|IIYIVHDEVKDK.3|IIYIVHDEVKDK.2|LYEEGSNKR.2|AFELELSWVGELTNGRHEIVPK.4|AFELELSWVGELTNGRHEIVPK.3|AFELELSWVGELTNGR.2
SEN / CTL,Ribonuclease T2,RNASET2,O00584,-0.38,0.89,2.23E-02,1.04E-02,1.98E+00,"RNA catabolic process,RNA phosphodiester bond hydrolysis, endonucleolytic","RNA binding,ribonuclease activity,ribonuclease T2 activity","extracellular region,extracellular space,lysosome,endoplasmic reticulum lumen,lysosomal lumen,extracellular exosome",33,17,29,SWPFNLEEIKDLLPEMR.3|ELDLNSVLLK.2|LGIKPSINYYQVADFKDALAR.4|SLELYRELDLNSVLLK.3|KLIMVQHWPETVC[CAM]EK.4|KLIMVQHWPETVC[CAM]EK.3|KLIMVQHWPETVC[CAM]EK.2|LIMVQHWPETVC[CAM]EK.3|LIMVQHWPETVC[CAM]EK.2|LIM[Oxi]VQHWPETVC[CAM]EK.3|HGTC[CAM]AAQVDALNSQK.3|HGTC[CAM]AAQVDALNSQK.2|VC[CAM]EDGPVFYPPPKK.3|VC[CAM]EDGPVFYPPPKK.4|LGIKPSINYYQVADFK.3|LGIKPSINYYQVADFK.4|LGIKPSINYYQVADFK.2|HGTC[CAM]AAQVDALNSQKK.4|HGTC[CAM]AAQVDALNSQKK.3|HGTC[CAM]AAQVDALNSQKK.2|DPPDYWTIHGLWPDK.3|DPPDYWTIHGLWPDK.2|SWPFNLEEIK.2|IQNDC[CAM]RDPPDYWTIHGLWPDK.4|IQNDC[CAM]RDPPDYWTIHGLWPDK.3|PSINYYQVADFK.2|QEVWLANGAAESR.2|VC[CAM]EDGPVFYPPPK.2|IQC[CAM]LPPSQDEEVQTIGQIELC[CAM]LTK.3
SEN / CTL,EGF-like repeat and discoidin I-like domain-containing protein 3,EDIL3,O43854,-0.38,0.46,4.76E-03,2.86E-03,2.54E+00,"cell adhesion,multicellular organism development,positive regulation of cell-substrate adhesion","integrin binding,calcium ion binding","extracellular matrix,extracellular exosome,extracellular vesicle",15,11,13,SGHIQDYQITASSIFR.3|SGHIQDYQITASSIFR.2|GNIDNNTPYANSFTPPIK.2|DFGHVQFVGSYK.3|DFGHVQFVGSYK.2|NVIDPPIYAR.2|VTGIITQGAK.2|VFQGNFDNDTHRK.3|SELLGC[CAM]TEEE.2|LAYSNDGEHWTVYQDEK.3|C[CAM]SGPLGIEGGIISNQQITASSTHR.3|VNAWTSGHNDQSQWLQVDLLVPTK.3|GLINAWTAAENDRWPWIQINLQR.3
SEN / CTL,Protein disulfide-isomerase A4,PDIA4,P13667,-0.38,1.14,8.41E-03,4.65E-03,2.33E+00,"protein folding,protein secretion,response to endoplasmic reticulum stress,cell redox homeostasis,chaperone-mediated protein folding","protein disulfide isomerase activity,protein binding,poly(A) RNA binding","endoplasmic reticulum lumen,cell surface,melanosome",60,69,125,FDVSGYPTIK.2|FDVSGYPTLK.2|IANILKDKDPPIPVAK.4|IANILKDKDPPIPVAK.3|IDATSASVLASR.2|VDATAETDLAK.2|SPPIPLAK.2|RFDVSGYPTLK.3|RFDVSGYPTLK.2|QLEPVYNSLAK.2|FAMEPEEFDSDTLREFVTAFKK.4|FAM[Oxi]EPEEFDSDTLREFVTAFKK.4|KGQAVDYEGSRTQEEIVAK.4|KGQAVDYEGSRTQEEIVAK.3|VSQGQLVVMQPEK.2|VSQGQLVVMQPEK.3|VSQGQLVVM[Oxi]QPEK.2|YGIVDYMIEQSGPPSKEILTLK.3|YGIVDYMIEQSGPPSKEILTLK.4|VDATAETDLAKR.3|VDATAETDLAKR.2|EVSQPDWTPPPEVTLVLTK.3|EVSQPDWTPPPEVTLVLTK.4|EVSQPDWTPPPEVTLVLTK.2|SHMMDVQGSTQDSAIKDFVLK.4|SHM[Oxi]M[Oxi]DVQGSTQDSAIKDFVLK.4|SHM[Oxi]MDVQGSTQDSAIKDFVLK.4|SHMM[Oxi]DVQGSTQDSAIKDFVLK.4|SHM[Oxi]M[Oxi]DVQGSTQDSAIKDFVLK.3|SHM[Oxi]MDVQGSTQDSAIKDFVLK.3|SHMMDVQGSTQDSAIKDFVLK.3|GQAVDYEGSRTQEEIVAK.3|YGIVDYMIEQSGPPSK.3|YGIVDYMIEQSGPPSK.2|YGIVDYM[Oxi]IEQSGPPSK.2|VREVSQPDWTPPPEVTLVLTK.3|VREVSQPDWTPPPEVTLVLTK.4|VREVSQPDWTPPPEVTLVLTK.2|KGQAVDYEGSR.3|KGQAVDYEGSR.2|DLEHLSK.2|LAPEYEK.2|TFDSIVMDPKK.3|TFDSIVMDPKK.2|AATQFWR.2|FHHTFSTEIAK.3|FHHTFSTEIAK.2|QVQEFLK.2|TQEEIVAK.2|FIEEHATK.2|KLAPEYEK.2|RSPPIPLAK.2|KDVLIEFYAPWC[CAM]GHC[CAM]K.4|KDVLIEFYAPWC[CAM]GHC[CAM]K.3|KDVLIEFYAPWC[CAM]GHC[CAM]K.2|QFAPEYEK.2|EKYGIVDYMIEQSGPPSK.4|EKYGIVDYMIEQSGPPSK.3|EKYGIVDYMIEQSGPPSK.2|YALPLVGHR.2|YKVEGFPTIYFAPSGDKK.4|YKVEGFPTIYFAPSGDKK.3|YKVEGFPTIYFAPSGDKK.2|MDATANDVPSDRYK.3|M[Oxi]DATANDVPSDRYK.3|DKDPPIPVAK.2|GQAVDYEGSR.2|VEGFPTIYFAPSGDK.3|VEGFPTIYFAPSGDK.2|VEGFPTIYFAPSGDKKNPVK.4|DLGLSESGEDVNAAILDESGKK.4|DLGLSESGEDVNAAILDESGKK.3|DLGLSESGEDVNAAILDESGKK.2|FAMEPEEFDSDTLR.3|FAMEPEEFDSDTLR.2|FAM[Oxi]EPEEFDSDTLR.2|SHMMDVQGSTQDSAIK.3|SHM[Oxi]MDVQGSTQDSAIK.3|SHMM[Oxi]DVQGSTQDSAIK.3|SHM[Oxi]M[Oxi]DVQGSTQDSAIK.3|SHMM[Oxi]DVQGSTQDSAIK.2|SHMMDVQGSTQDSAIK.2|TFDSIVMDPK.2|TFDSIVM[Oxi]DPK.2|VEGFPTIYFAPSGDKK.3|VEGFPTIYFAPSGDKK.2|GRPYDYNGPR.2|KFAMEPEEFDSDTLR.3|KFAM[Oxi]EPEEFDSDTLR.3|KFAMEPEEFDSDTLR.2|EDYKFHHTFSTEIAK.3|EDYKFHHTFSTEIAK.2|FAMEPEEFDSDTLREFVTAFK.4|FAM[Oxi]EPEEFDSDTLREFVTAFK.3|FAMEPEEFDSDTLREFVTAFK.3|DVLIEFYAPWC[CAM]GHC[CAM]K.3|DVLIEFYAPWC[CAM]GHC[CAM]K.2|TFDSIVMDPKKDVLIEFYAPWC[CAM]GHC[CAM]K.5|TFDSIVMDPKKDVLIEFYAPWC[CAM]GHC[CAM]K.4|DGDDVIIIGVFK.2|MDATANDVPSDR.2|M[Oxi]DATANDVPSDR.2|VSQGQLVVMQPEKFQSK.3|YKVEGFPTIYFAPSGDK.3|YKVEGFPTIYFAPSGDK.2|KFAMEPEEFDSDTLREFVTAFK.4|DTVLLEFYAPWC[CAM]GHC[CAM]K.3|DTVLLEFYAPWC[CAM]GHC[CAM]K.2|GESDPAYQQYQDAANNLR.3|GESDPAYQQYQDAANNLR.2|DLGLSESGEDVNAAILDESGK.3|DLGLSESGEDVNAAILDESGK.2|QVQEFLKDGDDVIIIGVFK.3|QVQEFLKDGDDVIIIGVFK.2|FEGGDRDLEHLSK.2|IDATSASVLASRFDVSGYPTIK.3|DFPEYTFAIADEEDYAGEVK.3|DFPEYTFAIADEEDYAGEVK.2|GESDPAYQQYQDAANNLREDYK.3|EKYGIVDYMIEQSGPPSKEILTLK.3|DGDDVIIIGVFKGESDPAYQQYQDAANNLREDYK.4|VLEVAKDFPEYTFAIADEEDYAGEVK.3|ENAIEDEEEEEEEDDDEEEDDLEVK.3|ENFDEVVNDADIILVEFYAPWC[CAM]GHC[CAM]K.3|EENGVLVLNDANFDNFVADK.2
SEN / CTL,14-3-3 protein epsilon,YWHAE,P62258,-0.38,1.20,6.99E-03,3.98E-03,2.40E+00,"G2/M transition of mitotic cell cycle,neuron migration,regulation of heart rate by hormone,protein targeting,viral process,substantia nigra development,hippocampus development,cerebral cortex development,hippo signaling,intracellular signal transduction,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,regulation of membrane repolarization,membrane organization,membrane repolarization during cardiac muscle cell action potential,regulation of heart rate by cardiac conduction,cell-cell adhesion,regulation of cellular response to heat,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,regulation of potassium ion transmembrane transporter activity,negative regulation of peptidyl-serine dephosphorylation","protein binding,potassium channel regulator activity,enzyme binding,protein domain specific binding,MHC class II protein complex binding,ubiquitin protein ligase binding,histone deacetylase binding,ion channel binding,poly(A) RNA binding,protein heterodimerization activity,phosphoserine binding,phosphoprotein binding,cadherin binding involved in cell-cell adhesion","mitochondrion,cytosol,kinesin complex,cell-cell adherens junction,focal adhesion,membrane,axon,cytoplasmic vesicle membrane,melanosome,extracellular exosome",90,36,102,LIC[CAM]C[CAM]DILDVLDKHLIPAANTGESK.4|LIC[CAM]C[CAM]DILDVLDKHLIPAANTGESK.3|QM[Oxi]VETELKLIC[CAM]C[CAM]DILDVLDKHLIPAANTGESK.5|QMVETELKLIC[CAM]C[CAM]DILDVLDKHLIPAANTGESK.5|QM[Oxi]VETELKLIC[CAM]C[CAM]DILDVLDKHLIPAANTGESK.4|QMVETELKLIC[CAM]C[CAM]DILDVLDKHLIPAANTGESK.4|YLAEFATGNDRKEAAENSLVAYK.4|YLAEFATGNDRKEAAENSLVAYK.3|EAAENSLVAYK.2|AAFDDAIAELDTLSEESYKDSTLIMQLLR.3|AAFDDAIAELDTLSEESYKDSTLIMQLLR.4|YLAEFATGNDR.2|AASDIAMTELPPTHPIR.3|AASDIAMTELPPTHPIR.4|AASDIAMTELPPTHPIR.2|AASDIAM[Oxi]TELPPTHPIR.2|AASDIAM[Oxi]TELPPTHPIR.4|AASDIAM[Oxi]TELPPTHPIR.3|YLAEFATGNDRK.3|YLAEFATGNDRK.2|LIC[CAM]C[CAM]DILDVLDK.2|LIC[CAM]C[CAM]DILDVLDK.3|NLLSVAYKNVIGAR.3|NLLSVAYKNVIGAR.2|LGLALNFSVFYYEILNSPDR.3|LGLALNFSVFYYEILNSPDR.2|LIC[CAM]C[CAM]DILDVLDKHLIPAANTGESKVFYYK.5|LIC[CAM]C[CAM]DILDVLDKHLIPAANTGESKVFYYK.4|KVAGMDVELTVEER.3|KVAGMDVELTVEER.2|KVAGM[Oxi]DVELTVEER.3|KVAGM[Oxi]DVELTVEER.2|VAGMDVELTVEER.2|VAGM[Oxi]DVELTVEER.3|VAGM[Oxi]DVELTVEER.2|LAEQAERYDEMVESMKK.4|LAEQAERYDEMVESMKK.3|LAEQAERYDEM[Oxi]VESM[Oxi]KK.4|LAEQAERYDEM[Oxi]VESMKK.4|LAEQAERYDEMVESM[Oxi]KK.4|LAEQAERYDEM[Oxi]VESMKK.3|LAEQAERYDEMVESM[Oxi]KK.3|LAEQAERYDEM[Oxi]VESM[Oxi]KK.3|LAEQAERYDEM[Oxi]VESMKK.2|LAEQAERYDEMVESM[Oxi]KK.2|LAEQAERYDEMVESMKK.2|LAEQAERYDEMVESMK.3|LAEQAERYDEMVESMK.2|LAEQAERYDEM[Oxi]VESM[Oxi]K.3|LAEQAERYDEM[Oxi]VESMK.3|LAEQAERYDEMVESM[Oxi]K.3|LAEQAERYDEM[Oxi]VESM[Oxi]K.2|LAEQAERYDEM[Oxi]VESMK.2|LAEQAERYDEMVESM[Oxi]K.2|AAFDDAIAELDTLSEESYK.3|AAFDDAIAELDTLSEESYK.2|QMVETELK.2|QM[Oxi]VETELK.2|QMVETELK.1|HLIPAANTGESK.3|HLIPAANTGESK.2|EENKGGEDKLK.3|EENKGGEDKLK.2|YDEMVESMKK.3|YDEM[Oxi]VESMKK.3|YDEMVESM[Oxi]KK.3|YDEM[Oxi]VESM[Oxi]KK.3|YDEMVESMKK.2|YDEM[Oxi]VESMKK.2|YDEMVESM[Oxi]KK.2|YDEM[Oxi]VESM[Oxi]KK.2|KEAAENSLVAYK.3|KEAAENSLVAYK.2|IISSIEQK.2|IISSIEQKEENK.3|IISSIEQKEENK.2|IISSIEQKEENKGGEDK.4|IISSIEQKEENKGGEDK.3|IISSIEQKEENKGGEDK.2|EDLVYQAK.2|EDLVYQAK.1|NLLSVAYKNVIGARR.3|YDEMVESMK.2|YDEM[Oxi]VESMK.2|YDEMVESM[Oxi]K.2|YDEM[Oxi]VESM[Oxi]K.2|EALQDVEDENQ.2|HLIPAANTGESKVFYYK.3|DDREDLVYQAK.2|DNLTLWTSDM[Oxi]QGDGEEQNK.3|DNLTLWTSDMQGDGEEQNK.3|DNLTLWTSDM[Oxi]QGDGEEQNK.2|DNLTLWTSDMQGDGEEQNK.2|VAGM[Oxi]DVELTVEERNLLSVAYKNVIGAR.4|VAGMDVELTVEERNLLSVAYKNVIGAR.4|VAGMDVELTVEERNLLSVAYKNVIGAR.3|LAKAAFDDAIAELDTLSEESYK.3|QMVETELKLIC[CAM]C[CAM]DILDVLDK.3|DNLTLWTSDMQGDGEEQNKEALQDVEDENQ.4|DNLTLWTSDM[Oxi]QGDGEEQNKEALQDVEDENQ.4|DNLTLWTSDM[Oxi]QGDGEEQNKEALQDVEDENQ.3|DNLTLWTSDMQGDGEEQNKEALQDVEDENQ.3
SEN / CTL,Gamma-glutamyl hydrolase,GGH,Q92820,-0.39,0.21,1.34E-12,6.70E-12,1.12E+01,"proteolysis,glutamine metabolic process,response to zinc ion,response to insulin,response to drug,response to ethanol,tetrahydrofolylpolyglutamate metabolic process","exopeptidase activity,omega peptidase activity,gamma-glutamyl-peptidase activity","extracellular space,nucleus,lysosome,vacuole,cytosol,melanosome,extracellular exosome",30,19,26,YYIAASYVK.2|SINGILFPGGSVDLRR.3|VVPVRLDLTEKDYEILFK.4|TAFYLAEFFVNEAR.3|TAFYLAEFFVNEAR.2|SINGILFPGGSVDLR.2|SINGILFPGGSVDLR.3|MFQNFPTELLLSLAVEPLTANFHK.3|M[Oxi]FQNFPTELLLSLAVEPLTANFHK.3|LDLTEKDYEILFK.3|LDLTEKDYEILFK.2|YLESAGAR.2|NLDGISHAPNAVK.3|NLDGISHAPNAVK.2|DYEILFK.2|DYEILFK.1|YPVYGVQWHPEK.3|YPVYGVQWHPEK.2|APYEWKNLDGISHAPNAVK.4|KPIIGILMQK.2|TAFYLAEFFVNEARK.3|VVPVRLDLTEK.2|IEFISTMEGYK.2|FFNVLTTNTDGK.2|IEFISTMEGYKYPVYGVQWHPEK.4|FFNVLTTNTDGKIEFISTMEGYKYPVYGVQWHPEK.5
SEN / CTL,60 kDa SS-A/Ro ribonucleoprotein,TROVE2,P10155,-0.39,0.66,1.68E-02,8.18E-03,2.09E+00,"immune system development,transcription from RNA polymerase III promoter,smoothened signaling pathway,response to UV,cilium morphogenesis","RNA binding,U2 snRNA binding,metal ion binding","nucleus,cytoplasm,intracellular ribonucleoprotein complex",24,27,39,LGLENAEALIR.2|ALLQEMPLTALLR.2|ALLQEMPLTALLR.3|ALLQEM[Oxi]PLTALLR.2|LIEDGRGC[CAM]EVIQEIK.3|LIEDGRGC[CAM]EVIQEIK.2|FLC[CAM]FGSEGGTYYIK.2|VLGSILNASTVAAAMC[CAM]MVVTR.3|VLGSILNASTVAAAMC[CAM]M[Oxi]VVTR.3|TRDELEVIHLIEEHR.4|TRDELEVIHLIEEHR.3|LSHLKPSSEGLAIVTK.4|LSHLKPSSEGLAIVTK.3|LSHLKPSSEGLAIVTK.2|YLEAVEK.2|GWKEVHELYK.3|ALSVETEK.2|ALDAAFYK.2|IPTHLFTFIQFK.3|IPTHLFTFIQFK.2|GGMALALAVTK.2|GGM[Oxi]ALALAVTK.2|RTRDELEVIHLIEEHR.4|GC[CAM]EVIQEIK.2|DELEVIHLIEEHR.3|EHLLTNHLK.2|PSSEGLAIVTK.2|AIADWYNEK.2|IHPFHILIALETYK.3|WRPDEEILK.2|GMLDMC[CAM]GFDTGALDVIR.3|GMLDMC[CAM]GFDTGALDVIR.2|MTANSVLEPGNSEVSLVC[CAM]EK.3|MTANSVLEPGNSEVSLVC[CAM]EK.2|TNTPADVFIVFTDNETFAGGVHPAIALR.4|TNTPADVFIVFTDNETFAGGVHPAIALR.3|QEPMLFALAIC[CAM]SQC[CAM]SDISTK.3|TTKQEPMLFALAIC[CAM]SQC[CAM]SDISTK.3|QIANSQDGYVWQVTDMNR.2
SEN / CTL,Kynurenine--oxoglutarate transaminase 3,CCBL2,Q6YP21,-0.39,0.25,1.21E-02,6.24E-03,2.21E+00,"2-oxoglutarate metabolic process,cellular amino acid metabolic process,biosynthetic process,kynurenine metabolic process,L-kynurenine metabolic process","kynurenine-oxoglutarate transaminase activity,pyridoxal phosphate binding,protein homodimerization activity,poly(A) RNA binding,kynurenine-glyoxylate transaminase activity,cysteine-S-conjugate beta-lyase activity",mitochondrion,6,19,24,IAAIDSLNQYTR.2|MAGATPVFIPLR.2|M[Oxi]AGATPVFIPLR.2|LGWSIGPNHLIK.3|LGWSIGPNHLIK.2|AIILNTPHNPLGK.3|AIILNTPHNPLGK.2|KDSTLDAAEEIIK.3|ALSYLYEK.2|NNEPYDYK.2|KLSAIPVSAFC[CAM]NSETK.3|KLSAIPVSAFC[CAM]NSETK.2|RMDDPEC[CAM]YFNSLPK.3|IATFPGMWER.2|RIEGLDSNVWIEFTK.3|DSTLDAAEEIIK.2|RWSSSDWTLDPQELESK.3|LSAIPVSAFC[CAM]NSETK.2|IEGLDSNVWIEFTK.2|LAADPSVVNLGQGFPDISPPTYVK.3|HLQTVQQNTIYTC[CAM]ATPLQEALAQAFWIDIK.4|HLQTVQQNTIYTC[CAM]ATPLQEALAQAFWIDIK.3|WSSSDWTLDPQELESK.2|LAADPSVVNLGQGFPDISPPTYVKEELSK.3
SEN / CTL,Laminin subunit beta-1,LAMB1,P07942,-0.39,0.48,1.47E-12,7.23E-12,1.11E+01,"cell adhesion,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,extracellular matrix organization,positive regulation of cell migration,neuron projection development,substrate adhesion-dependent cell spreading,endodermal cell differentiation,odontogenesis,positive regulation of epithelial cell proliferation","structural molecule activity,extracellular matrix structural constituent","extracellular region,basement membrane,laminin-1 complex,laminin-2 complex,extracellular space,extracellular matrix,laminin-8 complex,laminin-10 complex,perinuclear region of cytoplasm,extracellular exosome",84,76,100,YSDIEPSTEGEVIFR.2|YSDIEPSTEGEVIFR.3|ISGVIGPYRETVDSVER.3|YVVLPRPVC[CAM]FEK.3|SC[CAM]YQDPVTLQLAC[CAM]VC[CAM]DPGYIGSR.3|QYIQDRIPSWTGAGFVR.3|TFRPAAMLIER.3|GIETPQC[CAM]DQSTGQC[CAM]VC[CAM]VEGVEGPR.3|YYYAVYDMVVR.2|IPSWTGAGFVR.2|C[CAM]GGPGC[CAM]GGLVTVAHNAWQK.3|SLDIFTVGGSGDGVVTNSAWETFQR.3|EALEEAEKAQVAAEK.3|LELPQYTSSDSDVESPYTLIDSLVLMPYC[CAM]K.3|ALDPAFKIEDPYSPR.3|ALDPAFKIEDPYSPR.2|C[CAM]GNTIPDDDNQVVSLSPGSR.3|C[CAM]GNTIPDDDNQVVSLSPGSR.2|LHTLGDNLLDSR.3|LHTLGDNLLDSR.2|NFLTQDSADLDSIEAVANEVLK.3|NFLTQDSADLDSIEAVANEVLK.2|VESLSQVEVILQHSAADIAR.3|VESLSQVEVILQHSAADIAR.2|AMDLDQDVLSALAEVEQLSK.3|AM[Oxi]DLDQDVLSALAEVEQLSK.3|AMDLDQDVLSALAEVEQLSK.2|AM[Oxi]DLDQDVLSALAEVEQLSK.2|C[CAM]LAGYYGDPIIGSGDHC[CAM]RPC[CAM]PC[CAM]PDGPDSGR.4|GNC[CAM]FC[CAM]YGHASEC[CAM]APVDGFNEEVEGMVHGHC[CAM]MC[CAM]R.5|GNC[CAM]FC[CAM]YGHASEC[CAM]APVDGFNEEVEGMVHGHC[CAM]MC[CAM]R.4|TC[CAM]SEC[CAM]QELFWGDPDVEC[CAM]R.2|ELAEQLEFIK.2|GALDSITK.2|YLEDKAQELAR.3|YLEDKAQELAR.2|ISELERNVEELKR.4|PFYYQHPER.3|PFYYQHPER.2|LLDELAGK.2|DIRDPNFC[CAM]ER.3|RKAEM[Oxi]LQNEAK.3|KVENLIAK.2|VAVYSTC[CAM]L.2|EALEEAEK.2|ETVDSVER.2|SSDFGKTWGVYR.3|C[CAM]LYHTEGEHC[CAM]QFC[CAM]R.4|C[CAM]LYHTEGEHC[CAM]QFC[CAM]R.3|TLLAQANSK.2|ISGVIGPYR.2|IEDPYSPR.2|LNVEGEHC[CAM]DVC[CAM]K.3|LNVEGEHC[CAM]DVC[CAM]K.2|TPMTDVC[CAM]R.2|KVSEIKDILAQSPAAEPLK.4|KVSEIKDILAQSPAAEPLK.3|LSVTSTC[CAM]GLHKPEPYC[CAM]IVSHLQEDKK.6|LSVTSTC[CAM]GLHKPEPYC[CAM]IVSHLQEDKK.5|LSVTSTC[CAM]GLHKPEPYC[CAM]IVSHLQEDKK.4|QSAEDILLK.2|TLDGELDEK.2|AEMLLEEAK.2|AEM[Oxi]LLEEAK.2|AEMLQNEAK.2|AEM[Oxi]LQNEAK.2|KAAQNSGEAEYIEK.3|KAAQNSGEAEYIEK.2|NC[CAM]EQC[CAM]KPFYYQHPER.4|TLLAQANSKLQLLKDLER.4|TLLAQANSKLQLLKDLER.3|ESQFKEKQEEQAR.3|ESQFKEKQEEQAR.2|VDDIIC[CAM]DSR.2|KAAQNSGEAEYIEKVVYTVK.4|KAAQNSGEAEYIEKVVYTVK.3|FGYYGDALQQDC[CAM]RK.3|KAEMLQNEAK.2|LIKDVTEMMAQVEVK.3|KVDDIIC[CAM]DSR.2|ELDSLQTEAESLDNTVK.3|ELDSLQTEAESLDNTVK.2|DRVEDVMMER.2|NIGNLFEEAEK.2|VSEIKDILAQSPAAEPLK.3|TLDGELDEKYK.2|DILAQSPAAEPLK.2|GLNC[CAM]ELC[CAM]MDFYHDLPWRPAEGR.4|DVTEMMAQVEVK.2|AAQNSGEAEYIEK.2|AAQNSGEAEYIEKVVYTVK.3|YFQMSLEAEER.2|YFAYDC[CAM]EASFPGISTGPMKK.3|ERVESLSQVEVILQHSAADIAR.3|EGFYDLSSEDPFGC[CAM]K.2|PC[CAM]EC[CAM]HLQGSVNAFC[CAM]NPVTGQC[CAM]HC[CAM]FQGVYAR.4|C[CAM]FIC[CAM]NSQDPYHETLNPDSHLIENVVTTFAPNR.4|C[CAM]APGTFGFGPSGC[CAM]KPC[CAM]EC[CAM]HLQGSVNAFC[CAM]NPVTGQC[CAM]HC[CAM]FQGVYAR.5|SC[CAM]AC[CAM]NPLGTIPGGNPC[CAM]DSETGHC[CAM]YC[CAM]K.3|ATGQC[CAM]LC[CAM]LPNVIGQNC[CAM]DR.2
SEN / CTL,Purine nucleoside phosphorylase,PNP,P00491,-0.39,0.39,1.81E-08,4.40E-08,7.36E+00,"nucleobase-containing compound metabolic process,inosine catabolic process,purine nucleotide catabolic process,nicotinamide riboside catabolic process,immune response,NAD biosynthesis via nicotinamide riboside salvage pathway,urate biosynthetic process,positive regulation of T cell proliferation,response to drug,purine-containing compound salvage,positive regulation of alpha-beta T cell differentiation,interleukin-2 secretion","nucleoside binding,purine nucleobase binding,purine-nucleoside phosphorylase activity,drug binding,phosphate ion binding","intracellular,nucleus,cytoplasm,cytosol,cytoskeleton,extracellular exosome",48,26,53,VFGFSLITNK.2|HRPQVAIIC[CAM]GSGLGGLTDKLTQAQIFDYGEIPNFPR.5|HRPQVAIIC[CAM]GSGLGGLTDKLTQAQIFDYGEIPNFPR.4|LVFGFLNGR.2|QAAQKLEQFVSILMASIPLPDKAS.4|QAAQKLEQFVSILMASIPLPDKAS.3|LGADAVGMSTVPEVIVAR.2|LGADAVGMSTVPEVIVAR.3|LGADAVGM[Oxi]STVPEVIVAR.2|FGDRFPAMSDAYDR.3|FGDRFPAMSDAYDR.2|FGDRFPAM[Oxi]SDAYDR.3|LEQFVSILMASIPLPDKAS.3|FEVGDIMLIR.2|FEVGDIM[Oxi]LIR.2|VIMDYESLEK.2|VIM[Oxi]DYESLEK.2|LTQAQIFDYGEIPNFPR.2|LTQAQIFDYGEIPNFPR.4|LTQAQIFDYGEIPNFPR.3|VFHLLGVDTLVVTNAAGGLNPK.3|VFHLLGVDTLVVTNAAGGLNPK.4|VFHLLGVDTLVVTNAAGGLNPK.2|FHMYEGYPLWK.3|FHM[Oxi]YEGYPLWK.3|FHMYEGYPLWK.2|DHINLPGFSGQNPLR.4|DHINLPGFSGQNPLR.3|DHINLPGFSGQNPLR.2|NTAEWLLSHTK.3|NTAEWLLSHTK.2|AC[CAM]VMMQGR.2|AC[CAM]VM[Oxi]MQGR.2|AC[CAM]VM[Oxi]M[Oxi]QGR.2|HRPQVAIIC[CAM]GSGLGGLTDK.4|HRPQVAIIC[CAM]GSGLGGLTDK.3|HRPQVAIIC[CAM]GSGLGGLTDK.2|ANHEEVLAAGK.2|DHINLPGFSGQNPLRGPNDER.4|DHINLPGFSGQNPLRGPNDER.3|FPAMSDAYDR.2|FPAM[Oxi]SDAYDR.2|LEQFVSILM[Oxi]ASIPLPDK.3|LEQFVSILMASIPLPDK.3|LEQFVSILM[Oxi]ASIPLPDK.2|LEQFVSILMASIPLPDK.2|FEVGDIM[Oxi]LIRDHINLPGFSGQNPLRGPNDER.5|FEVGDIMLIRDHINLPGFSGQNPLRGPNDER.5|FEVGDIMLIRDHINLPGFSGQNPLR.4|VTFPVRVFHLLGVDTLVVTNAAGGLNPK.4|VFGFSLITNKVIMDYESLEK.3|QAAQKLEQFVSILMASIPLPDK.3|ELQEGTYVMVAGPSFETVAEC[CAM]R.3
SEN / CTL,Transaldolase,TALDO1,P37837,-0.39,0.89,1.30E-02,6.60E-03,2.18E+00,"carbohydrate metabolic process,xylulose biosynthetic process,fructose 6-phosphate metabolic process,pentose-phosphate shunt,pentose-phosphate shunt, non-oxidative branch","sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,protein binding,monosaccharide binding","nucleus,cytoplasm,cytosol,extracellular exosome",30,31,43,LLGELLQDNAK.2|LLGELLQDNAK.3|LIELYKEAGISKDR.4|NAIDKLFVLFGAEILK.3|AAQASDLEKIHLDEK.4|ALAGC[CAM]DFLTISPK.2|ALAGC[CAM]DFLTISPK.3|SYEPLEDPGVK.2|TIVMGASFR.2|TIVM[Oxi]GASFR.2|WLHNEDQMAVEK.3|WLHNEDQM[Oxi]AVEK.3|WLHNEDQMAVEK.2|KLGGSQEDQIK.3|KLGGSQEDQIK.2|KFAADAVKLER.3|LSFDKDAMVAR.3|LSFDKDAMVAR.2|KFAADAVK.2|ILDWHVANTDK.3|ILDWHVANTDK.2|VSTEVDAR.2|LIELYKEAGISK.3|MFNAENGK.2|LFVLFGAEILKK.3|AAQASDLEK.2|RLIELYK.2|ILDWHVANTDKK.3|ILDWHVANTDKK.2|NAIDKLFVLFGAEILKK.4|NAIDKLFVLFGAEILKK.3|RLIELYKEAGISK.3|MESALDQLK.2|M[Oxi]ESALDQLK.2|LGGSQEDQIK.2|LGGSQEDQIKNAIDK.3|KLGGSQEDQIKNAIDK.3|LFVLFGAEILK.2|LSSTWEGIQAGK.2|QRMESALDQLK.2|LLGELLQDNAKLVPVLSAK.3|LLGELLQDNAKLVPVLSAK.2|QFTTVVADTGDFHAIDEYKPQDATTNPSLILAAAQMPAYQELVEEAIAYGR.5
SEN / CTL,Nucleophosmin,NPM1,P06748,-0.39,0.23,4.35E-11,1.68E-10,9.77E+00,"DNA repair,nucleosome assembly,intracellular protein transport,nucleocytoplasmic transport,response to stress,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,centrosome cycle,signal transduction,cell aging,protein localization,positive regulation of cell proliferation,negative regulation of cell proliferation,negative regulation of centrosome duplication,viral process,regulation of endodeoxyribonuclease activity,CENP-A containing nucleosome assembly,ribosome assembly,negative regulation of apoptotic process,positive regulation of catalytic activity,regulation of neuron apoptotic process,negative regulation of protein kinase activity by regulation of protein phosphorylation,positive regulation of translation,positive regulation of DNA replication,positive regulation of transcription, DNA-templated,regulation of centriole replication,positive regulation of NF-kappaB transcription factor activity,protein oligomerization,protein homooligomerization,regulation of endoribonuclease activity,regulation of eIF2 alpha phosphorylation by dsRNA,positive regulation of cell cycle G2/M phase transition","DNA binding,transcription coactivator activity,RNA binding,protein kinase inhibitor activity,protein binding,phosphatidylinositol-3,4,5-trisphosphate binding,protein kinase binding,Tat protein binding,histone binding,protein homodimerization activity,ribosomal large subunit binding,ribosomal small subunit binding,poly(A) RNA binding,protein heterodimerization activity,NF-kappaB binding,unfolded protein binding","nucleus,nucleoplasm,nucleolus,cytoplasm,centrosome,cytosol,focal adhesion,membrane,intracellular ribonucleoprotein complex,spindle pole centrosome",30,26,61,MSVQPTVSLGGFEITPPVVLR.3|MSVQPTVSLGGFEITPPVVLR.2|M[Oxi]SVQPTVSLGGFEITPPVVLR.3|MSVQPTVSLGGFEITPPVVLR.4|M[Oxi]SVQPTVSLGGFEITPPVVLR.4|M[Oxi]SVQPTVSLGGFEITPPVVLR.2|MTDQEAIQDLWQWR.3|MTDQEAIQDLWQWR.2|M[Oxi]TDQEAIQDLWQWR.3|M[Oxi]TDQEAIQDLWQWR.2|ADKDYHFKVDNDENEHQLSLR.5|ADKDYHFKVDNDENEHQLSLR.4|ADKDYHFKVDNDENEHQLSLR.6|ADKDYHFKVDNDENEHQLSLR.3|MTDQEAIQDLWQWRK.3|M[Oxi]TDQEAIQDLWQWRK.3|MTDQEAIQDLWQWRK.2|TVSLGAGAKDELHIVEAEAMNYEGSPIK.4|TVSLGAGAKDELHIVEAEAMNYEGSPIK.5|TVSLGAGAKDELHIVEAEAM[Oxi]NYEGSPIK.4|TVSLGAGAKDELHIVEAEAM[Oxi]NYEGSPIK.3|TVSLGAGAKDELHIVEAEAMNYEGSPIK.3|MQASIEK.2|M[Oxi]QASIEK.2|SNQNGKDSKPSSTPR.4|SNQNGKDSKPSSTPR.2|SAPGGGSKVPQKK.3|SAPGGGSKVPQKK.2|TPKGPSSVEDIK.3|RSAPGGGSKVPQK.3|SIRDTPAK.2|MQASIEKGGSLPK.3|DYHFKVDNDENEHQLSLR.5|DYHFKVDNDENEHQLSLR.4|DYHFKVDNDENEHQLSLR.3|DYHFKVDNDENEHQLSLR.2|FINYVKNC[CAM]FR.3|GPSSVEDIK.2|DSKPSSTPR.2|TPKGPSSVEDIKAK.3|TPKGPSSVEDIKAK.2|ADKDYHFK.2|VDNDENEHQLSLR.3|VDNDENEHQLSLR.2|DELHIVEAEAMNYEGSPIK.4|DELHIVEAEAM[Oxi]NYEGSPIK.3|DELHIVEAEAMNYEGSPIK.3|DELHIVEAEAM[Oxi]NYEGSPIK.2|DELHIVEAEAMNYEGSPIK.2|SAPGGGSKVPQK.2|GPSSVEDIKAK.2|TVSLGAGAKDELHIVEAEAM[Oxi]NYEGSPIKVTLATLK.6|TVSLGAGAKDELHIVEAEAMNYEGSPIKVTLATLK.6|TVSLGAGAKDELHIVEAEAM[Oxi]NYEGSPIKVTLATLK.5|TVSLGAGAKDELHIVEAEAMNYEGSPIKVTLATLK.5|TVSLGAGAKDELHIVEAEAMNYEGSPIKVTLATLK.4|TVSLGAGAKDELHIVEAEAM[Oxi]NYEGSPIKVTLATLK.4|NAQKSNQNGKDSKPSSTPR.3|PQNYLFGC[CAM]ELK.2|DELHIVEAEAMNYEGSPIKVTLATLK.4|DELHIVEAEAMNYEGSPIKVTLATLK.3
SEN / CTL,UPF0587 protein C1orf123,C1orf123,Q9NWV4,-0.40,0.09,1.26E-02,6.44E-03,2.19E+00,biological_process,molecular_function,extracellular exosome,3,8,11,ATLENITNLRPVGEDFR.3|ATLENITNLRPVGEDFR.4|ATLENITNLRPVGEDFR.2|TIVEFEC[CAM]R.2|C[CAM]GNC[CAM]GEISDK.2|AQESVGIYEVTHQFVK.3|AQESVGIYEVTHQFVK.2|C[CAM]GNC[CAM]GEISDKWQYIR.3|ENSIEILSSTIK.2|PYNAEDNENFK.2|ENSIEILSSTIKPYNAEDNENFK.3
SEN / CTL,Laminin subunit gamma-1,LAMC1,P11047,-0.40,0.39,2.94E-12,1.39E-11,1.09E+01,"protein complex assembly,cell adhesion,endoderm development,cell migration,extracellular matrix disassembly,extracellular matrix organization,hemidesmosome assembly,substrate adhesion-dependent cell spreading,positive regulation of epithelial cell proliferation",extracellular matrix structural constituent,"extracellular region,basement membrane,laminin-1 complex,extracellular space,extracellular matrix,laminin-10 complex,laminin-11 complex,extracellular exosome",72,77,97,LSAEDLVLEGAGLR.2|LSAEDLVLEGAGLR.3|SQEC[CAM]YFDPELYR.2|RC[CAM]ELC[CAM]DDGYFGDPLGR.3|AFDITYVR.2|TREDGPWIPYQYYSGSC[CAM]ENTYSK.3|TLPSGC[CAM]FNTPSIEKP.2|LNTFGDEVFNDPK.2|QDIAVISDSYFPR.2|C[CAM]IYNTAGFYC[CAM]DR.2|NTIEETGNLAEQAR.2|NTIEETGNLAEQAR.3|EAQQALGSAAADATEAK.2|EAQQALGSAAADATEAK.3|DGSEASLEWSSER.2|SYYYAISDFAVGGR.2|SYYYAISDFAVGGR.3|LGNNEAC[CAM]SSC[CAM]HC[CAM]SPVGSLSTQC[CAM]DSYGR.3|DTRLSAEDLVLEGAGLR.3|VSVPLIAQGNSYPSETTVK.2|VSVPLIAQGNSYPSETTVK.3|LHEATDYPWRPALTPFEFQK.4|LHEATDYPWRPALTPFEFQK.3|EAQDVKDVDQNLMDR.3|LC[CAM]QC[CAM]SDNIDPNAVGNC[CAM]NR.2|GKTEQQTADQLLAR.3|GKTEQQTADQLLAR.2|ALAEEAAK.2|HKQEADDIVR.3|HKQEADDIVR.2|YFIAPAKFLGK.3|AHVENTERLIEIASR.4|LIEIASRELEK.3|TAAEEALR.2|SAGYLDDVTLASAR.3|SAGYLDDVTLASAR.2|TKEVVC[CAM]TNC[CAM]PTGTTGKR.4|RDTRLSAEDLVLEGAGLR.4|STGHGGHC[CAM]TNC[CAM]QDNTDGAHC[CAM]ER.5|STGHGGHC[CAM]TNC[CAM]QDNTDGAHC[CAM]ER.4|VSDLENEAK.2|EAQQALGSAAADATEAKNKAHEAER.5|FHTSRPESFAIYK.3|C[CAM]KDGFFGNPLAPNPADKC[CAM]K.4|DTLQEANDILNNLK.3|DTLQEANDILNNLK.2|LQNIRNTIEETGNLAEQAR.4|LQNIRNTIEETGNLAEQAR.3|C[CAM]KPGFFNLESSNPR.3|C[CAM]KPGFFNLESSNPR.2|DVDQNLMDR.2|DVDQNLM[Oxi]DR.2|AHVENTERLIEIASRELEK.4|C[CAM]SC[CAM]KPGVMGDKC[CAM]DR.3|KVSDLENEAK.2|LNEIEGTLNK.2|GRDTLQEANDILNNLKDFDR.4|TKEVVC[CAM]TNC[CAM]PTGTTGK.3|LVKDKVADHR.2|C[CAM]VC[CAM]KDNVEGFNC[CAM]ER.3|GRDTLQEANDILNNLK.3|GRDTLQEANDILNNLK.2|HNTYGVDC[CAM]EK.2|LNTFGDEVFNDPKVLK.3|C[CAM]DC[CAM]HALGSTNGQC[CAM]DIR.3|C[CAM]SC[CAM]KPGVMGDK.2|DGFFGNPLAPNPADKC[CAM]K.3|DGFFGNPLAPNPADKC[CAM]K.2|DNVEGFNC[CAM]ER.2|EAQQALGSAAADATEAKNK.3|TREAQQALGSAAADATEAK.3|VSVPLIAQGNSYPSETTVKYVFR.4|VSVPLIAQGNSYPSETTVKYVFR.3|TFAEVTDLDNEVNNMLK.3|TFAEVTDLDNEVNNMLK.2|LKFHTSRPESFAIYKR.3|TGQC[CAM]EC[CAM]QPGITGQHC[CAM]ER.3|RATAESASEC[CAM]LPC[CAM]DC[CAM]NGR.3|TEQQTADQLLAR.2|VTLNRLNTFGDEVFNDPK.3|DTLQEANDILNNLKDFDR.3|KQEAAIMDYNRDIEEIMK.3|KQEAAIM[Oxi]DYNRDIEEIMK.3|EVVC[CAM]TNC[CAM]PTGTTGK.2|DGFFGNPLAPNPADK.2|M[Oxi]EAENLEQLIDQK.2|MEAENLEQLIDQK.2|TFAEVTDLDNEVNNMLKQLQEAEKELK.4|EVVC[CAM]TNC[CAM]PTGTTGKR.2|PSAYNFDNSPVLQEWVTATDIR.3|SWPGC[CAM]QEC[CAM]PAC[CAM]YR.2|C[CAM]EVNHFGFGPEGC[CAM]KPC[CAM]DC[CAM]HPEGSLSLQC[CAM]K.4|C[CAM]ELC[CAM]DDGYFGDPLGR.2|ATAESASEC[CAM]LPC[CAM]DC[CAM]NGR.2|LC[CAM]QC[CAM]SDNIDPNAVGNC[CAM]NRLTGEC[CAM]LK.3|LQELESLIANLGTGDEMVTDQAFEDR.3|AVEIYASVAQLSPLDSETLENEANNIK.3
SEN / CTL,Thioredoxin domain-containing protein 17,TXNDC17,Q9BRA2,-0.40,0.30,6.64E-06,8.98E-06,5.05E+00,"tumor necrosis factor-mediated signaling pathway,oxidation-reduction process,cellular oxidant detoxification","peroxidase activity,protein binding,protein-disulfide reductase activity","cytosol,extracellular exosome",21,11,18,TIFAYFTGSK.2|SWC[CAM]PDC[CAM]VQAEPVVR.2|SWC[CAM]PDC[CAM]VQAEPVVR.3|NLKVTAVPTLLK.3|YEEVSVSGFEEFHR.3|YEEVSVSGFEEFHR.2|VTAVPTLLK.2|HISEGC[CAM]VFIYC[CAM]QVGEKPYWKDPNNDFRK.5|HISEGC[CAM]VFIYC[CAM]QVGEKPYWKDPNNDFRK.6|HISEGC[CAM]VFIYC[CAM]QVGEKPYWKDPNNDFRK.4|HISEGC[CAM]VFIYC[CAM]QVGEKPYWKDPNNDFRK.3|DPNNDFR.2|HISEGC[CAM]VFIYC[CAM]QVGEKPYWK.4|HISEGC[CAM]VFIYC[CAM]QVGEKPYWK.3|HISEGC[CAM]VFIYC[CAM]QVGEK.3|HISEGC[CAM]VFIYC[CAM]QVGEK.2|AVEQHNGKTIFAYFTGSK.3|LVESEC[CAM]LQANLVEMLFSED.2
SEN / CTL,Vesicular integral-membrane protein VIP36,LMAN2,Q12907,-0.40,0.36,1.25E-02,6.41E-03,2.19E+00,"ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,endoplasmic reticulum organization,Golgi organization,protein transport,positive regulation of phagocytosis","glycoprotein binding,mannose binding,carbohydrate binding,heat shock protein binding,metal ion binding","Golgi membrane,extracellular space,endoplasmic reticulum membrane,endoplasmic reticulum-Golgi intermediate compartment,Golgi apparatus,integral component of plasma membrane,cell surface,ER to Golgi transport vesicle,endoplasmic reticulum-Golgi intermediate compartment membrane,extracellular exosome",9,21,31,WTELAGC[CAM]TADFR.2|NLHGDGIALWYTR.3|NLHGDGIALWYTR.2|DNFHGLAIFLDTYPNDETTER.3|DRLVPGPVFGSK.3|DRLVPGPVFGSK.2|NRDHDTFLAVR.3|NRDHDTFLAVR.2|GRLTVMTDLEDKNEWK.4|GRLTVMTDLEDKNEWK.3|LVPGPVFGSK.2|IEPSVNFLK.2|NC[CAM]IDITGVR.2|SPKDNVDDPTGNFR.3|SPKDNVDDPTGNFR.2|DHDTFLAVR.2|EGSIWNHQPC[CAM]FLK.3|EGSIWNHQPC[CAM]FLK.2|LTVMTDLEDKNEWK.3|LTVMTDLEDKNEWK.2|LTVMTDLEDK.2|DWEMHVHFK.2|DNVDDPTGNFR.2|LFQLMVEHTPDEESIDWTK.3|LFQLMVEHTPDEESIDWTK.2|LFQLMVEHTPDEESIDWTKIEPSVNFLK.4|LPTGYYFGASAGTGDLSDNHDIISMK.3|EHSLIKPYQGVGSSSM[Oxi]PLWDFQGSTMLTSQYVR.4|EHSLIKPYQGVGSSSMPLWDFQGSTM[Oxi]LTSQYVR.4|EHSLIKPYQGVGSSSMPLWDFQGSTMLTSQYVR.4|PYQGVGSSSMPLWDFQGSTMLTSQYVR.3
SEN / CTL,"HLA class I histocompatibility antigen, A-3 alpha chain;HLA class I histocompatibility antigen, A-11 alpha chain",HLA-A,P04439;P13746,-0.41,0.65,2.67E-02,1.21E-02,1.92E+00,;,;,;,39,10,16,WAAVVVPSGEEQR.2|SWTAADMAAQITKR.3|SWTAADMAAQITKR.2|SWTAADMAAQITK.2|KGGSYTQAASSDSAQGSDVSLTAC[CAM]KV.3|FIAVGYVDDTQFVR.2|FIAVGYVDDTQFVR.3|DGEDQTQDTELVETRPAGDGTFQK.3|DGEDQTQDTELVETRPAGDGTFQK.4|APWIEQEGPEYWDQETR.2|APWIEQEGPEYWDQETR.3|AQSQTDRVDLGTLR.3|AQSQTDRVDLGTLR.2|WAAVVVPSGEEQRYTC[CAM]HVQHEGLPKPLTLR.6|YTC[CAM]HVQHEGLPKPLTLR.5|YTC[CAM]HVQHEGLPKPLTLR.4
SEN / CTL,Chitinase domain-containing protein 1,CHID1,Q9BWS9,-0.41,0.07,1.09E-02,5.72E-03,2.24E+00,"carbohydrate metabolic process,chitin catabolic process,innate immune response,negative regulation of cytokine production involved in inflammatory response","chitinase activity,protein binding,chitin binding,oligosaccharide binding","extracellular space,nucleus,lysosome,late endosome,trans-Golgi network,membrane,extracellular exosome",3,18,27,FTQISPVWLQLK.2|FTQISPVWLQLK.3|GLVVTDLK.2|SQFSDKPVQDR.3|SQFSDKPVQDR.2|VGLIHMLTHLAEALHQAR.4|AC[CAM]VQVLDPK.2|AESVVLEHR.2|DAREPVVGAR.2|HVVFYPTLK.2|NQHFDGFVVEVWNQLLSQK.4|NQHFDGFVVEVWNQLLSQK.3|GLVVTDLKAESVVLEHR.3|HFAGDVLGYVTPWNSHGYDVTK.4|HFAGDVLGYVTPWNSHGYDVTK.3|LLALLVIPPAITPGTDQLGMFTHK.4|LLALLVIPPAITPGTDQLGM[Oxi]FTHK.4|LLALLVIPPAITPGTDQLGM[Oxi]FTHK.3|LLALLVIPPAITPGTDQLGMFTHK.3|DRHFAGDVLGYVTPWNSHGYDVTK.4|DRHFAGDVLGYVTPWNSHGYDVTK.3|EMFEVTGLHDVDQGWMR.3|EM[Oxi]FEVTGLHDVDQGWMR.3|LLFEDWTYDDFR.2|NVLDSEDEIEELSK.2|ILLGLNFYGMDYATSK.2|EFEQLAPVLDGFSLMTYDYSTAHQPGPNAPLSWVR.4
SEN / CTL,Polyadenylate-binding protein 2,PABPN1,Q86U42,-0.41,0.21,7.13E-02,2.70E-02,1.57E+00,"MAPK cascade,mRNA splicing, via spliceosome,termination of RNA polymerase II transcription,RNA processing,muscle contraction,poly(A)+ mRNA export from nucleus,mRNA 3'-end processing,modification by virus of host mRNA processing,cellular response to lipopolysaccharide,positive regulation of polynucleotide adenylyltransferase activity","nucleotide binding,RNA binding,protein binding,poly(A) RNA binding,RNA polymerase binding","nucleus,nucleoplasm,cytoplasm,nuclear speck,intracellular ribonucleoprotein complex,nuclear inclusion body",3,10,15,TSLALDESLFR.2|VREMEEEAEK.3|VREM[Oxi]EEEAEK.3|VTILC[CAM]DK.2|ELQNEVEK.2|GFAYIEFSDKESVR.3|GFAYIEFSDKESVR.2|GFAYIEFSDK.2|LKELQNEVEK.2|SIYVGNVDYGATAEELEAHFHGC[CAM]GSVNR.5|SIYVGNVDYGATAEELEAHFHGC[CAM]GSVNR.4|SIYVGNVDYGATAEELEAHFHGC[CAM]GSVNR.3|APPGAPGPGPGSGAPGSQEEEEEPGLVEGDPGDGAIEDPELEAIK.5|APPGAPGPGPGSGAPGSQEEEEEPGLVEGDPGDGAIEDPELEAIK.4|QMNMSPPPGNAGPVIMSIEEK.2
SEN / CTL,40S ribosomal protein S21,RPS21,P63220,-0.42,0.23,1.53E-04,1.48E-04,3.83E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","structural constituent of ribosome,poly(A) RNA binding,protein N-terminus binding","nucleoplasm,cytoplasm,cytosol,small ribosomal subunit,cytosolic small ribosomal subunit",9,7,18,TYAIC[CAM]GAIR.2|DHASIQMNVAEVDKVTGR.4|DHASIQMNVAEVDKVTGR.3|DHASIQM[Oxi]NVAEVDKVTGR.4|DHASIQM[Oxi]NVAEVDKVTGR.3|DHASIQMNVAEVDKVTGR.2|RMGESDDSILR.3|RM[Oxi]GESDDSILR.3|RMGESDDSILR.2|RM[Oxi]GESDDSILR.2|ADGIVSKNF.2|DHASIQMNVAEVDK.3|DHASIQM[Oxi]NVAEVDK.3|DHASIQMNVAEVDK.2|DHASIQM[Oxi]NVAEVDK.2|MGESDDSILR.2|M[Oxi]GESDDSILR.2|IIGAKDHASIQMNVAEVDKVTGR.4
SEN / CTL,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,Q16881,-0.42,0.27,1.06E-16,7.99E-16,1.51E+01,"response to reactive oxygen species,mesoderm formation,selenium compound metabolic process,signal transduction,cell proliferation,nucleobase-containing small molecule interconversion,cell redox homeostasis,oxidation-reduction process,cellular oxidant detoxification","thioredoxin-disulfide reductase activity,electron carrier activity,protein disulfide oxidoreductase activity,flavin adenine dinucleotide binding,methylselenol reductase activity,methylseleninic acid reductase activity","nucleus,mitochondrion,cytosol,extracellular exosome",48,37,60,QFVPIKVEQIEAGTPGR.3|VVAQSTNSEEIIEGEYNTVMLAIGR.3|KVVYENAYGQFIGPHR.4|KVVYENAYGQFIGPHR.3|WGLGGTC[CAM]VNVGC[CAM]IPK.2|QLDSTIGIHPVC[CAM]AEVFTTLSVTKR.4|VMVLDFVTPTPLGTR.2|VMVLDFVTPTPLGTR.3|VM[Oxi]VLDFVTPTPLGTR.2|KLMHQAALLGQALQDSR.3|KLMHQAALLGQALQDSR.4|KLM[Oxi]HQAALLGQALQDSR.3|KLMHQAALLGQALQDSR.2|TGKIPVTDEEQTNVPYIYAIGDILEDKVELTPVAIQAGR.4|VVGFHVLGPNAGEVTQGFAAALK.3|VVGFHVLGPNAGEVTQGFAAALK.4|VVGFHVLGPNAGEVTQGFAAALK.2|MIEAVQNHIGSLNWGYR.3|M[Oxi]IEAVQNHIGSLNWGYR.3|M[Oxi]IEAVQNHIGSLNWGYR.2|MIEAVQNHIGSLNWGYR.2|VVYENAYGQFIGPHR.3|VVYENAYGQFIGPHR.2|KVMVLDFVTPTPLGTR.3|KVMVLDFVTPTPLGTR.2|IIC[CAM]NTKDNER.3|LYAGSTVK.2|IGEHMEEHGIK.3|IGEHMEEHGIK.2|IGGHGPTLK.2|IGLETVGVK.2|VEETVKHDWDR.3|MNGPEDLPK.2|GFDQDMANK.2|GFDQDM[Oxi]ANK.2|KIGLETVGVK.2|GFDQDMANKIGEHMEEHGIK.4|FLIATGERPR.2|VEQIEAGTPGR.2|LMHQAALLGQALQDSR.3|LM[Oxi]HQAALLGQALQDSR.3|LMHQAALLGQALQDSR.2|LM[Oxi]HQAALLGQALQDSR.2|QLDSTIGIHPVC[CAM]AEVFTTLSVTK.4|QLDSTIGIHPVC[CAM]AEVFTTLSVTK.3|VELTPVAIQAGR.2|SYDYDLIIIGGGSGGLAAAK.3|SYDYDLIIIGGGSGGLAAAK.2|KQLDSTIGIHPVC[CAM]AEVFTTLSVTK.4|NYGWKVEETVK.2|EYC[CAM]ISSDDLFSLPYC[CAM]PGK.3|EYC[CAM]ISSDDLFSLPYC[CAM]PGK.2|FGEENIEVYHSYFWPLEWTIPSR.4|FGEENIEVYHSYFWPLEWTIPSR.3|ALEGTLSELAAETDLPVVFVK.3|ALEGTLSELAAETDLPVVFVK.2|IPVTDEEQTNVPYIYAIGDILEDK.3|C[CAM]DYENVPTTVFTPLEYGAC[CAM]GLSEEK.3|IPVTDEEQTNVPYIYAIGDILEDKVELTPVAIQAGR.4|YLGIPGDKEYC[CAM]ISSDDLFSLPYC[CAM]PGK.3
SEN / CTL,Aldehyde dehydrogenase family 16 member A1,ALDH16A1,Q8IZ83,-0.42,0.08,7.05E-03,4.00E-03,2.40E+00,oxidation-reduction process,"aminobutyraldehyde dehydrogenase activity,4-trimethylammoniobutyraldehyde dehydrogenase activity","membrane,extracellular exosome",3,23,29,AALLWALAAALER.2|LAEVIQK.2|LLWTLESLVTGR.3|LLWTLESLVTGR.2|VQAQGHTLQVAGLR.3|VQAQGHTLQVAGLR.2|DPSVPTGGC[CAM]K.2|GAVEAAHQAFPGWAGQSPGAR.4|GAVEAAHQAFPGWAGQSPGAR.3|C[CAM]LGHYVNGK.2|DSSGNLHGYVAEGGAK.3|DSSGNLHGYVAEGGAK.2|GGSASVWSER.2|GAAAC[CAM]DLVQR.2|GLDGAVDMGAR.2|AAEAEVELSAR.2|EALLVANGTPR.2|VAFC[CAM]GAPEEGR.2|KVAFC[CAM]GAPEEGR.2|ESGC[CAM]SWHGGPDGLYEYLRPSGTPAR.4|ESGC[CAM]SWHGGPDGLYEYLRPSGTPAR.3|LLIQESVWDEAMR.2|AREIFTSLEYGPVPESHAC[CAM]ALAWLDTQDR.4|AWDQEAEGAGPELGLR.2|LGQALELGYGLQVGTVWINAHGLR.3|NSVPC[CAM]QDPITGENLASC[CAM]LQAQAEDVAAAVEAAR.4|NSVPC[CAM]QDPITGENLASC[CAM]LQAQAEDVAAAVEAAR.3|NLNYDTFGLAVPSTLPAGPEIGPSPAPPYGLFVGGR.4|EIFTSLEYGPVPESHAC[CAM]ALAWLDTQDR.3
SEN / CTL,Laminin subunit alpha-4,LAMA4,Q16363,-0.42,0.46,4.11E-03,2.53E-03,2.60E+00,"cell adhesion,regulation of cell adhesion,extracellular matrix organization,regulation of cell migration,regulation of embryonic development","receptor binding,extracellular matrix structural constituent","extracellular region,basement membrane,basal lamina,extracellular exosome,extracellular matrix",12,42,51,SLLSDVEELVEKENQASR.3|C[CAM]LDGYIGDSIR.2|ELVDEEADEAYELLSQAESWQR.3|AHLPLDINFR.2|SGVLSVSSGAAAHR.3|LHSSDMNGLVQK.3|LHSSDMNGLVQK.2|HFVIDGHPVSFSK.3|VDRDVEVEDFQR.3|LAALSIEEGK.2|YHEISIIYHNDK.3|AESSSDEAVADTSRR.3|MLYYGEEHELSPK.3|MLYYGEEHELSPK.2|VFLTVPSLSSTAEEK.3|VFLTVPSLSSTAEEK.2|AIEHAYQYGGTANSR.3|C[CAM]APGYYGDAR.2|QDPPETSEPR.2|HIYNMDPSTSVPC[CAM]AR.3|HIYNMDPSTSVPC[CAM]AR.2|VHTSLYEC[CAM]PIESSPLFLLHK.4|VHTSLYEC[CAM]PIESSPLFLLHK.3|GKIEQTQASEK.2|IYDAVSGIDTQIIYHK.3|LSDLQEALDQALNYVR.3|LSDLQEALDQALNYVR.2|TLFPVVLEQLDDYNAK.3|TLFPVVLEQLDDYNAK.2|LTLSELDDIIK.2|IQINNAENTMK.2|DESENLLNQAR.2|QYNDGLSHFVISSVSPTR.3|VFLTVPSLSSTAEEKFIK.3|SLLSDVEELVEK.2|IPFTDIYIGGAPPEILQSR.3|IPFTDIYIGGAPPEILQSR.2|RPELTETADQFILYLGSK.3|AESSSDEAVADTSR.2|QYNDGLSHFVISSVSPTRYELIVDK.4|GAPQFC[CAM]QPC[CAM]PC[CAM]PLPHLANFAESC[CAM]YR.4|GAPQFC[CAM]QPC[CAM]PC[CAM]PLPHLANFAESC[CAM]YR.3|NDNLVYVYNLGTK.2|AYFNGQSFIASIQK.2|AASYFFDGSGYAVVR.2|DVEIPLDSKPVSSWPAYFSIVK.3|ISFFDGFEGGFNFR.2|C[CAM]IC[CAM]NENYAGPNC[CAM]ER.2|C[CAM]APGYYGNPLLIGSTC[CAM]K.2|KC[CAM]DC[CAM]SGNSDPNLIFEDC[CAM]DEVTGQC[CAM]R.3|KGEFSGDDSLLDLDPEDTVFYVGGVPSNFK.3
SEN / CTL,Translin,TSN,Q15631,-0.42,0.37,1.69E-04,1.61E-04,3.79E+00,"DNA recombination,RNA metabolic process,gene silencing by RNA,nucleic acid phosphodiester bond hydrolysis","DNA binding,single-stranded DNA binding,mRNA binding,endonuclease activity,protein binding,protein complex binding,sequence-specific DNA binding","nucleus,cytosol",15,16,25,KVEEVVYDLSIR.3|KVEEVVYDLSIR.2|EAVTEILGIEPDREK.3|LSVNSVTAGDYSRPLHISTFINELDSGFR.4|LSVNSVTAGDYSRPLHISTFINELDSGFR.3|EILTLLQGVHQGAGFQDIPKR.4|EILTLLQGVHQGAGFQDIPKR.3|THLTSLK.2|KVVQSLEQTAR.3|KVVQSLEQTAR.2|TKFPAEQYYR.3|GFNKETAAAC[CAM]VEK.3|GFNKETAAAC[CAM]VEK.2|EAVTEILGIEPDR.3|EAVTEILGIEPDR.2|ETAAAC[CAM]VEK.2|FPAEQYYR.2|EILTLLQGVHQGAGFQDIPK.4|EILTLLQGVHQGAGFQDIPK.3|EILTLLQGVHQGAGFQDIPK.2|VVQSLEQTAR.2|PLHISTFINELDSGFR.3|PLHISTFINELDSGFR.2|VEEVVYDLSIR.2|LSVNSVTAGDYSR.2
SEN / CTL,"Keratin, type II cytoskeletal 78",KRT78,Q8N1N4,-0.42,0.15,3.39E-02,1.45E-02,1.84E+00,,structural molecule activity,"extracellular space,keratin filament,extracellular exosome",3,13,14,TLNNQFASFIDKVR.3|VQISQLHQEIQR.3|VQISQLHQEIQR.2|TQETQEIR.2|VDELEAALR.2|QLEQLQGER.2|TQETQEIRTLNNQFASFIDKVR.4|IEIDPQFQVVR.2|SLNSFGGC[CAM]LEGSR.2|TLNNQFASFIDK.2|YLDFSSIITEVR.2|LLC[CAM]EYQELTSTK.2|QNASLQAAITDAEQR.2|HLNEEELGQLQTQASDTSVVLSMDNNR.3
SEN / CTL,Carboxypeptidase Q,CPQ,Q9Y646,-0.43,0.54,3.73E-02,1.56E-02,1.81E+00,"proteolysis,thyroid hormone generation,tissue regeneration,peptide catabolic process","carboxypeptidase activity,protein homodimerization activity,metal ion binding,metallodipeptidase activity","extracellular space,cytoplasm,lysosome,endoplasmic reticulum,Golgi apparatus,extracellular exosome",6,10,10,LALLVDTVGPR.2|AIINLAVYGK.2|VHLEPVRIPHWER.4|VGALASLIR.2|GEESAVMLEPR.2|IVVYNQPYINYSR.2|LVLWTAEEQGGVGAFQYYQLHK.3|SVASFSIYSPHTGIQEYQDGVPK.3|AIQIMYQNLQQDGLEK.2|TYPDTDSFNTVAEITGSK.2
SEN / CTL,Beta-hexosaminidase subunit beta,HEXB,P07686,-0.43,0.31,1.29E-02,6.60E-03,2.18E+00,"skeletal system development,glycosphingolipid metabolic process,ganglioside catabolic process,cellular calcium ion homeostasis,lysosome organization,penetration of zona pellucida,sensory perception of sound,locomotory behavior,male courtship behavior,regulation of cell shape,phospholipid biosynthetic process,oligosaccharide catabolic process,lipid storage,chondroitin sulfate catabolic process,hyaluronan catabolic process,keratan sulfate catabolic process,myelination,astrocyte cell migration,cellular protein metabolic process,positive regulation of transcription from RNA polymerase II promoter,oogenesis,neuromuscular process controlling balance","beta-N-acetylhexosaminidase activity,acetylglucosaminyltransferase activity,protein homodimerization activity,protein heterodimerization activity","acrosomal vesicle,extracellular space,membrane,azurophil granule,lysosomal lumen,extracellular exosome",9,27,38,VLDIIATINK.2|LAPGTIVEVWKDSAYPEELSR.3|LAPGTIVEVWKDSAYPEELSR.4|LAPGTIVEVWKDSAYPEELSR.2|YHGYIFGFYK.3|YHGYIFGFYK.2|LAPGTIVEVWK.3|LAPGTIVEVWK.2|GILIDTSR.2|DVRDMDDAYDR.3|C[CAM]WESNPK.2|WHHEPAEFQAK.3|WHHEPAEFQAK.2|RYHGYIFGFYK.3|TLDAMAFNK.2|LESFYIQK.2|GSIVWQEVFDDKAK.3|GSIVWQEVFDDKAK.2|YYKVEPLDFGGTQK.3|YYKVEPLDFGGTQK.2|DLLTPC[CAM]YSR.2|GSYSLSHVYTPNDVR.3|GSYSLSHVYTPNDVR.2|DVRDMDDAYDRLTR.3|KLESFYIQK.2|DSAYPEELSR.2|KYYKVEPLDFGGTQK.3|VEPLDFGGTQK.2|VLPEFDTPGHTLSWGK.3|VLPEFDTPGHTLSWGK.2|PGPALWPLPLSVK.2|GSIVWQEVFDDK.2|VTASGFPVILSAPWYLDLISYGQDWRK.4|VTASGFPVILSAPWYLDLISYGQDWRK.3|EISEVFPDQFIHLGGDEVEFK.3|FNVLHWHIVDDQSFPYQSITFPELSNK.4|FNVLHWHIVDDQSFPYQSITFPELSNK.3|GIAAQPLYAGYC[CAM]NHENM.2
SEN / CTL,Glutathione peroxidase 3,GPX3,P22352,-0.43,0.18,4.10E-04,3.49E-04,3.46E+00,"response to reactive oxygen species,response to lipid hydroperoxide,hydrogen peroxide catabolic process,protein homotetramerization,oxidation-reduction process,cellular oxidant detoxification","glutathione peroxidase activity,transcription factor binding,selenium binding","extracellular region,extracellular space,extracellular exosome",6,7,10,MDILSYMR.2|FLVGPDGIPIMR.2|FLVGPDGIPIM[Oxi]R.2|LFWEPMK.2|QEPGENSEILPTLK.3|QEPGENSEILPTLK.2|YVRPGGGFVPNFQLFEK.3|YVRPGGGFVPNFQLFEK.2|PGGGFVPNFQLFEK.2|NSC[CAM]PPTSELLGTSDR.2
SEN / CTL,Receptor-type tyrosine-protein phosphatase F,PTPRF,P10586,-0.43,0.26,1.63E-15,1.08E-14,1.40E+01,"cell adhesion,transmembrane receptor protein tyrosine phosphatase signaling pathway,chemical synaptic transmission,cell migration,neuron projection regeneration,peptidyl-tyrosine dephosphorylation,regulation of axon regeneration,negative regulation of receptor binding","protein tyrosine phosphatase activity,transmembrane receptor protein tyrosine phosphatase activity,heparin binding,protein complex binding,chondroitin sulfate proteoglycan binding","plasma membrane,integral component of plasma membrane,neuron projection,neuronal cell body,extracellular exosome",45,55,65,NVLELSNVVR.2|IISYTVVFR.2|WFYIVVVPIDR.2|SDMGVGVFTPTIEAR.2|AAGTEGPFQEVDGVATTR.2|SGALQIESSEESDQGKYEC[CAM]VATNSAGTR.3|HNTDAGLLTTVGSLLPGITYSLR.3|HNTDAGLLTTVGSLLPGITYSLR.4|YSIGGLSPFSEYAFR.2|YSIGGLSPFSEYAFR.3|IQLSWLLPPQER.2|VLAFTAVGDGPPSPTIQVK.3|VLAFTAVGDGPPSPTIQVK.2|TAPDLLPHKPLPASAYIEDGRFDLSMPHVQDPSLVR.6|FEVIEFDDGAGSVLR.2|FTLTGLKPDTTYDIK.3|ADEARPNTIDFGKDDQHFTVTGLHK.6|ADEARPNTIDFGKDDQHFTVTGLHK.4|YANVIAYDHSR.3|YANVIAYDHSR.2|GSSAGGLQHLVSIR.3|GSSAGGLQHLVSIR.2|VGGSMLTPR.2|VLAVNSIGR.2|AGLGEEFEK.2|GYQVTYVR.2|TATVVMMTR.2|TGEGFIDFIGQVHK.3|TGEGFIDFIGQVHK.2|TKEQFGQDGPITVHC[CAM]SAGVGR.4|AHTDVGPGPESSPVLVR.3|AHTDVGPGPESSPVLVR.2|YSAPANLYVR.2|FISANLPC[CAM]NK.2|TDEDVPSGPPR.2|GSGPLSPSIQSR.2|DHPPIPITDLADNIER.3|ILYNGQSVEVDGHSMR.3|MLWEHNSTIIVMLTK.3|LKPYVAAQLDVLPETFTLGDKK.4|LKPYVAAQLDVLPETFTLGDKK.3|C[CAM]HQYWPAER.2|EQFGQDGPITVHC[CAM]SAGVGR.3|LVNIMPYELTR.2|VPEDQTGLSGGVASFVC[CAM]QATGEPKPR.4|VPEDQTGLSGGVASFVC[CAM]QATGEPKPR.3|AC[CAM]NPLDAGPMVVHC[CAM]SAGVGR.3|DFLPVDPATSNGR.2|EHSSWDLVGLEK.2|DEAIYEC[CAM]TATNSLGEINTSAK.3|TQRPAMVQTEDQYQLC[CAM]YR.3|AALEYLGSFDHYAT.2|GFYNRPLSPDLSYQC[CAM]FVLASLKEPMDQK.4|VTFDPTSSYTLEDLKPDTLYR.3|GFYNRPLSPDLSYQC[CAM]FVLASLK.3|QFQFTDWPEQGVPK.2|VILTSIDGVPGSDYINANYIDGYR.3|NYMVQTEDQYVFIHEALLEAATC[CAM]GHTEVPAR.4|VILTSIDGVPGSDYINANYIDGYRK.3|GVEGSDYINASFLDGYR.2|QFQFMAWPDHGVPEYPTPILAFLR.3|FSQEYESIDPGQQFTWENSNLEVNKPK.3|LIADLQPNTEYSFVLMNR.2|TATMLC[CAM]AAGGNPDPEISWFK.2|TQQGVPAQPADFQAEVESDTR.2
SEN / CTL,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",HADH,Q16836,-0.43,0.43,2.65E-03,1.75E-03,2.76E+00,"fatty acid beta-oxidation,response to activity,response to insulin,response to drug,negative regulation of insulin secretion","3-hydroxyacyl-CoA dehydrogenase activity,NAD+ binding","nucleoplasm,cytoplasm,mitochondrion,mitochondrial inner membrane,mitochondrial matrix",12,22,45,TFESLVDFSK.2|TLSTIATSTDAASVVHSTDLVVEAIVENLK.4|TLSTIATSTDAASVVHSTDLVVEAIVENLK.3|LLVPYLMEAIR.2|LLVPYLMEAIR.3|LLVPYLM[Oxi]EAIR.2|QDRFAGLHFFNPVPVMK.4|QDRFAGLHFFNPVPVMK.3|TGEGFYK.2|HPVSC[CAM]KDTPGFIVNR.4|HPVSC[CAM]KDTPGFIVNR.3|AGDEFVEK.2|GDASKEDIDTAMK.3|GDASKEDIDTAM[Oxi]K.3|GDASKEDIDTAMK.2|GDASKEDIDTAM[Oxi]K.2|KTGEGFYK.2|DTPGFIVNR.2|ALGKHPVSC[CAM]KDTPGFIVNR.4|FAGLHFFNPVPVMK.3|FAGLHFFNPVPVM[Oxi]K.3|FAGLHFFNPVPVMK.2|FAGLHFFNPVPVM[Oxi]K.2|FIVDGWHEMDAENPLHQPSPSLNK.5|FIVDGWHEM[Oxi]DAENPLHQPSPSLNK.4|FIVDGWHEMDAENPLHQPSPSLNK.4|FIVDGWHEM[Oxi]DAENPLHQPSPSLNK.3|FIVDGWHEMDAENPLHQPSPSLNK.3|TGEGFYKYK.2|LYERGDASKEDIDTAM[Oxi]K.3|FAAEHTIFASNTSSLQITSIANATTR.4|FAAEHTIFASNTSSLQITSIANATTR.3|HVTVIGGGLMGAGIAQVAAATGHTVVLVDQTEDILAK.5|HVTVIGGGLM[Oxi]GAGIAQVAAATGHTVVLVDQTEDILAK.5|HVTVIGGGLM[Oxi]GAGIAQVAAATGHTVVLVDQTEDILAK.4|HVTVIGGGLMGAGIAQVAAATGHTVVLVDQTEDILAK.4|LDKFAAEHTIFASNTSSLQITSIANATTR.4|LDKFAAEHTIFASNTSSLQITSIANATTR.3|FAAEHTIFASNTSSLQITSIANATTRQDR.4|LGAGYPM[Oxi]GPFELLDYVGLDTTK.3|LGAGYPMGPFELLDYVGLDTTK.3|LGAGYPM[Oxi]GPFELLDYVGLDTTK.2|LGAGYPMGPFELLDYVGLDTTK.2|TLSTIATSTDAASVVHSTDLVVEAIVENLKVKNELFK.5|TLSTIATSTDAASVVHSTDLVVEAIVENLKVK.4
SEN / CTL,Proteasome subunit alpha type-5,PSMA5,P28066,-0.43,0.33,1.40E-05,1.73E-05,4.76E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","threonine-type endopeptidase activity,protein binding","proteasome complex,nucleus,nucleoplasm,cytoplasm,cytosol,proteasome core complex,proteasome core complex, alpha-subunit complex,extracellular exosome",21,17,34,LFQVEYAIEAIK.2|LFQVEYAIEAIK.3|SEYDRGVNTFSPEGR.3|AIGSASEGAQSSLQEVYHK.3|AIGSASEGAQSSLQEVYHK.2|AIGSASEGAQSSLQEVYHK.4|ITSPLMEPSSIEK.2|ITSPLM[Oxi]EPSSIEK.2|IVEIDAHIGC[CAM]AMSGLIADAK.3|IVEIDAHIGC[CAM]AM[Oxi]SGLIADAK.3|IVEIDAHIGC[CAM]AMSGLIADAK.2|PFGVALLFGGVDEK.3|PFGVALLFGGVDEK.2|EELEEVIK.2|GVNTFSPEGR.2|RITSPLMEPSSIEK.3|RITSPLM[Oxi]EPSSIEK.3|RITSPLM[Oxi]EPSSIEK.2|RITSPLMEPSSIEK.2|GPQLFHMDPSGTFVQC[CAM]DAR.4|GPQLFHMDPSGTFVQC[CAM]DAR.3|GPQLFHM[Oxi]DPSGTFVQC[CAM]DAR.3|EELEEVIKDI.2|LNATNIELATVQPGQNFHM[Oxi]FTK.4|LNATNIELATVQPGQNFHMFTK.4|LNATNIELATVQPGQNFHM[Oxi]FTK.3|LNATNIELATVQPGQNFHMFTK.3|LGSTAIGIQTSEGVC[CAM]LAVEK.3|LGSTAIGIQTSEGVC[CAM]LAVEK.2|LGSTAIGIQTSEGVC[CAM]LAVEKR.3|LNATNIELATVQPGQNFHMFTKEELEEVIK.4|LNATNIELATVQPGQNFHMFTKEELEEVIK.3|PFGVALLFGGVDEKGPQLFHMDPSGTFVQC[CAM]DAR.4|LNATNIELATVQPGQNFHMFTKEELEEVIKDI.4
SEN / CTL,Proteasome subunit beta type-9,PSMB9,P28065,-0.44,0.33,1.13E-03,8.38E-04,3.08E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,viral process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,regulation of cysteine-type endopeptidase activity",threonine-type endopeptidase activity,"proteasome complex,nucleoplasm,cytoplasm,cytosol,proteasome core complex,extracellular exosome,spermatoproteasome complex",12,8,12,FTTDAIALAMSR.2|FTTDAIALAMSR.3|EGGQVYGTLGGMLTR.2|VILGNELPKFYDE.2|AGAPTGDLPR.2|VSAGEAVVNR.2|YREDLSAHLMVAGWDQR.4|YREDLSAHLMVAGWDQR.3|DGSSGGVIYLVTITAAGVDHR.4|DGSSGGVIYLVTITAAGVDHR.3|DGSSGGVIYLVTITAAGVDHR.2|QPFAIGGSGSTFIYGYVDAAYKPGMSPEEC[CAM]RR.4
SEN / CTL,Nucleolin,NCL,P19338,-0.44,0.66,7.97E-12,3.36E-11,1.05E+01,"angiogenesis,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter","nucleotide binding,RNA binding,protein binding,protein C-terminus binding,telomeric DNA binding,identical protein binding,poly(A) RNA binding","nucleus,nucleoplasm,nucleolus,cell cortex,membrane,intracellular ribonucleoprotein complex,cytoplasmic ribonucleoprotein granule,extracellular exosome",60,63,97,NDLAVVDVR.2|GFGFVDFNSEEDAK.2|EVFEDAAEIR.2|NLPYKVTQDELKEVFEDAAEIR.4|NLPYKVTQDELKEVFEDAAEIR.3|TLVLSNLSYSATEETLQEVFEK.3|TLVLSNLSYSATEETLQEVFEK.4|TGISDVFAKNDLAVVDVR.3|TGISDVFAKNDLAVVDVR.2|KFGYVDFESAEDLEK.3|KFGYVDFESAEDLEK.2|VTQDELKEVFEDAAEIR.3|VTQDELKEVFEDAAEIR.2|FGYVDFESAEDLEK.2|FGYVDFESAEDLEK.3|GIAYIEFK.2|AIRLELQGPR.2|GLSEDTTEETLKESFDGSVR.3|GLSEDTTEETLKESFDGSVR.4|GLSEDTTEETLKESFDGSVR.2|SISLYYTGEK.2|FGYVDFESAEDLEKALELTGLK.3|TGISDVFAK.2|KFGYVDFESAEDLEKALELTGLK.4|KFGYVDFESAEDLEKALELTGLK.3|KQKVEGTEPTTAFNLFVGNLNFNK.4|KQKVEGTEPTTAFNLFVGNLNFNK.3|GYAFIEFASFEDAKEALNSC[CAM]NKR.4|GYAFIEFASFEDAKEALNSC[CAM]NKR.3|EAMEDGEIDGNKVTLDWAKPK.4|EAM[Oxi]EDGEIDGNKVTLDWAKPK.4|EAM[Oxi]EDGEIDGNKVTLDWAKPK.3|EAMEDGEIDGNKVTLDWAKPK.3|EAMEDGEIDGNKVTLDWAKPK.2|LELQGPR.2|VTLDWAK.2|VTLDWAK.1|VTQDELK.2|ALELTGLK.2|ALELTGLK.1|KVVVSPTK.2|ALVATPGKK.2|GLSEDTTEETLK.3|GLSEDTTEETLK.2|KVAVATPAK.2|QGTEIDGR.2|VAVATPAKK.2|ESFDGSVR.2|EALNSC[CAM]NK.2|TEADAEKTFEEK.3|TEADAEKTFEEK.2|VFGNEIKLEKPK.3|VFGNEIKLEKPK.2|SKGIAYIEFKTEADAEK.4|SKGIAYIEFKTEADAEK.3|ATFIKVPQNQNGK.3|ATFIKVPQNQNGK.2|NLPYKVTQDELK.3|NLPYKVTQDELK.2|KVVVSPTKK.2|NSTWSGESK.2|KVAVATPAKK.2|AAKEAMEDGEIDGNKVTLDWAKPK.5|AAKEAMEDGEIDGNKVTLDWAKPK.4|GYAFIEFASFEDAK.3|GYAFIEFASFEDAK.2|VTLDWAKPK.2|ALELTGLKVFGNEIK.3|ALELTGLKVFGNEIK.2|EALNSC[CAM]NKR.2|GIAYIEFKTEADAEK.3|SISLYYTGEKGQNQDYRGGK.4|TEADAEKTFEEKQGTEIDGR.4|TEADAEKTFEEKQGTEIDGR.3|GIAYIEFKTEADAEKTFEEK.4|GIAYIEFKTEADAEKTFEEK.3|SKGIAYIEFK.2|VFGNEIKLEK.2|IVTDRETGSSK.2|SKGYAFIEFASFEDAK.3|SKGYAFIEFASFEDAK.2|GFGFVDFNSEEDAKAAK.3|QKVEGTEPTTAFNLFVGNLNFNK.4|QKVEGTEPTTAFNLFVGNLNFNK.3|EAMEDGEIDGNK.2|EAM[Oxi]EDGEIDGNK.2|SISLYYTGEKGQNQDYR.3|SISLYYTGEKGQNQDYR.2|SKGYAFIEFASFEDAKEALNSC[CAM]NK.4|SKGYAFIEFASFEDAKEALNSC[CAM]NK.3|EAMEDGEIDGNKVTLDWAK.3|TFEEKQGTEIDGR.2|VEGTEPTTAFNLFVGNLNFNK.3|VEGTEPTTAFNLFVGNLNFNK.2|IGMTRKFGYVDFESAEDLEK.3|FGYVDFESAEDLEKALELTGLKVFGNEIK.4|GYAFIEFASFEDAKEALNSC[CAM]NK.3
SEN / CTL,Glutathione synthetase,GSS,P48637,-0.44,0.42,3.09E-07,5.84E-07,6.23E+00,"cellular amino acid metabolic process,glutathione biosynthetic process,response to oxidative stress,nervous system development,aging,response to xenobiotic stimulus,response to nutrient levels,response to tumor necrosis factor,response to amino acid,response to cadmium ion","magnesium ion binding,glutathione synthase activity,ATP binding,glycine binding,protein homodimerization activity,glutathione binding","cytosol,extracellular exosome",30,27,39,AWELYGSPNALVLLIAQEKER.3|ALAEGVLLR.2|EGIAQTVFLGLNR.2|EGIAQTVFLGLNR.3|EGGGNNLYGEEMVQALK.2|EGGGNNLYGEEMVQALK.3|IEPEPFENC[CAM]LLRPGSPAR.3|IEPEPFENC[CAM]LLRPGSPAR.4|ATFAGLYSLDVGEEGDQAIAEALAAPSR.3|VVQC[CAM]ISELGIFGVYVR.3|VVQC[CAM]ISELGIFGVYVR.2|QVLKEGIAQTVFLGLNR.3|VQQELSRPGMLEMLLPGQPEAVAR.4|VQQELSRPGMLEMLLPGQPEAVAR.3|QIEINTISASFGGLASR.2|QIEINTISASFGGLASR.3|SADGSPALK.2|HVLSVLSK.2|C[CAM]PDIATQLAGTKK.3|C[CAM]PDIATQLAGTKK.2|ASYILMEK.2|SDYMFQR.2|TFEDISEK.2|QQLEELAR.2|AIENELLAR.2|LFVDGQEIAVVYFR.3|LFVDGQEIAVVYFR.2|RTFEDISEK.2|C[CAM]PDIATQLAGTK.2|QYSLQNWEAR.2|KVQQELSRPGMLEMLLPGQPEAVAR.4|KVQQELSRPGM[Oxi]LEMLLPGQPEAVAR.4|KVQQELSRPGMLEMLLPGQPEAVAR.3|AWELYGSPNALVLLIAQEK.3|AWELYGSPNALVLLIAQEK.2|AIEHADGGVAAGVAVLDNPYPV.3|AIEHADGGVAAGVAVLDNPYPV.2|AWELYGSPNALVLLIAQEKERNIFDQR.4|SADGSPALKQIEINTISASFGGLASR.3
SEN / CTL,SH3 domain-binding glutamic acid-rich-like protein 3,SH3BGRL3,Q9H299,-0.45,1.47,1.16E-01,4.01E-02,1.40E+00,"regulation of actin filament depolymerization,regulation of actin cytoskeleton organization,regulation of blood vessel endothelial cell migration,positive regulation of GTPase activity,cell redox homeostasis,oxidation-reduction process","GTPase activator activity,electron carrier activity,protein disulfide oxidoreductase activity,semaphorin receptor binding","nucleus,cytoplasm,lamellipodium,extracellular exosome",12,7,15,ATPPQIVNGDQYC[CAM]GDYELFVEAVEQNTLQEFLK.4|IQYQLVDISQDNALRDEMR.3|IQYQLVDISQDNALRDEMR.4|IQYQLVDISQDNALRDEM[Oxi]R.3|IQYQLVDISQDNALRDEMR.2|RIQYQLVDISQDNALRDEMR.4|RIQYQLVDISQDNALRDEM[Oxi]R.4|RIQYQLVDISQDNALRDEM[Oxi]R.3|RIQYQLVDISQDNALRDEMR.3|VYSTSVTGSR.2|SQQSEVTR.2|IQYQLVDISQDNALR.3|IQYQLVDISQDNALR.2|RIQYQLVDISQDNALR.3|RIQYQLVDISQDNALR.2
SEN / CTL,Phosphatidylethanolamine-binding protein 1,PEBP1,P30086,-0.45,0.78,3.86E-03,2.42E-03,2.62E+00,"MAPK cascade,negative regulation of endopeptidase activity","serine-type endopeptidase inhibitor activity,protein binding,ATP binding,phosphatidylethanolamine binding,enzyme binding,protein kinase binding,poly(A) RNA binding","nucleus,cytosol,extracellular exosome",57,25,48,YVWLVYEQDRPLKC[CAM]DEPILSNR.4|YVWLVYEQDRPLKC[CAM]DEPILSNR.3|GNDISSGTVLSDYVGSGPPK.3|GNDISSGTVLSDYVGSGPPK.2|GNDISSGTVLSDYVGSGPPKGTGLHR.4|GNDISSGTVLSDYVGSGPPKGTGLHR.3|LYTLVLTDPDAPSRKDPK.4|LYTLVLTDPDAPSRKDPK.3|LYTLVLTDPDAPSRKDPK.2|VLTPTQVK.2|LYEQLSGK.2|APVAGTC[CAM]YQAEWDDYVPK.3|APVAGTC[CAM]YQAEWDDYVPK.2|YREWHHFLVVNMK.4|YREWHHFLVVNMK.3|YREWHHFLVVNM[Oxi]K.4|YREWHHFLVVNM[Oxi]K.3|NRPTSISWDGLDSGK.3|NRPTSISWDGLDSGK.2|WSGPLSLQEVDEQPQHPLHVTYAGAAVDELGK.4|WSGPLSLQEVDEQPQHPLHVTYAGAAVDELGK.5|WSGPLSLQEVDEQPQHPLHVTYAGAAVDELGK.3|NRPTSISWDGLDSGKLYTLVLTDPDAPSR.4|NRPTSISWDGLDSGKLYTLVLTDPDAPSR.3|LYTLVLTDPDAPSR.2|LYTLVLTDPDAPSR.3|YVWLVYEQDRPLK.3|YVWLVYEQDRPLK.2|PVDLSKWSGPLSLQEVDEQPQHPLHVTYAGAAVDELGK.5|PVDLSKWSGPLSLQEVDEQPQHPLHVTYAGAAVDELGK.6|EWHHFLVVNMK.3|EWHHFLVVNMK.2|C[CAM]DEPILSNR.2|LYTLVLTDPDAPSRK.3|LYTLVLTDPDAPSRK.2|NRPTSISWDGLDSGKLYTLVLTDPDAPSRK.5|NRPTSISWDGLDSGKLYTLVLTDPDAPSRK.4|PTSISWDGLDSGK.2|YVWLVYEQDR.2|KYELRAPVAGTC[CAM]YQAEWDDYVPK.4|KYELRAPVAGTC[CAM]YQAEWDDYVPK.3|PVDLSKWSGPLSLQEVDEQPQHPLHVTYAGAAVDELGKVLTPTQVK.7|PVDLSKWSGPLSLQEVDEQPQHPLHVTYAGAAVDELGKVLTPTQVK.6|PVDLSKWSGPLSLQEVDEQPQHPLHVTYAGAAVDELGKVLTPTQVK.5|YREWHHFLVVNMKGNDISSGTVLSDYVGSGPPK.5|APVAGTC[CAM]YQAEWDDYVPKLYEQLSGK.4|APVAGTC[CAM]YQAEWDDYVPKLYEQLSGK.3|WSGPLSLQEVDEQPQHPLHVTYAGAAVDELGKVLTPTQVK.5
SEN / CTL,U6 snRNA-associated Sm-like protein LSm3,LSM3,P62310,-0.45,0.38,6.05E-03,3.55E-03,2.45E+00,"mRNA splicing, via spliceosome,mRNA processing,cytoplasmic mRNA processing body assembly,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay","RNA binding,protein binding,poly(A) RNA binding","cytoplasmic mRNA processing body,nucleus,nucleoplasm,U6 snRNP,cytosol,U4/U6 x U5 tri-snRNP complex,precatalytic spliceosome,catalytic step 2 spliceosome,Lsm1-7-Pat1 complex",9,4,4,GDGVVLVAPPLRVG.2|NIPMLFVR.2|GDGVVLVAPPLR.2|RNIPMLFVR.2
SEN / CTL,"Acetyl-CoA acetyltransferase, cytosolic",ACAT2,Q9BWD1,-0.46,0.20,2.49E-08,5.86E-08,7.23E+00,"lipid metabolic process,fatty acid beta-oxidation",acetyl-CoA C-acetyltransferase activity,"nucleus,nucleolus,cytoplasm,mitochondrion,extracellular exosome",18,22,41,ILVTLLHTLER.3|ILVTLLHTLER.2|AGHFDKEIVPVLVSTR.4|AGHFDKEIVPVLVSTR.3|ELGLNPEKVNIEGGAIALGHPLGASGC[CAM]R.4|IVSWSQVGVEPSIMGIGPIPAIK.3|IVSWSQVGVEPSIMGIGPIPAIK.4|IVSWSQVGVEPSIM[Oxi]GIGPIPAIK.3|IVSWSQVGVEPSIM[Oxi]GIGPIPAIK.2|IVSWSQVGVEPSIMGIGPIPAIK.2|VAVLSQNR.2|APHLAYLR.2|GLIEVKTDEFPR.3|VNIEGGAIALGHPLGASGC[CAM]R.4|VNIEGGAIALGHPLGASGC[CAM]R.3|VNIEGGAIALGHPLGASGC[CAM]R.2|EDQDKVAVLSQNR.3|EDQDKVAVLSQNR.2|HGSNIEAMSK.2|HGSNIEAM[Oxi]SK.2|EIVPVLVSTR.2|TIIGSFNGALAAVPVQDLGSTVIK.4|TIIGSFNGALAAVPVQDLGSTVIK.3|TIIGSFNGALAAVPVQDLGSTVIK.2|LKPYFLTDGTGTVTPANASGINDGAAAVVLMK.5|LKPYFLTDGTGTVTPANASGINDGAAAVVLMK.4|LKPYFLTDGTGTVTPANASGINDGAAAVVLM[Oxi]K.3|LKPYFLTDGTGTVTPANASGINDGAAAVVLMK.3|ATVAPEDVSEVIFGHVLAAGC[CAM]GQNPVR.4|ATVAPEDVSEVIFGHVLAAGC[CAM]GQNPVR.3|RATVAPEDVSEVIFGHVLAAGC[CAM]GQNPVR.4|RATVAPEDVSEVIFGHVLAAGC[CAM]GQNPVR.3|IGEMPLTDSILC[CAM]DGLTDAFHNC[CAM]HMGITAENVAKK.5|TIIGSFNGALAAVPVQDLGSTVIKEVLKR.4|VAVLSQNRTENAQK.2|IGEM[Oxi]PLTDSILC[CAM]DGLTDAFHNC[CAM]HMGITAENVAK.4|IGEMPLTDSILC[CAM]DGLTDAFHNC[CAM]HMGITAENVAK.4|QASVGAGIPYSVPAWSC[CAM]QM[Oxi]IC[CAM]GSGLK.3|QASVGAGIPYSVPAWSC[CAM]QMIC[CAM]GSGLK.3|TIIGSFNGALAAVPVQDLGSTVIKEVLK.3|PYFLTDGTGTVTPANASGINDGAAAVVLMK.3
SEN / CTL,DBH-like monooxygenase protein 1,MOXD1,Q6UVY6,-0.46,0.05,3.12E-03,2.02E-03,2.69E+00,oxidation-reduction process,"copper ion binding,protein binding,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen","endoplasmic reticulum membrane,integral component of membrane",3,2,2,LVLSLPVNVR.2|ELHTC[CAM]DINDK.2
SEN / CTL,Tropomyosin alpha-4 chain,TPM4,P67936,-0.46,1.24,4.39E-03,2.67E-03,2.57E+00,"osteoblast differentiation,movement of cell or subcellular component,muscle contraction,muscle filament sliding","actin binding,calcium ion binding,protein binding,structural constituent of muscle","stress fiber,podosome,cytosol,cytoskeleton,muscle thin filament tropomyosin,focal adhesion,membrane,cortical cytoskeleton,filamentous actin,extracellular exosome",99,36,62,IQLVEEELDRAQER.3|IQLVEEELDRAQER.2|RIQLVEEELDRAQER.4|RIQLVEEELDRAQER.3|KLVILEGELERAEER.4|KLVILEGELERAEER.3|IQLVEEELDR.2|KLVILEGELER.3|KLVILEGELER.2|LATALQKLEEAEK.3|LATALQKLEEAEK.2|LATALQKLEEAEKAADESER.4|LATALQKLEEAEKAADESER.3|LATALQKLEEAEKAADESER.2|LVILEGELER.2|KIQALQQQADEAEDRAQGLQR.4|KIQALQQQADEAEDRAQGLQR.3|KIQALQQQADEAEDRAQGLQR.5|IQALQQQADEAEDRAQGLQR.3|IQALQQQADEAEDRAQGLQR.4|IQALQQQADEAEDRAQGLQR.2|HIAEEADRKYEEVAR.4|HIAEEADRKYEEVAR.3|HIAEEADRKYEEVAR.2|LVILEGELERAEER.3|LVILEGELERAEER.2|AEVSELKC[CAM]GDLEEELKNVTNNLK.4|AEVSELKC[CAM]GDLEEELKNVTNNLK.3|IQALQQQADEAEDR.3|IQALQQQADEAEDR.2|KIQALQQQADEAEDR.3|KIQALQQQADEAEDR.2|TIDDLEEKLAQAK.2|EAETRAEFAER.3|KYEEVAR.2|LLSDKLKEAETR.3|RIQLVEEELDR.3|RIQLVEEELDR.2|MEIQEMQLK.2|M[Oxi]EIQEMQLK.2|MEIQEM[Oxi]QLK.2|C[CAM]GDLEEELKNVTNNLK.3|C[CAM]GDLEEELKNVTNNLK.2|AEERAEVSELK.3|SLEAASEK.2|EKAEGDVAALNR.3|EKAEGDVAALNR.2|YSEKEDKYEEEIK.4|YSEKEDKYEEEIK.3|YSEKEDKYEEEIK.2|REKAEGDVAALNR.3|RKIQALQQQADEAEDR.4|RKIQALQQQADEAEDR.3|TIDDLEEK.2|AEGDVAALNR.2|AEGDVAALNRR.2|SLEAASEKYSEK.2|EENVGLHQTLDQTLNELNC[CAM]I.3|EENVGLHQTLDQTLNELNC[CAM]I.2|AEVSELKC[CAM]GDLEEELK.2|LAQAKEENVGLHQTLDQTLNELNC[CAM]I.3|TIDDLEEKLAQAKEENVGLHQTLDQTLNELNC[CAM]I.4
SEN / CTL,Nucleobindin-1,NUCB1,Q02818,-0.46,0.99,3.75E-06,5.45E-06,5.26E+00,"response to cisplatin,regulation of protein targeting","G-protein alpha-subunit binding,DNA binding,calcium ion binding","extracellular space,nucleus,early endosome,rough endoplasmic reticulum,endoplasmic reticulum-Golgi intermediate compartment,Golgi apparatus,Golgi-associated vesicle,cis-Golgi network,trans-Golgi network,microtubule cytoskeleton,membrane,Golgi cisterna membrane,extracellular exosome,extrinsic component of Golgi membrane,lumenal side of Golgi membrane",63,33,46,DLELLIQTATR.2|LLERLPEVEVPQHL.3|LPEVEVPQHL.2|ELQQAVLHMEQR.3|ELQQAVLHMEQR.2|YLQEVIDVLETDGHFR.3|LSQETEALGR.2|AKMDAEQDPNVQVDHLNLLK.3|AKMDAEQDPNVQVDHLNLLK.4|LVTLEEFLASTQR.2|LVTLEEFLASTQR.3|QFEHLDPQNQHTFEAR.4|QFEHLDPQNQHTFEAR.3|FHPDTDDVPVPAPAGDQKEVDTSEK.4|YLQEVIDVLETDGHFREK.4|YLQEVIDVLETDGHFREK.3|LVTLEEFLASTQRK.3|LVTLEEFLASTQRK.2|VNVPGSQAQLKEVWEELDGLDPNRFNPK.4|EVWEELDGLDPNRFNPK.3|MDAEQDPNVQVDHLNLLK.3|MDAEQDPNVQVDHLNLLK.2|TFFILHDINSDGVLDEQELEALFTK.3|VNVPGSQAQLK.2|ELDFVSHHVR.3|ELDFVSHHVR.2|RELQQAVLHMEQR.4|RELQQAVLHMEQR.3|RELQQAVLHMEQR.2|DLAQYDAAHHEEFK.4|DLAQYDAAHHEEFK.3|DLAQYDAAHHEEFK.2|LQAANAEDIKSGK.3|YLESLGEEQRK.3|YLESLGEEQRK.2|DLAQYDAAHHEEFKR.4|QQQQQQQGHKAPAAHPEGQLK.5|FEEELAAR.2|LQAANAEDIK.2|APAAHPEGQLK.2|RFEEELAAR.2|NEEDDMREMEEER.3|YLESLGEEQR.2|FHPDTDDVPVPAPAGDQK.3|EFGDTGEGWETVEMHPAYTEEELRR.4|EVWEELDGLDPNR.2
SEN / CTL,"Malate dehydrogenase, cytoplasmic",MDH1,P40925,-0.46,0.39,4.43E-06,6.23E-06,5.21E+00,"gluconeogenesis,tricarboxylic acid cycle,oxaloacetate metabolic process,malate metabolic process,NADH metabolic process","malic enzyme activity,L-malate dehydrogenase activity,diiodophenylpyruvate reductase activity,NAD binding","extracellular space,cytoplasm,mitochondrion,centrosome,cytosol,myelin sheath,extracellular exosome",33,23,39,FVEGLPINDFSR.2|VIVVGNPANTNC[CAM]LTASK.2|VIVVGNPANTNC[CAM]LTASK.3|SAPSIPKENFSC[CAM]LTR.3|SAPSIPKENFSC[CAM]LTR.2|EVGVYEALKDDSWLKGEFVTTVQQR.4|EVGVYEALKDDSWLKGEFVTTVQQR.3|NVIIWGNHSSTQYPDVNHAK.4|NVIIWGNHSSTQYPDVNHAK.3|NVIIWGNHSSTQYPDVNHAK.5|NVIIWGNHSSTQYPDVNHAK.2|ELTEEKESAFEFLSSA.2|ELTEEKESAFEFLSSA.3|EVGVYEALKDDSWLK.3|EVGVYEALKDDSWLK.2|AIC[CAM]DHVR.2|LSSAMSAAK.2|LGVTANDVK.2|DVIATDKEDVAFK.3|DVIATDKEDVAFK.2|KLSSAMSAAK.2|KLSSAM[Oxi]SAAK.2|EVGVYEALK.2|ENFSC[CAM]LTR.2|LGVTANDVKNVIIWGNHSSTQYPDVNHAK.6|LGVTANDVKNVIIWGNHSSTQYPDVNHAK.5|LGVTANDVKNVIIWGNHSSTQYPDVNHAK.4|ESAFEFLSSA.2|FVEGLPINDFSREK.3|SQGAALDKYAK.2|GEFVTTVQQR.2|VLVTGAAGQIAYSLLYSIGNGSVFGK.4|VLVTGAAGQIAYSLLYSIGNGSVFGK.3|DLDVAILVGSMPR.2|DLDVAILVGSM[Oxi]PR.2|SVKVIVVGNPANTNC[CAM]LTASK.3|DVIATDKEDVAFKDLDVAILVGSMPR.4|DVIATDKEDVAFKDLDVAILVGSM[Oxi]PR.4|DVIATDKEDVAFKDLDVAILVGSMPR.3
SEN / CTL,"Aspartate aminotransferase, cytoplasmic",GOT1,P17174,-0.46,0.23,1.75E-10,6.20E-10,9.21E+00,"gluconeogenesis,2-oxoglutarate metabolic process,oxaloacetate metabolic process,glycerol biosynthetic process,aspartate metabolic process,aspartate biosynthetic process,aspartate catabolic process,glutamate metabolic process,Notch signaling pathway,cellular amino acid biosynthetic process,glutamate catabolic process to aspartate,glutamate catabolic process to 2-oxoglutarate,cellular response to insulin stimulus,response to glucocorticoid,fatty acid homeostasis","L-aspartate:2-oxoglutarate aminotransferase activity,phosphatidylserine decarboxylase activity,pyridoxal phosphate binding,carboxylic acid binding,identical protein binding,L-cysteine:2-oxoglutarate aminotransferase activity,L-phenylalanine:2-oxoglutarate aminotransferase activity","nucleus,cytoplasm,lysosome,cytosol,axon terminus,extracellular exosome,mitochondrion",30,36,57,VGGVQSLGGTGALR.2|IGADFLAR.2|TDDC[CAM]HPWVLPVVK.3|TDDC[CAM]HPWVLPVVK.2|FLFPFFDSAYQGFASGNLER.3|FLFPFFDSAYQGFASGNLER.2|NLDYVATSIHEAVTK.3|NLDYVATSIHEAVTK.2|IANDNSLNHEYLPILGLAEFR.3|IANDNSLNHEYLPILGLAEFR.4|IANDNSLNHEYLPILGLAEFR.2|APPSVFAEVPQAQPVLVFK.3|APPSVFAEVPQAQPVLVFK.4|APPSVFAEVPQAQPVLVFK.2|IVASTLSNPELFEEWTGNVK.3|IVASTLSNPELFEEWTGNVK.4|IVASTLSNPELFEEWTGNVK.2|VGNLTVVGKEPESILQVLSQMEK.3|VGNLTVVGKEPESILQVLSQMEK.4|VGNLTVVGKEPESILQVLSQM[Oxi]EK.3|VGNLTVVGK.2|LALGDDSPALKEK.3|INVSGLTTK.2|RVGGVQSLGGTGALR.3|RVGGVQSLGGTGALR.2|VNLGVGAYR.2|LTADFREDPDPR.3|WYNGTNNK.2|LALGDDSPALKEKR.3|LALGDDSPALKEKR.2|NFGLYNER.2|HIYLLPSGR.2|KVNLGVGAYR.2|EPESILQVLSQMEK.3|EPESILQVLSQMEK.2|QVEYLVNEKHIYLLPSGR.4|LALGDDSPALK.2|QVEYLVNEK.2|NLDYVATSIHEAVTKIQ.3|TPGTWNHITDQIGM[Oxi]FSFTGLNPK.4|TPGTWNHITDQIGMFSFTGLNPK.4|TPGTWNHITDQIGM[Oxi]FSFTGLNPK.3|TPGTWNHITDQIGMFSFTGLNPK.3|HRFLFPFFDSAYQGFASGNLER.4|HRFLFPFFDSAYQGFASGNLER.3|ITWSNPPAQGAR.2|YFVSEGFEFFC[CAM]AQSFSK.3|YFVSEGFEFFC[CAM]AQSFSK.2|INVSGLTTKNLDYVATSIHEAVTKIQ.4|NTPVYVSSPTWENHNAVFSAAGFKDIR.4|NTPVYVSSPTWENHNAVFSAAGFKDIR.3|LEALKTPGTWNHITDQIGMFSFTGLNPK.4|VNLGVGAYRTDDC[CAM]HPWVLPVVK.3|KVNLGVGAYRTDDC[CAM]HPWVLPVVK.3|NTPVYVSSPTWENHNAVFSAAGFK.3|RGLDLQGFLNDLENAPEFSIVVLHAC[CAM]AHNPTGIDPTPEQWK.5|RGLDLQGFLNDLENAPEFSIVVLHAC[CAM]AHNPTGIDPTPEQWK.4
SEN / CTL,Peptidyl-prolyl cis-trans isomerase C,PPIC,P45877,-0.46,0.26,2.92E-03,1.90E-03,2.72E+00,"protein peptidyl-prolyl isomerization,protein folding","peptidyl-prolyl cis-trans isomerase activity,protein binding,cyclosporin A binding","cytoplasm,extracellular exosome",6,3,3,TPFVVEIADW.2|IVIGLFGK.2|TVENFVALATGEK.2
SEN / CTL,Endoplasmic reticulum aminopeptidase 1,ERAP1,Q9NZ08,-0.46,0.29,1.00E-08,2.58E-08,7.59E+00,"angiogenesis,adaptive immune response,antigen processing and presentation of peptide antigen via MHC class I,membrane protein ectodomain proteolysis,regulation of blood pressure,response to bacterium,antigen processing and presentation of endogenous peptide antigen via MHC class I,peptide catabolic process,regulation of innate immune response,fat cell differentiation,positive regulation of angiogenesis","endopeptidase activity,aminopeptidase activity,interleukin-6 receptor binding,interleukin-1, Type II receptor binding,protein binding,metalloexopeptidase activity,zinc ion binding,peptide binding,metalloaminopeptidase activity","extracellular region,extracellular space,endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum membrane,cytosol,plasma membrane,membrane,integral component of membrane,extracellular exosome",24,41,61,GFPLITITVR.2|ILASTQFEPTAAR.2|TKTDVLILPEEVEWIK.3|TKTDVLILPEEVEWIK.2|YQFSLSSTEK.2|LLRDLIDKQTWTDEGSVSER.4|MAFPC[CAM]FDEPAFK.2|M[Oxi]AFPC[CAM]FDEPAFK.2|ASLINNAFQLVSIGK.2|ASLINNAFQLVSIGK.3|TQEFPQILTLIGR.2|TQEFPQILTLIGR.3|SQHSSSSSHWHQEGVDVK.5|SQHSSSSSHWHQEGVDVK.4|SQHSSSSSHWHQEGVDVK.3|HLAISNMPLVK.3|HLAISNMPLVK.2|RDMNEVETQFK.3|RDMNEVETQFK.2|VGDYFFGK.2|VSVYAVPDK.2|LSEEPLQVLEHPR.3|LSEEPLQVLEHPR.2|VEITASQPTSTIILHSHHLQISR.5|VEITASQPTSTIILHSHHLQISR.4|VEITASQPTSTIILHSHHLQISR.3|ALDLSLYLK.2|EYLSADAFK.2|GAC[CAM]ILNMLR.2|NPVGYPLAWQFLR.3|NPVGYPLAWQFLR.2|SGIVQYLQK.2|LQWLLDESFKGDK.3|ESALLFDAEK.2|SQIEFALC[CAM]R.2|GTHTAVSSNDR.2|FMEFVSVSVTHPELK.3|FMEFVSVSVTHPELK.2|IKTQEFPQILTLIGR.3|FELGSSSIAHMVMGTTNQFSTR.4|FELGSSSIAHM[Oxi]VMGTTNQFSTR.3|FELGSSSIAHMVM[Oxi]GTTNQFSTR.3|FELGSSSIAHMVMGTTNQFSTR.3|DMNEVETQFK.2|EMFDDVSYDK.2|TMMNTWTLQK.2|LQWLLDESFK.2|RSDGTPFPWNK.2|SVTVAEGLIEDHFDVTVK.3|DLIDKQTWTDEGSVSER.3|QTWTDEGSVSER.2|C[CAM]VQQTIETIEENIGWMDK.3|SQLLLLAC[CAM]VHNYQPC[CAM]VQR.3|SQLLLLAC[CAM]VHNYQPC[CAM]VQR.2|GSDGAPDTGYLWHVPLTFITSK.3|GSDGAPDTGYLWHVPLTFITSK.2|HETEIM[Oxi]PVFQGLNELIPMYK.3|HETEIMPVFQGLNELIPM[Oxi]YK.3|HETEIMPVFQGLNELIPMYK.3|TDVLILPEEVEWIK.2|QDLAAIPDFQSGAMENWGLTTYR.3
SEN / CTL,CD166 antigen,ALCAM,Q13740,-0.47,0.48,1.63E-10,5.93E-10,9.23E+00,"adaptive immune response,cell adhesion,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,signal transduction,motor neuron axon guidance,retinal ganglion cell axon guidance,axon extension involved in axon guidance,neuron projection extension","receptor binding,protein binding","immunological synapse,integral component of plasma membrane,focal adhesion,external side of plasma membrane,axon,dendrite,intrinsic component of plasma membrane,neuronal cell body,extracellular exosome,T cell receptor complex",51,30,45,ALFLETEQLK.2|ESLTLIVEGKPQIK.3|ESLTLIVEGKPQIK.2|WKYEKPDGSPVFIAFR.4|WKYEKPDGSPVFIAFR.3|FVC[CAM]MLVTEDNVFEAPTIVK.3|VLHPLEGAVVIIFKK.3|VLHPLEGAVVIIFKK.4|QIGDALPVSC[CAM]TISASR.2|QIGDALPVSC[CAM]TISASR.3|ADIQMPFTC[CAM]SVTYYGPSGQK.3|ADIQMPFTC[CAM]SVTYYGPSGQK.2|LDVPQNLMFGK.2|LDVPQNLM[Oxi]FGK.2|C[CAM]LGNGNPPPEEFLFYLPGQPEGIR.3|SMIASTAITVHYLDLSLNPSGEVTR.3|EMDPVTQLYTMTSTLEYK.3|EMDPVTQLYTMTSTLEYK.2|VLHPLEGAVVIIFK.3|VLHPLEGAVVIIFK.2|YEKPDGSPVFIAFR.3|YEKPDGSPVFIAFR.2|TIIC[CAM]HVEGFPK.3|ALFLETEQLKK.3|ALFLETEQLKK.2|KTDPSGLSK.2|SSNTYTLTDVRR.3|DLGNMEENK.2|QPSKPEIVSK.2|KSVQYDDVPEYKDR.3|RFVC[CAM]MLVTEDNVFEAPTIVK.4|RFVC[CAM]MLVTEDNVFEAPTIVK.3|RFVC[CAM]M[Oxi]LVTEDNVFEAPTIVK.3|RFVC[CAM]MLVTEDNVFEAPTIVK.2|PDGSPVFIAFR.2|SSNTYTLTDVR.2|SVQYDDVPEYK.2|KSVQYDDVPEYK.2|TIHSEQAVFDIYYPTEQVTIQVLPPK.4|TIHSEQAVFDIYYPTEQVTIQVLPPK.3|SSPSFSSLHYQDAGNYVC[CAM]ETALQEVEGLK.4|SSPSFSSLHYQDAGNYVC[CAM]ETALQEVEGLK.3|SVQYDDVPEYKDR.2|TTKADIQMPFTC[CAM]SVTYYGPSGQK.3|SSPSFSSLHYQDAGNYVC[CAM]ETALQEVEGLKK.3
SEN / CTL,Ubiquitin-conjugating enzyme E2 K,UBE2K,P61086,-0.47,0.49,1.26E-01,4.29E-02,1.37E+00,"ubiquitin-dependent protein catabolic process,positive regulation of peptidyl-threonine phosphorylation,free ubiquitin chain polymerization,regulation of proteasomal ubiquitin-dependent protein catabolic process,cellular response to interferon-beta,proteasome-mediated ubiquitin-dependent protein catabolic process,positive regulation of type I interferon-mediated signaling pathway,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,protein K48-linked ubiquitination","ubiquitin-protein transferase activity,protein binding,ATP binding,ubiquitin protein ligase binding,ubiquitin-ubiquitin ligase activity","nucleus,cytoplasm,filopodium tip,extracellular exosome",6,16,27,LWAHVYAGAPVSSPEYTK.3|LWAHVYAGAPVSSPEYTK.4|LWAHVYAGAPVSSPEYTK.2|NAVIVALSSK.2|VDLVDENFTELR.3|VDLVDENFTELR.2|KIENLC[CAM]AM[Oxi]GFDR.3|KIENLC[CAM]AMGFDR.3|KIENLC[CAM]AM[Oxi]GFDR.2|KIENLC[CAM]AMGFDR.2|GEIAGPPDTPYEGGR.3|GEIAGPPDTPYEGGR.2|LWAHVYAGAPVSSPEYTKK.4|IWHPNISSVTGAIC[CAM]LDILK.4|IWHPNISSVTGAIC[CAM]LDILK.3|IWHPNISSVTGAIC[CAM]LDILK.2|DQWAAAMTLR.2|NQIKVDLVDENFTELR.3|IPETYPFNPPK.2|IENLC[CAM]AMGFDR.2|YQLEIKIPETYPFNPPK.3|TVLLSLQALLAAAEPDDPQDAVVANQYK.4|TVLLSLQALLAAAEPDDPQDAVVANQYK.3|VDLVDENFTELRGEIAGPPDTPYEGGR.4|VDLVDENFTELRGEIAGPPDTPYEGGR.3|EFKEVLKSEETSK.2|SWDVETATELLLSN.2
SEN / CTL,Glypican-1,GPC1,P35052,-0.47,0.36,3.17E-05,3.52E-05,4.45E+00,"retinoid metabolic process,glycosaminoglycan biosynthetic process,glycosaminoglycan catabolic process,axon guidance,Schwann cell differentiation,heparan sulfate proteoglycan catabolic process,glycosaminoglycan metabolic process,myelin assembly,negative regulation of fibroblast growth factor receptor signaling pathway,positive regulation of skeletal muscle cell differentiation","copper ion binding,fibroblast growth factor binding,laminin binding,heparan sulfate proteoglycan binding","proteinaceous extracellular matrix,extracellular space,endosome,Golgi lumen,plasma membrane,integral component of plasma membrane,anchored component of membrane,lysosomal lumen,membrane raft,extracellular exosome",21,13,13,VLQAMLATQLR.2|SFVQGLGVASDVVR.2|GFSLSDVPQAEISGEHLR.3|QLHPQLLLPDDYLDC[CAM]LGK.3|LVYC[CAM]AHC[CAM]LGVPGARPC[CAM]PDYC[CAM]R.4|SFVQGLGVASDVVRK.3|GC[CAM]LANQADLDAEWR.2|QAEALRPFGEAPR.3|SHAELETALR.2|VAQVPLGPEC[CAM]SR.2|DVQDFWISLPGTLC[CAM]SEK.3|NLLDSMVLITDK.2|TLQATFPGAFGELYTQNAR.2
SEN / CTL,Splicing factor 1,SF1,Q15637,-0.48,0.12,1.57E-02,7.67E-03,2.12E+00,"spliceosomal complex assembly,mRNA 3'-splice site recognition,mRNA splicing, via spliceosome,transcription, DNA-templated,regulation of transcription, DNA-templated,male sex determination,Leydig cell differentiation,negative regulation of smooth muscle cell proliferation,regulation of steroid biosynthetic process,negative regulation of nucleic acid-templated transcription","transcription corepressor activity,RNA binding,protein binding,zinc ion binding,poly(A) RNA binding","nucleus,nucleoplasm,spliceosomal complex,ribosome",3,20,37,VSDKVMIPQDEYPEINFVGLLIGPR.3|C[CAM]GGAGHIASDC[CAM]K.3|C[CAM]GGAGHIASDC[CAM]K.2|ILRPWQSSETR.3|ILRPWQSSETR.2|HNLITEMVALNPDFKPPADYKPPATR.6|HNLITEMVALNPDFKPPADYKPPATR.5|HNLITEM[Oxi]VALNPDFKPPADYKPPATR.5|HNLITEMVALNPDFKPPADYKPPATR.4|HNLITEM[Oxi]VALNPDFKPPADYKPPATR.4|HNLITEMVALNPDFKPPADYKPPATR.3|FQRPGDPQSAQDK.3|FQRPGDPQSAQDK.2|PGDPQSAQDK.2|QGIETPEDQNDLRK.3|QGIETPEDQNDLRK.2|TVIPGMPTVIPPGLTR.3|TVIPGM[Oxi]PTVIPPGLTR.2|TVIPGMPTVIPPGLTR.2|AYIVQLQIEDLTRK.3|AYIVQLQIEDLTRK.2|SITNTTVC[CAM]TK.2|KDGQMLPGEDEPLHALVTANTMENVKK.5|KDGQMLPGEDEPLHALVTANTMENVKK.4|WNQDTMEQK.2|WNQDTM[Oxi]EQK.2|VMIPQDEYPEINFVGLLIGPR.4|VM[Oxi]IPQDEYPEINFVGLLIGPR.3|VMIPQDEYPEINFVGLLIGPR.3|KLEEERHNLITEMVALNPDFKPPADYKPPATR.6|C[CAM]GGAGHIASDC[CAM]KFQRPGDPQSAQDK.4|DGQMLPGEDEPLHALVTANTMENVKK.4|DGQMLPGEDEPLHALVTANTMENVKK.3|SRWNQDTMEQK.2|QGIETPEDQNDLR.2|AYIVQLQIEDLTR.2|DGQMLPGEDEPLHALVTANTMENVK.3
SEN / CTL,Calmodulin,CALM1,P62158,-0.48,0.46,4.79E-08,1.05E-07,6.98E+00,"G2/M transition of mitotic cell cycle,MAPK cascade,response to amphetamine,regulation of heart rate,platelet degranulation,detection of calcium ion,glycogen catabolic process,muscle contraction,G-protein coupled receptor signaling pathway,activation of adenylate cyclase activity,Wnt signaling pathway, calcium modulating pathway,positive regulation of peptidyl-threonine phosphorylation,negative regulation of peptidyl-threonine phosphorylation,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,substantia nigra development,regulation of rhodopsin mediated signaling pathway,positive regulation of cyclic nucleotide metabolic process,positive regulation of protein autophosphorylation,regulation of cytokinesis,positive regulation of phosphoprotein phosphatase activity,ion transmembrane transport,positive regulation of protein dephosphorylation,Fc-epsilon receptor signaling pathway,positive regulation of DNA binding,positive regulation of GTPase activity,inositol phosphate metabolic process,regulation of nitric-oxide synthase activity,positive regulation of nitric-oxide synthase activity,positive regulation of cyclic-nucleotide phosphodiesterase activity,response to corticosterone,response to calcium ion,regulation of cardiac muscle contraction,negative regulation of ryanodine-sensitive calcium-release channel activity,positive regulation of ryanodine-sensitive calcium-release channel activity,positive regulation of protein serine/threonine kinase activity,regulation of high voltage-gated calcium channel activity,regulation of cell communication by electrical coupling involved in cardiac conduction","Ras guanyl-nucleotide exchange factor activity,calcium ion binding,protein binding,adenylate cyclase binding,inositol-1,4,5-trisphosphate 3-kinase activity,ligand-gated ion channel activity,protein kinase binding,protein domain specific binding,nitric-oxide synthase regulator activity,titin binding,type 3 metabotropic glutamate receptor binding,thioesterase binding,N-terminal myristoylation domain binding,phospholipase binding,protein serine/threonine kinase activator activity,phosphatidylinositol 3-kinase binding,ion channel binding,calcium-dependent protein binding,nitric-oxide synthase binding,protein phosphatase activator activity","spindle pole,extracellular region,nucleus,nucleoplasm,cytoplasm,centrosome,cytosol,spindle microtubule,plasma membrane,voltage-gated potassium channel complex,sarcomere,growth cone,vesicle,extracellular exosome,calcium channel complex",33,14,31,VFDKDGNGYISAAELR.3|VFDKDGNGYISAAELR.2|EAFSLFDKDGDGTITTK.3|EAFSLFDKDGDGTITTK.2|DTDSEEEIREAFR.3|DTDSEEEIREAFR.2|MKDTDSEEEIREAFR.4|MKDTDSEEEIREAFR.3|MKDTDSEEEIREAFR.2|M[Oxi]KDTDSEEEIREAFR.4|M[Oxi]KDTDSEEEIREAFR.3|EAFSLFDK.2|SLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMAR.4|SLGQNPTEAELQDM[Oxi]INEVDADGNGTIDFPEFLTMMAR.4|SLGQNPTEAELQDMINEVDADGNGTIDFPEFLTM[Oxi]M[Oxi]AR.4|SLGQNPTEAELQDMINEVDADGNGTIDFPEFLTM[Oxi]MAR.4|SLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMM[Oxi]AR.4|DGDGTITTK.2|M[Oxi]KDTDSEEEIR.3|MKDTDSEEEIR.3|MKDTDSEEEIR.2|M[Oxi]KDTDSEEEIR.2|KMKDTDSEEEIR.3|KM[Oxi]KDTDSEEEIR.3|HVMTNLGEK.2|DTDSEEEIR.2|DGNGYISAAELR.2|LTDEEVDEMIR.2|EADIDGDGQVNYEEFVQMMTAK.3|EADIDGDGQVNYEEFVQM[Oxi]MTAK.3|EADIDGDGQVNYEEFVQMM[Oxi]TAK.3
SEN / CTL,Tubulin-specific chaperone A,TBCA,O75347,-0.48,1.08,1.33E-02,6.74E-03,2.17E+00,"protein folding,tubulin complex assembly,post-chaperonin tubulin folding pathway","poly(A) RNA binding,beta-tubulin binding,chaperone binding","nucleolus,cytoplasm,microtubule,microtubule cytoskeleton,extracellular exosome",24,14,23,LVLDSVKLEA.2|ILENEKDLEEAEEYKEAR.4|ILENEKDLEEAEEYKEAR.3|LEAAYLDLQR.2|RLEAAYLDLQR.3|RLEAAYLDLQR.2|DLEEAEEYKEAR.2|DLEEAEEYKEAR.3|MMIPDC[CAM]QR.2|MM[Oxi]IPDC[CAM]QR.2|M[Oxi]M[Oxi]IPDC[CAM]QR.2|AEDGENYDIKK.3|AEDGENYDIKK.2|MRAEDGENYDIK.3|M[Oxi]RAEDGENYDIK.3|MRAEDGENYDIKK.3|M[Oxi]RAEDGENYDIKK.3|QAEILQESR.2|DLEEAEEYK.2|AEDGENYDIK.2|KQAEILQESR.2|ILENEKDLEEAEEYK.3|ILENEKDLEEAEEYK.2
SEN / CTL,DNA damage-binding protein 1,DDB1,Q16531,-0.49,0.45,1.45E-14,7.99E-14,1.31E+01,"nucleotide-excision repair, DNA damage recognition,nucleotide-excision repair, DNA duplex unwinding,DNA repair,transcription-coupled nucleotide-excision repair,nucleotide-excision repair,nucleotide-excision repair, preincision complex stabilization,nucleotide-excision repair, preincision complex assembly,nucleotide-excision repair, DNA incision, 3'-to lesion,nucleotide-excision repair, DNA incision, 5'-to lesion,viral process,Wnt signaling pathway,nucleotide-excision repair, DNA incision,histone H2A monoubiquitination,DNA damage response, detection of DNA damage,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,negative regulation of apoptotic process,proteasome-mediated ubiquitin-dependent protein catabolic process,positive regulation of viral genome replication,positive regulation by virus of viral protein levels in host cell,interaction with symbiont,global genome nucleotide-excision repair,UV-damage excision repair,regulation of mitotic cell cycle phase transition,positive regulation of viral release from host cell","DNA binding,protein binding,damaged DNA binding","nuclear chromosome, telomeric region,extracellular space,nucleus,nucleoplasm,cytoplasm,Cul4A-RING E3 ubiquitin ligase complex,Cul4B-RING E3 ubiquitin ligase complex,extracellular exosome,Cul4-RING E3 ubiquitin ligase complex",87,71,100,IGRPSETGIIGIIDPEC[CAM]R.3|LLASINSTVR.2|QSGESIDIITR.2|KTEPATGFIDGDLIESFLDISRPK.4|KTEPATGFIDGDLIESFLDISRPK.3|SDPNRETDDTLVLSFVGQTR.3|IVVFQYSDGKLQTVAEKEVK.4|LYDGLFK.2|LGKDPNTYFIVGTAMVYPEEAEPK.3|ALYYLQIHPQELR.3|ALYYLQIHPQELR.2|TKGDFILVGDLMR.3|TKGDFILVGDLMR.2|FLYGC[CAM]QAPTIC[CAM]FVYQDPQGR.3|EATADDLIKVVEELTR.3|EATADDLIKVVEELTR.2|IVVFQYSDGK.2|KIC[CAM]YQEVSQC[CAM]FGVLSSR.3|KIC[CAM]YQEVSQC[CAM]FGVLSSR.2|GLWPLRSDPNRETDDTLVLSFVGQTR.4|DLLFILTAK.2|QGQGQLVTC[CAM]SGAFKEGSLR.3|MQEVVANLQYDDGSGMKR.3|M[Oxi]QEVVANLQYDDGSGMKR.3|TEC[CAM]NHYNNIMALYLK.3|TEC[CAM]NHYNNIM[Oxi]ALYLK.3|TEC[CAM]NHYNNIMALYLK.2|SVLLLAYKPMEGNFEEIAR.3|SVLLLAYKPM[Oxi]EGNFEEIAR.3|SVLLLAYKPM[Oxi]EGNFEEIAR.2|SVLLLAYKPMEGNFEEIAR.2|EMLGGEIIPR.2|EM[Oxi]LGGEIIPR.2|SLSTTNVFAC[CAM]SDRPTVIYSSNHK.4|SLSTTNVFAC[CAM]SDRPTVIYSSNHK.3|IEVQDTSGGTTALRPSASTQALSSSVSSSK.4|IEVQDTSGGTTALRPSASTQALSSSVSSSK.3|NTRLEIYVVTAEGLRPVKEVGMYGK.5|NTRLEIYVVTAEGLRPVKEVGMYGK.4|NGIGIHEHASIDLPGIK.4|NGIGIHEHASIDLPGIK.3|NGIGIHEHASIDLPGIK.2|IAVM[Oxi]ELFRPK.3|IAVMELFRPK.3|IAVMELFRPK.2|IAVM[Oxi]ELFRPK.2|VVEELTR.2|LGDSQLVK.2|TYEVSLR.2|ALVSEWKEPQAK.3|ALVSEWKEPQAK.2|GESKDLLFILTAK.3|GESKDLLFILTAK.2|ILKLPSFELLHK.3|EATADDLIK.2|IAVMELFR.2|IEHSFWR.2|LYEWTTEKELR.3|LFMLLLEK.2|LFM[Oxi]LLLEK.2|LVFSNVNLK.2|NTRLEIYVVTAEGLRPVK.4|NTRLEIYVVTAEGLRPVK.3|TVPLYESPR.2|YLLGDMEGR.2|LYEWTTEK.2|LPSFELLHK.2|DSAATTDEER.2|YLAIAPPIIK.2|QSTIVC[CAM]HNR.2|LEIYVVTAEGLRPVK.3|LEIYVVTAEGLRPVK.2|REATADDLIK.2|ELRTEC[CAM]NHYNNIMALYLK.4|ELRTEC[CAM]NHYNNIMALYLK.3|YNAC[CAM]ILEYK.2|VTLGTQPTVLR.2|LEELHVIDVK.2|LEIYVVTAEGLRPVKEVGMYGK.4|NISVASC[CAM]NSSQVVVAVGR.3|NISVASC[CAM]NSSQVVVAVGR.2|GDFILVGDLMR.2|EEQMDGTVTLK.2|TEPATGFIDGDLIESFLDISRPK.4|TEPATGFIDGDLIESFLDISRPK.3|IC[CAM]YQEVSQC[CAM]FGVLSSR.3|IC[CAM]YQEVSQC[CAM]FGVLSSR.2|IVVFQYSDGKLQTVAEK.3|PMEGNFEEIAR.2|GAVYSMVEFNGK.2|IEVQDTSGGTTALR.2|QGQGQLVTC[CAM]SGAFK.2|LFMLLLEKEEQMDGTVTLK.3|PSASTQALSSSVSSSK.2|DPNTYFIVGTAMVYPEEAEPK.3|KTEPATGFIDGDLIESFLDISR.3|PSETGIIGIIDPEC[CAM]R.2|ETDDTLVLSFVGQTR.2|MQEVVANLQYDDGSGMK.2|QISHTEMEHEVAC[CAM]LDITPLGDSNGLSPLC[CAM]AIGLWTDISAR.4
SEN / CTL,Acylamino-acid-releasing enzyme,APEH,P13798,-0.49,0.37,2.50E-07,4.79E-07,6.32E+00,"translational termination,proteolysis,beta-amyloid metabolic process","serine-type endopeptidase activity,omega peptidase activity,poly(A) RNA binding","cytoplasm,cytosol,nuclear membrane,extracellular exosome",33,34,45,VTSVVVDVVPR.2|QVLLSEPEEAAALYR.2|QVLLSEPEEAAALYR.3|ALDVSASDDEIAR.2|ALDVSASDDEIAR.3|TPLLLMLGQEDR.2|TPLLLM[Oxi]LGQEDR.2|MGFAVLLVNYR.2|M[Oxi]GFAVLLVNYR.2|QYLVFHDGDSVVFAGPAGNSVETR.3|AGGTGPGEEKQFLEVWEK.3|QPALSAAC[CAM]LGPEVTTQYGGQYR.3|QPALSAAC[CAM]LGPEVTTQYGGQYR.2|LLTIDQDLMVAQFSTPSLPPTLK.3|GSTGFGQDSILSLPGNVGHQDVK.3|GSTGFGQDSILSLPGNVGHQDVK.2|TVHTEWTQRDLER.4|VGFLPSAGK.2|VVFDSAQR.2|AESFFQTK.2|RSALYYVDLIGGK.3|RSALYYVDLIGGK.2|SFNLSALEK.2|TPLLLMLGQEDRR.3|QFLEVWEK.2|C[CAM]ELLSDDSLAVSSPR.3|C[CAM]ELLSDDSLAVSSPR.2|TVHTEWTQR.2|LKKPDQAIKGDQFVFYEDWGENMVSK.5|SALYYVDLIGGK.2|HGPVYEDDC[CAM]FGC[CAM]LSWSHSETHLLYVAEK.5|HGPVYEDDC[CAM]FGC[CAM]LSWSHSETHLLYVAEK.4|QYLVFHDGDSVVFAGPAGNSVETRGELLSR.4|DVQFAVEQVLQEEHFDASHVALMGGSHGGFISC[CAM]HLIGQYPETYR.6|DVQFAVEQVLQEEHFDASHVALMGGSHGGFISC[CAM]HLIGQYPETYR.5|IVYLQYPSLIPHHQC[CAM]SQLC[CAM]LYDWYTK.4|IVYLQYPSLIPHHQC[CAM]SQLC[CAM]LYDWYTK.3|TQVPMVVMPHGGPHSSFVTAWMLFPAMLC[CAM]K.4|QDLFAVDTQVGTVTSLTAGGSGGSWK.3|STHALSEVEVESDSFMNAVLWLR.3|EQSVLWVSLEEAEPIPDIHWGIR.3|QLGENFSGIYC[CAM]SLLPLGC[CAM]WSADSQR.3|SRQDLFAVDTQVGTVTSLTAGGSGGSWK.3|GDQFVFYEDWGENMVSK.2|VLQPPPEQENVQYAGLDFEAILLQPGSPPDK.3
SEN / CTL,Xaa-Pro dipeptidase,PEPD,P12955,-0.49,0.45,1.46E-05,1.78E-05,4.75E+00,"proteolysis,cellular amino acid metabolic process,collagen catabolic process","aminopeptidase activity,metallocarboxypeptidase activity,manganese ion binding,proline dipeptidase activity",extracellular exosome,24,27,41,VPLALFALNR.2|YAVDDVQYVDEIASVLTSQKPSVLLTLR.3|YAVDDVQYVDEIASVLTSQKPSVLLTLR.4|YC[CAM]TDTGVLFR.2|VGMKEYELESLFEHYC[CAM]YSR.4|VFKTDMELEVLR.3|VFKTDMELEVLR.2|AVMGAMKPGVWWPDMHR.4|AVMGAMKPGVWWPDMHR.3|AVYEAVLR.2|IDEPGLR.2|LPASHATWMGK.3|LPASHATWMGK.2|LPASHATWM[Oxi]GK.2|STLFVPR.2|PSVLLTLR.2|AFTPFSGPK.2|EASFDGISK.2|FTADQKAVYEAVLR.3|TVEEIEAC[CAM]MAGC[CAM]DK.3|TVEEIEAC[CAM]MAGC[CAM]DK.2|TDMELEVLR.2|GVNTDSGSVC[CAM]R.2|HSSYTC[CAM]IC[CAM]GSGENSAVLHYGHAGAPNDR.5|HSSYTC[CAM]IC[CAM]GSGENSAVLHYGHAGAPNDR.4|HSSYTC[CAM]IC[CAM]GSGENSAVLHYGHAGAPNDR.3|FEVNNTILHPEIVEC[CAM]R.3|FEVNNTILHPEIVEC[CAM]R.2|EYELESLFEHYC[CAM]YSR.3|EYELESLFEHYC[CAM]YSR.2|NPAVQAGSIVVLQGGEETQR.3|NPAVQAGSIVVLQGGEETQR.2|EASFDGISKFEVNNTILHPEIVEC[CAM]R.4|EASFDGISKFEVNNTILHPEIVEC[CAM]R.3|KNPAVQAGSIVVLQGGEETQR.3|IEEDVVVTDSGIELLTC[CAM]VPR.3|IEEDVVVTDSGIELLTC[CAM]VPR.2|YAVDDVQYVDEIASVLTSQK.3|YAVDDVQYVDEIASVLTSQK.2|HLQPGM[Oxi]VLTVEPGIYFIDHLLDEALADPAR.4|TVEEIEAC[CAM]MAGC[CAM]DKAFTPFSGPK.3
SEN / CTL,U6 snRNA-associated Sm-like protein LSm8,LSM8,O95777,-0.49,0.19,3.40E-02,1.45E-02,1.84E+00,"mRNA splicing, via spliceosome","RNA binding,protein binding,U6 snRNA binding,poly(A) RNA binding","nucleoplasm,spliceosomal complex,U4/U6 x U5 tri-snRNP complex",3,4,6,GFDQTINLILDESHER.3|GFDQTINLILDESHER.2|TVAVITSDGR.2|VFSSSQGVEQVVLGLYIVR.3|VFSSSQGVEQVVLGLYIVR.2|GDNVAVIGEIDEETDSALDLGNIR.3
SEN / CTL,Splicing factor 3B subunit 3,SF3B3,Q15393,-0.50,0.19,2.67E-08,6.21E-08,7.21E+00,"RNA splicing, via transesterification reactions,mRNA splicing, via spliceosome,mRNA processing,protein complex assembly,RNA splicing,negative regulation of protein catabolic process",RNA binding,"nucleus,nucleoplasm,spliceosomal complex,U12-type spliceosomal complex,nucleolus,small nuclear ribonucleoprotein complex,catalytic step 2 spliceosome",15,61,96,FLAVGLVDNTVR.2|TVLDPVTGDLSDTR.2|TVLDPVTGDLSDTR.3|MFLYNLTLQR.2|MFLYNLTLQR.3|M[Oxi]FLYNLTLQR.2|FSNTGEDWYVLVGVAK.2|MQGQEAVLAMSSR.2|MQGQEAVLAMSSR.3|M[Oxi]QGQEAVLAMSSR.2|HIANYISGIQTIGHR.4|HIANYISGIQTIGHR.3|HIANYISGIQTIGHR.2|QDELGER.2|RRNDLDDPER.3|GLLNGASQK.2|LVYILNR.2|SYYFPVK.2|AVMISAIEK.2|AVM[Oxi]ISAIEK.2|FGNIC[CAM]VVR.2|IHQETFGK.2|LGAVFNQVAFPLQYTPR.4|LGAVFNQVAFPLQYTPR.3|LGAVFNQVAFPLQYTPR.2|NVSEELDR.2|RIVPGQFLAVDPK.3|RIVPGQFLAVDPK.2|ILELLRPDPNTGK.3|NDLDDPER.2|QKNVSEELDRTPPEVSK.4|NFGDQPDIR.2|SEHPPLC[CAM]GR.2|VHTLLTVEVFGVIR.3|VHTLLTVEVFGVIR.2|ATGISFAIHGNFSGTK.3|ATGISFAIHGNFSGTK.2|VIVSDVQESFIWVR.3|VIVSDVQESFIWVR.2|NVSEELDRTPPEVSK.3|NVSEELDRTPPEVSK.2|TPVEEVPAAIAPFQGR.3|TPVEEVPAAIAPFQGR.2|YFDTVPVAAAMC[CAM]VLK.3|YFDTVPVAAAMC[CAM]VLK.2|AGNGQWASVIR.2|DYIVVGSDSGR.2|IVILEYQPSK.2|LTISSPLEAHK.2|SVAGGFVYTYK.2|NENQLIIFADDTYPR.3|NENQLIIFADDTYPR.2|IVILEYQPSKNMFEK.3|LPPNTNDEVDEDPTGNK.3|LPPNTNDEVDEDPTGNK.2|GMIFVC[CAM]SATHK.2|GM[Oxi]IFVC[CAM]SATHK.2|ELAAEMAAAFLNENLPESIFGAPK.4|ELAAEMAAAFLNENLPESIFGAPK.3|SMFFFLAQTEQGDIFK.3|SM[Oxi]FFFLAQTEQGDIFK.2|SMFFFLAQTEQGDIFK.2|SWLSYSYQSR.2|IVPGQFLAVDPK.2|LKYFDTVPVAAAMC[CAM]VLK.3|LKYFDTVPVAAAMC[CAM]VLK.2|HGLEVSEMAVSELPGNPNAVWTVR.4|HGLEVSEMAVSELPGNPNAVWTVR.3|HGLEVSEM[Oxi]AVSELPGNPNAVWTVR.3|KQQMAEEMVEAAGEDER.3|RNENQLIIFADDTYPR.3|RNENQLIIFADDTYPR.2|AEVIMNYHVGETVLSLQK.3|AEVIM[Oxi]NYHVGETVLSLQK.3|AEVIMNYHVGETVLSLQK.2|HGLEVSEMAVSELPGNPNAVWTVRR.4|HGLEVSEMAVSELPGNPNAVWTVRR.3|NVIDGDLC[CAM]EQFNSMEPNK.3|NVIDGDLC[CAM]EQFNSMEPNK.2|FVIHPESNNLIIIETDHNAYTEATK.4|FVIHPESNNLIIIETDHNAYTEATK.3|KFVIHPESNNLIIIETDHNAYTEATK.4|KFVIHPESNNLIIIETDHNAYTEATK.3|FHLTPLSYETLEFASGFASEQC[CAM]PEGIVAISTNTLR.5|FHLTPLSYETLEFASGFASEQC[CAM]PEGIVAISTNTLR.4|LVNNGEKLEFLHK.2|NVIDGDLC[CAM]EQFNSMEPNKQK.3|TTLIPGGSESLVYTTLSGGIGILVPFTSHEDHDFFQHVEMHLR.6|TTLIPGGSESLVYTTLSGGIGILVPFTSHEDHDFFQHVEMHLR.5|ITLETDEDMVTEIR.2|FSNTGEDWYVLVGVAKDLILNPR.3|QQMAEEMVEAAGEDER.2|IISLDPSDC[CAM]LQPLSMQALPAQPESLC[CAM]IVEMGGTEK.4|WVTTASLLDYDTVAGADK.2|WVTTASLLDYDTVAGADKFGNIC[CAM]VVR.3|VMNPIQGNTLDLVQLEQNEAAFSVAVC[CAM]R.3
SEN / CTL,NIF3-like protein 1,NIF3L1,Q9GZT8,-0.50,0.37,2.13E-04,1.98E-04,3.70E+00,"neuron differentiation,positive regulation of transcription, DNA-templated,negative regulation of nucleic acid-templated transcription","protein binding,transcription factor binding,identical protein binding","nucleus,cytoplasm,mitochondrion",12,15,19,GIDGVSVTSFSAR.2|ALMQVVDFLSR.2|ALM[Oxi]QVVDFLSR.2|VGIYSPHTAYDAAPQGVNNWLAK.3|VGIYSPHTAYDAAPQGVNNWLAK.4|TEILSLEKPLLLHTGMGR.4|TEILSLEKPLLLHTGMGR.3|DMLDSHLENK.3|APNYPTEGNHR.3|APNYPTEGNHR.2|TEILSLEK.2|INLNC[CAM]TQK.2|ADLILSYHPPIFR.3|GFLSDLRDMLDSHLENK.3|APNYPTEGNHRVEFNVNYTQDLDK.4|VEFNVNYTQDLDKVMSAVK.3|VEFNVNYTQDLDK.2|INIILSETDRDPLQVV.2|LC[CAM]TLDESVSLATMIDR.2
SEN / CTL,"HLA class I histocompatibility antigen, B-44 alpha chain;HLA class I histocompatibility antigen, B-45 alpha chain",HLA-B,P30481;P30483,-0.50,1.16,9.19E-03,4.98E-03,2.30E+00,;,;,;,9,3,4,DGEDQTQDTELVETRPAGDR.3|DGEDQTQDTELVETRPAGDR.4|AYLEGLC[CAM]VESLR.2|DGEDQTQDTELVETRPAGDRTFQK.4
SEN / CTL,L-lactate dehydrogenase A-like 6B,LDHAL6B,Q9BYZ2,-0.51,0.30,4.67E-03,2.82E-03,2.55E+00,"carbohydrate metabolic process,pyruvate metabolic process,oxidation-reduction process",L-lactate dehydrogenase activity,"nucleus,mitochondrial matrix",6,1,2,LIIVSNPVDILTYVAWK.3|LIIVSNPVDILTYVAWK.2
SEN / CTL,Mesencephalic astrocyte-derived neurotrophic factor,MANF,P55145,-0.51,0.25,1.14E-05,1.45E-05,4.84E+00,"response to unfolded protein,biological_process,neuron projection development,dopaminergic neuron differentiation","growth factor activity,poly(A) RNA binding","extracellular space,nucleus,endoplasmic reticulum",12,16,22,FYQDLKDRDVTFSPATIENELIK.4|IINEVSKPLAHHIPVEK.4|IINEVSKPLAHHIPVEK.3|LC[CAM]YYIGATDDAATK.2|LC[CAM]YYIGATDDAATK.3|QIDLSTVDLK.2|QIDLSTVDLKK.3|QIDLSTVDLKK.2|INELMPK.2|KILDDWGETC[CAM]K.3|KILDDWGETC[CAM]K.2|KINELMPK.2|DSQIC[CAM]ELK.2|PLAHHIPVEK.2|ILDDWGETC[CAM]KGC[CAM]AEK.3|ILDDWGETC[CAM]KGC[CAM]AEK.2|ILDDWGETC[CAM]K.2|KILDDWGETC[CAM]KGC[CAM]AEK.3|DRDVTFSPATIENELIK.3|DRDVTFSPATIENELIK.2|DSQIC[CAM]ELKYDK.2|DVTFSPATIENELIK.2
SEN / CTL,CD44 antigen,CD44,P16070,-0.51,0.46,7.62E-03,4.27E-03,2.37E+00,"cell-matrix adhesion,single organismal cell-cell adhesion,extracellular matrix disassembly,extracellular matrix organization,hyaluronan catabolic process,positive regulation of peptidyl-serine phosphorylation,positive regulation of heterotypic cell-cell adhesion,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,negative regulation of DNA damage response, signal transduction by p53 class mediator,cellular response to fibroblast growth factor stimulus,positive regulation of peptidyl-tyrosine phosphorylation,leukocyte migration,cartilage development,interferon-gamma-mediated signaling pathway,positive regulation of ERK1 and ERK2 cascade,monocyte aggregation,positive regulation of monocyte aggregation,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator","collagen binding,hyaluronic acid binding,cytokine receptor activity","cytoplasm,Golgi apparatus,plasma membrane,integral component of plasma membrane,focal adhesion,cell surface,macrophage migration inhibitory factor receptor complex,extracellular exosome",12,12,18,YGFIEGHVVIPR.3|YGFIEGHVVIPR.2|ALSIGFETC[CAM]R.2|SQEMVHLVNKESSETPDQFMTADETR.4|SQEM[Oxi]VHLVNK.3|SQEMVHLVNK.2|SQEM[Oxi]VHLVNK.2|TEAADLC[CAM]K.2|NLQNVDMK.2|NLQNVDM[Oxi]K.2|KLVINSGNGAVEDR.3|KLVINSGNGAVEDR.2|FAGVFHVEK.2|KPSGLNGEASK.2|LVINSGNGAVEDRKPSGLNGEASK.4|LVINSGNGAVEDR.2|ESSETPDQFM[Oxi]TADETR.2|ESSETPDQFMTADETR.2
SEN / CTL,Heterogeneous nuclear ribonucleoproteins A2/B1,HNRNPA2B1,P22626,-0.51,1.10,2.42E-05,2.81E-05,4.55E+00,"negative regulation of transcription from RNA polymerase II promoter,mRNA splicing, via spliceosome,mRNA processing,mRNA export from nucleus,gene expression,primary miRNA processing,negative regulation of mRNA splicing, via spliceosome,RNA transport,miRNA transport","nucleotide binding,RNA binding,mRNA 3'-UTR binding,protein binding,miRNA binding,single-stranded telomeric DNA binding,poly(A) RNA binding,pre-mRNA intronic binding,N6-methyladenosine-containing RNA binding","nucleus,nucleoplasm,spliceosomal complex,cytoplasm,membrane,intracellular ribonucleoprotein complex,extracellular exosome,catalytic step 2 spliceosome",60,47,96,IDTIEIITDR.2|LFIGGLSFETTEESLR.3|LFIGGLSFETTEESLR.2|GFGFVTFDDHDPVDKIVLQK.4|GFGFVTFDDHDPVDKIVLQK.3|GFGFVTFDDHDPVDKIVLQK.2|GGNFGFGDSR.2|KLFIGGLSFETTEESLR.3|KLFIGGLSFETTEESLR.2|KLFIGGLSFETTEESLRNYYEQWGK.4|KLFIGGLSFETTEESLRNYYEQWGK.3|GGGGNFGPGPGSNFRGGSDGYGSGR.3|LTDC[CAM]VVMRDPASKR.4|LTDC[CAM]VVMRDPASKR.3|LTDC[CAM]VVM[Oxi]RDPASKR.4|GGGGNFGPGPGSNFR.2|GGGGNFGPGPGSNFR.3|GFGFVTFDDHDPVDK.3|GFGFVTFDDHDPVDK.2|GFGFVTFSSMAEVDAAMAARPHSIDGR.4|GFGFVTFSSM[Oxi]AEVDAAMAARPHSIDGR.4|GFGFVTFSSMAEVDAAMAARPHSIDGR.5|GFGFVTFSSMAEVDAAM[Oxi]AARPHSIDGR.4|GFGFVTFSSM[Oxi]AEVDAAM[Oxi]AARPHSIDGR.4|GFGFVTFSSM[Oxi]AEVDAAMAARPHSIDGR.3|GFGFVTFSSMAEVDAAM[Oxi]AARPHSIDGR.3|GFGFVTFSSMAEVDAAMAARPHSIDGR.3|RGFGFVTFDDHDPVDKIVLQK.4|RGFGFVTFDDHDPVDKIVLQK.3|SRGFGFVTFSSMAEVDAAMAARPHSIDGR.5|SRGFGFVTFSSMAEVDAAM[Oxi]AARPHSIDGR.5|ALSRQEMQEVQSSR.3|ALSRQEM[Oxi]QEVQSSR.3|ALSRQEMQEVQSSR.2|LFIGGLSFETTEESLRNYYEQWGK.3|LFIGGLSFETTEESLRNYYEQWGK.4|KLFVGGIKEDTEEHHLR.5|KLFVGGIKEDTEEHHLR.4|KLFVGGIKEDTEEHHLR.3|KLFVGGIKEDTEEHHLR.2|PGAHVTVK.2|QEMQEVQSSR.3|QEMQEVQSSR.2|QEM[Oxi]QEVQSSR.2|AVAREESGKPGAHVTVK.4|AVAREESGKPGAHVTVK.3|KLFVGGIK.2|SGRGGNFGFGDSR.3|EESGKPGAHVTVK.3|EESGKPGAHVTVK.2|GGSDGYGSGR.2|RGFGFVTFDDHDPVDK.4|RGFGFVTFDDHDPVDK.3|RGFGFVTFDDHDPVDK.2|LFVGGIKEDTEEHHLR.4|LFVGGIKEDTEEHHLR.3|PGAHVTVKK.2|YHTINGHNAEVR.3|YHTINGHNAEVR.2|RAVAREESGKPGAHVTVK.4|EESGKPGAHVTVKK.3|EESGKPGAHVTVKK.2|KRGFGFVTFDDHDPVDK.4|LTDC[CAM]VVMR.2|LTDC[CAM]VVM[Oxi]R.2|LTDC[CAM]VVM[Oxi]RDPASK.3|LTDC[CAM]VVMRDPASK.3|LTDC[CAM]VVM[Oxi]RDPASK.2|LTDC[CAM]VVMRDPASK.2|YHTINGHNAEVRK.3|YHTINGHNAEVRK.2|DYFEEYGK.2|IDTIEIITDRQSGK.3|TLETVPLER.2|NYYEQWGK.2|EDTEEHHLRDYFEEYGK.4|EDTEEHHLRDYFEEYGK.3|EDTEEHHLRDYFEEYGK.2|NMGGPYGGGNYGPGGSGGSGGYGGR.4|NM[Oxi]GGPYGGGNYGPGGSGGSGGYGGR.3|NMGGPYGGGNYGPGGSGGSGGYGGR.3|NM[Oxi]GGPYGGGNYGPGGSGGSGGYGGR.2|NMGGPYGGGNYGPGGSGGSGGYGGR.2|LFVGGIKEDTEEHHLRDYFEEYGK.5|LFVGGIKEDTEEHHLRDYFEEYGK.4|LFVGGIKEDTEEHHLRDYFEEYGK.3|TLETVPLERK.2|EDTEEHHLRDYFEEYGKIDTIEIITDR.5|EDTEEHHLRDYFEEYGKIDTIEIITDR.4|GFGFVTFSSMAEVDAAMAAR.3|GFGFVTFSSMAEVDAAMAAR.2|DYFEEYGKIDTIEIITDR.3|DYFEEYGKIDTIEIITDR.2|GGNFGFGDSRGGGGNFGPGPGSNFR.3|GFGDGYNGYGGGPGGGNFGGSPGYGGGR.3|SGNFGGSRNMGGPYGGGNYGPGGSGGSGGYGGR.3
SEN / CTL,Beta-hexosaminidase subunit alpha,HEXA,P06865,-0.52,0.37,1.54E-06,2.47E-06,5.61E+00,"carbohydrate metabolic process,glycosaminoglycan biosynthetic process,glycosphingolipid metabolic process,chondroitin sulfate catabolic process,hyaluronan catabolic process,keratan sulfate catabolic process","beta-N-acetylhexosaminidase activity,acetylglucosaminyltransferase activity,protein heterodimerization activity","membrane,azurophil granule,lysosomal lumen,extracellular exosome",24,21,32,ALLSAPWYLNR.2|GLETFSQLVWK.2|SNPEIQDFMR.2|LTSDLTFAYER.2|LNVFHWHLVDDPSFPYESFTFPELMR.4|LNVFHWHLVDDPSFPYESFTFPELMR.3|GYVVWQEVFDNKVK.3|GYVVWQEVFDNKVK.2|HYLPLSSILDTLDVMAYNK.3|HYLPLSSILDTLDVMAYNK.4|HYLPLSSILDTLDVM[Oxi]AYNK.3|HYLPLSSILDTLDVM[Oxi]AYNK.2|HYLPLSSILDTLDVMAYNK.2|IQPDTIIQVWR.2|IQPDTIIQVWR.3|GLLLDTSR.2|ISYGPDWK.2|GYVVWQEVFDNK.3|GYVVWQEVFDNK.2|TEIEDFPR.2|EDIPVNYMK.2|YRDLLFGSGSWPRPYLTGK.4|GSYNPVTHIYTAQDVK.3|GSYNPVTHIYTAQDVK.2|IQPDTIIQVWREDIPVNYMK.4|IQPDTIIQVWREDIPVNYMK.3|DLLFGSGSWPRPYLTGK.3|KGSYNPVTHIYTAQDVK.3|RGVQAQPLNVGFC[CAM]EQEFEQT.3|RGVQAQPLNVGFC[CAM]EQEFEQT.2|YVLYPNNFQFQYDVSSAAQPGC[CAM]SVLDEAFQR.4|GVQAQPLNVGFC[CAM]EQEFEQT.2
SEN / CTL,Brain acid soluble protein 1,BASP1,P80723,-0.52,0.72,4.90E-02,1.97E-02,1.71E+00,"thorax and anterior abdomen determination,gonad development,substantia nigra development,negative regulation of transcription, DNA-templated,mesenchymal to epithelial transition,positive regulation of heart growth,diaphragm development,metanephric mesenchyme development,glomerular visceral epithelial cell differentiation,positive regulation of metanephric ureteric bud development","transcription corepressor activity,protein binding,protein domain specific binding,transcription regulatory region DNA binding","nucleus,cytoplasm,cytoskeleton,plasma membrane,nuclear speck,cell junction,growth cone,vesicle,extracellular exosome,COP9 signalosome",9,28,41,AQGPAASAEEPKPVEAPAANSDQTVTVKE.3|AQGPAASAEEPKPVEAPAANSDQTVTVKE.4|AAEAAAAPAESAAPAAGEEPSKEEGEPK.3|AAEAAAAPAESAAPAAGEEPSKEEGEPK.4|DAAAAKEEAPKAEPEK.4|DAAAAKEEAPKAEPEK.3|AEPEKTEGAAEAK.3|ETPAATEAPSSTPK.3|ETPAATEAPSSTPK.2|EEAPKAEPEKTEGAAEAK.4|EEAPKAEPEKTEGAAEAK.3|GYNVNDEK.2|KTEAPAAPAAQETK.3|KTEAPAAPAAQETK.2|ESEPQAAAEPAEAK.3|ESEPQAAAEPAEAK.2|KAEGAATEEEGTPK.3|KAEGAATEEEGTPK.2|EKPDQDAEGKAEEKEGEK.4|EKPDQDAEGKAEEK.3|KGYNVNDEK.2|DAAAAKEEAPK.2|DKKAEGAATEEEGTPK.3|DKKAEGAATEEEGTPK.2|EEAPKAEPEK.2|AEPPKAPEQEQAAPGPAAGGEAPK.4|AEPPKAPEQEQAAPGPAAGGEAPK.3|ESEPQAAAEPAEAKEGK.3|APEQEQAAPGPAAGGEAPK.3|APEQEQAAPGPAAGGEAPK.2|AEGAATEEEGTPK.2|SDGAPASDSKPGSSEAAPSSK.3|TEAPAAPAAQETK.2|AAEAAAAPAESAAPAAGEEPSK.3|AAEAAAAPAESAAPAAGEEPSK.2|KTEAPAAPAAQETKSDGAPASDSKPGSSEAAPSSK.5|AAEAAAAPAESAAPAAGEEPSKEEGEPKK.4|AQGPAASAEEPKPVEAPAANSDQTVTVK.4|AQGPAASAEEPKPVEAPAANSDQTVTVK.3|KAEGAATEEEGTPKESEPQAAAEPAEAK.4|AEGAATEEEGTPKESEPQAAAEPAEAK.3
SEN / CTL,"Glutathione reductase, mitochondrial",GSR,P00390,-0.53,0.86,5.03E-02,2.01E-02,1.70E+00,"response to reactive oxygen species,glutathione metabolic process,nucleobase-containing small molecule interconversion,cell redox homeostasis,oxidation-reduction process,cellular oxidant detoxification","glutathione-disulfide reductase activity,electron carrier activity,flavin adenine dinucleotide binding,NADP binding","mitochondrial matrix,cytosol,external side of plasma membrane,extracellular exosome",33,32,54,GIYAVGDVC[CAM]GK.2|ALLTPVAIAAGR.2|GHAAFTSDPKPTIEVSGK.4|GHAAFTSDPKPTIEVSGK.3|GHAAFTSDPKPTIEVSGK.2|AAVVESHKLGGTC[CAM]VNVGC[CAM]VPK.4|AAVVESHKLGGTC[CAM]VNVGC[CAM]VPK.3|ADFDNTVAIHPTSSEELVTLR.3|ADFDNTVAIHPTSSEELVTLR.2|LPVMTMIPDVDC[CAM]LLWAIGR.3|LPVM[Oxi]TMIPDVDC[CAM]LLWAIGR.3|SFDSMISTNC[CAM]TEELENAGVEVLK.3|VVGIHMQGLGC[CAM]DEMLQGFAVAVK.3|VVGIHM[Oxi]QGLGC[CAM]DEMLQGFAVAVK.3|TYSTSFTPMYHAVTK.3|TYSTSFTPM[Oxi]YHAVTK.3|TYSTSFTPMYHAVTK.2|ALLTPVAIAAGRK.3|ALLTPVAIAAGRK.2|YGIENVK.2|AAVVESHK.2|RAAELGAR.2|LNAIYQNNLTK.3|LNAIYQNNLTK.2|RDAYVSR.2|SHIEIIR.2|LGIQTDDK.2|GHAAFTSDPKPTIEVSGKK.4|GHIIVDEFQNTNVK.3|GHIIVDEFQNTNVK.2|TLSGLEVSMVTAVPGR.3|TLSGLEVSMVTAVPGR.2|KTLSGLEVSMVTAVPGR.3|EDSKLDYNNIPTVVFSHPPIGTVGLTEDEAIHK.6|EDSKLDYNNIPTVVFSHPPIGTVGLTEDEAIHK.4|VMWNTAVHSEFMHDHADYGFPSC[CAM]EGK.5|VMWNTAVHSEFMHDHADYGFPSC[CAM]EGK.4|LFEYKEDSKLDYNNIPTVVFSHPPIGTVGLTEDEAIHK.7|LFEYKEDSKLDYNNIPTVVFSHPPIGTVGLTEDEAIHK.6|LFEYKEDSKLDYNNIPTVVFSHPPIGTVGLTEDEAIHK.5|LFEYKEDSKLDYNNIPTVVFSHPPIGTVGLTEDEAIHK.4|LGIQTDDKGHIIVDEFQNTNVK.4|LGIQTDDKGHIIVDEFQNTNVK.3|KVMWNTAVHSEFMHDHADYGFPSC[CAM]EGK.5|KVMWNTAVHSEFMHDHADYGFPSC[CAM]EGK.4|DAYVSRLNAIYQNNLTK.3|LGGTC[CAM]VNVGC[CAM]VPK.2|LDYNNIPTVVFSHPPIGTVGLTEDEAIHK.4|LDYNNIPTVVFSHPPIGTVGLTEDEAIHK.3|QEPQPQGPPPAAGAVASYDYLVIGGGSGGLASAR.4|QEPQPQGPPPAAGAVASYDYLVIGGGSGGLASAR.3|KYTAPHILIATGGMPSTPHESQIPGASLGITSDGFFQLEELPGR.5|YTAPHILIATGGM[Oxi]PSTPHESQIPGASLGITSDGFFQLEELPGR.4|YTAPHILIATGGMPSTPHESQIPGASLGITSDGFFQLEELPGR.4
SEN / CTL,Tumor necrosis factor-inducible gene 6 protein,TNFAIP6,P98066,-0.54,0.15,2.74E-02,1.23E-02,1.91E+00,"inflammatory response,cell adhesion,signal transduction,cell-cell signaling,positive regulation of cell migration,ovulation,negative regulation of inflammatory response","protein binding,hyaluronic acid binding",extracellular space,3,1,1,FLSDASVTAGGFQIK.2
SEN / CTL,UV excision repair protein RAD23 homolog B,RAD23B,P54727,-0.54,0.32,2.45E-07,4.72E-07,6.33E+00,"nucleotide-excision repair, DNA damage recognition,nucleotide-excision repair, DNA duplex unwinding,nucleotide-excision repair,nucleotide-excision repair, preincision complex assembly,spermatogenesis,regulation of proteasomal ubiquitin-dependent protein catabolic process,proteasome-mediated ubiquitin-dependent protein catabolic process,embryonic organ development,global genome nucleotide-excision repair","damaged DNA binding,single-stranded DNA binding,protein binding,polyubiquitin binding","proteasome complex,nucleus,nucleoplasm,cytoplasm,XPC complex",21,20,33,NFVVVMVTKPK.2|NFVVVMVTKPK.3|ILNDDTALKEYKIDEK.4|ILNDDTALKEYKIDEK.3|TLQQQTFKIDIDPEETVK.3|TLQQQTFKIDIDPEETVK.2|EQVIAALR.2|QIIQQNPSLLPALLQQIGR.3|QIIQQNPSLLPALLQQIGR.4|QIIQQNPSLLPALLQQIGR.2|ASFNNPDR.2|ILNDDTALKEYK.3|ILNDDTALK.2|GKDAFPVAGQK.2|IDIDPEETVK.2|NQPQFQQMR.2|NQPQFQQM[Oxi]R.2|PAEKPAETPVATSPTATDSTSGDSSR.4|PAEKPAETPVATSPTATDSTSGDSSR.3|NENLAANFLLQQNFDED.3|NENLAANFLLQQNFDED.2|ALGFPEGLVIQAYFAC[CAM]EK.3|ALGFPEGLVIQAYFAC[CAM]EK.2|PAETPVATSPTATDSTSGDSSR.3|PAETPVATSPTATDSTSGDSSR.2|AVEYLLM[Oxi]GIPGDR.2|AVEYLLMGIPGDR.2|QEKPAEKPAETPVATSPTATDSTSGDSSR.4|QEKPAEKPAETPVATSPTATDSTSGDSSR.3|ASFNNPDRAVEYLLMGIPGDR.3|IESEKGKDAFPVAGQK.2|ESQAVVDPPQAASTGAPQSSAVAAAAATTTATTTTTSSGGHPLEFLR.5|ESQAVVDPPQAASTGAPQSSAVAAAAATTTATTTTTSSGGHPLEFLR.4
SEN / CTL,Hypoxanthine-guanine phosphoribosyltransferase,HPRT1,P00492,-0.54,0.52,7.51E-05,7.68E-05,4.11E+00,"response to amphetamine,purine nucleotide biosynthetic process,purine ribonucleoside salvage,adenine salvage,guanine salvage,grooming behavior,locomotory behavior,cytolysis,striatum development,cerebral cortex neuron differentiation,central nervous system neuron development,GMP salvage,IMP salvage,dopamine metabolic process,purine-containing compound salvage,hypoxanthine salvage,positive regulation of dopamine metabolic process,GMP catabolic process,IMP metabolic process,hypoxanthine metabolic process,lymphocyte proliferation,dendrite morphogenesis,protein homotetramerization","nucleotide binding,magnesium ion binding,hypoxanthine phosphoribosyltransferase activity,protein binding,protein homodimerization activity,guanine phosphoribosyltransferase activity","cytoplasm,cytosol,extracellular exosome",21,17,27,SIPMTVDFIR.2|NVLIVEDIIDTGK.2|TMQTLLSLVR.2|TM[Oxi]QTLLSLVR.2|VFIPHGLIMDR.3|VFIPHGLIM[Oxi]DR.3|DLNHVC[CAM]VISETGK.3|DLNHVC[CAM]VISETGK.2|VIGGDDLSTLTGK.2|FFADLLDYIK.2|SYC[CAM]NDQSTGDIK.3|SYC[CAM]NDQSTGDIK.2|DVMKEMGGHHIVALC[CAM]VLK.4|EMGGHHIVALC[CAM]VLK.3|EM[Oxi]GGHHIVALC[CAM]VLK.3|EMGGHHIVALC[CAM]VLK.2|LKSYC[CAM]NDQSTGDIK.3|GGYKFFADLLDYIK.3|GGYKFFADLLDYIK.2|FVVGYALDYNEYFR.3|FVVGYALDYNEYFR.2|SVGYKPDFVGFEIPDK.3|SVGYKPDFVGFEIPDK.2|PDFVGFEIPDK.2|SPGVVISDDEPGYDLDLFC[CAM]IPNHYAEDLER.4|SPGVVISDDEPGYDLDLFC[CAM]IPNHYAEDLER.3|SVGYKPDFVGFEIPDKFVVGYALDYNEYFR.4
SEN / CTL,"Fumarate hydratase, mitochondrial",FH,P07954,-0.55,0.71,5.40E-03,3.21E-03,2.49E+00,"tricarboxylic acid cycle,fumarate metabolic process,malate metabolic process,homeostasis of number of cells within a tissue,protein tetramerization",fumarate hydratase activity,"cytoplasm,mitochondrion,mitochondrial matrix,cytosol,tricarboxylic acid cycle enzyme complex,extracellular exosome",18,30,61,IYELAAGGTAVGTGLNTR.2|IYELAAGGTAVGTGLNTR.3|THTQDAVPLTLGQEFSGYVQQVK.3|THTQDAVPLTLGQEFSGYVQQVK.4|AAAEVNQDYGLDPK.2|AAAEVNQDYGLDPK.3|RAAAEVNQDYGLDPK.3|RAAAEVNQDYGLDPK.2|VAALTGLPFVTAPNKFEALAAHDALVELSGAMNTTAC[CAM]SLMK.4|VAALTGLPFVTAPNKFEALAAHDALVELSGAMNTTAC[CAM]SLMK.5|VAALTGLPFVTAPNKFEALAAHDALVELSGAMNTTAC[CAM]SLM[Oxi]K.5|VAALTGLPFVTAPNKFEALAAHDALVELSGAMNTTAC[CAM]SLM[Oxi]K.4|EFAQIIK.2|IPVHPNDHVNK.3|IPVHPNDHVNK.2|LHDALDAK.2|AADEVAEGK.2|IANDIRFLGSGPR.3|YYGAQTVR.2|AIEMLGGELGSKIPVHPNDHVNK.5|AIEMLGGELGSKIPVHPNDHVNK.4|VAALTGLPFVTAPNK.3|VAALTGLPFVTAPNK.2|VPNDKYYGAQTVR.3|SKEFAQIIK.2|LMNESLMLVTALNPHIGYDK.4|LMNESLMLVTALNPHIGYDK.3|LM[Oxi]NESLM[Oxi]LVTALNPHIGYDK.3|LM[Oxi]NESLMLVTALNPHIGYDK.3|LMNESLM[Oxi]LVTALNPHIGYDK.3|LMNESLMLVTALNPHIGYDK.2|IEYDTFGELKVPNDK.3|IEYDTFGELKVPNDK.2|AIEMLGGELGSK.2|AIEM[Oxi]LGGELGSK.2|IEYDTFGELK.2|NGSTLKETAIELGYLTAEQFDEWVKPK.5|NGSTLKETAIELGYLTAEQFDEWVKPK.4|NGSTLKETAIELGYLTAEQFDEWVKPK.3|ETAIELGYLTAEQFDEWVKPK.4|ETAIELGYLTAEQFDEWVKPK.3|SQSSNDTFPTAMHIAAAIEVHEVLLPGLQK.5|SQSSNDTFPTAM[Oxi]HIAAAIEVHEVLLPGLQK.4|SQSSNDTFPTAMHIAAAIEVHEVLLPGLQK.4|SQSSNDTFPTAMHIAAAIEVHEVLLPGLQK.3|INKLMNESLMLVTALNPHIGYDK.4|IEYDTFGELKVPNDKYYGAQTVR.4|IEYDTFGELKVPNDKYYGAQTVR.3|FEALAAHDALVELSGAMNTTAC[CAM]SLMK.4|FEALAAHDALVELSGAMNTTAC[CAM]SLMK.3|SGLGELILPENEPGSSIM[Oxi]PGK.3|SGLGELILPENEPGSSIMPGK.3|SGLGELILPENEPGSSIM[Oxi]PGK.2|SGLGELILPENEPGSSIMPGK.2|IGRTHTQDAVPLTLGQEFSGYVQQVK.4|ETAIELGYLTAEQFDEWVK.3|LNDHFPLVVWQTGSGTQTNMNVNEVISNR.4|LNDHFPLVVWQTGSGTQTNM[Oxi]NVNEVISNR.4|LNDHFPLVVWQTGSGTQTNM[Oxi]NVNEVISNR.3|LNDHFPLVVWQTGSGTQTNMNVNEVISNR.3|LLGDASVSFTENC[CAM]VVGIQANTER.3
SEN / CTL,Uroporphyrinogen decarboxylase,UROD,P06132,-0.55,0.52,1.16E-03,8.58E-04,3.07E+00,"protoporphyrinogen IX biosynthetic process,heme biosynthetic process",uroporphyrinogen decarboxylase activity,"nucleoplasm,cytoplasm,cytosol",12,12,18,LRDPEVVASELGYVFQAITLTR.3|LRDPEVVASELGYVFQAITLTR.4|LREAGLAPVPMIIFAK.3|LREAGLAPVPMIIFAK.2|SPEAC[CAM]C[CAM]ELTLQPLR.2|QMLDDFGPHR.3|EAGLAPVPMIIFAK.3|EAGLAPVPMIIFAK.2|EAGLAPVPM[Oxi]IIFAK.2|YIANLGHGLYPDMDPEHVGAFVDAVHK.5|YIANLGHGLYPDMDPEHVGAFVDAVHK.4|YIANLGHGLYPDMDPEHVGAFVDAVHK.3|AAQDFFSTC[CAM]R.2|SPEAC[CAM]C[CAM]ELTLQPLRR.3|GPSFPEPLREEQDLER.3|TVTLQGNLDPC[CAM]ALYASEEEIGQLVK.3|DGHFALEELAQAGYEVVGLDWTVAPK.3|AAWGEETDYTPVWC[CAM]MR.2
SEN / CTL,"Beta-1,4-glucuronyltransferase 1",B4GAT1,O43505,-0.55,0.29,3.93E-03,2.44E-03,2.61E+00,"axon guidance,keratan sulfate biosynthetic process,poly-N-acetyllactosamine biosynthetic process,protein O-linked mannosylation","N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,glucuronosyltransferase activity,metal ion binding","Golgi membrane,Golgi apparatus,integral component of Golgi membrane,extracellular exosome",6,5,5,TALASGGVLDASGDYR.2|TTMDPNDVILATHASVDNLLHLSGLLER.4|YEAAVPDPR.2|WVNLPEESLLR.2|ISQAC[CAM]ELHVAGFDFEVLNEGFLVHK.4
SEN / CTL,Hepatoma-derived growth factor,HDGF,P51858,-0.56,0.36,8.89E-09,2.31E-08,7.64E+00,"negative regulation of transcription from RNA polymerase II promoter,transcription, DNA-templated,signal transduction,cell proliferation,IRE1-mediated unfolded protein response","nucleotide binding,RNA polymerase II transcription corepressor activity,transcription corepressor binding,DNA binding,growth factor activity,heparin binding,poly(A) RNA binding","extracellular space,nucleoplasm,cytoplasm,transcriptional repressor complex",21,29,48,KGFSEGLWEIENNPTVK.3|KGFSEGLWEIENNPTVK.2|GPPQEEEEEEDEEEEATKEDAEAPGIRDHESL.4|GFSEGLWEIENNPTVK.2|GFSEGLWEIENNPTVK.3|IDEMPEAAVK.2|IDEM[Oxi]PEAAVK.2|STANKYQVFFFGTHETAFLGPK.4|STANKYQVFFFGTHETAFLGPK.3|EAENPEGEEKEAATLEVERPLPMEVEK.4|EAENPEGEEKEAATLEVERPLPM[Oxi]EVEK.4|EAENPEGEEKEAATLEVERPLPMEVEK.3|C[CAM]GDLVFAK.2|DLFPYEESKEK.3|DLFPYEESKEK.2|ASGYQSSQK.2|EDAEAPGIR.2|YQVFFFGTHETAFLGPK.4|YQVFFFGTHETAFLGPK.3|YQVFFFGTHETAFLGPK.2|GYPHWPARIDEMPEAAVK.4|AGDLLEDSPK.2|RKGFSEGLWEIENNPTVK.4|NSTPSEPGSGR.2|SC[CAM]VEEPEPEPEAAEGDGDKK.4|SC[CAM]VEEPEPEPEAAEGDGDKK.3|SC[CAM]VEEPEPEPEAAEGDGDKK.2|DLFPYEESK.2|EAENPEGEEK.2|KSC[CAM]VEEPEPEPEAAEGDGDKK.4|KSC[CAM]VEEPEPEPEAAEGDGDKK.3|RAGDLLEDSPK.2|GPPQEEEEEEDEEEEATKEDAEAPGIR.5|GPPQEEEEEEDEEEEATKEDAEAPGIR.4|GPPQEEEEEEDEEEEATKEDAEAPGIR.3|EAATLEVERPLPM[Oxi]EVEK.3|EAATLEVERPLPMEVEK.3|EAATLEVERPLPMEVEK.2|EAATLEVERPLPM[Oxi]EVEK.2|GNAEGSSDEEGKLVIDEPAK.3|SC[CAM]VEEPEPEPEAAEGDGDK.3|SC[CAM]VEEPEPEPEAAEGDGDK.2|GPPQEEEEEEDEEEEATK.3|GPPQEEEEEEDEEEEATK.2|KSC[CAM]VEEPEPEPEAAEGDGDK.3|EDAEAPGIRDHESL.2|SC[CAM]VEEPEPEPEAAEGDGDKKGNAEGSSDEEGK.4|NSTPSEPGSGRGPPQEEEEEEDEEEEATKEDAEAPGIR.4
SEN / CTL,Scaffold attachment factor B1,SAFB,Q15424,-0.56,0.54,4.48E-02,1.83E-02,1.74E+00,"chromatin organization,transcription, DNA-templated,regulation of transcription from RNA polymerase II promoter,intracellular estrogen receptor signaling pathway,growth,hormone metabolic process,positive regulation of transcription from RNA polymerase II promoter,regulation of mRNA processing","nucleotide binding,core promoter binding,chromatin binding,double-stranded DNA binding,protein binding,sequence-specific DNA binding,poly(A) RNA binding","nucleus,nucleoplasm",6,36,54,AIEDEGGNPDEIEITSEGNKK.3|AIEDEGGNPDEIEITSEGNKK.4|AIEDEGGNPDEIEITSEGNKK.2|NFWVSGLSSTTR.2|NFWVSGLSSTTR.3|DGWGGYGSDKR.3|DGWGGYGSDKR.2|GRYPDHSVDR.3|RAALDER.2|REPAEQPGDGER.3|REPAEQPGDGER.2|DQDDQKPGPSER.3|MSSPEDDSDTKR.3|M[Oxi]SSPEDDSDTKR.3|M[Oxi]SSPEDDSDTKR.2|ADSLLAVVK.2|ELVEGEMK.2|MHVEHER.2|RSVVSFDK.2|EGQHYPER.2|DGWGGYGSDK.2|SKDQDDQKPGPSER.3|SKDQDDQKPGPSER.2|ADSLLAVVKR.2|FDFDAC[CAM]NEVPPAPK.3|FDFDAC[CAM]NEVPPAPK.2|DDAYWPEAK.2|ELPEQLQEHAIEDK.3|ELPEQLQEHAIEDK.2|ILDILGETC[CAM]K.2|KFDFDAC[CAM]NEVPPAPK.3|KFDFDAC[CAM]NEVPPAPK.2|EPAEQPGDGER.2|KAIEDEGGNPDEIEITSEGNKK.4|KAIEDEGGNPDEIEITSEGNKK.3|MSSPEDDSDTK.2|M[Oxi]SSPEDDSDTK.2|EDDRSWQGTADGGMMDR.3|AIEDEGGNPDEIEITSEGNK.3|AIEDEGGNPDEIEITSEGNK.2|SWQGTADGGMMDR.2|SEPVKEESSELEQPFAQDTSSVGPDR.4|SEPVKEESSELEQPFAQDTSSVGPDR.3|SEPVKEESSELEQPFAQDTSSVGPDRK.4|SEPVKEESSELEQPFAQDTSSVGPDRK.3|KAIEDEGGNPDEIEITSEGNK.3|EESSELEQPFAQDTSSVGPDR.3|EESSELEQPFAQDTSSVGPDR.2|EESSELEQPFAQDTSSVGPDRK.3|C[CAM]YGFVTMSTAEEATK.2|LAEEEDLFDSAHPEEGDLDLASESTAHAQSSK.4|LAEEEDLFDSAHPEEGDLDLASESTAHAQSSK.3|KLAEEEDLFDSAHPEEGDLDLASESTAHAQSSK.4|ETINNLDTSSSDFTILQEIEEPSLEPENEK.3
SEN / CTL,Bone morphogenetic protein 1,BMP1,P13497,-0.56,0.25,5.91E-02,2.31E-02,1.64E+00,"skeletal system development,cartilage condensation,ossification,proteolysis,multicellular organism development,positive regulation of pathway-restricted SMAD protein phosphorylation,extracellular matrix disassembly,BMP signaling pathway,lipoprotein metabolic process,regulation of apoptotic process,regulation of MAPK cascade,cell development,SMAD protein signal transduction,positive regulation of cartilage development","metalloendopeptidase activity,serine-type endopeptidase activity,cytokine activity,transforming growth factor beta receptor binding,calcium ion binding,growth factor activity,peptidase activity,metallopeptidase activity,zinc ion binding","extracellular region,proteinaceous extracellular matrix,extracellular space,Golgi apparatus,membrane-bounded vesicle",3,2,2,AGFAVNFFK.2|NC[CAM]IWQLVAPTQYR.2
SEN / CTL,Tax1-binding protein 3,TAX1BP3,O14907,-0.56,0.19,2.05E-02,9.59E-03,2.02E+00,"Rho protein signal transduction,negative regulation of cell proliferation,Wnt signaling pathway,negative regulation of Wnt signaling pathway,activation of GTPase activity,negative regulation of protein localization to cell surface","protein binding,beta-catenin binding,protein C-terminus binding","nucleus,cytoplasm,cytosol,plasma membrane,extracellular exosome",3,4,5,VSEGGPAEIAGLQIGDK.2|VSEGGPAEIAGLQIGDK.3|AVQQSMLS.2|RSEEVVR.2|IMQVNGWDMTMVTHDQAR.3
SEN / CTL,"Keratin, type II cytoskeletal 2 epidermal",KRT2,P35908,-0.58,0.94,1.03E-03,7.79E-04,3.11E+00,"keratinocyte development,epidermis development,keratinization,keratinocyte activation,keratinocyte proliferation,intermediate filament organization,keratinocyte migration","structural constituent of cytoskeleton,protein binding,cytoskeletal protein binding","extracellular space,nucleus,cytoplasm,Golgi apparatus,intermediate filament,membrane,keratin filament,intermediate filament cytoskeleton,extracellular exosome",54,56,105,YEELQVTVGR.2|FLEQQNQVLQTK.2|FLEQQNQVLQTK.3|VDLLNQEIEFLK.2|VDLLNQEIEFLK.3|NKLNDLEEALQQAKEDLAR.4|NKLNDLEEALQQAKEDLAR.3|NKLNDLEEALQQAKEDLAR.2|NLDLDSIIAEVK.2|NLDLDSIIAEVK.3|LLRDYQELMNVK.3|LLRDYQELMNVK.2|LLRDYQELM[Oxi]NVK.3|LALDVEIATYR.2|WELLQQM[Oxi]NVGTRPINLEPIFQGYIDSLKR.4|WELLQQMNVGTRPINLEPIFQGYIDSLKR.4|WELLQQM[Oxi]NVGTRPINLEPIFQGYIDSLKR.3|WELLQQMNVGTRPINLEPIFQGYIDSLKR.3|NKLNDLEEALQQAK.3|NKLNDLEEALQQAK.2|SLVGLGGTK.2|GFSSGSAVVSGGSR.2|HGDSLKEIKIEISELNR.4|HGDSLKEIKIEISELNR.3|HGDSLKEIKIEISELNR.2|TSQNSELNNMQDLVEDYKK.3|TSQNSELNNMQDLVEDYKK.4|TSQNSELNNM[Oxi]QDLVEDYKK.3|TSQNSELNNM[Oxi]QDLVEDYKK.2|TSQNSELNNMQDLVEDYKK.2|RSTSSFSC[CAM]LSR.3|RSTSSFSC[CAM]LSR.2|HGGGGGGFGGGGFGSR.3|HGGGGGGFGGGGFGSR.2|NVQDAIADAEQR.3|NVQDAIADAEQR.2|TAAENDFVTLKK.3|TAAENDFVTLKK.2|LNDLEEALQQAK.3|LNDLEEALQQAK.2|SKEEAEALYHSK.3|SKEEAEALYHSK.2|GGSISGGGYGSGGGKHSSGGGSR.4|GGSISGGGYGSGGGKHSSGGGSR.3|IEISELNR.2|NVQDAIADAEQRGEHALK.4|NVQDAIADAEQRGEHALK.3|GEHALKDAR.2|LQGEIAHVK.2|HGDSLKEIK.2|VDPEIQNVK.2|YLDGLTAER.2|GGSSSGGGYGSGGGGSSSVK.3|GGSSSGGGYGSGGGGSSSVK.2|DVDNAYMIK.2|DVDNAYM[Oxi]IK.2|LQGEIAHVKK.2|STSSFSC[CAM]LSR.2|GGSGGGGSISGGGYGSGGGSGGR.3|GGSGGGGSISGGGYGSGGGSGGR.2|GSSSGGGYSSGSSSYGSGGR.3|GSSSGGGYSSGSSSYGSGGR.2|HSSGGGSRGGSSSGGGYGSGGGGSSSVK.4|HSSGGGSRGGSSSGGGYGSGGGGSSSVK.3|HSSGGGSRGGSSSGGGYGSGGGGSSSVK.2|NVQDAIADAEQRGEHALKDAR.4|NVQDAIADAEQRGEHALKDAR.3|EEAEALYHSK.2|GGSISGGGYGSGGGK.2|KDVDNAYMIK.2|KDVDNAYM[Oxi]IK.2|RYLDGLTAER.2|TSQNSELNNMQDLVEDYKKK.4|TSQNSELNNMQDLVEDYKKK.3|TAAENDFVTLK.2|PINLEPIFQGYIDSLK.3|SISISVAGGGGGFGAAGGFGGR.3|SISISVAGGGGGFGAAGGFGGR.2|YGSGGGSKGGSISGGGYGSGGGK.3|SKEEAEALYHSKYEELQVTVGR.4|SKEEAEALYHSKYEELQVTVGR.3|LNDLEEALQQAKEDLAR.3|LNDLEEALQQAKEDLAR.2|PINLEPIFQGYIDSLKR.3|FGGFGGPGGVGGLGGPGGFGPGGYPGGIHEVSVNQSLLQPLNVK.6|FGGFGGPGGVGGLGGPGGFGPGGYPGGIHEVSVNQSLLQPLNVK.5|FGGFGGPGGVGGLGGPGGFGPGGYPGGIHEVSVNQSLLQPLNVK.4|TSQNSELNNM[Oxi]QDLVEDYK.3|TSQNSELNNMQDLVEDYK.3|TSQNSELNNM[Oxi]QDLVEDYK.2|TSQNSELNNMQDLVEDYK.2|QSGSRGGSGGGGSISGGGYGSGGGSGGR.3|QSGSRGGSGGGGSISGGGYGSGGGSGGR.2|VLYDAEISQIHQSVTDTNVILSM[Oxi]DNSR.4|VLYDAEISQIHQSVTDTNVILSMDNSR.4|VLYDAEISQIHQSVTDTNVILSM[Oxi]DNSR.3|VLYDAEISQIHQSVTDTNVILSMDNSR.3|GGGFGGGSSFGGGSGFSGGGFGGGGFGGGR.3|GGGFGGGSSFGGGSGFSGGGFGGGGFGGGR.2|M[Oxi]SGDLSSNVTVSVTSSTISSNVASK.3|MSGDLSSNVTVSVTSSTISSNVASK.3|WELLQQM[Oxi]NVGTRPINLEPIFQGYIDSLK.4|AAFGGSGGRGSSSGGGYSSGSSSYGSGGR.3|FLEQQNQVLQTKWELLQQM[Oxi]NVGTRPINLEPIFQGYIDSLKR.5|FLEQQNQVLQTKWELLQQMNVGTRPINLEPIFQGYIDSLKR.5
SEN / CTL,Complement C1r subcomponent,C1R,P00736,-0.58,0.34,7.26E-09,1.92E-08,7.72E+00,"proteolysis,immune response,complement activation,complement activation, classical pathway,innate immune response","serine-type endopeptidase activity,calcium ion binding,serine-type peptidase activity","extracellular region,extracellular exosome,blood microparticle",27,25,35,M[Oxi]GNFPWQVFTNIHGR.3|MGNFPWQVFTNIHGR.3|LPVANPQAC[CAM]ENWLR.2|TLDEFTIIQNLQPQYQFR.3|QRPPDLDTSSNAVDLLFFTDESGDSR.3|LVFQQFDLEPSEGC[CAM]FYDYVK.3|QGYQLIEGNQVLHSFTAVC[CAM]QDDGTWHR.4|YTTTMGVNTYK.2|YTTTM[Oxi]GVNTYK.2|DYFIATC[CAM]K.2|GGGALLGDR.2|NIGEFC[CAM]GK.2|WILTAAHTLYPK.3|VSVHPDYR.2|MDVFSQNMFC[CAM]AGHPSLK.4|MDVFSQNMFC[CAM]AGHPSLK.3|M[Oxi]DVFSQNMFC[CAM]AGHPSLK.3|MDVFSQNM[Oxi]FC[CAM]AGHPSLK.3|MDVFSQNMFC[CAM]AGHPSLK.2|IQYYC[CAM]HEPYYK.3|IQYYC[CAM]HEPYYK.2|FC[CAM]GQLGSPLGNPPGKK.3|VLNYVDWIK.2|C[CAM]LPVC[CAM]GKPVNPVEQR.3|C[CAM]LPVC[CAM]GKPVNPVEQR.2|ESEQGVYTC[CAM]TAQGIWK.3|ESEQGVYTC[CAM]TAQGIWK.2|LFGEVTSPLFPK.2|PYPNNFETTTVITVPTGYR.3|PYPNNFETTTVITVPTGYR.2|FC[CAM]GQLGSPLGNPPGK.2|QDAC[CAM]QGDSGGVFAVR.2|WVATGIVSWGIGC[CAM]SR.2|GFLAYYQAVDLDEC[CAM]ASR.2|LFGEVTSPLFPKPYPNNFETTTVITVPTGYR.3
SEN / CTL,Heterogeneous nuclear ribonucleoprotein A/B,HNRNPAB,Q99729,-0.58,0.40,9.05E-04,7.02E-04,3.15E+00,"epithelial to mesenchymal transition,positive regulation of transcription, DNA-templated","nucleotide binding,RNA binding,mRNA binding,protein binding,poly(A) RNA binding,transcription factor activity, sequence-specific DNA binding,sequence-specific DNA binding","nucleus,nucleoplasm,cytoplasm,intracellular ribonucleoprotein complex,RNA polymerase II transcription factor complex",9,14,26,GFGFILFK.2|MFVGGLSWDTSKK.3|M[Oxi]FVGGLSWDTSKK.3|M[Oxi]FVGGLSWDTSKK.2|MFVGGLSWDTSKK.2|GFVFITFKEEEPVKK.4|GFVFITFKEEEPVKK.3|GFVFITFKEEEPVKK.2|FHTVSGSK.2|RGGHQNNYKPY.3|GFVFITFK.2|KFHTVSGSK.2|EVYQQQQYGSGGR.3|EVYQQQQYGSGGR.2|GFGFILFKDAASVEK.3|GFGFILFKDAASVEK.2|GFVFITFKEEEPVK.3|GFVFITFKEEEPVK.2|GGHQNNYKPY.2|MFVGGLSWDTSK.2|M[Oxi]FVGGLSWDTSK.2|EYFGEFGEIEAIELPM[Oxi]DPK.3|EYFGEFGEIEAIELPMDPK.3|EYFGEFGEIEAIELPMDPK.2|EYFGEFGEIEAIELPM[Oxi]DPK.2|IREYFGEFGEIEAIELPMDPK.3
SEN / CTL,Thioredoxin domain-containing protein 5,TXNDC5,Q8NBS9,-0.58,0.79,6.69E-05,7.00E-05,4.15E+00,"protein folding,response to endoplasmic reticulum stress,negative regulation of apoptotic process,apoptotic cell clearance,cell redox homeostasis",protein disulfide isomerase activity,"endoplasmic reticulum,endoplasmic reticulum lumen,lysosomal lumen,extracellular exosome",33,30,49,GYPTLLLFR.2|GYPTLLWFR.2|FVLSQAKDEL.2|IGKVDC[CAM]TQHYELC[CAM]SGNQVR.4|IGKVDC[CAM]TQHYELC[CAM]SGNQVR.3|TLAPTWEELSKKEFPGLAGVK.4|DLESLREYVESQLQR.3|DLESLREYVESQLQR.2|TLAPTWEELSKK.3|TLAPTWEELSKK.2|ALAPTWEQLALGLEHSETVK.3|ALAPTWEQLALGLEHSETVK.4|ALAPTWEQLALGLEHSETVK.2|LQPTWNDLGDKYNSMEDAK.3|LQPTWNDLGDKYNSM[Oxi]EDAK.3|LQPTWNDLGDKYNSMEDAK.2|VDC[CAM]TQHYELC[CAM]SGNQVR.3|VDC[CAM]TQHYELC[CAM]SGNQVR.4|VDC[CAM]TQHYELC[CAM]SGNQVR.2|VSEHSGGRDLDSLHR.4|VSEHSGGRDLDSLHR.3|DLDSLHR.2|FFAPWC[CAM]GHC[CAM]K.3|FYAPWC[CAM]GHC[CAM]K.3|FYAPWC[CAM]GHC[CAM]K.2|VDC[CAM]TAHSDVC[CAM]SAQGVR.4|VDC[CAM]TAHSDVC[CAM]SAQGVR.3|VDC[CAM]TAHSDVC[CAM]SAQGVR.2|KVSEHSGGRDLDSLHR.4|KVSEHSGGRDLDSLHR.3|YNSMEDAK.2|YNSM[Oxi]EDAK.2|KEFPGLAGVK.2|QGLYELSASNFELHVAQGDHFIK.5|QGLYELSASNFELHVAQGDHFIK.4|QGLYELSASNFELHVAQGDHFIK.3|LFKPGQEAVK.2|EYVESQLQR.2|IAEVDC[CAM]TAER.2|GTVLALTENNFDDTIAEGITFIK.4|GTVLALTENNFDDTIAEGITFIK.3|TLAPTWEELSK.2|LQPTWNDLGDK.2|RDLESLREYVESQLQR.3|HLYTADMFTHGIQSAAHFVMFFAPWC[CAM]GHC[CAM]QR.5|HLYTADMFTHGIQSAAHFVM[Oxi]FFAPWC[CAM]GHC[CAM]QR.5|TETGATETVTPSEAPVLAAEPEADK.3|DFQTLENWMLQTLNEEPVTPEPEVEPPSAPELK.4|TETGATETVTPSEAPVLAAEPEADKGTVLALTENNFDDTIAEGITFIK.5
SEN / CTL,Histone H3.2,HIST2H3A,Q71DI3,-0.58,0.35,1.70E-02,8.25E-03,2.08E+00,"negative regulation of transcription from RNA polymerase II promoter,chromatin silencing at rDNA,nucleosome assembly,blood coagulation,gene silencing by RNA,cellular protein metabolic process,negative regulation of gene expression, epigenetic,positive regulation of gene expression, epigenetic","protein binding,nucleosomal DNA binding,histone binding,protein heterodimerization activity","nucleosome,extracellular region,nucleus,nucleoplasm,extracellular exosome",6,1,4,FQSSAVMALQEASEAYLVGLFEDTNLC[CAM]AIHAK.4|FQSSAVM[Oxi]ALQEASEAYLVGLFEDTNLC[CAM]AIHAK.3|FQSSAVM[Oxi]ALQEASEAYLVGLFEDTNLC[CAM]AIHAK.4|FQSSAVMALQEASEAYLVGLFEDTNLC[CAM]AIHAK.3
SEN / CTL,Amyloid beta A4 protein,APP,P05067,-0.58,0.44,1.25E-09,3.71E-09,8.43E+00,"response to yeast,suckling behavior,platelet degranulation,mRNA polyadenylation,regulation of translation,protein phosphorylation,cellular copper ion homeostasis,endocytosis,response to oxidative stress,cell adhesion,regulation of epidermal growth factor-activated receptor activity,Notch signaling pathway,axonogenesis,mating behavior,locomotory behavior,axo-dendritic transport,cholesterol metabolic process,adult locomotory behavior,visual learning,cellular process,response to lead ion,negative regulation of endopeptidase activity,positive regulation of peptidase activity,positive regulation of G2/M transition of mitotic cell cycle,axon midline choice point recognition,neuron remodeling,dendrite development,antibacterial humoral response,antifungal humoral response,extracellular matrix organization,forebrain development,neuron projection development,ionotropic glutamate receptor signaling pathway,regulation of multicellular organism growth,regulation of protein binding,cellular protein metabolic process,innate immune response,negative regulation of neuron differentiation,positive regulation of mitotic cell cycle,positive regulation of transcription from RNA polymerase II promoter,collateral sprouting in absence of injury,regulation of synapse structure or activity,defense response to Gram-negative bacterium,defense response to Gram-positive bacterium,neuromuscular process controlling balance,synaptic growth at neuromuscular junction,neuron apoptotic process,smooth endoplasmic reticulum calcium ion homeostasis,cellular response to cAMP,cellular response to norepinephrine stimulus,amyloid fibril formation,cellular response to nerve growth factor stimulus","DNA binding,serine-type endopeptidase inhibitor activity,receptor binding,protein binding,heparin binding,peptidase activator activity,enzyme binding,identical protein binding,transition metal ion binding,PTB domain binding,growth factor receptor binding","extracellular region,extracellular space,nuclear envelope lumen,cytoplasm,endosome,smooth endoplasmic reticulum,rough endoplasmic reticulum,Golgi apparatus,cytosol,plasma membrane,integral component of plasma membrane,clathrin-coated pit,cell-cell junction,cell surface,integral component of membrane,ER to Golgi transport vesicle,axon,platelet alpha granule lumen,neuromuscular junction,endosome lumen,trans-Golgi network membrane,ciliary rootlet,terminal bouton,dendritic spine,dendritic shaft,intracellular membrane-bounded organelle,receptor complex,main axon,membrane raft,apical part of cell,synapse,perinuclear region of cytoplasm,spindle midzone,extracellular exosome,astrocyte projection,growth cone lamellipodium,growth cone filopodium",36,21,26,LALENYITALQAVPPRPR.3|WYFDVTEGK.2|ISYGNDALMPSLTETK.2|AVIQHFQEKVESLEQEAANER.3|C[CAM]LVGEFVSDALLVPDK.2|C[CAM]LVGEFVSDALLVPDK.3|THPHFVIPYR.3|C[CAM]APFFYGGC[CAM]GGNR.2|STNLHDYGMLLPC[CAM]GIDK.3|STNLHDYGMLLPC[CAM]GIDK.2|LNMHMNVQNGKWDSDPSGTK.4|LNMHMNVQNGKWDSDPSGTK.3|VESLEQEAANER.2|QQLVETHMAR.3|HDSGYEVHHQK.3|YLETPGDENEHAHFQK.4|YLETPGDENEHAHFQK.3|WDSDPSGTK.2|AVIQHFQEK.2|QYTSIHHGVVEVDAAVTPEER.4|QYTSIHHGVVEVDAAVTPEER.3|LVFFAEDVGSNK.2|MQQNGYENPTYK.2|EVC[CAM]SEQAETGPC[CAM]R.2|EGILQYC[CAM]QEVYPELQITNVVEANQPVTIQNWC[CAM]K.4|EQNYSDDVLANMISEPR.2
SEN / CTL,Tubulointerstitial nephritis antigen-like,TINAGL1,Q9GZM7,-0.59,0.41,3.25E-06,4.80E-06,5.32E+00,"receptor-mediated endocytosis,immune response,cell adhesion,endosomal transport,proteolysis involved in cellular protein catabolic process","scavenger receptor activity,extracellular matrix structural constituent,protein binding,polysaccharide binding,laminin binding,cysteine-type endopeptidase activity","extracellular region,extracellular space,extracellular matrix,extracellular exosome,lysosome",21,21,33,ITGWGEETLPDGR.2|LDGAWWFLR.2|QATAHC[CAM]PNSYVNNNDIYQVTPVYR.3|GVNEC[CAM]DIESFVLGVWGR.3|GVNEC[CAM]DIESFVLGVWGR.2|IYPVLGTYWDNC[CAM]NR.2|IYPVLGTYWDNC[CAM]NR.3|GGRLDGAWWFLR.3|GGRLDGAWWFLR.2|YWTAANSWGPAWGER.2|YWTAANSWGPAWGER.3|RGVVSDHC[CAM]YPFSGR.4|GGIYSHTPVSLGRPER.4|GGIYSHTPVSLGRPER.3|ERDEAGPAPPC[CAM]MMHSR.4|YC[CAM]QEQDLC[CAM]C[CAM]R.3|YC[CAM]QEQDLC[CAM]C[CAM]R.2|GVVSDHC[CAM]YPFSGR.3|GVVSDHC[CAM]YPFSGR.2|TLKYWTAANSWGPAWGERGHFR.5|VGM[Oxi]EDM[Oxi]GHH.2|DAGGRYC[CAM]QEQDLC[CAM]C[CAM]R.3|VSIHSLGHM[Oxi]TPVLSPQNLLSC[CAM]DTHQQQGC[CAM]R.5|VSIHSLGHM[Oxi]TPVLSPQNLLSC[CAM]DTHQQQGC[CAM]R.4|VSIHSLGHMTPVLSPQNLLSC[CAM]DTHQQQGC[CAM]R.4|TLKYWTAANSWGPAWGER.3|TLKYWTAANSWGPAWGER.2|RQATAHC[CAM]PNSYVNNNDIYQVTPVYR.4|LGTIRPSSSVMNMHEIYTVLNPGEVLPTAFEASEK.5|LGTIRPSSSVM[Oxi]NMHEIYTVLNPGEVLPTAFEASEK.4|LGTIRPSSSVMNMHEIYTVLNPGEVLPTAFEASEK.4|ELMENGPVQALMEVHEDFFLYK.3|WPNLIHEPLDQGNC[CAM]AGSWAFSTAAVASDR.3
SEN / CTL,Amyloid-like protein 2,APLP2,Q06481,-0.63,0.34,2.46E-09,7.08E-09,8.15E+00,"platelet degranulation,G-protein coupled receptor signaling pathway,negative regulation of endopeptidase activity","DNA binding,serine-type endopeptidase inhibitor activity,protein binding,heparin binding,transition metal ion binding","nucleus,plasma membrane,membrane,integral component of membrane,platelet alpha granule membrane,extracellular exosome",24,16,20,C[CAM]LVGEFVSDVLLVPEK.3|C[CAM]LVGEFVSDVLLVPEK.2|VPYVAQEIQEEIDELLQEQR.3|MALENYLAALQSDPPRPHR.4|LNMHVNIQTGKWEPDPTGTK.4|HYQHVLAVDPEKAAQMK.4|SQVMTHLHVIEER.3|EWEEAELQAK.2|HYQHVLAVDPEK.3|HYQHVLAVDPEK.2|MQNHGYENPTYK.3|MQNHGYENPTYK.2|FIYGGC[CAM]GGNR.2|ERMEVC[CAM]ENHQHWHTVVK.4|ERMEVC[CAM]ENHQHWHTVVK.3|QQLVETHLAR.2|LNMHVNIQTGK.2|ADMDQFTASISETPVDVR.3|AVC[CAM]SQEAMTGPC[CAM]R.2|VKKEWEEAELQAK.2
SEN / CTL,Glucose-6-phosphate isomerase,GPI,P06744,-0.63,0.60,7.28E-20,8.55E-19,1.81E+01,"angiogenesis,in utero embryonic development,mesoderm formation,carbohydrate metabolic process,gluconeogenesis,humoral immune response,hemostasis,learning or memory,methylglyoxal biosynthetic process,response to estradiol,response to progesterone,response to testosterone,erythrocyte homeostasis,response to immobilization stress,response to muscle stretch,glucose homeostasis,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,response to morphine,negative regulation of neuron apoptotic process,aldehyde catabolic process,response to cadmium ion,glucose 6-phosphate metabolic process,canonical glycolysis","glucose-6-phosphate isomerase activity,cytokine activity,growth factor activity,intramolecular transferase activity,ubiquitin protein ligase binding,monosaccharide binding","extracellular space,nucleoplasm,cytoplasm,cytosol,plasma membrane,membrane,neuron projection,myelin sheath,ciliary membrane,extracellular exosome",141,49,107,TLAQLNPESSLFIIASK.2|TLAQLNPESSLFIIASK.3|VKEFGIDPQNMFEFWDWVGGR.3|AVLHVALR.2|SGTRVDHQTGPIVWGEPGTNGQHAFYQLIHQGTK.6|SGTRVDHQTGPIVWGEPGTNGQHAFYQLIHQGTK.5|SGTRVDHQTGPIVWGEPGTNGQHAFYQLIHQGTK.4|ILLANFLAQTEALMR.2|ILLANFLAQTEALMR.3|ILLANFLAQTEALM[Oxi]R.3|ILLANFLAQTEALM[Oxi]R.2|SNTPILVDGKDVMPEVNKVLDK.4|SNTPILVDGKDVMPEVNKVLDK.3|VWYVSNIDGTHIAK.3|VWYVSNIDGTHIAK.2|VWYVSNIDGTHIAK.4|MIPC[CAM]DFLIPVQTQHPIRK.4|MIPC[CAM]DFLIPVQTQHPIRK.3|M[Oxi]IPC[CAM]DFLIPVQTQHPIRK.4|TFTTQETITNAETAKEWFLQAAKDPSAVAK.4|TFTTQETITNAETAKEWFLQAAKDPSAVAK.3|VFEGNRPTNSIVFTK.3|VFEGNRPTNSIVFTK.2|FNHFSLTLNTNHGHILVDYSK.4|FNHFSLTLNTNHGHILVDYSK.5|FNHFSLTLNTNHGHILVDYSK.3|MIPC[CAM]DFLIPVQTQHPIR.3|M[Oxi]IPC[CAM]DFLIPVQTQHPIR.3|MIPC[CAM]DFLIPVQTQHPIR.4|M[Oxi]IPC[CAM]DFLIPVQTQHPIR.4|MIPC[CAM]DFLIPVQTQHPIR.2|KIEPELDGSAQVTSHDASTNGLINFIK.4|KIEPELDGSAQVTSHDASTNGLINFIK.3|NLVTEDVMR.2|NLVTEDVM[Oxi]R.2|TFTTQETITNAETAK.2|TFTTQETITNAETAK.3|ELQAAGKSPEDLER.3|ELQAAGKSPEDLER.2|FAAYFQQGDMESNGK.3|FAAYFQQGDMESNGK.2|FAAYFQQGDM[Oxi]ESNGK.3|FAAYFQQGDM[Oxi]ESNGK.2|NRSNTPILVDGKDVMPEVNK.3|LFDANKDRFNHFSLTLNTNHGHILVDYSK.6|LFDANKDRFNHFSLTLNTNHGHILVDYSK.5|LFDANKDRFNHFSLTLNTNHGHILVDYSK.4|TFTTQETITNAETAKEWFLQAAK.3|TFTTQETITNAETAKEWFLQAAK.4|FAAYFQQGDMESNGKYITK.3|FAAYFQQGDM[Oxi]ESNGKYITK.3|LTPFMLGALVAMYEHK.3|LTPFMLGALVAMYEHK.2|LTPFMLGALVAM[Oxi]YEHK.3|LTPFMLGALVAMYEHK.4|LTPFM[Oxi]LGALVAMYEHK.3|LTPFM[Oxi]LGALVAM[Oxi]YEHK.3|LTPFM[Oxi]LGALVAMYEHK.2|LTPFMLGALVAM[Oxi]YEHK.2|SNTPILVDGKDVMPEVNK.3|SNTPILVDGKDVM[Oxi]PEVNK.3|SNTPILVDGKDVM[Oxi]PEVNK.2|SNTPILVDGKDVMPEVNK.2|VDHQTGPIVWGEPGTNGQHAFYQLIHQGTK.5|VDHQTGPIVWGEPGTNGQHAFYQLIHQGTK.4|VDHQTGPIVWGEPGTNGQHAFYQLIHQGTK.6|VDHQTGPIVWGEPGTNGQHAFYQLIHQGTK.3|TITDVINIGIGGSDLGPLMVTEALKPYSSGGPR.4|TITDVINIGIGGSDLGPLMVTEALKPYSSGGPR.5|TITDVINIGIGGSDLGPLM[Oxi]VTEALKPYSSGGPR.4|TITDVINIGIGGSDLGPLM[Oxi]VTEALKPYSSGGPR.3|TITDVINIGIGGSDLGPLMVTEALKPYSSGGPR.3|IFVQGIIWDINSFDQWGVELGK.3|EWFLQAAK.2|HFVALSTNTTK.3|HFVALSTNTTK.2|M[Oxi]LVDLAK.2|KELQAAGKSPEDLER.4|KELQAAGKSPEDLER.3|INYTEGR.2|KELQAAGK.2|SPEDLER.2|RLFDANK.2|NRSNTPILVDGK.3|NRSNTPILVDGK.2|DRFNHFSLTLNTNHGHILVDYSK.6|DRFNHFSLTLNTNHGHILVDYSK.5|DRFNHFSLTLNTNHGHILVDYSK.4|DRFNHFSLTLNTNHGHILVDYSK.3|VRSGDWKGYTGK.3|DVM[Oxi]PEVNK.2|SPEDLERLLPHK.3|STEEARKELQAAGK.3|STEEARKELQAAGK.2|SNTPILVDGK.2|SGDWKGYTGK.2|EWFLQAAKDPSAVAK.3|EWFLQAAKDPSAVAK.2|GLHHKILLANFLAQTEALM[Oxi]R.4|GLHHKILLANFLAQTEALMR.4|RLFDANKDR.2|IEPELDGSAQVTSHDASTNGLINFIK.4|IEPELDGSAQVTSHDASTNGLINFIK.3|KIEPELDGSAQVTSHDASTNGLINFIKQQR.4|TITDVINIGIGGSDLGPLM[Oxi]VTEALK.3|TITDVINIGIGGSDLGPLMVTEALK.3|EFGIDPQNMFEFWDWVGGR.2
SEN / CTL,Tropomyosin alpha-1 chain,TPM1,P09493,-0.64,1.39,2.90E-02,1.28E-02,1.89E+00,"in utero embryonic development,positive regulation of heart rate by epinephrine,movement of cell or subcellular component,muscle contraction,regulation of muscle contraction,cytoskeleton organization,regulation of heart contraction,regulation of cell shape,muscle filament sliding,negative regulation of cell migration,ruffle organization,positive regulation of ATPase activity,cellular response to reactive oxygen species,wound healing,sarcomere organization,positive regulation of cell adhesion,positive regulation of stress fiber assembly,ventricular cardiac muscle tissue morphogenesis,cardiac muscle contraction,negative regulation of vascular smooth muscle cell proliferation,negative regulation of vascular associated smooth muscle cell migration","actin binding,structural constituent of cytoskeleton,cytoskeletal protein binding,structural constituent of muscle","stress fiber,cytosol,cytoskeleton,muscle thin filament tropomyosin,sarcomere,filamentous actin,bleb,ruffle membrane",60,27,42,AQKDEEKMEIQEIQLK.4|AQKDEEKMEIQEIQLK.3|SKQLEDELVSLQK.3|SKQLEDELVSLQK.2|QLEDELVSLQK.2|KLVIIESDLERAEER.3|KLVIIESDLERAEER.4|SKQLEDELVSLQKK.4|SKQLEDELVSLQKK.3|AEQAEADKKAAEDR.3|QLEDELVSLQKK.3|MEIQEIQLK.2|M[Oxi]EIQEIQLK.2|ATDAEADVASLNRR.3|ATDAEADVASLNRR.2|HIAEDADRKYEEVAR.4|HIAEDADRKYEEVAR.3|LVIIESDLERAEER.3|ATDAEADVASLNR.2|ATDAEADVASLNR.3|KATDAEADVASLNR.3|KATDAEADVASLNR.2|KLVIIESDLER.3|KLVIIESDLER.2|LVIIESDLER.2|AEERAELSEGK.3|ENALDRAEQAEADKK.4|ENALDRAEQAEADKK.3|ENALDRAEQAEADKK.2|HIAEDADR.2|ENALDRAEQAEADK.3|ENALDRAEQAEADK.2|DEEKMEIQEIQLK.3|DEEKMEIQEIQLK.2|C[CAM]AELEEELK.2|YSQKEDRYEEEIK.3|YSQKEDRYEEEIK.2|EDRYEEEIK.2|C[CAM]AELEEELKTVTNNLK.3|VLSDKLKEAETR.2|SIDDLEDELYAQK.2|LVIIESDLERAEERAELSEGK.3
SEN / CTL,ICOS ligand,ICOSLG,O75144,-0.64,0.27,4.58E-02,1.86E-02,1.73E+00,"adaptive immune response,defense response,hyperosmotic response,signal transduction,T cell costimulation,positive regulation of activated T cell proliferation,T cell activation,B cell activation",receptor binding,"plasma membrane,integral component of membrane,extracellular exosome",3,1,1,GLYDVVSVLR.2
SEN / CTL,Serine/arginine-rich splicing factor 2,SRSF2,Q01130,-0.65,0.20,3.88E-06,5.61E-06,5.25E+00,"regulation of alternative mRNA splicing, via spliceosome,mRNA splicing, via spliceosome,termination of RNA polymerase II transcription,mRNA processing,RNA export from nucleus,mRNA export from nucleus,mitotic nuclear division,RNA splicing,mRNA 3'-end processing,response to vitamin E,negative regulation of nucleic acid-templated transcription","nucleotide binding,transcription corepressor activity,protein kinase C binding,protein binding,pre-mRNA binding,poly(A) RNA binding","nucleus,nucleoplasm,spliceosomal complex,nuclear speck,interchromatin granule,extracellular exosome,PML body",9,7,13,FHDKRDAEDAMDAMDGAVLDGR.4|VGDVYIPR.2|DAEDAMDAMDGAVLDGR.3|DAEDAM[Oxi]DAMDGAVLDGR.3|DAEDAMDAMDGAVLDGR.2|DAEDAM[Oxi]DAM[Oxi]DGAVLDGR.2|DAEDAM[Oxi]DAMDGAVLDGR.2|DAEDAMDAM[Oxi]DGAVLDGR.2|VDNLTYR.2|YGRPPDSHHSR.3|YGRPPDSHHSR.2|RYGGGGYGR.2|RDAEDAMDAMDGAVLDGR.3
SEN / CTL,L-lactate dehydrogenase B chain,LDHB,P07195,-0.65,1.22,5.72E-08,1.22E-07,6.91E+00,"carbohydrate metabolic process,lactate metabolic process,pyruvate metabolic process,NAD metabolic process,oxidation-reduction process","L-lactate dehydrogenase activity,protein binding,kinase binding,identical protein binding,NAD binding","cytoplasm,mitochondrion,cytosol,membrane,myelin sheath,membrane raft,extracellular exosome",99,35,73,IVVVTAGVR.2|SADTLWDIQKDLKDL.2|SADTLWDIQKDLKDL.3|FIIPQIVK.2|LIAPVAEEEATVPNNKITVVGVGQVGMAC[CAM]AISILGK.4|SADTLWDIQK.2|GLTSVINQK.2|GMYGIENEVFLSLPC[CAM]ILNAR.3|GM[Oxi]YGIENEVFLSLPC[CAM]ILNAR.2|GMYGIENEVFLSLPC[CAM]ILNAR.2|GM[Oxi]YGIENEVFLSLPC[CAM]ILNAR.3|GMYGIENEVFLSLPC[CAM]ILNAR.4|SADTLWDIQKDLK.3|SADTLWDIQKDLK.2|SLADELALVDVLEDKLKGEMM[Oxi]DLQHGSLFLQTPK.5|SLADELALVDVLEDKLKGEM[Oxi]MDLQHGSLFLQTPK.5|SLADELALVDVLEDKLKGEMMDLQHGSLFLQTPK.5|SLADELALVDVLEDKLKGEM[Oxi]MDLQHGSLFLQTPK.4|SLADELALVDVLEDKLKGEMMDLQHGSLFLQTPK.4|SLADELALVDVLEDKLKGEM[Oxi]M[Oxi]DLQHGSLFLQTPK.5|MVVESAYEVIK.2|MVVESAYEVIK.3|M[Oxi]VVESAYEVIK.2|MVVESAYEVIKLK.3|LIAPVAEEEATVPNNK.2|LIAPVAEEEATVPNNK.3|EKLIAPVAEEEATVPNNK.3|EKLIAPVAEEEATVPNNK.2|IVADKDYSVTANSK.3|IVADKDYSVTANSK.2|SLADELALVDVLEDK.2|SLADELALVDVLEDK.3|ITVVGVGQVGMAC[CAM]AISILGK.3|ITVVGVGQVGM[Oxi]AC[CAM]AISILGK.3|ITVVGVGQVGM[Oxi]AC[CAM]AISILGK.2|ITVVGVGQVGMAC[CAM]AISILGK.2|LKDDEVAQLKK.3|LKDDEVAQLKK.2|SLADELALVDVLEDKLK.3|SLADELALVDVLEDKLK.2|KSADTLWDIQK.3|KSADTLWDIQK.2|DDEVAQLK.2|GEMMDLQHGSLFLQTPK.4|GEMMDLQHGSLFLQTPK.3|GEM[Oxi]MDLQHGSLFLQTPK.3|GEMM[Oxi]DLQHGSLFLQTPK.3|GEM[Oxi]M[Oxi]DLQHGSLFLQTPK.3|GEMMDLQHGSLFLQTPK.2|GEM[Oxi]MDLQHGSLFLQTPK.2|DYSVTANSK.2|IHPVSTMVK.2|IHPVSTM[Oxi]VK.1|HRVIGSGC[CAM]NLDSAR.3|HRVIGSGC[CAM]NLDSAR.2|LKGEMMDLQHGSLFLQTPK.4|LKGEM[Oxi]M[Oxi]DLQHGSLFLQTPK.4|LKGEM[Oxi]MDLQHGSLFLQTPK.4|LKGEMM[Oxi]DLQHGSLFLQTPK.4|LKGEMMDLQHGSLFLQTPK.3|LKGEM[Oxi]MDLQHGSLFLQTPK.3|LKGEMM[Oxi]DLQHGSLFLQTPK.3|LKGEMMDLQHGSLFLQTPK.2|NVNVFKFIIPQIVK.3|IVVVTAGVRQQEGESR.3|LKDDEVAQLK.2|IVVVTAGVRQQEGESRLNLVQR.4|GYTNWAIGLSVADLIESM[Oxi]LK.3|LKGYTNWAIGLSVADLIESM[Oxi]LKNLSR.4|LKGYTNWAIGLSVADLIESM[Oxi]LK.3|YSPDC[CAM]IIIVVSNPVDILTYVTWK.3|EKLIAPVAEEEATVPNNKITVVGVGQVGMAC[CAM]AISILGK.4|LGIHPSSC[CAM]HGWILGEHGDSSVAVWSGVNVAGVSLQELNPEMGTDNDSENWK.5
SEN / CTL,Growth-regulated alpha protein;C-X-C motif chemokine 2;C-X-C motif chemokine 3,CXCL1;CXCL2;CXCL3,P09341;P19875;P19876,-0.66,0.28,1.10E-03,8.27E-04,3.08E+00,"chemotaxis,inflammatory response,immune response,signal transduction,G-protein coupled receptor signaling pathway,nervous system development,cell proliferation,negative regulation of cell proliferation,actin cytoskeleton organization,response to lipopolysaccharide,intracellular signal transduction,positive regulation of catalytic activity,cell chemotaxis,chemokine-mediated signaling pathway,positive regulation of neutrophil chemotaxis;response to molecule of bacterial origin,chemotaxis,inflammatory response,immune response,G-protein coupled receptor signaling pathway,response to lipopolysaccharide,regulation of cell proliferation,cell chemotaxis,chemokine-mediated signaling pathway,positive regulation of neutrophil chemotaxis;inflammatory response,immune response,G-protein coupled receptor signaling pathway,neutrophil chemotaxis,response to lipopolysaccharide,regulation of cell proliferation,chemokine-mediated signaling pathway,positive regulation of neutrophil chemotaxis","receptor binding,chemokine activity,enzyme activator activity,growth factor activity,CXCR chemokine receptor binding;chemokine activity,CXCR chemokine receptor binding;chemokine activity,CXCR chemokine receptor binding","extracellular region,extracellular space,intracellular;extracellular region,extracellular space;extracellular region,extracellular space",6,1,2,SPGPHC[CAM]AQTEVIATLK.3|SPGPHC[CAM]AQTEVIATLK.2
SEN / CTL,Superoxide dismutase [Cu-Zn],SOD1,P00441,-0.66,0.61,1.81E-05,2.17E-05,4.66E+00,"activation of MAPK activity,response to reactive oxygen species,response to superoxide,ovarian follicle development,positive regulation of cytokine production,placenta development,retina homeostasis,response to amphetamine,myeloid cell homeostasis,platelet degranulation,glutathione metabolic process,superoxide metabolic process,cellular iron ion homeostasis,spermatogenesis,embryo implantation,cell aging,sensory perception of sound,locomotory behavior,anterograde axonal transport,retrograde axonal transport,regulation of blood pressure,response to heat,response to organic substance,transmission of nerve impulse,removal of superoxide radicals,response to nutrient levels,peripheral nervous system myelin maintenance,positive regulation of superoxide anion generation,regulation of T cell differentiation in thymus,response to carbon monoxide,cellular response to potassium ion,regulation of multicellular organism growth,response to drug,response to hydrogen peroxide,superoxide anion generation,positive regulation of apoptotic process,positive regulation of catalytic activity,regulation of GTPase activity,negative regulation of neuron apoptotic process,response to ethanol,negative regulation of cholesterol biosynthetic process,regulation of protein kinase activity,regulation of organ growth,response to antibiotic,response to copper ion,muscle cell cellular homeostasis,thymus development,response to axon injury,hydrogen peroxide biosynthetic process,regulation of mitochondrial membrane potential,oxidation-reduction process,heart contraction,neurofilament cytoskeleton organization,relaxation of vascular smooth muscle,auditory receptor cell stereocilium organization,cellular response to cadmium ion,cellular response to ATP,reactive oxygen species metabolic process,response to antipsychotic drug,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway","superoxide dismutase activity,copper ion binding,protein binding,zinc ion binding,protein phosphatase 2B binding,identical protein binding,protein homodimerization activity,Rac GTPase binding,chaperone binding","extracellular region,extracellular space,nucleus,nucleoplasm,cytoplasm,mitochondrion,mitochondrial intermembrane space,mitochondrial matrix,lysosome,peroxisome,cytosol,extracellular matrix,dense core granule,cytoplasmic vesicle,dendrite cytoplasm,neuronal cell body,myelin sheath,protein complex,extracellular exosome,axon cytoplasm,plasma membrane",30,20,39,LAC[CAM]GVIGIAQ.2|HVGDLGNVTADKDGVADVSIEDSVISLSGDHC[CAM]IIGR.4|HVGDLGNVTADKDGVADVSIEDSVISLSGDHC[CAM]IIGR.5|HVGDLGNVTADKDGVADVSIEDSVISLSGDHC[CAM]IIGR.6|GLTEGLHGFHVHEFGDNTAGC[CAM]TSAGPHFNPLSR.5|GLTEGLHGFHVHEFGDNTAGC[CAM]TSAGPHFNPLSR.6|GLTEGLHGFHVHEFGDNTAGC[CAM]TSAGPHFNPLSR.4|GLTEGLHGFHVHEFGDNTAGC[CAM]TSAGPHFNPLSR.7|GLTEGLHGFHVHEFGDNTAGC[CAM]TSAGPHFNPLSR.3|AVC[CAM]VLKGDGPVQGIINFEQK.3|AVC[CAM]VLKGDGPVQGIINFEQK.2|GDGPVQGIINFEQK.2|GDGPVQGIINFEQK.3|HVGDLGNVTADK.3|HVGDLGNVTADK.2|TLVVHEK.2|DEERHVGDLGNVTADK.4|DEERHVGDLGNVTADK.3|TLVVHEKADDLGKGGNEESTK.5|TLVVHEKADDLGKGGNEESTK.4|TLVVHEKADDLGKGGNEESTK.3|ADDLGKGGNEESTK.3|ADDLGKGGNEESTK.2|TLVVHEKADDLGK.3|TLVVHEKADDLGK.2|ADDLGKGGNEESTKTGNAGSR.4|ADDLGKGGNEESTKTGNAGSR.3|GLTEGLHGFHVHEFGDNTAGC[CAM]TSAGPHFNPLSRK.7|GLTEGLHGFHVHEFGDNTAGC[CAM]TSAGPHFNPLSRK.5|HGGPKDEERHVGDLGNVTADK.4|HGGPKDEERHVGDLGNVTADK.3|DGVADVSIEDSVISLSGDHC[CAM]IIGR.4|DGVADVSIEDSVISLSGDHC[CAM]IIGR.3|ESNGPVKVWGSIK.2|AVC[CAM]VLKGDGPVQGIINFEQKESNGPVK.4|AVC[CAM]VLKGDGPVQGIINFEQKESNGPVK.3|GDGPVQGIINFEQKESNGPVKVWGSIK.4|GGNEESTKTGNAGSRLAC[CAM]GVIGIAQ.3|TGNAGSRLAC[CAM]GVIGIAQ.2
SEN / CTL,Proteasome subunit beta type-4,PSMB4,P28070,-0.66,0.59,3.92E-02,1.62E-02,1.79E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,negative regulation of inflammatory response to antigenic stimulus,regulation of cellular amino acid metabolic process,viral process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","lipopolysaccharide binding,threonine-type endopeptidase activity","proteasome complex,nucleus,nucleoplasm,cytosol,proteasome core complex,extracellular exosome",15,10,21,TQNPMVTGTSVLGVK.2|TQNPMVTGTSVLGVK.3|TQNPM[Oxi]VTGTSVLGVK.2|VNNSTMLGASGDYADFQYLK.3|VNNSTM[Oxi]LGASGDYADFQYLK.2|VNNSTMLGASGDYADFQYLK.2|EVLEKQPVLSQTEAR.3|EVLEKQPVLSQTEAR.2|FQIATVTEK.2|QVLGQMVIDEELLGDGHSYSPR.3|QVLGQMVIDEELLGDGHSYSPR.4|QVLGQM[Oxi]VIDEELLGDGHSYSPR.3|AIHSWLTR.2|QPVLSQTEAR.2|FEGGVVIAADM[Oxi]LGSYGSLAR.3|FEGGVVIAADMLGSYGSLAR.3|FEGGVVIAADM[Oxi]LGSYGSLAR.2|FEGGVVIAADMLGSYGSLAR.2|SGLWAGGPAPGQFYR.2|GVEIEGPLSTETNWDIAHM[Oxi]ISGFE.3|GVEIEGPLSTETNWDIAHMISGFE.3
SEN / CTL,Transforming growth factor-beta-induced protein ig-h3,TGFBI,Q15582,-0.67,0.69,1.25E-17,9.89E-17,1.60E+01,"angiogenesis,chondrocyte differentiation,cell adhesion,negative regulation of cell adhesion,visual perception,cell proliferation,extracellular matrix organization,cellular protein metabolic process,response to stimulus","integrin binding,protein binding,collagen binding,extracellular matrix binding","extracellular region,proteinaceous extracellular matrix,basement membrane,extracellular space,trans-Golgi network,plasma membrane,extracellular matrix,extracellular exosome",93,38,60,LTLLAPLNSVFKDGTPPIDAHTR.4|LTLLAPLNSVFKDGTPPIDAHTR.3|EGVYTVFAPTNEAFR.2|YHIGDEILVSGGIGALVR.3|STVISYEC[CAM]C[CAM]PGYEKVPGEK.3|ILGDPEALRDLLNNHILK.3|ILGDPEALRDLLNNHILK.4|VISTITNNIQQIIEIEDTFETLR.3|VISTITNNIQQIIEIEDTFETLR.4|TLFELAAESDVSTAIDLFR.3|YGTLFTMDR.2|LLGDAKELANILK.3|GDELADSALEIFK.2|STVISYEC[CAM]C[CAM]PGYEK.2|YLYHGQTLETLGGK.3|YLYHGQTLETLGGK.2|SLQGDKLEVSLK.3|SLQGDKLEVSLK.2|YLYHGQTLETLGGKK.4|YLYHGQTLETLGGKK.3|NSLC[CAM]IENSC[CAM]IAAHDKR.4|NSLC[CAM]IENSC[CAM]IAAHDKR.3|SPYQLVLQHSR.3|SPYQLVLQHSR.2|LTLLAPLNSVFK.2|LTLLAPLNSVFK.3|AIISNKDILATNGVIHYIDELLIPDSAK.4|AIISNKDILATNGVIHYIDELLIPDSAK.3|GC[CAM]PAALPLSNLYETLGVVGSTTTQLYTDRTEK.4|GC[CAM]PAALPLSNLYETLGVVGSTTTQLYTDRTEK.3|VLTPPMGTVMDVLK.2|VLTPPM[Oxi]GTVMDVLK.2|VLTPPMGTVM[Oxi]DVLK.2|FSMLVAAIQSAGLTETLNR.3|FSM[Oxi]LVAAIQSAGLTETLNR.3|FSMLVAAIQSAGLTETLNR.2|GC[CAM]PAALPLSNLYETLGVVGSTTTQLYTDR.3|QAGLGNHLSGSER.3|QAGLGNHLSGSER.2|ADHHATNGVVHLIDK.4|ADHHATNGVVHLIDK.3|ADHHATNGVVHLIDK.2|QHGPNVC[CAM]AVQK.3|QHGPNVC[CAM]AVQK.2|NNVVSVNK.2|IPSETLNR.2|GRQHGPNVC[CAM]AVQK.3|ILGDPEALR.2|NSLC[CAM]IENSC[CAM]IAAHDK.3|DGTPPIDAHTR.2|DILATNGVIHYIDELLIPDSAK.4|DILATNGVIHYIDELLIPDSAK.3|NHIIKDQLASK.2|AAVAASGLNTMLEGNGQYTLLAPTNEAFEK.4|AAVAASGLNTMLEGNGQYTLLAPTNEAFEK.3|GDNRFSM[Oxi]LVAAIQSAGLTETLNR.3|GDNRFSMLVAAIQSAGLTETLNR.3|HGMTLTSMYQNSNIQIHHYPNGIVTVNC[CAM]AR.4|EPVAEPDIMATNGVVHVITNVLQPPANRPQER.4|NNVVSVNKEPVAEPDIMATNGVVHVITNVLQPPANRPQER.5
SEN / CTL,Prostaglandin F2 receptor negative regulator,PTGFRN,Q9P2B2,-0.68,0.41,1.96E-10,6.87E-10,9.16E+00,lipid particle organization,protein binding,"endoplasmic reticulum membrane,Golgi apparatus,plasma membrane,cell surface,integral component of membrane",24,22,23,FTVSWYYR.2|LDRDSLVHSSPHVALSHVDAR.5|LDRDSLVHSSPHVALSHVDAR.4|MYQTQVSDAGLYR.2|SKDVFSKPVNIFWALEDSVLVVK.4|VPGFADDPTELAC[CAM]R.2|C[CAM]MVTAWSPVR.2|VLADSLHVGPSARPPPSLSLR.4|FHPGLGYEQR.3|TANDAVELHIK.3|VPTATLVR.2|RTANDAVELHIK.3|MPDSTLPGSR.2|ALSADQGSYR.2|APVLLSSLDR.2|SVLALTHEGR.2|LDTVGSDAYR.2|ADDVRPEVTWSFSR.3|EHTDTFNFR.2|APVLLSSLDRK.2|YIISLDQDSVVK.2|TTEEDRGNYYC[CAM]VVSAWTK.3|PFFAAGNTFEMTC[CAM]K.2
SEN / CTL,DNA-(apurinic or apyrimidinic site) lyase,APEX1,P27695,-0.69,0.64,6.73E-06,9.04E-06,5.04E+00,"telomere maintenance,DNA repair,base-excision repair,base-excision repair, base-free sugar-phosphate removal,DNA recombination,transcription, DNA-templated,regulation of transcription, DNA-templated,aging,negative regulation of smooth muscle cell migration,response to drug,regulation of mRNA stability,cell redox homeostasis,positive regulation of DNA repair,oxidation-reduction process,cellular response to hydrogen peroxide,cellular response to cAMP,cellular response to peptide hormone stimulus,DNA demethylation,RNA phosphodiester bond hydrolysis, endonucleolytic,positive regulation of G1/S transition of mitotic cell cycle,negative regulation of nucleic acid-templated transcription","DNA binding,damaged DNA binding,double-stranded telomeric DNA binding,transcription coactivator activity,transcription corepressor activity,DNA-(apurinic or apyrimidinic site) lyase activity,endonuclease activity,endodeoxyribonuclease activity,RNA-DNA hybrid ribonuclease activity,phosphodiesterase I activity,uracil DNA N-glycosylase activity,protein binding,phosphoric diester hydrolase activity,double-stranded DNA exodeoxyribonuclease activity,double-stranded DNA 3'-5' exodeoxyribonuclease activity,3'-5' exonuclease activity,oxidoreductase activity,site-specific endodeoxyribonuclease activity, specific for altered base,chromatin DNA binding,protein complex binding,poly(A) RNA binding,metal ion binding,NF-kappaB binding","nuclear chromosome, telomeric region,nucleus,nucleoplasm,transcription factor complex,nucleolus,cytoplasm,mitochondrion,endoplasmic reticulum,centrosome,ribosome,nuclear speck,perinuclear region of cytoplasm",27,28,52,QGFGELLQAVPLADSFR.2|QGFGELLQAVPLADSFR.3|IC[CAM]SWNVDGLR.2|GLDWVKEEAPDILC[CAM]LQETK.3|GLDWVKEEAPDILC[CAM]LQETK.2|KPLVLC[CAM]GDLNVAHEEIDLRNPK.5|KPLVLC[CAM]GDLNVAHEEIDLRNPK.4|KPLVLC[CAM]GDLNVAHEEIDLRNPK.3|HLYPNTPYAYTFWTYMMNAR.3|HLYPNTPYAYTFWTYM[Oxi]M[Oxi]NAR.3|HLYPNTPYAYTFWTYM[Oxi]MNAR.3|LDYFLLSHSLLPALC[CAM]DSK.3|LDYFLLSHSLLPALC[CAM]DSK.4|LDYFLLSHSLLPALC[CAM]DSK.2|C[CAM]SENKLPAELQELPGLSHQYWSAPSDKEGYSGVGLLSR.5|C[CAM]SENKLPAELQELPGLSHQYWSAPSDKEGYSGVGLLSR.6|C[CAM]SENKLPAELQELPGLSHQYWSAPSDKEGYSGVGLLSR.4|QRWDEAFRK.3|KGAVAEDGDELR.3|KGAVAEDGDELR.2|GAVAEDGDELRTEPEAKK.4|GAVAEDGDELRTEPEAKK.3|KGAVAEDGDELRTEPEAK.4|KGAVAEDGDELRTEPEAK.3|NAGFTPQER.2|EEAPDILC[CAM]LQETK.3|EEAPDILC[CAM]LQETK.2|TSPSGKPATLK.2|KPLVLC[CAM]GDLNVAHEEIDLR.4|KPLVLC[CAM]GDLNVAHEEIDLR.3|KPLVLC[CAM]GDLNVAHEEIDLR.2|GAVAEDGDELR.2|VSYGIGDEEHDQEGR.3|VSYGIGDEEHDQEGR.2|EGYSGVGLLSR.2|KNDKEAAGEGPALYEDPPDQK.4|KNDKEAAGEGPALYEDPPDQK.3|KGLDWVKEEAPDILC[CAM]LQETK.4|KGLDWVKEEAPDILC[CAM]LQETK.3|EAAGEGPALYEDPPDQK.3|EAAGEGPALYEDPPDQK.2|GAVAEDGDELRTEPEAK.3|GAVAEDGDELRTEPEAK.2|PLVLC[CAM]GDLNVAHEEIDLRNPK.4|PLVLC[CAM]GDLNVAHEEIDLRNPK.3|NDKEAAGEGPALYEDPPDQK.3|C[CAM]SENKLPAELQELPGLSHQYWSAPSDK.4|C[CAM]SENKLPAELQELPGLSHQYWSAPSDK.3|ALGSDHC[CAM]PITLYLAL.2|LPAELQELPGLSHQYWSAPSDK.3|LPAELQELPGLSHQYWSAPSDKEGYSGVGLLSR.4|LPAELQELPGLSHQYWSAPSDKEGYSGVGLLSR.3
SEN / CTL,CD81 antigen,CD81,P60033,-0.69,0.36,1.60E-05,1.93E-05,4.71E+00,"activation of MAPK activity,cell surface receptor signaling pathway,protein localization,cell proliferation,positive regulation of cell proliferation,positive regulation of B cell proliferation,receptor internalization,regulation of protein stability,positive regulation of 1-phosphatidylinositol 4-kinase activity,positive regulation of transcription from RNA polymerase II promoter,viral entry into host cell,receptor-mediated virion attachment to host cell,positive regulation of peptidyl-tyrosine phosphorylation,regulation of immune response,protein localization to lysosome,cellular response to low-density lipoprotein particle stimulus,positive regulation of protein catabolic process in the vacuole,regulation of cell motility","protein binding,MHC class II protein complex binding,transferrin receptor binding","immunological synapse,plasma membrane,integral component of plasma membrane,focal adhesion,membrane,vesicle,extracellular exosome",12,5,8,TFHETLDC[CAM]C[CAM]GSSTLTALTTSVLK.3|TFHETLDC[CAM]C[CAM]GSSTLTALTTSVLK.4|QFYDQALQQAVVDDDANNAK.3|QFYDQALQQAVVDDDANNAK.2|NNLC[CAM]PSGSNIISNLFK.3|NNLC[CAM]PSGSNIISNLFK.2|NNLC[CAM]PSGSNIISNLFKEDC[CAM]HQK.4|DVKQFYDQALQQAVVDDDANNAK.3
SEN / CTL,Acyl-CoA-binding protein,DBI,P07108,-0.70,0.19,3.45E-06,5.03E-06,5.30E+00,"transport,phosphatidylcholine acyl-chain remodeling,protein palmitoylation","lipid binding,benzodiazepine receptor binding,long-chain fatty acyl-CoA binding,protein dimerization activity","endoplasmic reticulum,Golgi apparatus,extracellular exosome",9,8,18,TKPSDEEMLFIYGHYK.3|TKPSDEEMLFIYGHYK.4|TKPSDEEM[Oxi]LFIYGHYK.4|TKPSDEEM[Oxi]LFIYGHYK.3|TKPSDEEMLFIYGHYK.2|QATVGDINTERPGMLDFTGK.3|QATVGDINTERPGM[Oxi]LDFTGK.4|QATVGDINTERPGM[Oxi]LDFTGK.3|QATVGDINTERPGMLDFTGK.2|AYINKVEELK.3|AYINKVEELK.2|AKWDAWNELK.3|AKWDAWNELK.2|AYINKVEELKK.3|AYINKVEELKK.2|PGMLDFTGK.2|AAEEVRHLK.2|WDAWNELK.2
SEN / CTL,Cytochrome c,CYCS,P99999,-0.71,0.36,6.36E-05,6.73E-05,4.17E+00,"response to reactive oxygen species,mitochondrial electron transport, ubiquinol to cytochrome c,mitochondrial electron transport, cytochrome c to oxygen,protein dephosphorylation,mitochondrion organization,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,cellular respiration,intrinsic apoptotic signaling pathway","protein binding,heme binding,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,metal ion binding,protein serine/threonine phosphatase activity","protein phosphatase type 2A complex,nucleus,mitochondrion,mitochondrial inner membrane,mitochondrial intermembrane space,cytosol,respiratory chain",9,13,27,ADLIAYLK.2|ADLIAYLK.1|MIFVGIK.2|M[Oxi]IFVGIK.2|MIFVGIK.1|M[Oxi]IFVGIK.1|GIIWGEDTLMEYLENPKK.3|GIIWGEDTLMEYLENPKK.4|GIIWGEDTLM[Oxi]EYLENPKK.3|GIIWGEDTLMEYLENPKK.2|KYIPGTK.2|TGPNLHGLFGRK.3|KTGQAPGYSYTAANKNK.4|KTGQAPGYSYTAANKNK.3|TGQAPGYSYTAANK.3|TGQAPGYSYTAANK.2|KTGQAPGYSYTAANK.3|KTGQAPGYSYTAANK.2|TGQAPGYSYTAANKNK.3|TGPNLHGLFGR.2|NKGIIWGEDTLMEYLENPKK.4|NKGIIWGEDTLMEYLENPKK.3|GIIWGEDTLM[Oxi]EYLENPK.3|GIIWGEDTLMEYLENPK.3|GIIWGEDTLMEYLENPK.2|GIIWGEDTLM[Oxi]EYLENPK.2|NKGIIWGEDTLMEYLENPK.3
SEN / CTL,Small ubiquitin-related modifier 1,SUMO1,P63165,-0.71,0.48,1.16E-01,4.02E-02,1.40E+00,"DNA repair,double-strand break repair via nonhomologous end joining,viral process,protein sumoylation,PML body organization,positive regulation of protein complex assembly,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,regulation of protein localization,negative regulation of DNA binding,negative regulation of sequence-specific DNA binding transcription factor activity,negative regulation of action potential,negative regulation of transcription, DNA-templated,protein stabilization,palate development,regulation of interferon-gamma-mediated signaling pathway,global genome nucleotide-excision repair,regulation of cardiac muscle cell contraction,protein localization to nuclear pore,positive regulation of calcium-transporting ATPase activity,negative regulation of delayed rectifier potassium channel activity","protein binding,transcription factor binding,potassium channel regulator activity,protein tag,ubiquitin protein ligase binding,ion channel binding,poly(A) RNA binding","heterochromatin,fibrillar center,XY body,nucleus,nuclear pore,nucleoplasm,nucleolus,cytoplasm,plasma membrane,nuclear body,PML body,nuclear speck,dendrite,nuclear membrane,synapse,voltage-gated potassium channel complex",3,6,8,VIGQDSSEIHFK.3|VIGQDSSEIHFK.2|FLFEGQR.2|IADNHTPK.2|QGVPMNSLR.2|QGVPM[Oxi]NSLR.2|LKVIGQDSSEIHFK.3|PSTEDLGDKK.2
SEN / CTL,Huntingtin-interacting protein K,HYPK,Q9NX55,-0.72,0.40,9.02E-02,3.29E-02,1.48E+00,,protein binding,"nucleoplasm,cytoplasm,microtubule cytoskeleton",3,11,15,SLREHMGNVVEALIALTN.3|KHDSGAADLER.3|KHDSGAADLER.2|HDSGAADLER.2|VTIKKEDLELIMTEMEISR.4|KEDLELIMTEMEISR.3|KEDLELIMTEMEISR.2|EIQSSNLETAMSVIGDR.3|EIQSSNLETAMSVIGDR.2|EIQSSNLETAMSVIGDRR.3|VTDYAEEKEIQSSNLETAMSVIGDRR.4|EHMGNVVEALIALTN.2|EHM[Oxi]GNVVEALIALTN.2|EDLELIMTEMEISR.2|VTDYAEEKEIQSSNLETAMSVIGDR.3
SEN / CTL,Syntenin-1,SDCBP,O00560,-0.72,0.37,1.98E-05,2.33E-05,4.63E+00,"negative regulation of receptor internalization,protein targeting to membrane,substrate-dependent cell migration, cell extension,Ras protein signal transduction,chemical synaptic transmission,regulation of mitotic cell cycle,positive regulation of cell proliferation,positive regulation of epithelial to mesenchymal transition,positive regulation of pathway-restricted SMAD protein phosphorylation,actin cytoskeleton organization,positive regulation of cell growth,positive regulation of cell migration,positive regulation of transforming growth factor beta receptor signaling pathway,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,intracellular signal transduction,positive regulation of phosphorylation,positive regulation of JNK cascade,ephrin receptor signaling pathway,cell-cell adhesion,positive regulation of exosomal secretion,positive regulation of extracellular exosome assembly","glycoprotein binding,frizzled binding,interleukin-5 receptor binding,protein binding,protein C-terminus binding,cytoskeletal adaptor activity,growth factor binding,neurexin family protein binding,identical protein binding,protein homodimerization activity,syndecan binding,ephrin receptor binding,protein heterodimerization activity,protein N-terminus binding,cadherin binding involved in cell-cell adhesion","extracellular space,nucleus,cytoplasm,endoplasmic reticulum membrane,cytosol,cytoskeleton,plasma membrane,interleukin-5 receptor complex,adherens junction,cell-cell adherens junction,focal adhesion,membrane,melanosome,membrane raft,extracellular exosome,blood microparticle,extracellular vesicle",12,13,25,SLMDHTIPEV.2|DSTGHVGFIFK.3|DSTGHVGFIFK.2|SIDNGIFVQLVQANSPASLVGLR.3|SIDNGIFVQLVQANSPASLVGLR.4|SIDNGIFVQLVQANSPASLVGLR.2|ANVAVVSGAPLQGQLVARPSSINYMVAPVTGNDVGIR.4|ANVAVVSGAPLQGQLVAR.3|ANVAVVSGAPLQGQLVAR.2|NGLLTEHNIC[CAM]EINGQNVIGLK.4|NGLLTEHNIC[CAM]EINGQNVIGLK.3|NGLLTEHNIC[CAM]EINGQNVIGLK.2|EVILC[CAM]KDQDGK.2|PSSINYMVAPVTGNDVGIR.3|PSSINYM[Oxi]VAPVTGNDVGIR.2|PSSINYMVAPVTGNDVGIR.2|VIQAQTAFSANPANPAILSEASAPIPHDGNLYPR.5|VIQAQTAFSANPANPAILSEASAPIPHDGNLYPR.4|VIQAQTAFSANPANPAILSEASAPIPHDGNLYPR.3|PSSINYMVAPVTGNDVGIRR.3|FGDQVLQINGENC[CAM]AGWSSDK.3|FGDQVLQINGENC[CAM]AGWSSDK.2|LYPELSQYMGLSLNEEEIR.3|LYPELSQYMGLSLNEEEIR.2|LKSIDNGIFVQLVQANSPASLVGLR.3
SEN / CTL,Serine/arginine-rich splicing factor 7,SRSF7,Q16629,-0.72,0.38,5.67E-03,3.35E-03,2.47E+00,"mRNA splicing, via spliceosome,termination of RNA polymerase II transcription,mRNA processing,RNA export from nucleus,mRNA export from nucleus,RNA splicing,mRNA 3'-end processing,negative regulation of mRNA splicing, via spliceosome","nucleotide binding,protein binding,zinc ion binding,poly(A) RNA binding","nucleus,nucleoplasm,cytoplasm,extracellular exosome",6,10,17,VYVGNLGTGAGKGELER.3|VYVGNLGTGAGKGELER.2|VRVELSTGMPR.3|VRVELSTGM[Oxi]PR.3|VRVELSTGMPR.2|RPFDPNDRC[CAM]YEC[CAM]GEK.4|RPFDPNDRC[CAM]YEC[CAM]GEK.3|VELSTGMPR.2|VELSTGM[Oxi]PR.2|RPFDPNDR.2|AFSYYGPLR.2|VYVGNLGTGAGK.2|GHYAYDC[CAM]HR.2|NPPGFAFVEFEDPRDAEDAVR.4|NPPGFAFVEFEDPRDAEDAVR.3|NPPGFAFVEFEDPRDAEDAVR.2|NPPGFAFVEFEDPRDAEDAVRGLDGK.4
SEN / CTL,"Beta-1,4-galactosyltransferase 1",B4GALT1,P15291,-0.72,0.26,5.53E-09,1.52E-08,7.82E+00,"epithelial cell development,acute inflammatory response,lactose biosynthetic process,galactose metabolic process,protein N-linked glycosylation,cell adhesion,binding of sperm to zona pellucida,penetration of zona pellucida,negative regulation of cell proliferation,oligosaccharide biosynthetic process,keratan sulfate biosynthetic process,extracellular matrix organization,mammary gland development,development of secondary sexual characteristics,branching morphogenesis of an epithelial tube,leukocyte migration,regulation of cellular component movement,regulation of acrosome reaction,positive regulation of epithelial cell proliferation involved in wound healing,angiogenesis involved in wound healing,positive regulation of apoptotic process involved in mammary gland involution","beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,N-acetyllactosamine synthase activity,lactose synthase activity,cytoskeletal protein binding,galactosyltransferase activity,manganese ion binding,UDP-galactosyltransferase activity","Golgi trans cisterna,Golgi membrane,extracellular space,Golgi apparatus,plasma membrane,external side of plasma membrane,membrane,integral component of membrane,basolateral plasma membrane,desmosome,glycocalyx,filopodium,brush border membrane,Golgi cisterna membrane,extracellular exosome",15,7,9,VAIIIPFR.2|YWLYYLHPVLQR.3|QQLDYGIYVINQAGDTIFNR.3|ETMLSDGLNSLTYQVLDVQR.3|ETMLSDGLNSLTYQVLDVQR.2|FGFSLPYVQYFGGVSALSK.3|FGFSLPYVQYFGGVSALSK.2|HISVAMDK.2|LLNVGFQEALK.2
SEN / CTL,Glia-derived nexin,SERPINE2,P07093,-0.73,0.22,1.55E-15,1.04E-14,1.40E+01,"blood coagulation,negative regulation of cell proliferation,negative regulation of plasminogen activation,negative regulation of sodium ion transport,negative regulation of endopeptidase activity,negative regulation of protein processing,negative regulation of phosphatidylinositol 3-kinase signaling,cerebellar granular layer morphogenesis,negative regulation of blood coagulation,negative regulation of cell growth,regulation of cell migration,secretion by cell,secretory granule organization,negative regulation of protein catabolic process,mating plug formation,negative regulation of proteolysis,negative regulation of smoothened signaling pathway,regulation of timing of cell differentiation,positive regulation of astrocyte differentiation,detection of mechanical stimulus involved in sensory perception,regulation of synaptic transmission, glutamatergic,long-term synaptic potentiation,innervation,seminal vesicle epithelium development,negative regulation of platelet aggregation","serine-type endopeptidase inhibitor activity,receptor binding,protein binding,glycosaminoglycan binding,heparin binding","extracellular region,extracellular space,cytosol,extracellular matrix,platelet alpha granule,extrinsic component of external side of plasma membrane,neuromuscular junction,extracellular vesicle",27,11,14,LVLVNAVYFK.2|SYQVPMLAQLSVFR.2|ASAATTAILIAR.2|TIDSWMSIMVPK.2|DMIDNLLSPDLIDGVLTR.3|DMIDNLLSPDLIDGVLTR.2|SRPHDNIVISPHGIASVLGMLQLGADGR.5|SRPHDNIVISPHGIASVLGMLQLGADGR.4|VLGITDMFDSSK.2|NKDIVTVANAVFVK.3|NKDIVTVANAVFVK.2|AKIEVSEDGTK.2|ITTGSENLHVSHILQK.3|DIVTVANAVFVK.2
SEN / CTL,Low-density lipoprotein receptor,LDLR,P01130,-0.73,0.43,7.22E-03,4.08E-03,2.39E+00,"lipid metabolic process,endocytosis,receptor-mediated endocytosis,cholesterol metabolic process,positive regulation of gene expression,negative regulation of gene expression,positive regulation of triglyceride biosynthetic process,regulation of phosphatidylcholine catabolic process,phospholipid transport,intestinal cholesterol absorption,cholesterol transport,low-density lipoprotein particle clearance,lipoprotein catabolic process,cholesterol homeostasis,viral entry into host cell,positive regulation of inflammatory response,cholesterol import,cellular response to fatty acid,regulation of cholesterol homeostasis","virus receptor activity,glycoprotein binding,protease binding,receptor activity,low-density lipoprotein receptor activity,calcium ion binding,protein binding,low-density lipoprotein particle binding,very-low-density lipoprotein particle receptor activity,clathrin heavy chain binding,identical protein binding","lysosome,early endosome,late endosome,Golgi apparatus,plasma membrane,integral component of plasma membrane,clathrin-coated pit,external side of plasma membrane,cell surface,endosome membrane,membrane,basolateral plasma membrane,clathrin-coated endocytic vesicle membrane,low-density lipoprotein particle,receptor complex,apical part of cell,PCSK9-LDLR complex",6,18,20,NVVALDTEVASNR.2|AVGSIAYLFFTNR.2|AHGVSSYDTVISR.3|AHGVSSYDTVISR.2|SGDFSC[CAM]GGR.2|RLAHPFSLAVFEDK.3|MIC[CAM]STQLDR.2|NEFQC[CAM]QDGK.2|C[CAM]QC[CAM]EEGFQLDPHTK.3|TTEDEVHIC[CAM]HNQDGYSYPSR.4|VFWTDIINEAIFSANR.3|VFWTDIINEAIFSANR.2|SEYTSLIPNLR.2|C[CAM]HSGEC[CAM]ITLDK.2|FTC[CAM]AC[CAM]PDGMLLAR.2|AIVVDPVHGFMYWTDWGTPAK.3|NINSINFDNPVYQK.2|GLYVFQGDSSPC[CAM]SAFEFHC[CAM]LSGEC[CAM]IHSSWR.4|TTLSNGGC[CAM]QYLC[CAM]LPAPQINPHSPK.3|IGYEC[CAM]LC[CAM]PDGFQLVAQR.2
SEN / CTL,Insulin-like growth factor-binding protein 6,IGFBP6,P24592,-0.74,0.09,4.78E-06,6.58E-06,5.18E+00,"regulation of cell growth,signal transduction,negative regulation of cell proliferation,regulation of insulin-like growth factor receptor signaling pathway,cellular protein metabolic process,negative regulation of canonical Wnt signaling pathway","receptor binding,insulin-like growth factor I binding,insulin-like growth factor II binding","extracellular region,extracellular space,Golgi apparatus,extracellular exosome",6,4,4,HLDSVLQQLQTEVYR.3|EGQEC[CAM]GVYTPNC[CAM]APGLQC[CAM]HPPKDDEAPLR.4|APAVAEENPK.2|GAQTLYVPNC[CAM]DHR.2
SEN / CTL,Neuropilin-1,NRP1,O14786,-0.74,0.31,2.94E-10,9.92E-10,9.00E+00,"angiogenesis,patterning of blood vessels,neuron migration,positive regulation of endothelial cell proliferation,sprouting angiogenesis,cell migration involved in sprouting angiogenesis,signal transduction,cell-cell signaling,axon guidance,axonal fasciculation,response to wounding,animal organ morphogenesis,positive regulation of endothelial cell migration,positive regulation of smooth muscle cell migration,dendrite development,facial nerve structural organization,trigeminal nerve structural organization,vestibulocochlear nerve structural organization,nerve development,branchiomotor neuron axon guidance,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,retinal ganglion cell axon guidance,cellular response to hepatocyte growth factor stimulus,endothelial cell chemotaxis,cellular response to vascular endothelial growth factor stimulus,ventral trunk neural crest cell migration,VEGF-activated neuropilin signaling pathway,negative regulation of neuron apoptotic process,platelet-derived growth factor receptor signaling pathway,vascular endothelial growth factor receptor signaling pathway,hepatocyte growth factor receptor signaling pathway,positive regulation of axon extension involved in axon guidance,negative regulation of axon extension involved in axon guidance,artery morphogenesis,axon extension involved in axon guidance,positive regulation of peptidyl-tyrosine phosphorylation,positive chemotaxis,positive regulation of cytokine activity,axonogenesis involved in innervation,regulation of vesicle-mediated transport,dichotomous subdivision of terminal units involved in salivary gland branching,angiogenesis involved in coronary vascular morphogenesis,coronary artery morphogenesis,retina vasculature morphogenesis in camera-type eye,renal artery morphogenesis,sympathetic ganglion development,trigeminal ganglion development,positive regulation of ERK1 and ERK2 cascade,semaphorin-plexin signaling pathway,commissural neuron axon guidance,regulation of retinal ganglion cell axon guidance,endothelial tip cell fate specification,sensory neuron axon guidance,sympathetic neuron projection extension,sympathetic neuron projection guidance,neural crest cell migration involved in autonomic nervous system development,toxin transport,semaphorin-plexin signaling pathway involved in neuron projection guidance,semaphorin-plexin signaling pathway involved in axon guidance,positive regulation of retinal ganglion cell axon guidance,VEGF-activated neuropilin signaling pathway involved in axon guidance,protein localization to early endosome,facioacoustic ganglion development,dorsal root ganglion morphogenesis,otic placode development,negative regulation of extrinsic apoptotic signaling pathway","vascular endothelial growth factor-activated receptor activity,heparin binding,coreceptor activity,semaphorin receptor activity,growth factor binding,cytokine binding,vascular endothelial growth factor binding,metal ion binding","semaphorin receptor complex,extracellular space,early endosome,cytosol,neurofilament,plasma membrane,focal adhesion,cell surface,integral component of membrane,axon,growth cone,cytoplasmic vesicle,neuronal cell body,receptor complex,sorting endosome",21,12,14,FVTAVGTQGAISK.2|IAPPPVVSSGPFLFIK.3|IAPPPVVSSGPFLFIK.2|YDRLEIWDGFPDVGPHIGR.4|FVSDYETHGAGFSIR.3|EGNKPVLFQGNTNPTDVVVAVFPKPLITR.4|SFEGNNNYDTPELR.2|IESPGYLTSPGYPHSYHPSEK.4|IESPGYLTSPGYPHSYHPSEK.3|C[CAM]GDTIKIESPGYLTSPGYPHSYHPSEK.5|SSSGILSMVFYTDSAIAK.3|DKLNTQSTYSEA.2|LYQVIFEGEIGK.2|EGNKPVLFQGNTNPTDVVVAVFPK.3
SEN / CTL,Protein dpy-30 homolog,DPY30,Q9C005,-0.75,2.58,9.28E-02,3.36E-02,1.47E+00,"chromatin silencing at telomere,transcription, DNA-templated,endosomal transport,histone H3-K4 methylation","protein binding,histone-lysine N-methyltransferase activity,identical protein binding,protein homodimerization activity,histone methyltransferase activity (H3-K4 specific)","chromosome, telomeric region,nucleus,nucleoplasm,Golgi apparatus,trans-Golgi network,histone methyltransferase complex,MLL3/4 complex,Set1C/COMPASS complex",6,4,6,ERPPNPIEFLASYLLK.3|ERPPNPIEFLASYLLK.4|ERPPNPIEFLASYLLK.2|AYLDQTVVPILLQGLAVLAK.3|QKVDLQSLPTR.3|VDLQSLPTR.2
SEN / CTL,Tropomyosin beta chain,TPM2,P07951,-0.75,0.76,8.46E-02,3.14E-02,1.50E+00,"muscle contraction,muscle filament sliding,regulation of ATPase activity","actin binding,structural constituent of muscle","cytosol,muscle thin filament tropomyosin",12,24,37,AMKDEEKMELQEMQLK.4|AMKDEEKMELQEMQLK.3|KLVILEGELERSEER.3|MELQEMQLK.2|M[Oxi]ELQEMQLK.2|MELQEM[Oxi]QLK.2|KATDAEADVASLNRR.4|KATDAEADVASLNRR.3|KATDAEADVASLNRR.2|SEERAEVAESK.3|ENAIDRAEQAEADKK.4|ENAIDRAEQAEADKK.3|C[CAM]KQLEEEQQALQKK.4|C[CAM]KQLEEEQQALQKK.3|QLEEEQQALQK.3|QLEEEQQALQK.2|SLEAQADKYSTK.3|SLEAQADKYSTK.2|GTEDEVEK.2|HIAEDSDRKYEEVAR.4|HIAEDSDRKYEEVAR.3|HIAEDSDR.2|EAQEKLEQAEKK.3|QLEEEQQALQKK.3|QLEEEQQALQKK.2|ENAIDRAEQAEADK.3|LDKENAIDR.2|C[CAM]KQLEEEQQALQK.3|C[CAM]KQLEEEQQALQK.2|C[CAM]GDLEEELK.2|AISEELDNALNDITSL.3|AISEELDNALNDITSL.2|LKGTEDEVEK.2|EAQEKLEQAEK.2|YSESVKEAQEK.2|TIDDLEDEVYAQK.2|GTEDEVEKYSESVK.2
SEN / CTL,Latent-transforming growth factor beta-binding protein 2,LTBP2,Q14767,-0.75,0.17,1.45E-02,7.22E-03,2.14E+00,"protein targeting,transforming growth factor beta receptor signaling pathway,protein secretion,extracellular fibril organization","calcium ion binding,protein binding,heparin binding,growth factor binding","proteinaceous extracellular matrix,extracellular space,intracellular,extracellular exosome,extracellular matrix",3,8,8,SSEVYAQLC[CAM]NVAR.2|RSTPLGQQQPAPR.3|SSAAGEGTLAR.2|IVFTPTIC[CAM]K.2|STPLGQQQPAPR.2|GC[CAM]QDVDEC[CAM]ASR.2|EQDAPVAGLQPVER.2|ALLEAPLKQSTFTLPLSNQLASVNPSLVK.3
SEN / CTL,GDNF family receptor alpha-1,GFRA1,P56159,-0.75,0.29,6.21E-02,2.41E-02,1.62E+00,"MAPK cascade,cell surface receptor signaling pathway,nervous system development,glial cell-derived neurotrophic factor receptor signaling pathway,positive regulation of GTPase activity","Ras guanyl-nucleotide exchange factor activity,receptor binding,glial cell-derived neurotrophic factor receptor activity","intracellular,plasma membrane,extrinsic component of membrane,anchored component of membrane,extracellular exosome",3,5,5,LADFFTNC[CAM]QPESR.2|EGLGASSHITTK.3|NKPLGPAGSENEIPTHVLPPC[CAM]ANLQAQK.4|QTIVPVC[CAM]SYEER.2|SAYITPC[CAM]TTSVSNDVC[CAM]NR.2
SEN / CTL,"Keratin, type I cytoskeletal 10",KRT10,P13645,-0.75,0.83,2.62E-12,1.26E-11,1.09E+01,keratinocyte differentiation,structural constituent of epidermis,"extracellular space,nucleus,cytoplasm,intermediate filament,membrane,extracellular exosome",93,52,104,IRLENEIQTYR.3|IRLENEIQTYR.2|LKYENEVALR.3|LKYENEVALR.2|DAEAWFNEK.2|TIDDLKNQILNLTTDNANILLQIDNAR.4|TIDDLKNQILNLTTDNANILLQIDNAR.3|YC[CAM]VQLSQIQAQISALEEQLQQIR.3|YC[CAM]VQLSQIQAQISALEEQLQQIR.4|QSLEASLAETEGR.2|QSLEASLAETEGR.3|AETEC[CAM]QNTEYQQLLDIK.2|AETEC[CAM]QNTEYQQLLDIK.3|VLDELTLTK.2|VLDELTLTKADLEM[Oxi]QIESLTEELAYLKK.4|VLDELTLTKADLEMQIESLTEELAYLKK.4|VLDELTLTKADLEM[Oxi]QIESLTEELAYLKK.5|VLDELTLTKADLEMQIESLTEELAYLKK.3|ALEESNYELEGK.2|ALEESNYELEGK.3|GSLGGGFSSGGFSGGSFSR.2|GSLGGGFSSGGFSGGSFSR.3|SEITELR.2|QSVEADINGLRR.3|QSVEADINGLRR.2|SQYEQLAEQNRKDAEAWFNEK.4|SQYEQLAEQNRKDAEAWFNEK.3|VTMQNLNDRLASYLDKVR.4|VTM[Oxi]QNLNDRLASYLDKVR.4|VTMQNLNDRLASYLDKVR.3|VTM[Oxi]QNLNDRLASYLDKVR.3|GSSGGGC[CAM]FGGSSGGYGGLGGFGGGSFR.3|GSSGGGC[CAM]FGGSSGGYGGLGGFGGGSFR.2|NVSTGDVNVEMNAAPGVDLTQLLNNMR.3|NVSTGDVNVEM[Oxi]NAAPGVDLTQLLNNMR.3|NVSTGDVNVEMNAAPGVDLTQLLNNM[Oxi]R.3|NVSTGDVNVEM[Oxi]NAAPGVDLTQLLNNM[Oxi]R.3|NVSTGDVNVEM[Oxi]NAAPGVDLTQLLNNMR.4|NVSTGDVNVEMNAAPGVDLTQLLNNMR.4|NVSTGDVNVEM[Oxi]NAAPGVDLTQLLNNM[Oxi]R.4|ADLEM[Oxi]QIESLTEELAYLKK.3|ADLEM[Oxi]QIESLTEELAYLKK.4|ADLEMQIESLTEELAYLKK.4|ADLEMQIESLTEELAYLKK.3|ADLEM[Oxi]QIESLTEELAYLKK.2|ADLEMQIESLTEELAYLKK.2|QSVEADINGLR.2|QSVEADINGLR.3|KDAEAWFNEK.3|KDAEAWFNEK.2|SLLEGEGSSGGGGR.3|SLLEGEGSSGGGGR.2|NHEEEMKDLR.3|NHEEEM[Oxi]KDLR.3|NHEEEMKDLR.2|NHEEEM[Oxi]KDLR.2|YSSSKHYSSSR.3|SQYEQLAEQNR.3|SQYEQLAEQNR.2|NHEEEMK.2|KNHEEEMKDLR.3|KNHEEEM[Oxi]KDLR.3|KNHEEEMKDLR.2|IKEWYEK.2|SEITELRR.2|SQYEQLAEQNRK.3|SQYEQLAEQNRK.2|SSSSGSVGESSSKGPR.3|YENEVALR.2|SGGGGGGGGC[CAM]GGGGGVSSLR.3|SGGGGGGGGC[CAM]GGGGGVSSLR.2|IKEWYEKHGNSHQGEPR.4|IKEWYEKHGNSHQGEPR.3|KNHEEEMK.2|VRALEESNYELEGK.3|VRALEESNYELEGK.2|HGNSHQGEPR.2|HYSSSRSGGGGGGGGC[CAM]GGGGGVSSLR.4|HYSSSRSGGGGGGGGC[CAM]GGGGGVSSLR.3|LENEIQTYR.2|ALEESNYELEGKIKEWYEK.4|RVLDELTLTK.2|SSSSGSVGESSSK.2|NVQALEIELQSQLALK.3|NVQALEIELQSQLALK.2|ELTTEIDNNIEQISSYK.3|ELTTEIDNNIEQISSYK.2|ADLEM[Oxi]QIESLTEELAYLK.3|ADLEMQIESLTEELAYLK.3|ADLEMQIESLTEELAYLK.2|ADLEM[Oxi]QIESLTEELAYLK.2|ELTTEIDNNIEQISSYKSEITELR.4|ELTTEIDNNIEQISSYKSEITELR.3|ISSSKGSLGGGFSSGGFSGGSFSR.3|SKELTTEIDNNIEQISSYK.3|SKELTTEIDNNIEQISSYK.2|ELTTEIDNNIEQISSYKSEITELRR.4|ELTTEIDNNIEQISSYKSEITELRR.3|SKELTTEIDNNIEQISSYKSEITELR.4|SKELTTEIDNNIEQISSYKSEITELR.3|NQILNLTTDNANILLQIDNAR.3|NQILNLTTDNANILLQIDNAR.2|NVQALEIELQSQLALKQSLEASLAETEGR.4|YYKTIDDLKNQILNLTTDNANILLQIDNAR.4
SEN / CTL,Calreticulin,CALR,P27797,-0.75,1.08,1.94E-08,4.67E-08,7.33E+00,"negative regulation of transcription from RNA polymerase II promoter,antigen processing and presentation of peptide antigen via MHC class I,peptide antigen assembly with MHC class I protein complex,regulation of transcription, DNA-templated,protein folding,protein export from nucleus,cellular calcium ion homeostasis,receptor-mediated endocytosis,cell cycle arrest,spermatogenesis,positive regulation of cell proliferation,positive regulation of gene expression,negative regulation of translation,protein maturation by protein folding,cortical actin cytoskeleton organization,response to estradiol,negative regulation of intracellular steroid hormone receptor signaling pathway,response to testosterone,protein localization to nucleus,protein folding in endoplasmic reticulum,ATF6-mediated unfolded protein response,regulation of meiotic nuclear division,response to drug,glucocorticoid receptor signaling pathway,regulation of apoptotic process,negative regulation of neuron differentiation,positive regulation of DNA replication,positive regulation of cell cycle,negative regulation of transcription, DNA-templated,negative regulation of retinoic acid receptor signaling pathway,positive regulation of phagocytosis,protein stabilization,sequestering of calcium ion,cardiac muscle cell differentiation,chaperone-mediated protein folding,cellular response to lithium ion,cellular senescence,positive regulation of substrate adhesion-dependent cell spreading,positive regulation of NIK/NF-kappaB signaling,positive regulation of dendritic cell chemotaxis","complement component C1q binding,glycoprotein binding,DNA binding,mRNA binding,integrin binding,iron ion binding,calcium ion binding,protein binding,zinc ion binding,carbohydrate binding,ubiquitin protein ligase binding,peptide binding,hormone binding,protein binding involved in protein folding,poly(A) RNA binding,androgen receptor binding,unfolded protein binding,chaperone binding","acrosomal vesicle,extracellular region,proteinaceous extracellular matrix,extracellular space,intracellular,nucleus,cytoplasm,endoplasmic reticulum,endoplasmic reticulum lumen,smooth endoplasmic reticulum,Golgi apparatus,cytosol,polysome,focal adhesion,external side of plasma membrane,cell surface,membrane,sarcoplasmic reticulum lumen,MHC class I peptide loading complex,perinuclear region of cytoplasm,extracellular exosome,integral component of lumenal side of endoplasmic reticulum membrane,endocytic vesicle lumen",87,52,95,EQFLDGDGWTSR.2|FYALSASFEPFSNK.2|FYALSASFEPFSNK.3|GQTLVVQFTVK.2|C[CAM]KDDEFTHLYTLIVRPDNTYEVK.4|C[CAM]KDDEFTHLYTLIVRPDNTYEVK.5|C[CAM]KDDEFTHLYTLIVRPDNTYEVK.3|FYGDEEKDKGLQTSQDAR.4|FYGDEEKDKGLQTSQDAR.3|FYGDEEKDKGLQTSQDAR.2|IKDPDASKPEDWDER.4|IKDPDASKPEDWDER.3|IKDPDASKPEDWDER.2|SGTIFDNFLITNDEAYAEEFGNETWGVTK.3|SGTIFDNFLITNDEAYAEEFGNETWGVTK.4|VHVIFNYK.2|VHVIFNYK.1|LFPNSLDQTDMHGDSEYNIMFGPDIC[CAM]GPGTK.3|LFPNSLDQTDMHGDSEYNIMFGPDIC[CAM]GPGTK.4|LFPNSLDQTDM[Oxi]HGDSEYNIMFGPDIC[CAM]GPGTK.3|LFPNSLDQTDMHGDSEYNIM[Oxi]FGPDIC[CAM]GPGTK.4|LFPNSLDQTDMHGDSEYNIM[Oxi]FGPDIC[CAM]GPGTK.3|LFPNSLDQTDM[Oxi]HGDSEYNIMFGPDIC[CAM]GPGTK.4|LFPNSLDQTDM[Oxi]HGDSEYNIM[Oxi]FGPDIC[CAM]GPGTK.4|GTWIHPEIDNPEYSPDPSIYAYDNFGVLGLDLWQVK.4|GTWIHPEIDNPEYSPDPSIYAYDNFGVLGLDLWQVK.5|IDNSQVESGSLEDDWDFLPPKK.3|IDNSQVESGSLEDDWDFLPPKK.4|LFPNSLDQTDMHGDSEYNIMFGPDIC[CAM]GPGTKK.4|LFPNSLDQTDM[Oxi]HGDSEYNIMFGPDIC[CAM]GPGTKK.4|LFPNSLDQTDMHGDSEYNIM[Oxi]FGPDIC[CAM]GPGTKK.4|LFPNSLDQTDMHGDSEYNIMFGPDIC[CAM]GPGTKK.3|AKIDDPTDSKPEDWDKPEHIPDPDAK.4|AKIDDPTDSKPEDWDKPEHIPDPDAK.5|AKIDDPTDSKPEDWDKPEHIPDPDAK.6|AKIDDPTDSKPEDWDKPEHIPDPDAK.3|SDFGKFVLSSGK.2|KPEDWDEEM[Oxi]DGEWEPPVIQNPEYK.3|KPEDWDEEMDGEWEPPVIQNPEYK.4|KPEDWDEEMDGEWEPPVIQNPEYK.3|HEQNIDC[CAM]GGGYVK.3|HEQNIDC[CAM]GGGYVK.2|FVLSSGKFYGDEEKDK.4|FVLSSGKFYGDEEKDK.3|DKGLQTSQDAR.3|DKGLQTSQDAR.2|IKDPDASKPEDWDERAK.5|IKDPDASKPEDWDERAK.4|IKDPDASKPEDWDERAK.3|IKDPDASKPEDWDERAK.2|HKSDFGK.2|FYGDEEK.2|GKNVLINK.2|KIKDPDASKPEDWDER.4|KIKDPDASKPEDWDER.3|KIKDPDASKPEDWDER.2|GLQTSQDAR.2|QIDNPDYK.2|LKEEEEDK.2|HKSDFGKFVLSSGK.3|HKSDFGKFVLSSGK.2|DPDASKPEDWDER.3|DPDASKPEDWDER.2|FVLSSGKFYGDEEK.3|FVLSSGKFYGDEEK.2|NVLINKDIR.2|IDDPTDSKPEDWDKPEHIPDPDAK.5|IDDPTDSKPEDWDKPEHIPDPDAK.4|IDDPTDSKPEDWDKPEHIPDPDAK.3|KEEEEAEDK.2|FYGDEEKDK.2|EEEEAEDKEDDEDK.3|KVHVIFNYK.2|IDNSQVESGSLEDDWDFLPPK.4|IDNSQVESGSLEDDWDFLPPK.3|IDNSQVESGSLEDDWDFLPPK.2|KEEEEAEDKEDDEDK.3|DEDEEDEEDK.2|GKNVLINKDIR.2|DDEFTHLYTLIVRPDNTYEVK.4|DDEFTHLYTLIVRPDNTYEVK.3|EDDEDKDEDEEDEEDK.3|KVHVIFNYKGK.2|GQTLVVQFTVKHEQNIDC[CAM]GGGYVK.4|GQTLVVQFTVKHEQNIDC[CAM]GGGYVK.3|EEEEAEDKEDDEDKDEDEEDEEDK.4|EEDEEEDVPGQAK.2|FVLSSGK.1|KPEDWDEEMDGEWEPPVIQNPEYKGEWKPR.5|KPEDWDEEMDGEWEPPVIQNPEYKGEWKPR.4|EDDEDKDEDEEDEEDKEEDEEEDVPGQAK.4|DEDEEDEEDKEEDEEEDVPGQAK.3|EEDEEEDVPGQAKDEL.2|FYALSASFEPFSNKGQTLVVQFTVK.3|DEDEEDEEDKEEDEEEDVPGQAKDEL.3
SEN / CTL,Metalloproteinase inhibitor 2,TIMP2,P16035,-0.76,0.26,6.22E-12,2.75E-11,1.06E+01,"central nervous system development,aging,negative regulation of cell proliferation,response to hormone,negative regulation of endopeptidase activity,extracellular matrix disassembly,regulation of Rap protein signal transduction,response to cytokine,response to drug,positive regulation of MAPK cascade,positive regulation of neuron differentiation,positive regulation of adenylate cyclase activity,negative regulation of mitotic cell cycle,negative regulation of Ras protein signal transduction,negative regulation of membrane protein ectodomain proteolysis","protease binding,integrin binding,metalloendopeptidase inhibitor activity,metal ion binding","extracellular region,proteinaceous extracellular matrix,extracellular space,cell surface,growth cone,extracellular matrix,neuronal cell body,extracellular exosome",21,8,11,AVSEKEVDSGNDIYGNPIKR.4|AVSEKEVDSGNDIYGNPIKR.3|GAAPPKQEFLDIEDP.2|MHITLC[CAM]DFIVPWDTLSTTQKK.4|MHITLC[CAM]DFIVPWDTLSTTQKK.3|C[CAM]PMIPC[CAM]YISSPDEC[CAM]LWMDWVTEK.3|MHITLC[CAM]DFIVPWDTLSTTQK.3|M[Oxi]HITLC[CAM]DFIVPWDTLSTTQK.3|EVDSGNDIYGNPIKR.3|EVDSGNDIYGNPIK.2|DIEFIYTAPSSAVC[CAM]GVSLDVGGKK.3
SEN / CTL,60S ribosomal protein L10a,RPL10A,P62906,-0.77,0.32,1.64E-10,5.93E-10,9.23E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,maturation of LSU-rRNA,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,viral transcription,response to ethanol","RNA binding,structural constituent of ribosome,protein binding,poly(A) RNA binding","nucleus,nucleolus,cytoplasm,cytosol,focal adhesion,membrane,cytosolic large ribosomal subunit,extracellular exosome",21,19,35,KYDAFLASESLIK.3|KYDAFLASESLIK.2|FSVC[CAM]VLGDQQHC[CAM]DEAK.3|FSVC[CAM]VLGDQQHC[CAM]DEAK.2|DTLYEAVR.2|AVDIPHMDIEALK.3|AVDIPHM[Oxi]DIEALK.3|AVDIPHM[Oxi]DIEALK.2|AVDIPHMDIEALK.2|AGKFPSLLTHNENMVAK.3|AGKFPSLLTHNENMVAK.4|AGKFPSLLTHNENM[Oxi]VAK.4|AGKFPSLLTHNENM[Oxi]VAK.3|AGKFPSLLTHNENMVAK.2|AVDIPHMDIEALKK.3|AVDIPHM[Oxi]DIEALKK.4|AVDIPHMDIEALKK.2|ILGPGLNK.2|RFSGTVR.2|VLC[CAM]LAVAVGHVK.3|VLC[CAM]LAVAVGHVK.2|VSRDTLYEAVR.3|VSRDTLYEAVR.2|KVLC[CAM]LAVAVGHVK.3|EVLHGNQR.2|AGKFPSLLTHNENMVAKVDEVK.5|KYDAFLASESLIKQIPR.4|KFLETVELQISLK.3|KFLETVELQISLK.2|FPSLLTHNENM[Oxi]VAK.3|FPSLLTHNENMVAK.3|FPSLLTHNENMVAK.2|VSRDTLYEAVREVLHGNQR.4|YDAFLASESLIK.2|FLETVELQISLK.2
SEN / CTL,Major prion protein,PRNP,P04156,-0.77,0.30,3.90E-02,1.62E-02,1.79E+00,"negative regulation of protein phosphorylation,cellular copper ion homeostasis,response to oxidative stress,cell cycle arrest,learning or memory,metabolic process,negative regulation of interferon-gamma production,negative regulation of interleukin-17 production,negative regulation of interleukin-2 production,regulation of protein localization,cellular response to drug,negative regulation of apoptotic process,negative regulation of sequence-specific DNA binding transcription factor activity,negative regulation of activated T cell proliferation,response to cadmium ion,negative regulation of T cell receptor signaling pathway,protein homooligomerization,negative regulation of calcineurin-NFAT signaling cascade,cellular response to copper ion,regulation of potassium ion transmembrane transport","copper ion binding,lamin binding,microtubule binding,tubulin binding,identical protein binding,ATP-dependent protein binding,ion channel binding,chaperone binding","nucleus,cytoplasm,endoplasmic reticulum,Golgi apparatus,plasma membrane,cell surface,extrinsic component of membrane,anchored component of membrane,membrane raft,extracellular exosome",3,4,5,VVEQMC[CAM]ITQYER.2|VVEQM[Oxi]C[CAM]ITQYER.2|PIIHFGSDYEDR.3|ESQAYYQR.2|HMAGAAAAGAVVGGLGGYMLGSAMSR.3
SEN / CTL,"Fatty acid-binding protein, epidermal",FABP5,Q01469,-0.77,0.91,1.34E-03,9.75E-04,3.01E+00,"glucose metabolic process,lipid metabolic process,phosphatidylcholine biosynthetic process,epidermis development,response to wounding,glucose transport,triglyceride catabolic process","transporter activity,fatty acid binding,protein binding,lipid binding","nucleoplasm,cytoplasm,cytosol,extracellular exosome",24,17,34,ELGVGIALR.2|TTQFSC[CAM]TLGEKFEETTADGRK.4|TTQFSC[CAM]TLGEKFEETTADGRK.3|LVVEC[CAM]VMNNVTC[CAM]TR.3|LVVEC[CAM]VMNNVTC[CAM]TR.2|LVVEC[CAM]VM[Oxi]NNVTC[CAM]TR.3|LVVEC[CAM]VM[Oxi]NNVTC[CAM]TR.2|ELGVGIALRK.2|TTQFSC[CAM]TLGEKFEETTADGR.3|TQTVC[CAM]NFTDGALVQHQEWDGKESTITR.4|TTQFSC[CAM]TLGEK.3|TTQFSC[CAM]TLGEK.2|GFDEYMK.2|GFDEYM[Oxi]K.2|KMGAMAKPDC[CAM]IITC[CAM]DGK.4|KMGAMAKPDC[CAM]IITC[CAM]DGK.3|FEETTADGR.2|FEETTADGRK.2|M[Oxi]GAMAKPDC[CAM]IITC[CAM]DGK.3|MGAM[Oxi]AKPDC[CAM]IITC[CAM]DGK.3|MGAMAKPDC[CAM]IITC[CAM]DGK.3|M[Oxi]GAM[Oxi]AKPDC[CAM]IITC[CAM]DGK.3|M[Oxi]GAMAKPDC[CAM]IITC[CAM]DGK.2|MGAM[Oxi]AKPDC[CAM]IITC[CAM]DGK.2|MGAMAKPDC[CAM]IITC[CAM]DGK.2|M[Oxi]GAM[Oxi]AKPDC[CAM]IITC[CAM]DGK.2|PDC[CAM]IITC[CAM]DGK.2|TQTVC[CAM]NFTDGALVQHQEWDGK.4|TQTVC[CAM]NFTDGALVQHQEWDGK.3|KTQTVC[CAM]NFTDGALVQHQEWDGK.4|KTQTVC[CAM]NFTDGALVQHQEWDGK.3|KTQTVC[CAM]NFTDGALVQHQEWDGKESTITR.5|KTQTVC[CAM]NFTDGALVQHQEWDGKESTITR.4|TQTVC[CAM]NFTDGALVQHQEWDGKESTITRK.5
SEN / CTL,Acidic leucine-rich nuclear phosphoprotein 32 family member B,ANP32B,Q92688,-0.78,0.37,2.89E-07,5.50E-07,6.26E+00,"vasculature development,nucleosome assembly,activation of cysteine-type endopeptidase activity involved in apoptotic process,ventricular system development,histone exchange,negative regulation of cell differentiation,positive regulation of protein export from nucleus,inner ear development,palate development","protein binding,histone binding,RNA polymerase binding","nucleus,cytoplasm,extracellular exosome,nucleolus",15,10,17,SLDLFNC[CAM]EVTNLNDYRESVFK.3|IFGGLDM[Oxi]LAEKLPNLTHLNLSGNK.4|IFGGLDMLAEKLPNLTHLNLSGNK.4|IFGGLDM[Oxi]LAEKLPNLTHLNLSGNK.3|IFGGLDMLAEKLPNLTHLNLSGNK.3|IFGGLDMLAEK.2|IFGGLDM[Oxi]LAEK.2|LKDISTLEPLK.3|LKDISTLEPLK.2|LKDISTLEPLKK.3|LKDISTLEPLKK.2|LPNLTHLNLSGNK.3|LPNLTHLNLSGNK.2|ELVLDNC[CAM]K.2|KLELSENR.2|DISTLEPLK.2|DISTLEPLKK.2
SEN / CTL,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA",MAN1A1,P33908,-0.78,0.85,5.80E-02,2.28E-02,1.64E+00,"N-glycan processing,Golgi apparatus mannose trimming","mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,calcium ion binding,mannosidase activity","Golgi membrane,cytoplasm,endoplasmic reticulum,endoplasmic reticulum-Golgi intermediate compartment,Golgi apparatus,membrane,integral component of membrane,extracellular exosome",6,12,15,FDGGVEAIATR.2|WAWEAVEALENHC[CAM]R.3|HEFEEAK.2|MYFDAVQAIETHLIRK.4|MYFDAVQAIETHLIRK.3|GYAWGLNELKPISK.3|GYAWGLNELKPISK.2|GGHSSSLFGNIK.2|MYFDAVQAIETHLIR.3|SSSGLTYIAEWK.2|LLPAFHTPSGIPWALLNMK.3|PVGGLLPLFSSPAGGVLGGGLGGGGGR.3|PVGGLLPLFSSPAGGVLGGGLGGGGGR.2|GLPPVDFVPPIGVESR.2|EEGAPGDPEAALEDNLAR.2
SEN / CTL,Lamin-B1,LMNB1,P20700,-0.78,0.78,2.26E-03,1.54E-03,2.81E+00,,"structural molecule activity,phospholipase binding","nuclear envelope,nuclear inner membrane,lamin filament,nucleoplasm,membrane,nuclear matrix,nuclear membrane",30,59,97,LQIELGK.2|SLEGDLEDLKDQIAQLEASLAAAK.4|SLEGDLEDLKDQIAQLEASLAAAK.3|SLEGDLEDLKDQIAQLEASLAAAKK.4|SLEGDLEDLKDQIAQLEASLAAAKK.3|QLADETLLKVDLENR.3|C[CAM]QSLTEDLEFRK.3|C[CAM]QSLTEDLEFRK.2|SMYEEEINETR.2|SMYEEEINETR.3|SM[Oxi]YEEEINETR.2|ALYETELADARR.3|LAVYIDK.2|LALDMEISAYRK.3|LALDMEISAYRK.2|KESDLNGAQIK.3|KESDLNGAQIK.2|LAQALHEMREQHDAQVR.5|LAQALHEM[Oxi]REQHDAQVR.5|LAQALHEMREQHDAQVR.4|LAQALHEM[Oxi]REQHDAQVR.4|LAQALHEMREQHDAQVR.3|LYKEELEQTYHAK.4|LYKEELEQTYHAK.3|LYKEELEQTYHAK.2|EELEQTYHAK.3|EELEQTYHAK.2|C[CAM]KAEHDQLLLNYAK.4|C[CAM]KAEHDQLLLNYAK.3|C[CAM]KAEHDQLLLNYAK.2|LREYEAALNSK.3|LREYEAALNSK.2|LVEVDSGR.2|RALDDTAR.2|AEHDQLLLNYAK.3|AEHDQLLLNYAK.2|DQIAQLEASLAAAK.3|DQIAQLEASLAAAK.2|IESLSSQLSNLQK.3|IESLSSQLSNLQK.2|IGDTSVSYK.2|QIEYEYK.2|KSMYEEEINETR.3|EYEAALNSK.2|QLADETLLK.2|DAALATALGDK.2|DQIAQLEASLAAAKK.3|DQIAQLEASLAAAKK.2|SMYEEEINETRR.3|ESDLNGAQIK.2|LAQALHEMR.2|LAQALHEM[Oxi]R.2|KIGDTSVSYK.2|NSQGEEVAQR.2|SLEGDLEDLK.2|LKNTSEQDQPMGGWEMIRK.4|AGGPTTPLSPTR.2|KQLADETLLK.2|MRIESLSSQLSNLQK.3|M[Oxi]RIESLSSQLSNLQK.3|M[Oxi]RIESLSSQLSNLQK.2|MRIESLSSQLSNLQK.2|DAALATALGDKK.2|IQELEDLLAK.2|NQNSWGTGEDVKVILK.3|SLETENSALQLQVTER.3|SLETENSALQLQVTER.2|LVEVDSGRQIEYEYK.3|ALYETELADAR.2|KQLADETLLKVDLENR.3|NTSEQDQPMGGWEMIR.3|NTSEQDQPMGGWEMIR.2|LALDMEISAYR.2|KSLEGDLEDLKDQIAQLEASLAAAK.4|KSLEGDLEDLKDQIAQLEASLAAAK.3|NQNSWGTGEDVK.2|NTSEQDQPMGGWEMIRK.3|NTSEQDQPM[Oxi]GGWEMIRK.3|NTSEQDQPMGGWEM[Oxi]IRK.3|NTSEQDQPMGGWEMIRK.2|C[CAM]QSLTEDLEFR.2|DQMQQQLNDYEQLLDVK.3|DQM[Oxi]QQQLNDYEQLLDVK.3|DQM[Oxi]QQQLNDYEQLLDVK.2|DQMQQQLNDYEQLLDVK.2|LKNTSEQDQPMGGWEMIR.3|LKNTSEQDQPMGGWEMIR.2|LSSEM[Oxi]NTSTVNSAR.2|LSSEMNTSTVNSAR.2|SLETENSALQLQVTEREEVR.3|EREMAEIRDQMQQQLNDYEQLLDVK.4|EREMAEIRDQMQQQLNDYEQLLDVK.3|LSSEMNTSTVNSAREELMESR.3|AGQTVTIWAANAGVTASPPTDLIWK.3|TTIPEEEEEEEEAAGVVVEEELFHQQGTPR.4|TTIPEEEEEEEEAAGVVVEEELFHQQGTPR.3|EMAEIRDQMQQQLNDYEQLLDVK.3
SEN / CTL,Betaine--homocysteine S-methyltransferase 1,BHMT,Q93088,-0.79,0.57,1.54E-02,7.58E-03,2.12E+00,"sulfur amino acid metabolic process,protein methylation,amino-acid betaine metabolic process,amino-acid betaine catabolic process,choline catabolic process,regulation of homocysteine metabolic process,L-methionine salvage,S-adenosylmethionine metabolic process","zinc ion binding,S-adenosylmethionine-homocysteine S-methyltransferase activity,betaine-homocysteine S-methyltransferase activity","cytoplasm,cytosol,extracellular exosome",6,35,57,ISGQEVNEAAC[CAM]DIAR.2|ISGQEVNEAAC[CAM]DIAR.3|AGPWTPEAAVEHPEAVR.4|AGPWTPEAAVEHPEAVR.3|AGPWTPEAAVEHPEAVR.2|ARKEYWENLR.3|ARKEYWENLR.2|EAYNLGVR.2|AGPWTPEAAVEHPEAVRQLHR.5|GFLPPASEK.2|AHLMSQPLAYHTPDC[CAM]NK.4|AHLMSQPLAYHTPDC[CAM]NK.3|HGSWGSGLDM[Oxi]HTKPWVR.4|AGASIIGVNC[CAM]HFDPTISLK.4|AGASIIGVNC[CAM]HFDPTISLK.3|AGASIIGVNC[CAM]HFDPTISLK.2|GTAELMQQK.2|GTAELM[Oxi]QQK.2|VATRWDIQKYAR.3|AIAEELAPERGFLPPASEK.4|AIAEELAPERGFLPPASEK.3|AIAEELAPERGFLPPASEK.2|EYWENLR.2|KVFLQQLEVFMK.3|KVFLQQLEVFMK.2|VFLQQLEVFMKK.3|VFLQQLEVFMKK.2|EATTEQQLK.2|AIAEELAPER.2|EATTEQQLKELFEK.3|EATTEQQLKELFEK.2|IASGRPYNPSMSKPDGWGVTK.4|IASGRPYNPSM[Oxi]SKPDGWGVTK.3|IASGRPYNPSMSKPDGWGVTK.3|YIGGC[CAM]C[CAM]GFEPYHIR.3|YIGGC[CAM]C[CAM]GFEPYHIR.2|AGASIIGVNC[CAM]HFDPTISLKTVK.4|QGFIDLPEFPFGLEPR.3|QGFIDLPEFPFGLEPR.2|AGSNVMQTFTFYASEDK.3|AGSNVMQTFTFYASEDK.2|LNAGEIVIGDGGFVFALEKRGYVK.4|EATTEQQLKELFEKQK.3|LNAGEIVIGDGGFVFALEK.3|LNAGEIVIGDGGFVFALEK.2|EAYNLGVRYIGGC[CAM]C[CAM]GFEPYHIR.4|VFLQQLEVFMK.2|VFLQQLEVFM[Oxi]K.2|LNAGEIVIGDGGFVFALEKR.3|LNAGEIVIGDGGFVFALEKR.2|HGSWGSGLDMHTK.2|AHLM[Oxi]SQPLAYHTPDC[CAM]NKQGFIDLPEFPFGLEPR.5|AGSNVMQTFTFYASEDKLENR.3|AGSNVM[Oxi]QTFTFYASEDKLENR.3|AGSNVMQTFTFYASEDKLENRGNYVLEK.4|QVADEGDALVAGGVSQTPSYLSC[CAM]K.3|QVADEGDALVAGGVSQTPSYLSC[CAM]KSETEVKK.4
SEN / CTL,Translationally-controlled tumor protein,TPT1,P13693,-0.80,0.56,8.15E-06,1.07E-05,4.97E+00,"calcium ion transport,cellular calcium ion homeostasis,response to virus,cell differentiation,regulation of apoptotic process,negative regulation of apoptotic process,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage","calcium ion binding,protein binding,microtubule binding,poly(A) RNA binding","extracellular space,nucleus,cytoplasm,multivesicular body,extracellular exosome,tubulin complex",18,14,26,VKPFMTGAAEQIKHILANFK.4|IREIADGLC[CAM]LEVEGK.3|IREIADGLC[CAM]LEVEGK.2|DLISHDEMFSDIYK.3|DLISHDEMFSDIYK.2|DLISHDEM[Oxi]FSDIYK.3|DLISHDEM[Oxi]FSDIYK.2|EIADGLC[CAM]LEVEGK.2|EIADGLC[CAM]LEVEGK.3|VKPFMTGAAEQIK.3|VKPFM[Oxi]TGAAEQIK.3|VKPFMTGAAEQIK.2|VKPFM[Oxi]TGAAEQIK.2|DGLEMEK.2|DGLEM[Oxi]EK.2|HILANFK.2|MIIYRDLISHDEMFSDIYK.4|MIIYRDLISHDEMFSDIYK.3|PFMTGAAEQIK.2|PFM[Oxi]TGAAEQIK.2|GKLEEQRPER.2|EDGVTPYMIFFK.2|EDGVTPYMIFFKDGLEMEK.3|TEGNIDDSLIGGNASAEGPEGEGTESTVITGVDIVMNHHLQETSFTK.6|TEGNIDDSLIGGNASAEGPEGEGTESTVITGVDIVMNHHLQETSFTK.5|NYQFFIGENMNPDGMVALLDYR.3
SEN / CTL,Plasma protease C1 inhibitor,SERPING1,P05155,-0.81,0.69,5.39E-08,1.17E-07,6.93E+00,"negative regulation of complement activation, lectin pathway,platelet degranulation,complement activation, classical pathway,aging,blood coagulation, intrinsic pathway,blood circulation,negative regulation of endopeptidase activity,fibrinolysis,innate immune response","serine-type endopeptidase inhibitor activity,protein binding","extracellular region,extracellular space,platelet alpha granule lumen,extracellular exosome,blood microparticle",51,19,34,FQPTLLTLPR.2|LVLLNAIYLSAK.2|LLDSLPSDTR.2|TNLESILSYPK.2|TNLESILSYPKDFTC[CAM]VHQALK.4|IKVTTSQDMLSIMEK.3|HRLEDMEQALSPSVFK.3|HRLEDMEQALSPSVFK.4|HRLEDMEQALSPSVFK.2|HRLEDM[Oxi]EQALSPSVFK.3|KYPVAHFIDQTLK.3|KYPVAHFIDQTLK.2|NSVIKVPMMNSK.3|GVTSVSQIFHSPDLAIR.3|GVTSVSQIFHSPDLAIR.2|GVTSVSQIFHSPDLAIR.4|LEDMEQALSPSVFK.2|LEDMEQALSPSVFK.3|LEDM[Oxi]EQALSPSVFK.2|TLYSSSPR.2|LLDSLPSDTRLVLLNAIYLSAK.3|DFTC[CAM]VHQALK.3|DFTC[CAM]VHQALK.2|FPVFMGR.2|YPVAHFIDQTLK.3|YPVAHFIDQTLK.2|VTTSQDMLSIMEK.3|VTTSQDMLSIMEK.2|VTTSQDM[Oxi]LSIMEK.2|VTTSQDMLSIM[Oxi]EK.2|VTTSQDM[Oxi]LSIM[Oxi]EK.2|LYHAFSAMK.2|TLLVFEVQQPFLFVLWDQQHK.4|TLLVFEVQQPFLFVLWDQQHK.3
SEN / CTL,Acidic leucine-rich nuclear phosphoprotein 32 family member A,ANP32A,P39687,-0.82,0.92,2.66E-05,3.04E-05,4.52E+00,"transcription, DNA-templated,regulation of transcription, DNA-templated,nucleocytoplasmic transport,intracellular signal transduction,regulation of apoptotic process,regulation of mRNA stability,nucleosome assembly,histone exchange","histone binding,poly(A) RNA binding","nucleus,nucleoplasm,cytoplasm,endoplasmic reticulum,perinuclear region of cytoplasm",27,19,33,SNEGKLEGLTDEFEELEFLSTINVGLTSIANLPK.4|VSGGLEVLAEK.2|NRTPSDVKELVLDNSR.3|NRTPSDVKELVLDNSR.4|NRTPSDVKELVLDNSR.2|SLDLFNC[CAM]EVTNLNDYRENVFK.3|SLDLFNC[CAM]EVTNLNDYRENVFK.4|TPSDVKELVLDNSR.3|TPSDVKELVLDNSR.2|IKDLSTIEPLK.3|IKDLSTIEPLK.2|ELVLDNSR.2|KLELSDNRVSGGLEVLAEK.4|KLELSDNRVSGGLEVLAEK.3|KLELSDNRVSGGLEVLAEK.2|LELSDNR.2|IKDLSTIEPLKK.3|IKDLSTIEPLKK.2|KREPEDEGEDDD.3|KREPEDEGEDDD.2|C[CAM]PNLTHLNLSGNK.3|C[CAM]PNLTHLNLSGNK.2|KLELSDNR.2|DLSTIEPLK.2|LLPQLTYLDGYDR.3|LLPQLTYLDGYDR.2|DLSTIEPLKK.2|VSGGLEVLAEKC[CAM]PNLTHLNLSGNK.4|VSGGLEVLAEKC[CAM]PNLTHLNLSGNK.3|LLPQLTYLDGYDRDDK.3|LLPQLTYLDGYDRDDK.2|SLDLFNC[CAM]EVTNLNDYR.3|SLDLFNC[CAM]EVTNLNDYR.2
SEN / CTL,Extracellular matrix protein 1,ECM1,Q16610,-0.82,0.51,1.73E-08,4.29E-08,7.37E+00,"ossification,angiogenesis,positive regulation of endothelial cell proliferation,negative regulation of cytokine-mediated signaling pathway,platelet degranulation,regulation of type 2 immune response,regulation of transcription from RNA polymerase II promoter,inflammatory response,signal transduction,negative regulation of peptidase activity,negative regulation of bone mineralization,biomineral tissue development,positive regulation of I-kappaB kinase/NF-kappaB signaling,positive regulation of angiogenesis,regulation of T cell migration","protease binding,signal transducer activity,interleukin-2 receptor binding,protein binding,protein C-terminus binding,enzyme binding,laminin binding","extracellular region,proteinaceous extracellular matrix,extracellular space,extracellular matrix,platelet dense granule lumen,extracellular exosome",24,22,28,ELLALIQLER.2|LVWEEAMSR.2|FC[CAM]EAEFSVK.2|RAPYPNYDRDILTIDIGR.4|FSC[CAM]FQEEAPQPHYQLR.3|FSC[CAM]FQEEAPQPHYQLR.4|QHVVYGPWNLPQSSYSHLTR.4|QHVVYGPWNLPQSSYSHLTR.3|QGETLNFLEIGYSR.2|QGETLNFLEIGYSR.3|LLPAQLPAEKEVGPPLPQEAVPLQK.3|DILTIDIGR.2|AWEDTLDKYC[CAM]DR.3|AWEDTLDKYC[CAM]DR.2|EVGPPLPQEAVPLQK.3|EVGPPLPQEAVPLQK.2|VTPNLMGHLC[CAM]GNQR.3|QLRPEHFQEVGYAAPPSPPLSR.4|QLRPEHFQEVGYAAPPSPPLSR.3|LTFINDLC[CAM]GPR.2|NVALVSGDTENAK.2|PSPDNLNQIC[CAM]LPNR.2|LDGFPPGRPSPDNLNQIC[CAM]LPNR.3|AC[CAM]PSHQPDISSGLELPFPPGVPTLDNIK.3|DPALC[CAM]C[CAM]YLSPGDEQVNC[CAM]FNINYLR.3|SLPMDHPDSSQHGPPFEGQSQVQPPPSQEATPLQQEK.4|C[CAM]C[CAM]DLPFPEQAC[CAM]C[CAM]AEEEK.2|NIWRDPALC[CAM]C[CAM]YLSPGDEQVNC[CAM]FNINYLR.3
SEN / CTL,Neogenin,NEO1,Q92859,-0.82,0.29,3.68E-02,1.54E-02,1.81E+00,"cell adhesion,axon guidance,positive regulation of BMP signaling pathway,iron ion homeostasis","receptor activity,protein binding,co-receptor binding","nucleoplasm,Golgi apparatus,plasma membrane,integral component of plasma membrane,plasma membrane protein complex",3,6,6,QLLPDGSLFISNVVHSK.3|SHLYHPGSPWPIGTSMSLSDR.4|EHNLQVLGLVK.2|HGPGVSTPDVAVR.2|NEEALDTESSER.2|HGSGESSAPLRVETQPEVQLPGPAPNLR.3
SEN / CTL,V-type proton ATPase subunit S1,ATP6AP1,Q15904,-0.83,0.16,4.92E-05,5.26E-05,4.28E+00,"insulin receptor signaling pathway,ATP hydrolysis coupled proton transport,proton transport,transferrin transport,ion transmembrane transport,positive regulation of osteoblast differentiation,positive regulation of bone resorption,pH reduction,positive regulation of exocytosis,establishment of organelle localization,positive regulation of ERK1 and ERK2 cascade,positive regulation of osteoclast development","transporter activity,ATP binding,Rab GTPase binding,proton-transporting ATP synthase activity, rotational mechanism,proton-transporting ATPase activity, rotational mechanism","endosome membrane,integral component of membrane,proton-transporting two-sector ATPase complex,proton-transporting V-type ATPase, V1 domain,extracellular exosome",6,9,11,LGASPLHVDLATLR.3|LGASPLHVDLATLR.2|EVLTGNDEVIGQVLSTLK.3|EVLTGNDEVIGQVLSTLK.2|DVAVVAGGLGR.2|LFGTTVTFK.2|GPTISLTQIV.2|NVLLFLQDK.2|SEDVPYTAALTAVRPSR.3|LPYTASSGLMAPR.2|LSIEDFTAYGGVFGNK.2
SEN / CTL,Proliferating cell nuclear antigen,PCNA,P12004,-0.83,0.72,1.29E-03,9.46E-04,3.02E+00,"G1/S transition of mitotic cell cycle,regulation of transcription involved in G1/S transition of mitotic cell cycle,telomere maintenance via recombination,telomere maintenance,DNA strand elongation involved in DNA replication,leading strand elongation,transcription-coupled nucleotide-excision repair,nucleotide-excision repair, DNA incision, 5'-to lesion,nucleotide-excision repair, DNA gap filling,mismatch repair,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,heart development,cell proliferation,protein sumoylation,translesion synthesis,epithelial cell differentiation,replication fork processing,positive regulation of deoxyribonuclease activity,response to estradiol,nucleotide-excision repair, DNA incision,cellular response to UV,error-prone translesion synthesis,DNA damage response, detection of DNA damage,estrous cycle,positive regulation of DNA repair,positive regulation of DNA replication,response to cadmium ion,cellular response to hydrogen peroxide,error-free translesion synthesis,response to dexamethasone,liver regeneration,response to L-glutamate,mitotic telomere maintenance via semi-conservative replication","purine-specific mismatch base pair DNA N-glycosylase activity,chromatin binding,damaged DNA binding,protein binding,enzyme binding,estrogen receptor binding,DNA polymerase processivity factor activity,receptor tyrosine kinase binding,dinucleotide insertion or deletion binding,MutLalpha complex binding,histone acetyltransferase binding,identical protein binding,DNA polymerase binding","nuclear chromosome, telomeric region,nucleus,nucleoplasm,replication fork,DNA replication factor C complex,cytoplasm,centrosome,replisome,nuclear replication fork,PCNA complex,extracellular exosome,PCNA-p21 complex",18,21,41,DLSHIGDAVVISC[CAM]AK.3|DLSHIGDAVVISC[CAM]AK.2|YLNFFTK.2|NLAMGVNLTSMSK.2|NLAMGVNLTSMSK.3|NLAM[Oxi]GVNLTSMSK.2|NLAMGVNLTSM[Oxi]SK.2|NLAM[Oxi]GVNLTSM[Oxi]SK.2|LMDLDVEQLGIPEQEYSC[CAM]VVK.3|LM[Oxi]DLDVEQLGIPEQEYSC[CAM]VVK.3|FSASGELGNGNIK.2|FSASGELGNGNIK.3|LVQGSILK.2|VSDYEMK.2|VSDYEM[Oxi]K.2|IADMGHLK.2|IADM[Oxi]GHLK.2|MPSGEFAR.2|M[Oxi]PSGEFAR.2|SEGFDTYR.2|LSQTSNVDK.2|LVQGSILKK.2|IC[CAM]RDLSHIGDAVVISC[CAM]AK.4|IC[CAM]RDLSHIGDAVVISC[CAM]AK.3|C[CAM]DRNLAMGVNLTSMSK.3|C[CAM]DRNLAM[Oxi]GVNLTSMSK.3|C[CAM]DRNLAMGVNLTSM[Oxi]SK.3|C[CAM]DRNLAMGVNLTSMSK.2|C[CAM]AGNEDIITLR.2|LSQTSNVDKEEEAVTIEMNEPVQLTFALR.5|LSQTSNVDKEEEAVTIEMNEPVQLTFALR.4|LSQTSNVDKEEEAVTIEM[Oxi]NEPVQLTFALR.3|LSQTSNVDKEEEAVTIEMNEPVQLTFALR.3|AEDNADTLALVFEAPNQEK.3|AEDNADTLALVFEAPNQEK.2|YYLAPKIEDEEGS.2|ATPLSSTVTLSMSADVPLVVEYK.3|ATPLSSTVTLSM[Oxi]SADVPLVVEYK.3|C[CAM]AGNEDIITLRAEDNADTLALVFEAPNQEK.4|C[CAM]AGNEDIITLRAEDNADTLALVFEAPNQEK.3|AEDNADTLALVFEAPNQEKVSDYEMK.3
SEN / CTL,Serine/arginine-rich splicing factor 1,SRSF1,Q07955,-0.84,0.48,4.31E-05,4.63E-05,4.33E+00,"alternative mRNA splicing, via spliceosome,mRNA 5'-splice site recognition,mRNA splicing, via spliceosome,in utero embryonic development,termination of RNA polymerase II transcription,mRNA splice site selection,mRNA processing,RNA export from nucleus,mRNA export from nucleus,mRNA 3'-end processing,positive regulation of RNA splicing,oligodendrocyte differentiation,cardiac muscle contraction,liver regeneration","nucleotide binding,RNA binding,mRNA binding,protein binding,protein kinase B binding,poly(A) RNA binding,RS domain binding","nucleus,nucleoplasm,cytoplasm,nuclear speck,extracellular exosome,catalytic step 2 spliceosome,exon-exon junction complex",15,24,32,EAGDVC[CAM]YADVYR.2|EAGDVC[CAM]YADVYRDGTGVVEFVR.3|EAGDVC[CAM]YADVYRDGTGVVEFVR.4|IYVGNLPPDIR.2|EAGDVC[CAM]YADVYRDGTGVVEFVRK.4|TKDIEDVFYK.3|TKDIEDVFYK.2|DGTGVVEFVRK.3|DGTGVVEFVRK.2|GPAGNNDC[CAM]R.2|FRSHEGETAYIR.3|FRSHEGETAYIR.2|EDMTYAVR.2|DAEDAVYGR.2|DIEDVFYK.2|DGTGVVEFVR.2|SENRVVVSGLPPSGSWQDLKDHMR.5|VVVSGLPPSGSWQDLKDHMR.4|VVVSGLPPSGSWQDLKDHM[Oxi]R.4|KEDMTYAVR.2|VVVSGLPPSGSWQDLK.3|VVVSGLPPSGSWQDLK.2|DGYDYDGYR.2|RGGPPFAFVEFEDPR.3|SHEGETAYIR.2|YGAIRDIDLK.2|GGPPFAFVEFEDPRDAEDAVYGR.4|GGPPFAFVEFEDPRDAEDAVYGR.3|RGGPPFAFVEFEDPRDAEDAVYGR.4|RGGPPFAFVEFEDPRDAEDAVYGR.3|GGPPFAFVEFEDPR.2|GGPPFAFVEFEDPRDAEDAVYGRDGYDYDGYR.4
SEN / CTL,Myosin regulatory light polypeptide 9,MYL9,P24844,-0.84,0.42,3.99E-03,2.47E-03,2.61E+00,"muscle contraction,regulation of muscle contraction,platelet aggregation","calcium ion binding,structural constituent of muscle,myosin heavy chain binding","stress fiber,cytosol,muscle myosin complex,Z disc",6,6,10,GNFNYVEFTR.2|NAFAC[CAM]FDEEASGFIHEDHLR.4|NAFAC[CAM]FDEEASGFIHEDHLR.3|KGNFNYVEFTR.3|KGNFNYVEFTR.2|FTDEEVDEM[Oxi]YREAPIDK.3|FTDEEVDEMYREAPIDK.2|FTDEEVDEM[Oxi]YR.2|FTDEEVDEMYR.2|ELLTTMGDRFTDEEVDEMYR.3
SEN / CTL,Vitamin K-dependent protein S,PROS1,P07225,-0.84,0.48,2.10E-03,1.44E-03,2.84E+00,"platelet degranulation,signal peptide processing,ER to Golgi vesicle-mediated transport,blood coagulation,negative regulation of endopeptidase activity,peptidyl-glutamic acid carboxylation,regulation of complement activation,fibrinolysis,leukocyte migration","endopeptidase inhibitor activity,calcium ion binding","Golgi membrane,extracellular region,extracellular space,endoplasmic reticulum membrane,Golgi lumen,plasma membrane,platelet alpha granule lumen,extracellular exosome,blood microparticle",9,20,26,SFQTGLFTAAR.2|VYFAGFPR.2|NNLELSTPLKIETISHEDLQR.4|NNLELSTPLKIETISHEDLQR.3|IETISHEDLQR.3|IETISHEDLQR.2|HC[CAM]LVTVEK.2|KVESELIKPINPR.3|KVESELIKPINPR.2|AHSC[CAM]PSVWK.2|NNLELSTPLK.2|ASFTC[CAM]TC[CAM]KPGWQGEK.3|ASFTC[CAM]TC[CAM]KPGWQGEK.2|QSTNAYPDLR.2|DC[CAM]KDVDEC[CAM]SLKPSIC[CAM]GTAVC[CAM]K.4|DC[CAM]KDVDEC[CAM]SLKPSIC[CAM]GTAVC[CAM]K.3|EAVMDINKPGPLFKPENGLLETK.4|IQALSLC[CAM]SDQQSHLEFR.3|DVDEC[CAM]SLKPSIC[CAM]GTAVC[CAM]K.3|DVDEC[CAM]SLKPSIC[CAM]GTAVC[CAM]K.2|SQDILLSVENTVIYR.2|SC[CAM]EVVSVC[CAM]LPLNLDTK.2|NIPGDFEC[CAM]EC[CAM]PEGYR.2|SC[CAM]VNAIPDQC[CAM]SPLPC[CAM]NEDGYMSC[CAM]K.3|TYDSEGVILYAESIDHSAWLLIALR.3|ITTGGDVINNGLWNMVSVEELEHSISIK.3
SEN / CTL,N-acetylgalactosaminyltransferase 7,GALNT7,Q86SF2,-0.85,0.67,7.30E-04,5.79E-04,3.24E+00,"carbohydrate metabolic process,protein O-linked glycosylation,O-glycan processing","polypeptide N-acetylgalactosaminyltransferase activity,carbohydrate binding,metal ion binding","Golgi membrane,membrane,integral component of membrane,extracellular exosome",15,23,30,GFETAYC[CAM]IDSMGK.2|C[CAM]LDRSEVLHQVFISNC[CAM]DSSK.4|SPAMAGGLFAIER.2|GAWDWSMLWK.2|LLFVPC[CAM]SR.2|TNGGFVELGPC[CAM]HR.3|TNGGFVELGPC[CAM]HR.2|PLVLGPEFK.2|VMITHC[CAM]NLNEFK.3|VMITHC[CAM]NLNEFK.2|GGNGLAPGEDR.2|DVNDPMPNR.2|VM[Oxi]ITHC[CAM]NLNEFKEWQYFK.4|VMITHC[CAM]NLNEFKEWQYFK.3|FKPVVPWPHVEGVEVDLESIR.4|FKPVVPWPHVEGVEVDLESIR.3|SEVLHQVFISNC[CAM]DSSK.3|SEVLHQVFISNC[CAM]DSSK.2|FKPVVPWPHVEGVEVDLESIRR.4|INEANQLMQYDQC[CAM]LTK.3|INEANQLMQYDQC[CAM]LTK.2|EPEPPGVVGGPGEK.2|VVEVWWDEYK.2|SVNDLRQEEC[CAM]K.2|LEGWQGNPPPIYVGSSPTLK.3|LEGWQGNPPPIYVGSSPTLK.2|AKNEQEHHAGGDSQKDIMQR.3|TTQKWEMNNIHSV.2|DYFYASRPESQALPYGDISELK.3|EFGFNMVASDMISLDR.2
SEN / CTL,Fibrillin-1,FBN1,P35555,-0.86,0.68,5.70E-19,5.50E-18,1.73E+01,"skeletal system development,metanephros development,heart development,extracellular matrix disassembly,extracellular matrix organization,cell adhesion mediated by integrin,sequestering of BMP in extracellular matrix,sequestering of TGFbeta in extracellular matrix,camera-type eye development,negative regulation of osteoclast differentiation,embryonic eye morphogenesis,post-embryonic eye morphogenesis,cellular response to transforming growth factor beta stimulus,regulation of cellular response to growth factor stimulus,cellular response to insulin-like growth factor stimulus,negative regulation of osteoclast development","integrin binding,hormone activity,extracellular matrix structural constituent,calcium ion binding,protein binding,heparin binding,extracellular matrix constituent conferring elasticity,protein complex binding","microfibril,extracellular region,proteinaceous extracellular matrix,basement membrane,extracellular space,extracellular matrix,extracellular exosome",66,32,32,ILELLPALTTLTNHNR.3|TLPGGNQC[CAM]IVPIC[CAM]R.2|TC[CAM]VDINEC[CAM]LLEPR.2|C[CAM]EC[CAM]FPGLAVGLDGR.2|C[CAM]EC[CAM]EIGYELDR.2|NLIGTYMC[CAM]IC[CAM]GPGYQR.2|C[CAM]LC[CAM]PEGFSLSSSGR.2|YEDEEC[CAM]TLPIAGR.2|C[CAM]QC[CAM]PSGMTLDATGR.2|C[CAM]EC[CAM]PVGFFYNDK.2|RPDGEGC[CAM]VDENEC[CAM]QTKPGIC[CAM]ENGR.4|YNAYC[CAM]C[CAM]PGWK.2|TGC[CAM]TDINEC[CAM]EIGAHNC[CAM]GK.3|GYILQEDGR.2|AC[CAM]EDIDEC[CAM]SLPNIC[CAM]VFGTC[CAM]HNLPGLFR.3|C[CAM]IC[CAM]KPGFQLASDGR.3|C[CAM]SC[CAM]SPGWIGDGIK.2|AWGHPC[CAM]EMC[CAM]PAQPHPC[CAM]R.4|GWGPHC[CAM]EIC[CAM]PFQGTVAFK.3|DINEC[CAM]ETPGIC[CAM]MNGR.2|C[CAM]SNQLPQSITK.2|C[CAM]PVGYVLR.2|C[CAM]VNLIGK.2|NGLC[CAM]VNTR.2|PGFQLASDGR.2|MC[CAM]KDEDEC[CAM]EEGKHDC[CAM]TEK.4|YQC[CAM]AC[CAM]NPGYHSTPDR.3|GEC[CAM]IDVDEC[CAM]EK.2|NC[CAM]EDMDEC[CAM]SIR.2|C[CAM]PPGFYTSPDGTR.2|C[CAM]PTGYYLNEDTR.2|C[CAM]IC[CAM]NSGYEVDSTGK.2
SEN / CTL,D-tyrosyl-tRNA(Tyr) deacylase 1,DTD1,Q8TEA8,-0.87,0.30,3.17E-02,1.38E-02,1.86E+00,"DNA replication,tRNA metabolic process,regulation of translational fidelity,D-amino acid catabolic process","aminoacyl-tRNA editing activity,DNA binding,metal ion binding,D-tyrosyl-tRNA(Tyr) deacylase activity","nucleus,cytoplasm",3,6,8,ASVTVGGEQISAIGR.2|SASSGAEGDVSSEREP.3|SASSGAEGDVSSEREP.2|GNKPDFHLAMPTEQAEGFYNSFLEQLRK.5|GNKPDFHLAMPTEQAEGFYNSFLEQLRK.4|SASSGAEGDVSSER.2|QYEILC[CAM]VSQFTLQC[CAM]VLK.3|GNKPDFHLAMPTEQAEGFYNSFLEQLR.4
SEN / CTL,Stathmin,STMN1,P16949,-0.87,0.40,9.85E-10,2.98E-09,8.53E+00,"mitotic cytokinesis,microtubule depolymerization,mitotic spindle organization,signal transduction,axonogenesis,brain development,response to virus,negative regulation of microtubule polymerization,neuron projection development,intracellular signal transduction,positive regulation of cellular component movement,regulation of cytoskeleton organization","signal transducer activity,tubulin binding","intracellular,cytoplasm,cytosol,microtubule,membrane,neuron projection,extracellular exosome",21,18,24,ASGQAFELILSPR.2|ASGQAFELILSPR.3|SKESVPEFPLSPPK.3|SKESVPEFPLSPPK.2|DLSLEEIQK.2|ESVPEFPLSPPK.2|RASGQAFELILSPR.3|RASGQAFELILSPR.2|DLSLEEIQKK.3|DLSLEEIQKK.2|LEAAEER.2|REHEKEVLQK.3|KKDLSLEEIQK.3|KKDLSLEEIQK.2|HIEEVRK.2|SHEAEVLK.2|KLEAAEER.2|NKESKDPADETEAD.3|NKESKDPADETEAD.2|KSHEAEVLK.2|EHEKEVLQK.2|ENREAQMAAK.2|AIEENNNFSK.2|ESKDPADETEAD.2
SEN / CTL,Enhancer of rudimentary homolog,ERH,P84090,-0.88,0.54,6.27E-03,3.65E-03,2.44E+00,"nucleobase-containing compound metabolic process,pyrimidine nucleoside metabolic process,pyrimidine nucleotide biosynthetic process,cell cycle,positive regulation of Notch signaling pathway","protein binding,methyl-CpG binding,poly(A) RNA binding","midbody,methylosome",6,5,10,TYADYESVNEC[CAM]MEGVC[CAM]K.2|TYADYESVNEC[CAM]MEGVC[CAM]K.3|TYADYESVNEC[CAM]M[Oxi]EGVC[CAM]K.3|TYADYESVNEC[CAM]M[Oxi]EGVC[CAM]K.2|MYEEHLK.2|M[Oxi]YEEHLK.2|ADTQTYQPYNKDWIKEK.4|ADTQTYQPYNKDWIK.3|ADTQTYQPYNKDWIK.2|ADTQTYQPYNK.2
SEN / CTL,"ATP-dependent 6-phosphofructokinase, liver type",PFKL,P17858,-0.88,1.20,1.79E-02,8.59E-03,2.07E+00,"fructose 6-phosphate metabolic process,glycolytic process,response to glucose,fructose 1,6-bisphosphate metabolic process,negative regulation of insulin secretion,protein oligomerization,protein homotetramerization,canonical glycolysis","6-phosphofructokinase activity,protein binding,ATP binding,kinase binding,identical protein binding,metal ion binding,fructose binding,fructose-6-phosphate binding","cytosol,6-phosphofructokinase complex,membrane,extracellular exosome",30,42,74,GQLESIVENIR.2|TFVLEVMGR.2|TFVLEVM[Oxi]GR.2|AIGVLTSGGDAQGMNAAVR.3|AIGVLTSGGDAQGMNAAVR.2|AIGVLTSGGDAQGM[Oxi]NAAVR.3|AIGVLTSGGDAQGM[Oxi]NAAVR.2|VFANAPDSAC[CAM]VIGLK.2|EQWWLSLR.2|QANWLSVSNIIQLGGTIIGSAR.3|SNFSLAILNVGAPAAGMNAAVR.3|SNFSLAILNVGAPAAGM[Oxi]NAAVR.3|SNFSLAILNVGAPAAGM[Oxi]NAAVR.2|SNFSLAILNVGAPAAGMNAAVR.2|GQVQEVGWHDVAGWLGR.3|GQVQEVGWHDVAGWLGR.2|TGISHGHTVYVVHDGFEGLAK.4|TGISHGHTVYVVHDGFEGLAK.5|TGISHGHTVYVVHDGFEGLAK.3|M[Oxi]GIYVGAK.2|AVAFSPVTELKK.3|AVAFSPVTELKK.2|GGTPSAFDR.2|GRVFANAPDSAC[CAM]VIGLKK.4|KAVAFSPVTELKK.3|KAVAFSPVTELKK.2|GGTPSAFDRILSSK.3|IMEVIDAITTTAQSHQR.4|IMEVIDAITTTAQSHQR.3|IM[Oxi]EVIDAITTTAQSHQR.3|IMEVIDAITTTAQSHQR.2|ISMAAYVSGELEHVTRR.4|ISMAAYVSGELEHVTRR.3|AMLWLSEK.2|FDEATQLR.2|VTVLGHVQR.2|VNVEHMTEK.2|VNVEHM[Oxi]TEK.2|SEWGSLLEELVAEGK.3|SEWGSLLEELVAEGK.2|AMDDKRFDEATQLR.3|VFANAPDSAC[CAM]VIGLKK.3|RFDEATQLR.2|AVAFSPVTELK.2|ISMAAYVSGELEHVTR.3|ISMAAYVSGELEHVTR.2|GRVFANAPDSAC[CAM]VIGLK.3|GRVFANAPDSAC[CAM]VIGLK.2|AAAYNLVQHGITNLC[CAM]VIGGDGSLTGANIFR.5|AAAYNLVQHGITNLC[CAM]VIGGDGSLTGANIFR.4|AAAYNLVQHGITNLC[CAM]VIGGDGSLTGANIFR.3|TNVLGHLQQGGAPTPFDRNYGTK.4|TNVLGHLQQGGAPTPFDRNYGTK.3|RFDEATQLRGGSFENNWNIYK.4|TNVLGHLQQGGAPTPFDR.3|TNVLGHLQQGGAPTPFDR.2|LNIIIIAEGAIDRNGKPISSSYVK.4|LNIIIIAEGAIDRNGKPISSSYVK.3|LPLMEC[CAM]VQMTK.2|LPLMEC[CAM]VQM[Oxi]TK.2|LNIIIIAEGAIDR.2|GGSFENNWNIYK.2|TYSHLNIAGLVGSIDNDFC[CAM]GTDMTIGTDSALHR.5|TYSHLNIAGLVGSIDNDFC[CAM]GTDMTIGTDSALHR.4|VFLIYEGYEGLVEGGENIK.3|VFLIYEGYEGLVEGGENIK.2|MGMEAVMALLEATPDTPAC[CAM]VVTLSGNQSVR.4|MGMEAVMALLEATPDTPAC[CAM]VVTLSGNQSVR.3|M[Oxi]GMEAVMALLEATPDTPAC[CAM]VVTLSGNQSVR.3|C[CAM]HDYYTTEFLYNLYSSEGK.3|C[CAM]HDYYTTEFLYNLYSSEGK.2|SEWGSLLEELVAEGKISETTAR.3|RAAAYNLVQHGITNLC[CAM]VIGGDGSLTGANIFR.4|RAAAYNLVQHGITNLC[CAM]VIGGDGSLTGANIFR.3
SEN / CTL,Hematological and neurological expressed 1-like protein,HN1L,Q9H910,-0.88,0.42,5.63E-09,1.54E-08,7.81E+00,,,"nucleus,cytoplasm,plasma membrane",21,11,17,TSDIFGSPVTATSR.2|GSGIFDESTPVQTR.2|AMKPPGGESSNLFGSPEEATPSSRPNR.4|AM[Oxi]KPPGGESSNLFGSPEEATPSSRPNR.4|AMKPPGGESSNLFGSPEEATPSSRPNR.3|LAHPNKPKDHVFLC[CAM]EGEEPKSDLK.6|MASNIFGPTEEPQNIPK.2|MASNIFGPTEEPQNIPK.3|DHVFLC[CAM]EGEEPKSDLK.4|DHVFLC[CAM]EGEEPKSDLK.3|DHVFLC[CAM]EGEEPK.3|DHVFLC[CAM]EGEEPK.2|AGPAKEQEPMPTVDSHEPR.4|SIPAGAEPGEK.2|EQEPMPTVDSHEPR.3|EQEPMPTVDSHEPR.2|AMKPPGGESSNLFGSPEEATPSSR.3
SEN / CTL,Cathepsin Z,CTSZ,Q9UBR2,-0.88,1.57,2.07E-02,9.66E-03,2.01E+00,"angiotensin maturation,proteolysis,ER to Golgi vesicle-mediated transport,COPII vesicle coating,proteolysis involved in cellular protein catabolic process,epithelial tube branching involved in lung morphogenesis","cysteine-type endopeptidase activity,protein binding,cysteine-type peptidase activity","Golgi membrane,extracellular space,lysosome,endoplasmic reticulum,endoplasmic reticulum lumen,plasma membrane,ER to Golgi transport vesicle,endoplasmic reticulum-Golgi intermediate compartment membrane,intracellular membrane-bounded organelle,extracellular exosome",15,16,25,NVDGVNYASITR.2|NVDGVNYASITR.3|NQHIPQYC[CAM]GSC[CAM]WAHASTSAMADR.4|NQHIPQYC[CAM]GSC[CAM]WAHASTSAMADR.3|NQHIPQYC[CAM]GSC[CAM]WAHASTSAM[Oxi]ADR.4|NQHIPQYC[CAM]GSC[CAM]WAHASTSAM[Oxi]ADR.3|VGDYGSLSGR.2|STYPRPHEYLSPADLPK.4|STYPRPHEYLSPADLPK.3|VGDYGSLSGREK.3|FNQC[CAM]GTC[CAM]NEFKEC[CAM]HAIR.4|DQEC[CAM]DKFNQC[CAM]GTC[CAM]NEFKEC[CAM]HAIR.5|DQEC[CAM]DKFNQC[CAM]GTC[CAM]NEFKEC[CAM]HAIR.4|NSWGEPWGER.2|NQHIPQYC[CAM]GSC[CAM]WAHASTSAMADRINIK.5|SWDWRNVDGVNYASITR.3|FNQC[CAM]GTC[CAM]NEFK.2|IVTSTYKDGKGAR.2|DQEC[CAM]DKFNQC[CAM]GTC[CAM]NEFK.3|M[Oxi]MAEIYANGPISC[CAM]GIMATER.3|MM[Oxi]AEIYANGPISC[CAM]GIMATER.3|MMAEIYANGPISC[CAM]GIMATER.3|MMAEIYANGPISC[CAM]GIMATER.2|YNLAIEEHC[CAM]TFGDPIV.2|KGAWPSTLLSVQNVIDC[CAM]GNAGSC[CAM]EGGNDLSVWDYAHQHGIPDETC[CAM]NNYQAK.5
SEN / CTL,Fibulin-1,FBLN1,P23142,-0.88,0.44,5.81E-04,4.74E-04,3.32E+00,"negative regulation of protein phosphorylation,negative regulation of cell adhesion,embryo implantation,positive regulation of peptidase activity,viral process,extracellular matrix organization,negative regulation of ERK1 and ERK2 cascade,blood coagulation, fibrin clot formation,negative regulation of substrate adhesion-dependent cell spreading,negative regulation of cell motility,negative regulation of stem cell proliferation,integrin-mediated signaling pathway","fibronectin binding,extracellular matrix structural constituent,calcium ion binding,protein C-terminus binding,peptidase activator activity,protein complex binding,identical protein binding,fibrinogen binding","extracellular region,proteinaceous extracellular matrix,basement membrane,extracellular space,extracellular exosome,elastic fiber,fibrinogen complex,extracellular matrix",9,25,36,RGYQLSDVDGVTC[CAM]EDIDEC[CAM]ALPTGGHIC[CAM]SYR.4|YMDGMTVGVVR.2|EFTRPEEIIFLR.3|EFTRPEEIIFLR.2|C[CAM]C[CAM]HC[CAM]C[CAM]LLGR.3|SAATLQQEK.2|C[CAM]VNSPGSFR.2|SAATLQQEKTDTVR.3|SAATLQQEKTDTVR.2|LEMNYVVGGVVSHR.3|LEMNYVVGGVVSHR.2|GYHLNEEGTR.2|TGYYFDGISR.2|C[CAM]VDVDEC[CAM]APPAEPC[CAM]GK.3|C[CAM]VDVDEC[CAM]APPAEPC[CAM]GK.2|DC[CAM]SLPYATESK.2|DSSC[CAM]GTGYELTEDNSC[CAM]K.3|DSSC[CAM]GTGYELTEDNSC[CAM]K.2|SC[CAM]RPNDVTC[CAM]VFDPVHTISHTVISLPTFR.5|SC[CAM]RPNDVTC[CAM]VFDPVHTISHTVISLPTFR.4|SC[CAM]RPNDVTC[CAM]VFDPVHTISHTVISLPTFR.3|MC[CAM]VDVNEC[CAM]QR.2|IIEVEEEQEDPYLNDR.3|IIEVEEEQEDPYLNDR.2|AITPPHPASQANIIFDITEGNLRDSFDIIKR.5|C[CAM]LAFEC[CAM]PENYR.2|AITPPHPASQANIIFDITEGNLR.3|AITPPHPASQANIIFDITEGNLRDSFDIIK.4|M[Oxi]VQEQC[CAM]C[CAM]HSQLEELHC[CAM]ATGISLANEQDR.4|MVQEQC[CAM]C[CAM]HSQLEELHC[CAM]ATGISLANEQDR.4|M[Oxi]VQEQC[CAM]C[CAM]HSQLEELHC[CAM]ATGISLANEQDR.3|MVQEQC[CAM]C[CAM]HSQLEELHC[CAM]ATGISLANEQDR.3|SQETGDLDVGGLQETDK.2|SQETGDLDVGGLQETDKIIEVEEEQEDPYLNDR.4|DIDEC[CAM]ESGIHNC[CAM]LPDFIC[CAM]QNTLGSFR.3|GYQLSDVDGVTC[CAM]EDIDEC[CAM]ALPTGGHIC[CAM]SYR.3
SEN / CTL,Connective tissue growth factor,CTGF,P29279,-0.89,0.54,5.28E-03,3.14E-03,2.50E+00,"cartilage condensation,ossification,angiogenesis,regulation of cell growth,tissue homeostasis,transcription initiation from RNA polymerase II promoter,cell adhesion,cell-matrix adhesion,integrin-mediated signaling pathway,cell-cell signaling,aging,positive regulation of cell proliferation,fibroblast growth factor receptor signaling pathway,epidermis development,response to wounding,response to glucose,positive regulation of gene expression,negative regulation of gene expression,cell migration,cell differentiation,lung development,regulation of chondrocyte differentiation,response to estradiol,positive regulation of collagen biosynthetic process,response to anoxia,intracellular signal transduction,chondrocyte proliferation,response to amino acid,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,response to peptide hormone,positive regulation of cell differentiation,positive regulation of JNK cascade,positive regulation of cell activation,response to mineralocorticoid,positive regulation of stress fiber assembly,cytosolic calcium ion transport,positive regulation of cardiac muscle contraction,negative regulation of cell death,extracellular matrix constituent secretion,positive regulation of G0 to G1 transition,positive regulation of ERK1 and ERK2 cascade,response to fatty acid,DNA biosynthetic process,reactive oxygen species metabolic process","fibronectin binding,integrin binding,protein binding,insulin-like growth factor binding,protein C-terminus binding,growth factor activity,heparin binding","extracellular region,proteinaceous extracellular matrix,extracellular space,Golgi apparatus,cis-Golgi network,cytosol,plasma membrane,cell cortex,intracellular membrane-bounded organelle,perinuclear region of cytoplasm",9,8,8,DGAPC[CAM]IFGGTVYR.2|C[CAM]PAGVSLVLDGC[CAM]GC[CAM]C[CAM]R.2|LEDTFGPDPTMIR.2|C[CAM]PDEPAPR.2|TTTLPVEFK.2|FC[CAM]GVC[CAM]TDGR.2|SGESFQSSC[CAM]K.2|ANC[CAM]LVQTTEWSAC[CAM]SK.2
SEN / CTL,E3 ubiquitin-protein ligase UHRF2,UHRF2,Q96PU4,-0.90,0.22,2.02E-02,9.52E-03,2.02E+00,"cell cycle,cell proliferation,maintenance of DNA methylation,protein ubiquitination,cell differentiation,regulation of cell cycle,protein autoubiquitination,positive regulation of cell cycle arrest,regulation of methylation-dependent chromatin silencing","DNA binding,ubiquitin-protein transferase activity,protein binding,zinc ion binding,ligase activity,histone binding,ubiquitin protein ligase activity","nucleus,nucleoplasm,nuclear heterochromatin",3,14,15,IISVDEIFK.2|RPISDDDC[CAM]PSASK.3|IERPGAHPLSFADGK.3|VWALFDVRPEC[CAM]QR.3|AQVFSC[CAM]PAC[CAM]R.2|LQYPAGYPSDK.2|YWPEISSSHGFLVWR.3|YWPEISSSHGFLVWR.2|DVGLGAWFEAHIHSVTR.3|LWDEVLSHLVEGPNFLK.3|ALALNC[CAM]DAPLDDK.2|IFLGGSEGTLNDC[CAM]K.2|NDPEC[CAM]DLC[CAM]GGDPEK.2|ASDSAEAIEAFQLTPQQQHLIR.3|EC[CAM]TIVPSNHYGPIPGIPVGSTWR.3
SEN / CTL,Inactive tyrosine-protein kinase 7,PTK7,Q13308,-0.90,0.38,3.97E-10,1.29E-09,8.89E+00,"establishment of planar polarity,ventricular septum development,axis elongation,protein phosphorylation,cell adhesion,signal transduction,positive regulation of neuron projection development,cell migration,actin cytoskeleton reorganization,wound healing,establishment of epithelial cell apical/basal polarity,convergent extension,canonical Wnt signaling pathway,lung-associated mesenchyme development,coronary vasculature development,cellular response to retinoic acid,cochlea morphogenesis,planar cell polarity pathway involved in neural tube closure","protein kinase activity,protein binding,ATP binding,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway","integral component of plasma membrane,cell-cell junction,focal adhesion",24,30,35,VVLAPQDVVVAR.2|ADGSSLPEWVTDNAGTLHFAR.3|INSVEVYDGTWYR.2|WIEAGPVVLKHPASEAEIQPQTQVTLR.4|FAQGSSLSFAAVDR.2|LKFTPPPQPQQC[CAM]MEFDKEATVPC[CAM]SATGR.4|GLPEPSVWWEHAGVR.3|GLPEPSVWWEHAGVR.2|HPASEAEIQPQTQVTLR.3|HPASEAEIQPQTQVTLR.4|DVYNSEYYHFR.3|DVYNSEYYHFR.2|VFTAGSEER.2|AQGLEEGVAETLVLVK.3|AQGLEEGVAETLVLVK.2|LPQPEGC[CAM]PSK.2|WIEAGPVVLK.2|SEFGEVFLAK.2|SSLQPITTLGK.2|DEQQQLDFR.2|QPSSQDALQGR.2|NQMLISEDSR.2|KPQDSQLEEGKPGYLDC[CAM]LTQATPK.4|VALC[CAM]TQVALGMEHLSNNR.3|LQDSGTFQC[CAM]VAR.2|YTC[CAM]IAGNSC[CAM]NIK.2|EAEPHYMVLEYVDLGDLK.3|KPQDSQLEEGKPGYLDC[CAM]LTQATPKPTVVWYR.5|DRPSFSEIASALGDSTVDSKP.3|GHELVLANIAESDAGVYTC[CAM]HAANLAGQR.4|HTEAPLYVVDKPVPEESEGPGSPPPYK.4|TTVYQGHTALLQC[CAM]EAQGDPKPLIQWK.4|TTVYQGHTALLQC[CAM]EAQGDPKPLIQWK.3|C[CAM]MSSTPAGSIEAQAR.2|GPPIILEATLHLAEIEDMPLFEPR.3
SEN / CTL,Insulin-like growth factor-binding protein 7,IGFBP7,Q16270,-0.91,0.98,4.86E-10,1.56E-09,8.81E+00,"regulation of cell growth,cell adhesion,embryo implantation,negative regulation of cell proliferation,response to heat,response to retinoic acid,cellular response to hormone stimulus,regulation of steroid biosynthetic process,response to cortisol","protein binding,insulin-like growth factor binding","extracellular region,extracellular space,extracellular exosome,extracellular matrix",36,12,15,TELLPGDRDNLAIQTR.3|TELLPGDRDNLAIQTR.2|SRYPVC[CAM]GSDGTTYPSGC[CAM]QLR.3|ITVVDALHEIPVK.3|GYC[CAM]APGMEC[CAM]VK.2|AGAAAGGPGVSGVC[CAM]VC[CAM]K.2|AGAAAGGPGVSGVC[CAM]VC[CAM]K.3|GGPEKHEVTGWVLVSPLSK.4|HEVTGWVLVSPLSKEDAGEYEC[CAM]HASNSQGQASASAK.5|DAC[CAM]GC[CAM]C[CAM]PMC[CAM]AR.2|HEVTGWVLVSPLSK.3|HEVTGWVLVSPLSK.2|GTC[CAM]EQGPSIVTPPK.2|GEGEPC[CAM]GGGGAGR.2|EDAGEYEC[CAM]HASNSQGQASASAK.3
SEN / CTL,Signal-regulatory protein beta-1,SIRPB1,O00241,-0.92,0.27,2.86E-02,1.27E-02,1.90E+00,"signal transduction,cell surface receptor signaling pathway,innate immune response",,"plasma membrane,integral component of plasma membrane,extracellular exosome",3,2,2,ATPEHTVSFTC[CAM]ESHGFSPR.4|SVSVAAGESATLR.2
SEN / CTL,Attractin,ATRN,O75882,-0.92,0.09,2.92E-03,1.90E-03,2.72E+00,"inflammatory response,response to oxidative stress,cerebellum development,regulation of multicellular organism growth,myelination,pigmentation","receptor activity,carbohydrate binding","extracellular space,cytoplasm,plasma membrane,integral component of plasma membrane,extracellular exosome",3,29,41,LTLTPWVGLR.2|EQYAVVGHSAHIVTLK.4|EQYAVVGHSAHIVTLK.3|C[CAM]ENLTTGK.2|WSVLPRPDLHHDVNR.4|WSVLPRPDLHHDVNR.3|NHNALLASLTTQK.3|NHNALLASLTTQK.2|AKEQYAVVGHSAHIVTLK.4|ALYVHGGYK.2|YGHSLALYK.2|GEAC[CAM]DIPHC[CAM]TDNC[CAM]GFPHR.4|SC[CAM]ALDQNC[CAM]QWEPR.3|SC[CAM]ALDQNC[CAM]QWEPR.2|IMQSSQSMSK.2|C[CAM]DQHTDC[CAM]YSC[CAM]TANTNDC[CAM]HWC[CAM]NDHC[CAM]VPR.6|C[CAM]DQHTDC[CAM]YSC[CAM]TANTNDC[CAM]HWC[CAM]NDHC[CAM]VPR.5|C[CAM]DQHTDC[CAM]YSC[CAM]TANTNDC[CAM]HWC[CAM]NDHC[CAM]VPR.3|DLDMFINASK.2|DLDM[Oxi]FINASK.2|NTWSILHTQGALVQGGYGHSSVYDHR.5|NTWSILHTQGALVQGGYGHSSVYDHR.4|GVKGDEC[CAM]QLC[CAM]EVENR.3|DNPMYYC[CAM]NK.2|DNPM[Oxi]YYC[CAM]NK.2|SEAAC[CAM]LAAGPGIR.2|YYTAINFVATPDEQNR.3|YYTAINFVATPDEQNR.2|HC[CAM]ETC[CAM]ISGFYGDPTNGGK.3|HC[CAM]ETC[CAM]ISGFYGDPTNGGK.2|C[CAM]TWLIEGQPNR.2|TLDHDRC[CAM]DQHTDC[CAM]YSC[CAM]TANTNDC[CAM]HWC[CAM]NDHC[CAM]VPR.6|TLDHDRC[CAM]DQHTDC[CAM]YSC[CAM]TANTNDC[CAM]HWC[CAM]NDHC[CAM]VPR.5|GDEC[CAM]QLC[CAM]EVENR.2|YDVDTQMWTILK.2|C[CAM]NGHASLC[CAM]NTNTGK.2|TAC[CAM]GDC[CAM]TSGSSEC[CAM]MWC[CAM]SNMK.3|LTGSSGFVTDGPGNYK.2|C[CAM]FSSDFMAYDIAC[CAM]DR.2|C[CAM]NPGTGQC[CAM]VC[CAM]PAGWVGEQC[CAM]QHC[CAM]GGR.3|NQEC[CAM]IALPENIC[CAM]GIGWHLVGNSC[CAM]LK.3
SEN / CTL,Agrin,AGRN,O00468,-0.93,0.81,1.72E-26,3.10E-25,2.45E+01,"retinoid metabolic process,glycosaminoglycan biosynthetic process,glycosaminoglycan catabolic process,cytoskeleton organization,signal transduction,G-protein coupled acetylcholine receptor signaling pathway,extracellular matrix organization,glycosaminoglycan metabolic process,receptor clustering,positive regulation of GTPase activity,clustering of voltage-gated sodium channels,positive regulation of synaptic growth at neuromuscular junction,positive regulation of transcription from RNA polymerase II promoter,synapse organization,positive regulation of filopodium assembly","dystroglycan binding,structural constituent of cytoskeleton,calcium ion binding,protein binding,sialic acid binding,chondroitin sulfate binding,laminin binding,heparan sulfate proteoglycan binding","extracellular region,basal lamina,cytoplasm,Golgi lumen,plasma membrane,integral component of membrane,cell junction,extracellular matrix,lysosomal lumen,synapse,extracellular exosome",159,54,64,SFLAFPTLR.2|KFDGPC[CAM]DPC[CAM]QGALPDPSR.3|KFDGPC[CAM]DPC[CAM]QGALPDPSR.2|SIESTLDDLFR.2|VLGAPVPAFEGR.2|AIVDVHFDPTTAFR.3|AIVDVHFDPTTAFR.2|AYGTGFVGC[CAM]LR.2|FDTGSGPAVLTSAVPVEPGQWHR.3|GKDFLALALLDGR.3|AIVDVHFDPTTAFRAPDVAR.4|SAGDVDTLAFDGR.2|EGSLQVGNEAPVTGSSPLGATQLDTDGALWLGGLPELPVGPALPK.4|TEATQGLVLWSGK.2|ALQSNHFELSLR.3|EAAC[CAM]LQQTQIEEAR.2|EAAC[CAM]LQQTQIEEAR.3|ALEPQGLLLYNGNAR.2|ALEPQGLLLYNGNAR.3|LELGIGPGAATR.2|GMLC[CAM]GFGAVC[CAM]EPNAEGPGR.2|KSPC[CAM]PSVVAPVC[CAM]GSDASTYSNEC[CAM]ELQR.3|TDGKGDFVSLALR.3|HPLHLLEDAVTKPELRPC[CAM]PTP.4|FGALC[CAM]EAETGR.2|ESLLDGGNKVVISGFGDPLIC[CAM]DNQVSTGDTR.3|GAPEGTVC[CAM]GSDGADYPGEC[CAM]QLLRR.3|ASC[CAM]YNSALGC[CAM]C[CAM]SDGKTPSLDAEGSNC[CAM]PATK.3|SADGLTASC[CAM]LC[CAM]PATC[CAM]R.2|SREPVTLGAWTR.3|GLYVAAQGAC[CAM]R.2|VLPEGGAQC[CAM]EC[CAM]PLGR.2|TDGKGDFVSLALRDR.4|GSGVGEC[CAM]GDHPC[CAM]LPNPC[CAM]HGGAPC[CAM]QNLEAGR.4|HQGPC[CAM]DQAPSPC[CAM]LGVQC[CAM]AFGATC[CAM]AVK.3|VGPTC[CAM]ADEKSPC[CAM]QPNPC[CAM]HGAAPC[CAM]R.4|LLDVNNQR.2|VC[CAM]GSDGVTYGNEC[CAM]QLK.2|AAAVSSGFDGAIQLVSLGGR.3|AAAVSSGFDGAIQLVSLGGR.2|QVDVTSFAGHPC[CAM]TR.3|QVDVTSFAGHPC[CAM]TR.2|QLLTPEHVLR.3|QLLTPEHVLR.2|TYDSDC[CAM]WR.2|EAAYVC[CAM]LC[CAM]PGGFSGPHC[CAM]EK.3|EAAYVC[CAM]LC[CAM]PGGFSGPHC[CAM]EK.2|LLDVNNQRLELGIGPGAATR.3|LLDVNNQRLELGIGPGAATR.2|AYGTGFVGC[CAM]LRDVVVGR.3|VTC[CAM]DGAYRPVC[CAM]AQDGR.3|DFLALALLDGR.2|SELFGETAR.2|GPSGLLLYNGQK.2|IFFVNPAPPYLWPAHK.3|RPLQEHVR.2|DQC[CAM]PEPC[CAM]R.2|SGQC[CAM]QGRDQC[CAM]PEPC[CAM]R.3|EPLYVGGAPDFSK.2|SGQC[CAM]QGRDQC[CAM]PEPC[CAM]RFNAVC[CAM]LSR.4|FDTGSGPAVLTSAVPVEPGQWHRLELSR.4|TPSLDAEGSNC[CAM]PATK.2|VVISGFGDPLIC[CAM]DNQVSTGDTR.3|VVISGFGDPLIC[CAM]DNQVSTGDTR.2
SEN / CTL,Epididymal secretory protein E1,NPC2,P61916,-0.94,0.48,7.02E-08,1.45E-07,6.84E+00,"cholesterol metabolic process,response to virus,phospholipid transport,regulation of isoprenoid metabolic process,cholesterol transport,intracellular sterol transport,intracellular cholesterol transport,cholesterol efflux,cholesterol homeostasis,glycolipid transport","protein binding,cholesterol binding,enzyme binding","lysosome,endoplasmic reticulum,extracellular exosome",21,12,19,AVVHGILMGVPVPFPIPEPDGC[CAM]K.3|AVVHGILMGVPVPFPIPEPDGC[CAM]K.4|AVVHGILM[Oxi]GVPVPFPIPEPDGC[CAM]K.3|AVVHGILM[Oxi]GVPVPFPIPEPDGC[CAM]K.4|AVVHGILMGVPVPFPIPEPDGC[CAM]KSGINC[CAM]PIQK.4|AVVHGILMGVPVPFPIPEPDGC[CAM]KSGINC[CAM]PIQK.5|AVVHGILM[Oxi]GVPVPFPIPEPDGC[CAM]KSGINC[CAM]PIQK.4|EVNVSPC[CAM]PTQPC[CAM]QLSK.2|EVNVSPC[CAM]PTQPC[CAM]QLSK.3|DKTYSYLNKLPVK.3|DC[CAM]GSVDGVIKEVNVSPC[CAM]PTQPC[CAM]QLSK.3|LPVKSEYPSIK.3|TYSYLNK.2|SGINC[CAM]PIQK.2|DC[CAM]GSVDGVIK.2|DKTYSYLNK.2|LVVEWQLQDDK.2|NQSLFC[CAM]WEIPVQIVSHL.3|NQSLFC[CAM]WEIPVQIVSHL.2
SEN / CTL,Leucine-rich repeat neuronal protein 4,LRRN4,Q8WUT4,-0.94,0.25,2.09E-02,9.75E-03,2.01E+00,"long-term memory,visual learning",,"integral component of plasma membrane,extracellular exosome",3,2,2,ALSTSELGHLEQLQVLTLR.3|HLQTPC[CAM]AELQR.2
SEN / CTL,Complement factor I,CFI,P05156,-0.96,0.79,1.32E-06,2.16E-06,5.67E+00,"proteolysis,receptor-mediated endocytosis,complement activation, classical pathway,regulation of complement activation,innate immune response","serine-type endopeptidase activity,scavenger receptor activity,protein binding,metal ion binding","extracellular region,extracellular space,membrane,extracellular exosome",18,26,36,VFSLQWGEVK.2|GLETSLAEC[CAM]TFTK.2|IVIEYVDR.2|AC[CAM]DGINDC[CAM]GDQSDELC[CAM]C[CAM]K.3|AC[CAM]DGINDC[CAM]GDQSDELC[CAM]C[CAM]K.2|YQIWTTVVDWIHPDLKR.4|YQIWTTVVDWIHPDLKR.3|TMGYQDFADVVC[CAM]YTQK.2|TMGYQDFADVVC[CAM]YTQK.3|TM[Oxi]GYQDFADVVC[CAM]YTQK.2|HGNTDSEGIVEVK.3|HGNTDSEGIVEVK.2|YTHLSC[CAM]DK.2|RAQLGDLPWQVAIK.3|VFC[CAM]QPWQR.2|C[CAM]IEGTC[CAM]VC[CAM]K.2|SLEC[CAM]LHPGTK.2|ADSPMDDFFQC[CAM]VNGK.3|ADSPMDDFFQC[CAM]VNGK.2|KYTHLSC[CAM]DK.2|SFPTYC[CAM]QQK.2|VANYFDWISYHVGR.3|RIVIEYVDR.2|YQIWTTVVDWIHPDLK.3|YQIWTTVVDWIHPDLK.2|RTMGYQDFADVVC[CAM]YTQK.3|RTM[Oxi]GYQDFADVVC[CAM]YTQK.3|EANVAC[CAM]LDLGFQQGADTQR.3|EANVAC[CAM]LDLGFQQGADTQR.2|VTYTSQEDLVEK.2|AQLGDLPWQVAIK.2|IIFHENYNAGTYQNDIALIEMK.3|VANYFDWISYHVGRPFISQYNV.3|DASGITC[CAM]GGIYIGGC[CAM]WILTAAHC[CAM]LR.3|EM[Oxi]EC[CAM]AGTYDGSIDAC[CAM]K.2|EMEC[CAM]AGTYDGSIDAC[CAM]K.2
SEN / CTL,Complement factor B,CFB,P00751,-0.96,0.49,1.21E-02,6.24E-03,2.20E+00,"proteolysis,complement activation,complement activation, alternative pathway,regulation of complement activation","complement binding,serine-type endopeptidase activity","extracellular region,extracellular space,plasma membrane,extracellular exosome,blood microparticle",6,51,78,DFHINLFQVLPWLK.3|DFHINLFQVLPWLK.4|DFHINLFQVLPWLK.2|YGLVTYATYPK.2|QLNEINYEDHKLK.4|QLNEINYEDHKLK.3|QLNEINYEDHKLK.2|VKDISEVVTPR.3|VKDISEVVTPR.2|LPPTTTC[CAM]QQQK.3|LPPTTTC[CAM]QQQK.2|AIHC[CAM]PRPHDFENGEYWPR.5|AIHC[CAM]PRPHDFENGEYWPR.4|AIHC[CAM]PRPHDFENGEYWPR.3|DAQYAPGYDKVK.3|LEDSVTYHC[CAM]SR.3|LEDSVTYHC[CAM]SR.2|QLNEINYEDHK.3|QLNEINYEDHK.2|STGSWSTLK.2|GTDYHKQPWQAK.3|VASYGVKPR.2|C[CAM]LVNLIEK.2|VSEADSSNADWVTK.3|VSEADSSNADWVTK.2|DISEVVTPR.2|DNEQHVFK.2|PHDFENGEYWPR.3|ALFVSEEEK.2|LQDEDLGFL.2|YGQTIRPIC[CAM]LPC[CAM]TEGTTR.4|YGQTIRPIC[CAM]LPC[CAM]TEGTTR.3|YGQTIRPIC[CAM]LPC[CAM]TEGTTR.2|GDSGGPLIVHK.2|DAQYAPGYDK.2|RDLEIEVVLFHPNYNINGK.4|RDLEIEVVLFHPNYNINGK.3|EELLPAQDIK.2|ALFVSEEEKK.2|DAQYAPGYDKVKDISEVVTPR.4|DAQYAPGYDKVKDISEVVTPR.3|LKYGQTIRPIC[CAM]LPC[CAM]TEGTTR.4|FLC[CAM]TGGVSPYADPNTC[CAM]RGDSGGPLIVHK.5|FLC[CAM]TGGVSPYADPNTC[CAM]RGDSGGPLIVHK.4|GHESC[CAM]MGAVVSEYFVLTAAHC[CAM]FTVDDKEHSIK.6|GHESC[CAM]MGAVVSEYFVLTAAHC[CAM]FTVDDKEHSIK.5|GHESC[CAM]MGAVVSEYFVLTAAHC[CAM]FTVDDKEHSIK.4|EAGIPEFYDYDVALIK.3|EAGIPEFYDYDVALIK.2|LPPTTTC[CAM]QQQKEELLPAQDIK.4|LPPTTTC[CAM]QQQKEELLPAQDIK.3|FLC[CAM]TGGVSPYADPNTC[CAM]RGDSGGPLIVHKR.5|FLC[CAM]TGGVSPYADPNTC[CAM]R.3|FLC[CAM]TGGVSPYADPNTC[CAM]R.2|EKLQDEDLGFL.2|KEAGIPEFYDYDVALIK.3|WSGQTAIC[CAM]DNGAGYC[CAM]SNPGIPIGTR.4|WSGQTAIC[CAM]DNGAGYC[CAM]SNPGIPIGTR.3|ALRLPPTTTC[CAM]QQQKEELLPAQDIK.4|HVIILMTDGLHNMGGDPITVIDEIR.4|HVIILMTDGLHNMGGDPITVIDEIR.3|DLEIEVVLFHPNYNINGK.3|LLQEGQALEYVC[CAM]PSGFYPYPVQTR.4|LLQEGQALEYVC[CAM]PSGFYPYPVQTR.3|PIC[CAM]LPC[CAM]TEGTTR.2|PQGSC[CAM]SLEGVEIK.2|HVIILM[Oxi]TDGLHNMGGDPITVIDEIRDLLYIGK.5|HVIILMTDGLHNM[Oxi]GGDPITVIDEIRDLLYIGK.5|GHESC[CAM]MGAVVSEYFVLTAAHC[CAM]FTVDDK.4|GHESC[CAM]MGAVVSEYFVLTAAHC[CAM]FTVDDK.3|STGSWSTLKTQDQK.2|VKDMENLEDVFYQMIDESQSLSLC[CAM]GMVWEHRK.5|KNPREDYLDVYVFGVGPLVNQVNINALASK.4|FIQVGVISWGVVDVC[CAM]K.2|EDYLDVYVFGVGPLVNQVNINALASK.3|VKDMENLEDVFYQMIDESQSLSLC[CAM]GM[Oxi]VWEHR.4|VKDMENLEDVFYQMIDESQSLSLC[CAM]GMVWEHR.4|NPREDYLDVYVFGVGPLVNQVNINALASK.3
SEN / CTL,Chromobox protein homolog 3,CBX3,Q13185,-0.97,0.32,8.82E-09,2.31E-08,7.64E+00,"chromatin remodeling,transcription, DNA-templated,chromatin modification,negative regulation of transcription, DNA-templated,rhythmic process","protein binding,enzyme binding,protein domain specific binding,histone methyltransferase binding","chromosome, centromeric region,condensed chromosome, centromeric region,nuclear chromosome, telomeric region,chromatin,nucleus,nuclear envelope,nuclear inner membrane,nuclear euchromatin,nuclear heterochromatin,spindle,nuclear pericentric heterochromatin",15,13,22,C[CAM]PQIVIAFYEER.2|C[CAM]PQIVIAFYEER.3|WKDSDEADLVLAK.3|WKDSDEADLVLAK.2|IIGATDSSGELMFLMK.2|IIGATDSSGELMFLMK.3|IIGATDSSGELM[Oxi]FLMK.2|IIGATDSSGELMFLM[Oxi]K.2|SLSDSESDDSKSK.3|SLSDSESDDSKSK.2|SKKVEEAEPEEFVVEK.4|SKKVEEAEPEEFVVEK.3|KVEEAEPEEFVVEK.3|KVEEAEPEEFVVEK.2|DSDEADLVLAK.2|SLSDSESDDSK.2|VVNGKVEYFLK.2|LTWHSC[CAM]PEDEAQ.2|VEEAEPEEFVVEK.2|GLDPERIIGATDSSGELMFLMK.3|GFTDADNTWEPEENLDC[CAM]PELIEAFLNSQK.4|GFTDADNTWEPEENLDC[CAM]PELIEAFLNSQK.3
SEN / CTL,Bleomycin hydrolase,BLMH,Q13867,-0.97,0.18,9.45E-03,5.09E-03,2.29E+00,"protein polyubiquitination,proteolysis,response to toxic substance,response to drug,homocysteine catabolic process","aminopeptidase activity,carboxypeptidase activity,cysteine-type endopeptidase activity,cysteine-type peptidase activity","nucleus,cytoplasm,cytosol,extracellular exosome",3,32,47,IGPITPLEFYR.2|IGPITPLEFYR.3|AQHVFQHAVPQEGKPITNQK.5|AQHVFQHAVPQEGKPITNQK.4|AQHVFQHAVPQEGKPITNQK.3|NLVHSGATK.2|C[CAM]WIFSC[CAM]LNVMR.3|C[CAM]WIFSC[CAM]LNVMR.2|C[CAM]WIFSC[CAM]LNVM[Oxi]R.2|EHVKPLFNMEDK.3|EHVKPLFNM[Oxi]EDK.3|EHVKPLFNMEDKIC[CAM]LVNDPRPQHK.6|EHVKPLFNMEDKIC[CAM]LVNDPRPQHK.5|IC[CAM]LVNDPR.2|IC[CAM]LVNDPRPQHK.3|IC[CAM]LVNDPRPQHK.2|MNDILNHK.2|DDQDGAFTK.2|AQHVFQHAVPQEGK.3|KTLYNNQPIDFLK.3|TLYNNQPIDFLKK.3|TLYNNQPIDFLKK.2|LYTVEYLSNMVGGR.3|LYTVEYLSNMVGGR.2|KTLYNNQPIDFLKK.3|LYTVEYLSNMVGGRK.3|WRVENSWGEDHGHK.3|YNKLYTVEYLSNMVGGR.3|NLVHSGATKGEISATQDVMMEEIFR.4|LNSDPQFVLAQNVGTTHDLLDIC[CAM]LK.4|LNSDPQFVLAQNVGTTHDLLDIC[CAM]LK.3|VENSWGEDHGHK.2|YNKLYTVEYLSNMVGGRK.3|DGEAVWFGC[CAM]DVGK.2|LTFGESLMTHAMTFTAVSEK.3|LTFGESLMTHAMTFTAVSEK.2|TLYNNQPIDFLK.2|LNSDPQFVLAQNVGTTHDLLDIC[CAM]LKR.4|LGLSDM[Oxi]NLYDHELVFGVSLK.3|LGLSDMNLYDHELVFGVSLK.3|LGLSDMNLYDHELVFGVSLK.2|VVC[CAM]IC[CAM]LGNPPETFTWEYR.3|VVC[CAM]IC[CAM]LGNPPETFTWEYR.2|LTFGESLMTHAMTFTAVSEKDDQDGAFTK.4|C[CAM]YFFLSAFVDTAQR.2|GEISATQDVMMEEIFR.2|LVQFLLMNPANDGGQWDMLVNIVEK.3
SEN / CTL,Vasorin,VASN,Q6EMK4,-0.98,0.31,9.34E-08,1.88E-07,6.73E+00,"negative regulation of epithelial to mesenchymal transition,negative regulation of transforming growth factor beta receptor signaling pathway,cellular response to hypoxia,cellular response to redox state,cell-cell adhesion","transforming growth factor beta binding,cadherin binding involved in cell-cell adhesion","extracellular space,mitochondrion,lysosomal membrane,plasma membrane,cell-cell adherens junction,cell surface,integral component of membrane,extracellular exosome",12,8,8,SLTLGIEPVSPTSLR.2|NPFNC[CAM]VC[CAM]PLSWFGPWVR.3|LLLLDLSHNSLLALEPGILDTANVEALR.3|LAGLGLQQLDEGLFSR.2|ESHVTLASPEETR.3|NLHDLDVSDNQLER.3|YLQGSSVQLR.2|HIQPGAFDTLDR.2
SEN / CTL,Small acidic protein,SMAP,O00193,-0.98,0.57,5.69E-03,3.36E-03,2.47E+00,biological_process,molecular_function,cellular_component,6,6,12,SASPDDDLGSSNWEAADLGNEER.3|TGEEDKKINEELESQYQQSMDSK.4|TGEEDKKINEELESQYQQSMDSK.3|INEELESQYQQSMDSK.3|INEELESQYQQSM[Oxi]DSK.3|INEELESQYQQSMDSK.2|INEELESQYQQSM[Oxi]DSK.2|KINEELESQYQQSMDSK.3|KINEELESQYQQSMDSK.2|RSASPDDDLGSSNWEAADLGNEERK.4|RSASPDDDLGSSNWEAADLGNEERK.3|RSASPDDDLGSSNWEAADLGNEER.3
SEN / CTL,Disintegrin and metalloproteinase domain-containing protein 10,ADAM10,O14672,-1.00,0.88,9.83E-04,7.52E-04,3.12E+00,"in utero embryonic development,protein phosphorylation,membrane protein ectodomain proteolysis,negative regulation of cell adhesion,Notch signaling pathway,Notch receptor processing,integrin-mediated signaling pathway,cell-cell signaling,positive regulation of cell proliferation,positive regulation of T cell chemotaxis,protein processing,extracellular matrix disassembly,positive regulation of cell growth,positive regulation of cell migration,response to tumor necrosis factor,monocyte activation,ephrin receptor signaling pathway,PMA-inducible membrane protein ectodomain proteolysis,constitutive protein ectodomain proteolysis","endopeptidase activity,metalloendopeptidase activity,receptor binding,integrin binding,protein binding,metallopeptidase activity,SH3 domain binding,protein kinase binding,protein homodimerization activity,metal ion binding","nucleus,cytoplasm,Golgi apparatus,Golgi-associated vesicle,plasma membrane,focal adhesion,cell surface,postsynaptic density,membrane,integral component of membrane,intracellular membrane-bounded organelle,extracellular exosome,perinuclear endoplasmic reticulum,tetraspanin-enriched microdomain",21,21,28,EAVIAQISSHVK.3|EAVIAQISSHVK.2|AIDTIYQTTDFSGIR.2|AIDTIYQTTDFSGIR.3|HTQVC[CAM]INGQC[CAM]AGSIC[CAM]EK.3|HTQVC[CAM]INGQC[CAM]AGSIC[CAM]EK.2|GGTFYVEPAER.2|NTC[CAM]QLYIQTDHLFFK.3|NTC[CAM]QLYIQTDHLFFK.2|ELC[CAM]HVC[CAM]C[CAM]MK.3|ELC[CAM]HVC[CAM]C[CAM]MK.2|LPPPKPLPGTLK.3|RAVSHEDQFLR.3|RRPPQPIQQPQR.3|LVDADGPLAR.2|GYC[CAM]DVFMR.2|VSHITFAHEVGHNFGSPHDSGTEC[CAM]TPGESK.6|VSHITFAHEVGHNFGSPHDSGTEC[CAM]TPGESK.5|YGPQGGC[CAM]ADHSVFER.3|ESYQMGHMR.2|HYEGLSYNVDSLHQK.3|HYEGLSYNVDSLHQK.2|YGLEEC[CAM]TC[CAM]ASSDGKDDK.3|VLDYDTSHIYTGHIYGEEGSFSHGSVIDGR.5|SLNTGIITVQNYGSHVPPK.3|DEC[CAM]C[CAM]FDANQPEGR.2|TITLQPGSPC[CAM]NDFR.2|QC[CAM]SPSQGPC[CAM]C[CAM]TAQC[CAM]AFK.2
SEN / CTL,Histone H2A type 1;Histone H2A type 1-D;Histone H2A type 1-H;Histone H2A type 1-J;Histone H2A.J,HIST1H2AG;HIST1H2AD;HIST1H2AH;HIST1H2AJ;H2AFJ,P0C0S8;P20671;Q96KK5;Q99878;Q9BTM1,-1.00,1.08,3.64E-02,1.53E-02,1.81E+00,"chromatin silencing,biological_process;chromatin silencing,biological_process;chromatin silencing,biological_process;chromatin silencing,biological_process;chromatin silencing,biological_process","DNA binding,protein binding,enzyme binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity","nucleosome,nuclear chromatin,nucleus,extracellular exosome;nucleosome,nuclear chromatin,nucleus,extracellular exosome;nucleosome,nuclear chromatin,extracellular exosome;nucleosome,nuclear chromatin,nucleus,extracellular exosome;nucleosome,nuclear chromatin,extracellular exosome",6,1,3,HLQLAIRNDEELNKLLGK.4|HLQLAIRNDEELNKLLGK.3|HLQLAIRNDEELNKLLGK.2
SEN / CTL,Thrombospondin-1,THBS1,P07996,-1.01,0.97,2.94E-21,3.78E-20,1.94E+01,"activation of MAPK activity,response to hypoxia,negative regulation of endothelial cell proliferation,negative regulation of cell-matrix adhesion,sprouting angiogenesis,chronic inflammatory response,platelet degranulation,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,negative regulation of dendritic cell antigen processing and presentation,inflammatory response,immune response,response to unfolded protein,cell cycle arrest,cell adhesion,positive regulation of cell proliferation,response to mechanical stimulus,response to glucose,positive regulation of endothelial cell migration,negative regulation of endothelial cell migration,negative regulation of plasma membrane long-chain fatty acid transport,negative regulation of nitric oxide mediated signal transduction,negative regulation of cGMP-mediated signaling,negative regulation of plasminogen activation,positive regulation of macrophage chemotaxis,positive regulation of fibroblast migration,cell migration,negative regulation of angiogenesis,peptide cross-linking,positive regulation of blood coagulation,extracellular matrix organization,positive regulation of cell migration,positive regulation of transforming growth factor beta receptor signaling pathway,regulation of cGMP metabolic process,response to magnesium ion,response to progesterone,negative regulation of interleukin-12 production,positive regulation of transforming growth factor beta1 production,response to testosterone,cellular response to heat,response to endoplasmic reticulum stress,protein O-linked fucosylation,negative regulation of fibroblast growth factor receptor signaling pathway,positive regulation of phosphorylation,response to drug,positive regulation of tumor necrosis factor biosynthetic process,positive regulation of macrophage activation,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,positive regulation of blood vessel endothelial cell migration,negative regulation of blood vessel endothelial cell migration,engulfment of apoptotic cell,positive regulation of translation,positive regulation of angiogenesis,behavioral response to pain,positive regulation of smooth muscle cell proliferation,positive regulation of chemotaxis,response to calcium ion,negative regulation of focal adhesion assembly,positive regulation of protein kinase B signaling,negative regulation of fibrinolysis,cellular response to tumor necrosis factor,cellular response to growth factor stimulus,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,positive regulation of endothelial cell apoptotic process,positive regulation of reactive oxygen species metabolic process,negative regulation of endothelial cell chemotaxis,negative regulation of extrinsic apoptotic signaling pathway","phosphatidylserine binding,glycoprotein binding,fibronectin binding,integrin binding,calcium ion binding,protein binding,heparin binding,fibroblast growth factor binding,low-density lipoprotein particle binding,identical protein binding,laminin binding,proteoglycan binding,transforming growth factor beta binding,fibrinogen binding,collagen V binding","extracellular region,fibrinogen complex,extracellular space,endoplasmic reticulum,endoplasmic reticulum lumen,external side of plasma membrane,cell surface,sarcoplasmic reticulum,secretory granule,extracellular matrix,platelet alpha granule,platelet alpha granule lumen,extracellular exosome",129,63,89,FVFGTTPEDILR.2|TIVTTLQDSIR.2|GFLLLASLR.2|SITLFVQEDR.2|GGVNDNFQGVLQNVR.2|FYVVMWK.2|FQMIPLDPK.2|TKDLQAIC[CAM]GISC[CAM]DELSSMVLELR.3|AGTLDLSLTVQGK.2|TIVTTLQDSIRK.3|GTLLALER.2|QVTQSYWDTNPTR.2|GTSQNDPNWVVR.2|AQGYSGLSVK.2|FTGSQPFGQGVEHATANKQVC[CAM]KPR.4|IEDANLIPPVPDDKFQDLVDAVR.4|IEDANLIPPVPDDKFQDLVDAVR.3|C[CAM]ENTDPGYNC[CAM]LPC[CAM]PPR.3|C[CAM]ENTDPGYNC[CAM]LPC[CAM]PPR.2|DNC[CAM]QYVYNVDQR.2|DLQAIC[CAM]GISC[CAM]DELSSMVLELR.3|MENAELDVPIQSVFTR.2|MENAELDVPIQSVFTR.3|M[Oxi]ENAELDVPIQSVFTR.2|DTDMDGVGDQC[CAM]DNC[CAM]PLEHNPDQLDSDSDR.4|DTDMDGVGDQC[CAM]DNC[CAM]PLEHNPDQLDSDSDR.3|LVKGPDPSSPAFR.3|NALWHTGNTPGQVR.3|NALWHTGNTPGQVR.2|GPDPSSPAFRIEDANLIPPVPDDKFQDLVDAVR.4|FTGSQPFGQGVEHATANK.3|FTGSQPFGQGVEHATANK.2|C[CAM]NYLGHYSDPMYR.3|C[CAM]NYLGHYSDPMYR.2|C[CAM]NYLGHYSDPM[Oxi]YR.3|KVTEENKELANELR.4|KVTEENKELANELR.3|KVTEENKELANELR.2|NNEEWTVDSC[CAM]TEC[CAM]HC[CAM]QNSVTIC[CAM]K.3|QHVVSVEEALLATGQWK.3|QHVVSVEEALLATGQWK.4|QHVVSVEEALLATGQWK.2|LC[CAM]NSPSPQMNGKPC[CAM]EGEAR.3|LC[CAM]NSPSPQMNGKPC[CAM]EGEAR.2|C[CAM]TSYPDGSWK.2|IPESGGDNSVFDIFELTGAAR.3|IPESGGDNSVFDIFELTGAAR.2|GPDPSSPAFR.2|DHSGQVFSVVSNGK.3|DHSGQVFSVVSNGK.2|KIMADSGPIYDK.3|KIMADSGPIYDK.2|TC[CAM]HIQEC[CAM]DKR.3|TC[CAM]HIQEC[CAM]DKR.2|LVPNPDQK.2|NPC[CAM]TDGTHDC[CAM]NK.3|NPC[CAM]TDGTHDC[CAM]NK.2|SC[CAM]DSLNNR.2|C[CAM]EGSSVQTR.2|VTEENKELANELR.3|VTEENKELANELR.2|FQDLVDAVR.2|KDHSGQVFSVVSNGK.3|KDHSGQVFSVVSNGK.2|RPPLC[CAM]YHNGVQYR.3|RPPLC[CAM]YHNGVQYR.2|EVPDAC[CAM]FNHNGEHR.3|PRNPC[CAM]TDGTHDC[CAM]NK.3|AQLYIDC[CAM]EK.2|TC[CAM]HIQEC[CAM]DK.2|GDAC[CAM]DHDDDNDGIPDDKDNC[CAM]R.4|GDAC[CAM]DHDDDNDGIPDDKDNC[CAM]R.3|IMADSGPIYDK.2|SC[CAM]DSLNNRC[CAM]EGSSVQTR.3|LC[CAM]NNPTPQFGGK.2|DGKGDAC[CAM]DHDDDNDGIPDDKDNC[CAM]R.4|DNC[CAM]PFHYNPAQYDYDRDDVGDR.4|GDAC[CAM]KDDFDHDSVPDIDDIC[CAM]PENVDISETDFR.5|GDAC[CAM]KDDFDHDSVPDIDDIC[CAM]PENVDISETDFR.4|IEDANLIPPVPDDK.2|DC[CAM]VGDVTENQIC[CAM]NK.2|DSDGDGRGDAC[CAM]KDDFDHDSVPDIDDIC[CAM]PENVDISETDFR.5|DSDGDGRGDAC[CAM]KDDFDHDSVPDIDDIC[CAM]PENVDISETDFR.4|IGDTC[CAM]DNNQDIDEDGHQNNLDNC[CAM]PYVPNANQADHDKDGK.5|IGDTC[CAM]DNNQDIDEDGHQNNLDNC[CAM]PYVPNANQADHDKDGK.4|DNC[CAM]PNLPNSGQEDYDK.2|C[CAM]DNC[CAM]PYNHNPDQADTDNNGEGDAC[CAM]AADIDGDGILNER.4|IGDTC[CAM]DNNQDIDEDGHQNNLDNC[CAM]PYVPNANQADHDK.4|DDFDHDSVPDIDDIC[CAM]PENVDISETDFR.3
SEN / CTL,Polypeptide N-acetylgalactosaminyltransferase 2,GALNT2,Q10471,-1.02,0.81,1.35E-07,2.65E-07,6.58E+00,"immunoglobulin biosynthetic process,protein O-linked glycosylation,O-glycan processing,protein O-linked glycosylation via serine,protein O-linked glycosylation via threonine","polypeptide N-acetylgalactosaminyltransferase activity,manganese ion binding,carbohydrate binding","Golgi membrane,endoplasmic reticulum membrane,Golgi apparatus,Golgi stack,membrane,integral component of Golgi membrane,Golgi cisterna membrane,perinuclear region of cytoplasm,extracellular exosome",27,28,40,VWQC[CAM]GGSLEIIPC[CAM]SR.2|VLTFLDSHC[CAM]EC[CAM]NEHWLEPLLER.4|VLTFLDSHC[CAM]EC[CAM]NEHWLEPLLER.3|HMDLC[CAM]LTVVDRAPGSLIK.4|HMDLC[CAM]LTVVDRAPGSLIK.3|HM[Oxi]DLC[CAM]LTVVDRAPGSLIK.3|GGFDWNLVFK.2|QHPYTFPGGSGTVFAR.3|QHPYTFPGGSGTVFAR.2|HVGSNLC[CAM]LDSR.3|HVGSNLC[CAM]LDSR.2|SGGLSVEVC[CAM]GPALSQQWK.2|SGGLSVEVC[CAM]GPALSQQWK.3|VDLPATSVVITFHNEAR.3|VDLPATSVVITFHNEAR.2|QKWEQIEGNSK.3|QKWEQIEGNSK.2|SGQDPYAR.2|KEDWNEIDPIK.3|KEDWNEIDPIK.2|RAAEVWMDEYK.3|RAAEVWMDEYK.2|FNQVESDK.2|NKFNQVESDKLR.3|FYFEELGK.2|NVPYGNIQSR.2|WDYMTPEQR.2|AAEVWMDEYK.2|EDWNEIDPIK.2|NFYYAAVPSAR.2|HMDLC[CAM]LTVVDR.2|TPMIAGGLFVMDK.2|VRWPDFNQEAYVGGTMVR.3|EIILVDDYSNDPEDGALLGK.3|EIILVDDYSNDPEDGALLGK.2|WYLENVYPELR.2|VPDHQDIAFGALQQGTNC[CAM]LDTLGHFADGVVGVYEC[CAM]HNAGGNQEWALTK.6|VPDHQDIAFGALQQGTNC[CAM]LDTLGHFADGVVGVYEC[CAM]HNAGGNQEWALTK.5|VVSPIIDVINMDNFQYVGASADLK.3|WPDFNQEAYVGGTMVR.2
SEN / CTL,dCTP pyrophosphatase 1,DCTPP1,Q9H773,-1.03,0.60,8.75E-02,3.22E-02,1.49E+00,"nucleoside triphosphate catabolic process,protein homotetramerization","magnesium ion binding,pyrimidine deoxyribonucleotide binding,identical protein binding,nucleoside-triphosphate diphosphatase activity,dCTP diphosphatase activity",cytosol,3,12,18,C[CAM]RVDLPLAVLSK.3|C[CAM]RVDLPLAVLSK.2|RLHAEFAAER.3|DWEQFHQPR.3|DWEQFHQPR.2|LHAEFAAERDWEQFHQPR.5|LHAEFAAERDWEQFHQPR.4|LHAEFAAERDWEQFHQPR.3|RLHAEFAAERDWEQFHQPR.5|RLHAEFAAERDWEQFHQPR.4|VDLPLAVLSK.2|FSFSPEPTLEDIRR.3|GDTGGEDTAAPGR.2|TDGEPGPQGWSPR.2|FSFSPEPTLEDIR.2|KYTELPHGAISEDQAVGPADIPC[CAM]DSTGQTST.4|KYTELPHGAISEDQAVGPADIPC[CAM]DSTGQTST.3|YTELPHGAISEDQAVGPADIPC[CAM]DSTGQTST.3
SEN / CTL,Collagen alpha-1(VII) chain,COL7A1,Q02388,-1.06,0.78,4.01E-12,1.84E-11,1.07E+01,"ER to Golgi vesicle-mediated transport,cell adhesion,epidermis development,negative regulation of endopeptidase activity,extracellular matrix organization,collagen catabolic process,endodermal cell differentiation,COPII vesicle coating","serine-type endopeptidase inhibitor activity,protein binding,identical protein binding","Golgi membrane,extracellular region,collagen type VII trimer,basement membrane,extracellular space,endoplasmic reticulum lumen,ER to Golgi transport vesicle,endoplasmic reticulum-Golgi intermediate compartment membrane,extracellular matrix",33,34,44,QHVPGVMVLLVDEPLRGDIFSPIR.4|SFLEGLVLPFSGAASAQGVR.3|SFLEGLVLPFSGAASAQGVR.2|VLGPELSSYHLDGLEPATQYR.3|VAWGPVPGASGFR.2|LSVLGPAGEGPSAEVTAR.2|VVDTSIDSVTLAWTPVSR.2|ITWVGVTGATAYR.2|GLEGGVSYSVR.2|GLADVVFLPHATQDNAHR.4|GLADVVFLPHATQDNAHR.3|GLADVVFLPHATQDNAHR.2|DLVLSEPSSQSLR.2|GPEASVTQTPVC[CAM]PR.3|GPEASVTQTPVC[CAM]PR.2|EGSASVLTVR.2|TGAAILHVADHVFLPQLAR.4|TGAAILHVADHVFLPQLAR.3|TGAAILHVADHVFLPQLAR.2|GEMGQPGPSGER.2|RVC[CAM]TTAGGVPVTRPPDDSTSAPR.4|VVQSQGTGTAQD.2|FATVQYSDDPR.2|QEVNVPAGETSVR.2|PLPSYAADTAGSQLHAVPVLR.3|VTALVGDREGTPVSIVVTTPPEAPPALGTLHVVQR.5|VTALVGDREGTPVSIVVTTPPEAPPALGTLHVVQR.4|VTALVGDREGTPVSIVVTTPPEAPPALGTLHVVQR.3|EIVETWDESSGSFLPVPER.3|VQWTAASGPVTGYK.2|VLSGGPTQQQELGPGQGSVLLR.3|VLSGGPTQQQELGPGQGSVLLR.2|DMPYMDPSGNNLGTAVVTAHR.3|HQILPGNTDSAEIR.2|VTGLEPGVSYIFSLTPVLDGVR.3|VTGLEPGVSYIFSLTPVLDGVR.2|AVTGSTEAC[CAM]HPFVYGGC[CAM]GGNANR.3|TEFGLDALGSGGDVIR.2|EGTPVSIVVTTPPEAPPALGTLHVVQR.3|VQYTPLTGLGQPLPSER.2|VTGLEPGVSYIFSLTPVLDGVRGPEASVTQTPVC[CAM]PR.4|AQGFLLHWQPEGGQEQSR.2|GPGQEVPGSPQTLPGISSSQR.2|QEMSQHC[CAM]AC[CAM]QGQFIASGSRPLPSYAADTAGSQLHAVPVLR.4
SEN / CTL,Ephrin type-B receptor 2,EPHB2,P29323,-1.06,0.73,6.65E-06,8.98E-06,5.05E+00,"angiogenesis,urogenital system development,nervous system development,axon guidance,axonal fasciculation,learning,phosphorylation,peptidyl-tyrosine phosphorylation,optic nerve morphogenesis,central nervous system projection neuron axonogenesis,corpus callosum development,retinal ganglion cell axon guidance,inner ear morphogenesis,ephrin receptor signaling pathway,positive regulation of long-term neuronal synaptic plasticity,camera-type eye morphogenesis,negative regulation of axonogenesis,regulation of body fluid levels,positive regulation of synapse assembly,palate development,dendritic spine development,dendritic spine morphogenesis,commissural neuron axon guidance","protein tyrosine kinase activity,transmembrane-ephrin receptor activity,receptor binding,ATP binding,axon guidance receptor activity,identical protein binding","extracellular region,cytosol,plasma membrane,integral component of plasma membrane,axon,dendrite,neuronal cell body",21,21,25,AGAIYVFQVR.2|VDTIAADESFSQVDLGGR.2|WTAPEAIQYR.2|AMAPLSSGINLPLLDR.2|AM[Oxi]APLSSGINLPLLDR.2|NILVNSNLVC[CAM]K.2|QNDGQFTVIQLVGMLR.2|QNDGQFTVIQLVGMLR.3|YLADMNYVHR.3|YLADMNYVHR.2|LQHYTSGHMTPGMK.3|C[CAM]GDNVQYAPR.2|ANQGDEAC[CAM]THC[CAM]PINSR.3|SPTNTVTVQGLK.2|IEQVIGAGEFGEVC[CAM]SGHLK.3|IEQVIGAGEFGEVC[CAM]SGHLK.2|TTSEGATNC[CAM]VC[CAM]R.2|DC[CAM]SSIPSVPGSC[CAM]K.2|DFLSEASIMGQFDHPNVIHLEGVVTK.4|GSC[CAM]IANAEEVDVPIK.2|DSGGREDLVYNIIC[CAM]K.2|LYC[CAM]NGDGEWLVPIGR.2|FLEDDTSDPTYTSALGGK.2|IYIDPFTYEDPNEAVR.2|TYQVC[CAM]NVFESSQNNWLR.2
SEN / CTL,Complement C1s subcomponent,C1S,P09871,-1.08,0.97,2.47E-05,2.84E-05,4.55E+00,"proteolysis,complement activation,complement activation, classical pathway,innate immune response","serine-type endopeptidase activity,calcium ion binding","extracellular region,extracellular exosome,blood microparticle",15,26,38,TNFDNDIALVR.2|MLTPEHVFIHPGWK.4|M[Oxi]LTPEHVFIHPGWK.4|MLTPEHVFIHPGWK.2|SSNNPHSPIVEEFQVPYNK.3|SSNNPHSPIVEEFQVPYNK.4|GFQVVVTLR.2|LLEVPEGR.2|VEDPESTLFGSVIR.3|VEDPESTLFGSVIR.2|TMQENSTPR.2|NYVDWIMK.2|GDSGGAFAVQDPNDKTK.3|GDSGGAFAVQDPNDKTK.2|SNALDIIFQTDLTGQK.3|SNALDIIFQTDLTGQK.2|GMDSC[CAM]KGDSGGAFAVQDPNDKTK.4|YHGDPMPC[CAM]PK.2|YHGDPMPC[CAM]PKEDTPNSVWEPAK.4|DVVQITC[CAM]LDGFEVVEGR.3|DVVQITC[CAM]LDGFEVVEGR.2|TMQENSTPRED.2|TM[Oxi]QENSTPRED.2|VEKPTADAEAYVFTPNMIC[CAM]AGGEK.4|VEKPTADAEAYVFTPNM[Oxi]IC[CAM]AGGEK.3|VEKPTADAEAYVFTPNMIC[CAM]AGGEK.3|EDTPNSVWEPAK.2|QFGPYC[CAM]GHGFPGPLNIETK.3|QFGPYC[CAM]GHGFPGPLNIETK.2|GMDSC[CAM]KGDSGGAFAVQDPNDK.3|GDSGGAFAVQDPNDK.2|FYAAGLVSWGPQC[CAM]GTYGLYTR.3|FYAAGLVSWGPQC[CAM]GTYGLYTR.2|VGATSFYSTC[CAM]QSNGK.2|EPTMYVGSTSVQTSR.2|REDFDVEAADSAGNC[CAM]LDSLVFVAGDR.3|C[CAM]QPVDC[CAM]GIPESIENGKVEDPESTLFGSVIR.3|MGPTVSPIC[CAM]LPGTSSDYNLMDGDLGLISGWGR.3
SEN / CTL,Collagen alpha-1(VI) chain,COL6A1,P12109,-1.08,0.87,6.20E-10,1.97E-09,8.71E+00,"osteoblast differentiation,cell adhesion,extracellular matrix organization,collagen catabolic process,endodermal cell differentiation,protein heterotrimerization,cellular response to amino acid stimulus",platelet-derived growth factor binding,"extracellular region,collagen type VI trimer,lysosomal membrane,endoplasmic reticulum lumen,membrane,extracellular matrix,sarcolemma,protein complex,extracellular exosome",48,49,69,VFSVAITPDHLEPR.3|VFSVAITPDHLEPR.2|LLLFSDGNSQGATPAAIEK.2|LLLFSDGNSQGATPAAIEK.3|IALVITDGR.2|VPSYQALLR.2|GLEQLLVGGSHLKENK.4|TAEYDVAYGESHLFR.3|TAEYDVAYGESHLFR.2|TAEYDVAYGESHLFR.4|YLIVVTDGHPLEGYKEPC[CAM]GGLEDAVNEAK.4|YLIVVTDGHPLEGYKEPC[CAM]GGLEDAVNEAK.3|LSIIATDHTYR.3|LSIIATDHTYR.2|VAVVQYSGTGQQRPER.3|VAVVQYSGTGQQRPER.4|VAVVQYSGTGQQRPER.2|LSIIATDHTYRR.3|AVAFQDC[CAM]PVDLFFVLDTSESVALR.3|GLEQLLVGGSHLK.3|GLEQLLVGGSHLK.2|LKPYGALVDKVK.3|LKPYGALVDKVK.2|PYGALVDK.2|TDPAHDVR.2|RFIDNLR.2|GDPGFEGER.2|KGLEQLLVGGSHLK.3|QVNEPHIR.2|LAERFLTAGRTDPAHDVR.4|GTYTDC[CAM]AIK.2|GVFHQTVSR.2|ENYAELLEDAFLK.3|ENYAELLEDAFLK.2|LKPYGALVDK.2|DALKSSVDAVK.2|GDEGPPGSEGAR.2|MC[CAM]SC[CAM]C[CAM]EC[CAM]K.2|YLIVVTDGHPLEGYK.3|YLIVVTDGHPLEGYK.2|AGIEIFVVVVGR.2|DQLLPPSPNNR.2|GDEGEAGDPGDDNNDIAPR.3|GDEGEAGDPGDDNNDIAPR.2|NNVEQVC[CAM]C[CAM]SFEC[CAM]QPAR.3|NNVEQVC[CAM]C[CAM]SFEC[CAM]QPAR.2|TDPAHDVRVAVVQYSGTGQQRPER.4|DAEEAISQTIDTIVDM[Oxi]IK.3|GDPGEAGPQGDQGR.2|FEPGQSYAGVVQYSHSQMQEHVSLRSPSIR.5|RLLLFSDGNSQGATPAAIEK.3|SLQWMAGGTFTGEALQYTR.3|TAEYDVAYGESHLFRVPSYQALLR.4|FEPGQSYAGVVQYSHSQM[Oxi]QEHVSLR.4|FEPGQSYAGVVQYSHSQMQEHVSLR.4|FEPGQSYAGVVQYSHSQM[Oxi]QEHVSLR.3|FEPGQSYAGVVQYSHSQMQEHVSLR.3|DTTPLNVLC[CAM]SPGIQVVSVGIK.3|DTTPLNVLC[CAM]SPGIQVVSVGIK.2|EPC[CAM]GGLEDAVNEAK.2|C[CAM]DRNLVWNAGALHYSDEVEIIQGLTR.4|C[CAM]DRNLVWNAGALHYSDEVEIIQGLTR.3|DALKSSVDAVKYFGK.2|DVFDFIPGSDQLNVISC[CAM]QGLAPSQGRPGLSLVK.4|DVFDFIPGSDQLNVISC[CAM]QGLAPSQGRPGLSLVK.3|NLVWNAGALHYSDEVEIIQGLTR.3|SDTQRDTTPLNVLC[CAM]SPGIQVVSVGIK.3|C[CAM]PDYTC[CAM]PITFSSPADITILLDGSASVGSHNFDTTKR.4|KC[CAM]PDYTC[CAM]PITFSSPADITILLDGSASVGSHNFDTTK.4
SEN / CTL,Vascular cell adhesion protein 1,VCAM1,P19320,-1.09,0.79,5.91E-06,8.10E-06,5.09E+00,"response to hypoxia,acute inflammatory response,chronic inflammatory response,cell adhesion,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,leukocyte cell-cell adhesion,cell-matrix adhesion,aging,response to nutrient,amine metabolic process,response to zinc ion,response to ionizing radiation,viral process,membrane to membrane docking,B cell differentiation,extracellular matrix organization,response to lipopolysaccharide,response to nicotine,calcium-mediated signaling using intracellular calcium source,cellular response to vascular endothelial growth factor stimulus,positive regulation of T cell proliferation,response to ethanol,regulation of immune response,leukocyte tethering or rolling,oxidation-reduction process,cell chemotaxis,interferon-gamma-mediated signaling pathway,cellular response to tumor necrosis factor","integrin binding,primary amine oxidase activity,cell adhesion molecule binding","podosome,extracellular space,early endosome,endoplasmic reticulum,Golgi apparatus,plasma membrane,microvillus,external side of plasma membrane,cell surface,integral component of membrane,filopodium,sarcolemma,apical part of cell,extracellular exosome,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex",18,11,11,QSTQTLYVNVAPR.2|MEDSGVYLC[CAM]EGINQAGR.2|SLEVTFTPVIEDIGK.2|LHIDDMEFEPK.2|NTVISVNPSTK.2|SLEMTFIPTIEDTGK.2|DAGVYEC[CAM]ESK.2|PFTVEISPGPR.2|GIQVEIYSFPK.2|GIQVELYSFPR.2|VTNEGTTSTLTMNPVSFGNEHSYLC[CAM]TATC[CAM]ESR.4
SEN / CTL,Farnesyl pyrophosphate synthase,FDPS,P14324,-1.11,0.78,6.51E-05,6.84E-05,4.16E+00,"cholesterol biosynthetic process,viral process,geranyl diphosphate biosynthetic process,farnesyl diphosphate biosynthetic process","dimethylallyltranstransferase activity,geranyltranstransferase activity,poly(A) RNA binding,metal ion binding","nucleoplasm,cytoplasm,cytosol",15,17,27,GLTVVVAFR.2|LKEVLEYNAIGGK.3|LKEVLEYNAIGGK.2|C[CAM]SWLVVQC[CAM]LQR.2|C[CAM]SWLVVQC[CAM]LQR.3|VLTEDEMGHPEIGDAIAR.3|VLTEDEMGHPEIGDAIAR.4|VLTEDEM[Oxi]GHPEIGDAIAR.3|VLTEDEMGHPEIGDAIAR.2|QDFVQHFSQIVR.3|QDFVQHFSQIVR.2|IGTDIQDNK.2|KQDADSLQR.2|ATPEQYQILKENYGQKEAEK.4|ATPEQYQILKENYGQKEAEK.3|ATPEQYQILK.2|EVLEYNAIGGK.2|ATPEQYQILKENYGQK.3|ATPEQYQILKENYGQK.2|TAFYSFYLPIAAAMYMAGIDGEKEHANAKK.5|TAFYSFYLPIAAAMYMAGIDGEKEHANAKK.4|PGVGLDAINDANLLEAC[CAM]IYR.3|PGVGLDAINDANLLEAC[CAM]IYR.2|TAFYSFYLPIAAAMYMAGIDGEKEHANAK.4|SVGVFLLPAPYWAPR.2|RGQIC[CAM]WYQKPGVGLDAINDANLLEAC[CAM]IYR.4|GQIC[CAM]WYQKPGVGLDAINDANLLEAC[CAM]IYR.3
SEN / CTL,Thrombospondin-2,THBS2,P35442,-1.11,0.59,1.31E-05,1.62E-05,4.79E+00,"cell adhesion,negative regulation of angiogenesis,positive regulation of synapse assembly","calcium ion binding,heparin binding","extracellular region,basement membrane,platelet alpha granule",15,8,9,GTLLALEGPGLSQR.2|SC[CAM]DVTSNTC[CAM]LGPSIQTR.2|GLLQNVHLVFENSVEDILSK.3|VSNDNQFLWELIGGPPK.3|LGPHVTTEYVGPSSER.3|AC[CAM]VGDVQER.2|DDDYAGFVFGYQSSSR.3|DDDYAGFVFGYQSSSR.2|GNQPVGVGLEAAK.2
SEN / CTL,Cadherin-6,CDH6,P55285,-1.12,0.40,1.18E-05,1.48E-05,4.83E+00,"cell adhesion,homophilic cell adhesion via plasma membrane adhesion molecules,Notch signaling pathway,adherens junction organization",calcium ion binding,"plasma membrane,integral component of membrane,extracellular exosome",9,12,12,IVVEDVDEPPVFSK.2|LAYILQIR.2|FLYLGPFKDSATVR.3|LHSDQDRGDGSLK.3|IHDINDNEPIFTK.3|VYTLKVEASNPYVEPR.3|VEASNPYVEPR.2|DIVPEALFLPR.2|TPESSPPGTPIGR.2|TGRPVEPESEFIIK.2|VVYSILQGQPYFSVESETGIIK.3|VLDVNDNAPEFAEFYETFVC[CAM]EK.3
SEN / CTL,Protein SET,SET,Q01105,-1.12,1.12,7.37E-05,7.57E-05,4.12E+00,"DNA replication,nucleosome assembly,nucleosome disassembly,nucleocytoplasmic transport,viral process,regulation of protein phosphatase type 2A activity,negative regulation of histone acetylation,negative regulation of catalytic activity,regulation of mRNA stability,negative regulation of neuron apoptotic process,negative regulation of transcription, DNA-templated","DNA binding,protein phosphatase inhibitor activity,protein binding,protein phosphatase type 2A regulator activity,histone binding","nucleus,nucleoplasm,cytoplasm,endoplasmic reticulum,cytosol,protein complex,perinuclear region of cytoplasm",24,18,30,VEVTEFEDIK.2|VEVTEFEDIKSGYR.3|IPNFWVTTFVNHPQVSALLGEEDEEALHYLTR.4|IPNFWVTTFVNHPQVSALLGEEDEEALHYLTR.5|SGYRIDFYFDENPYFENK.3|SGYRIDFYFDENPYFENK.2|IDFYFDENPYFENK.2|IDFYFDENPYFENK.3|EFHLNESGDPSSK.3|EFHLNESGDPSSK.2|KKPRPPPALGPEETSASAGLPK.4|KKPRPPPALGPEETSASAGLPK.5|KKPRPPPALGPEETSASAGLPK.3|LRQPFFQKR.3|RSELIAK.2|VLSKEFHLNESGDPSSK.4|VLSKEFHLNESGDPSSK.3|KPRPPPALGPEETSASAGLPK.4|KPRPPPALGPEETSASAGLPK.3|LNEQASEEILKVEQK.3|LNEQASEEILKVEQK.2|LNEQASEEILK.2|PRPPPALGPEETSASAGLPK.3|EQQEAIEHIDEVQNEIDR.3|EQQEAIEHIDEVQNEIDR.2|EQQEAIEHIDEVQNEIDRLNEQASEEILKVEQK.5|EQQEAIEHIDEVQNEIDRLNEQASEEILKVEQK.4|EQQEAIEHIDEVQNEIDRLNEQASEEILK.4|EQQEAIEHIDEVQNEIDRLNEQASEEILK.3|IPNFWVTTFVNHPQVSALLGEEDEEALHYLTRVEVTEFEDIK.5
SEN / CTL,Poliovirus receptor,PVR,P15151,-1.12,0.39,4.05E-05,4.39E-05,4.36E+00,"positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,homophilic cell adhesion via plasma membrane adhesion molecules,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,cell recognition,adherens junction organization,susceptibility to natural killer cell mediated cytotoxicity,positive regulation of natural killer cell mediated cytotoxicity,viral entry into host cell,regulation of immune response,susceptibility to T cell mediated cytotoxicity","virus receptor activity,receptor activity,receptor binding,protein binding,protein homodimerization activity,cell adhesion molecule binding","extracellular space,cytoplasm,plasma membrane,integral component of plasma membrane,cell-cell adherens junction,focal adhesion,cell surface,integral component of membrane,extracellular exosome",9,5,6,VQLTGEPVPMAR.2|HGESGSMAVFHQTQGPSYSESK.4|HGESGSMAVFHQTQGPSYSESK.3|VLAKPQNTAEVQK.3|RLEFVAAR.2|ENSSSQDPQTEGTR.2
SEN / CTL,Extracellular superoxide dismutase [Cu-Zn],SOD3,P08294,-1.14,1.47,9.79E-05,9.79E-05,4.01E+00,"response to reactive oxygen species,response to hypoxia,removal of superoxide radicals,response to copper ion,oxidation-reduction process","superoxide dismutase activity,copper ion binding,protein binding,heparin binding,zinc ion binding","extracellular region,extracellular space,nucleus,cytoplasm,Golgi lumen,trans-Golgi network,extracellular exosome,extracellular matrix",33,10,14,VTGVVLFR.2|AVVVHAGEDDLGRGGNQASVENGNAGR.4|DDDGALHAAC[CAM]QVQPSATLDAAQPR.3|VTEIWQEVMQR.2|VTEIWQEVM[Oxi]QR.2|LAC[CAM]C[CAM]VVGVC[CAM]GPGLWER.2|AIHVHQFGDLSQGC[CAM]ESTGPHYNPLAVPHPQHPGDFGNFAVR.6|AIHVHQFGDLSQGC[CAM]ESTGPHYNPLAVPHPQHPGDFGNFAVR.7|AIHVHQFGDLSQGC[CAM]ESTGPHYNPLAVPHPQHPGDFGNFAVR.5|RLAC[CAM]C[CAM]VVGVC[CAM]GPGLWER.3|AGLAASLAGPHSIVGR.3|AGLAASLAGPHSIVGR.2|GGNQASVENGNAGR.2|AVVVHAGEDDLGR.3
SEN / CTL,Galectin-3-binding protein,LGALS3BP,Q08380,-1.14,0.72,1.31E-18,1.18E-17,1.69E+01,"platelet degranulation,receptor-mediated endocytosis,cellular defense response,cell adhesion,signal transduction",scavenger receptor activity,"extracellular region,proteinaceous extracellular matrix,extracellular space,membrane,platelet dense granule lumen,extracellular exosome,blood microparticle,extracellular matrix",72,23,30,SDLAVPSELALLK.2|ELSEALGQIFDSQR.2|ELSEALGQIFDSQR.3|TLQALEFHTVPFQLLAR.3|TLQALEFHTVPFQLLAR.2|IYTSPTWSAFVTDSSWSAR.3|IYTSPTWSAFVTDSSWSAR.2|GQWGTVC[CAM]DNLWDLTDASVVC[CAM]R.3|YSSDYFQAPSDYR.2|LADGGATNQGRVEIFYR.3|AVDTWSWGER.2|KTLQALEFHTVPFQLLAR.4|KTLQALEFHTVPFQLLAR.3|YYPYQSFQTPQHPSFLFQDKR.4|STHTLDLSRELSEALGQIFDSQR.4|RIDITLSSVK.2|IDITLSSVK.2|ASHEEVEGLVEK.3|ASHEEVEGLVEK.2|AAFGQGSGPIMLDEVQC[CAM]TGTEASLADC[CAM]K.3|AAFGQGSGPIMLDEVQC[CAM]TGTEASLADC[CAM]K.4|STSSFPC[CAM]PAGHFNGFR.3|STSSFPC[CAM]PAGHFNGFR.2|YYPYQSFQTPQHPSFLFQDK.3|IYTSPTWSAFVTDSSWSARK.3|TIAYENK.2|SQLVYQSR.2|STHTLDLSR.2|LADGGATNQGR.2|KSQLVYQSR.2
SEN / CTL,Thioredoxin domain-containing protein 12,TXNDC12,O95881,-1.15,0.65,3.79E-03,2.40E-03,2.62E+00,"cell differentiation,cell redox homeostasis,oxidation-reduction process,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway","peptide disulfide oxidoreductase activity,protein-disulfide reductase (glutathione) activity",endoplasmic reticulum lumen,9,10,16,ILFLDPSGK.2|EAAASGLPLMVIIHK.3|EAAASGLPLM[Oxi]VIIHK.3|EAAASGLPLMVIIHK.2|EAAASGLPLM[Oxi]VIIHK.2|YFYVSAEQVVQGMK.2|YFYVSAEQVVQGMK.3|YFYVSAEQVVQGM[Oxi]K.2|KHLEDEL.2|KKHLEDEL.2|GFGDHIHWR.2|VHPEIINENGNPSYK.3|VHPEIINENGNPSYK.2|ILFLDPSGKVHPEIINENGNPSYK.4|DEDFSPDGGYIPR.2|TLEDGKKEAAASGLPLMVIIHK.3
SEN / CTL,AP-2 complex subunit alpha-2,AP2A2,O94973,-1.15,1.06,1.35E-01,4.49E-02,1.35E+00,"intracellular protein transport,microtubule-based movement,antigen processing and presentation of exogenous peptide antigen via MHC class II,negative regulation of epidermal growth factor receptor signaling pathway,ephrin receptor signaling pathway,regulation of defense response to virus by virus,Wnt signaling pathway, planar cell polarity pathway,clathrin-dependent endocytosis","molecular_function,lipid binding,protein transporter activity,protein kinase binding,clathrin adaptor activity","cytosol,plasma membrane,cytoplasmic, membrane-bounded vesicle,AP-2 adaptor complex,endocytic vesicle membrane,clathrin-coated endocytic vesicle membrane,endolysosome membrane",18,41,64,GLAVFISDIR.2|TSVSLAVSR.2|NAVLFEAISLIIHHDSEPNLLVR.4|NAVLFEAISLIIHHDSEPNLLVR.3|AVDLLYAMC[CAM]DR.2|EMAEAFAGEIPK.2|VGGYILGEFGNLIAGDPR.3|VGGYILGEFGNLIAGDPR.2|THIETVINALKTER.4|THIETVINALKTER.3|THIETVINALK.3|THIETVINALK.2|AKHPMDTEVTK.3|AKHPM[Oxi]DTEVTK.3|AKHPMDTEVTK.2|KGPSTVTDLEDTK.3|KGPSTVTDLEDTK.2|GPSTVTDLEDTKR.3|GPSTVTDLEDTKR.2|SSPLIQFHLLHSK.3|SSPLIQFHLLHSK.2|LLQC[CAM]YPPPDPAVR.3|LLQC[CAM]YPPPDPAVR.2|MFIFYGNK.2|M[Oxi]FIFYGNK.2|GRLTEC[CAM]LETILNK.3|GRLTEC[CAM]LETILNK.2|KGPSTVTDLEDTKR.3|HPMDTEVTK.2|TTQIGC[CAM]LLR.2|LC[CAM]ELLSAQF.2|VVHLLNDQHLGVVTAATSLITTLAQK.5|VVHLLNDQHLGVVTAATSLITTLAQK.4|VVHLLNDQHLGVVTAATSLITTLAQK.3|FHLC[CAM]SVPTR.2|QLSNPQQEVQNIFK.3|QLSNPQQEVQNIFK.2|SDSQLRNADVELQQR.3|NNGVLFENQLLQIGLK.3|NNGVLFENQLLQIGLK.2|VLVAGDTMDSVK.2|FFQPTEMASQDFFQR.3|FFQPTEMASQDFFQR.2|GPSTVTDLEDTK.2|VIQIVINRDDVQGYAAK.3|NPTFMGLALHC[CAM]IASVGSR.3|TVFEALQAPAC[CAM]HENLVK.3|NDLASRNPTFMGLALHC[CAM]IASVGSR.4|YGGTFQNVSVQLPITLNK.3|YGGTFQNVSVQLPITLNK.2|LTEC[CAM]LETILNK.2|FVNLFPEVKPTIQDVLR.3|FVNLFPEVKPTIQDVLR.2|LEPNLQAQMYR.2|VVHLLNDQHLGVVTAATSLITTLAQKNPEEFK.5|VVHLLNDQHLGVVTAATSLITTLAQKNPEEFK.3|IIGFGSALLEEVDPNPANFVGAGIIHTK.4|IIGFGSALLEEVDPNPANFVGAGIIHTK.3|IVTSASTDLQDYTYYFVPAPWLSVK.4|IVTSASTDLQDYTYYFVPAPWLSVK.3|TSPDLVPMGDWTSR.2|LSTVASTDILATVLEEMPPFPERESSILAK.4|LSTVASTDILATVLEEMPPFPERESSILAK.3|LSTVASTDILATVLEEMPPFPER.3
SEN / CTL,Twisted gastrulation protein homolog 1,TWSG1,Q9GZX9,-1.16,0.40,1.75E-03,1.23E-03,2.91E+00,"ossification,mesoderm formation,salivary gland morphogenesis,hemopoiesis,cell differentiation,BMP signaling pathway,positive regulation of BMP signaling pathway,negative regulation of BMP signaling pathway,forebrain development,camera-type eye development,negative regulation of osteoblast differentiation",,"extracellular space,extracellular exosome",6,4,6,STVEELHEPIPSLFR.3|STVEELHEPIPSLFR.2|WFHNAC[CAM]C[CAM]EC[CAM]IGPEC[CAM]IDYGSK.3|ALC[CAM]ASDVSK.2|ISC[CAM]ESMGASK.2|ISC[CAM]ESM[Oxi]GASK.2
SEN / CTL,Histone H1.4;Histone H1.3;Histone H1.2;Histone H1t;Histone H1.1,HIST1H1E;HIST1H1D;HIST1H1C;HIST1H1T;HIST1H1A,P10412;P16402;P16403;P22492;Q02539,-1.16,1.07,6.39E-02,2.46E-02,1.61E+00,"negative regulation of transcription from RNA polymerase II promoter,nucleosome assembly,nucleosome positioning,histone H3-K4 trimethylation,histone H3-K27 trimethylation;negative regulation of transcription from RNA polymerase II promoter,nucleosome assembly,nucleosome positioning,histone H3-K4 trimethylation,histone H3-K27 trimethylation;negative regulation of transcription from RNA polymerase II promoter,nucleosome assembly,nucleosome positioning,histone H3-K4 trimethylation,histone H3-K27 trimethylation;nucleosome assembly,multicellular organism development,spermatogenesis,cell differentiation;nucleosome assembly,spermatogenesis","protein binding,chromatin DNA binding,poly(A) RNA binding;chromatin DNA binding,poly(A) RNA binding;protein binding,chromatin DNA binding,poly(A) RNA binding;DNA binding;chromatin DNA binding","nucleosome,nucleus,nuclear heterochromatin,extracellular exosome;nucleosome,nuclear chromatin,nuclear euchromatin;nucleosome,nucleus,nuclear euchromatin,transcriptionally active chromatin;nucleosome,nucleus;nucleosome,nuclear chromatin,nuclear euchromatin",6,2,3,ALAAAGYDVEK.2|ALAAAGYDVEKNNSR.3|ALAAAGYDVEKNNSR.2
SEN / CTL,Ubiquitin-40S ribosomal protein S27a,RPS27A,P62979,-1.18,0.86,4.94E-07,8.78E-07,6.06E+00,"G2/M transition of mitotic cell cycle,negative regulation of transcription from RNA polymerase II promoter,MAPK cascade,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,activation of MAPK activity,protein polyubiquitination,nucleotide-excision repair, DNA damage recognition,nucleotide-excision repair, DNA duplex unwinding,stimulatory C-type lectin receptor signaling pathway,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,glycogen biosynthetic process,transcription-coupled nucleotide-excision repair,nucleotide-excision repair, preincision complex assembly,nucleotide-excision repair, DNA incision, 5'-to lesion,nucleotide-excision repair, DNA gap filling,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,transforming growth factor beta receptor signaling pathway,Notch signaling pathway,I-kappaB kinase/NF-kappaB signaling,JNK cascade,fibroblast growth factor receptor signaling pathway,regulation of tumor necrosis factor-mediated signaling pathway,regulation of necrotic cell death,Wnt signaling pathway,endosomal transport,macroautophagy,viral life cycle,virion assembly,viral transcription,translesion synthesis,negative regulation of transforming growth factor beta receptor signaling pathway,anaphase-promoting complex-dependent catabolic process,regulation of type I interferon production,negative regulation of type I interferon production,tumor necrosis factor-mediated signaling pathway,nucleotide-excision repair, DNA incision,ion transmembrane transport,TRIF-dependent toll-like receptor signaling pathway,interstrand cross-link repair,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,ERBB2 signaling pathway,negative regulation of epidermal growth factor receptor signaling pathway,error-prone translesion synthesis,DNA damage response, detection of DNA damage,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,positive regulation of apoptotic process,negative regulation of apoptotic process,positive regulation of I-kappaB kinase/NF-kappaB signaling,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,cellular protein metabolic process,innate immune response,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of transcription from RNA polymerase II promoter,T cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,stress-activated MAPK cascade,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,nucleotide-binding oligomerization domain containing signaling pathway,global genome nucleotide-excision repair,error-free translesion synthesis,intracellular transport of virus,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,regulation of signal transduction by p53 class mediator","structural constituent of ribosome,protein binding,poly(A) RNA binding,metal ion binding","extracellular space,nucleus,nucleoplasm,nucleolus,cytoplasm,cytosol,plasma membrane,endosome membrane,small ribosomal subunit,membrane,cytosolic small ribosomal subunit,endocytic vesicle membrane,myelin sheath,extracellular exosome",27,9,19,TITLEVEPSDTIENVK.2|TITLEVEPSDTIENVK.3|ESTLHLVLR.2|TLSDYNIQKESTLHLVLR.4|TLSDYNIQKESTLHLVLR.3|TLSDYNIQKESTLHLVLR.2|TITLEVEPSDTIENVKAK.3|TITLEVEPSDTIENVKAK.2|QLEDGRTLSDYNIQKESTLHLVLR.4|QLEDGRTLSDYNIQKESTLHLVLR.5|QLEDGRTLSDYNIQKESTLHLVLR.3|EC[CAM]PSDEC[CAM]GAGVFMASHFDR.3|EC[CAM]PSDEC[CAM]GAGVFM[Oxi]ASHFDR.3|EC[CAM]PSDEC[CAM]GAGVFMASHFDR.2|YYKVDENGK.2|C[CAM]C[CAM]LTYC[CAM]FNKPEDK.3|C[CAM]C[CAM]LTYC[CAM]FNKPEDK.2|REC[CAM]PSDEC[CAM]GAGVFMASHFDR.4|REC[CAM]PSDEC[CAM]GAGVFMASHFDR.3
SEN / CTL,Coagulation factor V,F5,P12259,-1.20,0.28,1.56E-02,7.65E-03,2.12E+00,"platelet degranulation,proteolysis,ER to Golgi vesicle-mediated transport,blood coagulation,blood circulation,platelet activation,COPII vesicle coating","serine-type endopeptidase activity,copper ion binding,protein binding","Golgi membrane,extracellular region,extracellular space,endoplasmic reticulum lumen,plasma membrane,membrane,ER to Golgi transport vesicle,platelet alpha granule lumen,endoplasmic reticulum-Golgi intermediate compartment membrane,extracellular vesicle",3,40,46,AEVDDVIQVR.2|FC[CAM]ENPDEVKR.3|SQHLDNFSNQIGK.3|SQHLDNFSNQIGK.2|PYSLHAHGLSYEK.3|SHEFHAINGMIYSLPGLK.4|SHEFHAINGMIYSLPGLK.3|EDGILGPIIR.2|ITAIITQGC[CAM]K.2|SGPESPGSAC[CAM]R.2|DIHSGLIGPLLIC[CAM]QK.3|DPPSDLLLLK.2|KGTLTEGGTQK.2|GEYEEHLGILGPIIR.3|GEYEEHLGILGPIIR.2|LELFGC[CAM]DIY.2|QHQLGVWPLLPGSFK.3|KVMYTQYEDESFTK.3|LSEGASYLDHTFPAEK.3|LSEGASYLDHTFPAEK.2|SEAYNTFSER.2|KITAIITQGC[CAM]K.2|AVQPGETYTYK.2|FTVNNLAEPQK.2|AADIEQQAVFAVFDENK.3|AADIEQQAVFAVFDENK.2|DGTDYIEIIPK.2|ENQFDPPIVAR.2|SWYLEDNINK.2|EFNPLVIVGLSK.2|LAAEFASKPWIQVDMQK.3|DPDNIAAWYLR.2|ASEFLGYWEPR.2|EVIITGIQTQGAK.2|HEDTLTLFPMR.2|ASKPGWWLLNTEVGENQR.3|AWAYYSAVNPEK.2|ETDIEDSDDIPEDTTYKK.3|SYTIHYSEQGVEWKPYR.3|DIASGLIGLLLIC[CAM]K.2|HLSQDTGSPSGMRPWEDLPSQDTGSPSR.4|VM[Oxi]YTQYEDESFTK.2|VMYTQYEDESFTK.2|EKPQSTISGLLGPTLYAEVGDIIK.3|MPMGLSTGIISDSQIK.2|ETDIEDSDDIPEDTTYK.2
SEN / CTL,Craniofacial development protein 1,CFDP1,Q9UEE9,-1.21,0.54,8.06E-02,3.00E-02,1.52E+00,"cell adhesion,multicellular organism development,biological_process,regulation of cell shape,regulation of cell proliferation,negative regulation of fibroblast apoptotic process",molecular_function,"condensed chromosome kinetochore,cellular_component",3,9,11,VFDFAGEEVR.2|SSGMSSLLGK.2|EKPQANVPSALPSLPAGSGLKR.4|LDWESFKEEEGIGEELAIHNR.4|LDWESFKEEEGIGEELAIHNR.3|KKEDELWASFLNDVGPK.3|KKEDELWASFLNDVGPK.2|SKLDWESFKEEEGIGEELAIHNR.4|EKPQANVPSALPSLPAGSGLK.3|EEEGIGEELAIHNR.2|EDELWASFLNDVGPK.2
SEN / CTL,Dystroglycan,DAG1,Q14118,-1.22,0.22,2.96E-05,3.32E-05,4.48E+00,"morphogenesis of an epithelial sheet,protein O-linked glycosylation,membrane protein ectodomain proteolysis,NLS-bearing protein import into nucleus,cytoskeletal anchoring at plasma membrane,regulation of gastrulation,regulation of epithelial to mesenchymal transition,calcium-dependent cell-matrix adhesion,regulation of embryonic cell shape,modulation by virus of host morphology or physiology,nerve maturation,myelination in peripheral nervous system,extracellular matrix organization,negative regulation of cell migration,microtubule anchoring,negative regulation of MAPK cascade,response to peptide hormone,viral entry into host cell,negative regulation of protein kinase B signaling,epithelial tube branching involved in lung morphogenesis,branching involved in salivary gland morphogenesis,commissural neuron axon guidance,basement membrane organization,positive regulation of basement membrane assembly involved in embryonic body morphogenesis","virus receptor activity,dystroglycan binding,actin binding,calcium ion binding,protein binding,structural constituent of muscle,tubulin binding,vinculin binding,protein complex binding,SH2 domain binding,laminin-1 binding,alpha-actinin binding","extracellular region,basement membrane,extracellular space,nucleoplasm,cytoplasm,cytosol,cytoskeleton,plasma membrane,cell-cell adherens junction,focal adhesion,cell outer membrane,dystrophin-associated glycoprotein complex,dystroglycan complex,integral component of membrane,basolateral plasma membrane,lamellipodium,filopodium,node of Ranvier,sarcolemma,costamere,membrane raft,postsynaptic membrane,extracellular exosome,contractile ring",6,17,21,VTIPTDLIASSGDIIK.2|LGC[CAM]SLNQNSVPDIHGVEAPAR.3|GGLSAVDAFEIHVHR.4|GGLSAVDAFEIHVHR.3|GGLSAVDAFEIHVHR.2|LREQQLVGEK.3|LREQQLVGEK.2|FVGDPALVLNDIHKK.4|FVGDPALVLNDIHKK.3|FVGDPALVLNDIHK.3|IAEDDGKPRPAFSNALEPDFK.4|RIAEDDGKPRPAFSNALEPDFK.4|IPSDTFYDHEDTTTDK.3|LTLEDQATFIK.2|ATSITVTGSGSC[CAM]R.2|PAFSNALEPDFK.2|EGAMSAQLGYPVVGWHIANK.3|VDAWVGTYFEVK.2|SWVQFNSNSQLMYGLPDSSHVGKHEYFMHATDK.5|SWVQFNSNSQLMYGLPDSSHVGK.3|GVPIIFADELDDSKPPPSSSMPLILQEEK.3
SEN / CTL,Pigment epithelium-derived factor,SERPINF1,P36955,-1.25,0.94,3.85E-04,3.31E-04,3.48E+00,"kidney development,multicellular organism development,aging,short-term memory,cell proliferation,response to acidic pH,negative regulation of endothelial cell migration,negative regulation of gene expression,negative regulation of endopeptidase activity,positive regulation of neuron projection development,negative regulation of angiogenesis,ovulation cycle,response to arsenic-containing substance,negative regulation of inflammatory response,positive regulation of neurogenesis,retina development in camera-type eye,negative regulation of epithelial cell proliferation involved in prostate gland development,cellular response to cobalt ion,cellular response to retinoic acid,cellular response to glucose stimulus,cellular response to dexamethasone stimulus,negative regulation of neuron death","serine-type endopeptidase inhibitor activity,protein binding","extracellular region,basement membrane,extracellular space,melanosome,axon hillock,perinuclear region of cytoplasm,extracellular exosome,extracellular matrix",12,20,26,SSTSPTTNVLLSPLSVATALSALSLGAEQR.3|DTDTGALLFIGK.2|LAAAVSNFGYDLYR.2|LAAAVSNFGYDLYR.3|LKLSYEGEVTK.3|TESIIHR.2|SSFVAPLEK.2|LSYEGEVTK.2|TVQAVLTVPK.2|KTSLEDFYLDEER.3|KTSLEDFYLDEER.2|YGLDSDLSC[CAM]K.2|ELLDTVTAPQK.2|LDLQEINNWVQAQMK.3|LDLQEINNWVQAQMK.2|EIPDEISILLLGVAHFK.3|ALYYDLISSPDIHGTYK.3|ALYYDLISSPDIHGTYK.2|LQSLFDSPDFSK.2|IAQLPLTGSMSIIFFLPLK.3|IAQLPLTGSMSIIFFLPLK.2|TSLEDFYLDEER.2|ALYYDLISSPDIHGTYKELLDTVTAPQK.4|AGFEWNEDGAGTTPSPGLQPAHLTFPLDYHLNQPFIFVLR.5|AGFEWNEDGAGTTPSPGLQPAHLTFPLDYHLNQPFIFVLR.4|SSTSPTTNVLLSPLSVATALSALSLGAEQRTESIIHR.4
SEN / CTL,DnaJ homolog subfamily C member 8,DNAJC8,O75937,-1.25,0.97,3.85E-03,2.42E-03,2.62E+00,"mRNA splicing, via spliceosome",,"nucleoplasm,cytoplasm,intercellular bridge",9,21,31,LFAELEIK.2|EGKPTIVEEDDPELFK.3|EGKPTIVEEDDPELFK.2|LTRPGSSYFNLNPFEVLQIDPEVTDEEIKKR.5|LTRPGSSYFNLNPFEVLQIDPEVTDEEIKKR.4|ALDVIQAGK.2|QREEEIEAQEK.3|QREEEIEAQEK.2|KEGKPTIVEEDDPELFK.4|KEGKPTIVEEDDPELFK.3|LLLDQEQK.2|QLSILVHPDKNQDDADR.4|QLSILVHPDKNQDDADR.3|EYVEHTVK.2|RQREEEIEAQEK.3|RALDVIQAGK.2|ALDVIQAGKEYVEHTVKER.4|EEEIEAQEK.2|LLLDQEQKK.2|QLSILVHPDKNQDDADRAQK.4|QLSILVHPDKNQDDADRAQK.3|LTRPGSSYFNLNPFEVLQIDPEVTDEEIKK.6|LTRPGSSYFNLNPFEVLQIDPEVTDEEIKK.5|LTRPGSSYFNLNPFEVLQIDPEVTDEEIKK.4|LTRPGSSYFNLNPFEVLQIDPEVTDEEIKK.3|QLSILVHPDK.2|ALDVIQAGKEYVEHTVK.3|PTIVEEDDPELFK.2|LTRPGSSYFNLNPFEVLQIDPEVTDEEIK.4|LTRPGSSYFNLNPFEVLQIDPEVTDEEIK.3|PGSSYFNLNPFEVLQIDPEVTDEEIK.3
SEN / CTL,Testican-1,SPOCK1,Q08629,-1.28,0.07,9.02E-04,7.01E-04,3.15E+00,"regulation of cell growth,neuron migration,cell adhesion,signal transduction,nervous system development,negative regulation of cell-substrate adhesion,negative regulation of endopeptidase activity,negative regulation of neuron projection development,central nervous system neuron differentiation,neurogenesis","serine-type endopeptidase inhibitor activity,cysteine-type endopeptidase inhibitor activity,calcium ion binding,metalloendopeptidase inhibitor activity","proteinaceous extracellular matrix,extracellular space,cytoplasm,postsynaptic density,sarcoplasm,neuromuscular junction,node of Ranvier",3,2,2,SLLGAFIPR.2|ATQC[CAM]HGSTGQC[CAM]WC[CAM]VDK.3
SEN / CTL,Golgi membrane protein 1,GOLM1,Q8NBJ4,-1.30,0.54,6.61E-03,3.83E-03,2.42E+00,"nucleus organization,regulation of lipid metabolic process",protein binding,"extracellular space,Golgi apparatus,integral component of plasma membrane,extracellular exosome",6,21,27,DTINLLDQR.2|KFSYDLSQC[CAM]INQMK.3|KNEFQGELEK.3|KNEFQGELEK.2|IMELEGR.2|EQVVEDRPVGGR.3|NIDVFNVEDQKR.3|NIDVFNVEDQKR.2|LQAAGLPHTEVPQGK.3|LPQEPGREQVVEDRPVGGR.4|DLSENNDQR.2|IQSSHNFQLESVNK.3|IQSSHNFQLESVNK.2|QAALAGNDRNIDVFNVEDQKR.4|QAALAGNDRNIDVFNVEDQKR.3|DRLPQEPGREQVVEDRPVGGR.4|EETNEIQVVNEEPQR.3|EETNEIQVVNEEPQR.2|RQVEKEETNEIQVVNEEPQR.4|LQQDVLQFQK.2|NIDVFNVEDQK.2|EETNEIQVVNEEPQRDR.3|QQLQALSEPQPR.2|DQLVIPDGQEEEQEAAGEGR.3|DQLVIPDGQEEEQEAAGEGR.2|QVEKEETNEIQVVNEEPQR.3|FSYDLSQC[CAM]INQMK.2
SEN / CTL,Nidogen-1,NID1,P14543,-1.33,0.91,2.03E-08,4.84E-08,7.32E+00,"cell-matrix adhesion,positive regulation of cell-substrate adhesion,extracellular matrix disassembly,extracellular matrix organization,glomerular basement membrane development,basement membrane organization","calcium ion binding,collagen binding,laminin binding,laminin-1 binding,proteoglycan binding","extracellular region,basement membrane,basal lamina,extracellular matrix,extracellular exosome,cell periphery",27,39,51,VLFETDLVNPR.2|VYYREDLSPSITQR.3|TQFTC[CAM]EC[CAM]SIGFR.2|QDLGSPEGIAVDHLGR.3|QDLGSPEGIAVDHLGR.2|RVLFETDLVNPR.3|RVLFETDLVNPR.2|QAEVTFVGHPGNLVIK.3|QAEVTFVGHPGNLVIK.2|MVYWTDITEPSIGR.2|M[Oxi]VYWTDITEPSIGR.2|EGSPDALQNPC[CAM]YIGTHGC[CAM]DTNAAC[CAM]RPGPR.4|KALEGLQYPFAVTSYGK.3|KALEGLQYPFAVTSYGK.2|GIVTDSVR.2|HQC[CAM]SVHAEC[CAM]R.3|ASLHGGEPTTIIR.3|ASLHGGEPTTIIR.2|ETDAFQPHK.2|RGGADTYSVPSVLSPR.3|EYTVTEPER.2|QC[CAM]VAEGSPQR.2|ALEGLQYPFAVTSYGK.3|ALEGLQYPFAVTSYGK.2|GNLYWTDWNRDNPK.3|GNLYWTDWNRDNPK.2|YALSNSIGPVR.2|ASLHGGEPTTIIRQDLGSPEGIAVDHLGR.5|ASLHGGEPTTIIRQDLGSPEGIAVDHLGR.4|EYTVTEPERDGASPSR.3|AEC[CAM]LNPSQPSR.2|IETSYMDGTNR.2|NGFSITGGEFTR.2|NIFWTDSNLDRIEVAK.3|NIFWTDSNLDRIEVAK.2|GNLYWTDWNR.2|VIIGLAFDC[CAM]VDK.2|MNSVVALDLAISK.2|M[Oxi]NSVVALDLAISK.2|NIFWTDSNLDR.2|FSGIDEHGHLTIDTELEGR.3|SNGAYNIFANDRESVENLAK.3|IFVGSSQVPIVFENTDLHSYVVM[Oxi]NHGR.4|IFVGSSQVPIVFENTDLHSYVVMNHGR.4|KENNQVPAVVAFSQGSVGFLWK.3|C[CAM]PDNTLGVDC[CAM]IEQK.2|VPQIPFGSSVHIEPYTELYHYSTSVITSSSTR.4|GFPEISFQPSSAVVVTWESVAPYQGPSRDPDQK.4|ESHPGLFPPTFGAVAPFLADLDTTDGLGK.3|LYGITTALSQC[CAM]PQGHNYC[CAM]SVNNGGC[CAM]THLC[CAM]LATPGSR.4|QELFPFGPGQGDLELEDGDDFVSPALELSGALR.3
SEN / CTL,Receptor-type tyrosine-protein phosphatase kappa,PTPRK,Q15262,-1.35,0.24,3.35E-10,1.12E-09,8.95E+00,"protein dephosphorylation,cell adhesion,signal transduction,transforming growth factor beta receptor signaling pathway,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,cell migration,negative regulation of cell migration,neuron projection development,protein localization to cell surface,cellular response to reactive oxygen species,cellular response to UV,peptidyl-tyrosine dephosphorylation,negative regulation of cell cycle,negative regulation of transcription, DNA-templated,focal adhesion assembly","protein tyrosine phosphatase activity,transmembrane receptor protein tyrosine phosphatase activity,protein binding,beta-catenin binding,protein kinase binding,gamma-catenin binding","photoreceptor outer segment,integral component of plasma membrane,cell-cell junction,adherens junction,cell surface,integral component of membrane,axon,dendrite,leading edge membrane,neuronal cell body",12,12,13,VLLTRPGEGGTGLPGPPLITR.3|GLNPGTLNILVR.2|GSGVSNFAQLIVR.2|MTSGSWTETHAVNAPTYK.3|YENHSATAESSR.3|VADLLQHINLMK.3|VADLLQHINLMK.2|GAPISAYQIVVEELHPHR.4|ADC[CAM]LDMDPK.2|NGEDIPVAQTK.2|TYQGFWNPPLAPR.2|YLC[CAM]EGTESPYQTGQLHPAIR.3|IFLNWKEPLDPNGIITQYEISYSSIR.3
SEN / CTL,Collagen alpha-2(IV) chain,COL4A2,P08572,-1.36,0.94,4.26E-12,1.92E-11,1.07E+01,"angiogenesis,transcription, DNA-templated,negative regulation of angiogenesis,extracellular matrix organization,collagen catabolic process,endodermal cell differentiation,cellular response to transforming growth factor beta stimulus",extracellular matrix structural constituent,"extracellular region,collagen type IV trimer,endoplasmic reticulum lumen,extracellular matrix,intracellular membrane-bounded organelle,extracellular exosome",39,15,19,SVSIGYLLVK.2|FSTMPFLYC[CAM]NPGDVC[CAM]YYASR.3|C[CAM]SVC[CAM]EAPAIAIAVHSQDVSIPHC[CAM]PAGWR.4|IAVQPGTVGPQGR.2|LWSGYSLLYFEGQEK.3|LWSGYSLLYFEGQEK.2|ATPFIEC[CAM]NGGR.2|AHNQDLGLAGSC[CAM]LAR.3|AHNQDLGLAGSC[CAM]LAR.2|HSQTDQEPMC[CAM]PVGMNK.3|HSQTDQEPM[Oxi]C[CAM]PVGMNK.3|GVSGFPGADGIPGHPGQGGPR.3|GLDGYQGPDGPR.2|SYWLSTTAPLPMMPVAEDEIKPYISR.3|SYWLSTTAPLPM[Oxi]M[Oxi]PVAEDEIKPYISR.3|AGFPGLPGSPGAR.2|GEQGFMGNTGPTGAVGDRGPK.3|RGPPGAPGEMGPQGPPGEPGFR.3|GGVSAVPGFRGDEGPIGHQGPIGQEGAPGRPGSPGLPGMPGR.5
SEN / CTL,Transgelin,TAGLN,Q01995,-1.36,0.93,7.03E-09,1.88E-08,7.73E+00,"muscle organ development,epithelial cell differentiation",actin binding,cytoplasm,30,24,41,LGFQVWLK.2|EFTESQLQEGKHVIGLQMGSNR.4|QMEQVAQFLK.2|QM[Oxi]EQVAQFLK.2|LVEWIIVQC[CAM]GPDVGRPDR.3|LVEWIIVQC[CAM]GPDVGRPDR.4|LVEWIIVQC[CAM]GPDVGRPDR.2|HVIGLQMGSNR.3|HVIGLQMGSNR.2|HVIGLQM[Oxi]GSNR.2|TLMALGSLAVTK.2|TLMALGSLAVTK.3|TLM[Oxi]ALGSLAVTK.2|LVNSLYPDGSKPVKVPENPPSMVFK.4|LVNSLYPDGSKPVKVPENPPSM[Oxi]VFK.4|LVNSLYPDGSKPVKVPENPPSMVFK.3|EFTESQLQEGK.2|GPSYGMSR.2|NDGHYRGDPNWFMK.4|NDGHYRGDPNWFM[Oxi]K.4|NDGHYRGDPNWFMK.3|NDGHYRGDPNWFM[Oxi]K.2|GASQAGMTGYGRPR.3|AAEDYGVIK.2|REFTESQLQEGK.3|REFTESQLQEGK.2|GDPNWFMK.2|LVNSLYPDGSKPVK.3|LVNSLYPDGSKPVK.2|TDMFQTVDLFEGK.3|TDMFQTVDLFEGK.2|TDM[Oxi]FQTVDLFEGK.2|PVKVPENPPSMVFK.3|YDEELEER.2|GASQAGMTGYGR.2|LVNSLYPDGSK.2|KYDEELEER.2|VPENPPSMVFK.2|VPENPPSM[Oxi]VFK.2|TDMFQTVDLFEGKDMAAVQR.3|AAEDYGVIKTDMFQTVDLFEGK.3
SEN / CTL,Lumican,LUM,P51884,-1.38,0.79,3.39E-08,7.56E-08,7.12E+00,"visual perception,response to organic cyclic compound,keratan sulfate biosynthetic process,extracellular matrix organization,collagen fibril organization,positive regulation of transforming growth factor beta1 production,keratan sulfate catabolic process,positive regulation of transcription from RNA polymerase II promoter,cartilage development,response to growth factor,axonogenesis","extracellular matrix structural constituent,collagen binding","extracellular region,proteinaceous extracellular matrix,fibrillar collagen trimer,extracellular space,Golgi lumen,lysosomal lumen,extracellular exosome,extracellular matrix",18,21,29,FNALQYLR.2|SLEYLDLSFNQIAR.3|SLEYLDLSFNQIAR.2|LPSGLPVSLLTLYLDNNKISNIPDEYFKR.4|LPSGLPVSLLTLYLDNNKISNIPDEYFKR.5|LPSGLPVSLLTLYLDNNK.3|LPSGLPVSLLTLYLDNNK.2|LPSGLPVSLLTLYLDNNKISNIPDEYFK.4|LPSGLPVSLLTLYLDNNKISNIPDEYFK.3|NNQIDHIDEK.3|NNQIDHIDEK.2|SLEDLQLTHNKITK.4|SLEDLQLTHNKITK.3|SLEDLQLTHNK.3|SLEDLQLTHNK.2|VANEVTLN.2|ISNIPDEYFKR.3|EDAVSAAFK.2|ILGPLSYSK.2|LKEDAVSAAFKGLK.3|SVPMVPPGIK.2|LKEDAVSAAFK.2|RFNALQYLR.2|ISNIPDEYFK.2|NIPTVNENLENYYLEVNQLEK.3|AFENVTDLQWLILDHNLLENSK.3|ISETSLPPDM[Oxi]YEC[CAM]LR.2|ISETSLPPDMYEC[CAM]LR.2|NIPTVNENLENYYLEVNQLEKFDIK.3
SEN / CTL,"HLA class I histocompatibility antigen, Cw-7 alpha chain",HLA-C,P10321,-1.39,0.37,1.16E-11,4.73E-11,1.03E+01,,,,18,9,11,SWTAADTAAQITQR.2|SWTAADTAAQITQR.3|FISVGYVDDTQFVR.2|AYLEGTC[CAM]VEWLR.2|GYDQSAYDGKDYIALNEDLR.3|WAAVVVPSGQEQR.2|THVTHHPLSDHEATLR.4|THVTHHPLSDHEATLR.3|AEPPKTHVTHHPLSDHEATLR.5|GYDQSAYDGK.2|MSGC[CAM]DLGPDGR.2
SEN / CTL,Chromobox protein homolog 5,CBX5,P45973,-1.39,0.25,9.02E-03,4.92E-03,2.31E+00,"blood coagulation,viral process,negative regulation of transcription, DNA-templated","chromatin binding,protein binding,protein binding, bridging,methylated histone binding,protein homodimerization activity,histone deacetylase binding,repressing transcription factor binding","histone deacetylase complex,kinetochore,nuclear chromosome, telomeric region,nucleus,nuclear envelope,nucleoplasm,nuclear heterochromatin,pericentric heterochromatin,nucleolus,chromocenter,transcriptional repressor complex,nuclear pericentric heterochromatin,histone methyltransferase complex,PML body",3,14,21,WKDTDEADLVLAK.3|WKDTDEADLVLAK.2|GQVEYLLK.2|WKGFSEEHNTWEPEK.4|WKGFSEEHNTWEPEK.3|GFSEEHNTWEPEK.3|GFSEEHNTWEPEK.2|LTWHAYPEDAENK.3|LTWHAYPEDAENK.2|NLDC[CAM]PELISEFMK.3|NLDC[CAM]PELISEFM[Oxi]K.2|NLDC[CAM]PELISEFMK.2|LTWHAYPEDAENKEKETAK.4|LTWHAYPEDAENKEKETAK.3|NLDC[CAM]PELISEFMKK.3|DTDEADLVLAK.2|SNFSNSADDIK.2|LTWHAYPEDAENKEK.3|KSNFSNSADDIK.2|GLEPEKIIGATDSC[CAM]GDLMFLMK.3|IIGATDSC[CAM]GDLMFLMK.2
SEN / CTL,Versican core protein,VCAN,P13611,-1.39,0.98,9.82E-17,7.58E-16,1.51E+01,"skeletal system development,osteoblast differentiation,cell adhesion,multicellular organism development,central nervous system development,cell recognition,extracellular matrix organization,glycosaminoglycan metabolic process,chondroitin sulfate biosynthetic process,chondroitin sulfate catabolic process,dermatan sulfate biosynthetic process","extracellular matrix structural constituent,calcium ion binding,glycosaminoglycan binding,hyaluronic acid binding,carbohydrate binding","extracellular region,proteinaceous extracellular matrix,extracellular space,Golgi lumen,membrane,extracellular matrix,lysosomal lumen,intracellular membrane-bounded organelle",60,17,23,LATVGELQAAWR.2|YTLNFEAAQK.2|VSVPTHPEAVGDASLTVVK.3|LLASDAGLYR.2|YEINSLIR.2|NGFDQC[CAM]DYGWLSDASVRHPVTVAR.4|ETTVLVAQNGNIK.2|SPQETYDVYC[CAM]YVDHLDGDVFHLTVPSK.4|SPQETYDVYC[CAM]YVDHLDGDVFHLTVPSK.5|AQC[CAM]GGGLLGVR.2|KGTVAC[CAM]GQPPVVENAK.3|LQGAHLTSILSHEEQMFVNR.4|LQGAHLTSILSHEEQMFVNR.3|LQGAHLTSILSHEEQM[Oxi]FVNR.3|LGEPNYGAEIR.2|GTVAC[CAM]GQPPVVENAK.2|VGHDYQWIGLNDK.3|VGHDYQWIGLNDK.2|GRVSVPTHPEAVGDASLTVVK.4|GRVSVPTHPEAVGDASLTVVK.3|AATSRYTLNFEAAQK.3|AATSRYTLNFEAAQK.2|TQEEYEDK.2
SEN / CTL,Nuclear autoantigenic sperm protein,NASP,P49321,-1.42,0.56,3.32E-06,4.87E-06,5.31E+00,"blastocyst development,DNA replication,DNA replication-dependent nucleosome assembly,DNA replication-independent nucleosome assembly,cell cycle,cell proliferation,male gonad development,protein transport,response to testosterone,histone exchange",Hsp90 protein binding,"nuclear chromatin,nucleus,nucleoplasm,cytoplasm,protein complex",12,59,92,KPTDGASSSNC[CAM]VTDISHLVR.4|KPTDGASSSNC[CAM]VTDISHLVR.3|KPTDGASSSNC[CAM]VTDISHLVR.2|SLLELAR.2|HLVMGDIPAAVNAFQEAASLLGK.3|HLVM[Oxi]GDIPAAVNAFQEAASLLGK.4|HLVMGDIPAAVNAFQEAASLLGK.4|HLVM[Oxi]GDIPAAVNAFQEAASLLGK.3|HLVM[Oxi]GDIPAAVNAFQEAASLLGK.2|HLVMGDIPAAVNAFQEAASLLGK.2|EAEGSSAEYKK.3|EAEGSSAEYKK.2|KLLGLGQK.2|ELLPEIR.2|VESLDVDSEAKK.3|VESLDVDSEAKK.2|EAQLYAAQAHLK.3|EAQLYAAQAHLK.2|EKIEDAKESQR.3|SAEEPQEK.2|LTETKDGSGLEEK.3|SIEVIENR.2|QGEVIVSIEEKPK.3|QGEVIVSIEEKPK.2|EVSEEQPVVTLEK.3|EVSEEQPVVTLEK.2|SLAKPETDKEQDSEM[Oxi]EK.4|SLAKPETDKEQDSEMEK.4|SLAKPETDKEQDSEM[Oxi]EK.3|SLAKPETDKEQDSEMEK.3|SGNVAELALK.2|LVPSQEETK.2|MAVLNEQVK.2|M[Oxi]AVLNEQVK.2|VVTSENEAGK.2|EAEGSSAEYK.2|EIEELKELLPEIR.3|EIEELKELLPEIR.2|LSVEESEAAGDGVDTK.3|LSVEESEAAGDGVDTK.2|EQVYDAMGEKEEAK.3|EQVYDAM[Oxi]GEKEEAK.3|SVSGTDVQEEC[CAM]REK.3|SVSGTDVQEEC[CAM]REK.2|SLAKPETDKEQDSEMEKGGR.4|EQVYDAMGEK.2|VESLDVDSEAK.2|HLVMGDIPAAVNAFQEAASLLGKK.4|HLVM[Oxi]GDIPAAVNAFQEAASLLGKK.4|HLVMGDIPAAVNAFQEAASLLGKK.3|PVDVGGDEPEEK.2|SPEDKVQIAANEETQEREEQMK.4|IEDVPAPSTSADKVESLDVDSEAKK.4|LVPSQEETKLSVEESEAAGDGVDTK.4|LVPSQEETKLSVEESEAAGDGVDTK.3|IEDVPAPSTSADK.2|YGETANEC[CAM]GEAFFFYGK.3|YGETANEC[CAM]GEAFFFYGK.2|SVSGTDVQEEC[CAM]R.2|VQIAANEETQEREEQMK.3|VQIAANEETQER.2|SLQENEEEEIGNLELAWDMLDLAK.4|SLQENEEEEIGNLELAWDMLDLAK.3|TEDESLVENNDNIDEEAR.3|KYGETANEC[CAM]GEAFFFYGK.3|KYGETANEC[CAM]GEAFFFYGK.2|GGAAPEGPNEAEVTSGKPEQEVPDAEEEK.4|GGAAPEGPNEAEVTSGKPEQEVPDAEEEK.3|QGTAVEVEAESLDPTVKPVDVGGDEPEEK.4|QGTAVEVEAESLDPTVKPVDVGGDEPEEK.3|TEEMPNDSVLENK.2|MENGVLGNALEGVHVEEEEGEK.3|LLAETHYQLGLAYGYNSQYDEAVAQFSK.4|LLAETHYQLGLAYGYNSQYDEAVAQFSK.3|ATLVESSTSGFTPGGGGSSVSMIASR.3|ATLVESSTSGFTPGGGGSSVSM[Oxi]IASR.3|AVLEQLVGQEVPPAEESPEVTTEAAEASAVEAGSEVSEKPGQEAPVLPK.6|AVLEQLVGQEVPPAEESPEVTTEAAEASAVEAGSEVSEKPGQEAPVLPK.5|DGAVNGPSVVGDQTPIEPQTSIER.3|IEDVPAPSTSADKVESLDVDSEAK.3|QEPEVNGGSGDAVPSGNEVSENMEEEAENQAESR.4|QEPEVNGGSGDAVPSGNEVSENMEEEAENQAESR.3|GGAAPEGPNEAEVTSGKPEQEVPDAEEEKSVSGTDVQEEC[CAM]REK.5|GGAAPEGPNEAEVTSGKPEQEVPDAEEEKSVSGTDVQEEC[CAM]REK.4|SAEEPQEKVDLTLDWLTETSEEAK.3|VDLTLDWLTETSEEAK.2|AKQEPEVNGGSGDAVPSGNEVSENMEEEAENQAESR.4|LGEVSVESENYVQAVEEFQSC[CAM]LNLQEQYLEAHDR.4|MENGVLGNALEGVHVEEEEGEKTEDESLVENNDNIDEEAREELR.5|QGEVIVSIEEKPKEVSEEQPVVTLEK.3|QGTAVEVEAESLDPTVKPVDVGGDEPEEKVVTSENEAGK.4|GGAAPEGPNEAEVTSGKPEQEVPDAEEEKSVSGTDVQEEC[CAM]R.4
SEN / CTL,Lysyl oxidase homolog 2,LOXL2,Q9Y4K0,-1.47,1.43,5.99E-07,1.05E-06,5.98E+00,"response to hypoxia,epithelial to mesenchymal transition,endothelial cell proliferation,sprouting angiogenesis,transcription, DNA-templated,cellular protein modification process,receptor-mediated endocytosis,cell adhesion,aging,histone modification,protein deamination,collagen fibril organization,positive regulation of chondrocyte differentiation,endothelial cell migration,negative regulation of transcription, DNA-templated,response to copper ion,oxidation-reduction process","chromatin binding,transcription corepressor activity,protein-lysine 6-oxidase activity,scavenger receptor activity,copper ion binding,protein binding,electron carrier activity,methylated histone binding,oligosaccharide binding","basement membrane,extracellular space,nucleus,nucleoplasm,chromosome,membrane,extracellular matrix",42,16,19,VVC[CAM]GMFGFPGER.2|LGQGIGPIHLNEIQC[CAM]TGNEK.3|NGEWGTVC[CAM]DDKWDLVSASVVC[CAM]R.3|FNAESQGC[CAM]NHEEDAGVR.3|ASFC[CAM]LEDTEC[CAM]EGDIQK.2|RTPVMEGYVEVK.2|KFEHFSGLLNNQLSPQ.3|C[CAM]SGTELSLAHC[CAM]R.3|C[CAM]SGTELSLAHC[CAM]R.2|IWMYNC[CAM]HIGGSFSEETEK.3|FDNSLINQIENLNIQVEDIR.3|FDNSLINQIENLNIQVEDIR.2|QRYWPFSMDC[CAM]TGTEAHISSC[CAM]K.4|C[CAM]NTPAMGLQK.2|C[CAM]NTPAM[Oxi]GLQK.2|AYKPEQPLVR.3|HTEDVGVVC[CAM]SDKR.3|HTEDVGVVC[CAM]SDK.2|HAWIWHDC[CAM]HR.2
SEN / CTL,Vitamin D-binding protein,GC,P02774,-1.48,1.58,1.32E-01,4.44E-02,1.35E+00,"vitamin D metabolic process,vitamin transport","actin binding,vitamin D binding,vitamin transporter activity,calcidiol binding","extracellular region,extracellular space,cytosol,lysosomal lumen,extracellular exosome,blood microparticle",15,46,77,HQPQEFPTYVEPTNDEIC[CAM]EAFRKDPK.5|HQPQEFPTYVEPTNDEIC[CAM]EAFRKDPK.4|HQPQEFPTYVEPTNDEIC[CAM]EAFR.3|HQPQEFPTYVEPTNDEIC[CAM]EAFR.4|YTFELSR.2|VLEPTLK.2|EFSHLGK.2|HLSLLTTLSNR.3|HLSLLTTLSNR.2|RTHLPEVFLSK.3|RTHLPEVFLSK.2|AKLPDATPKELAK.3|VMDKYTFELSR.3|VM[Oxi]DKYTFELSR.3|VMDKYTFELSR.2|ELSSFIDK.2|KLC[CAM]MAALK.2|ELPEHTVK.2|LC[CAM]DNLSTK.2|C[CAM]C[CAM]ESASEDC[CAM]MAK.3|C[CAM]C[CAM]ESASEDC[CAM]M[Oxi]AK.3|C[CAM]C[CAM]ESASEDC[CAM]MAK.2|C[CAM]C[CAM]ESASEDC[CAM]M[Oxi]AK.2|NSKFEDC[CAM]C[CAM]QEK.3|NSKFEDC[CAM]C[CAM]QEK.2|DVC[CAM]DPGNTK.2|EDFTSLSLVLYSR.3|EDFTSLSLVLYSR.2|RTHLPEVFLSKVLEPTLK.4|KELSSFIDK.2|GQELC[CAM]ADYSENTFTEYKK.4|GQELC[CAM]ADYSENTFTEYKK.3|FEDC[CAM]C[CAM]QEK.2|KFPSGTFEQVSQLVK.3|KFPSGTFEQVSQLVK.2|SC[CAM]ESNSPFPVHPGTAEC[CAM]C[CAM]TK.4|SC[CAM]ESNSPFPVHPGTAEC[CAM]C[CAM]TK.3|SC[CAM]ESNSPFPVHPGTAEC[CAM]C[CAM]TK.2|EFSHLGKEDFTSLSLVLYSR.4|EFSHLGKEDFTSLSLVLYSR.3|EFSHLGKEDFTSLSLVLYSR.2|THLPEVFLSK.2|SYLSMVGSC[CAM]C[CAM]TSASPTVC[CAM]FLK.4|SYLSM[Oxi]VGSC[CAM]C[CAM]TSASPTVC[CAM]FLK.3|SYLSMVGSC[CAM]C[CAM]TSASPTVC[CAM]FLK.3|SYLSM[Oxi]VGSC[CAM]C[CAM]TSASPTVC[CAM]FLK.2|SYLSMVGSC[CAM]C[CAM]TSASPTVC[CAM]FLK.2|C[CAM]C[CAM]ESASEDC[CAM]MAKELPEHTVK.4|ELSSFIDKGQELC[CAM]ADYSENTFTEYKK.5|ELSSFIDKGQELC[CAM]ADYSENTFTEYKK.4|ELSSFIDKGQELC[CAM]ADYSENTFTEYKK.3|EVVSLTEAC[CAM]C[CAM]AEGADPDC[CAM]YDTR.4|EVVSLTEAC[CAM]C[CAM]AEGADPDC[CAM]YDTR.3|VC[CAM]SQYAAYGEK.2|GQELC[CAM]ADYSENTFTEYK.3|GQELC[CAM]ADYSENTFTEYK.2|VC[CAM]KEFSHLGKEDFTSLSLVLYSR.4|LAQKVPTADLEDVLPLAEDITNILSK.4|LAQKVPTADLEDVLPLAEDITNILSK.3|SLGEC[CAM]C[CAM]DVEDSTTC[CAM]FNAK.3|SLGEC[CAM]C[CAM]DVEDSTTC[CAM]FNAK.2|HQPQEFPTYVEPTNDEIC[CAM]EAFRK.4|HQPQEFPTYVEPTNDEIC[CAM]EAFRK.3|SC[CAM]ESNSPFPVHPGTAEC[CAM]C[CAM]TKEGLER.4|SDFASNC[CAM]C[CAM]SINSPPLYC[CAM]DSEIDAELK.4|SDFASNC[CAM]C[CAM]SINSPPLYC[CAM]DSEIDAELK.3|KELSSFIDKGQELC[CAM]ADYSENTFTEYK.4|FPSGTFEQVSQLVK.2|RSDFASNC[CAM]C[CAM]SINSPPLYC[CAM]DSEIDAELK.4|RSDFASNC[CAM]C[CAM]SINSPPLYC[CAM]DSEIDAELK.3|VPTADLEDVLPLAEDITNILSK.3|VPTADLEDVLPLAEDITNILSK.2|SYLSMVGSC[CAM]C[CAM]TSASPTVC[CAM]FLKER.3|ELSSFIDKGQELC[CAM]ADYSENTFTEYK.3|KFPSGTFEQVSQLVKEVVSLTEAC[CAM]C[CAM]AEGADPDC[CAM]YDTR.4|EYANQFMWEYSTNYGQAPLSLLVSYTK.3|TAMDVFVC[CAM]TYFMPAAQLPELPDVELPTNK.3
SEN / CTL,Collagen alpha-1(I) chain,COL1A1,P02452,-1.53,0.58,2.94E-14,1.59E-13,1.28E+01,"skeletal system development,blood vessel development,osteoblast differentiation,intramembranous ossification,endochondral ossification,blood coagulation,visual perception,sensory perception of sound,positive regulation of epithelial to mesenchymal transition,negative regulation of cell-substrate adhesion,protein transport,platelet activation,extracellular matrix organization,collagen fibril organization,positive regulation of cell migration,collagen catabolic process,response to corticosteroid,response to estradiol,collagen biosynthetic process,protein localization to nucleus,tooth mineralization,response to drug,response to hydrogen peroxide,response to peptide hormone,skin morphogenesis,cellular response to fibroblast growth factor stimulus,tooth eruption,positive regulation of transcription, DNA-templated,embryonic skeletal system development,regulation of immune response,leukocyte migration,response to cAMP,response to hyperoxia,face morphogenesis,bone trabecula formation,cartilage development involved in endochondral bone morphogenesis,protein heterotrimerization,cellular response to amino acid stimulus,cellular response to mechanical stimulus,cellular response to retinoic acid,cellular response to vitamin E,cellular response to tumor necrosis factor,cellular response to epidermal growth factor stimulus,cellular response to transforming growth factor beta stimulus,positive regulation of canonical Wnt signaling pathway,cellular response to fluoride","extracellular matrix structural constituent,protein binding,identical protein binding,metal ion binding,platelet-derived growth factor binding","extracellular region,collagen type I trimer,extracellular space,endoplasmic reticulum lumen,Golgi apparatus,secretory granule,extracellular matrix",33,46,54,SLSQQIENIRSPEGSR.3|DRDLEVDTTLK.3|DRDLEVDTTLK.2|VLC[CAM]DDVIC[CAM]DETK.2|VFC[CAM]NMETGETC[CAM]VYPTQPSVAQK.3|ALLLQGSNEIEIR.2|SLSQQIENIR.2|FTYSVTVDGC[CAM]TSHTGAWGK.3|FTYSVTVDGC[CAM]TSHTGAWGK.2|SGEYWIDPNQGC[CAM]NLDAIK.2|SGEYWIDPNQGC[CAM]NLDAIK.3|NSVAYMDQQTGNLKK.3|NSVAYM[Oxi]DQQTGNLKK.3|NSVAYMDQQTGNLKK.2|STGGISVPGPMGPSGPR.2|STGGISVPGPM[Oxi]GPSGPR.2|NGDDGEAGKPGRPGER.4|NGDDGEAGKPGRPGER.3|GPAGPQGPR.2|GFSGLDGAK.2|ADDANVVR.2|GEAGPQGPR.2|GSEGPQGVR.2|GVVGLPGQR.2|YHDRDVWKPEPC[CAM]R.4|GPPGSAGAPGK.2|QGPSGASGER.2|IC[CAM]VC[CAM]DNGK.2|GPAGPQGPRGDKGETGEQGDR.4|GPAGPQGPRGDKGETGEQGDR.3|GRPGAPGPAGAR.2|GFPGADGVAGPK.2|EGAPGAEGSPGR.2|GVQGPPGPAGPR.2|GADGSPGKDGVR.2|GQAGVM[Oxi]GFPGPK.2|GVPGPPGAVGPAGK.2|GLTGSPGSPGPDGK.2|GPSGPQGPGGPPGPK.2|GESGPSGPAGPTGAR.2|GEPGPVGVQGPPGPAGEEGKR.3|TGPPGPAGQDGRPGPPGPPGAR.3|GEPGPTGLPGPPGER.2|GSAGPPGATGFPGAAGR.2|GETGPAGRPGEVGPPGPPGPAGEK.3|GANGAPGIAGAPGFPGAR.2|NSVAYMDQQTGNLK.2|GDRGETGPAGPPGAPGAPGAPGPVGPAGK.3|DGEAGAQGPPGPAGPAGER.2|VGPPGPSGNAGPPGPPGPAGK.2|GFSGLQGPPGPPGSPGEQGPSGASGPAGPR.3|GPPGPMGPPGLAGPPGESGR.2|GLTGPIGPPGPAGAPGDKGESGPSGPAGPTGAR.3|GVPGPPGAVGPAGKDGEAGAQGPPGPAGPAGER.3
SEN / CTL,Collagen alpha-1(IV) chain,COL4A1,P02462,-1.55,1.61,1.44E-03,1.04E-03,2.98E+00,"patterning of blood vessels,brain development,neuromuscular junction development,extracellular matrix organization,collagen catabolic process,epithelial cell differentiation,blood vessel morphogenesis,retinal blood vessel morphogenesis,renal tubule morphogenesis,cellular response to amino acid stimulus,basement membrane organization","extracellular matrix structural constituent,extracellular matrix constituent conferring elasticity,platelet-derived growth factor binding","extracellular region,collagen type IV trimer,basement membrane,endoplasmic reticulum lumen,extracellular matrix",15,7,11,GTC[CAM]NYYANAYSFWLATIER.3|FSTMPFLFC[CAM]NINNVC[CAM]NFASR.3|FSTM[Oxi]PFLFC[CAM]NINNVC[CAM]NFASR.3|ILYHGYSLLYVQGNER.3|ILYHGYSLLYVQGNER.2|AHGQDLGTAGSC[CAM]LR.3|AHGQDLGTAGSC[CAM]LR.2|AHGQDLGTAGSC[CAM]LRK.3|GPPGGVGFPGSR.2|HSQTIDDPQC[CAM]PSGTK.3|HSQTIDDPQC[CAM]PSGTK.2
SEN / CTL,Endothelial protein C receptor,PROCR,Q9UNN8,-1.57,0.36,1.65E-10,5.93E-10,9.23E+00,"blood coagulation,negative regulation of coagulation,leukocyte migration",receptor activity,"extracellular region,centrosome,plasma membrane,integral component of plasma membrane,focal adhesion,cell surface,extracellular exosome",15,5,7,TLAFPLTIR.2|LHMLQISYFR.3|EFLEDTC[CAM]VQYVQK.2|TQSGLQSYLLQFHGLVR.3|TQSGLQSYLLQFHGLVR.4|TQSGLQSYLLQFHGLVR.2|HISAENTK.2
SEN / CTL,Pterin-4-alpha-carbinolamine dehydratase,PCBD1,P61457,-1.58,0.32,1.36E-02,6.81E-03,2.17E+00,"transcription, DNA-templated,L-phenylalanine catabolic process,tetrahydrobiopterin biosynthetic process,regulation of protein homodimerization activity,positive regulation of transcription, DNA-templated,protein homotetramerization,protein heterooligomerization,oxidation-reduction process","transcription coactivator activity,phenylalanine 4-monooxygenase activity,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,identical protein binding","nucleoplasm,cytoplasm,cytosol,extracellular exosome",3,10,15,LSAEERDQLLPNLR.3|AFGFMTR.2|LDHHPEWFNVYNK.4|LDHHPEWFNVYNK.3|LDHHPEWFNVYNK.2|VHITLSTHEC[CAM]AGLSER.4|VHITLSTHEC[CAM]AGLSER.3|DQLLPNLR.2|AHRLSAEERDQLLPNLR.4|AVGWNELEGR.2|AVGWNELEGRDAIFK.3|VALQAEKLDHHPEWFNVYNK.4|VALQAEKLDHHPEWFNVYNK.3|DINLASFIEQVAVSM[Oxi]T.2|DINLASFIEQVAVSMT.2
SEN / CTL,Fibronectin,FN1,P02751,-1.66,1.04,1.96E-140,5.29E-138,1.37E+02,"angiogenesis,regulation of protein phosphorylation,platelet degranulation,acute-phase response,cell-substrate junction assembly,cell adhesion,calcium-independent cell-matrix adhesion,positive regulation of cell proliferation,regulation of cell shape,response to wounding,positive regulation of gene expression,positive regulation of peptidase activity,peptide cross-linking,extracellular matrix disassembly,extracellular matrix organization,integrin activation,substrate adhesion-dependent cell spreading,endodermal cell differentiation,wound healing,positive regulation of axon extension,positive regulation of fibroblast proliferation,leukocyte migration,regulation of ERK1 and ERK2 cascade,positive regulation of substrate-dependent cell migration, cell attachment to substrate,negative regulation of transforming growth factor-beta secretion","protease binding,integrin binding,protein binding,collagen binding,heparin binding,peptidase activator activity","extracellular region,fibrinogen complex,basal lamina,extracellular space,endoplasmic reticulum-Golgi intermediate compartment,apical plasma membrane,extracellular matrix,platelet alpha granule lumen,extracellular exosome,blood microparticle",474,126,209,VTWAPPPSIDLTNFLVR.2|VTWAPPPSIDLTNFLVR.3|WLPSSSPVTGYR.2|LLC[CAM]QC[CAM]LGFGSGHFR.3|LLC[CAM]QC[CAM]LGFGSGHFR.2|FLATTPNSLLVSWQPPR.3|FLATTPNSLLVSWQPPR.2|TYLGNALVC[CAM]TC[CAM]YGGSR.2|TYLGNALVC[CAM]TC[CAM]YGGSR.3|VGDTYERPKDSMIWDC[CAM]TC[CAM]IGAGR.4|VGDTYERPKDSMIWDC[CAM]TC[CAM]IGAGR.3|VGDTYERPKDSM[Oxi]IWDC[CAM]TC[CAM]IGAGR.4|SSPVVIDASTAIDAPSNLR.3|SSPVVIDASTAIDAPSNLR.2|SYTITGLQPGTDYK.2|SYTITGLQPGTDYK.3|NTFAEVTGLSPGVTYYFK.2|NTFAEVTGLSPGVTYYFK.3|GLAFTDVDVDSIK.2|WSRPQAPITGYR.3|IYLYTLNDNAR.2|IYLYTLNDNAR.3|GFNC[CAM]ESKPEAEETC[CAM]FDKYTGNTYR.4|GFNC[CAM]ESKPEAEETC[CAM]FDKYTGNTYR.3|TNTNVNC[CAM]PIEC[CAM]FMPLDVQADREDSRE.3|TNTNVNC[CAM]PIEC[CAM]FMPLDVQADREDSRE.4|TKTETITGFQVDAVPANGQTPIQR.3|YSFC[CAM]TDHTVLVQTR.3|YSFC[CAM]TDHTVLVQTR.2|NLQPASEYTVSLVAIKGNQESPK.3|NLQPASEYTVSLVAIKGNQESPK.4|NLQPASEYTVSLVAIK.2|NLQPASEYTVSLVAIK.3|DLQFVEVTDVK.2|EYLGAIC[CAM]SC[CAM]TC[CAM]FGGQR.2|EYLGAIC[CAM]SC[CAM]TC[CAM]FGGQR.3|AAVYQPQPHPQPPPYGHC[CAM]VTDSGVVYSVGMQWLK.4|AAVYQPQPHPQPPPYGHC[CAM]VTDSGVVYSVGMQWLK.5|AAVYQPQPHPQPPPYGHC[CAM]VTDSGVVYSVGM[Oxi]QWLK.4|GEWTC[CAM]IAYSQLR.2|GEWTC[CAM]IAYSQLR.3|QYNVGPSVSKYPLR.3|QYNVGPSVSKYPLR.2|STTPDITGYR.2|FTQVTPTSLSAQWTPPNVQLTGYR.3|FTQVTPTSLSAQWTPPNVQLTGYR.4|ITYGETGGNSPVQEFTVPGSK.2|ITYGETGGNSPVQEFTVPGSK.3|VVTPLSPPTNLHLEANPDTGVLTVSWER.3|RPHETGGYMLEC[CAM]VC[CAM]LGNGKGEWTC[CAM]KPIAEK.5|RPHETGGYMLEC[CAM]VC[CAM]LGNGKGEWTC[CAM]KPIAEK.6|RPHETGGYMLEC[CAM]VC[CAM]LGNGKGEWTC[CAM]KPIAEK.4|VPGTSTSATLTGLTR.2|VPGTSTSATLTGLTR.3|QKTGLDSPTGIDFSDITANSFTVHWIAPR.4|DSMIWDC[CAM]TC[CAM]IGAGR.2|DSM[Oxi]IWDC[CAM]TC[CAM]IGAGR.2|SYTITGLQPGTDYKIYLYTLNDNAR.3|C[CAM]FDHAAGTSYVVGETWEKPYQGWMMVDC[CAM]TC[CAM]LGEGSGR.4|FTNIGPDTMR.2|DGQERDAPIVNKVVTPLSPPTNLHLEANPDTGVLTVSWER.5|VTIMWTPPESAVTGYRVDVIPVNLPGEHGQR.4|IAWESPQGQVSR.2|DAPIVNKVVTPLSPPTNLHLEANPDTGVLTVSWER.4|VDVIPVNLPGEHGQR.3|VDVIPVNLPGEHGQR.2|VREEVVTVGNSVNEGLNQPTDDSC[CAM]FDPYTVSHYAVGDEWER.4|VTDATETTITISWR.2|VDVIPVNLPGEHGQRLPISR.4|KKTDELPQLVTLPHPNLHGPEILDVPSTVQK.5|KKTDELPQLVTLPHPNLHGPEILDVPSTVQK.6|KKTDELPQLVTLPHPNLHGPEILDVPSTVQK.4|RPGGEPSPEGTTGQSYNQYSQR.3|C[CAM]TC[CAM]VGNGRGEWTC[CAM]IAYSQLR.3|GNLLQC[CAM]IC[CAM]TGNGRGEWK.3|C[CAM]DPVDQC[CAM]QDSETGTFYQIGDSWEK.3|GNLLQC[CAM]IC[CAM]TGNGR.2|C[CAM]DPHEATC[CAM]YDDGKTYHVGEQWQK.5|C[CAM]DPHEATC[CAM]YDDGKTYHVGEQWQK.4|TFYSC[CAM]TTEGR.2|TETITGFQVDAVPANGQTPIQR.3|TETITGFQVDAVPANGQTPIQR.2|GEFKC[CAM]DPHEATC[CAM]YDDGKTYHVGEQWQK.5|NSITLTNLTPGTEYVVSIVALNGR.3|YQC[CAM]YC[CAM]YGR.2|HRPRPYPPNVGEEIQIGHIPR.5|HRPRPYPPNVGEEIQIGHIPR.4|YEVSVYALK.2|NTFAEVTGLSPGVTYYFKVFAVSHGR.4|ITGYIIK.2|QGENGQMMSC[CAM]TC[CAM]LGNGKGEFK.3|QGENGQMMSC[CAM]TC[CAM]LGNGK.2|WC[CAM]GTTQNYDADQK.2|TEIDKPSQM[Oxi]QVTDVQDNSISVK.3|TEIDKPSQMQVTDVQDNSISVK.3|TEIDKPSQMQVTDVQDNSISVK.4|ITGYIIKYEKPGSPPR.4|ITGYIIKYEKPGSPPR.3|QAQQMVQPQSPVAVSQSKPGC[CAM]YDNGK.3|QAQQM[Oxi]VQPQSPVAVSQSKPGC[CAM]YDNGK.3|HTSVQTTSSGSGPFTDVR.3|HTSVQTTSSGSGPFTDVR.2|TGLDSPTGIDFSDITANSFTVHWIAPR.3|TGLDSPTGIDFSDITANSFTVHWIAPR.4|DDKESVPISDTIIPAVPPPTDLR.3|DDKESVPISDTIIPAVPPPTDLR.4|NSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSDVPR.4|TNTNVNC[CAM]PIEC[CAM]FMPLDVQADR.3|QYNVGPSVSK.2|RQAQQMVQPQSPVAVSQSKPGC[CAM]YDNGK.4|STATISGLKPGVDYTITVYAVTGR.3|STATISGLKPGVDYTITVYAVTGR.4|HYQINQQWER.3|HYQINQQWER.2|VTIMWTPPESAVTGYR.2|VTIM[Oxi]WTPPESAVTGYR.2|VTIMWTPPESAVTGYR.3|VTIM[Oxi]WTPPESAVTGYR.3|TAGPDQTEMTIEGLQPTVEYVVSVYAQNPSGESQPLVQTAVTNIDRPK.5|WKEATIPGHLNSYTIK.4|WKEATIPGHLNSYTIK.3|TPFVTHPGYDTGNGIQLPGTSGQQPSVGQQMIFEEHGFRR.5|TPFVTHPGYDTGNGIQLPGTSGQQPSVGQQMIFEEHGFRR.6|ISC[CAM]TIANR.2|FGFC[CAM]PMAAHEEIC[CAM]TTNEGVMYR.3|FGFC[CAM]PMAAHEEIC[CAM]TTNEGVMYR.4|FGFC[CAM]PMAAHEEIC[CAM]TTNEGVM[Oxi]YR.3|FGFC[CAM]PM[Oxi]AAHEEIC[CAM]TTNEGVMYR.3|FGFC[CAM]PMAAHEEIC[CAM]TTNEGVM[Oxi]YR.4|FGFC[CAM]PM[Oxi]AAHEEIC[CAM]TTNEGVM[Oxi]YR.3|QDGHLWC[CAM]STTSNYEQDQK.3|QDGHLWC[CAM]STTSNYEQDQK.2|QDGHLWC[CAM]STTSNYEQDQK.4|DTLTSRPAQGVVTTLENVSPPR.3|DTLTSRPAQGVVTTLENVSPPR.4|DTLTSRPAQGVVTTLENVSPPR.2|YEKPGSPPREVVPRPRPGVTEATITGLEPGTEYTIYVIALK.6|WC[CAM]HDNGVNYK.3|WC[CAM]HDNGVNYK.2|IGDQWDKQHDMGHMMR.4|IGDQWDKQHDM[Oxi]GHMMR.4|RPHETGGYMLEC[CAM]VC[CAM]LGNGK.4|RPHETGGYMLEC[CAM]VC[CAM]LGNGK.3|RPHETGGYM[Oxi]LEC[CAM]VC[CAM]LGNGK.3|RPHETGGYMLEC[CAM]VC[CAM]LGNGK.2|EVVPRPRPGVTEATITGLEPGTEYTIYVIALK.4|EVVPRPRPGVTEATITGLEPGTEYTIYVIALK.3|DTLTSRPAQGVVTTLENVSPPRR.4|DTLTSRPAQGVVTTLENVSPPRR.3|PRPGVTEATITGLEPGTEYTIYVIALK.3|PRPGVTEATITGLEPGTEYTIYVIALK.4|GEWTC[CAM]KPIAEK.3|GEWTC[CAM]KPIAEK.2|GFNC[CAM]ESKPEAEETC[CAM]FDK.3|GFNC[CAM]ESKPEAEETC[CAM]FDK.2|EVTSDSGSIVVSGLTPGVEYVYTIQVLR.3|QMLC[CAM]TC[CAM]LGNGVSC[CAM]QETAVTQTYGGNSNGEPC[CAM]VLPFTYNGR.4|LGVRPSQGGEAPREVTSDSGSIVVSGLTPGVEYVYTIQVLR.4|EEVVTVGNSVNEGLNQPTDDSC[CAM]FDPYTVSHYAVGDEWER.4|GDSPASSKPISINYR.3|GDSPASSKPISINYR.2|VEYELSEEGDEPQYLDLPSTATSVNIPDLLPGRK.4|GLKPGVVYEGQLISIQQYGHQEVTR.4|GLKPGVVYEGQLISIQQYGHQEVTR.3|EATIPGHLNSYTIK.3|EATIPGHLNSYTIK.2|TDELPQLVTLPHPNLHGPEILDVPSTVQK.4|YEVSVYALKDTLTSRPAQGVVTTLENVSPPRR.5|IGDQWDK.2|SDTVPSPR.2|EINLAPDSSSVVVSGLMVATK.3|EINLAPDSSSVVVSGLM[Oxi]VATK.3|EINLAPDSSSVVVSGLM[Oxi]VATK.2|EINLAPDSSSVVVSGLMVATK.2|LGVRPSQGGEAPR.3|LGVRPSQGGEAPR.2|TYHVGEQWQK.3|TYHVGEQWQK.2|PAQGVVTTLENVSPPR.4|PAQGVVTTLENVSPPR.3|PAQGVVTTLENVSPPR.2|VFAVSHGR.2|YTGNTYR.2|DGQERDAPIVNK.3|DGQERDAPIVNK.2|ESKPLTAQQTTK.3|ESKPLTAQQTTK.2|PAQGVVTTLENVSPPRR.4|PAQGVVTTLENVSPPRR.3|PAQGVVTTLENVSPPRR.2|C[CAM]TC[CAM]VGNGR.2|PLTAQQTTK.2|C[CAM]DPHEATC[CAM]YDDGK.3|C[CAM]DPHEATC[CAM]YDDGK.2|VGDTYERPK.2|C[CAM]HEGGQSYK.2|PRPYPPNVGEEIQIGHIPR.4|QHDMGHMMR.2|EESPLLIGQQSTVSDVPR.3|EESPLLIGQQSTVSDVPR.2|C[CAM]FDHAAGTSYVVGETWEK.3|ESVPISDTIIPAVPPPTDLR.3|ESVPISDTIIPAVPPPTDLR.2|PYQGWMMVDC[CAM]TC[CAM]LGEGSGR.3|PYQGWMMVDC[CAM]TC[CAM]LGEGSGR.2|RPHETGGYMLEC[CAM]VC[CAM]LGNGKGEWTC[CAM]K.4|DLEVVAATPTSLLISWDAPAVTVR.3|VEYELSEEGDEPQYLDLPSTATSVNIPDLLPGR.4|TPFVTHPGYDTGNGIQLPGTSGQQPSVGQQMIFEEHGFR.4
SEN / CTL,Unconventional myosin-If,MYO1F,O00160,-1.77,0.88,6.53E-02,2.50E-02,1.60E+00,biological_process,"motor activity,actin binding,calmodulin binding,ATP binding",unconventional myosin complex,3,27,32,GFGDLAVLK.2|GRLHGQEGLFPGNYVEK.4|GRLHGQEGLFPGNYVEK.3|GRLHGQEGLFPGNYVEK.2|GGPLPLEIMSGGGTHRPPR.4|GRLHGQEGLFPGNYVEKI.4|GPPSTSLGASR.2|VVC[CAM]DLIENK.2|YFEIQFSR.2|TEFVSLLC[CAM]K.2|VVMQNENER.2|RPLPLTFSDTLQFR.3|RPLPLTFSDTLQFR.2|NPESLFLLEEVRER.3|TLTVSVGDGLPK.2|QANDLVATLMR.2|NFVGDYLGLEERPELR.3|VFVKNPESLFLLEEVR.3|VSYDVSGFC[CAM]ER.2|LFDFLVEAINR.2|ARPPSEHNTEFLNVPDQGMAGMQR.4|YAILTPETWPR.2|NFHIYYQLLEGASQEQR.3|NFHIYYQLLEGASQEQR.2|VESVDLLAFPAYLLGIDSGR.3|NPESLFLLEEVR.2|LSPPGIMSVLDDVC[CAM]ATMHATGGGADQTLLQK.4|LSPPGIMSVLDDVC[CAM]ATMHATGGGADQTLLQK.3|QSGVDDMVLLPQITEDAIAANLR.3|LHGQEGLFPGNYVEK.2|AVNMEPDQYQMGSTK.2|EIDLYQGAAQYENPPHIYALTDNMYR.3
SEN / CTL,"Neurolysin, mitochondrial",NLN,Q9BYT8,-1.77,1.20,2.90E-02,1.28E-02,1.89E+00,"regulation of gluconeogenesis,proteolysis,peptide metabolic process,regulation of skeletal muscle fiber differentiation","metalloendopeptidase activity,peptide binding,metal ion binding","mitochondrial intermembrane space,plasma membrane",9,35,48,LVNTGLLTLR.2|LKPLGEAEREFILNLK.4|C[CAM]KEENTIILQQLLPLR.3|C[CAM]KEENTIILQQLLPLR.2|TRTEELIVQTK.3|TRTEELIVQTK.2|RNGLHLPEQVQNEIK.4|RNGLHLPEQVQNEIK.3|RNGLHLPEQVQNEIK.2|SVTLYTVK.2|C[CAM]C[CAM]IPETR.2|IVHLQETC[CAM]DLGK.3|IVHLQETC[CAM]DLGK.2|TMLDFPQHVSSDKEVR.4|TMLDFPQHVSSDKEVR.3|MEMAFNTR.2|TMLDFPQHVSSDK.3|TMLDFPQHVSSDK.2|FDIEMSMR.2|NLNEDDTFLVFSK.3|NLNEDDTFLVFSK.2|TEELIVQTK.2|NGLHLPEQVQNEIK.3|WDLSPEQIK.2|HYKDGSPIADDLLEK.3|YSIDQEFLK.2|AELGALPDDFIDSLEK.3|AELGALPDDFIDSLEK.2|NLILKPGGSLDGMDMLHNFLK.4|NLILKPGGSLDGMDMLHNFLK.3|PGGSLDGMDMLHNFLK.3|YPHYFPVMK.2|EGIMNPEVGMK.2|MMAVAALVVNFSQPVAGRPSLLR.4|MMAVAALVVNFSQPVAGRPSLLR.3|EVMSPLQAMSSYTVAGR.3|EVMSPLQAMSSYTVAGR.2|NLILKPGGSLDGMDMLHNFLKR.4|VTAFLDDLSQK.2|DGSPIADDLLEK.2|AELGALPDDFIDSLEKTDDDKYK.4|TYFHEFGHVMHQIC[CAM]AQTDFAR.4|TYFHEFGHVMHQIC[CAM]AQTDFAR.3|VDQSLHTNTSLDAASEYAK.3|INAWDLYYYMTQTEELK.3|YNHAAC[CAM]FGLQPGC[CAM]LLPDGSR.3|EENTIILQQLLPLR.2|ATGEVLGQFYLDLYPR.2
SEN / CTL,Follistatin-related protein 1,FSTL1,Q12841,-1.81,0.86,3.28E-07,6.14E-07,6.21E+00,"BMP signaling pathway,response to starvation","calcium ion binding,protein binding,heparin binding","extracellular region,extracellular space,extracellular exosome",15,12,12,IIQWLEAEIIPDGWFSK.3|LSFQEFLK.2|IC[CAM]ANVFC[CAM]GAGR.2|C[CAM]LNPSFNPPEKK.3|C[CAM]VC[CAM]AC[CAM]GNWVC[CAM]TAMTC[CAM]DGK.2|GEPTC[CAM]LC[CAM]IEQC[CAM]KPHK.3|IQVDYDGHC[CAM]K.2|C[CAM]LNPSFNPPEK.2|TYLNHC[CAM]ELHR.2|GAQTQTEEEMTR.2|GEPTC[CAM]LC[CAM]IEQC[CAM]K.2|SVSPSASPVVC[CAM]YQSNR.2
SEN / CTL,Metalloproteinase inhibitor 1,TIMP1,P01033,-1.84,0.45,5.33E-16,3.79E-15,1.44E+01,"cell activation,platelet degranulation,aging,positive regulation of cell proliferation,response to hormone,negative regulation of endopeptidase activity,extracellular matrix disassembly,response to cytokine,wound healing,negative regulation of apoptotic process,negative regulation of catalytic activity,response to peptide hormone,negative regulation of membrane protein ectodomain proteolysis,cartilage development,negative regulation of trophoblast cell migration,regulation of integrin-mediated signaling pathway","protease binding,cytokine activity,protein binding,growth factor activity,metalloendopeptidase inhibitor activity,metal ion binding","extracellular region,proteinaceous extracellular matrix,basement membrane,extracellular space,platelet alpha granule lumen,extracellular exosome",27,7,11,LQDGLLHITTC[CAM]SFVAPWNSLSLAQR.3|TYTVGC[CAM]EEC[CAM]TVFPC[CAM]LSIPC[CAM]K.3|EPGLC[CAM]TWQSLR.2|GFQALGDAADIR.2|LQSGTHC[CAM]LWTDQLLQGSEK.3|LQSGTHC[CAM]LWTDQLLQGSEK.2|FVYTPAMESVC[CAM]GYFHR.3|FVYTPAMESVC[CAM]GYFHR.2|FVYTPAM[Oxi]ESVC[CAM]GYFHR.3|FVYTPAMESVC[CAM]GYFHR.4|SEEFLIAGK.2
SEN / CTL,Insulin-like growth factor-binding protein 4,IGFBP4,P22692,-1.86,0.78,6.31E-08,1.33E-07,6.88E+00,"skeletal system development,regulation of cell growth,DNA metabolic process,inflammatory response,signal transduction,cell proliferation,regulation of glucose metabolic process,positive regulation of MAPK cascade,regulation of insulin-like growth factor receptor signaling pathway,positive regulation of insulin-like growth factor receptor signaling pathway,cellular protein metabolic process,type B pancreatic cell proliferation,negative regulation of canonical Wnt signaling pathway","receptor binding,insulin-like growth factor I binding,insulin-like growth factor II binding","extracellular region,extracellular space",15,3,5,EDARPVPQGSC[CAM]QSELHR.4|THEDLYIIPIPNC[CAM]DR.3|THEDLYIIPIPNC[CAM]DR.2|GELDC[CAM]HQLADSFRE.3|GELDC[CAM]HQLADSFRE.2
SEN / CTL,Beta-2-microglobulin,B2M,P61769,-1.90,1.53,3.51E-04,3.05E-04,3.52E+00,"retina homeostasis,positive regulation of T cell mediated cytotoxicity,antigen processing and presentation of peptide antigen via MHC class I,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,positive regulation of T cell cytokine production,regulation of membrane depolarization,negative regulation of neuron projection development,antibacterial humoral response,antigen processing and presentation of endogenous peptide antigen via MHC class I,positive regulation of protein binding,T cell differentiation in thymus,protein refolding,response to drug,cellular protein metabolic process,innate immune response,response to cadmium ion,positive regulation of receptor-mediated endocytosis,regulation of defense response to virus by virus,regulation of immune response,defense response to Gram-negative bacterium,defense response to Gram-positive bacterium,iron ion homeostasis,interferon-gamma-mediated signaling pathway,cellular response to lipopolysaccharide,cellular response to iron ion,negative regulation of receptor binding,positive regulation of receptor binding,positive regulation of ferrous iron import into cell,positive regulation of ferrous iron binding,positive regulation of transferrin receptor binding","glycoprotein binding,protein binding,identical protein binding","Golgi membrane,extracellular region,extracellular space,cytoplasm,endoplasmic reticulum lumen,Golgi apparatus,plasma membrane,focal adhesion,external side of plasma membrane,ER to Golgi transport vesicle membrane,membrane,phagocytic vesicle membrane,early endosome membrane,early endosome lumen,MHC class I protein complex,extracellular exosome,HFE-transferrin receptor complex",15,7,9,SNFLNC[CAM]YVSGFHPSDIEVDLLK.3|SNFLNC[CAM]YVSGFHPSDIEVDLLK.4|VNHVTLSQPK.2|SNFLNC[CAM]YVSGFHPSDIEVDLLKNGER.4|SNFLNC[CAM]YVSGFHPSDIEVDLLKNGER.3|IEKVEHSDLSFSK.3|IQVYSRHPAENGK.3|VEHSDLSFSK.2|DEYAC[CAM]RVNHVTLSQPK.3
SEN / CTL,Plasminogen activator inhibitor 1,SERPINE1,P05121,-1.92,1.85,4.25E-04,3.59E-04,3.44E+00,"chronological cell aging,angiogenesis,platelet degranulation,circadian rhythm,regulation of receptor activity,negative regulation of plasminogen activation,negative regulation of endopeptidase activity,negative regulation of smooth muscle cell migration,positive regulation of blood coagulation,negative regulation of blood coagulation,extracellular matrix organization,negative regulation of cell migration,positive regulation of interleukin-8 production,negative regulation of cell adhesion mediated by integrin,positive regulation of leukotriene production involved in inflammatory response,fibrinolysis,positive regulation of angiogenesis,positive regulation of transcription from RNA polymerase II promoter,positive regulation of receptor-mediated endocytosis,positive regulation of inflammatory response,defense response to Gram-negative bacterium,negative regulation of fibrinolysis,negative regulation of vascular wound healing,negative regulation of wound healing,cellular response to lipopolysaccharide,positive regulation of monocyte chemotaxis,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of smooth muscle cell-matrix adhesion,negative regulation of endothelial cell apoptotic process","protease binding,serine-type endopeptidase inhibitor activity,receptor binding,protein binding","extracellular region,extracellular space,plasma membrane,extracellular matrix,platelet alpha granule lumen,extracellular exosome",21,9,10,MAPEEIIMDRPFLFVVR.3|HNPTGTVLFMGQVMEP.2|QFQADFTSLSDQEPLHVAQALQK.3|LVQGFMPHFFR.3|ELMGPWNKDEISTTDAIFVQR.3|EVPLSALTNILSAQLISHWK.3|EVPLSALTNILSAQLISHWK.2|VFQQVAQASK.2|TPFPDSSTHR.2|LVLVNALYFNGQWK.2
SEN / CTL,Alpha-2-macroglobulin,A2M,P01023,-1.92,1.55,9.37E-02,3.38E-02,1.47E+00,"negative regulation of complement activation, lectin pathway,platelet degranulation,blood coagulation, intrinsic pathway,negative regulation of endopeptidase activity,extracellular matrix disassembly,positive regulation of GTPase activity,stem cell differentiation,regulation of small GTPase mediated signal transduction","protease binding,serine-type endopeptidase inhibitor activity,GTPase activator activity,receptor binding,protein binding,growth factor binding,enzyme binding,interleukin-8 binding,interleukin-1 binding,tumor necrosis factor binding,calcium-dependent protein binding","extracellular region,cytosol,platelet alpha granule lumen,extracellular exosome,blood microparticle",18,89,144,ATVLNYLPK.2|QTVSWAVTPK.2|MVSGFIPLKPTVK.3|M[Oxi]VSGFIPLKPTVK.2|IAQWQSFQLEGGLKQFSFPLSSEPFQGSYK.4|SLNEEAVK.2|AFQPFFVELTMPYSVIR.2|AFQPFFVELTMPYSVIR.3|AFQPFFVELTM[Oxi]PYSVIR.3|AFQPFFVELTM[Oxi]PYSVIR.2|GPTQEFK.2|LVHVEEPHTETVRK.4|VTAAPQSVC[CAM]ALR.3|VTAAPQSVC[CAM]ALR.2|DLKPAIVK.2|PVPGHVTVSIC[CAM]R.3|YGAATFTR.2|YNILPEK.2|GVPIPNKVIFIR.3|ALLAYAFALAGNQDKRK.4|ALLAYAFALAGNQDKRK.3|NEDSLVFVQTDK.3|NEDSLVFVQTDK.2|TGTHGLLVK.2|EQAPHC[CAM]IC[CAM]ANGR.3|EQAPHC[CAM]IC[CAM]ANGR.2|LVDGKGVPIPNKVIFIR.4|GHFSISIPVKSDIAPVAR.4|GHFSISIPVKSDIAPVAR.3|HYDGSYSTFGER.3|HYDGSYSTFGER.2|KDTVIKPLLVEPEGLEK.4|KDTVIKPLLVEPEGLEK.3|VDSHFRQGIPFFGQVR.4|FQVDNNNR.2|SGGRTEHPFTVEEFVLPK.4|SGGRTEHPFTVEEFVLPK.3|SLNEEAVKK.2|TAQEGDHGSHVYTK.3|TAQEGDHGSHVYTK.2|LVHVEEPHTETVR.3|LVHVEEPHTETVR.2|VDLSFSPSQSLPASHAHLR.4|VDLSFSPSQSLPASHAHLR.3|VDLSFSPSQSLPASHAHLR.2|ALLAYAFALAGNQDK.3|ALLAYAFALAGNQDK.2|FEVQVTVPK.2|LHTEAQIQEEGTVVELTGR.4|LHTEAQIQEEGTVVELTGR.3|LHTEAQIQEEGTVVELTGR.2|IAQWQSFQLEGGLK.3|IAQWQSFQLEGGLK.2|DNSVHWERPQKPK.3|DNSVHWERPQKPK.2|GHFSISIPVK.2|KSGGRTEHPFTVEEFVLPK.4|TEVSSNHVLIYLDK.3|TEVSSNHVLIYLDK.2|SSGSLLNNAIK.2|KYSDASDC[CAM]HGEDSQAFC[CAM]EK.4|KYSDASDC[CAM]HGEDSQAFC[CAM]EK.3|SIYKPGQTVK.2|TEHPFTVEEFVLPK.3|TEHPFTVEEFVLPK.2|SASNMAIVDVK.2|SASNM[Oxi]AIVDVK.2|SSSNEEVMFLTVQVK.3|SSSNEEVM[Oxi]FLTVQVK.2|SSSNEEVMFLTVQVK.2|ALLAYAFALAGNQDKR.3|NALFC[CAM]LESAWKTAQEGDHGSHVYTK.5|QGIPFFGQVR.2|DTVIKPLLVEPEGLEK.3|DTVIKPLLVEPEGLEK.2|QQNAQGGFSSTQDTVVALHALSK.4|QQNAQGGFSSTQDTVVALHALSK.3|QQNAQGGFSSTQDTVVALHALSK.2|LPPNVVEESAR.2|LLIYAVLPTGDVIGDSAK.3|LLIYAVLPTGDVIGDSAK.2|PLLVEPEGLEK.2|SGGRTEHPFTVEEFVLPKFEVQVTVPK.5|YDVENC[CAM]LANK.2|QFSFPLSSEPFQGSYK.3|QFSFPLSSEPFQGSYK.2|SLFTDLEAENDVLHC[CAM]VAFAVPK.4|SLFTDLEAENDVLHC[CAM]VAFAVPK.3|AIGYLNTGYQR.2|LSFYYLIMAK.2|VGFYESDVMGR.2|VGFYESDVM[Oxi]GR.2|VSVQLEASPAFLAVPVEK.3|VSVQLEASPAFLAVPVEK.2|FSGQLNSHGC[CAM]FYQQVK.3|SFVHLEPM[Oxi]SHELPC[CAM]GHTQTVQAHYILNGGTLLGLK.6|SFVHLEPMSHELPC[CAM]GHTQTVQAHYILNGGTLLGLK.6|SFVHLEPMSHELPC[CAM]GHTQTVQAHYILNGGTLLGLK.5|SFVHLEPMSHELPC[CAM]GHTQTVQAHYILNGGTLLGLK.4|YDVENC[CAM]LANKVDLSFSPSQSLPASHAHLR.5|SPC[CAM]YGYQWVSEEHEEAHHTAYLVFSPSK.5|SPC[CAM]YGYQWVSEEHEEAHHTAYLVFSPSK.4|NALFC[CAM]LESAWK.2|TEHPFTVEEFVLPKFEVQVTVPK.4|LLLQQVSLPELPGEYSMK.3|LLLQQVSLPELPGEYSM[Oxi]K.3|LLLQQVSLPELPGEYSMK.2|AGAFC[CAM]LSEDAGLGISSTASLR.3|AGAFC[CAM]LSEDAGLGISSTASLR.2|KLSFYYLIMAK.2|MC[CAM]PQLQQYEMHGPEGLR.3|M[Oxi]C[CAM]PQLQQYEMHGPEGLR.3|MC[CAM]PQLQQYEM[Oxi]HGPEGLR.3|PQYMVLVPSLLHTETTEK.3|PQYM[Oxi]VLVPSLLHTETTEK.3|VVSMDENFHPLNELIPLVYIQDPK.4|VVSMDENFHPLNELIPLVYIQDPK.3|VVSM[Oxi]DENFHPLNELIPLVYIQDPK.3|YSDASDC[CAM]HGEDSQAFC[CAM]EK.3|HNVYINGITYTPVSSTNEK.3|HNVYINGITYTPVSSTNEK.2|DMYSFLEDMGLK.2|DM[Oxi]YSFLEDMGLK.2|DRSPC[CAM]YGYQWVSEEHEEAHHTAYLVFSPSK.5|VSNQTLSLFFTVLQDVPVR.3|AVDQSVLLM[Oxi]KPDAELSASSVYNLLPEK.4|AVDQSVLLMKPDAELSASSVYNLLPEK.4|AVDQSVLLM[Oxi]KPDAELSASSVYNLLPEK.3|AVDQSVLLMKPDAELSASSVYNLLPEK.3|AAQVTIQSSGTFSSK.2|NQGNTWLTAFVLK.2|EEFPFALGVQTLPQTC[CAM]DEPK.3|VTGEGC[CAM]VYLQTSLK.2|FRVVSMDENFHPLNELIPLVYIQDPK.4|FRVVSMDENFHPLNELIPLVYIQDPK.3|AYIFIDEAHITQALIWLSQR.3|AYIFIDEAHITQALIWLSQR.2|ETTFNSLLC[CAM]PSGGEVSEELSLK.3|ETTFNSLLC[CAM]PSGGEVSEELSLK.2|GC[CAM]VLLSYLNETVTVSASLESVR.3|VYDYYETDEFAIAEYNAPC[CAM]SK.3|ETTFNSLLC[CAM]PSGGEVSEELSLKLPPNVVEESAR.4|APVGHFYEPQAPSAEVEMTSYVLLAYLTAQPAPTSEDLTSATNIVK.5|YNILPEKEEFPFALGVQTLPQTC[CAM]DEPK.3
SEN / CTL,Prostaglandin-H2 D-isomerase,PTGDS,P41222,-1.94,0.06,2.74E-04,2.44E-04,3.61E+00,"prostaglandin biosynthetic process,transport,cyclooxygenase pathway,regulation of circadian sleep/wake cycle, sleep,response to glucocorticoid,negative regulation of male germ cell proliferation","prostaglandin-D synthase activity,transporter activity,retinoid binding,fatty acid binding,small molecule binding","extracellular region,extracellular space,endoplasmic reticulum membrane,rough endoplasmic reticulum,Golgi apparatus,nuclear membrane,perinuclear region of cytoplasm,extracellular exosome",3,2,4,TMLLQPAGSLGSYSYR.2|TM[Oxi]LLQPAGSLGSYSYR.2|AQGFTEDTIVFLPQTDK.3|AQGFTEDTIVFLPQTDK.2
SEN / CTL,Serum albumin,ALB,P02768,-2.04,1.07,1.53E-42,8.26E-41,4.01E+01,"retina homeostasis,platelet degranulation,transport,receptor-mediated endocytosis,cellular response to starvation,bile acid and bile salt transport,hemolysis by symbiont of host erythrocytes,lipoprotein metabolic process,negative regulation of apoptotic process,negative regulation of programmed cell death,sodium-independent organic anion transport,maintenance of mitochondrion location,cellular oxidant detoxification","DNA binding,fatty acid binding,copper ion binding,protein binding,drug binding,toxic substance binding,antioxidant activity,pyridoxal phosphate binding,identical protein binding,chaperone binding,oxygen binding","extracellular region,extracellular space,nucleus,endoplasmic reticulum,Golgi apparatus,platelet alpha granule lumen,myelin sheath,protein complex,extracellular exosome,blood microparticle",201,107,232,KVPQVSTPTLVEVSR.3|KVPQVSTPTLVEVSR.2|KVPQVSTPTLVEVSR.4|YLYEIAR.2|VPQVSTPTLVEVSR.2|VPQVSTPTLVEVSR.3|C[CAM]C[CAM]TESLVNR.2|LVNEVTEFAK.2|RHPYFYAPELLFFAK.3|RHPYFYAPELLFFAK.4|RHPYFYAPELLFFAK.2|RHPDYSVVLLLR.3|RHPDYSVVLLLR.2|LVAASQAALGL.2|QNC[CAM]ELFEQLGEYK.2|QNC[CAM]ELFEQLGEYK.3|QTALVELVK.2|VHTEC[CAM]C[CAM]HGDLLEC[CAM]ADDRADLAK.5|VHTEC[CAM]C[CAM]HGDLLEC[CAM]ADDRADLAK.4|VHTEC[CAM]C[CAM]HGDLLEC[CAM]ADDRADLAK.3|VHTEC[CAM]C[CAM]HGDLLEC[CAM]ADDRADLAK.6|ALVLIAFAQYLQQC[CAM]PFEDHVK.4|ALVLIAFAQYLQQC[CAM]PFEDHVK.3|VFDEFKPLVEEPQNLIK.3|VFDEFKPLVEEPQNLIK.2|VFDEFKPLVEEPQNLIK.4|AVMDDFAAFVEK.2|AVMDDFAAFVEK.3|AVM[Oxi]DDFAAFVEK.3|AVM[Oxi]DDFAAFVEK.2|AEFAEVSKLVTDLTK.3|AEFAEVSKLVTDLTK.2|QEPERNEC[CAM]FLQHKDDNPNLPR.4|QEPERNEC[CAM]FLQHKDDNPNLPR.3|RHPYFYAPELLFFAKR.4|RHPYFYAPELLFFAKR.3|RMPC[CAM]AEDYLSVVLNQLC[CAM]VLHEK.4|RMPC[CAM]AEDYLSVVLNQLC[CAM]VLHEK.3|RM[Oxi]PC[CAM]AEDYLSVVLNQLC[CAM]VLHEK.4|RM[Oxi]PC[CAM]AEDYLSVVLNQLC[CAM]VLHEK.5|RMPC[CAM]AEDYLSVVLNQLC[CAM]VLHEK.5|RM[Oxi]PC[CAM]AEDYLSVVLNQLC[CAM]VLHEK.3|SHC[CAM]IAEVENDEM[Oxi]PADLPSLAADFVESKDVC[CAM]K.4|SHC[CAM]IAEVENDEMPADLPSLAADFVESKDVC[CAM]K.4|SHC[CAM]IAEVENDEMPADLPSLAADFVESKDVC[CAM]K.5|SHC[CAM]IAEVENDEM[Oxi]PADLPSLAADFVESKDVC[CAM]K.5|SHC[CAM]IAEVENDEM[Oxi]PADLPSLAADFVESKDVC[CAM]K.3|SHC[CAM]IAEVENDEMPADLPSLAADFVESKDVC[CAM]K.3|ALVLIAFAQYLQQC[CAM]PFEDHVKLVNEVTEFAK.4|ALVLIAFAQYLQQC[CAM]PFEDHVKLVNEVTEFAK.5|SLHTLFGDKLC[CAM]TVATLR.4|SLHTLFGDKLC[CAM]TVATLR.3|SLHTLFGDKLC[CAM]TVATLR.2|EQLKAVMDDFAAFVEK.3|EQLKAVM[Oxi]DDFAAFVEK.3|EQLKAVM[Oxi]DDFAAFVEK.2|QNC[CAM]ELFEQLGEYKFQNALLVR.3|QNC[CAM]ELFEQLGEYKFQNALLVR.5|QNC[CAM]ELFEQLGEYKFQNALLVR.4|FKDLGEENFK.3|FKDLGEENFK.2|HPYFYAPELLFFAK.3|HPYFYAPELLFFAK.2|KLVAASQAALGL.2|AEFAEVSK.2|LVRPEVDVMC[CAM]TAFHDNEETFLKK.5|LVRPEVDVMC[CAM]TAFHDNEETFLKK.4|LVRPEVDVM[Oxi]C[CAM]TAFHDNEETFLKK.5|LVRPEVDVMC[CAM]TAFHDNEETFLKK.6|LVRPEVDVM[Oxi]C[CAM]TAFHDNEETFLKK.6|LVRPEVDVM[Oxi]C[CAM]TAFHDNEETFLKK.4|LVRPEVDVM[Oxi]C[CAM]TAFHDNEETFLKK.3|LVRPEVDVMC[CAM]TAFHDNEETFLKK.3|TC[CAM]VADESAENC[CAM]DKSLHTLFGDKLC[CAM]TVATLR.5|TC[CAM]VADESAENC[CAM]DKSLHTLFGDKLC[CAM]TVATLR.4|TC[CAM]VADESAENC[CAM]DKSLHTLFGDKLC[CAM]TVATLR.6|TC[CAM]VADESAENC[CAM]DKSLHTLFGDKLC[CAM]TVATLR.3|YKAAFTEC[CAM]C[CAM]QAADK.3|YKAAFTEC[CAM]C[CAM]QAADK.2|SHC[CAM]IAEVENDEMPADLPSLAADFVESK.3|SHC[CAM]IAEVENDEM[Oxi]PADLPSLAADFVESK.3|SHC[CAM]IAEVENDEMPADLPSLAADFVESK.4|SHC[CAM]IAEVENDEM[Oxi]PADLPSLAADFVESK.5|SHC[CAM]IAEVENDEMPADLPSLAADFVESK.5|SHC[CAM]IAEVENDEM[Oxi]PADLPSLAADFVESK.4|MPC[CAM]AEDYLSVVLNQLC[CAM]VLHEK.3|M[Oxi]PC[CAM]AEDYLSVVLNQLC[CAM]VLHEK.3|MPC[CAM]AEDYLSVVLNQLC[CAM]VLHEK.4|M[Oxi]PC[CAM]AEDYLSVVLNQLC[CAM]VLHEK.4|RPC[CAM]FSALEVDETYVPKEFNAETFTFHADIC[CAM]TLSEKER.6|RPC[CAM]FSALEVDETYVPKEFNAETFTFHADIC[CAM]TLSEKER.5|RPC[CAM]FSALEVDETYVPKEFNAETFTFHADIC[CAM]TLSEKER.7|RPC[CAM]FSALEVDETYVPKEFNAETFTFHADIC[CAM]TLSEKER.4|NYAEAKDVFLGMFLYEYAR.3|NYAEAKDVFLGMFLYEYAR.4|NYAEAKDVFLGM[Oxi]FLYEYAR.3|NYAEAKDVFLGM[Oxi]FLYEYAR.2|NYAEAKDVFLGMFLYEYAR.2|DVFLGMFLYEYAR.2|DVFLGMFLYEYAR.3|DVFLGM[Oxi]FLYEYAR.3|DVFLGM[Oxi]FLYEYAR.2|LVRPEVDVMC[CAM]TAFHDNEETFLK.4|LVRPEVDVMC[CAM]TAFHDNEETFLK.5|LVRPEVDVM[Oxi]C[CAM]TAFHDNEETFLK.4|LVRPEVDVM[Oxi]C[CAM]TAFHDNEETFLK.3|LVRPEVDVMC[CAM]TAFHDNEETFLK.3|VFDEFKPLVEEPQNLIKQNC[CAM]ELFEQLGEYKFQNALLVR.5|VFDEFKPLVEEPQNLIKQNC[CAM]ELFEQLGEYKFQNALLVR.7|VFDEFKPLVEEPQNLIKQNC[CAM]ELFEQLGEYKFQNALLVR.6|VFDEFKPLVEEPQNLIKQNC[CAM]ELFEQLGEYKFQNALLVR.4|RMPC[CAM]AEDYLSVVLNQLC[CAM]VLHEKTPVSDR.5|RM[Oxi]PC[CAM]AEDYLSVVLNQLC[CAM]VLHEKTPVSDR.5|RM[Oxi]PC[CAM]AEDYLSVVLNQLC[CAM]VLHEKTPVSDR.4|AAFTEC[CAM]C[CAM]QAADKAAC[CAM]LLPK.3|AAFTEC[CAM]C[CAM]QAADKAAC[CAM]LLPK.4|AAFTEC[CAM]C[CAM]QAADKAAC[CAM]LLPK.2|TC[CAM]VADESAENC[CAM]DKSLHTLFGDK.4|TC[CAM]VADESAENC[CAM]DKSLHTLFGDK.3|AAC[CAM]LLPKLDELRDEGK.4|AAC[CAM]LLPKLDELRDEGK.3|HPDYSVVLLLR.3|HPDYSVVLLLR.2|ETYGEMADC[CAM]C[CAM]AK.2|ETYGEM[Oxi]ADC[CAM]C[CAM]AK.3|ETYGEMADC[CAM]C[CAM]AK.3|ETYGEM[Oxi]ADC[CAM]C[CAM]AK.2|ADDKETC[CAM]FAEEGKK.4|ADDKETC[CAM]FAEEGKK.3|ADDKETC[CAM]FAEEGKK.2|ETC[CAM]FAEEGKK.3|ETC[CAM]FAEEGKK.2|FPKAEFAEVSK.3|EC[CAM]C[CAM]EKPLLEK.3|EC[CAM]C[CAM]EKPLLEK.2|LAKTYETTLEK.3|LSQRFPKAEFAEVSK.4|LSQRFPKAEFAEVSK.3|AAFTEC[CAM]C[CAM]QAADK.3|AAFTEC[CAM]C[CAM]QAADK.2|DDNPNLPR.2|LC[CAM]TVATLR.2|DLGEENFK.2|HPYFYAPELLFFAKR.4|HPYFYAPELLFFAKR.3|LKC[CAM]ASLQK.2|FQNALLVR.2|RPC[CAM]FSALEVDETYVPK.4|RPC[CAM]FSALEVDETYVPK.3|RPC[CAM]FSALEVDETYVPK.2|YIC[CAM]ENQDSISSK.3|YIC[CAM]ENQDSISSK.2|TYETTLEK.2|ADDKETC[CAM]FAEEGK.3|ADDKETC[CAM]FAEEGK.2|NEC[CAM]FLQHKDDNPNLPR.4|NEC[CAM]FLQHKDDNPNLPR.3|TC[CAM]VADESAENC[CAM]DK.3|TC[CAM]VADESAENC[CAM]DK.2|TPVSDRVTK.2|AFKAWAVAR.2|LDELRDEGKASSAK.3|LDELRDEGKASSAK.2|SLHTLFGDK.2|YTKKVPQVSTPTLVEVSR.4|YTKKVPQVSTPTLVEVSR.3|KVPQVSTPTLVEVSRNLGK.4|LKEC[CAM]C[CAM]EKPLLEK.3|LKEC[CAM]C[CAM]EKPLLEK.2|C[CAM]C[CAM]AAADPHEC[CAM]YAK.3|C[CAM]C[CAM]AAADPHEC[CAM]YAK.2|VHTEC[CAM]C[CAM]HGDLLEC[CAM]ADDR.4|VHTEC[CAM]C[CAM]HGDLLEC[CAM]ADDR.3|KYLYEIAR.2|ATKEQLKAVMDDFAAFVEK.4|ATKEQLKAVM[Oxi]DDFAAFVEK.4|ATKEQLKAVMDDFAAFVEK.3|ATKEQLKAVMDDFAAFVEK.2|ETC[CAM]FAEEGK.2|LDELRDEGK.2|NEC[CAM]FLQHK.2|LVTDLTKVHTEC[CAM]C[CAM]HGDLLEC[CAM]ADDRADLAK.6|LVTDLTKVHTEC[CAM]C[CAM]HGDLLEC[CAM]ADDRADLAK.4|KQTALVELVK.2|YIC[CAM]ENQDSISSKLK.3|DAHKSEVAHR.2|YIC[CAM]ENQDSISSKLKEC[CAM]C[CAM]EKPLLEK.5|YIC[CAM]ENQDSISSKLKEC[CAM]C[CAM]EKPLLEK.3|AVMDDFAAFVEKC[CAM]C[CAM]K.3|DVC[CAM]KNYAEAK.2|YKAAFTEC[CAM]C[CAM]QAADKAAC[CAM]LLPK.4|YKAAFTEC[CAM]C[CAM]QAADKAAC[CAM]LLPK.3|LVRPEVDVMC[CAM]TAFHDNEETFLKKYLYEIAR.6|LVRPEVDVM[Oxi]C[CAM]TAFHDNEETFLKKYLYEIAR.6|LVRPEVDVM[Oxi]C[CAM]TAFHDNEETFLKKYLYEIAR.5|LVRPEVDVMC[CAM]TAFHDNEETFLKKYLYEIAR.5|NYAEAKDVFLGMFLYEYARR.4|NYAEAKDVFLGMFLYEYARR.3|FKDLGEENFKALVLIAFAQYLQQC[CAM]PFEDHVK.6|FKDLGEENFKALVLIAFAQYLQQC[CAM]PFEDHVK.5|FKDLGEENFKALVLIAFAQYLQQC[CAM]PFEDHVK.4|TYETTLEKC[CAM]C[CAM]AAADPHEC[CAM]YAK.4|TYETTLEKC[CAM]C[CAM]AAADPHEC[CAM]YAK.3|EFNAETFTFHADIC[CAM]TLSEKER.4|EFNAETFTFHADIC[CAM]TLSEKER.3|PLVEEPQNLIK.2|HPDYSVVLLLRLAKTYETTLEK.4|VHTEC[CAM]C[CAM]HGDLLEC[CAM]ADDRADLAKYIC[CAM]ENQDSISSK.6|SLHTLFGDKLC[CAM]TVATLRETYGEM[Oxi]ADC[CAM]C[CAM]AK.5|DVC[CAM]KNYAEAKDVFLGMFLYEYAR.4|DVC[CAM]KNYAEAKDVFLGMFLYEYAR.3|ETYGEM[Oxi]ADC[CAM]C[CAM]AKQEPER.3|M[Oxi]PC[CAM]AEDYLSVVLNQLC[CAM]VLHEKTPVSDRVTK.5|MPC[CAM]AEDYLSVVLNQLC[CAM]VLHEKTPVSDRVTK.5|TPVSDRVTKC[CAM]C[CAM]TESLVNR.3|EFNAETFTFHADIC[CAM]TLSEK.3|EFNAETFTFHADIC[CAM]TLSEK.2|C[CAM]C[CAM]TESLVNRRPC[CAM]FSALEVDETYVPK.4|C[CAM]C[CAM]TESLVNRRPC[CAM]FSALEVDETYVPK.3|LC[CAM]TVATLRETYGEM[Oxi]ADC[CAM]C[CAM]AK.3|LC[CAM]TVATLRETYGEMADC[CAM]C[CAM]AK.3|M[Oxi]PC[CAM]AEDYLSVVLNQLC[CAM]VLHEKTPVSDR.4|MPC[CAM]AEDYLSVVLNQLC[CAM]VLHEKTPVSDR.4|MPC[CAM]AEDYLSVVLNQLC[CAM]VLHEKTPVSDR.3|RPC[CAM]FSALEVDETYVPKEFNAETFTFHADIC[CAM]TLSEK.5|RPC[CAM]FSALEVDETYVPKEFNAETFTFHADIC[CAM]TLSEK.4|SHC[CAM]IAEVENDEM[Oxi]PADLPSLAADFVESKDVC[CAM]KNYAEAK.5|DLGEENFKALVLIAFAQYLQQC[CAM]PFEDHVK.4|DLGEENFKALVLIAFAQYLQQC[CAM]PFEDHVK.3|PC[CAM]FSALEVDETYVPK.2|DLGEENFKALVLIAFAQYLQQC[CAM]PFEDHVKLVNEVTEFAK.5|VFDEFKPLVEEPQNLIKQNC[CAM]ELFEQLGEYK.4
SEN / CTL,Adipocyte enhancer-binding protein 1,AEBP1,Q8IUX7,-2.05,2.39,2.45E-02,1.12E-02,1.95E+00,"negative regulation of transcription from RNA polymerase II promoter,skeletal system development,transcription, DNA-templated,peptide metabolic process,muscle organ development,protein processing","RNA polymerase II regulatory region sequence-specific DNA binding,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,transcription factor activity, sequence-specific DNA binding,transcription corepressor activity,carboxypeptidase activity,metallocarboxypeptidase activity,serine-type carboxypeptidase activity,calmodulin binding,zinc ion binding","extracellular space,nucleus,cytoplasm,extracellular exosome,extracellular matrix",15,9,11,YLSPDATVSTEVR.2|YTAGIHGNEVLGR.3|YTAGIHGNEVLGR.2|VVNEEC[CAM]PTITR.2|FTGVITQGR.2|VTAHAEGYTPSAK.3|VTAHAEGYTPSAK.2|APAPAPEER.2|EALLTFMEQVHR.3|NPFVLGANLNGGER.2|KGEELEEEWTPTEK.2
SEN / CTL,Matrix metalloproteinase-9,MMP9,P14780,-2.07,0.79,1.41E-14,7.93E-14,1.31E+01,"skeletal system development,ossification,positive regulation of protein phosphorylation,proteolysis,embryo implantation,extracellular matrix disassembly,macrophage differentiation,collagen catabolic process,endodermal cell differentiation,negative regulation of apoptotic process,positive regulation of DNA binding,positive regulation of epidermal growth factor receptor signaling pathway,ephrin receptor signaling pathway,leukocyte migration,positive regulation of keratinocyte migration,positive regulation of release of cytochrome c from mitochondria,positive regulation of receptor binding,positive regulation of vascular smooth muscle cell proliferation,negative regulation of intrinsic apoptotic signaling pathway,negative regulation of cation channel activity,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway","endopeptidase activity,metalloendopeptidase activity,serine-type endopeptidase activity,protein binding,collagen binding,metallopeptidase activity,zinc ion binding","extracellular region,proteinaceous extracellular matrix,extracellular space,extracellular exosome",30,30,40,SLGPALLLLQK.2|AFALWSAVTPLTFTR.2|AFALWSAVTPLTFTR.3|GSRPQGPFLIADKWPALPR.4|QSTLVLFPGDLR.2|QVWVYTGASVLGPR.2|LGLGADVAQVTGALR.2|LGLGADVAQVTGALR.3|QLSLPETGELDSATLK.2|QLSLPETGELDSATLK.3|RLDKLGLGADVAQVTGALR.4|RLDKLGLGADVAQVTGALR.3|GSRPQGPFLIADK.3|AYFC[CAM]QDR.2|AVIDDAFAR.2|FGFC[CAM]PSER.2|LFGFC[CAM]PTR.2|FQTFEGDLK.2|LWC[CAM]ATTSNFDSDKK.3|SYSAC[CAM]TTDGR.2|EYSTC[CAM]TSEGR.2|QLAEEYLYR.2|FTEGPPLHKDDVNGIR.3|FTEGPPLHKDDVNGIR.2|WC[CAM]ATTANYDRDKLFGFC[CAM]PTR.4|WC[CAM]ATTANYDRDKLFGFC[CAM]PTR.3|WC[CAM]ATTANYDR.2|MFPGVPLDTHDVFQYR.3|MFPGVPLDTHDVFQYR.2|FGNADGAAC[CAM]HFPFIFEGR.3|FGNADGAAC[CAM]HFPFIFEGR.2|SDGLPWC[CAM]STTANYDTDDRFGFC[CAM]PSER.4|SDGLPWC[CAM]STTANYDTDDRFGFC[CAM]PSER.3|LWC[CAM]ATTSNFDSDK.2|DGLLAHAFPPGPGIQGDAHFDDDELWSLGK.4|ADSTVM[Oxi]GGNSAGELC[CAM]VFPFTFLGK.3|ADSTVMGGNSAGELC[CAM]VFPFTFLGK.3|SELNQVDQVGYVTYDILQC[CAM]PED.3|LYTQDGNADGKPC[CAM]QFPFIFQGQSYSAC[CAM]TTDGR.4|SDGLPWC[CAM]STTANYDTDDR.2
SEN / CTL,Sodium/potassium-transporting ATPase subunit gamma,FXYD2,P54710,-2.07,1.16,1.94E-02,9.14E-03,2.04E+00,"regulation of cell growth,transport,establishment or maintenance of transmembrane electrochemical gradient,ion transmembrane transport,sodium ion export from cell,regulation of cell proliferation,ATP hydrolysis coupled transmembrane transport,regulation of cardiac conduction,potassium ion import across plasma membrane,regulation of sodium ion transmembrane transporter activity","transporter activity,ion channel activity,sodium:potassium-exchanging ATPase activity,sodium channel regulator activity","plasma membrane,sodium:potassium-exchanging ATPase complex,basolateral plasma membrane,intracellular membrane-bounded organelle,extracellular exosome",6,2,3,GDVDPFYYDYETVR.2|TGLSMDGGGSPK.2|TGLSM[Oxi]DGGGSPK.2
SEN / CTL,SPARC,SPARC,P09486,-2.15,0.60,5.19E-23,7.78E-22,2.11E+01,"ossification,negative regulation of endothelial cell proliferation,platelet degranulation,receptor-mediated endocytosis,signal transduction,heart development,response to gravity,response to lead ion,positive regulation of endothelial cell migration,negative regulation of angiogenesis,regulation of cell morphogenesis,extracellular matrix organization,lung development,response to lipopolysaccharide,response to L-ascorbic acid,response to cytokine,wound healing,response to peptide hormone,response to ethanol,response to cadmium ion,inner ear development,response to glucocorticoid,response to cAMP,response to calcium ion,bone development,cellular response to growth factor stimulus","calcium ion binding,protein binding,collagen binding,extracellular matrix binding","extracellular region,basement membrane,extracellular space,cytoplasm,cell surface,nuclear matrix,platelet alpha granule,platelet alpha granule membrane,platelet alpha granule lumen,endocytic vesicle lumen,mitochondrion,plasma membrane",42,14,22,YIPPC[CAM]LDSELTEFPLR.3|YIPPC[CAM]LDSELTEFPLR.2|FFETC[CAM]DLDNDKYIALDEWAGC[CAM]FGIK.3|NVLVTLYERDEDNNLLTEK.3|LHLDYIGPC[CAM]K.3|LHLDYIGPC[CAM]K.2|RLEAGDHPVELLAR.3|NVLVTLYER.2|LEAGDHPVELLAR.3|LEAGDHPVELLAR.2|VC[CAM]ELDENNTPMC[CAM]VC[CAM]QDPTSC[CAM]PAPIGEFEK.3|VC[CAM]ELDENNTPMC[CAM]VC[CAM]QDPTSC[CAM]PAPIGEFEK.4|NYNMYIFPVHWQFGQLDQHPIDGYLSHTELAPLR.5|NYNMYIFPVHWQFGQLDQHPIDGYLSHTELAPLR.4|APLIPMEHC[CAM]TTR.3|APLIPM[Oxi]EHC[CAM]TTR.3|APLIPMEHC[CAM]TTR.2|TFDSSC[CAM]HFFATK.3|TFDSSC[CAM]HFFATK.2|DEDNNLLTEK.2|FFETC[CAM]DLDNDK.2|YIALDEWAGC[CAM]FGIK.2
SEN / CTL,Serotransferrin,TF,P02787,-2.26,1.19,1.14E-53,1.03E-51,5.10E+01,"retina homeostasis,platelet degranulation,cellular iron ion homeostasis,regulation of protein stability,transferrin transport,positive regulation of receptor-mediated endocytosis,iron ion homeostasis,cellular response to iron ion,ferrous iron import into cell","protein binding,ferrous iron binding,ferric iron binding,ferric iron transmembrane transporter activity,transferrin receptor binding","extracellular region,extracellular space,early endosome,late endosome,clathrin-coated pit,basal plasma membrane,cell surface,endosome membrane,cytoplasmic, membrane-bounded vesicle,apical plasma membrane,endocytic vesicle,extrinsic component of external side of plasma membrane,vesicle,secretory granule lumen,basal part of cell,perinuclear region of cytoplasm,recycling endosome,extracellular exosome,blood microparticle,HFE-transferrin receptor complex",240,86,160,SASDLTWDNLK.2|SVIPSDGPSVAC[CAM]VK.2|LKC[CAM]DEWSVNSVGKIEC[CAM]VSAETTEDC[CAM]IAK.4|YLGEEYVK.2|C[CAM]LVEKGDVAFVK.3|C[CAM]LVEKGDVAFVK.2|SETKDLLFRDDTVC[CAM]LAK.4|SETKDLLFRDDTVC[CAM]LAK.3|INHC[CAM]RFDEFFSEGC[CAM]APGSKK.4|INHC[CAM]RFDEFFSEGC[CAM]APGSKK.3|DLLFRDDTVC[CAM]LAK.3|DLLFRDDTVC[CAM]LAK.2|IEC[CAM]VSAETTEDC[CAM]IAK.2|IEC[CAM]VSAETTEDC[CAM]IAK.3|FDEFFSEGC[CAM]APGSK.2|FDEFFSEGC[CAM]APGSK.3|ASYLDC[CAM]IR.2|EGYYGYTGAFR.2|WC[CAM]ALSHHER.2|EGTC[CAM]PEAPTDEC[CAM]KPVKWC[CAM]ALSHHER.5|EGTC[CAM]PEAPTDEC[CAM]KPVKWC[CAM]ALSHHER.6|EGTC[CAM]PEAPTDEC[CAM]KPVKWC[CAM]ALSHHER.4|MYLGYEYVTAIR.2|MYLGYEYVTAIR.3|M[Oxi]YLGYEYVTAIR.2|M[Oxi]YLGYEYVTAIR.3|C[CAM]STSSLLEAC[CAM]TFR.2|C[CAM]STSSLLEAC[CAM]TFR.3|KPVDEYKDC[CAM]HLAQVPSHTVVAR.5|KPVDEYKDC[CAM]HLAQVPSHTVVAR.6|KPVDEYKDC[CAM]HLAQVPSHTVVAR.4|KPVDEYKDC[CAM]HLAQVPSHTVVAR.3|HSTIFENLANKADRDQYELLC[CAM]LDNTR.5|HSTIFENLANKADRDQYELLC[CAM]LDNTR.4|NLREGTC[CAM]PEAPTDEC[CAM]KPVKWC[CAM]ALSHHER.6|NLREGTC[CAM]PEAPTDEC[CAM]KPVKWC[CAM]ALSHHER.5|NLNEKDYELLC[CAM]LDGTRKPVEEYANC[CAM]HLAR.5|NLNEKDYELLC[CAM]LDGTRKPVEEYANC[CAM]HLAR.6|NLNEKDYELLC[CAM]LDGTRKPVEEYANC[CAM]HLAR.4|NLNEKDYELLC[CAM]LDGTR.3|NLNEKDYELLC[CAM]LDGTR.2|SKEFQLFSSPHGKDLLFK.4|DLLFKDSAHGFLK.3|DGAGDVAFVK.2|TAGWNIPMGLLYNK.2|TAGWNIPMGLLYNK.3|TAGWNIPM[Oxi]GLLYNK.2|TAGWNIPM[Oxi]GLLYNK.3|INHC[CAM]RFDEFFSEGC[CAM]APGSK.4|INHC[CAM]RFDEFFSEGC[CAM]APGSK.3|SAGWNIPIGLLYC[CAM]DLPEPR.3|SAGWNIPIGLLYC[CAM]DLPEPR.2|SAGWNIPIGLLYC[CAM]DLPEPR.4|SMGGKEDLIWELLNQAQEHFGKDK.4|SMGGKEDLIWELLNQAQEHFGKDK.5|SM[Oxi]GGKEDLIWELLNQAQEHFGKDK.5|SM[Oxi]GGKEDLIWELLNQAQEHFGKDK.4|DSGFQMNQLR.2|DSGFQM[Oxi]NQLR.2|SVIPSDGPSVAC[CAM]VKK.3|SVIPSDGPSVAC[CAM]VKK.2|FDEFFSEGC[CAM]APGSKK.3|FDEFFSEGC[CAM]APGSKK.2|C[CAM]LKDGAGDVAFVK.3|C[CAM]LKDGAGDVAFVK.2|NLREGTC[CAM]PEAPTDEC[CAM]KPVK.4|NLREGTC[CAM]PEAPTDEC[CAM]KPVK.3|EDPQTFYYAVAVVKK.3|EDPQTFYYAVAVVKK.2|EFQLFSSPHGKDLLFK.4|SM[Oxi]GGKEDLIWELLNQAQEHFGK.4|SMGGKEDLIWELLNQAQEHFGK.4|SMGGKEDLIWELLNQAQEHFGK.3|SM[Oxi]GGKEDLIWELLNQAQEHFGK.5|SMGGKEDLIWELLNQAQEHFGK.5|KC[CAM]STSSLLEAC[CAM]TFR.3|KC[CAM]STSSLLEAC[CAM]TFR.2|HQTVPQNTGGKNPDPWAK.4|HQTVPQNTGGKNPDPWAK.3|EGTC[CAM]PEAPTDEC[CAM]KPVK.3|EGTC[CAM]PEAPTDEC[CAM]KPVK.2|LC[CAM]MGSGLNLC[CAM]EPNNKEGYYGYTGAFR.3|LC[CAM]M[Oxi]GSGLNLC[CAM]EPNNKEGYYGYTGAFR.4|LC[CAM]M[Oxi]GSGLNLC[CAM]EPNNKEGYYGYTGAFR.3|LC[CAM]MGSGLNLC[CAM]EPNNK.2|LC[CAM]MGSGLNLC[CAM]EPNNK.3|LC[CAM]M[Oxi]GSGLNLC[CAM]EPNNK.3|LC[CAM]M[Oxi]GSGLNLC[CAM]EPNNK.2|NLNEKDYELLC[CAM]LDGTRK.3|DC[CAM]HLAQVPSHTVVAR.4|DC[CAM]HLAQVPSHTVVAR.3|AIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVVK.5|EDPQTFYYAVAVVK.2|EDPQTFYYAVAVVK.3|WC[CAM]AVSEHEATK.3|WC[CAM]AVSEHEATK.2|IMNGEADAMSLDGGFVYIAGK.3|IM[Oxi]NGEADAM[Oxi]SLDGGFVYIAGK.3|IMNGEADAM[Oxi]SLDGGFVYIAGK.2|IMNGEADAMSLDGGFVYIAGK.2|AVANFFSGSC[CAM]APC[CAM]ADGTDFPQLC[CAM]QLC[CAM]PGC[CAM]GC[CAM]STLNQYFGYSGAFK.5|AVANFFSGSC[CAM]APC[CAM]ADGTDFPQLC[CAM]QLC[CAM]PGC[CAM]GC[CAM]STLNQYFGYSGAFK.6|ADRDQYELLC[CAM]LDNTR.3|ADRDQYELLC[CAM]LDNTR.4|ADRDQYELLC[CAM]LDNTR.2|DYELLC[CAM]LDGTRKPVEEYANC[CAM]HLAR.5|DYELLC[CAM]LDGTRKPVEEYANC[CAM]HLAR.4|DYELLC[CAM]LDGTRKPVEEYANC[CAM]HLAR.3|KDSGFQMNQLR.3|KDSGFQM[Oxi]NQLR.3|KDSGFQMNQLR.2|KDSGFQM[Oxi]NQLR.2|NPDPWAK.2|EFQLFSSPHGK.3|EFQLFSSPHGK.2|HSTIFENLANK.3|HSTIFENLANK.2|DSAHGFLK.2|KPVDEYK.2|DYELLC[CAM]LDGTR.3|DYELLC[CAM]LDGTR.2|DDTVC[CAM]LAK.2|KSASDLTWDNLK.3|KSASDLTWDNLK.2|APNHAVVTR.2|ADRDQYELLC[CAM]LDNTRK.4|SKEFQLFSSPHGK.3|SKEFQLFSSPHGK.2|LKC[CAM]DEWSVNSVGK.3|LKC[CAM]DEWSVNSVGK.2|DQYELLC[CAM]LDNTR.3|DQYELLC[CAM]LDNTR.2|EDLIWELLNQAQEHFGK.4|EDLIWELLNQAQEHFGK.3|EDLIWELLNQAQEHFGK.2|SASDLTWDNLKGKK.3|KPVEEYANC[CAM]HLAR.3|KPVEEYANC[CAM]HLAR.2|GDVAFVKHQTVPQNTGGKNPDPWAK.5|HSTIFENLANKADR.3|ADRDQYELLC[CAM]LDNTRKPVDEYK.5|ADRDQYELLC[CAM]LDNTRKPVDEYK.4|APNHAVVTRK.2|PVVAEFYGSK.2|KASYLDC[CAM]IR.2|EDLIWELLNQAQEHFGKDK.4|HQTVPQNTGGK.2|LHDRNTYEK.2|C[CAM]LVEKGDVAFVKHQTVPQNTGGK.4|C[CAM]DEWSVNSVGK.2|LHDRNTYEKYLGEEYVK.3|LHDRNTYEKYLGEEYVK.2|SASDLTWDNLKGK.2|AIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSK.5|AIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSK.4|NTYEKYLGEEYVK.2|QQQHLFGSNVTDC[CAM]SGNFC[CAM]LFR.3|PVVAEFYGSKEDPQTFYYAVAVVK.3|AIAANEADAVTLDAGLVYDAYLAPNNLK.3|C[CAM]DEWSVNSVGKIEC[CAM]VSAETTEDC[CAM]IAK.3
SEN / CTL,Lactotransferrin,LTF,P02788,-2.50,1.10,2.37E-03,1.59E-03,2.80E+00,"ossification,regulation of cytokine production,retina homeostasis,innate immune response in mucosa,transcription, DNA-templated,proteolysis,ion transport,humoral immune response,antibacterial humoral response,antifungal humoral response,negative regulation of lipopolysaccharide-mediated signaling pathway,regulation of tumor necrosis factor production,negative regulation of ATPase activity,iron assimilation by chelation and transport,positive regulation of osteoblast proliferation,positive regulation of toll-like receptor 4 signaling pathway,negative regulation of apoptotic process,positive regulation of I-kappaB kinase/NF-kappaB signaling,cellular protein metabolic process,negative regulation by host of viral process,negative regulation of viral genome replication,cell redox homeostasis,positive regulation of osteoblast differentiation,negative regulation of viral process,positive regulation of NF-kappaB transcription factor activity,bone morphogenesis,positive regulation of protein serine/threonine kinase activity,positive regulation of bone mineralization involved in bone maturation,negative regulation of single-species biofilm formation in or on host organism,positive regulation of chondrocyte proliferation,negative regulation of tumor necrosis factor (ligand) superfamily member 11 production,negative regulation of osteoclast development","DNA binding,serine-type endopeptidase activity,iron ion binding,protein binding,heparin binding,protein serine/threonine kinase activator activity","extracellular region,extracellular space,nucleus,cytoplasm,cell surface,secretory granule,specific granule,protein complex,extracellular exosome,phagocytic vesicle lumen",9,76,117,C[CAM]GLVPVLAENYK.2|YYGYTGAFR.2|C[CAM]LAENAGDVAFVKDVTVLQNTDGNNNEAWAK.4|C[CAM]LAENAGDVAFVKDVTVLQNTDGNNNEAWAK.3|KPVDKFKDC[CAM]HLAR.4|SC[CAM]HLAMAPNHAVVSR.4|SC[CAM]HLAM[Oxi]APNHAVVSR.4|SC[CAM]HLAMAPNHAVVSR.3|SC[CAM]HLAM[Oxi]APNHAVVSR.3|SC[CAM]HLAM[Oxi]APNHAVVSR.2|YLGPQYVAGITNLKK.4|YLGPQYVAGITNLKK.3|DSAIGFSR.2|VRGPPVSC[CAM]IKR.3|VRGPPVSC[CAM]IKR.2|LKQVLLHQQAK.3|LKQVLLHQQAK.2|SEEEVAAR.2|C[CAM]LAENAGDVAFVK.3|C[CAM]LAENAGDVAFVK.2|LRPVAAEVYGTERQPR.4|LRPVAAEVYGTERQPR.3|RSDTSLTWNSVK.3|RSDTSLTWNSVK.2|VPSHAVVAR.2|LC[CAM]AGTGENK.2|SC[CAM]HTAVDR.2|C[CAM]LRDGAGDVAFIR.3|DLLFKDSAIGFSR.3|DLLFKDSAIGFSR.2|KC[CAM]STSPLLEAC[CAM]EFLRK.4|KC[CAM]STSPLLEAC[CAM]EFLRK.3|LRPVAAEVYGTER.3|LRPVAAEVYGTER.2|LADFALLC[CAM]LDGKR.3|GPPVSC[CAM]IKR.2|KGGSFQLNELQGLK.3|KGGSFQLNELQGLK.2|KSEEEVAAR.2|DGAGDVAFIR.2|YLGPQYVAGITNLK.3|YLGPQYVAGITNLK.2|FKDC[CAM]HLAR.2|IDSGLYLGSGYFTAIQNLR.4|IDSGLYLGSGYFTAIQNLR.3|IDSGLYLGSGYFTAIQNLR.2|NLLFNDNTEC[CAM]LAR.3|NLLFNDNTEC[CAM]LAR.2|VVWC[CAM]AVGEQELRK.3|VVWC[CAM]AVGEQELRK.2|DSPIQC[CAM]IQAIAENR.3|DSPIQC[CAM]IQAIAENR.2|KSC[CAM]HTAVDR.2|QVLLHQQAK.2|SVNGKEDAIWNLLR.3|SVNGKEDAIWNLLR.2|IDSGLYLGSGYFTAIQNLRK.4|IDSGLYLGSGYFTAIQNLRK.3|IDSGLYLGSGYFTAIQNLRK.2|VRGPPVSC[CAM]IK.2|EDAIWNLLR.2|FC[CAM]LFQSETK.2|THYYAVAVVK.2|KSEEEVAARR.2|RSVQWC[CAM]AVSQPEATK.3|RSVQWC[CAM]AVSQPEATK.2|RDSPIQC[CAM]IQAIAENR.3|FQLFGSPSGQK.2|C[CAM]STSPLLEAC[CAM]EFLRK.3|FQLFGSPSGQKDLLFK.3|FQLFGSPSGQKDLLFK.2|GEADAMSLDGGYVYTAGK.3|GEADAM[Oxi]SLDGGYVYTAGK.2|GEADAMSLDGGYVYTAGK.2|KC[CAM]STSPLLEAC[CAM]EFLR.3|KC[CAM]STSPLLEAC[CAM]EFLR.2|FDEYFSQSC[CAM]APGSDPR.3|FDEYFSQSC[CAM]APGSDPR.2|SDTSLTWNSVK.2|THYYAVAVVKK.2|VPPRIDSGLYLGSGYFTAIQNLR.4|VPPRIDSGLYLGSGYFTAIQNLR.3|FFSASC[CAM]VPGADK.2|DVTVLQNTDGNNNEAWAK.3|DVTVLQNTDGNNNEAWAK.2|FQLFGSPSGQKDLLFKDSAIGFSR.4|FQLFGSPSGQKDLLFKDSAIGFSR.3|LADFALLC[CAM]LDGK.2|VPPRIDSGLYLGSGYFTAIQNLRK.4|NGSDC[CAM]PDKFC[CAM]LFQSETK.3|NGSDC[CAM]PDKFC[CAM]LFQSETK.2|ADAVTLDGGFIYEAGLAPYK.3|ADAVTLDGGFIYEAGLAPYK.2|GGSFQLNELQGLK.2|SNLC[CAM]ALC[CAM]IGDEQGENKC[CAM]VPNSNER.4|SNLC[CAM]ALC[CAM]IGDEQGENKC[CAM]VPNSNER.3|SQQSSDPDPNC[CAM]VDRPVEGYLAVAVVR.4|SQQSSDPDPNC[CAM]VDRPVEGYLAVAVVR.3|VVWC[CAM]AVGEQELR.2|ESTVFEDLSDEAERDEYELLC[CAM]PDNTRKPVDK.5|ESTVFEDLSDEAERDEYELLC[CAM]PDNTRKPVDK.4|FFSASC[CAM]VPGADKGQFPNLC[CAM]R.3|ESTVFEDLSDEAERDEYELLC[CAM]PDNTR.4|ESTVFEDLSDEAERDEYELLC[CAM]PDNTR.3|SVQWC[CAM]AVSQPEATK.2|TAGWNVPIGTLRPFLNWTGPPEPIEAAVAR.4|TAGWNVPIGTLRPFLNWTGPPEPIEAAVAR.3|KC[CAM]NQWSGLSEGSVTC[CAM]SSASTTEDC[CAM]IALVLK.4|KC[CAM]NQWSGLSEGSVTC[CAM]SSASTTEDC[CAM]IALVLK.3|C[CAM]STSPLLEAC[CAM]EFLR.2|RTAGWNVPIGTLRPFLNWTGPPEPIEAAVAR.4|DSPIQC[CAM]IQAIAENRADAVTLDGGFIYEAGLAPYK.4|SNLC[CAM]ALC[CAM]IGDEQGENK.2|LC[CAM]AGTGENKC[CAM]AFSSQEPYFSYSGAFK.3|C[CAM]AFSSQEPYFSYSGAFK.2|KC[CAM]NQWSGLSEGSVTC[CAM]SSASTTEDC[CAM]IALVLKGEADAMSLDGGYVYTAGK.5|C[CAM]NQWSGLSEGSVTC[CAM]SSASTTEDC[CAM]IALVLK.3
SEN / CTL,Tyrosine-protein kinase receptor UFO,AXL,P30530,-2.52,0.43,1.35E-02,6.79E-03,2.17E+00,"neuron migration,natural killer cell differentiation,positive regulation of cytokine-mediated signaling pathway,blood vessel remodeling,phagocytosis,inflammatory response,signal transduction,spermatogenesis,peptidyl-tyrosine phosphorylation,forebrain cell migration,platelet activation,animal organ regeneration,cellular response to extracellular stimulus,negative regulation of interferon-gamma production,negative regulation of tumor necrosis factor production,positive regulation of natural killer cell differentiation,secretion by cell,erythrocyte homeostasis,substrate adhesion-dependent cell spreading,cellular response to interferon-alpha,ovulation cycle,apoptotic cell clearance,protein kinase B signaling,negative regulation of neuron apoptotic process,innate immune response,viral entry into host cell,vascular endothelial growth factor receptor signaling pathway,cell maturation,positive regulation of pinocytosis,negative regulation of lymphocyte activation,positive regulation of protein kinase B signaling,vagina development,cellular response to hydrogen peroxide,cellular response to lipopolysaccharide,dendritic cell differentiation,negative regulation of dendritic cell apoptotic process","virus receptor activity,phosphatidylserine binding,protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase activity,protein binding,ATP binding,myosin heavy chain binding,phosphatidylinositol 3-kinase binding,protein heterodimerization activity","extracellular space,intracellular,plasma membrane,integral component of plasma membrane,cell surface,host cell surface,extracellular exosome",3,9,10,APLQGTLLGYR.2|HGDLHSFLLYSR.3|HGDLHSFLLYSR.2|YGEVFEPTVER.2|RTTEATLNSLGISEELKEK.3|ESFPAPVVILPFMK.2|SELEDFLSEAVC[CAM]MK.2|LGDQPVYLPTQMLVK.2|RTTEATLNSLGISEELK.2|GQTPYPGVENSEIYDYLR.2
SEN / CTL,Retinoic acid receptor responder protein 2,RARRES2,Q99969,-2.67,0.44,7.63E-08,1.56E-07,6.81E+00,"retinoid metabolic process,in utero embryonic development,positive regulation of protein phosphorylation,platelet degranulation,chemotaxis,inflammatory response,positive regulation of macrophage chemotaxis,positive regulation of fat cell differentiation,embryonic digestive tract development,brown fat cell differentiation,positive regulation of chemotaxis,regulation of lipid catabolic process,positive regulation of glucose import in response to insulin stimulus","receptor binding,protein binding","extracellular region,extracellular matrix,platelet dense granule lumen,extracellular exosome",9,4,5,GLQVALEEFHK.3|LVHC[CAM]PIETQVLR.3|LVHC[CAM]PIETQVLR.2|EAEEHQETQC[CAM]LR.3|HPPVQWAFQETSVESAVDTPFPAGIFVR.3
SEN / CTL,Pregnancy zone protein,PZP,P20742,-2.69,0.99,7.50E-02,2.81E-02,1.55E+00,"female pregnancy,negative regulation of endopeptidase activity","endopeptidase inhibitor activity,serine-type endopeptidase inhibitor activity","extracellular region,extracellular exosome,blood microparticle",3,23,26,DLFHC[CAM]VSFTLPR.3|DLFHC[CAM]VSFTLPR.2|SGTHTLPVESGDMK.3|TLLVEAEGIEQEK.3|TLLVEAEGIEQEK.2|VVVQTESGGR.2|IREEGTDLEVTANR.3|ISEITNIVSK.2|IQHPFTVEEFVLPK.3|SLFTDLVAEK.2|YNILPEKEDSPFALK.3|ASPAFLASQNTK.2|AVGYLITGYQR.2|GSFALSFPVESDVAPIAR.3|GSFALSFPVESDVAPIAR.2|HQDGSYSTFGER.2|MLQITNTGFEMK.2|VFSLSGSYIHLEPVAGTLPC[CAM]GHTETITAHYTLNR.5|LEAGINQLSFPLSSEPIQGSYR.3|NELIPLIYLENPR.2|QQNAQGGFSSTQDTVVALHALSR.3|NALFC[CAM]LESAWNVAK.2|QGIPFFAQVLLVDGK.2|VDLSFSPAQSPPASHAHLQVAAAPQSLC[CAM]ALR.4|DLTNFPDNVDQQEEEQGHC[CAM]PR.3|PYVPQLGTYNVIPLNNEQSSGPVPETVR.3
SEN / CTL,Alpha-1-antitrypsin,SERPINA1,P01009,-2.93,1.40,1.82E-30,4.90E-29,2.83E+01,"platelet degranulation,ER to Golgi vesicle-mediated transport,acute-phase response,blood coagulation,negative regulation of endopeptidase activity,COPII vesicle coating","glycoprotein binding,protease binding,serine-type endopeptidase inhibitor activity,protein binding,identical protein binding","Golgi membrane,extracellular region,proteinaceous extracellular matrix,extracellular space,endoplasmic reticulum,endoplasmic reticulum lumen,Golgi apparatus,ER to Golgi transport vesicle,platelet alpha granule lumen,endoplasmic reticulum-Golgi intermediate compartment membrane,extracellular exosome",105,44,85,LSITGTYDLK.2|ITPNLAEFAFSLYR.2|ITPNLAEFAFSLYR.3|SVLGQLGITK.2|KLSSWVLLMK.2|KLSSWVLLMK.3|AVLTIDEK.2|LVDKFLEDVK.3|VFSNGADLSGVTEEAPLKLSK.3|VFSNGADLSGVTEEAPLKLSK.2|VFSNGADLSGVTEEAPLKLSK.4|LVDKFLEDVKK.3|LVDKFLEDVKK.2|VFSNGADLSGVTEEAPLK.2|VFSNGADLSGVTEEAPLK.3|ELDRDTVFALVNYIFFK.3|ELDRDTVFALVNYIFFK.2|ELDRDTVFALVNYIFFK.4|LYHSEAFTVNFGDTEEAKK.3|LYHSEAFTVNFGDTEEAKK.4|LYHSEAFTVNFGDTEEAKK.2|FLEDVKK.2|LSSWVLLMK.2|LSSWVLLM[Oxi]K.2|GKWERPFEVKDTEEEDFHVDQVTTVK.4|GKWERPFEVKDTEEEDFHVDQVTTVK.5|GKWERPFEVKDTEEEDFHVDQVTTVK.6|GKWERPFEVKDTEEEDFHVDQVTTVK.3|LQHLENELTHDIITK.3|LQHLENELTHDIITK.4|LQHLENELTHDIITK.2|LGMFNIQHC[CAM]K.3|LGM[Oxi]FNIQHC[CAM]K.3|KLYHSEAFTVNFGDTEEAKK.4|KLYHSEAFTVNFGDTEEAKK.3|QINDYVEKGTQGK.3|QINDYVEKGTQGK.2|RLGMFNIQHC[CAM]K.3|QINDYVEK.2|GTEAAGAMFLEAIPMSIPPEVK.3|GTEAAGAMFLEAIPMSIPPEVK.4|GTEAAGAM[Oxi]FLEAIPM[Oxi]SIPPEVK.3|GTEAAGAM[Oxi]FLEAIPMSIPPEVK.3|GTEAAGAMFLEAIPM[Oxi]SIPPEVK.3|GTEAAGAMFLEAIPMSIPPEVK.2|TLNQPDSQLQLTTGNGLFLSEGLK.3|TLNQPDSQLQLTTGNGLFLSEGLK.4|TDTSHHDQDHPTFNKITPNLAEFAFSLYR.5|TDTSHHDQDHPTFNKITPNLAEFAFSLYR.6|TDTSHHDQDHPTFNKITPNLAEFAFSLYR.4|TDTSHHDQDHPTFNKITPNLAEFAFSLYR.3|KQINDYVEKGTQGK.4|KQINDYVEKGTQGK.3|KQINDYVEKGTQGK.2|SASLHLPK.2|AVHKAVLTIDEK.3|AVHKAVLTIDEK.2|TDTSHHDQDHPTFNK.4|TDTSHHDQDHPTFNK.3|FLENEDR.2|FLENEDRR.2|KLYHSEAFTVNFGDTEEAK.4|KLYHSEAFTVNFGDTEEAK.3|KQINDYVEK.2|SASLHLPKLSITGTYDLKSVLGQLGITK.5|SASLHLPKLSITGTYDLKSVLGQLGITK.4|FNKPFVFLMIEQNTK.3|FNKPFVFLM[Oxi]IEQNTK.3|FNKPFVFLM[Oxi]IEQNTK.2|FNKPFVFLMIEQNTK.2|PFEVKDTEEEDFHVDQVTTVK.4|DTEEEDFHVDQVTTVK.3|DTEEEDFHVDQVTTVK.2|FNKPFVFLMIEQNTKSPLFM[Oxi]GK.4|FNKPFVFLMIEQNTKSPLFMGK.4|LYHSEAFTVNFGDTEEAK.3|LYHSEAFTVNFGDTEEAK.2|LSITGTYDLKSVLGQLGITK.3|PFVFLMIEQNTK.2|PFVFLM[Oxi]IEQNTK.2|WERPFEVKDTEEEDFHVDQVTTVK.4|DTVFALVNYIFFK.2|SVLGQLGITKVFSNGADLSGVTEEAPLKLSK.4|LYHSEAFTVNFGDTEEAKKQINDYVEK.4|ADTHDEILEGLNFNLTEIPEAQIHEGFQELLR.4
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,